Citrus Sinensis ID: 001171
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1133 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGS2 | 1136 | Probable LRR receptor-lik | no | no | 0.992 | 0.989 | 0.635 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.941 | 0.909 | 0.326 | 1e-150 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.930 | 0.884 | 0.323 | 1e-146 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.893 | 0.810 | 0.330 | 1e-145 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.869 | 0.786 | 0.332 | 1e-142 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.905 | 0.931 | 0.317 | 1e-141 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.882 | 0.901 | 0.313 | 1e-139 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.879 | 0.904 | 0.329 | 1e-138 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.880 | 0.888 | 0.312 | 1e-128 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.875 | 0.874 | 0.320 | 1e-128 |
| >sp|C0LGS2|Y4361_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g36180 OS=Arabidopsis thaliana GN=At4g36180 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1384 bits (3581), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 726/1143 (63%), Positives = 898/1143 (78%), Gaps = 19/1143 (1%)
Query: 1 MAATSTATAIFLFVTLTHFAYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAP 60
MA + IFL + +Y +++ +EI ALT+FKL+L DPLGAL WD STP+AP
Sbjct: 1 MAMDISLFFIFLVIYAPLVSYADESQ---AEIDALTAFKLNLHDPLGALTSWDPSTPAAP 57
Query: 61 CDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSL 120
CDWRG+ C N+RV E+RLPRLQL+GR++D+++ L LRKLSL SN NG+IP SL C+
Sbjct: 58 CDWRGVGCTNHRVTEIRLPRLQLSGRISDRISGLRMLRKLSLRSNSFNGTIPTSLAYCTR 117
Query: 121 LRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGE 180
L +V+LQYNS SG LP ++ NLT+L V NVA N LSG+I + SL++LD+SSN F+G+
Sbjct: 118 LLSVFLQYNSLSGKLPPAMRNLTSLEVFNVAGNRLSGEIPVGLPSSLQFLDISSNTFSGQ 177
Query: 181 IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
IP ++ +QLQL+NLSYN +GE+PAS+G LQ L+YLWLD N L GTLPSAISNCSSLV
Sbjct: 178 IPSGLANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLV 237
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
HLSA +N + G+IP G + L+VLSLS N +G VP S+ CN +SL IVQLGFN
Sbjct: 238 HLSASENEIGGVIPAAYGALPKLEVLSLSNNNFSGTVPFSLFCN-----TSLTIVQLGFN 292
Query: 301 AFTGVVKPPN-GRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV 359
AF+ +V+P C + L+VLDLQ NRI FP WLTN+ SL+ +D+SGN FSG +P +
Sbjct: 293 AFSDIVRPETTANCRTGLQVLDLQENRISGRFPLWLTNILSLKNLDVSGNLFSGEIPPDI 352
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419
G+L +LE L++ANNSL+G +P EI +C L + D EGN GQ+P FLG ++ LK++SLG
Sbjct: 353 GNLKRLEELKLANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLG 412
Query: 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV 479
RN FSG +P S NL QLE LNL EN++ G+ P E+ L++L+ L+LS N+F G VP +
Sbjct: 413 RNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSI 472
Query: 480 GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
NL L LNLS +GFSG+IP S+G+L +LT LDLS QN+SGE+P+EL GLP++QV++L+
Sbjct: 473 SNLSNLSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQ 532
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
NN SG VPEGFSSLV L+Y+NLS N+F+G+IP T+GFLR LV LSLS N ISG IP E+
Sbjct: 533 GNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPEI 592
Query: 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLD 659
G CSALEVLELRSN G+IP D+S L R+K LDLGQN LSGEIP EIS+ SSL SL+LD
Sbjct: 593 GNCSALEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSLNSLSLD 652
Query: 660 MNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISS-LRYLNLSRNNLEGEIPKM 718
N LSG IP SFS LSNLT ++LS N L+G IPA LALISS L Y N+S NNL+GEIP
Sbjct: 653 HNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLKGEIPAS 712
Query: 719 LSSRFNDPSIFAMNRELCGKPLDRECANVR---KRKRKRLIILICVSAAGACLLALCCCG 775
L SR N+ S F+ N ELCGKPL+R C + K+K++++I++I ++A GA LL+L CC
Sbjct: 713 LGSRINNTSEFSGNTELCGKPLNRRCESSTAEGKKKKRKMILMIVMAAIGAFLLSLFCCF 772
Query: 776 YIYSLLRWRQTLRAWA-TGEKKPSPSRGSSG----AERGRGSGENGGPKLVMFNNKITYV 830
Y+Y+LL+WR+ L+ + TGEKK SP R S+G + R S ENG PKLVMFNNKIT
Sbjct: 773 YVYTLLKWRKKLKQQSTTGEKKRSPGRTSAGSRVRSSTSRSSTENGEPKLVMFNNKITLA 832
Query: 831 ETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGT-IDENTFRKEAEALGKV 889
ET+EATRQFDEENVLSR RYGL+FKA+Y DGMVLSIRRL +G+ ++EN F+KEAE LGKV
Sbjct: 833 ETIEATRQFDEENVLSRTRYGLLFKANYNDGMVLSIRRLPNGSLLNENLFKKEAEVLGKV 892
Query: 890 KHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
KHRN+TVLRGYYAGPPD+RLLVYDYMPNGNL+TLLQEASHQDGHVLNWPMRHLI+LG+AR
Sbjct: 893 KHRNITVLRGYYAGPPDLRLLVYDYMPNGNLSTLLQEASHQDGHVLNWPMRHLIALGIAR 952
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL FLH +MVHGDIKPQNVLFDADFEAH+S+FGLDRL I +P+ ++ + IG+LGYVS
Sbjct: 953 GLGFLHQSNMVHGDIKPQNVLFDADFEAHISDFGLDRLTIRSPSRSAVTANTIGTLGYVS 1012
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
PEA +G+ T+E+D+YSFGIVLLEILTG++PVMFTQDEDIVKWVKKQLQRGQ++ELLEPG
Sbjct: 1013 PEATLSGEITRESDIYSFGIVLLEILTGKRPVMFTQDEDIVKWVKKQLQRGQVTELLEPG 1072
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSL 1129
LLELDPESSEWEEFLLG+KVGLLCTA DPLDRP+M+D+VFMLEGCRVGPD+PSSADPTS
Sbjct: 1073 LLELDPESSEWEEFLLGIKVGLLCTATDPLDRPTMSDVVFMLEGCRVGPDVPSSADPTSQ 1132
Query: 1130 PSP 1132
PSP
Sbjct: 1133 PSP 1135
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 532 bits (1371), Expect = e-150, Method: Compositional matrix adjust.
Identities = 390/1194 (32%), Positives = 607/1194 (50%), Gaps = 127/1194 (10%)
Query: 8 TAIFLFVTLTHFAYGEQNA--VVLSEIQALTSFKLHL-KDPLGALDGWDSSTPSAPCDWR 64
+ FL +TLT F +G A EI+AL SFK + DPLG L W C+W
Sbjct: 5 SKTFLILTLTFFFFGIALAKQSFEPEIEALKSFKNGISNDPLGVLSDWTIIGSLRHCNWT 64
Query: 65 GIVCYNN-RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRA 123
GI C + V + L QL G L+ +A+L L+ L L SN G IPA + + + L
Sbjct: 65 GITCDSTGHVVSVSLLEKQLEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQ 124
Query: 124 VYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI--SPSLRYLDLSSNAFTGEI 181
+ L N FSG +P I+ L N+ L++ +NLLSG + +I + SL + N TG+I
Sbjct: 125 LILYLNYFSGSIPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKI 184
Query: 182 PGNFSSKSQLQL------------------------INLSYNSFSGEVPASVGQLQELEY 217
P LQ+ ++LS N +G++P G L L+
Sbjct: 185 PECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQS 244
Query: 218 LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLV 277
L L N L G +P+ I NCSSLV L DN L G IP +G + LQ L + +N+LT +
Sbjct: 245 LVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSI 304
Query: 278 PVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTN 337
P S+ ++ L + L N G + G S LEVL L +N FP +TN
Sbjct: 305 PSSLF-----RLTQLTHLGLSENHLVGPISEEIGFLES-LEVLTLHSNNFTGEFPQSITN 358
Query: 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
+ +L V+ + N SG LPA +G L L L +N L+G +P I+ C+ L++ DL N
Sbjct: 359 LRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHN 418
Query: 398 RFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITR 457
+ +G++P G + L +S+GRN F+G IP N S LETL++++N++ G + I +
Sbjct: 419 QMTGEIPRGFGRMN-LTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGK 477
Query: 458 LSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQ 517
L L L +SYN G +P ++GNLK L +L L ++GF+G+IP + +L L L + +
Sbjct: 478 LQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSN 537
Query: 518 NLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF 577
+L G +P E+F + L V+ L N SG +P FS L L YL+L N F G IPA+
Sbjct: 538 DLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKS 597
Query: 578 LRSL--------------------------VFLSLSHNQISGMIPAELGACSALEVLELR 611
L L ++L+ S+N ++G IP ELG ++ ++L
Sbjct: 598 LSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLS 657
Query: 612 SNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISK-CSSLVSLTLDMNSLSGRIPES 670
+N F+G+IP + + LD QN LSG IP E+ + ++SL L NS SG IP+S
Sbjct: 658 NNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQS 717
Query: 671 FSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFA 730
F +++L +L+LS+N L+G IP LA +S+L++L L+ NNL+G +P+ + + S
Sbjct: 718 FGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLM 777
Query: 731 MNRELCG--KPLDRECANVRK----RKRKRLIILICVS-----AAGACLLALCCCGYIYS 779
N +LCG KPL + C +K KR R+I++I S +L L CC
Sbjct: 778 GNTDLCGSKKPL-KPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEK 836
Query: 780 LLRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQF 839
+ + P S+ KL F K E +AT F
Sbjct: 837 KIE---------NSSESSLPDLDSA-------------LKLKRFEPK----ELEQATDSF 870
Query: 840 DEENVLSRGRYGLIFKASYQDGMVLSIR--RLRDGTIDENT-FRKEAEALGKVKHRNLTV 896
+ N++ ++K +DG V++++ L++ + + + F EA+ L ++KHRNL
Sbjct: 871 NSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVK 930
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
+ G+ + LV +M NGNL + ++ G +L + + + +A G+ +LHS
Sbjct: 931 ILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLE---KIDLCVHIASGIDYLHS 987
Query: 957 ---LDMVHGDIKPQNVLFDADFEAHLSEFGLDR-LAIATPAEASSSTTPI-GSLGYVSPE 1011
+VH D+KP N+L D+D AH+S+FG R L ++ST+ G++GY++PE
Sbjct: 988 GYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPE 1047
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKPVMF----TQDEDIVKWVKKQL---QRGQISE 1064
A + T +ADV+SFGI+++E++T ++P +QD + + V+K + ++G +
Sbjct: 1048 FAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRV 1107
Query: 1065 L---LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
L L ++ L E + E+FL K+ L CT+ P DRP M +I+ L R
Sbjct: 1108 LDMELGDSIVSLKQEEA-IEDFL---KLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1341), Expect = e-146, Method: Compositional matrix adjust.
Identities = 387/1195 (32%), Positives = 593/1195 (49%), Gaps = 141/1195 (11%)
Query: 30 SEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLTD 89
SE +L SFK L++P L W+ S+ ++ CDW G+ C RV L LP L L G++
Sbjct: 25 SETTSLISFKRSLENP-SLLSSWNVSSSASHCDWVGVTCLLGRVNSLSLPSLSLRGQIPK 83
Query: 90 QLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLN 149
+++ L LR+L L N +G IP + L+ + L NS +G LP + L LL L+
Sbjct: 84 EISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQLLYLD 143
Query: 150 VAHNLLSGKI--SADIS-PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
++ N SG + S IS P+L LD+S+N+ +GEIP S L + + NSFSG++P
Sbjct: 144 LSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQIP 203
Query: 207 ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVL 266
+ +G + L+ S G LP IS L L N LK IP + G + L +L
Sbjct: 204 SEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSIL 263
Query: 267 SLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK------------------- 307
+L EL GL+P + GN SL+ + L FN+ +G +
Sbjct: 264 NLVSAELIGLIPPEL-----GNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQLS 318
Query: 308 ---PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVT------------------------S 340
P VL+ L L NNR P + + S
Sbjct: 319 GSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGS 378
Query: 341 LRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFS 400
L +DLSGN SG + L L + NN ++G +P+++ K L+ + DL+ N F+
Sbjct: 379 LEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMAL-DLDSNNFT 437
Query: 401 GQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSN 460
G++P L L + N G +P GN + L+ L LS+N + G IP EI +L++
Sbjct: 438 GEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTS 497
Query: 461 LTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS 520
L+ LNL+ N F GK+P ++G+ L L+L ++ G+IP I +L +L L LS NLS
Sbjct: 498 LSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLS 557
Query: 521 GELP---------IELFGLPSLQ---------------------------VVSLEENNLS 544
G +P IE+ L LQ +SL N+LS
Sbjct: 558 GSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLS 617
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA 604
G++P S L L L+LS NA TG IP G L L+L++NQ++G IP G +
Sbjct: 618 GEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGS 677
Query: 605 LEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664
L L L N G +P + +L + +DL N LSGE+ E+S LV L ++ N +
Sbjct: 678 LVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFT 737
Query: 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFN 724
G IP L+ L L++S N LSG IP + + +L +LNL++NNL GE+P
Sbjct: 738 GEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPS--DGVCQ 795
Query: 725 DPS--IFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACL-LALCCCGYIYSLL 781
DPS + + N+ELCG+ + +C + R I AG L + +++SL
Sbjct: 796 DPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGI------AGLMLGFTIIVFVFVFSLR 849
Query: 782 RWRQTLRAWATGEKKPSPSRGSSGAER-----------GRGSGENGGPKLVMFNN---KI 827
RW T R +++ P R + G S E + MF K+
Sbjct: 850 RWAMTKRV----KQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKV 905
Query: 828 TYVETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDEN-TFRKEAEAL 886
+ +EAT F ++N++ G +G ++KA +++++L + N F E E L
Sbjct: 906 RLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETL 965
Query: 887 GKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG--HVLNWPMRHLIS 944
GKVKH NL L GY + + +LLVY+YM NG+L L+ +Q G VL+W R I+
Sbjct: 966 GKVKHPNLVSLLGYCSFSEE-KLLVYEYMVNGSLDHWLR---NQTGMLEVLDWSKRLKIA 1021
Query: 945 LGLARGLSFLHS---LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
+G ARGL+FLH ++H DIK N+L D DFE +++FGL RL A E+ ST
Sbjct: 1022 VGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISA--CESHVSTVI 1079
Query: 1002 IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM--FTQDE--DIVKWVKKQL 1057
G+ GY+ PE + + T + DVYSFG++LLE++TG++P F + E ++V W +++
Sbjct: 1080 AGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKI 1139
Query: 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+G+ ++++P L+ + ++S+ L +++ +LC A P RP+M D++ L+
Sbjct: 1140 NQGKAVDVIDPLLVSVALKNSQ----LRLLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 518 bits (1334), Expect = e-145, Method: Compositional matrix adjust.
Identities = 364/1102 (33%), Positives = 571/1102 (51%), Gaps = 90/1102 (8%)
Query: 73 VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFS 132
+R LR+ +L G + + L +L L+ L+L S L G IP+ L + ++++ LQ N
Sbjct: 145 IRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLE 204
Query: 133 GHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQ 190
G +P + N ++L V A N+L+G I A++ +L L+L++N+ TGEIP SQ
Sbjct: 205 GPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQ 264
Query: 191 LQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLK 250
LQ ++L N G +P S+ L L+ L L +N+L G +P N S L+ L +N L
Sbjct: 265 LQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLS 324
Query: 251 GLIPGTIGRIST-LQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPP 309
G +P +I +T L+ L LS +L+G +PV + SL+ + L N+ G +
Sbjct: 325 GSLPKSICSNNTNLEQLVLSGTQLSGEIPVEL-----SKCQSLKQLDLSNNSLAGSIPEA 379
Query: 310 NGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLR 369
V + + L L NN + ++N+T+L+ + L N G LP + +L KLEVL
Sbjct: 380 LFELVELTD-LYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLF 438
Query: 370 VANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVP------------------------A 405
+ N SG +P EI C+ L+M D+ GN F G++P A
Sbjct: 439 LYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPA 498
Query: 406 FLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLN 465
LG L I+ L N SG IP SFG L LE L L N ++GN+P+ + L NLT +N
Sbjct: 499 SLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRIN 558
Query: 466 LSYNKFGG-----------------------KVPYDVGNLKGLLVLNLSASGFSGKIPGS 502
LS+N+ G ++P ++GN + L L L + +GKIP +
Sbjct: 559 LSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWT 618
Query: 503 IGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562
+G + L+ LD+S+ L+G +P++L L + L N LSG +P L L L L
Sbjct: 619 LGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKL 678
Query: 563 SDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVD 622
S N F +P L+ LSL N ++G IP E+G AL VL L N F+G++P
Sbjct: 679 SSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQA 738
Query: 623 ISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS-LTLDMNSLSGRIPESFSKLSNLTTLN 681
+ LS++ +L L +N L+GEIP EI + L S L L N+ +G IP + LS L TL+
Sbjct: 739 MGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLD 798
Query: 682 LSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPLD 741
LS N+L+G +P + + SL YLN+S NNL G++ K S D F N LCG PL
Sbjct: 799 LSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADS--FLGNTGLCGSPLS 856
Query: 742 RECANVRKRKRKR------LIILICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATGEK 795
R C VR +++ ++I+ +SA A L + + + + G
Sbjct: 857 R-CNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFK--QRHDFFKKVGHGST 913
Query: 796 KPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFK 855
+ S SS A + NG K + I + + +EAT EE ++ G G ++K
Sbjct: 914 AYTSSSSSSQATH-KPLFRNGASK-----SDIRWEDIMEATHNLSEEFMIGSGGSGKVYK 967
Query: 856 ASYQDGMVLSIRRL--RDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD-VRLLVY 912
A ++G ++++++ +D + +F +E + LG+++HR+L L GY + + + LL+Y
Sbjct: 968 AELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIY 1027
Query: 913 DYMPNGNLATLLQEAS---HQDGHVLNWPMRHLISLGLARGLSFLHS---LDMVHGDIKP 966
+YM NG++ L E + +L+W R I++GLA+G+ +LH +VH DIK
Sbjct: 1028 EYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKS 1087
Query: 967 QNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIG-SLGYVSPEAASTGQPTKEADVY 1025
NVL D++ EAHL +FGL ++ + S T S GY++PE A + + T+++DVY
Sbjct: 1088 SNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVY 1147
Query: 1026 SFGIVLLEILTGRKPV--MFTQDEDIVKWVKKQLQRGQIS--ELLEPGLLELDPESSEWE 1081
S GIVL+EI+TG+ P +F + D+V+WV+ L+ + +L++P L L P E +
Sbjct: 1148 SMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLP--FEED 1205
Query: 1082 EFLLGVKVGLLCTAPDPLDRPS 1103
+++ L CT P +RPS
Sbjct: 1206 AACQVLEIALQCTKTSPQERPS 1227
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 506 bits (1302), Expect = e-142, Method: Compositional matrix adjust.
Identities = 366/1101 (33%), Positives = 548/1101 (49%), Gaps = 116/1101 (10%)
Query: 73 VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFS 132
++ L L +L G + + L +L+ L L N L G IPA + C+ L +N +
Sbjct: 170 LQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLN 229
Query: 133 GHLPLSIFNLTNLLVLNVAHNLLSGKISADISP--SLRYLDLSSNAFTGEIPGNFSSKSQ 190
G LP + L NL LN+ N SG+I + + S++YL+L N G IP + +
Sbjct: 230 GSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELAN 289
Query: 191 LQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVL 249
LQ ++LS N+ +G + ++ +LE+L L N L G+LP I SN +SL L + L
Sbjct: 290 LQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQL 349
Query: 250 KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPP 309
G IP I +L++L LS N LTG +P S+ ++V+L
Sbjct: 350 SGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLF----------QLVEL------------ 387
Query: 310 NGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLR 369
L L NN + S ++N+T+L+ L N G +P +G L KLE++
Sbjct: 388 --------TNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMY 439
Query: 370 VANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVP------------------------A 405
+ N SG +P EI C+ LQ D GNR SG++P A
Sbjct: 440 LYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPA 499
Query: 406 FLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLN 465
LG + ++ L N SG IP SFG L+ LE + N ++GN+P+ + L NLT +N
Sbjct: 500 SLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRIN 559
Query: 466 LSYNKFGGKV-----------------------PYDVGNLKGLLVLNLSASGFSGKIPGS 502
S NKF G + P ++G L L L + F+G+IP +
Sbjct: 560 FSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRT 619
Query: 503 IGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562
G + L+ LD+S +LSG +P+EL L + L N LSG +P L L L L
Sbjct: 620 FGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKL 679
Query: 563 SDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVD 622
S N F G +P L +++ L L N ++G IP E+G AL L L N +G +P
Sbjct: 680 SSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPST 739
Query: 623 ISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS-LTLDMNSLSGRIPESFSKLSNLTTLN 681
I LS++ +L L +N L+GEIP EI + L S L L N+ +GRIP + S L L +L+
Sbjct: 740 IGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLD 799
Query: 682 LSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPLD 741
LS N+L G +P + + SL YLNLS NNLEG++ K S D F N LCG PL
Sbjct: 800 LSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADA--FVGNAGLCGSPLS 857
Query: 742 REC-----ANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATGEKK 796
C N R K ++I+ +S+ A +AL I + + G
Sbjct: 858 H-CNRAGSKNQRSLSPKTVVIISAISSLAA--IALMVLVIILFFKQNHDLFKKVRGGNSA 914
Query: 797 PSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKA 856
S + SS A NGG K + I + + +EAT +EE ++ G G ++KA
Sbjct: 915 FSSNSSSSQAPL----FSNGGAK-----SDIKWDDIMEATHYLNEEFMIGSGGSGKVYKA 965
Query: 857 SYQDGMVLSIRRL--RDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD-VRLLVYD 913
++G ++++++ +D + +F +E + LG ++HR+L L GY + D + LL+Y+
Sbjct: 966 ELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYE 1025
Query: 914 YMPNGNLATLLQEASH-QDGHVLNWPMRHLISLGLARGLSFLHS---LDMVHGDIKPQNV 969
YM NG++ L + + VL W R I+LGLA+G+ +LH +VH DIK NV
Sbjct: 1026 YMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNV 1085
Query: 970 LFDADFEAHLSEFGLDRLAIAT-PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFG 1028
L D++ EAHL +FGL ++ S+T GS GY++PE A + + T+++DVYS G
Sbjct: 1086 LLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMG 1145
Query: 1029 IVLLEILTGRKPV--MFTQDEDIVKWVKKQLQRGQISE----LLEPGLLELDPESSEWEE 1082
IVL+EI+TG+ P MF ++ D+V+WV+ L SE L++ L L P E E
Sbjct: 1146 IVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLP--CEEEA 1203
Query: 1083 FLLGVKVGLLCTAPDPLDRPS 1103
+++ L CT P +RPS
Sbjct: 1204 AYQVLEIALQCTKSYPQERPS 1224
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 501 bits (1291), Expect = e-141, Method: Compositional matrix adjust.
Identities = 352/1109 (31%), Positives = 547/1109 (49%), Gaps = 83/1109 (7%)
Query: 31 EIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNR-VRELRLPRLQLAGRLTD 89
E + L FK L D G L W+ S PC+W GI C + R V + L + L+G L+
Sbjct: 27 EGRVLLEFKAFLNDSNGYLASWNQ-LDSNPCNWTGIACTHLRTVTSVDLNGMNLSGTLSP 85
Query: 90 QLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLN 149
+ LH LRKL++ +N ++G IP L C L + L N F G +P+ + + L L
Sbjct: 86 LICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLY 145
Query: 150 VAHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPA 207
+ N L G I I SL+ L + SN TG IP + + QL++I N FSG +P+
Sbjct: 146 LCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPS 205
Query: 208 SVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLS 267
+ + L+ L L N L G+LP + +L L N L G IP ++G IS L+VL+
Sbjct: 206 EISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLA 265
Query: 268 LSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRI 327
L N TG +P + G ++ ++ + L N TG + G + E+ D N++
Sbjct: 266 LHENYFTGSIPREI-----GKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEI-DFSENQL 319
Query: 328 RAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCS 387
P ++ +L+++ L N G +P +G L LE L ++ N L+G +P E+
Sbjct: 320 TGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLP 379
Query: 388 LLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI 447
L L N+ G++P +G ++ + N SG IP F L L+L N +
Sbjct: 380 YLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKL 439
Query: 448 RGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLM 507
GNIP ++ +LT L L N+ G +P ++ NL+ L L L + SG I +G L
Sbjct: 440 SGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLK 499
Query: 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
L L L+N N +GE+P E+ L + ++ N L+G +P+ S V +Q L+LS N F
Sbjct: 500 NLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKF 559
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLS 627
+G I G L L L LS N+++G IP G + L L+L N + NIPV++ L+
Sbjct: 560 SGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLT 619
Query: 628 RIK-KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686
++ L++ N LSG IP + L L L+ N LSG IP S L +L N+S N
Sbjct: 620 SLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNN 679
Query: 687 LSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCG------KPL 740
L G +P D A+ + D S FA N LC +PL
Sbjct: 680 LVGTVP-DTAVFQRM-----------------------DSSNFAGNHGLCNSQRSHCQPL 715
Query: 741 DRECAN-----VRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATGEK 795
+ + +R++++ + C+ L+ G +++ R R+ +
Sbjct: 716 VPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITF--LGLCWTIKR-REPAFVALEDQT 772
Query: 796 KPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFK 855
KP ++G TY ++ATR F E+ VL RG G ++K
Sbjct: 773 KPDVMDSYYFPKKG-----------------FTYQGLVDATRNFSEDVVLGRGACGTVYK 815
Query: 856 ASYQDGMVLSIRRLR---DGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912
A G V+++++L +G +N+FR E LGK++HRN+ L G + + LL+Y
Sbjct: 816 AEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYG-FCYHQNSNLLLY 874
Query: 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS---LDMVHGDIKPQNV 969
+YM G+L LQ + +L+W R+ I+LG A GL +LH +VH DIK N+
Sbjct: 875 EYMSKGSLGEQLQRG--EKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNI 932
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGI 1029
L D F+AH+ +FGL +L + +++ S+ GS GY++PE A T + T++ D+YSFG+
Sbjct: 933 LLDERFQAHVGDFGLAKLIDLSYSKSMSAVA--GSYGYIAPEYAYTMKVTEKCDIYSFGV 990
Query: 1030 VLLEILTGRKPVM-FTQDEDIVKWVKKQLQRGQIS--ELLEPGLLELDPESSEWEEFLLG 1086
VLLE++TG+ PV Q D+V WV++ + R I E+ + L D + E L
Sbjct: 991 VLLELITGKPPVQPLEQGGDLVNWVRRSI-RNMIPTIEMFDARLDTNDKRTV--HEMSLV 1047
Query: 1087 VKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
+K+ L CT+ P RP+M ++V M+ R
Sbjct: 1048 LKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 495 bits (1275), Expect = e-139, Method: Compositional matrix adjust.
Identities = 365/1164 (31%), Positives = 566/1164 (48%), Gaps = 164/1164 (14%)
Query: 19 FAYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNR-VRELR 77
FA A +LS + TS P W++S S PC W G+ C + V L
Sbjct: 22 FALNSDGAALLSLTRHWTSI------PSDITQSWNASD-STPCSWLGVECDRRQFVDTLN 74
Query: 78 LPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPL 137
L ++G +++ L L+K+ L N GSIP+ L CSLL
Sbjct: 75 LSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLE--------------- 119
Query: 138 SIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLS 197
++DLSSN+FTG IP + L+ ++L
Sbjct: 120 -------------------------------HIDLSSNSFTGNIPDTLGALQNLRNLSLF 148
Query: 198 YNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTI 257
+NS G P S+ + LE ++ N L G++PS I N S L L +DN G +P ++
Sbjct: 149 FNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSL 208
Query: 258 GRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317
G I+TLQ L L+ N L G +PV++ N+ +L + + N+ G + P + +
Sbjct: 209 GNITTLQELYLNDNNLVGTLPVTL-----NNLENLVYLDVRNNSLVGAI-PLDFVSCKQI 262
Query: 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSG 377
+ + L NN+ P L N TSLR SG +P+ G L KL+ L +A N SG
Sbjct: 263 DTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSG 322
Query: 378 LVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQL 437
+P E+ KC + L+ N+ G++P LG + L+ + L N SG +PLS + L
Sbjct: 323 RIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSL 382
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497
++L L +N++ G +P ++T L L +L L N F G +P D+G L VL+L+ + F+G
Sbjct: 383 QSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTG 442
Query: 498 KIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGL 557
IP ++ S +L L L L G +P +L G +L+ + LEENNL G +P+ F L
Sbjct: 443 HIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPD-FVEKQNL 501
Query: 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG 617
+ +LS N FTG IP + G L+++ + LS NQ+SG IP ELG+ LE L L N G
Sbjct: 502 LFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKG 561
Query: 618 NIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSK---- 673
+P ++S+ ++ +LD N L+G IP + + L L+L NS SG IP S +
Sbjct: 562 ILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKL 621
Query: 674 -------------------LSNLTTLNLSTNRLSGAIPADL------------------- 695
L L +LNLS+N+L+G +P DL
Sbjct: 622 LNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGT 681
Query: 696 ----ALISSLRYLNLSRNNLEGEIPKMLSSRFND-PSIFAMNRELC-GKPLD-------- 741
+ I SL ++N+S N G +P L+ N P+ F+ N +LC P D
Sbjct: 682 LRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLACPESS 741
Query: 742 --RECANVRKRKRKRLIIL-ICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATGEKKPS 798
R C + L L I + GA L +C A+ K S
Sbjct: 742 ILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIIC-----------LFLFSAFLFLHCKKS 790
Query: 799 PSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKASY 858
+ A+ G GS N + LEAT +++ V+ +G +G I+KA+
Sbjct: 791 VQEIAISAQEGDGSLLN---------------KVLEATENLNDKYVIGKGAHGTIYKATL 835
Query: 859 QDGMVLSIRRL-----RDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913
V ++++L ++G++ + +E E +GKV+HRNL L ++ + L++Y
Sbjct: 836 SPDKVYAVKKLVFTGIKNGSV---SMVREIETIGKVRHRNLIKLEEFWLRK-EYGLILYT 891
Query: 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH---SLDMVHGDIKPQNVL 970
YM NG+L +L E + L+W RH I++G A GL++LH +VH DIKP N+L
Sbjct: 892 YMENGSLHDILHETNPPK--PLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNIL 949
Query: 971 FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIV 1030
D+D E H+S+FG+ +L + A + S T G++GY++PE A T ++E+DVYS+G+V
Sbjct: 950 LDSDLEPHISDFGIAKL-LDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVV 1008
Query: 1031 LLEILTGRKPV--MFTQDEDIVKWVKK-QLQRGQISELLEPGLLELDPESSEWEEFLLGV 1087
LLE++T +K + F + DIV WV+ Q G+I ++++P LL+ +SS E+ +
Sbjct: 1009 LLELITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEAL 1068
Query: 1088 KVGLLCTAPDPLDRPSMADIVFML 1111
+ L C + RP+M D+V L
Sbjct: 1069 SLALRCAEKEVDKRPTMRDVVKQL 1092
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1273), Expect = e-138, Method: Compositional matrix adjust.
Identities = 373/1133 (32%), Positives = 560/1133 (49%), Gaps = 136/1133 (12%)
Query: 31 EIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNN----RVRELRLPRLQLAGR 86
E Q L K D L W+S+ S PC W G++C N V L L + L+G+
Sbjct: 30 EGQYLLEIKSKFVDAKQNLRNWNSND-SVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGK 88
Query: 87 LTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLL 146
L+ + L L++L L N L+G IP + CS L + L N F G +P+ I L +L
Sbjct: 89 LSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLE 148
Query: 147 VLNVAHNLLSGKISADISP--SLRYLDLSSNAFTGEIP--------------------GN 184
L + +N +SG + +I SL L SN +G++P G+
Sbjct: 149 NLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGS 208
Query: 185 FSSK----SQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
S+ L ++ L+ N SGE+P +G L++L + L N G +P ISNC+SL
Sbjct: 209 LPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLE 268
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
L+ N L G IP +G + +L+ L L RN L G +P + GN+S + N
Sbjct: 269 TLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREI-----GNLSYAIEIDFSEN 323
Query: 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360
A TG + G + LE+L L N++ P L+ + +L +DLS N +G +P
Sbjct: 324 ALTGEIPLELGN-IEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQ 382
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420
L L +L++ NSLSG +P ++ S L + D+ N SG++P++L + I++LG
Sbjct: 383 YLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGT 442
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG 480
N SG IP L L L+ N++ G P + + N+T + L N+F G +P +VG
Sbjct: 443 NNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVG 502
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
N L L L+ +GF+G++P IG L +L TL++S+ L+GE+P E+F LQ + +
Sbjct: 503 NCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCC 562
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600
NN SG +P SL L+ L LS+N +G IP G L L L + N +G IP ELG
Sbjct: 563 NNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELG 622
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
+ + L++ L+L NKL+GEIP E+S L L L+
Sbjct: 623 SLTGLQI-----------------------ALNLSYNKLTGEIPPELSNLVMLEFLLLNN 659
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLS 720
N+LSG IP SF+ LS+L N S N L+G IP LR +++S
Sbjct: 660 NNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL-------LRNISMSS------------ 700
Query: 721 SRFNDPSIFAMNRELCGKPLDRECANVR---------KRKRKRLIILICVSAAGACLLAL 771
F N LCG PL+ +C + K R +I ++AA ++L
Sbjct: 701 --------FIGNEGLCGPPLN-QCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSL 751
Query: 772 CCCGYIYSLLRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNK--ITY 829
I L+ R+ +R A+ + PS S + F K T+
Sbjct: 752 MLIALIVYLM--RRPVRTVASSAQDGQPSEMSLD---------------IYFPPKEGFTF 794
Query: 830 VETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRL-------RDGTIDENTFRKE 882
+ + AT FDE V+ RG G ++KA G L++++L + +D N+FR E
Sbjct: 795 QDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVD-NSFRAE 853
Query: 883 AEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL 942
LG ++HRN+ L G + LL+Y+YMP G+L +L + S L+W R
Sbjct: 854 ILTLGNIRHRNIVKLHG-FCNHQGSNLLLYEYMPKGSLGEILHDPSCN----LDWSKRFK 908
Query: 943 ISLGLARGLSFLH---SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
I+LG A+GL++LH + H DIK N+L D FEAH+ +FGL ++ I P S S
Sbjct: 909 IALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV-IDMPHSKSMSA 967
Query: 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM-FTQDEDIVKWVKKQLQ 1058
GS GY++PE A T + T+++D+YS+G+VLLE+LTG+ PV Q D+V WV+ ++
Sbjct: 968 IA-GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIR 1026
Query: 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
R +S + L L+ E L +K+ LLCT+ P+ RPSM +V ML
Sbjct: 1027 RDALSSGVLDARLTLEDERI-VSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 350/1119 (31%), Positives = 568/1119 (50%), Gaps = 121/1119 (10%)
Query: 54 SSTPSAPCDWRGIVCYNNR-VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIP 112
+++ + PC+W GI C +++ V L R +++G+L ++ +L L+ L L +N+ +G+IP
Sbjct: 57 NASEATPCNWFGITCDDSKNVASLNFTRSRVSGQLGPEIGELKSLQILDLSTNNFSGTIP 116
Query: 113 ASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYL 170
++L C+ L + L N FS +P ++ +L L VL + N L+G++ + P L+ L
Sbjct: 117 STLGNCTKLATLDLSENGFSDKIPDTLDSLKRLEVLYLYINFLTGELPESLFRIPKLQVL 176
Query: 171 DLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLP 230
L N TG IP + +L +++ N FSG +P S+G L+ L+L N L G+LP
Sbjct: 177 YLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNKLVGSLP 236
Query: 231 SAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNIS 290
+++ +L L +N L+G + L L LS NE G VP ++ GN S
Sbjct: 237 ESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPAL-----GNCS 291
Query: 291 SLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNF 350
SL + + +G + P + + L +L+L NR+ P+ L N +SL ++ L+ N
Sbjct: 292 SLDALVIVSGNLSGTI-PSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQ 350
Query: 351 FSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGI 410
G +P+A+G L KLE L + N SG +P EI K L + N +G++P + +
Sbjct: 351 LVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEM 410
Query: 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNK 470
+ LKI +L N F G IP G S LE ++ N + G IP + L LNL N
Sbjct: 411 KKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNL 470
Query: 471 FGGKVPYDVG-------------NLKGLL----------VLNLSASGFSGKIPGSIGSLM 507
G +P +G NL GLL L+ +++ F G IPGS+GS
Sbjct: 471 LHGTIPASIGHCKTIRRFILRENNLSGLLPEFSQDHSLSFLDFNSNNFEGPIPGSLGSCK 530
Query: 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
L++++LS +G++P +L L +L ++L N L G +P S+ V L+ ++ N+
Sbjct: 531 NLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSL 590
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLS 627
G +P+ + + L L LS N+ SG IP L L L++ N F G IP I +
Sbjct: 591 NGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIE 650
Query: 628 R-IKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTL---NLS 683
I LDL N L+GEIP ++ L L + N+L+G S S L LT+L ++S
Sbjct: 651 DLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTG----SLSVLKGLTSLLHVDVS 706
Query: 684 TNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELC------- 736
N+ +G IP +NLEG++ ++PS F+ N LC
Sbjct: 707 NNQFTGPIP----------------DNLEGQL-------LSEPSSFSGNPNLCIPHSFSA 743
Query: 737 ---GKPLDRECANVRKRKRKRL----IILICVSAAGACLLALCCCGYIYSLLRWRQTLRA 789
+ + C + K ++ L I+LI V ++ L+ + +I LR R+
Sbjct: 744 SNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFI--CLRRRK---- 797
Query: 790 WATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGR 849
+P E GP L++ NK+ L AT +E+ + RG
Sbjct: 798 -----GRPEKDAYVFTQEE--------GPSLLL--NKV-----LAATDNLNEKYTIGRGA 837
Query: 850 YGLIFKASYQDGMVLSIRRLRDGT-IDEN-TFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907
+G++++AS G V +++RL + I N + +E + +GKV+HRNL L G++ D
Sbjct: 838 HGIVYRASLGSGKVYAVKRLVFASHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDD- 896
Query: 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH---SLDMVHGDI 964
L++Y YMP G+L +L S ++ +VL+W R+ ++LG+A GL++LH +VH DI
Sbjct: 897 GLMLYRYMPKGSLYDVLHGVSPKE-NVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDI 955
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADV 1024
KP+N+L D+D E H+ +FGL RL + S+ T G+ GY++PE A +E+DV
Sbjct: 956 KPENILMDSDLEPHIGDFGLARLLDDSTV---STATVTGTTGYIAPENAFKTVRGRESDV 1012
Query: 1025 YSFGIVLLEILTGRKPV--MFTQDEDIVKWVKKQLQ------RGQISELLEPGLLELDPE 1076
YS+G+VLLE++T ++ V F + DIV WV+ L ++ +++P L++ +
Sbjct: 1013 YSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLD 1072
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
SS E+ + ++ L CT DP RP+M D V +LE +
Sbjct: 1073 SSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLLEDVK 1111
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 459 bits (1182), Expect = e-128, Method: Compositional matrix adjust.
Identities = 374/1166 (32%), Positives = 566/1166 (48%), Gaps = 174/1166 (14%)
Query: 14 VTLTHFA---------YGEQNAVVLSEIQALTSFKLHLKD--PLGALDGWDSSTPSAPCD 62
+T++HF+ + + +E+ AL S+ LH + P GW+ S S PC
Sbjct: 13 LTVSHFSITLSLFLAFFISSTSASTNEVSALISW-LHSSNSPPPSVFSGWNPSD-SDPCQ 70
Query: 63 WRGIVCY---NNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCS 119
W I C N V E+ + +QLA ++ L+KL + + +L G+I + + CS
Sbjct: 71 WPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCS 130
Query: 120 LLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISP--SLRYLDLSSN-- 175
L + L NS G +P S+ L NL L + N L+GKI ++ SL+ L++ N
Sbjct: 131 ELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYL 190
Query: 176 -----------------------AFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQL 212
+G+IP + L+++ L+ SG +P S+GQL
Sbjct: 191 SENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQL 250
Query: 213 QELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNE 272
+L+ L + S L G +P + NCS L++L DN L G +P +G++ L+ + L +N
Sbjct: 251 SKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNN 310
Query: 273 LTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFP 332
L G +P + G + SL + L N F+G + G +S L+ L L +N I P
Sbjct: 311 LHGPIPEEI-----GFMKSLNAIDLSMNYFSGTIPKSFGN-LSNLQELMLSSNNITGSIP 364
Query: 333 SWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMF 392
S L+N T L + N SG +P +G L +L + N L G +PDE+A C LQ
Sbjct: 365 SILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQAL 424
Query: 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIP 452
DL N +G +PA L +R L + L N SG+IPL GN + L L L N I G IP
Sbjct: 425 DLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIP 484
Query: 453 EEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTL 512
+ I L NL+ L+LS N G VP ++ N + L +LNLS + G +P S+ SL +L L
Sbjct: 485 KGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVL 544
Query: 513 DLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP 572
D+S+ N+L+G +P+ L+ L L LS N+F G+IP
Sbjct: 545 DVSS------------------------NDLTGKIPDSLGHLISLNRLILSKNSFNGEIP 580
Query: 573 ATYGFLRSLVFLSLSHNQISGMIPAELGACSALEV-LELRSNHFTGNIPVDISHLSRIKK 631
++ G +L L LS N ISG IP EL L++ L L N G IP IS L+R+
Sbjct: 581 SSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSV 640
Query: 632 LDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAI 691
LD+ N LSG D+++LSG L NL +LN+S NR SG +
Sbjct: 641 LDISHNMLSG-----------------DLSALSG--------LENLVSLNISHNRFSGYL 675
Query: 692 PADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPLDRECANVRKRK 751
P D + L + NN + S F S F N L + R
Sbjct: 676 P-DSKVFRQLIGAEMEGNN------GLCSKGFR--SCFVSN----SSQLTTQRGVHSHRL 722
Query: 752 RKRLIILICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATGEKKPSPSRGSSGAERGRG 811
R + +LI V+A A L L +++R +Q +R E
Sbjct: 723 RIAIGLLISVTAVLAVLGVL-------AVIRAKQMIRDDNDSE----------------- 758
Query: 812 SGENGGPKLVMFNNKITYVETLEAT-----RQFDEENVLSRGRYGLIFKASYQDGMVLSI 866
+GEN ++ + T + L T + E NV+ +G G+++KA + V+++
Sbjct: 759 TGEN------LWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAV 812
Query: 867 RRLRDGTID-----------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915
++L T+ ++F E + LG ++H+N+ G + RLL+YDYM
Sbjct: 813 KKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWN-KNTRLLMYDYM 871
Query: 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS---LDMVHGDIKPQNVLFD 972
NG+L +LL E S L W +R+ I LG A+GL++LH +VH DIK N+L
Sbjct: 872 SNGSLGSLLHERSGVCS--LGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG 929
Query: 973 ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLL 1032
DFE ++ +FGL +L + A SS T GS GY++PE + + T+++DVYS+G+V+L
Sbjct: 930 PDFEPYIGDFGLAKL-VDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVL 988
Query: 1033 EILTGRKPVMFTQDE--DIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVG 1090
E+LTG++P+ T + IV WVKK + ++++ G L+ PE SE EE + + V
Sbjct: 989 EVLTGKQPIDPTIPDGLHIVDWVKKI----RDIQVIDQG-LQARPE-SEVEEMMQTLGVA 1042
Query: 1091 LLCTAPDPLDRPSMADIVFML-EGCR 1115
LLC P P DRP+M D+ ML E C+
Sbjct: 1043 LLCINPIPEDRPTMKDVAAMLSEICQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1133 | ||||||
| 224082954 | 1127 | predicted protein [Populus trichocarpa] | 0.992 | 0.998 | 0.760 | 0.0 | |
| 224066020 | 1124 | predicted protein [Populus trichocarpa] | 0.989 | 0.997 | 0.756 | 0.0 | |
| 255538838 | 1135 | protein with unknown function [Ricinus c | 0.992 | 0.991 | 0.758 | 0.0 | |
| 225458087 | 1127 | PREDICTED: probable LRR receptor-like se | 0.989 | 0.994 | 0.753 | 0.0 | |
| 359476840 | 1130 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.997 | 0.695 | 0.0 | |
| 356517992 | 1133 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.987 | 0.701 | 0.0 | |
| 356509642 | 1130 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.986 | 0.705 | 0.0 | |
| 255581412 | 1143 | Leucine-rich repeat receptor protein kin | 0.974 | 0.965 | 0.684 | 0.0 | |
| 449531097 | 1131 | PREDICTED: probable LRR receptor-like se | 0.993 | 0.995 | 0.672 | 0.0 | |
| 449434496 | 1131 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.992 | 0.673 | 0.0 |
| >gi|224082954|ref|XP_002306906.1| predicted protein [Populus trichocarpa] gi|222856355|gb|EEE93902.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1719 bits (4452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 862/1133 (76%), Positives = 984/1133 (86%), Gaps = 8/1133 (0%)
Query: 1 MAATSTATAIFLFVTLTHFAYGEQNAVVLSE-IQALTSFKLHLKDPLGALDGWDSSTPSA 59
M+ T+ + + +F T+ + + V LSE IQALTSFKL+L DPLGALDGWD+STPSA
Sbjct: 1 MSRTTAISLLVIFATVITCC--QSDVVSLSEEIQALTSFKLNLNDPLGALDGWDASTPSA 58
Query: 60 PCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCS 119
PCDWRGIVCYNNRV ELRLPRL L+G+L+DQL++L +LRKLSLHSN+ NGSIP SL QCS
Sbjct: 59 PCDWRGIVCYNNRVHELRLPRLYLSGQLSDQLSNLRQLRKLSLHSNNFNGSIPPSLSQCS 118
Query: 120 LLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTG 179
LLRAVYLQYNS SG+LP +I NLTNL VLNVAHN L+GKIS DIS SLRYLD+SSN+F+G
Sbjct: 119 LLRAVYLQYNSLSGNLPSTIVNLTNLQVLNVAHNFLNGKISGDISFSLRYLDVSSNSFSG 178
Query: 180 EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSL 239
EIPGNFSSKSQLQLINLSYN FSGE+PA +GQLQELEYLWLDSN L+GTLPSA++NCSSL
Sbjct: 179 EIPGNFSSKSQLQLINLSYNKFSGEIPARIGQLQELEYLWLDSNQLHGTLPSAVANCSSL 238
Query: 240 VHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGF 299
+HLS DN LKG++P +IG I L+VLSLSRNEL+G +P S++C + SLRIV+LGF
Sbjct: 239 IHLSTGDNSLKGMVPASIGSIPKLEVLSLSRNELSGTIPASIICGV-----SLRIVKLGF 293
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV 359
NAFTG+ P NG C S LEVLD+ N I VFPSWLT +T++RV+D S NFFSG+LP +
Sbjct: 294 NAFTGIDPPSNGSCFSNLEVLDIHENHITGVFPSWLTGLTTVRVVDFSTNFFSGSLPGGI 353
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419
G+L +LE +RVANNSL+G +P++I KCS LQ+ DLEGNRF GQ+P FL +R LK++SLG
Sbjct: 354 GNLWRLEEIRVANNSLTGDIPNKIVKCSSLQVLDLEGNRFDGQIPLFLSELRRLKLLSLG 413
Query: 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV 479
RN+FSG IP SFG L +LETL L N++ GN+PEEI +L+NL+TL+LS+NK G++PY +
Sbjct: 414 RNLFSGSIPASFGGLFELETLKLESNNLSGNLPEEIMKLTNLSTLSLSFNKLSGEIPYSI 473
Query: 480 GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
G LKGL+VLNLS GFSG+IPGSIGSL++LTTLDLS QNLSGELPIE+FGLPSLQVV+LE
Sbjct: 474 GELKGLMVLNLSGCGFSGRIPGSIGSLLKLTTLDLSKQNLSGELPIEIFGLPSLQVVALE 533
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
EN LSG VPEGFSSLV LQYLNL+ N FTG+IPA YGFL SLV LSLS N ISGMIPAEL
Sbjct: 534 ENKLSGVVPEGFSSLVSLQYLNLTSNFFTGEIPANYGFLTSLVALSLSRNYISGMIPAEL 593
Query: 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLD 659
G CS+LE+LELR NH G+IP DIS LSR+K+LDLG++ L+GEIP++I +CSSL SL LD
Sbjct: 594 GNCSSLEMLELRFNHLRGSIPGDISRLSRLKRLDLGEDALTGEIPEDIHRCSSLSSLLLD 653
Query: 660 MNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKML 719
+N LSGRIPES SKLSNL L+LS+N L+G IPA+L+ I SLRYLNLSRNNLEGEIP++L
Sbjct: 654 LNHLSGRIPESLSKLSNLAVLSLSSNSLNGTIPANLSHIPSLRYLNLSRNNLEGEIPRLL 713
Query: 720 SSRFNDPSIFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYS 779
SRFNDPS+FAMNRELCGKPLDRECANVR RKRK+LI+ I V A LLALCCC YIYS
Sbjct: 714 GSRFNDPSVFAMNRELCGKPLDRECANVRNRKRKKLILFIGVPIAATVLLALCCCAYIYS 773
Query: 780 LLRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQF 839
LLRWR+ LR TGEKK SP+ SSGA+R RGSGENGGPKLVMFNNKITY ETLEATRQF
Sbjct: 774 LLRWRKRLRDGVTGEKKRSPASASSGADRSRGSGENGGPKLVMFNNKITYAETLEATRQF 833
Query: 840 DEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG 899
DE+NVLSRGRYGL+FKASYQDGMVLS+RRL DG+I E FRKEAE+L KVKHRNLTVLRG
Sbjct: 834 DEDNVLSRGRYGLVFKASYQDGMVLSVRRLPDGSISEGNFRKEAESLDKVKHRNLTVLRG 893
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM 959
YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI+LG+ARGL+FLHSL +
Sbjct: 894 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHSLSL 953
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPT 1019
VHGD+KPQNVLFDADFEAHLSEFGLD+L ATPAEASSS+TP+GSLGY+SPE A TGQPT
Sbjct: 954 VHGDLKPQNVLFDADFEAHLSEFGLDKLTTATPAEASSSSTPVGSLGYISPEVALTGQPT 1013
Query: 1020 KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079
KEADVYSFGIVLLEILTG+KPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE
Sbjct: 1014 KEADVYSFGIVLLEILTGKKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1073
Query: 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
WEEFLLG+KVGLLCTAPDPLDRPSMADIVFMLEGCR GPD+PSSADPTSLPSP
Sbjct: 1074 WEEFLLGIKVGLLCTAPDPLDRPSMADIVFMLEGCRAGPDIPSSADPTSLPSP 1126
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066020|ref|XP_002301998.1| predicted protein [Populus trichocarpa] gi|222843724|gb|EEE81271.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1696 bits (4391), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 856/1131 (75%), Positives = 967/1131 (85%), Gaps = 10/1131 (0%)
Query: 5 STATAIFLF-VTLTHFAYGEQNAVVLSE-IQALTSFKLHLKDPLGALDGWDSSTPSAPCD 62
STATAIFLF ++ T Y + + V LSE IQALTSFKL+L DPLGALDGWD ST SAPCD
Sbjct: 2 STATAIFLFFISATIITYTQSDVVSLSEEIQALTSFKLNLNDPLGALDGWDESTQSAPCD 61
Query: 63 WRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLR 122
W GIVCYN RV E+RLPRLQL+G+LTDQL+ LH+LRKLSLHSN+ NGSIP SL QCSLLR
Sbjct: 62 WHGIVCYNKRVHEVRLPRLQLSGQLTDQLSKLHQLRKLSLHSNNFNGSIPPSLSQCSLLR 121
Query: 123 AVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIP 182
AVYLQ NS G+ P +I NLTNL LNVAHN LSGKIS IS SLRYLD+SSN+ +GEIP
Sbjct: 122 AVYLQSNSLYGNFPSAIVNLTNLQFLNVAHNFLSGKISGYISNSLRYLDISSNSLSGEIP 181
Query: 183 GNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHL 242
GNFSSKSQLQLINLSYN FSGEVPAS+GQLQELEYLWLDSN LYGTLPSAI+NCSSL+HL
Sbjct: 182 GNFSSKSQLQLINLSYNKFSGEVPASIGQLQELEYLWLDSNQLYGTLPSAIANCSSLIHL 241
Query: 243 SAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAF 302
S EDN LKGL+P +IG I L+VLSLSRNE++G +P +V+C G LRI++ G NAF
Sbjct: 242 SIEDNSLKGLVPASIGLIPKLEVLSLSRNEISGSIPANVVC---GVSKKLRILKFGVNAF 298
Query: 303 TGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSL 362
TG+ P N C S LEVLD+ N I VFPSWLT +T++RV+D SGN FSG+LP +G+L
Sbjct: 299 TGIEPPSNEGCFSTLEVLDIHENHINGVFPSWLTGLTTVRVVDFSGNLFSGSLPDGIGNL 358
Query: 363 DKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNM 422
+LE RVANNSL+G +P+ I KC LQ+ DLEGNRF G++P FL IR L+++SLG N+
Sbjct: 359 SRLEEFRVANNSLTGDIPNHIVKCGFLQVLDLEGNRFGGRIPMFLSEIRRLRLLSLGGNL 418
Query: 423 FSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482
FSG IP SFG L +LETL L N++ GN+PEEI RL+NL+TL+LS+NKF G+VPY++G+L
Sbjct: 419 FSGSIPPSFGGLFELETLKLEANNLSGNVPEEIMRLTNLSTLDLSFNKFYGEVPYNIGDL 478
Query: 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENN 542
KGL+VLNLSA GFSG+IP SIGSL++LTTLDLS QNLSGELPIE+FGLPSLQVVSLEEN
Sbjct: 479 KGLMVLNLSACGFSGRIPASIGSLLKLTTLDLSKQNLSGELPIEIFGLPSLQVVSLEENK 538
Query: 543 LSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGAC 602
LSG VPEGFSSLV LQYLNL+ N+FTG++P YGFL SL LSLS N ISGMIPAELG C
Sbjct: 539 LSGAVPEGFSSLVSLQYLNLTSNSFTGEVPENYGFLTSLAVLSLSRNYISGMIPAELGNC 598
Query: 603 SALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNS 662
S+LEVLE+RSNH G IP DIS LSR+KKLDLG+N L+GEIP+ I +CS L+SL+LD N
Sbjct: 599 SSLEVLEMRSNHLRGGIPGDISRLSRLKKLDLGENALTGEIPENIYRCSPLISLSLDGNH 658
Query: 663 LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSR 722
LSG IPES SKL NLT LNLS+N L+G IPA+L+ I SL YLNLSRNNLEGEIP++L SR
Sbjct: 659 LSGHIPESLSKLPNLTVLNLSSNSLNGTIPANLSYIPSLIYLNLSRNNLEGEIPELLGSR 718
Query: 723 FNDPSIFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLR 782
FNDPS+FA+N +LCGKP+DRECA+V+KRKRK+L + I V A LLALCCC YIYSLLR
Sbjct: 719 FNDPSVFAVNGKLCGKPVDRECADVKKRKRKKLFLFIGVPIAATILLALCCCAYIYSLLR 778
Query: 783 WRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEE 842
WR LR TGEKK SP+R SSGA+R RGSGENGGPKLVMFNNKITY ETLEATRQFDE+
Sbjct: 779 WRSRLRDGVTGEKKRSPARASSGADRSRGSGENGGPKLVMFNNKITYAETLEATRQFDED 838
Query: 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYA 902
NVLSRGRYGL+FKASYQDGMVLS+RRL DG+I FRKEAE+LGKVKHRNLTVLRGYYA
Sbjct: 839 NVLSRGRYGLVFKASYQDGMVLSVRRLPDGSISAGNFRKEAESLGKVKHRNLTVLRGYYA 898
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI+LG+ARGL+FLHSL M+HG
Sbjct: 899 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHSLSMIHG 958
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEA 1022
D+KPQNVLFDADFEAHLSEFGLD+L IATPAEASSS+TP+GSLGY SPE A TGQPTKEA
Sbjct: 959 DVKPQNVLFDADFEAHLSEFGLDKLTIATPAEASSSSTPMGSLGYTSPEVALTGQPTKEA 1018
Query: 1023 DVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEE 1082
DVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEE
Sbjct: 1019 DVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEE 1078
Query: 1083 FLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSPM 1133
FLLG+KVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD+PS SLPSP+
Sbjct: 1079 FLLGIKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDIPS-----SLPSPI 1124
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538838|ref|XP_002510484.1| protein with unknown function [Ricinus communis] gi|223551185|gb|EEF52671.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1671 bits (4328), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 859/1132 (75%), Positives = 969/1132 (85%), Gaps = 7/1132 (0%)
Query: 7 ATAIFLFVTLTHFA---YGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDW 63
ATAIFLF ++A +AV LSEIQALTSFK L DPLGALDGWD STPSAPCDW
Sbjct: 2 ATAIFLFSICYYYATFFLFLSDAVPLSEIQALTSFKQSLHDPLGALDGWDVSTPSAPCDW 61
Query: 64 RGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRA 123
RGIVCY+NRVRELRLPRLQL G +T QLA+L +LRKLSLHSN+ NGSIP SL QC LLRA
Sbjct: 62 RGIVCYSNRVRELRLPRLQLGGSITPQLANLRQLRKLSLHSNNFNGSIPPSLSQCPLLRA 121
Query: 124 VYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPG 183
VY QYNS SG+LP SI NLTN+ VLNVAHN SG I DIS SL+YLD+SSN+F+GEIPG
Sbjct: 122 VYFQYNSLSGNLPSSILNLTNIQVLNVAHNFFSGNIPTDISHSLKYLDISSNSFSGEIPG 181
Query: 184 NFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLS 243
N SSKSQLQLINLSYN SGE+PAS+GQLQEL+YLWLD N+LYGTLPSAI+NCSSL+ LS
Sbjct: 182 NLSSKSQLQLINLSYNKLSGEIPASIGQLQELKYLWLDYNNLYGTLPSAIANCSSLIQLS 241
Query: 244 AEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFT 303
AEDN L+GLIP TIG I L+VLSLS NEL+G +P ++ C ++GN+SSLRIVQLG NAFT
Sbjct: 242 AEDNKLRGLIPPTIGSILKLEVLSLSSNELSGSIPANIFCRVFGNVSSLRIVQLGVNAFT 301
Query: 304 GVVKPPNGR---CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360
GVVK G CVSVLEVLD+ NRI++VFPSWLTN+T LR +DLSGNFF G+ PA +G
Sbjct: 302 GVVKNERGGGGGCVSVLEVLDIHENRIQSVFPSWLTNLTWLRYIDLSGNFFFGSFPAGLG 361
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420
+L +LE LRV+NNSL+G +P +IA+CS LQ+ DLEGNRF G++P FL ++ LK++SLG
Sbjct: 362 NLLRLEELRVSNNSLTGNIPSQIAQCSKLQVLDLEGNRFLGEIPVFLSELKRLKLLSLGG 421
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG 480
N F G IP G L +L+TL L+ N++ G +PEE+ LSNLT+L+L YNKF G++PY++G
Sbjct: 422 NRFVGDIPKGLGGLFELDTLKLNNNNLTGKLPEELLNLSNLTSLSLGYNKFSGEIPYNIG 481
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
LKGL++LNLS+ G SG+IP SIGSL++L TLDLS QNLSGELPIELFGLPSLQVV+LEE
Sbjct: 482 ELKGLMLLNLSSCGLSGRIPASIGSLLKLNTLDLSKQNLSGELPIELFGLPSLQVVALEE 541
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600
N L+GDVPEGFSSLV LQYLN+S N+FTG IPATYGFL SLV LSLS N +SG IP ELG
Sbjct: 542 NKLAGDVPEGFSSLVSLQYLNVSSNSFTGVIPATYGFLSSLVILSLSWNHVSGGIPPELG 601
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
C +LEVLELRSNH G+IP DIS LS +KKLDLG+N L+GEIP+EI +CSSL+SL LD
Sbjct: 602 NCYSLEVLELRSNHLKGSIPGDISRLSHLKKLDLGRNNLTGEIPEEIYRCSSLISLFLDG 661
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLS 720
N LSG IPES S+LSNL+ LNLS+N L+G IPA+L+ I LRYLNLS NNLEGEIP+ L+
Sbjct: 662 NQLSGHIPESLSRLSNLSILNLSSNSLNGVIPANLSQIYGLRYLNLSSNNLEGEIPRSLA 721
Query: 721 SRFNDPSIFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSL 780
S FNDPS+FAMN ELCGKPL REC NVR RKRKRL +LI V+ AG LL LCCCGYIYSL
Sbjct: 722 SHFNDPSVFAMNGELCGKPLGRECTNVRNRKRKRLFLLIGVTVAGGFLLLLCCCGYIYSL 781
Query: 781 LRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFD 840
LRWR+ LR GEKKPSP+R SSGAER R SGENGGPKLVMFNNKITY ETLEATRQFD
Sbjct: 782 LRWRKRLREGLNGEKKPSPARTSSGAERSRRSGENGGPKLVMFNNKITYAETLEATRQFD 841
Query: 841 EENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY 900
EENVLSRGRYGL+FKASYQDGMVLSIRRL D +IDE TFRKEAE+LGKVKHRNLTVLRGY
Sbjct: 842 EENVLSRGRYGLVFKASYQDGMVLSIRRLPDASIDEGTFRKEAESLGKVKHRNLTVLRGY 901
Query: 901 YAG-PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM 959
YAG PPDVRLLVYDYMPNGNLATLLQEAS+QDGHVLNWPMRHLI+LG+ARGL+FLHSL M
Sbjct: 902 YAGPPPDVRLLVYDYMPNGNLATLLQEASYQDGHVLNWPMRHLIALGIARGLAFLHSLSM 961
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPT 1019
VHGDIKPQNVLFDADFEAHLSEFGL++L I TPAEAS S+TPIGSLGY SPEAA TGQPT
Sbjct: 962 VHGDIKPQNVLFDADFEAHLSEFGLEKLTIPTPAEASISSTPIGSLGYFSPEAALTGQPT 1021
Query: 1020 KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079
KEAD YS+GIVLLEILTGRKPVMFTQDEDIVKWVK+QLQ GQ+SELLEPGLLELDPESSE
Sbjct: 1022 KEADAYSYGIVLLEILTGRKPVMFTQDEDIVKWVKRQLQTGQVSELLEPGLLELDPESSE 1081
Query: 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPS 1131
WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD+PSSADPT+LPS
Sbjct: 1082 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDIPSSADPTTLPS 1133
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458087|ref|XP_002280668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1671 bits (4328), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 852/1130 (75%), Positives = 971/1130 (85%), Gaps = 9/1130 (0%)
Query: 8 TAIFLFVTLTHFA----YGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDW 63
TAIFL+++L FA +++A LSEI+ALT+FKL+L DPLGALDGW+SSTPSAPCDW
Sbjct: 3 TAIFLYLSLLLFAPTLTCAQRSADALSEIKALTAFKLNLHDPLGALDGWNSSTPSAPCDW 62
Query: 64 RGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRA 123
RGI+CYN RV ELRLPRLQL GRLTDQL++L +LRKLSLHSN NGS+P SL QCSLLRA
Sbjct: 63 RGILCYNGRVWELRLPRLQLGGRLTDQLSNLRQLRKLSLHSNAFNGSVPLSLSQCSLLRA 122
Query: 124 VYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPG 183
VYL YNSFSG LP ++ NLTNL VLNVAHN LSG I ++ +LRYLDLSSNAF+G IP
Sbjct: 123 VYLHYNSFSGGLPPALTNLTNLQVLNVAHNFLSGGIPGNLPRNLRYLDLSSNAFSGNIPA 182
Query: 184 NFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLS 243
NFS S LQLINLS+N FSG VPAS+G+LQ+L+YLWLDSN LYGT+PSAISNCSSL+HLS
Sbjct: 183 NFSVASSLQLINLSFNQFSGGVPASIGELQQLQYLWLDSNQLYGTIPSAISNCSSLLHLS 242
Query: 244 AEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFT 303
AEDN LKGLIP T+G I L+VLSLSRNEL+G VP S+ CN+ N +L IVQLGFNAFT
Sbjct: 243 AEDNALKGLIPATLGAIPKLRVLSLSRNELSGSVPASMFCNVSANPPTLVIVQLGFNAFT 302
Query: 304 GVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLD 363
G+ KP N SVLEVLDLQ N I VFPSWLT V++LR++DLSGNFFSG LP +G+L
Sbjct: 303 GIFKPQNATFFSVLEVLDLQENHIHGVFPSWLTEVSTLRILDLSGNFFSGVLPIEIGNLL 362
Query: 364 KLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMF 423
+LE LRVANNSL G VP EI KCSLLQ+ DLEGNRFSGQ+P FLG + LK +SLGRN F
Sbjct: 363 RLEELRVANNSLQGEVPREIQKCSLLQVLDLEGNRFSGQLPPFLGALTSLKTLSLGRNHF 422
Query: 424 SGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLK 483
SG IP SF NLSQLE LNLSEN++ G++ EE+ LSNL+ LNLS+NKF G+V ++G+L
Sbjct: 423 SGSIPASFRNLSQLEVLNLSENNLIGDVLEELLLLSNLSILNLSFNKFYGEVWSNIGDLS 482
Query: 484 GLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
L LN+S GFSG++P SIGSLM+L TLDLS QN+SGELP+E+FGLP+LQVV+L+EN
Sbjct: 483 SLQELNMSGCGFSGRLPKSIGSLMKLATLDLSKQNMSGELPLEIFGLPNLQVVALQENLF 542
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603
SGDVPEGFSSL+ ++YLNLS NAF+G++PAT+GFL+SLV LSLS N +S +IP+ELG CS
Sbjct: 543 SGDVPEGFSSLLSMRYLNLSSNAFSGEVPATFGFLQSLVVLSLSQNHVSSVIPSELGNCS 602
Query: 604 ALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSL 663
LE LELRSN +G IP ++S LS +K+LDLGQN L+GEIP++ISKCSS+ SL LD N L
Sbjct: 603 DLEALELRSNRLSGEIPGELSRLSHLKELDLGQNNLTGEIPEDISKCSSMTSLLLDANHL 662
Query: 664 SGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRF 723
SG IP+S SKLSNLT LNLS+NR SG IP + + IS+L+YLNLS+NNLEGEIPKML S+F
Sbjct: 663 SGPIPDSLSKLSNLTMLNLSSNRFSGVIPVNFSGISTLKYLNLSQNNLEGEIPKMLGSQF 722
Query: 724 NDPSIFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRW 783
DPS+FAMN +LCGKPL EC V KRKR++LI+L+CV+ GA LLALCCCGYI+SLLRW
Sbjct: 723 TDPSVFAMNPKLCGKPLKEECEGVTKRKRRKLILLVCVAVGGATLLALCCCGYIFSLLRW 782
Query: 784 RQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEEN 843
R+ LR A GEKK SP+ SSG ERGRGSGENGGPKLVMFNNKITY ETLEATRQFDEEN
Sbjct: 783 RKKLREGAAGEKKRSPAP-SSGGERGRGSGENGGPKLVMFNNKITYAETLEATRQFDEEN 841
Query: 844 VLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAG 903
VLSRGRYGL+FKAS+QDGMVLSIRRL DG+I+ENTFRKEAE+LGKVKHRNLTVLRGYYAG
Sbjct: 842 VLSRGRYGLVFKASFQDGMVLSIRRLPDGSIEENTFRKEAESLGKVKHRNLTVLRGYYAG 901
Query: 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGD 963
PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI+LG+ARGLSFLHS+ MVHGD
Sbjct: 902 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLSFLHSVSMVHGD 961
Query: 964 IKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEAD 1023
+KPQNVLFDADFEAHLS+FGLDRL I TPAE SSSTTPIGSLGYVSPEAA TG EAD
Sbjct: 962 VKPQNVLFDADFEAHLSDFGLDRLTIPTPAEPSSSTTPIGSLGYVSPEAALTG----EAD 1017
Query: 1024 VYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEF 1083
VYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE+DPESSEWEEF
Sbjct: 1018 VYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEIDPESSEWEEF 1077
Query: 1084 LLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSPM 1133
LLGVKVGLLCTAPDPLDRPSM+DIVFMLEGCRVGPD+PSSADPTSLPSP+
Sbjct: 1078 LLGVKVGLLCTAPDPLDRPSMSDIVFMLEGCRVGPDIPSSADPTSLPSPV 1127
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476840|ref|XP_003631896.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1561 bits (4043), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 789/1134 (69%), Positives = 938/1134 (82%), Gaps = 7/1134 (0%)
Query: 1 MAATSTATAIFLFVTLTHF-AYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSA 59
MA T T FL ++ T F + +++A L+EI+ALT+FKL+L DPLG L+GWDSSTPSA
Sbjct: 1 MAVTLTPL-FFLMLSFTPFLSCAQRSAETLAEIEALTAFKLNLHDPLGVLNGWDSSTPSA 59
Query: 60 PCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCS 119
PCDWRG+ C + RV +LRLPRLQL GRLTD L DL +LRKLSL SN NG+IP+SL +C+
Sbjct: 60 PCDWRGVGCSSGRVSDLRLPRLQLGGRLTDHLGDLTQLRKLSLRSNAFNGTIPSSLSKCT 119
Query: 120 LLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTG 179
LLRAV+LQYNSFSG+LP I NLTNL V NVA NLLSG++ D+ +LRYLDLSSN F+G
Sbjct: 120 LLRAVFLQYNSFSGNLPPEIGNLTNLQVFNVAQNLLSGEVPGDLPLTLRYLDLSSNLFSG 179
Query: 180 EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSL 239
+IP +FS+ S LQLINLSYN FSGE+P + G LQ+L+YLWLD N L GTLPSAI+NCS+L
Sbjct: 180 QIPASFSAASDLQLINLSYNDFSGEIPVTFGALQQLQYLWLDYNFLDGTLPSAIANCSAL 239
Query: 240 VHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGF 299
+HLS E N L+G++P I + LQV+SLS N L+G VP S+ CN +SSLRIVQLGF
Sbjct: 240 IHLSVEGNALRGVVPVAIASLPKLQVISLSHNNLSGAVPSSMFCN----VSSLRIVQLGF 295
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV 359
NAFT +V P C SVL+VLD+Q N + VFP WLT VTSL ++D+SGN F+G LP +
Sbjct: 296 NAFTDIVAPGTATCSSVLQVLDVQQNLMHGVFPLWLTFVTSLTMLDVSGNSFAGALPVQI 355
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419
G+L +L+ L++ANNSL G +P+E+ KCS L++ DLEGN+FSG VPAFLG + LK +SLG
Sbjct: 356 GNLLRLQELKMANNSLDGEIPEELRKCSYLRVLDLEGNQFSGAVPAFLGDLTSLKTLSLG 415
Query: 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV 479
N+FSGLIP FG LSQLETLNL N++ G IPEE+ RLSNLTTL+LS+NK G++P ++
Sbjct: 416 ENLFSGLIPPIFGKLSQLETLNLRHNNLSGTIPEELLRLSNLTTLDLSWNKLSGEIPANI 475
Query: 480 GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
GNL LLVLN+S + +SGKIP ++G+L +LTTLDLS Q LSGE+P EL GLP+LQ+++L+
Sbjct: 476 GNLSKLLVLNISGNAYSGKIPATVGNLFKLTTLDLSKQKLSGEVPDELSGLPNLQLIALQ 535
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
EN LSGDVPEGFSSLV L+YLNLS N+F+G IPAT+GFL+S+V LSLS N I G+IP+E+
Sbjct: 536 ENMLSGDVPEGFSSLVSLRYLNLSSNSFSGHIPATFGFLQSVVVLSLSENLIGGLIPSEI 595
Query: 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLD 659
G CS L VLEL SN +G+IP D+S LS + +L+LG+N L+GEIP+EISKCS+L SL LD
Sbjct: 596 GNCSELRVLELGSNSLSGDIPADLSRLSHLNELNLGRNNLTGEIPEEISKCSALTSLLLD 655
Query: 660 MNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKML 719
N LSG IP S S LSNLTTL+LSTN L+G IPA+L LIS L N+SRN+LEGEIP +L
Sbjct: 656 TNHLSGHIPNSLSNLSNLTTLDLSTNNLTGEIPANLTLISGLVNFNVSRNDLEGEIPGLL 715
Query: 720 SSRFNDPSIFAMNRELCGKPLDRECANVRKR-KRKRLIILICVSAAGACLLALCCCGYIY 778
SRFN+PS+FAMN LCGKPLDR+C + +RKRLI+L V+A+GACL+ALCCC YI+
Sbjct: 716 GSRFNNPSVFAMNENLCGKPLDRKCKEINTGGRRKRLILLFAVAASGACLMALCCCFYIF 775
Query: 779 SLLRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQ 838
SLLRWR+ L+ A GEKK SP+R SSGA GRGS +NGGPKLVMFNN IT ET EATRQ
Sbjct: 776 SLLRWRKRLKEGAAGEKKRSPARASSGASGGRGSTDNGGPKLVMFNNNITLAETSEATRQ 835
Query: 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLR 898
FDEENVLSR RYGL+FKA Y DGMVLSIRRL DG +DENTFRKEAEALGKVKHRNLTVLR
Sbjct: 836 FDEENVLSRTRYGLVFKACYNDGMVLSIRRLPDGLLDENTFRKEAEALGKVKHRNLTVLR 895
Query: 899 GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
GYYAG DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI+LG+ARGL+FLH+
Sbjct: 896 GYYAGASDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHTAS 955
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
MVHGD+KPQNVLFDADFEAHLS+FGLDRL IA PAEAS+S+T +G+LGYVSPEA TG+
Sbjct: 956 MVHGDVKPQNVLFDADFEAHLSDFGLDRLTIAAPAEASTSSTSVGTLGYVSPEAVLTGET 1015
Query: 1019 TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESS 1078
TKE+DVYSFGIVLLE+LTG++PVMFTQDEDIVKWVK+QLQRGQ+SELLEPGLLELDPESS
Sbjct: 1016 TKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKRQLQRGQVSELLEPGLLELDPESS 1075
Query: 1079 EWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
EWEEFLLGVKVGLLCTAPDPLDRP+MAD VFMLEGCRVGPD+PSSADPTS PSP
Sbjct: 1076 EWEEFLLGVKVGLLCTAPDPLDRPTMADTVFMLEGCRVGPDIPSSADPTSQPSP 1129
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517992|ref|XP_003527668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1492 bits (3862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 798/1137 (70%), Positives = 927/1137 (81%), Gaps = 18/1137 (1%)
Query: 7 ATAIFLFVTLTHF------AYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAP 60
T IF +TL F + N + EIQALTSFK +L DPLG+LD WD STPSAP
Sbjct: 3 TTVIFFSLTLVAFFATLNITFAHNNTAL--EIQALTSFKRNLHDPLGSLDTWDPSTPSAP 60
Query: 61 CDWRGIVCYNNRVRELRLPRLQLAGRLT-DQLADLHELRKLSLHSNHLNGSIPASLHQCS 119
CDWRGIVC+NNRV +LRLPRLQLAG+L + L++L +LRKLSLHSN+LN SIP SL +C
Sbjct: 61 CDWRGIVCHNNRVHQLRLPRLQLAGQLAPNSLSNLLQLRKLSLHSNNLNSSIPLSLTRCV 120
Query: 120 LLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTG 179
LRAVYL N SGHLP + NLTNL +LN+A NLL+GK+ +S SLR+LDLS NAF+G
Sbjct: 121 FLRAVYLHNNKLSGHLPPPLLNLTNLQILNLAGNLLTGKVPGHLSASLRFLDLSDNAFSG 180
Query: 180 EIPGNFSSKS-QLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSS 238
+IP NFSSKS QLQLINLSYNSF+G +PAS+G LQ L+YLWLDSNH++GTLPSA++NCSS
Sbjct: 181 DIPANFSSKSSQLQLINLSYNSFTGGIPASIGTLQFLQYLWLDSNHIHGTLPSALANCSS 240
Query: 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLG 298
LVHL+AEDN L GL+P T+G + L VLSLSRN+L+G VP SV CN + LR V+LG
Sbjct: 241 LVHLTAEDNALTGLLPPTLGTMPKLHVLSLSRNQLSGSVPASVFCN-----AHLRSVKLG 295
Query: 299 FNAFTGVVKPPNGRCVSVLEVLDLQNNRI-RAVFPSWLTN--VTSLRVMDLSGNFFSGNL 355
FN+ TG P N C SVLEVLD++ NRI A FPSWLT+ TSL+ +DLSGNFF+G+L
Sbjct: 296 FNSLTGFYTPQNVECDSVLEVLDVKENRIAHAPFPSWLTHAATTSLKALDLSGNFFTGSL 355
Query: 356 PAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKI 415
P +G+L LE LRV NN LSG VP I +C L + DLEGNRFSG +P FLG +R LK
Sbjct: 356 PVDIGNLSALEELRVKNNLLSGGVPRSIVRCRGLTVLDLEGNRFSGLIPEFLGELRNLKE 415
Query: 416 VSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV 475
+SL N F+G +P S+G LS LETLNLS+N + G +P+EI +L N++ LNLS NKF G+V
Sbjct: 416 LSLAGNKFTGSVPSSYGTLSALETLNLSDNKLTGVVPKEIMQLGNVSALNLSNNKFSGQV 475
Query: 476 PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQV 535
++G++ GL VLNLS GFSG++P S+GSLMRLT LDLS QNLSGELP+E+FGLPSLQV
Sbjct: 476 WANIGDMTGLQVLNLSQCGFSGRVPSSLGSLMRLTVLDLSKQNLSGELPLEVFGLPSLQV 535
Query: 536 VSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMI 595
V+L+EN+LSGDVPEGFSS+V L+YLNLS N F G+IP TYGFL SL LSLSHN +SG I
Sbjct: 536 VALQENHLSGDVPEGFSSIVSLRYLNLSSNEFVGNIPITYGFLSSLTVLSLSHNGVSGEI 595
Query: 596 PAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS 655
P E+G CS L+VL+LRSN GNI DIS LSR+K+L+LG N+L G+IP EIS+C SL S
Sbjct: 596 PPEIGGCSQLQVLQLRSNFLEGNILGDISRLSRLKELNLGHNRLKGDIPDEISECPSLSS 655
Query: 656 LTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEI 715
L LD N +G IP S SKLSNLT LNLS+N+L+G IP +L+ IS L YLN+S NNLEGEI
Sbjct: 656 LLLDSNHFTGHIPGSLSKLSNLTVLNLSSNQLTGKIPVELSSISGLEYLNVSSNNLEGEI 715
Query: 716 PKMLSSRFNDPSIFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCCCG 775
P ML + FNDPS+FAMN+ LCGKPL RECAN ++RKR+RLII I V+ AG CLLALCCCG
Sbjct: 716 PHMLGATFNDPSVFAMNQGLCGKPLHRECANEKRRKRRRLIIFIGVAVAGLCLLALCCCG 775
Query: 776 YIYSLLRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEA 835
Y+YSLLRWR+ LR TGEKK SP+ S G RGSGENGGPKLVMFNNKIT ETLEA
Sbjct: 776 YVYSLLRWRKKLRERVTGEKKRSPTTSSGGERGSRGSGENGGPKLVMFNNKITLAETLEA 835
Query: 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT 895
TR FDEENVLSRGRYGL+FKASYQDGMVLSIRR DG DE TFRKEAE+LGKVKHRNLT
Sbjct: 836 TRNFDEENVLSRGRYGLVFKASYQDGMVLSIRRFVDGFTDEATFRKEAESLGKVKHRNLT 895
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
VLRGYYAGPPD+RLLVYDYMPNGNL TLLQEAS QDGHVLNWPMRHLI+LG+ARGL+FLH
Sbjct: 896 VLRGYYAGPPDMRLLVYDYMPNGNLGTLLQEASQQDGHVLNWPMRHLIALGIARGLAFLH 955
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
S+ +VHGD+KPQNVLFDADFEAHLSEFGL+RL + PAEASSS+T +GSLGYVSPEAAS+
Sbjct: 956 SMPIVHGDVKPQNVLFDADFEAHLSEFGLERLTLTAPAEASSSSTAVGSLGYVSPEAASS 1015
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
G TKE DVYSFGIVLLEILTG+KPVMFT+DEDIVKWVKKQLQRGQISELLEPGLLELDP
Sbjct: 1016 GMATKEGDVYSFGIVLLEILTGKKPVMFTEDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
Query: 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
ESSEWEEFLLGVKVGLLCTA DPLDRPSM+D+ FML+GCRVGP++PSSADPT+LPSP
Sbjct: 1076 ESSEWEEFLLGVKVGLLCTATDPLDRPSMSDVAFMLQGCRVGPEIPSSADPTTLPSP 1132
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509642|ref|XP_003523555.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1472 bits (3811), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 798/1131 (70%), Positives = 924/1131 (81%), Gaps = 16/1131 (1%)
Query: 6 TATAIFLFVTLTHFAYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRG 65
T A F +TL H N EIQALTSFK L DPLG+LDGWD STPSAPCDWRG
Sbjct: 11 TLVAFFATLTLAH-----NNTSF--EIQALTSFKRSLHDPLGSLDGWDPSTPSAPCDWRG 63
Query: 66 IVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVY 125
IVC+NNRV +LRLPRLQL+G+L+ L++L LRKLSLHSN LN SIP SL +C LRAVY
Sbjct: 64 IVCHNNRVHQLRLPRLQLSGQLSPSLSNLLLLRKLSLHSNDLNSSIPLSLTRCVFLRAVY 123
Query: 126 LQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNF 185
L N SGHLP + NLTNL +LN+A NLL+GK+ +S SLR+LDLS NAF+G+IP NF
Sbjct: 124 LHNNKLSGHLPPPLLNLTNLQILNLARNLLTGKVPCYLSASLRFLDLSDNAFSGDIPANF 183
Query: 186 SSKS-QLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSA 244
SSKS QLQLINLSYNSFSG +PAS+G LQ L+YLWLDSNH++G LPSA++NCSSLVHL+A
Sbjct: 184 SSKSSQLQLINLSYNSFSGGIPASIGTLQFLQYLWLDSNHIHGILPSALANCSSLVHLTA 243
Query: 245 EDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTG 304
EDN L GL+P T+G + LQVLSLSRN+L+G VP SV CN + LR V+LGFN+ TG
Sbjct: 244 EDNALTGLLPPTLGSMPKLQVLSLSRNQLSGSVPASVFCN-----AHLRSVKLGFNSLTG 298
Query: 305 VVKPPNGRCVSVLEVLDLQNNRI-RAVFPSWLTN--VTSLRVMDLSGNFFSGNLPAAVGS 361
P +G C SVLEVLD++ N I A FP+WLT+ TSL+++D+SGNFF+G+LP +G+
Sbjct: 299 FSTPQSGECDSVLEVLDVKENGIAHAPFPTWLTHAATTSLKLLDVSGNFFAGSLPVDIGN 358
Query: 362 LDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRN 421
L L+ LR+ NN LSG VP I C LL + DLEGNRFSG +P FLG + LK +SLG N
Sbjct: 359 LSALQELRMKNNLLSGEVPVSIVSCRLLTVLDLEGNRFSGLIPEFLGELPNLKELSLGGN 418
Query: 422 MFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGN 481
+F+G +P S+G LS LETLNLS+N + G +P+EI +L N++ LNLS N F G+V ++G+
Sbjct: 419 IFTGSVPSSYGTLSALETLNLSDNKLTGVVPKEIMQLGNVSALNLSNNNFSGQVWSNIGD 478
Query: 482 LKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEEN 541
L GL VLNLS GFSG++P S+GSLMRLT LDLS QNLSGELP+E+FGLPSLQVV+L+EN
Sbjct: 479 LTGLQVLNLSQCGFSGRVPSSLGSLMRLTVLDLSKQNLSGELPLEVFGLPSLQVVALQEN 538
Query: 542 NLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGA 601
LSG+VPEGFSS+V LQYLNL+ N F G IP TYGFL SL LSLSHN +SG IP E+G
Sbjct: 539 RLSGEVPEGFSSIVSLQYLNLTSNEFVGSIPITYGFLGSLRVLSLSHNGVSGEIPPEIGG 598
Query: 602 CSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661
CS LEV +LRSN GNIP DIS LSR+K+L+LG NKL G+IP EIS+CS+L SL LD N
Sbjct: 599 CSQLEVFQLRSNFLEGNIPGDISRLSRLKELNLGHNKLKGDIPDEISECSALSSLLLDSN 658
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
+G IP S SKLSNLT LNLS+N+L G IP +L+ IS L Y N+S NNLEGEIP ML +
Sbjct: 659 HFTGHIPGSLSKLSNLTVLNLSSNQLIGEIPVELSSISGLEYFNVSNNNLEGEIPHMLGA 718
Query: 722 RFNDPSIFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLL 781
FNDPS+FAMN+ LCGKPL RECAN +RKR+RLII I V+ AG CLLALCCCGY+YSLL
Sbjct: 719 TFNDPSVFAMNQGLCGKPLHRECANEMRRKRRRLIIFIGVAVAGLCLLALCCCGYVYSLL 778
Query: 782 RWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDE 841
RWR+ LR TGEKK SP+ S G RGSGENGGPKLVMFNNKIT ETLEATR FDE
Sbjct: 779 RWRKKLREGVTGEKKRSPTTSSGGERGSRGSGENGGPKLVMFNNKITLAETLEATRNFDE 838
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
ENVLSRGRYGL+FKASYQDGMVLSIRR DG IDE+TFRKEAE+LGKVKHRNLTVLRGYY
Sbjct: 839 ENVLSRGRYGLVFKASYQDGMVLSIRRFVDGFIDESTFRKEAESLGKVKHRNLTVLRGYY 898
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
AGPP++RLLVYDYMPNGNL TLLQEAS QDGHVLNWPMRHLI+LG+ARGL+FLHS+ +VH
Sbjct: 899 AGPPEMRLLVYDYMPNGNLGTLLQEASQQDGHVLNWPMRHLIALGIARGLAFLHSVPIVH 958
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKE 1021
GD+KPQNVLFDADFEAHLSEFGL+RL IA PAEASSS+TP+GSLGYVSPEAAS+G TKE
Sbjct: 959 GDVKPQNVLFDADFEAHLSEFGLERLTIAAPAEASSSSTPVGSLGYVSPEAASSGMATKE 1018
Query: 1022 ADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWE 1081
DVYSFGIVLLEILTG+KPVMFT+DEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWE
Sbjct: 1019 GDVYSFGIVLLEILTGKKPVMFTEDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWE 1078
Query: 1082 EFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
EFLLGVKVGLLCTA DPLDRPSM+D+ FML+GCRVGP++PSSADPT+LPSP
Sbjct: 1079 EFLLGVKVGLLCTATDPLDRPSMSDVAFMLQGCRVGPEIPSSADPTTLPSP 1129
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255581412|ref|XP_002531514.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223528867|gb|EEF30868.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1456 bits (3770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 758/1108 (68%), Positives = 911/1108 (82%), Gaps = 4/1108 (0%)
Query: 29 LSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLT 88
L+EI++L SFKL+L DPLGAL+GWDSSTPSAPCDWRG+ C NRV ELRLP LQL GRL+
Sbjct: 29 LAEIESLMSFKLNLDDPLGALNGWDSSTPSAPCDWRGVFCTKNRVTELRLPNLQLGGRLS 88
Query: 89 DQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVL 148
D L++L L KLSL SN NG+IP+SL +C+LLRA++LQYNS SG+LP + NLT L VL
Sbjct: 89 DHLSNLQMLSKLSLRSNSFNGTIPSSLSKCTLLRALFLQYNSLSGNLPPDMSNLTQLQVL 148
Query: 149 NVAHNLLSGKISAD-ISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPA 207
NVA N LSG+IS++ + P+L Y+DLSSN+F +P + S+ SQLQLINLSYN FSG +PA
Sbjct: 149 NVAQNHLSGQISSNNLPPNLVYMDLSSNSFISALPESISNMSQLQLINLSYNQFSGPIPA 208
Query: 208 SVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLS 267
S G LQ L++LWLD NHL GTLPSAI NCSSLVHLSA N L G+IP IG + LQVLS
Sbjct: 209 SFGHLQYLQFLWLDYNHLVGTLPSAIVNCSSLVHLSANGNALGGVIPAAIGALPHLQVLS 268
Query: 268 LSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNR 326
LS N L+G VP+S+ CN+ SLRIVQLGFN F+ +V P +G C SVL+VLDL N+
Sbjct: 269 LSENNLSGSVPLSIFCNVSVYPPSLRIVQLGFNGFSEIVGPESGGDCFSVLQVLDLSKNQ 328
Query: 327 IRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKC 386
I FP WLT V SL ++D SGN FSG +PA +G + +LE L +ANNS SG +P E+ +C
Sbjct: 329 IHGGFPVWLTKVASLTMLDFSGNLFSGEIPAEIGDMSRLEQLWMANNSFSGALPVEMKQC 388
Query: 387 SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
S L++ DLE NRFSG++PAFL IR LK +SLG N F G +P +F + +QLETL+L +N
Sbjct: 389 SSLRVLDLERNRFSGEIPAFLSDIRALKELSLGGNQFFGSVPATFRSFTQLETLSLHDNG 448
Query: 447 IRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSL 506
+ G++PEE+ +SNLTTL++S NKF G++P ++GNL ++ LNLS + FSGKIP S+G+L
Sbjct: 449 LNGSLPEELITMSNLTTLDVSGNKFSGEIPANIGNLSRIMSLNLSRNVFSGKIPSSLGNL 508
Query: 507 MRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566
+RLTTLDLS QNLSG++P EL GLP+LQV++L+EN LSGD+ EGFSSL+GL+YLNLS N
Sbjct: 509 LRLTTLDLSKQNLSGQVPSELSGLPNLQVIALQENRLSGDIREGFSSLMGLRYLNLSSNG 568
Query: 567 FTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHL 626
+G IP TYGFLRSLV LSLS+N ISG+IP ELG CS LE+ EL+SN+ TG+IP D+SHL
Sbjct: 569 LSGQIPPTYGFLRSLVVLSLSNNHISGVIPPELGNCSDLEIFELQSNYVTGHIPADLSHL 628
Query: 627 SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686
S +K L+LG+N LSG+IP+EIS+CSSL SL LD N LSG IP+S S LSNL++L+LSTN
Sbjct: 629 SHLKVLNLGKNNLSGDIPEEISQCSSLTSLLLDTNHLSGSIPDSLSNLSNLSSLDLSTNN 688
Query: 687 LSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPLDRECAN 746
LSG IPA+L I+SL YLN+S NNLEGEIP +L SRFNDPS FA N ELCGKPL+R+C +
Sbjct: 689 LSGEIPANLTRIASLAYLNVSGNNLEGEIPFLLGSRFNDPSAFAGNAELCGKPLNRKCVD 748
Query: 747 VRKR-KRKRLIILICVSAAGACLLALCCCGYIYSLLRWRQTLRA-WATGEKKPSPSRGSS 804
+ +R +RKRLI+LI ++A+GACLL LCCC Y++SLLRWR+ L+ A GEKK SP+R SS
Sbjct: 749 LAERDRRKRLILLIVIAASGACLLTLCCCFYVFSLLRWRKRLKQRAAAGEKKRSPARASS 808
Query: 805 GAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKASYQDGMVL 864
A GRGS +NGGPKL+MFNNKIT ET+EATRQFDEENVLSR RYGL+FKA Y DGMVL
Sbjct: 809 AASGGRGSTDNGGPKLIMFNNKITLAETIEATRQFDEENVLSRTRYGLVFKACYNDGMVL 868
Query: 865 SIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLL 924
SIRRL DG++DEN FRKEAE L KVKHRNLTVLRGYYAGPPD+RLLVYDYMPNGNLATLL
Sbjct: 869 SIRRLPDGSMDENMFRKEAEFLSKVKHRNLTVLRGYYAGPPDMRLLVYDYMPNGNLATLL 928
Query: 925 QEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984
QEASHQDGHVLNWPMRHLI+LG+ARGL+FLH+ +MVHGDIKPQNVLFDADFEAHLS+FGL
Sbjct: 929 QEASHQDGHVLNWPMRHLIALGIARGLAFLHTSNMVHGDIKPQNVLFDADFEAHLSDFGL 988
Query: 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFT 1044
+ L A +SS+T +G+LGYVSPE TG+ TKE+DVYSFGIVLLE+LTG++PVMFT
Sbjct: 989 EHLTTAATTAEASSSTTVGTLGYVSPEVILTGEVTKESDVYSFGIVLLELLTGKRPVMFT 1048
Query: 1045 QDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104
+DEDIVKWVKKQLQRGQI+ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP+M
Sbjct: 1049 EDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPTM 1108
Query: 1105 ADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
+DIVFMLEGCRV D+PSSADPTS PSP
Sbjct: 1109 SDIVFMLEGCRVATDIPSSADPTSQPSP 1136
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531097|ref|XP_004172524.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1451 bits (3757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 759/1129 (67%), Positives = 914/1129 (80%), Gaps = 3/1129 (0%)
Query: 6 TATAIFLFVTLTHFAY-GEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWR 64
++ F+F+ F+ + A EIQAL SFKL+L DPLGAL WDSSTP APCDWR
Sbjct: 3 ASSVFFVFLCGGLFSSSADTGAQTQLEIQALMSFKLNLHDPLGALTAWDSSTPLAPCDWR 62
Query: 65 GIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAV 124
G+VC NNRV ELRLPRLQL+GRLTDQLA+L LRK S+ SN NG+IP+SL +C+LLR++
Sbjct: 63 GVVCTNNRVTELRLPRLQLSGRLTDQLANLRMLRKFSIRSNFFNGTIPSSLSKCALLRSL 122
Query: 125 YLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGN 184
+LQYN FSG LP NLTNL VLNVA N LSG IS+D+ SL+YLDLSSNAF+G+IP +
Sbjct: 123 FLQYNLFSGGLPAEFGNLTNLHVLNVAENRLSGVISSDLPSSLKYLDLSSNAFSGQIPRS 182
Query: 185 FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSA 244
+ +QLQ++NLS+N F GE+PAS G+LQEL++LWLD N L GTLPSA++NCSSLVHLS
Sbjct: 183 VVNMTQLQVVNLSFNRFGGEIPASFGELQELQHLWLDHNVLEGTLPSALANCSSLVHLSV 242
Query: 245 EDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTG 304
E N L+G+IP IG ++ LQV+SLS+N L+G VP S+ CN+ + SLRIVQLGFNAFT
Sbjct: 243 EGNALQGVIPAAIGALTNLQVISLSQNGLSGSVPYSMFCNVSSHAPSLRIVQLGFNAFTD 302
Query: 305 VVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDK 364
+VKP C S L+VLD+Q+N+IR FP WLT V++L V+D S N FSG +P+ +G+L
Sbjct: 303 IVKPQTATCFSALQVLDIQHNQIRGEFPLWLTGVSTLSVLDFSVNHFSGQIPSGIGNLSG 362
Query: 365 LEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424
L+ LR++NNS G +P EI C+ + + D EGNR +G++P+FLG +RGLK +SLG N FS
Sbjct: 363 LQELRMSNNSFQGEIPLEIKNCASISVIDFEGNRLTGEIPSFLGYMRGLKRLSLGGNRFS 422
Query: 425 GLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKG 484
G +P S GNL +LE LNL +N + G P E+ L NLT + L NK G+VP +GNL
Sbjct: 423 GTVPASLGNLLELEILNLEDNGLNGTFPLELMGLGNLTVMELGGNKLSGEVPTGIGNLSR 482
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS 544
L +LNLSA+ SG IP S+G+L +LTTLDLS QNLSGELP EL GLP+LQV++L+EN LS
Sbjct: 483 LEILNLSANSLSGMIPSSLGNLFKLTTLDLSKQNLSGELPFELSGLPNLQVIALQENKLS 542
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA 604
G+VPEGFSSLVGL+YLNLS N F+G IP+ YGFLRSLV LSLS N ISG++P++LG CS
Sbjct: 543 GNVPEGFSSLVGLRYLNLSSNRFSGQIPSNYGFLRSLVSLSLSDNHISGLVPSDLGNCSD 602
Query: 605 LEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664
LE LE+RSN +G+IP D+S LS +++LDLG+N L+GEIP+EIS CS+L SL L+ N LS
Sbjct: 603 LETLEVRSNALSGHIPADLSRLSNLQELDLGRNNLTGEIPEEISSCSALESLRLNSNHLS 662
Query: 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFN 724
G IP S S+LSNLTTL+LS+N LSG IPA+L+ I+ L LN+S NNLEG+IP +L SRFN
Sbjct: 663 GPIPGSLSELSNLTTLDLSSNNLSGVIPANLSSITGLTSLNVSSNNLEGKIPSLLGSRFN 722
Query: 725 DPSIFAMNRELCGKPLDREC-ANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRW 783
S+FA N +LCGKPL R C +K K KRLI+ I V+A+GA LL LCCC YI+SLLRW
Sbjct: 723 SSSVFANNSDLCGKPLARHCKDTDKKDKMKRLILFIAVAASGAVLLTLCCCFYIFSLLRW 782
Query: 784 RQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEEN 843
R+ L+ A+GEKK SP+R SS GRGS ENGGPKLVMFNNKIT ET+EATRQFDEEN
Sbjct: 783 RKRLKERASGEKKTSPARVSSAGSGGRGSSENGGPKLVMFNNKITLAETIEATRQFDEEN 842
Query: 844 VLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAG 903
VLSR RYGL+FKA Y DGMVLSIRRL +G++DEN FRKEAEALGKV+HRNLTVLRGYYAG
Sbjct: 843 VLSRTRYGLVFKACYNDGMVLSIRRLSNGSLDENMFRKEAEALGKVRHRNLTVLRGYYAG 902
Query: 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGD 963
PPD+RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI+LG+ARGL+FLHS ++HGD
Sbjct: 903 PPDMRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHSSSIIHGD 962
Query: 964 IKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEAD 1023
+KPQ+VLFDADFEAHLS+FGLDRL IA AEAS+ST +G+LGY++PEA TG+ TKE+D
Sbjct: 963 VKPQSVLFDADFEAHLSDFGLDRLTIAASAEASTSTL-VGTLGYIAPEAVLTGEATKESD 1021
Query: 1024 VYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEF 1083
VYSFGIVLLEILTG+KPVMFT+DEDIVKWVKKQLQRGQI+ELLEPGLLELDPESSEWEEF
Sbjct: 1022 VYSFGIVLLEILTGKKPVMFTEDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEF 1081
Query: 1084 LLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
LLGVKVGLLCTAPDP DRP+M+DIVFMLEGCRVGPD+PSSADPTS PSP
Sbjct: 1082 LLGVKVGLLCTAPDPRDRPTMSDIVFMLEGCRVGPDIPSSADPTSQPSP 1130
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434496|ref|XP_004135032.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g36180-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1450 bits (3754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 759/1127 (67%), Positives = 912/1127 (80%), Gaps = 5/1127 (0%)
Query: 10 IFLFVTLTHFAY---GEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGI 66
+F FV L + + A EIQAL SFKL+L DPLGAL WDSSTP APCDWRG+
Sbjct: 5 LFFFVFLCGGLFSSSADTGAQTQLEIQALMSFKLNLHDPLGALTAWDSSTPLAPCDWRGV 64
Query: 67 VCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYL 126
VC NNRV ELRLPRLQL+GRLTDQLA+L LRK S+ SN NG+IP+SL +C+LLR+++L
Sbjct: 65 VCTNNRVTELRLPRLQLSGRLTDQLANLRMLRKFSIRSNFFNGTIPSSLSKCALLRSLFL 124
Query: 127 QYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFS 186
QYN FSG LP NLTNL VLNVA N LSG IS+D+ SL+YLDLSSNAF+G+IP +
Sbjct: 125 QYNLFSGGLPAEFGNLTNLHVLNVAENRLSGVISSDLPSSLKYLDLSSNAFSGQIPRSVV 184
Query: 187 SKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAED 246
+ +QLQ++NLS+N F GE+PAS G+LQEL++LWLD N L GTLPSA++NCSSLVHLS E
Sbjct: 185 NMTQLQVVNLSFNRFGGEIPASFGELQELQHLWLDHNVLEGTLPSALANCSSLVHLSVEG 244
Query: 247 NVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVV 306
N L+G+IP IG ++ LQV+SLS+N L+G VP S+ CN+ + SLRIVQLGFNAFT +V
Sbjct: 245 NALQGVIPAAIGALTNLQVISLSQNGLSGSVPYSMFCNVSSHAPSLRIVQLGFNAFTDIV 304
Query: 307 KPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLE 366
KP C S L+VLD+Q+N+IR FP WLT V++L V+D S N FSG +P+ +G+L L+
Sbjct: 305 KPQTATCFSALQVLDIQHNQIRGEFPLWLTGVSTLSVLDFSVNHFSGQIPSGIGNLSGLQ 364
Query: 367 VLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGL 426
LR++NNS G +P EI C+ + + D EGNR +G++P+FLG +RGLK +SLG N FSG
Sbjct: 365 ELRMSNNSFHGEIPLEIKNCASISVIDFEGNRLTGEIPSFLGYMRGLKRLSLGGNRFSGT 424
Query: 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
+P S GNL +LE LNL +N + G P E+ L NLT + L NK G+VP +GNL L
Sbjct: 425 VPASLGNLLELEILNLEDNGLNGTFPLELMGLGNLTVMELGGNKLSGEVPTGIGNLSRLE 484
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD 546
+LNLSA+ SG IP S+G+L +LTTLDLS QNLSGELP EL GLP+LQV++L+EN LSG+
Sbjct: 485 ILNLSANSLSGMIPSSLGNLFKLTTLDLSKQNLSGELPFELSGLPNLQVIALQENKLSGN 544
Query: 547 VPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALE 606
VPEGFSSLVGL+YLNLS N F+G IP+ YGFLRSLV LSLS N ISG++P++LG CS LE
Sbjct: 545 VPEGFSSLVGLRYLNLSSNRFSGQIPSNYGFLRSLVSLSLSDNHISGLVPSDLGNCSDLE 604
Query: 607 VLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR 666
LE+RSN +G+IP D+S LS +++LDLG+N L+GEIP+EIS CS+L SL L+ N LSG
Sbjct: 605 TLEVRSNALSGHIPADLSRLSNLQELDLGRNNLTGEIPEEISSCSALESLRLNSNHLSGP 664
Query: 667 IPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDP 726
IP S S+LSNLTTL+LS+N LSG IPA+L+ I+ L LN+S NNLEG+IP +L SRFN
Sbjct: 665 IPGSLSELSNLTTLDLSSNNLSGVIPANLSSITGLTSLNVSSNNLEGKIPSLLGSRFNSS 724
Query: 727 SIFAMNRELCGKPLDREC-ANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRWRQ 785
S+FA N +LCGKPL R C +K K KRLI+ I V+A+GA LL LCCC YI+SLLRWR+
Sbjct: 725 SVFANNSDLCGKPLARHCKDTDKKDKMKRLILFIAVAASGAVLLTLCCCFYIFSLLRWRK 784
Query: 786 TLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVL 845
L+ A+GEKK SP+R SS GRGS ENGGPKLVMFNNKIT ET+EATRQFDEENVL
Sbjct: 785 RLKERASGEKKTSPARVSSAGSGGRGSSENGGPKLVMFNNKITLAETIEATRQFDEENVL 844
Query: 846 SRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP 905
SR RYGL+FKA Y DGMVLSIRRL +G++DEN FRKEAEALGK++HRNLTVLRGYYAGPP
Sbjct: 845 SRTRYGLVFKACYNDGMVLSIRRLSNGSLDENMFRKEAEALGKIRHRNLTVLRGYYAGPP 904
Query: 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIK 965
D+RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI+LG+ARGL+FLHS ++HGD+K
Sbjct: 905 DMRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHSSSIIHGDVK 964
Query: 966 PQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVY 1025
PQ+VLFDADFEAHLS+FGLDRL IA AEAS+ST +G+LGY++PEA TG+ TKE+DVY
Sbjct: 965 PQSVLFDADFEAHLSDFGLDRLTIAASAEASTSTL-VGTLGYIAPEAVLTGEATKESDVY 1023
Query: 1026 SFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLL 1085
SFGIVLLEILTG+KPVMFT+DEDIVKWVKKQLQRGQI+ELLEPGLLELDPESSEWEEFLL
Sbjct: 1024 SFGIVLLEILTGKKPVMFTEDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEFLL 1083
Query: 1086 GVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
GVKVGLLCTAPDP DRP+M+DIVFMLEGCRVGPD+PSSADPTS PSP
Sbjct: 1084 GVKVGLLCTAPDPRDRPTMSDIVFMLEGCRVGPDIPSSADPTSQPSP 1130
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1133 | ||||||
| TAIR|locus:2005629 | 1140 | AT1G75640 [Arabidopsis thalian | 0.993 | 0.987 | 0.575 | 0.0 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.992 | 0.989 | 0.565 | 0.0 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.578 | 0.594 | 0.303 | 2e-130 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.625 | 0.639 | 0.307 | 1.5e-125 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.596 | 0.613 | 0.303 | 2.9e-124 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.581 | 0.577 | 0.310 | 4.2e-122 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.578 | 0.583 | 0.297 | 1.9e-120 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.593 | 0.520 | 0.295 | 9.8e-120 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.587 | 0.533 | 0.311 | 1.9e-117 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.896 | 0.811 | 0.294 | 1e-116 |
| TAIR|locus:2005629 AT1G75640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3258 (1151.9 bits), Expect = 0., P = 0.
Identities = 652/1132 (57%), Positives = 790/1132 (69%)
Query: 7 ATAIF-LFVTLTHFAYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRG 65
AT IF L F+ + + SE QALTSFKL L DPLGAL+ W+ S+PSAPCDW G
Sbjct: 3 ATVIFFLHFAAIFFSRFHHTSAISSETQALTSFKLSLHDPLGALESWNQSSPSAPCDWHG 62
Query: 66 IVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVY 125
+ C++ RVRELRLPRL L G L+ +L +L +LRKLSLH+N +NG++P+SL +C LRA+Y
Sbjct: 63 VSCFSGRVRELRLPRLHLTGHLSPRLGELTQLRKLSLHTNDINGAVPSSLSRCVFLRALY 122
Query: 126 LQYNSFSGHLPLSIFXXXXXXXXXXXXXXXSGKIS-ADISPSLRYLDLSSNAFTGEIPGN 184
L YNSFSG P I +G +S +S SLRY+DLSSNA +G+IP N
Sbjct: 123 LHYNSFSGDFPPEILNLRNLQVLNAAHNSLTGNLSDVTVSKSLRYVDLSSNAISGKIPAN 182
Query: 185 FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSA 244
FS+ S LQLINLS+N FSGE+PA++GQLQ+LEYLWLDSN L GT+PSA++NCSSL+H S
Sbjct: 183 FSADSSLQLINLSFNHFSGEIPATLGQLQDLEYLWLDSNQLQGTIPSALANCSSLIHFSV 242
Query: 245 EDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTG 304
N L GLIP T+G I +LQV+SLS N TG VPVS+LC G SS+RI+QLG N FTG
Sbjct: 243 TGNHLTGLIPVTLGTIRSLQVISLSENSFTGTVPVSLLCGYSGYNSSMRIIQLGVNNFTG 302
Query: 305 VVKPPNGRCVSV-LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLD 363
+ KP N CV+ LE+LD+ NRI FP+WLT++TSL V+D+SGN FSG + A VG+L
Sbjct: 303 IAKPSNAACVNPNLEILDIHENRINGDFPAWLTDLTSLVVLDISGNGFSGGVTAKVGNLM 362
Query: 364 KLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMF 423
L+ LRVANNSL G +P I C L++ D EGN+FSGQ+P FL +R L +SLGRN F
Sbjct: 363 ALQELRVANNSLVGEIPTSIRNCKSLRVVDFEGNKFSGQIPGFLSQLRSLTTISLGRNGF 422
Query: 424 SGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDXXXXX 483
SG IP +L LETLNL+EN + G IP EIT+ +N+F G+VP +
Sbjct: 423 SGRIPSDLLSLYGLETLNLNENHLTGAIPSEITKLANLTILNLSFNRFSGEVPSNVGDLK 482
Query: 484 XXXXXXXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
S G +G+IP SI LM+L LD+S Q +SG+LP+ELFGLP LQVV+L N L
Sbjct: 483 SLSVLNISGCGLTGRIPVSISGLMKLQVLDISKQRISGQLPVELFGLPDLQVVALGNNLL 542
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603
G VPEGFSSLV L+YLNLS N F+G IP YGFL+SL LSLSHN+ISG IP E+G CS
Sbjct: 543 GGVVPEGFSSLVSLKYLNLSSNLFSGHIPKNYGFLKSLQVLSLSHNRISGTIPPEIGNCS 602
Query: 604 ALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSL 663
+LEVLEL SN G+IPV +S LS +KKLDL N L+G IP +ISK SSL SL L+ NSL
Sbjct: 603 SLEVLELGSNSLKGHIPVYVSKLSLLKKLDLSHNSLTGSIPDQISKDSSLESLLLNSNSL 662
Query: 664 SGRIPESFSKXXXXXXXXXXXXXXXGAIPADLAXXXXXXXXXXXXXXXEGEIPKMLSSRF 723
SGRIPES S+ IP+ L+ EGEIP+ L++RF
Sbjct: 663 SGRIPESLSRLTNLTALDLSSNRLNSTIPSSLSRLRFLNYFNLSRNSLEGEIPEALAARF 722
Query: 724 NDPSIFAMNRELCGKPLDRECANVXXXXXXXXXXXXCVSXXXXXXXXXXXXXYIYSLLRW 783
+P++F N LCGKPL EC NV ++ Y++SL +W
Sbjct: 723 TNPTVFVKNPGLCGKPLGIECPNVRRRRRRKLILLVTLAVAGALLLLLCCCGYVFSLWKW 782
Query: 784 RQTLRAWATGEKKXXXXXXXXXXXXXXXXXXXXXX-KLVMFNNKITYVETLEATRQFDEE 842
R LR + +KK KLVMFNNKIT ETLEATRQFDEE
Sbjct: 783 RNKLRLGLSRDKKGTPSRTSRASSGGTRGEDNNGGPKLVMFNNKITLAETLEATRQFDEE 842
Query: 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDG-TIDENTFRKEAEALGKVKHRNLTVLRGYY 901
NVLSRGRYGL+FKA+++DGMVLS+RRL DG +I + TFR +AEALG+VKH+N+TVLRGYY
Sbjct: 843 NVLSRGRYGLVFKATFRDGMVLSVRRLMDGASITDATFRNQAEALGRVKHKNITVLRGYY 902
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
GPPD+RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI+LG+ARGLSFLHSL ++H
Sbjct: 903 CGPPDLRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLSFLHSLSIIH 962
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA-SSSTTPIGSLGYVSPEAASTGQPTK 1020
GD+KPQNVLFDADFEAHLSEFGLDRL TPAE S+S+TP+GSLGY++PEA TG+ +K
Sbjct: 963 GDLKPQNVLFDADFEAHLSEFGLDRLTALTPAEEPSTSSTPVGSLGYIAPEAGLTGETSK 1022
Query: 1021 EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIXXXXXXXXXXXXXXXXXW 1080
E+DVYSFGIVLLEILTG+K VMFT+DEDIVKWVK+QLQ+GQI W
Sbjct: 1023 ESDVYSFGIVLLEILTGKKAVMFTEDEDIVKWVKRQLQKGQIVELLEPGLLELDPESSEW 1082
Query: 1081 EEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
EEFLLG+KVGLLCT D +DRPSMAD+VFMLEGCRVGP + SADPTS SP
Sbjct: 1083 EEFLLGIKVGLLCTGGDVVDRPSMADVVFMLEGCRVGPAISLSADPTSPTSP 1134
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3227 (1141.0 bits), Expect = 0., P = 0.
Identities = 646/1143 (56%), Positives = 796/1143 (69%)
Query: 1 MAATSTATAIFLFVTLTHFAYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAP 60
MA + IFL + +Y +++ +EI ALT+FKL+L DPLGAL WD STP+AP
Sbjct: 1 MAMDISLFFIFLVIYAPLVSYADESQ---AEIDALTAFKLNLHDPLGALTSWDPSTPAAP 57
Query: 61 CDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSL 120
CDWRG+ C N+RV E+RLPRLQL+GR++D+++ L LRKLSL SN NG+IP SL C+
Sbjct: 58 CDWRGVGCTNHRVTEIRLPRLQLSGRISDRISGLRMLRKLSLRSNSFNGTIPTSLAYCTR 117
Query: 121 LRAVYLQYNSFSGHLPLSIFXXXXXXXXXXXXXXXSGKISADISPSLRYLDLSSNAFTGE 180
L +V+LQYNS SG LP ++ SG+I + SL++LD+SSN F+G+
Sbjct: 118 LLSVFLQYNSLSGKLPPAMRNLTSLEVFNVAGNRLSGEIPVGLPSSLQFLDISSNTFSGQ 177
Query: 181 IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
IP ++ +QLQL+NLSYN +GE+PAS+G LQ L+YLWLD N L GTLPSAISNCSSLV
Sbjct: 178 IPSGLANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLV 237
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
HLSA +N + G+IP G + L+VLSLS N +G VP S+ CN +SL IVQLGFN
Sbjct: 238 HLSASENEIGGVIPAAYGALPKLEVLSLSNNNFSGTVPFSLFCN-----TSLTIVQLGFN 292
Query: 301 AFTGVVKPPN-GRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV 359
AF+ +V+P C + L+VLDLQ NRI FP WLTN+ SL+ +D+SGN FSG +P +
Sbjct: 293 AFSDIVRPETTANCRTGLQVLDLQENRISGRFPLWLTNILSLKNLDVSGNLFSGEIPPDI 352
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419
G+L +LE L++ANNSL+G +P EI +C L + D EGN GQ+P FLG ++ LK++SLG
Sbjct: 353 GNLKRLEELKLANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLG 412
Query: 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDX 479
RN FSG +P S NL QLE LNL EN++ G+ P E+ N+F G VP
Sbjct: 413 RNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSI 472
Query: 480 XXXXXXXXXXXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
S +GFSG+IP S+G+L +LT LDLS QN+SGE+P+EL GLP++QV++L+
Sbjct: 473 SNLSNLSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQ 532
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
NN SG VPEGFSSLV L+Y+NLS N+F+G+IP T+GFLR LV LSLS N ISG IP E+
Sbjct: 533 GNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPEI 592
Query: 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLD 659
G CSALEVLELRSN G+IP D+S L R+K LDLGQN LSGEIP EIS+ SSL SL+LD
Sbjct: 593 GNCSALEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSLNSLSLD 652
Query: 660 MNSLSGRIPESFSKXXXXXXXXXXXXXXXGAIPADLAXXXXXXXXXXXXXXX-EGEIPKM 718
N LSG IP SFS G IPA LA +GEIP
Sbjct: 653 HNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLKGEIPAS 712
Query: 719 LSSRFNDPSIFAMNRELCGKPLDRECANVXXXXXXXXXXXXCVSXXXXXXXXXXXXX--- 775
L SR N+ S F+ N ELCGKPL+R C + +
Sbjct: 713 LGSRINNTSEFSGNTELCGKPLNRRCESSTAEGKKKKRKMILMIVMAAIGAFLLSLFCCF 772
Query: 776 YIYSLLRWRQTLRAWAT-GEKKXXXXXXXXXXXXXXXXXXXXXX----KLVMFNNKITYV 830
Y+Y+LL+WR+ L+ +T GEKK KLVMFNNKIT
Sbjct: 773 YVYTLLKWRKKLKQQSTTGEKKRSPGRTSAGSRVRSSTSRSSTENGEPKLVMFNNKITLA 832
Query: 831 ETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI-DENTFRKEAEALGKV 889
ET+EATRQFDEENVLSR RYGL+FKA+Y DGMVLSIRRL +G++ +EN F+KEAE LGKV
Sbjct: 833 ETIEATRQFDEENVLSRTRYGLLFKANYNDGMVLSIRRLPNGSLLNENLFKKEAEVLGKV 892
Query: 890 KHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
KHRN+TVLRGYYAGPPD+RLLVYDYMPNGNL+TLLQEASHQDGHVLNWPMRHLI+LG+AR
Sbjct: 893 KHRNITVLRGYYAGPPDLRLLVYDYMPNGNLSTLLQEASHQDGHVLNWPMRHLIALGIAR 952
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL FLH +MVHGDIKPQNVLFDADFEAH+S+FGLDRL I +P+ ++ + IG+LGYVS
Sbjct: 953 GLGFLHQSNMVHGDIKPQNVLFDADFEAHISDFGLDRLTIRSPSRSAVTANTIGTLGYVS 1012
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIXXXXXXX 1069
PEA +G+ T+E+D+YSFGIVLLEILTG++PVMFTQDEDIVKWVKKQLQRGQ+
Sbjct: 1013 PEATLSGEITRESDIYSFGIVLLEILTGKRPVMFTQDEDIVKWVKKQLQRGQVTELLEPG 1072
Query: 1070 XXXXXXXXXXWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSL 1129
WEEFLLG+KVGLLCTA DPLDRP+M+D+VFMLEGCRVGPD+PSSADPTS
Sbjct: 1073 LLELDPESSEWEEFLLGIKVGLLCTATDPLDRPTMSDVVFMLEGCRVGPDVPSSADPTSQ 1132
Query: 1130 PSP 1132
PSP
Sbjct: 1133 PSP 1135
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 2.0e-130, Sum P(2) = 2.0e-130
Identities = 202/666 (30%), Positives = 308/666 (46%)
Query: 31 EIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNR-VRELRLPRLQLAGRLTD 89
E + L FK L D G L W+ S PC+W GI C + R V + L + L+G L+
Sbjct: 27 EGRVLLEFKAFLNDSNGYLASWNQ-LDSNPCNWTGIACTHLRTVTSVDLNGMNLSGTLSP 85
Query: 90 QLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFXXXXXXXXX 149
+ LH LRKL++ +N ++G IP L C L + L N F G +P+ +
Sbjct: 86 LICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLY 145
Query: 150 XXXXXXSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPA 207
G I I SL+ L + SN TG IP + + QL++I N FSG +P+
Sbjct: 146 LCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPS 205
Query: 208 SVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLS 267
+ + L+ L L N L G+LP + +L L N L G IP ++G IS L+VL+
Sbjct: 206 EISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLA 265
Query: 268 LSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRI 327
L N TG +P + G ++ ++ + L N TG + G + E+ D N++
Sbjct: 266 LHENYFTGSIPREI-----GKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEI-DFSENQL 319
Query: 328 RAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCS 387
P ++ +L+++ L N G +P +G L LE L ++ N L+G +P E+
Sbjct: 320 TGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLP 379
Query: 388 LLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI 447
L L N+ G++P +G ++ + N SG IP F L L+L N +
Sbjct: 380 YLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKL 439
Query: 448 RGNIPEEITRXXXXXXXXXXYNKFGGKVPYDXXXXXXXXXXXXSASGFSGKIPGSIGSLM 507
GNIP ++ N+ G +P + + SG I +G L
Sbjct: 440 SGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLK 499
Query: 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
L L L+N N +GE+P E+ L + ++ N L+G +P+ S V +Q L+LS N F
Sbjct: 500 NLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKF 559
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLS 627
+G I G L L L LS N+++G IP G + L L+L N + NIPV++ L+
Sbjct: 560 SGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLT 619
Query: 628 RIK-KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKXXXXXXXXXXXXX 686
++ L++ N LSG IP + L L L+ N LSG IP S
Sbjct: 620 SLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNN 679
Query: 687 XXGAIP 692
G +P
Sbjct: 680 LVGTVP 685
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.5e-125, Sum P(2) = 1.5e-125
Identities = 226/734 (30%), Positives = 330/734 (44%)
Query: 12 LFVTLTHFAYGEQNAVVL-SEIQALTSFKLHLKD-PLGALDGWDSSTPSAPCDWRGIVCY 69
LF+ T Y A L S+ AL S H P W++S S PC W G+ C
Sbjct: 10 LFLCSTSSIYA---AFALNSDGAALLSLTRHWTSIPSDITQSWNASD-STPCSWLGVECD 65
Query: 70 NNR-VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQY 128
+ V L L ++G +++ L L+K+ L N GSIP+ L CSLL + L
Sbjct: 66 RRQFVDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSS 125
Query: 129 NSFSGHLPLSIFXXXXXXXXXXXXXXXSGKISADIS--PSLRYLDLSSNAFTGEIPGNFS 186
NSF+G++P ++ G + P L + + N G IP N
Sbjct: 126 NSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIG 185
Query: 187 SKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAED 246
+ S+L + L N FSG VP+S+G + L+ L+L+ N+L GTLP ++N +LV+L +
Sbjct: 186 NMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRN 245
Query: 247 NVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVV 306
N L G IP + +SLS N+ TG +P + GN +SLR F AF+ +
Sbjct: 246 NSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGL-----GNCTSLR----EFGAFSCAL 296
Query: 307 KPPNGRCVSVLEVLD---LQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLD 363
P C L LD L N P L S+ + L N G +P +G L
Sbjct: 297 SGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLS 356
Query: 364 KLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMF 423
+L+ L + N+LSG VP I K LQ L N SG++P + ++ L ++L N F
Sbjct: 357 QLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHF 416
Query: 424 SGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDXXXXX 483
+G+IP G S LE L+L+ N G+IP + YN G VP D
Sbjct: 417 TGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCS 476
Query: 484 XXXXXXXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
+ G +P + L DLS N +G +P L L ++ + L N L
Sbjct: 477 TLERLILEENNLRGGLPDFVEK-QNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQL 535
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603
SG +P SLV L++LNLS N G +P+ L L SHN ++G IP+ LG+ +
Sbjct: 536 SGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLT 595
Query: 604 ALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSL 663
L L L N F+G IP + +++ L LG N L+G+IP + +L SL L N L
Sbjct: 596 ELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPP-VGALQALRSLNLSSNKL 654
Query: 664 SGRIPESFSKXXXXXXXXXXXXXXXGAIPADLAXXXXXXXXXXXXXXXEGEIPKMLSSRF 723
+G++P K G + L+ G +P L+
Sbjct: 655 NGQLPIDLGKLKMLEELDVSHNNLSGTLRV-LSTIQSLTFINISHNLFSGPVPPSLTKFL 713
Query: 724 ND-PSIFAMNRELC 736
N P+ F+ N +LC
Sbjct: 714 NSSPTSFSGNSDLC 727
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 2.9e-124, Sum P(2) = 2.9e-124
Identities = 210/691 (30%), Positives = 312/691 (45%)
Query: 9 AIFLFVTLTHFAYGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVC 68
A+F L E + L E Q L K D L W+S+ S PC W G++C
Sbjct: 9 AVFFISLLLILLISETTGLNL-EGQYLLEIKSKFVDAKQNLRNWNSND-SVPCGWTGVMC 66
Query: 69 YNN----RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAV 124
N V L L + L+G+L+ + L L++L L N L+G IP + CS L +
Sbjct: 67 SNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEIL 126
Query: 125 YLQYNSFSGHLPLSIFXXXXXXXXXXXXXXXSGKISADISP--SLRYLDLSSNAFTGEIP 182
L N F G +P+ I SG + +I SL L SN +G++P
Sbjct: 127 KLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLP 186
Query: 183 GNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHL 242
+ + +L N SG +P+ +G + L L L N L G LP I L +
Sbjct: 187 RSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQV 246
Query: 243 SAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAF 302
+N G IP I ++L+ L+L +N+L G +P + G++ SL + L N
Sbjct: 247 ILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKEL-----GDLQSLEFLYLYRNGL 301
Query: 303 TGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSL 362
G + G +E+ D N + P L N+ L ++ L N +G +P + +L
Sbjct: 302 NGTIPREIGNLSYAIEI-DFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTL 360
Query: 363 DKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNM 422
L L ++ N+L+G +P L M L N SG +P LG L ++ + N
Sbjct: 361 KNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNH 420
Query: 423 FSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDXXXX 482
SG IP S + LNL N++ GNIP IT N G+ P +
Sbjct: 421 LSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQ 480
Query: 483 XXXXXXXXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENN 542
+ F G IP +G+ L L L++ +GELP E+ L L +++ N
Sbjct: 481 VNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNK 540
Query: 543 LSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGAC 602
L+G+VP + LQ L++ N F+G +P+ G L L L LS+N +SG IP LG
Sbjct: 541 LTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNL 600
Query: 603 SALEVLELRSNHFTGNIPVDISHLSRIK-KLDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661
S L L++ N F G+IP ++ L+ ++ L+L NKL+GEIP E+S L L L+ N
Sbjct: 601 SRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNN 660
Query: 662 SLSGRIPESFSKXXXXXXXXXXXXXXXGAIP 692
+LSG IP SF+ G IP
Sbjct: 661 NLSGEIPSSFANLSSLLGYNFSYNSLTGPIP 691
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 811 (290.5 bits), Expect = 4.2e-122, Sum P(2) = 4.2e-122
Identities = 210/677 (31%), Positives = 321/677 (47%)
Query: 3 ATSTATAIFLFVTLTHFAYGEQNAVVLSEIQALTSFKLHLKDPLGA---LDGWDSSTPSA 59
++S+++ +F F + F + +A E L S+ LH P + L W+S +
Sbjct: 10 SSSSSSLLFSFFFIFIFCFSLSDAEQNPEASILYSW-LHSSSPTPSSLSLFNWNS-IDNT 67
Query: 60 PCD-WRGIVCYNNR-VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQ 117
PC+ W I C + + ++ + + L L L L+KL++ +L G++P SL
Sbjct: 68 PCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGD 127
Query: 118 CSLLRAVYLQYNSFSGHLPLSIFXXXXXXXXXXXXXXXSGKISADISP--SLRYLDLSSN 175
C L+ + L N G +P S+ +GKI DIS L+ L L N
Sbjct: 128 CLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDN 187
Query: 176 AFTGEIPGNFSSKSQLQLINLSYNS-FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAIS 234
TG IP S L++I + N SG++P+ +G L L L + G LPS++
Sbjct: 188 LLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLG 247
Query: 235 NCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRI 294
L LS ++ G IP +G S L L L N L+G +P + G ++ L
Sbjct: 248 KLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREI-----GQLTKLEQ 302
Query: 295 VQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGN 354
+ L N+ G + G C S L+++DL N + PS + ++ L +S N FSG+
Sbjct: 303 LFLWQNSLVGGIPEEIGNC-SNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGS 361
Query: 355 LPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLK 414
+P + + L L++ N +SGL+P E+ + L +F N+ G +P L L+
Sbjct: 362 IPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQ 421
Query: 415 IVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGK 474
+ L RN +G IP L L L L N + G IP+EI +N+ G+
Sbjct: 422 ALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGE 481
Query: 475 VPYDXXXXXXXXXXXXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQ 534
+P S++ GK+P IGS L +DLSN +L G LP + L LQ
Sbjct: 482 IPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQ 541
Query: 535 VVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGM 594
V+ + N SG +P LV L L LS N F+G IP + G L L L N++SG
Sbjct: 542 VLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGE 601
Query: 595 IPAELGACSALEV-LELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSL 653
IP+ELG LE+ L L SN TG IP I+ L+++ LDL N L G++ ++ +L
Sbjct: 602 IPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENL 660
Query: 654 VSLTLDMNSLSGRIPES 670
VSL + NS SG +P++
Sbjct: 661 VSLNISYNSFSGYLPDN 677
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 1.9e-120, Sum P(2) = 1.9e-120
Identities = 201/676 (29%), Positives = 303/676 (44%)
Query: 30 SEIQALTSFKLH-LKDPLGALDGWDSSTPSAPCDWRGIVCYNNR---------VRELRLP 79
S+ Q L K +D L L W+ PC+W G+ C + V L L
Sbjct: 35 SDGQFLLELKNRGFQDSLNRLHNWNG-IDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLS 93
Query: 80 RLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSI 139
+ L+G ++ + L L L+L N L G IP + CS L ++L N F G +P+ I
Sbjct: 94 SMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEI 153
Query: 140 FXXXXXXXXXXXXXXXSGKISADISP--SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLS 197
SG + +I +L L +N TG +P + + ++L
Sbjct: 154 NKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAG 213
Query: 198 YNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTI 257
N FSG +P +G+ L+ L L N + G LP I L + N G IP I
Sbjct: 214 QNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDI 273
Query: 258 GRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317
G +++L+ L+L N L G +P + GN+ SL+ + L N G + G+ V+
Sbjct: 274 GNLTSLETLALYGNSLVGPIPSEI-----GNMKSLKKLYLYQNQLNGTIPKELGKLSKVM 328
Query: 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSG 377
E+ D N + P L+ ++ LR++ L N +G +P + L L L ++ NSL+G
Sbjct: 329 EI-DFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTG 387
Query: 378 LVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQL 437
+P + ++ L N SG +P LG L +V N SG IP S L
Sbjct: 388 PIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNL 447
Query: 438 ETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDXXXXXXXXXXXXSASGFSG 497
LNL N I GNIP + R N+ G+ P + + FSG
Sbjct: 448 ILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSG 507
Query: 498 KIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGL 557
+P IG+ +L L L+ S LP E+ L +L ++ N+L+G +P ++ L
Sbjct: 508 PLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKML 567
Query: 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG 617
Q L+LS N+F G +P G L L L LS N+ SG IP +G + L L++ N F+G
Sbjct: 568 QRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSG 627
Query: 618 NIPVDISHLSRIK-KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKXXX 676
+IP + LS ++ ++L N SGEIP EI L+ L+L+ N LSG IP +F
Sbjct: 628 SIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSS 687
Query: 677 XXXXXXXXXXXXGAIP 692
G +P
Sbjct: 688 LLGCNFSYNNLTGQLP 703
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 9.8e-120, Sum P(2) = 9.8e-120
Identities = 209/708 (29%), Positives = 339/708 (47%)
Query: 7 ATAIFLFVTLTHF----AYGEQNAVVLSEIQALTSFKLHLKDPLGALDGW-DSSTPSAPC 61
+ + +LF+ L F A+ E +I L + + + + G L W DS TP PC
Sbjct: 3 SNSFWLFILLVSFIPISAWAESR-----DISTLFTLRDSITEGKGFLRNWFDSETP--PC 55
Query: 62 DWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLL 121
W GI C + V + L + L + L +L+ +G +P +L L
Sbjct: 56 SWSGITCIGHNVVAIDLSSVPLYAPFPLCIGAFQSLVRLNFSGCGFSGELPEALGNLQNL 115
Query: 122 RAVYLQYNSFSGHLPLSIFXXXXXXXXXXXXXXXSGKISADISP--SLRYLDLSSNAFTG 179
+ + L N +G +P+S++ SG++S I+ L L +S N+ +G
Sbjct: 116 QYLDLSNNELTGPIPISLYNLKMLKEMVLDYNSLSGQLSPAIAQLQHLTKLSISMNSISG 175
Query: 180 EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSL 239
+P + S L+L+++ N+F+G +PA+ G L L + N+L G++ I++ ++L
Sbjct: 176 SLPPDLGSLKNLELLDIKMNTFNGSIPATFGNLSCLLHFDASQNNLTGSIFPGITSLTNL 235
Query: 240 VHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGF 299
+ L N +G IP IG++ L++L L +N+LTG +P + G++ L+++ L
Sbjct: 236 LTLDLSSNSFEGTIPREIGQLENLELLILGKNDLTGRIPQEI-----GSLKQLKLLHLEE 290
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV 359
FTG + P + +S L LD+ +N A PS + + +L + SGN+P +
Sbjct: 291 CQFTGKI-PWSISGLSSLTELDISDNNFDAELPSSMGELGNLTQLIAKNAGLSGNMPKEL 349
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419
G+ KL V+ ++ N+L G +P+E A + F +EGN+ SG+VP ++ + + + LG
Sbjct: 350 GNCKKLTVINLSFNALIGPIPEEFADLEAIVSFFVEGNKLSGRVPDWIQKWKNARSIRLG 409
Query: 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDX 479
+N FSG +P+ L L + N + G+IP I + +N G +
Sbjct: 410 QNKFSGPLPVL--PLQHLLSFAAESNLLSGSIPSHICQANSLHSLLLHHNNLTGTIDEAF 467
Query: 480 XXXXXXXXXXXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
+ G++PG + L L TL+LS +G LP EL+ +L +SL
Sbjct: 468 KGCTNLTELNLLDNHIHGEVPGYLAELP-LVTLELSQNKFAGMLPAELWESKTLLEISLS 526
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
N ++G +PE L LQ L++ +N G IP + G LR+L LSL N++SG+IP L
Sbjct: 527 NNEITGPIPESIGKLSVLQRLHIDNNLLEGPIPQSVGDLRNLTNLSLRGNRLSGIIPLAL 586
Query: 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEIS--------KCS 651
C L L+L N+ TGNIP ISHL+ + L L N+LSG IP EI S
Sbjct: 587 FNCRKLATLDLSYNNLTGNIPSAISHLTLLDSLILSSNQLSGSIPAEICVGFENEAHPDS 646
Query: 652 SLVS----LTLDMNSLSGRIPESFSKXXXXXXXXXXXXXXXGAIPADL 695
+ L L N L+G+IP S G IP +L
Sbjct: 647 EFLQHHGLLDLSYNQLTGQIPTSIKNCAMVMVLNLQGNLLNGTIPVEL 694
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 1.9e-117, Sum P(2) = 1.9e-117
Identities = 212/680 (31%), Positives = 314/680 (46%)
Query: 72 RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSF 131
RV+ L L L G + +L + +L + N LNG+IPA L + L + L NS
Sbjct: 192 RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251
Query: 132 SGHLPLSIFXXXXXXXXXXXXXXXSGKISADISP--SLRYLDLSSNAFTGEIPGNFSSKS 189
+G +P + G I ++ +L+ LDLS+N TGEIP F + S
Sbjct: 252 TGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMS 311
Query: 190 QLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
QL + L+ N SG +P S+ LE L L L G +P +S C SL L +N
Sbjct: 312 QLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNS 371
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP 308
L G IP + + L L L N L G + S+ N+++L+ + L N G + P
Sbjct: 372 LAGSIPEALFELVELTDLYLHNNTLEGTLSPSI-----SNLTNLQWLVLYHNNLEGKL-P 425
Query: 309 PNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVL 368
+ LEVL L NR P + N TSL+++D+ GN F G +P ++G L +L +L
Sbjct: 426 KEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLL 485
Query: 369 RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
+ N L G +P + C L + DL N+ SG +P+ G ++GL+ + L N G +P
Sbjct: 486 HLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLP 545
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDXXXXXXXXXX 488
S +L L +NLS N + G I + N F ++P +
Sbjct: 546 DSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRL 604
Query: 489 XXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVP 548
+ +GKIP ++G + L+ LD+S+ L+G +P++L L + L N LSG +P
Sbjct: 605 RLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIP 664
Query: 549 EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVL 608
L L L LS N F +P L+ LSL N ++G IP E+G AL VL
Sbjct: 665 PWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVL 724
Query: 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS-LTLDMNSLSGRI 667
L N F+G++P + LS++ +L L +N L+GEIP EI + L S L L N+ +G I
Sbjct: 725 NLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDI 784
Query: 668 PESFSKXXXXXXXXXXXXXXXGAIPADLAXXXXXXXXXXXXXXXEGEIPKMLSSRFNDPS 727
P + G +P + G++ K S R+ S
Sbjct: 785 PSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFS-RWPADS 843
Query: 728 IFAMNRELCGKPLDRECANV 747
F N LCG PL R C V
Sbjct: 844 -FLGNTGLCGSPLSR-CNRV 861
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1150 (409.9 bits), Expect = 1.0e-116, P = 1.0e-116
Identities = 309/1048 (29%), Positives = 484/1048 (46%)
Query: 72 RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSF 131
+++ L L +L G + ++ + L + N LNGS+PA L++ L+ + L NSF
Sbjct: 193 QLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSF 252
Query: 132 SGHLPLSIFXXXXXXXXXXXXXXXSGKISADISP--SLRYLDLSSNAFTGEIPGNFSSKS 189
SG +P + G I ++ +L+ LDLSSN TG I F +
Sbjct: 253 SGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMN 312
Query: 190 QLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
QL+ + L+ N SG +P ++ L+ L+L L G +P+ ISNC SL L +N
Sbjct: 313 QLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNT 372
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP 308
L G IP ++ ++ L L L+ N L G + S+ N+++L+ L N G V
Sbjct: 373 LTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSI-----SNLTNLQEFTLYHNNLEGKVPK 427
Query: 309 PNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVL 368
G + LE++ L NR P + N T L+ +D GN SG +P+++G L L L
Sbjct: 428 EIG-FLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRL 486
Query: 369 RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
+ N L G +P + C + + DL N+ SG +P+ G + L++ + N G +P
Sbjct: 487 HLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLP 546
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRXXXXXXXXXXYNKFGGKVPYDXXXXXXXXXX 488
S NL L +N S N G+I + N F G +P +
Sbjct: 547 DSLINLKNLTRINFSSNKFNGSI-SPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRL 605
Query: 489 XXSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVP 548
+ F+G+IP + G + L+ LD+S +LSG +P+EL L + L N LSG +P
Sbjct: 606 RLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIP 665
Query: 549 EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVL 608
L L L LS N F G +P L +++ L L N ++G IP E+G AL L
Sbjct: 666 TWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNAL 725
Query: 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS-LTLDMNSLSGRI 667
L N +G +P I LS++ +L L +N L+GEIP EI + L S L L N+ +GRI
Sbjct: 726 NLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRI 785
Query: 668 PESFSKXXXXXXXXXXXXXXXGAIPADLAXXXXXXXXXXXXXXXEGEIPKMLSSRFNDPS 727
P + S G +P + EG++ K S R+ +
Sbjct: 786 PSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFS-RWQADA 844
Query: 728 IFAMNRELCGKPLDRECANVXXXXXXXXXXXXCVSXXXXXXXXXXXXXYIYSLLRWRQTL 787
F N LCG PL C V + +L ++Q
Sbjct: 845 -FVGNAGLCGSPLSH-CNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH 902
Query: 788 RAWATGEKKXXXXXXXXXXXXXXXXXXXXXXKLVMFNNKITYVETLEATRQFDEENVLSR 847
+ KK + I + + +EAT +EE ++
Sbjct: 903 DLF----KKVRGGNSAFSSNSSSSQAPLFSNGGA--KSDIKWDDIMEATHYLNEEFMIGS 956
Query: 848 GRYGLIFKASYQDGMVLSIRRL--RDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP 905
G G ++KA ++G ++++++ +D + +F +E + LG ++HR+L L GY +
Sbjct: 957 GGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKA 1016
Query: 906 D-VRLLVYDYMPNGNLATLLQEASH-QDGHVLNWPMRHLISLGLARGLSFLHS---LDMV 960
D + LL+Y+YM NG++ L + + VL W R I+LGLA+G+ +LH +V
Sbjct: 1017 DGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIV 1076
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIAT-PAEASSSTTPIGSLGYVSPEAASTGQPT 1019
H DIK NVL D++ EAHL +FGL ++ S+T GS GY++PE A + + T
Sbjct: 1077 HRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKAT 1136
Query: 1020 KEADVYSFGIVLLEILTGRKPV--MFTQDEDIVKWVKKQLQR--GQIXXXXXXXXXXXXX 1075
+++DVYS GIVL+EI+TG+ P MF ++ D+V+WV+ L G
Sbjct: 1137 EKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSL 1196
Query: 1076 XXXXWEEFLLGVKVGLLCTAPDPLDRPS 1103
E +++ L CT P +RPS
Sbjct: 1197 LPCEEEAAYQVLEIALQCTKSYPQERPS 1224
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | grail3.0002062801 | hypothetical protein (1127 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1133 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-132 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-67 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-65 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-12 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 425 bits (1095), Expect = e-132
Identities = 316/1000 (31%), Positives = 493/1000 (49%), Gaps = 125/1000 (12%)
Query: 154 LLSGKISADISPSLRYLDL--SSNAF---TGEIPGNFSSKSQLQLINLSYNSFSGEVPAS 208
LLS K S I+ L+YL SS G N S ++ I+LS + SG++ ++
Sbjct: 34 LLSFKSS--INDPLKYLSNWNSSADVCLWQGITCNNSS---RVVSIDLSGKNISGKISSA 88
Query: 209 VGQLQELEYLWLDSNHLYGTLPSAISN-CSSLVHLSAEDNVLKGLIPGTIGRISTLQVLS 267
+ +L ++ + L +N L G +P I SSL +L+ +N G IP G I L+ L
Sbjct: 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146
Query: 268 LSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRI 327
LS N L+G +P + G+ SSL+++ LG N G +
Sbjct: 147 LSNNMLSGEIPNDI-----GSFSSLKVLDLGGNVLVGKI--------------------- 180
Query: 328 RAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCS 387
P+ LTN+TSL + L+ N G +P +G + L+ + + N+LSG +P EI +
Sbjct: 181 ----PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236
Query: 388 LLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI 447
L DL N +G +P+ LG ++ L+ + L +N SG IP S +L +L +L+LS+N +
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 448 RGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLM 507
G IPE + +L NL L+L N F GK+P + +L L VL L ++ FSG+IP ++G
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
Query: 508 RLTTLDLSNQNLSGEL------------------------PIELFGLPSLQVVSLEENNL 543
LT LDLS NL+GE+ P L SL+ V L++N+
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603
SG++P F+ L + +L++S+N G I + + SL LSL+ N+ G +P G+
Sbjct: 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-K 475
Query: 604 ALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSL 663
LE L+L N F+G +P + LS + +L L +NKLSGEIP E+S C LVSL L N L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 664 SGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRF 723
SG+IP SFS++ L+ L+LS N+LSG IP +L + SL +N+S N+L G +P +
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA 595
Query: 724 NDPSIFAMNRELCGKPLD---RECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSL 780
+ S A N +LCG C VRK I + A L L + +
Sbjct: 596 INASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGA----FLVLALVAFGFVF 651
Query: 781 LRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEAT-RQF 839
+R R L E R E+G +L F++K++ T+
Sbjct: 652 IRGRNNL-------------------ELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692
Query: 840 DEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRD-GTIDENTFRKEAEALGKVKHRNLTVL 897
EENV+SRG+ G +K S ++GM ++ + D +I + +GK++H N+ L
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKL 748
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH-- 955
G L+++Y+ NL+ +L+ L+W R I++G+A+ L FLH
Sbjct: 749 IG-LCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCR 799
Query: 956 -SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
S +V G++ P+ ++ D E H L ++ P + T S YV+PE
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPH--------LRLSLPGLLCTDTKCFISSAYVAPETRE 851
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
T T+++D+Y FG++L+E+LTG+ P F IV+W + + ++P +
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911
Query: 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
S E + + + L CTA DP RP D++ LE
Sbjct: 912 --DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 8e-67
Identities = 158/444 (35%), Positives = 233/444 (52%), Gaps = 33/444 (7%)
Query: 83 LAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNL 142
L G++ + L +L L L+L SN L G IP L Q L+ +YL YN+ SG +P I L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 143 TNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
T+L L++ +N L+G I + + +L+YL L N +G IP + S +L ++LS NS
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
SGE+P V QLQ LE L L SN+ G +P A+++ L L N G IP +G+
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
+ L VL LS N LTG +P LC+ GN+ L + N+ G + G C
Sbjct: 356 NNLTVLDLSTNNLTGEIPEG-LCSS-GNLFKLILFS---NSLEGEIPKSLGAC------- 403
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP 380
SLR + L N FSG LP+ L + L ++NN+L G +
Sbjct: 404 ------------------RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445
Query: 381 DEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440
LQM L N+F G +P G R L+ + L RN FSG +P G+LS+L L
Sbjct: 446 SRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQL 504
Query: 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIP 500
LSEN + G IP+E++ L +L+LS+N+ G++P + L L+LS + SG+IP
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564
Query: 501 GSIGSLMRLTTLDLSNQNLSGELP 524
++G++ L +++S+ +L G LP
Sbjct: 565 KNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 5e-65
Identities = 156/468 (33%), Positives = 246/468 (52%), Gaps = 33/468 (7%)
Query: 83 LAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNL 142
L+G + + + L+ L L N L G IP SL NL
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT------------------------NL 187
Query: 143 TNLLVLNVAHNLLSGKISADISP--SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
T+L L +A N L G+I ++ SL+++ L N +GEIP + L ++L YN+
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
+G +P+S+G L+ L+YL+L N L G +P +I + L+ L DN L G IP + ++
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
L++L L N TG +PV++ ++ L+++QL N F+G + P N + L VL
Sbjct: 308 QNLEILHLFSNNFTGKIPVAL-----TSLPRLQVLQLWSNKFSGEI-PKNLGKHNNLTVL 361
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP 380
DL N + P L + +L + L N G +P ++G+ L +R+ +NS SG +P
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
Query: 381 DEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440
E K L+ D+ N G++ + + L+++SL RN F G +P SFG+ +LE L
Sbjct: 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENL 480
Query: 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIP 500
+LS N G +P ++ LS L L LS NK G++P ++ + K L+ L+LS + SG+IP
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
Query: 501 GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVP 548
S + L+ LDLS LSGE+P L + SL V++ N+L G +P
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-36
Identities = 95/243 (39%), Positives = 129/243 (53%), Gaps = 9/243 (3%)
Query: 71 NRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNS 130
N + L L L G + + L L KL L SN L G IP SL C LR V LQ NS
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 131 FSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI--SPSLRYLDLSSNAFTGEIPGNFSSK 188
FSG LP L + L++++N L G+I++ PSL+ L L+ N F G +P +F SK
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSK 475
Query: 189 SQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
+L+ ++LS N FSG VP +G L EL L L N L G +P +S+C LV L N
Sbjct: 476 -RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP 308
L G IP + + L L LS+N+L+G +P ++ GN+ SL V + N G + P
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL-----GNVESLVQVNISHNHLHGSL-P 588
Query: 309 PNG 311
G
Sbjct: 589 STG 591
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 61/233 (26%), Positives = 113/233 (48%), Gaps = 30/233 (12%)
Query: 845 LSRGRYGLIFKASY-QDGMVLSIRRLR--DGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
L G +G ++ A + G ++I+ ++ D + +E E L K+ H N+ L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
+ LV +Y G+L LL+E + L+ I L + GL +LHS ++H
Sbjct: 61 EDENHL-YLVMEYCEGGSLKDLLKE----NEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 962 GDIKPQNVLFDAD-FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-T 1019
D+KP+N+L D+D + L++FG L+ ++ S T +G+ Y++PE +
Sbjct: 116 RDLKPENILLDSDNGKVKLADFG---LSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 1020 KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ-----RGQISELLE 1067
+++D++S G++L E+ ++ ++K LQ R E+LE
Sbjct: 173 EKSDIWSLGVILYEL------------PELKDLIRKMLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 67/272 (24%), Positives = 119/272 (43%), Gaps = 27/272 (9%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLT 895
++ L G +G ++ A + G +++I+ ++ I + +E + L K+KH N+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L + + LV +Y G+L LL++ L+ + L +LH
Sbjct: 61 RLYDVFEDEDKL-YLVMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSALEYLH 114
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
S +VH D+KP+N+L D D L++FGL R TT +G+ Y++PE
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFVGTPEYMAPEVLLG 170
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
K D++S G++L E+LTG+ P F D+ +++ KK I + P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP--FPGDDQLLELFKK------IGKPKPPFPPPEWD 222
Query: 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S E ++ + DP R + +
Sbjct: 223 ISPEAKDLIRK------LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 29/272 (10%)
Query: 844 VLSRGRYGLIFKASYQDG----MVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG 899
L G +G ++KA ++ V +++ + + + T R+E L ++ H N+ L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL--ISLGLARGLSFLHSL 957
+ D LV +Y G+L L + G + I+L + RGL +LHS
Sbjct: 66 AFE-DKDHLYLVMEYCEGGDLFDYL----SRGGPL---SEDEAKKIALQILRGLEYLHSN 117
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++H D+KP+N+L D + +++FGL + + + +SS TT +G+ Y++PE G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS---SSSLTTFVGTPWYMAPEVLLGGN 174
Query: 1018 P-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
+ DV+S G++L E+LTG+ P F+ + + + QL R + LE +
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPP--FSGENIL---DQLQLIRRILGPPLEFDEPKWSSG 229
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
S E ++ + C DP RP+ +I+
Sbjct: 230 SEEAKDLIKK------CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 843 NVLSRGRYGLIFKASYQDG-----MVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLT 895
L G +G ++K + V ++ L++ + F KEA + K+ H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVA-VKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 896 VLRGYY--AGPPDVRLLVYDYMPNGNLATLLQE----ASHQDGHVLNWPMRHLISLGLAR 949
L G P LV +YM G+L L++ + L+ ++ +A+
Sbjct: 60 RLLGVCTEEEPL---YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
G+ +L S VH D+ +N L D +S+FGL R + + + +++
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL-PIRWMA 175
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILT-GRKP---VMFTQDEDIVKWVKKQLQRGQISEL 1065
PE+ G T ++DV+SFG++L EI T G P + +E+++++++K
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEEVLEYLRK---------- 222
Query: 1066 LEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
G PE E E + L C DP DRP+ +++V LE
Sbjct: 223 ---GYRLPKPEYCPDELYELM------LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 41/281 (14%)
Query: 844 VLSRGRYGLIFKASYQDGMVLS-----IRRLRDGTIDENT--FRKEAEALGKVKHRNLTV 896
L G +G ++K + + + ++ L++G +E F +EA + K+ H N+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 897 LRGYY--AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
L G P +V +YMP G+L L + G L ++L +A+G+ +L
Sbjct: 66 LLGVCTQGEPL---YIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
S + VH D+ +N L + +S+FGL R + + +++PE+
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLK 177
Query: 1015 TGQPTKEADVYSFGIVLLEILT-GRKP-VMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
G+ T ++DV+SFG++L EI T G +P + +E V + L+ G L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLELLEDG---YRLPR---- 225
Query: 1073 LDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
PE E E + L C A DP DRP+ +++V L
Sbjct: 226 --PENCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 70/286 (24%), Positives = 130/286 (45%), Gaps = 47/286 (16%)
Query: 842 ENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTIDENT--FRKEAEALGKVKHRN 893
L G +G ++K + ++ V ++ L++ ++ F +EA + K+ H N
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVA-VKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ L G + ++V +YMP G+L L++ L+ +L +ARG+ +
Sbjct: 63 IVKLLGV-CTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEY 118
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV----- 1008
L S + +H D+ +N L + +S+FGL R + G +
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSR-------DLYDDDYYKVKGGKLPIRWM 171
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISEL 1065
+PE+ G+ T ++DV+SFG++L EI T G +P M + ++++++KK
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYLKK-------GYR 222
Query: 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
L P + E K+ L C A DP DRP+ +++V +L
Sbjct: 223 LPK------PPNCP-PEL---YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 67/285 (23%), Positives = 127/285 (44%), Gaps = 46/285 (16%)
Query: 842 ENVLSRGRYGLIFKASYQDG------MVLSIRRLRDGTIDENT--FRKEAEALGKVKHRN 893
L G +G ++K + V ++ L++ ++ F +EA + K+ H N
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVA-VKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ L G + +V +YM G+L + L++ + L+ +L +ARG+ +
Sbjct: 63 VVKLLGV-CTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEY 117
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS----LGYVS 1009
L S + +H D+ +N L + +S+FGL R + +++
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSR------DLYDDDYYRKRGGKLPIRWMA 171
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELL 1066
PE+ G+ T ++DV+SFG++L EI T G +P M +E++++++K L
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLKN-------GYRL 222
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
P + E + L C A DP DRP+ +++V +L
Sbjct: 223 PQ------PPNCP-PEL---YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 22/282 (7%)
Query: 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE----NTFRKEAEALGKVKHRNL 894
+ L G +G ++ A +D +++++ L + F +E + L + H
Sbjct: 2 YRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 895 TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
V + Y + L LV +Y+ G+L LL+ L+ I + L +
Sbjct: 60 IV-KLYDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEY 116
Query: 954 LHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLA---IATPAEASSSTTPIGSLGYVS 1009
LHS ++H DIKP+N+L D D L +FGL +L +T + + +T +G+ GY++
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 1010 PE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
PE S + +D++S GI L E+LTG P ++ K I EL
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-----IILELP 231
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
P L S+ + A DP +R S + +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 63/268 (23%), Positives = 124/268 (46%), Gaps = 30/268 (11%)
Query: 843 NVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRNLTVLR 898
+L RG +G ++ A +D G +++++ + E +E L ++H N+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 899 GYYAGPPDVRLLVY-DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
G L ++ +Y+ G+L++LL++ V+ R ++ GL++LHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-----GLAYLHSN 120
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
+VH DIK N+L D+D L++FG + + + + G+ +++PE +
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 1018 PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE- 1076
+ AD++S G ++E+ TG+ P +++ + + + K G+ E+ PE
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALYKIGSSGEPPEI---------PEH 228
Query: 1077 -SSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
S E ++FL C DP RP+
Sbjct: 229 LSEEAKDFL------RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 28/268 (10%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDE-NTFRKEAEALGKVKHRNLTV 896
F+ + +G +G ++KA + + G ++I+ ++ + ++ E + L K KH N+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 897 LRG-YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G Y D +V ++ G+L LL+ L + L +GL +LH
Sbjct: 62 YYGSYL--KKDELWIVMEFCSGGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLH 115
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
S ++H DIK N+L +D E L +FGL A ++ + T +G+ +++PE +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGL----SAQLSDTKARNTMVGTPYWMAPEVING 171
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
+AD++S GI +E+ G+ P + +K + K I+ PGL +
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYS---ELPPMKALFK------IATNGPPGLRNPEK 222
Query: 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
S E+++FL C +P RP+
Sbjct: 223 WSDEFKDFL------KKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 76/295 (25%), Positives = 125/295 (42%), Gaps = 53/295 (17%)
Query: 844 VLSRGRYGLIFKAS------YQDGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLT 895
L G +G +F D +++++ L++ ++ F +EAE L +H N+
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 896 VLRGYY--AGPPDVRLLVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHL 942
G PP ++V++YM +G+L L+ SH L
Sbjct: 72 KFYGVCTEGDPP---IMVFEYMEHGDLNKFLR--SHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-- 1000
I++ +A G+ +L S VH D+ +N L D + +FG+ R T T
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQR 1059
PI ++ PE+ + T E+DV+SFG+VL EI T G++P W L
Sbjct: 187 PIR---WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-----------WY--GLSN 230
Query: 1060 GQISELLEPGLLELDPES--SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
++ E + G L P + SE + +LG C DP R ++ DI L+
Sbjct: 231 EEVIECITQGRLLQRPRTCPSEVYDIMLG------CWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 845 LSRGRYGLIFKASYQD-----GM-VLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLR 898
L +G +G + +D M VL +++ E+T E L ++ H + L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKL- 58
Query: 899 GYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR-------- 949
+YA + +L LV +Y P G L + L + S AR
Sbjct: 59 -HYAFQTEEKLYLVLEYAPGGELFSHLSK-------------EGRFSEERARFYAAEIVL 104
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
L +LHSL +++ D+KP+N+L DAD L++FGL + +E S + T G+ Y++
Sbjct: 105 ALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELS---SEGSRTNTFCGTPEYLA 161
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
PE K D +S G++L E+LTG+ P
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 71/283 (25%), Positives = 140/283 (49%), Gaps = 37/283 (13%)
Query: 841 EENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNL 894
++ V+ G +G +F+ + + ++I+ L+ G ++ F EA +G+ H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
L G +++ +YM NG L L++ DG ++ + ++ G+A G+ +L
Sbjct: 69 IRLEGVVTKFKPA-MIITEYMENGALDKYLRD---HDGEFSSYQLVGMLR-GIAAGMKYL 123
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT----PIGSLGYVSP 1010
++ VH D+ +N+L +++ E +S+FGL R+ P E + +T+ PI + +P
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP-EGTYTTSGGKIPIR---WTAP 179
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
EA + + T +DV+SFGIV+ E+++ G +P + +++K + + L P
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR------LPAP- 232
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+D S+ ++ + L C D RP DIV +L+
Sbjct: 233 ---MDCPSAVYQ-------LMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYA-- 902
L G++G ++ ++ ++++ L+ GT+ F +EA+ + K++H L L YA
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70
Query: 903 --GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
P +V +YM G+L L+ +G L P ++ +A G+++L S + +
Sbjct: 71 SEEEP--IYIVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPT 1019
H D+ +N+L + +++FGL RL A PI + +PEAA+ G+ T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK---WTAPEAANYGRFT 182
Query: 1020 KEADVYSFGIVLLEILT-GRKP 1040
++DV+SFGI+L EI+T GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 66/269 (24%), Positives = 125/269 (46%), Gaps = 36/269 (13%)
Query: 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRK----EAEALGKVKHRNLTVLR 898
VL +G G+++K ++ G + +++++ DE FRK E + L + +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEE-FRKQLLRELKTLRSCESPYVVKCY 65
Query: 899 GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-L 957
G + ++ + V +YM G+LA LL++ + P+ I+ + +GL +LH+
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLLKKVGK-----IPEPVLAYIARQILKGLDYLHTKR 119
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++H DIKP N+L ++ E +++FG+ ++ T + ++ +G++ Y+SPE
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPERIQGES 176
Query: 1018 PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV-KKQLQRGQISELLEPGLLELDPE 1076
+ AD++S G+ LLE G+ P F + + + G L E
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDGPP--------PSLPAE 226
Query: 1077 --SSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
S E+ +F+ C DP RPS
Sbjct: 227 EFSPEFRDFI------SACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 847 RGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY-YAGPP 905
+G +G + Y+ G ++++ L+D + F EA + ++H NL L G G P
Sbjct: 16 KGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP 74
Query: 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIK 965
+V +YM G+L L+ + V+ + +L + G+ +L + VH D+
Sbjct: 75 --LYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 966 PQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL--GYVSPEAASTGQPTKEAD 1023
+NVL D A +S+FGL A+ +S G L + +PEA + + ++D
Sbjct: 130 ARNVLVSEDLVAKVSDFGL--------AKEASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 1024 VYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
V+SFGI+L EI + GR P +D+V V+K
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 60/220 (27%), Positives = 118/220 (53%), Gaps = 18/220 (8%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L +G +G ++ ++ ++I+ L+ GT+ F +EA+ + K++H L L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
P +V ++M G+L L+E DG L P ++ +A G++++ ++ +H D+
Sbjct: 74 P--IYIVTEFMGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS---LGYVSPEAASTGQPTKE 1021
+ N+L + +++FGL RL E + T G+ + + +PEAA G+ T +
Sbjct: 129 RAANILVGDNLVCKIADFGLARL-----IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1022 ADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060
+DV+SFGI+L E++T GR P + +++ +Q++RG
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVL----EQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 65/253 (25%), Positives = 127/253 (50%), Gaps = 22/253 (8%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L G++G ++ ++ ++++ L+ GT+ +F +EA+ + K++H L L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
P +V +YM G+L L++ +G L P ++ +A G++++ ++ +H D+
Sbjct: 74 P--IYIVTEYMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS---LGYVSPEAASTGQPTKE 1021
+ N+L +++FGL RL E + T G+ + + +PEAA G+ T +
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1022 ADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL------- 1073
+DV+SFGI+L E++T GR P + ++++ V++ R + L EL
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMPCPQDCPISLHELMLQCWKK 242
Query: 1074 DPESSEWEEFLLG 1086
DPE E+L
Sbjct: 243 DPEERPTFEYLQS 255
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-19
Identities = 60/165 (36%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 629 IKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS 688
I L L L G IP +ISK L S+ L NS+ G IP S +++L L+LS N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 689 GAIPADLALISSLRYLNLSRNNLEGEIPKMLSSR------FNDPSIFAMNRELCGKPLDR 742
G+IP L ++SLR LNL+ N+L G +P L R FN F N LCG P R
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN----FTDNAGLCGIPGLR 535
Query: 743 ECANVRKRKRKRLIILICVSAAGACLL--ALCCCGYIYSLLRWRQ 785
C K + I VS A L+ A+C ++LR ++
Sbjct: 536 ACGPHLSVGAK-IGIAFGVSVAFLFLVICAMCWWKRRQNILRAQR 579
|
Length = 623 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 60/220 (27%), Positives = 115/220 (52%), Gaps = 18/220 (8%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L +G +G ++ ++ ++I+ L+ GT+ F +EA+ + K++H L L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
P +V +YM G+L L+ + G L P ++ +A G++++ ++ VH D+
Sbjct: 74 P--IYIVTEYMSKGSLLDFLK---GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS---LGYVSPEAASTGQPTKE 1021
+ N+L + +++FGL RL E + T G+ + + +PEAA G+ T +
Sbjct: 129 RAANILVGENLVCKVADFGLARL-----IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1022 ADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060
+DV+SFGI+L E+ T GR P + +++ Q++RG
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 34/274 (12%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYA-- 902
L G++G +++ + + ++++ L+ GT+D F EA+ + K++H L L YA
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAVC 70
Query: 903 --GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
P +V + M G+L LQ G L P ++ +A G+++L + + +
Sbjct: 71 TLEEP--IYIVTELMKYGSLLEYLQ---GGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPT 1019
H D+ +NVL + +++FGL R+ EA PI + +PEAA + +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK---WTAPEAALYNRFS 182
Query: 1020 KEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESS 1078
++DV+SFGI+L EI+T GR P + ++ + ++ G P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPY-------------PGMTNAEVLQQVDQGYRMPCPPGC 229
Query: 1079 EWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
E + + L C DP DRP+ + + LE
Sbjct: 230 PKELY----DIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 28/281 (9%)
Query: 843 NVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLT 895
L G +G + Y G ++++ L ++ + F +E E L + H N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 896 VLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+G G +RL + +Y+P+G+L LQ Q +N L S + +G+ +
Sbjct: 70 KYKGVCEKPGGRSLRL-IMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDY 124
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS-LGYVSPEA 1012
L S +H D+ +N+L +++ +S+FGL + + + P S + + +PE
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 1013 ASTGQPTKEADVYSFGIVLLEILT-GRK----PVMFTQDEDIVKWVKKQLQRGQISELLE 1067
T + + +DV+SFG+ L E+ T G P F + I + ++ ELL+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT---RLLELLK 240
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
G P S E + L LC +P DRPS AD++
Sbjct: 241 EGERLPRPPSCPDEVYDLMK----LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L G++G ++ Y ++I+ L+ G++ F EA + +++H L L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
P ++ +YM NG+L L+ +G L ++ +A G++F+ + +H D+
Sbjct: 74 P--IYIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPTKEAD 1023
+ N+L +++FGL RL A PI + +PEA + G T ++D
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK---WTAPEAINYGTFTIKSD 185
Query: 1024 VYSFGIVLLEILT-GRKP 1040
V+SFGI+L EI+T GR P
Sbjct: 186 VWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 59/203 (29%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRL-RDGTIDENTFRKEAEALGKVKHRNLTV 896
+F E L G +G +++ +++ + ++I+ L D + + F+KE +AL +++H++L
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLG--LARGLSFL 954
L + V ++ + M G+L L+ +G VL P+ LI + +A G+++L
Sbjct: 67 LFAVCSVGEPV-YIITELMEKGSLLAFLRSP---EGQVL--PVASLIDMACQVAEGMAYL 120
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAA 1013
+ +H D+ +N+L D +++FGL RL I SS P + +PEAA
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARL-IKEDVYLSSDKKIPYK---WTAPEAA 176
Query: 1014 STGQPTKEADVYSFGIVLLEILT 1036
S G + ++DV+SFGI+L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 34/270 (12%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIR--RLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYA 902
+ +G +G ++K + ++++ R + F +EAE L + H N+ L G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI--SLGLARGLSFLHSLDMV 960
+ +V + +P G+L T L++ ++ ++ L+ SL A G+ +L S + +
Sbjct: 63 QKQPI-YIVMELVPGGSLLTFLRKKKNR------LTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTK 1020
H D+ +N L + +S+FG+ R S I + + +PEA + G+ T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYTS 174
Query: 1021 EADVYSFGIVLLEILTGRK---PVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077
E+DV+S+GI+L E + P M Q Q E +E G P+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQ---------------QTRERIESGYRMPAPQL 219
Query: 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
E + ++ L C A DP +RPS ++I
Sbjct: 220 CPEEIY----RLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 68/252 (26%), Positives = 113/252 (44%), Gaps = 29/252 (11%)
Query: 845 LSRGRYGLIFKASY-QDGMVLSIRRL-RDGTIDENTFR---KEAEALGKVKHRNLTVLRG 899
+S+G YG +F A G + +I+ + + I +N E + L + ++ V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA--QSPYVVKL 58
Query: 900 YYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
YY+ L LV +Y+P G+LA+LL G L+ + + + L +LHS
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLL----ENVG-SLDEDVARIYIAEIVLALEYLHSNG 113
Query: 959 MVHGDIKPQNVLFD-------ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
++H D+KP N+L D DF LS+ GL R I + +G+ Y++PE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDF--GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKP-VMFTQDEDIVKWVKKQLQRGQISEL----- 1065
+K D +S G +L E L G P T +E + +++ + E+
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAI 231
Query: 1066 -LEPGLLELDPE 1076
L LL DPE
Sbjct: 232 DLISKLLVPDPE 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 58/223 (26%), Positives = 117/223 (52%), Gaps = 16/223 (7%)
Query: 842 ENVLSRGRYGLI----FKASYQDGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLT 895
E V+ G +G + K + + ++I+ L+ G ++ F EA +G+ H N+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL--GLARGLSF 953
L G V ++V +YM NG+L L++ DG + + L+ + G+A G+ +
Sbjct: 69 HLEGVVTKSKPV-MIVTEYMENGSLDAFLRK---HDGQ---FTVIQLVGMLRGIASGMKY 121
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
L + VH D+ +N+L +++ +S+FGL R+ P A ++ + + +PEA
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 1014 STGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
+ + T +DV+S+GIV+ E+++ G +P ++D++K +++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 67/276 (24%), Positives = 131/276 (47%), Gaps = 31/276 (11%)
Query: 842 ENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY 900
++ L G+YG +++ ++ + ++++ L++ T++ F KEA + ++KH NL L G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 901 YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
P ++ ++M GNL L+E + Q+ +N + ++ ++ + +L + +
Sbjct: 71 CTREPPF-YIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS---LGYVSPEAASTGQ 1017
H D+ +N L + +++FGL RL + T G+ + + +PE+ + +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRL-----MTGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 1018 PTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
+ ++DV++FG++L EI T G P + Q+ ELLE G PE
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLSQVYELLEKGYRMERPE 228
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + L C +P DRPS A+I E
Sbjct: 229 GCPPKVYELMRA----CWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 64/284 (22%), Positives = 125/284 (44%), Gaps = 46/284 (16%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRR--LRDGTIDE-NTFRKEAEALGKVKHRN 893
+++ + +G +G ++ DG + ++ L + + E E + L K+ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGH-----VLNWPMRHLISLGLA 948
+ + + +V +Y G+L+ +++ + +L+W + L LA
Sbjct: 61 IIKYYESFEEKGKL-CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW----FVQLCLA 115
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
L +LHS ++H DIKPQN+ ++ L +FG+ ++ +T + T +G+ Y+
Sbjct: 116 --LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTPYYL 170
Query: 1009 SPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQD--EDIVKWVKKQLQRGQISEL 1065
SPE +P ++D++S G VL E+ T + P F + ++ ++ +GQ +
Sbjct: 171 SPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHP--FEGENLLELA----LKILKGQYPPI 223
Query: 1066 LEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
P SSE + DP +RPS+A I
Sbjct: 224 ---------PSQYSSELRNLVSS------LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 64/272 (23%), Positives = 124/272 (45%), Gaps = 25/272 (9%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
E L G++G ++ A+Y ++++ ++ G++ F EA + ++H L L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
P ++ ++M G+L L+ +G P S +A G++F+ + +H
Sbjct: 71 TKEP--IYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKE 1021
D++ N+L A +++FGL R + E ++ + + +PEA + G T +
Sbjct: 126 RDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 1022 ADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEW 1080
+DV+SFGI+L+EI+T GR P + +++ + L+RG E EL
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVI----RALERGYRMPRPENCPEEL------- 232
Query: 1081 EEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + C P +RP+ I +L+
Sbjct: 233 ------YNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 50/199 (25%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
+ G++GL++ + + ++I+ +R+G + E F +EA+ + K+ H L L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 905 PDVRLLVYDYMPNGNLATLL--QEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
+ LV+++M +G L+ L Q +L + L + G+++L S +++H
Sbjct: 72 SPI-CLVFEFMEHGCLSDYLRAQRGKFSQETLLG------MCLDVCEGMAYLESSNVIHR 124
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEA 1022
D+ +N L + +S+FG+ R + + +SST + + SPE S + + ++
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 1023 DVYSFGIVLLEILT-GRKP 1040
DV+SFG+++ E+ + G+ P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L G++G ++ Y + ++++ L+ GT+ F +EA + ++H L L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
+ ++ +YM G+L L+ +G + P S +A G++++ + +H D+
Sbjct: 74 EPI-YIITEYMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS---LGYVSPEAASTGQPTKE 1021
+ NVL +++FGL R+ E + T G+ + + +PEA + G T +
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 1022 ADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060
+DV+SFGI+L EI+T G+ P + D++ LQRG
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVM----SALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 58/229 (25%), Positives = 118/229 (51%), Gaps = 26/229 (11%)
Query: 842 ENVLSRGRYGLI----FKASYQDGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLT 895
E V+ G +G + K + + ++I+ L+ G ++ F EA +G+ H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL--GLARGLSF 953
L G V +++ ++M NG L + L++ DG + + L+ + G+A G+ +
Sbjct: 69 HLEGVVTKSRPV-MIITEFMENGALDSFLRQ---NDGQ---FTVIQLVGMLRGIAAGMKY 121
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG------Y 1007
L ++ VH D+ +N+L +++ +S+FGL R + +S T SLG +
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL----EDDTSDPTYTSSLGGKIPIRW 177
Query: 1008 VSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
+PEA + + T +DV+S+GIV+ E+++ G +P ++D++ +++
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 47/293 (16%)
Query: 833 LEATRQFDEEN---VLSRGRYGLIFKASYQDGMV-LSIRRLRDGTIDENTFRKEAEALGK 888
LE ++DE VL +G YG+++ A V ++I+ + + E AL
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 889 -VKHRNLTVLRGYYAGPPDVRLLVYDYM---PNGNLATLLQEASHQDGHVLNWPMRHLIS 944
+KHRN+ Y G +M P G+L+ LL+ S N +
Sbjct: 61 YLKHRNIV----QYLGSDSENGFFKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYT 114
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLD-RLAIATPAEASSSTTPI 1002
+ GL +LH +VH DIK NVL + +S+FG RLA P + T
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC----TETFT 170
Query: 1003 GSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
G+L Y++PE G AD++S G ++E+ TG+ P + +L
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-------------ELGEP 217
Query: 1061 QISELLEPGLLELDPE-----SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
Q + + + G+ ++ PE S+E + F+L C PDP R S D++
Sbjct: 218 Q-AAMFKVGMFKIHPEIPESLSAEAKNFILR------CFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-16
Identities = 35/94 (37%), Positives = 61/94 (64%)
Query: 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSL 375
++ L L N +R P+ ++ + L+ ++LSGN GN+P ++GS+ LEVL ++ NS
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGG 409
+G +P+ + + + L++ +L GN SG+VPA LGG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 55/220 (25%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 844 VLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG--YY 901
++ G +G + + Y G ++++ ++ + F +E + K+ H+NL L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
G +V + M GNL L+ +++ SL +A G+ +L S +VH
Sbjct: 71 NG----LYIVMELMSKGNLVNFLRTRGRA---LVSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKE 1021
D+ +N+L D A +S+FGL R +S P+ + +PEA + + +
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKLPV---KWTAPEALKHKKFSSK 177
Query: 1022 ADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060
+DV+S+G++L E+ + GR P + +K VK+ +++G
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY----PKMSLKEVKECVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 47/295 (15%)
Query: 845 LSRGRYGLIFKA------SYQDGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLTV 896
+ +G +G +F+A Y+ +++++ L++ + F++EA + + H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 897 LRGYYA-GPPDVRLLVYDYMPNGNLATLLQ--------EASHQDGHV---------LNWP 938
L G A G P L+++YM G+L L+ SH L+
Sbjct: 73 LLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
+ I+ +A G+++L VH D+ +N L + +++FGL R + +S
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190
Query: 999 TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057
I + ++ PE+ + T E+DV+++G+VL EI + G +P E+++ +V+
Sbjct: 191 NDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD-- 247
Query: 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
G + P++ E + L LC + P DRPS A I +L+
Sbjct: 248 --GNVLSC---------PDNCPLELYNLMR----LCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 845 LSRGRYGLIFKAS------YQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRNLT 895
L G +G +F A QD M+++++ L++ + E+ F++EAE L ++H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIV 70
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNL----------ATLLQEASHQDGHVLNWPMRHLISL 945
G L+V++YM +G+L A +L L I+
Sbjct: 71 RFYGV-CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 946 GLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
+A G+ +L SL VH D+ +N L + +FG+ R +T T + +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PI 188
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP 1040
++ PE+ + T E+D++SFG+VL EI T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 59/227 (25%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 842 ENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLT 895
E V+ G +G + + + + ++I+ L+ G+ D+ F EA +G+ H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 896 VLRGYY-AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL-----GLAR 949
L G P +++ +YM NG+L L+ DG + L G+A
Sbjct: 69 RLEGVVTKSRP--VMIITEYMENGSLDKFLR---ENDGKF------TVGQLVGMLRGIAS 117
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
G+ +L ++ VH D+ +N+L +++ +S+FGL R + A ++ I + + +
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI-PIRWTA 176
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
PEA + + T +DV+SFGIV+ E+++ G +P ++D++K V+
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 66/247 (26%), Positives = 114/247 (46%), Gaps = 29/247 (11%)
Query: 831 ETLEATRQFDEENVLSRGRYGLIFKAS-YQDGMVLSIRRLRDGTIDENT-------FRKE 882
L A R F EE L G +G ++K LS + T+ EN FR+E
Sbjct: 2 IPLSAVR-FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 883 AEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLAT-LLQEASHQD---------- 931
AE + ++H N+ L G +L ++Y+ +G+L L++ + H D
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 932 GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991
L+ I++ +A G+ +L S VH D+ +N L +S+FGL R +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 992 P--AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDED 1048
S S P+ ++ PEA G+ T E+D++SFG+VL EI + G +P +++
Sbjct: 178 DYYRVQSKSLLPVR---WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
Query: 1049 IVKWVKK 1055
+++ ++
Sbjct: 235 VIEMIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-15
Identities = 37/92 (40%), Positives = 56/92 (60%)
Query: 440 LNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKI 499
L L +RG IP +I++L +L ++NLS N G +P +G++ L VL+LS + F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 500 PGSIGSLMRLTTLDLSNQNLSGELPIELFGLP 531
P S+G L L L+L+ +LSG +P L G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-15
Identities = 37/90 (41%), Positives = 55/90 (61%)
Query: 512 LDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDI 571
L L NQ L G +P ++ L LQ ++L N++ G++P S+ L+ L+LS N+F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 572 PATYGFLRSLVFLSLSHNQISGMIPAELGA 601
P + G L SL L+L+ N +SG +PA LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 73/292 (25%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 845 LSRGRYGLIFKASY---QD--GMVLSIRRLRDGTIDE-NTFRKEAEALGKVKHRNLTVLR 898
L +G +G + Y QD G V+++++L+ T + F +E E L ++H N+ +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 899 G--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
G Y AG ++RL V +Y+P G+L LQ+ + L+ L + + +G+ +L S
Sbjct: 72 GVCYSAGRRNLRL-VMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYLGS 126
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRL--------AIATPAEASSSTTPIGSLGYV 1008
VH D+ +N+L +++ + +FGL ++ + P E +PI +
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE-----SPIF---WY 178
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILT-----GRKPVMFTQDEDIVKWVKKQLQRGQIS 1063
+PE+ + + + +DV+SFG+VL E+ T P F + + + Q+ +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR--MMGNDKQGQMIVYHLI 236
Query: 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
ELL+ P E + + C DP RPS +++ +E R
Sbjct: 237 ELLKNNGRLPAPPGCPAEIYAI----MKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 845 LSRGRYGLIFKAS------YQDGMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVL 897
L G +G +F A +D M+++++ L+D T+ F++EAE L ++H ++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVL--NWPMRHLISLGL-------- 947
G G D ++V++YM +G+L L+ A D +L P + LGL
Sbjct: 73 YGV-CGDGDPLIMVFEYMKHGDLNKFLR-AHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 948 --ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
A G+ +L S VH D+ +N L A+ + +FG+ R +T T + +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-PI 189
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP 1040
++ PE+ + T E+DV+SFG++L EI T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-15
Identities = 34/82 (41%), Positives = 51/82 (62%)
Query: 425 GLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKG 484
G IP L L+++NLS N IRGNIP + +++L L+LSYN F G +P +G L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 485 LLVLNLSASGFSGKIPGSIGSL 506
L +LNL+ + SG++P ++G
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 40/274 (14%)
Query: 848 GRYGLIFKA-SYQDGMVLSIRRLRDGTIDENTFRK---EAEALGKVKHRNLTVLRGYYAG 903
G +G ++ A + G +++++ +R D T ++ E + L +KH NL YY
Sbjct: 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---KYYG- 66
Query: 904 PPDV---RLLVY-DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM 959
+V ++ ++ +Y G L LL+ D HV+ + +L L GL++LHS +
Sbjct: 67 -VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI-----RVYTLQLLEGLAYLHSHGI 120
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLD-RLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
VH DIKP N+ D + L +FG +L T + G+ Y++PE TG
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI-TGGK 179
Query: 1019 TKE----ADVYSFGIVLLEILTGRKPVMFTQDEDIVKW-VKKQLQRGQISELLEPGLLEL 1073
K AD++S G V+LE+ TG++P +E + + + G +P + +
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHVGAGH-----KPPIPDS 230
Query: 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S E ++FL C DP RP+ +++
Sbjct: 231 LQLSPEGKDFL------DRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 20/206 (9%)
Query: 844 VLSRGRYGLIF---KASYQD-GMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTV 896
VL +G +G +F K + D G + +++ L+ T+ D + E + L +V H +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHP--FI 60
Query: 897 LRGYYAGPPDVRL-LVYDYMPNGNLATLL-QEASHQDGHVLNWPMRHLISLGLARGLSFL 954
++ +YA + +L L+ D++ G+L T L +E + V + LA L L
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE------LALALDHL 114
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
HSL +++ D+KP+N+L D + L++FGL + +I +A S G++ Y++PE +
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAPEVVN 171
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKP 1040
T+ AD +SFG+++ E+LTG P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 22/148 (14%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
V +Y PNG L +++ D + ++ L +LHS ++H D+KP+N+
Sbjct: 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL-----ALEYLHSKGIIHRDLKPENI 133
Query: 970 LFDADFEAHLSEFG----LDR--LAIATPAEASSSTTPI-----------GSLGYVSPEA 1012
L D D +++FG LD + +A++ + I G+ YVSPE
Sbjct: 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL 193
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+ K +D+++ G ++ ++LTG+ P
Sbjct: 194 LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-14
Identities = 87/287 (30%), Positives = 125/287 (43%), Gaps = 58/287 (20%)
Query: 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
+ NL L +L+L+ N +R NI E + L+NLT+L+L N
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-------------- 129
Query: 487 VLNLSASGFSGKIPGSIGSL-MRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
IP IG L L LDLS+ + LP L LP+L+ + L N+LS
Sbjct: 130 -----------DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605
D+P L +L L LS N+IS +P E+ SAL
Sbjct: 177 ------------------------DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
E L+L +N + +S+L + L+L NKL ++P+ I S+L +L L N +S
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS- 268
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
S L+NL L+LS N LS A+P L+ L L L+
Sbjct: 269 -SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L G++G++ ++ + ++I+ +R+G + E+ F +EA+ + K+ H NL L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
+ +V +YM NG L L+E L + + + +L S +H D+
Sbjct: 72 RPIF-IVTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPTKEAD 1023
+N L D +S+FGL R + +S T P+ + PE + + ++D
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKSD 183
Query: 1024 VYSFGIVLLEILTGRK 1039
V+SFG+++ E+ + K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 65/268 (24%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRK---EAEALGKVKHRNLTVLR 898
L G G++ K ++ G +++++ +R I+E ++ E + L K +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 899 GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL--ISLGLARGLSFLHS 956
G + D+ + + +YM G+L +L+E + P R L I++ + +GL++LH
Sbjct: 66 GAFYNNGDISICM-EYMDGGSLDKILKEVQGR------IPERILGKIAVAVLKGLTYLHE 118
Query: 957 -LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
++H D+KP N+L ++ + L +FG+ + + A+ T+ Y++PE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS-----YMAPERIQG 173
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
+ ++D++S G+ L+E+ TGR P D + + LQ ++E P L
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQY-IVNE--PPPRLPSGK 228
Query: 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
S ++++F+ LC DP +RPS
Sbjct: 229 FSPDFQDFV------NLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 45/289 (15%)
Query: 845 LSRGRYGLIFKAS------YQDGMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVL 897
L G +G +F A QD ++++++ L+D + + F +EAE L ++H ++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVL----NWP-------MRHLISLG 946
G D ++V++YM +G+L L+ +H VL N P M H I+
Sbjct: 73 YGVCV-EGDPLIMVFEYMKHGDLNKFLR--AHGPDAVLMAEGNRPAELTQSQMLH-IAQQ 128
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
+A G+ +L S VH D+ +N L + + +FG+ R +T T + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIR 187
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065
++ PE+ + T E+DV+S G+VL EI T G++P W QL ++ E
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------WY--QLSNNEVIEC 234
Query: 1066 LEPGLLELDPESSEWE--EFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ G + P + E + +LG C +P R ++ +I +L+
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLMLG------CWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP 938
F KEA + + H NL L G P ++V + P G+L L++ GH L
Sbjct: 43 FLKEAAIMHSLDHENLIRLYGVVLTHP--LMMVTELAPLGSLLDRLRK--DALGHFL-IS 97
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
++ +A G+ +L S +H D+ +N+L +D + + +FGL R A P
Sbjct: 98 TLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR---ALPQNEDHY 154
Query: 999 TT------PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051
P + +PE+ T + +DV+ FG+ L E+ T G +P I+K
Sbjct: 155 VMEEHLKVPF---AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211
Query: 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
+ K+ +R LE PE+ + + + ++ C A +P DRP+ A + L
Sbjct: 212 KIDKEGER------LE------RPEACPQDIYNVMLQ----CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 62/280 (22%), Positives = 120/280 (42%), Gaps = 60/280 (21%)
Query: 843 NVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLR 898
+++ RG +G+++K + G ++I+++ I E + +E + L +KH N+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 899 GYYAGPPDVRLL--VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA---RGLSF 953
G L + +Y NG+L ++ + G L+++ + +GL++
Sbjct: 66 GSI---ETSDSLYIILEYAENGSLRQII----KKFGP-FP---ESLVAVYVYQVLQGLAY 114
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
LH ++H DIK N+L D L++FG +A + + +G+ +++PE
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFG---VATKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKKQLQRGQISEL 1065
+ +D++S G ++E+LTG P +F +I +
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF-----------------RIVQD 214
Query: 1066 LEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P L PE S E ++FL + C DP RP+
Sbjct: 215 DHPPL----PEGISPELKDFL------MQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 848 GRYGLIFKASY-QDGMVLSIRRL----RDGTIDENTFRKEAEALGKVKHRNLTVLRGYYA 902
G +G++FKA + G ++++++ +G I R E +AL +H + L +
Sbjct: 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFP 69
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
+LV +YMP+ L+ +L++ L L +G++++H+ ++H
Sbjct: 70 HGSGF-VLVMEYMPSD-LSEVLRDEERP----LPEAQVKSYMRMLLKGVAYMHANGIMHR 123
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP--TK 1020
D+KP N+L AD +++FGL RL + E + + + Y +PE G
Sbjct: 124 DLKPANLLISADGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELL-YGARKYDP 180
Query: 1021 EADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
D+++ G + E+L G +F + DI
Sbjct: 181 GVDLWAVGCIFAELLNGSP--LFPGENDI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 49/212 (23%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 848 GRYGLIFKA-SYQDGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAG 903
G YG+++KA G +++I++++ T +E + L ++ H N+ L +
Sbjct: 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH 69
Query: 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGD 963
D+ LV+++M L + + + ++ + L +GL+F HS ++H D
Sbjct: 70 KGDL-YLVFEFM----DTDLYKLIKDRQRGLPESLIKSYL-YQLLQGLAFCHSHGILHRD 123
Query: 964 IKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEA 1022
+KP+N+L + + L++FGL R +P T + + Y +PE +
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSF-GSPVRP--YTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 1023 DVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054
D++S G + E+L+ R +F +I + K
Sbjct: 181 DIWSVGCIFAELLSRR--PLFPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 19/176 (10%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
LV D + G+L L + + + + ++ L +LHS ++H DIKP N+
Sbjct: 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL-----ALEYLHSKGIIHRDIKPDNI 131
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTTPI-GSLGYVSPEAASTGQPTKEADVYSFG 1028
L D H+++F IAT + TT G+ GY++PE + D +S G
Sbjct: 132 LLDEQGHVHITDFN-----IATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLG 186
Query: 1029 IVLLEILTGRKPVMFTQDEDIVKWVKKQLQR------GQISELLE--PGLLELDPE 1076
+ E L G++P + KQ +E ++ LLE DP+
Sbjct: 187 VTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQ 242
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 55/232 (23%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 880 RKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPM 939
R E E L + H N+ G+ + + + +Y+P G++ + L+ + ++
Sbjct: 56 RSEIETLKDLDHLNIVQYLGFETTEEYLSIFL-EYVPGGSIGSCLRTYGRFEEQLV---- 110
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
R L GL++LHS ++H D+K N+L DAD +S+FG+ + + + +
Sbjct: 111 RFFTEQVL-EGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNM 168
Query: 1000 TPIGSLGYVSPEAASTGQPTKEA--DVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK--K 1055
+ GS+ +++PE + A D++S G V+LE+ GR+P ++ +E I K
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEEAIAAMFKLGN 226
Query: 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ I + L S +FL C +P +RP+ ++
Sbjct: 227 KRSAPPIPPDVSMNL------SPVALDFLNA------CFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRL---RDGTIDENTFRKEAEALGKVKHRNL 894
F+ N + +G +G++FK + D V +++++ + + EA L K+
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY- 60
Query: 895 TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLN----WPMRHLISLGLAR 949
++R Y + +L +V +Y NG+L LL+ Q G L W R I + L
Sbjct: 61 -IIRYYESFLDKGKLNIVMEYAENGDLHKLLKM---QRGRPLPEDQVW--RFFIQILL-- 112
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL+ LHS ++H DIK N+ DA + + G+ +L A+ T +G+ Y+S
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN---TIVGTPYYLS 169
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
PE +++DV++ G+VL E TG+ P
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 839 FDEENVLSRGRYGLIF---KASYQD-GMVLSIRRLRDGTI------DENTFRKEAEALGK 888
F+ VL G YG +F K S D G + +++ L+ TI E+T R E + L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEH 60
Query: 889 VKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLAT-LLQEASHQDGHVLNWPMRHLISLG 946
++ V +YA D +L L+ DY+ G L T L Q ++ V + S
Sbjct: 61 IRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEV------QIYSGE 113
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
+ L LH L +++ DIK +N+L D++ L++FGL + E + S G++
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC--GTIE 171
Query: 1007 YVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDED 1048
Y++P+ G K D +S G+++ E+LTG P FT D +
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP--FTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI-----SLGLARGLSFLHSLDMVHGD 963
L+V + M G+L + L+ + + L + +A G+++L + VH D
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRD 144
Query: 964 IKPQNVLFDADFEAHLSEFGLDRLAIATP--AEASSSTTPIGSLGYVSPEAASTGQPTKE 1021
+ +N + D + +FG+ R T + P+ +++PE+ G T +
Sbjct: 145 LAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WMAPESLKDGVFTTK 201
Query: 1022 ADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEW 1080
+DV+SFG+VL E+ T +P +E+++K+V G L+L PE
Sbjct: 202 SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG------------GHLDL-PE--NC 246
Query: 1081 EEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ LL ++ +C +P RP+ +IV L+
Sbjct: 247 PDKLL--ELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-13
Identities = 32/89 (35%), Positives = 49/89 (55%)
Query: 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDV 547
L L G G IP I L L +++LS ++ G +P L + SL+V+ L N+ +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 548 PEGFSSLVGLQYLNLSDNAFTGDIPATYG 576
PE L L+ LNL+ N+ +G +PA G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 51/217 (23%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L G++G++ ++ ++I+ +++G++ E+ F +EA+ + K+ H L L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL--GLARGLSFLHSLDMVHG 962
+ +V +YM NG L L+E + + L+ + + G+++L S +H
Sbjct: 72 RPI-YIVTEYMSNGCLLNYLREHGKR------FQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEA 1022
D+ +N L D +S+FGL R + E +SS + + PE + + ++
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 1023 DVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQ 1058
DV++FG+++ E+ + G+ P + + V+ V + L+
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 14/221 (6%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRNLT 895
++ + +G +G + Y+ G ++++ ++ D T F EA + +++H NL
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLV 62
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L G +V +YM G+L L+ VL SL + + +L
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLE 119
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
+ + VH D+ +NVL D A +S+FGL + A +T + P+ + +PEA
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPV---KWTAPEALRE 173
Query: 1016 GQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
+ + ++DV+SFGI+L EI + GR P +D+V V+K
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 51/291 (17%)
Query: 844 VLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLRG 899
V+ G YG++ K + G +++I++ ++ DE T +E + L +++H N+ L+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 900 YYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
+ RL LV++Y+ TLL+ G + +R L + +++ HS +
Sbjct: 68 AFRR--KGRLYLVFEYVER----TLLELLEASPGGLPPDAVR-SYIWQLLQAIAYCHSHN 120
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE----AAS 1014
++H DIKP+N+L L +FG R A P AS T + + Y +PE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARP--ASPLTDYVATRWYRAPELLVGDTN 178
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED------IVKWVKKQLQRGQ------- 1061
G K DV++ G ++ E+L G +F D D I K + Q
Sbjct: 179 YG---KPVDVWAIGCIMAELLDGEP--LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233
Query: 1062 ------ISELLEPGLLELDPE---SSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
E +P LE SS +FL C DP +R +
Sbjct: 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKA------CLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 844 VLSRGRYGLIF---KASYQD-GMVLSIRRLRDGTI------DENTFRKEAEALGKVKHRN 893
VL G YG +F K D G + +++ L+ TI E+T R E + L V+ R
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLEAVR-RC 64
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
++ +YA D +L L+ DY+ G L T L + H + + ++ LA L
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV---LA--LD 119
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
LH L +++ DIK +N+L D++ L++FGL + +A E + S G++ Y++PE
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC--GTIEYMAPEV 177
Query: 1013 ASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQD 1046
G K D +S G++ E+LTG P FT D
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASP--FTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-13
Identities = 33/85 (38%), Positives = 48/85 (56%)
Query: 536 VSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMI 595
+ L+ L G +P S L LQ +NLS N+ G+IP + G + SL L LS+N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 596 PAELGACSALEVLELRSNHFTGNIP 620
P LG ++L +L L N +G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 41/280 (14%)
Query: 843 NVLSRGRYGLIFKASYQDG-------MVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT 895
V+ +G +G ++ + D V S+ R+ D + F KE + H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVL 59
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL--ARGLSF 953
L G L+V YM +G+L ++ +H N ++ LI GL A+G+ +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH------NPTVKDLIGFGLQVAKGMEY 113
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR----LAIATPAEASSSTTPIGSLGYVS 1009
L S VH D+ +N + D F +++FGL R + + + P+ +++
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMA 170
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068
E+ T + T ++DV+SFG++L E++T G P DI + L +G+ LL+P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LLQGR--RLLQP 224
Query: 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
E P+ +V L C P P RP+ +++V
Sbjct: 225 ---EYCPDPL--------YEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-13
Identities = 74/223 (33%), Positives = 105/223 (47%), Gaps = 8/223 (3%)
Query: 387 SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
L DL NR + L + L + L N + + PL S L+ L+LS+N
Sbjct: 93 LPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK 151
Query: 447 IRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSL 506
I ++P + L NL L+LS+N +P + NL L L+LS + S +P I L
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDL-SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208
Query: 507 MRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566
L LDLSN N EL L L +L + L NN D+PE +L L+ L+LS+N
Sbjct: 209 SALEELDLSN-NSIIELLSSLSNLKNLSGLEL-SNNKLEDLPESIGNLSNLETLDLSNNQ 266
Query: 567 FTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLE 609
+ I + G L +L L LS N +S +P LE+L
Sbjct: 267 IS-SISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 65/283 (22%), Positives = 121/283 (42%), Gaps = 43/283 (15%)
Query: 845 LSRGRYGLIFKASYQ--DGMVL--SIRRLRDGTIDENT--FRKEAEALGKVKHRNLTVLR 898
L G +G + K Y G + +++ L+ I F +EA + ++ H + L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 899 GYYAGPPDVRLLVYDYMPNGNLATLLQEASH-QDGHVLNWPMRHLISLGLARGLSFLHSL 957
G G P +LV + P G L L++ + + +A G+++L S
Sbjct: 63 GVCKGEP--LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT----PIGSLGYVSPEAA 1013
VH D+ +NVL +A +S+FG+ R A+ ++ +TT P L + +PE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWP---LKWYAPECI 170
Query: 1014 STGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL-L 1071
+ G+ + ++DV+S+G+ L E + G KP +++ ++ +LE G L
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPY-------------GEMKGAEVIAMLESGERL 217
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
E + ++ L C P DRP+ +++
Sbjct: 218 PRPEECPQEIYSIM-----LSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 42/236 (17%)
Query: 881 KEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMR 940
KE L +++H N +G Y LV +Y G+ + +L+ V P++
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYL-REHTAWLVMEYCL-GSASDILE--------VHKKPLQ 113
Query: 941 HL----ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
+ I G +GL++LHS + +H DIK N+L L++FG ++ +PA
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG--SASLVSPAN-- 169
Query: 997 SSTTPIGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053
+ +G+ +++PE A GQ + DV+S GI +E L RKP +F + +
Sbjct: 170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALY- 224
Query: 1054 KKQLQRGQISELLEPGLLELDPESSEW-EEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
I++ P L S++W + F V C P DRPS +++
Sbjct: 225 -------HIAQNDSPTL-----SSNDWSDYFRNFVD---SCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRNLTVLRGY 900
+S+G +G ++ A + G +I+ L+ + T K A+ ++ + V + Y
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 901 YA-GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM 959
Y+ D LV +Y+ G+ A+L++ +W +++ + L G+ LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWAKQYIAEVVL--GVEDLHQRGI 118
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPT 1019
+H DIKP+N+L D L++FGL R + +G+ Y++PE
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-------KFVGTPDYLAPETILGVGDD 171
Query: 1020 KEADVYSFGIVLLEILTGRKP 1040
K +D +S G V+ E L G P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 67/279 (24%), Positives = 123/279 (44%), Gaps = 44/279 (15%)
Query: 844 VLSRGRYGLIFKASYQ-DG----MVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNLTV 896
VL G +G ++K + +G + ++I+ LR+ T + EA + V H ++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG----HVLNWPMRHLISLGLARGLS 952
L G L+ MP G L ++ H+D ++LNW + +A+G+S
Sbjct: 74 LLGICLSSQ--VQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNW------CVQIAKGMS 123
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE--ASSSTTPIGSLGYVSP 1010
+L +VH D+ +NVL +++FGL +L E A PI +++
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI---KWMAL 180
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
E+ T ++DV+S+G+ + E++T G KP + + +I +LLE G
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPY-------------EGIPAVEIPDLLEKG 227
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
P + +++ VK C D RP+ +++
Sbjct: 228 ERLPQPPICTIDVYMVLVK----CWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFR---KEAEALGKVKHRNLTVLRGY 900
L +G YG ++K ++ G+ ++++ +R +DE+ F E + L K + G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 901 YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL-HSLDM 959
+ V + + +YM G+L L +G + + I+ + +GL FL ++
Sbjct: 68 FFIEGAVYMCM-EYMDAGSLDKLYAGGVATEG--IPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP- 1018
+H D+KP NVL + + + L +FG ++ AS + T IG Y++PE +G P
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFG-----VSGNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 1019 -----TKEADVYSFGIVLLEILTGRKP 1040
T ++DV+S G+ +LE+ GR P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 35/85 (41%), Positives = 49/85 (57%)
Query: 560 LNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNI 619
L L + G IP LR L ++LS N I G IP LG+ ++LEVL+L N F G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 620 PVDISHLSRIKKLDLGQNKLSGEIP 644
P + L+ ++ L+L N LSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 40/109 (36%), Positives = 60/109 (55%), Gaps = 10/109 (9%)
Query: 127 QYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISP--SLRYLDLSSNAFTGEIPGN 184
Q++S G + L N L G I DIS L+ ++LS N+ G IP +
Sbjct: 410 QFDSTKGKWFIDGLGLDN--------QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS 461
Query: 185 FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAI 233
S + L++++LSYNSF+G +P S+GQL L L L+ N L G +P+A+
Sbjct: 462 LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 75/296 (25%), Positives = 134/296 (45%), Gaps = 44/296 (14%)
Query: 833 LEATRQFDEENVLSRGRYGLIFKAS-YQDGM----VLSIRRLRDGTIDEN--TFRKEAEA 885
L A R +E L +G I+K Y GM +++I+ L+D + F++EA
Sbjct: 4 LSAVRFMEE---LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQE---------ASHQDGHVLN 936
+ ++ H N+ L G V +L ++Y+ G+L L +S +DG V +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 937 WPMRH----LISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
+ H I++ +A G+ +L S VH D+ +N+L +S+ GL R +
Sbjct: 120 -SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051
+ + + ++ PEA G+ + ++D++SFG+VL EI + G +P ++++++
Sbjct: 179 YYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
V+K+ Q SE P + L E W+E P RP DI
Sbjct: 238 MVRKR-QLLPCSEDCPPRMYSLMTEC--WQEG--------------PSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-12
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 1/99 (1%)
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF 431
N L G +P++I+K LQ +L GN G +P LG I L+++ L N F+G IP S
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 432 GNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
G L+ L LNL+ N + G +P + RL + + N + N
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRNLT 895
FD L G YG ++KA + + G V++I+ + + + E KE L + +
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIV 61
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G Y D+ +V +Y G+++ +++ + L I +GL +LH
Sbjct: 62 KYYGSYFKNTDL-WIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLEYLH 116
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
S +H DIK N+L + + +A L++FG+ T A+ + T IG+ +++PE
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN---TVIGTPFWMAPEVIQE 173
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKP 1040
+AD++S GI +E+ G+ P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972
+Y G+L ++ ++ + G + + I+ + +GLS+LHS ++H DIKP N+L
Sbjct: 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGK-IAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 973 ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLL 1032
+ L +FG+ + S + T G+ Y++PE + +DV+S G+ LL
Sbjct: 140 RKGQVKLCDFGVSGELV-----NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194
Query: 1033 EILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE------PGLLELDPESS-EW-EEFL 1084
E+ R P F + + G I ELL L+ +P + +W EEF
Sbjct: 195 EVAQNRFP--FPPE--------GEPPLGPI-ELLSYIVNMPNPELKDEPGNGIKWSEEFK 243
Query: 1085 LGVKVGLLCTAPDPLDRPS---MADIVFMLEGCRVGPDM 1120
+K C DP RP+ M + ++ + +M
Sbjct: 244 DFIKQ---CLEKDPTRRPTPWDMLEHPWIKAQMKKKVNM 279
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 32/282 (11%)
Query: 844 VLSRGRYGLIFKASYQ-----DGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRNLT 895
L RG +G +F A + G L + + T DEN FR+E + K+ H+N+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPM--RHLISLG--LARGL 951
L G + ++ +Y G+L L+ +D + P+ + ++L +A G+
Sbjct: 72 RLLGL-CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
L + VH D+ +N L + E +S L + + E + L +++PE
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--EYYKLRNALIPLRWLAPE 188
Query: 1012 AASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
A + ++DV+SFG+++ E+ T G P DE+++ +LQ G+
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL----NRLQAGK--------- 235
Query: 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
LEL K+ C A +P DRPS +++V L
Sbjct: 236 LELPVPEGCPSRLY---KLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 65/245 (26%), Positives = 116/245 (47%), Gaps = 37/245 (15%)
Query: 845 LSRGRYGLIFKA-SYQDGMVLSIRRLR----DGTIDENTFRKEAEALGKVKHRNLTVLRG 899
+ G YG +FKA + + +++++R+R D + + R E L ++KH+N+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNI----- 61
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQD--------GHVLNWPMRHLISLGLARGL 951
VRL YD + + TL+ E QD ++ + L +GL
Sbjct: 62 -------VRL--YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
+F HS +++H D+KPQN+L + + E L++FGL R A P S+ + +L Y P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAE--VVTLWYRPPD 169
Query: 1012 A--ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD-EDIVKWVKKQLQRGQISELLEP 1068
+ T D++S G + E+ +P+ D +D +K + + L G +E P
Sbjct: 170 VLFGAKLYST-SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTPTEESWP 226
Query: 1069 GLLEL 1073
G+ +L
Sbjct: 227 GVSKL 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 71/262 (27%), Positives = 122/262 (46%), Gaps = 52/262 (19%)
Query: 839 FDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR-----DG----TIDENTFRKEAEALGK 888
++E + G YG ++KA G ++++++R +G T+ E K+ E+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE- 59
Query: 889 VKHRNLTVLRGYYAGPPDVR----LLVYDYMPNGNLATLLQEASHQDG---HVLNWPMRH 941
H N+ L GP R LV++++ + +LAT L + + G + MR
Sbjct: 60 --HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCP-KPGLPPETIKDLMRQ 115
Query: 942 LISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
L+ RG+ FLHS +VH D+KPQN+L +D + +++FGL R + + T+
Sbjct: 116 LL-----RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR----IYSFEMALTSV 166
Query: 1002 IGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058
+ +L Y +PE +S P D++S G + E L R+P+ E QL
Sbjct: 167 VVTLWYRAPEVLLQSSYATPV---DMWSVGCIFAE-LFRRRPLFRGTSE------ADQLD 216
Query: 1059 RGQISELLEPGLLELDPESSEW 1080
+ I +++ GL P EW
Sbjct: 217 K--IFDVI--GL----PSEEEW 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 899 GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-L 957
G + ++ + ++M G+L + ++ +L I++ + GL++L++
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVH 123
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++H DIKP N+L ++ + L +FG+ I + A+ T +G+ Y+SPE G+
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGK 178
Query: 1018 PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL------EPGLL 1071
T ++DV+S GI ++E+ G+ P F+ +D Q I +LL P L
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDD-----DGQDDPMGILDLLQQIVQEPPPRL 233
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
+ +F+ C DP +RP+ +
Sbjct: 234 PSSDFPEDLRDFV------DACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 843 NVLSRGRYGLIFKASYQD-GMVLSIRRL----RDGTIDENTFRKEAEALGKVKHRNLTVL 897
V+ G +++ A ++I+R+ ++DE RKE +A+ + H N+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE--LRKEVQAMSQCNHPNVV-- 62
Query: 898 RGYYAG--PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
YY D LV Y+ G+L +++ + + G L+ + + + +GL +LH
Sbjct: 63 -KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLH 119
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS--TTPIGSLGYVSPEAA 1013
S +H DIK N+L D +++FG+ ++A + + T +G+ +++PE
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSA-SLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 1014 STGQP-TKEADVYSFGIVLLEILTGRKP 1040
+AD++SFGI +E+ TG P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 64/278 (23%), Positives = 126/278 (45%), Gaps = 36/278 (12%)
Query: 843 NVLSRGRYGLIFKASYQDGMV-------LSIRRLRDGTIDEN--TFRKEAEALGKVKHRN 893
N L G +G +++ + D + ++++ LR G D+ F KEA + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL--ARGL 951
+ L G + + ++ + M G+L + L++A + ++ L+ + L A+G
Sbjct: 61 IVKLLGVCL-LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 952 SFLHSLDMVHGDIKPQNVL-----FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
+L + +H D+ +N L +DAD + +FGL R I + +
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065
+++PE+ G+ T ++DV+SFG+++ EILT G++P ++++++ V
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT----------- 227
Query: 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
G L+ + L+ C A DP +RP+
Sbjct: 228 -AGGRLQKPENCPDKIYQLM-----TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-12
Identities = 64/247 (25%), Positives = 95/247 (38%), Gaps = 35/247 (14%)
Query: 509 LTTLDLSNQNLSGE----LPIELFGLPSLQVVSLEENNLSGD------VPEGFSSLVGLQ 558
L L L L E L L PSL+ + L N + +G + GLQ
Sbjct: 25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84
Query: 559 YLNLSDNAFTGDIPATYGFLRSLVFL---SLSHNQISGMIPAELGA-----CSALEVLEL 610
L+LSDNA D L L L++N + L ALE L L
Sbjct: 85 ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144
Query: 611 RSNHFTGNIPVDIS----HLSRIKKLDLGQNKLSGE----IPKEISKCSSLVSLTLDMNS 662
N G ++ +K+L+L N + + + + +L L L+ N
Sbjct: 145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG 204
Query: 663 L----SGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALI-----SSLRYLNLSRNNLEG 713
L + + E+ + L +L LNL N L+ A A LA SL L+LS N++
Sbjct: 205 LTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITD 264
Query: 714 EIPKMLS 720
+ K L+
Sbjct: 265 DGAKDLA 271
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 38/114 (33%), Positives = 55/114 (48%), Gaps = 30/114 (26%)
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP 308
L+G IP I ++ LQ ++LS N + G +P S+ G+I+SL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL-----GSITSL---------------- 468
Query: 309 PNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSL 362
EVLDL N P L +TSLR+++L+GN SG +PAA+G
Sbjct: 469 ---------EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 96/357 (26%), Positives = 142/357 (39%), Gaps = 50/357 (14%)
Query: 213 QELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNE 272
L L SN L LPS++S SL LS + + L L L+ N
Sbjct: 47 VNRLALNLSSNTL-LLLPSSLSRLLSLDLLSPSGISSLDGS-ENLLNLLPLPSLDLNLNR 104
Query: 273 LTGLVPVSVLCNLWGNISSLRIVQLGFNAFT---GVVKPPNGRCVSVLEVLDLQNNRIRA 329
L + +++L + L N T ++ L+ LDL +N+I +
Sbjct: 105 LRSN------ISELLELTNLTSLDLDNNNITDIPPLIGLLKSN----LKELDLSDNKIES 154
Query: 330 VFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLL 389
PS L N+ +L+ +DLS N S +LP + +L L L ++ N +S +P EI S L
Sbjct: 155 -LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 390 QMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG 449
+ DL N + S NL L L LS N +
Sbjct: 212 EELDLSNNSII-------------------------ELLSSLSNLKNLSGLELSNNKLE- 245
Query: 450 NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRL 509
++PE I LSNL TL+LS N+ + +G+L L L+LS + ++ + L
Sbjct: 246 DLPESIGNLSNLETLDLSNNQ-ISSISS-LGSLTNLRELDLS----GNSLSNALPLIALL 299
Query: 510 TTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566
L NL L L S+ + + +N PE S L L L DNA
Sbjct: 300 LLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNA 356
|
Length = 394 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-11
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 859 QDGMVLSIRRLRDGTIDEN----TFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914
G ++I+ LR +E FR+E ++ H N+ L PP + V++Y
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA- 973
+P L +L DG + L+ L + L+ H+ +VH D+KPQN++
Sbjct: 61 VPGRTLREVLA----ADGALPAGETGRLM-LQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 974 DFEAH--LSEFGLDRL----AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSF 1027
H + +FG+ L A A + +T +G+ Y +PE T +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 1028 GIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
G++ LE LTG + V+ Q + + + +QL
Sbjct: 176 GLIFLECLTG-QRVV--QGASVAEILYQQL 202
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 69/247 (27%), Positives = 113/247 (45%), Gaps = 30/247 (12%)
Query: 844 VLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAE--------ALGKVKHRNL 894
V+ +G +G + A + DG +++ L+ I + +KE + L VKH L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK---KKEQKHIMAERNVLLKNVKHPFL 58
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
L Y D V DY+ G L LQ P + +A L +L
Sbjct: 59 VGLH-YSFQTADKLYFVLDYVNGGELFFHLQRERS-----FPEPRARFYAAEIASALGYL 112
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
HSL++++ D+KP+N+L D+ L++FGL + I + +++T G+ Y++PE
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH---SKTTSTFCGTPEYLAPEVLR 169
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKPVMFTQD--EDIVKWVKKQLQ-RGQIS----ELLE 1067
+ D + G VL E+L G P +++D E + K L+ + IS LLE
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP-FYSRDTAEMYDNILNKPLRLKPNISVSARHLLE 228
Query: 1068 PGLLELD 1074
GLL+ D
Sbjct: 229 -GLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 842 ENVLSRGRYGLI----FKASYQDGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLT 895
E +L GR+G + K + + ++I LR G D+ F EA LG+ H N+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L G + ++V +YM NG L + L++ +G ++ + ++ GLA G+ +L
Sbjct: 70 RLEGVIT-RGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLP-GLASGMKYLS 124
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGL---DRLAIATPAEASSSTTPIGSLG-YVSPE 1011
+ VH + VL ++D +S F D+ EA +T S + +PE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS------EAIYTTMSGKSPVLWAAPE 178
Query: 1012 AASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVK 1054
A + +DV+SFGIV+ E+++ G +P +D++K V+
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 30/270 (11%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLTVLRGYYA 902
L G +G ++KA +++ + + ++ +E F E + L + KH N+ L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
+ +L+ ++ G L +++ E L P + + L+FLHS ++H
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST----GQP 1018
D+K N+L D + L++FG+ +T + T IG+ +++PE + P
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD---TFIGTPYWMAPEVVACETFKDNP 184
Query: 1019 TK-EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077
+AD++S GI L+E+ P E V ++ + + L +P S
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP----HHELNPMRVLLKILKSEPPTLDQPSKW-----S 235
Query: 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S + +FL C DP DRP+ A++
Sbjct: 236 SSFNDFLKS------CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 890 KHRNL-TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
KH N+ L Y G D +V +Y+ G+L ++ E +G + +
Sbjct: 74 KHPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECL 125
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
+ L FLHS ++H DIK N+L D L++FG A TP E S +T +G+ ++
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITP-EQSKRSTMVGTPYWM 182
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
+PE + + D++S GI+ +E++ G P +
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT-FRKEAEALGKVKH-RNLTV 896
F+ ++ G YG ++K + L+ ++ D T DE ++E L K H RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 897 LRGYY--AGPP---DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
G + PP D LV ++ G++ L++ G+ L I + RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGL 124
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG----LDRLAIATPAEASSSTTPIGSLGY 1007
S LH ++H DIK QNVL + E L +FG LDR T IG+ +
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-------TVGRRNTFIGTPYW 177
Query: 1008 VSPEAASTGQPTK-----EADVYSFGIVLLEILTGRKPV 1041
++PE + + ++D++S GI +E+ G P+
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 846 SRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP 905
S GR L+ + + RL + RKEA L K+KH N+ + +
Sbjct: 12 SFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71
Query: 906 DVRLLVYDYMPNGNLATLLQEASHQDGH------VLNWPMRHLISLGLARGLSFLHSLDM 959
+ +V +Y G+L +Q+ Q G +L W ++ + G+ +H +
Sbjct: 72 HL-YIVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEKRV 121
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPT 1019
+H DIK +N+ + + L +FG RL + +P + + T +G+ YV PE
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPG--AYACTYVGTPYYVPPEIWENMPYN 178
Query: 1020 KEADVYSFGIVLLEILTGRKP 1040
++D++S G +L E+ T + P
Sbjct: 179 NKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 63/278 (22%), Positives = 117/278 (42%), Gaps = 36/278 (12%)
Query: 838 QFDEENVLSRGRYGLIFKAS-YQDGMVLSIRRLRDGTIDENTFRKEA----EALGKVKHR 892
F L +G YG ++K D +++ + G++ + R++A L V H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHP 59
Query: 893 NLTVLRGYYAGPPDVRLL--VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
N+ Y D L V +Y P G+L+ + + + ++ I + L RG
Sbjct: 60 NII---SYKEAFLDGNKLCIVMEYAPFGDLSKAISK-RKKKRKLIPEQEIWRIFIQLLRG 115
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
L LH ++H D+K N+L A+ + + G I+ + + + T IG+ Y++P
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLG-----ISKVLKKNMAKTQIGTPHYMAP 170
Query: 1011 EAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
E G+P + ++D++S G +L E+ T P +D+ + ++QRG+
Sbjct: 171 EVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL----RYKVQRGK-------- 217
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
P + + L +L P RP+ I
Sbjct: 218 ---YPPIPPIYSQDLQNFIRSML--QVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKH-RNLTV 896
F+ V+ G YG ++K + + G + +I+ + +E + E L K H RN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 897 LRGYY-----AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
G + G D LV ++ G++ L++ G+ L I + RGL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGL 134
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG----LDRLAIATPAEASSSTTPIGSLGY 1007
+ LH+ ++H DIK QNVL + E L +FG LDR T IG+ +
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-------TVGRRNTFIGTPYW 187
Query: 1008 VSPEA-ASTGQPTK----EADVYSFGIVLLEILTGRKPV 1041
++PE A P +D++S GI +E+ G P+
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 40/139 (28%), Positives = 63/139 (45%), Gaps = 20/139 (14%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
+V +YMP G+L L+ + W + + LA L +HS+ +H D+KP N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE----KWARFYTAEVVLA--LDAIHSMGFIHRDVKPDNM 173
Query: 970 LFDADFEAHLSEFG----LDRLAIATPAEASSSTTPIGSLGYVSPEA----ASTGQPTKE 1021
L D L++FG +D + T +G+ Y+SPE G +E
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 1022 ADVYSFGIVLLEILTGRKP 1040
D +S G+ L E+L G P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 66/237 (27%), Positives = 118/237 (49%), Gaps = 27/237 (11%)
Query: 848 GRYGLIFKA-SYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLRGYYAG 903
G YG+++KA + G V++++++R T E +T +E L ++ H N+ L
Sbjct: 11 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL----- 65
Query: 904 PPDV-----RL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
DV +L LV++++ + +L + +AS G L +L L +GL+F HS
Sbjct: 66 --DVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQL--LQGLAFCHSH 119
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA-ASTG 1016
++H D+KPQN+L + + L++FGL R A P + T + +L Y +PE
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVR--TYTHEVVTLWYRAPEILLGCK 176
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
+ D++S G + E++T R +F D +I + + G E++ PG+ L
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR--ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 61/245 (24%), Positives = 114/245 (46%), Gaps = 30/245 (12%)
Query: 835 ATRQFDEENVLSRGRYGLIFK------ASYQDGMVLSIRRLRD---GTIDENTFRKEAEA 885
+T +F EE L R+G ++K A + ++I+ L+D G + E F+ EA
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE-FKHEAMM 61
Query: 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLAT-LLQEASHQD----------GHV 934
+++H N+ L G + + ++ Y + +L L+ + H D
Sbjct: 62 RSRLQHPNIVCLLGVVTKEQPLSM-IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 935 LNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994
L I +A G+ FL S +VH D+ +NVL +S+ GL R A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 995 A--SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051
+S PI ++SPEA G+ + ++D++S+G+VL E+ + G +P ++D+++
Sbjct: 181 KLMGNSLLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237
Query: 1052 WVKKQ 1056
++ +
Sbjct: 238 MIRNR 242
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEA-----LGKVKHRNLTVL 897
V+ +G +G + A + DG +++ L+ + +K A L VKH L L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQ-EASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
Y + V D++ G L LQ E S + P + +A L +LHS
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE------PRARFYAAEIASALGYLHS 114
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+++V+ D+KP+N+L D+ L++FGL + I A++ ++TT G+ Y++PE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI---AQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 1017 QPTKEADVYSFGIVLLEILTGRKP 1040
D + G VL E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 33/231 (14%)
Query: 881 KEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY-DYMPNGNLATLLQEASHQDGHVLNWPM 939
+E L K++H N +++ + L ++ + +P G+LA LL++ V+
Sbjct: 51 QEIALLSKLQHPN--IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
R ++ GL +LH + VH DIK N+L D + L++FG+ + + + A S
Sbjct: 109 RQILL-----GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFK 162
Query: 1000 TPIGSLGYVSPEA-ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058
GS +++PE A G AD++S G +LE+ TG+ P ++Q E +
Sbjct: 163 ---GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP--WSQLEGV--------- 208
Query: 1059 RGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ ++ L P+ S E ++F+ L C DP RP+ A++
Sbjct: 209 -AAVFKIGRSKELPPIPDHLSDEAKDFI------LKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 48/212 (22%), Positives = 106/212 (50%), Gaps = 8/212 (3%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
L G++G++ ++ + ++I+ + +G + E F +EA+ + K+ H L L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
+ +V ++M NG L L++ + G L+ M + + G+ +L +H D+
Sbjct: 72 KPL-YIVTEFMENGCLLNYLRQ---RQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADV 1024
+N L + +S+FG+ R + E +SS+ + + PE + + + ++DV
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 1025 YSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
+SFG+++ E+ T G+ P + ++V+ + +
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 29 LSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCD--WRGIVCYNNR------VRELRLPR 80
L E+ AL + K L PL GW+ P P W G C + + L L
Sbjct: 371 LEEVSALQTLKSSLGLPLRF--GWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427
Query: 81 LQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF 140
L G + + ++ L L+ ++L N + G+IP SL + L + L YNSF+G +P S+
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRY---LDLSSNAFTGEIPG 183
LT+L +LN+ N LSG++ A + L + + + NA IPG
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533
|
Length = 623 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 41/135 (30%), Positives = 66/135 (48%), Gaps = 16/135 (11%)
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
L LH ++++ D+KP+N+L D L +FGL +L + + + T G+ Y++P
Sbjct: 106 LENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNM---KDDDKTNTFCGTPEYLAP 162
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ---------RGQ 1061
E TK D ++ G++L E+LTG P DE++ + +K LQ
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY---DENVNEMYRKILQEPLRFPDGFDRD 219
Query: 1062 ISELLEPGLLELDPE 1076
+LL GLL DP
Sbjct: 220 AKDLLI-GLLSRDPT 233
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 66/281 (23%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN-LTV 896
+ + G G ++KA+ G ++I+++R ++ E + KH N +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
Y G D +V +YM G+L ++ + + +N P + + +GL +LHS
Sbjct: 81 YDSYLVG--DELWVVMEYMDGGSLTDIITQNFVR----MNEPQIAYVCREVLQGLEYLHS 134
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+++H DIK N+L D L++FG A T E S + +G+ +++PE
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGF--AAQLTK-EKSKRNSVVGTPYWMAPEVIKRK 191
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
+ D++S GI+ +E+ G P + E ++ + I+ P L +
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYL---REPPLRALF------LITTKGIPPLKNPEKW 242
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV---FMLEGC 1114
S E+++FL C DP RPS +++ F+ + C
Sbjct: 243 SPEFKDFL------NKCLVKDPEKRPSAEELLQHPFLKKAC 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 845 LSRGRYGLIFKASYQD-GMVLSIRRLRDGTI---DE-NTFRKEAEALGKVKHRNLTVLRG 899
+ +G YG +F A +D G +++++R++ + +E E + L K L L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66
Query: 900 YYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
YA D L L +Y+P G+ TLL + M + + LH L
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-----AVDALHELG 121
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
+H D+KP+N L DA L++FG L+ A+S +GS Y++PE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFG---LSKGIVTYANSV---VGSPDYMAPEVLRGKGY 175
Query: 1019 TKEADVYSFGIVLLEILTGRKPVMFTQD------EDIVKWVKKQLQR 1059
D +S G +L E L G P F+ E++ W K+ LQR
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPP--FSGSTPNETWENLKYW-KETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVL--SIRRLRD--GTIDENTFRKEAEALGKV-KHRNLT 895
++V+ G +G + KA +DG+ + +I+R+++ D F E E L K+ H N+
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 896 VL------RGYYAGPPDVRLLVYDYMPNGNLATLLQEA-----------SHQDGHVLNWP 938
L RGY L +Y P+GNL L+++ ++ L+
Sbjct: 72 NLLGACEHRGYL-------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
+ +ARG+ +L +H D+ +N+L ++ A +++FGL R + +
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMG 183
Query: 999 TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
P+ +++ E+ + T +DV+S+G++L EI++
Sbjct: 184 RLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGK-VKHRNLTVL 897
V+ +G +G + A + DG +++ L+ TI ++N E L K +KH L L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
Y + V DY+ G L LQ P + +A + +LHSL
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSL 115
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++++ D+KP+N+L D+ L++FGL + + P E +S T G+ Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGV-EPEETTS--TFCGTPEYLAPEVLRKEP 172
Query: 1018 PTKEADVYSFGIVLLEILTGRKPVMFTQD 1046
+ D + G VL E+L G P +++D
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP-FYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 32/88 (36%), Positives = 51/88 (57%)
Query: 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIP 452
L+ G +P + +R L+ ++L N G IP S G+++ LE L+LS N G+IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 453 EEITRLSNLTTLNLSYNKFGGKVPYDVG 480
E + +L++L LNL+ N G+VP +G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 40/277 (14%)
Query: 844 VLSRGRYGLIFKASY-QDG----MVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLTV 896
VL G +G ++K + DG + ++I+ LR+ T + EA + V +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG--HVLNWPMRHLISLGLARGLSFL 954
L G LV MP G L ++E + G +LNW ++ +A+G+S+L
Sbjct: 74 LLGICL--TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYL 125
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE--ASSSTTPIGSLGYVSPEA 1012
+ +VH D+ +NVL + +++FGL RL E A PI +++ E+
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI---KWMALES 182
Query: 1013 ASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ T ++DV+S+G+ + E++T G KP + +I +LLE G
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPY-------------DGIPAREIPDLLEKGER 229
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
P + +++ VK C D RP ++V
Sbjct: 230 LPQPPICTIDVYMIMVK----CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 33/271 (12%)
Query: 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRN 893
F + VL +G +G + + G + + ++L I E+ E + L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLA---TLLQEASHQDGHVLNWPMRHLISLGLARG 950
+ L Y D LV M G+L + EA ++G + + + G
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE------ICCG 114
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
L LH +V+ D+KP+N+L D +S+ G LA+ P E + +G++GY++P
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLG---LAVHVP-EGQTIKGRVGTVGYMAP 170
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
E + T D ++ G +L E++ G+ P F Q KK+++R ++ L++
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQR-------KKKIKREEVERLVKEVQ 221
Query: 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDR 1101
E + S L + LLC DP +R
Sbjct: 222 EEYSEKFSPDARSLCKM---LLCK--DPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 25/208 (12%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRH 941
E + L KV V Y D LV M G+L + +
Sbjct: 43 EKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHI---YNVGEPGFPEARAI 98
Query: 942 LISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
+ + GL LH +V+ D+KP+NVL D +S+ G LA+
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLG---LAVELK-GGKKIKGR 154
Query: 1002 IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ 1061
G+ GY++PE D ++ G L E++ GR P F Q ++ V+ K++L+R
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP--FRQRKEKVE--KEELKRRT 210
Query: 1062 ISELLE-------------PGLLELDPE 1076
+ +E LL+ DPE
Sbjct: 211 LEMAVEYPDKFSPEAKDLCEALLQKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 20/166 (12%)
Query: 881 KEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH-QDGHVLNWPM 939
+E E L V H N+ + ++++L+ ++M G+L E +H D L
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSL-----EGTHIADEQFLADVA 174
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
R ++S G+++LH +VH DIKP N+L ++ +++FG+ R+ T +SS
Sbjct: 175 RQILS-----GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 1000 TPIGSLGYVSPEAAST----GQPTKEA-DVYSFGIVLLEILTGRKP 1040
+G++ Y+SPE +T G A D++S G+ +LE GR P
Sbjct: 229 --VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 844 VLSRGRYGLIFKASYQDGM----VLSIRRLRDGTI-----DENTFRKEAEALGKVKHRNL 894
VL +G YG +F+ G + +++ L+ TI D + E L VKH +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 895 TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVL-NWPMRHLISLGLARGLS 952
L YA +L L+ +Y+ G L L+ ++G + + +L + LA L
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLA--LE 114
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
LH +++ D+KP+N+L DA L++FGL + +I E + + T G++ Y++PE
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI---HEGTVTHTFCGTIEYMAPEI 171
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD 1046
K D +S G ++ ++LTG P FT +
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP--FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 33/89 (37%), Positives = 46/89 (51%)
Query: 170 LDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTL 229
L L + G IP + S LQ INLS NS G +P S+G + LE L L N G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 230 PSAISNCSSLVHLSAEDNVLKGLIPGTIG 258
P ++ +SL L+ N L G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 33/98 (33%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
I++ + +GL++L SL ++H D+KP N+L + + L +FG ++T S + T +
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFG-----VSTQLVNSIAKTYV 154
Query: 1003 GSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
G+ Y++PE S Q +DV+S GI +E+ GR P
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 62/271 (22%), Positives = 118/271 (43%), Gaps = 35/271 (12%)
Query: 844 VLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLTVLRGYY 901
+L +G +G +FK + +D ++++ ++ E F EA L + H N+ L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI--SLGLARGLSFLHSLDM 959
+ +V + +P G+ + L++ + + L+ +L A G+++L S +
Sbjct: 62 TQRQPI-YIVMELVPGGDFLSFLRKKKDE------LKTKQLVKFALDAAAGMAYLESKNC 114
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPT 1019
+H D+ +N L + +S+FG+ R SSS + + +PEA + G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 1020 KEADVYSFGIVLLEILT---GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
E+DV+S+GI+L E + P M Q Q E +E G P+
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQ---------------QAREQVEKGYRMSCPQ 217
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ + KV C P +RP +++
Sbjct: 218 KCPDDVY----KVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 42/137 (30%), Positives = 78/137 (56%), Gaps = 20/137 (14%)
Query: 913 DYMPNGNLATLL-QEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF 971
+Y+P G++A LL + ++ V N+ +R ++ +GL++LH+ ++H DIK N+L
Sbjct: 86 EYVPGGSVAALLNNYGAFEETLVRNF-VRQIL-----KGLNYLHNRGIIHRDIKGANILV 139
Query: 972 DADFEAHLSEFGLDRLAIATPAEASSSTTPI--------GSLGYVSPEAASTGQPTKEAD 1023
D +S+FG I+ EA+S +T GS+ +++PE T++AD
Sbjct: 140 DNKGGIKISDFG-----ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKAD 194
Query: 1024 VYSFGIVLLEILTGRKP 1040
++S G +++E+LTG+ P
Sbjct: 195 IWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 14/143 (9%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
LV +Y P G+L +LL ++D + +L L LA + +H + VH DIKP+NV
Sbjct: 78 LVMEYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLA--IHSVHQMGYVHRDIKPENV 133
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST------GQPTKEAD 1023
L D L++FG A T + +S P+G+ Y++PE +T G E D
Sbjct: 134 LIDRTGHIKLADFG--SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 1024 VYSFGIVLLEILTGRKPVMFTQD 1046
+S G++ E++ GR P F +
Sbjct: 192 WWSLGVIAYEMIYGRSP--FHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 75/315 (23%), Positives = 138/315 (43%), Gaps = 53/315 (16%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDG----MVLSIRRLRDGTIDE--NTFRKEAEALGKVK 890
+F + VL G +G ++K + +G + ++I+ LR+ T + EA + V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 891 HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG----HVLNWPMRHLISLG 946
+ ++ L G L+ MP G L ++E H+D ++LNW ++
Sbjct: 68 NPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQ------ 117
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE--ASSSTTPIGS 1004
+A+G+++L +VH D+ +NVL +++FGL +L A E A PI
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI-- 175
Query: 1005 LGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQIS 1063
+++ E+ T ++DV+S+G+ + E++T G KP + +IS
Sbjct: 176 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-------------DGIPASEIS 221
Query: 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPS- 1122
+LE G P + +++ VK C D RP +++ +E ++ D P
Sbjct: 222 SILEKGERLPQPPICTIDVYMIMVK----CWMIDADSRPKFRELI--IEFSKMARD-PQR 274
Query: 1123 -----SADPTSLPSP 1132
+ LPSP
Sbjct: 275 YLVIQGDERMHLPSP 289
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 33/89 (37%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 218 LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLV 277
L LD+ L G +P+ IS L ++ N ++G IP ++G I++L+VL LS N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 278 PVSVLCNLWGNISSLRIVQLGFNAFTGVV 306
P S+ G ++SLRI+ L N+ +G V
Sbjct: 483 PESL-----GQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 40/235 (17%)
Query: 881 KEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMR 940
KE + L ++KH N +G Y LV +Y G+ + LL+ V P++
Sbjct: 70 KEVKFLQQLKHPNTIEYKGCYL-KEHTAWLVMEYCL-GSASDLLE--------VHKKPLQ 119
Query: 941 HL----ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
+ I+ G +GL++LHS +M+H DIK N+L + L++FG + ++PA +
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG--SASKSSPANSF 177
Query: 997 SSTTPIGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053
+G+ +++PE A GQ + DV+S GI +E L RKP +F + +
Sbjct: 178 -----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALY- 230
Query: 1054 KKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
I++ P L +S+EW + G C P +RP+ A+++
Sbjct: 231 -------HIAQNDSPTL-----QSNEWTDSFRGFVD--YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 71/282 (25%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 839 FDEENVLSRGRYGLIFKA-SYQDGMVLSIRRL----RDGTIDENTFRKEAEALGKVKHRN 893
F + + G +G ++ A + V++I+++ + KE + L ++KH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL----ISLGLAR 949
+G Y LV +Y G+ + LL+ V P++ + I+ G +
Sbjct: 87 SIEYKGCYL-REHTAWLVMEYCL-GSASDLLE--------VHKKPLQEVEIAAITHGALQ 136
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL++LHS +M+H DIK N+L + L++FG +IA+PA + +G+ +++
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG--SASIASPANSF-----VGTPYWMA 189
Query: 1010 PE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
PE A GQ + DV+S GI +E L RKP +F + + I++
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALY--------HIAQNE 240
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
P L +S+EW ++ C P DRP+ +++
Sbjct: 241 SPTL-----QSNEWSDYFRNFVDS--CLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 63/233 (27%), Positives = 111/233 (47%), Gaps = 21/233 (9%)
Query: 839 FDEENVLSRGRYGLIF---KASYQD-GMVLSIRRLRDGTI------DENTFRKEAEALGK 888
F+ VL G YG +F K + D G + +++ L+ + E+T R E L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-RTERNVLEH 60
Query: 889 VKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL 947
V+ V +YA + +L L+ DY+ G + T L + + + + +I L
Sbjct: 61 VRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEII---L 116
Query: 948 ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
A L LH L +V+ DIK +N+L D++ L++FGL + ++ E + S G++ Y
Sbjct: 117 A--LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC--GTIEY 172
Query: 1008 VSPEAA-STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059
++PE G K D +S GI++ E+LTG P + + V +++ +
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 39/132 (29%), Positives = 68/132 (51%), Gaps = 14/132 (10%)
Query: 943 ISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
I++ + + L +LHS L ++H D+KP NVL + + + L +FG+ + + A+ T
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----TID 163
Query: 1002 IGSLGYVSPEAASTGQPTK----EADVYSFGIVLLEILTGRKP-----VMFTQDEDIVKW 1052
G Y++PE + K ++DV+S GI ++E+ TGR P F Q + +V+
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223
Query: 1053 VKKQLQRGQISE 1064
QL + S
Sbjct: 224 PSPQLPAEKFSP 235
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 845 LSRGRYGLIFKASYQD------GMVLSIRRLRDGTIDEN--TFRKEAEALGKV-KHRNLT 895
L G +G + KA ++++ L+D +++ E E + + KH+N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 896 VLRG--YYAGPPDVRLLVYDYMPNGNLATLL-------QEASHQDGHVLNWPM--RHLIS 944
L G GP V V +Y +GNL L + AS D + + L+S
Sbjct: 80 NLLGVCTQEGPLYV---VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 945 LG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR--LAIATPAEASSSTT 1000
+ARG+ FL S +H D+ +NVL D +++FGL R I + ++
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
P+ +++PEA T ++DV+SFG++L EI T
Sbjct: 197 PVK---WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 844 VLSRGRYGLIFKASYQD-GMVLSIRRL------RDGTIDENTFRKEAEALGKVKHRNLTV 896
+L RG +G ++ D G L+++++ ++ + + N E + L ++H +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 897 LRGYYAGPPDVRLLVY-DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G P + +L ++ +YMP G++ L+ +V R ++ +G+S+LH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL-----QGVSYLH 123
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
S +VH DIK N+L D+ L +FG + + + G+ ++SPE S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKP 1040
++ADV+S ++E+LT + P
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 38/130 (29%), Positives = 71/130 (54%), Gaps = 11/130 (8%)
Query: 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLF 971
++M G+L +L++A ++L IS+ + RGL++L ++H D+KP N+L
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKHKIMHRDVKPSNILV 133
Query: 972 DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVL 1031
++ E L +FG+ I S + + +G+ Y+SPE T ++D++S G+ L
Sbjct: 134 NSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 1032 LEILTGRKPV 1041
+E+ GR P+
Sbjct: 189 VEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 21/221 (9%)
Query: 832 TLEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRL----RDGTIDENTFRKEAEAL 886
E T ++ + + G +GL+ A Q G ++I+++ + + T+R E + L
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLL 63
Query: 887 GKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLG 946
++H N+ L + P + V + + +L LL + + + + L
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL---- 118
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
RGL ++HS +VH D+KP N+L + + + + +FGL R+ + T + +
Sbjct: 119 --RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI------QDPQMTGYVSTRY 170
Query: 1007 YVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQD 1046
Y +PE T Q E D++S G + E+L G KP+ +D
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 14/168 (8%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNW 937
FR+E + L ++ +T L +YA + L LV DY G+L TLL + + L
Sbjct: 48 FREERDVLVNGDNQWITTL--HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR----LPE 101
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997
M + + +H L VH DIKP N+L D + L++FG L + S
Sbjct: 102 DMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 998 STTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKP 1040
S +G+ Y+SPE G+ E D +S G+ + E+L G P
Sbjct: 161 SVA-VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 40/137 (29%), Positives = 68/137 (49%), Gaps = 13/137 (9%)
Query: 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972
+Y G L T+L++ G + R I+ + +LH+ +++ D+KP+N+L D
Sbjct: 73 EYCLGGELWTILRDR----GLFDEYTARFYIA-CVVLAFEYLHNRGIIYRDLKPENLLLD 127
Query: 973 ADFEAHLSEFGLDRLAIATPAEASSST-TPIGSLGYVSPEAASTGQPTKEADVYSFGIVL 1031
++ L +FG A ++ T T G+ YV+PE D +S GI+L
Sbjct: 128 SNGYVKLVDFGF-----AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 1032 LEILTGRKPVMFTQDED 1048
E+LTGR P F +D++
Sbjct: 183 YELLTGRPP--FGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 5e-10
Identities = 57/226 (25%), Positives = 109/226 (48%), Gaps = 31/226 (13%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR--------DGTIDENTFRKEAEALGK 888
++++ L G Y +++KA + G +++I++++ DG I+ R E + L +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALR-EIKLLQE 58
Query: 889 VKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH--QDGHVLNWPMRHLISLG 946
+KH N+ L + ++ L V+++M +L ++++ S + ++ M +
Sbjct: 59 LKHPNIIGLLDVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIKSY-MLMTL--- 112
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
RGL +LHS ++H D+KP N+L +D L++FGL R + +P T + +
Sbjct: 113 --RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRK--MTHQVVTRW 167
Query: 1007 YVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
Y +PE A D++S G + E+L R P D DI
Sbjct: 168 YRAPELLFGARHYGVG--VDMWSVGCIFAELLL-RVP-FLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 5e-10
Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L Y G D +V +Y+ G+L ++ E +G + + + L FLHS
Sbjct: 82 LDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALDFLHS 133
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
++H DIK N+L D L++FG A TP E S +T +G+ +++PE +
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITP-EQSKRSTMVGTPYWMAPEVVTRK 190
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVM 1042
+ D++S GI+ +E++ G P +
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 66/279 (23%), Positives = 118/279 (42%), Gaps = 38/279 (13%)
Query: 844 VLSRGRYGLIFKASYQD----GMVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNLTVL 897
+ G++G +++ Y + ++++ ++ T F +EA + + H ++ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI--SLGLARGLSFLH 955
G P +V + P G L + LQ + + LI S L+ L++L
Sbjct: 73 IGVITENP--VWIVMELAPLGELRSYLQVNKYS------LDLASLILYSYQLSTALAYLE 124
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDR-LAIATPAEASSSTTPIGSLGYVSPEAAS 1014
S VH DI +NVL + L +FGL R L + +AS PI +++PE+ +
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI---KWMAPESIN 181
Query: 1015 TGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
+ T +DV+ FG+ + EIL G KP ++ D++ ++ +R + P L L
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSL 240
Query: 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ C A DP RP ++ L
Sbjct: 241 MTK----------------CWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 48/205 (23%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 844 VLSRGRYGLIFKASYQD-GMVLSIRRLR------DGTIDENTFRKEAEALGKVKHRNLTV 896
+L +G +G ++ D G L++++++ + + + N E + L + H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 897 LRGYYAGPPDVRLLVY-DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G P + L ++ ++MP G++ L+ +V R ++ G+S+LH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-----EGVSYLH 123
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
S +VH DIK N+L D+ L +FG + + + G+ ++SPE S
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKP 1040
++AD++S G ++E+LT + P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 49/207 (23%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLT 895
F++ + L G G++FK S++ ++ R+L I N +E + L + +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G + ++ + + ++M G+L +L++A +L +S+ + +GL++L
Sbjct: 67 GFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLR 120
Query: 956 SL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
++H D+KP N+L ++ E L +FG+ I + A + +G+ Y+SPE
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERLQ 175
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKPV 1041
+ ++D++S G+ L+E+ GR P+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 67/290 (23%), Positives = 129/290 (44%), Gaps = 28/290 (9%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQ-----DGMVLSIRRLRDGTIDENT--FRKEAEALGKV 889
R + VL G +G + Y G +++++ L+ +NT ++KE L +
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 890 KHRNLTVLRGYYA-GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
H N+ +G + L+ +Y+P G+L L + H LN L + +
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQIC 117
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE----ASSSTTPIGS 1004
G+++LHS +H D+ +NVL D D + +FGL + A+ E +P+
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPV-- 174
Query: 1005 LGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF--TQDEDIVKWVKKQLQRGQI 1062
+ + E + + +DV+SFG+ L E+LT + E+++ + Q+ ++
Sbjct: 175 -FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
ELLE G+ P++ E ++L C + RP+ ++ +L+
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKN----CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 39/100 (39%), Positives = 58/100 (58%), Gaps = 3/100 (3%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP-IGSLGY 1007
GL ++HS +++H D+KP N+L +AD E + +FGL R P E + T + + Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 1008 VSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQD 1046
+PE + Q TK DV+S G +L E+L GRKPV +D
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKD 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 7e-10
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 848 GRYGLIFKASYQ-DGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRNLTVLRGYYAG 903
G YG ++KA + G +++++++R E T +E + L K++H N+ L+
Sbjct: 10 GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS 69
Query: 904 PPDVRL-LVYDYMPNGNLATLLQEASHQ--DGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
+ +V++YM + +L LL + + + + L GL +LHS ++
Sbjct: 70 KGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQI-----KC-YMKQLLEGLQYLHSNGIL 122
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE--AASTGQP 1018
H DIK N+L + D L++FGL R T ++ T + +L Y PE +T +
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPPELLLGAT-RY 179
Query: 1019 TKEADVYSFGIVLLEILTGRKPVM 1042
E D++S G +L E+ G KP+
Sbjct: 180 GPEVDMWSVGCILAELFLG-KPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-10
Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 20/139 (14%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
+V +YMP G+L L+ + W + + LA L +HS+ ++H D+KP N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE----KWAKFYTAEVVLA--LDAIHSMGLIHRDVKPDNM 173
Query: 970 LFDADFEAHLSEFG----LDRLAIATPAEASSSTTPIGSLGYVSPEAAST----GQPTKE 1021
L D L++FG +D + T +G+ Y+SPE + G +E
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 1022 ADVYSFGIVLLEILTGRKP 1040
D +S G+ L E+L G P
Sbjct: 228 CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 22/139 (15%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL FLH +++ D+K NVL D D +++FG+ + + +AS T G+ Y++
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS---TFCGTPDYIA 164
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV------------KWVKKQL 1057
PE + + D +SFG++L E+L G+ P +DED + +W+ K
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP-FHGEDEDELFDSILNDRPHFPRWISK-- 221
Query: 1058 QRGQISELLEPGLLELDPE 1076
+ + L L E DP
Sbjct: 222 ---EAKDCLS-KLFERDPT 236
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-10
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGK-VKHRNLTVL 897
V+ +G +G + A ++ + +++ L+ I +E E L K VKH L L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
+ D V DY+ G L LQ P + +A L +LHSL
Sbjct: 62 H-FSFQTADKLYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSL 115
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++V+ D+KP+N+L D+ L++FGL + I +++T G+ Y++PE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENI---EHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 1018 PTKEADVYSFGIVLLEILTGRKP 1040
+ D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 72/296 (24%), Positives = 132/296 (44%), Gaps = 61/296 (20%)
Query: 848 GRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRK----EAEALGKVKHRNLTVL----- 897
G YG++ K +++ G +++I++ + D+ +K E L +++H NL L
Sbjct: 12 GSYGMVMKCKHKETGQIVAIKKFLESE-DDKMVKKIAMREIRMLKQLRHENLVNLIEVFR 70
Query: 898 ---RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
R Y LV++++ + T+L + + L+ + RG+ F
Sbjct: 71 RKKRLY---------LVFEFVDH----TVLDDLEKYP-NGLDESRVRKYLFQILRGIEFC 116
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA-- 1012
HS +++H DIKP+N+L L +FG R +A P E T + + Y +PE
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEV--YTDYVATRWYRAPELLV 173
Query: 1013 --ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED------IVKWVKKQLQRGQISE 1064
G+ D+++ G ++ E+LTG +F D D I+K + + R Q E
Sbjct: 174 GDTKYGRAV---DIWAVGCLVTEMLTGEP--LFPGDSDIDQLYHIIKCLGNLIPRHQ--E 226
Query: 1065 LLE----------PGLLELDPESSEWEEFLLGVKVGLL--CTAPDPLDRPSMADIV 1108
+ + P + E++P + + L G+ + L C DP DRPS + ++
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 15/176 (8%)
Query: 864 LSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATL 923
++I ++ +E+ RKE L +KH N+ + + ++ +V DY G+L
Sbjct: 33 INISKMSPKEREES--RKEVAVLSNMKHPNIVQYQESFEENGNL-YIVMDYCEGGDLYKK 89
Query: 924 LQEAS---HQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLS 980
+ + +L+W + + LA L +H ++H DIK QN+ D L
Sbjct: 90 INAQRGVLFPEDQILDW----FVQICLA--LKHVHDRKILHRDIKSQNIFLTKDGTIKLG 143
Query: 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
+FG+ R+ +T A T IG+ Y+SPE ++D+++ G VL E+ T
Sbjct: 144 DFGIARVLNSTVELAR---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 31/80 (38%), Positives = 47/80 (58%), Gaps = 2/80 (2%)
Query: 133 GHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQ 190
G +P I L +L +N++ N + G I + SL LDLS N+F G IP + +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 191 LQLINLSYNSFSGEVPASVG 210
L+++NL+ NS SG VPA++G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 31/269 (11%)
Query: 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLTVLRGYY 901
+ RG +G +F + D ++++ R+ + F +EA L + H N+ L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL--GLARGLSFLHSLDM 959
+ +V + + G+ T L+ +G L ++ LI + A G+ +L S
Sbjct: 63 TQKQPI-YIVMELVQGGDFLTFLR----TEGPRLK--VKELIQMVENAAAGMEYLESKHC 115
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPT 1019
+H D+ +N L +S+FG+ R AS+ + + +PEA + G+ +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREE-EDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 1020 KEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESS 1078
E+DV+SFGI+L E + G P L Q E +E G+ PE
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPY-------------ANLSNQQTREAIEQGVRLPCPELC 221
Query: 1079 EWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ L + C DP RPS + +
Sbjct: 222 PDAVYRLMER----CWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 49/207 (23%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLT 895
F+ + L G G++ K ++ ++ R+L I N +E + L + +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G + ++ + + ++M G+L +L+EA +L +S+ + RGL++L
Sbjct: 67 GFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLR 120
Query: 956 SL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
++H D+KP N+L ++ E L +FG+ I + A + +G+ Y+SPE
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERLQ 175
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKPV 1041
+ ++D++S G+ L+E+ GR P+
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 47/306 (15%)
Query: 844 VLSRGRYGLIFKASY-QDG----MVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNLTV 896
VL G +G ++K + +G + ++I+ L + T + F EA + + H +L
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGH--VLNWPMRHLISLGLARGLSFL 954
L G P LV MP+G L + E G +LNW ++ +A+G+ +L
Sbjct: 74 LLGVCLSP--TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE--ASSSTTPIGSLGYVSPEA 1012
+VH D+ +NVL + +++FGL RL E A PI +++ E
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI---KWMALEC 182
Query: 1013 ASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ T ++DV+S+G+ + E++T G KP + +I +LLE G
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPY-------------DGIPTREIPDLLEKGER 229
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD-----MPSSADP 1126
P + +++ VK C D RP ++ E R+ D + D
Sbjct: 230 LPQPPICTIDVYMVMVK----CWMIDADSRPKFKELA--AEFSRMARDPQRYLVIQGDDR 283
Query: 1127 TSLPSP 1132
LPSP
Sbjct: 284 MKLPSP 289
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 61/278 (21%), Positives = 124/278 (44%), Gaps = 35/278 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT--FRKEAEALGKVKH--- 891
+ ++ RG YG +++ + G V++++ + T D++ ++E L +++
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 892 RNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
N+T G Y P + ++ +Y G++ TL++ + ++ +I + L
Sbjct: 62 PNITKYYGSYLKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKYI------SVIIREVLVAL 114
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
++H + ++H DIK N+L L +FG+ L +S +T +G+ +++PE
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN---SSKRSTFVGTPYWMAPE 171
Query: 1012 AASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
+ G+ TK AD++S GI + E+ TG P D D + + +P
Sbjct: 172 VITEGKYYDTK-ADIWSLGITIYEMATGNPPY---SDVD-------AFRAMMLIPKSKPP 220
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
LE + S EF+ C +P +R S ++
Sbjct: 221 RLEDNGYSKLLREFVAA------CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 45/209 (21%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 838 QFDEENVLSRGRYGLIF----KASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN 893
++++ V+ RG +G++ KA + ++ I + + + E + L + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 894 LTVLRGYYAG--PPDVRLLVYDYMPNGNLATLLQEASHQ---DGHVLNWPMRHLISLGLA 948
+ YY ++V +Y P G LA +Q+ + + +L++ ++ L++L
Sbjct: 61 II---EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL--- 114
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
+H+ ++H D+K QN+L D + +FG+ ++ + S + T +G+ Y
Sbjct: 115 ---HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPCY 167
Query: 1008 VSPEAASTGQPTKEADVYSFGIVLLEILT 1036
+SPE +++D+++ G VL E+ +
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 38/285 (13%)
Query: 845 LSRGRYGLIFKASYQDGMVLS---IRRLRD-GTIDEN-TFRKEAEALGKVKHRNLTVLRG 899
+ G +G + GM + ++ LR T DE F +E + ++ H N+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL---ISLGLARGLSFLHS 956
LLV ++ P G+L L+ G V + + ++ +A GL +LH
Sbjct: 63 QCIESIPY-LLVLEFCPLGDLKNYLRS---NRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP--IGSLGYVSPEAAS 1014
D +H D+ +N AD + ++G LA+ E T L +++PE
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYG---LALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 1015 -------TGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
TK+++++S G+ + E+ T +P DE ++ KQ+ R Q +L
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL----KQVVREQDIKLP 231
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
+P L+L S W E + C DP RP+ ++ +L
Sbjct: 232 KPQ-LDL-KYSDRWYEVM------QFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 837 RQFDEENVLSRGRYGLIFKAS--YQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL 894
+Q++ + G YG +FKA G ++++R+R T E + R +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--------GEEGMPLSTIREV 52
Query: 895 TVLRGY--YAGPPDVRL----------------LVYDYMPNGNLATLLQEASHQDGHVLN 936
VLR + P VRL LV++++ + +L T L + + V
Sbjct: 53 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVP--EPGVPT 109
Query: 937 WPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
++ ++ L RGL FLHS +VH D+KPQN+L + + L++FGL R+ +
Sbjct: 110 ETIKDMM-FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQM 164
Query: 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ T+ + +L Y +PE D++S G + E+ RKP +F D+
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP-LFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 58/180 (32%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
+N +P S L+ L L+ S + + D L L L L+ N++ I EL
Sbjct: 55 SSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNIS-EL 112
Query: 600 GACSALEVLELRSNHFTGNIPVDISHL-SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTL 658
+ L L+L +N+ T +IP I L S +K+LDL NK+ +P + +L +L L
Sbjct: 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170
Query: 659 DMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKM 718
N LS +P+ S LSNL L+LS N++S +P ++ L+S+L L+LS N++ + +
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSL 228
|
Length = 394 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 43/233 (18%)
Query: 844 VLSRGRYG---LIFKASYQDGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTV 896
V+ RG +G L+ G V +++ LR + R E + L + +
Sbjct: 8 VIGRGAFGEVWLVRDK--DTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL--ADADSPWI 63
Query: 897 LRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
++ YY+ + L LV +YMP G+L LL +D ++ L LA L +H
Sbjct: 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELVLA--LDSVH 118
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGL------------------------DRLAIAT 991
L +H DIKP N+L DAD L++FGL + L
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 992 PAEASS--STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
+ + + +G+ Y++PE E D +S G++L E+L G P
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 881 KEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMR 940
KE L K++H N RG Y LV +Y G+ + LL+ V P++
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYL-REHTAWLVMEYCL-GSASDLLE--------VHKKPLQ 113
Query: 941 HL----ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
+ ++ G +GL++LHS +M+H D+K N+L L +FG +I PA
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPANXF 171
Query: 997 SSTTPIGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD 1046
+G+ +++PE A GQ + DV+S GI +E L RKP +F +
Sbjct: 172 -----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMN 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 59/239 (24%), Positives = 113/239 (47%), Gaps = 31/239 (12%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYA-GPPDVRLLVYDYMPNGNLATLLQ--EASHQDGHVL 935
F EA + + ++ L G + G P L++ + M G+L + L+ ++ V
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVQ 113
Query: 936 NWP-MRHLISLG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
P ++ +I + +A G+++L++ VH D+ +N + DF + +FG+ R T
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 993 A--EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDI 1049
+ P+ ++SPE+ G T +DV+SFG+VL EI T +P +E +
Sbjct: 174 YYRKGGKGLLPVR---WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230
Query: 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
+++V +E GLL+ P++ + L ++ +C +P RPS +I+
Sbjct: 231 LRFV------------MEGGLLD-KPDNC--PDMLF--ELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L Y G D +V +Y+ G+L ++ E +G + + + L FLHS
Sbjct: 83 LDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALEFLHS 134
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
++H DIK N+L D L++FG A TP E S +T +G+ +++PE +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITP-EQSKRSTMVGTPYWMAPEVVTRK 191
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVM 1042
+ D++S GI+ +E++ G P +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYL 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 59/247 (23%), Positives = 111/247 (44%), Gaps = 36/247 (14%)
Query: 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRN 893
++ + +G +G + K + DG +L + + G + E E L ++KH N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 894 LTVLRGYY---AGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLN---WPMRHLISLG 946
+ YY + L +V +Y G+LA L+Q+ + ++ W R L L
Sbjct: 61 IV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW--RILTQLL 115
Query: 947 LARGLSFLHSLD-----MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
LA L H+ ++H D+KP N+ DA+ L +FGL ++ ++S + T
Sbjct: 116 LA--LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI---LGHDSSFAKTY 170
Query: 1002 IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFT---QDEDIVKWVKKQLQ 1058
+G+ Y+SPE + +++D++S G ++ E+ P FT Q + K ++
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FTARNQLQLASK-----IK 223
Query: 1059 RGQISEL 1065
G+ +
Sbjct: 224 EGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLR------DGTIDENTFRKEAEALGKVKHRNLTV 896
+L +G +G +F A + +I+ L+ D ++ K +L +H LT
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L + ++ V +Y+ G+L +Q H + P + + GL FLHS
Sbjct: 61 LYCTFQTKENL-FFVMEYLNGGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHS 114
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+V+ D+K N+L D D +++FG+ + + A+ T G+ Y++PE
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC---TFCGTPDYIAPEILLGQ 171
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054
+ D +SFG++L E+L G+ P +E++ + ++
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 843 NVLSRGRYGLIFKASYQDGMVLS-----IRRLRDGT--IDENTFRKEAEALGKVKHRNLT 895
++L G +G IF D ++ ++D I +E+ L + H+N+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGL--ARG 950
+ + ++Y YM GNL LQ+ + L+ + L+ + + A G
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS--TQQLVHMAIQIACG 129
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE----ASSSTTPIGSLG 1006
+S+LH ++H DI +N + D + + +++ L R P + + P+
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLF--PMDYHCLGDNENRPV---K 184
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065
+++ E+ + + +DV+SFG++L E++T G+ P + ++ ++K + Q
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ---- 240
Query: 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
P + E F V C A DP +RPS + +V L
Sbjct: 241 ---------PINCPDELF----AVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L R L ++H+ ++ H D+KP+N+L +AD + + +FGL R+A A T + +
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 1007 YVSPEAAST--GQPTKEADVYSFGIVLLEILTGR 1038
Y +PE + + T D++S G + E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 844 VLSRGRYG-LIFKASYQDGMVLSIRRLRDGTI---DENTFR-KEAEALGKVKHRNLTVLR 898
+L +G +G +I G +++ LR I DE E+ L +H LT L+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 899 GYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
YA RL V +Y G L L V + L +LHS
Sbjct: 62 --YAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSR 114
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
D+V+ DIK +N++ D D +++FGL + I+ A + T G+ Y++PE
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDND 171
Query: 1018 PTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048
+ D + G+V+ E++ GR P + QD +
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP-FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 63/274 (22%), Positives = 126/274 (45%), Gaps = 30/274 (10%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFR----KEAEALGKVKHRN 893
F E + RG++ +++A+ DG+ +++++++ + + R KE + L ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS--LGLARG 950
V++ Y + D L +V + G+L+ +++ Q + P + + + L
Sbjct: 64 --VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI---PEKTVWKYFVQLCSA 118
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
L +HS ++H DIKP NV A L + GL R ++ +++ + +G+ Y+SP
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSP 175
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
E ++D++S G +L E+ + P F D+ + + K++++ L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPL----- 228
Query: 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104
P EE V +C PDP RP +
Sbjct: 229 ----PSDHYSEELRQLVN---MCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 16/241 (6%)
Query: 845 LSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDENTFR--KEAEALGKVKHRNLTVLRGYY 901
L G Y ++K S +G +++++ + T + F +EA L +KH N+ +L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
+ V++YM L Q G + + +R L L RGL+++H ++H
Sbjct: 73 H-TKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVR-LFMFQLLRGLAYIHGQHILH 126
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA-ASTGQPTK 1020
D+KPQN+L E L++FGL R A + P++ SS + +L Y P+ +
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSE--VVTLWYRPPDVLLGATDYSS 183
Query: 1021 EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ-RGQISELLEPGLLELDPESSE 1079
D++ G + +E+L G +P F D+ + ++K G +E PG+ +L E
Sbjct: 184 ALDIWGAGCIFIEMLQG-QPA-FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241
Query: 1080 W 1080
W
Sbjct: 242 W 242
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 58/171 (33%), Positives = 81/171 (47%), Gaps = 20/171 (11%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNW 937
FR+E + L R +T L +YA + L LV DY G+L TLL S + +
Sbjct: 48 FREERDVLVNGDRRWITNL--HYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPED 102
Query: 938 PMR-HLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG--LDRLAIATPAE 994
R +L + LA + +H L VH DIKP NVL D + L++FG L LA T
Sbjct: 103 MARFYLAEMVLA--IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ- 159
Query: 995 ASSSTTPIGSLGYVSPE-----AASTGQPTKEADVYSFGIVLLEILTGRKP 1040
S +G+ Y+SPE G+ E D +S G+ + E+L G P
Sbjct: 160 ---SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 10/166 (6%)
Query: 878 TFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY-DYMPNGNLATLLQEASHQDGHVLN 936
RKE + ++ H ++ +R A D ++ ++M G+++ LL + V+
Sbjct: 49 ALRKEIRLMARLNHPHI--IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII 106
Query: 937 WPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE-AHLSEFGLD-RLAIATPAE 994
L+ RGLS+LH ++H D+K N+L D+ + +++FG RLA
Sbjct: 107 NYTEQLL-----RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
Query: 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+G++ +++PE Q + DV+S G V++E+ T + P
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 54/248 (21%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 875 DENTFRKEAEALGKVKHRNLT-----VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH 929
D F +EA + + H N+ LR G + +++ +M +G+L T L S
Sbjct: 44 DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSR 102
Query: 930 QDGHVLNWPMRHLIS--LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987
P++ L+ + +A G+ +L S + +H D+ +N + + + +++FGL +
Sbjct: 103 IGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
Query: 988 AIATP--AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFT 1044
+ + +S P+ +++ E+ + T +DV++FG+ + EI+T G+ P
Sbjct: 163 IYSGDYYRQGCASKLPV---KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
Query: 1045 QDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104
++ +I ++ K + Q + LE + E + C +P+P RPS
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLE-----------DVYELMCQ------CWSPEPKCRPSF 262
Query: 1105 ADIVFMLE 1112
+ LE
Sbjct: 263 QHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 52/168 (30%), Positives = 75/168 (44%), Gaps = 14/168 (8%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNW 937
FR+E L + +T L +YA + L LV DY G+L TLL + + L
Sbjct: 48 FREERNVLVNGDCQWITTL--HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR----LPE 101
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997
M + + +H L VH DIKP NVL D + L++FG L + S
Sbjct: 102 DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQS 160
Query: 998 STTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKP 1040
S +G+ Y+SPE G+ E D +S G+ + E+L G P
Sbjct: 161 SVA-VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 9/132 (6%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
LV DYM G L LQ ++G + I+ L L LH D+V+ D+KP+N+
Sbjct: 73 LVTDYMSGGELFWHLQ----KEGRFSEDRAKFYIA-ELVLALEHLHKYDIVYRDLKPENI 127
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFG 1028
L DA L +FGL + A + ++ T G+ Y++PE + TK D +S G
Sbjct: 128 LLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 1029 IVLLEILTGRKP 1040
+++ E+ G P
Sbjct: 185 VLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 50/218 (22%), Positives = 99/218 (45%), Gaps = 14/218 (6%)
Query: 828 TYVETLEATRQFDEENVLSRGRYGLIFKAS-YQDGMVLSIRRLR-DGTIDENTFRKEAEA 885
T V + +++ + +G G +F A G ++I+++ + E
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 886 LGKVKHRNL-TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS 944
+ ++K+ N+ L + G D +V +Y+ G+L ++ E + + +
Sbjct: 70 MKELKNPNIVNFLDSFLVG--DELFVVMEYLAGGSLTDVVTETCMDEAQIA------AVC 121
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
+ L FLH+ ++H DIK NVL D L++FG A TP E S +T +G+
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF--CAQITP-EQSKRSTMVGT 178
Query: 1005 LGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
+++PE + + D++S GI+ +E++ G P +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 61/280 (21%), Positives = 118/280 (42%), Gaps = 51/280 (18%)
Query: 838 QFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLR-DGTIDENTF-RKEAEALGKVKHRNL 894
F + +G +G ++KA + V++I+ + + DE ++E + L + + +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 895 TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
T G + +L ++ +Y G+ LL+ + ++ I + GL +
Sbjct: 62 TKYYGSFLK--GSKLWIIMEYCGGGSCLDLLKPGKLDETYI------AFILREVLLGLEY 113
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS--TTPIGSLGYVSPE 1011
LH +H DIK N+L + + L++FG ++ ++ S T +G+ +++PE
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFG-----VSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKKQLQRGQIS 1063
++AD++S GI +E+ G P V+F I K
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----IPK------------ 212
Query: 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P LE + S +++F+ LC DP +RPS
Sbjct: 213 --NNPPSLEGNKFSKPFKDFV------SLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 15/186 (8%)
Query: 877 NTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLL--QEASHQDGHV 934
N F KE + + ++K+ N+ L G D ++ +YM NG+L L +E H
Sbjct: 62 NDFLKEIKIMSRLKNPNIIRLLGVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 935 LNWPMRHL-----ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989
N P + +++ +A G+ +L SL+ VH D+ +N L + +++FG+ R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 990 ATPAE--ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEI--LTGRKPVMFTQ 1045
+ + PI + + E+ G+ T +DV++FG+ L E+ L +P
Sbjct: 181 SGDYYRIQGRAVLPIRWMAW---ESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237
Query: 1046 DEDIVK 1051
DE +++
Sbjct: 238 DEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 21/154 (13%)
Query: 896 VLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
V++ +YA D L +V +YMP G+L L+ + W + + LA L +
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE----KWARFYTAEVVLA--LDAI 158
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFG----LDRLAIATPAEASSSTTPIGSLGYVSP 1010
HS+ +H D+KP N+L D L++FG +++ + T +G+ Y+SP
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV------RCDTAVGTPDYISP 212
Query: 1011 EAAST----GQPTKEADVYSFGIVLLEILTGRKP 1040
E + G +E D +S G+ L E+L G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL FLHS +++ D+K NV+ D D +++FG+ + + AS T G+ Y++
Sbjct: 108 GLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS---TFCGTPDYIA 164
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048
PE + T D +SFG++L E+L G+ P DED
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSP-FHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
+ G+ LHS+D+V+ D+KP+NVL D LS+ G LA+ + + T G+ G
Sbjct: 104 ITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLG---LAVELK-DGKTITQRAGTNG 159
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
Y++PE + D ++ G + E++ GR P
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 844 VLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFR---KEAEALGKVKHRNLTVLRG 899
V+ +G YG + + DG I++L + +EA+ L ++KH N+ R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS--LGLARGLSFLHSL 957
+ G + +V + G+L L+E Q G +L P ++ + +A L +LH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKE---QKGKLL--PENQVVEWFVQIAMALQYLHEK 121
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++H D+K QNV + + G+ R+ + ++T IG+ Y+SPE S
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV---LENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 1018 PTKEADVYSFGIVLLEILT 1036
++DV++ G + E+ T
Sbjct: 179 YNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 57/213 (26%), Positives = 107/213 (50%), Gaps = 27/213 (12%)
Query: 848 GRYGLIFKA-SYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLRGYYAG 903
G YG+++KA G +++++++R T DE +T +E L ++ H N ++R
Sbjct: 10 GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPN--IVRLLDVV 67
Query: 904 PPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
+ +L LV++++ + +L + + L+ P+ L +G+++ HS ++H
Sbjct: 68 HSENKLYLVFEFL-DLDLKKYMDSSPLT---GLDPPLIKSYLYQLLQGIAYCHSHRVLHR 123
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA------STG 1016
D+KPQN+L D + L++FGL R A P T + +L Y +PE ST
Sbjct: 124 DLKPQNLLIDREGALKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTP 180
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
D++S G + E++ R+P +F D +I
Sbjct: 181 -----VDIWSIGCIFAEMVN-RRP-LFPGDSEI 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 22/193 (11%)
Query: 877 NTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGH--- 933
N F KE + L ++K N+ L G D ++ +YM NG+L L D
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 934 -----------VLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982
+++ ++L +A G+ +L SL+ VH D+ +N L + +++F
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 983 GLDRLAIATPAE--ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
G+ R A + PI + + E G+ T +DV++FG+ L EIL K
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAW---ECILMGKFTTASDVWAFGVTLWEILMLCKE 239
Query: 1041 VMFTQ--DEDIVK 1051
+ + DE +++
Sbjct: 240 QPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 6/160 (3%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRLLVY-DYMPNGNLATLLQEASHQDGHVLNWPMR 940
E + L ++H + G + L ++ +YMP G++ L+ V R
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 941 HLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000
++ G+S+LHS +VH DIK N+L D+ L +FG + + +
Sbjct: 114 QIL-----EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
G+ ++SPE S ++ADV+S G ++E+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-08
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 165 PSLRYLDLSSNAFTGEIPGN-FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223
+L LDL +N T +IP KS L+ ++LS N +P+ + L L+ L L N
Sbjct: 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173
Query: 224 HLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLC 283
L LP +SN S+L +L N + +P I +S L+ L LS N + L+
Sbjct: 174 DL-SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSL--- 228
Query: 284 NLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRV 343
N+ +L ++L N + + +S LE LDL NN+I ++ S L ++T+LR
Sbjct: 229 ---SNLKNLSGLELSNNKLEDLPESIGN--LSNLETLDLSNNQISSI--SSLGSLTNLRE 281
Query: 344 MDLSGNFFSGNLPAAVGSLDKLEVL 368
+DLSGN S LP L LE+L
Sbjct: 282 LDLSGNSLSNALPLIALLLLLLELL 306
|
Length = 394 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENT----FRKEAEALGKVKHRN 893
F+ V+ RG +G + +D G V +++ LR + E R E + L V+ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL--VEADS 60
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
L V++ +Y+ + L L+ +++P G++ TLL + +D ++ LA +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLA--ID 115
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL-------------DRLAIATPAEASSST 999
+H L +H DIKP N+L D+ LS+FGL L + P++ +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 1000 -------------------TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+ +G+ Y++PE K D +S G+++ E+L G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 62/259 (23%), Positives = 113/259 (43%), Gaps = 48/259 (18%)
Query: 838 QFDEENVLSRGRYGLIFKA---SYQDGMVLSIRRLR----DGT-IDENTFRKEAEALGKV 889
+++ E + RG YG ++KA + +DG +I++ + T I ++ R E L ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59
Query: 890 KHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNW---PMRHLISL 945
KH N+ L + D + L++DY A H ++ + R I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY------------AEHDLWQIIKFHRQAKRVSIPP 107
Query: 946 GLAR--------GLSFLHSLDMVHGDIKPQNVLFDADFEAH----LSEFGLDRLAIATPA 993
+ + G+ +LHS ++H D+KP N+L + + + GL RL A
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 994 EASSSTTPIGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV 1050
+ + ++ Y +PE A TK D+++ G + E+LT P+ ++ I
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTLE-PIFKGREAKIK 224
Query: 1051 KWV---KKQLQRGQISELL 1066
K + QL+R I E+L
Sbjct: 225 KSNPFQRDQLER--IFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 10/167 (5%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRH 941
E+ L +H LT L+ Y D V +Y+ G L L V +
Sbjct: 45 ESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGELFFHLSRE-----RVFSEDRTR 98
Query: 942 LISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
+ L +LHS +V+ D+K +N++ D D +++FGL + I +A++ T
Sbjct: 99 FYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI---TDAATMKTF 155
Query: 1002 IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048
G+ Y++PE + D + G+V+ E++ GR P + QD +
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 47/201 (23%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 845 LSRGRYGLIFKASY-----QDGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKHRNLTVL 897
L G +G + Y G ++++ L+ + +KE E L + H N+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 898 RGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
+G + L+ +++P+G+L L ++ +N + ++ + +G+ +L S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMDYLGS 127
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS-LGYVSPEAAST 1015
VH D+ +NVL +++ + + +FGL + AI T E + + S + + +PE
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 1016 GQPTKEADVYSFGIVLLEILT 1036
+ +DV+SFG+ L E+LT
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL-DRLAIATPAEASSSTTP 1001
+ L + + LSFLH+ ++H DIK ++L +D LS+FG +++ P S TP
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 179
Query: 1002 IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+++PE S E D++S GI+++E++ G P
Sbjct: 180 Y----WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 866 IRRLRDGTIDE--NTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATL 923
++ LR D F KE + L ++ N+ L G P ++ +YM NG+L
Sbjct: 51 VKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP-PLCMIMEYMENGDLNQF 109
Query: 924 LQEASHQDGHVLNW----PMRHLISLG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEA 977
LQ+ + + L+ + +A G+ +L SL+ VH D+ +N L ++
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI 169
Query: 978 HLSEFGLDRLAIA---------TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFG 1028
+++FG+ R + P PI +++ E+ G+ T ++DV++FG
Sbjct: 170 KIADFGMSRNLYSSDYYRVQGRAPL-------PI---RWMAWESVLLGKFTTKSDVWAFG 219
Query: 1029 IVLLEILT 1036
+ L EILT
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 38/220 (17%)
Query: 842 ENVLSRGRYGLIFKASYQ-DG--MVLSIRRLRD--GTIDENTFRKEAEALGKV-KHRNLT 895
E+V+ G +G + +A + DG M +I+ L++ D F E E L K+ H N+
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 896 VL------RGYYAGPPDVRLLVYDYMPNGNLATLLQEA---------SHQDGHVLNWPMR 940
L RGY + +Y P GNL L+++ + + G +
Sbjct: 67 NLLGACENRGYL-------YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 941 HLISLG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
L+ +A G+ +L +H D+ +NVL + + +++FGL R E
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYV 173
Query: 999 TTPIGSLG--YVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
+G L +++ E+ + T ++DV+SFG++L EI++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL LH + V+ D+KP+N+L D +S+ G LA+ P E S +G++GY++
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLG---LAVKIP-EGESIRGRVGTVGYMA 169
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
PE + + T D + G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-08
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 39/217 (17%)
Query: 843 NVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRK----EAEALGKVKHRNLTVL 897
+ G YG++ A + G ++I+++ + D+ K E + L ++H N+ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISN-VFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 898 RGYYAGPPDVRL------LVYDYMPNGNLATLLQEASHQ---DGHVLNWPMRHLISLGLA 948
P +V + M +L +++ S Q D H+ + + ++
Sbjct: 65 LDIL--RPPSPEDFNDVYIVTELMET-DLHKVIK--SPQPLTDDHI-QYFLYQIL----- 113
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
RGL +LHS +++H D+KP N+L +++ + + +FGL R E T YV
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYV 167
Query: 1009 ------SPEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
+PE S+ + TK D++S G + E+LT +
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 59/251 (23%), Positives = 96/251 (38%), Gaps = 65/251 (25%)
Query: 893 NLTVLRGYYA-GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
N V+R YY+ D V DY+P G++ +LL + + L +
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAV 114
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL--------------------------- 984
+H + +H DIKP N+L D D L++FGL
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 985 ------------DRLA-----IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSF 1027
DRL A + + + +G+ Y++PE T+ D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 1028 GIVLLEILTGRKPVMFTQD-EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLG 1086
G++L E+L G+ P + E +K + Q + L P +L PE+S+ L
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQ------TSLHIPPQAKLSPEASD-----LI 283
Query: 1087 VKVGLLCTAPD 1097
+K LC P+
Sbjct: 284 IK---LCRGPE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 29/91 (31%), Positives = 49/91 (53%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
G+ +LHS +VH DIK N+L D+ L +FG + + + + G+ ++S
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
PE S ++ADV+S G ++E+LT + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLR--DGTIDENTFRKEAEALGKVKHRNLTVLRGYYA 902
+ RG YG ++KA +DG L+ +GT + +E L ++KH N+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 903 GPPDVRL-LVYDYMPNGNLATL-LQEASHQDGHVLNWPMRHLISL--GLARGLSFLHSLD 958
D ++ L++DY + + AS + + P + SL + G+ +LH+
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 959 MVHGDIKPQNVLFDAD----FEAHLSEFGLDRLAIATPAEASSSTTP-IGSLGYVSPEAA 1013
++H D+KP N+L + +++ G RL +P + + P + + Y +PE
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 1014 STGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ TK D+++ G + E+LT +P+ + EDI
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (137), Expect = 2e-08
Identities = 67/247 (27%), Positives = 114/247 (46%), Gaps = 35/247 (14%)
Query: 845 LSRGRYGLIFKA-SYQDGMVLSIRRLR-----DGTIDENTFRKEAEALGKVKHRNLTVLR 898
L G YG+++KA + G +++++++R +G I R E L ++KH N+ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IPSTALR-EISLLKELKHPNIVKLL 64
Query: 899 GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
+ LV++Y +L L + L+ + I L RGL++ HS
Sbjct: 65 DVIHTERKL-YLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
++H D+KPQN+L + D L++FGL R A P + T + +L Y +PE G
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLAR-AFGIP--LRTYTHEVVTLWYRAPEIL-LGSK 174
Query: 1019 --TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
+ D++S G + E++TG+ +F D +I QL + I ++L G P
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGK--PLFPGDSEI-----DQLFK--IFQIL--GT----PT 219
Query: 1077 SSEWEEF 1083
W
Sbjct: 220 EESWPGV 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 37/139 (26%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
V +Y+ G+L +Q+ P + +A GL FLHS +++ D+K NV
Sbjct: 78 FVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGI 1029
+ D++ +++FG+ + + + ++ T G+ Y++PE + K D ++FG+
Sbjct: 133 MLDSEGHIKIADFGMCKENM---WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 1030 VLLEILTGRKPVMFTQDED 1048
+L E+L G+ P +DED
Sbjct: 190 LLYEMLAGQAPFE-GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 17/232 (7%)
Query: 845 LSRGRYGLIFKASYQ--DGMV-LSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
L G Y ++K + D +V L RL T +E L +KH N+ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
+ L V++Y+ + +L L + G+ +N L L RGL++ H ++H
Sbjct: 74 HTEKSLTL-VFEYL-DKDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA--ASTGQPT 1019
D+KPQN+L + E L++FGL R A + P + S+ + +L Y P+ ST T
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNE--VVTLWYRPPDILLGSTDYST 184
Query: 1020 KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ D++ G + E+ TGR + E+ + ++ + L G +E PG+L
Sbjct: 185 -QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL--GTPTEETWPGIL 233
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS--TTPIGSLG 1006
RGL ++HS +++H D+KP N+L + + + + +FGL R IA P + T + +
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHTGFLTEYVATRW 174
Query: 1007 YVSPEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
Y +PE ++ TK D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-08
Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 900 YYA-GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
YY+ +L+ DY+ +G+L LL+ ++G L+ I L L+ LH +
Sbjct: 75 YYSVTTLKGHVLIMDYIKDGDLFDLLK----KEGK-LSEAEVKKIIRQLVEALNDLHKHN 129
Query: 959 MVHGDIKPQNVLFD-ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++H DIK +NVL+D A +L ++GL + I TP + G+L Y SPE G
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTP------SCYDGTLDYFSPEKIK-GH 181
Query: 1018 PTKEA-DVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ D ++ G++ E+LTG+ P +DE++
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRN 893
Q+++ + G YG+++KA + ++++++R DE +T +E L +++H N
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL---AR 949
++R + RL LV++Y+ L H D LI L R
Sbjct: 63 --IVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEA-HLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
G+++ HS ++H D+KPQN+L D A L++FGL R A P T + +L Y
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRT--FTHEVVTLWYR 170
Query: 1009 SPEA-ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+PE + + D++S G + E++ +KP +F D +I
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP-LFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 839 FDEENVLSRGRYGLIFKA---SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT 895
F + + +G +G +FK Q + + I L + + ++E L + +T
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 896 VLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
G Y D +L ++ +Y+ G+ LL+ + + +R ++ +GL +L
Sbjct: 66 KYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI-LREIL-----KGLDYL 117
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
HS +H DIK NVL E L++FG+ T + ++ +G+ +++PE
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---VGTPFWMAPEVIK 174
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKP 1040
+AD++S GI +E+ G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGM-VLSIRRLRDGT----IDENTFRKEAEALGKVKHR 892
+F+ V+ G YG++ K +++ +++I++ +D + E T R E + L +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQE 60
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
N+ L+ + + LV++Y+ N+ LL+E +G V +R I L + +
Sbjct: 61 NIVELKEAFRRRGKL-YLVFEYVEK-NMLELLEE--MPNG-VPPEKVRSYI-YQLIKAIH 114
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR-LAIATPAEASSSTTPIGSLGYVSPE 1011
+ H D+VH DIKP+N+L + L +FG R L+ + A + T + + Y SPE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA---NYTEYVATRWYRSPE 171
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGR 1038
K D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 8/101 (7%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL FLH +++ D+K NVL D++ +++FG+ + I +++T G+ Y++
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI---LGGVTTSTFCGTPDYIA 164
Query: 1010 PEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
PE S QP D ++ G++L E+L G+ P F DED
Sbjct: 165 PEILS-YQPYGPAVDWWALGVLLYEMLAGQSP--FEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 40/131 (30%), Positives = 71/131 (54%), Gaps = 7/131 (5%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L +G++F H ++H D+KPQN+L + E L++FGL R A P S+ + +L
Sbjct: 109 LLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNE--VVTLW 165
Query: 1007 YVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065
Y +P+ + + D++S G ++ E++TGR T +ED + + + + G +E
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM--GTPTES 223
Query: 1066 LEPGLLELDPE 1076
PG+ +L PE
Sbjct: 224 TWPGISQL-PE 233
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 47/255 (18%)
Query: 882 EAEALGKVKHRNLTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEAS----------- 928
E L +V H ++ L G GP LL+ +Y G+L + L+E+
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPL---LLIVEYAKYGSLRSFLRESRKVGPSYLGSDG 109
Query: 929 --------HQDGHVLNWPMRHLISLG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978
+ D L M LIS ++RG+ +L + +VH D+ +NVL +
Sbjct: 110 NRNSSYLDNPDERALT--MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMK 167
Query: 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-G 1037
+S+FGL R + S I + +++ E+ T ++DV+SFG++L EI+T G
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226
Query: 1038 RKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPD 1097
P E + LL+ G PE+ E + + L C +
Sbjct: 227 GNPYPGIAPERLFN-------------LLKTGYRMERPENCSEEMY----NLMLTCWKQE 269
Query: 1098 PLDRPSMADIVFMLE 1112
P RP+ ADI LE
Sbjct: 270 PDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 3/97 (3%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP-IGSL 1005
L RGL ++HS +++H D+KP N+L + D E + +FG+ R ++P E T + +
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 1006 GYVSPEAA-STGQPTKEADVYSFGIVLLEILTGRKPV 1041
Y +PE S + T D++S G + E+L GR+ +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-08
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRH----LISLGLARGLSFLHSLDMVHGDIK 965
LV DY G+L ++ + N R L+ + + + +HS M+H DIK
Sbjct: 116 LVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIK 170
Query: 966 PQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVY 1025
N+L ++ L +FG ++ AT ++ T G+ YV+PE +K+AD++
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAPEIWRRKPYSKKADMF 229
Query: 1026 SFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLL 1085
S G++L E+LT ++P E++ + + K L G+ L + PE E
Sbjct: 230 SLGVLLYELLTLKRPF---DGENMEEVMHKTLA-GRYDPLPP----SISPEMQE------ 275
Query: 1086 GVKVGLLCTAPDPLDRPSMADIVFM 1110
+ LL + DP RPS + ++ M
Sbjct: 276 -IVTALLSS--DPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLR------DGTIDENTFRKEAEALGKVKHRNLTV 896
VL +G +G + A + V +I+ L+ D +D K AL KH LT
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L + D V +Y+ G+L +Q + D P + + L FLH
Sbjct: 61 LHCCFQ-TKDRLFFVMEYVNGGDLMFQIQRSRKFDE-----PRSRFYAAEVTLALMFLHR 114
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+++ D+K N+L DA+ L++FG+ + I ++TT G+ Y++PE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI---LNGVTTTTFCGTPDYIAPEILQEL 171
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ D ++ G+++ E++ G+ P ++D+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 71/289 (24%), Positives = 129/289 (44%), Gaps = 35/289 (12%)
Query: 836 TRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDENTFR----KEAEALGKVK 890
F E + +G++ +++KA DG V+++++++ + + R KE + L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 891 HRNLTVLRGYYAGPPDVRLL--VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL--G 946
H N V++ Y A + L V + G+L+ +++ Q + P R +
Sbjct: 61 HPN--VIK-YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI---PERTIWKYFVQ 114
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L L +HS ++H DIKP NV A L + GL R + A S +G+
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPY 171
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
Y+SPE ++D++S G +L E+ + P F D+ + + K++++ L
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEKCDYPPL- 228
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
P D S E + L+ C PDP RP DI ++L+ +
Sbjct: 229 -PA----DHYSEELRD-LVSR-----CINPDPEKRP---DISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLR--DGTIDENTFRKEAEALGKVKHRNLTVLRGYYA 902
+ RG YG ++KA +DG L+ +GT + +E L ++KH N+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 903 GPPDVRL-LVYDYMPNGNLATL-LQEASHQDGHVLNWPMRHLISL--GLARGLSFLHSLD 958
D ++ L++DY + + AS + + P + SL + G+ +LH+
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 959 MVHGDIKPQNVLFDAD----FEAHLSEFGLDRLAIATPAEASSSTTP-IGSLGYVSPEAA 1013
++H D+KP N+L + +++ G RL +P + + P + + Y +PE
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 1014 STGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ TK D+++ G + E+LT +P+ + EDI
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 21/220 (9%)
Query: 853 IFKASYQDGMVLSIRRLRDGTIDEN--TFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909
I K ++ + ++++ L+D +++ E E + + KH+N+ L G + +
Sbjct: 39 IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98
Query: 910 LVYDYMPNGNLATLLQ-------EASHQDGHVLNWPM--RHLISLG--LARGLSFLHSLD 958
+V +Y GNL L+ E S+ V + M + L+S +ARG+ +L S
Sbjct: 99 IV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLA--IATPAEASSSTTPIGSLGYVSPEAASTG 1016
+H D+ +NVL + +++FGL R I + ++ P+ +++PEA
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV---KWMAPEALFDR 214
Query: 1017 QPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
T ++DV+SFG+++ EI T G P E++ K +K+
Sbjct: 215 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 843 NVLSRGRYGLIFKA--SYQDG----MVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNL 894
L G +G +++ +DG + ++++ L + DE+ F EA + K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 895 TVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL--ARG 950
L G + P R ++ + M G+L + L+E + + M+ L+ A+G
Sbjct: 72 VRLIGVSFERLP---RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 951 LSFLHSLDMVHGDIKPQNVLFD---ADFEAHLSEFGLDRLAIATP--AEASSSTTPIGSL 1005
+L +H DI +N L A +++FG+ R + + PI
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-- 186
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP 1040
++ PEA G T + DV+SFG++L EI + G P
Sbjct: 187 -WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 42/163 (25%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 885 ALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG----HVLNWPMR 940
A+G + H + L G G LV P G+L +++ H+D +LNW ++
Sbjct: 62 AMGSLDHAYIVRLLGICPGAS--LQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQ 117
Query: 941 HLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA--SSS 998
+A+G+ +L MVH ++ +N+L +D +++FG+ L + S
Sbjct: 118 ------IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 999 TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP 1040
TPI +++ E+ G+ T ++DV+S+G+ + E+++ G +P
Sbjct: 172 KTPI---KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 29/98 (29%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
+ L + R LS+LH+ ++H DIK ++L +D LS+FG E + +
Sbjct: 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLV 179
Query: 1003 GSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
G+ +++PE S E D++S GI+++E++ G P
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 890 KHRNLTVLRGYYA--GPPDVRLLVYDYMPNGNLATLLQ-------EASHQDGHV--LNWP 938
KH+N+ L G GP V + +Y GNL L+ E + V
Sbjct: 82 KHKNIINLLGACTQDGPLYV---IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 939 MRHLISLG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR--LAIATPAE 994
+ L+S +ARG+ +L S +H D+ +NVL D +++FGL R I +
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWV 1053
++ P+ +++PEA T ++DV+SFG++L EI T G P E++ K +
Sbjct: 199 TTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
Query: 1054 KK 1055
K+
Sbjct: 256 KE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLTVLRGYYA 902
L G +G ++KA ++ L+ ++ + +E + E E L H + L G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
+ +++ ++ P G + ++ E L P +I + L +LHS+ ++H
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIHR 134
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA--STGQPTK 1020
D+K NVL D + L++FG+ + T S IG+ +++PE T + T
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF---IGTPYWMAPEVVMCETMKDTP 191
Query: 1021 ---EADVYSFGIVLLEI 1034
+AD++S GI L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 27/227 (11%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRNL 894
FD + G YG ++KA +D G +++++++R E T +E + L ++ HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 895 TVLRGYYAGPPDVR---------LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL 945
L+ D LV++YM + +L LL+ ++++ H+ S
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESG------LVHFSEDHIKSF 121
Query: 946 --GLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIG 1003
L GL++ H + +H DIK N+L + + L++FGL RL + E+ T +
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS--EESRPYTNKVI 179
Query: 1004 SLGYVSPE-AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+L Y PE + DV+S G +L E+ T +KP +F ++++
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP-IFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 26/179 (14%)
Query: 939 MRHLI--SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP--AE 994
M LI S +ARG+ FL S +H D+ +N+L + + +FGL R P
Sbjct: 173 MEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232
Query: 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQ-DEDIVKW 1052
S+ P L +++PE+ T ++DV+SFG++L EI + G P Q +E+ +
Sbjct: 233 KGSARLP---LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289
Query: 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
+K R + E P + ++ L C DP +RP+ + +V +L
Sbjct: 290 LKDG-TRMRAPENATPEIY----------------RIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 845 LSRGRYGLIFKA-SYQDGMVLSIRRLR----DGTIDENTFRKEAEALGKVKHRNLTVLRG 899
L G Y +FK S +++++ +R +G T +E L +KH N+ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKNLKHANIVTLHD 70
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM 959
+ L V++Y+ + L++ G++++ + L RGLS+ H +
Sbjct: 71 IIHTERCLTL-VFEYLDSD-----LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA--ASTGQ 1017
+H D+KPQN+L + E L++FGL R A + P + S+ + +L Y P+ ST
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNE--VVTLWYRPPDVLLGSTEY 181
Query: 1018 PTKEADVYSFGIVLLEILTGR 1038
T D++ G +L E+ TGR
Sbjct: 182 STP-IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 65/269 (24%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 852 LIFKASYQDGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909
S ++++++ LR+ N F KE + + ++K N+ L D
Sbjct: 37 FSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-TSDPLC 95
Query: 910 LVYDYMPNGNLATLLQ----EASHQDGHVLNWPMRHLISLG--LARGLSFLHSLDMVHGD 963
++ +YM NG+L L + + + V+ LI + +A G+ +L SL+ VH D
Sbjct: 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD 155
Query: 964 IKPQNVLFDADFEAHLSEFGLDRLAIATPAE--ASSSTTPIGSLGYVSPEAASTGQPTKE 1021
+ +N L ++ +++FG+ R + + PI ++S E+ G+ T
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPI---RWMSWESILLGKFTTA 212
Query: 1022 ADVYSFGIVLLEILTGRKPVMFTQ--DEDIVKWVKKQLQ-RGQISELLEPGLLELDPESS 1078
+DV++FG+ L EILT K ++Q DE +++ + + +G+ L +P L P+S
Sbjct: 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALC---PDSL 269
Query: 1079 EWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
K+ L C + +RPS +I
Sbjct: 270 --------YKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 62/290 (21%), Positives = 118/290 (40%), Gaps = 46/290 (15%)
Query: 844 VLSRGRYGLIFKA--SYQDG---------MVLSIRRLRDGTIDENTFRKEAEALGKVKHR 892
+L G +G + + S DG M L I + I+E F EA + H
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE--IEE--FLSEAACMKDFDHP 61
Query: 893 NLTVL-----RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI--SL 945
N+ L +++ +M +G+L + L S G P++ L+ +
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMV 120
Query: 946 GLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP--AEASSSTTPIG 1003
+A G+ +L + + +H D+ +N + D +++FGL + + + + P+
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV- 179
Query: 1004 SLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQI 1062
+++ E+ + T ++DV++FG+ + EI T G+ P ++ +I
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-------------PGVENHEI 224
Query: 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ L G PE E + L C DP DRP+ + +LE
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYS----CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR-----DGTIDENTFRKEAEALGKVKH 891
+F++ N + G YG++++A G +++++++R DG I ++ R E L ++H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLR-EITLLLNLRH 65
Query: 892 RNLTVLRGYYAGPP-DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
N+ L+ G D LV +Y +LA+LL + + L L RG
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP----FSESQVKCLMLQLLRG 120
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP-IGSLGYVS 1009
L +LH ++H D+K N+L +++FGL R PA+ TP + +L Y +
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAK---PMTPKVVTLWYRA 176
Query: 1010 PEA--ASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
PE T T D+++ G +L E+L KP++
Sbjct: 177 PELLLGCTTY-TTAIDMWAVGCILAELLAH-KPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 36/104 (34%), Positives = 61/104 (58%), Gaps = 8/104 (7%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
+A GL FLHS +++ D+K NV+ DA+ +++FG+ + I ++ T G+
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPD 166
Query: 1007 YVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
Y++PE + QP K D ++FG++L E+L G+ P F +DED
Sbjct: 167 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPP--FDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 33/207 (15%)
Query: 845 LSRGRYGLIFKA-SYQDGMVLSIR--RLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
L G Y ++K S +G +++++ RL++ T +EA L +KH N+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI------- 65
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRH----------LISLGLARGL 951
+L++D + TL+ E H D + + +H L L RGL
Sbjct: 66 -------VLLHDIIHTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
S++H ++H D+KPQN+L E L++FGL R A + P+ S+ + +L Y P+
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNE--VVTLWYRPPD 173
Query: 1012 A-ASTGQPTKEADVYSFGIVLLEILTG 1037
+ + + D++ G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL LH +V+ D+KP+N+L D +S+ G LA+ P E + +G++GY++
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHIRISDLG---LAVEIP-EGETIRGRVGTVGYMA 169
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
PE + T D + G ++ E++ G+ P F Q ++ VK E +E
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP--FRQRKEKVKR-----------EEVERR 216
Query: 1070 LLELDPE--SSEWEEFLLGVKVGLLCTAP 1096
+ E D E S ++ E + LL P
Sbjct: 217 VKE-DQEEYSEKFSEAARSICRQLLTKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 844 VLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT-FRKEAEALGKV-KHRNLTVLRGY 900
V+ G YG ++KA + + G +++I+ + D DE ++E L K H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 901 Y-----AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
+ G D LV + G+ T L + + G L I RGL++LH
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGS-VTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA-AS 1014
++H DIK QN+L + E L +FG+ +T ++ IG+ +++PE A
Sbjct: 131 ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF---IGTPYWMAPEVIAC 187
Query: 1015 TGQPTK----EADVYSFGIVLLEILTGRKP 1040
QP +DV+S GI +E+ G+ P
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L RGL ++HS +++H D+KP N+L +A+ + + +FGL R T + T + +
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---TTSEKGDFMTEYVVTRW 173
Query: 1007 YVSPEAA-STGQPTKEADVYSFGIVLLEILTGRKPV 1041
Y +PE + + T DV+S G + E+L GRKP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 845 LSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRK----EAEALGKVKHRNLTVLRG 899
+ G YG++FK ++ G +++I++ + + D+ +K E L ++KH NL L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 900 YYAGPPDVRL-LVYDYMPNGNLATLLQE-ASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
+ +L LV++Y + T+L E + G + + I + ++F H
Sbjct: 68 VFR--RKRKLHLVFEYCDH----TVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKH 119
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA----A 1013
+ +H D+KP+N+L + L +FG R+ + T + + Y +PE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYRAPELLVGDT 176
Query: 1014 STGQPTKEADVYSFGIVLLEILTG 1037
G P DV++ G V E+LTG
Sbjct: 177 QYGPPV---DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-07
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS--TTPIGS 1004
L + L ++HS +++H D+KP N+L ++D L++FGL R + T + +
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 1005 LGYVSPEA--ASTGQPTKEADVYSFGIVLLEILTGR 1038
Y +PE ST + TK D++S G +L E+L G+
Sbjct: 176 RWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 49/214 (22%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 838 QFDEENVLSRGRYGLIFKASY---QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL 894
++ + G YG ++KA + + + + +L G D ++E L + +H N+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNI 62
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
G Y D +V +Y G+L Q+ L+ + +GL++L
Sbjct: 63 VAYFGSYLRR-DKLWIVMEYCGGGSL----QDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS--TTPIGSLGYVSPEA 1012
H +H DIK N+L D + L++FG ++ A+ + + IG+ +++PE
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFG-----VSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 1013 A---STGQPTKEADVYSFGIVLLEILTGRKPVMF 1043
A G + D+++ GI +E+ +P MF
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAEL-QPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 27/185 (14%)
Query: 863 VLSIR---RLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL--VYDYMPN 917
V++I RL+ E E L +V H + L + D R L + +Y+P
Sbjct: 33 VMAIPEVIRLKQ----EQHVHNEKRVLKEVSHPFIIRL---FWTEHDQRFLYMLMEYVPG 85
Query: 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEA 977
G L + L+ + + + + L +LHS ++V+ D+KP+N+L D +
Sbjct: 86 GELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHI 140
Query: 978 HLSEFGLDRLAIATPAEASSST-TPIGSLGYVSPEA-ASTGQPTKEADVYSFGIVLLEIL 1035
L++FG + + T T G+ Y++PE S G K D ++ GI++ E+L
Sbjct: 141 KLTDFGFAK-------KLRDRTWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEML 192
Query: 1036 TGRKP 1040
G P
Sbjct: 193 VGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 880 RKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDG------ 932
+KE L K+KH N+ + + + RL +V +Y G+L ++ + Q G
Sbjct: 47 KKEVILLAKMKHPNIVTF--FASFQENGRLFIVMEYCDGGDL---MKRINRQRGVLFSED 101
Query: 933 HVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLAIAT 991
+L+W ++ ISLGL +H ++H DIK QN+ + A L +FG+ R +
Sbjct: 102 QILSWFVQ--ISLGLKH----IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155
Query: 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
A T +G+ Y+SPE + D++S G VL E+ T + P
Sbjct: 156 MELAY---TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 65/286 (22%), Positives = 132/286 (46%), Gaps = 41/286 (14%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIR-RLRDGTIDEN-TFRKEAEALGKVK-------HRNLT 895
L +G +G++++ + +D + R+ T++E+ + R+ E L + H +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQ----EASHQDGHVLNWPMRHLISLG--LAR 949
+L G P L+V + M +G+L + L+ EA + G ++ +I + +A
Sbjct: 74 LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPP-TLQEMIQMAAEIAD 130
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP--AEASSSTTPIGSLGY 1007
G+++L++ VH D+ +N + DF + +FG+ R T + P+ +
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---RW 187
Query: 1008 VSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
++PE+ G T +D++SFG+VL EI + +P +E ++K+V +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------M 235
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ G L+ E L+ +C +P RP+ +IV +L+
Sbjct: 236 DGGYLDQPDNCPERVTDLMR-----MCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 14/112 (12%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
RGL ++HS ++H D+KP N+ + D E + +FGL R T + + Y
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT------DDEMTGYVATRWYR 182
Query: 1009 SPEAA-STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059
+PE + + D++S G ++ E+LTG+ +F + I QL+R
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK--TLFPGSDHI-----DQLKR 227
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 55/237 (23%), Positives = 103/237 (43%), Gaps = 29/237 (12%)
Query: 825 NKITYVETLEATRQFDEENVLSRGRYGLIFKASYQDGMV--LSIRRLRDGTID-----EN 877
NK+ Y F+ L G +G + A+Y++ ++I+R I ++
Sbjct: 25 NKMKY-------EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 878 TFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNW 937
F E + L + H L G + + LV +++ G T L+ V +
Sbjct: 78 VF-SERKILNYINHPFCVNLYGSFKDESYL-YLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997
++ + +L SL++V+ D+KP+N+L D D +++FG ++ +
Sbjct: 136 YAAQIVLI-----FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTR 184
Query: 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054
+ T G+ Y++PE K AD ++ GI + EIL G P F +E ++ + K
Sbjct: 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP--FYANEPLLIYQK 239
|
Length = 340 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 53/241 (21%), Positives = 102/241 (42%), Gaps = 26/241 (10%)
Query: 844 VLSRGRYGLIFKA-SYQDGMVLSIRRLR------DGTIDENTFRKEAEALGKVKHRNLTV 896
VL +G +G + A + G + +++ L+ D ++ K +L + H LT
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 897 LRGYYA-GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L Y PD V +++ G+L +Q++ D + + L FLH
Sbjct: 61 L--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE-----ARARFYAAEITSALMFLH 113
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
+++ D+K NVL D + L++FG+ + I +++T G+ Y++PE
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI---FNGKTTSTFCGTPDYIAPEILQE 170
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
D ++ G++L E+L G P ++D+ + + E++ P L D
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------DEVVYPTWLSQDA 223
Query: 1076 E 1076
Sbjct: 224 V 224
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL-DRLAIATPAEASSSTTPIGSLGY 1007
+ L +LHS ++H DIK ++L D LS+FG +++ P S TP +
Sbjct: 128 QALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY----W 183
Query: 1008 VSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
++PE S E D++S GI+++E++ G P
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 25/60 (41%), Positives = 33/60 (55%)
Query: 652 SLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
+L SL L N L+ +F L NL L+LS N L+ P + + SLR L+LS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 831 ETLEATRQFDEENV--LSRGRYGLIFKA-SYQDGMVLSIR--RLRDGTIDENTFRKEAEA 885
+ L Q D E + + G YG ++KA + G + +++ +L G D + ++E
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFM 59
Query: 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL 945
+ + KH N+ G Y + + + +Y G+L Q+ H G + + ++
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICM-EYCGGGSL----QDIYHVTGPLSELQIAYVCRE 114
Query: 946 GLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
L +GL++LHS +H DIK N+L + + L++FG+ AT A+ S IG+
Sbjct: 115 TL-QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF---IGTP 170
Query: 1006 GYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMF 1043
+++PE A+ G + D+++ GI +E L +P MF
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 14/96 (14%)
Query: 954 LHSLDMVHG----DIKPQNVLFDADFEAHLSEFGLD-RLAIATPAEASSSTTPIGSLGYV 1008
LH L HG D+KP N+L DA L +FG+ RL ++ + T G Y+
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-----VDSKAKTRSAGCAAYM 181
Query: 1009 SPEAASTGQPTKE----ADVYSFGIVLLEILTGRKP 1040
+PE P + ADV+S GI L+E+ TG+ P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPD--VRLLVYDYMPNGNLATLL--QEASHQDGHVLNW 937
E L ++H N+ YY D L+ +Y G L + Q+ + ++ W
Sbjct: 49 EIVILSLLQHPNII---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW 105
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997
+ ++S +S++H ++H DIK N+ L +FG+ ++ +E S
Sbjct: 106 YLFQIVS-----AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSM 157
Query: 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK 1039
+ T +G+ Y+SPE + ++D+++ G VL E+LT ++
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRH--LISLGLARGLSFLHSLDMVHGDIKP 966
LV +Y+ G+L +Q P H + + L+FLH +++ D+K
Sbjct: 72 FLVIEYVNGGDLMFHMQRQR-------KLPEEHARFYAAEICIALNFLHERGIIYRDLKL 124
Query: 967 QNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYS 1026
NVL DAD L+++G+ + + P + +S T G+ Y++PE + D ++
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLG-PGDTTS--TFCGTPNYIAPEILRGEEYGFSVDWWA 181
Query: 1027 FGIVLLEILTGRKPV-MFTQDEDI 1049
G+++ E++ GR P + T + D+
Sbjct: 182 LGVLMFEMMAGRSPFDIITDNPDM 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 30/103 (29%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL L +V+ D+KP+N+L D +S+ G LA+ P E + +G++GY++
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLG---LAVQIP-EGETVRGRVGTVGYMA 169
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKW 1052
PE + + T D + G ++ E++ G+ P F + ++ VK
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP--FRKRKERVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 45/240 (18%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENT----FRKEAEALGKVKHRN 893
F+ V+ RG +G + +D G + +++ LR + E R E + L V+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDIL--VEADG 60
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
V++ +Y+ L L+ +++P G++ TLL + + + + LA +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV---LA--ID 115
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL-------------DRLAIATPAEASSST 999
+H L +H DIKP N+L DA LS+FGL L P++ S
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 1000 -------------------TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+ +G+ Y++PE K D +S G+++ E+L G P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 845 LSRGRYGLIFK--ASYQDGMV-LSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
L G Y +FK + + +V L RL T +E L +KH N+ L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
+ L V++Y+ L++ G++++ + + RGL++ H ++H
Sbjct: 74 HTDKSLTL-VFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA-ASTGQPTK 1020
D+KPQN+L + E L++FGL R A + P + S+ + +L Y P+ + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNE--VVTLWYRPPDVLLGSSEYST 184
Query: 1021 EADVYSFGIVLLEILTGR 1038
+ D++ G + E+ +GR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 38/219 (17%)
Query: 843 NVLSRGRYGLIFKASYQ-DGMVL--SIRRLRD--GTIDENTFRKEAEALGKVKHR-NLTV 896
+V+ G +G + KA + DG+ + +I+R+++ D F E E L K+ H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 897 L------RGYYAGPPDVRLLVYDYMPNGNLATLLQEA---------SHQDGHVLNWPMRH 941
L RGY L +Y P+GNL L+++ + + +
Sbjct: 61 LLGACEHRGYL-------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 942 LISLG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
L+ +ARG+ +L +H D+ +N+L ++ A +++FGL R +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVK 167
Query: 1000 TPIGSLG--YVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
+G L +++ E+ + T +DV+S+G++L EI++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 834 EATRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR---DGTIDENTFRKEAEALGKV 889
E ++ + + G YG + A + G+ +++++L I +E L +
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 890 KHRNLTVLRGYYAGPP------DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI 943
KH N+ L + DV L+ + + +L +++ D HV +
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTH--LMGADLNNIVKCQKLTDDHV------QFL 125
Query: 944 SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIG 1003
+ RGL ++HS D++H D+KP N+ + D E + +FGL R T +
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVA 179
Query: 1004 SLGYVSPEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
+ Y +PE + + D++S G ++ E+LTGR
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGK-------VKHRNLT 895
VL +G YG ++ G +++++++ T + KE E L + +KH N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G + + + +++P G+++++L V + ++ G+++LH
Sbjct: 66 QYLGTCLDDNTISIFM-EFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLH 119
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST---TPIGSLGYVSPEA 1012
+ +VH DIK NV+ + L +FG R + S + G+ +++PE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+ +++D++S G + E+ TG+ P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 39/137 (28%), Positives = 59/137 (43%), Gaps = 11/137 (8%)
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
PD + D M G+L L Q G MR + + GL +H+ +V+ D+
Sbjct: 69 PDKLCFILDLMNGGDLHYHLS----QHGVFSEKEMR-FYATEIILGLEHMHNRFVVYRDL 123
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEAD 1023
KP N+L D +S+ GL A +G+ GY++PE G AD
Sbjct: 124 KPANILLDEHGHVRISDLGL-----ACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 1024 VYSFGIVLLEILTGRKP 1040
+S G +L ++L G P
Sbjct: 179 WFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 44/207 (21%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 837 RQFDEENVLSRGRYGLIFKA---SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN 893
F + + +G +G ++K ++ + + I L + + ++E L +
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+T G Y + ++ +Y+ G+ LL+ ++ ++ +R ++ +GL +
Sbjct: 64 ITRYYGSYLKGTKL-WIIMEYLGGGSALDLLKPGPLEETYIATI-LREIL-----KGLDY 116
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
LHS +H DIK NVL + L++FG+ T + T +G+ +++PE
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVI 173
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKP 1040
+AD++S GI +E+ G P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMR 940
E+ L +H LT L+ Y+ RL V +Y G L L S + V +
Sbjct: 45 ESRVLQNTRHPFLTALK--YSFQTHDRLCFVMEYANGGELFFHL---SRE--RVFSEDRA 97
Query: 941 HLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000
+ L +LHS D+V+ D+K +N++ D D +++FGL + I ++ ++ T
Sbjct: 98 RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI---SDGATMKT 154
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED------IVKWVK 1054
G+ Y++PE + D + G+V+ E++ GR P + QD + +++ ++
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILMEEIR 213
Query: 1055 KQLQRGQISELLEPGLLELDP 1075
++ L GLL+ DP
Sbjct: 214 FPRTLSPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 20/184 (10%)
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
+ L + + LS LH+ ++H DIK ++L D LS+FG E + +
Sbjct: 121 VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLV 177
Query: 1003 GSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062
G+ +++PE S E D++S GI+++E++ G P +E +K +K I
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF---NEPPLKAMK------MI 228
Query: 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPS 1122
+ L P L L S + FL + V DP R + A+++ + GP PS
Sbjct: 229 RDNLPPKLKNLHKVSPSLKGFLDRLLV------RDPAQRATAAELLKHPFLAKAGP--PS 280
Query: 1123 SADP 1126
P
Sbjct: 281 CIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 45/205 (21%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 839 FDEENVLSRGRYGLIFKA---SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT 895
F + + +G +G +FK Q + + I L + + ++E L + +T
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G Y + ++ +Y+ G+ LL+ + + ++ ++ +GL +LH
Sbjct: 66 KYYGSYLKGTKL-WIIMEYLGGGSALDLLRAGPFDEFQIATM-LKEIL-----KGLDYLH 118
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
S +H DIK NVL + L++FG+ T + + T +G+ +++PE
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN---TFVGTPFWMAPEVIQQ 175
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKP 1040
+AD++S GI +E+ G P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 34/139 (24%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
V +Y+ G+L +Q+ P + ++ GL FLH +++ D+K NV
Sbjct: 78 FVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGI 1029
+ D++ +++FG+ + + + ++ T G+ Y++PE + K D +++G+
Sbjct: 133 MLDSEGHIKIADFGMCKEHM---VDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189
Query: 1030 VLLEILTGRKPVMFTQDED 1048
+L E+L G+ P +DED
Sbjct: 190 LLYEMLAGQPP-FDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 5e-07
Identities = 28/59 (47%), Positives = 37/59 (62%), Gaps = 2/59 (3%)
Query: 508 RLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDN 565
L +LDLSN L+ +P F GLP+L+V+ L NNL+ PE FS L L+ L+LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 64/261 (24%)
Query: 893 NLTVLRGYYA-GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
N V++ YY+ D V DY+P G++ +LL + + ++ L LA +
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF---YIAELTLA--I 114
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL--------------------------- 984
+H + +H DIKP N+L D D L++FGL
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 985 ------------DRLAIATPAEASS-----STTPIGSLGYVSPEAASTGQPTKEADVYSF 1027
DRL + + +G+ Y++PE T+ D +S
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234
Query: 1028 GIVLLEILTGRKPVMF-TQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLG 1086
G++L E+L G+ P + T E +K + + + L P ++L PE+ + L+
Sbjct: 235 GVILFEMLVGQPPFLAPTPTETQLKVINWE------NTLHIPPQVKLSPEAVD----LIT 284
Query: 1087 VKVGLLCTAPDPLDRPSMADI 1107
L C+A + L R DI
Sbjct: 285 ---KLCCSAEERLGRNGADDI 302
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 6e-07
Identities = 38/120 (31%), Positives = 61/120 (50%), Gaps = 14/120 (11%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
RGL +LHS ++H DIKP N+L +++ + +FGL R+ P E+ T + + Y
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV--EEPDESKHMTQEVVTQYYR 171
Query: 1009 SPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
+PE G T D++S G + E+L R ++F I +QL I++LL
Sbjct: 172 APEIL-MGSRHYTSAVDIWSVGCIFAELLGRR--ILFQAQSPI-----QQLD--LITDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQN 968
+LV + G L LQ+ H + + H +S+G+ +L + VH D+ +N
Sbjct: 71 MLVMELAELGPLNKFLQKNKHVTEKNIT-ELVHQVSMGM----KYLEETNFVHRDLAARN 125
Query: 969 VLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFG 1028
VL A +S+FGL + A + T + + +PE + + + ++DV+SFG
Sbjct: 126 VLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFG 185
Query: 1029 IVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGV 1087
+++ E + G+KP K ++ ++++++E G P+ E + L +
Sbjct: 186 VLMWEAFSYGQKPY-------------KGMKGNEVTQMIESGERMECPQRCPPEMYDL-M 231
Query: 1088 KVGLLCTAPDPLDRPSMA 1105
K LC +RP A
Sbjct: 232 K---LCWTYGVDERPGFA 246
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 939 MRHLI--SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
+ LI S +ARG+ FL S +H D+ +N+L + + +FGL R P
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQ-DEDIVKWVK 1054
+ L +++PE+ T ++DV+SFG++L EI + G P Q DE+ + +K
Sbjct: 232 KGDARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
Query: 1055 KQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
+ + PE + E + + L C +P DRP+ +++V
Sbjct: 291 EGTRMRA-------------PEYATPEIY----SIMLDCWHNNPEDRPTFSELV 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-07
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 862 MVLSIRRLRDGTIDEN--TFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMPNG 918
+ ++++ L+D D++ E E + + KH+N+ L G + +LV +Y G
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKG 103
Query: 919 NLATLLQEASHQDGHVLNW----------PMRHLISLG--LARGLSFLHSLDMVHGDIKP 966
NL L+ A G ++ + L+S +ARG+ +L S +H D+
Sbjct: 104 NLREYLR-ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162
Query: 967 QNVLFDADFEAHLSEFGLDRLA--IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADV 1024
+NVL D +++FGL R I + ++ P+ +++PEA T ++DV
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV---KWMAPEALFDRVYTHQSDV 219
Query: 1025 YSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055
+SFG++L EI T G P E++ K +K+
Sbjct: 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 50/181 (27%), Positives = 79/181 (43%), Gaps = 28/181 (15%)
Query: 866 IRRLRDGTIDENTFRKEAEALGKVKHR------NLTVLRGYYAGPPDVRLLVYDYMPNGN 919
IRRL D + K E LG +LT L Y +V +YM +
Sbjct: 56 IRRL-----DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY--------IVQEYM-ETD 101
Query: 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAH 978
LA +L++ + H L L RGL ++HS +++H D+KP NV + D
Sbjct: 102 LANVLEQGPLSEEHA------RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155
Query: 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA-STGQPTKEADVYSFGIVLLEILTG 1037
+ +FGL R+ + + + + Y SP S TK D+++ G + E+LTG
Sbjct: 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 1038 R 1038
+
Sbjct: 216 K 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 844 VLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEAL----------GKVKHR 892
VL RG +G + A Y+ G + +I+ L+ G I R E E+L +H
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA---RDEVESLMCEKRIFETANSERHP 62
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
L L + V V +Y G+L + V + P + + GL
Sbjct: 63 FLVNLFACFQTEDHV-CFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQ 115
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+LH +V+ D+K N+L D + +++FGL + + ++T G+ +++PE
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF---GDRTSTFCGTPEFLAPEV 172
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ T+ D + G+++ E+L G P +E++
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 50/198 (25%), Positives = 76/198 (38%), Gaps = 65/198 (32%)
Query: 910 LVYDYMPNGNLATLL-------QEASHQDGHVLNWPMRHLIS-LGLARGLSFLHSLDMVH 961
L+ +Y+P G++ TLL +E + R I+ LA + +H L +H
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEET-----------RFYIAETILA--IDSIHKLGYIH 124
Query: 962 GDIKPQNVLFDADFEAHLSEFGL-----------------------DRLAIATPAEASSS 998
DIKP N+L DA LS+FGL I+ P +
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 999 TTP------------IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD 1046
+G+ Y++PE KE D +S G+++ E+L G P F D
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP--FCSD 242
Query: 1047 E------DIVKWVKKQLQ 1058
I+ W K+ LQ
Sbjct: 243 NPQETYRKIINW-KETLQ 259
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-06
Identities = 18/40 (45%), Positives = 23/40 (57%), Gaps = 2/40 (5%)
Query: 30 SEIQALTSFKLHL-KDPLGALDGWDSSTPSAPCDWRGIVC 68
+ AL +FK L DP GAL W+ S+ S PC W G+ C
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSS-SDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 845 LSRGRYGLIFKASYQDGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLTVLRGYYA 902
L G +G ++KA ++ VL+ ++ D +E + E + L H N+ L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
++ +L+ ++ G + ++ E L P ++ L++LH ++H
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA----ASTGQP 1018
D+K N+LF D + L++FG+ T S IG+ +++PE S +P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMCETSKDRP 184
Query: 1019 TK-EADVYSFGIVLLEI 1034
+ADV+S GI L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL LH +++ D+KP+NVL D D +S+ G LA+ S + G+ G+++
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLG---LAVELKDGQSKTKGYAGTPGFMA 165
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
PE + D ++ G+ L E++ R P
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 63/253 (24%), Positives = 116/253 (45%), Gaps = 34/253 (13%)
Query: 833 LEATRQFDEENV-----LSRGRYGLIFKA-------SYQDGMV-LSIRRLRDGTIDEN-- 877
L+ +F + + L G +G + +A S D V ++++ L+D D++
Sbjct: 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA 62
Query: 878 TFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQ-------EASH 929
E E + + KH+N+ L G + ++V +Y GNL L+ + +
Sbjct: 63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTF 121
Query: 930 QDGHVLNWPM--RHLISLG--LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985
V + + L+S +ARG+ +L S +H D+ +NVL D +++FGL
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 986 RLA--IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVM 1042
R I + S+ P+ +++PEA T ++DV+SFGI++ EI T G P
Sbjct: 182 RGVHDIDYYKKTSNGRLPV---KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238
Query: 1043 FTQDEDIVKWVKK 1055
E++ K +++
Sbjct: 239 GIPVEELFKLLRE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 848 GRYGLIFKASYQD-GMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLRGYYAG 903
G YG+++K + G +++++++R + +E +T +E L +++H N+ L+
Sbjct: 11 GTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ 70
Query: 904 PPDVRLLV----------YDYMPNGNL--ATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
+ L+ D +P G A L++ +Q + +G+
Sbjct: 71 ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ----------------ILQGI 114
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
F HS ++H D+KPQN+L D L++FGL R A P T + +L Y +PE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRV--YTHEVVTLWYRAPE 171
Query: 1012 AASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ D++S G + E+ T +KP +F D +I
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT-KKP-LFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 845 LSRGRYGLIFKA-SYQDGMVLSIR--RLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
+ G YG ++KA + G + +I+ +L G D ++E + KH N+ G Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL----ISLGLARGLSFLHSL 957
D + ++ G+L QD + + P+ +S +GL +LHS
Sbjct: 76 L-RRDKLWICMEFCGGGSL---------QDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-- 1015
+H DIK N+L + L++FG+ AT A+ S IG+ +++PE A+
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF---IGTPYWMAPEVAAVER 182
Query: 1016 -GQPTKEADVYSFGIVLLEILTGRKPVMF 1043
G + D+++ GI +E L +P MF
Sbjct: 183 KGGYNQLCDIWAVGITAIE-LAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 20/171 (11%)
Query: 944 SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIG 1003
S +A+G+SFL S + +H D+ +N+L + +FGL R I +
Sbjct: 220 SYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARL 278
Query: 1004 SLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPV-MFTQDEDIVKWVKKQLQRGQ 1061
+ +++PE+ T E+DV+S+GI+L EI + G P D K +K+
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE------ 332
Query: 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
G L PE + E + + C DPL RP+ IV ++E
Sbjct: 333 -------GYRMLSPECAPSEMY----DIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 20/166 (12%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L + +HS ++H DIKP NV A L + GL R ++ +++ + +G+
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPY 171
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
Y+SPE ++D++S G +L E+ + P + ++ +K I +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMNLFSLCQK------IEQCD 224
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
P L P E+ V +C PDP RP DI ++ +
Sbjct: 225 YPPL----PTEHYSEKLRELVS---MCIYPDPDQRP---DIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 46/188 (24%), Positives = 84/188 (44%), Gaps = 22/188 (11%)
Query: 925 QEASHQDGHVLNWPMRHLI--SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982
+EA +D + + LI S +A+G+ FL S +H D+ +N+L + + +F
Sbjct: 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDF 223
Query: 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPV 1041
GL R P + L +++PE T ++DV+SFG++L EI + G P
Sbjct: 224 GLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
Query: 1042 MFTQ-DEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD 1100
+ DE+ + +K+ G P+ + E + + L C +P
Sbjct: 283 PGVKIDEEFCRRLKE-------------GTRMRAPDYTTPEMY----QTMLDCWHGEPSQ 325
Query: 1101 RPSMADIV 1108
RP+ +++V
Sbjct: 326 RPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 44/199 (22%), Positives = 72/199 (36%), Gaps = 72/199 (36%)
Query: 896 VLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLG-----LAR 949
V++ YY+ L V DY+P G++ +LL I LG LAR
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLL------------------IRLGIFEEDLAR 104
Query: 950 --------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL----------------- 984
+ +H + +H DIKP N+L D D L++FGL
Sbjct: 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 985 ----------DRLAIATPAEASS-------------STTPIGSLGYVSPEAASTGQPTKE 1021
+ + + + +G+ Y++PE T+
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224
Query: 1022 ADVYSFGIVLLEILTGRKP 1040
D +S G++L E+L G+ P
Sbjct: 225 CDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 50/268 (18%)
Query: 843 NVLSRGRYGLIFKA-SYQDGMVLSIRRLR------DGTIDEN---------TFRKEAEAL 886
L G YG + KA G +++I++++ D T D T +E + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 887 GKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLG 946
++KH N+ L Y D LV D M +L ++ L I L
Sbjct: 75 NEIKHENIMGLVDVYV-EGDFINLVMDIM-ASDLKKVVDRKIR-----LTESQVKCILLQ 127
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS-------- 998
+ GL+ LH +H D+ P N+ ++ +++FGL R P + S
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 999 ---TTPIGSLGYVSPEAASTGQPTKEA-DVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054
T+ + +L Y +PE + A D++S G + E+LTG KP +F + +I
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP-LFPGENEI----- 240
Query: 1055 KQLQRGQISELLEPGLLELDPESSEWEE 1082
QL G+I ELL P W +
Sbjct: 241 DQL--GRIFELLG------TPNEDNWPQ 260
|
Length = 335 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-06
Identities = 19/60 (31%), Positives = 31/60 (51%)
Query: 412 GLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKF 471
LK + L N + + +F L L+ L+LS N++ PE + L +L +L+LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 34/136 (25%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 947 LARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
+ L +LHS ++V+ D+K +N++ D D +++FGL + I + ++ T G+
Sbjct: 104 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK---DGATMKTFCGTP 160
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED------IVKWVKKQLQR 1059
Y++PE + D + G+V+ E++ GR P + QD + +++ ++
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILMEEIRFPRTL 219
Query: 1060 GQISELLEPGLLELDP 1075
++ L GLL+ DP
Sbjct: 220 SPEAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L RGL++ H ++H D+KPQN+L E L++FGL R A + P++ S+ + +L
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNE--VVTLW 168
Query: 1007 YVSPEA--ASTGQPTKEADVYSFGIVLLEILTGR 1038
Y P+ ST T D++ G + E+ TGR
Sbjct: 169 YRPPDVLLGSTEYST-SLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 36/177 (20%)
Query: 937 WPMRHLISLGLARGLSFLH-SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
W + + + LA L +LH +VH D+ P N++ D + +++FGL +
Sbjct: 116 WNI--FVQMVLA--LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPE 167
Query: 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPV----MFTQDEDIVK 1051
S T+ +G++ Y PE ++ADV++FG +L ++ T + P M + IV+
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
V + L G SE + ++ C PD RP DI+
Sbjct: 228 AVYEPLPEGMYSEDV---------------TDVITS-----CLTPDAEARP---DII 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 34/134 (25%), Positives = 61/134 (45%), Gaps = 23/134 (17%)
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+LHS D+++ D+KP+N+L D +++FG + + T G+ Y++PE
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTPEYLAPEV 186
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVM----FTQDEDIV-------KWVKKQLQRGQ 1061
+ K D ++ G++L E + G P F E I+ W G+
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD-----GR 241
Query: 1062 ISELLEPGLLELDP 1075
+L++ GLL+ D
Sbjct: 242 ARDLVK-GLLQTDH 254
|
Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP-IGSL 1005
RGL FLH+ +VH D+KP+N+L + + L++FGL R+ + TP + +L
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI-----YSCQMALTPVVVTL 171
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPV 1041
Y +PE D++S G + E+ RKP+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-06
Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 9/140 (6%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
GL +LH+ ++H D+K +N+ + + + + G + + PA + G++
Sbjct: 168 EGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVETN 223
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD---EDIVKWVKKQLQRGQISEL 1065
+PE + + +AD++S GIVL E+L + E+ VK L + IS L
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK-IISTL 282
Query: 1066 -LEPGLLELDPESSEWEEFL 1084
+ P DP S F+
Sbjct: 283 KVHPEEFPRDPGSRLVRGFI 302
|
Length = 357 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 35/244 (14%)
Query: 871 DGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQ 930
D F + A + ++ H++L L G ++ +V +Y+ G L L
Sbjct: 41 DHRDSL-AFFETASLMSQLSHKHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREK-- 95
Query: 931 DGHV-LNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF--DADFEAHLSEFGLDRL 987
+V L+W + ++ LA L +L +VHG++ +N+L E ++ L
Sbjct: 96 -NNVSLHWKL--DVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152
Query: 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQ--PTKEADVYSFGIVLLEILT-GRKPVMFT 1044
I S + + +++PE GQ T AD +SFG LLEI + G +P+
Sbjct: 153 GIPIT--VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL--- 207
Query: 1045 QDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104
+ + + ++ P+ +E + C DP RPS
Sbjct: 208 STLSSSEKERFYQDQHRLPM----------PDCAELANLINQ------CWTYDPTKRPSF 251
Query: 1105 ADIV 1108
I+
Sbjct: 252 RAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-06
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 835 ATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN 893
+ + N++ G +G++++A D ++I+++ D +E + + H N
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ---DPQYKNRELLIMKNLNHIN 120
Query: 894 LTVLRGYY------AGPPDVRL-LVYDYMPNGNLATLLQEASH--QDGHVLNWPMRHLIS 944
+ L+ YY ++ L +V +++P T+ + H ++ H L + L S
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ----TVHKYMKHYARNNHALPLFLVKLYS 176
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEA-HLSEFGLDRLAIATPAEASSSTTPIG 1003
L R L+++HS + H D+KPQN+L D + L +FG + +A S + I
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA----GQRSVSYIC 232
Query: 1004 SLGYVSPE-AASTGQPTKEADVYSFGIVLLEILTG 1037
S Y +PE T D++S G ++ E++ G
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 39/137 (28%), Positives = 59/137 (43%), Gaps = 11/137 (8%)
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964
PD + D M G+L L Q G MR + + GL +H+ +V+ D+
Sbjct: 69 PDKLSFILDLMNGGDLHYHLS----QHGVFSEAEMRFYAA-EIILGLEHMHNRFVVYRDL 123
Query: 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEAD 1023
KP N+L D +S+ GL A +G+ GY++PE G AD
Sbjct: 124 KPANILLDEHGHVRISDLGL-----ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 1024 VYSFGIVLLEILTGRKP 1040
+S G +L ++L G P
Sbjct: 179 WFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 6e-06
Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 32/169 (18%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRLL--VYDYMPNGNLATLLQEASHQDGHVLNWPM 939
E L ++H L L G + D L V +Y+P G L + L+++
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQ---DDSNLYLVMEYVPGGELFSHLRKS------------ 95
Query: 940 RHLISLGLAR--------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991
+AR L +LHSLD+V+ D+KP+N+L D+D +++FG +
Sbjct: 96 -GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR---- 150
Query: 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+ T G+ Y++PE + K D ++ GI++ E+L G P
Sbjct: 151 --VKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
+GL ++H+ ++H D+KP N+ + D E + +FGL R S T + + Y
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT------DSEMTGYVVTRWYR 182
Query: 1009 SPEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
+PE + T+ D++S G ++ E+LTG+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 7e-06
Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 26/212 (12%)
Query: 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL 894
A R EE RG + ++ +R++ G+ E ALG++ H N+
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLI--AKRVKAGSRAAIQLENEILALGRLNHENI 225
Query: 895 TVLRGYYAGPPDVRLL-------VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL 947
+ + ++ +Y +M + +D +L R ++ L
Sbjct: 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-------DWKDRPLL-KQTRAIMK-QL 276
Query: 948 ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
+ ++H ++H DIK +N+ + D + L +FG A P E G +G
Sbjct: 277 LCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-----TAMPFEKEREAFDYGWVGT 331
Query: 1008 V---SPEAASTGQPTKEADVYSFGIVLLEILT 1036
V SPE + + D++S G++LL++L+
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 42/140 (30%), Positives = 70/140 (50%), Gaps = 13/140 (9%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEA-HLSEFGLDRLAIATPAEASSSTTPIGSL 1005
L +G++ H ++H D+KPQN+L D +++ GL R A + P + S T I +L
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVK--SYTHEIVTL 175
Query: 1006 GYVSPEA--ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063
Y +PE ST T D++S G + E+ RK +F D ++ + + G +
Sbjct: 176 WYRAPEVLLGSTHYSTP-VDIWSVGCIFAEMS--RKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 1064 ELLEPGLLELDPESSEWEEF 1083
E + PG+ +L +W EF
Sbjct: 233 EQVWPGVSKL----RDWHEF 248
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 14/114 (12%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L RGL ++HS ++H D+KP NV + D E + +FGL R A T + +
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA------DDEMTGYVATRW 180
Query: 1007 YVSPEAA-STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059
Y +PE + + D++S G ++ E+L G+ +F ++ I QL+R
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK--ALFPGNDYI-----DQLKR 227
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 58/260 (22%), Positives = 118/260 (45%), Gaps = 40/260 (15%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRN 893
++++ + +G +G +FKA + + +++++++ E T +E + L +KH N
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 894 LTVL--------RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQ-DGHVLNWPMRHLIS 944
+ L Y LV+++ + +LA LL + + + M+ L++
Sbjct: 73 VVNLIEICRTKATPYNRYKGSF-YLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR-LAIATPAEASSSTTPIG 1003
GL ++H ++H D+K N+L D L++FGL R +++ ++ + T +
Sbjct: 131 -----GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 1004 SLGYVSPE----AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ- 1058
+L Y PE G P D++ G ++ E+ T R P+M E + QL
Sbjct: 186 TLWYRPPELLLGERDYGPPI---DMWGAGCIMAEMWT-RSPIMQGNTE------QHQLTL 235
Query: 1059 ----RGQISELLEPGLLELD 1074
G I+ + PG+ +L+
Sbjct: 236 ISQLCGSITPEVWPGVDKLE 255
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 34/133 (25%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRH--LISLGLARGLSFLHSLDMVHGDIKPQ 967
V +++ G+L +Q P H S ++ L+FLH +++ D+K
Sbjct: 73 FVIEFVSGGDLMFHMQRQR-------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLD 125
Query: 968 NVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSF 1027
NVL DA+ L+++G+ + I P + +S T G+ Y++PE D ++
Sbjct: 126 NVLLDAEGHIKLTDYGMCKEGIR-PGDTTS--TFCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 1028 GIVLLEILTGRKP 1040
G+++ E++ GR P
Sbjct: 183 GVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 29/149 (19%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
+V +Y+ G+ ATLL+ L M + L +LH+ +VH D+KP N+
Sbjct: 78 MVMEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTTPI------------------GSLGYVSPE 1011
L + L++FGL ++ + S TT + G+ Y++PE
Sbjct: 133 LITSMGHIKLTDFGLSKIGLM------SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKP 1040
K D ++ GI+L E L G P
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 55/248 (22%), Positives = 107/248 (43%), Gaps = 39/248 (15%)
Query: 879 FRKEAEALGKVKHRNLTVLRGY---------YAGPPDVRLLVYDYMPNGNLATLLQEASH 929
F EA + + H N+ L G Y P +++ +M +G+L + L +
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----VVILPFMKHGDLHSFLLYSRL 102
Query: 930 QDGHVLNWPMRHLISL--GLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987
D P + L+ +A G+ +L S +H D+ +N + + + +++FGL +
Sbjct: 103 GDCPQY-LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161
Query: 988 AIATP--AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFT 1044
+ + P+ +++ E+ + T ++DV+SFG+ + EI T G+ P
Sbjct: 162 IYNGDYYRQGRIAKMPV---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218
Query: 1045 QDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104
++ +I ++++ + Q + L+ GL L SS W +P DRPS
Sbjct: 219 ENSEIYDYLRQGNRLKQPPDCLD-GLYSL--MSSCWLL--------------NPKDRPSF 261
Query: 1105 ADIVFMLE 1112
+ LE
Sbjct: 262 ETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 881 KEAEALGKVKHRNLTVLRGYYAGPPDVR-----LLVYDYMPNGNLATLLQEASHQDGHVL 935
+E L ++H N+ L + LV YM T LQ+ GH L
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIM---GHPL 114
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
+ + + GL ++HS ++H D+KP N+ + D E + +FGL R A A
Sbjct: 115 SEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----- 169
Query: 996 SSSTTPIGSLGYVSPEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
T + + Y +PE + + D++S G ++ E+LTG+
Sbjct: 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 63/248 (25%), Positives = 93/248 (37%), Gaps = 67/248 (27%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR--------GLSFLHSLDMVH 961
LV DY P G L LLQ Q G L S +AR L +LH L +V+
Sbjct: 78 LVMDYCPGGELFRLLQR---QPGKCL--------SEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 962 GDIKPQNVLFDADFEAHLSEFGL----------------------DRLAIATPAEASSST 999
D+KP+N+L LS+F L +I + + +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 1000 TP----IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF---TQDEDIVKW 1052
+G+ Y++PE S D ++ GI+L E+L G P F +DE
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP--FKGSNRDETFSNI 244
Query: 1053 VKKQL---QRGQISELLEP---GLLELDPES--------SEWEE--FLLGVKVGLL-CTA 1095
+KK++ +S LL DP +E ++ F GV L+ T
Sbjct: 245 LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTT 304
Query: 1096 PDPLDRPS 1103
P + RP
Sbjct: 305 PPIIPRPD 312
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 55/233 (23%), Positives = 104/233 (44%), Gaps = 14/233 (6%)
Query: 820 LVMFNNKITYVETL-EATRQFDEENVLSRGRYGLIFK-ASYQDGMVLSIRRLRDGTIDEN 877
L +N+ + +E+L + T ++ + +G YG ++K + +DG + +++ L + +
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 878 TFRKEAEALGKV-KHRNLTVLRG-YYAGPPDV--RLLVYDYMPNGNLATLLQEASHQDGH 933
E L + H N+ G +Y V +L + + NG T L + G
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 934 VLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993
L+ M I G GL LH+ ++H D+K N+L + L +FG+ +T
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 994 EASSSTTPIGSLGYVSPEAASTGQP-----TKEADVYSFGIVLLEILTGRKPV 1041
++S +G+ +++PE + Q DV+S GI +E+ G P+
Sbjct: 184 RRNTS---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 28/280 (10%)
Query: 845 LSRGRYGLIFKASYQDGM-----VLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG 899
+ G +G + G V+ R+ ++ F +EA+ ++H NL G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM 959
LLV ++ P G+L L+ + + ++ +A GL LH +
Sbjct: 63 QCTEVTPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS----- 1014
+H D+ +N L AD + ++GL + + L +++PE
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-PLRWIAPELVDEVHGN 180
Query: 1015 --TGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
TKE++V+S G+ + E+ G +P DE ++ + ++ Q +L +P L
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----KLPKP-RL 235
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
+L P S W E V C P RPS ++ +L
Sbjct: 236 KL-PLSDRWYE------VMQFCWLQ-PEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 28/226 (12%)
Query: 891 HRNLTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
H N+ L G GP L++ +Y G+L L+ + + S +A
Sbjct: 98 HENIVNLLGACTIGGPI---LVITEYCCYGDLLNFLRRKRES--FLTLEDLLSF-SYQVA 151
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
+G++FL S + +H D+ +NVL + +FGL R + + + ++
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL-PVKWM 210
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVM-FTQDEDIVKWVKKQLQRGQISELL 1066
+PE+ T E+DV+S+GI+L EI + G P D K +K+ + Q
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ----- 265
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
PE + E + + C DPL RP+ IV ++
Sbjct: 266 --------PEHAPAEIYDIMKT----CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 31/134 (23%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRH--LISLGLARGLSFLHSLDMVHGDIKP 966
V +Y+ G+L +Q P H S ++ L++LH +++ D+K
Sbjct: 72 FFVIEYVNGGDLMFHMQRQR-------KLPEEHARFYSAEISLALNYLHERGIIYRDLKL 124
Query: 967 QNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYS 1026
NVL D++ L+++G+ + + P + +S+ G+ Y++PE D ++
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGL-RPGDTTSTFC--GTPNYIAPEILRGEDYGFSVDWWA 181
Query: 1027 FGIVLLEILTGRKP 1040
G+++ E++ GR P
Sbjct: 182 LGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 845 LSRGRYGLIFKASYQ---DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHR--NLTVLRG 899
L G +G + K Y+ + ++I+ L++ E + R E ++ H+ N ++R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPM-RHLISLGLARGLSFLHSLD 958
+ +LV + G L L + V N H +S+G+ +L +
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLS-GKKDEITVSNVVELMHQVSMGM----KYLEGKN 115
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
VH D+ +NVL A +S+FGL + A + + + L + +PE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 1019 TKEADVYSFGIVLLEILT-GRKP 1040
+ +DV+S+GI + E + G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 944 SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIG 1003
S +A G+ FL S + VH D+ +NVL + +FGL R + S +T +
Sbjct: 245 SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL- 303
Query: 1004 SLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
L +++PE+ T +DV+SFGI+L EI T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-05
Identities = 57/260 (21%), Positives = 88/260 (33%), Gaps = 65/260 (25%)
Query: 332 PSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDK---LEVLRVANNSLSGLVPDEIAK--C 386
LT L+ +DLS N + + SL + L+ L++ NN L +AK
Sbjct: 74 LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133
Query: 387 SL---LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS--FGNLSQLETLN 441
L L+ L NR G L+ L+ LN
Sbjct: 134 DLPPALEKLVLGRNRLEGA----------------------SCEALAKALRANRDLKELN 171
Query: 442 LSENDIRGN----IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497
L+ N I + E + NL L+L+ N D G +
Sbjct: 172 LANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT-----DEG---------------AS 211
Query: 498 KIPGSIGSLMRLTTLDLSNQNLSGE-----LPIELFGLPSLQVVSLEENNL----SGDVP 548
+ ++ SL L L+L + NL+ L SL +SL N++ + D+
Sbjct: 212 ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLA 271
Query: 549 EGFSSLVGLQYLNLSDNAFT 568
E + L L+L N F
Sbjct: 272 EVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-05
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 628 RIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686
+K LDL N+L+ IP +L L L N+L+ PE+FS L +L +L+LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 687 L 687
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 24/83 (28%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
L+ LDL NNR+ + + +L+V+DLS N+L+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLS------------------------GNNLT 37
Query: 377 GLVPDEIAKCSLLQMFDLEGNRF 399
+ P+ + L+ DL GN
Sbjct: 38 SISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-05
Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL---------DRLAIATPAEA---SS 997
+ ++HS ++H D+KP N+L E + ++G D L I SS
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 998 STTP---IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
T P +G+ Y++PE ++ D+Y+ G++L ++LT P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-05
Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP-IGSLGYV 1008
G+ LHS ++H D+KP N++ +D + +FGL R A + TP + + Y
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TACTNFMMTPYVVTRYYR 189
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054
+PE + D++S G ++ E++ G V+F + I +W K
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGS--VIFQGTDHIDQWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-05
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
+ARG+ FL S + VH D+ +NVL + +FGL R + S +T + +
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PVK 304
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
+++PE+ T +DV+S+GI+L EI +
Sbjct: 305 WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 23/179 (12%)
Query: 889 VKHRNLTVLRGYYAGPPDVR-----LLVYDYMPNGNLATLLQ-EASHQDGHVLNWPMRHL 942
V H+N+ L + + LV + M + NL ++Q E H+ M +L
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHER-------MSYL 124
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP- 1001
+ L G+ LHS ++H D+KP N++ +D + +FGL R A S TP
Sbjct: 125 LYQMLC-GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPY 178
Query: 1002 IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
+ + Y +PE + D++S G ++ E++ R ++F + I +W K Q G
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 943 ISLGLARGLSFL-HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
I++ + L++L L ++H D+KP N+L D + L +FG+ + + A+ T
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRD 167
Query: 1002 IGSLGYVSPEAASTGQPTK---EADVYSFGIVLLEILTGRKP 1040
G Y++PE +DV+S GI L E+ TG+ P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 6/111 (5%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
G+ LHS ++H D+KP N++ +D + +FGL R T + T + + Y +
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRA 193
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
PE + D++S G ++ E++ G V+F + I +W K Q G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG--VLFPGTDHIDQWNKVIEQLG 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-05
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP-IGSLGYV 1008
G+ LHS ++H D+KP N++ +D + +FGL R A S TP + + Y
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-----TSFMMTPYVVTRYYR 184
Query: 1009 SPEAASTGQPTKE-ADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054
+PE G KE D++S G ++ E++ G V+F + I +W K
Sbjct: 185 APEVI-LGMGYKENVDIWSVGCIMGEMIRGT--VLFPGTDHIDQWNK 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 29/106 (27%), Positives = 53/106 (50%), Gaps = 7/106 (6%)
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL---AIATPAEASSSTTPIGSLGY 1007
L +HS M+H D+K N+ L +FG + +++ +S TP Y
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY----Y 237
Query: 1008 VSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053
++PE + +K+AD++S G++L E+LT +P +I++ V
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
|
Length = 478 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 845 LSRGRYGLIFKASYQD-GMVLSIRRLRDG--TIDENTFRKEAEALGKVK-HRNLTVLRGY 900
L G +G ++ A ++ G +++I++++ + +E +E ++L K+ H N+ L+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64
Query: 901 YAGPPDVRL------LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
+V V++YM GNL Q + G + + I + +GL+ +
Sbjct: 65 -----EVFRENDELYFVFEYM-EGNL---YQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS---TTPIGSLGYVSPE 1011
H H D+KP+N+L +++FGL R E S T + + Y +PE
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPE 168
Query: 1012 ----AASTGQPTKEADVYSFGIVLLEILTGR 1038
+ S P D+++ G ++ E+ T R
Sbjct: 169 ILLRSTSYSSPV---DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 3e-04
Identities = 22/61 (36%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 532 SLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQ 590
+L+ + L N L+ +P+G F L L+ L+LS N T P + L SL L LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 591 I 591
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 944 SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIG 1003
S +A+G+ FL S + +H D+ +NVL A + +FGL R S+ G
Sbjct: 218 SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272
Query: 1004 S----LGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP 1040
+ + +++PE+ T ++DV+S+GI+L EI + G+ P
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
L+ +++P G+L T+L + V + M + LA + +H L +H DIKP N+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV---LA--IEAVHKLGFIHRDIKPDNI 132
Query: 970 LFDADFEAHLSEFGL 984
L D LS+FGL
Sbjct: 133 LIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 24/175 (13%)
Query: 878 TFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNW 937
+F + A + ++ H++L + G + ++V +Y+ G+L T L+ ++ +++N
Sbjct: 45 SFFEAASMMSQLSHKHLVLNYGVCVCGDE-SIMVQEYVKFGSLDTYLK----KNKNLINI 99
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH--------LSEFGLDRLAI 989
+ ++ LA L FL + HG++ +NVL + + LS+ G ++I
Sbjct: 100 SWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG---ISI 156
Query: 990 AT-PAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTG-RKPV 1041
P E P +V PE Q + AD +SFG L EI +G KP+
Sbjct: 157 TVLPKEILLERIP-----WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQ-----DGHVLN 936
EA+ L K+ H + + D ++ +Y +L L+E H + V
Sbjct: 52 EAQLLSKLDHPAIVKFHASFL-ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 937 WPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
W I L L G+ ++H ++H D+K +N+ + + +FG+ RL + +
Sbjct: 111 W----FIQLLL--GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS---CD 160
Query: 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEI 1034
+TT G+ Y+SPEA ++D++S G +L E+
Sbjct: 161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-04
Identities = 29/108 (26%), Positives = 46/108 (42%), Gaps = 11/108 (10%)
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP- 1001
I L L++LH ++H D+K +N+ D A L +FG A + TP
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG------AACKLDAHPDTPQ 243
Query: 1002 ----IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045
G+L SPE + + D++S G+VL E+ + Q
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 9e-04
Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHV-LNW 937
F + A + +V H +L + G + ++V +++ +G L L++ + G V + W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSE-NIMVEEFVEHGPLDVCLRK---EKGRVPVAW 118
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA---E 994
+ ++ LA LS+L ++VHG++ +N+L L+E + ++ P
Sbjct: 119 KI--TVAQQLASALSYLEDKNLVHGNVCAKNILLA---RLGLAEGTSPFIKLSDPGVSFT 173
Query: 995 ASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEI-------LTGRKP 1040
A S + + +++PE G + AD +SFG LLEI L R P
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 5/162 (3%)
Query: 86 RLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNL 145
L L++L L L L N ++ +P + S L + L NS L S+ NL NL
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 146 LVLNVAHNLLSGKISADISP-SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGE 204
L +++N L + + +L LDLS+N + S + L+ ++LS NS S
Sbjct: 235 SGLELSNNKLEDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNA 292
Query: 205 VPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAED 246
+P L LE L L S + LS +
Sbjct: 293 LPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L + L +H + H DIKP+N+L D L++FG R + P T I +
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP----PYTEYISTRW 163
Query: 1007 YVSPEAAST-GQPTKEADVYSFGIVLLEILT 1036
Y +PE T G + D+++ G V EIL+
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 50/224 (22%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 875 DENTFRKEAEALGKVKHRNLTVLRG--YYAGPPDVRLLVYDYMPNGNLATLL--QEASHQ 930
++N F ++ + ++H N+ G A P LLV++Y G+L + L ++ +
Sbjct: 38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRR 94
Query: 931 DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990
+ +L + ++ +A G++ +H + +H D+ +N +D + ++G + +
Sbjct: 95 NSQLL---LLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG---IGPS 148
Query: 991 TPAEASSST--TPIGSLGYVSPEAAS-------TGQPTKEADVYSFGIVLLEIL-TGRKP 1040
E T L +++PE T + TK ++V++ G+ L E+ +P
Sbjct: 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
Query: 1041 VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFL 1084
D +++ V K Q +L +P LEL P S W E L
Sbjct: 209 YSHLSDREVLNHVIKDQQ----VKLFKPQ-LEL-PYSERWYEVL 246
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 166 SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHL 225
+L+ LDLS+N T G F L++++LS N+ + P + L L L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 19/60 (31%), Positives = 30/60 (50%)
Query: 580 SLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKL 639
+L L LS+N+++ + L+VL+L N+ T P S L ++ LDL N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 22/87 (25%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI----GSLG 1006
L ++H + HGDIKP+N++ D + ++ ++G+ I S G+L
Sbjct: 139 LEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY 198
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLE 1033
Y +A + T+ D+ S G +L+
Sbjct: 199 YAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 28/168 (16%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVR----LLVYDYMPNGNLATLLQEASHQDGHV 934
F + A + +V H+++ +L G VR ++V +++ G L + H+ V
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVC-----VRDVENIMVEEFVEFGPLDLFM----HRKSDV 101
Query: 935 LNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF-----DADFEA--HLSEFGLDRL 987
L P + ++ LA LS+L D+VHG++ +N+L D + LS+ G+
Sbjct: 102 LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI--- 158
Query: 988 AIATPAEASSSTTPIGSLGYVSPEAAS-TGQPTKEADVYSFGIVLLEI 1034
P S + + +++PE + + AD +SFG L EI
Sbjct: 159 ----PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 18/59 (30%), Positives = 30/59 (50%)
Query: 389 LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI 447
L+ DL NR + G+ LK++ L N + + P +F L L +L+LS N++
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 35/147 (23%), Positives = 59/147 (40%), Gaps = 14/147 (9%)
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNL-ATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
N+ L Y V LV + G L + + + + + V W +++L
Sbjct: 46 NMVCLHKYIVSEDSV-FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL------ 98
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
LH +V D+ P N+L D L+ F E S + ++ Y +PE
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS-----EVEDSCDGEAVENM-YCAPE 152
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGR 1038
+ T+ D +S G +L E+LTG+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 23/60 (38%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 605 LEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSL 663
L+ L+L +N T IP L +K LDL N L+ P+ S SL SL L N+L
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1133 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.46 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.13 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.98 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.65 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.65 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.59 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.46 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.44 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-112 Score=1104.64 Aligned_cols=912 Identities=34% Similarity=0.574 Sum_probs=642.1
Q ss_pred chhHHHHHHHHHHhCCCCCCCccCCCCCCCCCCCccceeeeCC-CceEEEeeCCcccCcccchhhcccccCcEEEcccCc
Q 001171 28 VLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYN-NRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNH 106 (1133)
Q Consensus 28 ~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c~w~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~ 106 (1133)
.+.|++||++||+++.||.+.+.+|+.. .+||.|.||+|++ ++|++|+|.+++++|.+++.++.+++|+.|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS--ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 5589999999999999898889999654 3799999999985 688888888888888777777777777777777777
Q ss_pred ccCCCCcccc-CCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCC
Q 001171 107 LNGSIPASLH-QCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNF 185 (1133)
Q Consensus 107 l~~~~p~~~~-~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~ 185 (1133)
++|.+|..+. .+++|+.|+|++|.++|.+|. .
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~------------------------~----------------------- 137 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR------------------------G----------------------- 137 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc------------------------c-----------------------
Confidence 7776766544 666666666666666554442 1
Q ss_pred CCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccE
Q 001171 186 SSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQV 265 (1133)
Q Consensus 186 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 265 (1133)
.+++|++|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..+.++++|++|++++|++.+.+|..++++++|++
T Consensus 138 -~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 216 (968)
T PLN00113 138 -SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKW 216 (968)
T ss_pred -ccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccE
Confidence 1233444444444444444444444444444444444444444444444444444444444444444444555555555
Q ss_pred EEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceee
Q 001171 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMD 345 (1133)
Q Consensus 266 L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 345 (1133)
|+|++|++++.+ |..+.++++|++|+
T Consensus 217 L~L~~n~l~~~~------------------------------------------------------p~~l~~l~~L~~L~ 242 (968)
T PLN00113 217 IYLGYNNLSGEI------------------------------------------------------PYEIGGLTSLNHLD 242 (968)
T ss_pred EECcCCccCCcC------------------------------------------------------ChhHhcCCCCCEEE
Confidence 555555554322 44556667777777
Q ss_pred ccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCcc
Q 001171 346 LSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSG 425 (1133)
Q Consensus 346 Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 425 (1133)
|++|.+.+.+|..|+++++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|..+.++++|+.|++++|.+++
T Consensus 243 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 322 (968)
T PLN00113 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTG 322 (968)
T ss_pred CcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCC
Confidence 77777777777788888888888888888887777777777788888888777777777666666666666666666665
Q ss_pred ccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCC
Q 001171 426 LIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGS 505 (1133)
Q Consensus 426 ~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 505 (1133)
.+|..+..+++|+.|++++|.+.+.+|..+. .+++|+.|++++|++++.+|..+..
T Consensus 323 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~------------------------~~~~L~~L~Ls~n~l~~~~p~~~~~ 378 (968)
T PLN00113 323 KIPVALTSLPRLQVLQLWSNKFSGEIPKNLG------------------------KHNNLTVLDLSTNNLTGEIPEGLCS 378 (968)
T ss_pred cCChhHhcCCCCCEEECcCCCCcCcCChHHh------------------------CCCCCcEEECCCCeeEeeCChhHhC
Confidence 5555555555555555555555544444444 4445555555555555555556666
Q ss_pred cccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceee
Q 001171 506 LMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLS 585 (1133)
Q Consensus 506 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 585 (1133)
+++|+.|++++|++.+.+|..+..+++|+.|++++|++++..|..|..++.|+.|++++|.+++.++..+..+++|+.|+
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 458 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLS 458 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEE
Confidence 66666677777777666777777777777777777777777777777777777777777777777777777788888888
Q ss_pred cccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCc
Q 001171 586 LSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665 (1133)
Q Consensus 586 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 665 (1133)
|++|++.+.+|..+ ..++|+.|++++|++++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++
T Consensus 459 L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 537 (968)
T PLN00113 459 LARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537 (968)
T ss_pred CcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccc
Confidence 88888887777665 35789999999999998899889999999999999999999999999999999999999999999
Q ss_pred cCCccccCcccccccccccccccccCCccccccccCcccccccccccccCCcccc-CCCCCCcccCcCccccCCCCC---
Q 001171 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLS-SRFNDPSIFAMNRELCGKPLD--- 741 (1133)
Q Consensus 666 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~-~~~~~~~~~~~n~~lcg~~~~--- 741 (1133)
.+|..|..+++|+.|||++|+++|.+|..+..+++|+.||+++|+++|.+|.... ..+.. +.+.+|+.+||.+..
T Consensus 538 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~-~~~~~n~~lc~~~~~~~~ 616 (968)
T PLN00113 538 QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA-SAVAGNIDLCGGDTTSGL 616 (968)
T ss_pred cCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccCh-hhhcCCccccCCccccCC
Confidence 9999999999999999999999999999999999999999999999999997532 12333 348999999996532
Q ss_pred CCCcchhhcccccchhhHHHHHHHHHHHHHHHhhhhhhhHhHHhhhhhhccCCCCCCCCCCCCCCCCCCCCCCCCCCcee
Q 001171 742 RECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATGEKKPSPSRGSSGAERGRGSGENGGPKLV 821 (1133)
Q Consensus 742 ~~c~~~~~~~~~~l~~~iiv~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (1133)
.+|..... ...... ++++++++++++++++ +++.++|+|+..+. ++.....+. ....
T Consensus 617 ~~c~~~~~--~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~--------------~~~~ 673 (968)
T PLN00113 617 PPCKRVRK--TPSWWF-YITCTLGAFLVLALVA-FGFVFIRGRNNLEL-----KRVENEDGT--------------WELQ 673 (968)
T ss_pred CCCccccc--cceeee-ehhHHHHHHHHHHHHH-HHHHHHHhhhcccc-----ccccccccc--------------cccc
Confidence 35643222 111111 2222222222222222 22222222211110 000000000 0000
Q ss_pred ee----cCcccHHHHHHHhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeee
Q 001171 822 MF----NNKITYVETLEATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTV 896 (1133)
Q Consensus 822 ~~----~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 896 (1133)
.+ ...+.+. .....|...++||+|+||.||+|++ .+|+.||||++..... ...+|++++++++|||||+
T Consensus 674 ~~~~~~~~~~~~~---~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~ 747 (968)
T PLN00113 674 FFDSKVSKSITIN---DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVK 747 (968)
T ss_pred ccccccchhhhHH---HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcce
Confidence 00 1112222 2345678889999999999999987 4789999999864332 2245789999999999999
Q ss_pred EEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHh---cCCceecccCccceeeCC
Q 001171 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH---SLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 897 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH---~~~ivH~Dlkp~NIll~~ 973 (1133)
+++++.+... .++||||+++|+|.++++. ++|..+..++.|||+|++||| +.+|+|||+||+||+++.
T Consensus 748 ~~~~~~~~~~-~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~ 818 (968)
T PLN00113 748 LIGLCRSEKG-AYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818 (968)
T ss_pred EEEEEEcCCC-CEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC
Confidence 9999987654 5999999999999999963 789999999999999999999 669999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccC--ChhhHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFT--QDEDIVK 1051 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~--~~~~~~~ 1051 (1133)
++.+++. ||.+.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||... ......+
T Consensus 819 ~~~~~~~-~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~ 890 (968)
T PLN00113 819 KDEPHLR-LSLPGLLC-------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE 890 (968)
T ss_pred CCceEEE-eccccccc-------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHH
Confidence 9888875 55543221 112336889999999999999999999999999999999999998532 2344566
Q ss_pred HHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
|.+...........+++....... ...++.....+++.+||+.||++||+|+||+++|++....
T Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 891 WARYCYSDCHLDMWIDPSIRGDVS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHhcCccchhheeCccccCCCC--ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 665544444444455554432111 1233444455899999999999999999999999987653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=621.18 Aligned_cols=499 Identities=37% Similarity=0.610 Sum_probs=428.1
Q ss_pred cceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCccccc-CccccceEecccccccCCCCccccCccccceeec
Q 001171 166 SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVG-QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSA 244 (1133)
Q Consensus 166 ~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 244 (1133)
.++.|||++|.++|.+|..|..+++|+.|+|++|+++|.+|..+. .+++|++|+|++|++++.+|. ..+++|++|++
T Consensus 70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L 147 (968)
T PLN00113 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL 147 (968)
T ss_pred cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence 567788888888888888888888888888888888887887654 788888888888888777664 34556666666
Q ss_pred cccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccC
Q 001171 245 EDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQN 324 (1133)
Q Consensus 245 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~ 324 (1133)
++|.+++.+|..++.+++|++|+|++|.+.+.+
T Consensus 148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~----------------------------------------------- 180 (968)
T PLN00113 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI----------------------------------------------- 180 (968)
T ss_pred cCCcccccCChHHhcCCCCCEEECccCcccccC-----------------------------------------------
Confidence 666666555655666666666666655554433
Q ss_pred CcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCC
Q 001171 325 NRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVP 404 (1133)
Q Consensus 325 n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 404 (1133)
|..+.++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|
T Consensus 181 -------p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 181 -------PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred -------ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 5556666777777777777776777777777777777777777777777777777777777777777777777
Q ss_pred CccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCC
Q 001171 405 AFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKG 484 (1133)
Q Consensus 405 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 484 (1133)
..++++++|+.|++++|.+++.+|..+.++++|++|++++|.+.+.+|..+.++++|+.|++++|.+++..|..+..+++
T Consensus 254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~ 333 (968)
T PLN00113 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333 (968)
T ss_pred hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence 77778888888888888887778888888888888888888888888888888999999999999998888888999999
Q ss_pred CcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEccc
Q 001171 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSD 564 (1133)
Q Consensus 485 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 564 (1133)
|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++
T Consensus 334 L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~ 413 (968)
T PLN00113 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413 (968)
T ss_pred CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCc
Q 001171 565 NAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIP 644 (1133)
Q Consensus 565 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 644 (1133)
|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+. .++|+.|+|++|++++.+|
T Consensus 414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~ 492 (968)
T PLN00113 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVP 492 (968)
T ss_pred CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccC
Confidence 999999999999999999999999999999999999999999999999999998887664 5899999999999999999
Q ss_pred hhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccccCCccccC
Q 001171 645 KEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721 (1133)
Q Consensus 645 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~ 721 (1133)
..+.++++|+.|+|++|++++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|||++|+++|.+|..+..
T Consensus 493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 569 (968)
T PLN00113 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569 (968)
T ss_pred hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=421.46 Aligned_cols=286 Identities=41% Similarity=0.705 Sum_probs=244.3
Q ss_pred cCcccHHHHHHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC-HHHHHHHHHHHhhccCCCeeeEEEEEe
Q 001171 824 NNKITYVETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVLRGYYA 902 (1133)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~ 902 (1133)
...|++.+...||++|...++||+|+||.||+|...+|+.||||++...... .++|.+|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 4568999999999999999999999999999999999999999998765554 667999999999999999999999999
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC---ceecccCccceeeCCCCceEE
Q 001171 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD---MVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 903 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 979 (1133)
+.++..++|||||++|+|.++++..... .++|.+|.+||.++|+||+|||... |+||||||+|||+|+++.+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 8754469999999999999999874432 6899999999999999999999854 999999999999999999999
Q ss_pred eccCcccccccCCCCCCCCCCC-CCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccC---ChhhHHHHHHH
Q 001171 980 SEFGLDRLAIATPAEASSSTTP-IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFT---QDEDIVKWVKK 1055 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~---~~~~~~~~~~~ 1055 (1133)
+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+.. .......|++.
T Consensus 219 sDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 219 SDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred cCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999654321 1111111 7999999999999999999999999999999999999988743 34458899999
Q ss_pred HhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
....+.+.+++|+.+.. ......++....+.++.+|++.+|.+||+|.||+++|+.....
T Consensus 296 ~~~~~~~~eiiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88888999999998763 1111114555566999999999999999999999999776554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=401.75 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=213.7
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+....+.||+|+||+||+|.|+....||||++.....+ .++|.+|+.+|.+++|||||+++|+|.+.....++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34455679999999999999985555999999765433 458999999999999999999999999876456899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC-ceecccCccceeeCCCC-ceEEeccCcccccccCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD-MVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 992 (1133)
+++|+|.++++.. ....+++..+..++.|||+||.|||+++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999874 2345999999999999999999999999 99999999999999998 99999999997653321
Q ss_pred CCCCCCCCCCCCCCccCccccC--CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 993 AEASSSTTPIGSLGYVSPEAAS--TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||...........+.....+..++..+++.
T Consensus 199 ---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~- 274 (362)
T KOG0192|consen 199 ---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH- 274 (362)
T ss_pred ---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH-
Confidence 2233468999999999998 5689999999999999999999999998777655555555444443333322211
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
...++.+||+.||++||++.|++..|+.+....
T Consensus 275 ---------------l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 275 ---------------LSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ---------------HHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 126777899999999999999999999776533
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=379.23 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=202.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccC--CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG--TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+.+..++||+|..|+||+++++ +++.+|+|.+... ....+++.+|++++++.+||+||.++|.|........++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3456788999999999999886 6899999999432 223578899999999999999999999998765446899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|.+|||++++...++ +++....+++.+|++||.|||+ ++||||||||+|||++..|.+||||||.++.....
T Consensus 160 MDgGSLd~~~k~~g~-----i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR-----IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999987543 8999999999999999999995 89999999999999999999999999999766433
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccC--ChhhHHHHHHHHhhhccccccccCCcC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFT--QDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||... ...+..+.+...... ..+.+.+.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~--- 305 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG--- 305 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc---
Confidence 446689999999999999999999999999999999999999999764 122333333332221 11111111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.-..++. .++..|+++||.+||++.|++++
T Consensus 306 ---~fS~ef~------~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 ---EFSPEFR------SFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---cCCHHHH------HHHHHHhcCCcccCCCHHHHhcC
Confidence 0111122 56778999999999999999865
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=379.78 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=204.5
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc--------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI--------DENTFRKEAEALGKVKHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 905 (1133)
..+.|.+.+.+|+|+||.|-+|.. ++|+.||||.+.+... ....+++|+++|++++|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688899999999999999955 5799999999964322 1234679999999999999999999999875
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC---CceEEecc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD---FEAHLSEF 982 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Df 982 (1133)
.. |+||||++||+|.+.+-.++. +.+..-..+++|++.|+.|||++||+||||||+|||+..+ ..+||+||
T Consensus 250 s~-YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SS-YMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ce-EEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 54 999999999999999987654 5566667899999999999999999999999999999765 78999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCC---CCCCCchhHHHHHHHHHHhCCCCCccCChhh-HHHHHHHHhh
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ---PTKEADVYSFGIVLLEILTGRKPVMFTQDED-IVKWVKKQLQ 1058 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~-~~~~~~~~~~ 1058 (1133)
|+|+... ......+.+||+.|.|||++.++. +..++|+||+||++|-+++|.+||.....+. +.+.+.+
T Consensus 324 GlAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~--- 396 (475)
T KOG0615|consen 324 GLAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK--- 396 (475)
T ss_pred chhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc---
Confidence 9998653 345567789999999999997654 3458899999999999999999997544333 4444433
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+ .+......|.++...+ ++|.+|+..||++||+++|++++
T Consensus 397 -G-----------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 -G-----------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -C-----------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2 1223344566666555 99999999999999999998853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=391.84 Aligned_cols=247 Identities=22% Similarity=0.409 Sum_probs=213.3
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEccc----CCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRD----GTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.+|...+.||+|+|+.||+++. ..|+.||+|++.+ .....+.+.+|++|.++++|||||+++++|++..+. |+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV-Yiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV-YIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce-EEE
Confidence 5799999999999999999987 7899999999976 344567889999999999999999999999988655 999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
.|+|+.++|..++++. ..+++.+++.+.+||+.|+.|||+++|+|||||-.|+|++++.++||+|||+|..+...
T Consensus 97 LELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999999853 34899999999999999999999999999999999999999999999999999766432
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
..+..+.+|||.|.|||++....++..+||||+|||||-|+.|++||....-.+++..++.. ++.-|...
T Consensus 172 ---~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------~Y~~P~~l 241 (592)
T KOG0575|consen 172 ---GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------EYSMPSHL 241 (592)
T ss_pred ---ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------Cccccccc
Confidence 24556789999999999999999999999999999999999999999877777777766553 22222211
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ..+.++|.+++++||.+|||+++|+.+
T Consensus 242 s-----------~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 242 S-----------AEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred C-----------HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 122389999999999999999999854
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=389.48 Aligned_cols=260 Identities=25% Similarity=0.461 Sum_probs=220.8
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.+.++..+.||+|.||+||.|.++....||+|.++.+....++|.+|+++|++++|++||+++|+|..++ ..+||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEec
Confidence 3345678899999999999999998889999999988888899999999999999999999999998865 459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
+.|+|.++++.. .+..+...+...++.|||+||+||+++++|||||.++||||+++..+||+|||+||...+ +..
T Consensus 284 ~~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d--~~Y 358 (468)
T KOG0197|consen 284 PKGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD--DEY 358 (468)
T ss_pred ccCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC--Cce
Confidence 999999999972 235588999999999999999999999999999999999999999999999999994322 222
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......-...|+|||.+..+.++.|+|||||||+||||+| |+.||......++.+.+.++.+-.... .+.
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~-~CP------- 430 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE-GCP------- 430 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC-CCC-------
Confidence 23333345568999999999999999999999999999999 999999999888888887765543211 111
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
.+- -+++..||+.+|++|||++.+...|+.+....
T Consensus 431 -----~~v----Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 431 -----DEV----YELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -----HHH----HHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 111 16888999999999999999999999876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=368.74 Aligned_cols=211 Identities=24% Similarity=0.436 Sum_probs=185.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..+|...+.||+|+||+||+|+++ ++..||||.+.+.... .+.+..|+++++.++|||||.+++++..++ ..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-FIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-eEEEE
Confidence 457888899999999999999886 5899999999765433 355678999999999999999999998874 55999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC------CceEEeccCcc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD------FEAHLSEFGLD 985 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~------~~~kl~Dfg~a 985 (1133)
||||.||+|.+|+++.+ .+++.....++.|+|.|+++||+++||||||||+|||++.. ..+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999865 38899999999999999999999999999999999999765 45799999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHH
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
|.... .....+.+|++-|||||++...+|+.|+|+||+|+|+|+|++|+.||......++..++++.
T Consensus 163 R~L~~----~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 163 RFLQP----GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred hhCCc----hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 87642 23445678999999999999999999999999999999999999999988888877766554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=356.81 Aligned_cols=257 Identities=22% Similarity=0.387 Sum_probs=209.2
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEE-EEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRG-YYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~~~l 910 (1133)
..+|.+.++||+|+||+||++.. .+|..||.|.+.-+..+ .++...|+.++++++|||||++++ -+.+..+..++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34688899999999999999955 57999999999865554 356788999999999999999998 45555566789
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc--CC--ceecccCccceeeCCCCceEEeccCccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS--LD--MVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
|||||..|+|.+.+++.+.+ .+.+++..+|+++.|++.||.++|+ .. |+||||||.||+++.+|.+|++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999987654 4679999999999999999999998 45 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
+.... .......+|||.||+||.+.+..|+.++||||+||++|||+.-++||.+.+-.++...+.+ +.++...
T Consensus 177 ~l~s~---~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q----gd~~~~p 249 (375)
T KOG0591|consen 177 FLSSK---TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ----GDYPPLP 249 (375)
T ss_pred Hhcch---hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc----CCCCCCc
Confidence 76432 2234567899999999999999999999999999999999999999987654444444333 3322222
Q ss_pred cCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1067 EPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
+ +-+...+ .+|..|+..||+.||+...++..+..
T Consensus 250 ~-------------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D-------------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H-------------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 2223333 68889999999999996555555543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.48 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=201.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||+||.++.+ +++.+|+|++++... +.+...+|..++.+++||.||.++..|++.+ ..|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-KLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-eEEE
Confidence 457999999999999999999765 589999999976543 2456788999999999999999999888764 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|+||+.||.|..++++.+. +++..+..++..|+.||.|||++|||||||||+|||+|.+|+++++|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999998654 78888899999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. .....+.+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+...+.+.+.+.. ....+..+++.
T Consensus 178 ~---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~- 252 (357)
T KOG0598|consen 178 D---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEE- 252 (357)
T ss_pred C---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHH-
Confidence 2 234455799999999999999999999999999999999999999998887777766665532 01111111111
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRP 1102 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 1102 (1133)
+.+++.+.+..||++|.
T Consensus 253 ---------------ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 253 ---------------ARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---------------HHHHHHHHhccCHHHhc
Confidence 12688889999999995
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=390.47 Aligned_cols=496 Identities=30% Similarity=0.423 Sum_probs=311.6
Q ss_pred hhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcce
Q 001171 89 DQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLR 168 (1133)
Q Consensus 89 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~ 168 (1133)
..+|.-.-|++|++++|.+. .+...+.++..|++|++++|+++ .+|.+++.+.+++.|++++|.++
T Consensus 39 e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls------------ 104 (565)
T KOG0472|consen 39 ENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS------------ 104 (565)
T ss_pred hhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh------------
Confidence 34667778899999999998 55557899999999999999999 89999999999999999999887
Q ss_pred EEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccc
Q 001171 169 YLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248 (1133)
Q Consensus 169 ~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 248 (1133)
.+|+..+++.+|++|+.++|.+. ++|++++.+..|+.|+..+|+++ ..|..+.++.+|..|++.+|+
T Consensus 105 -----------~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~ 171 (565)
T KOG0472|consen 105 -----------ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNK 171 (565)
T ss_pred -----------hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccc
Confidence 56777777778888888888887 57777888888888888888887 677777777888888888888
Q ss_pred cCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCccc
Q 001171 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIR 328 (1133)
Q Consensus 249 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~ 328 (1133)
++...|..+. ++.|++||+-.|.++. +|..+ + .+..|+.|||..|+|.
T Consensus 172 l~~l~~~~i~-m~~L~~ld~~~N~L~t-lP~~l-----g-------------------------~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 172 LKALPENHIA-MKRLKHLDCNSNLLET-LPPEL-----G-------------------------GLESLELLYLRRNKIR 219 (565)
T ss_pred hhhCCHHHHH-HHHHHhcccchhhhhc-CChhh-----c-------------------------chhhhHHHHhhhcccc
Confidence 8766655555 7777777777777753 33333 3 3444555666666666
Q ss_pred ccCCchhhcccccceeeccCceeecccCcccC-CCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCcc
Q 001171 329 AVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG-SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFL 407 (1133)
Q Consensus 329 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 407 (1133)
.+ | .|..|..|++|+++.|+|+ .+|.... ++++|.+|||+.|+++ ..|+.+..+++|++||+|+|.|+ ..|..+
T Consensus 220 ~l-P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sL 294 (565)
T KOG0472|consen 220 FL-P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSL 294 (565)
T ss_pred cC-C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCccc
Confidence 65 4 6888999999999999998 6676554 8999999999999998 56888888888999999988888 456666
Q ss_pred CCCCCCcEEEccCCcCccccCccccCcc--ccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCC
Q 001171 408 GGIRGLKIVSLGRNMFSGLIPLSFGNLS--QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGL 485 (1133)
Q Consensus 408 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 485 (1133)
+++ .|+.|-+.+|.+..+-.+.+..-+ -|++|.= .+.. -.++.. .=+...
T Consensus 295 gnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~~-------------------dglS~s---e~~~e~-- 346 (565)
T KOG0472|consen 295 GNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIKD-------------------DGLSQS---EGGTET-- 346 (565)
T ss_pred ccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhcc-------------------CCCCCC---cccccc--
Confidence 666 666666666666532111111100 1222110 0000 000000 000000
Q ss_pred cEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCC---CcEeeccCCcccccCCCCCCCCccCcEE-E
Q 001171 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPS---LQVVSLEENNLSGDVPEGFSSLVGLQYL-N 561 (1133)
Q Consensus 486 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~ 561 (1133)
.-+. .. ........+.+.+.|+++.-+++ .+|.+.+.-.. ....++++|++. ++|..+..++.+.+. +
T Consensus 347 -~~t~----~~-~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 347 -AMTL----PS-ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLV 418 (565)
T ss_pred -cCCC----CC-Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHH
Confidence 0000 00 11112334556778888888877 66776665444 566777777766 455555544443332 2
Q ss_pred cccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccC
Q 001171 562 LSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSG 641 (1133)
Q Consensus 562 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 641 (1133)
+++|.+ +.+|..+..+++|+.|+|++|-+. .+|.+++.+..|+.|++++|+|. .+|..+-.+..|+.+-.++|++..
T Consensus 419 lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 419 LSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred hhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence 233333 345555555555555555555554 44555555555555555555554 345444444444444444455543
Q ss_pred cCchhhhccCCCcEEEeecCCCCccCCccccCccccccccccccccc
Q 001171 642 EIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS 688 (1133)
Q Consensus 642 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 688 (1133)
..|..+.+|.+|..|||.+|.+. .+|+.+++|++|++|+|++|++.
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 33333455555555555555554 34444555555555555555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=346.18 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=205.8
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|+...++|+|+||+||+++++ +|+.||||++...+.+ .+-..+|++++++++|||+|.++++|..... .++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk-lhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK-LHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce-eEEEe
Confidence 46888889999999999999887 5999999999765543 3556899999999999999999999987644 58999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|||+. ++.+-+.+... -.+.....++++|+++|+.|+|+++++||||||+|||++.+|.+|+||||+|+.....
T Consensus 81 E~~dh-TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred eecch-HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99965 45555555432 3788899999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----------
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---------- 1061 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---------- 1061 (1133)
....+.++.|.+|+|||.+.+ .+|++.+||||+||++.||++|++-|.+.++-+..-.+.+.+..--
T Consensus 155 --gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 --GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred --cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 233456789999999999977 7899999999999999999999999988777666655555433211
Q ss_pred --ccccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1062 --ISELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1062 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
+..+--|......+-...+.... ..++++.+|++.||.+|++-+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111111111222222 2349999999999999999999874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.47 Aligned_cols=478 Identities=29% Similarity=0.415 Sum_probs=358.7
Q ss_pred CCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEE
Q 001171 187 SKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVL 266 (1133)
Q Consensus 187 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 266 (1133)
.-..|++|++++|.+.. +...+.++..|..|++.+|+++ ..|.+++.+..++.|++++|+++ .+|.+++.+.+|..|
T Consensus 43 ~qv~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l 119 (565)
T KOG0472|consen 43 EQVDLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKL 119 (565)
T ss_pred hhcchhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhh
Confidence 33445555555555552 3333555555666666666655 55555555556666666666655 345555566666666
Q ss_pred EcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeec
Q 001171 267 SLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDL 346 (1133)
Q Consensus 267 ~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 346 (1133)
++++|++....+ ++ +.+ ..++.|+..+|+|+++ |+.+.++.+|..|++
T Consensus 120 ~~s~n~~~el~~-~i-----~~~-------------------------~~l~dl~~~~N~i~sl-p~~~~~~~~l~~l~~ 167 (565)
T KOG0472|consen 120 DCSSNELKELPD-SI-----GRL-------------------------LDLEDLDATNNQISSL-PEDMVNLSKLSKLDL 167 (565)
T ss_pred hccccceeecCc-hH-----HHH-------------------------hhhhhhhccccccccC-chHHHHHHHHHHhhc
Confidence 666666653322 22 222 2244445555555555 777888999999999
Q ss_pred cCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccc
Q 001171 347 SGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGL 426 (1133)
Q Consensus 347 s~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 426 (1133)
.+|++....|..+. ++.|++||.-.|.++ .+|..++.+.+|+.|||..|.|. .+| .|.+++.|++++++.|.|...
T Consensus 168 ~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~l 243 (565)
T KOG0472|consen 168 EGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEML 243 (565)
T ss_pred cccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhh
Confidence 99999955555554 999999999999997 46888999999999999999998 566 889999999999999999955
Q ss_pred cCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCc
Q 001171 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSL 506 (1133)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 506 (1133)
..+...+++++..|||++|+++ ..|+.++-+++|..||+|+|.++ ..|.+++++ .|+.|-+.+|.+... ...+-+.
T Consensus 244 pae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTi-Rr~ii~~ 319 (565)
T KOG0472|consen 244 PAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTI-RREIISK 319 (565)
T ss_pred HHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHH-HHHHHcc
Confidence 4455559999999999999999 78999999999999999999998 678899999 999999999988632 1111111
Q ss_pred c---cccEEe-------ccccCCC----CC----CChhccCCCCCcEeeccCCcccccCCCCCCCC--ccCcEEEccccc
Q 001171 507 M---RLTTLD-------LSNQNLS----GE----LPIELFGLPSLQVVSLEENNLSGDVPEGFSSL--VGLQYLNLSDNA 566 (1133)
Q Consensus 507 ~---~L~~L~-------Ls~N~l~----~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~ 566 (1133)
. -|++|. ++.-.=. .. .......+.+.+.|++++-+++..+.+.|..- .-.+..+++.|+
T Consensus 320 gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNq 399 (565)
T KOG0472|consen 320 GTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQ 399 (565)
T ss_pred cHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccch
Confidence 1 122221 1111100 01 11122345678899999999985444444332 238899999999
Q ss_pred ccCCCCcccccccccc-eeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCch
Q 001171 567 FTGDIPATYGFLRSLV-FLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPK 645 (1133)
Q Consensus 567 l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 645 (1133)
+. .+|..+..+..+. .+.+++|.++ .+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||+++|+|. .+|.
T Consensus 400 L~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~ 475 (565)
T KOG0472|consen 400 LC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPE 475 (565)
T ss_pred Hh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchH
Confidence 98 7888888777654 5566666666 88999999999999999999988 59999999999999999999998 8999
Q ss_pred hhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCccccccccccc
Q 001171 646 EISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712 (1133)
Q Consensus 646 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~ 712 (1133)
.+..+..|+.+-.++|++....|..+.+|.+|.+|||.+|.+. .+|+.++++++|++|++++|++.
T Consensus 476 ~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 476 CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999999999999999777777999999999999999998 89999999999999999999998
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=375.22 Aligned_cols=389 Identities=23% Similarity=0.257 Sum_probs=196.1
Q ss_pred ccCccCCcceEEEccCCcCCCCCCCCCCC--CCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCc
Q 001171 159 ISADISPSLRYLDLSSNAFTGEIPGNFSS--KSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNC 236 (1133)
Q Consensus 159 ~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~--l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 236 (1133)
.|+..+..-+.||.+++.+..+-...+.. .+.-+.||+|+|+++.+-+.+|.++++|+++++..|.++ .||...+..
T Consensus 46 cpa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~s 124 (873)
T KOG4194|consen 46 CPATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHES 124 (873)
T ss_pred CCCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccc
Confidence 34444445556666666664321111111 123345777777777666666777777777777777776 666665555
Q ss_pred cccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCcccc
Q 001171 237 SSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSV 316 (1133)
Q Consensus 237 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~ 316 (1133)
.+|+.|+|.+|.|+.+-.+++..++.|+.||||.|.|+. +|..- |..=.++++|+|++|.|+.. ....|..+++
T Consensus 125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~-i~~~s----fp~~~ni~~L~La~N~It~l-~~~~F~~lns 198 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISE-IPKPS----FPAKVNIKKLNLASNRITTL-ETGHFDSLNS 198 (873)
T ss_pred cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhc-ccCCC----CCCCCCceEEeecccccccc-ccccccccch
Confidence 667777777777776666667777777777777777763 22211 11122333444444443332 1233344445
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccC
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG 396 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 396 (1133)
|.+|.|++|+|+.+++..|.++++|+.|||..|+|.-.---.|.+|++|+.|.|..|.+..+-...|-.|.++++|+|+.
T Consensus 199 L~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~ 278 (873)
T KOG4194|consen 199 LLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLET 278 (873)
T ss_pred heeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeeccc
Confidence 55555555555555555555555555555555555422233455555555555555555554445555555555555555
Q ss_pred CcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCC
Q 001171 397 NRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476 (1133)
Q Consensus 397 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 476 (1133)
|+++..-..++-+++.|+.|+|++|.|..+.+++..-+++|++|+|++|+|+...++.|..++.|++|+|++|.++..-.
T Consensus 279 N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e 358 (873)
T KOG4194|consen 279 NRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAE 358 (873)
T ss_pred chhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHh
Confidence 55554444444455555555555555544444444444444455555444444444444444444444444444443333
Q ss_pred CCCCCCCCCcEEEcccCCCccccC---CCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCC
Q 001171 477 YDVGNLKGLLVLNLSASGFSGKIP---GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSS 553 (1133)
Q Consensus 477 ~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 553 (1133)
..|..+++|+.|||++|.++..+. ..|..+++|+.|++.+|++..+...+|.+++.|++|+|.+|.|..+-|.+|..
T Consensus 359 ~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~ 438 (873)
T KOG4194|consen 359 GAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEP 438 (873)
T ss_pred hHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccccc
Confidence 444444444444444444443322 12333344444444444443333333334444444444444443333333333
Q ss_pred C
Q 001171 554 L 554 (1133)
Q Consensus 554 l 554 (1133)
+
T Consensus 439 m 439 (873)
T KOG4194|consen 439 M 439 (873)
T ss_pred c
Confidence 3
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=361.65 Aligned_cols=266 Identities=19% Similarity=0.292 Sum_probs=212.6
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHH--HHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT--FRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~--~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~l 910 (1133)
..++|.+.++||.|+||.||+|+. ..|+.||||++++.-...++ =.||++.+++++ |||||++.+++.+.+...++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456899999999999999999965 46899999999865544433 358999999998 99999999999887667799
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||| ..+|+++++.. +..+++..++.|++||++||+|+|++|+.|||+||+|||+.....+||+|||+||.+..
T Consensus 88 VfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999 67999999874 35699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCCCCccCccccC-CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC-
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAS-TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP- 1068 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1068 (1133)
. ...+.++-|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++-|.+.++.+....+.+.+..+........
T Consensus 163 k----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 K----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred C----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 2 3345678899999999975 566899999999999999999999999887777666666665544332222110
Q ss_pred --------CcCCCCCCChhHH-----HHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1069 --------GLLELDPESSEWE-----EFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1069 --------~~~~~~~~~~~~~-----~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.+....+ .... .-..+++++.+|+..||.+|||+.|.+++=
T Consensus 239 ~La~~mnf~~P~~~~--~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKP--SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCC--CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0000000 0011 112334889999999999999999999753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=379.36 Aligned_cols=279 Identities=24% Similarity=0.427 Sum_probs=229.2
Q ss_pred eeecCcccHHHHHHHhc---------CCCcccccccccceeEEEEEECC----ceEEEEEEcccCCcC--HHHHHHHHHH
Q 001171 821 VMFNNKITYVETLEATR---------QFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTID--ENTFRKEAEA 885 (1133)
Q Consensus 821 ~~~~~~~~~~~~~~~~~---------~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~ 885 (1133)
..+.++.+|++...|.. ...+.++||.|.||.||+|+++- ...||||.++.+..+ ..+|..|+.|
T Consensus 604 k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsI 683 (996)
T KOG0196|consen 604 KTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASI 683 (996)
T ss_pred eeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhh
Confidence 34555666665544443 34568999999999999998752 467999999876554 4689999999
Q ss_pred HhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccC
Q 001171 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIK 965 (1133)
Q Consensus 886 l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlk 965 (1133)
|.+.+||||+++.|++...... ++|+|||++|+|+.+|+... ..+.+.+..-+.++||.||.||.++++|||||.
T Consensus 684 MGQFdHPNIIrLEGVVTks~Pv-MIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLA 758 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPV-MIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLA 758 (996)
T ss_pred cccCCCCcEEEEEEEEecCcee-EEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcCchhhhhh
Confidence 9999999999999999877554 89999999999999998754 338999999999999999999999999999999
Q ss_pred ccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccC
Q 001171 966 PQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFT 1044 (1133)
Q Consensus 966 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~ 1044 (1133)
++|||++.+..+||+|||++|...+............-..+|.|||.+..++++.++||||||++|||.++ |..||...
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 99999999999999999999976554433333333344579999999999999999999999999999998 99999999
Q ss_pred ChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1045 QDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
+.+++...+.+.++-+. +.+... ..-+++..||++|-.+||.+.||+..|+++-..|+-=
T Consensus 839 SNQdVIkaIe~gyRLPp-------------PmDCP~----aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 839 SNQDVIKAIEQGYRLPP-------------PMDCPA----ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred chHHHHHHHHhccCCCC-------------CCCCcH----HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 99998888877655432 121111 1127888999999999999999999999887766543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=360.46 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=209.5
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
...+|.+++.||+|+|++||+|+. ..++.||||++.+.. ...+.+.+|-++|.+| .||.|++++..|.+.. ..
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-sL 149 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-SL 149 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-ce
Confidence 345899999999999999999965 468999999985432 2345678899999999 8999999999998764 45
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+|+||+++|+|.+++++.+. +++...+.++.+|+.|++|||++|||||||||+|||+|+|++++|+|||.|+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999999765 888899999999999999999999999999999999999999999999999876
Q ss_pred ccCCCC----------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 989 IATPAE----------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 989 ~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
.+.... ......++||..|.+||++.....++.+|+|+||||+|+|+.|++||.+.++--+.+.+.+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--
Confidence 543221 11124579999999999999999999999999999999999999999877766666665543
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+.+++. + .+.+++.+.+..||.+|++..||.++
T Consensus 303 ----~y~fp~~fp----------~--~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ----DYEFPEGFP----------E--DARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----cccCCCCCC----------H--HHHHHHHHHHccCccccccHHHHhhC
Confidence 111222221 1 12278999999999999999999865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=387.17 Aligned_cols=266 Identities=25% Similarity=0.413 Sum_probs=218.1
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
+.+....+.||+|+||+||+|+.. +.+.||||.+++.... .++|++|++++..++|||||+++|+|..++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P- 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP- 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe-
Confidence 445667788999999999999653 3578999999876544 5789999999999999999999999998755
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCC---------CCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGH---------VLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~---------~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
.++|+|||..|||.++|......... .++..+.+.||.|||.||+||.++.+|||||.++|+||.++..||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 49999999999999999876533222 278889999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
|+|||++|.....+... ......-..+|||||.+..++|+.++|||||||+|||+++ |+.||.+...+++.+.++++.
T Consensus 644 IsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 99999998654432211 1113345679999999999999999999999999999999 999999988888887776642
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
- -..++.+...+ .+++..||+..|.+||+++||-..|+........
T Consensus 723 l-L~~Pe~CP~~v----------------Y~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 723 L-LSCPENCPTEV----------------YSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred c-ccCCCCCCHHH----------------HHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 2 12222222221 2788999999999999999999999987665443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.48 Aligned_cols=276 Identities=22% Similarity=0.370 Sum_probs=213.2
Q ss_pred HHHHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 831 ETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 831 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
++....+++.+.+.||+|+||+||+|+|. -.||||++...... .++|+.|+.++++-+|.||+-+.|||..++ .
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-~ 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-L 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-e
Confidence 34445556778899999999999999986 35899999765444 468999999999999999999999998764 3
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.+|+.+|+|.+|+.+++... ..++......||+|||+||.|||.++|||||||..||++++++.|||+|||++..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 89999999999999998754 3488999999999999999999999999999999999999999999999999853
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCC---CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTG---QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
...- ..........|..-|||||++... .|++++||||||+|+|||++|..||.....+.+...+-++....+
T Consensus 538 k~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd--- 613 (678)
T KOG0193|consen 538 KTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD--- 613 (678)
T ss_pred eeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc---
Confidence 2221 222334455688899999998543 589999999999999999999999984444443333222211111
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCCCCCCCC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLP 1130 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~~~~~~ 1130 (1133)
... ........ ..+++..||..++++||.+.+|+..|+.+... .|+..++.+.|
T Consensus 614 -----~s~---~~s~~pk~--mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~--~pki~RS~S~P 667 (678)
T KOG0193|consen 614 -----LSK---IRSNCPKA--MKRLLSDCWKFDREERPLFPQLLSKLEELLPS--LPKINRSASEP 667 (678)
T ss_pred -----chh---hhccCHHH--HHHHHHHHHhcCcccCccHHHHHHHHHHhhhc--ccccccCcCcc
Confidence 110 01111111 12678889999999999999999999987774 55555555554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.10 Aligned_cols=261 Identities=23% Similarity=0.406 Sum_probs=202.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC-cEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPD-VRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~lV~e 913 (1133)
.+|...+.||+|+||.||.+... +|+..|||.+..... ..+.+.+|+++|++++|||||+.+|....... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35778899999999999999775 499999999865421 14668999999999999999999998655444 5689999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|+++|+|.+++.+.+. .+++..+..+..||++||+|||++|||||||||+|||++. ++.+||+|||.++......
T Consensus 97 y~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998653 3899999999999999999999999999999999999999 7999999999987654312
Q ss_pred CCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
..........||+.|||||++..+ ...+++||||+||++.||+||+.||... .+...++.........+++.+ .+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~ip~-~l- 248 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEIPD-SL- 248 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCCCc-cc-
Confidence 222334457899999999999853 3446999999999999999999999652 222222223222222221111 11
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.. .+.+++.+|+..||++|||+.|++++---...
T Consensus 249 -----s~------~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 249 -----SD------EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -----CH------HHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 01 11267888999999999999999987654443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=369.63 Aligned_cols=403 Identities=25% Similarity=0.286 Sum_probs=256.8
Q ss_pred cccEEeccCCcccccccC-CCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEE
Q 001171 291 SLRIVQLGFNAFTGVVKP-PNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLR 369 (1133)
Q Consensus 291 ~L~~l~l~~n~l~~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 369 (1133)
.-+.|+++.+.+...-+. ..+..++.-+.||+++|.|..+.+..|.++++|++++|..|.++ .+|...+...+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 346788888887653221 12334556677888888888888888888888888888888887 6676666666788888
Q ss_pred ccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccc
Q 001171 370 VANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG 449 (1133)
Q Consensus 370 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 449 (1133)
|.+|.|+......+..++.|+.||||.|.|+.+.-..|..-.++++|+|++|.|+......|..+.+|..|.|+.|+|+.
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 88888887777778888888888888888876666666666777888888888877777777777777777788887776
Q ss_pred cCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccC
Q 001171 450 NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFG 529 (1133)
Q Consensus 450 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 529 (1133)
..+..|.++++|+.|+|..|+|.-.....|.++++|+.|.|..|.++..-.+.|..+.++++|+|+.|+++..-..++++
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfg 291 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFG 291 (873)
T ss_pred cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccc
Confidence 66667777777777777777776333455666666666666666666555555666666666666666665544555555
Q ss_pred CCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEE
Q 001171 530 LPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLE 609 (1133)
Q Consensus 530 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 609 (1133)
++.|+.|+|++|.|...-++.++..++|++|+|++|+|+...+.+|..+..|++|+|++|+|+..--..|..+++|+.||
T Consensus 292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld 371 (873)
T KOG4194|consen 292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD 371 (873)
T ss_pred cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence 55555555555555555555555555555555555555555555555555555555555555533333444444555555
Q ss_pred ecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccc
Q 001171 610 LRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSG 689 (1133)
Q Consensus 610 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 689 (1133)
|++|.|++.+.+ ....|..|++|+.|+|.+|++....-.+|..+..|++|||.+|.|..
T Consensus 372 Lr~N~ls~~IED---------------------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 372 LRSNELSWCIED---------------------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred CcCCeEEEEEec---------------------chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCccee
Confidence 555544432221 12234455555666666666554333455666666666666666655
Q ss_pred cCCccccccccCcccccccccccccCC
Q 001171 690 AIPADLALISSLRYLNLSRNNLEGEIP 716 (1133)
Q Consensus 690 ~~p~~l~~l~~L~~L~ls~N~l~~~~p 716 (1133)
.-|..|..+ .|+.|-++.-.+-+.+.
T Consensus 431 Iq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 431 IQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred ecccccccc-hhhhhhhcccceEEecc
Confidence 555555555 55555555544444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.47 Aligned_cols=263 Identities=20% Similarity=0.307 Sum_probs=206.4
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.+|...+++|+|.||+||+|++ ++|+.||||+++.+... .....+|++.++.++|+||+.++++|...... -+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l-~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL-SLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce-EEEE
Confidence 4688889999999999999965 57999999999765443 34678899999999999999999999877554 8999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|||+ .+|...++... ..+....+..++.++++|++|||++.|+|||+||.|+|++++|.+|++|||+|+.+....
T Consensus 81 Efm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred Eecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9995 58998887643 458888899999999999999999999999999999999999999999999999775433
Q ss_pred CCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. ..+..+.|.+|+|||.+.|. .|+..+|+||.|||+.||+-|.+-|.+.++-+....+-+.+..+...+.. ++.
T Consensus 156 ~---~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP--~~~ 230 (318)
T KOG0659|consen 156 R---IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP--EMT 230 (318)
T ss_pred c---ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc--ccc
Confidence 2 23334789999999998765 58999999999999999999887777777766666665554433222211 111
Q ss_pred CCC---------CCC--hhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELD---------PES--SEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~---------~~~--~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+++ ... .-+... ...++++.+++..||.+|+++.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 000 001111 122589999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=347.92 Aligned_cols=268 Identities=21% Similarity=0.321 Sum_probs=208.5
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~l 910 (1133)
.+.|+..++||+|.||.||+|+. .+|+.||+|+++.+..+ .....+|+.||++++||||+++.+...+. ....|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34678889999999999999965 57999999999765433 35567899999999999999999998776 456799
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|+|||+. +|..++...+ -.++..++..++.|++.||+|+|++||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999954 7877776532 3489999999999999999999999999999999999999999999999999997644
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc-----
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE----- 1064 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 1064 (1133)
... ...+..+.|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|.+..+-+....+-+....+.-..
T Consensus 271 ~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 332 336778899999999998765 589999999999999999999999987776665665555443322111
Q ss_pred cccCCcCCC-CCCChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 LLEPGLLEL-DPESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~~~-~~~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+......+. .+......+ + ..+++++..++..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 110011000 011111111 1 123488999999999999999999853
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=350.40 Aligned_cols=255 Identities=21% Similarity=0.327 Sum_probs=207.8
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++..+||+|+||.||.|+.+ +|..+|+|++++... ..+.++.|-.+|...++|.||+++..|.+. +..|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-EYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-CeeE
Confidence 4568999999999999999999765 699999999987543 235678899999999999999999999887 5569
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||++||++..+|.+.+ .+++.....++.+++.|++.+|+.|+|||||||+|+|||..|++|++|||++.-..
T Consensus 218 LiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999999854 48899999999999999999999999999999999999999999999999984332
Q ss_pred cCC--------------------CCCC-----C-------------------CCCCCCCCCccCccccCCCCCCCCCchh
Q 001171 990 ATP--------------------AEAS-----S-------------------STTPIGSLGYVSPEAASTGQPTKEADVY 1025 (1133)
Q Consensus 990 ~~~--------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 1025 (1133)
... .... . ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 210 0000 0 0134799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC---
Q 001171 1026 SFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP--- 1102 (1133)
Q Consensus 1026 SlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP--- 1102 (1133)
|+|||+|||+.|.+||....+.++.+.+......-.+++..+.. ..+.++|.+|+. ||++|.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s--------------~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLS--------------DEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCccc--------------HHHHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999999999888887776643332222222111 122389999998 999996
Q ss_pred CHHHHHHH
Q 001171 1103 SMADIVFM 1110 (1133)
Q Consensus 1103 s~~evl~~ 1110 (1133)
.+.||.++
T Consensus 438 G~~EIK~H 445 (550)
T KOG0605|consen 438 GAEEIKKH 445 (550)
T ss_pred cHHHHhcC
Confidence 47777643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=327.25 Aligned_cols=209 Identities=22% Similarity=0.420 Sum_probs=184.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|+..+.||.|+||.|..++.+ +|..+|+|++.+...- .+....|-.+++.+.||.++++++.+.+.. ..++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eEEE
Confidence 357889999999999999999876 5889999999754331 244567999999999999999999888764 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||++||.|+.++++.++ +++..++.+|.+|+.|++|||+.+|++||+||+|||+|++|++||+|||+|+.+.
T Consensus 122 vmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred EEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 9999999999999998654 8899999999999999999999999999999999999999999999999998652
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHH
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
....+.+|||.|+|||++....|.+++|.|||||++|||+.|.+||.......+++.+.+.
T Consensus 196 -----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~ 256 (355)
T KOG0616|consen 196 -----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG 256 (355)
T ss_pred -----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC
Confidence 2355679999999999999999999999999999999999999999888887777776553
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.64 Aligned_cols=274 Identities=20% Similarity=0.336 Sum_probs=211.5
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..+.|++.++||.|..++||+|+. ..++.||||++.-+. .+.+.+.+|++.|+.++||||+.++..|..+. ..|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-ELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-eeEEe
Confidence 345799999999999999999976 468999999996433 23578999999999999999999999888764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|.||.+||+.++++..-... +++..+..|.+++++||.|||.+|.||||||+.||||+.+|.+||+|||.+-.....
T Consensus 103 mpfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999999865433 889999999999999999999999999999999999999999999999998665554
Q ss_pred CCCCCCC-CCCCCCCCccCccccC--CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 992 PAEASSS-TTPIGSLGYVSPEAAS--TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 992 ~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
....... ...+||+.|||||++. ...|+.|+||||||++..|+.+|+.||....+..+.-...+ . ..+.....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq---n-~pp~~~t~ 255 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ---N-DPPTLLTS 255 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc---C-CCCCcccc
Confidence 3222222 5678999999999953 34589999999999999999999999976665443322211 1 11111100
Q ss_pred CcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 001171 1069 GLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPDMP 1121 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~~~ 1121 (1133)
. ...++...+...+ +++..|+++||.+|||+++++++ +...+.....+
T Consensus 256 ~-----~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~ 306 (516)
T KOG0582|consen 256 G-----LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLV 306 (516)
T ss_pred c-----CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcc
Confidence 0 0112222222233 68888999999999999999954 44444444433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=358.10 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=206.2
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccC-----C-cCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDG-----T-IDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 906 (1133)
..++|.+.+.||+|+||.||.|.+ .+|+.||+|.+.+. . ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999966 46899999976543 1 12456778999999999 9999999999988765
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLD 985 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 985 (1133)
.++||||+.+|+|.+++...++ +.+.....+++|++.|++|||++||+||||||+||++|.+ +.+||+|||++
T Consensus 95 -~~ivmEy~~gGdL~~~i~~~g~-----l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 -IYIVMEYCSGGDLFDYIVNKGR-----LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred -EEEEEEecCCccHHHHHHHcCC-----CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 6999999999999999998433 7778999999999999999999999999999999999999 99999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCC-C-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQ-P-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
.... .........+||+.|+|||++.+.. | +.++||||+||++|.|++|+.||.......+...+.+. .-.++
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p 243 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIP 243 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCC
Confidence 7542 2334566789999999999998877 7 58999999999999999999999876555555543221 11122
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
..+. . ..+..++.+|+..||.+|+++.||+ .-.-++
T Consensus 244 ~~~~---------S------~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 244 SYLL---------S------PEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred CCcC---------C------HHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 2221 0 1123788999999999999999999 433333
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=363.36 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=203.6
Q ss_pred HhcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.++||+|+||.||+|.+ ..++.||||++..... ..+.+.+|+++++++ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 356899999999999999999964 2357899999975432 235688999999999 8999999999988766
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC-------------------------------------------------------
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ------------------------------------------------------- 930 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 930 (1133)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 6678999999999999999763210
Q ss_pred --CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCcc
Q 001171 931 --DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008 (1133)
Q Consensus 931 --~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~ 1008 (1133)
....+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++....... ........++..|+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~ 243 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLKWM 243 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCcccc
Confidence 012477888899999999999999999999999999999999999999999999875432211 11122334667899
Q ss_pred CccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhH
Q 001171 1009 SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGV 1087 (1133)
Q Consensus 1009 aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1087 (1133)
|||++.+..++.++|||||||++|||++ |..||......... ......+..... . .... ....
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~---~~~~~~~~~~~~-----~--~~~~------~~l~ 307 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---CQRLKDGTRMRA-----P--ENAT------PEIY 307 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH---HHHHhcCCCCCC-----C--CCCC------HHHH
Confidence 9999988899999999999999999997 99999754432211 111111111000 0 0000 1123
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1088 KVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1088 ~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
+++.+||+.||++||++.|+++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=354.94 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=203.1
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC-HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
....|+.-.+||+|+.|.||.|.. ..++.||||++...... ++-+.+|+.+|+..+|+|||.+++.|...+ ..|+||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-eLWVVM 349 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-ELWVVM 349 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-eeEEEE
Confidence 345788889999999999999954 56899999999765554 455789999999999999999999887764 459999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|||+||+|.+.+... .+++.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~- 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE- 422 (550)
T ss_pred eecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc-
Confidence 999999999999863 3889999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......+||+.|||||+.....|+.++||||||++++||+.|++||..+.+-.....+.. .+ .++ +
T Consensus 423 --~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~---ng-~P~-----l-- 489 (550)
T KOG0578|consen 423 --QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NG-TPK-----L-- 489 (550)
T ss_pred --cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---cC-CCC-----c--
Confidence 2355678999999999999999999999999999999999999999976544322222211 11 111 1
Q ss_pred CCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+.....+ ++..+|++.||++||++.|++++
T Consensus 490 -----k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -----KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -----CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1111222222 56778999999999999999964
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.52 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=201.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCH---HHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....+ +.+.+|++|+++++|||||.++++|+...+. ++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~-~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHL-WVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceE-EEEe
Confidence 47888899999999999999665 58999999997655444 5678999999999999999999999987554 9999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+.| +|.+++...+ .++++.+..++.+++.||.|||+.+|.|||+||.||+++..+.+|+||||+||....
T Consensus 81 e~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 99966 9999998754 389999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.....+...|||-|||||...++.|+..+|.||+|||+||+++|++||...+...+++.+.+ +.. .+
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---d~v-------~~-- 219 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---DPV-------KP-- 219 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---CCC-------CC--
Confidence 22344566899999999999999999999999999999999999999976554444433332 211 00
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.......+ ..++...+.+||.+|.+..+++.+
T Consensus 220 p~~~S~~f------~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 PSTASSSF------VNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cccccHHH------HHHHHHHhhcChhhcccHHHHhcC
Confidence 01111222 256667899999999999998853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.45 Aligned_cols=246 Identities=21% Similarity=0.328 Sum_probs=207.0
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
-|++++.||.|+.|.|-.|++. +|+.+|||.+.+.. .....+++|+-||+-+.||||++++++++...+ .|+|.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~-lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH-LYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce-EEEEE
Confidence 4788999999999999999775 69999999997652 124678999999999999999999999988744 59999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|.|++++.+.+. +++.+..+++.||+.|+.|+|+.+|+|||+||+|+|+|..+.+||+|||+|..-
T Consensus 92 Eyv~gGELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---- 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---- 162 (786)
T ss_pred EecCCchhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc----
Confidence 99999999999988654 788899999999999999999999999999999999999999999999998643
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
..+....+.||++.|+|||++.|..| +.++||||.|||+|.|+||+.||++.+-..+...++++.-+ ++..+.+
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--MPs~Is~--- 237 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--MPSNISS--- 237 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--CCCcCCH---
Confidence 23344567899999999999999988 78999999999999999999999866655555555543211 1111111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.+-+++.+|+..||++|.|++||.++-
T Consensus 238 -------------eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 238 -------------EAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -------------HHHHHHHHHhccCccccccHHHHhhCc
Confidence 112789999999999999999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.90 Aligned_cols=252 Identities=19% Similarity=0.323 Sum_probs=205.4
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEccc---CCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRD---GTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
..+.|++.++||+|.|+.||+..+ .+|+.+|+|.+.. ...+.+.+++|+.|.+.++|||||++.+.+.+. .++|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-ceeEE
Confidence 345788999999999999999965 4688888887742 233567889999999999999999999988765 67799
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCcccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLDRL 987 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~ 987 (1133)
|+|+|.|++|..-+-.. ...++..+-.+++||++|++|+|.++|||||+||+|+++.+ ...+|++|||+|..
T Consensus 88 vFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999998655432 23677788889999999999999999999999999999943 44689999999976
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
+. .......+.|||+|||||++...+|+..+|||+.|||+|-++.|++||.+++...+++.+.+.-- ++..
T Consensus 163 l~----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y-----d~~~ 233 (355)
T KOG0033|consen 163 VN----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY-----DYPS 233 (355)
T ss_pred eC----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc-----CCCC
Confidence 64 33445668899999999999999999999999999999999999999998888888877766421 1111
Q ss_pred CCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.+|..+...+ +++++|+..||.+|.|+.|.+.+=
T Consensus 234 ----------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 234 ----------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ----------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 2223333333 899999999999999999988653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=321.29 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=210.8
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCH---HHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~l 910 (1133)
.++|+..+.|++|+||.||+|++ ++++.||+|+++.+.... -...+|+.++.+++|||||.+..++... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 34688899999999999999976 468999999998655321 2457899999999999999999988653 244699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|||||+. +|..+++..+ +.+...++..++.|+++|++|||.+.|+|||||++|+|+...|.+||+|||+||.+..
T Consensus 155 VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 9999964 8999998765 4488888999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
. ....+..+.|.+|+|||.+.+. .|+.++|+||+|||+.||+++++-|.+.+..+..+.+.+... ...+.+.++
T Consensus 230 p---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG--tPte~iwpg 304 (419)
T KOG0663|consen 230 P---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG--TPSEAIWPG 304 (419)
T ss_pred C---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC--CCccccCCC
Confidence 3 2345667889999999998765 589999999999999999999999988777666666665543 233444444
Q ss_pred cCCCCCC----------C---hhHHHH---HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPE----------S---SEWEEF---LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~----------~---~~~~~~---~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.+++.. . ..+... ...+++....+..||.+|.|+.|.+++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 4333211 0 111111 123488999999999999999999865
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.92 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=209.8
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
...+|++.+.||+|.||.|-+|.. ..|+.||||.++++... .-.+++|++||..++||||+.++.+|+..+. .+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK-Iv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK-IV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce-EE
Confidence 345789999999999999999954 67999999999876553 2357899999999999999999999998754 48
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||..+|.|++|+.+.+. +++.+.+.+++||+.|+.|+|.++|+|||||-+|||+|.++++||+|||++-++.
T Consensus 130 ivMEYaS~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEecCCccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999987543 8899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
. .....+++|++-|.+||++.+..| ++.+|.||+||++|-++.|.+||++.+...++.++..+ .+ .++
T Consensus 205 ~----~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G----aY---rEP 273 (668)
T KOG0611|consen 205 D----KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG----AY---REP 273 (668)
T ss_pred c----ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc----cc---cCC
Confidence 2 234567899999999999999888 68899999999999999999999988877766665543 21 111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.-. ..+--+|++|+..+|++|.|+.+|..+-
T Consensus 274 ~~P------------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ETP------------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCC------------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 1112578999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.99 Aligned_cols=274 Identities=20% Similarity=0.297 Sum_probs=210.0
Q ss_pred HHHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhc--cCCCeeeEEEEEeCCC---C
Q 001171 832 TLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV--KHRNLTVLRGYYAGPP---D 906 (1133)
Q Consensus 832 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~---~ 906 (1133)
.....++..+.+.||+|+||.||+|+|+ |+.||||++. ..+++.+.+|.+|++.+ +|+||..+++.-..+. .
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~--srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS--SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEec--ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4456678899999999999999999998 9999999997 44678999999999885 9999999887654332 3
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc--------CCceecccCccceeeCCCCceE
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS--------LDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
..++|++|.+.|||+||+.+ .+++.....+++..+|.||+|||. ..|.|||||+.|||+..++.+.
T Consensus 283 QLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 45899999999999999997 348889999999999999999993 3499999999999999999999
Q ss_pred EeccCcccccccC-CCCCCCCCCCCCCCCccCccccCCC------CCCCCCchhHHHHHHHHHHhC----------CCCC
Q 001171 979 LSEFGLDRLAIAT-PAEASSSTTPIGSLGYVSPEAASTG------QPTKEADVYSFGIVLLEILTG----------RKPV 1041 (1133)
Q Consensus 979 l~Dfg~a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~el~tg----------~~Pf 1041 (1133)
|+|+|+|...... ..-.......+||.+|||||++... .....+||||||.|+||+.-+ +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999654433 2223345678999999999998543 224678999999999998763 3677
Q ss_pred ccCC-hhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1042 MFTQ-DEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1042 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
...- .+.-.+.+++.+-..++..-+++. ....+......+++..||..+|..|-++-.|.+.|.++...++.
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnr-------W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNR-------WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcc-------cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 4321 111122222222222222222222 23345555556999999999999999999999999988765554
Q ss_pred C
Q 001171 1121 P 1121 (1133)
Q Consensus 1121 ~ 1121 (1133)
.
T Consensus 510 ~ 510 (513)
T KOG2052|consen 510 I 510 (513)
T ss_pred h
Confidence 4
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=310.54 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=209.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++++.||+|.||.||.|+.+ ++-.||+|++.+... .++++.+|++|...++||||.++++||.+.... |+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri-yL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI-YL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee-EE
Confidence 457999999999999999999775 578999999976433 357899999999999999999999999887544 99
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
++||.++|+++..++..+. ..+++...+.+..|+|.|+.|+|.++|+||||||+|+|++.++..|++|||.+...
T Consensus 100 ilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred EEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 9999999999999985432 34778888899999999999999999999999999999999999999999988532
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
...+..+.+||..|.|||+..+..++..+|+|++|+..||++.|.+||.....++.++.+.+. +...|..
T Consensus 175 ---p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------~~~~p~~ 244 (281)
T KOG0580|consen 175 ---PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------DLKFPST 244 (281)
T ss_pred ---CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------cccCCcc
Confidence 234556789999999999999999999999999999999999999999877777777776663 1111111
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
. . ..+.++|.+|+..+|.+|.+..|++++=
T Consensus 245 i---s--------~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 245 I---S--------GGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred c---C--------hhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1 0 0123899999999999999999998763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=354.95 Aligned_cols=265 Identities=25% Similarity=0.361 Sum_probs=211.4
Q ss_pred HHHHhcCCCcccccccccceeEEEEEECC--c--eE-EEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEe
Q 001171 832 TLEATRQFDEENVLSRGRYGLIFKASYQD--G--MV-LSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYA 902 (1133)
Q Consensus 832 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 902 (1133)
++..-++..+.++||+|+||.||+|.++. + .. ||||..+.+. ....+|.+|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33344566677999999999999997643 3 23 8999987422 23467899999999999999999999998
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 903 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
.... .++|||+|.||+|.+++++.+. .++..++..++.+.|+||+|||+++++||||.++|+|++.++.+||+||
T Consensus 232 ~~~P-l~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEP-LMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCc-cEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 7654 4999999999999999998653 4899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++.... .........-..+|+|||.+..+.|+.++|||||||++||+++ |..||.+....++..++.....+..
T Consensus 307 GLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 307 GLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP 383 (474)
T ss_pred ccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence 99875421 1111112235579999999999999999999999999999999 8999998888877777744322221
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
.+. . ..... ..++.+||..||++||+|.++.+.++.+......
T Consensus 384 ~~~-----------~---~p~~~--~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 384 IPS-----------K---TPKEL--AKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCC-----------C---CHHHH--HHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111 0 11111 1566789999999999999999999988776654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.58 Aligned_cols=242 Identities=24% Similarity=0.415 Sum_probs=194.8
Q ss_pred cccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCH
Q 001171 841 EENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNL 920 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL 920 (1133)
..+-+|+|+.|.||.|+.+ ++.||||+++.- -+.+++-|++++||||+.+.|+|...+ ..+||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCc-eeEEeeeccccccH
Confidence 4567999999999999987 788999998632 245788899999999999999998874 44899999999999
Q ss_pred HHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCC
Q 001171 921 ATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000 (1133)
Q Consensus 921 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 1000 (1133)
+..++.. ..+.......+..+||.||.|||.+.|||||||.-||||..+..+||+|||-++.... ......
T Consensus 200 ~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~----~STkMS 270 (904)
T KOG4721|consen 200 YEVLKAG-----RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD----KSTKMS 270 (904)
T ss_pred HHHHhcc-----CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh----hhhhhh
Confidence 9999863 4477778888999999999999999999999999999999999999999999875432 234456
Q ss_pred CCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhH
Q 001171 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEW 1080 (1133)
Q Consensus 1001 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1080 (1133)
+.||..|||||++.....+.|+||||||||||||+||..||...+...+.--+ ..+.+.++-...-.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-------------GsNsL~LpvPstcP 337 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-------------GSNSLHLPVPSTCP 337 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-------------cCCcccccCcccCc
Confidence 78999999999999999999999999999999999999999654433222111 11111111100001
Q ss_pred HHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1081 EEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1081 ~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
+.|. -++..||+..|..||++.+|+.+|+-..
T Consensus 338 ~Gfk---lL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 338 DGFK---LLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred hHHH---HHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 1121 3678899999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=374.24 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=213.2
Q ss_pred hcCCCcccccccccceeEEEEEECC--c----eEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD--G----MVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
....+..+.||+|.||.||+|...+ | ..||||.+++.. .+..+|.+|+.+|+.++|||||+++|++.+.. .
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-P 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-C
Confidence 4466788999999999999997643 4 359999997653 34578999999999999999999999998854 4
Q ss_pred EEEEEeccCCCCHHHHHHhhccCC--CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQD--GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
.++++|||++|+|..+++..+... ...+.......++.|||+|+.||+++++|||||.++|+|+++...+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 499999999999999999874322 345888899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
|....... ........-...|||||.+..+.++.|+|||||||++||++| |..||...+..++...+...- +-+.+.
T Consensus 850 rDiy~~~y-yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~ 927 (1025)
T KOG1095|consen 850 RDIYDKDY-YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPS 927 (1025)
T ss_pred Hhhhhchh-eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCC
Confidence 84433221 111111234468999999999999999999999999999999 999998888877776555543 222222
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
.+...+ .+++..||+.+|++||++..|++.++.+.....
T Consensus 928 ~CP~~l----------------y~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 928 YCPEKL----------------YQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCChHH----------------HHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 222111 178999999999999999999998887765443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=330.08 Aligned_cols=264 Identities=21% Similarity=0.307 Sum_probs=200.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC----cEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD----VRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~~lV~ 912 (1133)
.|...+++|.|+||.||+|... +++.||||++-.+.. --.+|+++|++++|||||++..+|....+ +..+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4677899999999999999775 479999999865443 33579999999999999999988864322 234899
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+ .+|.++++..... +..++...+..+.+||.+|++|||+.||+||||||.|+|+|.+ |.+||||||.|+.....
T Consensus 102 eymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred Hhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 9995 5899999864332 3457788888899999999999999999999999999999987 88999999999876443
Q ss_pred CCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc--cC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL--EP 1068 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1068 (1133)
. .......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+....+.+.+..+.-.++. .+
T Consensus 180 e----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 180 E----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred C----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 2 23456788899999998765 58999999999999999999999998877777666666655433211111 01
Q ss_pred C-----cCCCCCCC----hhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 G-----LLELDPES----SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~-----~~~~~~~~----~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ..++.... -....-...++++.+++..+|.+|.++.|++.+
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1 00000000 000011233488999999999999999999843
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.91 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=206.0
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---------------CHHHHHHHHHHHhhccCCCeeeE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---------------DENTFRKEAEALGKVKHRNLTVL 897 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~l 897 (1133)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+... ..+.+.+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 35568999999999999999999764 689999999954321 12578999999999999999999
Q ss_pred EEEEeCCC-CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc
Q 001171 898 RGYYAGPP-DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE 976 (1133)
Q Consensus 898 ~~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 976 (1133)
+.+..++. +..|+|+|||..|.+...- .....+.+.++++++.+++.||+|||.+|||||||||+|+|++++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99997653 4558999999988764321 11222889999999999999999999999999999999999999999
Q ss_pred eEEeccCcccccccCCCC--CCCCCCCCCCCCccCccccCCCC----CCCCCchhHHHHHHHHHHhCCCCCccCChhhHH
Q 001171 977 AHLSEFGLDRLAIATPAE--ASSSTTPIGSLGYVSPEAASTGQ----PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV 1050 (1133)
Q Consensus 977 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~ 1050 (1133)
+||+|||.+......... .......+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||......++.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999998655333211 11223478999999999987633 368889999999999999999999766665655
Q ss_pred HHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1051 KWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
+.+.... ..++.. . +.....-++|.+++.+||+.|.+..+|..+......+...
T Consensus 329 ~KIvn~p-------------L~fP~~-p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 329 DKIVNDP-------------LEFPEN-P--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHHhcCc-------------ccCCCc-c--cccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 5544321 011111 0 1111222899999999999999999999888776654443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=340.13 Aligned_cols=246 Identities=17% Similarity=0.299 Sum_probs=197.8
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCCcCH----HHHHHHHHHHhhccCCCeeeEEEEEeC--C-CCcEEEEEecc
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE----NTFRKEAEALGKVKHRNLTVLRGYYAG--P-PDVRLLVYDYM 915 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~--~-~~~~~lV~e~~ 915 (1133)
..||+|++|.||+|.+ +|+.||||++....... +.+.+|++++++++||||+++++++.+ . ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 58999999997654332 567799999999999999999999865 2 23558999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
++|+|.+++... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 105 ~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 105 TRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 999999999763 2478999999999999999999984 8999999999999999999999999998754221
Q ss_pred CCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 995 ASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.....+.. .
T Consensus 177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~------ 243 (283)
T PHA02988 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----L------ 243 (283)
T ss_pred ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----C------
Confidence 123468889999999976 6789999999999999999999999987665555444332211111 0
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
+.. ... ...+++.+||+.||++||++.|+++.|+.++.
T Consensus 244 -~~~---~~~--~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 244 -PLD---CPL--EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCc---CcH--HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000 011 12378999999999999999999999987653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=347.84 Aligned_cols=242 Identities=21% Similarity=0.385 Sum_probs=202.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
..++|.+.++||+|.||+|+.|..+ +++.+|||+++++.+ +.+....|.+|+..+ +||.++.++..|...+ ..
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-HL 444 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-eE
Confidence 4568999999999999999999876 588999999987643 356778899998888 5999999999998764 45
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+||||+.||++..+.+ ...+++..+..++..|+.||+|||++||||||||-+|||+|.+|++||+|||+++..
T Consensus 445 ~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999998443333 245899999999999999999999999999999999999999999999999999753
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
. ..+....+.+||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+.+.+++.+.+... +..-|
T Consensus 519 m---~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------~~~yP 588 (694)
T KOG0694|consen 519 M---GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------EVRYP 588 (694)
T ss_pred C---CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------CCCCC
Confidence 2 2344667889999999999999999999999999999999999999999988888887776542 22222
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1104 (1133)
.+.. ...+.++.+++..+|++|..+
T Consensus 589 ~~ls-----------~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 RFLS-----------KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred Cccc-----------HHHHHHHHHHhccCcccccCC
Confidence 2221 123478889999999999866
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.04 Aligned_cols=273 Identities=22% Similarity=0.329 Sum_probs=209.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCC-eeeEEEEEeCCCC----
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRN-LTVLRGYYAGPPD---- 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~---- 906 (1133)
...|+..++||+|+||+||+|+.+ +|+.||+|+++-... ......+|+.++++++|+| ||.+++++.....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777888999999999999764 689999999975433 2456788999999999999 9999999987653
Q ss_pred -cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 907 -VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 907 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
..++|+||+ .-+|.+++....... ..++...+..+++||++|++|||+++|+||||||+||+++++|.+|++|||+|
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 668999999 569999998755321 33666788999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+...- .....+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|.+..+.+....+-+....+. +
T Consensus 168 ra~~i---p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~--e 242 (323)
T KOG0594|consen 168 RAFSI---PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN--E 242 (323)
T ss_pred HHhcC---CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC--c
Confidence 84421 11224556789999999999877 689999999999999999999999987777665555555443321 1
Q ss_pred cccCCcCCCC------CC---ChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCc
Q 001171 1065 LLEPGLLELD------PE---SSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCR 1115 (1133)
Q Consensus 1065 ~~~~~~~~~~------~~---~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~ 1115 (1133)
...|+....+ +. ....... ....+++.+|++.+|.+|.|++.++++ +....
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1111111000 00 1111111 123489999999999999999999987 55543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=321.40 Aligned_cols=279 Identities=22% Similarity=0.336 Sum_probs=210.7
Q ss_pred HHHhcCCCcccccccccceeEEEEEE-CCceEEEEEEccc---CCcCHHHHHHHHHHHhhccCCCeeeEEEEEeC----C
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRD---GTIDENTFRKEAEALGKVKHRNLTVLRGYYAG----P 904 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~ 904 (1133)
.+...+|...+.||+|+||.|+.|.. ++|+.||||++.. .....++..+|+++++.++|+||+.+.+.+.. .
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34556677789999999999999966 4689999999963 33445778899999999999999999998864 2
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
-...|+|+|+| +.+|.+.++.. +.++......+.+||++|+.|+|+.+|+|||+||+|++++.+...||+|||+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccc
Confidence 24459999999 67899999863 3388889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccC-CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc--
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAAS-TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ-- 1061 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-- 1061 (1133)
||..... ......+..+.|.+|+|||.+. ...|+.+.||||.|||+.||++|++-|.+.+.-+....+......+.
T Consensus 172 AR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 172 ARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred eeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 9876544 3344457788999999999975 45799999999999999999999999976554333333322221110
Q ss_pred ---------ccccccCCcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 001171 1062 ---------ISELLEPGLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPDMP 1121 (1133)
Q Consensus 1062 ---------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~~~ 1121 (1133)
...++... ... ....+... ..++++..+|+..||.+|+|++|.+++ ++..-...+.|
T Consensus 251 ~l~~i~s~~ar~yi~sl-p~~--p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSL-PQI--PKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHhccHHHHHHHHhC-CCC--CCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 00010000 000 01111111 233589999999999999999999975 45555555544
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=331.28 Aligned_cols=252 Identities=21% Similarity=0.419 Sum_probs=204.6
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
.+|++.+.||+|+||.||+|+++++..+|+|.+.......+.+.+|++++++++||||+++++++.... ..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-PLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-CEEEEEEcCC
Confidence 458889999999999999999988889999998776666788999999999999999999999987764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.++++... ..+++..+..++.|++.|++|||++||+||||||+||+++.++.++++|||.++....... .
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--T 156 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce--e
Confidence 999999987532 2378999999999999999999999999999999999999999999999999875422111 1
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+.+.... ..+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~------~~~~~----- 225 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL------YRPKL----- 225 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC------CCCCC-----
Confidence 1122345668999999988889999999999999999999 89999776655555554332110 00100
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
. . ....+++.+||+.+|.+||+++|+++.|.
T Consensus 226 ~----~--~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 A----S--MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred C----C--HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0 12248899999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=328.13 Aligned_cols=266 Identities=21% Similarity=0.357 Sum_probs=215.4
Q ss_pred HHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
-+.+...+.++||+|.||+|..+....+..||||.++.+... ..+|.+|+++|.+++|||||+++|+|..++.. ++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi-cmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL-CMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch-HHH
Confidence 356677889999999999999999988899999999865543 36899999999999999999999999887555 899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
+|||++|+|.+++.++.... ..-..-..|+.|||.|++||.+.++||||+.++|+|+|+++++||+|||++|-....
T Consensus 614 ~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999999864321 334445669999999999999999999999999999999999999999999855433
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh--CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT--GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
+. .......+-..+|||||.+.-++++.++|||+||+++||+++ .+.||....+++.++........+....++...
T Consensus 691 ~y-y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 691 DY-YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred Cc-eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 22 222334456679999999999999999999999999999876 788998888888777766655544333332211
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
...... ..+++.+||..|-++||+++++...|.+.
T Consensus 770 ------~~cp~~----lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 770 ------PACPQG----LYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------CcCcHH----HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111 12788999999999999999999998763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=348.97 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=200.1
Q ss_pred HhcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.++||+|+||.||+|.+ ..+..||||+++.... ..+.+.+|+++++.+ +||||+++++++....
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345799999999999999999964 2367899999864332 245788999999999 8999999999998765
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC-------------------------------------------------------
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ------------------------------------------------------- 930 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 930 (1133)
. .++||||+++|+|.++++.....
T Consensus 113 ~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 113 P-TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred c-ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 4 59999999999999999753210
Q ss_pred ---------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 931 ---------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 931 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
....+++..+..++.||++||+|||+.+|+||||||+||+++.++.+|++|||+++....... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-Y 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-c
Confidence 112478888999999999999999999999999999999999999999999999875432211 1
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChh-hHHHHHHHHhhhccccccccCCcCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDE-DIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+.+...... . .+..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----~--~~~~--- 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM----L--SPEC--- 341 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC----C--CCCC---
Confidence 11222345678999999999999999999999999999998 88998654332 233322221100 0 0000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.. ....+++.+||+.||++||++.||++.|++
T Consensus 342 --~~------~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 --AP------SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CC------HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00 112378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=338.59 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=202.3
Q ss_pred hcCCCcccccccccceeEEEEEECC-----------------ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeee
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-----------------GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTV 896 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~ 896 (1133)
.++|.+.++||+|+||.||+|.+++ +..||+|.+..... ....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 34799999875432 2357889999999999999999
Q ss_pred EEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccC--------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceec
Q 001171 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQ--------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962 (1133)
Q Consensus 897 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~ 962 (1133)
+++++.... ..++||||+++|+|.+++...... ....+++..+..++.||+.|++|||+.||+||
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 84 LLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999998764 459999999999999998764311 11246788899999999999999999999999
Q ss_pred ccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh--CCCC
Q 001171 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT--GRKP 1040 (1133)
Q Consensus 963 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~P 1040 (1133)
||||+||+++.++.+||+|||+++....... ........++..|+|||++.++.++.++|||||||++|||++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999875432211 111223456788999999988889999999999999999987 5678
Q ss_pred CccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1041 VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1041 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
|......+....+.............. ...... ....+++.+||+.||++||++.||.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~------~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLF----RPPPCP------QGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhcccccccc----CCCCCC------HHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 876555555554444322211100000 000011 112378999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=342.38 Aligned_cols=244 Identities=18% Similarity=0.285 Sum_probs=198.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||.||+|..+ +|+.||+|++.... ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEE
Confidence 36889999999999999999775 68999999986432 1235678899999999999999999888765 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 80 MEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 99999999999997643 378888999999999999999999999999999999999999999999999865421
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...........+... ...+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~--------- 217 (291)
T cd05612 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEF--------- 217 (291)
T ss_pred -----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCC---------
Confidence 122356899999999999888999999999999999999999999776655544443321 1111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
+... . ....+++.+|++.||.+||+ +.|++++
T Consensus 218 --~~~~---~--~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 --PRHL---D--LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CccC---C--HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1110 0 11237899999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=336.74 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=196.5
Q ss_pred CCcccccccccceeEEEEEE-CCceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
|+..+.||+|+||.||+|.. .+|+.||+|.+..... ....+.+|++++++++|++++.+.+++.... ..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-ALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-eEEEEEE
Confidence 67889999999999999976 4689999999864322 2345778999999999999999999987764 5599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.+++..... ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 9999999988865332 34789999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||...........+......... .+
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~ 224 (285)
T cd05631 156 --ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE---------EY 224 (285)
T ss_pred --CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc---------cC
Confidence 1123457899999999999999999999999999999999999999765443333333322221110 00
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
... ... ...+++.+||+.||++||+ ++|++++
T Consensus 225 ~~~---~s~--~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 225 SEK---FSE--DAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred Ccc---CCH--HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 000 001 1237899999999999997 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=349.07 Aligned_cols=262 Identities=21% Similarity=0.338 Sum_probs=199.5
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.++||+|+||.||+|.+. ++..||+|++...... ...+.+|+++++.+ +|||||++++++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457999999999999999999742 2457999999754322 34678999999999 8999999999998764
Q ss_pred CcEEEEEeccCCCCHHHHHHhhcc--------------------------------------------------------
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASH-------------------------------------------------------- 929 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 929 (1133)
..++||||+++|+|.+++.....
T Consensus 116 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 116 -PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred -CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 45999999999999999865321
Q ss_pred ---------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCC
Q 001171 930 ---------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000 (1133)
Q Consensus 930 ---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 1000 (1133)
.....+++..+++++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... ......
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~~ 273 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGN 273 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeeccC
Confidence 0112477888899999999999999999999999999999999999999999999865432211 111222
Q ss_pred CCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1001 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.............+. . .... .+.. ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~---~-~~~~-~~~~-----~~-- 341 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR---G-YQMS-RPDF-----AP-- 341 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc---c-cCcc-CCCC-----CC--
Confidence 345678999999988899999999999999999997 99999654433222222111 1 0000 0000 00
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
....+++.+||+.||++||++.||++.|+++
T Consensus 342 ----~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 342 ----PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1123788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=330.15 Aligned_cols=256 Identities=21% Similarity=0.389 Sum_probs=206.4
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++||||+++++++.... ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-PIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CcEEEEecC
Confidence 3578999999999999999999888889999998766556678999999999999999999999987764 459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.++++... ...+++..+..++.|++.|++|||+.+++||||||+||+++.++.++++|||.++.......
T Consensus 84 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 158 (261)
T cd05072 84 AKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-- 158 (261)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce--
Confidence 9999999997642 23478889999999999999999999999999999999999999999999999875432111
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+...... +...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~--- 227 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM--------PRME--- 227 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------CCCC---
Confidence 11222345678999999988889999999999999999998 99999765555544443221100 0000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... ....+++.+|+..+|++||+++++.+.|+++
T Consensus 228 ----~~~--~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 ----NCP--DELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCC--HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000 1123789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.83 Aligned_cols=261 Identities=22% Similarity=0.364 Sum_probs=198.1
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhh--ccCCCeeeEEEEEeCCC---CcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGK--VKHRNLTVLRGYYAGPP---DVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~---~~~~lV~ 912 (1133)
..++.++||+|+||.||+|.+. ++.||||+++.. +++.|..|-+|++. ++|+||++++++-.... -..++|+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3456788999999999999987 599999999743 45788888888665 58999999998765432 2348999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc---------CCceecccCccceeeCCCCceEEeccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS---------LDMVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------~~ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
||.+.|+|.+++.. .+++|....+|+..+++||+|||+ .+|+|||||++|||+..|+.+.|+|||
T Consensus 288 ~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999987 348999999999999999999995 359999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCC------CCCCCchhHHHHHHHHHHhCCC------------CCc---
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ------PTKEADVYSFGIVLLEILTGRK------------PVM--- 1042 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~el~tg~~------------Pf~--- 1042 (1133)
+|..+.+... .......+||.+|||||++.+.- .-.+.||||+|.|+|||+++.. ||.
T Consensus 362 LAl~~~p~~~-~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 362 LALRLEPGKP-QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred eeEEecCCCC-CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9987654433 23344579999999999997643 2256899999999999998643 232
Q ss_pred --cCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1043 --FTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1043 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
...-+++...+.+...++.+++. +... .......+.+..||+.||+.|.|+.=+-+++.++.....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~----W~~h-------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDA----WRKH-------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhh----hhcC-------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 12234555555554444433322 2211 111112267778999999999999888877776665543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.39 Aligned_cols=252 Identities=19% Similarity=0.326 Sum_probs=211.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|...+++|+|+||.++.++++ ++..|++|++...... .+...+|+.++++++|||||.+.+.|..++...++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999999776 5789999999654432 457789999999999999999999999887767999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|+|++||++.+.+.+.+ +..++++....++.|++.|+.|||+++|+|||||+.|||++.++.++++|||+|+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999999866 345899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. ......+||+.||.||.+.+..|..|+||||+||++|||++-+++|...+...+...+.+.... +
T Consensus 160 ~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~--------P--- 225 (426)
T KOG0589|consen 160 D---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS--------P--- 225 (426)
T ss_pred h---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC--------C---
Confidence 2 2345678999999999999999999999999999999999999999888777766665553211 0
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
-...+.... ..++..|+..+|+.||++.+++.+
T Consensus 226 ----lp~~ys~el--~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ----LPSMYSSEL--RSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCccccHHH--HHHHHHHhhcCCccCCCHHHHhhC
Confidence 001111111 157888999999999999999865
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=345.25 Aligned_cols=244 Identities=19% Similarity=0.293 Sum_probs=197.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|+++ +++.||+|++.... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-RVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-EEEEE
Confidence 47899999999999999999875 58999999986432 22356889999999999999999999998764 55999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 99999999999998643 378888889999999999999999999999999999999999999999999865421
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...........+... ...++..+
T Consensus 171 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~----- 238 (329)
T PTZ00263 171 -----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWF----- 238 (329)
T ss_pred -----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCC-----
Confidence 122357899999999999888999999999999999999999999766554444333221 00111100
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
. ....+++.+||+.||.+||+ ++|++++
T Consensus 239 -----~------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 -----D------GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----C------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 01237899999999999986 6888755
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.14 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=206.3
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|++|.||+|.+.+++.||+|.+.......+.+.+|++++++++|||++++++++.... ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-PIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCC-Ceeeeeecc
Confidence 4578999999999999999998877889999999876666778999999999999999999999987764 459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... +..+++..+..++.|++.|+.|||+.||+||||||+||+++.++.++++|||+++.......
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (261)
T cd05068 84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-- 158 (261)
T ss_pred cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc--
Confidence 9999999997643 24588999999999999999999999999999999999999999999999999876532111
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
........+..|+|||++.+..++.++||||||+++|||++ |+.||...........+.+... . . ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~-~-~~~------ 227 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR---M-P-CPP------ 227 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---C-C-CCC------
Confidence 11112223457999999988889999999999999999999 9999976555444443322110 0 0 000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... ....+++.+|++.+|.+||++.++++.|+.+
T Consensus 228 ~~~------~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 228 GCP------KELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred cCC------HHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 000 1223788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=329.89 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=200.4
Q ss_pred cCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.+|++.++||+|+||.||+|.++ .+..||+|.+...... .+.+.+|++++++++||||+++++++.... ..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN-TMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-CcEE
Confidence 46889999999999999999753 3678999998754322 357889999999999999999999998764 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++.... ..+++..++.++.||+.|++|||+.|++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999997642 2488999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ........++..|+|||++.+..++.++|||||||++||+++ |+.||......+....+.+... .. .
T Consensus 160 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----~~-~--- 229 (266)
T cd05064 160 EA--IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR----LP-A--- 229 (266)
T ss_pred cc--hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----CC-C---
Confidence 11 111122345678999999998999999999999999999876 9999977666554444322110 00 0
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
+.. ... ...+++.+||+.+|++||++.||.+.|+++
T Consensus 230 -----~~~--~~~--~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 -----PRN--CPN--LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCC--CCH--HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 011 122788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=342.07 Aligned_cols=265 Identities=23% Similarity=0.343 Sum_probs=203.1
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.++||+|+||.||+|... +++.||+|++...... .+.+.+|+++++++ +||||+++++++...+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457999999999999999999542 2578999998753322 34677899999999 8999999999987766
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC-------------------------------------------------------
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ------------------------------------------------------- 930 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 930 (1133)
...++||||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 7778999999999999998653211
Q ss_pred -CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccC
Q 001171 931 -DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009 (1133)
Q Consensus 931 -~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a 1009 (1133)
....+++..+..++.||+.|++|||+.+|+||||||+||+++.++.++|+|||+++....... ........++..|+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~~y~a 243 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMA 243 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCccccC
Confidence 012578999999999999999999999999999999999999999999999999976532221 111223456678999
Q ss_pred ccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHh
Q 001171 1010 PEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVK 1088 (1133)
Q Consensus 1010 PE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1133)
||++.+..++.++||||+||++|||++ |..||......+... +........ ..+. ... ....+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~---~~~~~~~~~-~~~~------~~~------~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC---RRLKEGTRM-RAPE------YAT------PEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH---HHHhccCCC-CCCc------cCC------HHHHH
Confidence 999999999999999999999999998 999996543322211 111111100 0000 000 11237
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1089 VGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1089 li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
++.+||+.+|++||++.|++++|+++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=367.94 Aligned_cols=503 Identities=28% Similarity=0.342 Sum_probs=281.1
Q ss_pred EeccCCcccCcCCCccccccchhhhhhcccccCCCccCcc---CCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCc
Q 001171 124 VYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200 (1133)
Q Consensus 124 L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~---~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~ 200 (1133)
+|++..+++ .||..+.+-..|+.|++.+|.+-... -++ .-.|+.||||+|+++ ..|..+..+.+|+.|+++.|-
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~p-l~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRP-LEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCc-hHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 566666666 67777766666888888888764211 111 123666666666664 345555555566666666665
Q ss_pred CCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccc
Q 001171 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVS 280 (1133)
Q Consensus 201 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 280 (1133)
|. ..|.+..++.+|++|.|.+|++. ..|.++..+.+|+.|+++.|.+. .+|..+..++.++.++.++|......
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l--- 153 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL--- 153 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh---
Confidence 55 45555555566666666655554 55555555555555555555554 23444555555555555555111000
Q ss_pred cccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccC
Q 001171 281 VLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360 (1133)
Q Consensus 281 ~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 360 (1133)
+. ..++.++|..|.+.+-.+....++++ .|||++|.+. -..+.
T Consensus 154 ------g~--------------------------~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls 196 (1081)
T KOG0618|consen 154 ------GQ--------------------------TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLS 196 (1081)
T ss_pred ------cc--------------------------ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhh
Confidence 00 01334444444444333444444444 5666666654 12344
Q ss_pred CCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCcccccee
Q 001171 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440 (1133)
Q Consensus 361 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 440 (1133)
++.+|+.|....|++.... -.-++|+.|+.++|.++...+.. .-.+|+++++++|++++
T Consensus 197 ~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~--------------- 255 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLSN--------------- 255 (1081)
T ss_pred hccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecccc--ccccceeeecchhhhhc---------------
Confidence 5566666666666665321 12245556666666554221111 11244445555555543
Q ss_pred ecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCC
Q 001171 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 441 ~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
+|++++.+.+|+.|+..+|+++ .+|..+....+|+.|.+..|.++ .+|.....++.|++|||..|+|.
T Consensus 256 ----------lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~ 323 (1081)
T KOG0618|consen 256 ----------LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP 323 (1081)
T ss_pred ----------chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc
Confidence 3344444444444444444443 44444444444444444444444 34444455555555555555554
Q ss_pred CCCChhccC-CC-CCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCcc
Q 001171 521 GELPIELFG-LP-SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAE 598 (1133)
Q Consensus 521 ~~~p~~l~~-l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 598 (1133)
..|..+.. .. .|..|+.+.|++.......=..++.|+.|.+.+|.+++..-..+.++++|+.|+|++|+|.......
T Consensus 324 -~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~ 402 (1081)
T KOG0618|consen 324 -SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASK 402 (1081)
T ss_pred -ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHH
Confidence 33333322 22 2555555566555332111223556777777777777777677777777777777777777444455
Q ss_pred ccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccc
Q 001171 599 LGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLT 678 (1133)
Q Consensus 599 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 678 (1133)
+.++..|+.|+||+|+++ .+|..+..++.|++|...+|++. ..| ++..++.|+.+|+|.|+++...-..-..-++|+
T Consensus 403 ~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~Lk 479 (1081)
T KOG0618|consen 403 LRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLK 479 (1081)
T ss_pred HhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccc
Confidence 677777888888888887 47777777888888888888887 666 777788888888888887743322222226788
Q ss_pred ccccccccccccCCccccccccCcccccccc
Q 001171 679 TLNLSTNRLSGAIPADLALISSLRYLNLSRN 709 (1133)
Q Consensus 679 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N 709 (1133)
+|||++|.-.-.--..+..+.++..+++.-|
T Consensus 480 yLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 480 YLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred eeeccCCcccccchhhhHHhhhhhheecccC
Confidence 8888888633233344555666666666665
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=342.62 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=201.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-EYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-CEEEEE
Confidence 36899999999999999999876 58999999986432 1235678899999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999997643 378889999999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.........+...++.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 226 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR-- 226 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc--
Confidence 2334579999999999998899999999999999999999999998766655544443321111111111100
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ... ....+++.+|+..+|.+||++.|++++
T Consensus 227 ---~---~~s--~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 ---F---NLS--DEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---c---ccC--HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 000 112378889999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.96 Aligned_cols=250 Identities=22% Similarity=0.395 Sum_probs=205.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---------HHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---------ENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
-.+|...+++|+|..++|-+..++ +|..+|+|++...... .++-.+|+.|++++ -||+|+.+.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 446788899999999999998664 6888999988532211 13456799999998 699999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
...++|+|.|+.|.|++++... -.+++...+.|+.|+.+|++|||.+.||||||||+|||+|++.+++|+|||+
T Consensus 96 -sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 -AFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred -chhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 5558999999999999999864 3488999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccC------CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAAS------TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
|.... .+.+....+|||+|.|||.+. ...|+..+|+|+.|||||-++.|.+||......-+...+.++
T Consensus 170 a~~l~----~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG-- 243 (411)
T KOG0599|consen 170 ACQLE----PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG-- 243 (411)
T ss_pred eeccC----CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc--
Confidence 97653 334556789999999999984 345789999999999999999999999755444444333332
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
++.+...+|.+....+ ++|.+|++.||.+|.|++|++++
T Consensus 244 -------------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 -------------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -------------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2334566677776666 89999999999999999999864
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.26 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=203.6
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++|++.+.||+|+||.||+|+++++..+|+|.+.......+.+.+|++++++++||||+++++++.... ..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-PIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-CcEEEEEcCC
Confidence 468889999999999999998887778999998866666778999999999999999999999997664 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++..... .+++..++.++.||+.|++|||+.|++|+||||+||+++.++.+|++|||.++....... .
T Consensus 83 ~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~ 156 (256)
T cd05113 83 NGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--T 156 (256)
T ss_pred CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce--e
Confidence 9999999976332 478999999999999999999999999999999999999999999999999875432211 1
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+...... . ..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~-~~-------- 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----Y-RP-------- 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----C-CC--------
Confidence 1122345678999999988889999999999999999998 99999766655544443322110 0 00
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
.. .. ....+++.+||+.+|++||++.++++.|+
T Consensus 224 ~~--~~--~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HL--AS--EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CC--CC--HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 00 12237889999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.69 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=197.0
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
...|+..+.||+|+||.||+|.+ +.++.||+|++.-+.. +.+.+++|+.++.+.+++||.++++.|..+. ..+++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-KLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-cHHHHH
Confidence 34677789999999999999966 5689999999964332 3568899999999999999999999888764 458999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|||.||++.+.++.... +++.....+.+++..|+.|+|.++.+|||||+.||++..+|.+|++|||++.....
T Consensus 91 ey~~gGsv~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~-- 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN-- 163 (467)
T ss_pred HHhcCcchhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec--
Confidence 99999999999986433 36666667889999999999999999999999999999999999999999864422
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
......+++||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+....+..+...+ ++-..|.+..
T Consensus 164 -~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------pk~~PP~L~~ 233 (467)
T KOG0201|consen 164 -TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------PKSAPPRLDG 233 (467)
T ss_pred -hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------cCCCCCcccc
Confidence 222336789999999999999889999999999999999999999999755442211111 1111111111
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.....+. +++..|+.+||+.||++.+++++
T Consensus 234 --~~S~~~k------EFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 --DFSPPFK------EFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --ccCHHHH------HHHHHHhhcCcccCcCHHHHhhh
Confidence 1122233 45666999999999999998854
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=334.67 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=211.1
Q ss_pred HhcCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCc----CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTI----DENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 908 (1133)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+... +...+.+|+++|+++. |||||.+++.|+... ..
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eE
Confidence 45578999999999999999998875 99999999975443 3468999999999998 999999999999875 45
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC----CceEEeccCc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD----FEAHLSEFGL 984 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~ 984 (1133)
++|||++.||.|.+.+.+. . +++.....++.||+.|++|||+.||+|||+||+|+|+... +.+|++|||+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 9999999999999999875 1 8899999999999999999999999999999999999543 5799999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+... .+
T Consensus 186 a~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----~~-- 255 (382)
T KOG0032|consen 186 AKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----DF-- 255 (382)
T ss_pred ceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC----CC--
Confidence 976533 33456678999999999999899999999999999999999999999887766655543332 11
Q ss_pred cccCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+....|+.+...+ +++.+|+..||.+|+++.+++++
T Consensus 256 ---------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ---------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22333444444444 88999999999999999999997
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=341.18 Aligned_cols=241 Identities=20% Similarity=0.319 Sum_probs=192.6
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
++||+|+||.||+|+.+ +|+.||+|++.... .....+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-EEEEEEeCCCC
Confidence 46999999999999764 68999999986432 12346778999999999999999999988764 55999999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
|+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~~ 151 (323)
T cd05571 80 GELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---GAT 151 (323)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC---CCc
Confidence 99999987643 3789999999999999999999999999999999999999999999999998643211 122
Q ss_pred CCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCC
Q 001171 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1133)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...+ +...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~-----------p~~~ 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRF-----------PRTL 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCC-----------CCCC
Confidence 33457999999999999999999999999999999999999999766554444333221 1111 1110
Q ss_pred hhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1078 SEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1078 ~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
. ....+++.+|++.||++|| ++.|++++
T Consensus 219 ---~--~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 ---S--PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---C--HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 1123788899999999999 79998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.79 Aligned_cols=265 Identities=19% Similarity=0.284 Sum_probs=198.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.++||+|+||.||+|..+ ++..||+|++..... ....+.+|++++++++||||+++++++... ...++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEEe
Confidence 57999999999999999999775 688999999864322 245678899999999999999999998765 45689999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ |+|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-- 156 (288)
T cd07871 84 YLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-- 156 (288)
T ss_pred CCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--
Confidence 996 58999887543 23788889999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc---cccccC-
Q 001171 994 EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI---SELLEP- 1068 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 1068 (1133)
........+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.+....... +.....
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 -TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred -CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 112234568899999999865 46899999999999999999999999776655554444433221110 000000
Q ss_pred CcCCCC--C-CChhHHH-----HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELD--P-ESSEWEE-----FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~--~-~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.... . ....... -....+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0 0000000 0123489999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=316.03 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=205.3
Q ss_pred cCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
+.|++.+.||+|.-|+||.++.++ +..+|+|++.+.... ..+.+.|-+||+.++||.+..+++.++.+ ++.++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-KYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-ceeEEE
Confidence 457788999999999999998874 589999999654332 34677899999999999999999999876 566999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||||+||+|..+.+++ .+..+++..++.++..|+.||+|||-.|||+|||||+||||.++|++.++||.++......
T Consensus 156 meyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999864 3567999999999999999999999999999999999999999999999999987433210
Q ss_pred C-------------------------------C-C---------------------CCCCCCCCCCCCccCccccCCCCC
Q 001171 992 P-------------------------------A-E---------------------ASSSTTPIGSLGYVSPEAASTGQP 1018 (1133)
Q Consensus 992 ~-------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 1018 (1133)
+ . . ..+....+||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 011234579999999999999999
Q ss_pred CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHh-HhhhhccCCCC
Q 001171 1019 TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLG-VKVGLLCTAPD 1097 (1133)
Q Consensus 1019 ~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~li~~Cl~~d 1097 (1133)
+.++|.|+|||++|||+.|..||.+.+..+....+... ...+++ . .++... .++|++.+.+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--~l~Fp~-----------~----~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--PLKFPE-----------E----PEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--CCcCCC-----------C----CcchhHHHHHHHHHhccC
Confidence 99999999999999999999999888777666555432 111111 1 022222 38999999999
Q ss_pred CCCCCC----HHHHHHH
Q 001171 1098 PLDRPS----MADIVFM 1110 (1133)
Q Consensus 1098 P~~RPs----~~evl~~ 1110 (1133)
|.+|.. ++||.++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999987 8888754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.69 Aligned_cols=259 Identities=23% Similarity=0.416 Sum_probs=204.2
Q ss_pred cCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
++|++.+.||+|+||.||+|.... ...||+|.+..... ..+.+.+|++++++++||||+++++++.... ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ-PT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC-ce
Confidence 468899999999999999997642 26799999864332 2356889999999999999999999987654 45
Q ss_pred EEEEeccCCCCHHHHHHhhccCCC-----------CCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCce
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDG-----------HVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEA 977 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 977 (1133)
+++|||+++|+|.+++........ ..+++..+..++.|++.|++|||+.+|+||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 899999999999999987533222 457888999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHH
Q 001171 978 HLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 978 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
+|+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+.+.
T Consensus 164 ~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 164 KISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875432211 112233456788999999988889999999999999999998 99999776665555444332
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
...... . . .. ....+++.+||+.||.+||++.||+++|+.+
T Consensus 243 ----~~~~~~-~-------~---~~--~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 243 ----QLLPCP-E-------D---CP--ARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ----CcCCCc-c-------c---CC--HHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111110 0 0 00 1123788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=341.70 Aligned_cols=244 Identities=20% Similarity=0.280 Sum_probs=197.0
Q ss_pred cCCCcccccccccceeEEEEEECC--ceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD--GMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|++.++||+|+||.||+|.++. +..||+|++.... ...+.+.+|+++++.++||||+++++++... ...++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEEE
Confidence 468999999999999999997643 3689999985422 2245678899999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999998643 378889999999999999999999999999999999999999999999999875421
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+.... ..+ +
T Consensus 184 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~----p--- 248 (340)
T PTZ00426 184 ------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYF----P--- 248 (340)
T ss_pred ------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCC----C---
Confidence 1234578999999999988889999999999999999999999997665544444332211 000 1
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.... . ...+++.+|++.||++|+ +++|++++
T Consensus 249 ----~~~~---~--~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 ----KFLD---N--NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCC---H--HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1100 0 123788899999999995 89988865
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=341.60 Aligned_cols=263 Identities=20% Similarity=0.287 Sum_probs=201.6
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVK-HRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 905 (1133)
..++|.+.++||+|+||.||+|.+. .+..||||++..... ..+.+.+|+++++++. ||||+++++++...
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 4668999999999999999999753 235799999965332 2457889999999996 99999999999776
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC-------------------------------------------------------
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ------------------------------------------------------- 930 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 930 (1133)
...++||||+++|+|.+++......
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 4459999999999999998764210
Q ss_pred ------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC
Q 001171 931 ------------------------------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD 974 (1133)
Q Consensus 931 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~ 974 (1133)
....+++..+..++.||++|++|||+.+|+||||||+||+++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 01247788889999999999999999999999999999999999
Q ss_pred CceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhh-HHHH
Q 001171 975 FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDED-IVKW 1052 (1133)
Q Consensus 975 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~-~~~~ 1052 (1133)
+.+|++|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 274 ~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999875432211 112233456788999999988889999999999999999997 999986543222 2222
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
+.. +.... .. .. .. ....+++.+||+.||++||++.+|.+.|+++..
T Consensus 353 ~~~----~~~~~-~~-------~~---~~--~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IKS----GYRMA-KP-------DH---AT--QEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred Hhc----CCCCC-CC-------cc---CC--HHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 211 10000 00 00 00 112378999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=334.61 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=202.3
Q ss_pred cCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.+|++.+.||+|+||.||+|.+. +|+ .||+|++..... ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence 46899999999999999999764 333 489999864332 246788999999999999999999998764 347
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+|+||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999998643 237888899999999999999999999999999999999999999999999997653
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+..... . ..+
T Consensus 161 ~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~---~~~ 233 (316)
T cd05108 161 ADEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---L---PQP 233 (316)
T ss_pred CCCc-ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC---C---CCC
Confidence 2211 111122334678999999999999999999999999999998 9999976555444332221100 0 000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
. ... ....+++.+||+.+|++||++.+++..+..+...+.
T Consensus 234 ~-----~~~------~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 234 P-----ICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred C-----CCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0 001 112378889999999999999999999988776553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=340.36 Aligned_cols=266 Identities=22% Similarity=0.376 Sum_probs=195.8
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC----CcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~ 909 (1133)
+|++.++||+|+||.||+|... +|+.||||++.... .....+.+|++++++++||||+++++++.... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999765 68999999986422 22456889999999999999999999885432 2358
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+ +++|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 478999887532 38899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc------
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ------ 1061 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------ 1061 (1133)
.............|++.|+|||++.+ ..++.++||||+||++|||++|+.||...+.......+........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 22222222234579999999999865 5789999999999999999999999976554333322222111100
Q ss_pred -----ccccccCCcCCCCCC--ChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 -----ISELLEPGLLELDPE--SSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 -----~~~~~~~~~~~~~~~--~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+.... +....+. ...+... ....+++.+|++.||++||+++|++++
T Consensus 235 i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 0000000 0000000 112378999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.85 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=201.5
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
+|++.+.||+|+||.||+|.++.+..+|+|.+.......+.+.+|++++++++||||+++++++... ...++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecCCC
Confidence 5788999999999999999888778899999876665667889999999999999999999998766 455999999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
++|.+++.... ..+++..+..++.|++.|++|||+.||+||||||+||+++.++.+|++|||+++....... ..
T Consensus 84 ~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--~~ 157 (256)
T cd05059 84 GCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TS 157 (256)
T ss_pred CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc--cc
Confidence 99999997543 2478999999999999999999999999999999999999999999999999875432111 11
Q ss_pred CCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+...... . ... ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~-~~~------~~ 226 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL----Y-RPK------LA 226 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----C-CCC------CC
Confidence 112234457999999998899999999999999999999 89999766555544433221100 0 000 00
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
. ....+++.+||..+|++||++.|+++.|.
T Consensus 227 ~------~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 227 P------TEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred C------HHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0 11237899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.66 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=197.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.+.||+|+||.||+|+++ +++.||+|++..... ..+.+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-GKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-CEEEEEE
Confidence 36899999999999999999886 588999999865432 245678999999999999999999998775 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++++.+..+... ...+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++......
T Consensus 80 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 80 EYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred ecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99988776654432 1247888999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhh------------c
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR------------G 1060 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~------------~ 1060 (1133)
........|++.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+...... .
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 155 --NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred --cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 11223456899999999998888999999999999999999999999765544333222221110 0
Q ss_pred cccccccCCcCCCCCCChh-HHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEPGLLELDPESSE-WEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.......+........... ..... ...+++.+|++.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000000 00011 23389999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.12 Aligned_cols=255 Identities=22% Similarity=0.393 Sum_probs=203.2
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.+|++.+.||+|+||.||+|.++ .++.||+|++.......+.+.+|++++++++|||++++++++.... ..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-CcEEEEEeC
Confidence 45788899999999999999765 5889999998766555678899999999999999999999987764 448999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... ...+++..+..++.|+++|++|||+.|++||||||+||++++++.+|++|||+++.......
T Consensus 85 ~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-- 159 (263)
T cd05052 85 TYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 159 (263)
T ss_pred CCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee--
Confidence 9999999997643 23488999999999999999999999999999999999999999999999999865432111
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.....++....+..... ... +
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------~~~---~ 227 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---------MER---P 227 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---------CCC---C
Confidence 11112234568999999988889999999999999999998 9999976555444333322110 000 0
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... . ....+++.+||+.||++||++.|+++.|+.+
T Consensus 228 ~~~---~--~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGC---P--PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCC---C--HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000 0 1123789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=339.78 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=188.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|+..++||+|+||.||+|.+. +|+.||||++...... .+.+.+|++++++++|+||+++++++.... ..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-EIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-eEEEEEe
Confidence 35677889999999999999775 6899999998643322 457889999999999999999999997764 4589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.+.. ...+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 99999986422 24567778899999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCCCCCCCccCccccCC-----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 994 EASSSTTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||......+....+..... ...... ..
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-~~ 298 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-SQPPEA-PA 298 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-cCCCCC-CC
Confidence 12234578999999998743 2345689999999999999999999974333332222221111 100000 00
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ....+++.+||+.||++||++.|++++
T Consensus 299 ------~~~------~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 ------TAS------REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------ccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 112378889999999999999999987
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.26 Aligned_cols=239 Identities=20% Similarity=0.331 Sum_probs=189.1
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
||+|+||.||+|.+. +++.||+|++... ......+.+|++++++++||||+++++++... ...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCc
Confidence 799999999999775 5889999998642 22245678899999999999999999998876 45599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++..... .....
T Consensus 80 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~ 151 (312)
T cd05585 80 LFHHLQREG-----RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD---DDKTN 151 (312)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC---CCccc
Confidence 999997643 3788999999999999999999999999999999999999999999999998643221 12233
Q ss_pred CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.. ... .++...
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~~~---------~~~~~~-- 216 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----EPL---------RFPDGF-- 216 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----CCC---------CCCCcC--
Confidence 45799999999999998999999999999999999999999976555443333221 100 000000
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCC---HHHHHHH
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPS---MADIVFM 1110 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs---~~evl~~ 1110 (1133)
. ....+++.+||+.||++||+ +.|++.+
T Consensus 217 -~--~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 -D--RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -C--HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 0 11227888999999999975 5666643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=327.44 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=204.9
Q ss_pred hcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|.+.+.||+|+||.||+|.+.+ ++.||+|.+...... .+.+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CC
Confidence 3468889999999999999997643 478999998754433 46889999999999999999999999876 45
Q ss_pred EEEEEeccCCCCHHHHHHhhcc---------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 908 RLLVYDYMPNGNLATLLQEASH---------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
.++||||+++++|.+++...+. .....+++..+..++.|++.|++|||++|++||||||+||+++.++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 6999999999999999986532 1224478889999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
++|||+++....... ........+++.|+|||++.+..++.++||||+||++|||++ |..||......+..+.+...
T Consensus 163 l~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~- 240 (280)
T cd05049 163 IGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG- 240 (280)
T ss_pred ECCcccceecccCcc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence 999999865422211 111223346788999999999999999999999999999998 99999766665555444321
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
..... ... .. ....+++.+||+.||++||++.||++.|++
T Consensus 241 ---~~~~~-~~~------~~------~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 241 ---RLLQR-PRT------CP------SEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---CcCCC-CCC------CC------HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11110 000 00 112378999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=328.67 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=197.1
Q ss_pred cCCCcccccccccceeEEEEEEC--CceEEEEEEcccCCc---CHHHHHHHHHHHhhc---cCCCeeeEEEEEeC----C
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ--DGMVLSIRRLRDGTI---DENTFRKEAEALGKV---KHRNLTVLRGYYAG----P 904 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~hpniv~l~~~~~~----~ 904 (1133)
++|++.+.||+|+||.||+|++. +|+.||+|++..... ....+.+|+++++++ +||||+++++++.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999763 478899999864322 234566788887766 69999999998852 2
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
....++||||++ ++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+|++|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345689999995 689999876432 3478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc---
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ--- 1061 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--- 1061 (1133)
++..... .......|++.|+|||++.+..++.++||||+||++|||++|++||....+.+....+........
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 8654221 223345689999999999888899999999999999999999999987766655555544322110
Q ss_pred ccccc---cCCcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1062 ISELL---EPGLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1062 ~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.+... ...+... .....+.. ....+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000000 00001111 11227899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=321.77 Aligned_cols=247 Identities=20% Similarity=0.320 Sum_probs=194.9
Q ss_pred ccccccceeEEEEEEC---CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 844 VLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
.||+|+||.||+|.++ ++..+|+|++.....+ .+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence 5899999999999653 5789999998654332 3578899999999999999999998864 345899999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
|+|.+++.... .+++..+..++.|++.|++|+|++||+||||||+||+++.++.++++|||+++...........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 80 GPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999997532 3788999999999999999999999999999999999999999999999998755332221111
Q ss_pred CCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
.....++..|+|||.+....++.++|||||||++|||++ |+.||......+....+.+. ...... . ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~----~~~~~~-~------~~ 223 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG----ERMECP-Q------RC 223 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC----CCCCCC-C------CC
Confidence 222344678999999988888999999999999999998 99999766655544443321 111100 0 00
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
. ....+++.+||+.||++||++.+|++.|+++
T Consensus 224 ~------~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 224 P------PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C------HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0 1123789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=334.07 Aligned_cols=204 Identities=23% Similarity=0.405 Sum_probs=174.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|++. +|..||+|.+..... ..+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EEEEEe
Confidence 357999999999999999999775 588999999865322 2357889999999999999999999987764 459999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||+++|+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 83 EHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 9999999999997643 378889999999999999999986 699999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHH
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV 1050 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~ 1050 (1133)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||...+..++.
T Consensus 157 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 157 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred ----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1223456899999999999889999999999999999999999999765554443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=321.75 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=206.3
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.++||+|+||.||+|..++++.||+|.+.......+.+.+|++++++++|||++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEEEcC
Confidence 45789999999999999999998889999999998777677889999999999999999999998754 3458999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... +..+++..+..++.|++.|++|||+.|++||||||+||+++.++.++++|||.+....... .
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 157 (260)
T cd05067 83 ENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE--Y 157 (260)
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC--c
Confidence 9999999987543 2348899999999999999999999999999999999999999999999999986543211 1
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||......+....+...... ...+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~------- 226 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----PRPD------- 226 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----CCCC-------
Confidence 11223345678999999988889999999999999999999 99999766655544443221110 0000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
... ....+++.+|++.+|++||+++++++.|+.
T Consensus 227 ~~~------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 NCP------EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC------HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000 112378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=365.38 Aligned_cols=483 Identities=26% Similarity=0.330 Sum_probs=342.7
Q ss_pred EccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCc-ccccCccccceEecccccccCCCCccccCccccceeecccccc
Q 001171 171 DLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP-ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVL 249 (1133)
Q Consensus 171 ~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l 249 (1133)
|+|..+++ .||..+.+-..++.|++..|-+-. .| +.+....+|+.|+|++|++. ..|..+..+++|+.|+++.|.|
T Consensus 4 d~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~-~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 4 DASDEQLE-LIPEQILNNEALQILNLRRNSLLS-RPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred ccccccCc-ccchhhccHHHHHhhhcccccccc-CchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 34444443 344433333345555555555442 22 22233334666666666654 5555555566666666666665
Q ss_pred CCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccc
Q 001171 250 KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRA 329 (1133)
Q Consensus 250 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~ 329 (1133)
.. .|...+.+.+|++|.|..|++. ..|.++ ..+.+|++|++++|.|. .
T Consensus 81 ~~-vp~s~~~~~~l~~lnL~~n~l~-~lP~~~-----~~lknl~~LdlS~N~f~-------------------------~ 128 (1081)
T KOG0618|consen 81 RS-VPSSCSNMRNLQYLNLKNNRLQ-SLPASI-----SELKNLQYLDLSFNHFG-------------------------P 128 (1081)
T ss_pred hh-Cchhhhhhhcchhheeccchhh-cCchhH-----HhhhcccccccchhccC-------------------------C
Confidence 53 3455555666666666666554 234333 33444444444444443 2
Q ss_pred cCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCC
Q 001171 330 VFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGG 409 (1133)
Q Consensus 330 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 409 (1133)
+ |..+..++.++.++.++|... ..++... ++.++|..|.+.+.++..+..+.. .|||.+|.+. -..+.+
T Consensus 129 ~-Pl~i~~lt~~~~~~~s~N~~~----~~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~ 197 (1081)
T KOG0618|consen 129 I-PLVIEVLTAEEELAASNNEKI----QRLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSN 197 (1081)
T ss_pred C-chhHHhhhHHHHHhhhcchhh----hhhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhh
Confidence 2 455566666666666666211 1122222 666777777776666666666555 5777777765 234556
Q ss_pred CCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEE
Q 001171 410 IRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLN 489 (1133)
Q Consensus 410 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 489 (1133)
++.|+.|....|+++...- .-++|+.|+.++|.++...+ -..-.+|+++++++|+++ .+|.+++.+.+|+.++
T Consensus 198 ~~~l~~l~c~rn~ls~l~~----~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~ 270 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEI----SGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALN 270 (1081)
T ss_pred ccchhhhhhhhcccceEEe----cCcchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEec
Confidence 6777777777777764322 34789999999999883322 233568999999999999 5669999999999999
Q ss_pred cccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCcc-CcEEEccccccc
Q 001171 490 LSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG-LQYLNLSDNAFT 568 (1133)
Q Consensus 490 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~ 568 (1133)
..+|++. .+|..+...++|+.|++..|.++ -+|....++++|++|+|..|+|...++..|.-+.. |..|+.+.|++.
T Consensus 271 ~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~ 348 (1081)
T KOG0618|consen 271 ANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS 348 (1081)
T ss_pred ccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc
Confidence 9999995 78888899999999999999998 67888888999999999999998544444444444 888999999998
Q ss_pred CCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhh
Q 001171 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEIS 648 (1133)
Q Consensus 569 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 648 (1133)
......-..++.|+.|++.+|.+++..-+.+..+..|+.|+|++|+|.......+.++..|++|+||+|+++ .+|.++.
T Consensus 349 ~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva 427 (1081)
T KOG0618|consen 349 TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVA 427 (1081)
T ss_pred ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHH
Confidence 544333335678999999999999988888899999999999999998544556889999999999999999 8999999
Q ss_pred ccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccc
Q 001171 649 KCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711 (1133)
Q Consensus 649 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l 711 (1133)
++..|+.|...+|++. ..| .+.+++.|+.+|+|.|+|+...-+.....++|++|||++|..
T Consensus 428 ~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 428 NLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999999999999 677 889999999999999999854444434448999999999984
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.89 Aligned_cols=241 Identities=21% Similarity=0.323 Sum_probs=192.1
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
++||+|+||.||+++.+ +|..||+|++.... .....+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-EEEEEEeCCCC
Confidence 46999999999999764 68999999986432 12345678999999999999999999988764 55999999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---~~~ 151 (323)
T cd05595 80 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GAT 151 (323)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC---CCc
Confidence 99999887643 3789999999999999999999999999999999999999999999999998643221 112
Q ss_pred CCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCC
Q 001171 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1133)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...++ ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p-----------~~~ 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFP-----------RTL 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCC-----------CCC
Confidence 23456999999999999889999999999999999999999999766555444333221 11111 110
Q ss_pred hhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1078 SEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1078 ~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
. ....+++.+|++.||++|| ++.+++++
T Consensus 219 ~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 S-----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C-----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0 0112788899999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=324.49 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=207.4
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
...+|++.++||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++||||+++++++.... ..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-CeEEEEe
Confidence 3457899999999999999999988899999999876544 4567899999999999999999999988764 4599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ...+++..+..++.||+.|++|||+.||+||||||+||+++.++.+|++|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred ecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 999999999997643 2347899999999999999999999999999999999999999999999999986542211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....... .. .
T Consensus 159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~---~- 227 (261)
T cd05148 159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP-----CP---A- 227 (261)
T ss_pred --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-----CC---C-
Confidence 11223346678999999988889999999999999999998 899997766555555443221100 00 0
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... ....+++.+||+.||.+||++.++++.|+.+
T Consensus 228 --~~~------~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 228 --KCP------QEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --CCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000 1123788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=327.43 Aligned_cols=249 Identities=29% Similarity=0.511 Sum_probs=191.1
Q ss_pred cccccccccceeEEEEEEC-----CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 841 EENVLSRGRYGLIFKASYQ-----DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+.+.||+|.||.||+|.++ .+..|+||.+..... ..+.+.+|++.+++++||||++++|++..... .++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-LFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-EEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-cccccc
Confidence 4678999999999999876 368899999965332 24789999999999999999999999995544 589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.+++.... ...+++..+..++.|||+||+|||+++++|+||+++||+++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~- 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS- 157 (259)
T ss_dssp --TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS-
T ss_pred ccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 999999999999852 2348999999999999999999999999999999999999999999999999986542111
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.........+...|+|||.+....++.++||||||+++||+++ |+.||......+....+.+..+ ...+..++
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~----- 231 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LPIPDNCP----- 231 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TTSBTTSB-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ceeccchh-----
Confidence 1122233456778999999988889999999999999999999 7899977666665555432211 11111000
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
. ...+++.+||+.||++||++.|+++.|
T Consensus 232 ---------~--~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 232 ---------K--DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------H--HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------H--HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 112688899999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=321.10 Aligned_cols=254 Identities=24% Similarity=0.478 Sum_probs=204.3
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.++||+|+||.||+|...++..||+|.+.......+.+.+|++++++++||+++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEec
Confidence 35789999999999999999988888889999998766667889999999999999999999998854 3358999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.++++... ...+++..+..++.+++.|++|||+.+|+||||||+||++++++.++++|||.+........
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 83 SKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 9999999997632 23478999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||+..+..++.++||||||+++|||++ |..||......+....+..... . . .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~-~-----~---- 224 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR---M-P-----C---- 224 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---C-C-----C----
Confidence 11122345668999999988889999999999999999999 8999976555544443322110 0 0 0
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
+. ... ....+++.+|+..+|++||++.++.+.|+.
T Consensus 225 ~~--~~~--~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQ--DCP--ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CC--cCC--HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 000 112378999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=335.59 Aligned_cols=241 Identities=21% Similarity=0.322 Sum_probs=191.9
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
++||+|+||.||+++.+ +|+.||+|++.... .....+.+|+++++.++||||+++++++... +..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-DRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CEEEEEEeCCCC
Confidence 46999999999999765 68999999986432 2235678899999999999999999998876 455999999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 80 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---~~~ 151 (328)
T cd05593 80 GELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---AAT 151 (328)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc---ccc
Confidence 99999887633 3789999999999999999999999999999999999999999999999998643211 112
Q ss_pred CCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCC
Q 001171 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1133)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...+ +...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~-----------p~~~ 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKF-----------PRTL 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccC-----------CCCC
Confidence 23457999999999999889999999999999999999999999765554433322110 0000 1110
Q ss_pred hhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1078 SEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1078 ~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
. ....+++.+|++.||++|| ++.|++++
T Consensus 219 ~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 S-----ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C-----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 0123788899999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.99 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=203.3
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.++||+|+||.||+|.+.++..||+|++.......+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEcC
Confidence 35699999999999999999988777789999998766666789999999999999999999998754 3358999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++|+|.+++.... ...+++..+..++.|++.||+|+|+.+|+||||||+||+++.++.++++|||.++.......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 83 SKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 9999999997532 23478999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||+..+..++.++|||||||++|||++ |..||...........+.... . .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---~--~~~~~------ 226 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---R--MPCPP------ 226 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC---C--CCCcc------
Confidence 11123346678999999988889999999999999999999 888887655444333221110 0 00000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... ....+++.+|++.||++||++.++++.|+..
T Consensus 227 ----~~~--~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ----ECP--ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----ccC--HHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 000 1123799999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.78 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=202.3
Q ss_pred cCCCcccccccccceeEEEEEECC----ceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|++.+.||+|+||.||+|.++. ...||||.+...... ...+.+|++++++++||||+++++++.... ..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR-PVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC-ceEE
Confidence 468899999999999999998742 467999998654332 357889999999999999999999987764 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+++|+||||||+||++++++.++++|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999997643 2488999999999999999999999999999999999999999999999999976531
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
... ........++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.+..... .+
T Consensus 159 ~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~- 230 (266)
T cd05033 159 SEA-TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP------PP- 230 (266)
T ss_pred ccc-ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC------CC-
Confidence 111 111222345678999999988889999999999999999998 999997665555444433211100 00
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
. ... ....+++.+|++.+|++||++.||+++|+++
T Consensus 231 -~---~~~------~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 -M---DCP------SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -C---CCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 000 1123789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=325.65 Aligned_cols=264 Identities=22% Similarity=0.378 Sum_probs=218.0
Q ss_pred HHHHHHhcCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 830 VETLEATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 830 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
..+.....+.+..++||-|.||.||.|.|+. .-.||||.++.+....++|..|+.+|+.++|||+|+++|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF- 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF- 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe-
Confidence 3444555677788999999999999999875 67899999999888899999999999999999999999999876555
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|||+|||..|+|.+|+++..+. .++....+.++-||+.||+||..+++|||||.++|.|+.++..+||+|||++|+.
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999986543 3677778889999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
-. +.........-.+.|.|||-+.-..++.|+|||+|||++||+.| |-.||.+.+-.+++..+.+.++..+
T Consensus 416 tg--DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~------ 487 (1157)
T KOG4278|consen 416 TG--DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG------ 487 (1157)
T ss_pred cC--CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC------
Confidence 32 22222233344568999999988889999999999999999999 8899988777776666665543221
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
++.+...- .++++.||+..|.+||+++|+-+.+|..-.
T Consensus 488 -------PeGCPpkV----YeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 488 -------PEGCPPKV----YELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -------CCCCCHHH----HHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 12221111 278889999999999999999998887543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.64 Aligned_cols=266 Identities=21% Similarity=0.360 Sum_probs=213.6
Q ss_pred CCCcccccccccceeEEEEEECC--c--eEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQD--G--MVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
+....+.||+|.||+|++|.|.. | ..||||.++.+... .++|.+|+.+|.+|+|||++++||++.+. ...+|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q--p~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ--PAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc--hhhHH
Confidence 34567889999999999998863 4 46899999876544 57899999999999999999999999873 34799
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||.++.|+|.+.+++.. ...+.......++.|||.||.||.+++.|||||.++|+++.....+||+|||+.|.....
T Consensus 189 ~ELaplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999999832 244777888899999999999999999999999999999999999999999999877655
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.+.+.......-...|+|||.+..+.++.++|||+|||++||||+ |+.||.+.....+.+.+.+..+-.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp---------- 335 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP---------- 335 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC----------
Confidence 554444445566778999999999999999999999999999999 899998888777766655321110
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCCC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSAD 1125 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~ 1125 (1133)
. +.. +.+. ..+++..||..+|++||++..|.+.+-..+..+.......
T Consensus 336 -R--Pk~--csed--IY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~ 383 (1039)
T KOG0199|consen 336 -R--PKY--CSED--IYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETY 383 (1039)
T ss_pred -C--CCC--ChHH--HHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeec
Confidence 1 111 1111 1278899999999999999999866655555544444333
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=333.24 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=190.7
Q ss_pred cccccccceeEEEEEE----CCceEEEEEEcccCC-----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASY----QDGMVLSIRRLRDGT-----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++||+|+||.||+++. ..++.||+|.+.... .....+.+|++++++++||||+++++++.... ..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-KLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-eEEEEEe
Confidence 5799999999999975 357899999986432 12345778999999999999999999988764 5599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.+++...+ .+.+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 81 YLSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999999997643 36778888899999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||...+.......+.+. .. ..
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~----~~---------~~ 219 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG----KL---------NL 219 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----CC---------CC
Confidence 1223456899999999998888999999999999999999999999765554433332221 10 00
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
+.... ....+++.+|++.||++|| ++.+++++
T Consensus 220 ~~~~~-----~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLT-----PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCC-----HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11100 0123788999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=341.67 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=193.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.|++.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+.. ..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-NLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-EEEEEE
Confidence 5888999999999999999764 588999999965321 2356789999999999999999999998764 569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 81 DYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999997643 37888888999999999999999999999999999999999999999999975321100
Q ss_pred CC--------------------------------------------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHH
Q 001171 993 AE--------------------------------------------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFG 1028 (1133)
Q Consensus 993 ~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 1028 (1133)
.. .......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 0001235799999999999888899999999999
Q ss_pred HHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhc--cCCCCCCCCCCHHH
Q 001171 1029 IVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLL--CTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1029 ~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--Cl~~dP~~RPs~~e 1106 (1133)
|++|||++|+.||......+....+........+ +... .... .+.+++.+ |+..+|..||++.|
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~~~---~~s~------~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHI-----PPQV---KLSP------EAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCC-----CCCC---CCCH------HHHHHHHHHccCcccccCCCCHHH
Confidence 9999999999999765554433322211000000 0000 0011 12255655 66677777999999
Q ss_pred HHHH
Q 001171 1107 IVFM 1110 (1133)
Q Consensus 1107 vl~~ 1110 (1133)
++++
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=337.83 Aligned_cols=211 Identities=23% Similarity=0.370 Sum_probs=176.5
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||+||+|... +++.||+|++.... .....+.+|++++.+++||+|+++++.+.+.. ..++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-NLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-eEEEE
Confidence 46899999999999999999765 58999999986432 12356788999999999999999999998764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.+.+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 80 MEFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999998643 3789999999999999999999999999999999999999999999999998654221
Q ss_pred CCC--------------------------------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCC
Q 001171 992 PAE--------------------------------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK 1039 (1133)
Q Consensus 992 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~ 1039 (1133)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 000123579999999999998899999999999999999999999
Q ss_pred CCccCChhhHHHHH
Q 001171 1040 PVMFTQDEDIVKWV 1053 (1133)
Q Consensus 1040 Pf~~~~~~~~~~~~ 1053 (1133)
||......+....+
T Consensus 235 Pf~~~~~~~~~~~i 248 (363)
T cd05628 235 PFCSETPQETYKKV 248 (363)
T ss_pred CCCCCCHHHHHHHH
Confidence 99766655544443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=327.84 Aligned_cols=266 Identities=20% Similarity=0.320 Sum_probs=195.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|+.+ +++.||+|++..... ....+.+|++++++++||||+++++++.... ..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-TLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-eEEEEE
Confidence 467999999999999999999876 689999999864332 2346778999999999999999999998764 559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++ +++.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP- 156 (303)
T ss_pred ECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-
Confidence 9995 68888876532 23788889999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCCh-hhHHHHHHHHhhhcc---c-----
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQD-EDIVKWVKKQLQRGQ---I----- 1062 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~~---~----- 1062 (1133)
........|++.|+|||++.+ ..++.++||||+||++|||++|+.||....+ .+....+........ .
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 122234568899999999865 4578899999999999999999999975432 222222222111110 0
Q ss_pred -cccccCCcCCCCCCC--hhHHH---HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 -SELLEPGLLELDPES--SEWEE---FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 -~~~~~~~~~~~~~~~--~~~~~---~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.......+....+.. ..+.. .....+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000000000 00000 0122379999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.04 Aligned_cols=258 Identities=22% Similarity=0.379 Sum_probs=200.5
Q ss_pred cCCCcccccccccceeEEEEEE-----CCceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.+|++.+.||+|+||.||+|.+ ..+..||+|.+...... .+.+.+|++++++++||||+++++++.... ..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ-PVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-ceE
Confidence 4678889999999999999974 24688999999753322 256889999999999999999999988764 459
Q ss_pred EEEeccCCCCHHHHHHhhccC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCce
Q 001171 910 LVYDYMPNGNLATLLQEASHQ------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEA 977 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 977 (1133)
+||||+++++|.+++...... ....+++.....++.|++.|++|||++||+||||||+||++++++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 999999999999998643210 12347888899999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHH
Q 001171 978 HLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 978 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
|++|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...........+...
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 164 KISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875432211 111233345678999999988889999999999999999998 99999765554444433321
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.... .. ... . ....+++.+||+.||++||++.+|.++|..
T Consensus 243 ----~~~~-~~-------~~~---~--~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 243 ----QLLP-CS-------EDC---P--PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----CcCC-CC-------CCC---C--HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1110 00 000 0 112368889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.89 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=201.4
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
..+|++.++||+|+||.||+|..+ |..||+|.+.... ..+.+.+|++++++++|+|++++++++...++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 347889999999999999999775 7889999986533 35678999999999999999999998766556679999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.++++.... ..+++..+..++.|++.|++|||++||+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence 99999999976432 34788999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+... ... .+.
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~~-~~~----- 223 (256)
T cd05082 156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MDA-PDG----- 223 (256)
T ss_pred --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----CCC-CCC-----
Confidence 122334568999999988889999999999999999998 9999976555444444332111 000 000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.. ....+++.+|++.+|++||++.++++.|+++
T Consensus 224 -~~------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 224 -CP------PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CC------HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 1122788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=325.94 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=197.4
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.|++.++||+|+||.||++... +++.||+|++..... ....+.+|++++++++||||+++++++.... ..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-eEEEEE
Confidence 4788899999999999999764 689999999864322 1345678999999999999999999987764 569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|+|.+++..... ..+++..+..++.|++.|++|||+.+|+||||||+||++++++.++++|||+++.....
T Consensus 80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 80 TLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred eccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 99999999988865322 34889999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||...........+........ ..
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~ 223 (285)
T cd05605 156 ---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------EE 223 (285)
T ss_pred ---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------cc
Confidence 112234689999999999888899999999999999999999999976554433333333222111 00
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
+... ... ...+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~---~~~--~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEK---FSE--AARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcc---cCH--HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0000 011 112789999999999999 88899765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=341.91 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=200.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... .....+.+|++++..++||||+++++++.+. ...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-EHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-CeEEEE
Confidence 36899999999999999999875 68999999986432 2345788999999999999999999988776 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999999864 23788999999999999999999999999999999999999999999999998754332
Q ss_pred CC--------------------------CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC
Q 001171 992 PA--------------------------EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045 (1133)
Q Consensus 992 ~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~ 1045 (1133)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 20 0112234579999999999999999999999999999999999999997666
Q ss_pred hhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-HHHHHHH
Q 001171 1046 DEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-MADIVFM 1110 (1133)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~~ 1110 (1133)
.......+........++.. .. .. ....+++.+|+. ||.+||+ ++|++++
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~-----~~---~~------~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETYNKIINWKESLRFPPD-----PP---VS------PEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHHhccCCcccCCCC-----CC---CC------HHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 54433333221111111000 00 00 112267888997 9999999 9999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=323.26 Aligned_cols=260 Identities=20% Similarity=0.357 Sum_probs=201.2
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
..++|++.+.||+|+||.||+|.++ .+..||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 4567999999999999999999753 256799999864322 2356889999999999999999999987654
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCC-----CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQD-----GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
..++||||+++|+|.++++..+... ....++..+..++.|++.|++|||+.+++||||||+||++++++.++++|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 4599999999999999997643211 12367788889999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhc
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
||+++....... ........+++.|+|||++.++.++.++|||||||++|||++ |..||.........+.+...
T Consensus 163 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---- 237 (277)
T cd05062 163 FGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG---- 237 (277)
T ss_pred CCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----
Confidence 999865432211 111222345778999999988889999999999999999999 78898766555444433221
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
..... ..... ....+++.+|++.||++||++.|+++.|++
T Consensus 238 ~~~~~--------~~~~~-----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLDK--------PDNCP-----DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCCC--------CCCCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11110 00000 112378999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=335.03 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=201.1
Q ss_pred hcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 906 (1133)
.++|++.++||+|+||.||+|.+ .+++.||||+++..... .+.+.+|++++.++ +||||+++++++...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45799999999999999999964 34789999999754322 35678899999999 68999999998877666
Q ss_pred cEEEEEeccCCCCHHHHHHhhccC--------------------------------------------------------
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQ-------------------------------------------------------- 930 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 930 (1133)
..++||||+++|+|.++++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999999753210
Q ss_pred ------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCC
Q 001171 931 ------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004 (1133)
Q Consensus 931 ------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt 1004 (1133)
....+++..+..++.||++|++|||+++|+||||||+||+++.++.+|++|||+++....... ........++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~ 244 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLP 244 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCCCCC
Confidence 012367888899999999999999999999999999999999999999999999875422211 1112223456
Q ss_pred CCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHH
Q 001171 1005 LGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEF 1083 (1133)
Q Consensus 1005 ~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1083 (1133)
..|+|||++.+..++.++|||||||++|||++ |..||......... .+....+..... +.. ..
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~--~~~-----~~------ 308 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---CRRLKEGTRMRA--PDY-----TT------ 308 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH---HHHHhccCCCCC--CCC-----CC------
Confidence 78999999988889999999999999999997 99998654322211 111111111000 000 00
Q ss_pred HHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1084 LLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1084 ~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
....+++.+||+.||++||++.||+++|+.+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112378889999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=331.12 Aligned_cols=201 Identities=22% Similarity=0.420 Sum_probs=172.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.++||+|+||.||+|.++ ++..+|+|.+..... ....+.+|++++++++||||+++++++... +..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEE
Confidence 468999999999999999999876 588899998865322 235688999999999999999999999876 4569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||+++|+|.+++...+ .+++.....++.+++.|++|||+. +|+||||||+||+++.++.+|++|||++......
T Consensus 83 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999997633 378888899999999999999975 7999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE 1047 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~ 1047 (1133)
......|+..|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 158 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred -----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 122346889999999998888999999999999999999999999755443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.74 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=202.8
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++|.+.+.||+|+||.||+|.+..+..+|+|++.......+.+.+|++++++++|||++++++++.. ...++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEcCC
Confidence 4688999999999999999988777789999987665566789999999999999999999998854 34589999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+++|.++++... ...+++..+..++.|++.|++|||+.|++||||||+||++++++.++++|||.++....... .
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--~ 158 (260)
T cd05069 84 KGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--T 158 (260)
T ss_pred CCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc--c
Confidence 999999997632 23478999999999999999999999999999999999999999999999999865432211 1
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......++..|+|||+..+..++.++||||+||++|||++ |+.||......+...++..... .....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~------- 226 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-----MPCPQ------- 226 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----CCCCc-------
Confidence 1122346678999999988889999999999999999999 8999976655554443322110 00000
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
. .. ....+++.+||+.||++||++++|++.|+.
T Consensus 227 ~---~~--~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 G---CP--ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred c---cC--HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 00 112378899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=341.97 Aligned_cols=253 Identities=18% Similarity=0.290 Sum_probs=193.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||.||+|... +|+.||||++.+... ..+.+.+|++++++++||||+++++++.+.. ..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-YLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-eeEEE
Confidence 36889999999999999999764 689999999864321 2356788999999999999999999998764 55999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+|++|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 80 MEFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999997643 3788888899999999999999999999999999999999999999999998632211
Q ss_pred CCC------------C--------------------------------CCCCCCCCCCCccCccccCCCCCCCCCchhHH
Q 001171 992 PAE------------A--------------------------------SSSTTPIGSLGYVSPEAASTGQPTKEADVYSF 1027 (1133)
Q Consensus 992 ~~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 1027 (1133)
... . ......+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 00012469999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCC---CCH
Q 001171 1028 GIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDR---PSM 1104 (1133)
Q Consensus 1028 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R---Ps~ 1104 (1133)
||++|||++|+.||......+....+........+ +... ... ....+++.+|+. +|.+| +++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----p~~~---~~s------~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYF-----PDDI---HLS------VEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCC-----CCCC---CCC------HHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999766554443333221111000 0000 000 112367888987 66665 699
Q ss_pred HHHHHH
Q 001171 1105 ADIVFM 1110 (1133)
Q Consensus 1105 ~evl~~ 1110 (1133)
.|++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.61 Aligned_cols=263 Identities=22% Similarity=0.391 Sum_probs=206.0
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|.+.+.||+|+||.||++... ++..+|+|.+..... ..+.+.+|++++++++|||++++++++.... ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-PL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-cc
Confidence 457889999999999999999742 356789999865432 2457899999999999999999999998764 45
Q ss_pred EEEEeccCCCCHHHHHHhhcc--------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEe
Q 001171 909 LLVYDYMPNGNLATLLQEASH--------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLS 980 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 980 (1133)
++||||+++++|.+++...+. .....+++..+..++.|++.||+|||++|++||||||+||++++++.++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 999999999999999976442 112348999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhh
Q 001171 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQR 1059 (1133)
Q Consensus 981 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 1059 (1133)
|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||......+....+..
T Consensus 163 dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~---- 237 (288)
T cd05093 163 DFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---- 237 (288)
T ss_pred cCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----
Confidence 9999875432211 111223345778999999988889999999999999999998 9999976655554443322
Q ss_pred ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
+......+ ... ....+++.+||+.||.+||++.|+.+.|+.+...
T Consensus 238 ~~~~~~~~-------~~~------~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 GRVLQRPR-------TCP------KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCcCCCCC-------CCC------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111000 000 1124789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.68 Aligned_cols=256 Identities=25% Similarity=0.456 Sum_probs=207.1
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..++|++.++||+|+||.||+|..+++..||||.+.......+.+.+|++++++++|||++++++++... ...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-EPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-CceEEEEec
Confidence 3467999999999999999999988888899999987767778899999999999999999999998765 445999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++++|.+++.... ...+++..+..++.+++.|++|||+++++||||||+||+++.++.++++|||.++......
T Consensus 83 ~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (261)
T cd05034 83 MSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-- 157 (261)
T ss_pred cCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh--
Confidence 99999999997633 2348899999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........++..|+|||.+.+..++.++||||+||++||+++ |+.||...........+....... ....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~---- 228 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-----RPPN---- 228 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----CCCC----
Confidence 111122234568999999988889999999999999999998 999997665555444433221100 0000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.. ....+++.+|++.+|++||+++|+++.|+.
T Consensus 229 --~~------~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 229 --CP------EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CC------HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 112378899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=340.67 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=196.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||+||+|+.. +|+.||||++.... .....+.+|+++++.++||||+++++++... ...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-NYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CeEEEE
Confidence 36899999999999999999875 58999999996432 1234578899999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 80 ~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred ECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999997633 3789999999999999999999999999999999999999999999999998654221
Q ss_pred CCCC-----------------------------------CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh
Q 001171 992 PAEA-----------------------------------SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036 (1133)
Q Consensus 992 ~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t 1036 (1133)
.... ......+||+.|+|||++.+..++.++||||+||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 00112469999999999998899999999999999999999
Q ss_pred CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC---HHHHHHH
Q 001171 1037 GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS---MADIVFM 1110 (1133)
Q Consensus 1037 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs---~~evl~~ 1110 (1133)
|+.||...+..+....+........+ ... . .... ...+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~-~---~~s~------~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQF----PDE-V---PLSP------EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCC----CCC-C---CCCH------HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999766554443333221100000 000 0 0011 12267778886 8999997 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=329.18 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=187.4
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|+++ +++.||+|+++... ...+.+..|..++... +||||+++++++... ...++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence 46999999999999875 57899999986432 2234556677777654 899999999998876 45699999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 80 gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~ 151 (316)
T cd05592 80 GGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---G 151 (316)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---C
Confidence 999999987643 37888899999999999999999999999999999999999999999999986432211 2
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... ...+ +...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~----~~~~------ 219 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHF----PRWI------ 219 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCC----CCCC------
Confidence 233457999999999999888999999999999999999999999876655544433221 0000 0000
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHH-HHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMA-DIVF 1109 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl~ 1109 (1133)
.. ...+++.+||+.||++||++. ++++
T Consensus 220 ~~------~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 220 SK------EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CH------HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00 112788899999999999876 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=298.79 Aligned_cols=254 Identities=20% Similarity=0.351 Sum_probs=210.9
Q ss_pred HhcCCCcc-cccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeC---CCCcE
Q 001171 835 ATRQFDEE-NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAG---PPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~~~~~ 908 (1133)
.+++|.+. ++||-|-.|.|..+.++ +|+.+|+|++.+. ...++|++..-+. .|||||.++++|.. .....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 56677764 67999999999999664 6899999999754 4567899986666 69999999999864 34556
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCcc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLD 985 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a 985 (1133)
.+|||.|+||.|+..++..+. ..+++.++..|+.||+.|++|||+.+|.||||||+|+|... +..+|++|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 799999999999999998665 45899999999999999999999999999999999999964 556899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
+.... .....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......+..-++..++.++
T Consensus 212 K~t~~----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq---- 283 (400)
T KOG0604|consen 212 KETQE----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ---- 283 (400)
T ss_pred cccCC----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC----
Confidence 75422 3345667889999999999999999999999999999999999999976665555555555554432
Q ss_pred ccCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.+...+|..+...+ ++|+.++..+|++|.++.|++.+
T Consensus 284 -------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 -------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 233456788888777 89999999999999999999865
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=291.21 Aligned_cols=266 Identities=19% Similarity=0.284 Sum_probs=205.5
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeC----CCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAG----PPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 908 (1133)
...+|++.+.+|+|+|+-||.++. .+++.||+|++.-.. .+.+...+|++..++++|||+++++++... .....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 356899999999999999999964 568999999997544 456788999999999999999999987642 33456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCCCCceEEeccCccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
|++++|...|+|.+.+...... +..+++.+.+.|+.+|++||++||+.. ++||||||.||++.+++.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999886543 456999999999999999999999998 9999999999999999999999999886
Q ss_pred ccccCCCCC------CCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHh
Q 001171 987 LAIATPAEA------SSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 987 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
...-.-... ........|..|+|||.+. +...++++|||||||++|+|+.|..||...- +
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~-- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------Q-- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------h--
Confidence 432111100 0112335788999999984 4456899999999999999999999995210 1
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
+.+.+.-.+...-..++.... +.+.+. +++.+|++.||.+||++.|++..++.+.
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~-yse~l~--~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSR-YSEALH--QLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCeEEEeeeccccccCCCCC-ccHHHH--HHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 122222222222222222222 233222 7999999999999999999999998753
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=346.37 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=201.3
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD---- 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 906 (1133)
..++|++.++||+|+||+||+|+. .+|+.||||++...... ...+.+|+.++..++|+|++++++.+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999976 46899999998654332 3567889999999999999999877653221
Q ss_pred ---cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccC
Q 001171 907 ---VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 907 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
..++||||+++|+|.++++.... ....+++..+..++.|++.||+|+|+.+|+||||||+||+++.++.+||+|||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 34799999999999999976432 23458889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ....
T Consensus 189 ls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~----~~~~ 263 (496)
T PTZ00283 189 FSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA----GRYD 263 (496)
T ss_pred cCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc----CCCC
Confidence 9875432211 1123345799999999999998999999999999999999999999976555443333222 1111
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. +. .... ....+++.+||+.||.+||++.+++++
T Consensus 264 ~-~~-------~~~~-----~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 P-LP-------PSIS-----PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-CC-------CCCC-----HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 01 0000 112378899999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.31 Aligned_cols=248 Identities=19% Similarity=0.301 Sum_probs=193.8
Q ss_pred ccccccceeEEEEEEC---CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCC
Q 001171 844 VLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNG 918 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~g 918 (1133)
.||+|+||.||+|.++ .+..||+|.+...... .+.+.+|++++++++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence 3899999999999764 3567999998654322 3568899999999999999999998864 3458999999999
Q ss_pred CHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCC
Q 001171 919 NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998 (1133)
Q Consensus 919 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 998 (1133)
+|.+++.... ..+++..+..++.|++.|++|||++|++||||||+||+++.++.+|++|||+++............
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999987532 348899999999999999999999999999999999999999999999999987543222111112
Q ss_pred CCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCC
Q 001171 999 TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077 (1133)
Q Consensus 999 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1133)
....++..|+|||++.+..++.++|||||||++||+++ |+.||......+....+.+... . .+++. ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~-~~~~~------~~ 224 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR----L-DCPAE------CP 224 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----C-CCCCC------CC
Confidence 22234578999999988889999999999999999996 9999976666554444332211 0 01110 00
Q ss_pred hhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1078 ~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
....+++.+||..||++||++.+|.+.|+..
T Consensus 225 ------~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 ------PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ------HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=333.80 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=192.9
Q ss_pred CCCcccccccccceeEEEEEEC----CceEEEEEEcccCC-----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGT-----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 907 (1133)
+|++.+.||+|+||.||+++.. +++.||+|++.+.. ...+.+.+|+++++++ +||+|+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE-AK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC-CE
Confidence 4888999999999999999653 57899999986422 1234678899999999 599999999988765 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 589999999999999987532 378899999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+......
T Consensus 155 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (332)
T cd05614 155 FLSEE--KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD----- 227 (332)
T ss_pred ccccC--CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-----
Confidence 42221 1122345799999999999765 478899999999999999999999965433322222222221111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
+... .... ....+++.+|++.||++|| ++++++++
T Consensus 228 -~~~~---~~~~-----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 -PPFP---SFIG-----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCC---CCCC-----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1110 0000 0122788899999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.28 Aligned_cols=258 Identities=19% Similarity=0.341 Sum_probs=197.3
Q ss_pred CCcccccccccceeEEEEEECC-c--eEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-----CCc
Q 001171 839 FDEENVLSRGRYGLIFKASYQD-G--MVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGP-----PDV 907 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~-g--~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 907 (1133)
|.+.++||+|+||.||+|.+.. + ..||+|.++.... ..+.+.+|++++++++||||+++++++... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999998754 3 3689998865422 245688899999999999999999987432 123
Q ss_pred EEEEEeccCCCCHHHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQ-DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
.++||||+++|+|.+++...+.. ....+++.....++.|++.|++|||+++|+||||||+||++++++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 48999999999999988543321 22458899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
....... ........+++.|+|||+..+..++.++|||||||++|||++ |+.||...........+.. +.....
T Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~ 235 (272)
T cd05075 161 KIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ----GNRLKQ 235 (272)
T ss_pred ccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----CCCCCC
Confidence 5432211 111223346678999999998889999999999999999999 8899976555444433322 111000
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.... .+ ...+++.+||+.||++||++.|+++.|+.+
T Consensus 236 --------~~~~---~~--~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 --------PPDC---LD--GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCC---CH--HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 00 123789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=334.53 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=200.6
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhcc-CCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVK-HRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 905 (1133)
..++|.+.++||+|+||.||+|+++ .++.||+|++...... .+.+.+|++++.++. |||||++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4457888999999999999999864 3468999999754322 346889999999997 999999999998764
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC-------------------------------------------------------
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ------------------------------------------------------- 930 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 930 (1133)
..++||||+++|+|.+++++.+..
T Consensus 115 -~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 115 -PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred -CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 459999999999999999764310
Q ss_pred --------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC
Q 001171 931 --------------------------------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 931 --------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~ 972 (1133)
....+++.....++.||+.|++|||+.+|+||||||+||+++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 112367778889999999999999999999999999999999
Q ss_pred CCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHH
Q 001171 973 ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~ 1051 (1133)
.++.++++|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999998754322111 11223457789999999988889999999999999999998 899986544333222
Q ss_pred HHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.... .+.... . +... . ....+++.+||+.+|++||+++||++.|+.+
T Consensus 353 ~~~~---~~~~~~--~------p~~~---~--~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 353 NAIK---RGYRMA--K------PAHA---S--DEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHH---cCCCCC--C------CCCC---C--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2111 110000 0 0000 0 1123788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.43 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=197.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
+.|++.+.||+|++|.||+|... +++.||+|.+..... ..+.+.+|++++++++||||+++++++.... ..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence 46889999999999999999764 689999999864321 1246788999999999999999999998764 569
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++++|.+++...+ .+++..+..++.|++.|++|||+.||+||||||+||+++.++.++|+|||.++...
T Consensus 81 ~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999997643 37788889999999999999999999999999999999999999999999986543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.............|+..|+|||++.+..++.++||||+|+++|||++|+.||.................... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~-- 229 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ----LP-- 229 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC----CC--
Confidence 221111111334678899999999988899999999999999999999999965443332222211100000 00
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... . ....+++.+||..+|.+||++.|++++
T Consensus 230 -----~~~---~--~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 -----SHV---S--PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----ccC---C--HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 0 112378899999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=330.89 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=193.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCC-CeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHR-NLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~lV 911 (1133)
+|++.+.||+|+||.||+|+.+ +++.||+|++.... ...+.+..|.+++..++|+ +|+.+++++... +..++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-CEEEEE
Confidence 4888999999999999999775 57899999986432 2345677899999999765 577888888765 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999997643 3788899999999999999999999999999999999999999999999998642211
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... ...++
T Consensus 155 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~-------- 221 (324)
T cd05587 155 ---GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYP-------- 221 (324)
T ss_pred ---CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCC--------
Confidence 11223456899999999999988999999999999999999999999876655554443321 00000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH-----HHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM-----ADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~~ 1110 (1133)
.... ....+++.+|+..||.+|++. .+++++
T Consensus 222 ---~~~~-----~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 222 ---KSLS-----KEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCC-----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0000 112378899999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=337.45 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=196.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||.||+|+.. +++.||+|++.+.. ...+.+.+|+++++.++||||+++++++... ...++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-KYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CEEEE
Confidence 457999999999999999999775 58899999986422 2234577899999999999999999988775 45699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++... .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998752 267788888999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCC----CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTG----QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.. ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.......+........++
T Consensus 195 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 269 (370)
T cd05596 195 NG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP--- 269 (370)
T ss_pred CC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC---
Confidence 11 1122345799999999998643 47899999999999999999999997665544443332211110000
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCC--CCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD--RPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1110 (1133)
... ... ....+++.+|+..+|.+ ||++.|++++
T Consensus 270 --~~~---~~s------~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 --DDI---EIS------KQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CcC---CCC------HHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 001 11227888999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=331.17 Aligned_cols=244 Identities=21% Similarity=0.349 Sum_probs=191.7
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHH---hhccCCCeeeEEEEEeCCCCcEEE
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEAL---GKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
|++.+.||+|+||.||+|.++ +|+.||||++.... ...+.+.+|++++ ++++||||+++++++.... ..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-HVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-EEEE
Confidence 677899999999999999775 68999999986432 1234566676655 5668999999999998764 5599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|..+++. ..+++..+..++.||+.|++|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 80 v~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 80 VMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999988764 2488999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. ........|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... ....+
T Consensus 154 ~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p------- 221 (324)
T cd05589 154 F---GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYP------- 221 (324)
T ss_pred C---CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC-------
Confidence 1 12233457999999999999889999999999999999999999999766655544433221 11010
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.... ....+++.+|++.||.+|| ++.+++++
T Consensus 222 ----~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 222 ----RFLS-----REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCC-----HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0000 1123789999999999999 57777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=341.54 Aligned_cols=267 Identities=20% Similarity=0.331 Sum_probs=195.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCC-------CC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP-------PD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------~~ 906 (1133)
...+|++.++||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++... ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 3457999999999999999999775 58999999986432 3456799999999999999999876421 12
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLD 985 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a 985 (1133)
..++||||++ +++.+++..... ....+++..+..++.||+.||+|||+++|+||||||+||+++.++ .+||+|||+|
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 3468999996 578777765322 234588999999999999999999999999999999999999765 6999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+..... .......||+.|+|||++.+. .++.++||||+||++|||++|++||......+....+.+.........
T Consensus 219 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 219 KNLLAG----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred hhccCC----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 754321 122345789999999998654 689999999999999999999999987665544444433322111000
Q ss_pred c--ccCCcCCC--CC-CChhHHHH------HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 L--LEPGLLEL--DP-ESSEWEEF------LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~--~~~~~~~~--~~-~~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ..+.+... +. ........ ..+.+++.+||+.||.+||++.|++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00111000 00 00011110 123489999999999999999999954
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.31 Aligned_cols=256 Identities=24% Similarity=0.449 Sum_probs=200.8
Q ss_pred cCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|++.+.||+|+||.||+|.+. .+..+|+|.+.....+ .+.+.+|++++++++||||+++++++...+ ..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-PVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-ccEE
Confidence 46888999999999999999763 2457999998654322 357889999999999999999999997664 5599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+.+++||||||+||+++.++.++++|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999997642 2478899999999999999999999999999999999999999999999999875533
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
............++..|+|||++.+..++.++|||||||++||+++ |..||......+....+.+... . +.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~-----~~ 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---L-----PA 230 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---C-----CC
Confidence 2221111122234568999999988889999999999999999887 9999976655544444332110 0 00
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.. ... ....+++.+|++.+|.+||++.++++.|++.
T Consensus 231 ~~---~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 PM---DCP------AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC---CCC------HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 000 1123788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=318.13 Aligned_cols=258 Identities=18% Similarity=0.325 Sum_probs=200.7
Q ss_pred CCcccccccccceeEEEEEECC----ceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC-----
Q 001171 839 FDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD----- 906 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 906 (1133)
|.+.++||+|+||.||+|.... +..||+|+++..... .+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999997642 478999998754332 3578899999999999999999998865432
Q ss_pred cEEEEEeccCCCCHHHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQ-DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
..++||||+++|+|.+++...... ....+++.....++.|++.||+|||+.+|+||||||+||++++++.+|++|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 358999999999999998664321 2245889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+....... ........++..|+|||++.+..++.++|||||||++|||++ |..||......+..+.+... ....
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~----~~~~ 235 (273)
T cd05035 161 KKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG----NRLK 235 (273)
T ss_pred eecccccc-ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----CCCC
Confidence 75533221 111222335678999999988889999999999999999999 88999766555544443321 1111
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... .. .....+++.+||+.||.+||++.|+++.|+++
T Consensus 236 ~~~-------~~------~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPE-------DC------LDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCc-------CC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00 01223788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.95 Aligned_cols=246 Identities=23% Similarity=0.419 Sum_probs=199.4
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc-C---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI-D---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..|.-.+.||.|+||.||.|++ ++.++||||++..... . -.++..|+..+++++|||++.+.|+|... ...|+|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-~TaWLV 104 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-HTAWLV 104 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-chHHHH
Confidence 3466778899999999999966 5789999999964332 2 35778999999999999999999999875 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||| -|+-.|++.-.+ +.+.+..+..|+.+.+.||+|||+.+.||||||+.|||+++.|.||++|||.|...
T Consensus 105 MEYC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--- 176 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--- 176 (948)
T ss_pred HHHH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---
Confidence 9999 678888887654 34778888999999999999999999999999999999999999999999988543
Q ss_pred CCCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.....++|||.|||||++. .+.|+-++||||+|++..|+...++|+...+.....-.+.+. . .|
T Consensus 177 ----~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN----e-----sP 243 (948)
T KOG0577|consen 177 ----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----E-----SP 243 (948)
T ss_pred ----CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc----C-----CC
Confidence 2345679999999999984 578999999999999999999999998765554444333332 0 11
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.+ ...+|.++.. .++..|+++-|.+|||.++++++-
T Consensus 244 tL-----qs~eWS~~F~--~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 244 TL-----QSNEWSDYFR--NFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CC-----CCchhHHHHH--HHHHHHHhhCcccCCcHHHHhhcc
Confidence 11 2344555443 688899999999999999998764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=330.69 Aligned_cols=241 Identities=23% Similarity=0.372 Sum_probs=192.0
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|+.+ +++.||+|++.... ...+.+..|.++++.+ +||||+++++++.... ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-RLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-eEEEEEeCCC
Confidence 46999999999999775 57899999986532 2234567899998876 7999999999998764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~---~~ 151 (321)
T cd05591 80 GGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---GV 151 (321)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---Cc
Confidence 999999987643 3788899999999999999999999999999999999999999999999998643221 11
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... . ...+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----~---~~~p~~~----- 219 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----D---VLYPVWL----- 219 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC----C---CCCCCCC-----
Confidence 223456899999999999889999999999999999999999999876665554443321 1 0011100
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCC-------CHHHHHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRP-------SMADIVFM 1110 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RP-------s~~evl~~ 1110 (1133)
. ....+++.+|++.||++|| ++.+++++
T Consensus 220 ~------~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 220 S------KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C------HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 1123788899999999999 78888755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=326.38 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=205.1
Q ss_pred CCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-C-----CCeeeEEEEEeCCCCcEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-H-----RNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~~l 910 (1133)
+|++.++||+|+||.|.+|.+ ++++.||||+++....-..+...|+.+|..++ | -|+|++++||..... .|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H-lci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH-LCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc-eee
Confidence 899999999999999999955 56999999999876655667778999999997 3 389999999987654 499
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC--CceEEeccCccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD--FEAHLSEFGLDRLA 988 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~ 988 (1133)
|+|.+ ..+|+++++..+..+ ++...++.++.||+.||.+||+.+|||+||||+|||+... ..+||+|||.|.+.
T Consensus 266 VfELL-~~NLYellK~n~f~G---lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRG---LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 679999999876543 8999999999999999999999999999999999999653 46899999998754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc-------
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ------- 1061 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------- 1061 (1133)
.. .....+-+..|+|||++.|..|+.+.||||||||++||++|.+-|.+.+..+....+.+.+..+.
T Consensus 342 ~q------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQ------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CC------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 22 12255677899999999999999999999999999999999888887777666666555332111
Q ss_pred --ccccccC-----------C------------------cC-CCCCCChhH------HHHHHhHhhhhccCCCCCCCCCC
Q 001171 1062 --ISELLEP-----------G------------------LL-ELDPESSEW------EEFLLGVKVGLLCTAPDPLDRPS 1103 (1133)
Q Consensus 1062 --~~~~~~~-----------~------------------~~-~~~~~~~~~------~~~~~~~~li~~Cl~~dP~~RPs 1103 (1133)
...+++. . .. ..+.....+ .+....++++.+|+..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0111111 0 00 000011111 11223358999999999999999
Q ss_pred HHHHHHH
Q 001171 1104 MADIVFM 1110 (1133)
Q Consensus 1104 ~~evl~~ 1110 (1133)
+.|.+++
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999965
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=320.63 Aligned_cols=258 Identities=19% Similarity=0.335 Sum_probs=200.2
Q ss_pred cCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
++|++.+.||+|+||+||+|.+. +++ .+++|.+..... ...++..|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~--~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA--SLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC--ccE
Confidence 46888999999999999999774 343 477888753322 235677888899999999999999988643 347
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+++||+++|+|.+++.... ..+++..+..++.||+.|++|||+++++||||||+||++++++.+|++|||+++...
T Consensus 85 ~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 8999999999999997643 248899999999999999999999999999999999999999999999999997553
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.... ........++..|+|||++.++.++.++|||||||++||+++ |+.||.........+.+.+ +.... .+
T Consensus 161 ~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~--~~ 233 (279)
T cd05111 161 PDDK-KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK----GERLA--QP 233 (279)
T ss_pred CCCc-ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----CCcCC--CC
Confidence 2221 112233457778999999988899999999999999999998 9999976655444333321 11110 00
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
. ... ....+++.+||..||++||++.|+++.|+.+...+
T Consensus 234 ~-------~~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 234 Q-------ICT----IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred C-------CCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0 000 11236788999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.81 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=197.3
Q ss_pred cccccccceeEEEEEECC----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+++++++.|||++++++++... ..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE--PLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC--ceEEEEEeCC
Confidence 469999999999996532 37899999876554 356788999999999999999999988643 3589999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++.... .+++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||.++..........
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999998643 378999999999999999999999999999999999999999999999999875533222111
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+.+... ... + .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~----~~~--~------~ 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER----LPR--P------E 221 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc----CCC--C------C
Confidence 1222234568999999988889999999999999999998 9999977666555544433210 000 0 0
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
. .. ....+++.+|+..+|++||++.++++.|++..
T Consensus 222 ~---~~--~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 E---CP--QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred C---CC--HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 00 11237899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.76 Aligned_cols=267 Identities=21% Similarity=0.334 Sum_probs=197.2
Q ss_pred CCcccccccccceeEEEEEE-----CCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEE
Q 001171 839 FDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLL 910 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~l 910 (1133)
|++.++||+|+||+||.+.+ .++..||+|.+..... ..+.+.+|++++++++||||+++++++... ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988643 3578899999875432 346788999999999999999999988654 345689
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++... .+++..+..++.|++.|++|||+++|+||||||+||++++++.++++|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999752 389999999999999999999999999999999999999999999999999875533
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh--hHHHHHHHHhhhccccccccC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE--DIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
............++..|+|||.+.+..++.++|||||||++|||++|..||...... +...............+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 221111122234566799999998888999999999999999999999998543211 111000000000011111111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
......+. ... ....+++.+||+.||++||+++++++.|+.+.
T Consensus 240 ~~~~~~~~--~~~--~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPK--NCP--QEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCC--CCC--HHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11100000 000 12237899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.99 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=205.3
Q ss_pred cCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC-HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
++|.+.+.||+|+||.||+|... ++..+++|.+...... .+.+.+|++++++++||||+++++++.... ..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-PLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC-ceE
Confidence 45888899999999999999642 3567899998654332 357899999999999999999999998764 459
Q ss_pred EEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 910 LVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
+||||+++++|.+++..... .....+++..++.++.||+.|++|||++||+||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999986432 1123488999999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
++|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+..+.+..
T Consensus 164 l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-- 240 (291)
T cd05094 164 IGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-- 240 (291)
T ss_pred ECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC--
Confidence 999999865432211 111233456788999999988889999999999999999999 9999976665554443222
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
+....... ... ....+++.+||+.||++||++.+|++.|+++..
T Consensus 241 --~~~~~~~~-------~~~------~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 241 --GRVLERPR-------VCP------KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --CCCCCCCc-------cCC------HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111100 000 112378999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=346.17 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=197.6
Q ss_pred CCCcccccccccceeEEEEEEC-C-ceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-D-GMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.|.+.+.||+|+||.||+|... + ++.||+|++..... ....+.+|++++++++|||||++++++... +..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEEC
Confidence 4889999999999999999654 3 67788887754332 234677899999999999999999999876 456999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.+++..... ....+++..+..++.||+.||+|+|+++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 147 ~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~-~ 224 (478)
T PTZ00267 147 GSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV-S 224 (478)
T ss_pred CCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-c
Confidence 999999998875322 12347888899999999999999999999999999999999999999999999997543221 1
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... ...... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~----~~~~~~-~------ 293 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG----KYDPFP-C------ 293 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCCCCC-c------
Confidence 11233457999999999999889999999999999999999999999766554444333221 111000 0
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
... ....+++.+||+.||++||++.+++.
T Consensus 294 ~~s------~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 PVS------SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred cCC------HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 11237888999999999999999874
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.42 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=198.0
Q ss_pred cccccccceeEEEEEECC--c--eEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQD--G--MVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|++|.||+|.+.+ + ..||+|.+..... ..+.+.+|++++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999997643 3 3699999976554 34678899999999999999999999877 55689999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+++|.+++..... ..+++...+.++.|++.||+|||+++++||||||+||+++.++.+|++|||+++..........
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999986432 3489999999999999999999999999999999999999999999999999876543222222
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+....... ..+ .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~------~ 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----ERP------E 224 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-----CCC------c
Confidence 2233457789999999988889999999999999999999 999997665555444433211000 000 0
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
. . .....+++.+|++.+|++||++.|+++.|.
T Consensus 225 ~---~--~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 A---C--PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred c---C--CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 0 012237889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.51 Aligned_cols=256 Identities=24% Similarity=0.472 Sum_probs=200.3
Q ss_pred cCCCcccccccccceeEEEEEEC-Cc---eEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DG---MVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.+|+..+.||+|+||.||+|..+ ++ ..+|+|++..... ..+.+.+|++++++++|||++++.+++..... .++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP-AMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC-cEE
Confidence 46788899999999999999764 23 4799999865432 24578899999999999999999999987644 599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+.|++||||||+||+++.++.++++|||+++....
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997532 3478999999999999999999999999999999999999999999999999865433
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.............+..|+|||++....++.++|||||||++|||++ |+.||......+....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~~~----- 231 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPA----- 231 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CCCC-----
Confidence 2211111112233457999999988889999999999999999998 999997665554444433211 0000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.. ... ....+++.+||+.+|++||++.+|++.|+++
T Consensus 232 ~~---~~~------~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 PM---DCP------SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC---CCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 000 1123789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=330.40 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=190.7
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|+.+ +++.||+|++.+.. ...+.+.+|.++++.+ +||||+++++++.... ..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-RLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-EEEEEEcCCC
Confidence 46999999999999875 58899999986432 2235667888888877 6999999999988764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~---~~ 151 (320)
T cd05590 80 GGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GK 151 (320)
T ss_pred CchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---CC
Confidence 999999987643 3788999999999999999999999999999999999999999999999998643211 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... .. ..+.. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----~~---~~~~~-----~ 219 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----EV---VYPTW-----L 219 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC----CC---CCCCC-----C
Confidence 233457999999999999888999999999999999999999999876655544443221 10 00100 0
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCH------HHHHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSM------ADIVFM 1110 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~------~evl~~ 1110 (1133)
. ....+++.+|++.||++||++ ++++++
T Consensus 220 ~------~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 220 S------QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred C------HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0 112378899999999999998 666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.19 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=200.3
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
+++|.+.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP- 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC-
Confidence 467899999999999999999775 357899998864332 24568899999999999999999998877644
Q ss_pred EEEEEeccCCCCHHHHHHhhccC--CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC---ceEEecc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQ--DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF---EAHLSEF 982 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Df 982 (1133)
.++||||+++++|.+++...+.. ....+++..+..++.||+.|++|||+++++||||||+||+++.++ .+|++||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 48999999999999999876432 123588999999999999999999999999999999999998754 5899999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++....... .........+..|+|||++.+..++.++|||||||++|||++ |+.||.....+.....+.... .
T Consensus 164 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~-- 239 (277)
T cd05036 164 GMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R-- 239 (277)
T ss_pred ccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c--
Confidence 99875522111 111122334568999999988889999999999999999997 999997666555443322210 0
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.+. . .... ....+++.+|++.+|++||++.||+++|+.
T Consensus 240 -~~~-~-------~~~~-----~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 240 -LDP-P-------KGCP-----GPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -CCC-C-------CCCC-----HHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 000 0 0000 122378899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=335.89 Aligned_cols=253 Identities=20% Similarity=0.300 Sum_probs=194.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++.++||+|+||.||+|+++ +++.||+|.+.+.. ...+.+.+|+++++.++||||+++++++... ...+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-KYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEE
Confidence 3467999999999999999999876 57899999985421 2245678899999999999999999998876 4569
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999752 26788889999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCC----CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTG----QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.......+........+++
T Consensus 194 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~- 270 (370)
T cd05621 194 ETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE- 270 (370)
T ss_pred cCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC-
Confidence 211 1122356799999999998653 378899999999999999999999976655444333322111111000
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCC--CCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD--RPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1110 (1133)
. ..... ...+++.+|+..++.+ |+++.|++++
T Consensus 271 ----------~-~~~s~--~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 271 ----------D-VEISK--HAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----------c-ccCCH--HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 00001 1126777788755544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=335.50 Aligned_cols=194 Identities=20% Similarity=0.277 Sum_probs=165.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..+|++.+.||+|+||.||+|... +++.||+|+.. .+.+.+|++++++++||||+++++++... ...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEEec
Confidence 357999999999999999999764 68899999753 24578899999999999999999999765 445899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+ .++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 165 ~-~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-- 236 (391)
T PHA03212 165 Y-KTDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-- 236 (391)
T ss_pred C-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence 9 478888886532 37889999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1222345799999999999988999999999999999999999988743
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.58 Aligned_cols=239 Identities=21% Similarity=0.346 Sum_probs=188.5
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|+++ +|+.||+|++.... ...+.+..|.+++... +||+|+++++++... +..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCC
Confidence 46999999999999875 58899999986532 2345567788888765 899999999999876 45599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.++|+|||+++..... ..
T Consensus 80 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 151 (316)
T cd05620 80 GGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG---DN 151 (316)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---CC
Confidence 999999987632 3788899999999999999999999999999999999999999999999998642111 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...++.. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~----------~ 219 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRW----------I 219 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCC----------C
Confidence 233457899999999999999999999999999999999999999766655444433221 0101000 0
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHH-HHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMA-DIV 1108 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl 1108 (1133)
. ....+++.+|++.||++||++. ++.
T Consensus 220 ~------~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 T------KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C------HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 1122788899999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.06 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=188.9
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
+.||+|+||.||+|++. +++.||||++.... ...+.+..|..++... +||||+++++++...+ ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-NLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-EEEEEEeCCC
Confidence 46999999999999875 47899999986532 2234566788888765 8999999999998764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 151 (316)
T cd05619 80 GGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---DA 151 (316)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---CC
Confidence 999999997632 3788899999999999999999999999999999999999999999999998643211 11
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... ...+ +. . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~----~~-~-----~ 219 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCY----PR-W-----L 219 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCC----Cc-c-----C
Confidence 223456899999999999889999999999999999999999999766655544443221 0000 00 0 0
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHH-HHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMA-DIVF 1109 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl~ 1109 (1133)
. ....+++.+|++.||++||++. ++.+
T Consensus 220 ~------~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 T------REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C------HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0 1123788899999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=316.22 Aligned_cols=254 Identities=22% Similarity=0.409 Sum_probs=204.4
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|...++..+|+|.+..+....+.+.+|++++++++|+|++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeC
Confidence 45789999999999999999988778889999987665556789999999999999999999999876 4458999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... ....++..+..++.|++.|++|||+.|++||||||+||+++.++.++++|||.+....... .
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 157 (260)
T cd05073 83 AKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--Y 157 (260)
T ss_pred CCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC--c
Confidence 9999999997642 2347888999999999999999999999999999999999999999999999986542211 1
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||++.+..++.++|+|||||++|++++ |+.||...+..+....+.... ..+.. .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~----~--- 226 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----RMPRP----E--- 226 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC----CCCCc----c---
Confidence 11222345678999999988889999999999999999999 999997665555444332211 00000 0
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
... ....+++.+|++.+|++||++.++.+.|+.
T Consensus 227 ~~~------~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCP------EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCC------HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 112378899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=321.51 Aligned_cols=266 Identities=22% Similarity=0.385 Sum_probs=205.0
Q ss_pred hcCCCcccccccccceeEEEEEECC-----------------ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeee
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-----------------GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTV 896 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~ 896 (1133)
.++|++.+.||+|+||.||+|.... +..||+|++..... ..+.+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4579999999999999999996642 25689999875432 2467889999999999999999
Q ss_pred EEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCC------CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcccee
Q 001171 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQD------GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVL 970 (1133)
Q Consensus 897 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIl 970 (1133)
+++++...+ ..++||||+++++|.+++....... ...+++..++.++.|++.|++|||+.+|+||||||+||+
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 LLGVCTVDP-PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecCC-CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 999998764 4599999999999999998755222 225899999999999999999999999999999999999
Q ss_pred eCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh--CCCCCccCChhh
Q 001171 971 FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT--GRKPVMFTQDED 1048 (1133)
Q Consensus 971 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~Pf~~~~~~~ 1048 (1133)
++.++.++++|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred ecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 99999999999999865432211 112233456778999999988889999999999999999998 778887655555
Q ss_pred HHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1049 IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
....+.............+. +.. .. ....+++.+|++.||++||++.||++.|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~-----~~~---~~--~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPR-----PPN---CP--KDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccCCC-----ccC---CC--HHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 55444433222111111110 000 00 123378999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=336.43 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=196.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|..+ +|+.||+|++..... ..+.+.+|+++++.++||||+++++++... ...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEE
Confidence 36889999999999999999765 689999999975332 345688999999999999999999988775 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred ECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999998742 24889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCCCCCCCccCccccC------CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAS------TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
.. .......||+.|+|||++. +..++.++||||+||++|||++|+.||...........+... ......
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---~~~~~~ 230 (330)
T cd05601 156 KM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF---QRFLKF 230 (330)
T ss_pred Cc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---CCccCC
Confidence 11 1223357899999999986 456789999999999999999999999765544433332221 111111
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+. ..... ...+++.+|+. +|.+||++.+++++
T Consensus 231 ~~~-----~~~~~------~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 PED-----PKVSS------DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC-----CCCCH------HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 00011 12267788997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=350.26 Aligned_cols=264 Identities=18% Similarity=0.284 Sum_probs=200.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|++++++++||||+++++++... +..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEE
Confidence 57999999999999999999775 589999999865322 135788999999999999999999998876 455999
Q ss_pred EeccCCCCHHHHHHhhccC------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 912 YDYMPNGNLATLLQEASHQ------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
|||+++|+|.+++...... .....++..+..++.||++||+|||++||+||||||+||+++.++.++++|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998753211 1123567778899999999999999999999999999999999999999999999
Q ss_pred cccccCCCC---------------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHH
Q 001171 986 RLAIATPAE---------------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV 1050 (1133)
Q Consensus 986 ~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~ 1050 (1133)
+........ .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 755211100 01112356999999999999999999999999999999999999999754433221
Q ss_pred HHHHHHhhhccccccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCC-CHHHHHHHHhcCcCC
Q 001171 1051 KWVKKQLQRGQISELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRP-SMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RP-s~~evl~~Le~~~~~ 1117 (1133)
.. ..... ..+. .+ ..... ...+++.+|++.||++|| +++++++.|+.....
T Consensus 241 ~~--~~i~~--P~~~-~p-----------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 241 YR--DVILS--PIEV-AP-----------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh--hhccC--hhhc-cc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 00000 0000 00 00111 112788899999999995 677787888776543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=341.86 Aligned_cols=262 Identities=19% Similarity=0.284 Sum_probs=202.2
Q ss_pred hcCCCcccccccccceeEEEEEECCc-eEEEEEEcccC-CcCHHHHHHHHHHHhhcc-CCCeeeEEE-EEeC---C--CC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDG-MVLSIRRLRDG-TIDENTFRKEAEALGKVK-HRNLTVLRG-YYAG---P--PD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~~---~--~~ 906 (1133)
..++++.++|.+|||+.||.|....+ ..||+|++... +..-+.+.+|+++|++|+ |||||.+++ .... . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 44678999999999999999988765 99999998643 333467889999999997 999999999 3321 1 23
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCCCCceEEeccCc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
..++.||||.+|.|-++|...... .+++.++++|++++++|+++||... |||||||-+|||++.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 447999999999999999875432 2899999999999999999999887 99999999999999999999999999
Q ss_pred ccccccCCCCCC------CCCCCCCCCCccCcccc---CCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHH
Q 001171 985 DRLAIATPAEAS------SSTTPIGSLGYVSPEAA---STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055 (1133)
Q Consensus 985 a~~~~~~~~~~~------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 1055 (1133)
|.-......... .......|+.|+|||++ .+...++|+|||++||+||-|+....||+....-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 854333221110 11234689999999997 46678999999999999999999999996443221
Q ss_pred HhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
+++..+ .+++. ..+.+.. .+||..||++||++||++.+|++.+-++...+-.
T Consensus 266 ---------Ilng~Y-~~P~~-p~ys~~l--~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 266 ---------ILNGNY-SFPPF-PNYSDRL--KDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ---------EEeccc-cCCCC-ccHHHHH--HHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 111111 22221 1122222 2799999999999999999999998776655433
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.03 Aligned_cols=263 Identities=21% Similarity=0.354 Sum_probs=207.4
Q ss_pred hcCCCcccccccccceeEEEEEECC-----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|++.++||+|+||.||+|.+.+ +..|++|++..... ..+.+.+|++++++++|||++++++++...+...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678999999999999999998765 78899999864322 2456789999999999999999999987765666
Q ss_pred EEEEeccCCCCHHHHHHhhccC---CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQ---DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
++++||+++++|.+++...... ....+++..+..++.|++.|++|||+.+++||||||+||++++++.+|++|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 9999999999999999765322 1245889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||......+...++..... +..
T Consensus 165 ~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~ 240 (280)
T cd05043 165 RDLFPMDYH-CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR---LAQ 240 (280)
T ss_pred ccccCCceE-EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC---CCC
Confidence 754332211 11122345678999999988889999999999999999999 9999976655554444332110 000
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
. .. .. + ...+++.+||..||++||++.|+++.|+.+..
T Consensus 241 --~---~~---~~----~--~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 241 --P---IN---CP----D--ELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --C---Cc---CC----H--HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00 00 1 12378999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=333.25 Aligned_cols=241 Identities=21% Similarity=0.334 Sum_probs=191.6
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
+.||+|+||.||+|..+ +|+.||+|.+.... .....+.+|+++++.++||||+++++++... ...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCC
Confidence 46999999999999764 68999999986432 1235667899999999999999999988776 455999999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
|+|.+++...+ .+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---~~ 151 (325)
T cd05594 80 GELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GA 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---Cc
Confidence 99999887633 37899999999999999999997 79999999999999999999999999998643221 11
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.....+.....+... ...++..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~---------- 219 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTL---------- 219 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCC----------
Confidence 223456999999999999889999999999999999999999999766554443333211 11111000
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.. ...+++.+|++.||++|+ ++.+++++
T Consensus 220 ~~------~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 SP------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CH------HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01 123788899999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=322.89 Aligned_cols=257 Identities=22% Similarity=0.390 Sum_probs=203.9
Q ss_pred HhcCCCcccccccccceeEEEEEEC---Cc--eEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ---DG--MVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~g--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++..+..+.||+|.||.||+|.+. .| -.||||.-+.+. .+.+.|.+|+.+|+.++|||||+++|+|.+. .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~--P 464 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--P 464 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc--c
Confidence 3445567789999999999999663 23 468888876532 2357899999999999999999999999875 3
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+|||.++-|.|..+++..+. .++......+++||+.||+|||+..+|||||.++|||+....-+|++|||++|.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 5999999999999999998654 388889999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..+... .......-...|||||.+.-++++.++|||.|||++||++. |..||.+....++.-.+..+ .+...++.+
T Consensus 541 ~ed~~y--YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~P~nC 617 (974)
T KOG4257|consen 541 LEDDAY--YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERLPCPPNC 617 (974)
T ss_pred ccccch--hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-CCCCCCCCC
Confidence 754322 22223345568999999999999999999999999999988 99999765544433322221 111122222
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.+ .-+ .++.+||++||.+||.+.|+...|.++..
T Consensus 618 Pp------------~LY----slmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 618 PP------------ALY----SLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred Ch------------HHH----HHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 22 222 67889999999999999999988876554
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=320.88 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=200.0
Q ss_pred CCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
+|.+.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+.++++++||||+++++++..... .+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP-LS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc-eE
Confidence 4778899999999999999763 2578999999754332 3568899999999999999999999987644 58
Q ss_pred EEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 910 LVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
+++||+++++|.+++..... .....+++..+..++.|++.|++|+|++||+||||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999999999999864211 1123478888999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
++|||+++....... ........+++.|+|||++.++.++.++||||+||++|||++ |..||......+..+.+...
T Consensus 165 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~- 242 (283)
T cd05091 165 ISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR- 242 (283)
T ss_pred ecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999875432211 112233456779999999988889999999999999999998 88898766555544443322
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
..... +.. .... ..+++.+||+.+|++||+++||++.|++
T Consensus 243 ---~~~~~--------~~~---~~~~--~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 243 ---QVLPC--------PDD---CPAW--VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---CcCCC--------CCC---CCHH--HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11110 000 1111 2278899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=321.84 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=202.2
Q ss_pred CCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
+|++.+.||+|+||.||+|... ....+++|.+..... ..+.+.+|++++++++||||+++++.+..... .+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP-LL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC-cE
Confidence 4788899999999999999753 235788888865432 23578899999999999999999999877644 58
Q ss_pred EEEeccCCCCHHHHHHhhccC-------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcccee
Q 001171 910 LVYDYMPNGNLATLLQEASHQ-------------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVL 970 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIl 970 (1133)
+||||+++|+|.+++...... ....+++..+..++.|++.|++|||+.+|+||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999999999998753211 1234788999999999999999999999999999999999
Q ss_pred eCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhH
Q 001171 971 FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDI 1049 (1133)
Q Consensus 971 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~ 1049 (1133)
+++++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.....+.+
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999998754332211 11223345678999999988889999999999999999998 9999976665555
Q ss_pred HHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
...+.+..... .. .... ....+++.+|++.+|++||+++|+++.|+++..
T Consensus 239 ~~~~~~~~~~~-----~~------~~~~------~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 FNLLKTGYRME-----RP------ENCS------EEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHhCCCCCC-----CC------CCCC------HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 54433221100 00 0000 112378899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.36 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=198.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC-----CCc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGP-----PDV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-----~~~ 907 (1133)
+++.|++.+.||+|+||.||+|... +++.||+|++.........+.+|+++++++ +|||++++++++... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 5667889999999999999999775 588999999976655667889999999999 799999999998643 234
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++++|.+++.... ...+++..+..++.|++.|++|||+++|+||||||+||++++++.++++|||+++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 689999999999999998643 23488999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
.... ........|+..|+|||++. +..++.++||||+||++|||++|+.||.............. ...
T Consensus 161 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~----~~~ 233 (272)
T cd06637 161 LDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPA 233 (272)
T ss_pred cccc---cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----CCC
Confidence 4221 12233456889999999985 34578899999999999999999999965433222211111 100
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....+. .+.. ...+++.+||..||.+||++.|++++
T Consensus 234 ~~~~~~----------~~~~--~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 234 PRLKSK----------KWSK--KFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCC----------CcCH--HHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 011000 0011 12378899999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=322.31 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=204.0
Q ss_pred HhcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.+.||+|+||.||+|.+.. ...+|+|.+...... ...+.+|+++++++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44578999999999999999997642 368999998754322 34678899999999 8999999999987764
Q ss_pred CcEEEEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD 974 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~ 974 (1133)
..++||||+++|+|.++++.... .....+++..+..++.|++.|++|||+.+|+||||||+||+++.+
T Consensus 90 -~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 90 -PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred -CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 45999999999999999976421 223458899999999999999999999999999999999999999
Q ss_pred CceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHH
Q 001171 975 FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWV 1053 (1133)
Q Consensus 975 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~ 1053 (1133)
+.+|++|||+++....... ........++..|+|||++.+..++.++|||||||++||+++ |..||......+....+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875432211 111122335678999999988889999999999999999998 99999766555544433
Q ss_pred HHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1054 KKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.... ... .+... .....+++.+|+..||++|||+.|+++.|+.+.
T Consensus 248 ~~~~----~~~--------~~~~~-----~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 248 KEGY----RME--------KPQNC-----TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HcCC----cCC--------CCCCC-----CHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2211 000 00000 112237899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=319.29 Aligned_cols=259 Identities=21% Similarity=0.356 Sum_probs=203.9
Q ss_pred hcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|..+. +..||+|.+..... ....+.+|++++++++||||+++++++.... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-P 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC-C
Confidence 4578899999999999999997642 47899999865432 2356889999999999999999999998764 4
Q ss_pred EEEEEeccCCCCHHHHHHhhccC-----CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQ-----DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
.++||||+++|+|.+++...... ....+++..+..++.||+.|++|||+.+|+||||||+||+++.++.+|++||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 59999999999999999764321 1234788899999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++....... ........++..|+|||.+.++.++.++|||||||++||+++ |..||...+..+....+.. ..
T Consensus 164 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~ 238 (277)
T cd05032 164 GMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID----GG 238 (277)
T ss_pred ccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc----CC
Confidence 99875433221 112233456789999999988889999999999999999998 9999976666555544431 11
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.....+ .. .....+++.+||+.+|++||++.|+++.|+.
T Consensus 239 ~~~~~~--------~~-----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 HLDLPE--------NC-----PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCC--------CC-----CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111110 00 0122378999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=339.07 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=193.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++++++||||+++++.+.+. +..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CEEEEE
Confidence 36899999999999999999765 58999999986422 2245678999999999999999999999876 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.+.+ .+++.....++.||+.||+|||++||+||||||+||+++.++.+||+|||+|......
T Consensus 80 ~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999997643 3778888889999999999999999999999999999999999999999997422100
Q ss_pred CC----------------------------------------CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHH
Q 001171 992 PA----------------------------------------EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVL 1031 (1133)
Q Consensus 992 ~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il 1031 (1133)
.. ........+||+.|+|||++.+..++.++||||+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 00011234799999999999998999999999999999
Q ss_pred HHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC---CHHHHH
Q 001171 1032 LEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP---SMADIV 1108 (1133)
Q Consensus 1032 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP---s~~evl 1108 (1133)
|||++|+.||......+....+...... ...+... .... ...+++.+|+ .+|.+|+ ++.|++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~---~~s~------~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETT-----LHIPSQA---KLSR------EASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCcc-----ccCCCCC---CCCH------HHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999999766654433332211000 0000000 0011 1125666665 5999999 899998
Q ss_pred HH
Q 001171 1109 FM 1110 (1133)
Q Consensus 1109 ~~ 1110 (1133)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=313.65 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=192.1
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
++||+|+||.||+|.+. +++.||+|.+..... ....+.+|++++++++||||+++++++.... ..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CeEEEEeeccCCc
Confidence 46999999999999774 689999998764322 2457899999999999999999999987764 4599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
|.+++...+ ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+|++|||+++....... .....
T Consensus 80 L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 154 (252)
T cd05084 80 FLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-ASTGG 154 (252)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc-cccCC
Confidence 999997532 2478999999999999999999999999999999999999999999999999864321110 11111
Q ss_pred CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCCh
Q 001171 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESS 1078 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1078 (1133)
...++..|+|||.+.++.++.++||||+||++|||++ |..||...........+.... ... .. ..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~----~~~-~~-------~~-- 220 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----RLP-CP-------EL-- 220 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----CCC-Cc-------cc--
Confidence 1223457999999988889999999999999999998 888986555443333222110 000 00 00
Q ss_pred hHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1079 EWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1079 ~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.. ....+++.+|++.+|++||++.|+.+.|+.
T Consensus 221 -~~--~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 221 -CP--DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred -CC--HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 00 122378999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.09 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=190.0
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
||+|+||.||+++.+ +|+.||+|++..... ..+.+..|++++++++||||+++++++... ...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-THLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-CeEEEEEecCCCCC
Confidence 799999999999765 589999999864221 234556799999999999999999998776 45599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
|.+++..... ..+++..+..++.||+.|++|||+.||+||||||+||+++.++.++|+|||++...... ....
T Consensus 80 L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~ 152 (277)
T cd05607 80 LKYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTIT 152 (277)
T ss_pred HHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----ceee
Confidence 9998865432 33788888999999999999999999999999999999999999999999998654221 1123
Q ss_pred CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
...|+..|+|||++.+..++.++||||+||++|||++|+.||...........+.+........ .....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---------- 221 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQN---------- 221 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-ccccc----------
Confidence 3468899999999988889999999999999999999999996543221111221211111110 00000
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... ...+++.+|++.||++||+++|+++.....
T Consensus 222 ~~~--~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 222 FTE--ESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred CCH--HHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 001 123789999999999999997776555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=336.62 Aligned_cols=366 Identities=28% Similarity=0.411 Sum_probs=290.0
Q ss_pred ccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEE
Q 001171 290 SSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLR 369 (1133)
Q Consensus 290 ~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 369 (1133)
+-.+-+|+++|.|+|.-.|.+...+++++.|-|...++..+ |+.++.+.+|+.|.+++|++. .+.+.+..|++|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~v-PeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQV-PEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhC-hHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 44566777778777766566666777888888888888887 889999999999999999998 5667888999999999
Q ss_pred ccCCcccc-cCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccccccc
Q 001171 370 VANNSLSG-LVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR 448 (1133)
Q Consensus 370 L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~ 448 (1133)
+++|++.. -+|+.+.++..|..||||+|+++ .+|..+...+++.+|+|++|+|..+.-..|.+++.|-+||||+|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 99999864 35888889999999999999998 78999999999999999999999776677889999999999999998
Q ss_pred ccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCc-cccCCCcCCcccccEEeccccCCCCCCChhc
Q 001171 449 GNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS-GKIPGSIGSLMRLTTLDLSNQNLSGELPIEL 527 (1133)
Q Consensus 449 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 527 (1133)
..|..+.++..|++|+|++|.+...--..+..++.|.+|.+++.+-+ ..+|.++..+.+|..+|+|.|++. .+|+++
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 67888899999999999999886433444556667777777776543 346777777777777777777776 667776
Q ss_pred cCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccE
Q 001171 528 FGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEV 607 (1133)
Q Consensus 528 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 607 (1133)
.++++|+.|+|++|+|+ .+....+...+|++|+||+|+++ .+|+.+.++++|+.
T Consensus 242 y~l~~LrrLNLS~N~it-------------------------eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKIT-------------------------ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhheeccCcCcee-------------------------eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 66666666666666665 22233445566677777777776 67777777777777
Q ss_pred EEecCCcccC-CCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccccccccccc
Q 001171 608 LELRSNHFTG-NIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686 (1133)
Q Consensus 608 L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 686 (1133)
|.+.+|+++- -+|..|+.+.+|+.+..++|.+. .+|..++.|.+|+.|.|++|++. .+|+.+.-|+.|+.|||..|.
T Consensus 296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 7777777652 27888888888888888888887 78888888888888888888887 678888888888888888886
Q ss_pred cc
Q 001171 687 LS 688 (1133)
Q Consensus 687 l~ 688 (1133)
--
T Consensus 374 nL 375 (1255)
T KOG0444|consen 374 NL 375 (1255)
T ss_pred Cc
Confidence 54
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.38 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=193.5
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV 911 (1133)
+|++.+.||+|+||.||+|+.+ +++.||+|++.+... ..+.+..|.+++..+ +||+|+++++++... +..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-DRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-CEEEEE
Confidence 4788999999999999999776 578999999865321 234566788888877 588999999988776 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred EcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999999987643 3788899999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+.... ..+
T Consensus 155 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~--------- 220 (323)
T cd05616 155 ---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAY--------- 220 (323)
T ss_pred ---CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCC---------
Confidence 112234578999999999999999999999999999999999999998766655554443210 000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH-----HHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM-----ADIVF 1109 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1109 (1133)
+.... ....+++.+|++.||.+|++. .++.+
T Consensus 221 --p~~~s-----~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 221 --PKSMS-----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCcCC-----HHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 00000 112378899999999999974 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=329.56 Aligned_cols=265 Identities=20% Similarity=0.256 Sum_probs=195.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP----- 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 905 (1133)
..++|++.+.||+|+||.||+|... .|+.||+|++.... .....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999764 58999999986432 22456788999999999999999999886432
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
...++||||+++ ++.+.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 235899999964 66666642 2678888899999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---- 1061 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 1061 (1133)
+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.+......
T Consensus 171 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 171 RTACT----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccc----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 64321 1122345789999999999999999999999999999999999999976654433322222111000
Q ss_pred ------cccccc--CCcCCC-----------CCCChhH-HHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1062 ------ISELLE--PGLLEL-----------DPESSEW-EEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1062 ------~~~~~~--~~~~~~-----------~~~~~~~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
...... +..... +...... ..-....+++.+|++.||++|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000 000000 0000000 0001223889999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=323.63 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=201.6
Q ss_pred cCCCcccccccccceeEEEEEECC-c--eEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD-G--MVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~-g--~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|++.++||+|+||.||+|..++ + ..+++|.++.... ..+.+.+|+++++++ +||||+++++++.... ..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-YLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-cceE
Confidence 578999999999999999997753 3 3478888763222 235788999999999 7999999999987764 4599
Q ss_pred EEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEE
Q 001171 911 VYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 979 (1133)
||||+++++|.++++..... ....+++..+..++.|++.|++|||++||+||||||+||++++++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 99999999999999764321 1134788899999999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+...
T Consensus 161 ~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 161 ADFGLSRGEEV----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred CCcCCCccccc----eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999853211 111112233457999999988889999999999999999997 9999976665554433322110
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
. . .. .. .. ....+++.+||+.+|.+||+++++++.|+.......+.
T Consensus 237 ~----~-~~-------~~---~~--~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 237 M----E-KP-------RN---CD--DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred C----C-CC-------CC---CC--HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 0 0 00 00 00 11237899999999999999999999998877655443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=336.99 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=191.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.|+..++||+|+||.||+|+.. +++.||+|++..... ..+.+.+|++++++++||||+++++.+.+. ...++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEE
Confidence 5889999999999999999775 588999999864321 235678899999999999999999999876 4569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|+|.+++.+.+ .+++.....++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999997643 37788888999999999999999999999999999999999999999999975321100
Q ss_pred C--------------------------------------------CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHH
Q 001171 993 A--------------------------------------------EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFG 1028 (1133)
Q Consensus 993 ~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 1028 (1133)
. ........+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 00001234699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC---HH
Q 001171 1029 IVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS---MA 1105 (1133)
Q Consensus 1029 ~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs---~~ 1105 (1133)
|++|||++|+.||...+..+....+........ .+.... .. .+ ..+++.+|+ .+|++|++ +.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----~p~~~~---~s---~~---~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLH-----IPPQAK---LS---PE---ASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC-----CCCccc---CC---HH---HHHHHHHHc-cCHhHcCCCCCHH
Confidence 999999999999976655443333222110000 000000 01 11 124555554 59999987 88
Q ss_pred HHHHH
Q 001171 1106 DIVFM 1110 (1133)
Q Consensus 1106 evl~~ 1110 (1133)
|++++
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 88754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=317.78 Aligned_cols=260 Identities=18% Similarity=0.313 Sum_probs=201.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||.||+|+.. +++.||||++.... .....+.+|++++++++|||++++++++.... ..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-eEEEE
Confidence 57899999999999999999764 68999999875321 12346788999999999999999999988764 45899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...... ...+++..+..++.|++.|++|||+++++||||||+||+++.++.++++|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999998754322 234788889999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. .......|+..|+|||++.+..++.++|+||+|+++|||++|+.||...... ..... ........+....
T Consensus 160 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~---- 230 (267)
T cd08228 160 T---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLC-QKIEQCDYPPLPT---- 230 (267)
T ss_pred h---HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHH-HHHhcCCCCCCCh----
Confidence 1 1122346888999999998888899999999999999999999998643221 11111 1111111111100
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.... ....+++.+||+.+|++||++.||++.+++++
T Consensus 231 ------~~~~--~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 231 ------EHYS--EKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------hhcC--HHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000 11237899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=314.32 Aligned_cols=252 Identities=24% Similarity=0.446 Sum_probs=203.0
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.......+.+.+|++++++++||+++++++++.... ..++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-PICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-ceEEEEEcCC
Confidence 367888999999999999998877889999999876666788999999999999999999999987664 4589999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+++|.+++.... ..+++..+..++.+++.|++|||+.+++||||||+||+++.++.++++|||.++....... .
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 156 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--T 156 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc--c
Confidence 999999987533 2378889999999999999999999999999999999999999999999999865432111 1
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......++..|+|||++.++.++.++||||+|+++|||++ |+.||...........+.+..+ ...+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~----- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------LYKPRL----- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------CCCCCC-----
Confidence 1122335678999999988889999999999999999998 9999976665554444322110 001111
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
.. ....+++.+||+.+|++||++.|++++|.
T Consensus 226 ~~------~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 AS------QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CC------HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 00 12237899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=318.95 Aligned_cols=266 Identities=21% Similarity=0.354 Sum_probs=202.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-----------------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeee
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-----------------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTV 896 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~ 896 (1133)
.++|++.++||+|+||.||++.+. ++..||+|++..... ..+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998543 245789999875432 2357889999999999999999
Q ss_pred EEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCC------CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcccee
Q 001171 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQD------GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVL 970 (1133)
Q Consensus 897 l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIl 970 (1133)
+++++..... .++||||+++|+|.+++....... ...+++..+..++.|++.|++|||+.||+||||||+||+
T Consensus 84 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 84 LLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecCCc-cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 9999987644 599999999999999998754221 134778889999999999999999999999999999999
Q ss_pred eCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh--CCCCCccCChhh
Q 001171 971 FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT--GRKPVMFTQDED 1048 (1133)
Q Consensus 971 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~Pf~~~~~~~ 1048 (1133)
++.++.++++|||+++....... ........++..|+|||+..++.++.++|||||||++|||++ |..||......+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999875432211 111222345678999999888889999999999999999998 778887655555
Q ss_pred HHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1049 IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.................... +.. .. ....+++.+||+.||++||++.||++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~-----~~~---~~--~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPK-----PAL---CP--DSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhccccccCCC-----CCC---CC--HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 44433332221111111100 000 01 122378999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.62 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=203.2
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
+-|.+.+.||+|-|++|-.|++- .|+.||||++-+... ....+.+|++.|+-++|||||++|.+...+ ...|+|.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-TKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-TKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-ceEEEEE
Confidence 45788899999999999999764 799999999965443 346788999999999999999999998776 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee-CCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF-DADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|.-.+|+|++|+.++. .-+.+....+++.||+.|+.|+|..+||||||||+||.+ ..-|-+|++|||++-.+.
T Consensus 97 ELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-- 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-- 170 (864)
T ss_pred EecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC--
Confidence 9999999999998753 348899999999999999999999999999999999876 567899999999985442
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCC-CCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPT-KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.+....+.+|+..|-|||++.+..|+ +++||||+|||+|.+++|++||...++.+....+..... -+..
T Consensus 171 --PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------tvPs-- 240 (864)
T KOG4717|consen 171 --PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------TVPS-- 240 (864)
T ss_pred --CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------cCch--
Confidence 23456778999999999999998884 678999999999999999999987777666555443210 0000
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.--..+.++|..|+..||.+|.+.+||+..
T Consensus 241 ----------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 241 ----------HVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----------hhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 001123389999999999999999999865
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=342.63 Aligned_cols=264 Identities=17% Similarity=0.191 Sum_probs=196.8
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCC------CeeeEEEEEeCCCCc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHR------NLTVLRGYYAGPPDV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~~~~~~~~ 907 (1133)
..++|++.++||+|+||+||+|.+. .++.||||++.........+..|++++++++|. +++.+++++......
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 4678999999999999999999765 588999999965433345667788888887654 588899998876666
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCC-----------
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADF----------- 975 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~----------- 975 (1133)
.++|||++ +++|.+++.+.+ .+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 78999998 788999887642 38899999999999999999997 5999999999999998765
Q ss_pred -----ceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHH
Q 001171 976 -----EAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV 1050 (1133)
Q Consensus 976 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~ 1050 (1133)
.+||+|||.+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus 281 ~~~~~~vkl~DfG~~~~~------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDE------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred CCCCceEEECCCCccccC------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 4899999987432 12233467999999999999999999999999999999999999999876655544
Q ss_pred HHHHHHhhhcc--c---------cccccCCc-CCCCCCCh---------hH---HHHHHhHhhhhccCCCCCCCCCCHHH
Q 001171 1051 KWVKKQLQRGQ--I---------SELLEPGL-LELDPESS---------EW---EEFLLGVKVGLLCTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1051 ~~~~~~~~~~~--~---------~~~~~~~~-~~~~~~~~---------~~---~~~~~~~~li~~Cl~~dP~~RPs~~e 1106 (1133)
..+.+...... + .++.+... ........ .. .......+++.+||+.||++||+++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 44433221100 0 00000000 00000000 00 01122348999999999999999999
Q ss_pred HHHH
Q 001171 1107 IVFM 1110 (1133)
Q Consensus 1107 vl~~ 1110 (1133)
++++
T Consensus 435 ~L~H 438 (467)
T PTZ00284 435 MTTH 438 (467)
T ss_pred HhcC
Confidence 9974
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=319.97 Aligned_cols=262 Identities=19% Similarity=0.344 Sum_probs=201.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
..++|++.++||+|+||.||+|..+ .+..||+|.+...... ...+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 4568999999999999999999653 2568999988644322 346788999999999999999999987764
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCC-----CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQD-----GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
..++||||+++|+|.++++..+... ....++..+..++.|++.|++|||+++|+||||||+||++++++.++++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 4599999999999999998643211 12356677888999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhc
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
||+++....... ........++..|+|||.+.++.++.++|||||||++|||++ |..||.....++....+.. +
T Consensus 163 fg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----~ 237 (288)
T cd05061 163 FGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----G 237 (288)
T ss_pred CCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----C
Confidence 999875432211 111222345678999999988889999999999999999998 7889976555544333221 1
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.... ..... . ....+++.+|++.||++||++.|+++.++...
T Consensus 238 ~~~~--------~~~~~---~--~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GYLD--------QPDNC---P--ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCC--------CCCCC---C--HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 00000 0 12237899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.89 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=203.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
-|.+.+++|+|+||.||+|.++ .|.++|||+++.+. +-+++..|+.+|++.+.|++|+++|.|....+ .|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhhcC
Confidence 4678889999999999999776 59999999997643 56788999999999999999999998876544 599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
.|+..+.++... +.+.+.++..+.++.++||+|||...-+|||||+.|||++.+|++|++|||.|-..-+. -.
T Consensus 112 AGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---MA 184 (502)
T KOG0574|consen 112 AGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---MA 184 (502)
T ss_pred CCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh---HH
Confidence 999999998643 55899999999999999999999999999999999999999999999999998544222 22
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
...+..||+.|||||++..-.|..++||||+|++..||..|++||....+...... ++.-..|.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------IPT~PPPT------- 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------IPTKPPPT------- 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------ccCCCCCC-------
Confidence 34567899999999999999999999999999999999999999965433211000 11122222
Q ss_pred ChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1077 SSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1077 ~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....+++...+ +++.+|+-+.|++|.++.+++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 23344555545 78889999999999999988765
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=321.25 Aligned_cols=269 Identities=22% Similarity=0.371 Sum_probs=196.0
Q ss_pred cCCCcccccccccceeEEEEEEC-----CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeC-CCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-----DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAG-PPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~~ 909 (1133)
..|++.+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|++++++++||||+++++++.. .....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999742 578999999865432 24578899999999999999999998753 334568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++...+ ..+++..+..++.|++.||+|||++||+||||||+||++++++.++++|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997542 237899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc----ccccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG----QISEL 1065 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~ 1065 (1133)
.............++..|+|||+..+..++.++|||||||++|||++|..|+..... .....+....... .+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHH
Confidence 322111111122344569999999888899999999999999999998877643211 1111000000000 00000
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
+........+. .... ...+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~--~~~~--~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPP--GCPA--EIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCC--CCCH--HHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000000 0001 123789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=323.17 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=200.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-Cce--EEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGM--VLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.++||+|+||.||+|.++ ++. .+|+|++..... ..+.+.+|++++.++ +||||+++++++.... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~-~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-Cce
Confidence 357889999999999999999875 343 467877754322 235788999999999 8999999999997764 459
Q ss_pred EEEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 910 LVYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
+||||+++++|.++++..+.. ....+++..+..++.|++.|++|||++||+||||||+||+++.++.+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 999999999999999865421 123578899999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
|+|||+++.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+....
T Consensus 165 l~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 165 IADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred eCccccCcccch----hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 999999853211 111122234668999999988888999999999999999998 999997655544433322110
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
. .+ ..... . ....+++.+||+.+|++||++.++++.|+.......
T Consensus 241 ~----~~--------~~~~~---~--~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 241 R----LE--------KPLNC---D--DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred c----CC--------CCCCC---C--HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0 00 00000 0 112378999999999999999999999887655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=322.68 Aligned_cols=200 Identities=21% Similarity=0.333 Sum_probs=161.9
Q ss_pred ccccccccceeEEEEEEC---CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEEEEeccCC
Q 001171 842 ENVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLLVYDYMPN 917 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~lV~e~~~~ 917 (1133)
.++||+|+||+||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++... +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 468999999999999764 468899999865432 35678899999999999999999988643 345589999984
Q ss_pred CCHHHHHHhhccC----CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee----CCCCceEEeccCcccccc
Q 001171 918 GNLATLLQEASHQ----DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF----DADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 918 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~~~ 989 (1133)
++|.+++...... ....+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 6888887643211 12347888899999999999999999999999999999999 456789999999997653
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
.............||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 32222223345678999999999876 4589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=328.78 Aligned_cols=264 Identities=20% Similarity=0.238 Sum_probs=197.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP----- 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 905 (1133)
..++|.+.++||+|+||.||+|... .++.||||++.... ...+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4568999999999999999999765 58899999986532 22456788999999999999999999875432
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
...++||||++ +++.+.+.. .+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 24589999995 577777753 2678888999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---- 1061 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 1061 (1133)
+.... ........||..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.+......
T Consensus 174 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCC----CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 65422 1122345789999999999998999999999999999999999999977665554444433211100
Q ss_pred ------cccccc--CCc---------CCCC-CCChh-H-HHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 ------ISELLE--PGL---------LELD-PESSE-W-EEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 ------~~~~~~--~~~---------~~~~-~~~~~-~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...... +.. .... +.... . .......+++.+|++.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 0000 00000 0 001123489999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=318.55 Aligned_cols=247 Identities=20% Similarity=0.286 Sum_probs=189.3
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
||+|+||+||++.++ +|+.||+|++...... .+.+..|++++++++||||+++.+++... ...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-CeEEEEEeCCCCCC
Confidence 799999999999765 6899999998643222 24567899999999999999999988765 44599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
|.+++..... ....+++..+..++.||+.|++|||+.+|+||||||+||+++.++.++++|||+++...... ....
T Consensus 80 L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (280)
T cd05608 80 LRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTK 155 (280)
T ss_pred HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---cccc
Confidence 9988864322 22458899999999999999999999999999999999999999999999999986542211 1223
Q ss_pred CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...........+........ . ..+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~-~~~~~--- 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--------V-TYPDK--- 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--------C-CCccc---
Confidence 45689999999999999999999999999999999999999975443222222222111110 0 00000
Q ss_pred HHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.. ....+++.+|++.||++|| +++|++++
T Consensus 224 ~~--~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FS--PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CC--HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00 1123788899999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=323.59 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=202.5
Q ss_pred hcCCCcccccccccceeEEEEEEC--------CceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
.++|.+.+.||+|+||.||+|++. .+..+|+|.+..... ....+.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 457999999999999999999753 235799999875422 235678899999999 799999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
. ..++||||+++|+|.+++...+. .....+++..+..++.|++.|++|||+.|++||||||+||+++.
T Consensus 97 ~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 97 G-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 4 55999999999999999986432 12235889999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.++++|||.++....... ........++..|+|||++.+..++.++||||+||++|||++ |..||......+....
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCcEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 99999999999865432111 111122234568999999988889999999999999999998 8899876554444333
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
+.. ....+. +... . ....+++.+|+..+|.+||++.||++.|+++...
T Consensus 255 ~~~----~~~~~~--------~~~~---~--~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 255 LKE----GHRMDK--------PSNC---T--NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHc----CCCCCC--------CCcC---C--HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 322 111110 0000 0 1222789999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=326.59 Aligned_cols=241 Identities=21% Similarity=0.345 Sum_probs=191.8
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
+.||+|+||.||+|.++ +++.||+|++.+.. .....+.+|.++++.+ +||||+++++++.... ..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-RLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 46999999999999775 57899999987532 2245667899999888 7999999999988764 5599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+||++++++.++|+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 151 (318)
T cd05570 80 GGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG---GV 151 (318)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---CC
Confidence 999999987643 3889999999999999999999999999999999999999999999999998642211 11
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... .. ... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----~~--~~~-------~~ 218 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----EV--RYP-------RW 218 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----CC--CCC-------Cc
Confidence 223346899999999999999999999999999999999999999766655444333221 10 000 00
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCH-----HHHHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSM-----ADIVFM 1110 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~~ 1110 (1133)
. . ....+++.+||+.||.+||++ .+++++
T Consensus 219 ~---~--~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 L---S--KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C---C--HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0 0 112378999999999999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=318.02 Aligned_cols=266 Identities=21% Similarity=0.372 Sum_probs=200.8
Q ss_pred hcCCCcccccccccceeEEEEEECC---------------ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD---------------GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLR 898 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~ 898 (1133)
.++|++.++||+|+||.||++...+ ...||+|++..... ....+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999986532 23589999865322 235688999999999999999999
Q ss_pred EEEeCCCCcEEEEEeccCCCCHHHHHHhhccC-------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee
Q 001171 899 GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQ-------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF 971 (1133)
Q Consensus 899 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll 971 (1133)
+++.... ..++||||+++++|.+++...... ....+++..+..++.|++.|++|||+.+++||||||+||++
T Consensus 84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 84 GVCVSDD-PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEcCCC-ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 9997764 459999999999999999753211 11236888899999999999999999999999999999999
Q ss_pred CCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh--CCCCCccCChhhH
Q 001171 972 DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT--GRKPVMFTQDEDI 1049 (1133)
Q Consensus 972 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~Pf~~~~~~~~ 1049 (1133)
+.++.+|++|||+++....... ........++..|+|||+..++.++.++|||||||++|||++ |..||.....++.
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999865432211 111223345678999999988889999999999999999998 6678876555554
Q ss_pred HHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
...+.+............. .+.. . ....+++.+||+.||++||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-----~~~~---~--~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQ-----TPLC---P--SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccCCC-----CCCC---C--HHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 4443332221110000000 0000 0 123489999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.63 Aligned_cols=255 Identities=22% Similarity=0.385 Sum_probs=189.5
Q ss_pred cccccccceeEEEEEECC---ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 843 NVLSRGRYGLIFKASYQD---GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
+.||+|+||.||+|.+.+ +..+|+|++..... ....+.+|+.++++++||||+++++++.+... .++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP-YLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC-cEEEEECCCC
Confidence 369999999999997643 46799999865432 23578889999999999999999999877644 5899999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
|+|.+++...........++..+..++.|++.|++|||+.+++||||||+||+++.++.++++|||.++....... ...
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~ 158 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-YVT 158 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce-eec
Confidence 9999999865433333467778888999999999999999999999999999999999999999999864322111 112
Q ss_pred CCCCCCCCCccCccccCCC-------CCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 998 STTPIGSLGYVSPEAASTG-------QPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||......+......... .....++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 234 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ----QLKLPKPR 234 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc----cCCCCCCc
Confidence 2334577889999998542 35789999999999999996 999997655444333222111 11111111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
... ... +. ..+++.+|| .+|++||+++||++.|+
T Consensus 235 ~~~--~~~---~~---~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKL--PLS---DR---WYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCC--CCC---hH---HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 110 011 11 125778898 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=327.31 Aligned_cols=245 Identities=20% Similarity=0.342 Sum_probs=189.6
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|+++ +++.||+|+++.... ..+.+.+|..+++++ +||||+++++++.... ..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-RLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-EEEEEEeCCC
Confidence 46999999999999775 588999999975322 234578899999998 7999999999988764 5599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~ 151 (329)
T cd05588 80 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---GD 151 (329)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC---CC
Confidence 999999887542 3889999999999999999999999999999999999999999999999998642211 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCCh-----hhHHHHHHHHhhhccccccccCCcC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD-----EDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....+..+.......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--------- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------
Confidence 23345799999999999998999999999999999999999999963211 1112222222222111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCC------HHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS------MADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs------~~evl~~ 1110 (1133)
..+.... ....+++.+|++.||.+||+ +.|++++
T Consensus 223 ~~p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLS-----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCC-----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0111100 11237899999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=327.53 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=206.6
Q ss_pred CCcccccccccceeEEEEEE-CCc----eEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 839 FDEENVLSRGRYGLIFKASY-QDG----MVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~-~~g----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
....++||+|+||+||+|.| .+| .+||+|++...... ..++.+|+-+|.+++|||+++++|++.... ..+|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 34568999999999999966 334 46889988654433 568899999999999999999999998753 4799
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
++|++.|+|.++++.++. .+-....+.|.+|||+||.|||.+++|||||.++|||+.+..++||.|||+++.....
T Consensus 776 tq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999998653 3777888999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
... .......-.+.|||-|.+....|+.++|||||||++||++| |..||.....+++.+.+++..+-.+
T Consensus 852 ~~e-y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsq--------- 921 (1177)
T KOG1025|consen 852 EKE-YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQ--------- 921 (1177)
T ss_pred ccc-ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCC---------
Confidence 332 22233345568999999999999999999999999999999 9999998887777766655433211
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
+.....+-+ .++.+||..|+..||+++++...+.+....|
T Consensus 922 ----PpiCtiDVy----~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 922 ----PPICTIDVY----MVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ----CCCccHHHH----HHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 111111122 4567899999999999999998887655443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=314.93 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=191.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc------CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI------DENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~ 909 (1133)
+|+..++||+|+||.||+|... ++..||+|++..... ....+.+|++++++++||||+++++++... ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6888999999999999999764 589999998854321 124678899999999999999999988653 35568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||+++...
T Consensus 83 l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999997633 37888889999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.............++..|+|||++.+..++.++||||+||++|||++|+.||........ +.+...... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~~~~~~~~~-----~~~ 229 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---IFKIATQPT-----NPQ 229 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---HHHHhcCCC-----CCC
Confidence 221111222334588899999999888899999999999999999999999965432221 111111110 111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .. ..+. ..+++ +||..+|++||+++||+++
T Consensus 230 ~~---~~---~~~~--~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 LP---SH---ISEH--ARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred Cc---hh---cCHH--HHHHH-HHhcCChhhCcCHHHHhcC
Confidence 10 00 0111 11344 6888999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=317.55 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=202.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
..+|++.++||+|+||+||+|.+. +|+ .||+|.+..... ..+.+.+|+.+++.+.||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--Cc
Confidence 357889999999999999999763 443 489999864332 245788999999999999999999998753 34
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
+++|||+++|+|.+++.... ..+++..+..++.||+.|++|||+.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 79999999999999997532 24889999999999999999999999999999999999999999999999998755
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
...... .......++..|+|||...+..++.++|||||||++|||++ |..||...........+... ..... .
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~-~ 233 (279)
T cd05109 160 DIDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG----ERLPQ-P 233 (279)
T ss_pred ccccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC----CcCCC-C
Confidence 322111 11122345678999999988889999999999999999998 99999765554444433221 10000 0
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
. .... ...+++.+||+.||++||++.|+++.|+++...+
T Consensus 234 ~------~~~~------~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 P------ICTI------DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred c------cCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 0000 1237888999999999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=320.39 Aligned_cols=259 Identities=21% Similarity=0.311 Sum_probs=199.8
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|.+.+.||+|+||.||+|... .+..||+|++...... .+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457899999999999999999641 3568999998754322 35688999999999 7999999999987764
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
..++||||+++|+|.++++.... ..+++..+..++.|++.|++|||+++|+|+||||+||+++.++.++++|||++
T Consensus 113 -~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 -PILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 45999999999999999975332 23789999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+....... ........++..|+|||++.+..++.++||||+||++|||++ |..||......+...... ..+. ..
T Consensus 189 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~---~~~~-~~ 263 (302)
T cd05055 189 RDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI---KEGY-RM 263 (302)
T ss_pred ccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH---HcCC-cC
Confidence 75432211 111222346778999999988889999999999999999998 999986544332221111 1110 00
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... .... ....+++.+|++.+|++||++.|+++.|++.
T Consensus 264 ~~~------~~~~------~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 AQP------EHAP------AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCC------CCCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 0000 1123789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=311.86 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=203.0
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.++||+|+||.||+|... |+.||+|.+.......+.+.+|+.++++++|+|++++++++... ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG-NPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-CCeEEEEEec
Confidence 347889999999999999999875 78899999976554567899999999999999999999998864 5569999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++..... ..+++..+..++.|++.|++|||+.|++||||||+||+++.++.++++|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99999999976432 248999999999999999999999999999999999999999999999999987542111
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
....++..|+|||++.++.++.++||||+|+++|||++ |+.||......+....+.+... ....
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~-------- 221 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR----MEAP-------- 221 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----CCCc--------
Confidence 12234568999999988889999999999999999998 9999976655554443332111 0000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.. .. ....+++.+|+..+|++||++.|++++|+.
T Consensus 222 ~~---~~--~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EG---CP--PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cC---CC--HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00 00 112378999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=334.93 Aligned_cols=365 Identities=24% Similarity=0.378 Sum_probs=210.9
Q ss_pred cccccCcEEEcccCcccC-CCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEE
Q 001171 92 ADLHELRKLSLHSNHLNG-SIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYL 170 (1133)
Q Consensus 92 ~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 170 (1133)
+-|++++-+|+++|.++| .+|.....+++++-|-|...++. .+|+.++.|.+|++|.++||++..
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~------------- 69 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS------------- 69 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-------------
Confidence 346788888999999985 78988999999999999988887 799999999999999999888762
Q ss_pred EccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCC-CcccccCccccceEecccccccCCCCccccCccccceeecccccc
Q 001171 171 DLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGE-VPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVL 249 (1133)
Q Consensus 171 ~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l 249 (1133)
+-+.++.++.|+.+++..|++... ||..+-.+..|+.||||+|++. ..|..+..-.++..|+|++|+|
T Consensus 70 ----------vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 70 ----------VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred ----------hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence 233445556666666666666422 5555666666666666666665 5566666556666666666666
Q ss_pred CCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccc
Q 001171 250 KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRA 329 (1133)
Q Consensus 250 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~ 329 (1133)
..++-..|-+++.|-+||||+|++..+.| .+ ..+..|+.|+|++|.+ ..
T Consensus 139 etIPn~lfinLtDLLfLDLS~NrLe~LPP-Q~-----RRL~~LqtL~Ls~NPL-------------------------~h 187 (1255)
T KOG0444|consen 139 ETIPNSLFINLTDLLFLDLSNNRLEMLPP-QI-----RRLSMLQTLKLSNNPL-------------------------NH 187 (1255)
T ss_pred ccCCchHHHhhHhHhhhccccchhhhcCH-HH-----HHHhhhhhhhcCCChh-------------------------hH
Confidence 54433344555555556666665553222 22 2223333333333222 21
Q ss_pred cCCchhhcccccceeeccCceee-cccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccC
Q 001171 330 VFPSWLTNVTSLRVMDLSGNFFS-GNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLG 408 (1133)
Q Consensus 330 ~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 408 (1133)
..-..+..+++|++|.+|+.+-+ ..+|.++..+.+|..+||+.|.+. .+|+.+-++++|+.|+||+|+|+ .+-...+
T Consensus 188 fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 188 FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 11122344667777777776543 356777777777777777777776 45666666667777777777665 2223333
Q ss_pred CCCCCcEEEccCCcCccccCccccCccccceeeccccccccc-CChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcE
Q 001171 409 GIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN-IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLV 487 (1133)
Q Consensus 409 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 487 (1133)
...+|+.|+|++|+++ ..|..+..+++|+.|.+.+|+++-. +|..++.+.+|+++..++|.+. .+|..++.+..|+.
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k 343 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK 343 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence 3444555555555555 2344455555555555555544321 3444444444444444444444 44444444444444
Q ss_pred EEcccCCCccccCCCcCCcccccEEecccc
Q 001171 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQ 517 (1133)
Q Consensus 488 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 517 (1133)
|.|++|++- .+|..+.-++.|+.||+.+|
T Consensus 344 L~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 344 LKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred hccccccee-echhhhhhcCCcceeeccCC
Confidence 444444443 33444444444444444443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=330.12 Aligned_cols=237 Identities=24% Similarity=0.389 Sum_probs=188.3
Q ss_pred cccccccceeEEEEEE----CCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 843 NVLSRGRYGLIFKASY----QDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
+.||+|+||.||+++. ..|+.||+|++..... ....+.+|++++++++||||+++++++... ...++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcCC
Confidence 5799999999999965 3578999999864322 234567899999999999999999999876 4559999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++|+|.+++.+. ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 81 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~ 152 (318)
T cd05582 81 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---E 152 (318)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC---C
Confidence 999999998753 23789999999999999999999999999999999999999999999999998654221 1
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.+. ...++ .
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p-----------~ 219 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMP-----------Q 219 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCC-----------C
Confidence 1223457899999999998888999999999999999999999999766554444333221 00011 0
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHH
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1106 (1133)
... ....+++.+||+.||++||++.+
T Consensus 220 ~~~-----~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLS-----PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC-----HHHHHHHHHHhhcCHhHcCCCCC
Confidence 100 01227889999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=322.07 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=203.4
Q ss_pred hcCCCcccccccccceeEEEEEEC--------CceEEEEEEcccCC--cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
.++|++.+.||+|+||.||+|++. ++..||+|.+.... ...+.+.+|+++++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457889999999999999999642 24579999986432 2245788999999999 899999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
. ..++||||+++|+|.+++...+.. ....+++..+..++.||++|++|||++||+||||||+||+++.
T Consensus 94 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 94 G-PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 4 559999999999999999864321 1235788899999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.+|++|||.++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......+....
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 999999999998755322111 11223345678999999988889999999999999999998 7888876655554443
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
+... ..... +.. .. ....+++.+||+.+|.+||++.|+++.|+++..
T Consensus 252 ~~~~----~~~~~---------~~~--~~--~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 252 LKEG----HRMDK---------PAN--CT--NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHcC----CcCCC---------CCC--CC--HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 3221 10000 000 00 112368899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=332.86 Aligned_cols=254 Identities=19% Similarity=0.282 Sum_probs=195.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++.+.||+|+||.||+|+++ +++.||+|++.+.. ...+.+.+|+++++.++||||+++++++... ...+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEE
Confidence 4578999999999999999999876 58899999985421 1234577899999999999999999998775 4569
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++... .++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999999998752 26788888899999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCC----CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTG----QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.......+........ .
T Consensus 194 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~ 268 (371)
T cd05622 194 KEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F 268 (371)
T ss_pred cCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C
Confidence 211 1223356799999999998653 378999999999999999999999976655444433322111111 1
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCC--CCCHHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD--RPSMADIVFML 1111 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~L 1111 (1133)
.+. ..... ...+++.+|+..++.+ ||++.|++++.
T Consensus 269 ~~~---------~~~s~--~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 PDD---------NDISK--EAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCc---------CCCCH--HHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 00011 1126788899744433 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=295.82 Aligned_cols=277 Identities=20% Similarity=0.266 Sum_probs=210.0
Q ss_pred HHhcCCCcccccccccceeEEEEEECC-----ceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQD-----GMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 905 (1133)
+....|+....||+|.||.||+|.-.+ .+.+|+|+++.... -....-+|+..++.++|||++.+..++...+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 456689999999999999999994332 24799999975421 1346678999999999999999999988766
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC----CceEEec
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD----FEAHLSE 981 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~----~~~kl~D 981 (1133)
...++++||.+. +|.++++.++......++...+..|..||+.|+.|||++-|+||||||.|||+..+ |.+||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 777999999965 89999988877666789999999999999999999999999999999999999877 8999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChh------hHHHHHH
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDE------DIVKWVK 1054 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~------~~~~~~~ 1054 (1133)
+|++|.+...-..-......+.|.+|+|||.+.+. .|+++.||||.|||+.||+|-++-|.+.... -..+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876554444455667889999999998775 5899999999999999999988877532211 1122222
Q ss_pred HHhhh-ccccccccCCcCCCCCCChhHHHHH---------------------HhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1055 KQLQR-GQISELLEPGLLELDPESSEWEEFL---------------------LGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1055 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
+.+.- +...+...+.+.+.+........+. ..+++..+++..||.+|.|+++.+++-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 22221 1122222233322222211111111 134789999999999999999998764
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.50 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=186.7
Q ss_pred cccccccceeEEEEEECC---ceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 843 NVLSRGRYGLIFKASYQD---GMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
+.||+|+||.||+|.... ...+|+|.+...... ...+.+|+++++.++||||+++++++.... ..++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-ceEEEEEeCCC
Confidence 359999999999996543 457888887643322 356788999999999999999999988764 45999999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
|+|.+++...........++.....++.||+.|++|||+++|+||||||+||+++.++.+|++|||+++....... ...
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~ 158 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YIT 158 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh-eec
Confidence 9999999875533333456778889999999999999999999999999999999999999999999864322111 111
Q ss_pred CCCCCCCCCccCccccC-------CCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 998 STTPIGSLGYVSPEAAS-------TGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.....++..|+|||++. ...++.++||||+||++|||++ |..||......+.......... .....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~ 234 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD----IKLPKPQ 234 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC----ccCCCCc
Confidence 23334667899999864 3356889999999999999999 7888876555443333322111 1111111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
... .....+ .+++..|| .||++||+++||++.|
T Consensus 235 ~~~--~~~~~~------~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 235 LDL--KYSDRW------YEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccc--cCCHHH------HHHHHHHh-cCcccccCHHHHHHHh
Confidence 110 001111 14667788 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.61 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=194.1
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCH
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNL 920 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL 920 (1133)
++||+|+||.||+|..+++..||+|.+...... ...+.+|++++++++||||+++++++.... ..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCCcH
Confidence 469999999999999888899999998654322 346889999999999999999999998764 45999999999999
Q ss_pred HHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCC
Q 001171 921 ATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000 (1133)
Q Consensus 921 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 1000 (1133)
.+++.... ..+++..+..++.+++.|+.|+|++|++||||||+||+++.++.++++|||+++...... ......
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~ 153 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--YSSSGL 153 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc--cccCCC
Confidence 99987533 237899999999999999999999999999999999999999999999999986432211 111122
Q ss_pred CCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1001 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
..++..|+|||++.+..++.++||||||+++|++++ |..||...........+.+.. .... .. ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----~~~~-~~------~~~-- 220 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----RMSC-PQ------KCP-- 220 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----CCCC-CC------CCC--
Confidence 234568999999988889999999999999999998 999997655444433332211 0000 00 000
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
....+++.+|++.+|++||++.|+++.|.
T Consensus 221 ----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 ----DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12237899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=326.47 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=188.1
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|+.+ +++.||+|++.+.. ...+.+.+|+.++.++ +||||+++++++... ...++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCC
Confidence 46999999999999875 57899999987532 1234577899988877 899999999998876 45599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|..++...+ .+++..+..++.||+.|++|||+++|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~---~~ 151 (329)
T cd05618 80 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---GD 151 (329)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---CC
Confidence 999998887643 3889999999999999999999999999999999999999999999999998643221 11
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC-----hhhHHHHHHHHhhhccccccccCCcC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ-----DEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ......++.+.......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------
Confidence 2234578999999999999999999999999999999999999995311 11112222222221111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCC------HHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS------MADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs------~~evl~~ 1110 (1133)
.++.... ....+++.+|++.||++||+ +.|++++
T Consensus 223 ~~p~~~~-----~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLS-----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCC-----HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 0111100 11237889999999999998 4677644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=316.68 Aligned_cols=260 Identities=19% Similarity=0.314 Sum_probs=197.2
Q ss_pred CCCcccccccccceeEEEEEE-----CCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~ 909 (1133)
-|++.+.||+|+||.||.+.+ .++..||+|.+..... ..+.+.+|++++++++|||++++++++... ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 468889999999999999974 2478899999864322 235788999999999999999999988765 34568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++++|.+++.+.. ..+++..+..++.||+.||+|+|++||+||||||+||+++.++.++++|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999997532 247899999999999999999999999999999999999999999999999987553
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC-----------hhhHHHHHHHHhh
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ-----------DEDIVKWVKKQLQ 1058 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-----------~~~~~~~~~~~~~ 1058 (1133)
.............++..|+|||++.+..++.++|||||||++|||++++.|+.... .+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 32221112233456778999999988889999999999999999999877653211 0000111111111
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
..... ..... .. ....+++.+|++.+|.+||++.++++.++++
T Consensus 241 ~~~~~--------~~~~~---~~--~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRL--------PRPPN---CP--EEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccC--------CCCCC---CC--HHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11000 00000 00 1223789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=311.71 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=199.4
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|++|.||+|..+ +++.|++|.+.... ...+.+.+|++++++++|||++++++++... ...++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEE
Confidence 4778899999999999999775 58999999986432 2356788999999999999999999998876 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ...+++..++.++.+++.|+.|||+.||+||||||+||+++.++.++++|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 80 YAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred eCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 999999999998642 2348889999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......|++.|+|||+..+..++.++|+|||||++|||++|+.||...........+.+ ........
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~------ 223 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR----GVFPPVSQ------ 223 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCcc------
Confidence 122334688899999999988899999999999999999999999976654443333222 11111000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. -....+++.+||+.+|++||++.|++++
T Consensus 224 -----~~--~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 -----MY--SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----cc--CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 0112378999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=313.15 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=191.8
Q ss_pred cccccccceeEEEEEEC----CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
+.||+|+||.||+|.+. .+..||+|++.... ...+.+.+|+.+++.++|||++++++++...+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 24679999985322 2245788899999999999999999988655566689999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC-C
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE-A 995 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~ 995 (1133)
+|+|.+++..... ..++..+..++.||+.|++|||+.+|+||||||+||++++++.+|++|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976432 2567778889999999999999999999999999999999999999999998644321110 1
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhC-CCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTG-RKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||++.+..++.++|||||||++|||++| .+||......+....+... .... .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~------ 224 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG----RRLL--QP------ 224 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC----CCCC--CC------
Confidence 111233456789999999888899999999999999999995 5667655444443333221 0000 00
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.. .. ....+++.+||+.+|++||++.|+++.|+.+.
T Consensus 225 -~~--~~--~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 225 -EY--CP--DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -Cc--CC--HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 00 11237899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=323.97 Aligned_cols=240 Identities=21% Similarity=0.333 Sum_probs=189.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV 911 (1133)
+|+..++||+|+||.||+|..+ +|+.||+|++.... ...+.+..|.++++.+. |++|+++++++... +..++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-DRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-CEEEEE
Confidence 4778899999999999999775 68999999986432 22345778999998886 56777888888765 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.... .+++..+..++.||+.|++|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999999987643 3889999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...........+... ...++
T Consensus 155 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p-------- 221 (323)
T cd05615 155 ---GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYP-------- 221 (323)
T ss_pred ---CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC--------
Confidence 11223456899999999999888999999999999999999999999876655544443321 00000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~ 1104 (1133)
.... ....+++.+|++.+|.+|++.
T Consensus 222 ---~~~~-----~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 ---KSLS-----KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---ccCC-----HHHHHHHHHHcccCHhhCCCC
Confidence 0000 112378899999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.40 Aligned_cols=245 Identities=27% Similarity=0.425 Sum_probs=190.2
Q ss_pred cccccccceeEEEEEECC-ceEEEEEEcccC-CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCH
Q 001171 843 NVLSRGRYGLIFKASYQD-GMVLSIRRLRDG-TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNL 920 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL 920 (1133)
-++|+|.||+||.|++.+ ...+|||.++.. ....+.+..|+...++++|.|||+++|.+.+.+ +.-+.||.++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCcH
Confidence 369999999999998764 677999999743 334567889999999999999999999987764 55799999999999
Q ss_pred HHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC-CCCceEEeccCcccccccCCCCCCCCC
Q 001171 921 ATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD-ADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 921 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
.++++..= +.-.-.+...-.+.+||++||.|||+..|||||||-+|||++ -.|.+||+|||-++.... ......
T Consensus 660 SsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg---inP~TE 734 (1226)
T KOG4279|consen 660 SSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG---INPCTE 734 (1226)
T ss_pred HHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc---CCcccc
Confidence 99998631 111125667778999999999999999999999999999996 478999999999876532 233456
Q ss_pred CCCCCCCccCccccCCC--CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCC
Q 001171 1000 TPIGSLGYVSPEAASTG--QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1133)
++.||..|||||++..+ .|++++|||||||++.||.||++||.........- .+-++- ...|.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-FkVGmy------KvHP~i------- 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-FKVGMY------KVHPPI------- 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-hhhcce------ecCCCC-------
Confidence 67899999999999765 48999999999999999999999996443322111 111100 011111
Q ss_pred hhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHH
Q 001171 1078 SEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1078 ~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.++..+.+ .+|.+|+.+||.+||++.++++
T Consensus 801 --Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 --PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 12333333 7999999999999999999985
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=315.33 Aligned_cols=256 Identities=22% Similarity=0.433 Sum_probs=199.3
Q ss_pred cCCCcccccccccceeEEEEEECC-c---eEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD-G---MVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.+|++.+.||+|+||.||+|.+.. + ..||+|.+..... ..+.|..|++++++++||||+++++++.... ..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-PVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-ceEE
Confidence 357889999999999999997753 3 4699999865322 2457899999999999999999999987664 4589
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... ..+++..++.++.|++.|++|||++|++||||||+||+++.++.++++|||.++....
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999987642 2478999999999999999999999999999999999999999999999999865433
Q ss_pred CCCCCCCCC--CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 991 TPAEASSST--TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 991 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
......... ....+..|+|||++.+..++.++||||+||++||+++ |..||...+..+...++..... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~--- 232 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR---LPP--- 232 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---CCC---
Confidence 221111111 1112457999999998899999999999999999987 9999976665555444422110 000
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... .. ....+++.+||+.+|.+||++.++++.|+.+
T Consensus 233 ------~~~---~~--~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 ------PMD---CP--TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------ccc---CC--HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00 0123788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=326.27 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=185.0
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHH-HHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEA-EALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|++. +++.||+|++..... ....+..|. .+++.++||||+++++++...+ ..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-eEEEEEeCCC
Confidence 46999999999999875 578899999864321 123344444 4567889999999999988764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++...+ .+.+.....++.||++||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~---~~ 151 (325)
T cd05602 80 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH---NG 151 (325)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---CC
Confidence 999999997633 3677788889999999999999999999999999999999999999999998643221 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... .. .+.+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~--~~~~~~------ 219 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PL--QLKPNI------ 219 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC----Cc--CCCCCC------
Confidence 233457999999999999989999999999999999999999999866655544443321 00 011111
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1108 (1133)
.. ...+++.+|++.||.+||++.+.+
T Consensus 220 ~~------~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 220 TN------SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CH------HHHHHHHHHcccCHHHCCCCCCCH
Confidence 01 112788899999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=326.78 Aligned_cols=264 Identities=20% Similarity=0.237 Sum_probs=196.4
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC----
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP---- 905 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 905 (1133)
...++|++.+.||+|+||.||+|... .++.||||++...... ...+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999764 5889999998653322 356778999999999999999999886432
Q ss_pred -CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 906 -DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 906 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
...++||||++ +++.+.+.. .+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 23589999996 467776653 277888889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc----
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG---- 1060 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---- 1060 (1133)
++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.+.....
T Consensus 166 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCC----ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 864321 112234578999999999998889999999999999999999999997655433333222211100
Q ss_pred ----------------ccc-----ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 ----------------QIS-----ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ----------------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ............. ..........+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE-HNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccc-cccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000000000000 000001122489999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=331.99 Aligned_cols=253 Identities=21% Similarity=0.334 Sum_probs=193.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|..+ +++.||+|++.... .....+.+|++++.+++||+|+++++.+... ...++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-RNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence 36889999999999999999775 58999999986422 2245678899999999999999999998876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 80 MEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999997643 3788899999999999999999999999999999999999999999999998643221
Q ss_pred CCC--------------------------------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCC
Q 001171 992 PAE--------------------------------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK 1039 (1133)
Q Consensus 992 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~ 1039 (1133)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 001123579999999999999999999999999999999999999
Q ss_pred CCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC---HHHHHHH
Q 001171 1040 PVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS---MADIVFM 1110 (1133)
Q Consensus 1040 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs---~~evl~~ 1110 (1133)
||...........+....... .+.+.. .... .+.+++.+|+ .||.+|++ +.|++++
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~----~~p~~~----~~s~------~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETL----VFPPEV----PISE------KAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCce----ecCCCC----CCCH------HHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 997666554443332210000 011100 0011 1225666665 49999985 6777755
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=325.67 Aligned_cols=236 Identities=25% Similarity=0.405 Sum_probs=184.4
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHH-HHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAE-ALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||+||+|.++ +|+.||+|++..... ....+.+|.. +++.++||||+++++++... +..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCC
Confidence 46999999999999875 689999999864321 2234445544 56789999999999998776 45599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~---~~ 151 (323)
T cd05575 80 GGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH---SK 151 (323)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---CC
Confidence 999999987632 3788889999999999999999999999999999999999999999999998643211 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... .. .+.+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~--~~~~~~------ 219 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK----PL--RLKPNI------ 219 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC----CC--CCCCCC------
Confidence 233456899999999999989999999999999999999999999766555444333221 00 001100
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ 1105 (1133)
. ....+++.+|++.||.+||++.
T Consensus 220 ~------~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 S------VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C------HHHHHHHHHHhhcCHHhCCCCC
Confidence 1 1123788899999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.24 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=200.6
Q ss_pred cccccccceeEEEEEECC----ceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|.... +..|++|.+...... .+.+.+|++++++++|+|++++++++... ...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-EPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-CceEEEEEecc
Confidence 469999999999997754 788999999765443 57889999999999999999999999874 55599999999
Q ss_pred CCCHHHHHHhhccC----CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 917 NGNLATLLQEASHQ----DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
+++|.+++...... ....+++..++.++.|++.|++|||+++|+||||||+||++++++.++++|||.++......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999874211 12458999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. ........++..|+|||.+.+..++.++||||+||++|||++ |..||......+..+.+... ..... +
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~--~--- 229 (262)
T cd00192 160 Y-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG----YRLPK--P--- 229 (262)
T ss_pred c-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----CCCCC--C---
Confidence 1 122334567889999999988889999999999999999999 69999776655554444331 10000 0
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
... -....+++.+|+..+|++||++.|++++|+
T Consensus 230 ---~~~-----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 ---EYC-----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---ccC-----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 012237888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=316.12 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=195.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhc---cCCCeeeEEEEEeCC----CC
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKV---KHRNLTVLRGYYAGP----PD 906 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~----~~ 906 (1133)
+|++.+.||+|+||.||+|..+ +|+.||+|.+..... ....+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999775 689999999864322 134566788887776 699999999988642 23
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 4589999996 589888876432 347899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc---cc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---IS 1063 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~ 1063 (1133)
..... .......|+..|+|||++.+..++.++||||+||++|||++|++||......+....+........ .+
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQ----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCc----ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 54221 122335688999999999888899999999999999999999999976655544444433221111 00
Q ss_pred cccc---CCcCCCCCC-Chh-HHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLE---PGLLELDPE-SSE-WEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~---~~~~~~~~~-~~~-~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ......... ... ...+. ...+++.+|++.||++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000000000 000 00111 12389999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.16 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=200.0
Q ss_pred cCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.+|...++||+|+||.||+|... ++..+|+|.+..... ..+.+.+|++++++++||||+++++++.... ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-PLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-ceE
Confidence 46788899999999999999642 367899998864332 2467899999999999999999999988764 459
Q ss_pred EEEeccCCCCHHHHHHhhccC----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEE
Q 001171 910 LVYDYMPNGNLATLLQEASHQ----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 979 (1133)
+||||+++++|.+++...+.. ....+++..+..++.|++.|++|||+.||+||||||+||++++++.+++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 999999999999999864321 1134788999999999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+.+...
T Consensus 164 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05092 164 GDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242 (280)
T ss_pred CCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence 99999864432111 111223345678999999988889999999999999999998 9999965555444333322110
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
... ... .. ....+++.+||+.||.+||++.||++.|++
T Consensus 243 ----~~~-~~~------~~------~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 243 ----LER-PRT------CP------PEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----CCC-CCC------CC------HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000 000 00 112378899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=320.52 Aligned_cols=265 Identities=18% Similarity=0.308 Sum_probs=197.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|.+.+.||+|+||.||+|+.+ +++.||+|++..... ....+.+|++++++++||||+++++++.... ..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-SLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-eEEEEEe
Confidence 57899999999999999999775 578899999864322 2346778999999999999999999998764 4599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ +++.+++...+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 85 YLD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 996 58888886543 347888899999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc---cc-----
Q 001171 994 EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI---SE----- 1064 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~----- 1064 (1133)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+.+....... +.
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12233467889999999865 45789999999999999999999999776655544444333221110 00
Q ss_pred -cccCCcCCCCCCC--hhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 -LLEPGLLELDPES--SEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 -~~~~~~~~~~~~~--~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+.......+.. ....... ...+++.+|++.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000 0000011 12379999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=321.22 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=203.9
Q ss_pred hcCCCcccccccccceeEEEEEEC--------CceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
.++|.+.++||+|+||.||+|... .+..||+|.+..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457889999999999999999652 246789999875332 235678899999999 699999999998765
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
...++||||+++|+|.+++..... .....+++..+..++.||+.|++|||++||+||||||+||+++.
T Consensus 91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 445999999999999999976432 11245888999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.+|++|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999998754322111 11112234567999999988889999999999999999999 8999976655554444
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
+... ...+. +... . ....+++.+|++.||++||++.|+++.|+++....
T Consensus 249 ~~~~----~~~~~--------~~~~---~--~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 249 LREG----HRMDK--------PSNC---T--HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHcC----CCCCC--------CCCC---C--HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 3221 11110 0000 0 11227889999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=314.98 Aligned_cols=259 Identities=20% Similarity=0.348 Sum_probs=200.9
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|.. .+++.+|||.+..... ..+.+.+|++++++++||||+++++++.... ..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEEE
Confidence 4688899999999999999976 4789999998764221 2357888999999999999999999987754 45899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.+++..... ....+++..++.++.||+.|++|||++|++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999999875432 2345889999999999999999999999999999999999999999999999988654221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. .......|+..|+|||++.+..++.++||||||+++|+|++|..||...... ..... +...........
T Consensus 160 ~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~----- 229 (267)
T cd08229 160 T---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLC-KKIEQCDYPPLP----- 229 (267)
T ss_pred C---cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHh-hhhhcCCCCCCC-----
Confidence 1 1122346888999999998888999999999999999999999999643321 11111 111111111000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.. .... ...+++.+||+.||.+|||+.+|++.++++
T Consensus 230 ---~~--~~~~--~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 ---SD--HYSE--ELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---cc--cccH--HHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00 0111 122788899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.17 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=196.8
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.|+..++||+|+||+||+|.+. +++.||+|.+...... ...+.+|++++++++|++++.+.+++... +..++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEE
Confidence 3677789999999999999774 6899999998643321 24567899999999999999999888775 4569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++...+. ..+++..+..++.|++.|++|||++||+||||||+||+++.++.++++|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 80 TIMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred EeccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 99999999988875432 24899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......|+..|+|||++.+..++.++|+||+||++|||++|+.||...........+.+...... .......
T Consensus 156 ---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-- 228 (285)
T cd05632 156 ---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKF-- 228 (285)
T ss_pred ---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccC--
Confidence 112345689999999999888899999999999999999999999976554433333333322211 0011000
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
.. ...+++.+|++.||++||+ +.+++++
T Consensus 229 --------~~--~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 229 --------SE--EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --------CH--HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00 1237888999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=330.44 Aligned_cols=263 Identities=20% Similarity=0.288 Sum_probs=196.5
Q ss_pred CCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC----CcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~ 909 (1133)
+|++.++||+|+||.||+|.. .+|+.||+|++..... ..+.+.+|+++++.++||||+++++++.... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999976 4689999999864322 2457889999999999999999999987653 2458
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6788877542 348899999999999999999999999999999999999999999999999987542
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc---
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL--- 1065 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--- 1065 (1133)
... ........+++.|+|||++.+. .++.++||||+||++|||++|+.||...+..+....+.+........+.
T Consensus 155 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDE--SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCc--cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 221 1122334678899999998764 4789999999999999999999999776655444443332211110000
Q ss_pred -------ccCCcCCCC------CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 -------LEPGLLELD------PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 -------~~~~~~~~~------~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+........ ...... .....+++.+|++.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQA--THEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCC--CHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 000000 1122379999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=315.61 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=201.1
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|++++++++|||++++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~- 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP- 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc-
Confidence 457899999999999999999763 468899999875432 24568899999999999999999999887644
Q ss_pred EEEEEeccCCCCHHHHHHhhcc-----------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcccee
Q 001171 908 RLLVYDYMPNGNLATLLQEASH-----------------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVL 970 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIl 970 (1133)
.++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+++||||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 4999999999999999975431 11124778889999999999999999999999999999999
Q ss_pred eCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhH
Q 001171 971 FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDI 1049 (1133)
Q Consensus 971 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~ 1049 (1133)
++.++.++++|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred ecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999864422211 111122334667999999988889999999999999999998 8889876555544
Q ss_pred HHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
...+.. +...... .. . .....+++.+|++.||++||++.|+++.|++
T Consensus 242 ~~~~~~----~~~~~~~--------~~---~--~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 IYYVRD----GNVLSCP--------DN---C--PLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHhc----CCCCCCC--------CC---C--CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 433322 1111000 00 0 0122378999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.90 Aligned_cols=260 Identities=20% Similarity=0.347 Sum_probs=202.4
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|... +|+.||+|.++... ...+.+.+|++++++++|++++++++++... +..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEE
Confidence 57899999999999999999876 78999999885321 1246788999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++..... ....+++..+..++.+++.|++|||+.||+||||||+||+++.++.++++|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999999876432 2244789999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. .......++..|+|||++.+..++.++||||+||++|+|++|+.||..... ...+.. +.............
T Consensus 160 ~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~--- 231 (267)
T cd08224 160 T---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLC-KKIEKCDYPPLPAD--- 231 (267)
T ss_pred C---cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHH-hhhhcCCCCCCChh---
Confidence 1 112234678899999999888899999999999999999999999954331 111111 11111111111000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.... ...+++.+||..+|++||++.+|++.|++..
T Consensus 232 -------~~~~--~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 232 -------HYSE--ELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -------hcCH--HHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0011 1227889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.40 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=193.9
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.|+..++||+|+||.||+|.+. +++.||+|.+...... .+.+.+|+.++++++|++++.+++.+.... ..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-EEEEEE
Confidence 3677889999999999999765 6899999998643221 245678999999999999999999987764 569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++...+. ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++++|||++......
T Consensus 80 e~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05630 80 TLMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 155 (285)
T ss_pred EecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-
Confidence 99999999999865432 34888999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||................... .......
T Consensus 156 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~--- 227 (285)
T cd05630 156 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--QEEYSEK--- 227 (285)
T ss_pred ---ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--hhhcCcc---
Confidence 11223468999999999998899999999999999999999999997543221111111111100 0000000
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
... ...+++.+||+.||++||+ +.|++++
T Consensus 228 ---~~~------~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 228 ---FSP------DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---CCH------HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 000 1227888999999999999 8898874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.89 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=203.4
Q ss_pred hcCCCcccccccccceeEEEEEEC--------CceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
..+|++.+.||+|+||.||+|++. .+..||+|.+...... .+.+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346899999999999999999652 1347899988643322 35788999999999 899999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
. ..++||||+++|+|.+++..... ..+..+++..+..++.|++.|++|||++||+||||||+||+++.
T Consensus 91 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 91 G-PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 4 45999999999999999986431 12345888999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.....++....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999875432111 111222334567999999988889999999999999999998 8899976655554433
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
+... ...+... ... ....+++.+||+.+|++||++.|+++.|+.+...
T Consensus 249 ~~~~----~~~~~~~-------~~~------~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 249 LKEG----HRMDKPA-------NCT------HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHcC----CCCCCCC-------CCC------HHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 3221 1111000 000 1123788999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=316.30 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=197.5
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.++||+|+||.||+|.+. ++..+|+|.+..... ....+.+|++++++++||||+++++++... +..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-GEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CEEEEEee
Confidence 36889999999999999999775 588899998864322 235688899999999999999999999876 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|+++++|.++++..+ .+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++++|||++......
T Consensus 80 y~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred ccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999998642 37888999999999999999997 58999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc--
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL-- 1070 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1070 (1133)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...+.........................
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 12345688999999999888899999999999999999999999965543333322211111000000000000
Q ss_pred ------------------CCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1071 ------------------LELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1071 ------------------~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
....+.... ..+. ...+++.+|+..||++||++.|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 0011 133889999999999999999999773
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=321.10 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=192.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||.||+++++ .++.||+|++.+.. .....+.+|+.++..++|++|+++++++... ...++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEE
Confidence 36899999999999999999876 47889999985421 1234578899999999999999999998876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.+.. ..+++..+..++.||+.|++|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999998643 23788889999999999999999999999999999999999999999999998644221
Q ss_pred CCCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
. ........||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+........++.
T Consensus 156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-- 231 (332)
T cd05623 156 G--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA-- 231 (332)
T ss_pred C--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC--
Confidence 1 11223357999999999985 34578999999999999999999999976655444433322111111110
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCC--CCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPL--DRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~--~RPs~~evl~~ 1110 (1133)
... .... ...+++.+|+..++. .|+++.|++++
T Consensus 232 --~~~---~~s~------~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 --QVT---DVSE------DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --ccc---cCCH------HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 0011 112567777655444 47899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=308.30 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=198.9
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|++|.||++..+ +++.||+|++..... ..+.+.+|++++++++|||++++++.+...+...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999765 578899999864332 245688999999999999999999988765556689999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ...+++..+..++.+++.|++|||+.||+||||||+||+++.++.++++|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999997632 2348899999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......+++.|+|||+..+..++.++||||+||++|+|++|+.||...+.......+.. +..... .
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~-~------ 223 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE----GKLPPM-P------ 223 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----cCCCCC-c------
Confidence 122345688999999999988899999999999999999999999975554333222211 111110 0
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .. ....+++.+|++.||++||++.|++++
T Consensus 224 -~~---~~--~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 -KD---YS--PELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -cc---cC--HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00 122378999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=312.93 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=197.6
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHH---HHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~---~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
|++.+.||+|+||+||+++.. +++.||+|++......... ..+|+.++++++||||+++++++... ...++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-NYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-SEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-ccccccccc
Confidence 677899999999999999876 5779999999766544333 34599999999999999999999875 455899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++++|.+++... ..+++..+..++.|+++||+|||+.+|+|+||||+||+++.++.++++|||.+... ...
T Consensus 80 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~---~~~ 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL---SEN 151 (260)
T ss_dssp ETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES---TST
T ss_pred ccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc
Confidence 9999999999843 23789999999999999999999999999999999999999999999999998643 112
Q ss_pred CCCCCCCCCCCCccCccccC-CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAAS-TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........++..|+|||++. +..++.++||||+|+++|+|++|..||......+....+.+.............
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 226 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS----- 226 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc-----
Confidence 22334567889999999998 788899999999999999999999999866333333333332221100000000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
........+++.+|++.||++||++.|++++
T Consensus 227 ------~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 227 ------REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ------TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ------chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000223378999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.88 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=192.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc------CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI------DENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~ 908 (1133)
.+|++.++||+|+||.||+|..+ +|..||+|.+..... ..+.+.+|++++++++||||+++++++.+. ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999775 589999998853221 124678899999999999999999988654 3456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++++|.+++.... .+++.....++.|++.||+|||+.+|+|+||||+||+++.++.++++|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 79999999999999987542 2678888899999999999999999999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
..............|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+...... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~-----~~ 228 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQPT-----NP 228 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---HHHhcCCC-----CC
Confidence 32211112223346888999999998888999999999999999999999999654322221 11111100 00
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. +. .......+++.+|+. +|++||+++||+++
T Consensus 229 ~~---~~-----~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 VL---PP-----HVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CC---ch-----hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00 00 001112267778884 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=313.69 Aligned_cols=254 Identities=20% Similarity=0.344 Sum_probs=195.0
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEe
Confidence 45799999999999999999976 468899999986433 2345678899999999999999999998766 45589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.++++... .+++..+..++.|++.|++|||+.+|+|||+||+||+++.++.++++|||+++......
T Consensus 87 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 87 YCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999999987532 37889999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 994 EASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.......|+..|+|||.+. ...++.++||||+||++|||++|+.||...........+.. .. ...+..
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~----~~---~~~~~~ 231 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK----SN---FQPPKL 231 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec----CC---CCCCCC
Confidence 1223346888999999874 34478899999999999999999999854332211111000 00 000001
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.. ...+. ....+++.+||+.||++||+++++++++
T Consensus 232 ~~----~~~~~--~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD----KTKWS--STFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc----ccccC--HHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 00111 1223789999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.14 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=191.2
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+++.. +++.||+|++.+. ....+.+.+|..+++.++||||+++++++... ...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEE
Confidence 47899999999999999999875 5899999998642 12245688899999999999999999998876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999997632 23788899999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCCCccCccccCC-----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
. ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+........ +
T Consensus 156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~ 229 (331)
T cd05597 156 G--TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ----F 229 (331)
T ss_pred C--CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----C
Confidence 1 112223468999999999863 4578899999999999999999999976554443333222110000 0
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCC--CCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAP--DPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~--dP~~RPs~~evl~~ 1110 (1133)
.+.... .... ..+++.+|+.. ++..||++.+++++
T Consensus 230 ~~~~~~---~~~~------~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPDVTD---VSEE------AKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccCC---CCHH------HHHHHHHHccCcccccCCCCHHHHhcC
Confidence 110000 0111 12556665544 44448899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.08 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=199.3
Q ss_pred HHHHHHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeC---
Q 001171 829 YVETLEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAG--- 903 (1133)
Q Consensus 829 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--- 903 (1133)
..+...+.+.|++.++||+|+||.||+|.+. +++.||+|.+.........+..|+.+++++ +|||++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 3444556778999999999999999999774 588999999866554556788999999999 79999999998853
Q ss_pred --CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 904 --PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 904 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
.....++||||+++|+|.+++..... ..+++..+..++.||+.|++|||+.+|+||||||+||+++.++.++++|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 23456899999999999999976432 3477888889999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHH
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
||++...... ........|+..|+|||++. +..++.++||||+||++|||++|+.||...........+
T Consensus 165 fg~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--- 238 (282)
T cd06636 165 FGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 238 (282)
T ss_pred Ccchhhhhcc---ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH---
Confidence 9998644221 11223456889999999975 345788999999999999999999999654332211111
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
......... .. .+. ....+++.+||+.||.+||++.|++++
T Consensus 239 -~~~~~~~~~--------~~--~~~--~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 -PRNPPPKLK--------SK--KWS--KKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -hhCCCCCCc--------cc--ccC--HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111000000 00 001 112378999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.82 Aligned_cols=251 Identities=20% Similarity=0.378 Sum_probs=195.8
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCcC-------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID-------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
+|++.+.||+|+||.||+|...+|+.+|+|.+...... .+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEEE
Confidence 47889999999999999998888999999988643211 24678899999999999999999999876 55699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.+.. .+++..+..++.|++.|++|||+.+|+|+||||+||++++++.++++|||.+.....
T Consensus 80 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 80 FMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999997642 378888999999999999999999999999999999999999999999999875422
Q ss_pred CCC---CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 991 TPA---EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 991 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
... .........|+..|+|||++.+..++.++||||+||++|+|++|+.||...+.......+.. .....+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~-~ 231 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA--HRGLMPRL-P 231 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh--ccCCCCCC-C
Confidence 111 11112334688999999999888899999999999999999999999965433221111111 11111111 0
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
. . .. ....+++.+||+.+|++||++.|+++
T Consensus 232 ~-------~---~~--~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 232 D-------S---FS--AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-------C---CC--HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0 00 11237889999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=328.97 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=194.5
Q ss_pred hcCCCcccccccccceeEEEEEEC---CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
..+|.+.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++... ...++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWK-STVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeC-CEEEEEe
Confidence 457999999999999999999653 3678999988643 3457899999999999999999988765 4458999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|++. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9994 7888888542 348999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh---HHHHHHHHhhhccc--cc---
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED---IVKWVKKQLQRGQI--SE--- 1064 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~~~--~~--- 1064 (1133)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.+..+.... +.
T Consensus 240 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 D-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred c-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 122234579999999999998899999999999999999999999996543322 22222222111100 00
Q ss_pred ------------cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 ------------LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+... .+........-....+++.+|+..||++||++.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCcc-ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00000000000122368899999999999999999976
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.93 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=192.4
Q ss_pred cccccccceeEEEEEECC-c--eEEEEEEcccCC--cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQD-G--MVLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~-g--~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|..++ + ..+|+|.+.... ...+.+.+|+++++++ +||||+++++++.... ..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeCC
Confidence 469999999999998753 4 357888886432 2245788999999999 8999999999998764 4599999999
Q ss_pred CCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 917 NGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
+|+|.+++...+.. ....+++..+..++.|++.|++|||+.|++||||||+||++++++.+|++|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 99999999764321 1234788999999999999999999999999999999999999999999999997
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+.... .........+..|+|||++....++.++|||||||++|||++ |+.||...+..+....+.... ..+
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----~~~ 231 (270)
T cd05047 160 RGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----RLE 231 (270)
T ss_pred cccch----hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----CCC
Confidence 53211 111112234567999999988889999999999999999997 999997655544443332210 000
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
..... .....+++.+||+.+|.+||++.|+++.|+++
T Consensus 232 --------~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 232 --------KPLNC-----DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCcC-----CHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00000 01123789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=317.79 Aligned_cols=200 Identities=21% Similarity=0.345 Sum_probs=161.2
Q ss_pred ccccccccceeEEEEEEC---CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeC-CCCcEEEEEeccCC
Q 001171 842 ENVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAG-PPDVRLLVYDYMPN 917 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~~lV~e~~~~ 917 (1133)
+.+||+|+||.||+|+.+ ++..||+|.+..... ...+.+|++++++++||||+++++++.. .+...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 357999999999999865 357899999865432 3567889999999999999999998854 3445689999985
Q ss_pred CCHHHHHHhhcc----CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee----CCCCceEEeccCcccccc
Q 001171 918 GNLATLLQEASH----QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF----DADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 918 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~~~ 989 (1133)
++|.+++..... .....+++..+..++.||+.||+|||+.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 578888764321 112347888899999999999999999999999999999999 566789999999997654
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
.............||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 33222223344578999999999876 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=323.31 Aligned_cols=236 Identities=23% Similarity=0.387 Sum_probs=183.3
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHH-HHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAE-ALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|++. +|+.||+|++.+... ....+.+|.. +++.++||||+++++++... +..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence 46999999999999875 588999999864321 2234455554 67889999999999988776 45599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|..++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~ 151 (321)
T cd05603 80 GGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---EE 151 (321)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---CC
Confidence 99999888753 23778888899999999999999999999999999999999999999999998643211 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... .. ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~---------~~~~~ 218 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----PL---------QLPGG 218 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC----CC---------CCCCC
Confidence 233457899999999998888999999999999999999999999766554443333211 00 01111
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ 1105 (1133)
.. ....+++.+|++.||.+||++.
T Consensus 219 ~~-----~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KT-----VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC-----HHHHHHHHHHccCCHhhcCCCC
Confidence 00 1123788999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.59 Aligned_cols=256 Identities=22% Similarity=0.359 Sum_probs=200.3
Q ss_pred cCCCcccccccccceeEEEEEECC----ceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.+|++.++||+|+||.||+|.+.+ ...||+|...... ...+.+.+|++++++++|||++++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN--PVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--CcEE
Confidence 468889999999999999997643 2468999886443 2245788999999999999999999988753 3489
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++.... ..+++..+..++.+++.|++|||+.+++||||||+||+++.++.++++|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997643 2378999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
... .......++..|+|||.+....++.++|||||||++||+++ |+.||......+....+.... .. ..
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~-~~---- 229 (270)
T cd05056 160 ESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE---RL-PM---- 229 (270)
T ss_pred ccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---cC-CC----
Confidence 211 11122334568999999988889999999999999999986 999997666554444332211 00 00
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
..... ....+++.+|+..+|++||++.++++.|+.+...
T Consensus 230 ----~~~~~-----~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 230 ----PPNCP-----PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00100 1123688899999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=311.32 Aligned_cols=258 Identities=22% Similarity=0.396 Sum_probs=200.4
Q ss_pred cCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
++|++.+.||+|+||.||+|+.+ ..+.|++|.+...... .+.+.+|++++++++|||++++++++... ...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-Ccc
Confidence 57889999999999999999864 2467899988643332 36789999999999999999999998765 445
Q ss_pred EEEEeccCCCCHHHHHHhhccCC----CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQD----GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
++||||+++|+|.+++....... ...+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++++|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999998654211 12489999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
++...... ........++..|+|||.+.+..++.++||||+|+++|+|++ |..||............... ...
T Consensus 164 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~----~~~ 237 (275)
T cd05046 164 SKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG----KLE 237 (275)
T ss_pred ccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC----CcC
Confidence 86432211 112233456778999999988888999999999999999999 88899665554444433221 111
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
..... . ... ...+++.+|++.+|++||++.|++++|.+
T Consensus 238 ~~~~~------~----~~~--~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 LPVPE------G----CPS--RLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCC------C----CCH--HHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00000 0 001 12378999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.40 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=191.2
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.++||+|+||.||+|.+ .+++.||+|.+..... ....+.+|++++++++||||+++++++.... ..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-RISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-EEEEEEe
Confidence 3678889999999999999976 4688999999865422 2356889999999999999999999998764 4589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|..+. .+++..+..++.|++.|++|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 99999986542 2678888899999999999999999999999999999999999999999998644221
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhH---HHHHHHHhhhccccccccCCc
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI---VKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
......|+..|+|||++.+..++.++||||+||++|+|++|+.||........ .....+...... .+..
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 220 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL 220 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC
Confidence 22335788999999999988899999999999999999999999964322110 011111111110 0000
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
. ...... ...+++.+|++.+|++||+++|++++-
T Consensus 221 ~----~~~~~~---~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 P----VGQFSE---KFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred C----CCcCCH---HHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0 000001 123788899999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=311.01 Aligned_cols=257 Identities=21% Similarity=0.343 Sum_probs=202.1
Q ss_pred hcCCCcccccccccceeEEEEEECC-c----eEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-G----MVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
..+|++.+.||+|+||.||+|.++. | ..||+|....... ....+.+|++++++++|||++++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--Cce
Confidence 3578899999999999999997642 3 3689998865433 23578899999999999999999999986 455
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.+++.... ..+++..+..++.||+.|++|||+.+|+||||||+||+++.++.+|++|||+++..
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 89999999999999997643 23889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
...... .......++..|+|||.+....++.++|+|||||++||+++ |+.||......++.+.+.+.... ..
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------~~ 232 (279)
T cd05057 160 DVDEKE-YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL------PQ 232 (279)
T ss_pred cCcccc-eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC------CC
Confidence 322111 11122234568999999988889999999999999999998 99999776655554444321100 00
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
+.. .. ....+++.+||..||.+||++.++++.|+.+..
T Consensus 233 ~~~-----~~------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 PPI-----CT------IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC-----CC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 00 112367889999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=325.16 Aligned_cols=263 Identities=18% Similarity=0.224 Sum_probs=192.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..+|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|||||++++++... ...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEEc
Confidence 447999999999999999999876 47889999643 23467899999999999999999998765 445899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+ .++|.+++.... ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 242 Y-RSDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 9 578988886532 2489999999999999999999999999999999999999999999999999875432111
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC--------hhhHHHHHHHHhhh-cccccc
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ--------DEDIVKWVKKQLQR-GQISEL 1065 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~--------~~~~~~~~~~~~~~-~~~~~~ 1065 (1133)
........||..|+|||++.+..++.++|||||||++|||++|..|+.... ...+...+.+.... ..+...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 112234569999999999999999999999999999999999887653211 11222222211000 001100
Q ss_pred ccCC-----------cCCCCCCChhHHHHH----HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPG-----------LLELDPESSEWEEFL----LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~-----------~~~~~~~~~~~~~~~----~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ..........|..+. ...+++.+|++.||.+|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000000111122111 22379999999999999999999975
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.49 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=197.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+|++.++||+|+||.||++... ++..||+|.+.... ...+.+.+|++++++++|||++++++++... ...++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEee
Confidence 4788999999999999999775 58899999885322 2346788899999999999999999998776 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.+++.... ...+++.....++.|++.|+.|||++||+|+||||+||++++++.++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 80 CDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 99999999887533 2347888899999999999999999999999999999999999999999999986542211
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...+.......+.. ...... .
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~-~------- 221 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ----GSYKPL-P------- 221 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc----CCCCCC-C-------
Confidence 122335688899999999888899999999999999999999999976554433332221 111110 0
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ... ...+++.+||+.||++||++.|++..
T Consensus 222 ~~---~~~--~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SH---YSY--ELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cc---cCH--HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 001 12378999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=320.85 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=187.8
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++.++ +||+|+.+++++.... ..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-RLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-EEEEEEeCCC
Confidence 46999999999999775 578999999975322 234577899999888 6999999999987764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++...+ .+++..+..++.||+.|++|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~ 151 (327)
T cd05617 80 GGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---GD 151 (327)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---CC
Confidence 999999887643 3889999999999999999999999999999999999999999999999998643211 11
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh---hHHHHHHHHhhhccccccccCCcCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE---DIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.+....... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RI 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CC
Confidence 223457999999999999999999999999999999999999999532211 111222222211110 00
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCH------HHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSM------ADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~------~evl~~ 1110 (1133)
+.... ....+++.+|++.||++|+++ .+++++
T Consensus 223 p~~~~-----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLS-----VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCC-----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 00000 112378899999999999984 566644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=314.73 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=198.8
Q ss_pred HHHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeC----CC
Q 001171 832 TLEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAG----PP 905 (1133)
Q Consensus 832 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~ 905 (1133)
...+.++|++.+.||+|+||.||+|... +++.+|+|++.........+.+|+.+++++ +|||++++++++.. .+
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 3446789999999999999999999774 578999998865443456788999999999 69999999998742 23
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
...++||||+++++|.+++..... ....+++..+..++.|+++|+.|||+.+|+||||||+||+++.++.++++|||++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 456899999999999998875322 2245788889999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCC-----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
+..... ........|+..|+|||++.. ..++.++||||+||++|||++|+.||............ ...
T Consensus 172 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~----~~~ 244 (286)
T cd06638 172 AQLTST---RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI----PRN 244 (286)
T ss_pred eecccC---CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc----ccc
Confidence 654221 112233468899999999753 44788999999999999999999999654332211111 111
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.......+.. +.. ...+++.+||+.||++||++.|++++.
T Consensus 245 ~~~~~~~~~~---------~~~--~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 245 PPPTLHQPEL---------WSN--EFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCcccCCCC---------cCH--HHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1011111110 001 123788999999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=314.69 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=196.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..+|++.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++++++|||++++++++... ...++|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeec
Confidence 347899999999999999999764 688999999865333 346788999999999999999999998765 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++... .+++..+..++.|++.|++|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 98 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred ccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 99999999998642 36888999999999999999999999999999999999999999999999886432211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||............. ... ......+
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~---~~~-~~~~~~~----- 239 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNG-TPELQNP----- 239 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh---cCC-CCCCCCc-----
Confidence 12233468889999999988888999999999999999999999997554322211111 110 0000000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ... ....+++.+||..||++||++.|++++
T Consensus 240 -~---~~~--~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 -E---KLS--AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -c---ccC--HHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 000 112378999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=308.40 Aligned_cols=250 Identities=19% Similarity=0.358 Sum_probs=194.7
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
+|.+.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 4788899999999999999764 5789999988643221 146788999999999999999999988764
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||+++++|.+++...+ .+++..+..++.|++.|++|||+.|++||||+|+||+++.++.++++|||.++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 5589999999999999997643 37888889999999999999999999999999999999999999999999987
Q ss_pred ccccCCCC---CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 987 LAIATPAE---ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 987 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
........ ........|+..|+|||.+.+..++.++||||+||++|+|++|+.||...........+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~--- 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE----N--- 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc----c---
Confidence 65321111 1111234588899999999888899999999999999999999999975443222221111 0
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+... .. .. ....+++.+||+.||.+||++.|++++
T Consensus 228 --~~~~~~---~~---~~--~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 --ASPEIP---SN---IS--SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --CCCcCC---cc---cC--HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 011110 00 00 112378889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=314.18 Aligned_cols=260 Identities=22% Similarity=0.338 Sum_probs=200.2
Q ss_pred HHHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC----
Q 001171 832 TLEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPP---- 905 (1133)
Q Consensus 832 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---- 905 (1133)
...+.++|++.+.||+|+||.||+|... +++.+|+|++.........+.+|+.+++++ +|||++++++++...+
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 3345778999999999999999999774 688999999875544456788999999999 8999999999986432
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
...++||||+++++|.++++.... ....+++..++.++.|++.|++|||+.+|+||||||+||+++.++.++++|||.+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 346899999999999999875322 2245889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCC-----CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTG-----QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
+...... .......|+..|+|||++... .++.++||||+||++|||++|+.||...........+.+ .
T Consensus 176 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~----~ 248 (291)
T cd06639 176 AQLTSTR---LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR----N 248 (291)
T ss_pred hhccccc---ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc----C
Confidence 6543211 112234688899999997543 368999999999999999999999975544332222111 1
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
......++ ..+. ....+++.+||+.+|++||++.|++++
T Consensus 249 ~~~~~~~~---------~~~~--~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTLLHP---------EKWC--RSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCcc---------cccC--HHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111110 0000 122378999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.15 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=192.5
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+++.+ +++.||+|.+.+.. .....+.+|..++..++|++|+++++++... +..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-NYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence 47899999999999999999875 57889999986421 1234578899999999999999999999876 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999998632 23788889999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCCCCCCCCCCCccCccccCC-----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.. .......|++.|+|||++.+ +.++.++||||+||++|||++|+.||...+..+....+.....+..+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---- 229 (331)
T cd05624 156 GT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF---- 229 (331)
T ss_pred Cc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC----
Confidence 11 12233569999999999865 46788999999999999999999999765544433332221111111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCC--CCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD--RPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1110 (1133)
..... ... ....+++.+|+..++.+ |+++++++++
T Consensus 230 p~~~~-------~~~--~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSHIT-------DVS--EEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCccc-------cCC--HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11110 000 11226777888765544 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=323.83 Aligned_cols=237 Identities=25% Similarity=0.402 Sum_probs=184.9
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHH-HHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAE-ALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||+||+|+.+ +|+.||+|++.... .....+.+|.. +++.++||||+++++++...+ ..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-KLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-EEEEEEcCCC
Confidence 46999999999999765 68999999986432 12334555555 467789999999999988764 5599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 80 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~---~~ 151 (325)
T cd05604 80 GGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ---SD 151 (325)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---CC
Confidence 999998887532 3789999999999999999999999999999999999999999999999998643211 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... .. ...+. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~----~~--~~~~~------~ 219 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK----PL--VLRPG------A 219 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC----Cc--cCCCC------C
Confidence 233457999999999999999999999999999999999999999766555444333221 10 01110 1
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1106 (1133)
. ....+++.+|++.||.+||++.+
T Consensus 220 ~------~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 220 S------LTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred C------HHHHHHHHHHhccCHHhcCCCCC
Confidence 1 11236888999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=320.17 Aligned_cols=193 Identities=21% Similarity=0.327 Sum_probs=163.0
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
....+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++.... ..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEE
Confidence 44568999999999999999999775 4788999975432 3456999999999999999999998764 458999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+ .++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.++.....
T Consensus 137 e~~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred Ecc-CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 999 568888886532 34889999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPV 1041 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf 1041 (1133)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999989999999999999999999865554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=310.15 Aligned_cols=238 Identities=22% Similarity=0.350 Sum_probs=182.4
Q ss_pred ccccccceeEEEEEECC-------------------------ceEEEEEEcccCCcC-HHHHHHHHHHHhhccCCCeeeE
Q 001171 844 VLSRGRYGLIFKASYQD-------------------------GMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVL 897 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l 897 (1133)
.||+|+||.||+|.+.. ...||+|.+...... ...+.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 245888888643322 3567889999999999999999
Q ss_pred EEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC--
Q 001171 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-- 975 (1133)
Q Consensus 898 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-- 975 (1133)
++++.... ..++||||+++|+|..++.... ..+++..+..++.||++||+|||+++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCC-ceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 99998764 4599999999999999987532 3478999999999999999999999999999999999997643
Q ss_pred -----ceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHH-hCCCCCccCChhh
Q 001171 976 -----EAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEIL-TGRKPVMFTQDED 1048 (1133)
Q Consensus 976 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~-tg~~Pf~~~~~~~ 1048 (1133)
.++++|||.+..... .....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCccceeeecCCcccccccc-------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 379999998753311 122357788999998865 56799999999999999995 6999997654443
Q ss_pred HHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1049 IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
........ ...++ +.. ....+++.+||+.+|++||++.+|++.|.
T Consensus 230 ~~~~~~~~---~~~~~----------~~~------~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKK---HRLPE----------PSC------KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhc---cCCCC----------CCC------hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 32222111 00000 000 11237889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.92 Aligned_cols=242 Identities=21% Similarity=0.373 Sum_probs=202.0
Q ss_pred cccccccccceeEEEEEEC-CceEEEEEEcc-----cCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC-cEEEEEe
Q 001171 841 EENVLSRGRYGLIFKASYQ-DGMVLSIRRLR-----DGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD-VRLLVYD 913 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~~lV~e 913 (1133)
...+||+|+|-+||+|.+. +|..||--.++ +.....++|..|+++|+.|+|||||+++.++.+... ...+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4568999999999999664 57777744332 223334789999999999999999999998876543 4468999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCC-CCceEEeccCccccccc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 990 (1133)
.+..|+|..|.++.++ .+......|++||++||.|||++. |+|||||-+||||+. .|.|||+|+|+|.....
T Consensus 124 L~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999998765 788899999999999999999874 999999999999976 58999999999976533
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCc-cCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM-FTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ....+|||.|||||+.. ..|...+||||||++|+||.|+.+||. ......+++.+..+.+...+..+-||.
T Consensus 199 s~-----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 199 SH-----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred cc-----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 22 23368999999999986 789999999999999999999999995 456778888888877776666666655
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+ ++|.+|+.. .++||++.|+++.
T Consensus 273 vr----------------~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 273 VR----------------EFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HH----------------HHHHHHhcC-chhccCHHHHhhC
Confidence 54 688899999 9999999999853
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=339.74 Aligned_cols=253 Identities=18% Similarity=0.285 Sum_probs=193.1
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~ 909 (1133)
..++|++.+.||+|+||+||+|.+. .+..||+|.+..... ....+.+|+.++++++|||||+++++|... ....|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4568999999999999999999775 578899998864332 245788999999999999999999987543 34568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-------CceecccCccceeeCC---------
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-------DMVHGDIKPQNVLFDA--------- 973 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~ivH~Dlkp~NIll~~--------- 973 (1133)
+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+. +||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999764321 23489999999999999999999984 4999999999999964
Q ss_pred --------CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 974 --------DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 974 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
.+.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||||+|||++|+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc----ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 234899999998654221 12234579999999999854 4578999999999999999999999965
Q ss_pred CChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1044 TQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
..... .+...+.... ... . .... ....+++.+||+.+|.+||++.|++.
T Consensus 246 ~~~~~---qli~~lk~~p--~lp---i---~~~S------~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFS---QLISELKRGP--DLP---I---KGKS------KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHH---HHHHHHhcCC--CCC---c---CCCC------HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 43322 1111111110 000 0 0011 11237889999999999999999984
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=309.53 Aligned_cols=252 Identities=24% Similarity=0.440 Sum_probs=195.4
Q ss_pred cccccccceeEEEEEECC-------ceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASYQD-------GMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+.||+|+||.||+|.+.+ ++.+|+|.+.... .....+.+|++++++++||||+++++++.... ..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEEe
Confidence 369999999999997642 3679999886543 23567889999999999999999999987654 4599999
Q ss_pred ccCCCCHHHHHHhhccC--CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-----ceEEeccCccc
Q 001171 914 YMPNGNLATLLQEASHQ--DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-----EAHLSEFGLDR 986 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~a~ 986 (1133)
|+++++|.+++...... ....+++..+..++.|++.|++|||+.+++|+||||+||+++.++ .++++|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999764321 223478899999999999999999999999999999999999877 89999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
....... ........++..|+|||++.++.++.++|||||||++|||++ |+.||......+....+... ..+
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~--- 232 (269)
T cd05044 160 DIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG---GRL--- 232 (269)
T ss_pred ccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC---Ccc---
Confidence 5432211 111223345678999999998899999999999999999998 99999765555444433211 000
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
..... ... ...+++.+||..+|.+||++.++++.|++
T Consensus 233 ------~~~~~---~~~--~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 ------QKPEN---CPD--KIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------CCccc---chH--HHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000 011 12378999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=315.23 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=201.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|+..++||+|+||.||+|.+. +|. .||+|.+...... ...+.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--Cc
Confidence 456888899999999999999764 343 5788888643322 34678999999999999999999998754 24
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+|++|||+++..
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 79999999999999987643 23788899999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...........+... .... .
T Consensus 160 ~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~--~ 232 (303)
T cd05110 160 EGDEK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG----ERLP--Q 232 (303)
T ss_pred cCccc-ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC----CCCC--C
Confidence 32211 111223345678999999988889999999999999999998 99999765544444333221 1000 0
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
+ .... ....+++.+||..+|++||+++|+++.|+.+...+.
T Consensus 233 ~-----~~~~------~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 233 P-----PICT------IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred C-----CCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 0 0011 112378889999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=306.21 Aligned_cols=238 Identities=23% Similarity=0.376 Sum_probs=187.0
Q ss_pred cccccccceeEEEEEECC-c----------eEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 843 NVLSRGRYGLIFKASYQD-G----------MVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++||+|+||.||+|.+.+ + ..|++|.+.........+.+|++++++++||||+++++++.. .. .++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~-~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE-NIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC-cEEE
Confidence 469999999999998754 2 357888776544436788999999999999999999999877 33 4899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-------ceEEeccCc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-------EAHLSEFGL 984 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg~ 984 (1133)
|||+++|+|.+++..... .+++..+..++.||+.||+|||+++|+||||||+||+++.++ .++++|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999986432 478899999999999999999999999999999999999887 799999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCC--CCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcc
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTG--QPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||............. ...
T Consensus 155 a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~----~~~ 223 (259)
T cd05037 155 PITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ----DQH 223 (259)
T ss_pred cccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----cCC
Confidence 865422 1223466789999999776 78999999999999999999 577776544322222211 000
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
.... +.. ....+++.+||..+|.+||++.|+++.|+
T Consensus 224 --------~~~~-~~~------~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 --------RLPM-PDC------AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------CCCC-CCc------hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 000 22337899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=305.98 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=197.0
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++|++.+.||+|+||.||++.. .++.||+|...... ..+.+.+|++++++++|||++++++++... . .++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-G-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-C-cEEEEECCC
Confidence 4689999999999999999975 57889999986533 356789999999999999999999998654 3 489999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+++|.+++..... ..+++..+..++.|++.|++|||+.|++||||||+||+++.++.++++|||.++.....
T Consensus 82 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 9999999976432 34789999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......+..|+|||++.+..++.++||||+||++|||++ |+.||......+....+.+. ...+. ...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----~~~~~-~~~------ 221 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG----YRMEP-PEG------ 221 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC----CCCCC-CCc------
Confidence 112234568999999988889999999999999999998 99999765554443332221 10000 000
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
. . ....+++.+||+.+|++||+++++++.|++
T Consensus 222 ~----~--~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 C----P--ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C----C--HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 0 112378999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=310.37 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=196.5
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.++||+|+||.||+|..+ +|+.||+|++..... ..+.+.+|++++++++|||++++++++.... ..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-KLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-EEEEEE
Confidence 36889999999999999999876 589999999864322 2356789999999999999999999998764 458999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++++++..+.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 80 EYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred eccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888776542 238899999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc--cccccC-
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI--SELLEP- 1068 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~- 1068 (1133)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.+....... .+..+.
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 D---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred c---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 1 2223457889999999865 45789999999999999999999999765544433333222111000 000000
Q ss_pred ----Cc-CCCCCCChhHH----HH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 ----GL-LELDPESSEWE----EF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ----~~-~~~~~~~~~~~----~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ..........+ .+ ....+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 00000000011 11 122389999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=311.66 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=200.4
Q ss_pred cCCCcccccccccceeEEEEEEC-----CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-----DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~ 908 (1133)
+.|++.+.||+|+||.||+|.+. .++.||+|++...... .+.+.+|++++++++|||++++++++... ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999753 3789999999765543 56899999999999999999999988652 3456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++++|.+++..... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 899999999999999976432 4889999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh-----------HHHHHHHHh
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED-----------IVKWVKKQL 1057 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~-----------~~~~~~~~~ 1057 (1133)
..............++..|+|||...+..++.++|||||||++|||++|+.|+....... ....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 322211111122345567999999988889999999999999999999999985432211 011111111
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
..... .. .+. ... ....+++.+||+.+|++||++.||+++|+.+
T Consensus 240 ~~~~~-------~~--~~~--~~~--~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGER-------LP--RPP--SCP--DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCc-------CC--CCc--cCC--HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11100 00 000 000 1233789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=305.43 Aligned_cols=239 Identities=23% Similarity=0.377 Sum_probs=182.3
Q ss_pred cccccccceeEEEEEECC-------------ceEEEEEEcccCCcC-HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 843 NVLSRGRYGLIFKASYQD-------------GMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
+.||+|+||.||+|.+.. ...|++|.+.....+ ...+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~-~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE-N 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC-C
Confidence 468999999999997532 236888887543322 3477889999999999999999999987644 4
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc-------eEEec
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE-------AHLSE 981 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~-------~kl~D 981 (1133)
++||||+++|+|..++.... ..+++..+..++.||++|++|||+++|+||||||+||+++.++. ++++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 89999999999998886532 34788999999999999999999999999999999999987654 89999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccC-CCCCCCCCchhHHHHHHHHHH-hCCCCCccCChhhHHHHHHHHhhh
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS-TGQPTKEADVYSFGIVLLEIL-TGRKPVMFTQDEDIVKWVKKQLQR 1059 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~-tg~~Pf~~~~~~~~~~~~~~~~~~ 1059 (1133)
||++.... ......++..|+|||.+. +..++.++|||||||++|||+ +|..||......+.... ..
T Consensus 156 ~g~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-----~~ 223 (262)
T cd05077 156 PGIPITVL-------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-----YE 223 (262)
T ss_pred CCCCcccc-------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-----Hh
Confidence 99875432 112345778999999986 466899999999999999997 58888865433222111 11
Q ss_pred ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
.... . ..+. .+ ...+++.+||+.||++||++.||++.+.
T Consensus 224 ~~~~-~-------~~~~---~~---~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQCM-L-------VTPS---CK---ELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCcc-C-------CCCC---hH---HHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1100 0 0011 11 1237899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=323.50 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=196.8
Q ss_pred HHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC---
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPP--- 905 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--- 905 (1133)
.+..++|++.+.||+|+||.||+|... +++.||||++..... ..+.+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999764 688999999865322 2356778999999999999999998875321
Q ss_pred --CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccC
Q 001171 906 --DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 906 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCc
Confidence 3358999988 7899888753 238899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
+++.... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+....+.+......
T Consensus 164 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 236 (343)
T cd07878 164 LARQADD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS- 236 (343)
T ss_pred cceecCC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC-
Confidence 9875321 1234568999999999876 5688999999999999999999999976554443333322211110
Q ss_pred ccccc-----------CCcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 SELLE-----------PGLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 ~~~~~-----------~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+... ........ ...... ....+++.+|++.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQ--QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccc--hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000 000000 112489999999999999999999966
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.71 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=198.7
Q ss_pred cCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
++|++.++||+|+||.||+|.++. +..|++|.+..... .+.+.+|++++++++|||++++++++... ...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEecC
Confidence 578999999999999999998865 78999999875433 67899999999999999999999999876 4559999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... ..+++..+..++.|++.|+.|||+.+|+||||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 81 GAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 9999999987533 348999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.. .. .+...
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~~-----~~~~~---- 220 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KP-----PPTLS---- 220 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----CC-----CCCCC----
Confidence 122334578899999999888899999999999999999999999975443322111100 00 00000
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...... ....+++.+||+.||++||++.|++++
T Consensus 221 ~~~~~~--~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWS--PEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcC--HHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 000011 112378999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=306.23 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=194.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
+|+..++||+|+||.||+|... +++.|++|.+..... ..+.+.+|++++++++|||++++++++.... ..++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-NLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-eEEE
Confidence 4778899999999999999776 789999999864331 2357889999999999999999999987764 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... .+++..+..++.|++.|++|||+.||+|+||+|+||+++.++.+||+|||.+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 80 FLELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999997642 378889999999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ......|+..|+|||.+.... ++.++|+||+||++|+|++|+.||...........+.+ ...... +.+.
T Consensus 155 ~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~-~~~~ 226 (258)
T cd06632 155 FS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR---SKELPP-IPDH 226 (258)
T ss_pred cc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh---cccCCC-cCCC
Confidence 21 223456888999999987766 89999999999999999999999965443222211111 111111 1100
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. . ....+++.+||+.+|.+||++.+++++
T Consensus 227 ~----------~--~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 227 L----------S--DEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred c----------C--HHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0 0 112368889999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=302.66 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=194.4
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCH
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNL 920 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL 920 (1133)
++||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.... ..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-PIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-CeEEEEEcCCCCcH
Confidence 46999999999999887799999999875443 2457889999999999999999999988764 45999999999999
Q ss_pred HHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCC
Q 001171 921 ATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000 (1133)
Q Consensus 921 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 1000 (1133)
.+++.... ..+++..+..++.+++.|++|||+++++||||||+||+++.++.++++|||.++...... .......
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~ 154 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI-YTVSDGL 154 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc-ceecccc
Confidence 99997532 237888899999999999999999999999999999999999999999999986442111 1111112
Q ss_pred CCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1001 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
..++..|+|||++.++.++.++|+||+||++|||++ |..||...........+..... . ..+ ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~---~---~~~-------~~-- 219 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR---M---PAP-------QL-- 219 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---C---CCC-------cc--
Confidence 234567999999988889999999999999999999 8888876555444333322110 0 000 00
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.. ....+++.+|+..+|.+||++.|+++.|+.
T Consensus 220 ~~--~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CP--EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CC--HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 00 122378999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=313.22 Aligned_cols=266 Identities=20% Similarity=0.298 Sum_probs=197.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|..+ +++.||+|.+..... ....+.+|++++++++||||+++++++... ...++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEEE
Confidence 357899999999999999999775 578999999864322 235677899999999999999999999876 4569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++ ++|.+++.... ..+++..+..++.||++||+|||+.+|+||||||+||+++.++.++++|||++......
T Consensus 84 e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 157 (301)
T cd07873 84 EYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP- 157 (301)
T ss_pred eccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC-
Confidence 9996 68998887643 23788899999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc---ccccccC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---ISELLEP 1068 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 1068 (1133)
........+++.|+|||++.+. .++.++||||+||++|||++|+.||...+..+....+........ .......
T Consensus 158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 --TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1112234578899999998654 478899999999999999999999976665544443333221110 0111000
Q ss_pred C-cCC--CCCCChhH-----HHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 G-LLE--LDPESSEW-----EEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~-~~~--~~~~~~~~-----~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ... .+....+. .... ...+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000 00000000 0001 12379999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=306.75 Aligned_cols=258 Identities=20% Similarity=0.362 Sum_probs=198.1
Q ss_pred CCcccccccccceeEEEEEEC----CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----C
Q 001171 839 FDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----D 906 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 906 (1133)
|.+.++||+|+||.||+|.++ .++.||||++...... .+++.+|++++++++|||++++++++.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999753 3689999998654322 456889999999999999999999886432 2
Q ss_pred cEEEEEeccCCCCHHHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQ-DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
..++++||+++|+|.+++...... ....+++.....++.||+.|++|||+.+|+||||||+||+++.++.+|++|||.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 337899999999999888643321 1234788889999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
+....... ........++..|++||.+....++.++|||||||++|||++ |+.||......+...++.+.. ...
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~- 235 (273)
T cd05074 161 KKIYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN---RLK- 235 (273)
T ss_pred ccccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC---cCC-
Confidence 75432211 111223345678999999988889999999999999999999 889987655544444333210 000
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.... ......+++.+|++.+|++||++.|+++.|+++
T Consensus 236 --------~~~~-----~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 --------QPPD-----CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------CCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 011233789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=302.38 Aligned_cols=252 Identities=21% Similarity=0.359 Sum_probs=194.6
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV 911 (1133)
...|++.+.||+|+.+.||++...+.+.||+|++.....+ ...|..|++.|.+++ |.+||++++|-.. +++.|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence 3468899999999999999999888899999998654443 467899999999995 9999999998766 4677999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||- ..+|..+++..... ...| .++.++.|++.|+.+.|.+||||.||||.|+|+ -.|.+||+|||.|..+...
T Consensus 439 mE~G-d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eecc-cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 9986 67999999876542 1334 778899999999999999999999999999998 4679999999999765332
Q ss_pred CCCCCCCCCCCCCCCccCccccCCC-----------CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTG-----------QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
.........+||+.||+||.+... +.++++||||+|||+|+|+.|+.||... ...+..+..
T Consensus 513 -TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~a----- 584 (677)
T KOG0596|consen 513 -TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHA----- 584 (677)
T ss_pred -ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHh-----
Confidence 222334567899999999998432 2568999999999999999999999521 112222222
Q ss_pred cccccccCCc-CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEPGL-LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.+++. .+++.....++ +++++..|++.||.+||++.|++++
T Consensus 585 ----I~~P~~~Iefp~~~~~~~----li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ----ITDPNHEIEFPDIPENDE----LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----hcCCCccccccCCCCchH----HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 223321 12222222233 4588999999999999999999853
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.70 Aligned_cols=254 Identities=19% Similarity=0.323 Sum_probs=196.6
Q ss_pred CCCcccccccccceeEEEEEECC--ceEEEEEEcccCC-----------cCHHHHHHHHHHHhh-ccCCCeeeEEEEEeC
Q 001171 838 QFDEENVLSRGRYGLIFKASYQD--GMVLSIRRLRDGT-----------IDENTFRKEAEALGK-VKHRNLTVLRGYYAG 903 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 903 (1133)
.|++.+.||+|+||.||+|.++. ++.+|+|.+.... .....+.+|++++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998764 6889999875321 112456678888865 799999999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEecc
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
. ...++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+ .+++||||||+||+++.++.++++||
T Consensus 81 ~-~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 N-DRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred C-CeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 6 4559999999999999998653322 2458889999999999999999996 78999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
|.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...........+... ..
T Consensus 159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----~~ 230 (269)
T cd08528 159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA----VY 230 (269)
T ss_pred cceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc----cC
Confidence 9986543221 233456888999999999888999999999999999999999999755444333332221 11
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
...... ... ....+++.+||+.||++||++.|+.++++.
T Consensus 231 ~~~~~~----------~~~--~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLPEG----------MYS--EDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCCcc----------cCC--HHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 100000 000 112378889999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=307.97 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=198.2
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.+.||.|+||.||+|... +++.||+|.+.... .....+.+|++++++++|||++++++++.+. ...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEE
Confidence 36888899999999999999775 58999999986543 2245788999999999999999999998776 55699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++... .+++..+..++.|++.|+.|||+++++||||+|+||++++++.++++|||.++......
T Consensus 80 ~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 80 YCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 99999999998753 47899999999999999999999999999999999999999999999999987653321
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ...+...+..
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~---- 222 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK----NNPPSLEGNK---- 222 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----cCCCCCcccc----
Confidence 222345688899999999888899999999999999999999999965443332222211 1111111100
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ...+++.+|+..||++||++++++++
T Consensus 223 ------~~~--~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 ------FSK--PFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ------cCH--HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 12378889999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=304.79 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=195.0
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|+||.||+|... +++.|++|.+..... ..+.+.+|++++++++|+||+++++++... +..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEe
Confidence 5888999999999999999764 689999999875544 356788999999999999999999998765 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... .+++..+..++.+++.|++|||+.||+|+||+|+||++++++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 80 YCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred cCCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999997632 367888999999999999999999999999999999999999999999999875533222
Q ss_pred CCCC-CCCCCCCCCccCccccCCCC---CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 994 EASS-STTPIGSLGYVSPEAASTGQ---PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 994 ~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.... .....++..|+|||++.+.. ++.++||||||+++||+++|+.||...+.......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~----- 226 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG---AGHKPP----- 226 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---cCCCCC-----
Confidence 1111 22356788999999997766 78999999999999999999999965432221111111 111000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
. +.... . .....+++.+|++.+|.+||++.|++.
T Consensus 227 ~---~~~~~-~--~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 I---PDSLQ-L--SPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred C---Ccccc-c--CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00000 0 011237889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=309.11 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=193.6
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
|++.+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|+++++.++|||++++++++... ...++||||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecC
Confidence 677889999999999999775 478889998864332 245688899999999999999999998776 45599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+++|..++.+.. ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.++++|||++...... ..
T Consensus 86 ~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---~~ 158 (282)
T cd06643 86 GGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQ 158 (282)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc---cc
Confidence 999999886532 34889999999999999999999999999999999999999999999999998643221 11
Q ss_pred CCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 997 SSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......++..|+|||++. +..++.++||||+||++|||++|+.||......+........ .......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~--- 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLAQP--- 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc----CCCCCCCc---
Confidence 223456889999999973 445788999999999999999999999755443322222111 00010000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
..+. ....+++.+||+.||.+||++.+++++-
T Consensus 232 ------~~~~--~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 232 ------SRWS--SEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ------cccC--HHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0011 1123788999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=315.02 Aligned_cols=202 Identities=20% Similarity=0.269 Sum_probs=163.6
Q ss_pred cccccccc--cceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 841 EENVLSRG--RYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 841 ~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+.++||+| +|++||++..+ +|+.||+|++...... .+.+.+|+++++.++||||+++++++.... ..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-EEEEEEec
Confidence 45789999 78899999764 6899999998654322 346778999999999999999999998764 55999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999975432 23789999999999999999999999999999999999999999999999865332211110
Q ss_pred ----CCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCccCCh
Q 001171 995 ----ASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVMFTQD 1046 (1133)
Q Consensus 995 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~ 1046 (1133)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 215 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 011122356778999999875 4588999999999999999999999975443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.73 Aligned_cols=250 Identities=19% Similarity=0.289 Sum_probs=199.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|+..++||+|+||.||.++.. +++.+++|++.... ...+.+.+|++++++++|+||+++++++.+. ...++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEE
Confidence 4888999999999999999764 58899999876432 2245688999999999999999999999876 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ...+++..+..++.|+++|++|||+.+++||||||+||+++.++.+|++|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~- 155 (256)
T cd08221 80 YANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY- 155 (256)
T ss_pred ecCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-
Confidence 999999999998643 2347889999999999999999999999999999999999999999999999986543222
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......+++.|+|||+..+..++.++||||+|+++|||++|..||......+....+.. +......
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~------- 222 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GNYTPVV------- 222 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CCCCCCc-------
Confidence 122345688999999999888889999999999999999999999976554443333221 1111110
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.... ....+++.+||+.+|++||++.|+++++
T Consensus 223 ----~~~~--~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 ----SVYS--SELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----cccC--HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0000 1122788899999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=314.13 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=197.4
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|++++++++||||+++++++... ...++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-TYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-CEEEEE
Confidence 36888999999999999999776 4899999999754332 35688899999999999999999998775 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.+++.... ...+++..+..++.|+++||+|||+.|++||||||+||+++.++.++++|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999987532 245889999999999999999999999999999999999999999999999998644221
Q ss_pred CCCC--------------------------CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC
Q 001171 992 PAEA--------------------------SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045 (1133)
Q Consensus 992 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~ 1045 (1133)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 01123468889999999998889999999999999999999999997665
Q ss_pred hhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC----HHHHHHH
Q 001171 1046 DEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS----MADIVFM 1110 (1133)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs----~~evl~~ 1110 (1133)
.......+... ... .. .... .-....+++.+|++.||++||+ ++|++.+
T Consensus 237 ~~~~~~~~~~~--~~~--------~~---~~~~---~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETFSNILKK--EVT--------FP---GSPP---VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHHHHHhcC--Ccc--------CC---Cccc---cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 54433222210 000 00 0000 0011237889999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=301.58 Aligned_cols=253 Identities=18% Similarity=0.356 Sum_probs=185.2
Q ss_pred ccccccceeEEEEEECCc---eEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCC
Q 001171 844 VLSRGRYGLIFKASYQDG---MVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNG 918 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~g 918 (1133)
.||+|+||.||+|...++ ..+++|.+..... ..+.+.+|+.+++.++||||+++++++.... ..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-PYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-ccEEEEecCCCC
Confidence 599999999999965433 3566776654322 2467899999999999999999999998764 459999999999
Q ss_pred CHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCC
Q 001171 919 NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998 (1133)
Q Consensus 919 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 998 (1133)
+|.+++++.... ....++.....++.||+.||+|||+.+|+||||||+||+++.++.++++|||++...... ......
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETE 158 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-hhhhcc
Confidence 999999864322 233566777889999999999999999999999999999999999999999987532111 111122
Q ss_pred CCCCCCCCccCccccCC-------CCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 999 TTPIGSLGYVSPEAAST-------GQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 999 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+.+... ....++..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 234 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ----VKLFKPQL 234 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc----cccCCCcc
Confidence 34567889999999743 235789999999999999997 5778865555444443332211 12222222
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
... .... ..+++..|| .+|++||+++||++.|.
T Consensus 235 ~~~--~~~~------~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ELP--YSER------WYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCC--CcHH------HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 110 1111 125677799 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=285.26 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=198.3
Q ss_pred cccccccceeEEEE-EECCceEEEEEEcccC-CcCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 843 NVLSRGRYGLIFKA-SYQDGMVLSIRRLRDG-TIDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
++||+|+|+.|--+ ...+|..||||++.+. .....++.+|++++.+.+ |+||+++++||+++.. .|+|||-|.||+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~-FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR-FYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce-EEEEEecccCch
Confidence 67999999999888 4578999999999643 334678899999999985 9999999999988755 499999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc---eEEeccCcccccccCC----
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE---AHLSEFGLDRLAIATP---- 992 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~---- 992 (1133)
|..++++.+. +++.++.++.++||.||+|||.+||.|||+||+|||-....+ +|||||.++.-.....
T Consensus 163 lLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 163 LLSHIQKRKH-----FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999998655 788899999999999999999999999999999999976544 6999998874322221
Q ss_pred CCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChh-----------hHHHHHHHH
Q 001171 993 AEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE-----------DIVKWVKKQ 1056 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-----------~~~~~~~~~ 1056 (1133)
.......+++|+..|||||+.. ...|++++|.||+|||+|-|++|.+||.+.-+. .-...+-..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1122345678999999999863 345899999999999999999999999643221 222333333
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHH
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
++++. +.+...+|..+...+ +++...+..|+.+|-++.+++.
T Consensus 318 IQEGk-----------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGK-----------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccC-----------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 33331 223345677777666 8999999999999999999986
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=309.81 Aligned_cols=249 Identities=20% Similarity=0.330 Sum_probs=197.0
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.+|++.+.||.|+||.||+|.. .+|+.||+|.+..... ..+.+.+|+++++.++|||++++++++... +..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEEEe
Confidence 4689999999999999999976 4689999999864332 356788999999999999999999999775 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++++|.+++... .+++..+..++.+++.|++|||+.|++||||||+||+++.++.++++|||++.......
T Consensus 98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 169 (296)
T cd06655 98 LAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-- 169 (296)
T ss_pred cCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence 9999999988642 37899999999999999999999999999999999999999999999999886432211
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. ........+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~----~~~~~~~~~------ 238 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----NGTPELQNP------ 238 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cCCcccCCc------
Confidence 112334688899999999888899999999999999999999999976554332222211 111110000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .. ...+++.+||..||++||++.+++++
T Consensus 239 ~~~---~~--~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKL---SP--IFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccC---CH--HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 00 12268899999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=307.46 Aligned_cols=239 Identities=23% Similarity=0.395 Sum_probs=182.7
Q ss_pred cccccccceeEEEEEECC--------ceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASYQD--------GMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+.||+|+||.||+|..+. ...||+|.+..... ..+.+.+|+.+++.++|||++++++++..... .++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-SIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-cEEEEe
Confidence 469999999999997642 23478888754332 23578889999999999999999999987644 489999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc--------eEEeccCcc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE--------AHLSEFGLD 985 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfg~a 985 (1133)
|+++|+|.++++..+. .+++..+..++.||+.|++|||++||+||||||+||+++.++. ++++|||.+
T Consensus 80 ~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999986432 4788999999999999999999999999999999999987765 589999987
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCC-CCCccCChhhHHHHHHHHhhhcccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGR-KPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~-~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
..... .....++..|+|||++.+. .++.++|||||||++|||++|. .||...+.......... ...
T Consensus 156 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---~~~-- 223 (258)
T cd05078 156 ITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---RHQ-- 223 (258)
T ss_pred cccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc---ccc--
Confidence 54321 1234578899999999764 5789999999999999999985 56544333322211110 100
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
. +.. .+. ...+++.+||+.||++||+++|+++.|+
T Consensus 224 -~--------~~~--~~~---~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -L--------PAP--KWT---ELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -C--------CCC--CcH---HHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 000 011 1237899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=308.65 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=198.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.+.||+|+||+||+|... +|+.||+|++..... ..+.+.+|+++++.++||||+++++++... ...++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEe
Confidence 56888999999999999999765 588999998764332 246788999999999999999999999876 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|+++++|.+++...+ .+++.....++.+++.|+.|||+ .+++||||||+||+++.++.++++|||++......
T Consensus 84 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999987632 37899999999999999999997 68999999999999999999999999987543211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh--------hHHHHHHHHhhhccccc
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE--------DIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~~~~~ 1064 (1133)
......|+..|+|||++.+..++.++|||||||++|++++|+.||...... .....+.......
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 122356889999999998888999999999999999999999999754332 1112221111110
Q ss_pred cccCCcCCCCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1065 LLEPGLLELDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.+.. .. ..+ ....+++.+|++.||++||++.|++++..-.+
T Consensus 230 --~~~~---~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 --PPRL---PS-----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred --CCCC---Cc-----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000 00 001 12237899999999999999999998754433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=320.94 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=182.6
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc---cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV---KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
||+|+||+||+|+.. +++.||+|++..... ....+..|..++.+. +||||+.+++++.... ..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-DLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-eEEEEEcCCC
Confidence 799999999999775 589999999864221 123345567777665 6999999999988764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++...+ .+++..+..++.||++||+|||++||+||||||+||+++.++.++|+|||+++..... ..
T Consensus 80 ~g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~---~~ 151 (330)
T cd05586 80 GGELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD---NK 151 (330)
T ss_pred CChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---CC
Confidence 999999987633 3788999999999999999999999999999999999999999999999998643221 12
Q ss_pred CCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+... ...+ +.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~-----------~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRF-----------PK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCC-----------CC
Confidence 23345799999999998654 4799999999999999999999999766554443332211 0000 00
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCC----CHHHHHH
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRP----SMADIVF 1109 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RP----s~~evl~ 1109 (1133)
.. ... ...+++.+|++.||.+|| ++.|+++
T Consensus 219 ~~--~~~--~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NV--LSD--EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cc--CCH--HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00 000 112688899999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.04 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=198.2
Q ss_pred CCcccccccccceeEEEEEECC-----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 839 FDEENVLSRGRYGLIFKASYQD-----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
+++.+.||+|+||.||++.+.. +..||+|++..... ..+.+.+|++++++++||||+++++++... ...+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEE
Confidence 3567899999999999997753 48899999976544 356889999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+.+++||||||+||+++.++.++++|||+++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999986432 12789999999999999999999999999999999999999999999999998755332
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.. .......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...........+.... .....
T Consensus 157 ~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~---- 226 (258)
T smart00219 157 DY--YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY----RLPKP---- 226 (258)
T ss_pred cc--cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----CCCCC----
Confidence 11 11112336789999999988889999999999999999998 888887655555544443321 11000
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.. .. ....+++.+|+..||++||++.|+++.|
T Consensus 227 ----~~---~~--~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ----EN---CP--PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----Cc---CC--HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 00 1123688899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=306.46 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=194.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.+++.++||||+++++++... +..++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEe
Confidence 347888899999999999999764 588999999865432 235678899999999999999999998776 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++...+ .+++..+..++.|++.|++|||+.||+|+||||+||+++.++.++++|||++......
T Consensus 87 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 87 FCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred ccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 999999999987643 3789999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 994 EASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
........|+..|+|||++. ...++.++||||+||++|||++|+.||.............. .... .+..
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~----~~~~---~~~~ 231 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK----SNFQ---PPKL 231 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc----cCCC---CCcc
Confidence 11223456899999999974 45578999999999999999999999864433221111111 1100 0101
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ..+.. ...+++.+|++.+|++||++++++++
T Consensus 232 ~~~----~~~~~--~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KDK----MKWSN--SFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc----CCCCH--HHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 00111 12378899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.50 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=194.2
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.+.|++.++||+|+||.||+|... +++.|++|.+..... ..+.+.+|++++++++|||++++++++... ...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-GKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-CeEEEEEe
Confidence 357899999999999999999875 488999999865432 245688899999999999999999998765 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|..++.... ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++|+|||.+......
T Consensus 90 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 90 FCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 999999998876532 23789999999999999999999999999999999999999999999999987643221
Q ss_pred CCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 994 EASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
........++..|+|||++. ...++.++|||||||++|||++|+.||...........+ . ....+....+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~-~~~~~~~~~~ 238 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---A-KSEPPTLSQP 238 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---h-cCCCccCCCC
Confidence 11223346788999999984 344678999999999999999999999654433222111 1 1111110000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+. ....+++.+||+.||++||++.|++++
T Consensus 239 ---------~~~~--~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 ---------SKWS--MEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---------cccC--HHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 112378899999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.71 Aligned_cols=266 Identities=20% Similarity=0.309 Sum_probs=193.5
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|++|.||+|..+ +++.||+|++..... ..+.+.+|++++++++|||++++++++..+ ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEe
Confidence 4788899999999999999875 689999999864322 235788999999999999999999999875 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ ++|.+++..... ...+++..+..++.||+.||+|||+.+|+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred cCC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 996 689888875332 245889999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc------ccccc
Q 001171 994 EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ------ISELL 1066 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~ 1066 (1133)
........+++.|+|||++.+. .++.++||||+||++|||++|+.||......+......+...... .....
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1122234578899999988654 468899999999999999999999975443322222111111000 00000
Q ss_pred --cCCcCCCCCCC--hhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 --EPGLLELDPES--SEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 --~~~~~~~~~~~--~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
........... .....+ ....+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 000000 112379999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=308.74 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=196.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||.||+|.++ ++..||+|.+..... ..+.+.+|++++++++|||++++++++... ...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-CeEEEEee
Confidence 456899999999999999999875 588999999864332 245788999999999999999999999875 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ..+++..+..++.|++.|+.|||+.+|+||||||+||+++.++.++++|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 83 FCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred ccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 999999999987643 34889999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 994 EASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
........++..|+|||++. +..++.++||||+||++|||++|+.||...+.......+. ....+....+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~ 231 (280)
T cd06611 157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL----KSEPPTLDQP 231 (280)
T ss_pred -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh----cCCCCCcCCc
Confidence 11223456888999999974 3446789999999999999999999997654433222221 1111110000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .+. ....+++.+||+.+|.+||++.+++++
T Consensus 232 ~---------~~~--~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 S---------KWS--SSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c---------cCC--HHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 000 112378889999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.42 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=195.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++++++||||+++++++.... ..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-NLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-eEEEE
Confidence 36889999999999999999775 58999999986432 12456888999999999999999999998764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 80 MEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999999764 23788999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+.......+.. ...
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~--------- 215 (290)
T cd05580 155 ------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE----GKV--------- 215 (290)
T ss_pred ------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----CCc---------
Confidence 2344688999999999888889999999999999999999999976554333333221 110
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.++... . ....+++.+||..||.+|| +++|++++
T Consensus 216 ~~~~~~---~--~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFF---S--PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccC---C--HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 000010 0 1122788899999999999 77777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.76 Aligned_cols=257 Identities=24% Similarity=0.374 Sum_probs=199.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC-----Cc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPP-----DV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-----~~ 907 (1133)
++++|++.++||+|+||.||+|..+ +++.+++|++.......+.+.+|+++++++ +||||+++++++.... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4678999999999999999999875 578999999876665567899999999999 7999999999986532 34
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+.+++||||+|+||+++.++.++++|||.+..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 58999999999999998764321 24588999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCC-----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
.... ........|+..|+|||++.. ..++.++||||+||++|+|++|+.||...........+.+ ...
T Consensus 163 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~ 235 (275)
T cd06608 163 LDST---LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR----NPP 235 (275)
T ss_pred cccc---hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc----cCC
Confidence 4221 122234568889999998753 3467899999999999999999999965433322222111 100
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+... ....+.+ ...+++.+|+..||++||++.|++++
T Consensus 236 -----~~~~----~~~~~~~--~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 236 -----PTLK----SPENWSK--KFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----CCCC----chhhcCH--HHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 0011111 12278999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=332.01 Aligned_cols=203 Identities=19% Similarity=0.272 Sum_probs=158.2
Q ss_pred HhcCCCcccccccccceeEEEEEECC--ceEEEEE------------------EcccCCcCHHHHHHHHHHHhhccCCCe
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQD--GMVLSIR------------------RLRDGTIDENTFRKEAEALGKVKHRNL 894 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~hpni 894 (1133)
..++|++.+.||+|+||+||++.++. +..+++| ++.........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999986542 2222222 222222224567899999999999999
Q ss_pred eeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC
Q 001171 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD 974 (1133)
Q Consensus 895 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~ 974 (1133)
+++++++...+ ..|+|+|++ ++++.+++..................++.||+.||+|||++||+||||||+|||++.+
T Consensus 226 v~l~~~~~~~~-~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSEA-NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEECC-eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999998764 458999998 5678877765332222223455677899999999999999999999999999999999
Q ss_pred CceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCC
Q 001171 975 FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPV 1041 (1133)
Q Consensus 975 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf 1041 (1133)
+.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 304 ~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCccc--ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999997553221 11223457999999999999989999999999999999999987644
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=308.62 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=195.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.++||+|+||.||+|.++ +|..||+|.+..... ..+.+.+|++++++++||||+++++++... ...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-GAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-CeEEEEEe
Confidence 36889999999999999999876 689999998865322 235788999999999999999999988775 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|+++++|.+++..... ...+++..+..++.+++.|+.|||+ .+|+||||||+||+++.++.++++|||.+.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 155 (286)
T cd06622 80 YMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-- 155 (286)
T ss_pred ecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC--
Confidence 9999999998876321 2358999999999999999999996 5999999999999999999999999999864421
Q ss_pred CCCCCCCCCCCCCCccCccccCCCC------CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQ------PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.......++..|+|||++.+.. ++.++|+||+||++|+|++|+.||...........+..... ......
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~- 230 (286)
T cd06622 156 ---SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTL- 230 (286)
T ss_pred ---CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-cCCCCC-
Confidence 1223345788999999985443 48899999999999999999999965544433333322211 111111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .. .. ....+++.+|++.+|++||++.+++.+
T Consensus 231 ~-------~~---~~--~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 231 P-------SG---YS--DDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C-------cc---cC--HHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 00 11 112278889999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=311.26 Aligned_cols=250 Identities=19% Similarity=0.307 Sum_probs=196.2
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..+|++.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+.+|+.+++.++|||++++++++.... ..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-EEEEeec
Confidence 45799999999999999999976 4689999999864332 3466889999999999999999999998764 5599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++... .+++..+..++.|++.|+.|||+.||+||||||+||+++.++.++++|||.+.......
T Consensus 97 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 97 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred ccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 99999999998652 37888999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......+++.|+|||...+..++.++||||+||++|+|++|+.||...+.......+.. . ..+....+
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---~-~~~~~~~~----- 238 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---N-GTPELQNP----- 238 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc---C-CCCCCCCc-----
Confidence 122334688899999999888899999999999999999999999965443221111100 0 00000000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..... ...+++.+||+.+|++||++++++++
T Consensus 239 ----~~~~~--~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 239 ----ERLSA--VFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----cccCH--HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001 12278899999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=303.75 Aligned_cols=254 Identities=20% Similarity=0.378 Sum_probs=192.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC-----------HHHHHHHHHHHhhccCCCeeeEEEEEeCCC
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID-----------ENTFRKEAEALGKVKHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 905 (1133)
+|...+.||+|+||.||+|... +|+.||+|.+...... .+.+.+|++++++++|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 5778899999999999999764 6899999987532110 23578899999999999999999998776
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
+..++||||+++++|.+++++.. .+++..+..++.||+.|+.|||+++++||||+|+||+++.++.++++|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 45599999999999999997642 3788889999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCC--CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQ--PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+....... ........|+..|+|||++.... ++.++||||+|+++||+++|..||......... .+...... .
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~-~ 230 (272)
T cd06629 156 KKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM---FKLGNKRS-A 230 (272)
T ss_pred cccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH---HHhhcccc-C
Confidence 65322111 11223346888999999987654 789999999999999999999999643322211 11111110 0
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..++.... ... .....+++.+|+.+||.+||++.||+++
T Consensus 231 ~~~~~~~~------~~~--~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPDVS------MNL--SPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCcccc------ccC--CHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111110 000 0122378889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.96 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=197.5
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|+||.||++... +|+.||+|++.... ...+.+.+|++++++++||||+++++++... +..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-GNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-CeEEEEEe
Confidence 5889999999999999999764 68899999986432 2345788999999999999999999998776 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++..... ..+++..+..++.|++.|++|||+.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 9999999999875332 237888999999999999999999999999999999999999999999999986442211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||...+..+....+.. +.....
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~-------- 221 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR----GSYPPV-------- 221 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc----CCCCCC--------
Confidence 112234578899999999888899999999999999999999999976554443333221 111110
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... . .....+++.+||+.+|.+||++.||+++
T Consensus 222 ~~~---~--~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 SSH---Y--SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccc---C--CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 0 0112378999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.43 Aligned_cols=251 Identities=20% Similarity=0.340 Sum_probs=194.0
Q ss_pred cCCCcccccccccceeEEEEEECCce-EEEEEEcc-cCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGM-VLSIRRLR-DGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+-|.++..||.|+||.||+|..++.. ..|.|++. +....-++|.-|++|+...+||+||++++.|.... ..++..||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEEEEee
Confidence 34667788999999999999877544 44556653 22333467888999999999999999998776553 45899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
|.||..+.++-..+ ..+.+.++..+++|++.||.|||++.|||||||+.|||++-+|.++++|||.+... ...
T Consensus 111 C~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn---~~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN---KST 183 (1187)
T ss_pred cCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc---hhH
Confidence 99999999887754 34899999999999999999999999999999999999999999999999987322 112
Q ss_pred CCCCCCCCCCCCccCcccc-----CCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 995 ASSSTTPIGSLGYVSPEAA-----STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
......+.|||+|||||+. ....|+.++||||||+++.||..+.+|....++..+.-.+.+ ...+.++.|
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK----SePPTLlqP- 258 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----SEPPTLLQP- 258 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh----cCCCcccCc-
Confidence 2344568999999999986 356799999999999999999999999765555443333322 222222221
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
......+. ++..+|+..+|..||++++++++
T Consensus 259 ----S~Ws~~F~------DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 ----SHWSRSFS------DFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----chhhhHHH------HHHHHHHhcCCccCCCHHHHhhC
Confidence 11122222 56778999999999999999854
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=307.91 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=196.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
+|++.+.||+|+||.||+|..+ +|+.||+|++...... ...+..|++++++++|+||+++++++... ...++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-SNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-CEEEE
Confidence 4788899999999999999875 6899999999754332 34567899999999999999999999875 55699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+ +|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 80 v~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 99999 999999997643 2488999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc--
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE-- 1067 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1067 (1133)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||....+.+....+.............+
T Consensus 155 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PN---RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CC---ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 11223356788999998854 4578999999999999999999888876555443333322211110000000
Q ss_pred --CCcCCC-CCCChhH----HH-HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 --PGLLEL-DPESSEW----EE-FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 --~~~~~~-~~~~~~~----~~-~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+..... ....... .. -....+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000000 00 1123389999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.40 Aligned_cols=264 Identities=21% Similarity=0.334 Sum_probs=192.7
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|+||.||+|.++ +|+.||+|++..... ....+.+|++++++++|||++++++++.+.. ..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-KLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-ceEEEEe
Confidence 4788899999999999999875 689999999864322 2356788999999999999999999987764 5599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ ++|.+++.... ..+++..++.++.||++||+|||+++|+||||||+||+++.++.++|+|||+++.....
T Consensus 80 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 152 (284)
T cd07839 80 YCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-- 152 (284)
T ss_pred cCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--
Confidence 996 58888876532 23889999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCcc-CChhhHHHHHHHHhhhcc------cccc
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMF-TQDEDIVKWVKKQLQRGQ------ISEL 1065 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~~------~~~~ 1065 (1133)
........++..|+|||++.+.. ++.++||||+||++|||++|+.||.. .+..+..+.+.+...... ..+.
T Consensus 153 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 153 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 11223346788999999986644 68999999999999999999988643 333333332222211100 0000
Q ss_pred ccCCcCCCCCCChhHHHH----H-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEF----L-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~----~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+............+.+. . ...+++.+|++.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 010000000111111111 1 22378999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=310.25 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=195.4
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.++||+|+||.||+|.++ +++.||+|++..... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-KRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-CeEEEEE
Confidence 36889999999999999999876 589999999864332 245688999999999999999999999765 4569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++++++.++.... ..+++..+..++.||++|++|||+.+|+|||++|+||++++++.++++|||++.......
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred ecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999888876542 237899999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc--c------c
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ--I------S 1063 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~------~ 1063 (1133)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......-. . .
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 ---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 12233467889999999865 3468899999999999999999999965544332222222111000 0 0
Q ss_pred ccccCCcCCCCCCChhHH----HH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWE----EF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~----~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+.............. .. ....+++.+||+.+|++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000000000 01 123379999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=299.83 Aligned_cols=248 Identities=20% Similarity=0.351 Sum_probs=196.0
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|+..+.||+|+||.||+|... +++.+|+|.+..... ....+.+|++++++++|||++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-KALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-CEEEEEEe
Confidence 5888999999999999999764 688999999865332 245788999999999999999999988765 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 992 (1133)
|+++++|.+++.... ...+++..+..++.++++|++|||++||+||||||+||++++++ .++++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK- 155 (256)
T ss_pred cCCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence 999999999997643 23478899999999999999999999999999999999998654 5799999998654221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+... ......+ ..
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~-- 225 (256)
T cd08220 156 ---SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG----TFAPISD-RY-- 225 (256)
T ss_pred ---ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc----CCCCCCC-Cc--
Confidence 1223356888999999998888899999999999999999999999765544433333221 1111110 00
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ....+++.+||+.+|++||++.|++++
T Consensus 226 ----~------~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 226 ----S------PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----C------HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 112278889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.29 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=191.6
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
+++.+.....||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|++++++++|+||+++++++... +..++|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 84 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKIFM 84 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEEEE
Confidence 4556666778999999999999765 578899998865432 346788999999999999999999998876 4568999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~ 991 (1133)
||+++++|.+++...... ...++..+..++.||+.|++|||+.||+||||||+||+++. ++.++|+|||.+......
T Consensus 85 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 85 EQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred ecCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999999999764211 11277888889999999999999999999999999999986 678999999998644221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCC--CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQ--PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
. .......|+..|+|||++.+.. ++.++||||+|+++|+|++|+.||..........+....... .+.
T Consensus 163 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~ 232 (268)
T cd06624 163 N---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI-------HPE 232 (268)
T ss_pred C---CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc-------CCC
Confidence 1 1122345788999999986543 789999999999999999999999643322211111110000 000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. +.. .. ....+++.+||+.+|.+||++.|++++
T Consensus 233 ~---~~~---~~--~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 I---PES---LS--AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred C---Ccc---cC--HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 000 00 112278899999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.12 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=198.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|...++||+|.||.|..++-+ .|+.+|+|++++...- .+.-..|-++++..+||.+..+...|... +..++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-DRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-ceEEE
Confidence 457889999999999999999654 6999999999865432 23345689999999999999887777665 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||..||.|+-++.+.+ .+++...+.+...|+.||.|||+++||.||+|-+|.|+|.||++||+|||+++....
T Consensus 246 VMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999999998743 477888888999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.+......+|||.|.|||++....|+.++|.|.+||+||||++|+.||...+.+.+...+... +..++.-+.+.
T Consensus 321 ---~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--d~kFPr~ls~e- 394 (516)
T KOG0690|consen 321 ---YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--DLKFPRTLSPE- 394 (516)
T ss_pred ---ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--hccCCccCCHH-
Confidence 233456789999999999999999999999999999999999999999887777666555432 11111111111
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVF 1109 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1109 (1133)
+..+....+.+||.+|. .+.||.+
T Consensus 395 ---------------AktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 395 ---------------AKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---------------HHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11456678899999995 4566654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=299.10 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=198.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.++||+|+||.||+|... +++.+++|.+..... ..+.+.+|++++++++|||++++++++... ...+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEEe
Confidence 357899999999999999999775 578899999875432 356789999999999999999999998775 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++++|||.+......
T Consensus 81 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 154 (262)
T cd06613 81 YCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-- 154 (262)
T ss_pred CCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence 999999999987642 23788999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCCCCCCCCccCccccCCC---CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 994 EASSSTTPIGSLGYVSPEAASTG---QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
........++..|+|||.+.+. .++.++||||+||++|||++|+.||...........+.. ..+ ..+..
T Consensus 155 -~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~----~~~---~~~~~ 226 (262)
T cd06613 155 -IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK----SNF---PPPKL 226 (262)
T ss_pred -hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----ccC---CCccc
Confidence 1122345688899999999776 788999999999999999999999975543332222111 100 00000
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ....+. ....+++.+||..+|.+||++.+|+.+
T Consensus 227 ~----~~~~~~--~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 K----DKEKWS--PVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c----chhhhh--HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000111 122378999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=304.75 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=200.1
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.++||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|++++++++|||++++++++... ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEec
Confidence 5888999999999999999875 689999999875432 246788999999999999999999998875 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+ +++|.+++.... ..+++..++.++.||++|++|||+.+|+|+||||+||+++.++.++++|||.+........
T Consensus 80 ~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred cc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99 999999987643 3488999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc------cccc
Q 001171 994 EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI------SELL 1066 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~------~~~~ 1066 (1133)
.......|+..|+|||++.+. .++.++||||+||++|||++|++||....+......+.+....... .+..
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 --RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred --CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 122345688999999998654 4689999999999999999998888765554444444433221110 0000
Q ss_pred cCCcCCCCCC-ChhHH----HH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPE-SSEWE----EF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~-~~~~~----~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+-........ ...+. .. ....+++.+|++.||++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00011 01 223389999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=313.84 Aligned_cols=275 Identities=19% Similarity=0.288 Sum_probs=199.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC----CcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 908 (1133)
.++|++.++||+|+||.||+|.+. +|+.||+|++.... .....+.+|++++++++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999764 68999999986322 22356788999999999999999998875432 245
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++|+||++ +++.+++.. ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.++++|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 89999995 588877754 23888999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc---cc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI---SE 1064 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~ 1064 (1133)
..............|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...+.......+......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 332222222234578899999998754 46789999999999999999999999765443333333222111100 00
Q ss_pred cccCCcC----CCC-CCChhHH----HH-HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCC
Q 001171 1065 LLEPGLL----ELD-PESSEWE----EF-LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVG 1117 (1133)
Q Consensus 1065 ~~~~~~~----~~~-~~~~~~~----~~-~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~ 1117 (1133)
..+.... ... .....+. .. ....+++.+||+.||++||++.|++++ ++.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0000000 000 0000000 01 122389999999999999999999987 6655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=341.97 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=196.7
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
+-+|.....||.|.||.||.|.. .+|+..|||-++..... .+.+.+|+.++..++|||+|+++|+=...+.. ++.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv-~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV-YIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH-HHH
Confidence 44788889999999999999965 57999999998643322 35678999999999999999999987765444 899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||||++|+|.+.+...+. .++.....+..|++.|++|||++|||||||||.||+++.+|.+|.+|||.|+.+...
T Consensus 1313 MEyC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999987433 556666678899999999999999999999999999999999999999999876544
Q ss_pred C-CCCCCCCCCCCCCCccCccccCCCC---CCCCCchhHHHHHHHHHHhCCCCCccCChh-hHHHHHHHHhhhccccccc
Q 001171 992 P-AEASSSTTPIGSLGYVSPEAASTGQ---PTKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 992 ~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 1066 (1133)
. ..........||+.|||||++.+.. ...++||||+|||+.||+||+.||...+.+ .+.-. +..+..+++.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----VAAGHKPQIP 1463 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH----HhccCCCCCc
Confidence 2 1222334678999999999996543 578899999999999999999999754432 22222 2222222222
Q ss_pred cCCcCCCCCCChhHHHHHH-hHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLL-GVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~-~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.. ... .-+++.+|+..||+.|-++.|++++=
T Consensus 1464 ~~--------------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1464 ER--------------LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hh--------------hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 21 111 12788899999999998888887653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.13 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=193.9
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-KLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-ceEEEEEc
Confidence 4667788999999999999764 578999998864332 2357889999999999999999999987754 55999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++++|.+++.. ..+++..+..++.|+++|+.|||+++++|+||+|+||+++.++.++++|||++.......
T Consensus 84 ~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 84 LGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred cCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 999999998864 237888999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+.. .. .+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----~~-----~~~~~--- 222 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK----NS-----PPTLE--- 222 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc----CC-----CCCCC---
Confidence 112234578899999999888899999999999999999999999864433332221111 10 01000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ......+++.+||+.+|++||++.|++++
T Consensus 223 ~~-----~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQ-----YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cc-----cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 01122378999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=299.10 Aligned_cols=258 Identities=21% Similarity=0.355 Sum_probs=199.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.+.||+|+||+||+|... ++..+|+|++..... ..+.+.+|+++++.++|+|++++++.+... +..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEe
Confidence 46899999999999999999764 578999999864332 346789999999999999999999988765 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++..... ...+++.....++.|++.|++|||+.||+||||||+||++++++.++++|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999976432 13478999999999999999999999999999999999999999999999999876543322
Q ss_pred CC-CCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 994 EA-SSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 994 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.. .......|+..|+|||++... .++.++|||||||++|||++|+.||.............+ .. .+...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~------~~~~~ 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---ND------PPSLE 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CC------CCCcC
Confidence 21 122344688999999998776 789999999999999999999999975544322222111 10 00000
Q ss_pred CCCCCChhHHHHHH-hHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLL-GVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~-~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....+..+.. ..+++.+|++.||++||++.|++++
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 229 ----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000111111 2378899999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=308.02 Aligned_cols=207 Identities=22% Similarity=0.344 Sum_probs=169.3
Q ss_pred CCCcccccccccceeEEEEEEC---CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~ 909 (1133)
+|++.+.||+|+||.||+|..+ .+..||+|.+.... .....+.+|++++++++||||+++++++... ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999775 47899999997632 1235678899999999999999999999765 24568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC----CCceEEeccCcc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA----DFEAHLSEFGLD 985 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg~a 985 (1133)
+||||++ +++.+++..........++...+..++.||+.|++|||+.+|+||||||+||+++. ++.+|++|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 57777776544433345888999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCC
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~ 1045 (1133)
+................++..|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 7553322212223345678899999988664 57899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=307.75 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=195.7
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
+|++.+.||+|+||.||++.++ .++.||+|.+..... ..+.+.+|+++++.++||||+++++.+... ...++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-RHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-CEEEEEE
Confidence 6888999999999999999875 478999999865432 234677899999999999999999998875 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++...+ .+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997643 37888899999999999999999999999999999999999999999999986421110
Q ss_pred CC------------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 993 AE------------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 993 ~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|..||......+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~---- 231 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD---- 231 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----
Confidence 00 00112245788999999998888999999999999999999999999765544433332221
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
... .+... .. ... ...+++.+||+.||++||++.++.+.|+.
T Consensus 232 ~~~---~~~~~---~~---~~~--~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIE---WPEGD---EA---LPA--DAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccC---CCCcc---cc---CCH--HHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 100 00000 00 000 11378999999999999996656555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=328.24 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=190.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCC--------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGP-------- 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------- 904 (1133)
..+|+..++||+|+||.||+++.+ +|+.||||+++-... .-..+.+|++.+.+++|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 446788899999999999999887 799999999975532 234678899999999999999986433100
Q ss_pred ----------------------------------------------C---------------------------------
Q 001171 905 ----------------------------------------------P--------------------------------- 905 (1133)
Q Consensus 905 ----------------------------------------------~--------------------------------- 905 (1133)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHH
Q 001171 906 -------------------------------DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954 (1133)
Q Consensus 906 -------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 954 (1133)
...||-||||+..++.+++++.... -.....++++++|++||+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHH
Confidence 1237889999998888888875432 13567788999999999999
Q ss_pred hcCCceecccCccceeeCCCCceEEeccCccccccc------C---------CCCCCCCCCCCCCCCccCccccCCCC--
Q 001171 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA------T---------PAEASSSTTPIGSLGYVSPEAASTGQ-- 1017 (1133)
Q Consensus 955 H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~------~---------~~~~~~~~~~~gt~~y~aPE~~~~~~-- 1017 (1133)
|++|||||||||.||++|++..|||+|||+|..... . .......+..+||.-|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 999999999999999999999999999999976220 0 11122346678999999999997654
Q ss_pred -CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCC
Q 001171 1018 -PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAP 1096 (1133)
Q Consensus 1018 -~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~ 1096 (1133)
|+.|+|+||+|||++||+. ||.. ..+ ...+...++.+.++.. +.+. ..+....+++|.++++.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sME-Ra~iL~~LR~g~iP~~--~~f~--------~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGT--SME-RASILTNLRKGSIPEP--ADFF--------DPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCc--hHH-HHHHHHhcccCCCCCC--cccc--------cccchHHHHHHHHHhcC
Confidence 9999999999999999973 5632 112 2233344445554443 1110 11122234789999999
Q ss_pred CCCCCCCHHHHHH
Q 001171 1097 DPLDRPSMADIVF 1109 (1133)
Q Consensus 1097 dP~~RPs~~evl~ 1109 (1133)
||.+|||+.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999984
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=299.26 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=199.1
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeC-CCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAG-PPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~~lV~ 912 (1133)
+|++.+.||+|+||.||+|... +++.||+|.+...... .+.+.+|++++++++|||++++++++.. .....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999764 6789999998654332 3567889999999999999999998754 344568999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHh-----cCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH-----SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
||+++++|.+++..... ....+++..++.++.+|+.|++||| +.+++||||||+||+++.++.++++|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999976532 2345899999999999999999999 88999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..... .......++..|+|||++.+..++.++||||||+++|+|++|+.||...+.....+.+.. ......
T Consensus 160 ~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~-- 230 (265)
T cd08217 160 LGHDS---SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE----GKFRRI-- 230 (265)
T ss_pred ccCCc---ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc----CCCCCC--
Confidence 43211 112334688999999999888899999999999999999999999976654443333222 111110
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... +. ....+++.+|++.+|++||++.||+++
T Consensus 231 ------~~~---~~--~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 ------PYR---YS--SELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------ccc---cC--HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00 112378899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=301.35 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=197.5
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~lV~ 912 (1133)
++|+..++||.|++|.||+|... +++.+|+|.+..... ....+.+|++++++++||||+++++++... ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999875 589999999865432 246788999999999999999999988543 34568999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++..... ....+++.....++.||+.|++|||+.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~- 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS- 158 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc-
Confidence 99999999998875432 2345788899999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCCh--hhHHHHHHHHhhhccccccccCCc
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD--EDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
......++..|+|||.+.+..++.++||||+||++|+|++|+.||..... ....+.. ........... .
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~-~--- 229 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPEL-K--- 229 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchhh-c---
Confidence 11234577899999999888899999999999999999999999975422 1111111 11111111111 0
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
........+.+. ..+++.+||+.+|++||++.|++++
T Consensus 230 -~~~~~~~~~~~~--~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 -DEPGNGIKWSEE--FKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -cCCCCCCchHHH--HHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000111112221 2389999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=304.39 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=192.8
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... ....+.+|++++++++||||+++++++... ...++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEEEEe
Confidence 57899999999999999999775 689999999864332 234567899999999999999999998865 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ ++|.+++.+.. ..+++.....++.|+++||.|||+++|+||||||+||+++.++.++++|||+++......
T Consensus 84 ~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 84 YLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred cCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 997 59999887643 247888999999999999999999999999999999999999999999999986432111
Q ss_pred CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCC-hhhHHHHHHHHhhhcc---ccc----
Q 001171 994 EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQ-DEDIVKWVKKQLQRGQ---ISE---- 1064 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~~---~~~---- 1064 (1133)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+.+...... ...
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11122346788999999865 457899999999999999999999996543 2222222222111100 000
Q ss_pred --cccCCcCCCCCCC-----hhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 --LLEPGLLELDPES-----SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 --~~~~~~~~~~~~~-----~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
............. ..........+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000000 000001223478999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=309.95 Aligned_cols=281 Identities=21% Similarity=0.301 Sum_probs=204.9
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC-CCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKV-KHRNLTVLRGYYAGP-PDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~~ 908 (1133)
..++|++.++||+|+||.||+|.+. +|+.+|+|++.... .....+.+|+++++++ +||||+++++++... ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4568999999999999999999875 58899999885422 2235677899999999 999999999988653 3456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++++|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 89999996 6998888652 3788889999999999999999999999999999999999999999999998755
Q ss_pred ccCCCC--CCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----
Q 001171 989 IATPAE--ASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---- 1061 (1133)
Q Consensus 989 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 1061 (1133)
...... ........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 332211 112234568899999998754 4578999999999999999999999976555443333322211100
Q ss_pred -------ccccccCCcCCCCCCChhHHH-----HHHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCCCCCCCC
Q 001171 1062 -------ISELLEPGLLELDPESSEWEE-----FLLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPDMPSSAD 1125 (1133)
Q Consensus 1062 -------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~~~~~~~ 1125 (1133)
....++ ..... ......+ -....+++.+||+.||++||++.+++++ ++.+......++...
T Consensus 238 ~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~ 312 (337)
T cd07852 238 ESIKSPFAATMLD-SLPSR--PRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPY 312 (337)
T ss_pred HHHHhhhHHHhhh-hcccc--cccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCC
Confidence 000000 00000 0000000 1122478999999999999999999976 566655544444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.33 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=195.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..|+..+.||+|+||.||+|.++ .+..||+|.+.... ...+.+.+|++++++++|||++++++++.+. ...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-TKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEe
Confidence 35778899999999999999775 58999999886432 2245788999999999999999999999876 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.+++... .+++.....++.|++.|++|+|+.+++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 83 YLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999999998642 37788888999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... +...
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~-----~~~~-- 222 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI----PKNNP-----PTLT-- 222 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh----hcCCC-----CCCc--
Confidence 1223346788999999998888999999999999999999999999755433322211 11100 0000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .......+++.+||+.+|++||++.|++++
T Consensus 223 ----~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 ----G--EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----h--hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0 011122378999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.12 Aligned_cols=248 Identities=19% Similarity=0.325 Sum_probs=193.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.|.....||+|+||.||++... ++..||||++..... ..+.+.+|+.++++++|||++++++.+... +..++||||+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~ 101 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEFL 101 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeCC
Confidence 3444567999999999999764 588999999864332 245688999999999999999999998776 4559999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.. ..+++..+..++.||+.|++|||+++|+||||||+||+++.++.++++|||++.......
T Consensus 102 ~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 102 EGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999998854 237888999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||...+.......+.... .+.......
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 243 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL---------PPRVKDSHK 243 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------CCccccccc
Confidence 12233568899999999988889999999999999999999999997655443332222111 111100000
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .. ...+++.+|+..||.+||+++|++++
T Consensus 244 ~----~~--~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 V----SS--VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c----CH--HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 11 11267888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=299.50 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=192.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC------cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-CcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT------IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~ 908 (1133)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999764 58999999875321 12357889999999999999999999986543 445
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++++|.+++.... .+++.....++.|++.|+.|||+.||+|+||||+||+++.++.++++|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 79999999999999987532 3678888899999999999999999999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
..............++..|+|||++.+..++.++|+|||||++|||++|+.||........ +.+..... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~p~ 232 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA---IFKIATQP-TKPMLPD 232 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH---HHHHHcCC-CCCCCCc
Confidence 3211111122345688999999999888889999999999999999999999965433222 12211111 1111111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. . ....+++.+|+. +|.+||++.+++.+
T Consensus 233 ~~----------~--~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 233 GV----------S--DACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cc----------C--HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11 0 112278888998 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=300.74 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=194.6
Q ss_pred CCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc-------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI-------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
+|+..++||+|+||.||+|.. .+++.||+|++..... ..+.+.+|++++++++|||++++++++.+.+ ..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-eEE
Confidence 478889999999999999976 5689999999864321 1357889999999999999999999998764 458
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLA 988 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 988 (1133)
+||||+++++|.+++...+ .+++..+..++.|++.|++|||++|++||||||+||+++.++ .++++|||.+...
T Consensus 80 ~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999997643 378889999999999999999999999999999999998876 5899999998655
Q ss_pred ccCCCCC-CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEA-SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
....... .......++..|+|||++.+..++.++||||+||++|+|++|+.||...........+.+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA----- 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC-----
Confidence 3321111 1122346888999999998888999999999999999999999999654433222222221111100
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
+.. +.. . .....+++.+|+..+|++||++.|+++
T Consensus 230 ~~~---~~~---~--~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 PSI---PEH---L--SPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCC---chh---h--CHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 000 0 011226888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.50 Aligned_cols=249 Identities=18% Similarity=0.258 Sum_probs=202.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
....|.+...||+|.|++|..|++. ++..||||.+.+...+ .+.+.+|+++|+.++|||||+++.+.... ...|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-ATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-ceeEE
Confidence 3457889999999999999999775 6999999998765443 24578999999999999999999999876 44599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+.+|.+++++.+.++ ........++.|+.+|++|||+++|||||||++||+++.+..+||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-
Confidence 9999999999999998765 3346777888999999999999999999999999999999999999999997653
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
........+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-.+....+.... -+++..+
T Consensus 207 ---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--~rIp~~m--- 278 (596)
T KOG0586|consen 207 ---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--YRIPFYM--- 278 (596)
T ss_pred ---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--eccccee---
Confidence 2345567899999999999998877 789999999999999999999997654433333222211 1111111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.. .+-+++++++..+|.+|+++++|.++=
T Consensus 279 -------s~------dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 279 -------SC------DCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -------ec------hhHHHHHHhhccCccccCCHHHhhhhc
Confidence 11 122678889999999999999998754
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.97 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=196.8
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|+..+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|++++++++||||+++++++... ...++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEE
Confidence 36788899999999999999876 589999999865432 345788999999999999999999998776 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|+++++|.+++.... ..+++.....++.|++.|++|+|+ .+++||||||+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999998643 347888899999999999999999 999999999999999999999999999986442211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC--hhhHHHHHHHHhhhccccccccCCc
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ--DEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. ....++..|+|||++.+..++.++||||+|+++|+|++|+.||...+ .......+....... ... .
T Consensus 156 ~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~-----~ 224 (265)
T cd06605 156 A-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPR-----L 224 (265)
T ss_pred h-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCC-----C
Confidence 1 11568889999999988899999999999999999999999996442 122222222221111 000 0
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ... ....+++.+||..||++||++.|++++
T Consensus 225 ---~~~--~~~--~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 ---PSG--KFS--PDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---Chh--hcC--HHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 000 112378899999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=303.90 Aligned_cols=268 Identities=20% Similarity=0.260 Sum_probs=195.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCC----c
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVK-HRNLTVLRGYYAGPPD----V 907 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~----~ 907 (1133)
++|++.+.||+|+||.||+|.+. +|+.||+|++..... ....+.+|+++++++. ||||+++++++...+. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36889999999999999999875 689999999864322 2356888999999995 6999999998865433 3
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEEeccCccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDR 986 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 986 (1133)
.++||||+++ ++.+++..........+++..++.++.||+.||+|||+++|+||||||+||+++. ++.++++|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 5899999975 8999887654332345899999999999999999999999999999999999998 8899999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.+....+. ..
T Consensus 160 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~ 234 (295)
T cd07837 160 AFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT--EQ 234 (295)
T ss_pred ecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC--hh
Confidence 442211 11223356788999998865 4578999999999999999999999976554433333222211110 00
Q ss_pred ccCCc------CCCCC-CChhH----HHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGL------LELDP-ESSEW----EEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~------~~~~~-~~~~~----~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+.. ...+. ..... +.. ....+++.+|+++||.+||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00000 00000 011 112378999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=305.99 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=198.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC-CcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~~l 910 (1133)
.++|++.+.||+|+||.||+|..+ +|+.||+|++...... ...+.+|++++++++|+|++++++++.... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457999999999999999999775 5899999998643222 235678999999999999999999987543 45689
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||++ ++|.+++.... ..+++..+..++.||+.|++|||+.|++||||||+||+++.++.++++|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58888887643 3488999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc------
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS------ 1063 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 1063 (1133)
.. .......++..|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+..........
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 11223345788999999865 457899999999999999999999998766665555544432211000
Q ss_pred ccccCCcCCCC--C--CC-hhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELD--P--ES-SEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~--~--~~-~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
........... + .. ....... ...+++.+|++.||++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 0 00 0000011 12379999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=296.83 Aligned_cols=244 Identities=22% Similarity=0.318 Sum_probs=191.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..|..-++||+|+||.||-++.+ +|+.+|.|++.+... .+.....|-+|++++..+.||.+-..|+.+ +..++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-d~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-DALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-CceEEE
Confidence 46778899999999999999765 699999998854322 345667899999999999999987777766 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
+..|.||+|.-++...+. ..+++.....++.+|+.||+|||+.+||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 999999999988876553 4489999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......++||.+|||||++..+.|+...|.||+||++|||+.|+.||.......-.+.+.+...... .
T Consensus 340 ---g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------~-- 407 (591)
T KOG0986|consen 340 ---GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------E-- 407 (591)
T ss_pred ---CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-------h--
Confidence 2334456899999999999999999999999999999999999999965443333333333322110 0
Q ss_pred CCCCCChhHHHHHHhH-hhhhccCCCCCCCCCC
Q 001171 1072 ELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPS 1103 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs 1103 (1133)
++ . +.+...+ ++-...+..||++|..
T Consensus 408 ey---~---~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 408 EY---S---DKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hc---c---cccCHHHHHHHHHHHccCHHHhcc
Confidence 00 0 1122222 4556678889999863
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=302.30 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=201.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++.|+..+.||+|+||.||+|.++ ++..|++|++.......+.+.+|++++++++|+|++++++++... ...++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEEe
Confidence 4557888899999999999999876 688999999975544467789999999999999999999998876 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ..+++..+..++.+++.|++|||+.||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999998753 248999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.. .......+..
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~---- 240 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----KGIPPLKNPE---- 240 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cCCCCCcchh----
Confidence 122334578899999999888899999999999999999999999975544332222211 1111111100
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.. ...+++.+|++.+|.+||++.+++++
T Consensus 241 -----~~~~--~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 241 -----KWSP--EFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----hCCH--HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0011 12378999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=302.09 Aligned_cols=252 Identities=19% Similarity=0.341 Sum_probs=189.2
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHH-HhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEA-LGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.+.||+|+||.||+|.+. +|+.||+|++..... ....+..|+.+ ++..+|||++++++++.... ..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-DVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEEh
Confidence 36889999999999999999775 689999999875432 23455666665 56678999999999998764 459999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||++ |+|.+++...... ...+++..+..++.||+.|++|||++ +++||||||+||+++.++.+||+|||.++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9995 7898888764322 24589999999999999999999997 9999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCCCccCccccCC----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAST----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.......|+..|+|||++.+ ..++.++|+||+||++|||++|+.||...... .+.+....... ......
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~~~ 230 (283)
T cd06617 158 ----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEP-SPQLPA 230 (283)
T ss_pred ----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhcC-CCCCCc
Confidence 11223467889999998864 44688999999999999999999999642211 11111111110 011100
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. +.+ ...+++.+||..+|++||++.+++++
T Consensus 231 ~~----------~~~--~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 231 EK----------FSP--EFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cc----------cCH--HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 001 12378899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=310.35 Aligned_cols=264 Identities=21% Similarity=0.265 Sum_probs=196.4
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPP----- 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 905 (1133)
..++|+..+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4678999999999999999999765 689999999864322 2346778999999999999999999886432
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
...++||||+. ++|.+.+... ++...+..++.|++.||+|||+.||+||||||+||+++.++.+|++|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 24589999995 5888887641 778888999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---- 1061 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 1061 (1133)
+..... .......++..|+|||++.+..++.++||||+||++|+|++|+.||...+.......+.+......
T Consensus 166 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 166 RTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred eeCCCC----CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 754221 122334678899999999998999999999999999999999999976554433333322111100
Q ss_pred ------ccccccCCc-------CCC------CCCChh-H-HHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 ------ISELLEPGL-------LEL------DPESSE-W-EEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 ------~~~~~~~~~-------~~~------~~~~~~-~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.....+... .+. ...... . .......+++.+|++.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000 000000 0 011122389999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=305.13 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=192.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-C---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-D---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
...|...+.||+|+||.||+|... +|+.||+|++..... . .+.+.+|+++++.++|||++++++++.... ..++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEEE
Confidence 356889999999999999999775 689999999864322 1 246889999999999999999999998764 4589
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||++ |++.+++.... ..+++..+..++.|++.|+.|||+.+|+||||+|+||+++.++.++++|||++.....
T Consensus 93 v~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 93 VMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EHHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999996 67777776432 2488999999999999999999999999999999999999999999999998864321
Q ss_pred CCCCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.....++..|+|||++. ...++.++||||||+++|||++|+.||...+.......+.. ...+...
T Consensus 168 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----~~~~~~~- 235 (307)
T cd06607 168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLS- 235 (307)
T ss_pred -------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc----CCCCCCC-
Confidence 12346788999999874 45678999999999999999999999976554333222211 1100000
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
. ..+.. ...+++.+||+.||++||++.+++.+.
T Consensus 236 -------~--~~~~~--~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 236 -------S--NDWSD--YFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -------c--hhhCH--HHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 01111 123789999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=302.49 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=196.8
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC-CcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~~lV 911 (1133)
++|++.+.||+|+||.||+|.++ +++.+|+|.++..... ...+.+|++++++++||||+++++++.... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999876 5889999998643322 235678999999999999999999886542 556999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||++ ++|.+++.... ..+++..+..++.||+.||+|||+.+++||||||+||+++.++.++++|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999887643 24899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc---------
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ--------- 1061 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--------- 1061 (1133)
. .......++..|+|||.+.+.. ++.++|+||+|+++|||++|+.||......+....+........
T Consensus 160 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 L---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 1223345788999999986544 68999999999999999999999986665554444333221100
Q ss_pred ccccccCCcCCCCC--CChhHHH--HH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 ISELLEPGLLELDP--ESSEWEE--FL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~--~~~~~~~--~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+............. ....+.. +. ...+++.+|++.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000 0000000 01 12278999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=303.22 Aligned_cols=266 Identities=23% Similarity=0.330 Sum_probs=196.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.++||+|+||.||+|.++ +++.||+|++..... ..+.+.+|++++++++|+||+++++++... +..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-GRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-CEEEEEE
Confidence 36889999999999999999876 588999999864322 246789999999999999999999999875 4569999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++++.+..+.... ..+++..+..++.+|+.|++|||+.+++|||++|+||++++++.++++|||.+.......
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 80 EYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred ecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887666555432 237889999999999999999999999999999999999999999999999986543322
Q ss_pred CCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc----cccc
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS----ELLE 1067 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~~ 1067 (1133)
. .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+............... ...+
T Consensus 155 ~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 A--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred c--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 1 122345678899999999887 78999999999999999999999997655443333322211100000 0000
Q ss_pred CCcC--CCCCCC--hhHH----H--HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLL--ELDPES--SEWE----E--FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~--~~~~~~--~~~~----~--~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+... ...... ...+ . -....+++.+||..+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000000 0000 0 1123389999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=305.67 Aligned_cols=247 Identities=17% Similarity=0.289 Sum_probs=193.5
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
|.....||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++|||++++++++... +..++||||++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~ 101 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQ 101 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCC
Confidence 444567999999999999764 68999999985432 2345788999999999999999999988765 45599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+++|.+++.. ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++|+|||++...... ..
T Consensus 102 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---~~ 172 (297)
T cd06659 102 GGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VP 172 (297)
T ss_pred CCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc---cc
Confidence 9999988754 23788999999999999999999999999999999999999999999999998643221 11
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.. .... ........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~-----~~~~~~~~ 243 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----SPPP-----KLKNAHKI 243 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----cCCC-----CccccCCC
Confidence 22345688999999999888899999999999999999999999976554433332211 1100 00000000
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ....+++.+|++.+|++||++.|++++
T Consensus 244 ~------~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 S------PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred C------HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1 112368889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=301.40 Aligned_cols=247 Identities=21% Similarity=0.388 Sum_probs=192.7
Q ss_pred CCCcccccccccceeEEEEEE-CCceEEEEEEcccCC--cCHHHHHHHHHHHhhcc---CCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT--IDENTFRKEAEALGKVK---HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~lV 911 (1133)
.|+..++||+|+||.||+|.+ .+++.||+|.+.... ...+.+.+|++++++++ |||++++++++... ...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEEEE
Confidence 477888999999999999976 468999999986432 23467889999999997 99999999998765 455899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.++++.. .+++.....++.|++.|++|||+.||+||||+|+||+++.++.++++|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 81 MEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999999998642 3789999999999999999999999999999999999999999999999998755332
Q ss_pred CCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||...........+ ..... +.+
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~----~~~~~-----~~~ 222 (277)
T cd06917 155 S---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI----PKSKP-----PRL 222 (277)
T ss_pred c---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----ccCCC-----CCC
Confidence 2 222334688899999998654 4689999999999999999999999654332211111 11111 111
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ... .. ....+++.+||+.||++||++.|++++
T Consensus 223 ~---~~~--~~--~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 E---DNG--YS--KLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred C---ccc--CC--HHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 000 00 112378899999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=302.12 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=194.0
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|+..+.||+|++|.||+|+.. +|+.||||++..... ..+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEee
Confidence 4788899999999999999775 689999999864332 235788999999999999999999998765 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+. ++|.+++.... ...+++..+..++.|++.|++|||+.+++||||+|+||+++.++.++++|||+++.....
T Consensus 80 ~~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~-- 153 (284)
T cd07860 80 FLH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 153 (284)
T ss_pred ccc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence 995 68988887543 234889999999999999999999999999999999999999999999999998644221
Q ss_pred CCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
........++..|+|||++.+.. ++.++|||||||++|||+||+.||...+..+....+.+..... .....+....
T Consensus 154 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 230 (284)
T cd07860 154 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP--DEVVWPGVTS 230 (284)
T ss_pred -ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC--ChhhhhhhhH
Confidence 11223335678999999886644 5889999999999999999999997655443332222221111 0000000000
Q ss_pred -------CCC-CChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 -------LDP-ESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 -------~~~-~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.. ....... + ....+++.+|++.||++||+++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0000000 0 112378999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=254.97 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=200.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|.-.++||+|.||+||+|+.+ +++.||+|+++-+..+ .....+|+-+++.++|+|||++++....+ ...-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-kkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-ceeEEeHH
Confidence 5677789999999999999765 5899999999754433 45788999999999999999999988765 34479999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|| ..+|..+.... +..++.+....++.|+++|+.++|++++.|||+||.|.+++.+|..|++|||+++...-
T Consensus 82 ~c-dqdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--- 153 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--- 153 (292)
T ss_pred Hh-hHHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC---
Confidence 99 45677766543 23488888899999999999999999999999999999999999999999999975422
Q ss_pred CCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhc------ccccc
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG------QISEL 1065 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~ 1065 (1133)
........+.|.+|++|+++.+.+ |+...|+||.|||+.|+.. |++-|.+.+.++....+-+..... .+...
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 112223456789999999998765 7889999999999999988 666666666555555544433221 11222
Q ss_pred ccCCcCCCCCCChhHHHHHHhH-----hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGV-----KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~-----~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.|-......+..-.|......+ ++..+.+.-+|..|.++++.+++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2222222233444555554433 67788888899999999988754
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=303.71 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=196.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.|+..+.||+|+||.||+|... ++..||+|++..... ....+.+|++++++++|||++++++++.... ..++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEEE
Confidence 4778889999999999999764 689999999864322 1246788999999999999999999998764 458999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++ |++.+.+.... ..+++..+..++.+++.|+.|||+.+|+||||+|+||+++.++.++++|||++.....
T Consensus 105 e~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 105 EYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred eCCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9996 57887776432 3388999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.....|+..|+|||++. ++.++.++|||||||++|||++|+.||...........+..... ....
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~~--- 245 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----PTLQ--- 245 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC----CCCC---
Confidence 22346888999999973 45688999999999999999999999976544333332222110 0000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
...+... ..+++.+|++.+|.+||++.+++++.......+..
T Consensus 246 -------~~~~~~~--l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 246 -------SNEWSDY--FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred -------CccccHH--HHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 0011111 23788999999999999999999987765554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=296.99 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=198.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+|++.+.||+|++|.||+|..+ +++.|++|++..... ..+.+.+|++++++++|||++++++++... ...++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEEe
Confidence 5888999999999999999876 489999999875543 356789999999999999999999999876 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
+++++|.+++... ..+++..+..++.|+++|++|+|+ .+++||||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999864 347899999999999999999999 9999999999999999999999999999865432211
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||.........+.+.... ....... +...
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~--- 227 (264)
T cd06623 156 ---QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSL-PAEE--- 227 (264)
T ss_pred ---cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCC-Cccc---
Confidence 1123457889999999988889999999999999999999999996553212222222211 1111111 1000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ....+++.+|+..+|++||++.|++++
T Consensus 228 ------~~--~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 ------FS--PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------CC--HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 112278889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=299.27 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=194.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
-|++.+.||+|+||.||+|... +++.||+|....... ..+.+.+|++++++++||||+++++++... ...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEe
Confidence 4778889999999999999764 689999998754332 235788999999999999999999999876 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++++|.+++.. ..+++..+..++.+++.|+.|||+.|++|+||||+||+++.++.++++|||++.......
T Consensus 84 ~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 84 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 999999999864 237899999999999999999999999999999999999999999999999986542211
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||.+.+..++.++||||+||++|+|++|..||...........+. ....+. ++...
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~-~~~~~---- 225 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP----KNNPPT-LEGNY---- 225 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh----cCCCCC-CCccc----
Confidence 11223467889999999988888999999999999999999999996544333222221 111110 11000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ....+++.+|++.+|.+||++.+++++
T Consensus 226 --~------~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 --S------KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --C------HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 112378889999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=300.67 Aligned_cols=246 Identities=19% Similarity=0.290 Sum_probs=194.6
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
+|++.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+. ...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-ENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-CeEEEEE
Confidence 4788999999999999999875 58999999986432 2346788999999999999999999988765 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++... ..+++.....++.|+++|+.|||+.+++|+||||+||++++++.++++|||.+.......
T Consensus 80 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 80 DLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred eCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999999764 237888999999999999999999999999999999999999999999999986542211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||....... ...+.+.... ......+..
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~~~~~~~~-- 225 (258)
T cd05578 155 ----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRAKQET--ADVLYPATW-- 225 (258)
T ss_pred ----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHHHhcc--ccccCcccC--
Confidence 2234568889999999988889999999999999999999999997655431 1222221111 000111110
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCH--HHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM--ADIV 1108 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~--~evl 1108 (1133)
. ....+++.+||+.||.+||++ +|++
T Consensus 226 --------~--~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 226 --------S--TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --------c--HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 122378899999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=296.77 Aligned_cols=241 Identities=20% Similarity=0.290 Sum_probs=188.2
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++.++. ..++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-YIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-ccEEEEecCCCCc
Confidence 699999999999875 489999999864332 2467889999999999999999999987664 4599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
|.+++.+.. .+++..+..++.||+.|++|+|+.+++|+||+|+||+++.++.++++|||.++...... ...
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~ 150 (262)
T cd05572 80 LWTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTW 150 (262)
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----ccc
Confidence 999997642 37888999999999999999999999999999999999999999999999986543221 223
Q ss_pred CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+. .....+........ ..+...
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~--------~~~~~~-- 219 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDILKGNGKL--------EFPNYI-- 219 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHhccCCCC--------CCCccc--
Confidence 3467889999999988889999999999999999999999997554211 11222211101000 000010
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCC-----HHHHHH
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPS-----MADIVF 1109 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1109 (1133)
.....+++.+||+.+|++||+ ++|+++
T Consensus 220 ---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 ---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011237889999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=273.36 Aligned_cols=247 Identities=21% Similarity=0.370 Sum_probs=185.2
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.+....||.|+.|+||+++++ .|..+|||.+...... .+++...++++.+- +.|.||+.+|||....+. ++.||.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV-~IcMel 172 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV-FICMEL 172 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH-HHHHHH
Confidence 445677999999999999887 4899999999764432 35666677776555 489999999999877565 799999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
| ......++++.. ..+++...-++...++.||.||.+ ++|+|||+||+|||+|+.|.+|+||||.+-+..+...
T Consensus 173 M-s~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 173 M-STCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred H-HHHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 8 445566666543 338888888899999999999974 5799999999999999999999999999866544322
Q ss_pred CCCCCCCCCCCCCccCccccCC---CCCCCCCchhHHHHHHHHHHhCCCCCccCC-hhhHHHHHHHHhhhccccccccCC
Q 001171 994 EASSSTTPIGSLGYVSPEAAST---GQPTKEADVYSFGIVLLEILTGRKPVMFTQ-DEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.+...|.+.|||||.+.- ..|+.++||||||++++|+.||+.||..-+ +-++...+.. . . .|.
T Consensus 248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~-e-----PP~ 314 (391)
T KOG0983|consen 248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---E-E-----PPL 314 (391)
T ss_pred ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---c-C-----CCC
Confidence 234568899999999854 468999999999999999999999997532 2233333322 1 1 112
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.....-..++. +++..|+.+|+.+||...+++++
T Consensus 315 L~~~~gFSp~F~------~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHMGFSPDFQ------SFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcccCcCHHHH------HHHHHHhhcCcccCcchHHHhcC
Confidence 211111223333 45556999999999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=293.14 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=199.1
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
+|+..+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|++++++++||+++++++++... ...++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence 4778899999999999999875 688999999976543 457889999999999999999999998876 4559999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... ..+++..+..++.+++.|++|||+.|++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 80 SGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999987642 3489999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......... ..........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~------ 221 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPE------ 221 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCccc------
Confidence 2345688899999999888899999999999999999999999976543332222211 1111111110
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+. ....+++.+|++.||++||++.|++++
T Consensus 222 ---~~~--~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 ---KWS--DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---ccC--HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001 112378899999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=302.50 Aligned_cols=248 Identities=20% Similarity=0.320 Sum_probs=195.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC-CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG-TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
++|.+.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++++++|||++++++++.... ..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-ELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-cEEEEEec
Confidence 57899999999999999999764 6788999998543 223467889999999999999999999987764 45999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++++|.+++.+. .+++..+..++.|++.|++|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred CCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 9999999998752 36788999999999999999999999999999999999999999999999876443221
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......|++.|+|||.+.+..++.++|||||||++|++++|+.||...........+.. .+ .+. . .
T Consensus 170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~---~~-~~~-----~---~ 236 (293)
T cd06647 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NG-TPE-----L---Q 236 (293)
T ss_pred -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---CC-CCC-----C---C
Confidence 122334688899999999888899999999999999999999999965443221111110 00 000 0 0
Q ss_pred CCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1075 PESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....+ ....+++.+||+.+|++||++.+++.+
T Consensus 237 ----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 ----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011 112278899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=303.08 Aligned_cols=269 Identities=19% Similarity=0.238 Sum_probs=196.8
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP----- 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 905 (1133)
..++|++.+.||+|+||.||+|..+ +++.||||++...... ...+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999775 5899999998643221 335678999999999999999999886532
Q ss_pred --CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccC
Q 001171 906 --DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 906 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
...++||||+. +++.+++.... ..+++..+..++.||+.|++|||++|++|+||||+||+++.++.+|++|||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 23489999995 58888876532 248899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC-CCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc
Q 001171 984 LDRLAIATPAE-ASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 984 ~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
++......... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||...........+.+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS-- 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC--
Confidence 98755332221 1122344678899999988654 3688999999999999999999999766554444433332211
Q ss_pred ccccccCCcC--------CCCCCCh-hH-------HHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 ISELLEPGLL--------ELDPESS-EW-------EEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 ~~~~~~~~~~--------~~~~~~~-~~-------~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
++....+... ....... .. .......+++.+|+..||++||+++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1100000000 0000000 00 001122379999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=299.70 Aligned_cols=267 Identities=21% Similarity=0.313 Sum_probs=191.5
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++.+|.+.+.||+|+||.||+|..+ +|..||+|++...... ...+.+|++++++++|+||+++++++... ...++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEEE
Confidence 3467999999999999999999764 6889999998643322 34678899999999999999999998865 456899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+. +++.+++.... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred Eeccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 99995 77877765432 23677888889999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChh-hHHHHHHHHhhhc---------
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQLQRG--------- 1060 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~--------- 1060 (1133)
. .......++..|+|||++.+. .++.++||||+||++|||++|+.||...... +....+.......
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 S---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred C---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 1 112234578899999998654 4788999999999999999999999754332 1111111111000
Q ss_pred cccccccCCcCCCCCCC-----hhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEPGLLELDPES-----SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+...........+.. .....-....+++.+|+..||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000 000001122378999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=283.25 Aligned_cols=267 Identities=21% Similarity=0.293 Sum_probs=215.9
Q ss_pred HHHHHHhcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEE
Q 001171 830 VETLEATRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYY 901 (1133)
Q Consensus 830 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~ 901 (1133)
.+......+++...++-+|.||.||+|.|++ .+.|-+|.+++.... ...+.+|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444556678889999999999999997753 355677777654433 45678899999999999999999999
Q ss_pred eCCCCcEEEEEeccCCCCHHHHHHhhcc---CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 902 AGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 902 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
.+.....++++.++.-|+|..++...+. ...+.++-.+...++.|++.|++|||++||||.||.++|.+||+..++|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 8877778999999999999999984432 1224566777888999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
++|=.++|...+.... .-.........||+||.+....|+.++|||||||++|||+| |+.||...++.++..+++++.
T Consensus 437 ltDsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred eccchhccccCccccc-ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 9999999877654322 22223345568999999999999999999999999999999 999999999999999888876
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
+-.+.-.-. + +- ..++.-||..+|++||+++|++..|.++
T Consensus 516 RlaQP~NCP-----------D--eL----f~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 516 RLAQPFNCP-----------D--EL----FTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred eecCCCCCc-----------H--HH----HHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 554322111 1 11 2456679999999999999999999765
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=295.91 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=195.1
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccC---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|+||.||+|..+ +|..||+|.+... ....+.+.+|++++++++|||++++++++... ...++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-GRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-CeEEEEEe
Confidence 4788999999999999999775 5888999998643 22356788999999999999999999988775 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc-eEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE-AHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~ 992 (1133)
|+++++|.+++..... ..+++..+..++.|+++|++|||+.+++|+||||+||++++++. ++++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999999976332 34789999999999999999999999999999999999998864 6999999886543211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||.......... +.. .......
T Consensus 157 ---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~-~~~~~~~------- 222 (257)
T cd08225 157 ---ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL---KIC-QGYFAPI------- 222 (257)
T ss_pred ---ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH---HHh-cccCCCC-------
Confidence 11223468889999999988889999999999999999999999996544333222 211 1111111
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+... ....+++.+|+..+|++||++.|++++
T Consensus 223 -~~~~~-----~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -SPNFS-----RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCC-----HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01000 112378889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=306.94 Aligned_cols=282 Identities=20% Similarity=0.282 Sum_probs=209.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC----CcEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DVRL 909 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~ 909 (1133)
+|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999875 48999999986532 23467889999999999999999999887653 3568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||++ ++|.+++.... .+++..+..++.+++.|++|||+.||+||||||+||+++.++.++++|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58888886532 48899999999999999999999999999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc---
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL--- 1065 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--- 1065 (1133)
.............++..|+|||++.+. .++.++|+||+|+++|+|++|+.||......+....+............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 332111123345678899999999877 7899999999999999999999999876665544444332211110000
Q ss_pred ccCCcCCC----CC-CChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCCCCCCCC
Q 001171 1066 LEPGLLEL----DP-ESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPDMPSSAD 1125 (1133)
Q Consensus 1066 ~~~~~~~~----~~-~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~~~~~~~ 1125 (1133)
........ .. ....+.. + ....+++.+||+.+|++||++.+++++ ++......+.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~ 306 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKP 306 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCC
Confidence 00000000 00 0000110 1 122379999999999999999999986 666666555444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=298.12 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=194.0
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.|...++||+|++|.||+|... +++.+++|++..... ..+.+.+|+.++++++|||++++++++...+ ..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-ELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-eEEEEEecc
Confidence 3455678999999999999764 688999998854332 2456889999999999999999999987754 459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.. ..+++..+..++.|++.|++|||++||+||||+|+||+++.++.++++|||.+...... .
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~---~ 169 (285)
T cd06648 99 EGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---V 169 (285)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC---C
Confidence 99999999876 22788899999999999999999999999999999999999999999999987643221 1
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
.......|+..|+|||+..+..++.++||||+||++|||++|+.||...+.......+... .. +.......
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~----~~-----~~~~~~~~ 240 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN----LP-----PKLKNLHK 240 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc----CC-----CCCccccc
Confidence 1223346889999999998888999999999999999999999999765443333322221 10 11110000
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ....+++.+||+.+|++||++.|++++
T Consensus 241 ~~------~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 241 VS------PRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CC------HHHHHHHHHHcccChhhCcCHHHHccC
Confidence 00 112378999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=307.33 Aligned_cols=277 Identities=20% Similarity=0.317 Sum_probs=202.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC----Cc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 907 (1133)
..+|.+.+.||+|+||+||+|... +++.||||++... ......+.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999764 6899999998642 223456778999999999999999999876432 23
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+. ++|.+++... ..+++..+..++.|++.|+.|||+++++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 589999995 7898888753 2388999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc---
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS--- 1063 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 1063 (1133)
..... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.......+........-.
T Consensus 158 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 43221 12234467889999998864 468899999999999999999999997654433333222221110000
Q ss_pred ccccCCcCC----C----CCC-ChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 001171 1064 ELLEPGLLE----L----DPE-SSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPDMP 1121 (1133)
Q Consensus 1064 ~~~~~~~~~----~----~~~-~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~~~ 1121 (1133)
...+....+ . ... ....... ....+++.+|++.||++||+++|++++ ++.+......+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~ 304 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP 304 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCc
Confidence 000000000 0 000 0000011 122389999999999999999999988 77665554443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=296.60 Aligned_cols=262 Identities=20% Similarity=0.235 Sum_probs=191.7
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCC-CCcEEEEEe
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVK-HRNLTVLRGYYAGP-PDVRLLVYD 913 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~-~~~~~lV~e 913 (1133)
|++.++||+|+||.||+|... +++.||+|++..... ......+|+.+++++. |||++++++++.+. .+..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999764 689999999875322 2234457899999985 99999999998765 145699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ |++.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-- 152 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-- 152 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--
Confidence 996 68888876532 34899999999999999999999999999999999999999 99999999998654221
Q ss_pred CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc--cccccCC-
Q 001171 994 EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI--SELLEPG- 1069 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~- 1069 (1133)
.......++..|+|||++.+ ..++.++||||+||++|||++|..||...+..+...+.........- .......
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 153 --PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 11223457889999997644 55788999999999999999999999776655554444332211100 0000000
Q ss_pred cC--CCCCCCh----h-HHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LL--ELDPESS----E-WEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~--~~~~~~~----~-~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ..+.... . .... ....+++.+|++++|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 0000000 0 0011 222389999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=295.47 Aligned_cols=241 Identities=19% Similarity=0.269 Sum_probs=180.3
Q ss_pred ccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhh---ccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGK---VKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~---l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
+||+|+||.||+|... +++.||+|.+...... ...+.+|..+++. .+||+++.+++++...+ ..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-KLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-eEEEEEecC
Confidence 4899999999999775 5899999988653321 2234455544443 47999999999887754 458999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++|+|.+++...+ .+++..+..++.|++.|++|||+.+|+||||||+||++++++.++++|||++......
T Consensus 80 ~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 80 NGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 9999999887543 3899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..+.+.... ....+.+..
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~--~~~~~~~~~---- 222 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT--VNVELPDSF---- 222 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhc--CCcCCcccc----
Confidence 1223468999999999864 5578999999999999999999999964332221 111111110 000010000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
. ....+++.+|+..||++|| +++|++++
T Consensus 223 ------~--~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 ------S--PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------C--HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0 1122788899999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=309.21 Aligned_cols=200 Identities=24% Similarity=0.383 Sum_probs=169.6
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccC--CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----CcEEE
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG--TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----DVRLL 910 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~~l 910 (1133)
|...+.||+|+||.||+|+++ .|+.||||.+... ....+..-+|++++++++|||||++++.=++.. ...++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 456688999999999999965 6999999999753 334678889999999999999999988755432 34489
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee--CCCCc--eEEeccCccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF--DADFE--AHLSEFGLDR 986 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll--~~~~~--~kl~Dfg~a~ 986 (1133)
|||||.+|||+..+++-... .-+++.+.+.+..+++.||.|||++||+||||||.||++ .++|. .|++|||.||
T Consensus 95 vmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999999864332 348999999999999999999999999999999999998 33343 5999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccC-CCCCCCCCchhHHHHHHHHHHhCCCCCccC
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAS-TGQPTKEADVYSFGIVLLEILTGRKPVMFT 1044 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~Pf~~~ 1044 (1133)
...+ .......+||..|.+||+.. .+.|+..+|.|||||++||..||..||...
T Consensus 173 el~d----~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELDD----NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCCC----CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 6633 33567789999999999998 488999999999999999999999999643
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=298.63 Aligned_cols=255 Identities=19% Similarity=0.312 Sum_probs=188.8
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|+..++||+|+||.||++.+. +++.||+|++..... ....+.+|+.++.++. ||||+++++++... ...+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-GDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-CcEEEEEe
Confidence 5667789999999999999775 589999999864332 3457889999999996 99999999988765 44589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|+. +++.++...........+++.....++.+++.|++|||+. +|+||||||+||+++.++.++++|||+++......
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 985 5665544322111224588999999999999999999974 99999999999999999999999999986543221
Q ss_pred CCCCCCCCCCCCCCccCccccCCC---CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTG---QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
......|+..|+|||++.+. .++.++||||+||++|||++|+.||.... .....+.+... ...+......
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~~ 235 (288)
T cd06616 163 ----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVK-GDPPILSNSE 235 (288)
T ss_pred ----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcC-CCCCcCCCcC
Confidence 12234578899999998766 68999999999999999999999996443 22222222111 1111110000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .... ....+++.+||+.||++||++.||+++
T Consensus 236 ~-------~~~~--~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 236 E-------REFS--PSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred C-------CccC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 112378999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=296.41 Aligned_cols=266 Identities=21% Similarity=0.321 Sum_probs=197.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+|++.+.||+|++|.||+|..+ +|+.||+|++..... ..+.+.+|++++++++|||++++++++...+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-KLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-cEEEEEec
Confidence 4788999999999999999875 589999999875432 2456778999999999999999999998764 45999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
++ ++|.+++..... ...+++..+..++.||+.|++|||+.|++||||||+||++++++.++++|||+++.....
T Consensus 80 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--- 153 (284)
T cd07836 80 MD-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--- 153 (284)
T ss_pred CC-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC---
Confidence 97 588888876432 234899999999999999999999999999999999999999999999999998644221
Q ss_pred CCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc---ccccc-CC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI---SELLE-PG 1069 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~ 1069 (1133)
........++..|+|||++.+. .++.++||||+||++|+|++|+.||...+..+....+........- ..... +.
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1112234578899999998654 4688999999999999999999999766655444433332111100 00000 00
Q ss_pred cC-CCCCCC-hhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LL-ELDPES-SEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~-~~~~~~-~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+. ..+... ..... . ....+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000000 00000 1 122388999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=292.13 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=198.5
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-CcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~~lV~ 912 (1133)
+|+..+.||+|++|.||+|..+ +++.|++|++.... ...+.+.+|++++++++|||++++++.+.... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 68999999986544 23567889999999999999999999987652 4558999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++.... .+++..+..++.++++|++|||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998643 48999999999999999999999999999999999999999999999999986553322
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.. .......++..|+|||...+..++.++||||+|+++|+|++|+.||...+.. ...+.+...........+
T Consensus 156 ~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~----- 227 (260)
T cd06606 156 TG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSGEPPEIPE----- 227 (260)
T ss_pred cc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccccCCCcCCCc-----
Confidence 11 1123456888999999998888999999999999999999999999755411 111111111011111000
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. . .....+++.+|++.||.+||++.|++++
T Consensus 228 ---~---~--~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 ---H---L--SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---c---c--CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0 0 1112378889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=295.24 Aligned_cols=265 Identities=21% Similarity=0.275 Sum_probs=197.4
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEEEEe
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLLVYD 913 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~lV~e 913 (1133)
|++.+.||+|+||.||+|... +|+.+|+|++.... .....+.+|++++++++|||++++++++... ....++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999876 48999999997542 2235688899999999999999999999765 356699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ ++|.+++.... ..+++..+..++.||++|++|||+.|++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 58888886532 3488999999999999999999999999999999999999999999999999875533221
Q ss_pred CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc---c--
Q 001171 994 EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL---E-- 1067 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 1067 (1133)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+........... +
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 --ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred --ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 12233456788999998754 457899999999999999999999997666554444443322211110000 0
Q ss_pred --CCcCCCCCCChhH----HH--HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 --PGLLELDPESSEW----EE--FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 --~~~~~~~~~~~~~----~~--~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
............. .. -...++++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000000 01 1223489999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=295.58 Aligned_cols=260 Identities=14% Similarity=0.219 Sum_probs=181.6
Q ss_pred hcCCCcccccccccceeEEEEEECC----ceEEEEEEcccCCcC---H---------HHHHHHHHHHhhccCCCeeeEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTID---E---------NTFRKEAEALGKVKHRNLTVLRG 899 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~---~---------~~~~~E~~~l~~l~hpniv~l~~ 899 (1133)
..+|.+.++||+|+||.||+|.+.+ +..+|+|........ + .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999998754 345566654322111 0 11123334556678999999998
Q ss_pred EEeCCC---CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc
Q 001171 900 YYAGPP---DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE 976 (1133)
Q Consensus 900 ~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 976 (1133)
++.... ...++++|++ ..++.+.+.... ..++..+..++.|++.|++|||+.+|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 765432 2346788877 346766665432 2467788899999999999999999999999999999999999
Q ss_pred eEEeccCcccccccCCCC----CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC-hhhHHH
Q 001171 977 AHLSEFGLDRLAIATPAE----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ-DEDIVK 1051 (1133)
Q Consensus 977 ~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-~~~~~~ 1051 (1133)
++|+|||+|+........ ........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ......
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999765332211 111223469999999999999999999999999999999999999997653 333222
Q ss_pred HHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
......... . ........... .. ..+++..|+..+|++||++.++++.++
T Consensus 245 ~~~~~~~~~----~-~~~~~~~~~~~----~~--~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKR----L-HEGKIKIKNAN----KF--IYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHH----h-hhhhhccCCCC----HH--HHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 222111000 0 00000111111 11 226788899999999999999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=295.43 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=193.5
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
|++.+.||+|++|.||+|.++ +|+.||+|++...... .+.+.+|++++++++|||++++++++... ...++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence 567889999999999999765 6899999998644322 35688899999999999999999998766 556999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+ +++|.+++..... ..+++..+..++.|+++||+|||+++++||||+|+||+++.++.++++|||.++......
T Consensus 80 ~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 80 L-DLDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred c-CcCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 9 4789999876432 348899999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc---------ccc
Q 001171 995 ASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---------ISE 1064 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~ 1064 (1133)
.......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...+.......+.+...... .++
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 112233567899999988654 468899999999999999999999976554333222222111000 000
Q ss_pred cccCCcCCCCCCC-hh-HHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 LLEPGLLELDPES-SE-WEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~-~~-~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ......... .. ...+ ....+++.+|++.||++||+++|++++
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKP-TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhh-hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000000000 00 0000 122379999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=299.56 Aligned_cols=200 Identities=21% Similarity=0.263 Sum_probs=160.7
Q ss_pred cccccc--cceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRG--RYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
..||+| +||+||+|.+. .|+.||+|.+...... .+.+.+|+.+++.++||||+++++++.... ..++||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-WLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-ceEEEEeccc
Confidence 456776 89999999874 6899999998654322 356788999999999999999999998764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC-
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA- 995 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 995 (1133)
++++.+++..... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999999987532 237888889999999999999999999999999999999999999999998653222111110
Q ss_pred ---CCCCCCCCCCCccCccccCCC--CCCCCCchhHHHHHHHHHHhCCCCCccCCh
Q 001171 996 ---SSSTTPIGSLGYVSPEAASTG--QPTKEADVYSFGIVLLEILTGRKPVMFTQD 1046 (1133)
Q Consensus 996 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~Pf~~~~~ 1046 (1133)
.......++..|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 011122356679999998763 478999999999999999999999975443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=302.47 Aligned_cols=270 Identities=23% Similarity=0.283 Sum_probs=195.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP------ 905 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 905 (1133)
.++|++.++||+|+||.||+|.++ +++.||+|++...... ...+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999875 5889999998643322 346788999999999999999998875432
Q ss_pred -CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 906 -DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 906 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
...++||||+. +++.+.+.... ..+++..+..++.|+++||+|||++||+||||||+||++++++.++++|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 23589999995 46777766432 3489999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC--------CCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHH
Q 001171 985 DRLAIATPAEA--------SSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055 (1133)
Q Consensus 985 a~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 1055 (1133)
++......... .......+++.|+|||++.+. .++.++||||+||++|||++|++||...........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 86543222111 111234578889999987654 578999999999999999999999976665544443333
Q ss_pred Hhhhccc---------cccccCC-cCCCCCCC-hhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1056 QLQRGQI---------SELLEPG-LLELDPES-SEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1056 ~~~~~~~---------~~~~~~~-~~~~~~~~-~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....... +...+.. ....+... ..+..+ ....+++.+|++.||++||++.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 2211100 0000000 00000000 000111 223489999999999999999999753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=294.84 Aligned_cols=243 Identities=21% Similarity=0.276 Sum_probs=186.9
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
||+|+||+||+|..+ +|+.||+|.+..... ....+.+|++++++++|||++++++++...+ ..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-DLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-eEEEEEecCCCCc
Confidence 699999999999764 689999999864321 2345678999999999999999999987764 4599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
|.+++..... ..+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.++++|||.+..... .....
T Consensus 80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 152 (277)
T cd05577 80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG----GKKIK 152 (277)
T ss_pred HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc----CCccc
Confidence 9999976542 3488999999999999999999999999999999999999999999999999865422 11223
Q ss_pred CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
...++..|+|||++.+..++.++||||+||++|+|++|+.||...........+.+...... . .....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~---~~~~~--- 220 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA------V---EYPDK--- 220 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc------c---cCCcc---
Confidence 34678899999999888899999999999999999999999965443222222222111100 0 00000
Q ss_pred HHHHHHhHhhhhccCCCCCCCCC-----CHHHHHH
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRP-----SMADIVF 1109 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1109 (1133)
+.. ...+++.+||+.||++|| ++.+++.
T Consensus 221 ~~~--~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSP--EAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCH--HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 001 112788999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=297.21 Aligned_cols=269 Identities=21% Similarity=0.301 Sum_probs=198.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPP----- 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 905 (1133)
..++|++.+.||+|+||.||+|.++ +|+.||+|++..... ....+.+|++++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4568999999999999999999875 588999999864322 2356788999999999999999999886543
Q ss_pred ----CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 906 ----DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 906 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
...++|+||+++ ++.+.+.... ..+++..+..++.||+.||+|||+.||+||||||+||++++++.+|++|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 356899999975 7777766431 3488999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|++||...+..+....+.+.....
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999875433221 11122346778999998864 346889999999999999999999997666555555544433221
Q ss_pred ccc---ccccCC-cCCCCC------C-ChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QIS---ELLEPG-LLELDP------E-SSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~---~~~~~~-~~~~~~------~-~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... +..... ...... . ...+..+ ....+++.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 000000 000000 0 0000001 122388999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=295.77 Aligned_cols=265 Identities=20% Similarity=0.293 Sum_probs=191.8
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.+.||+|++|.||+|..+ +|+.||+|++..... ..+.+.+|++++++++|||++++++++... ...++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEE
Confidence 46889999999999999999775 689999999864332 235688899999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~ 991 (1133)
||++ +++.+++..... ...++.....++.||+.||+|||+++|+||||||+||+++. ++.+|++|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred eccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9995 688888765322 23577788889999999999999999999999999999985 557899999998643221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc----
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL---- 1066 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 1066 (1133)
........+++.|+|||++.+. .++.++||||+||++|+|++|+.||......+....+....... ..+..
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (294)
T PLN00009 157 ---VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP-NEETWPGVT 232 (294)
T ss_pred ---ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-Chhhccccc
Confidence 1112234578899999988654 57899999999999999999999997655443333322211111 00000
Q ss_pred ---c--CCcCCCCCCChh--HHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 ---E--PGLLELDPESSE--WEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ---~--~~~~~~~~~~~~--~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+ ............ ...+ ....+++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000000000 0000 112378999999999999999999864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=290.04 Aligned_cols=246 Identities=21% Similarity=0.383 Sum_probs=196.1
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|++|.||+|... +++.|++|.+..... ..+.+.+|++++++++|||++++++++... ...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence 4788899999999999999765 578999999976543 346788999999999999999999998776 55699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++... ..+++..+..++.|++.|+.|||+.||+||||||+||+++.++.++++|||.+........
T Consensus 80 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 80 YAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred cCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999764 2388999999999999999999999999999999999999999999999999875533221
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
......++..|+|||...+..++.++||||+|+++|+|++|+.||............. . ..... +....
T Consensus 155 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~---~-~~~~~-~~~~~--- 223 (254)
T cd06627 155 ---DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---Q-DDHPP-LPEGI--- 223 (254)
T ss_pred ---cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---c-cCCCC-CCCCC---
Confidence 1233467889999999988788999999999999999999999997544322222111 1 11110 11000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
. ....+++.+|+..+|++||++.|++.
T Consensus 224 ---~------~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 ---S------PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---C------HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 11127888999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=321.72 Aligned_cols=255 Identities=24% Similarity=0.299 Sum_probs=198.8
Q ss_pred HHHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 832 TLEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 832 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
.....++|.+.++||+|+||.|..++++ ++++||+|++.+. ..+..-|..|-.+|.--+.+=||+++..|.+. .
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~-~ 148 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE-R 148 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc-c
Confidence 3345678999999999999999999886 5899999999752 22346788899999999999999998888775 5
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
+.|+|||||+||+|..++.+.. .+++..+..++..|+-||+-+|+.|+|||||||+|||+|..|++|++|||.+.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 6699999999999999998864 38899999999999999999999999999999999999999999999999886
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccC----C-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAS----T-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
..... ....+...+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||...+--+.+..+..-...-.
T Consensus 224 km~~d--G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 224 KMDAD--GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred hcCCC--CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 55332 223455678999999999984 3 5789999999999999999999999976554444433332211111
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCC---HHHHHHH
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPS---MADIVFM 1110 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs---~~evl~~ 1110 (1133)
+++..+ +...+ ++|.+.+ -+|+.|.. +.++..+
T Consensus 302 FP~~~~---------------VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 FPDETD---------------VSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CCcccc---------------cCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 221111 11111 4555544 36888877 8888765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-33 Score=280.29 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=189.8
Q ss_pred CcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 840 DEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
+-...||.|+||+|++..++ .|+..|||+++.... +++++..|.+...+- +.||||+++|.+...+. .|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-cWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-CWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-eeeeHHHH
Confidence 34567999999999999775 699999999975443 356788888875554 79999999998876644 49999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
..|++.+.+....-....+++...-.|....+.||+||-+ ..|+|||+||+|||+|..|.+|+||||.+-.....
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--- 221 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--- 221 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH---
Confidence 6788776655433333458888888888889999999975 57999999999999999999999999998654322
Q ss_pred CCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 995 ASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
...+.-.|...|||||.+.. ..|+.++||||+|+++||+.||..||..++. ..+++.+.+.. ..+.+..
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~g-dpp~l~~----- 292 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIG-DPPILLF----- 292 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcC-CCCeecC-----
Confidence 22334568899999999953 3489999999999999999999999975543 44554444332 2111111
Q ss_pred CCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1073 LDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1073 ~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
+.+ ..++. ...++|..|+.+|-..||.+.++.+
T Consensus 293 -~~~---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 -DKE---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -ccc---ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 11111 2237888899999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=292.90 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=195.2
Q ss_pred CCcccccccccceeEEEEEECC-ceEEEEEEcccCCcC---HHHHHHHHHHHhhc---cCCCeeeEEEEEeCCCC----c
Q 001171 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTID---ENTFRKEAEALGKV---KHRNLTVLRGYYAGPPD----V 907 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~----~ 907 (1133)
|++.++||+|+||.||+|.++. ++.||+|++...... ...+.+|+++++++ +|||++++++++...+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999998864 899999999643222 24566788887776 59999999999876543 2
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.+++|||+. ++|.+++..... ..+++..+..++.|+++||+|||+.+++|+||+|+||+++.++.++++|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 589999996 589988876432 2488999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc-
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL- 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~- 1066 (1133)
.... .......++..|+|||++.+..++.++|||||||++|||++|+.||......+....+.+...........
T Consensus 157 ~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFE----MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCC----cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 4221 11223357889999999998889999999999999999999999997666555444443322111000000
Q ss_pred -----cCCcCCCCCC--ChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 -----EPGLLELDPE--SSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 -----~~~~~~~~~~--~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.......... ....... ....+++.+||+.||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 0001111 122389999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=300.68 Aligned_cols=271 Identities=22% Similarity=0.332 Sum_probs=198.6
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..+++|++.++||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++|||++++++++.......+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46778999999999999999999765 78999999875422 224678889999999999999999999876556678
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+ +++|.++++. ..+++.....++.|+++|++|||+.+|+||||||+||+++.++.++++|||.+....
T Consensus 87 lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 999998 6789888764 236778888899999999999999999999999999999999999999999986431
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc---cccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---ISEL 1065 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~ 1065 (1133)
. ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||...........+.+...... ....
T Consensus 160 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 160 P------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1223457889999998765 5689999999999999999999999976554333322222111100 0000
Q ss_pred ccCC-------cCCCC--CCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCC
Q 001171 1066 LEPG-------LLELD--PESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVG 1117 (1133)
Q Consensus 1066 ~~~~-------~~~~~--~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~ 1117 (1133)
.+.. ..... +........ ....+++.+|++.+|++||++.|++.+ ++.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0000 00000 000000001 122378999999999999999999876 4443333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=299.12 Aligned_cols=265 Identities=17% Similarity=0.193 Sum_probs=187.2
Q ss_pred CcccccccccceeEEEEEECCceEEEEEEcccC---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 840 DEENVLSRGRYGLIFKASYQDGMVLSIRRLRDG---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
.+++.+|.|+++.||++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.... ..+++|||++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMA 82 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-eEEEEEeccC
Confidence 3445555565655555544 5899999998654 223467899999999999999999999987764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC--
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE-- 994 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 994 (1133)
+|+|.+++..... ..+++.....++.|+++||+|||+++|+||||||+||+++.++.++++|||.+.........
T Consensus 83 ~~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999999986432 23788889999999999999999999999999999999999999999999988644322111
Q ss_pred --CCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHH-HHHHHHhh----hcccccc
Q 001171 995 --ASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV-KWVKKQLQ----RGQISEL 1065 (1133)
Q Consensus 995 --~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~----~~~~~~~ 1065 (1133)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||......... +.+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 111233457778999999865 35789999999999999999999999754433221 11110000 0000000
Q ss_pred -----------ccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 -----------LEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 -----------~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.++... ..........+. ...+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNR-DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchh-hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000000011111 22379999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=294.73 Aligned_cols=247 Identities=23% Similarity=0.396 Sum_probs=193.0
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
||+|+||.||+|.+. +|+.|++|.+..... ..+.+.+|++++++++|||++++++.+... ...++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-KNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-cEEEEEEecCCCCc
Confidence 689999999999886 489999999865432 245788899999999999999999888765 45599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC-----
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE----- 994 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----- 994 (1133)
|.+++.+.+ .+++..+..++.||++||+|||+.+++||||+|+||++++++.++++|||++.........
T Consensus 80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999998643 3789999999999999999999999999999999999999999999999998654322110
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
........++..|+|||...+..++.++||||||+++|++++|+.||......+....+... ....+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~-------- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIEWPEDV-------- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcCCCccc--------
Confidence 11223446788999999998888999999999999999999999999766655444333221 00000000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
. . .....+++.+|++.+|++||++.++.+.|+.
T Consensus 225 ~----~--~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 225 E----V--SDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred c----C--CHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0 0 0112378899999999999999666665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=290.19 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=200.2
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.+.||+|+||.||++.+. +++.||+|++..... ..+.+.+|++++++++|||++++++.+... ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 5788899999999999999775 589999999865432 356788999999999999999999998776 55689999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++..... ....+++..+..++.+++.|++|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred ecCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999999987532 12458999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||...+.......... .......
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~------- 224 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK----GQYPPIP------- 224 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc----CCCCCCC-------
Confidence 122334688899999999888899999999999999999999999976554433332211 1111110
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .. ....+++.+||..+|++||++.|++++
T Consensus 225 -~~---~~--~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 -SQ---YS--SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CC---CC--HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00 112378889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=304.39 Aligned_cols=267 Identities=21% Similarity=0.317 Sum_probs=197.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCC---CCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGP---PDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~~ 908 (1133)
.++|++.++||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999765 58999999986532 2245677899999999999999999887532 2346
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 89999995 6888888643 23889999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCC-CCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc-----
Q 001171 989 IATPAE-ASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ----- 1061 (1133)
Q Consensus 989 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----- 1061 (1133)
...... ........|+..|+|||++.+ ..++.++||||+||++|||++|+.||...+.......+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 332221 111234578889999999865 4578999999999999999999999976544333322222211100
Q ss_pred ------ccccccCCcCCCCCCChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1062 ------ISELLEPGLLELDPESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1062 ------~~~~~~~~~~~~~~~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
+...... ... .....+.+ . ....+++.+|++.||++||++++++.+-
T Consensus 238 ~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 238 RIGSDRVRKYIQN-LPR--KQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhchhhHHHHHhh-ccc--CCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000000 000 00000111 1 1223799999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=296.35 Aligned_cols=245 Identities=20% Similarity=0.324 Sum_probs=192.6
Q ss_pred cccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCC
Q 001171 841 EENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNG 918 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~g 918 (1133)
...+||+|+||.||+|..+ +|+.||+|++..... ....+.+|+.++++++|||++++++++... +..++||||++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCC
Confidence 3467999999999999774 689999999854332 345688999999999999999999998876 4559999999999
Q ss_pred CHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCC
Q 001171 919 NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998 (1133)
Q Consensus 919 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 998 (1133)
+|.+++... .+++.....++.|++.|++|||+.|++||||||+||+++.++.++++|||++....... ...
T Consensus 103 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---~~~ 173 (292)
T cd06657 103 ALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRR 173 (292)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc---ccc
Confidence 999987542 37888999999999999999999999999999999999999999999999876442211 112
Q ss_pred CCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCCh
Q 001171 999 TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESS 1078 (1133)
Q Consensus 999 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1078 (1133)
....|+..|+|||++.+..++.++||||+||++|+|++|..||...........+..... +..........
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 244 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------PKLKNLHKVSP 244 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---------cccCCcccCCH
Confidence 334688899999999888889999999999999999999999976555444333322211 11111000111
Q ss_pred hHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1079 EWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1079 ~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+++.+|++.||.+||++.|++++
T Consensus 245 ------~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 ------SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ------HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 12367889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=290.11 Aligned_cols=246 Identities=20% Similarity=0.258 Sum_probs=185.5
Q ss_pred HHHHhcCCCccccc--ccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCc
Q 001171 832 TLEATRQFDEENVL--SRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 832 ~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 907 (1133)
.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +|||++++++++.... .
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~-~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLK-G 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCC-e
Confidence 34445677787777 99999999999764 67889999986433221 123332222 7999999999998764 5
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDR 986 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 986 (1133)
.++||||+++++|.+++.... .+++..+..++.||++|++|||+.|++||||||+||+++.++ .++++|||.++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 699999999999999997643 489999999999999999999999999999999999999988 99999999886
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHH-HHHHHHhhhcccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV-KWVKKQLQRGQISEL 1065 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~ 1065 (1133)
.... .....++..|+|||++.+..++.++||||+||++|||++|+.||.....+... ..+.... ... ...
T Consensus 159 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~ 229 (267)
T PHA03390 159 IIGT-------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK-LPF 229 (267)
T ss_pred ecCC-------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc-CCc
Confidence 4321 12345788999999999888999999999999999999999999754433321 1111111 100 000
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-HHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-MADIVF 1109 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~ 1109 (1133)
.. ... ....+++.+|++.+|.+||+ ++|+++
T Consensus 230 ~~-------~~~------~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 IK-------NVS------KNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cc-------ccC------HHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 000 11237888999999999996 688875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=298.69 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=191.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..|+..+.||+|+||.||+|+.. +++.||+|.+..... ....+.+|+++++.++|||++++++++... ...++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEE
Confidence 34777889999999999999875 578899999864211 134677899999999999999999998876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+. |++.+++.... ..+++..+..++.|++.|+.|||+.+++||||||+||+++.++.++++|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 99996 68888776432 2378889999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.....++..|+|||++. ...++.++|||||||++|+|++|+.||......+....+.+. ..+....
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~- 236 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQS- 236 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc----CCCCcCc-
Confidence 12345788999999974 356788999999999999999999998654433322222111 1111000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
..+.. ...+++.+||+.+|++||++.+++++-.-..
T Consensus 237 ---------~~~~~--~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 237 ---------GHWSE--YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---------ccccH--HHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00111 1237899999999999999999998755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=293.77 Aligned_cols=263 Identities=19% Similarity=0.273 Sum_probs=197.0
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
|++.+.||+|++|.||+|... +++.+++|++...... ...+.+|++++++++|||++++++++... ...++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence 567788999999999999775 6899999998654332 45788899999999999999999998776 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
++ +++.+++.... ..+++..+..++.|++.|++|||+.+|+|+||||+||+++.++.++++|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred cC-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 96 48888887642 348899999999999999999999999999999999999999999999999986553322
Q ss_pred CCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc---ccccc---
Q 001171 995 ASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI---SELLE--- 1067 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 1067 (1133)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+..+....+......... ....+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112234578899999998776 6899999999999999999999999766654444333332221100 00000
Q ss_pred CC---cCCCCC-C-ChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PG---LLELDP-E-SSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~---~~~~~~-~-~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ...... . ........ ...+++.+||++||.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 000000 0 00111112 22389999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.32 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=199.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|++.++||+|+||.||++... +++.+|+|++..... ....+.+|++++++++||||+++++++... ...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence 4788899999999999999664 688999999865332 245677899999999999999999988776 45699999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.+.... ...+++..++.++.|++.|++|||+.|++||||+|+||+++.++.++++|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999998764322 245889999999999999999999999999999999999999999999999998755332
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...+.......+. ........+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~------ 223 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ----RGKYPPIPP------ 223 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCCCCCch------
Confidence 2223457889999999998889999999999999999999999997665544333322 111111110
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .....+++.+|++.+|++||++.|++++
T Consensus 224 -----~~--~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 -----IY--SQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----hh--CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01 1112378999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=302.34 Aligned_cols=270 Identities=22% Similarity=0.305 Sum_probs=198.8
Q ss_pred cHHHHHHHhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeC
Q 001171 828 TYVETLEATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAG 903 (1133)
Q Consensus 828 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 903 (1133)
...+....+++|++.+.||+|+||.||+|.. .+|+.||+|++..... ..+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3445667889999999999999999999975 4689999999865322 23567789999999999999999998853
Q ss_pred CC-----CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 904 PP-----DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 904 ~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
.. ...+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+.||+||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEE
Confidence 21 2347888887 7899888764 2378999999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
++|||+++.... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...+.......+.+..
T Consensus 161 l~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred Eecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999864321 1233467889999999865 467889999999999999999999997655444333332221
Q ss_pred hhccccccc----cC-------CcCCCCCCC-hh-H-HHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1058 QRGQISELL----EP-------GLLELDPES-SE-W-EEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1058 ~~~~~~~~~----~~-------~~~~~~~~~-~~-~-~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
... ..+.. +. .....+... .. . ..-....+++.+|++.||.+||++.|++.+=
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 235 GTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCC-CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 110 00000 00 000000000 00 0 0011223899999999999999999999663
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=295.38 Aligned_cols=243 Identities=23% Similarity=0.385 Sum_probs=189.1
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
|...+.||+|+||.||+|... +|+.|++|++..... ..+.+.+|++++++++|||++++++++.+. ...++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEe
Confidence 666788999999999999764 689999999864322 124678899999999999999999999876 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+. |++.+++.... ..+++..+..++.||+.|++|||+.||+||||||+||+++.++.++++|||++...
T Consensus 102 ~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~----- 171 (313)
T cd06633 102 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS----- 171 (313)
T ss_pred cCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc-----
Confidence 995 67888776532 34789999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 994 EASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||...+.......+... ..+......
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~- 244 (313)
T cd06633 172 --SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLQSNE- 244 (313)
T ss_pred --CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCccc-
Confidence 1122346888999999984 456788999999999999999999999765543333322211 111111100
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.. ...+++.+|++.+|.+||++.+++.+
T Consensus 245 ---------~~~--~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 245 ---------WTD--SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---------cCH--HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 12378889999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=302.62 Aligned_cols=268 Identities=18% Similarity=0.285 Sum_probs=191.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC--------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPP-------- 905 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------- 905 (1133)
..+|.+.+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999764 589999999864332 3467889999999999999999998765432
Q ss_pred -----CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEE
Q 001171 906 -----DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHL 979 (1133)
Q Consensus 906 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl 979 (1133)
...++||||++ ++|.+++.. ..+++.....++.||+.|++|||+.||+||||||+||+++. ++.+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 23589999996 688888754 23788999999999999999999999999999999999975 557899
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
+|||.++................++..|+|||++.+ ..++.++||||+||++|||++|+.||......+......+...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998654322111111223457889999998754 4578899999999999999999999975554333322222110
Q ss_pred hcc------ccccccCCcC-CCCCCChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1059 RGQ------ISELLEPGLL-ELDPESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1059 ~~~------~~~~~~~~~~-~~~~~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .......... ........... . ....+++.+|++.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 0000000000 00000000000 1 122378999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=319.59 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=205.0
Q ss_pred hcCCCcccccccccceeEEEEEEC----C----ceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ----D----GMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
.++..+.+.+|+|.||.|++|... . ...||||.++....+ .+.+..|+++|+.+ +||||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344566779999999999999643 1 467999999765443 57899999999999 699999999999884
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhc---------cCCCC--CCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEAS---------HQDGH--VLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
...++|+||+..|+|.++++..+ ..... .++......++.|||.|++||++.++|||||.++|||+.+
T Consensus 375 -~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 375 -GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred -CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 55599999999999999999877 22222 3888999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCC-hhhHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQ-DEDIVK 1051 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~-~~~~~~ 1051 (1133)
+..+||+|||+|+................-...|||||.+....|+.++|||||||++||+++ |..||.... ..++.+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 999999999999854333222111111113446999999999999999999999999999999 999997644 555555
Q ss_pred HHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
+++++.+.. .++.+.+.+ .+++..||+.+|++||++.|+++.++..
T Consensus 534 ~l~~G~r~~-~P~~c~~ei----------------Y~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 FLKEGNRME-QPEHCSDEI----------------YDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHhcCCCCC-CCCCCCHHH----------------HHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 554433221 111111111 1678899999999999999999999884
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=300.63 Aligned_cols=266 Identities=21% Similarity=0.275 Sum_probs=195.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----C
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----D 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 906 (1133)
..+|.+.+.||+|+||.||+|... +|+.||+|++..... ....+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999764 689999999864322 2356788999999999999999999886432 2
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++|+||+. .++.++.. ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++++|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 3489999995 46766542 237889999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc--cc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ--IS 1063 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~ 1063 (1133)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+........ +.
T Consensus 166 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 4321 1223467889999999866 4588999999999999999999999976554433333322111000 00
Q ss_pred ccccC--------CcCCCCCCChhHH----HH-HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCC
Q 001171 1064 ELLEP--------GLLELDPESSEWE----EF-LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVG 1117 (1133)
Q Consensus 1064 ~~~~~--------~~~~~~~~~~~~~----~~-~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~ 1117 (1133)
+.... ...... ..... .. ....+++.+|++.||++||+++|++++ ++.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYP--RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcc--cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000 000000 00000 00 122388999999999999999999966 7776653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=295.26 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=193.1
Q ss_pred CCCcccccccccceeEEEEEEC----CceEEEEEEcccCCc-----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTI-----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 907 (1133)
+|++.+.||+|+||.||+|... +++.||||.++.... ..+.+.+|+++++++ +||+++++++.+... ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD-TK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-CE
Confidence 4778899999999999999653 478899999864321 235678899999999 599999999888765 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++|+|.+++... ..+++..+..++.|+++||+|||+.+++||||||+||+++.++.++++|||+++.
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 58999999999999998753 2378888899999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCC--CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQ--PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
...... .......|+..|+|||...+.. .+.++||||+|+++|||++|..||...........+.+......
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 228 (288)
T cd05583 155 FLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK---- 228 (288)
T ss_pred cccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC----
Confidence 432211 1122345888999999987655 68899999999999999999999964332222222222211110
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
+.. ... .. ....+++.+||+.||++||++.++.+.|+.
T Consensus 229 --~~~---~~~---~~--~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 --PPF---PKT---MS--AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --CCC---Ccc---cC--HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 000 00 112378889999999999998888777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=296.10 Aligned_cols=250 Identities=20% Similarity=0.339 Sum_probs=197.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~l 910 (1133)
++|.+.+.||+|+||.||+|..+ +|+.||+|++.... ...+.+.+|++++++++ ||||+++++++... ...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-ENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-ceEEE
Confidence 36889999999999999999775 68999999986522 22456888999999998 99999999988765 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.+.+ .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++++|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999998643 489999999999999999999999999999999999999999999999999865433
Q ss_pred CCCC-----------------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHH
Q 001171 991 TPAE-----------------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053 (1133)
Q Consensus 991 ~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 1053 (1133)
.... ........++..|+|||+..+..++.++||||+|+++|++++|+.||...........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 2211 01223346788999999998888999999999999999999999999765533332222
Q ss_pred HHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH----HHHHHH
Q 001171 1054 KKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM----ADIVFM 1110 (1133)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~----~evl~~ 1110 (1133)
... ...++. .+ . ....+++.+|++.+|.+||++ .|++++
T Consensus 235 ~~~--~~~~~~----~~----------~--~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 LKL--EYSFPP----NF----------P--PDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred Hhc--CCCCCC----cc----------C--HHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 210 000110 00 0 112378899999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=288.57 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=183.6
Q ss_pred cccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHH-hhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEAL-GKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
+.||+|+||.||+|... +|+.||+|.+...... ...+..|..++ ...+|||++++++++... +..++||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-DYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-CeEEEEEeccC
Confidence 56999999999999774 5899999998653321 22344555544 445899999999999875 45599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+++|.++++... .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.++++|||+++....
T Consensus 81 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 81 GGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999997643 378889999999999999999999999999999999999999999999998864321
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
.....++..|+|||.+.+..++.++||||+|+++|||++|..||...........+.... .......... .
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~------~ 220 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR--INWPEEVKEF------C 220 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc--cCCCCccccc------C
Confidence 223457889999999988888999999999999999999999997655544433322110 0000000000 0
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
. ....+++.+||+.+|++||++.++.+.|
T Consensus 221 ----~--~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 221 ----S--PEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ----C--HHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0 1123789999999999999775554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=299.26 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=195.0
Q ss_pred cCCC-cccccccccceeEEEEEEC-CceEEEEEEcccCCcCH---------------HHHHHHHHHHhhccCCCeeeEEE
Q 001171 837 RQFD-EENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDE---------------NTFRKEAEALGKVKHRNLTVLRG 899 (1133)
Q Consensus 837 ~~~~-~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~hpniv~l~~ 899 (1133)
++|. +.+.||+|+||+||+|..+ .++.||+|++....... ..+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4577999999999999765 68999999986432221 24778999999999999999999
Q ss_pred EEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEE
Q 001171 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 900 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 979 (1133)
++... +..++||||+. |+|.+++... ..+++.....++.|++.|++|||+.||+||||||+||+++.++.+++
T Consensus 88 ~~~~~-~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEG-DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecC-CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 98766 45699999996 6899988653 23788999999999999999999999999999999999999999999
Q ss_pred eccCcccccccCCC-----------CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChh
Q 001171 980 SEFGLDRLAIATPA-----------EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDE 1047 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~ 1047 (1133)
+|||.++....... .........++..|+|||++.+. .++.++||||+||++|||++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999865431110 01111223467889999998764 4689999999999999999999999876665
Q ss_pred hHHHHHHHHhhhcccccccc----CCcCCCCC-CChhHHH-----HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1048 DIVKWVKKQLQRGQISELLE----PGLLELDP-ESSEWEE-----FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+....+.............. +....... ....... -....+++.+|++.+|++||+++|++.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 55544444322211100000 00000000 0000000 0122388999999999999999999974
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=293.71 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=190.3
Q ss_pred CCCcccccccccceeEEEEEE----CCceEEEEEEcccCCc-----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCc
Q 001171 838 QFDEENVLSRGRYGLIFKASY----QDGMVLSIRRLRDGTI-----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 907 (1133)
.|++.+.||+|+||.||+|.. .+|..||+|++..... ..+.+.+|+++++++ +|++|+.+++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-TK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-Ce
Confidence 478889999999999999976 3688999999864321 235678899999999 599999999888765 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++++|.+++.... .+++.....++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 589999999999999997632 377888888999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCC--CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTG--QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
..... ........|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||...........+.+......
T Consensus 155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDE--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---- 228 (290)
T ss_pred ccccc--ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC----
Confidence 42211 1122235688899999998653 467899999999999999999999964333222222222211110
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
+.. +.. .. ....+++.+|++.||++|| ++.+++++
T Consensus 229 --~~~---~~~---~~--~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --PPY---PQE---MS--ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --CCC---Ccc---CC--HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 000 000 00 1122788899999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=291.20 Aligned_cols=241 Identities=21% Similarity=0.369 Sum_probs=192.1
Q ss_pred ccccccccceeEEEEEEC-CceEEEEEEcccC---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 842 ENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
.++||+|.||+||-|+++ +|+.||||++.+- ...+..+++|++|++.+.||.||.+...|+.++. .++|||-+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er-vFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER-VFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-EEEEehhh-c
Confidence 589999999999999775 6999999998543 3345789999999999999999999988887754 49999999 5
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCcccccccCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
|+..+.+-... ...+++.....+..||+.||.|||-++|+|+||||+|||+.. -.++|+||||+||....
T Consensus 647 GDMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---- 719 (888)
T KOG4236|consen 647 GDMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---- 719 (888)
T ss_pred chHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch----
Confidence 56655554322 234888888889999999999999999999999999999954 35789999999987633
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......+||+.|.|||++..+.|.+.-|+||+|||+|--++|..||.. ++++-+++ +... +.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQI----QNAa-----------FM 782 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQI----QNAA-----------FM 782 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHh----hccc-----------cc
Confidence 3344567899999999999999999999999999999999999999953 33433333 2221 11
Q ss_pred CCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHH
Q 001171 1075 PESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl 1108 (1133)
.....|.++...+ ++|...++..-++|-+.+.-+
T Consensus 783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 2233466665544 899999999999998887665
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=288.49 Aligned_cols=241 Identities=19% Similarity=0.264 Sum_probs=180.8
Q ss_pred ccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHH---HhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 844 VLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEA---LGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~---l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
+||+|+||.||+|... +++.||+|.+...... ...+..|..+ ++...||+|+.+++++...+ ..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-EEEEEEecC
Confidence 4899999999999764 5889999998653322 1223444443 44457999999999888764 458999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++|+|.+++... ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++.++++|||+++.....
T Consensus 80 ~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 80 NGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 999999988653 24899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
......|+..|+|||++.++ .++.++||||+||++|||++|+.||........... .+..... ...+.
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~------~~~~~--- 219 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTM------AVELP--- 219 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHhhcc------CCCCC---
Confidence 12234689999999998754 588999999999999999999999975432221111 1111100 11110
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.. .. ....+++.+|+..+|.+|| ++.|++++
T Consensus 220 ~~---~s--~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DS---FS--PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred Cc---CC--HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00 00 1123788899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=284.61 Aligned_cols=264 Identities=17% Similarity=0.235 Sum_probs=201.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccC--CC----eeeEEEEEeCCCCc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKH--RN----LTVLRGYYAGPPDV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--pn----iv~l~~~~~~~~~~ 907 (1133)
.+.+|.+...+|+|.||.|.++.++ .+..||+|+++.-..-.++..-|+++++++.+ |+ +|++.+||+..+.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh- 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH- 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc-
Confidence 3779999999999999999999654 47999999997655455677889999999942 32 6788888877644
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC---------------
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD--------------- 972 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~--------------- 972 (1133)
.++|+|.+ |-|+++++..... ..++...++.|++|++++++|||+.+++|.||||+||++.
T Consensus 166 iCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 48999998 6799999988655 3489999999999999999999999999999999999982
Q ss_pred -----CCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh
Q 001171 973 -----ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE 1047 (1133)
Q Consensus 973 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~ 1047 (1133)
....++|+|||.|++.... ....+.|..|+|||++.+-.++.++||||+|||++|+++|..-|...++.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 1345899999998754222 24557888999999999999999999999999999999999999876655
Q ss_pred hHHHHHHHHhhhccccccccCC-----------------------------cCCCCCCChhHHHHHHhHhhhhccCCCCC
Q 001171 1048 DIVKWVKKQLQRGQISELLEPG-----------------------------LLELDPESSEWEEFLLGVKVGLLCTAPDP 1098 (1133)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~li~~Cl~~dP 1098 (1133)
+....+.+.++ +....++... ............+....++++.+|+..||
T Consensus 316 EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 EHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 54433333222 1111111111 00000112233444455699999999999
Q ss_pred CCCCCHHHHHHH
Q 001171 1099 LDRPSMADIVFM 1110 (1133)
Q Consensus 1099 ~~RPs~~evl~~ 1110 (1133)
.+|+|+.|++.+
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999854
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.77 Aligned_cols=263 Identities=20% Similarity=0.326 Sum_probs=194.8
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEec
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
|++.+.||+|+||.||+|... +++.|++|++..... +.....+|++.+++++ |||++++++++... ...++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-DELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-CcEEEEEec
Confidence 667889999999999999875 478999999865433 2334567999999999 99999999998775 556999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+ +|+|.+++.... ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--- 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--- 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---
Confidence 9 889999887643 234899999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCccCccccC-CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc---------cc
Q 001171 995 ASSSTTPIGSLGYVSPEAAS-TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI---------SE 1064 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~ 1064 (1133)
.......++..|+|||++. ...++.++|+||||+++|||++|+.||......+....+........- ..
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 153 -PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred -CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1123346788999999874 445789999999999999999999999765544443333222111100 00
Q ss_pred cccCCcCCCCCC-ChhH--HHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 LLEPGLLELDPE-SSEW--EEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~~~~~~-~~~~--~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+......... .... .......+++.+||+.||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 0000 001223489999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=294.24 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=188.6
Q ss_pred hcCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCc--CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTI--DENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.+.||+|+||.||+|.++. ++.||||.+..... ....+.+|++++.+.. ||||+++++++.... ..++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-DVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-eEEEE
Confidence 4578899999999999999998864 89999999975432 2345667787777764 999999999998764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|||++ +++.+++.... ..+++..+..++.||+.|++|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 93 ~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99984 57777776532 248899999999999999999997 5999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCC----CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQ----PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.. ......++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .+...+..... .....
T Consensus 168 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~~ 240 (296)
T cd06618 168 SK----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEE-PPSLP 240 (296)
T ss_pred CC----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCC-CCCCC
Confidence 11 122335778999999987554 788999999999999999999999643221 11122211111 00000
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
. . .... ....+++.+||+.||.+||++.+++++-
T Consensus 241 ~--------~-~~~~--~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 241 P--------N-EGFS--PDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C--------C-CCCC--HHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 0 0000 1123788999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=271.55 Aligned_cols=270 Identities=19% Similarity=0.244 Sum_probs=202.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC-------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP------- 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 904 (1133)
...|+...+||+|.||.||+|+.+ +|+.||+|++..+... .....+|+++++.++|+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345677789999999999999775 4778899887543221 34567899999999999999998877532
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
....|+||++|+. +|..++.... ..++..++.+++.++..||.|+|+..|+|||+||.|+||+.++.+|++|||+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 2346899999964 7887776532 3478889999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 985 DRLAIAT-PAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 985 a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
++.+... .......+.++.|.+|++||.+.+ +.|+++.|||+.|||+.||+||.+-+.+.........+...... +
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs--~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS--I 248 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc--C
Confidence 9755433 333444567888999999999876 46899999999999999999999888776666555555443221 1
Q ss_pred cccccCCcCCCC-------------------CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1063 SELLEPGLLELD-------------------PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1063 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
.....|++..++ .....+.....+++++.+++..||.+|+++++++.+--
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 111222211110 00111111123458999999999999999999987653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.63 Aligned_cols=211 Identities=24% Similarity=0.415 Sum_probs=177.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
..+|.+..+||+|+||.|..|..+ +.+.+|||+++++.. +.+--..|-+++.-- +-|.+++++.+|..- +..|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-DRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-DRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-hhee
Confidence 347899999999999999999665 468899999976543 122234466666655 578889998888765 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+.||+|--++++.+. +.+..+..+|..||-||-+||++||+.||||.+|||+|.+|++||+|||+++.-.
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999999998765 6677888999999999999999999999999999999999999999999987432
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHH
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 1055 (1133)
.......+.+||+.|+|||++.-..|+..+|.||+||++|||+.|++||++++.+++.+.+.+
T Consensus 502 ---~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 502 ---FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred ---cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 223345678999999999999999999999999999999999999999999988887777655
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=296.13 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=193.6
Q ss_pred HHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC--
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD-- 906 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-- 906 (1133)
....++|++.+.||+|+||.||+|... +|+.||||++...... .+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999754 6899999998543222 3467889999999999999999998865432
Q ss_pred ---cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccC
Q 001171 907 ---VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 907 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
..++||||+ +++|.+++.. ..+++..+..++.||++|++|||+.||+||||||+||+++.++.++++|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999999 7799888764 237899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc-
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ- 1061 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~- 1061 (1133)
+++.... ......+++.|+|||++.+ ..++.++|+||+||++|++++|+.||...........+.+......
T Consensus 164 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDS------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccc------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9864321 1223457889999999865 4578999999999999999999999976544333222221110000
Q ss_pred -ccccccC----Cc-CCCC-CCChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1062 -ISELLEP----GL-LELD-PESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1062 -~~~~~~~----~~-~~~~-~~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
+.+.+.. .. .... ........ . ....+++.+|++.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00 0000 00000000 0 11338899999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=293.76 Aligned_cols=276 Identities=23% Similarity=0.287 Sum_probs=196.6
Q ss_pred CCCcccccccccceeEEEEEEC-C--ceEEEEEEcccCCc---CHHHHHHHHHHHhhc-cCCCeeeEEEEEeC---CCCc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-D--GMVLSIRRLRDGTI---DENTFRKEAEALGKV-KHRNLTVLRGYYAG---PPDV 907 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~~~~ 907 (1133)
+|++.+.||+|+||.||+|+.. . +..||+|++..... ..+.+.+|+++++++ +||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999775 3 78899999864321 245678899999999 59999999987532 2244
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++++||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 578899985 6899888643 3488999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCC-CCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc---
Q 001171 988 AIATPAE-ASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI--- 1062 (1133)
Q Consensus 988 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--- 1062 (1133)
....... ........|+..|+|||++.+ ..++.++||||+||++|+|++|++||...+.......+.........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4322211 112234578999999998765 46789999999999999999999999765544443333332211000
Q ss_pred cccccCC-------cCCCCCCChhHHH-----HHHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 001171 1063 SELLEPG-------LLELDPESSEWEE-----FLLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPDMP 1121 (1133)
Q Consensus 1063 ~~~~~~~-------~~~~~~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~~~ 1121 (1133)
.....+. ..... ...+.. -....+++.+|++.||++||++.|++++ +..+......+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~ 305 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIP--KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEP 305 (332)
T ss_pred HhhhhhhHHHHHHhccccC--CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccc
Confidence 0000000 00000 000000 0122378999999999999999999843 44444433444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=298.22 Aligned_cols=241 Identities=20% Similarity=0.259 Sum_probs=193.1
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++.|.+...+|.|+|+.|-++.+ .+++..+||++.+.. ....+|+.++... +|||++++.+.+.+..+. |+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~-~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI-YLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCcee-eeee
Confidence 467888888999999999988865 468899999997652 3455678776666 799999999999887554 9999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee-CCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF-DADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|.+.++-+.+.+...+. ....+..|+.+|+.|+.|||++||||||+||+|||+ +..++++++|||.++...+.
T Consensus 396 e~l~g~ell~ri~~~~~------~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE------FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcch------hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988877765432 225677799999999999999999999999999999 68999999999999765332
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+ ..+...++.+.+.+.
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s~~------ 534 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFSEC------ 534 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccccc------
Confidence 33446678999999999999999999999999999999999999766555 223333333333211
Q ss_pred CCCCCChhHHHHHHh-HhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLG-VKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~-~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
+... .+++.+|++.||.+||++.++..+=
T Consensus 535 -----------vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 535 -----------VSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred -----------cCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 1112 2899999999999999999998653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=301.37 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=209.8
Q ss_pred HHHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeC----CC
Q 001171 832 TLEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAG----PP 905 (1133)
Q Consensus 832 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~ 905 (1133)
....++.|++.++||.|.+|.||+++.+ +|+.+|+|++.......++++.|.+|++.. .|||++.++|+|.. .+
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3345678999999999999999999764 688899999876666678899999999988 69999999999853 34
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
+..|+|||||.+||.-|+++... +..+.|..+..|++.++.|+.|||...++|||||-.|||++.++.+|++|||.+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 56799999999999999998765 466999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCC-----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
..... ......+.+||+.|||||++.. ..|+.++|+||+|++..||..|.+|+....+...... .
T Consensus 171 aQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---I---- 240 (953)
T KOG0587|consen 171 AQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---I---- 240 (953)
T ss_pred eeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---C----
Confidence 65432 2334566789999999999853 3478899999999999999999999976544322111 1
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+..++....++.+...+ ++|..|+..|-++||++.+++++
T Consensus 241 ---------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 ---------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112233344455555555 88999999999999999998753
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=287.11 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=188.5
Q ss_pred CCCcccccccccceeEEEEEECC-ceEEEEEEccc---C---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRD---G---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~---~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
+|.+.++||+|+||.||++.+.. +..+++|.++. . ......+.+|++++++++|||++++++++.+.. ..++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence 58889999999999999997753 34444444432 1 112345778999999999999999999887664 4589
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++...... ...+++..+..++.|++.|++|||+.|++|+||||+||+++. +.++++|||.++....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999999998764322 345899999999999999999999999999999999999975 5699999999865432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.. .......|+..|+|||...+..++.++|+||+|+++|+|++|+.||........... .. ....+.. +
T Consensus 158 ~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---~~-~~~~~~~-~--- 226 (260)
T cd08222 158 SC---DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR---IV-EGPTPSL-P--- 226 (260)
T ss_pred Cc---ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HH-cCCCCCC-c---
Confidence 21 122234578899999999888889999999999999999999999964433222221 11 1111110 0
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ....+++.+|+..+|++||++.|++++
T Consensus 227 -------~~~~--~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 -------ETYS--RQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------chhc--HHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0011 122378999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=286.80 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=196.7
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
|+..+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++|||++++++++... ...++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence 566788999999999999776 48999999987542 2245678899999999999999999998876 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
++ ++|.+++.... ..+++..+..++.+++.|++|||+.||+||||+|+||+++.++.++|+|||.++.......
T Consensus 80 ~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 80 CD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred cC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 97 68999998643 2388999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc------cc--
Q 001171 995 ASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS------EL-- 1065 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~------~~-- 1065 (1133)
......++..|+|||.+.+. .++.++||||+||++||+++|+.||......+....+.+......-. ..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 22233456789999998766 78999999999999999999999997665544444433322111000 00
Q ss_pred ccCCcCCCCCCC--hhHHH-HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELDPES--SEWEE-FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~--~~~~~-~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.......... ..... .....+++.+|+..||++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 011111100000 00001 1123489999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=283.28 Aligned_cols=235 Identities=25% Similarity=0.391 Sum_probs=187.8
Q ss_pred cccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 845 LSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
||+|+||.||++..+ +++.||+|.+..... ..+.+..|++++++++|||++++++.+... ...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-EKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-CeeEEEEecCCCCc
Confidence 699999999999775 589999999865433 245788999999999999999999988765 45599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 999 (1133)
|.+++.... .+++.....++.|+++|+.|+|+.+++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 151 (250)
T cd05123 80 LFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTN 151 (250)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---Cccc
Confidence 999998643 37899999999999999999999999999999999999999999999999986543221 1233
Q ss_pred CCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1000 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
...++..|+|||...+...+.++|+||||+++|++++|+.||...+.......+.+ ....++... .
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~----------~-- 217 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFL----------S-- 217 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCC----------C--
Confidence 45678899999999888889999999999999999999999976554443333322 011111111 0
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCCHHH
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs~~e 1106 (1133)
....+++.+||..||++||++++
T Consensus 218 ----~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 ----PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ----HHHHHHHHHHhcCCHhhCCCccc
Confidence 11237888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=317.46 Aligned_cols=145 Identities=21% Similarity=0.374 Sum_probs=127.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|.+.++||+|+||.||+|.+. .++.||||++...... ...+.+|+++++.++||||+++++++... ...++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-NNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-CEEEE
Confidence 357899999999999999999876 6899999998653321 35688899999999999999999888765 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
||||+++++|.+++...+ .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999997643 37888899999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=298.20 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=195.2
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPD---- 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 906 (1133)
..++|++.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|++++++++|||++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4668999999999999999999875 578999999864321 23567789999999999999999987754432
Q ss_pred -cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 907 -VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 907 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
..++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+.||+||||||+||+++.++.++++|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 368999999 6799998874 23889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...........+....... ...
T Consensus 166 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~-~~~ 238 (343)
T cd07851 166 RHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP-DEE 238 (343)
T ss_pred cccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-CHH
Confidence 644221 233467889999999855 367899999999999999999999997655544443333321110 000
Q ss_pred cccCCcC---------CCC-CCChhHHH-----HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 LLEPGLL---------ELD-PESSEWEE-----FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~---------~~~-~~~~~~~~-----~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .+. ... .....+.. -....+++.+|++.||++||++.|++++
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQ-KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHh-hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 000 000 00000111 1123389999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=285.08 Aligned_cols=250 Identities=16% Similarity=0.247 Sum_probs=210.4
Q ss_pred hcCCCcccccccccceeEEEEEECCce-EEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGM-VLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
..+++....||-|+||.|-.+...... .+|+|.+++.. ..++.+..|-.+|...+.|.||+++.-|.+. .+.|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-KYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-hhhhh
Confidence 345667778999999999999776433 48888886532 2345677899999999999999999988876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
.||-|-||.+...++..+. ++......++..+++|++|||++|||.|||||+|.++|.+|-+|+.|||+|+...
T Consensus 498 LmEaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~- 571 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG- 571 (732)
T ss_pred hHHhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc-
Confidence 9999999999999987654 6777788899999999999999999999999999999999999999999998763
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
...+..+++||+.|.|||++..+..+.++|.||+|+.+||+++|.+||...++...+..+.+++....++..+...
T Consensus 572 ---~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~- 647 (732)
T KOG0614|consen 572 ---SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKT- 647 (732)
T ss_pred ---cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchh-
Confidence 3345667899999999999999999999999999999999999999999999999999998887766554333321
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFML 1111 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~L 1111 (1133)
+.+++.+.+..+|.+|.. +.||-++-
T Consensus 648 ---------------a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 648 ---------------ATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred ---------------HHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 237888888999999974 77887764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=250.41 Aligned_cols=262 Identities=18% Similarity=0.315 Sum_probs=196.9
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCC-CcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGPP-DVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~~~lV 911 (1133)
..++|++.+++|+|.++.||.|.. .+.+.++||.++. ...+.+.+|+.|++.+. ||||+.+++...++. ....+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 456899999999999999999964 5688999999874 34678999999999997 999999999987653 334699
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCccccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 990 (1133)
+||+.+.+...+... ++...++.++.+++.||.|+|++||+|||+||.|||+|.. -..+++|||+|.+..+
T Consensus 114 FE~v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999888777654 6777888899999999999999999999999999999864 5689999999987644
Q ss_pred CCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCcc-CChhhHHHHHHHHhhhccccc----
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMF-TQDEDIVKWVKKQLQRGQISE---- 1064 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~---- 1064 (1133)
... ..-++.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||.. .+..+....+.+.+...++..
T Consensus 186 ~~e----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Cce----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 322 233466778899999854 4578889999999999999999999853 333333333333322222111
Q ss_pred ---cccCCcCCCC--CCChhHHHH----------HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 ---LLEPGLLELD--PESSEWEEF----------LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ---~~~~~~~~~~--~~~~~~~~~----------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+|+.+..+. .....|+.| ..+++++.+.+..|-.+|+|++|.+.+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1222221110 111223332 234588999999999999999998854
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=259.42 Aligned_cols=199 Identities=21% Similarity=0.395 Sum_probs=173.5
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
..++|.+.++||+|+|+.|..++++ +.+.+|+|++++. ..+.+-++.|-.+..+. +||.+|.++.+|... ...
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-srl 326 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-SRL 326 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-ceE
Confidence 3458999999999999999999875 5788999998753 33445677888888887 799999999888765 456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++|.||++||+|--++++.+. ++++.++.+...|.-||.|||++||+.||+|.+||++|..|++|++|||+++..
T Consensus 327 ffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 899999999999888887543 889999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~ 1042 (1133)
.. ......+.+||+.|.|||++.+..|...+|.|++||+|+||+.|+.||+
T Consensus 402 l~---~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 402 LG---PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CC---CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 32 2334567899999999999999999999999999999999999999996
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=239.90 Aligned_cols=200 Identities=23% Similarity=0.393 Sum_probs=162.3
Q ss_pred CCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc--CHHHHHHHHHHHhh-ccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI--DENTFRKEAEALGK-VKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.......||+|++|.|-+.++ ++|+..|+|+++.... ..++..+|+.+..+ ..+|.+|.++|.+....+. ++.||
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv-wIcME 125 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV-WICME 125 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE-EEeHH
Confidence 445567799999999988877 4799999999975433 34567778887554 5899999999987765554 99999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
.| .-||+.+.++.-. .+..+++...-+||..|+.||.|||++ .|+|||+||+|||++.+|++|+||||.+-...+.-
T Consensus 126 ~M-~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred Hh-hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 99 5688877665433 346689999999999999999999976 79999999999999999999999999986553321
Q ss_pred CCCCCCCCCCCCCCccCccccCC----CCCCCCCchhHHHHHHHHHHhCCCCCccC
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST----GQPTKEADVYSFGIVLLEILTGRKPVMFT 1044 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~el~tg~~Pf~~~ 1044 (1133)
..+...|...|||||.+.. ..|+-++||||+|+++.||.++++||..+
T Consensus 204 ----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 204 ----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 1223468889999999853 36899999999999999999999999643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=271.41 Aligned_cols=219 Identities=18% Similarity=0.207 Sum_probs=169.7
Q ss_pred ccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHh
Q 001171 848 GRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQE 926 (1133)
Q Consensus 848 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 926 (1133)
|.+|.||+++++ +++.||+|++.... .+.+|...+....|||++++++++... +..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHHH
Confidence 899999999764 68999999997542 344566666667899999999998876 445999999999999999876
Q ss_pred hccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCC
Q 001171 927 ASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006 (1133)
Q Consensus 927 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 1006 (1133)
.. .+++..+..++.|+++|++|+|+.||+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~ 147 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVENM 147 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcCcc
Confidence 43 2789999999999999999999999999999999999999999999999987543221 122345678
Q ss_pred ccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHh
Q 001171 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLG 1086 (1133)
Q Consensus 1007 y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1086 (1133)
|+|||...+..++.++||||+||++|||++|+.|+...... . ... .. ...+... . ...
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~--------~~~--~~------~~~~~~~---~--~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I--------NTH--TT------LNIPEWV---S--EEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c--------ccc--cc------cCCcccC---C--HHH
Confidence 99999998888899999999999999999999887432110 0 000 00 0000000 0 112
Q ss_pred HhhhhccCCCCCCCCCCH
Q 001171 1087 VKVGLLCTAPDPLDRPSM 1104 (1133)
Q Consensus 1087 ~~li~~Cl~~dP~~RPs~ 1104 (1133)
.+++.+|++.||++||++
T Consensus 206 ~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 206 RSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHccCCHHHhcCC
Confidence 378899999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=277.46 Aligned_cols=206 Identities=21% Similarity=0.385 Sum_probs=171.3
Q ss_pred CCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
-|..++.||-|+||+|..++. ++...||+|.+++... ....++.|-+||...+.+=||+++..|.+++. .|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn-LYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-LYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc-eEEEE
Confidence 466788999999999999954 4578899999976433 23457889999999999999999998888754 59999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++||++-.+|-+.+. +++..++.++..+.+|+++.|..|+|||||||+|||||.+|++|++|||++.-+.=.+
T Consensus 709 dYIPGGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999988654 7788888899999999999999999999999999999999999999999984322110
Q ss_pred --------CCCC-------------------------------CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHH
Q 001171 993 --------AEAS-------------------------------SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLE 1033 (1133)
Q Consensus 993 --------~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~e 1033 (1133)
.... .....+||+.|+|||++....|+..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0000 0013479999999999999999999999999999999
Q ss_pred HHhCCCCCccCChhhH
Q 001171 1034 ILTGRKPVMFTQDEDI 1049 (1133)
Q Consensus 1034 l~tg~~Pf~~~~~~~~ 1049 (1133)
|+.|+.||....+.+.
T Consensus 864 m~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhCCCCccCCCCCcc
Confidence 9999999976555443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=298.47 Aligned_cols=263 Identities=19% Similarity=0.226 Sum_probs=165.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-C----ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEE----E-eCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-D----GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY----Y-AGP 904 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~----~-~~~ 904 (1133)
..++|.+.++||+|+||.||+|.+. + +..||+|++..... .+.+..| .++...+.+++.+... . ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4568999999999999999999875 4 68999999764321 1111111 1112222222221111 1 123
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccC---------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccce
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQ---------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NI 969 (1133)
+...++||||+++++|.++++..... .........+..++.||+.||+|||+++|+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 34568999999999999998753210 000112234557899999999999999999999999999
Q ss_pred eeCC-CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCC----------------------CCCCCCchhH
Q 001171 970 LFDA-DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG----------------------QPTKEADVYS 1026 (1133)
Q Consensus 970 ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwS 1026 (1133)
|++. ++.+||+|||+|+...... ........+++.|+|||.+... .++.++||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 9986 5789999999997542221 1223456789999999965322 2345679999
Q ss_pred HHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc-----ccccccCCcCCCCCCChh-HH----HHHHhHhhhhccCCC
Q 001171 1027 FGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ-----ISELLEPGLLELDPESSE-WE----EFLLGVKVGLLCTAP 1096 (1133)
Q Consensus 1027 lG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-~~----~~~~~~~li~~Cl~~ 1096 (1133)
+||++|||+++..|+.. +.... .+.+.... ......+.. ...... ++ ......+++.+|++.
T Consensus 365 lGviL~el~~~~~~~~~----~~~~~-~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDS----NLIQF-NRQLKRNDYDLVAWRKLVEPRA---SPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHhCcCCCch----HHHHH-HHHHHhcCCcHHHHHHhhcccc---chhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999997766431 11111 11111100 000111110 000000 00 001122799999999
Q ss_pred CCCCCCCHHHHHHH
Q 001171 1097 DPLDRPSMADIVFM 1110 (1133)
Q Consensus 1097 dP~~RPs~~evl~~ 1110 (1133)
||++|||+.|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=266.85 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=190.0
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcc--cCCcC------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR--DGTID------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~--~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
.++|-+...||+|+|+.||+|.+ ...+.||||+-. +.-.+ .+...+|.+|-+.++||.||++++|+.-+.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34677889999999999999954 567788888753 22111 2345689999999999999999999987767
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC--CceecccCccceeeC---CCCceEEec
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL--DMVHGDIKPQNVLFD---ADFEAHLSE 981 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--~ivH~Dlkp~NIll~---~~~~~kl~D 981 (1133)
..+-|.|||+|.+|+=+++.++. +++.+++.|+.||+.||.||.+. .|||-||||.|||+. .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 77999999999999999987543 78899999999999999999865 599999999999994 357899999
Q ss_pred cCcccccccCCCCC----CCCCCCCCCCCccCccccCCC----CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHH
Q 001171 982 FGLDRLAIATPAEA----SSSTTPIGSLGYVSPEAASTG----QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053 (1133)
Q Consensus 982 fg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 1053 (1133)
||+++......... .-.....||.+|.+||.+.-+ +.+.|+||||+|||+|..+.|+.||...... +.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdI 693 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDI 693 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHH
Confidence 99998765432221 112345799999999998433 4688999999999999999999999643322 112
Q ss_pred HHHhhhccccccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1054 KKQLQRGQISELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.+...-....++ .+++.. .+. .+.++|++|+++--++|....++..
T Consensus 694 LqeNTIlkAtEV------qFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQENTILKATEV------QFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhhhchhcceec------cCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111111 111111 111 1227899999999999998887753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=283.74 Aligned_cols=206 Identities=21% Similarity=0.300 Sum_probs=153.3
Q ss_pred HhcCCCcccccccccceeEEEEEE-----------------CCceEEEEEEcccCCcC---------------HHHHHHH
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-----------------QDGMVLSIRRLRDGTID---------------ENTFRKE 882 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~---------------~~~~~~E 882 (1133)
..++|++.++||+|+||+||+|.. ..++.||||++...... .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999954 23568999998643211 1223457
Q ss_pred HHHHhhccCCCe-----eeEEEEEeCC-------CCcEEEEEeccCCCCHHHHHHhhccC-------------------C
Q 001171 883 AEALGKVKHRNL-----TVLRGYYAGP-------PDVRLLVYDYMPNGNLATLLQEASHQ-------------------D 931 (1133)
Q Consensus 883 ~~~l~~l~hpni-----v~l~~~~~~~-------~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~ 931 (1133)
+.++.+++|.++ +++++||... ....++||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 6677776531 23468999999999999999753210 1
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCcc
Q 001171 932 GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011 (1133)
Q Consensus 932 ~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 1011 (1133)
....++..+..++.|++.|++|+|+.+|+||||||+||+++.++.+||+|||+++...... ........+++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--NFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC--ccCccccCCCcceeChh
Confidence 1235677888999999999999999999999999999999999999999999986432211 11122234578999999
Q ss_pred ccCCCC--------------------C--CCCCchhHHHHHHHHHHhCCC-CCc
Q 001171 1012 AASTGQ--------------------P--TKEADVYSFGIVLLEILTGRK-PVM 1042 (1133)
Q Consensus 1012 ~~~~~~--------------------~--~~~~DvwSlG~il~el~tg~~-Pf~ 1042 (1133)
.+.... + ..+.||||+||++|+|++|.. ||.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 875322 1 234799999999999999875 664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=287.43 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=184.9
Q ss_pred Ccccccccccce-eEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 840 DEENVLSRGRYG-LIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 840 ~~~~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
.-.+++|.|+.| .||+|.+. |+.||||++-.+. .+...+|++.++.- +|||||++++.-. ++...|++.|.| .
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~-d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQ-DRQFLYIALELC-A 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeecc-CCceEEEEehHh-h
Confidence 334679999998 56999886 8899999996433 35678999999888 6999999876544 346779999999 6
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---C--CceEEeccCcccccccCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---D--FEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfg~a~~~~~~~ 992 (1133)
.+|.+++...+ .+.....-...+.+..|++.|++|||+.+||||||||.||||+. + ..++|+|||+++......
T Consensus 587 ~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 CSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 79999998741 11111221345667899999999999999999999999999965 3 468999999998876665
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
..........||-+|+|||++....-+.++||||+||++|+.++ |.+||...-..+ ..+.. +.. .+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~----~~~------~L~ 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT----GNY------TLV 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc----Ccc------cee
Confidence 55555667789999999999988888899999999999999999 589996432211 11111 100 000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1108 (1133)
.+.+. .++ .+.++|.+|+++||..||++.+|+
T Consensus 734 ~L~~~-~d~----eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 HLEPL-PDC----EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eeccC-chH----HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11111 111 344899999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=261.97 Aligned_cols=236 Identities=26% Similarity=0.372 Sum_probs=186.7
Q ss_pred cceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCHHHHHH
Q 001171 849 RYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQ 925 (1133)
Q Consensus 849 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~ 925 (1133)
+||.||+|.++ +|+.+|+|++...... .+.+.+|++.+++++|+|++++++++... ...+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHH
Confidence 58999999886 4899999998754332 57899999999999999999999998775 45599999999999999987
Q ss_pred hhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCC
Q 001171 926 EASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005 (1133)
Q Consensus 926 ~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~ 1005 (1133)
.... +++..+..++.+++++++|||+.+++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 80 ~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 80 KRGR-----LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred hccC-----CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 6332 7889999999999999999999999999999999999999999999999987543321 233456788
Q ss_pred CccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCcc-CChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHH
Q 001171 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF-TQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFL 1084 (1133)
Q Consensus 1006 ~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1084 (1133)
.|++||...+..++.++||||+|+++|++++|..||.. .+.....+..... .... .. ..... ..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~----~~~~-~~--------~~~~~--~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP----KPPF-PP--------PEWKI--SP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc----CCCC-cc--------ccccC--CH
Confidence 99999999888889999999999999999999999965 3333333332221 1000 00 00000 01
Q ss_pred HhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1085 LGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1085 ~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
...+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 2237889999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-30 Score=254.10 Aligned_cols=266 Identities=18% Similarity=0.261 Sum_probs=191.4
Q ss_pred CCcccccccccceeEEEEEE-CCceEEEEEEcccC---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC----CcEEE
Q 001171 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDG---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DVRLL 910 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~l 910 (1133)
.+..+.||.|+||+||.+.+ ++|+.||.|++..- -...+.+.+|++++.-.+|.|+...++...-.. +..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45567899999999999965 68999999998632 223578889999999999999998887765332 12367
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
++|.| ..+|..++-. .+.++...+..+.+||++||.|||+.+|.||||||.|.+++++...||||||++|....
T Consensus 135 ~TELm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 77877 4466655543 24477777788899999999999999999999999999999999999999999975422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc--------
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ-------- 1061 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-------- 1061 (1133)
.. ....+..+.|..|+|||.+.+. .|+.+.||||.|||+.|++..+.-|...++-+..+.+.+......
T Consensus 209 d~--~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RD--RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hh--hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 21 1222334678899999999875 589999999999999999998888876665554444444332211
Q ss_pred ---ccccccCCcCC-----CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1062 ---ISELLEPGLLE-----LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1062 ---~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
-..++...... +..-..+.......+.+..+++..||++|.+.++.+.++.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111111 1111111112223346778899999999999999987764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.85 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=190.9
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEcccC---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----Cc
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDG---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----DV 907 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~ 907 (1133)
.+|.-.+.+|.|.- .|..|.+ -.++.||+|++... ....++..+|...+..++|+|+++++.+|.-.. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999988 6666644 36899999998543 223467789999999999999999999985321 23
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+|||+| ..+|.+.+.-. ++-.....+.+|+++|+.|||+.||+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e-------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME-------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh-------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 48999999 67888888731 67778889999999999999999999999999999999999999999999974
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc------
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ------ 1061 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------ 1061 (1133)
... .-..+..+.|..|+|||++.+..+.+.+||||.||++.||++|+.-|.+.+.-+.+..+.+......
T Consensus 168 e~~----~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 168 EDT----DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cCc----ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 322 1344567889999999999988899999999999999999999988865443332222222211110
Q ss_pred -------------------ccc-cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 -------------------ISE-LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 -------------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.+ +.|..+.... +.. ..+-..+-+++.+|+..||++|.++++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~-e~~-~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVL-EGS-KLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccc-cCC-ccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 001 1111111000 000 0111122278999999999999999999976
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=262.71 Aligned_cols=196 Identities=22% Similarity=0.343 Sum_probs=167.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHH---------HHHHHHHHHhhcc---CCCeeeEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDEN---------TFRKEAEALGKVK---HRNLTVLRGYYA 902 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---------~~~~E~~~l~~l~---hpniv~l~~~~~ 902 (1133)
-.+|+..+.+|+|+||.|+.|.++ +...|+||.+.+...-.+ .+-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346899999999999999999876 467889999876544322 3456999999997 999999999999
Q ss_pred CCCCcEEEEEeccC-CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 903 GPPDVRLLVYDYMP-NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 903 ~~~~~~~lV~e~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
+++.+ |++||-.. +.+|++++..+.. +++.....|+.||+.|++|||+.||||||||-+||.++.+|-+|++|
T Consensus 640 ddd~y-yl~te~hg~gIDLFd~IE~kp~-----m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYY-YLETEVHGEGIDLFDFIEFKPR-----MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCee-EEEecCCCCCcchhhhhhccCc-----cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 87554 99999874 4599999987543 78899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCc
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVM 1042 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~ 1042 (1133)
||.|.+... ......+||..|.|||++.+..| +..-|||++|+++|-++...-||.
T Consensus 714 fgsaa~~ks-----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS-----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC-----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999866532 34456789999999999998887 677899999999999998888874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=246.49 Aligned_cols=132 Identities=19% Similarity=0.334 Sum_probs=113.5
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-----C---CCeeeEEEEEeCC--
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-----H---RNLTVLRGYYAGP-- 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~~-- 904 (1133)
..+|.+.++||=|-|++||.|.+ +..+.||+|+.+....-.+....|++++++++ | .+||+++++|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 46899999999999999999955 56789999999876665677888999999984 2 4699999999642
Q ss_pred -CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceee
Q 001171 905 -PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLF 971 (1133)
Q Consensus 905 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll 971 (1133)
+...++|+|+. |.+|..++.....+. ++...+.+|++||+.||.|||+. ||||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrG---lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRG---LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCC---CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 23348999999 789999999877654 89999999999999999999975 79999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=254.76 Aligned_cols=268 Identities=20% Similarity=0.220 Sum_probs=204.7
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc------CCCeeeEEEEEeCCCC
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK------HRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l~~~~~~~~~ 906 (1133)
.-..+|.+....|+|-|++|.+|.++ .|..||||++.......+.=.+|+++|++|+ --|+++++..|....
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn- 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN- 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc-
Confidence 34568999999999999999999765 4789999999887766677788999999995 246788877776654
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLD 985 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 985 (1133)
..|+|+|.+ ..+|.+++++.+.. --+....+..+++|+.-||.+|-..||+|.||||.|||+++. ..+||||||.|
T Consensus 508 HLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 459999988 67999999998764 337788899999999999999999999999999999999875 45799999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHH--------Hh
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK--------QL 1057 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~--------~~ 1057 (1133)
..... ...+.+..+..|.|||++.|..|+...|+||+||++||+.||+.-|.+.....+...... .+
T Consensus 585 ~~~~e-----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 585 SFASE-----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred ccccc-----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 65432 223344566789999999999999999999999999999999999987766666555433 22
Q ss_pred hhcccc-ccccCCcCC-------------------CCC--------------CChhHHHHHHhHhhhhccCCCCCCCCCC
Q 001171 1058 QRGQIS-ELLEPGLLE-------------------LDP--------------ESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103 (1133)
Q Consensus 1058 ~~~~~~-~~~~~~~~~-------------------~~~--------------~~~~~~~~~~~~~li~~Cl~~dP~~RPs 1103 (1133)
+.+++. +.+|..+.= ..+ ...+...+....++..+|+..||++|.+
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 222221 122222110 000 0112222222237899999999999999
Q ss_pred HHHHHHH
Q 001171 1104 MADIVFM 1110 (1133)
Q Consensus 1104 ~~evl~~ 1110 (1133)
..+.+++
T Consensus 740 ~nqAL~H 746 (752)
T KOG0670|consen 740 VNQALKH 746 (752)
T ss_pred HHHHhcC
Confidence 9998864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=233.54 Aligned_cols=210 Identities=28% Similarity=0.463 Sum_probs=177.9
Q ss_pred cccccceeEEEEEECC-ceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCHH
Q 001171 845 LSRGRYGLIFKASYQD-GMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLA 921 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~ 921 (1133)
||+|.+|.||++...+ ++.+++|++...... .+.+.+|++.++.++|++++++++++... ...+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence 6899999999998764 899999999765442 47899999999999999999999999876 4559999999999999
Q ss_pred HHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEEeccCcccccccCCCCCCCCCC
Q 001171 922 TLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAEASSSTT 1000 (1133)
Q Consensus 922 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 1000 (1133)
+++.... ..+++..+..++.+++++++|||+.|++|+||+|.||+++. ++.++++|||.+........ ....
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKT 152 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhc
Confidence 9998642 24789999999999999999999999999999999999999 89999999999865432211 1233
Q ss_pred CCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChh
Q 001171 1001 PIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079 (1133)
Q Consensus 1001 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1133)
..+...|++||..... .++.+.|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577899999999777 788999999999999999
Q ss_pred HHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1080 ~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
....+++.+|++.+|++||++.++++.+
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1112677889999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=241.07 Aligned_cols=199 Identities=23% Similarity=0.405 Sum_probs=163.4
Q ss_pred HhcCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
....|..+++||+|.|++||+|... ..+.||+|.+.... ....+..|+++|..+ -+.||+++.+++...+.. .
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v-~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV-A 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCee-E
Confidence 4557899999999999999999553 46889999996533 457799999999999 589999999988776554 8
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEEeccCccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLA 988 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~ 988 (1133)
+|+||++.....++... ++...+..+.+.+..||.|+|..|||||||||.|++.+. .+.-.|.|||+|...
T Consensus 112 ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999988875 678888899999999999999999999999999999975 467799999998621
Q ss_pred ccC---------------C--C------------------------CCCCCCCCCCCCCccCccccCCC-CCCCCCchhH
Q 001171 989 IAT---------------P--A------------------------EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYS 1026 (1133)
Q Consensus 989 ~~~---------------~--~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwS 1026 (1133)
... . + .......+.||++|+|||++... ..+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 100 0 0 00001234699999999998654 4689999999
Q ss_pred HHHHHHHHHhCCCCCcc
Q 001171 1027 FGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 1027 lG~il~el~tg~~Pf~~ 1043 (1133)
.|||+..++++++||..
T Consensus 264 ~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccceeehhhcccccccc
Confidence 99999999999999953
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=256.15 Aligned_cols=252 Identities=21% Similarity=0.364 Sum_probs=195.2
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
..++|+..+++|.|.||.||||++ +.++..|+|.++.... +.+..++|+-+++..+|||||.++|.|...+. .+++|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-lwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-LWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-cEEEE
Confidence 456899999999999999999966 5789999999975433 35677899999999999999999998877644 49999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|||.+|+|++..+.-+ .+++.+...+++...+|++|||++|-+|||||-.||++++.|.+|++|||.+-.+.
T Consensus 92 EycgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit--- 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT--- 163 (829)
T ss_pred EecCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh---
Confidence 9999999999877533 37788888899999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCccCcccc---CCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAA---STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
....+.....||+.|||||+. ..+.|..++|||+.|+...|+-.-++|.....+......+.+- .+-.+.
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-------~~qpp~ 236 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-------GFQPPT 236 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-------CCCCCc
Confidence 223345567899999999986 4567899999999999999998877775433332222221111 111122
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1108 (1133)
+.+ ...|.++.. +++..|+..+|.+||+++.++
T Consensus 237 lkD----k~kws~~fh--~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 LKD----KTKWSEFFH--NFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ccC----CccchHHHH--HHHHHHhcCCCccCCChhhhe
Confidence 211 112222222 678889999999999988765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-26 Score=227.27 Aligned_cols=209 Identities=22% Similarity=0.349 Sum_probs=164.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
-.+.|++.+.+|+|.||.+-.++++ +.+.+++|.++......++|.+|...--.+ .|.||+.-++......+..++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3457899999999999999999887 478899999988887889999999876566 68999988776544445668999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee-CC-CCceEEeccCccccccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF-DA-DFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll-~~-~~~~kl~Dfg~a~~~~~ 990 (1133)
||++.|+|..-+...+ +.+..-.+++.|++.|+.|||++.+||||||.+|||| +. ..++|+||||.++....
T Consensus 102 E~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999998887643 5667778899999999999999999999999999999 33 34799999999864321
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCC-----CCCCCCchhHHHHHHHHHHhCCCCCccCC--hhhHHHHHHH
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTG-----QPTKEADVYSFGIVLLEILTGRKPVMFTQ--DEDIVKWVKK 1055 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~el~tg~~Pf~~~~--~~~~~~~~~~ 1055 (1133)
. .....-+..|.|||..... ...+.+|||.||+++|.++||+.||.... +...+.|...
T Consensus 176 t------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w 241 (378)
T KOG1345|consen 176 T------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW 241 (378)
T ss_pred e------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH
Confidence 1 1122344578999986432 24778999999999999999999997432 3344444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=231.21 Aligned_cols=198 Identities=28% Similarity=0.483 Sum_probs=168.7
Q ss_pred CCcccccccccceeEEEEEECC-ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
|.+.+.||+|++|.||+|...+ ++.+|+|.+..... ..+.+.+|++.+++++|+|++++++++... ...++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEecc
Confidence 5677899999999999998865 89999999976543 357889999999999999999999998765 4558999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++...... +++..+..++.+++.++.|+|+.+++|+|++|+||+++.++.++++|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-- 153 (225)
T smart00221 80 EGGDLFDYLRKKGGK----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-- 153 (225)
T ss_pred CCCCHHHHHHhcccC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence 999999999864321 68889999999999999999999999999999999999999999999999876533221
Q ss_pred CCCCCCCCCCCccCcccc-CCCCCCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 996 SSSTTPIGSLGYVSPEAA-STGQPTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
.......++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334677889999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-27 Score=248.14 Aligned_cols=387 Identities=24% Similarity=0.262 Sum_probs=216.6
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccC-CcccccCchhhccCCCccEEEc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVAN-NSLSGLVPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L 394 (1133)
.-.+++|..|+|+.|+|.+|+.+++|++||||+|+|+.+-|++|..+.+|..|.+-+ |+|+.+..+.|.++..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 345677777888888888888888888888888888877778888887777766655 7787777777888888888888
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccccccc------------ccCChhhcCCCCCc
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR------------GNIPEEITRLSNLT 462 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~------------~~~~~~l~~l~~L~ 462 (1133)
.-|++.......|..+++|..|.+..|.+..+--.+|..+..++.+.+..|.+- ...|-.++...-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 888887777777777888888888888777554457777777888877777621 12222233333233
Q ss_pred EEecccCcCCCCCCCCCCCC-CCCcEEEcccCCCccccC-CCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccC
Q 001171 463 TLNLSYNKFGGKVPYDVGNL-KGLLVLNLSASGFSGKIP-GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540 (1133)
Q Consensus 463 ~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 540 (1133)
-..+.++++..+.+..|... +.+..--.+.....+..| ..|..+++|++|+|++|+|+.+-+.+|.+..++++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 33334444433333222211 111111111111222222 2355556666666666666655555555666666666666
Q ss_pred CcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCC-----CCCccc-----------cCCCC
Q 001171 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISG-----MIPAEL-----------GACSA 604 (1133)
Q Consensus 541 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----~~p~~l-----------~~l~~ 604 (1133)
|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+.- -+.+|+ ++...
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGF 387 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCch
Confidence 66554444555556666666666666665555555555556666555554320 000111 11123
Q ss_pred ccEEEecCCcccC---CCccccccc---------cccCeee-cCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccc
Q 001171 605 LEVLELRSNHFTG---NIPVDISHL---------SRIKKLD-LGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESF 671 (1133)
Q Consensus 605 L~~L~L~~N~l~~---~~p~~l~~l---------~~L~~L~-Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 671 (1133)
++.+.++.+.+.. ..|++.+.. +-+.+.. -|++.+. .+|..+- ..-..|++.+|.++ .+|..
T Consensus 388 ~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~- 462 (498)
T KOG4237|consen 388 VRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE- 462 (498)
T ss_pred hccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH-
Confidence 4444444443321 122221111 1121111 1222222 3332221 12345667777777 45554
Q ss_pred cCcccccccccccccccccCCccccccccCcccccccc
Q 001171 672 SKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRN 709 (1133)
Q Consensus 672 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N 709 (1133)
.+.+| .+|+|+|+++..--..+.++++|.+|-||+|
T Consensus 463 -~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 463 -LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred -HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 45566 7777777776555556677777777777765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-27 Score=245.11 Aligned_cols=405 Identities=24% Similarity=0.289 Sum_probs=262.3
Q ss_pred CccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEeccc-ccccCCCCccccCc
Q 001171 158 KISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDS-NHLYGTLPSAISNC 236 (1133)
Q Consensus 158 ~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l 236 (1133)
.||.++|+....++|..|+|+.+.|+.|+.+++|+.||||+|+|+.+-|+.|..+.+|..|-+-+ |+|+..-...|.+|
T Consensus 60 eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL 139 (498)
T KOG4237|consen 60 EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL 139 (498)
T ss_pred cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH
Confidence 68999999999999999999999999999999999999999999999999999999998887765 99985444679999
Q ss_pred cccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccc----------
Q 001171 237 SSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVV---------- 306 (1133)
Q Consensus 237 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~---------- 306 (1133)
.+|+.|.+.-|++.-+..+.|..+++|..|.+..|.+.. ++. ..|..+.+++.+.+..|.+-..=
T Consensus 140 ~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~-i~~----~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a 214 (498)
T KOG4237|consen 140 SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQS-ICK----GTFQGLAAIKTLHLAQNPFICDCNLPWLADDLA 214 (498)
T ss_pred HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhh-hcc----ccccchhccchHhhhcCccccccccchhhhHHh
Confidence 999999999999998888899999999999999999974 333 13478899999999988843210
Q ss_pred -cCCCCCccccccEEeccCCcccccCCchhhcc-cccceeeccCceeecccC-cccCCCCCCcEEEccCCcccccCchhh
Q 001171 307 -KPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV-TSLRVMDLSGNFFSGNLP-AAVGSLDKLEVLRVANNSLSGLVPDEI 383 (1133)
Q Consensus 307 -~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~ 383 (1133)
.+..+.+..-..-..+.++++..+.+..|... .++..=..+.....++-| ..|+.|++|++|+|++|+|+.+-+.+|
T Consensus 215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF 294 (498)
T KOG4237|consen 215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF 294 (498)
T ss_pred hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence 01112222223334566666666655555432 222211122222222334 357777777777777777777777777
Q ss_pred ccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccC-----Chhh---
Q 001171 384 AKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNI-----PEEI--- 455 (1133)
Q Consensus 384 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~-----~~~l--- 455 (1133)
.+...+++|.|..|+|..+-...|.++.+|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+--.- -+++
T Consensus 295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~ 374 (498)
T KOG4237|consen 295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKK 374 (498)
T ss_pred cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhC
Confidence 77777777777777777666667777777777777777777777777777777777777666543210 0111
Q ss_pred --------cCCCCCcEEecccCcCCC---CCCCCCCCCCCCcEEEcccCCCccccCCCcCCccccc-EEeccccCCCCCC
Q 001171 456 --------TRLSNLTTLNLSYNKFGG---KVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT-TLDLSNQNLSGEL 523 (1133)
Q Consensus 456 --------~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~ 523 (1133)
..-..++.+.++++.+.. ..|++.+-. -+..-| ..++-+. ....|+..+. .+
T Consensus 375 ~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~------------~s~~cP---~~c~c~~tVvRcSnk~lk-~l 438 (498)
T KOG4237|consen 375 SVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCL------------TSSPCP---PPCTCLDTVVRCSNKLLK-LL 438 (498)
T ss_pred CCCCCCCCCCCchhccccchhccccccccCCccccCCC------------CCCCCC---CCcchhhhhHhhcccchh-hc
Confidence 111234444444443321 111111100 000011 1122222 2233333333 33
Q ss_pred ChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccC
Q 001171 524 PIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHN 589 (1133)
Q Consensus 524 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 589 (1133)
|..+- ..-.+|++.+|.++ .+|.. .+..| .+|+++|++...-...|.++.+|.+|-|++|
T Consensus 439 p~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 439 PRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 33221 13456677777776 34443 45556 7777777777555566777777777777765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=273.61 Aligned_cols=341 Identities=24% Similarity=0.287 Sum_probs=208.4
Q ss_pred cCCchhhcccccceeeccCce------eecccCcccCCCC-CCcEEEccCCcccccCchhhccCCCccEEEccCCccccc
Q 001171 330 VFPSWLTNVTSLRVMDLSGNF------FSGNLPAAVGSLD-KLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQ 402 (1133)
Q Consensus 330 ~~~~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 402 (1133)
+.++.|.++.+|+.|.+..+. +...+|..|..++ +|+.|++.++.++.+ |..| ...+|+.|+|++|++. .
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~l-P~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCM-PSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCC-CCcC-CccCCcEEECcCcccc-c
Confidence 456678888888888886553 2334566666654 588888888777643 5555 4577888888888776 4
Q ss_pred CCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCC
Q 001171 403 VPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482 (1133)
Q Consensus 403 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 482 (1133)
++..+..+++|+.|+|+++...+.+| .+..+++|++|+|++|.....+|..+.++++|+.|++++|..-+.+|..+ ++
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 56666777788888887765444555 36677778888887776555677777777778888877764444555544 67
Q ss_pred CCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCccc-------ccCCCCCCCCc
Q 001171 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS-------GDVPEGFSSLV 555 (1133)
Q Consensus 483 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-------~~~~~~~~~l~ 555 (1133)
++|+.|++++|.....+|.. ..+|+.|++++|.+. .+|..+ .+++|++|++.++... ...+..+...+
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~ 778 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSP 778 (1153)
T ss_pred CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccc
Confidence 77777777777554444432 346777777777765 455443 4666777766654321 11111122234
Q ss_pred cCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecC
Q 001171 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLG 635 (1133)
Q Consensus 556 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 635 (1133)
+|+.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|+|+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 56666666665555566666666666666666654333455444 4566666666665443333332 2456666666
Q ss_pred CCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccc
Q 001171 636 QNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685 (1133)
Q Consensus 636 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 685 (1133)
+|.++ .+|..+..+++|+.|++++|+-...+|..+..+++|+.+++++|
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence 66665 45666666666666666553322245555555666666666555
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=271.13 Aligned_cols=341 Identities=19% Similarity=0.232 Sum_probs=269.6
Q ss_pred cCcccCCCCCCcEEEccCCcc------cccCchhhccCC-CccEEEccCCcccccCCCccCCCCCCcEEEccCCcCcccc
Q 001171 355 LPAAVGSLDKLEVLRVANNSL------SGLVPDEIAKCS-LLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427 (1133)
Q Consensus 355 ~p~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 427 (1133)
.+.+|..+.+|+.|.+.++.. ...+|..+..++ +|+.|++.+|.++ .+|..| ...+|+.|+|.+|++.. +
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-L 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-c
Confidence 446788899999999976643 334566676664 6999999999987 567666 46899999999999884 5
Q ss_pred CccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcc
Q 001171 428 PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLM 507 (1133)
Q Consensus 428 p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 507 (1133)
+..+..+++|+.|+|++|.....+| .+..+++|++|+|++|.....+|..++.+++|+.|++++|..-..+|..+ +++
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 7778899999999999876544566 47889999999999987767889999999999999999976555677665 789
Q ss_pred cccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEccccccc-------CCCCcccccccc
Q 001171 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT-------GDIPATYGFLRS 580 (1133)
Q Consensus 508 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------~~~~~~~~~l~~ 580 (1133)
+|+.|++++|.....+|.. .++|++|++++|.+. .+|..+ .+++|++|++.++... ...+..+...++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 9999999998766566643 467899999999987 456554 5788888888774422 122223344578
Q ss_pred cceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeec
Q 001171 581 LVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660 (1133)
Q Consensus 581 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 660 (1133)
|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|.....+|.. ..+|+.|+|++
T Consensus 780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~ 855 (1153)
T PLN03210 780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSR 855 (1153)
T ss_pred chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCC
Confidence 9999999998877899999999999999999886555678766 6899999999998655455543 36889999999
Q ss_pred CCCCccCCccccCcccccccccccccccccCCccccccccCccccccccc
Q 001171 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNN 710 (1133)
Q Consensus 661 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~ 710 (1133)
|.++ .+|..+..+++|+.|+|++|+--..+|..+..+++|+.++++++.
T Consensus 856 n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 856 TGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 9998 688899999999999999854334688888899999999999875
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-24 Score=256.87 Aligned_cols=336 Identities=22% Similarity=0.314 Sum_probs=180.0
Q ss_pred cccCchhHHHHHHHHHHhCCCCCCCccC----CCCCCCCCCCccce----------------eeeCCCceEEEeeCCccc
Q 001171 24 QNAVVLSEIQALTSFKLHLKDPLGALDG----WDSSTPSAPCDWRG----------------IVCYNNRVRELRLPRLQL 83 (1133)
Q Consensus 24 ~~~~~~~~~~~l~~~k~~~~~~~~~l~~----w~~~~~~~~c~w~g----------------v~c~~~~v~~l~l~~~~l 83 (1133)
..+...+|.+.+++..+.+.-| +.+++ |+..+ ++|.=.. |.|.++.|+.+...+...
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~~~--~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~ 133 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFP-AYADNIQYSRGGAD--QYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQ 133 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCC-chhhccccccCCCC--cccccCCcchhhheeeecCCceEEecCCCcccccccccccc
Confidence 3455668999999999999766 44544 97654 6885444 889999999888765332
Q ss_pred Ccccchh--hcccccCcEEEcccCcccCC----------CCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhc
Q 001171 84 AGRLTDQ--LADLHELRKLSLHSNHLNGS----------IPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVA 151 (1133)
Q Consensus 84 ~g~~~~~--l~~l~~L~~L~l~~n~l~~~----------~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~ 151 (1133)
+..-..+ ..+...... +-..+.-.+. +..+ ...+...|+++++.++ .+|..+. ++|+.|+|+
T Consensus 134 ~~~~~~~~~~~~~~~~w~-~w~~~~~~~~~~~r~~a~~r~~~C--l~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls 207 (754)
T PRK15370 134 ASSASGSKDAVNYELIWS-EWVKEAPAKEAANREEAVQRMRDC--LKNNKTELRLKILGLT-TIPACIP--EQITTLILD 207 (754)
T ss_pred cccCCCCCChhhHHHHHH-HHHhcCCCCccccHHHHHHHHHhh--cccCceEEEeCCCCcC-cCCcccc--cCCcEEEec
Confidence 2221100 000000000 0000000000 0111 1134556666666666 4555443 356666666
Q ss_pred ccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCc
Q 001171 152 HNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPS 231 (1133)
Q Consensus 152 ~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 231 (1133)
+|.|+ .+|..++++|++|+|++|+|++ +|..+. .+|+.|+|++|++. .+|..+. .+|+.|++++|+++ .+|.
T Consensus 208 ~N~Lt-sLP~~l~~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~ 279 (754)
T PRK15370 208 NNELK-SLPENLQGNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPE 279 (754)
T ss_pred CCCCC-cCChhhccCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cccc
Confidence 66666 3555555667777777777763 454432 35677777777776 5665554 46777777777776 4565
Q ss_pred cccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCC
Q 001171 232 AISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG 311 (1133)
Q Consensus 232 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~ 311 (1133)
.+. ++|+.|++++|+|+++ |..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.+++
T Consensus 280 ~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt~-LP~~l-------~~sL~~L~Ls~N~Lt~------- 339 (754)
T PRK15370 280 NLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTA-LPETL-------PPGLKTLEAGENALTS------- 339 (754)
T ss_pred ccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCcccc-CCccc-------cccceeccccCCcccc-------
Confidence 553 4677777777777653 33332 367777777777764 33222 1334444444444433
Q ss_pred CccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccE
Q 001171 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQM 391 (1133)
Q Consensus 312 ~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 391 (1133)
+ |..+ .++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+.+ |..+. ..|+.
T Consensus 340 ------------------L-P~~l--~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~L-P~~l~--~sL~~ 392 (754)
T PRK15370 340 ------------------L-PASL--PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNL-PENLP--AALQI 392 (754)
T ss_pred ------------------C-Chhh--cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCC-CHhHH--HHHHH
Confidence 2 2222 134555555555554 2343331 3555555555555532 33332 24556
Q ss_pred EEccCCcccccCCC----ccCCCCCCcEEEccCCcCc
Q 001171 392 FDLEGNRFSGQVPA----FLGGIRGLKIVSLGRNMFS 424 (1133)
Q Consensus 392 L~Ls~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~ 424 (1133)
|++++|+|+ .+|. .++.++.+..|++.+|.++
T Consensus 393 LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 393 MQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 666666665 2332 3334456666777776665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=249.87 Aligned_cols=264 Identities=27% Similarity=0.355 Sum_probs=152.3
Q ss_pred eEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeecccc
Q 001171 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247 (1133)
Q Consensus 168 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 247 (1133)
..|+|++|.|+ .+|..+. ++|+.|++++|+|+. +|.. +++|++|+|++|+|+ .+|.. .++|++|++++|
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSN 272 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCC
Confidence 34455555554 3344332 244555555555542 3321 244555555555554 33321 234455555555
Q ss_pred ccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcc
Q 001171 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRI 327 (1133)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i 327 (1133)
.++.+ |.. .++|+.|+|++|+++. +|. .+++|+.|++++|.+++... ....|+.|++++|+|
T Consensus 273 ~L~~L-p~l---p~~L~~L~Ls~N~Lt~-LP~--------~p~~L~~LdLS~N~L~~Lp~-----lp~~L~~L~Ls~N~L 334 (788)
T PRK15387 273 PLTHL-PAL---PSGLCKLWIFGNQLTS-LPV--------LPPGLQELSVSDNQLASLPA-----LPSELCKLWAYNNQL 334 (788)
T ss_pred chhhh-hhc---hhhcCEEECcCCcccc-ccc--------cccccceeECCCCccccCCC-----CcccccccccccCcc
Confidence 55432 211 1344455555555542 221 12345555555555554311 123456666666666
Q ss_pred cccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCcc
Q 001171 328 RAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFL 407 (1133)
Q Consensus 328 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 407 (1133)
+++ |.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|+|+. +|.. ..+|+.|+|++|+|++ +|..
T Consensus 335 ~~L-P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l- 400 (788)
T PRK15387 335 TSL-PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL- 400 (788)
T ss_pred ccc-ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc-
Confidence 665 321 2467777777777773 4432 2456677777777775 3432 2467888888888874 4443
Q ss_pred CCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCC
Q 001171 408 GGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGN 481 (1133)
Q Consensus 408 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 481 (1133)
.++|+.|++++|.+++ +|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|++|+|++..+..+..
T Consensus 401 --~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 401 --PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred --ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 3568888888888885 4543 346788999999998 67888999999999999999999877665543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=248.06 Aligned_cols=266 Identities=28% Similarity=0.322 Sum_probs=175.1
Q ss_pred CcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCc
Q 001171 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNA 176 (1133)
Q Consensus 97 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~ 176 (1133)
-..|+|++|+|+ .+|..+. ++|+.|++++|+++ .+|.. +++|++|++++|+|+. +|. .+++|+.|+|++|.
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~-lp~sL~~L~Ls~N~ 273 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPV-LPPGLLELSIFSNP 273 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccC-cccccceeeccCCc
Confidence 345666666666 5565554 35666666666666 35542 4566666666666663 332 45677777777777
Q ss_pred CCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCc
Q 001171 177 FTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGT 256 (1133)
Q Consensus 177 ~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 256 (1133)
++. +|..+ .+|+.|++++|+++ .+|.. +++|++|+|++|++++ +|... ++|+.|++++|+|+++ |..
T Consensus 274 L~~-Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~L-P~l 340 (788)
T PRK15387 274 LTH-LPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTSL-PTL 340 (788)
T ss_pred hhh-hhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCccccc-ccc
Confidence 763 33322 45667777777776 35542 3567777777777763 44422 3566777777777653 321
Q ss_pred ccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhh
Q 001171 257 IGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLT 336 (1133)
Q Consensus 257 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~ 336 (1133)
..+|++|+|++|+|++ +|.. .++|+.|++++|.++++. ..++.|+.|++++|+|+.+++ .
T Consensus 341 ---p~~Lq~LdLS~N~Ls~-LP~l--------p~~L~~L~Ls~N~L~~LP-----~l~~~L~~LdLs~N~Lt~LP~-l-- 400 (788)
T PRK15387 341 ---PSGLQELSVSDNQLAS-LPTL--------PSELYKLWAYNNRLTSLP-----ALPSGLKELIVSGNRLTSLPV-L-- 400 (788)
T ss_pred ---ccccceEecCCCccCC-CCCC--------CcccceehhhccccccCc-----ccccccceEEecCCcccCCCC-c--
Confidence 2467777777777774 3321 245667777777777532 123568888888888887643 2
Q ss_pred cccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCC
Q 001171 337 NVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGI 410 (1133)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 410 (1133)
.++|+.|++++|+|+. +|.. ..+|+.|++++|+|+ .+|..+.++++|+.|+|++|+|++..+..+..+
T Consensus 401 -~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 401 -PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred -ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 3678889999999884 5653 346788999999998 468888999999999999999998877766443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=266.23 Aligned_cols=199 Identities=17% Similarity=0.225 Sum_probs=137.1
Q ss_pred hccC-CCeeeEEEEEeCC------CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCce
Q 001171 888 KVKH-RNLTVLRGYYAGP------PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960 (1133)
Q Consensus 888 ~l~h-pniv~l~~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~iv 960 (1133)
.++| +||+.+++++... ....+.++||+ +++|.+++... ...+++..+..++.||++||+|||++||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4455 5777777776221 13346788887 67999999742 23488999999999999999999999999
Q ss_pred ecccCccceeeCC-------------------CCceEEeccCcccccccCCC-------C------CCCCCCCCCCCCcc
Q 001171 961 HGDIKPQNVLFDA-------------------DFEAHLSEFGLDRLAIATPA-------E------ASSSTTPIGSLGYV 1008 (1133)
Q Consensus 961 H~Dlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~~-------~------~~~~~~~~gt~~y~ 1008 (1133)
||||||+|||++. ++.+|++|||+++....... . ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44556666666653211000 0 00111246889999
Q ss_pred CccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHh
Q 001171 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVK 1088 (1133)
Q Consensus 1009 aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1088 (1133)
|||++.+..++.++|||||||++|||++|..|+... ......+... . .++.. ........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~--~~~~~~~~~~----~----~~~~~---------~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK--SRTMSSLRHR----V----LPPQI---------LLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH--HHHHHHHHHh----h----cChhh---------hhcCHHHHH
Confidence 999999999999999999999999999998886421 1111111111 0 01100 001112236
Q ss_pred hhhccCCCCCCCCCCHHHHHHH
Q 001171 1089 VGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1089 li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
++.+||+++|.+||++.|++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 7788999999999999999865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=205.74 Aligned_cols=168 Identities=20% Similarity=0.176 Sum_probs=124.7
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 997 (1133)
|+|.++++..+ ..+++..++.++.||+.||+|||+.+ ||+||+++.++.+++ ||.++.....
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------
Confidence 68999997632 34899999999999999999999998 999999999999999 9998654221
Q ss_pred CCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCCh-hhHHHHHHHHhhhccccccccCCcCCCCCC
Q 001171 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD-EDIVKWVKKQLQRGQISELLEPGLLELDPE 1076 (1133)
Q Consensus 998 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1133)
...|++.|||||++.+..++.++|||||||++|||++|+.||..... ......+....... ++... ..
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~---~~ 131 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------DPRDR---SN 131 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------Ccccc---cc
Confidence 12588999999999999999999999999999999999999964332 12222222211110 00000 01
Q ss_pred ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1077 ~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.....+.....+++.+||+.||++||++.|+++++...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11111111234899999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=223.89 Aligned_cols=175 Identities=19% Similarity=0.195 Sum_probs=132.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC--CceEEEEEEcccCC------cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ--DGMVLSIRRLRDGT------IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
..++|.+.++||+|+||+||+|+++ +++.||||++.... ...+.+.+|++++++++|+|++..+..+ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4568999999999999999999775 57888999875321 1245689999999999999998533222 2
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceeccc-CccceeeCCCCceEEeccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI-KPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a 985 (1133)
..++||||+++++|... .. .. ...++.++++||+|||++||+|||| ||+||+++.++.++|+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 24899999999999632 11 01 1356789999999999999999999 999999999999999999999
Q ss_pred cccccCCCCCC-----CCCCCCCCCCccCccccCCCC------CCCCCchh
Q 001171 986 RLAIATPAEAS-----SSTTPIGSLGYVSPEAASTGQ------PTKEADVY 1025 (1133)
Q Consensus 986 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 1025 (1133)
+.......... ......+++.|+|||++...+ .+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 86644322111 124567888999999986432 23445666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-21 Score=216.86 Aligned_cols=264 Identities=19% Similarity=0.220 Sum_probs=193.2
Q ss_pred CCCcccccccccceeEEEEEECC--ceEEEEEEcccCCcC-HHHHHHHHHHHhhccC----CCeeeEEEEEeCCCCcEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQD--GMVLSIRRLRDGTID-ENTFRKEAEALGKVKH----RNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h----pniv~l~~~~~~~~~~~~l 910 (1133)
+|.+.+.||+|+||.||.|.... ...+|+|........ ...+..|..++..+.. +++..+++.....+.+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999997754 357888887653222 2278889999999973 5888888877534456799
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-----CceEEeccCcc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-----FEAHLSEFGLD 985 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~a 985 (1133)
||+.+ |.+|.++..... ...++..+...++.|++.+|+++|+.|++||||||.|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 889999887654 3558999999999999999999999999999999999999765 35899999999
Q ss_pred c--ccccCCCC---CCC--CCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 986 R--LAIATPAE---ASS--STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 986 ~--~~~~~~~~---~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
+ ........ ... .....||.+|++++...+...+++.|+||++.++.|+..|..||...........+.+...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 33222211 111 2345699999999999999999999999999999999999999965543333333333222
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
...... . ......++. ++...+-..+..++|....+...++......
T Consensus 255 ~~~~~~-----~-----~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KLLTDR-----F-----GDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhcccc-----c-----cCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 211111 0 001111222 2222233478899999999999887665543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=243.71 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=124.3
Q ss_pred ccceeeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCcccc
Q 001171 62 DWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFN 141 (1133)
Q Consensus 62 ~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~ 141 (1133)
-|+...|-..+++.|++.+.+++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|.
T Consensus 169 ~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~---- 237 (754)
T PRK15370 169 VQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPA---- 237 (754)
T ss_pred HHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCCh----
Confidence 344455655555566665555543 333222 34555555555555 3444332 35555555555555 3443
Q ss_pred ccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecc
Q 001171 142 LTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLD 221 (1133)
Q Consensus 142 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 221 (1133)
.++++|+.|+|++|+++ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+++
T Consensus 238 --------------------~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 238 --------------------TLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred --------------------hhhccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 34444555555555554 3344332 34555555555555 3444432 355555555
Q ss_pred cccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCc
Q 001171 222 SNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNA 301 (1133)
Q Consensus 222 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~ 301 (1133)
+|+|+ .+|..+. ++|++|++++|+++.+ |..+ .++|+.|++++|.+++ +|..+ .++|+.|++++|.
T Consensus 292 ~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~-LP~~l-------~~sL~~L~Ls~N~ 357 (754)
T PRK15370 292 DNSIR-TLPAHLP--SGITHLNVQSNSLTAL-PETL--PPGLKTLEAGENALTS-LPASL-------PPELQVLDVSKNQ 357 (754)
T ss_pred CCccc-cCcccch--hhHHHHHhcCCccccC-Cccc--cccceeccccCCcccc-CChhh-------cCcccEEECCCCC
Confidence 55555 3343332 3455566666666543 2222 1456666666666654 33322 1344555555554
Q ss_pred ccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcc----cCCCCCCcEEEccCCccc
Q 001171 302 FTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAA----VGSLDKLEVLRVANNSLS 376 (1133)
Q Consensus 302 l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~n~l~ 376 (1133)
++... . .....|++|+|++|+|+.+++ .+. .+|+.|++++|+|. .+|.. ++.++.+..|+|.+|.++
T Consensus 358 L~~LP--~--~lp~~L~~LdLs~N~Lt~LP~-~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 358 ITVLP--E--TLPPTITTLDVSRNALTNLPE-NLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCC--h--hhcCCcCEEECCCCcCCCCCH-hHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 44221 0 012345666666666665533 232 24666666666665 33332 222344555555555543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-22 Score=199.25 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=183.7
Q ss_pred CCcccccccccceeEEEEEECCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
..+.-+|.+...|+.|+|+|+.+ .+++|++..... -.++|..|.-.++-..||||..++|.|..+++. .++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnl-v~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL-VIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc-eEeeeec
Confidence 34556788999999999999844 445566643222 246799999999999999999999999988655 8999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
+.|+|+..++... +-..+-.+..+++.+||+|++|||+.. |..--+.+..|++|++..++|. .+-+++..
T Consensus 270 p~gslynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf---- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF---- 341 (448)
T ss_pred cchHHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee----
Confidence 9999999998643 345777889999999999999999875 4445688999999999988874 11112111
Q ss_pred CCCCCCCCCCCCCccCccccCCCCC---CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQP---TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
......-.+.||+||.++.... -+++|+|||++++||+.|...||...++.+.--.+.-.. +...+.|+.
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg----lrv~ippgi 414 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG----LRVHIPPGI 414 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc----ccccCCCCc
Confidence 1122345678999999976653 467899999999999999999998777665443332211 111222222
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
. ....+++.-|+..||.+||.+..|+-.||+.
T Consensus 415 s------------~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 415 S------------RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred c------------HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1 1112677889999999999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=189.79 Aligned_cols=214 Identities=18% Similarity=0.234 Sum_probs=169.7
Q ss_pred HHhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhccCC-CeeeEEEEEeCCCCcEEEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHR-NLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~lV 911 (1133)
....+|.++++||.|+||.+|.|.. .+|+.||||.-..... ...+..|.++++.+++- .|..+..|..+. .+-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEK-DYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhcccc-ccceee
Confidence 3456899999999999999999954 6799999998765332 34678899999999763 344444444443 555899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC---CceEEeccCccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD---FEAHLSEFGLDRLA 988 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~ 988 (1133)
||.. |.+|.++..-..+ .++..+++-++-|++.-++|+|.++++||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 90 MdLL-GPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eecc-CccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9998 8899998876543 38899999999999999999999999999999999999654 45689999999876
Q ss_pred ccCCCC----CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHH
Q 001171 989 IATPAE----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054 (1133)
Q Consensus 989 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 1054 (1133)
.+.... ........||.+|.+-....+...+.+.|+-|+|.++.+.--|..||.+.....-.+...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 554332 223455679999999888888888999999999999999999999998765544443333
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-20 Score=190.07 Aligned_cols=211 Identities=16% Similarity=0.263 Sum_probs=170.7
Q ss_pred CCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.|.++++||+|+||+++.|.. -+++.||||.-+... +.-++..|.+.++.+. .+.|...+-|-.++ -.-.+|+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG-KYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeecccc-chhhhhhhhh
Confidence 588999999999999999954 479999999876533 3456888999999985 56776665444443 3337999998
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-----ceEEeccCccccccc
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-----EAHLSEFGLDRLAIA 990 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~a~~~~~ 990 (1133)
|-||.|+..-.++ .++..++..+|.|++.-++|+|++..|.|||||+|+||...+ .+.++|||+|+.+.+
T Consensus 107 -GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8899999887654 489999999999999999999999999999999999997543 478999999998776
Q ss_pred CCCCCC----CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHH
Q 001171 991 TPAEAS----SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055 (1133)
Q Consensus 991 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 1055 (1133)
...... ......||.+||+-....+++.+++.|+-|+|-++.+.+-|..||.+...+..-+...+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK 250 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK 250 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence 544322 23456799999999999999999999999999999999999999986554443333333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-19 Score=200.70 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=192.5
Q ss_pred CCcccccccccceeEEEEEECCceEEEEEEcccCCc----CHHHHHHHHHHHhhccCC-CeeeEEEEEeCCCCcEEEEEe
Q 001171 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHR-NLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~lV~e 913 (1133)
|.+.+.||.|+||.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++.+++... ...+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-GSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-CEEEEEEe
Confidence 677889999999999999877 7888898865433 256789999999999988 799999999554 33589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 992 (1133)
|+.++++.+++...... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999999777653321 2478888999999999999999999999999999999999988 79999999987443322
Q ss_pred CCC---CCCCCCCCCCCccCccccCC---CCCCCCCchhHHHHHHHHHHhCCCCCccCCh----hhHHHHHHHHhhhccc
Q 001171 993 AEA---SSSTTPIGSLGYVSPEAAST---GQPTKEADVYSFGIVLLEILTGRKPVMFTQD----EDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 993 ~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~~~ 1062 (1133)
... .......|+..|+|||.+.+ ..+....|+||+|++++++++|..||..... ......+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 211 13456789999999999987 5788999999999999999999999865543 2333332222111 00
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
........ . ........+++.+|+..+|..|.+..+....
T Consensus 236 ~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN-------P-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc-------c-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 0 1111122367888999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=224.90 Aligned_cols=252 Identities=21% Similarity=0.227 Sum_probs=176.5
Q ss_pred CcccccccccceeEEEEEEC-CceEEEEEEccc---CCcCH----HHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 840 DEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRD---GTIDE----NTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
...+++|.|++|.|+.+... ..+..+.|.... ....+ ..+..|+-+-..+.|||++..+..+.+.... +-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-LQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-hhh
Confidence 34578999999988877543 334444443321 11112 1255677788888999998777766554443 444
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||||++ +|+.++.... .+....+..++.|+..|++|+|+.||.|||+|++|+++..+|.+||+|||.+......
T Consensus 400 mE~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hhcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 999999 9999998642 3667788889999999999999999999999999999999999999999998644322
Q ss_pred CC-CCCCCCCCCCCCCccCccccCCCCCC-CCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 992 PA-EASSSTTPIGSLGYVSPEAASTGQPT-KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 992 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ........+|+..|+|||++.+..|. ...||||.|+++..|.+|+.||......+-.. ... ....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~---------~~~~ 542 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTN---------NYSD 542 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhh---------cccc
Confidence 22 12445667899999999999988884 56799999999999999999996433222110 000 0000
Q ss_pred cCCCC-CCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1070 LLELD-PESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1070 ~~~~~-~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
..... ....-+.... ....++.++++.||.+|.++++|++
T Consensus 543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 0011111111 1127899999999999999999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.1e-20 Score=189.59 Aligned_cols=181 Identities=13% Similarity=0.154 Sum_probs=136.3
Q ss_pred CcccHHHHHH--HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHH----------HHHHHHHHhhccCC
Q 001171 825 NKITYVETLE--ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT----------FRKEAEALGKVKHR 892 (1133)
Q Consensus 825 ~~~~~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~hp 892 (1133)
+...|.+... ...+|...+++|.|+||.||.+.. ++..+|+|.+.......+. +++|++.+.+++||
T Consensus 17 ~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 17 NDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred CcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 3333444432 567999999999999999999866 4678999999644332222 68999999999999
Q ss_pred CeeeEEEEEeCCC-------CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccC
Q 001171 893 NLTVLRGYYAGPP-------DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIK 965 (1133)
Q Consensus 893 niv~l~~~~~~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlk 965 (1133)
+|..+.+++.... ...++||||++|.+|.++.. ++. ....+++.++..+|+.|++|||+|
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dik 162 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPH 162 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCC
Confidence 9999998865321 34689999999999987732 222 245589999999999999999999
Q ss_pred ccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHH
Q 001171 966 PQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEIL 1035 (1133)
Q Consensus 966 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 1035 (1133)
|+||++++++ ++++|||..+....... ...+.....+..++|+|++|+++....
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~e~~a---------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTAQRKA---------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hHHEEEeCCC-EEEEECCCcccccchhh---------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999999988 99999998753311110 011334455678999999999988654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-20 Score=219.82 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=174.6
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccC--CcCHHHHHHHHHH--HhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDG--TIDENTFRKEAEA--LGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+|...+.+|++.|=.|.+|++++|. |+||++.+. ..+-+.|.++++- ...++|||++++.-+... +...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t-~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT-DKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh-hHHHHHHHH
Confidence 5778899999999999999999998 788887543 3344555554443 445589999987655433 344578888
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+ .-+|+|.+... ..+...+...|+.|++.|+.-+|+.||+|||||.+|||++.-.-+.++||..-+...-+.+
T Consensus 102 yv-khnLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HH-hhhhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 88 56888888753 3367778888999999999999999999999999999999999999999976543332222
Q ss_pred CCCCCCCC----CCCCCccCccccCCC----------C-CCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 994 EASSSTTP----IGSLGYVSPEAASTG----------Q-PTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 994 ~~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
.......+ ..-..|.|||.+... . .+++-||||+||+++|+++ |++||.- .+.....-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc
Confidence 22222111 222369999998431 1 4678899999999999999 7888841 11111110
Q ss_pred hhcc-----ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1058 QRGQ-----ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1058 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.... +.++-|... .+++..|++.||++|.++++.++.-++..
T Consensus 250 ~~~~~~e~~Le~Ied~~~----------------Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIEDVSL----------------RNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred cCccCHHHHHHhCcCccH----------------HHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 0000 001111111 16888899999999999999998866644
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-19 Score=184.00 Aligned_cols=137 Identities=15% Similarity=0.209 Sum_probs=106.8
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcC----------HH-----------------HHHHHHHHHhhccCCCe
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID----------EN-----------------TFRKEAEALGKVKHRNL 894 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------~~-----------------~~~~E~~~l~~l~hpni 894 (1133)
.+.||+|+||.||+|...+|+.||||+++.+... .. ...+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998888999999999654221 01 22349999999988776
Q ss_pred eeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHH-hcCCceecccCccceeeCC
Q 001171 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL-HSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 895 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~ivH~Dlkp~NIll~~ 973 (1133)
.....+... . .++||||++++++....... ..++......++.|++.+++|+ |+.||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~-~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--S-HVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--C-CEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 443333222 2 28999999887766543221 2378888999999999999999 799999999999999998
Q ss_pred CCceEEeccCcccc
Q 001171 974 DFEAHLSEFGLDRL 987 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~ 987 (1133)
++.++++|||+|..
T Consensus 153 ~~~v~LiDFG~a~~ 166 (190)
T cd05147 153 DGKLYIIDVSQSVE 166 (190)
T ss_pred CCcEEEEEcccccc
Confidence 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=178.45 Aligned_cols=137 Identities=17% Similarity=0.228 Sum_probs=108.9
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcC---------------------------HHHHHHHHHHHhhccCCCe
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---------------------------ENTFRKEAEALGKVKHRNL 894 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~hpni 894 (1133)
.+.||+|+||.||+|...+|+.||||++...... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999998878999999998754211 1123579999999999987
Q ss_pred eeEEEEEeCCCCcEEEEEeccCCCCHHHH-HHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeC
Q 001171 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATL-LQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 895 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~ 972 (1133)
.....+.... .++||||++++++... +.. ..++......++.+++.++.++|+ .||+||||||+||+++
T Consensus 82 ~~p~~~~~~~---~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK---NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC---CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 5554443332 3899999988755433 332 225677888999999999999999 9999999999999998
Q ss_pred CCCceEEeccCccccc
Q 001171 973 ADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~~ 988 (1133)
++.++++|||+++..
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=184.18 Aligned_cols=199 Identities=20% Similarity=0.224 Sum_probs=134.1
Q ss_pred cCCCeeeEEEEEeCC--------------------------CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHH
Q 001171 890 KHRNLTVLRGYYAGP--------------------------PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI 943 (1133)
Q Consensus 890 ~hpniv~l~~~~~~~--------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 943 (1133)
+|||||++.++|.+. +...|+||... ..+|.+++-... .+...+..+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC------CchHHHHHH
Confidence 599999998877431 23458899877 468888887532 455666778
Q ss_pred HHHHHHHHHHHhcCCceecccCccceee--CCCC--ceEEeccCcccccccCC---CCCCCCCCCCCCCCccCccccCCC
Q 001171 944 SLGLARGLSFLHSLDMVHGDIKPQNVLF--DADF--EAHLSEFGLDRLAIATP---AEASSSTTPIGSLGYVSPEAASTG 1016 (1133)
Q Consensus 944 ~~~ia~~L~~LH~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~ 1016 (1133)
..|+++|+.|||++||.|||+|++|||+ |+|+ ...|+|||++-...... .........-|.-.-||||+....
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 8899999999999999999999999999 3333 45899999874221110 011112233467788999998543
Q ss_pred C------CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhh
Q 001171 1017 Q------PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVG 1090 (1133)
Q Consensus 1017 ~------~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 1090 (1133)
. ...|+|.|+.|.+.||+++..-||.......+... ..++.+++.+.+..-. . .-+++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---~Yqe~qLPalp~~vpp-----------~--~rqlV 490 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---TYQESQLPALPSRVPP-----------V--ARQLV 490 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh---hhhhhhCCCCcccCCh-----------H--HHHHH
Confidence 2 25789999999999999999999976433222111 1333333333221110 0 11677
Q ss_pred hccCCCCCCCCCCHHHHHHHH
Q 001171 1091 LLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1091 ~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
...++.||.+|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 788999999998866444433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=175.17 Aligned_cols=185 Identities=17% Similarity=0.099 Sum_probs=135.8
Q ss_pred CcccccccccceeEEEEEECCceEEEEEEcccCCcCH-----HHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEe
Q 001171 840 DEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE-----NTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.+..+|++|+||+||.+.. .+..++.+.+.....-. ..+.+|+++|+++. |+++.+++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEe
Confidence 3567899999999998765 57778877776544322 25789999999995 5788888886 22489999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceeccc-CccceeeCCCCceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI-KPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|++|.+|.+.... . ...++.+++++++++|+.||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 79 yI~G~~L~~~~~~-----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh-----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999998754321 0 1246778999999999999999999 7999999999999999999997443221
Q ss_pred CC----C-CC-----CCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCc
Q 001171 993 AE----A-SS-----STTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVM 1042 (1133)
Q Consensus 993 ~~----~-~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~ 1042 (1133)
.. . .. ......++.|++|+...- ..--.+.+.++-|+-+|.++|++.|+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 00 011235677888875422 122245688899999999999998864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-20 Score=172.47 Aligned_cols=181 Identities=28% Similarity=0.540 Sum_probs=150.8
Q ss_pred ccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCcc
Q 001171 527 LFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALE 606 (1133)
Q Consensus 527 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 606 (1133)
++++..++.|.|++|+++ ..|..+..+.+|+.|++++|+|+ ..|..+..+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445556666777777776 45556777888888888888887 67888888899999999999988 8899999999999
Q ss_pred EEEecCCccc-CCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccc
Q 001171 607 VLELRSNHFT-GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685 (1133)
Q Consensus 607 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 685 (1133)
+|||.+|++. ..+|..|..+..|+.|+|+.|.+. .+|..++++++|+.|.+..|.+. ..|..++.+++|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 9999999987 358889999999999999999998 89999999999999999999998 78999999999999999999
Q ss_pred cccccCCccccccccC---cccccccccccc
Q 001171 686 RLSGAIPADLALISSL---RYLNLSRNNLEG 713 (1133)
Q Consensus 686 ~l~~~~p~~l~~l~~L---~~L~ls~N~l~~ 713 (1133)
+++ .+|++++++.-+ +.+.+.+|+|-.
T Consensus 184 rl~-vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 184 RLT-VLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred eee-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 998 788888876322 344555555543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-20 Score=211.06 Aligned_cols=279 Identities=24% Similarity=0.332 Sum_probs=157.4
Q ss_pred EEEccCCcCc-cccCccccCccccceeeccccccccc----CChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEE
Q 001171 415 IVSLGRNMFS-GLIPLSFGNLSQLETLNLSENDIRGN----IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLN 489 (1133)
Q Consensus 415 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~i~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 489 (1133)
.|+|..+.++ ......|..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.+ .+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~---------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL---------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence 4667777776 33444556666777777777777432 34445556667777777766542 01000
Q ss_pred cccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCC---CcEeeccCCcccc----cCCCCCCCC-ccCcEEE
Q 001171 490 LSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPS---LQVVSLEENNLSG----DVPEGFSSL-VGLQYLN 561 (1133)
Q Consensus 490 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~ 561 (1133)
..++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+
T Consensus 71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~ 143 (319)
T cd00116 71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV 143 (319)
T ss_pred -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence 112223334445555555555554333333333333 5555555555542 111223334 5566666
Q ss_pred cccccccCC----CCcccccccccceeecccCccCCC----CCccccCCCCccEEEecCCcccCC----Ccccccccccc
Q 001171 562 LSDNAFTGD----IPATYGFLRSLVFLSLSHNQISGM----IPAELGACSALEVLELRSNHFTGN----IPVDISHLSRI 629 (1133)
Q Consensus 562 Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L 629 (1133)
+++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|
T Consensus 144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L 223 (319)
T cd00116 144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL 223 (319)
T ss_pred cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence 666666532 223344455677777777766632 222334455777777777776532 22334556778
Q ss_pred CeeecCCCcccCcCchhhhc-----cCCCcEEEeecCCCCc----cCCccccCccccccccccccccccc----CCcccc
Q 001171 630 KKLDLGQNKLSGEIPKEISK-----CSSLVSLTLDMNSLSG----RIPESFSKLSNLTTLNLSTNRLSGA----IPADLA 696 (1133)
Q Consensus 630 ~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~ 696 (1133)
+.|++++|.+++.....+.. .+.|++|++++|.++. .+...+..+++|+.+++++|+++.. ....+.
T Consensus 224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~ 303 (319)
T cd00116 224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL 303 (319)
T ss_pred CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence 88888888777544444332 2678888888888762 2334455667788888888888754 333444
Q ss_pred cc-ccCcccccccccc
Q 001171 697 LI-SSLRYLNLSRNNL 711 (1133)
Q Consensus 697 ~l-~~L~~L~ls~N~l 711 (1133)
.. +.|+.+|+.+|++
T Consensus 304 ~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 304 EPGNELESLWVKDDSF 319 (319)
T ss_pred hcCCchhhcccCCCCC
Confidence 44 6788888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-19 Score=201.53 Aligned_cols=185 Identities=27% Similarity=0.393 Sum_probs=152.4
Q ss_pred ccccccceeEEEEEE----CCceEEEEEEcccCCcC---HHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 844 VLSRGRYGLIFKASY----QDGMVLSIRRLRDGTID---ENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
++|+|.||.|+.++. ..|..+|+|..++.... ......|..++...+ ||.+|+++..+..+. ..+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-KLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-chhHhhhhc
Confidence 479999999988732 34788999988654332 124556888899997 999999987777654 448999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
.+|.+...+.... .+.+.....+...+|-+++++|+.+|+|||+|++||+++.+|++++.|||+++.......
T Consensus 80 rgg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred ccchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999998887643 366677777888899999999999999999999999999999999999999976543221
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
.+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999997 567889999999999999999999965
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-19 Score=206.91 Aligned_cols=262 Identities=25% Similarity=0.313 Sum_probs=130.5
Q ss_pred chhhcccccceeeccCceeec----ccCcccCCCCCCcEEEccCCcccc------cCchhhccCCCccEEEccCCccccc
Q 001171 333 SWLTNVTSLRVMDLSGNFFSG----NLPAAVGSLDKLEVLRVANNSLSG------LVPDEIAKCSLLQMFDLEGNRFSGQ 402 (1133)
Q Consensus 333 ~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L~~L~Ls~N~l~~~ 402 (1133)
..|..+.+|++|+++++.++. .++..+...+.|++|+++++.+.+ .++..+..+++|+.|++++|.+.+.
T Consensus 17 ~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~ 96 (319)
T cd00116 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPD 96 (319)
T ss_pred HHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChh
Confidence 445556667777777776642 234445556667777777666652 2234555666777777777766654
Q ss_pred CCCccCCCCC---CcEEEccCCcCcc----ccCccccCc-cccceeeccccccccc----CChhhcCCCCCcEEecccCc
Q 001171 403 VPAFLGGIRG---LKIVSLGRNMFSG----LIPLSFGNL-SQLETLNLSENDIRGN----IPEEITRLSNLTTLNLSYNK 470 (1133)
Q Consensus 403 ~p~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~i~~~----~~~~l~~l~~L~~L~Ls~N~ 470 (1133)
.+..+..+.. |+.|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+..+.+|++|++++|.
T Consensus 97 ~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~ 176 (319)
T cd00116 97 GCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNG 176 (319)
T ss_pred HHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCC
Confidence 4444443333 6666666666552 122233344 5566666666665532 22234445556666666665
Q ss_pred CCCCC----CCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCccccc
Q 001171 471 FGGKV----PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD 546 (1133)
Q Consensus 471 l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 546 (1133)
+++.. +..+..+++|++|++++|.+++.... .++..+..+++|++|++++|.+++.
T Consensus 177 l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------------------~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 177 IGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------------------ALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred CchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--------------------HHHHHhcccCCCCEEecCCCcCchH
Confidence 55311 11122233444444444444322110 1112233344455555555544431
Q ss_pred CCCCCC-----CCccCcEEEcccccccC----CCCcccccccccceeecccCccCCC----CCccccCC-CCccEEEecC
Q 001171 547 VPEGFS-----SLVGLQYLNLSDNAFTG----DIPATYGFLRSLVFLSLSHNQISGM----IPAELGAC-SALEVLELRS 612 (1133)
Q Consensus 547 ~~~~~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l-~~L~~L~L~~ 612 (1133)
....+. ..+.|++|++++|.+++ .+...+..+++|+++++++|.++.. ....+... +.|++|++.+
T Consensus 237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (319)
T cd00116 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD 316 (319)
T ss_pred HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence 111111 13456666666666542 1223344446666677777766644 22233333 5667777666
Q ss_pred Cc
Q 001171 613 NH 614 (1133)
Q Consensus 613 N~ 614 (1133)
|.
T Consensus 317 ~~ 318 (319)
T cd00116 317 DS 318 (319)
T ss_pred CC
Confidence 64
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=5e-18 Score=181.62 Aligned_cols=235 Identities=21% Similarity=0.302 Sum_probs=143.9
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccC----------CCeeeEEEEEe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKH----------RNLTVLRGYYA 902 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h----------pniv~l~~~~~ 902 (1133)
.+...+.||.|+++.||.+.+. +|+.+|+|++..... +.+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566789999999999999886 589999999854332 13556666655544322 12222222221
Q ss_pred ---------CCC--C-----cEEEEEeccCCCCHHHHHHhhccCC--CCCCChHHHHHHHHHHHHHHHHHhcCCceeccc
Q 001171 903 ---------GPP--D-----VRLLVYDYMPNGNLATLLQEASHQD--GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDI 964 (1133)
Q Consensus 903 ---------~~~--~-----~~~lV~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dl 964 (1133)
... . ..+++|+-+ .++|.+++..-.... ........+..+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 110 1 125677777 678888765422111 122445566777799999999999999999999
Q ss_pred CccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCC--------CCCCCCchhHHHHHHHHHHh
Q 001171 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG--------QPTKEADVYSFGIVLLEILT 1036 (1133)
Q Consensus 965 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlG~il~el~t 1036 (1133)
||+|++++++|.++++||+....... .. .....+..|.+||..... .++.+.|.|++|+++|.|++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~---~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT---RY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE---EE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc---ee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999987643321 11 112345789999986432 46888999999999999999
Q ss_pred CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCC
Q 001171 1037 GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDR 1101 (1133)
Q Consensus 1037 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R 1101 (1133)
|..||..........+ .+.... +..+... .+|..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~--~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQ--FLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GGTTSS----HHHH--HHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cchhcC-CcCHHHH--HHHHHHccCCcccC
Confidence 9999975433221111 011111 2222222 68899999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=168.39 Aligned_cols=135 Identities=15% Similarity=0.181 Sum_probs=103.2
Q ss_pred CCcccccccccceeEEEEEECCceEEEEEEcccC-CcCHHHHHHHHHHHhhc-----cCCCeeeEEEEEeCCCC--c-EE
Q 001171 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDG-TIDENTFRKEAEALGKV-----KHRNLTVLRGYYAGPPD--V-RL 909 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~--~-~~ 909 (1133)
+.-.+.||+|+||.||. +......+||++... ....+.+.+|+++++.+ .||||++++|++.++.+ . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 443333368887643 22356799999999999 57999999999987642 2 23
Q ss_pred EEEec--cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHH-HHHhcCCceecccCccceeeCC----CCceEEecc
Q 001171 910 LVYDY--MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL-SFLHSLDMVHGDIKPQNVLFDA----DFEAHLSEF 982 (1133)
Q Consensus 910 lV~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~ivH~Dlkp~NIll~~----~~~~kl~Df 982 (1133)
+|+|| +.+|+|.+++.+.. +++. ..++.+++.++ +|||+++|+||||||+||+++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 55799999997521 3443 34567777777 9999999999999999999974 347999995
Q ss_pred C
Q 001171 983 G 983 (1133)
Q Consensus 983 g 983 (1133)
+
T Consensus 154 ~ 154 (210)
T PRK10345 154 I 154 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=199.21 Aligned_cols=196 Identities=19% Similarity=0.277 Sum_probs=152.3
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhcc---CCCeeeEEEEEeCCCCcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVK---HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~lV 911 (1133)
-.++|.+.+.||+|+||.||+|...+|+.||+|+-+.... -+|.--.+++.||+ -+.|+.+...+...+. .++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-SVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeehHHHHHhhchhhhcchHHHHHHHccCCc-ceee
Confidence 3457889999999999999999888899999999764432 22333344555555 2233444433333333 3899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC-------CCCceEEeccCc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD-------ADFEAHLSEFGL 984 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~-------~~~~~kl~Dfg~ 984 (1133)
+||.+.|+|.++++. .+..+|...+.++.|+++.+++||..+||||||||+|.++. ....++|+|||.
T Consensus 773 ~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999999984 34589999999999999999999999999999999999993 234579999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCC
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK 1039 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~ 1039 (1133)
+-...--. ........++|-.+-.+|+..++.++.++|.|.++-+++.|+.|++
T Consensus 848 siDm~lfp-~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFP-DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcC-CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 84322111 1234456678888999999999999999999999999999999975
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-18 Score=163.20 Aligned_cols=165 Identities=33% Similarity=0.607 Sum_probs=103.9
Q ss_pred cCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcE
Q 001171 456 TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQV 535 (1133)
Q Consensus 456 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 535 (1133)
..+++.+.|.||+|+++ .+|..++++.+|+.|++++|+++ .+|.+++++++|+.|+++-|++.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~--------------- 92 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN--------------- 92 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh---------------
Confidence 34555666666666665 44445555555555555555554 34444444444444444444443
Q ss_pred eeccCCcccccCCCCCCCCccCcEEEccccccc-CCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCc
Q 001171 536 VSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT-GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNH 614 (1133)
Q Consensus 536 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 614 (1133)
..|..|+.++.|+.|||.+|++. ...|..|..+..|+.|+|+.|.+. .+|..++++++|+.|.++.|.
T Consensus 93 ----------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 93 ----------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred ----------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 44455555555555555555543 245666666777777777777776 677778888888888888888
Q ss_pred ccCCCccccccccccCeeecCCCcccCcCchhhhcc
Q 001171 615 FTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKC 650 (1133)
Q Consensus 615 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 650 (1133)
+- .+|.+++.+.+|++|.+.+|+++ .+|.+++++
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 77 47888888888888888888887 677776654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8e-17 Score=183.12 Aligned_cols=216 Identities=26% Similarity=0.387 Sum_probs=158.6
Q ss_pred HhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCc-eeccc
Q 001171 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM-VHGDI 964 (1133)
Q Consensus 886 l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~i-vH~Dl 964 (1133)
|+.+.|.|+.+++|.+..+ ...+.|.+||..|+|.+.+... ...++|.....+.++|+.||+|+|...| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999887 4448999999999999999863 2448999999999999999999998876 99999
Q ss_pred CccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCC-------CCCCCchhHHHHHHHHHHhC
Q 001171 965 KPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ-------PTKEADVYSFGIVLLEILTG 1037 (1133)
Q Consensus 965 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlG~il~el~tg 1037 (1133)
++.|.++|....+|++|||+.......... .......-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999998654321110 1111112334689999986531 46779999999999999999
Q ss_pred CCCCccC----ChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1038 RKPVMFT----QDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1038 ~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
+.||... +++++..++++. -...+.|...... +.....+.++..||..+|++||++++|-..++.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~-----~~~~~rP~i~~~~------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKG-----GSNPFRPSIELLN------ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cCccccccccCChHHHHHHHHhc-----CCCCcCcchhhhh------hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 9999642 223344443331 1111112111100 111134478999999999999999999999888
Q ss_pred CcCCC
Q 001171 1114 CRVGP 1118 (1133)
Q Consensus 1114 ~~~~~ 1118 (1133)
.....
T Consensus 224 ~~~~~ 228 (484)
T KOG1023|consen 224 INKGG 228 (484)
T ss_pred hcccc
Confidence 66543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=168.42 Aligned_cols=133 Identities=21% Similarity=0.394 Sum_probs=109.4
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCCcC---------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
+.||+|++|.||+|.+ .|..|++|+....... ...+.+|++++..++|+++.....++..... .++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-FIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-CEEEEE
Confidence 5799999999999987 5777888876532211 2357789999999999998776666654433 489999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
|++|++|.+++... .. .+..++.+++.++.++|+.+++|||++|.||+++ ++.++++|||.++.
T Consensus 80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998642 12 7788999999999999999999999999999999 78899999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=166.77 Aligned_cols=139 Identities=15% Similarity=0.161 Sum_probs=107.8
Q ss_pred CCCcccccccccceeEEEEE--ECCceEEEEEEcccCCcC-------------------------HHHHHHHHHHHhhcc
Q 001171 838 QFDEENVLSRGRYGLIFKAS--YQDGMVLSIRRLRDGTID-------------------------ENTFRKEAEALGKVK 890 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~ 890 (1133)
-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ...+.+|+++++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999998 467999999998643210 123568999999997
Q ss_pred CCC--eeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC-ceecccCcc
Q 001171 891 HRN--LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD-MVHGDIKPQ 967 (1133)
Q Consensus 891 hpn--iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-ivH~Dlkp~ 967 (1133)
+.. +...+++ . . .++||||++++++....... ..........++.||+.+++|+|+.| |+|||+||+
T Consensus 109 ~~~i~~p~~~~~---~-~-~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW---R-R-NVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe---c-C-ceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 633 3333332 2 2 38999999998877654221 12445556789999999999999999 999999999
Q ss_pred ceeeCCCCceEEeccCcccc
Q 001171 968 NVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 968 NIll~~~~~~kl~Dfg~a~~ 987 (1133)
||+++ ++.++++|||.+..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=188.12 Aligned_cols=210 Identities=23% Similarity=0.368 Sum_probs=146.2
Q ss_pred hcCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..+|+.++.|..|+||.||.++++. .+.+|+ ++.+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccch----hhhc--cccccCCccee-------------------
Confidence 4578899999999999999998874 677888 4433221 1110 22222333322
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
|+-.+.++..+. ++. +++.+++|+|+.||+|||+||+|.+|+.-|++|++|||+++........
T Consensus 136 ---gDc~tllk~~g~-----lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-----LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC-----Ccc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 444445544332 222 2367999999999999999999999999999999999998654322111
Q ss_pred ------------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 995 ------------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 995 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
.-.....+||+.|+|||++....|++.+|.|++|+|+||.+.|+.||.+...+++...+...... +
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~--w 277 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--W 277 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc--c
Confidence 11123458999999999999999999999999999999999999999988888877776653211 1
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP 1102 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP 1102 (1133)
++- |.. .++ .+.+++.+.++.+|..|-
T Consensus 278 pE~-dea---~p~---------Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 278 PEE-DEA---LPP---------EAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccc-CcC---CCH---------HHHHHHHHHHHhChHhhc
Confidence 111 111 111 122677778888998884
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=158.83 Aligned_cols=134 Identities=16% Similarity=0.142 Sum_probs=106.7
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCcC-----------------------HHHHHHHHHHHhhccCCC-
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID-----------------------ENTFRKEAEALGKVKHRN- 893 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~hpn- 893 (1133)
.|.+.+.||+|+||.||+|..++|+.||||++..+... ...+.+|..++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 48888999999999999998888999999987543210 123677899999998874
Q ss_pred -eeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC
Q 001171 894 -LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 894 -iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~ 972 (1133)
+...++. ...++||||+++++|...... .....++.+++.++.++|+.||+||||||+||+++
T Consensus 96 ~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 96 PVPKPIDW-----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCceeec-----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3333332 234899999999988765321 23456888999999999999999999999999999
Q ss_pred CCCceEEeccCcccc
Q 001171 973 ADFEAHLSEFGLDRL 987 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~ 987 (1133)
+++.++++|||++..
T Consensus 160 ~~~~~~liDfg~~~~ 174 (198)
T cd05144 160 DDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCcEEEEECCcccc
Confidence 999999999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.5e-16 Score=188.31 Aligned_cols=135 Identities=35% Similarity=0.595 Sum_probs=109.6
Q ss_pred ccCchhHHHHHHHHHHhCCCCCCCccCCCCCCCCCC--CccceeeeCC------CceEEEeeCCcccCcccchhhccccc
Q 001171 25 NAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAP--CDWRGIVCYN------NRVRELRLPRLQLAGRLTDQLADLHE 96 (1133)
Q Consensus 25 ~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~--c~w~gv~c~~------~~v~~l~l~~~~l~g~~~~~l~~l~~ 96 (1133)
.++...|++||++||+++.+|.. .+|+. ++..| |.|.||+|+. .+|+.|+|.++++.|.+|+.++.+++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 35667899999999999977643 58964 22111 2799999952 25899999999999999999999999
Q ss_pred CcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCc
Q 001171 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISAD 162 (1133)
Q Consensus 97 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 162 (1133)
|+.|+|++|++.|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|.++|.+|..
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 509 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence 999999999999999999999999999999999999999999998887766665555555544443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.8e-16 Score=172.61 Aligned_cols=176 Identities=22% Similarity=0.346 Sum_probs=128.9
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
+.|+.|++|...+|.+|+.+.+. ....++.....++.|++.|++| ++.+|||+||.||++..+..+||+|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 45899999999999999986443 3456788888999999999999 999999999999999999999999999975
Q ss_pred ccccCC---CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccc
Q 001171 987 LAIATP---AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 987 ~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
...... ......+...||..||+||.+.+..|+.++||||+|++++|++. =..+|. .......++.+.+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r~g~i 477 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-------RIATLTDIRDGII 477 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-------HHHhhhhhhcCCC
Confidence 443222 01223456689999999999999999999999999999999986 122221 1111122233333
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHH
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ev 1107 (1133)
++.+- .++.....+..+++.+.|.+||++.++
T Consensus 478 p~~~~-------------~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 478 PPEFL-------------QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ChHHh-------------hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 31111 111122356778999999999955443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=160.35 Aligned_cols=129 Identities=21% Similarity=0.405 Sum_probs=102.4
Q ss_pred ccccccceeEEEEEECCceEEEEEEcccCCc---------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 844 VLSRGRYGLIFKASYQDGMVLSIRRLRDGTI---------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.||+|+||.||+|.+. |..|++|+...... ....+.+|+++++.++|+++.....++..... .++||||
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-KTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-CEEEEEE
Confidence 4899999999999864 67888888643211 12456789999999998876544444443333 4899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
++|++|.+++.... . .++.+++.++.++|+.|++|||++|.||+++ ++.+++.|||.++.
T Consensus 79 ~~g~~l~~~~~~~~--------~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--------D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH--------H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998876421 0 6889999999999999999999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-15 Score=181.53 Aligned_cols=137 Identities=21% Similarity=0.325 Sum_probs=108.1
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc--------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI--------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
...|...+.||+|+||+||+|.+.....++.+++.+... ..+.+.+|++++++++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~- 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE- 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-
Confidence 345567889999999999999876544333222222111 12467899999999999999887776665433
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++++|.+++. .+..++.++++++.|||+.+|+|||+||+||++ .++.++++|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 489999999999998875 235688999999999999999999999999999 678999999999854
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=148.25 Aligned_cols=135 Identities=19% Similarity=0.240 Sum_probs=103.0
Q ss_pred ccccc-cccceeEEEEEECCceEEEEEEcccCC--------------cCHHHHHHHHHHHhhccCCCe--eeEEEEEeCC
Q 001171 842 ENVLS-RGRYGLIFKASYQDGMVLSIRRLRDGT--------------IDENTFRKEAEALGKVKHRNL--TVLRGYYAGP 904 (1133)
Q Consensus 842 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 904 (1133)
..+|| .|+.|+||.+... +..+++|++..+. .....+.+|++++.+++|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8889999999775 6778888774321 123567889999999998875 5666664433
Q ss_pred CCc---EEEEEeccCC-CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEe
Q 001171 905 PDV---RLLVYDYMPN-GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLS 980 (1133)
Q Consensus 905 ~~~---~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 980 (1133)
... .++||||+++ .+|.+++... .++.. .+.+|+.++.+||+.||+||||||+|||++.++.++++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence 222 2499999997 6899887642 13332 35789999999999999999999999999999999999
Q ss_pred ccCcccc
Q 001171 981 EFGLDRL 987 (1133)
Q Consensus 981 Dfg~a~~ 987 (1133)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.5e-14 Score=147.60 Aligned_cols=133 Identities=17% Similarity=0.199 Sum_probs=96.2
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcCH---HH----------------------HHHHHHHHhhccCCC--e
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE---NT----------------------FRKEAEALGKVKHRN--L 894 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~----------------------~~~E~~~l~~l~hpn--i 894 (1133)
.+.||+|+||.||+|...+|+.||||++....... .. ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988889999999986532211 11 135666666665443 3
Q ss_pred eeEEEEEeCCCCcEEEEEeccCCCCHHH-HHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeC
Q 001171 895 TVLRGYYAGPPDVRLLVYDYMPNGNLAT-LLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 895 v~l~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~ 972 (1133)
.+.+++. ..++||||++++.+.. .+.... .. .....++.+++.++.++|+ .+|+|||+||+||+++
T Consensus 82 ~~~~~~~-----~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDLN-----RHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEecC-----CCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333321 2389999999854321 111110 11 4567789999999999999 9999999999999999
Q ss_pred CCCceEEeccCcccc
Q 001171 973 ADFEAHLSEFGLDRL 987 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~ 987 (1133)
++.++++|||.+..
T Consensus 150 -~~~~~liDfg~a~~ 163 (187)
T cd05119 150 -DGKVYIIDVPQAVE 163 (187)
T ss_pred -CCcEEEEECccccc
Confidence 89999999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.2e-14 Score=171.07 Aligned_cols=118 Identities=41% Similarity=0.636 Sum_probs=81.0
Q ss_pred ccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccc
Q 001171 628 RIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLS 707 (1133)
Q Consensus 628 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls 707 (1133)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 35666777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cccccccCCccccCCCCC--CcccCcCccccCCCCCCCCc
Q 001171 708 RNNLEGEIPKMLSSRFND--PSIFAMNRELCGKPLDRECA 745 (1133)
Q Consensus 708 ~N~l~~~~p~~~~~~~~~--~~~~~~n~~lcg~~~~~~c~ 745 (1133)
+|+++|.+|..+...+.. .-.+.+|..+||.|....|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 777777777655432211 11277888899887666775
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.8e-13 Score=134.49 Aligned_cols=131 Identities=16% Similarity=0.178 Sum_probs=108.5
Q ss_pred cccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccC--CCeeeEEEEEeCCCCcEEEEEeccCCC
Q 001171 841 EENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKH--RNLTVLRGYYAGPPDVRLLVYDYMPNG 918 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~lV~e~~~~g 918 (1133)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+++++.++| ..+.+++++.... +..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecCCe
Confidence 35679999999999998864 7889999865443 5678999999999977 4888888877655 4559999999887
Q ss_pred CHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC---CceecccCccceeeCCCCceEEeccCccc
Q 001171 919 NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL---DMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 919 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
.+..+ +......++.+++++++++|.. +++|+|++|+||++++.+.+++.|||.++
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 66533 3455667889999999999985 69999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.6e-15 Score=175.10 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=182.6
Q ss_pred CCCcccccccccceeEEEEEEC--CceEEEEEEcccCCcC---HHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ--DGMVLSIRRLRDGTID---ENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV 911 (1133)
.|.+.+.||+|+|+.|-..... ....+|+|.+.....+ ......|..+-+.+. |+|++..++.....+. .+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~-~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS-YLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc-cccc
Confidence 5677788999999999888553 3456677776543322 234455888888886 9999999998877644 4899
Q ss_pred EeccCCCCHHHHH-HhhccCCCCCCChHHHHHHHHHHHHHHHHHh-cCCceecccCccceeeCCCC-ceEEeccCccccc
Q 001171 912 YDYMPNGNLATLL-QEASHQDGHVLNWPMRHLISLGLARGLSFLH-SLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLA 988 (1133)
Q Consensus 912 ~e~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 988 (1133)
.+|..++++.+-+ +... ...+......+..|+..++.|+| ..+++|||+||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998877 3221 12555666778899999999999 99999999999999999999 9999999999766
Q ss_pred ccCCCCCCCCCCCCC-CCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhh--HHHHHHHHhhhccccc
Q 001171 989 IATPAEASSSTTPIG-SLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDED--IVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~ 1064 (1133)
.............+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......+ ...|.... .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 252 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRFTQ 252 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccccc
Confidence 553344444556678 9999999999875 44788999999999999999999997554332 12221111 00000
Q ss_pred cccCCcCCCCCCChhHHHHHH-hHhhhhccCCCCCCCCCCHHHHH
Q 001171 1065 LLEPGLLELDPESSEWEEFLL-GVKVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~-~~~li~~Cl~~dP~~RPs~~evl 1108 (1133)
..|..... ..++..+++..+|..|.+.+++.
T Consensus 253 -------------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 253 -------------LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -------------CccccCChhhhhcccccccCCchhcccccccc
Confidence 00111111 12567778889999999988875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.3e-15 Score=163.75 Aligned_cols=182 Identities=30% Similarity=0.529 Sum_probs=124.1
Q ss_pred CcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCccccccccccee
Q 001171 505 SLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFL 584 (1133)
Q Consensus 505 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 584 (1133)
.++.-...|++.|++. ++|..+..+..|+.+.|..|.+. .+|..+.++..|++|||+.|+++ ..|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3444556777777776 67777777777777777777776 56667777777777777777776 5565665554 6677
Q ss_pred ecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCC
Q 001171 585 SLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664 (1133)
Q Consensus 585 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 664 (1133)
-+++|+++ .+|..++....|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|.+++ .-.|..||+|+|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee
Confidence 77777776 66666776677777777777776 46666777777777777777776 5666666 335667777777777
Q ss_pred ccCCccccCcccccccccccccccccCCcccc
Q 001171 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADLA 696 (1133)
Q Consensus 665 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 696 (1133)
.+|-.|.+|+.|++|-|.+|.|+ ..|..++
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 56777777777777777777776 3444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-14 Score=159.58 Aligned_cols=193 Identities=29% Similarity=0.510 Sum_probs=121.8
Q ss_pred CCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEc
Q 001171 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562 (1133)
Q Consensus 483 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 562 (1133)
..-...+|+.|++. .+|..++.+..|+.+.|+.|.+. .+|..++++..|++|+|+.|+++ ..|..+..++ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 33345666666666 56666666666677777776665 56666777777777777777766 4555555444 666777
Q ss_pred ccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCc
Q 001171 563 SDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGE 642 (1133)
Q Consensus 563 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 642 (1133)
++|+++ .+|..++..+.|..||.+.|.|. .+|..++.+.+|+.|.++.|++. .+|.++..| .|..||+|.|+++ .
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y 225 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence 777766 56666666666777777777766 56666666677777777777766 356566543 3666777777776 6
Q ss_pred CchhhhccCCCcEEEeecCCCCccCCcccc---Ccccccccccccc
Q 001171 643 IPKEISKCSSLVSLTLDMNSLSGRIPESFS---KLSNLTTLNLSTN 685 (1133)
Q Consensus 643 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N 685 (1133)
+|-+|.+|..|+.|-|.+|.++ ..|..++ ...=-++|+..-+
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 6777777777777777777776 3444332 2223344555444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.4e-12 Score=147.20 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=101.6
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcC-----------------------------------------HHHHH
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID-----------------------------------------ENTFR 880 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------------------------------~~~~~ 880 (1133)
.+.||+|++|.||+|+.++|+.||||+.+.+... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999998643210 01245
Q ss_pred HHHHHHhhcc----CCCeeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHH-HHHHHh
Q 001171 881 KEAEALGKVK----HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR-GLSFLH 955 (1133)
Q Consensus 881 ~E~~~l~~l~----hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH 955 (1133)
+|++.+.+++ |.+-+.+-.++.+.....++||||++|+++.++...... .. .+..++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 5777666663 333334434443322345899999999999887654211 01 23456666666 478899
Q ss_pred cCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 956 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
..|++|+|+||.||+++.++.++++|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=151.58 Aligned_cols=198 Identities=37% Similarity=0.548 Sum_probs=122.4
Q ss_pred EEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCc-cCcEEEcccccccCCCCcccccccccceeecccC
Q 001171 511 TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLV-GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHN 589 (1133)
Q Consensus 511 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 589 (1133)
.++++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555543 22233444455666666666665 3334444443 6666666666665 34455666677777777777
Q ss_pred ccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCc
Q 001171 590 QISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPE 669 (1133)
Q Consensus 590 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~ 669 (1133)
+++ .+|...+..++|+.|++++|+++ .+|..+.....|++|++++|.+. ..+..+.++.++..+.+.+|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 776 44444445667777777777776 46655555556777777777543 456666777777777777777763 356
Q ss_pred cccCcccccccccccccccccCCccccccccCcccccccccccccCCc
Q 001171 670 SFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 670 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
.++.+++|++|++++|.++. ++. ++.+.+|+.|++++|.+....|.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchh
Confidence 66777777777777777763 333 67777777777777777765554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3e-12 Score=149.97 Aligned_cols=109 Identities=35% Similarity=0.497 Sum_probs=47.9
Q ss_pred CCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCee
Q 001171 553 SLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKL 632 (1133)
Q Consensus 553 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 632 (1133)
.+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+..+.++..+.+.+|++.. .+..++.++.++.|
T Consensus 184 ~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L 260 (394)
T COG4886 184 NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETL 260 (394)
T ss_pred hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhcccccccee
Confidence 3344444444444443 23333333333444444444322 233334444444444444444442 23444444445555
Q ss_pred ecCCCcccCcCchhhhccCCCcEEEeecCCCCcc
Q 001171 633 DLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR 666 (1133)
Q Consensus 633 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 666 (1133)
++++|.++ .++. ++.+.+++.|++++|.+...
T Consensus 261 ~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 261 DLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred cccccccc-cccc-ccccCccCEEeccCcccccc
Confidence 55555554 2222 44455555555555555433
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-13 Score=143.39 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=129.2
Q ss_pred chhhcccccCcEEEcccCcccC----CCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCcc
Q 001171 88 TDQLADLHELRKLSLHSNHLNG----SIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI 163 (1133)
Q Consensus 88 ~~~l~~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~ 163 (1133)
-+.+.....+++|+|++|.+.- .+-..+.+.++|+..++|+ -|+| ..-..+
T Consensus 23 ~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftG------------------------R~~~Ei 77 (382)
T KOG1909|consen 23 EEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTG------------------------RLKDEI 77 (382)
T ss_pred HHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcC------------------------CcHHHH
Confidence 3445566777777777777652 3344455556666666654 2333 222222
Q ss_pred CCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCc----ccccCccccceEecccccccCCCC-ccccCccc
Q 001171 164 SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP----ASVGQLQELEYLWLDSNHLYGTLP-SAISNCSS 238 (1133)
Q Consensus 164 ~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~ 238 (1133)
|+.|+.| ...+...++|++||||+|-|.-.-+ +-+.++.+|++|+|.+|.+. ..- ..++ ..
T Consensus 78 ~e~L~~l-----------~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~--~a 143 (382)
T KOG1909|consen 78 PEALKML-----------SKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLG--RA 143 (382)
T ss_pred HHHHHHH-----------HHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHH--HH
Confidence 2222211 1222333456666666665542222 22445666777777766553 111 1111 12
Q ss_pred cceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCcccccc
Q 001171 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLE 318 (1133)
Q Consensus 239 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~ 318 (1133)
|.+|. .|+. ...-+.|+++..++|++.. -+...+...|..++.|+.+.+.+|.|...
T Consensus 144 l~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen-~ga~~~A~~~~~~~~leevr~~qN~I~~e------------- 200 (382)
T KOG1909|consen 144 LFELA--VNKK-------AASKPKLRVFICGRNRLEN-GGATALAEAFQSHPTLEEVRLSQNGIRPE------------- 200 (382)
T ss_pred HHHHH--HHhc-------cCCCcceEEEEeecccccc-ccHHHHHHHHHhccccceEEEecccccCc-------------
Confidence 33332 2221 2234577888888888753 34333344445555666666666555321
Q ss_pred EEeccCCcccccCCchhhcccccceeeccCceeecc----cCcccCCCCCCcEEEccCCcccccCchhh-----ccCCCc
Q 001171 319 VLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGN----LPAAVGSLDKLEVLRVANNSLSGLVPDEI-----AKCSLL 389 (1133)
Q Consensus 319 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L 389 (1133)
.+ .+.-..|..+++|++|||.+|.++.. +...+..+++|++|++++|.++..-...| ...++|
T Consensus 201 -------G~-~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L 272 (382)
T KOG1909|consen 201 -------GV-TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSL 272 (382)
T ss_pred -------hh-HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCC
Confidence 01 11235678888888888888887632 23456667778888888887775443333 234566
Q ss_pred cEEEccCCccc
Q 001171 390 QMFDLEGNRFS 400 (1133)
Q Consensus 390 ~~L~Ls~N~l~ 400 (1133)
++|.|.+|.|+
T Consensus 273 ~vl~l~gNeIt 283 (382)
T KOG1909|consen 273 EVLELAGNEIT 283 (382)
T ss_pred ceeccCcchhH
Confidence 66666666664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.8e-11 Score=121.29 Aligned_cols=127 Identities=20% Similarity=0.173 Sum_probs=95.6
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCee-eEEEEEeCCCCcEEEEEeccCCCCH
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT-VLRGYYAGPPDVRLLVYDYMPNGNL 920 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~lV~e~~~~gsL 920 (1133)
.+.++.|.++.||+++.. +..|++|...........+.+|+++++.+.+..++ +++.+. .. ..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~--~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-PE--TGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-CC--CCeEEEEecCCCcc
Confidence 356899999999999876 77899999865443334578899999999765554 344433 22 23799999999876
Q ss_pred HHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCc-----eecccCccceeeCCCCceEEeccCccc
Q 001171 921 ATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM-----VHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 921 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~i-----vH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
.+. . . ....++.+++++++.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~-~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-D---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-c---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 542 0 0 112356789999999999885 9999999999999 6789999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.9e-11 Score=138.99 Aligned_cols=142 Identities=16% Similarity=0.213 Sum_probs=96.8
Q ss_pred cCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCcC----------------------------------------
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTID---------------------------------------- 875 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---------------------------------------- 875 (1133)
..|+. +.||+|++|.||+|++++ |+.||||+.+.+...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999987 999999998644210
Q ss_pred -HHHHHHHHHHHhhcc----CCCeeeEEEEEeCCCCcEEEEEeccCCCCHHHHH--HhhccCCCCCCChHHHHHHHHHHH
Q 001171 876 -ENTFRKEAEALGKVK----HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLL--QEASHQDGHVLNWPMRHLISLGLA 948 (1133)
Q Consensus 876 -~~~~~~E~~~l~~l~----hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia 948 (1133)
+-++.+|+..+.+++ +...+.+-.+|.+-....++||||++|+.+.++- ...+ .+. ..++...+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g------~d~---~~la~~~v 269 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG------TDM---KLLAERGV 269 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC------CCH---HHHHHHHH
Confidence 012455666666663 4445555555544334458999999999998742 2211 111 12222222
Q ss_pred -HHHHHHhcCCceecccCccceeeCCCC----ceEEeccCccccc
Q 001171 949 -RGLSFLHSLDMVHGDIKPQNVLFDADF----EAHLSEFGLDRLA 988 (1133)
Q Consensus 949 -~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~ 988 (1133)
.-+..++..|++|+|+||.||+++.++ .+++.|||++...
T Consensus 270 ~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 270 EVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 223344579999999999999999888 8999999998654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.2e-12 Score=127.55 Aligned_cols=137 Identities=26% Similarity=0.323 Sum_probs=101.3
Q ss_pred cccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCC
Q 001171 573 ATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSS 652 (1133)
Q Consensus 573 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 652 (1133)
..+...+.|++||||+|.|+ .+.+...-.+.++.|++++|.|+. + ..+..+++|+.||||+|.++ .+..+-.++-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 33444566788888888887 555666667888888888888872 2 23777888888888888887 56666667788
Q ss_pred CcEEEeecCCCCccCCccccCccccccccccccccccc-CCccccccccCcccccccccccccC
Q 001171 653 LVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGA-IPADLALISSLRYLNLSRNNLEGEI 715 (1133)
Q Consensus 653 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~ls~N~l~~~~ 715 (1133)
.+.|.|+.|.|.. -..+.++-+|..||+++|++... -...+++++-|+.+.|.+|++.+.+
T Consensus 354 IKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 354 IKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred EeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 8888888888763 24567788888888888888632 2346788888999999999998643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.8e-11 Score=122.82 Aligned_cols=209 Identities=19% Similarity=0.301 Sum_probs=140.1
Q ss_pred HHHHHhhccCCCeeeEEEEEeCCC----CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 001171 882 EAEALGKVKHRNLTVLRGYYAGPP----DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957 (1133)
Q Consensus 882 E~~~l~~l~hpniv~l~~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 957 (1133)
-..-+-++.|.|+|+++.|+.+.. ....++.|||..|++.+++++.+... ..+......+++-||..||.|||+-
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 344466678999999999987542 23478999999999999999866532 3466777788999999999999976
Q ss_pred --CceecccCccceeeCCCCceEEeccCcccccccCC-CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHH
Q 001171 958 --DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP-AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEI 1034 (1133)
Q Consensus 958 --~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el 1034 (1133)
.|+|+++.-+-|++..+|-+|++--.-........ ..........+-++|.|||.-.....+.++|||+||+...||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 49999999999999999988875211100000000 000011122466799999987777778899999999999999
Q ss_pred HhCCCC-CccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1035 LTGRKP-VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1035 ~tg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
..+..- -...+.-.....+.. .......++. ...+.+|++..|..||+|.+++.+.-
T Consensus 276 ailEiq~tnseS~~~~ee~ia~------~i~~len~lq---------------r~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIAN------VIIGLENGLQ---------------RGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHheeccCCCcceeehhhhhhh------heeeccCccc---------------cCcCcccccCCCCCCcchhhhhcCce
Confidence 887642 111111110000000 0001111111 15678899999999999999886543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=126.73 Aligned_cols=134 Identities=31% Similarity=0.336 Sum_probs=106.4
Q ss_pred CCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccC
Q 001171 551 FSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIK 630 (1133)
Q Consensus 551 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 630 (1133)
......|++||||+|.|+ .+..+..-.|.++.|++|+|.|... ..+..+++|+.|||++|.++. +..+=..+.+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEe
Confidence 344567888888888887 4566777788899999999998733 337888999999999998873 555555678899
Q ss_pred eeecCCCcccCcCchhhhccCCCcEEEeecCCCCcc-CCccccCccccccccccccccccc
Q 001171 631 KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR-IPESFSKLSNLTTLNLSTNRLSGA 690 (1133)
Q Consensus 631 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~ 690 (1133)
.|.|++|.|.. -..+.++-+|..||+++|+|... -...+++++-|+++.|.+|.+.+.
T Consensus 356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 99999999873 24577888999999999999752 235789999999999999999853
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.2e-12 Score=145.80 Aligned_cols=244 Identities=29% Similarity=0.342 Sum_probs=114.5
Q ss_pred CccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccc
Q 001171 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNIS 290 (1133)
Q Consensus 211 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~ 290 (1133)
.+..++.+++..|.+. .+-..+..+.+|+.|++.+|+|..+. ..+..+++|++|+|++|+|+...+. ..++
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~~l-------~~l~ 140 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLEGL-------STLT 140 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcc-cchhhhhcchheeccccccccccch-------hhcc
Confidence 3444444455555554 22233445555556666666555432 1145566666666666666544332 2334
Q ss_pred cccEEeccCCcccccccCCCCCccccccEEeccCCcccccCC-chhhcccccceeeccCceeecccCcccCCCCCCcEEE
Q 001171 291 SLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFP-SWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLR 369 (1133)
Q Consensus 291 ~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 369 (1133)
.|+.|++.+|.++.. ..+..+..|+.+++++|++..+.+ . ...+.+|+.+++.+|.+.. ...+..+..+..++
T Consensus 141 ~L~~L~l~~N~i~~~---~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~ 214 (414)
T KOG0531|consen 141 LLKELNLSGNLISDI---SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLS 214 (414)
T ss_pred chhhheeccCcchhc---cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhh
Confidence 455555555555443 223334555566666666665544 2 3555566666666666542 12333344444445
Q ss_pred ccCCcccccCchhhccCC--CccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccc
Q 001171 370 VANNSLSGLVPDEIAKCS--LLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI 447 (1133)
Q Consensus 370 L~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i 447 (1133)
+..|.++...+ +..+. +|+.+++++|++.. ++ ..+..+.++..|++.+|++
T Consensus 215 l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~------------------------~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 215 LLDNKISKLEG--LNELVMLHLRELYLSGNRISR-SP------------------------EGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred cccccceeccC--cccchhHHHHHHhcccCcccc-cc------------------------ccccccccccccchhhccc
Confidence 55555543221 11111 24555555555541 11 3334444555555555544
Q ss_pred cccCChhhcCCCCCcEEecccCcCCC---CCCCC-CCCCCCCcEEEcccCCCccc
Q 001171 448 RGNIPEEITRLSNLTTLNLSYNKFGG---KVPYD-VGNLKGLLVLNLSASGFSGK 498 (1133)
Q Consensus 448 ~~~~~~~l~~l~~L~~L~Ls~N~l~~---~~~~~-~~~l~~L~~L~L~~N~l~~~ 498 (1133)
... ..+.....+..+.+..|.+.. ..... .+..+.++.+.+..|.+...
T Consensus 268 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 268 SNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred ccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccc
Confidence 421 223333444444455554431 11111 34455566666666655543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-11 Score=144.77 Aligned_cols=242 Identities=28% Similarity=0.323 Sum_probs=131.5
Q ss_pred CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeec
Q 001171 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSL 538 (1133)
Q Consensus 459 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 538 (1133)
..++.+++..|.+.. +-..+..+++|..|++.+|+|.. +...+..+++|++|++++|.|+... .+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhhee
Confidence 334444444444441 22334445555555555555542 2222556677777777777776432 2455555777777
Q ss_pred cCCcccccCCCCCCCCccCcEEEcccccccCCCC-cccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccC
Q 001171 539 EENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP-ATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG 617 (1133)
Q Consensus 539 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 617 (1133)
++|.|+.. ..+..++.|+.+++++|+++..-+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.++.
T Consensus 148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred ccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccccee
Confidence 77777632 345557777777777777764333 1 45666777777777777522 233444555555777777663
Q ss_pred CCcccccccc--ccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccccccccccccccc--CCc
Q 001171 618 NIPVDISHLS--RIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGA--IPA 693 (1133)
Q Consensus 618 ~~p~~l~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~ 693 (1133)
.-+ +..+. .|+.+++++|.+. .++..+..+..+..|++.+|++... ..+.....+..+.+..|.+... +..
T Consensus 223 ~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (414)
T KOG0531|consen 223 LEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQ 297 (414)
T ss_pred ccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhc
Confidence 221 22222 2677777777776 4434555566666666666666532 2334455555666666655421 111
Q ss_pred c--ccccccCccccccccccccc
Q 001171 694 D--LALISSLRYLNLSRNNLEGE 714 (1133)
Q Consensus 694 ~--l~~l~~L~~L~ls~N~l~~~ 714 (1133)
. ....+.++.+.+.+|++...
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 298 EYITSAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred cccccccccccccccccCccccc
Confidence 1 33344555555555555443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.2e-12 Score=135.90 Aligned_cols=197 Identities=22% Similarity=0.281 Sum_probs=113.6
Q ss_pred cCccccceeecccccccccCChh----hcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcc
Q 001171 432 GNLSQLETLNLSENDIRGNIPEE----ITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLM 507 (1133)
Q Consensus 432 ~~l~~L~~L~L~~N~i~~~~~~~----l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 507 (1133)
..+++|++|+||+|-+.-..+.. +.++.+|++|.|.+|.+...--..++ ..|..|. . ..-.++-+
T Consensus 89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~-------~kk~~~~~ 157 (382)
T KOG1909|consen 89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--V-------NKKAASKP 157 (382)
T ss_pred hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--H-------HhccCCCc
Confidence 34456666666666665443332 23456666666666655411111111 0111111 1 11233456
Q ss_pred cccEEeccccCCCCCCC----hhccCCCCCcEeeccCCccccc----CCCCCCCCccCcEEEcccccccCCC----Cccc
Q 001171 508 RLTTLDLSNQNLSGELP----IELFGLPSLQVVSLEENNLSGD----VPEGFSSLVGLQYLNLSDNAFTGDI----PATY 575 (1133)
Q Consensus 508 ~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~ 575 (1133)
+|++++..+|++..... ..|...+.|+.+.+..|.|... +...|..+++|+.|||.+|-|+... ...+
T Consensus 158 ~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL 237 (382)
T KOG1909|consen 158 KLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL 237 (382)
T ss_pred ceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHh
Confidence 78888888888874332 3445668888888888887532 2345677888888888888887432 3455
Q ss_pred ccccccceeecccCccCCCCCccc-----cCCCCccEEEecCCcccCC----CccccccccccCeeecCCCcc
Q 001171 576 GFLRSLVFLSLSHNQISGMIPAEL-----GACSALEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKL 639 (1133)
Q Consensus 576 ~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l 639 (1133)
..+++|++|++++|.+.......| ...++|++|.|.+|.++.. +...+...+.|+.|+|++|.+
T Consensus 238 ~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 238 SSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 566777777777777775544433 2356677777777766521 222233455566666666666
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-10 Score=132.90 Aligned_cols=247 Identities=22% Similarity=0.295 Sum_probs=170.9
Q ss_pred cCCCccccccc--ccceeEEEEEE---CCceEEEEEEcccC---CcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCc
Q 001171 837 RQFDEENVLSR--GRYGLIFKASY---QDGMVLSIRRLRDG---TIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 837 ~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 907 (1133)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. ......=.+|+...+++ .|++.|+.+..+.+.+ .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~-~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG-I 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC-c
Confidence 35677888999 99999999976 35788898884321 12223335677777777 4999999777777654 4
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHH----HHHHHhcCCceecccCccceeeCCC-CceEEecc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR----GLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEF 982 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Df 982 (1133)
.++-+|++ +.++.++.+.-. ..++....+.+..+..+ |+.++|+.+++|-|+||.||+...+ ..++.+||
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ceeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 47888888 578888776533 23666677777777777 9999999999999999999999999 88999999
Q ss_pred CcccccccCCCCCC--CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 983 GLDRLAIATPAEAS--SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 983 g~a~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
|+............ ......|...|++||.. .+-++.+.|+|++|.+..+..++..+....-... | ...+..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---W--~~~r~~ 341 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS---W--SQLRQG 341 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC---c--cccccc
Confidence 99876554432111 12223677899999987 4567899999999999999999877653221110 1 111111
Q ss_pred cc-cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHH
Q 001171 1061 QI-SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1061 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1108 (1133)
.+ .++++..-. + ....+..+++.+|..|++.+++.
T Consensus 342 ~ip~e~~~~~s~----------~---l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 342 YIPLEFCEGGSS----------S---LRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cCchhhhcCcch----------h---hhhHHHHhcCcchhhhhHHHHHh
Confidence 11 112211111 0 01256678999999999887665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=111.61 Aligned_cols=133 Identities=14% Similarity=0.192 Sum_probs=93.8
Q ss_pred cccccccceeEEEEEECC-------ceEEEEEEcccCCc----------------------C-HHHH----HHHHHHHhh
Q 001171 843 NVLSRGRYGLIFKASYQD-------GMVLSIRRLRDGTI----------------------D-ENTF----RKEAEALGK 888 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~----------------------~-~~~~----~~E~~~l~~ 888 (1133)
..||.|.-+.||.|...+ +..+|||..+.... + .+.+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999996543 47899998632110 0 1223 389999999
Q ss_pred ccC--CCeeeEEEEEeCCCCcEEEEEeccCCCCHHH-HHHhhccCCCCCCChHHHHHHHHHHHHHHHHH-hcCCceeccc
Q 001171 889 VKH--RNLTVLRGYYAGPPDVRLLVYDYMPNGNLAT-LLQEASHQDGHVLNWPMRHLISLGLARGLSFL-HSLDMVHGDI 964 (1133)
Q Consensus 889 l~h--pniv~l~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~ivH~Dl 964 (1133)
+.. -++..++++ ...++||||+.++.+.. .++. ..++......+..+++.++.++ |+.||||||+
T Consensus 83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 853 344445443 12389999997654322 2221 1133445566778999999999 8999999999
Q ss_pred CccceeeCCCCceEEeccCcccc
Q 001171 965 KPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 965 kp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
++.||+++ ++.+.++|||.+..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCcee
Confidence 99999996 46899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-10 Score=116.61 Aligned_cols=81 Identities=28% Similarity=0.372 Sum_probs=20.4
Q ss_pred cccEEeccCCcccccCCchhh-cccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLT-NVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 394 (1133)
.+++|+|++|+|+.| +.+. .+.+|+.|||++|.|+.. +.+..+++|++|++++|+|+.+.+.....+++|++|+|
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence 455666666666655 2344 456666677777766633 23555666666666666666442222234666666666
Q ss_pred cCCccc
Q 001171 395 EGNRFS 400 (1133)
Q Consensus 395 s~N~l~ 400 (1133)
++|+|.
T Consensus 96 ~~N~I~ 101 (175)
T PF14580_consen 96 SNNKIS 101 (175)
T ss_dssp TTS---
T ss_pred cCCcCC
Confidence 666665
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.4e-11 Score=131.46 Aligned_cols=162 Identities=22% Similarity=0.229 Sum_probs=82.3
Q ss_pred CcCCcccccEEeccccCCCCCCC--hhccCCCCCcEeeccCCcccccCCCCC-CCCccCcEEEcccccccCC-CCccccc
Q 001171 502 SIGSLMRLTTLDLSNQNLSGELP--IELFGLPSLQVVSLEENNLSGDVPEGF-SSLVGLQYLNLSDNAFTGD-IPATYGF 577 (1133)
Q Consensus 502 ~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~-~~~~~~~ 577 (1133)
....+++++.||||.|-+....+ .-...+|+|+.|+|+.|++.....+.. ..++.|+.|.|+.|.++-. +......
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 34456666666666666553211 223356677777777776652221111 2345666677777666521 1122345
Q ss_pred ccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCc--cccccccccCeeecCCCcccCc-Cchh-----hhc
Q 001171 578 LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIP--VDISHLSRIKKLDLGQNKLSGE-IPKE-----ISK 649 (1133)
Q Consensus 578 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~-~p~~-----l~~ 649 (1133)
+|+|+.|+|..|..-..-.....-+..|+.|||++|++.. .+ ...+.++.|+.|+++.+.+... +|+. ...
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~ 299 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT 299 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence 5666666666664222222223335556666666666553 22 2345566666666666665531 2222 233
Q ss_pred cCCCcEEEeecCCCC
Q 001171 650 CSSLVSLTLDMNSLS 664 (1133)
Q Consensus 650 l~~L~~L~Ls~N~l~ 664 (1133)
+++|++|+++.|++.
T Consensus 300 f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 300 FPKLEYLNISENNIR 314 (505)
T ss_pred cccceeeecccCccc
Confidence 455555555555553
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-10 Score=116.26 Aligned_cols=139 Identities=29% Similarity=0.387 Sum_probs=44.2
Q ss_pred ccCCcccccCCchhhcccccceeeccCceeecccCcccC-CCCCCcEEEccCCcccccCchhhccCCCccEEEccCCccc
Q 001171 322 LQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG-SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFS 400 (1133)
Q Consensus 322 L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 400 (1133)
|..+.|+.+ ..+.+..++++|+|++|+|+.+ +.++ .+.+|+.|+|++|.|+.+ +.+..+++|++|++++|+|+
T Consensus 4 lt~~~i~~~--~~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIEQI--AQYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---
T ss_pred ccccccccc--cccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC
Confidence 344555554 2356777889999999999843 3455 578899999999999865 45777888888898888888
Q ss_pred ccCCCccCCCCCCcEEEccCCcCccccC-ccccCccccceeecccccccccCC---hhhcCCCCCcEEec
Q 001171 401 GQVPAFLGGIRGLKIVSLGRNMFSGLIP-LSFGNLSQLETLNLSENDIRGNIP---EEITRLSNLTTLNL 466 (1133)
Q Consensus 401 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~---~~l~~l~~L~~L~L 466 (1133)
...+.....+++|+.|+|++|+|..... ..+..+++|+.|+|.+|.+....- ..+..+++|+.||-
T Consensus 78 ~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 78 SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 5432222457788888888888765322 345566777777777777763311 13445666666653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-09 Score=124.27 Aligned_cols=165 Identities=19% Similarity=0.235 Sum_probs=121.4
Q ss_pred EECCceEEEEEEcccCCcC-HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCC
Q 001171 857 SYQDGMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVL 935 (1133)
Q Consensus 857 ~~~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l 935 (1133)
+..++..|.|+........ .+...+.++.++.++||+|+++++.++..+ ..|+|+|.+. .|..++++.
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~--Pl~~~lk~l-------- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERVR--PLETVLKEL-------- 101 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeeccc--cHHHHHHHh--------
Confidence 4446778888777544331 345778889999999999999999887764 5599999984 577788763
Q ss_pred ChHHHHHHHHHHHHHHHHHh-cCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccC
Q 001171 936 NWPMRHLISLGLARGLSFLH-SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014 (1133)
Q Consensus 936 ~~~~~~~i~~~ia~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 1014 (1133)
........++||+.||.||| +.+++|++|....|++++.|+.||++|.++........ ......--..|..|+.+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcC
Confidence 34556667899999999997 56799999999999999999999999988743321111 111112223566777553
Q ss_pred CCCCCCCCchhHHHHHHHHHHhC
Q 001171 1015 TGQPTKEADVYSFGIVLLEILTG 1037 (1133)
Q Consensus 1015 ~~~~~~~~DvwSlG~il~el~tg 1037 (1133)
... -..|.|.|||++||++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 322 346999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.9e-09 Score=103.98 Aligned_cols=129 Identities=23% Similarity=0.390 Sum_probs=93.6
Q ss_pred cccccccceeEEEEEECCceEEEEEE-cccCCcC--------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRR-LRDGTID--------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..+++|+-+.+|.+.+.+.. +++|. +++.... ...-.+|+.++.+++--.|....-|..++ ....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-DNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCEEEEE
Confidence 35889999999999876434 44443 4433322 23567899999998654443333333333 33479999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
|++|-.|.+.+... +..++..|-.-+.-||..||+|+|+.++||.+..+. +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99998888888753 134566777788899999999999999999997765 9999999975
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.7e-10 Score=84.14 Aligned_cols=41 Identities=44% Similarity=0.931 Sum_probs=30.9
Q ss_pred hhHHHHHHHHHHhCC-CCCCCccCCCCCCCCCCCccceeeeC
Q 001171 29 LSEIQALTSFKLHLK-DPLGALDGWDSSTPSAPCDWRGIVCY 69 (1133)
Q Consensus 29 ~~~~~~l~~~k~~~~-~~~~~l~~w~~~~~~~~c~w~gv~c~ 69 (1133)
++|++||++||+++. ||.+.+.+|+.+...+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999997 67789999987533589999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.9e-10 Score=140.34 Aligned_cols=129 Identities=28% Similarity=0.384 Sum_probs=90.1
Q ss_pred cccceeeccCceeecccCcccCCCCCCcEEEccCCc--ccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEE
Q 001171 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS--LSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416 (1133)
Q Consensus 339 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 416 (1133)
...+...+-+|++. .++.... .++|++|-+..|. +.....+.|..++.|+.|||++|.=-+.+|..++++-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 45566666667665 3333332 3367777777775 554445567778888888888876666778888888888888
Q ss_pred EccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCc
Q 001171 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNK 470 (1133)
Q Consensus 417 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~ 470 (1133)
+|++..++ .+|..++++.+|.+|++..+.-...+|.....+++|++|.+-.-.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 88888877 567778888888888888776555556666667777777776543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-10 Score=126.60 Aligned_cols=190 Identities=27% Similarity=0.319 Sum_probs=94.4
Q ss_pred hhhcccccceeeccCceeecccC--cccCCCCCCcEEEccCCcccccCchh-hccCCCccEEEccCCcccccCCCccCCC
Q 001171 334 WLTNVTSLRVMDLSGNFFSGNLP--AAVGSLDKLEVLRVANNSLSGLVPDE-IAKCSLLQMFDLEGNRFSGQVPAFLGGI 410 (1133)
Q Consensus 334 ~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 410 (1133)
....|++++.||||.|-+....| .....|++|+.|+|+.|++....... -..+++|+.|.|+.|.++..-
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~------- 213 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKD------- 213 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHH-------
Confidence 45566777777777776653222 23345666666666666654221111 112334444444444443110
Q ss_pred CCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCC-CCCCCCCCCCcEEE
Q 001171 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV-PYDVGNLKGLLVLN 489 (1133)
Q Consensus 411 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ 489 (1133)
+......+++|+.|+|..|............+..|++|||++|++-... -...+.++.|+.|+
T Consensus 214 ----------------V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 214 ----------------VQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred ----------------HHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 1111223344444444444322222223333444555555555443211 12344555566666
Q ss_pred cccCCCccc-cCCC-----cCCcccccEEeccccCCCCC-CChhccCCCCCcEeeccCCccccc
Q 001171 490 LSASGFSGK-IPGS-----IGSLMRLTTLDLSNQNLSGE-LPIELFGLPSLQVVSLEENNLSGD 546 (1133)
Q Consensus 490 L~~N~l~~~-~~~~-----~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~ 546 (1133)
++.+.+... .|+. ...+++|++|+++.|++... .-..+..+++|+.|.+..|.++.+
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 666655433 2222 34567788888888887521 112455667888888888888743
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.8e-10 Score=137.26 Aligned_cols=272 Identities=24% Similarity=0.313 Sum_probs=156.9
Q ss_pred ccccEEeccCCcccccccCCCCCccccccEEeccCCc--ccccCCchhhcccccceeeccCceeecccCcccCCCCCCcE
Q 001171 290 SSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR--IRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEV 367 (1133)
Q Consensus 290 ~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~--i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 367 (1133)
...+...+-+|.+..... ....+.|..|-+..|. +..+..+.|..++.|++|||++|.=-+.+|..++.|-+|++
T Consensus 523 ~~~rr~s~~~~~~~~~~~---~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAG---SSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchhhccC---CCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 445555555555543321 1122258888888886 77777788999999999999988766789999999999999
Q ss_pred EEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCc--cccCccccCccccceeecccc
Q 001171 368 LRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS--GLIPLSFGNLSQLETLNLSEN 445 (1133)
Q Consensus 368 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N 445 (1133)
|+|++..++ .+|..+.++++|.+|++..+.-...+|.....+.+|++|.+...... ...-..+.++..|+.|.....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 999999998 56889999999999999988776666777778999999988776522 222223344455555544332
Q ss_pred cccccCChhhcCCCCCc----EEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCC------cccccEEecc
Q 001171 446 DIRGNIPEEITRLSNLT----TLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGS------LMRLTTLDLS 515 (1133)
Q Consensus 446 ~i~~~~~~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~Ls 515 (1133)
.. .+-..+..+..|. .+.+.++... ..+..++.+.+|+.|.+.++.+.......... ++++..+.+.
T Consensus 679 s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~ 755 (889)
T KOG4658|consen 679 SV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSIL 755 (889)
T ss_pred hh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhh
Confidence 22 1112222233322 2222222222 33445566666666666666654332222111 1122222222
Q ss_pred ccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccC
Q 001171 516 NQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569 (1133)
Q Consensus 516 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 569 (1133)
++..- ..+.+....++|+.|.+..+.....+......+..+..+.+..+.+.+
T Consensus 756 ~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 756 NCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred ccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 22111 122222334556666666555544444444444444444444444443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.6e-08 Score=96.58 Aligned_cols=141 Identities=16% Similarity=0.267 Sum_probs=99.4
Q ss_pred cccccccccceeEEEEEECCceEEEEEE-cccCCc--------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 841 EENVLSRGRYGLIFKASYQDGMVLSIRR-LRDGTI--------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
....+-+|+-+.|+++.+. |+.+.||. +.+... ..++..+|++.+.+++--.|....-++.+... ..++
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeEE
Confidence 4567889999999999987 66666654 333322 23567889999999864444333333333322 3799
Q ss_pred EeccCC-CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc---eEEeccCccc
Q 001171 912 YDYMPN-GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE---AHLSEFGLDR 986 (1133)
Q Consensus 912 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~ 986 (1133)
|||+++ .++.+++...-.. . ........++..|-+.+.-||..+|+|+||..+||++.+++. +.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~--~-~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMED--E-SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccC--c-ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999976 3778887764321 1 222223567888999999999999999999999999976553 4799999873
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.87 E-value=8.4e-09 Score=110.44 Aligned_cols=138 Identities=23% Similarity=0.301 Sum_probs=98.9
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCC--eeeEEEEEeCCC--CcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRN--LTVLRGYYAGPP--DVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~--~~~~lV~e~~~ 916 (1133)
+.|+.|.++.||++...+|+.+++|....... ....+.+|+++++.+.+.+ +.+++.+..... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999865433 3467899999999997643 455666665432 24489999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS---------------------------------------- 956 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------------------- 956 (1133)
|.++.+.+.. ..++...+..++.++++++.+||+
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 8877654321 113444444555555555555552
Q ss_pred ----------------CCceecccCccceeeCC--CCceEEeccCccc
Q 001171 957 ----------------LDMVHGDIKPQNVLFDA--DFEAHLSEFGLDR 986 (1133)
Q Consensus 957 ----------------~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~ 986 (1133)
..++|+|+.|.||+++. ++.+.++||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34799999999999998 5668899999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-09 Score=129.93 Aligned_cols=211 Identities=23% Similarity=0.248 Sum_probs=144.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.+.+.+.+-+-+|.++.++-+.-. .|...++|..... ..+.+...++-.+.-..+||-++....-+. .....++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcch
Confidence 345667778889999999888543 2433344333211 111223333444444445566654433221 2233489
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|++|..++++...++..+. .+..........+.++.+|||+..+.|||++|.|.+...+++.+++|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999987653 23333334455678899999999999999999999999999999999984322111
Q ss_pred C-CC---------------------------CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCc
Q 001171 991 T-PA---------------------------EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042 (1133)
Q Consensus 991 ~-~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~ 1042 (1133)
. .. .........||+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 0011234579999999999999999999999999999999999999998
Q ss_pred cCChhhHHHH
Q 001171 1043 FTQDEDIVKW 1052 (1133)
Q Consensus 1043 ~~~~~~~~~~ 1052 (1133)
....+.+.+.
T Consensus 1037 a~tpq~~f~n 1046 (1205)
T KOG0606|consen 1037 AETPQQIFEN 1046 (1205)
T ss_pred Ccchhhhhhc
Confidence 7766655533
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.9e-09 Score=120.77 Aligned_cols=247 Identities=19% Similarity=0.226 Sum_probs=163.1
Q ss_pred HhcCCCcccccccccceeEEEEEEC--CceEEEEEEcccCCcCH-H--HHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ--DGMVLSIRRLRDGTIDE-N--TFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~-~--~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
...+|..+..||.|.|+.|+....+ ++..|++|...++.... . .-..|+.+...+ .|.+++.....+..-+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~- 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG- 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-
Confidence 4557889999999999999998654 57899999986543321 1 123466666666 477777765544443333
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCcccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRL 987 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 987 (1133)
|+=-||+++++........ ..++...++++..|++.++.++|++.++|+|+||+||++..+ +..+++|||.+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 6888999999887666332 336777788899999999999999999999999999999886 7779999998753
Q ss_pred cccCCCCCCCCCCCCCCCCc-cCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGY-VSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
... .......++..| .+|+......+..+.|++|||..+.|..+|.. +.... ..|.. ++.+.+.
T Consensus 417 ~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~~~----~~~~~--i~~~~~p--- 481 (524)
T KOG0601|consen 417 LAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSESG----VQSLT--IRSGDTP--- 481 (524)
T ss_pred cce-----ecccccccccccccchhhccccccccccccccccccccccccCcc-cCccc----cccee--eeccccc---
Confidence 211 111111122233 25555566678899999999999999998754 32111 11100 0011000
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.. +. ...++ ..+...+..+|+..||.+.+...+.+.
T Consensus 482 --~~----~~--~~~~~---q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 482 --NL----PG--LKLQL---QVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --CC----Cc--hHHhh---hhhhhhhcCCccccchhhhhhcccchh
Confidence 00 00 01111 134556778999999999888766544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.6e-08 Score=104.73 Aligned_cols=140 Identities=9% Similarity=0.084 Sum_probs=98.2
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCC------------cCHHHHHHHHHHHhhccCCCe--eeEEEEEeCC----
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGT------------IDENTFRKEAEALGKVKHRNL--TVLRGYYAGP---- 904 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~---- 904 (1133)
+++-+.....|+++.+ +|+.|.||+..... .....+.+|.+.+.++..-.| ...+++....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 47789999764322 111247889999988853332 2334444321
Q ss_pred CCcEEEEEeccCCC-CHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-------CCc
Q 001171 905 PDVRLLVYDYMPNG-NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-------DFE 976 (1133)
Q Consensus 905 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-------~~~ 976 (1133)
....++|||++++. +|.+++..... ...+...+..++.+++..+..||..||+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCce
Confidence 22358999999876 89999864221 22455677789999999999999999999999999999975 467
Q ss_pred eEEeccCccc
Q 001171 977 AHLSEFGLDR 986 (1133)
Q Consensus 977 ~kl~Dfg~a~ 986 (1133)
+.++||+.++
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 8999999764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.7e-09 Score=85.32 Aligned_cols=60 Identities=37% Similarity=0.556 Sum_probs=44.6
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSL 375 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l 375 (1133)
+|++|++++|+|+.+++++|.++++|++|++++|.|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 467777777777777777777777777777777777766666777777777777777764
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.5e-08 Score=98.56 Aligned_cols=123 Identities=20% Similarity=0.285 Sum_probs=80.8
Q ss_pred eEEEEEECCceEEEEEEcccCCcC---------------------------HHHHHHHHHHHhhccCCC--eeeEEEEEe
Q 001171 852 LIFKASYQDGMVLSIRRLRDGTID---------------------------ENTFRKEAEALGKVKHRN--LTVLRGYYA 902 (1133)
Q Consensus 852 ~Vy~~~~~~g~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~hpn--iv~l~~~~~ 902 (1133)
.||.|...+|..+|+|..+.+..+ ....++|++.|.++..-. +.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999987432110 134678999999997653 44555442
Q ss_pred CCCCcEEEEEeccC--CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHH-HhcCCceecccCccceeeCCCCceEE
Q 001171 903 GPPDVRLLVYDYMP--NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF-LHSLDMVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 903 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~ivH~Dlkp~NIll~~~~~~kl 979 (1133)
. .++||||++ |..+..+.... ++......++.+++..+.. +|+.||+|||+.+.||+++++ .+.+
T Consensus 80 ~----~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 R----NVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp T----TEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred C----CEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence 1 279999998 54454433321 1133445677778875555 579999999999999999887 9999
Q ss_pred eccCcccc
Q 001171 980 SEFGLDRL 987 (1133)
Q Consensus 980 ~Dfg~a~~ 987 (1133)
+|||.+..
T Consensus 148 IDf~qav~ 155 (188)
T PF01163_consen 148 IDFGQAVD 155 (188)
T ss_dssp --GTTEEE
T ss_pred EecCccee
Confidence 99998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.3e-08 Score=101.05 Aligned_cols=132 Identities=17% Similarity=0.174 Sum_probs=98.1
Q ss_pred CCcccccccccceeEEEEEECCceEEEEEEcccCCc-----------------------CHHHHHHHHHHHhhccCC--C
Q 001171 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI-----------------------DENTFRKEAEALGKVKHR--N 893 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~hp--n 893 (1133)
+.++..||.|.-+.||.|...+|..+|||.=+.+.. +....++|.++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999997533221 123567899999999654 4
Q ss_pred eeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 894 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
+.+.+++ +.+.+||||++|-.|...- ++......++..|++-+...-+.||||+|+.+-||++++
T Consensus 173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW-----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc-----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 5555443 4458999999885554321 123333445666666666666899999999999999999
Q ss_pred CCceEEeccCcc
Q 001171 974 DFEAHLSEFGLD 985 (1133)
Q Consensus 974 ~~~~kl~Dfg~a 985 (1133)
+|.+.++||--+
T Consensus 238 dg~~~vIDwPQ~ 249 (304)
T COG0478 238 DGDIVVIDWPQA 249 (304)
T ss_pred CCCEEEEeCccc
Confidence 999999999654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.4e-08 Score=83.40 Aligned_cols=61 Identities=31% Similarity=0.514 Sum_probs=40.1
Q ss_pred cccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcc
Q 001171 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRF 399 (1133)
Q Consensus 339 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 399 (1133)
++|++|++++|+|+...+.+|..+++|++|++++|+++...|+.|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566677777777655555666666666666666666666666666666666666666654
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.8e-10 Score=127.27 Aligned_cols=128 Identities=34% Similarity=0.405 Sum_probs=93.4
Q ss_pred cccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchh-hhccCCCcEEE
Q 001171 579 RSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKE-ISKCSSLVSLT 657 (1133)
Q Consensus 579 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~ 657 (1133)
..|...+.++|.+. .....+.-++.|+.|+|++|+++. .. .+..+++|+.|||++|++. .+|.. ...+. |+.|+
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 34677778888877 455566667888888888888874 22 6777888888888888887 44432 33444 88888
Q ss_pred eecCCCCccCCccccCcccccccccccccccccCC-ccccccccCcccccccccccc
Q 001171 658 LDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIP-ADLALISSLRYLNLSRNNLEG 713 (1133)
Q Consensus 658 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~ls~N~l~~ 713 (1133)
+++|.++.. ..+.+|++|+.||||+|-|.+.-- .-++.|.+|+.|+|.||++.+
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 998888743 456788889999999998875321 125667888899999999864
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-09 Score=110.00 Aligned_cols=119 Identities=20% Similarity=0.217 Sum_probs=78.2
Q ss_pred cCcccchhhcccccCcEEEcccCcccC--CCCccccCCCCcceEeccCCcccC--cCCCccccccchhhhhhcccccCCC
Q 001171 83 LAGRLTDQLADLHELRKLSLHSNHLNG--SIPASLHQCSLLRAVYLQYNSFSG--HLPLSIFNLTNLLVLNVAHNLLSGK 158 (1133)
Q Consensus 83 l~g~~~~~l~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~L~~n~~~g--~~p~~l~~l~~L~~L~l~~N~l~~~ 158 (1133)
.+|..+-.++.+..++-|.|.+..|.. ..-..-..++.++.|||.+|+++. .|-..+.+||.|++||+++|.++..
T Consensus 33 ~~g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~ 112 (418)
T KOG2982|consen 33 SAGLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSD 112 (418)
T ss_pred ccccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCc
Confidence 345555555566666677777766652 222122356788889999999884 4556678899999999999999866
Q ss_pred ccCc-cC-CcceEEEccCCcCCC-CCCCCCCCCCcCcEEeccCCcC
Q 001171 159 ISAD-IS-PSLRYLDLSSNAFTG-EIPGNFSSKSQLQLINLSYNSF 201 (1133)
Q Consensus 159 ~~~~-~~-~~l~~L~Ls~N~~~~-~~p~~~~~l~~L~~L~ls~N~l 201 (1133)
|... +| .+|+.|.|.+..+.- .....+..++.++.|++|.|++
T Consensus 113 I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 113 IKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred cccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 6443 34 678888888777652 2334455666666666666633
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.4e-09 Score=96.23 Aligned_cols=136 Identities=29% Similarity=0.408 Sum_probs=105.4
Q ss_pred ccceeecccCccCCCCCcc---ccCCCCccEEEecCCcccCCCccccc-cccccCeeecCCCcccCcCchhhhccCCCcE
Q 001171 580 SLVFLSLSHNQISGMIPAE---LGACSALEVLELRSNHFTGNIPVDIS-HLSRIKKLDLGQNKLSGEIPKEISKCSSLVS 655 (1133)
Q Consensus 580 ~L~~L~Ls~N~l~~~~p~~---l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 655 (1133)
.+..++|+.++|- .+++. +.....|+.++|++|.+.. .|..|. ..+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3456677777664 33332 3445667778999999885 555544 4568999999999998 78999999999999
Q ss_pred EEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccccCCcccc
Q 001171 656 LTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLS 720 (1133)
Q Consensus 656 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~ 720 (1133)
|+++.|.+. ..|..+..|.+|..||.-+|.+. .+|-++..-+.....++..++|.+..|..++
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 999999999 57788888999999999999987 6777765556667778888999998887644
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-09 Score=109.97 Aligned_cols=213 Identities=24% Similarity=0.258 Sum_probs=106.1
Q ss_pred CCCCcCcEEeccCCcCCCCCccc----ccCccccceEecccccccCCCCc-cccCccccceeeccccccCCCCCCcccCc
Q 001171 186 SSKSQLQLINLSYNSFSGEVPAS----VGQLQELEYLWLDSNHLYGTLPS-AISNCSSLVHLSAEDNVLKGLIPGTIGRI 260 (1133)
Q Consensus 186 ~~l~~L~~L~ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 260 (1133)
-.+++|+..+||.|-|....|.. +..-+.|++|.|++|.+. .+.. -++ ..|.+| ..|+ ....-
T Consensus 89 lkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rig--kal~~l--a~nK-------Kaa~k 156 (388)
T COG5238 89 LKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIG--KALFHL--AYNK-------KAADK 156 (388)
T ss_pred hcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCC-ccchhHHH--HHHHHH--HHHh-------hhccC
Confidence 34556666666666665444432 334455555555555442 1111 011 111111 1111 12234
Q ss_pred CcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccc
Q 001171 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTS 340 (1133)
Q Consensus 261 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~ 340 (1133)
+.|++.++..|++.. .|.......+.....|+.+.+.+|.|... .++.+.-..+..+.+
T Consensus 157 p~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpe--------------------gv~~L~~~gl~y~~~ 215 (388)
T COG5238 157 PKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPE--------------------GVTMLAFLGLFYSHS 215 (388)
T ss_pred CCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcc--------------------hhHHHHHHHHHHhCc
Confidence 567777777777752 23333222223334455555555544311 000000113456778
Q ss_pred cceeeccCceeecc----cCcccCCCCCCcEEEccCCcccccCchhh------ccCCCccEEEccCCcccccCCCccCCC
Q 001171 341 LRVMDLSGNFFSGN----LPAAVGSLDKLEVLRVANNSLSGLVPDEI------AKCSLLQMFDLEGNRFSGQVPAFLGGI 410 (1133)
Q Consensus 341 L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~~------~~l~~L~~L~Ls~N~l~~~~p~~l~~l 410 (1133)
|++|||.+|.++.. +...+..++.|+.|.+..|-++....+++ ...++|..|-..+|.+.+.+
T Consensus 216 LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~------- 288 (388)
T COG5238 216 LEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGI------- 288 (388)
T ss_pred ceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCce-------
Confidence 88888888887632 23445566778888888887775444333 13456777777777664322
Q ss_pred CCCcEEEccCCcCccccCccccCccccceeeccccccc
Q 001171 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR 448 (1133)
Q Consensus 411 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~ 448 (1133)
+++.+.|.+. =.+++.|..|.+.+|+|.
T Consensus 289 ----i~~~~l~~~e------~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 289 ----ILDISLNEFE------QDAVPLLVDLERNGNRIK 316 (388)
T ss_pred ----eeeechhhhh------hcccHHHHHHHHccCcch
Confidence 1122222211 124566667777777765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.5e-06 Score=94.42 Aligned_cols=265 Identities=14% Similarity=0.152 Sum_probs=154.7
Q ss_pred CcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEE----e--CCCCcEEEEE
Q 001171 840 DEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYY----A--GPPDVRLLVY 912 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~----~--~~~~~~~lV~ 912 (1133)
..++.||+|+.+.+|-.--- +. .+.|+....... .+ .+-++.|... .||-+..-+.+= . ......-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa-~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPA-AQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCch-HH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35678999999999976211 11 233555433322 11 1223333333 566543311111 1 1122245777
Q ss_pred eccCCC-CHHHHHHh-hccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 913 DYMPNG-NLATLLQE-ASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 913 e~~~~g-sL~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
..+.+. -...++.. .+++.-...+|....+.++.+|.+.+.||..|.+-+|+.++|+|+.+++.+.+.|=..-.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq---- 165 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ---- 165 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee----
Confidence 777654 22333322 112222347899999999999999999999999999999999999999999998743211
Q ss_pred CCCCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhC-CCCCccCC----hhhHHH-HHHHHhhh
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTG-RKPVMFTQ----DEDIVK-WVKKQLQR 1059 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg-~~Pf~~~~----~~~~~~-~~~~~~~~ 1059 (1133)
.........+.+|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+.. ...-.+ .+ ..
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I----a~ 241 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI----AH 241 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh----hc
Confidence 112334455678999999999753 34457788999999999999885 99996421 111111 11 11
Q ss_pred ccccccccCC-cCCCCCCChhHHHHHHhH-hhhhccCCCC--CCCCCCHHHHHHHHhcCcC
Q 001171 1060 GQISELLEPG-LLELDPESSEWEEFLLGV-KVGLLCTAPD--PLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1060 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~li~~Cl~~d--P~~RPs~~evl~~Le~~~~ 1116 (1133)
+.+....+.. -....+....++.....+ .+-.+|+..- +.-||+++..+..|..+.+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1222221211 112222333333333333 3444565432 5689999998877766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.9e-06 Score=86.68 Aligned_cols=137 Identities=14% Similarity=0.156 Sum_probs=100.0
Q ss_pred cccccceeEEEEEECCceEEEEEEccc----C---CcCHHHHHHHHHHHhhccCCC--eeeEEEEEe---C-CCCcEEEE
Q 001171 845 LSRGRYGLIFKASYQDGMVLSIRRLRD----G---TIDENTFRKEAEALGKVKHRN--LTVLRGYYA---G-PPDVRLLV 911 (1133)
Q Consensus 845 lg~G~~g~Vy~~~~~~g~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~---~-~~~~~~lV 911 (1133)
-|+|+-+.|++.... |..+-+|+-.. . ......|.+|...++++..-+ +.+.. ++. . .....++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888899998776 44688887641 1 224678999999999985322 33333 322 1 12234799
Q ss_pred EeccCC-CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc--eEEeccCccc
Q 001171 912 YDYMPN-GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE--AHLSEFGLDR 986 (1133)
Q Consensus 912 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 986 (1133)
+|-+++ -+|.+++..... ...+...+..+..+|++.++-||+.|+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998864 489888865322 23567778889999999999999999999999999999986667 8999998654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.8e-09 Score=121.88 Aligned_cols=127 Identities=33% Similarity=0.321 Sum_probs=84.1
Q ss_pred CCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEec
Q 001171 532 SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELR 611 (1133)
Q Consensus 532 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 611 (1133)
.|...+.++|++. .+..++.-++.|+.|||++|+++... .+..++.|++|||+.|++. .+|..=..-..|+.|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 4666777777776 45556666777888888888887432 6677788888888888887 444321112238888888
Q ss_pred CCcccCCCccccccccccCeeecCCCcccCcC-chhhhccCCCcEEEeecCCCC
Q 001171 612 SNHFTGNIPVDISHLSRIKKLDLGQNKLSGEI-PKEISKCSSLVSLTLDMNSLS 664 (1133)
Q Consensus 612 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 664 (1133)
+|.++. -..+.+|.+|+.|||++|.|.+.- -.-++.+..|+.|+|.+|.+-
T Consensus 241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 887763 234677778888888888777531 122455666677777777664
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.7e-06 Score=96.81 Aligned_cols=171 Identities=21% Similarity=0.268 Sum_probs=123.9
Q ss_pred cceeEEEEEE-CCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeC---CCCcEEEEEeccCC-CCHHH
Q 001171 849 RYGLIFKASY-QDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAG---PPDVRLLVYDYMPN-GNLAT 922 (1133)
Q Consensus 849 ~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~lV~e~~~~-gsL~~ 922 (1133)
...+.|++.. .+|..|+.|++..... .......-+++++++.|+|+|++.+++.. ++...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899955 5799999999932221 11223456889999999999999998762 34456899999986 57776
Q ss_pred HHHhhc----------cCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 923 LLQEAS----------HQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 923 ~l~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
..-... ...+...++...|.++.|+..||.++|+.|..-+-|.+.+|+++++.+++|+..|........+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 543221 1123457788999999999999999999999999999999999999999998877654432221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK 1039 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~ 1039 (1133)
. |.+.+ -.+-|.-.+|.++..+.||..
T Consensus 448 ~-----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 448 T-----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred C-----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 0 11111 235688889999999998843
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.7e-06 Score=89.42 Aligned_cols=107 Identities=24% Similarity=0.330 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHhhccCCC--eeeEEEEEeCC---CCcEEEEEeccCCC-CHHHHHHhhccCCCCCCChHHHHHHHHHHHH
Q 001171 876 ENTFRKEAEALGKVKHRN--LTVLRGYYAGP---PDVRLLVYDYMPNG-NLATLLQEASHQDGHVLNWPMRHLISLGLAR 949 (1133)
Q Consensus 876 ~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~---~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 949 (1133)
.....+|...+.++.... +...+++.... ....++|+|++++. +|.+++..... .+...+..++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 456788999888885332 23444444432 22347999999874 79999876322 455667789999999
Q ss_pred HHHHHhcCCceecccCccceeeCCCC---ceEEeccCcccc
Q 001171 950 GLSFLHSLDMVHGDIKPQNVLFDADF---EAHLSEFGLDRL 987 (1133)
Q Consensus 950 ~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~ 987 (1133)
.++-||+.||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 130 ~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999999998887 789999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1133 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-51 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-41 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-36 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-51 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-36 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3t6q_A | 606 | Crystal Structure Of Mouse Rp105MD-1 Complex Length | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-08 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 7e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 8e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 4e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-06 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 6e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 9e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 7e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 6e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 7e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 1h6u_A | 308 | Internalin H: Crystal Structure Of Fused N-Terminal | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-05 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 5e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-04 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 1e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-04 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 4e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 4e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H6U|A Chain A, Internalin H: Crystal Structure Of Fused N-Terminal Domains Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 627 bits (1619), Expect = 0.0
Identities = 226/758 (29%), Positives = 337/758 (44%), Gaps = 59/758 (7%)
Query: 30 SEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLTD 89
EI L SFK L D L W S+ PC + G+ C +++V + L L +
Sbjct: 12 REIHQLISFKDVLPDK-NLLPDWSSNKN--PCTFDGVTCRDDKVTSIDLSSKPLNVGFSA 68
Query: 90 --------------------------QLADLHELRKLSLHSNHLNGSIPA--SLHQCSLL 121
L L L N L+G + SL CS L
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 122 RAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADIS-----PSLRYLDLSSN 175
+ + + N+ +S L +L VL+++ N +SG L++L +S N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 176 AFTGEIP-GNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAIS 234
+G++ + L+ +++S N+FS +P +G L++L + N L G AIS
Sbjct: 189 KISGDVDVSRCVN---LEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 244
Query: 235 NCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRI 294
C+ L L+ N G IP + +LQ LSL+ N+ TG +P L G +L
Sbjct: 245 TCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDF----LSGACDTLTG 298
Query: 295 VQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFP-SWLTNVTSLRVMDLSGNFFSG 353
+ L N F G V P G C LE L L +N P L + L+V+DLS N FSG
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSL-LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 354 NLPAAVGSL-DKLEVLRVANNSLSGLVPDEIAKCSL--LQMFDLEGNRFSGQVPAFLGGI 410
LP ++ +L L L +++N+ SG + + + LQ L+ N F+G++P L
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417
Query: 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNK 470
L + L N SG IP S G+LS+L L L N + G IP+E+ + L TL L +N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 471 FGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGL 530
G++P + N L ++LS + +G+IP IG L L L LSN + SG +P EL
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 531 PSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHN- 589
SL + L N +G +P G ++ N G + N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNL 593
Query: 590 -QISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEIS 648
+ G+ +L S + S + G+ + + LD+ N LSG IPKEI
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG 653
Query: 649 KCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSR 708
L L L N +SG IP+ L L L+LS+N+L G IP ++ ++ L ++LS
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 709 NNLEGEIPKMLSSRFNDPSIFAMNRELCGKPLDRECAN 746
NNL G IP+M P+ F N LCG PL R +
Sbjct: 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-123
Identities = 125/612 (20%), Positives = 220/612 (35%), Gaps = 36/612 (5%)
Query: 143 TNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFS 202
+ V + +H L+ ++ D+ ++ L+L+ N NF+ SQL +++ +N+ S
Sbjct: 4 VSHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 203 GEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRIST 262
P +L L+ L L N L + C++L L N ++ + +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 263 LQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCV-SVLEVLD 321
L L LS N L+ + L +L+ + L N + S L+ L+
Sbjct: 123 LITLDLSHNGLSST-KLGTQVQL----ENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 322 LQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG---SLDKLEVLRVANNSLSGL 378
L +N+I+ P + L + L+ +L + + + L ++N+ LS
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 379 VPDEIAKCSL--LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
L M DL N + + L+ L N L S L
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 437 LETLNLSEN---------DIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLV 487
+ LNL + + L L LN+ N G L L
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 488 LNLSASGFSGKIPGSIG----SLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
L+LS S S + + + L L+L+ +S L L+V+ L N +
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 544 SGDVPEG-FSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGM--IPAELG 600
++ + L + + LS N + ++ + SL L L + + P+
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLS--------GEIPKEISKCSS 652
L +L+L +N+ + L +++ LDL N L+ G + S
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 653 LVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
L L L+ N E F L L ++L N L+ + SL+ LNL +N +
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597
Query: 713 GEIPKMLSSRFN 724
K+ F
Sbjct: 598 SVEKKVFGPAFR 609
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-118
Identities = 139/667 (20%), Positives = 233/667 (34%), Gaps = 84/667 (12%)
Query: 73 VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFS 132
+ L L QL +L L + N ++ P + +L+ + LQ+N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 133 GHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQ 192
+ TN L L L SN+ F + L
Sbjct: 87 QLSDKTFAFCTN----------------------LTELHLMSNSIQKIKNNPFVKQKNLI 124
Query: 193 LINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAIS--NCSSLVHLSAEDNVLK 250
++LS+N S + QL+ L+ L L +N + + SSL L N +K
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 251 GLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPN 310
PG I L L L+ +L + LC N S
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLT-EKLCLELANTS-------------------- 223
Query: 311 GRCVSVLEVLDLQNNRIRAVFPSWLTN--VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVL 368
+ L L N+++ + T+L ++DLS N + + L +LE
Sbjct: 224 ------IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 369 RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
+ N++ L + ++ +L+ + S+ +
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQSISLASLPKIDD 322
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG----NLKG 484
SF L LE LN+ +NDI G T L NL L+LS + + +
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNL 543
L +LNL+ + S + L L LDL + EL + + GL ++ + L N
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTG--DIPATYGFLRSLVFLSLSHNQISGMIPAELGA 601
F+ + LQ L L A P+ + LR+L L LS+N I+ + L
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502
Query: 602 CSALEVLELRSNHFT--------GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSL 653
LE+L+L+ N+ G + LS + L+L N + L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562
Query: 654 VSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLA-LISSLRYLNLSRNNLE 712
+ L +N+L+ F+ +L +LNL N ++ +L L++ N +
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
Query: 713 GEIPKML 719
+
Sbjct: 623 CTCESIA 629
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-83
Identities = 101/425 (23%), Positives = 163/425 (38%), Gaps = 23/425 (5%)
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVA 371
+C EV D + ++ V TN+T L +L+ N A +L L V
Sbjct: 1 KCTVSHEVADCSHLKLTQVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF 431
N++S L P+ K +L++ +L+ N S L + L N + F
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 432 GNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKG--LLVLN 489
L TL+LS N + +L NL L LS NK ++ L L
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 490 LSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF---GLPSLQVVSLEENNLSGD 546
LS++ PG ++ RL L L+N L L +L S++ +SL + LS
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 547 VPEGFSSL--VGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA 604
F L L L+LS N ++ +L L + L +N I + L
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 605 LEVLELRSNHFTGNI---------PVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS 655
+ L L+ + +I L ++ L++ N + G + +L
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 656 LTLDMNSLSGR--IPESFSKL--SNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
L+L + S R E+F L S L LNL+ N++S + + L L+L N +
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 712 EGEIP 716
E+
Sbjct: 418 GQELT 422
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 7e-66
Identities = 79/354 (22%), Positives = 131/354 (37%), Gaps = 20/354 (5%)
Query: 385 KCSL-LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLS 443
KC++ ++ D + + QVP L + +++L N L +F SQL +L++
Sbjct: 1 KCTVSHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 444 ENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSI 503
N I PE +L L LNL +N+ L L+L ++
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 504 GSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL--VGLQYLN 561
L TLDLS+ LS L +LQ + L N + E L+ L
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 562 LSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG---ACSALEVLELRSNHFTGN 618
LS N P + + L L L++ Q+ + +L A +++ L L ++ +
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 619 IPVDISHL--SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
L + + LDL N L+ + L L+ N++ S L N
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 677 LTTLNL---------STNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
+ LNL S L + L +LN+ N++ G M +
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-43
Identities = 53/223 (23%), Positives = 83/223 (37%), Gaps = 5/223 (2%)
Query: 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
D S+ L+ ++P +L ++ V++L N L F+ L L++ N
Sbjct: 5 SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLS 627
+ P L L L+L HN++S + C+ L L L SN
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 628 RIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFS--KLSNLTTLNLSTN 685
+ LDL N LS + +L L L N + E S+L L LS+N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 686 RLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSI 728
++ P I L L L+ L + + L + SI
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-13
Identities = 26/132 (19%), Positives = 43/132 (32%), Gaps = 3/132 (2%)
Query: 77 RLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLP 136
RL + G L L L L+L SN + L+ + L N+ +
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 137 LSIFNLTNLLVLNVAHNLLSGKISADISP---SLRYLDLSSNAFTGEIPGNFSSKSQLQL 193
N +L LN+ NL++ P +L LD+ N F + +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 194 INLSYNSFSGEV 205
+ + S
Sbjct: 638 THTNIPELSSHY 649
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-113
Identities = 139/595 (23%), Positives = 225/595 (37%), Gaps = 59/595 (9%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
+ N+ + N I ++ S + LDLS N +F S +LQ+++LS
Sbjct: 6 VVPNITYQCMELNFYK--IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
+ L L L L N + A S SSL L A + L L IG +
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
TL+ L+++ N + NL + LE L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNL-----------------------------TNLEHL 154
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVM----DLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
DL +N+I++++ + L + + ++ DLS N + P A + +L L + NN S
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDS 213
Query: 377 GLVPDE-IAKCSLLQMFDLEGNRFSGQ---VPAFLGGIRGLKIVSLGRNMFSGL------ 426
V I + L++ L F + + GL +++ + L
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
I F L+ + + +L I + L L KFG + +LK L
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS--GELPIELFGLPSLQVVSLEENNLS 544
+ G S L L LDLS LS G FG SL+ + L N +
Sbjct: 332 FTSNK-----GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACS 603
+ F L L++L+ + + LR+L++L +SH S
Sbjct: 387 T-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 604 ALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNS 662
+LEVL++ N F N DI + L + LDL Q +L P + SSL L + N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 663 LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLA-LISSLRYLNLSRNNLEGEIP 716
+ L++L L+ S N + + +L SSL +LNL++N+
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = 5e-99
Identities = 112/604 (18%), Positives = 215/604 (35%), Gaps = 50/604 (8%)
Query: 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLS 156
+ L L N L S L+ + L + +L++L L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 157 GKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSF-SGEVPASVGQLQ 213
S SL+ L L+ +N+++N S ++P L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 214 ELEYLWLDSNHLYGTLPSAISNCSSL----VHLSAEDNVLKGLIPGTIGRISTLQVLSLS 269
LE+L L SN + + + + + L N + + PG I L L+L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLR 208
Query: 270 RNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRA 329
N + V + + L + L + +L F +
Sbjct: 209 NNFDSLNVMKTCIQGL----AGLEVHRLVLGEFRN-------------------EGNLEK 245
Query: 330 VFPSWLTNVTSLRVMDLSGN---FFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKC 386
S L + +L + + ++ ++ L + + + ++ + +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYN 303
Query: 387 SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
Q +L +F L ++ L G S +L LE L+LS N
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 447 I--RGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSI- 503
+ +G + ++L L+LS+N + + L+ L L+ S S+
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 504 GSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDV-PEGFSSLVGLQYLNL 562
SL L LD+S+ + GL SL+V+ + N+ + P+ F+ L L +L+L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 563 SDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVD 622
S P + L SL L++SHN + ++L+VL+ NH + +
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
Query: 623 ISHL-SRIKKLDLGQNKLSGEIPKE--ISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTT 679
+ H S + L+L QN + + + L +++ + P + + +
Sbjct: 538 LQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLS 596
Query: 680 LNLS 683
LN++
Sbjct: 597 LNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 4e-85
Identities = 111/545 (20%), Positives = 190/545 (34%), Gaps = 29/545 (5%)
Query: 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSG 133
+ L L R ++ L L L L N + + S L+ + + +
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 134 HLPLSIFNLTNLLVLNVAHNLL-SGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQ 190
I +L L LNVAHNL+ S K+ S +L +LDLSSN + Q
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 191 LQL----INLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPS-AISNCSSLVHLSAE 245
+ L ++LS N + + + L L L +N + I + L
Sbjct: 175 MPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 246 DNVLKG---LIPGTIGRISTLQVLSLSRNELTGL-VPVSVLCNLWGNISSLRIVQLGFNA 301
+ L + L L++ L L + + +L+ ++++ L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 302 FTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGS 361
V + + L+L N + L ++ L G +
Sbjct: 294 IERV---KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVD 345
Query: 362 LDKLEVLRVANNSLS--GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419
L LE L ++ N LS G + L+ DL N FL G+ L+ +
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL-GLEQLEHLDFQ 404
Query: 420 RNMFSGLIPLS-FGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYD 478
+ + S F +L L L++S R LS+L L ++ N F D
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 479 V-GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVS 537
+ L+ L L+LS P + SL L L++S+ N L SLQV+
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524
Query: 538 LEENNLSGDVPEGFSSLVG-LQYLNLSDNAFTGDIPATY--GFLRSLVFLSLSHNQISGM 594
N++ + L +LNL+ N F +++ L + ++
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584
Query: 595 IPAEL 599
P++
Sbjct: 585 TPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 4e-79
Identities = 94/545 (17%), Positives = 179/545 (32%), Gaps = 80/545 (14%)
Query: 192 QLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKG 251
Q + L++ +P S + L L N L + + L L ++
Sbjct: 13 QCMELNFYKIPDNLPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 252 LIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG 311
+ G +S L L L+ N + L L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLAL-GAFSGL-------------------------- 99
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFF-SGNLPAAVGSLDKLEVLRV 370
S L+ L + ++ + ++ +L+ ++++ N S LP +L LE L +
Sbjct: 100 ---SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 371 ANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS 430
++N + + ++ + + +L + L N + + P +
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLD--------------------LSLNPMNFIQPGA 196
Query: 431 FGNLSQLETLNLSENDIRGNIPEE-ITRLSNLTTLNLSYNKFGGK---VPYDVGNLKGLL 486
F + L L L N N+ + I L+ L L +F + +D L+GL
Sbjct: 197 FKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 487 VLNLSA------SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
L + + I L +++ L + + Q + L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS--GMIPAE 598
SL L + + + L SL FL LS N +S G
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 599 LGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLT 657
++L+ L+L N + + L +++ LD + L + +L+ L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 658 LDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNLSRNNLEGEIP 716
+ F+ LS+L L ++ N D + +L +L+LS+ LE P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 717 KMLSS 721
+S
Sbjct: 488 TAFNS 492
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-61
Identities = 89/422 (21%), Positives = 141/422 (33%), Gaps = 44/422 (10%)
Query: 313 CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVAN 372
V + P L S + +DLS N + S +L+VL ++
Sbjct: 5 EVVPNITYQCMELNFYKI-PDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 373 NSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFG 432
+ + S L L GN G+ L+ + + L G
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 433 NLSQLETLNLSENDIRG-NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLS 491
+L L+ LN++ N I+ +PE + L+NL L+LS NK D+ L + +LNLS
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 492 ASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG- 550
LDLS ++ + F L ++L N S +V +
Sbjct: 182 --------------------LDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 551 FSSLVGLQYLNLSDNAFTGDI---PATYGFLRSLVFLSLSHNQISGM------IPAELGA 601
L GL+ L F + L L L++ +++ + I
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 602 CSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661
+ + L S S+ + L+L K L
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ-----FPTLKLKSLKRLTFT 333
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLS--GAIPADLALISSLRYLNLSRNNLEGEIPKML 719
S G S L +L L+LS N LS G +SL+YL+LS N + L
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL 393
Query: 720 SS 721
Sbjct: 394 GL 395
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-50
Identities = 76/387 (19%), Positives = 138/387 (35%), Gaps = 25/387 (6%)
Query: 70 NNRVRELRLPRLQLAGRLTD----QLADLHELRKLSLHSNHLNGS---IPASLHQCSLLR 122
V L L + G L L L L +L+ I + + +
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 123 AVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIP 182
+ L + S L + + SL+ L +SN G
Sbjct: 286 SFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ-FPTLKLKSLKRLTFTSN--KGGNA 340
Query: 183 GNFSSKSQLQLINLSYN--SFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
+ L+ ++LS N SF G S L+YL L N + T+ S L
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399
Query: 241 HLSAEDNVLKGLIP-GTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGF 299
HL + + LK + + L L +S ++ +SSL ++++
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN-----GIFNGLSSLEVLKMAG 454
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV 359
N+F P + L LDL ++ + P+ +++SL+V+++S N F
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 514
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKC-SLLQMFDLEGNRFSG--QVPAFLGGIRGLKIV 416
L+ L+VL + N + E+ S L +L N F+ + +FL I+ + +
Sbjct: 515 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQL 574
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLS 443
+ P + + +LN++
Sbjct: 575 LVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-101
Identities = 123/580 (21%), Positives = 219/580 (37%), Gaps = 47/580 (8%)
Query: 147 VLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
N + L+ +I + S L+ S N FS L ++L+
Sbjct: 16 TYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE 74
Query: 207 ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVL 266
+ L+ L L +N L +A+S +L HL + + + TL+ L
Sbjct: 75 DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134
Query: 267 SLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR 326
L N ++ + K L+VLD QNN
Sbjct: 135 YLGSNHISSIKL---------------------PKGFPTEK---------LKVLDFQNNA 164
Query: 327 IRAVFPSWLTNVTSLRVM--DLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIA 384
I + ++++ + +L+GN +G + + L ++ +
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 385 KCSL--LQMFDLEGNRFSGQVPAFLGGIRGLKIVSL--GRNMFSGLIPLSFGNLSQLETL 440
++ L + E PA G+ + + S+ ++ F + +F S L+ L
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKI- 499
+L+ + +P + LS L L LS NKF N L L++ + ++
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 500 PGSIGSLMRLTTLDLSNQNL--SGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGL 557
G + +L L LDLS+ ++ S ++L L LQ ++L N E F L
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402
Query: 558 QYLNLSDNAFTG-DIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
+ L+L+ D + + L L L+LSH+ + AL+ L L+ NHF
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462
Query: 617 GNIPVD---ISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSK 673
+ L R++ L L LS + + + L N L+ E+ S
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 674 LSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEG 713
L + LNL++N +S +P+ L ++S R +NL +N L+
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-84
Identities = 116/632 (18%), Positives = 194/632 (30%), Gaps = 112/632 (17%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
+ L L L L + ++F
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHE----------------DTFQSQ---------------- 80
Query: 151 AHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVG 210
L L L++N S L+ + S +
Sbjct: 81 --------------HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH 126
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
+ LE L+L SNH+ L L ++N + L + + LSL
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL-- 184
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
N++ I + AF +V + L+ + V
Sbjct: 185 -----------------NLNGNDIAGIEPGAFDS----------AVFQSLNFGGTQNLLV 217
Query: 331 FPSWLTN--VTSLRVMDLSGNFFSGNLPAAVGSLDK--LEVLRVANNSLSGLVPDEIAKC 386
L N + SL + PA L + +E + + + + +
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277
Query: 387 SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
S LQ DL S ++P+ L G+ LK + L N F L +S N L L++ N
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 447 IRGNIPEE-ITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGS 505
R + + L NL L+LS++ S + +
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDI----------------------ETSDCCNLQLRN 374
Query: 506 LMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSD 564
L L +L+LS P L+++ L L + F +L L+ LNLS
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 565 NAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGA---CSALEVLELRSNHFTGNIPV 621
+ + L +L L+L N + + LE+L L +
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
Query: 622 DISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLN 681
+ L + +DL N+L+ + +S + L L N +S +P LS T+N
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTIN 553
Query: 682 LSTNRLSGAIPADLALISSLRYLNLSRNNLEG 713
L N L + I L + + LE
Sbjct: 554 LRQNPLDC----TCSNIYFLEWYKENMQKLED 581
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 5e-74
Identities = 80/415 (19%), Positives = 156/415 (37%), Gaps = 12/415 (2%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
E L+ N + + + + + +L +DL+ S +L+ L + N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
+ ++ L+ S L + L+ + LG N S + +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 437 LETLNLSENDIRGNIPEEITRLSNLT--TLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
L+ L+ N I E+++ L T +LNL+ N G + + LN +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQ 213
Query: 495 FSGKIPGSIG--SLMRLTTLDLSNQNLSGELPIELFGLP--SLQVVSLEENNLSGDVPEG 550
I + ++ L + + P GL S++ ++L+++
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 551 FSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLEL 610
F GLQ L+L+ + ++P+ L +L L LS N+ + +L L +
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 611 RSNHFTGNIPVD-ISHLSRIKKLDLGQNKL--SGEIPKEISKCSSLVSLTLDMNSLSGRI 667
+ N + + +L +++LDL + + S ++ S L SL L N
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 668 PESFSKLSNLTTLNLSTNRLSGAIP-ADLALISSLRYLNLSRNNLEGEIPKMLSS 721
E+F + L L+L+ RL + + L+ LNLS + L+ ++
Sbjct: 393 TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 4e-73
Identities = 105/554 (18%), Positives = 177/554 (31%), Gaps = 84/554 (15%)
Query: 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSG 133
L L L L+ L+ L ++ LH L ++YL N S
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 134 HLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQL 193
F L+ LD +NA + SS Q
Sbjct: 144 IKLPKGFPT----------------------EKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 194 I--NLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKG 251
+ NL+ N + + + L + + N +
Sbjct: 182 LSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST-------------- 226
Query: 252 LIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG 311
I +L + + + + P G
Sbjct: 227 --------IQSLWLGTFEDMDDEDISP----------------------------AVFEG 250
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVA 371
C +E ++LQ + + + + L+ +DL+ S LP+ + L L+ L ++
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQV-PAFLGGIRGLKIVSLGRNM--FSGLIP 428
N L + L ++GN ++ L + L+ + L + S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLV 487
L NLS L++LNLS N+ E L L+L++ + K NL L V
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSG--ELPIELF-GLPSLQVVSLEENNLS 544
LNLS S L L L+L + L L+++ L +LS
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA 604
F+SL + +++LS N T L+ + L+L+ N IS ++P+ L S
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQ 548
Query: 605 LEVLELRSNHFTGN 618
+ LR N
Sbjct: 549 QRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-35
Identities = 47/238 (19%), Positives = 77/238 (32%), Gaps = 6/238 (2%)
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD 546
N G + +IPG++ + L+ S L L +L + L +
Sbjct: 16 TYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 547 VPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALE 606
+ F S L L L+ N ++L L IS + L LE
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 607 VLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS-G 665
L L SNH + ++K LD N + +++S +L+L++N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLAL--ISSLRYLNLSRNNLEGEIPKMLSS 721
I + +LN + I L I SL + E P +
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-100
Identities = 92/578 (15%), Positives = 186/578 (32%), Gaps = 66/578 (11%)
Query: 166 SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSG----EVPASVGQLQELEYLWLD 221
+ L L +G +P ++L+++ L + P + E
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 222 SNHLYGTLPSAIS--NCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPV 279
H T + S L+ + + I + + N +T +
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFV-SK 200
Query: 280 SVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVT 339
+V ++ LR +G + F E + + + N+
Sbjct: 201 AV-----MRLTKLRQFYMGNSPFVAENIC------EAWENENSEYAQQYKTEDLKWDNLK 249
Query: 340 SLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRF 399
L +++ LP + +L +++++ VA N E +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG----------------EQLKD 293
Query: 400 SGQVPAFLGGIRGLKIVSLGRNMFSGL-IPLSFGNLSQLETLNLSENDIRGNIPEEITRL 458
Q A ++I+ +G N + S + +L L N + G
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSE 352
Query: 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIP--GSIGSLMRLTTLDLSN 516
L +LNL+YN+ G + + L+ + + IP S+ ++ +D S
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 517 QNLSG-------ELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569
+ L F ++ ++L N +S E FS+ L +NL N T
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
Query: 570 -------DIPATYGFLRSLVFLSLSHNQISGMIPAELGACS--ALEVLELRSNHFTGNIP 620
D + L + L N+++ + + A + L ++L N F+ P
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FP 529
Query: 621 VDISHLSRIKKLDLGQ------NKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKL 674
+ S +K + N+ E P+ I+ C SL L + N + + E
Sbjct: 530 TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--T 586
Query: 675 SNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
N++ L++ N + + L + +
Sbjct: 587 PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = 3e-94
Identities = 90/524 (17%), Positives = 177/524 (33%), Gaps = 47/524 (8%)
Query: 233 ISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSL 292
+++ + LS E G +P IG+++ L+VL+L + + + S
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI-SANMSD 135
Query: 293 RIVQLGFNAFTGVVKPPNGRCV-SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFF 351
Q + + R S L + ++ + + N
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 352 SGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIR 411
+ + AV L KL + N+ C + + E + ++
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLK 249
Query: 412 GLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR--------GNIPEEITRLSNLTT 463
L V + +P L +++ +N++ N + +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 464 LNLSYNKF-GGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGE 522
+ + YN V + +K L +L + GK+P + GS ++L +L+L+ ++
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE- 367
Query: 523 LPIELFG-LPSLQVVSLEENNLSGDVPEGFS--SLVGLQYLNLSDNAFTG-------DIP 572
+P G ++ +S N L +P F S+ + ++ S N +
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 573 ATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG-------NIPVDISH 625
T ++ ++LS+NQIS S L + L N T + + +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 626 LSRIKKLDLGQNKLSGEIPKEI--SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLS 683
+ +DL NKL+ + + + LV + L NS S P S L +
Sbjct: 487 TYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544
Query: 684 T------NRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
NR P + L SL L + N++ K+ +
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN 588
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 6e-62
Identities = 47/336 (13%), Positives = 105/336 (31%), Gaps = 37/336 (11%)
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGG----KVP 476
+M+ +S + ++ L+L G +P+ I +L+ L L L + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 477 YDVGNLKGLLVLNLSASGFSGKIPGSIG--SLMRLTTLDLSNQNLSGELPIELFGLPSLQ 534
+ + L +++ +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 535 VVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGD-------------------IPATY 575
+ NN++ V + L L+ + ++ F + +
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245
Query: 576 GFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT--------GNIPVDISHLS 627
L+ L + + + +P L A ++++ + N D
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 628 RIKKLDLGQNKL-SGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686
+I+ + +G N L + + + K L L N L G +F L +LNL+ N+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQ 364
Query: 687 LSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSR 722
++ + L+ + N L+ IP + ++
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK 399
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-40
Identities = 35/243 (14%), Positives = 80/243 (32%), Gaps = 14/243 (5%)
Query: 497 GKIPG-SIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD----VPEGF 551
G PG S+ S R+T L L SG +P + L L+V++L + + P+G
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 552 SSLVGLQYLNLSDNAFTGDIPATYGFLR--SLVFLSLSHNQISGMIPAELGACSALEVLE 609
S+ + + + L+ ++ + I +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 610 LRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPE 669
SN+ T + + L+++++ +G + E C + + +
Sbjct: 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDL 243
Query: 670 SFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIF 729
+ L +LT + + +P L + ++ +N++ N ++
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAP 302
Query: 730 AMN 732
Sbjct: 303 VGE 305
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-15
Identities = 19/133 (14%), Positives = 37/133 (27%), Gaps = 6/133 (4%)
Query: 613 NHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG----RIP 668
+ + V ++ R+ L L SG +P I + + L L L + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 669 ESFSKLSNLTTLNLSTNRLSGAIPADLAL--ISSLRYLNLSRNNLEGEIPKMLSSRFNDP 726
+ S + S L ++ + + I K D
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 727 SIFAMNRELCGKP 739
I ++ +
Sbjct: 187 QIGQLSNNITFVS 199
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-07
Identities = 10/67 (14%), Positives = 24/67 (35%)
Query: 655 SLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGE 714
+ +++ + S + +T L+L SG +P + ++ L L L + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 715 IPKMLSS 721
Sbjct: 121 ERLFGPK 127
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = 1e-94
Identities = 129/589 (21%), Positives = 225/589 (38%), Gaps = 43/589 (7%)
Query: 133 GHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQ 192
G L I + N+ LS K+ DI S + +DLS N +FS+ S+LQ
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 193 LINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGL 252
++LS + L L L L N + P + S +SL +L A + L L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 253 IPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP---P 309
IG++ TL+ L+++ N + + NL ++L V L +N +
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL----TNLVHVDLSYNYIQTITVNDLQF 175
Query: 310 NGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPA-AVGSLDKLEVL 368
V LD+ N I + L + L GNF S N+ + +L L V
Sbjct: 176 LRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234
Query: 369 RVANNSLSGLVPDEIAKCSLLQ-MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
R+ EI + S+++ + D+ + F L
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEF-----------------RLTYTNDFSDD 277
Query: 428 PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLV 487
+ F L+ + ++L+ I E++ + +L++ + +L L
Sbjct: 278 IVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPT---LDLPFLKS 332
Query: 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS--GELPIELFGLPSLQVVSLEENNLSG 545
L L + G I +L L+ LDLS LS G G SL+ + L N
Sbjct: 333 LTL--TMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI- 389
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGACS 603
+ F L LQ+L+ + + F L L++L +S+ +
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 604 ALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNS 662
+L L++ N F N ++ ++ + + LDL + +L L L + N+
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 663 LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
L +++L +L+TL+ S NR+ + SL + NL+ N++
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 4e-80
Identities = 101/565 (17%), Positives = 196/565 (34%), Gaps = 36/565 (6%)
Query: 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNL 154
L+ +P + S + + L +N S N + L L+++
Sbjct: 11 VPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCE 67
Query: 155 LSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQL 212
+ L L L+ N PG+FS + L+ + + +GQL
Sbjct: 68 IETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQL 127
Query: 213 QELEYLWLDSNHLYG-TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRIS----TLQVLS 267
L+ L + N ++ LP+ SN ++LVH+ N ++ + + + L
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187
Query: 268 LSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDL----- 322
+S N + + + L + L N + + + ++ L V L
Sbjct: 188 MSLNPIDFI-QDQAFQGI-----KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241
Query: 323 -QNNRIRAVFPSWLTNVTSLRV--MDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLV 379
+ PS + + + + L+ + L + + +A S+ L
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL- 300
Query: 380 PDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLET 439
+++ K Q + + L LK ++L N S I L L
Sbjct: 301 -EDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGS--ISFKKVALPSLSY 354
Query: 440 LNLSENDIR--GNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497
L+LS N + G ++L L+LS+N + + L+ L L+ S
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413
Query: 498 KIP-GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLV 555
+ SL +L LD+S N + GL SL + + N+ + F++
Sbjct: 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT 473
Query: 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
L +L+LS + L L L++SHN + + + +L L+ N
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 616 TGNIPVDISHLSRIKKLDLGQNKLS 640
+ + + +L N ++
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-35
Identities = 52/233 (22%), Positives = 83/233 (35%), Gaps = 12/233 (5%)
Query: 500 PGSI---GSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG 556
PGS+ ++ T +Q LS ++P ++ S + + L N L FS+
Sbjct: 1 PGSLNPCIEVVPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 557 LQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
LQ+L+LS + L L L L+ N I P ++LE L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 617 GNIPVDISHLSRIKKLDLGQNKLSG-EIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLS 675
I L +KKL++ N + ++P S ++LV + L N + L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 676 NLT----TLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFN 724
+L++S N + I L L L N I K
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLA 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-87
Identities = 90/320 (28%), Positives = 140/320 (43%), Gaps = 30/320 (9%)
Query: 427 IPLSFGNLSQL----ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482
I GN + L T + G + + T+ + L+LS
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK--------- 64
Query: 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQN-LSGELPIELFGLPSLQVVSLEEN 541
IP S+ +L L L + N L G +P + L L + +
Sbjct: 65 -------------PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 542 NLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGA 601
N+SG +P+ S + L L+ S NA +G +P + L +LV ++ N+ISG IP G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 602 CSAL-EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
S L + + N TG IP ++L+ + +DL +N L G+ + + L
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLS 720
NSL+ + NL L+L NR+ G +P L + L LN+S NNL GEIP+ +
Sbjct: 231 NSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 721 SRFNDPSIFAMNRELCGKPL 740
+ D S +A N+ LCG PL
Sbjct: 290 LQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 3e-74
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 9/284 (3%)
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQ--VPAFLGGIRGLKIVSL-GRNMFSGLIP 428
N + G++ D + + DL G +P+ L + L + + G N G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVL 488
+ L+QL L ++ ++ G IP+ ++++ L TL+ SYN G +P + +L L+ +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 489 NLSASGFSGKIPGSIGSLMRLTT-LDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDV 547
+ SG IP S GS +L T + +S L+G++P L +L V L N L GD
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 548 PEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEV 607
F S Q ++L+ N+ D+ G ++L L L +N+I G +P L L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 608 LELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCS 651
L + N+ G IP +L R NK P + C+
Sbjct: 273 LNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 9e-68
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 34/308 (11%)
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIR--AVFPSWLTNVTSLRVMDLSG-NFFSGNLP 356
+ GV+ + + V LDL + PS L N+ L + + G N G +P
Sbjct: 36 RTWLGVLCDTDTQTYRV-NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 357 AAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416
A+ L +L L + + ++SG +PD +++ L D N SG +P + + L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 417 SLGRNMFSGLIPLSFGNLSQLET-LNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV 475
+ N SG IP S+G+ S+L T + +S N + G IP L NL ++LS N
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM----- 208
Query: 476 PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQV 535
G GS + L+ +L+ +L ++ +L
Sbjct: 209 -------------------LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 536 VSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMI 595
+ L N + G +P+G + L L LN+S N G+IP G L+ + ++N+
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307
Query: 596 PAELGACS 603
P L AC+
Sbjct: 308 P--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-62
Identities = 82/402 (20%), Positives = 141/402 (35%), Gaps = 98/402 (24%)
Query: 30 SEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLTD 89
+ QAL K L +P L W +T W G++C D
Sbjct: 6 QDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLC--------------------D 44
Query: 90 QLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLN 149
+ + L L +L +P S+ NL L L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKP----------------------YPIPSSLANLPYLNFLY 82
Query: 150 VAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV 209
+ N G IP + +QL + +++ + SG +P +
Sbjct: 83 IGGI---------------------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 210 GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTL-QVLSL 268
Q++ L L N L GTLP +IS+ +LV ++ + N + G IP + G S L +++
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 269 SRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIR 328
SRN LTG +P + N++ L +DL N +
Sbjct: 182 SRNRLTGKIPPTF-----ANLN--------------------------LAFVDLSRNMLE 210
Query: 329 AVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSL 388
+ + + + L+ N + +L VG L L + NN + G +P + +
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 389 LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS 430
L ++ N G++P G ++ + + N PL
Sbjct: 270 LHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 8e-87
Identities = 79/586 (13%), Positives = 176/586 (30%), Gaps = 60/586 (10%)
Query: 153 NLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQL 212
SG I+ I + + + + + + ++ ++L+ G VP ++GQL
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 213 QELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPG-TIGRISTLQVLSLSRN 271
EL+ L ++ + + + ++ + L + L ++
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 272 ELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPN-GRCVSVLEVLDLQNNRIRAV 330
+ + + + N T + R L+++ N+
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFI--SKAIQRLTK-LQIIYFANSPF--- 460
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
++ + N + +L L + + N +PD + LQ
Sbjct: 461 --TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
++ NR R + +++ + N++
Sbjct: 519 SLNIACNRGISAAQLKADWTR---------------LADDEDTGPKIQIFYMGYNNLEE- 562
Query: 451 IPEE--ITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMR 508
P + ++ L L+ +NK + G L L L + IP +
Sbjct: 563 FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTD 619
Query: 509 -LTTLDLSNQNLSGELP--IELFGLPSLQVVSLEENNLSGDVPEGFSSLVG-----LQYL 560
+ L S+ L +P + + V N + + S+ +
Sbjct: 620 QVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 561 NLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS-------GMIPAELGACSALEVLELRSN 613
LS N + + + LS+N ++ L ++LR N
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 614 HFTGNIPVDI--SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM------NSLSG 665
T + D + L + +D+ N S P + S L + + N +
Sbjct: 739 KLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
+ P + +L L + +N + + L L L+++ N
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIRK-VDEK--LTPQLYILDIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 2e-80
Identities = 100/712 (14%), Positives = 207/712 (29%), Gaps = 133/712 (18%)
Query: 24 QNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQL 83
+ A + + +AL + L + +W +
Sbjct: 263 ETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDM-----------W 311
Query: 84 AGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLT 143
+ L + + LSL G +P ++ Q + L+ + +S + L
Sbjct: 312 GDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL 371
Query: 144 NLLVLNVAHNLLSG---KISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
+ + + K+ D L DL +A + I+L
Sbjct: 372 TPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQ 429
Query: 201 FSG------EVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIP 254
+ ++ +L +L+ ++ ++ + + +++
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYENEE 484
Query: 255 GTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCV 314
+ + L + L +P L +L P
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLP-DFLYDL-----------------------PE---- 516
Query: 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS 374
L+ L++ NR + L + K+++ + N+
Sbjct: 517 --LQSLNIACNRGISAAQL---------------KADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 375 LSGL-VPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGN 433
L + K L + D N+ + AF G L + L N +
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEEIPEDFCAF 617
Query: 434 LSQLETLNLSENDIRGNIPE--EITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLS 491
Q+E L S N ++ IP + + +++ SYNK G ++
Sbjct: 618 TDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDY----- 670
Query: 492 ASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFG-LPSLQVVSLEENNLS------ 544
+ +T+ LS + P ELF + + L N ++
Sbjct: 671 -------------KGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 545 -GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGA 601
+ + L ++L N T + + L L + +S+N S P +
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774
Query: 602 CSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661
S L+ +R D N++ + P I+ C SL+ L + N
Sbjct: 775 SSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSN 816
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRL-SGAIPADLALISSLRY-LNLSRNNL 711
+ + E L L+++ N S + + I + Y L +
Sbjct: 817 DIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 3e-75
Identities = 73/540 (13%), Positives = 174/540 (32%), Gaps = 58/540 (10%)
Query: 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVS 280
+ Y + + + + + E ++ + + LSL+ G VP +
Sbjct: 284 KNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 281 VLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTS 340
+ G ++ L+++ G ++ T + ++ + ++ +L
Sbjct: 343 I-----GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 341 LRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL------VPDEIAKCSLLQMFDL 394
L + DL + + N + + K + + + + L + I + + LQ+
Sbjct: 398 LNLSDLLQDAINRNPE--MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYF 455
Query: 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEE 454
+ F+ A + + LS+ NL L + L +P+
Sbjct: 456 ANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
Query: 455 ITRLSNLTTLNLSYNKFGG---------KVPYDVGNLKGLLVLNLSASGFSG-KIPGSIG 504
+ L L +LN++ N+ ++ D + + + + S+
Sbjct: 511 LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQ 570
Query: 505 SLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSD 564
+++L LD + + L L + L+ N + + + ++ L S
Sbjct: 571 KMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSH 628
Query: 565 NAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGA------CSALEVLELRSNHFT 616
N IP + + + + S+N+I + + L N
Sbjct: 629 NKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQ 686
Query: 617 GNIPVDISHLSRIKKLDLGQNKLS-------GEIPKEISKCSSLVSLTLDMNSLSGRIPE 669
+ S I + L N ++ L ++ L N L+ + +
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSD 745
Query: 670 S--FSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSR------NNLEGEIPKMLSS 721
+ L L+ +++S N S P S L+ + N + + P +++
Sbjct: 746 DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 7e-35
Identities = 43/299 (14%), Positives = 92/299 (30%), Gaps = 28/299 (9%)
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497
E L+ N N + +G + D+ N + L+L+ G G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 498 KIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGF-SSLVG 556
++P +IG L L L + + + + + ++ + + F
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 557 LQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
L +L +A + ++ +SL QI + +N T
Sbjct: 398 LNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNL-----------------TNRIT 438
Query: 617 GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
I I L++++ + + + + D S+S L +
Sbjct: 439 F-ISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKD 492
Query: 677 LTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNREL 735
LT + L +P L + L+ LN++ N ++ + ++
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRLADDEDTGPKI 550
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 4e-85
Identities = 103/297 (34%), Positives = 172/297 (57%), Gaps = 20/297 (6%)
Query: 828 TYVETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI--DENTFRKEAEA 885
+ E A+ F +N+L RG +G ++K DG +++++RL++ E F+ E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL 945
+ HRNL LRG+ P + RLLVY YM NG++A+ L+E L+WP R I+L
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQP-PLDWPKRQRIAL 138
Query: 946 GLARGLSFLH---SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
G ARGL++LH ++H D+K N+L D +FEA + +FGL +L + + TT +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAV 195
Query: 1003 -GSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFT-----QDEDIVKWVKKQ 1056
G++G+++PE STG+ +++ DV+ +G++LLE++TG++ D ++ WVK
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113
L+ ++ L++ L + EE ++V LLCT P++RP M+++V MLEG
Sbjct: 256 LKEKKLEALVDVDLQGNYKD----EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 9e-79
Identities = 87/322 (27%), Positives = 154/322 (47%), Gaps = 17/322 (5%)
Query: 800 SRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKASYQ 859
S A + + + ++ V+ EAT FD + ++ G +G ++K +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 860 DGMVLSIRRL-RDGTIDENTFRKEAEALGKVKHRNLTVLRGY-YAGPPDVRLLVYDYMPN 917
DG ++++R + + F E E L +H +L L G+ + +L+Y YM N
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMEN 119
Query: 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEA 977
GNL L + ++W R I +G ARGL +LH+ ++H D+K N+L D +F
Sbjct: 120 GNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP 178
Query: 978 HLSEFGLDRLAIATPAEASS--STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEIL 1035
+++FG+ + + ST G+LGY+ PE G+ T+++DVYSFG+VL E+L
Sbjct: 179 KITDFGISKKG---TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 1036 TGRKPVMFTQDED---IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLL 1092
R ++ + + + +W + GQ+ ++++P L +F +
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP-NLADKIRPESLRKFG---DTAVK 291
Query: 1093 CTAPDPLDRPSMADIVFMLEGC 1114
C A DRPSM D+++ LE
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 3e-70
Identities = 85/317 (26%), Positives = 145/317 (45%), Gaps = 29/317 (9%)
Query: 814 ENGGPKLVMFNNKI-TYVETLEATRQFDEE------NVLSRGRYGLIFKASYQDGMVLSI 866
EN ++ ++ E T FDE N + G +G+++K Y + +++
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAV 59
Query: 867 RRLRDGTIDENT-----FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLA 921
++L F +E + + K +H NL L G+ + D LVY YMPNG+L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-DDLCLVYVYMPNGSLL 118
Query: 922 TLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981
L + L+W MR I+ G A G++FLH +H DIK N+L D F A +S+
Sbjct: 119 DRL--SCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISD 176
Query: 982 FGLDRLAIATPAEASS--STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK 1039
FGL R + A + ++ +G+ Y++PE A G+ T ++D+YSFG+VLLEI+TG
Sbjct: 177 FGLARAS---EKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLP 232
Query: 1040 PVMFTQDED-IVKWVKKQLQ-RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPD 1097
V ++ ++ ++ I + ++ + + D V C
Sbjct: 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-----TSVEAMYSVASQCLHEK 287
Query: 1098 PLDRPSMADIVFMLEGC 1114
RP + + +L+
Sbjct: 288 KNKRPDIKKVQQLLQEM 304
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-66
Identities = 126/590 (21%), Positives = 204/590 (34%), Gaps = 84/590 (14%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
+ N+ + N I ++ S + LDLS N +F S +LQ+++LS
Sbjct: 6 VVPNITYQCMELNFYK--IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
+ L L L L N + A S SSL L A + L L IG +
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP---PNGRCVSVL 317
TL+ L+++ N + NL ++L + L N + + +
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNL----TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPA-AVGSLDKLEVLRVA----- 371
LDL N + + P L + L NF S N+ + L LEV R+
Sbjct: 180 LSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 372 -NNSLSGLVPDEIAKCSLLQMFDLEGNR---FSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
+L + L + + + + + + SL +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 428 PLSF-GNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
S+ LE +N +L +L L + NK G
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGN------------- 339
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS--GELPIELFGLPSLQVVSLEENNLS 544
S L L LDLS LS G FG SL+ + L N +
Sbjct: 340 -------------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGAC 602
+ F L L++L+ + + F LR+L++L +SH
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 603 SALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661
S+LEVL++ N F N DI + L + LDL Q +L ++
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS----------------- 486
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
P +F+ LS+L LN+++N+L ++SL+ + L N
Sbjct: 487 ------PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-59
Identities = 93/519 (17%), Positives = 171/519 (32%), Gaps = 40/519 (7%)
Query: 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLL 155
+ L L N L S L+ + L + + +L++L L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 156 SGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSF-SGEVPASVGQ 211
++ SL+ L L+ +N+++N S ++P
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 212 LQELEYLWLDSNHLYGTLPSAISNCSSL----VHLSAEDNVLKGLIPGTIGRISTLQVLS 267
L LE+L L SN + + + + + L N + + PG I L L+
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 268 LSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK-------PPNGRCVSVLEVL 320
L N + V + + L + L + +L F G C +E
Sbjct: 207 LRNNFDSLNVMKTCIQGL----AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 321 DLQNNRIRA-VFPSWLTNVTSLRVMDLSGNFFSGNLPAA-VGSLDKLEVLRVANNSLSGL 378
L +T++ L + LE++ L
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL 322
Query: 379 VPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNM--FSGLIPLSFGNLSQ 436
L+ N+ + + + L+ + L RN F G S +
Sbjct: 323 KLKS------LKRLTFTSNKGGN-AFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 437 LETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGF 495
L+ L+LS N + + L L L+ ++ + V +L+ L+ L++S +
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 496 SGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSS 553
G L L L ++ + ++F L +L + L + L + F+S
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNS 492
Query: 554 LVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS 592
L LQ LN++ N + L SL + L N
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-56
Identities = 93/534 (17%), Positives = 181/534 (33%), Gaps = 79/534 (14%)
Query: 195 NLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIP 254
+F ++P ++ + L L N L + + L L ++ +
Sbjct: 13 QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 255 GTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCV 314
G +S L L L+ N + L + L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSL-ALGAFSGL----------------------------- 99
Query: 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFF-SGNLPAAVGSLDKLEVLRVANN 373
S L+ L + ++ + ++ +L+ ++++ N S LP +L LE L +++N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 374 SLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGN 433
+ + ++ + + +L + L N + + P +F
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLD--------------------LSLNPMNFIQPGAFKE 199
Query: 434 LSQLETLNLSENDIRGNIPEE-ITRLSNLTTLNLSYNKFGGK---VPYDVGNLKGLLVLN 489
+ L L L N N+ + I L+ L L +F + +D L+GL L
Sbjct: 200 IR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 490 LSA------SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIE-LFGLPSLQVVSLEENN 542
+ + I L +++ L + + FG L++V+ +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 543 LSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS--GMIPAELG 600
L L+ L + N L SL FL LS N +S G
Sbjct: 319 FP------TLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLD 659
++L+ L+L N + + L +++ LD + L + +L+ L +
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 660 MNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNLSRNNLE 712
F+ LS+L L ++ N D + +L +L+LS+ LE
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-52
Identities = 96/445 (21%), Positives = 159/445 (35%), Gaps = 28/445 (6%)
Query: 290 SSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGN 349
S + + L FN + L+VLDL I+ + +++ L + L+GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 350 FFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRF-SGQVPAFLG 408
A L L+ L +L+ L I L+ ++ N S ++P +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 409 GIRGLKIVSLGRNMFSGLIPLSFGNLSQLE----TLNLSENDIRGNIPEEITRLSNLTTL 464
+ L+ + L N + L Q+ +L+LS N + I + L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205
Query: 465 NLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSG------KIPGSIGSLMRLTT--LDLS 515
L N V L GL V L F ++ L LT L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 516 NQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPAT 574
+ + I+LF L ++ SL + + FS G Q+L L + F
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQF---P 320
Query: 575 YGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT--GNIPVDISHLSRIKKL 632
L+SL L+ + N+ +E+ +LE L+L N + G + +K L
Sbjct: 321 TLKLKSLKRLTFTSNKGGN-AFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 633 DLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPES-FSKLSNLTTLNLSTNRLSGAI 691
DL N + + L L ++L S F L NL L++S A
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 692 PADLALISSLRYLNLSRNNLEGEIP 716
+SSL L ++ N+ +
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-20
Identities = 36/162 (22%), Positives = 58/162 (35%), Gaps = 4/162 (2%)
Query: 561 NLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIP 620
+ F IP S L LS N + + + L+VL+L
Sbjct: 13 QCMELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 621 VDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTL 680
LS + L L N + S SSL L +L+ L L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 681 NLSTNRL-SGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
N++ N + S +P + +++L +L+LS N ++ L
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-15
Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 15/164 (9%)
Query: 86 RLTDQLADLHELRKLSLHSNHLNGSIPAS-LHQCSLLRAVYLQYNSFSGHLPLSIF-NLT 143
++ L +L L ++L S L + + + IF L+
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 445
Query: 144 NLLVLNVAHNLLSGKISADIS---PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
+L VL +A N DI +L +LDLS P F+S S LQ++N++ N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 201 FSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLS 243
VP + +L L+ +WL +N + C + +LS
Sbjct: 506 LK-SVPDGIFDRLTSLQKIWLHTNPWDCS-------CPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-12
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 3/115 (2%)
Query: 607 VLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR 666
+ +F IP ++ K LDL N L L L L +
Sbjct: 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 667 IPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
++ LS+L+TL L+ N + + +SSL+ L NL +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-62
Identities = 136/725 (18%), Positives = 253/725 (34%), Gaps = 102/725 (14%)
Query: 93 DLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVA 151
L+ +L L N++ +S L+ + L + F NL NL +L++
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 152 HNLLSGKISADI---SPSLRYLDLSSNAFTGEI--PGNFSSKSQLQLINLSYNSFSG-EV 205
+ + + D L L L + + G F + L ++LS N +
Sbjct: 82 SSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 206 PASVGQLQELEYLWLDSNHLYGTLPSAISNCS--SLVHLSAEDNVLKGLIPGTIGRIS-- 261
S G+L L+ + SN ++ + +L S N L + G+
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 262 ----TLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317
L++L +S N T + N IS + L +
Sbjct: 201 FRNMVLEILDVSGNGWTVDIT----GNFSNAISKSQAFSLILA--------------HHI 242
Query: 318 EVLDLQNNRIRAVFPSWLTNV--TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSL 375
+ I+ + + +S+R +DLS F +L L+VL +A N +
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
+ + + LQ+ +L N + G+ + + L +N + + +F L
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362
Query: 436 QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGF 495
+L+TL+L +N + I + ++ + LS N L L +NL+
Sbjct: 363 KLQTLDLRDNAL-----TTIHFIPSIPDIFLSGN-----------KLVTLPKINLT---- 402
Query: 496 SGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSS 553
+ LS L + +P LQ++ L +N S + S
Sbjct: 403 -------------ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 554 LVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSN 613
L+ L L +N L VF LSH L+VL L N
Sbjct: 450 NPSLEQLFLGENMLQLAWETE---LCWDVFEGLSH----------------LQVLYLNHN 490
Query: 614 HFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSK 673
+ P SHL+ ++ L L N+L+ + ++L L + N L P+ F
Sbjct: 491 YLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPDVF-- 546
Query: 674 LSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNR 733
+L+ L+++ N+ I+ L + N++ +I + F+ S+F+++
Sbjct: 547 -VSLSVLDITHNKFICECEL-STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLST 604
Query: 734 ELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATG 793
E C + V K + L I+ V+ + L + +T +
Sbjct: 605 EGC------DEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFK 658
Query: 794 EKKPS 798
+
Sbjct: 659 DHPQG 663
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-59
Identities = 124/563 (22%), Positives = 216/563 (38%), Gaps = 64/563 (11%)
Query: 164 SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223
S R T ++P ++ + + LS+N +S L++L+ L L S
Sbjct: 3 SFDGRIAFYRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ 58
Query: 224 HLYGTL-PSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVL 282
+ T+ A N +L L + + L P + L L L L+ +
Sbjct: 59 YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA---VLK 115
Query: 283 CNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVT--S 340
+ N+ +L + L N + P+ ++ L+ +D +N+I V L + +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 341 LRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFS 400
L L+ N + G N +V L++ D+ GN ++
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKC---------MNPFRNMV---------LEILDVSGNGWT 217
Query: 401 GQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITR--- 457
+ I N S S + ++I+ + +
Sbjct: 218 ------------VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLA 264
Query: 458 LSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQ 517
S++ L+LS+ LK L VLNL+ + + + L L L+LS
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY- 323
Query: 518 NLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYG 576
NL GEL F GLP + + L++N+++ + F L LQ L+L DNA T I
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIH---- 378
Query: 577 FLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG-NIPVDISHLSRIKKLDLG 635
F+ S+ + LS N++ + L ++ L N +I + + ++ L L
Sbjct: 379 FIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILN 434
Query: 636 QNKLSGEIPKE--ISKCSSLVSLTLDMNSLSGRI-----PESFSKLSNLTTLNLSTNRLS 688
QN+ S + S+ SL L L N L + F LS+L L L+ N L+
Sbjct: 435 QNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 689 GAIPADLALISSLRYLNLSRNNL 711
P + +++LR L+L+ N L
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-44
Identities = 104/528 (19%), Positives = 189/528 (35%), Gaps = 78/528 (14%)
Query: 68 CYNNRVRELRLP--RLQLAGRLTDQLADLHELRKLSLHSNHLNG-SIPASLHQCSLLRAV 124
+ ELRL L A +L L +L L N + + S + + L+++
Sbjct: 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153
Query: 125 YLQYNSFSGHLPLSIFNLT--NLLVLNVAHNLLSGKISADIS--------PSLRYLDLSS 174
N + L L ++A N L ++S D L LD+S
Sbjct: 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213
Query: 175 NAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAIS 234
N +T +I GNFS N+ S S+ + +++ + +
Sbjct: 214 NGWTVDITGNFS------------NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 235 N--CSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSL 292
SS+ HL + L + L+VL+L+ N++ + + + +L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD-----EAFYGLDNL 316
Query: 293 RIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFS 352
+++ L +N + N + + +DLQ N I + + L+ +DL N +
Sbjct: 317 QVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
Query: 353 GNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG-QVPAFLGGIR 411
+ + + + ++ N L L + + L NR + FL +
Sbjct: 376 -----TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVP 426
Query: 412 GLKIVSLGRNMFSGLIP-LSFGNLSQLETLNLSENDIRGNIPEEITR-----LSNLTTLN 465
L+I+ L +N FS + LE L L EN ++ E+ LS+L L
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 466 LSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPI 525
L++N +L FS L L L L++ L+ L
Sbjct: 487 LNHNYL----------------NSLPPGVFSH--------LTALRGLSLNSNRLT-VLSH 521
Query: 526 ELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPA 573
+L+++ + N L P+ F S L L+++ N F +
Sbjct: 522 NDL-PANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECEL 565
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-27
Identities = 81/431 (18%), Positives = 148/431 (34%), Gaps = 78/431 (18%)
Query: 70 NNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYN 129
+ VR L L + + L +L+ L+L N +N +
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK----------------IADE 308
Query: 130 SFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKS 189
+F G L N L+ L+LS N NF
Sbjct: 309 AFYG--------LDN----------------------LQVLNLSYNLLGELYSSNFYGLP 338
Query: 190 QLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVL 249
++ I+L N + + L++L+ L L N L + I S+ + N L
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL 393
Query: 250 KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPP 309
L + T ++ LS N L L + L + L+I+ L N F+
Sbjct: 394 VTLPKINL----TANLIHLSENRLENLDILYFLLRV----PHLQILILNQNRFSSC--SG 443
Query: 310 NGRCV--SVLEVLDLQNNRIRAVFPSWL-----TNVTSLRVMDLSGNFFSGNLPAAVGSL 362
+ LE L L N ++ + + L ++ L+V+ L+ N+ + P L
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 363 DKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNM 422
L L + +N L+ L + + L++ D+ N+ P L ++ + N
Sbjct: 504 TALRGLSLNSNRLTVLSHN--DLPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNK 558
Query: 423 FSGLIPLS-FGNLSQLETLNLSEN--DIRGNIPEEI--TRLSNLTTLNLSYNKFGGKVPY 477
F LS F N + ++ DI P+ L +L+T + + +
Sbjct: 559 FICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKF 618
Query: 478 DVGNLKGLLVL 488
+ + + +
Sbjct: 619 SLFIVCTVTLT 629
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-61
Identities = 98/549 (17%), Positives = 198/549 (36%), Gaps = 56/549 (10%)
Query: 147 VLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
V + + I + ++ +++ LDLS N T G+ + + LQ++ L + +
Sbjct: 9 VCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 207 ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGL-IPGTIGRISTLQV 265
+ L LE+L L NHL S SSL +L+ N + L + ++ LQ
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSV--LEVLDLQ 323
L + E + L +SL +++ + + S+ + L L
Sbjct: 128 LRIGNVETFSEIRRIDFAGL----TSLNELEIKALSLRNY---QSQSLKSIRDIHHLTLH 180
Query: 324 NNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEI 383
+ + + ++S+R ++L + + + + ++ S L +
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 384 AKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLS 443
+ L + LE + + + + L + L++
Sbjct: 241 NELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 444 ENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSI 503
+ + ++ + L + + + +K + S
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF----------------LVPCSFSQH------ 332
Query: 504 GSLMRLTTLDLSN---QNLSGELPIELFGLPSLQVVSLEENNLS--GDVPEGFSSLVGLQ 558
L L LDLS + PSLQ + L +N+L E +L L
Sbjct: 333 --LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390
Query: 559 YLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGN 618
L++S N F +P + + + FL+LS I ++ LEVL++ +N+ +
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-S 445
Query: 619 IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLT 678
L R+++L + +NKL +P + S L+ + + N L F +L++L
Sbjct: 446 FS---LFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500
Query: 679 TLNLSTNRL 687
+ L TN
Sbjct: 501 KIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-55
Identities = 96/497 (19%), Positives = 178/497 (35%), Gaps = 35/497 (7%)
Query: 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLL 155
++ L L N + L C+ L+ + L+ + + + F +L +L L+++ N L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL 86
Query: 156 SGKISADI---SPSLRYLDLSSNAFTG-EIPGNFSSKSQLQLINLSYNSFSGEVPASV-G 210
S +S+ SL+YL+L N + + F + + LQ + + E+
Sbjct: 87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L L L + + L ++ + + HL+ + L+ +S+++ L L
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 271 NELTGL---VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNR 326
L + + R L +F ++K +S +E D N
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 327 IRAVFPSWLTNV--------TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL 378
+ PS V ++R + + + +L L+K++ + V N+ + +
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 379 VPDEIAKCSLLQMFDLEGNRFSGQV---PAFLGGIRGLKIVSLGRNMFSGL--IPLSFGN 433
L+ DL N + A G L+ + L +N +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 434 LSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSAS 493
L L +L++S N +P+ + LNLS V + + L VL++S +
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNN 441
Query: 494 GFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSS 553
L RL L +S L LP P L V+ + N L F
Sbjct: 442 NLD-SFS---LFLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDR 495
Query: 554 LVGLQYLNLSDNAFTGD 570
L LQ + L N +
Sbjct: 496 LTSLQKIWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-52
Identities = 87/458 (18%), Positives = 173/458 (37%), Gaps = 36/458 (7%)
Query: 290 SSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGN 349
+ + +FT + P + ++ LDL N+I + L +L+V+ L +
Sbjct: 5 DASGVCDGRSRSFTSI--PSG--LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 350 FFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG-QVPAFLG 408
+ A SL LE L +++N LS L S L+ +L GN + V +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 409 GIRGLKIVSLGR-NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLS 467
+ L+ + +G FS + + F L+ L L + +R + + + ++ L L
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 468 YNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTL-DLSNQNLS------ 520
++ + L + L L + + + + + L+ +
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 521 GELPIELFGLPSLQVVSLEENNLSG---------DVPEGFSSL--VGLQYLNLSDNAFTG 569
EL L + L V ++ L+G DV + V ++ L++
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 570 DIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNI---PVDISHL 626
D+ Y L + +++ ++++ + + +LE L+L N
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 627 SRIKKLDLGQNKLSGEIPKEISKCSSLVSLT-LDM--NSLSGRIPESFSKLSNLTTLNLS 683
++ L L QN L + K +L +LT LD+ N+ +P+S + LNLS
Sbjct: 361 PSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418
Query: 684 TNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
+ + + + +L L++S NNL+ L
Sbjct: 419 STGIR-VVKTC--IPQTLEVLDVSNNNLD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 66/363 (18%), Positives = 128/363 (35%), Gaps = 25/363 (6%)
Query: 386 CSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEN 445
C + D F+ +P+ L +K + L N + + + L+ L L +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 446 DIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSG-KIPGSI 503
I + L +L L+LS N + G L L LNL + + +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 504 GSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562
+L L TL + N E+ F GL SL + ++ +L + S+ + +L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 563 SDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG----- 617
+ + L S+ +L L ++ + L ++ + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 618 -----NIPVDISHLSRIKKLDLGQNKLSGEIPKEIS--------KCSSLVSLTLDMNSLS 664
+ I LS ++ D N L P E + ++ L + L
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFN 724
+ +S L + + + +++ + + SL +L+LS N + E K + +
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 725 DPS 727
PS
Sbjct: 360 WPS 362
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 53/307 (17%), Positives = 104/307 (33%), Gaps = 33/307 (10%)
Query: 433 NLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA 492
+ + +IP + + + +L+LS+NK +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIG---------------- 42
Query: 493 SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGF 551
G + + L L L + ++ + + F L SL+ + L +N+LS F
Sbjct: 43 -------HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWF 94
Query: 552 SSLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAE-LGACSALEVL 608
L L+YLNL N + + T F L +L L + + + I ++L L
Sbjct: 95 GPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIP 668
E+++ + + I L L ++ + + SS+ L L +L+
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213
Query: 669 ESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSI 728
+ + R S + L L + +E + + +PS
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273
Query: 729 FAMNREL 735
+ EL
Sbjct: 274 SDVVSEL 280
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-23
Identities = 36/200 (18%), Positives = 75/200 (37%), Gaps = 8/200 (4%)
Query: 528 FGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLS 587
+ V + + +P G ++ ++ L+LS N T +L L L
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 588 HNQISGMIPAELGACSALEVLELRSNHFTGNIPVD-ISHLSRIKKLDLGQNKLSG-EIPK 645
++I+ + + +LE L+L NH + ++ LS +K L+L N +
Sbjct: 59 SSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 646 EISKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYL 704
++L +L + I F+ L++L L + L L I + +L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 705 NLSRNNLEGEIPKMLSSRFN 724
L + + ++ + +
Sbjct: 178 TLHLSESA-FLLEIFADILS 196
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-61
Identities = 107/506 (21%), Positives = 192/506 (37%), Gaps = 66/506 (13%)
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L E L ++ T+ ++ + L A+ +K + + ++ L ++ S
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSN 77
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
N+LT + P+ N++ L + + N + P + L L L NN+I +
Sbjct: 78 NQLTDITPLK-------NLTKLVDILMNNNQIADI--TPLANLTN-LTGLTLFNNQITDI 127
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
P L N+T+L ++LS N S +A+ L L+ L N +A + L+
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE 180
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
D+ N+ S + L + L+ + N S + PL G L+ L+ L+L+ N ++
Sbjct: 181 RLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD- 235
Query: 451 IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
+ L+NLT L+L+ N+ P + L +LT
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAP--------------------------LSGLTKLT 268
Query: 511 TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGD 570
L L +S P+ GL +L + L EN L S+L L YL L N +
Sbjct: 269 ELKLGANQISNISPLA--GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI 324
Query: 571 IPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIK 630
P L L L +N++S + L + + L N + P +++L+RI
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 378
Query: 631 KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGA 690
+L L + P S+ + ++ P + S + T +++ N S
Sbjct: 379 QLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSY- 435
Query: 691 IPADLALISSLRYLNLSRNNLEGEIP 716
S + G +
Sbjct: 436 TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-59
Identities = 94/404 (23%), Positives = 158/404 (39%), Gaps = 33/404 (8%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
L + T++ + + V L+ L + +NN L+
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 81
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
+ P + + L + N+ + P L + L ++L N + + PL NL+
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL--KNLTN 135
Query: 437 LETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496
L L LS N I ++ L++L L+ + NL L L++S++ S
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVS 190
Query: 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG 556
+ L L +L +N +S P+ L +L +SL N L +SL
Sbjct: 191 D--ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTN 244
Query: 557 LQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
L L+L++N + ++ L L L L NQIS + P L +AL LEL N
Sbjct: 245 LTDLDLANNQIS-NLAPL-SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300
Query: 617 GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
P IS+L + L L N +S P +S + L L N +S S + L+N
Sbjct: 301 DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTN 354
Query: 677 LTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLS 720
+ L+ N++S P LA ++ + L L+ +
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-54
Identities = 93/482 (19%), Positives = 188/482 (39%), Gaps = 40/482 (8%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
L E K L ++ ++ + + + L NL +N
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75
Query: 151 AHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVG 210
++N L+ L + +++N P ++ + L + L N + P +
Sbjct: 76 SNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LK 131
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L L L L SN + + SA+S +SL LS N + L P + ++TL+ L +S
Sbjct: 132 NLTNLNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISS 186
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
N+++ + + +++L + N + + P G + L+ L L N+++ +
Sbjct: 187 NKVSDISVL-------AKLTNLESLIATNNQISDI--TPLGILTN-LDELSLNGNQLKDI 236
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
L ++T+L +DL+ N S P + L KL L++ N +S + P +A + L
Sbjct: 237 GT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 290
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
+L N+ + + ++ L ++L N S + P+S +L++L+ L N +
Sbjct: 291 NLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSD- 345
Query: 451 IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
+ L+N+ L+ +N+ P + NL + L L+ ++ ++
Sbjct: 346 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 511 TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGD 570
T+ L P + S + N S E + + F+G
Sbjct: 403 TVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGT 459
Query: 571 IP 572
+
Sbjct: 460 VT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-54
Identities = 102/471 (21%), Positives = 185/471 (39%), Gaps = 68/471 (14%)
Query: 246 DNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGV 305
D + + ++ L + +T V + L +++L+ +LG + GV
Sbjct: 11 DTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQTDL----DQVTTLQADRLGIKSIDGV 64
Query: 306 VKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKL 365
N L ++ NN++ + P L N+T L + ++ N + + +L L
Sbjct: 65 EYLNN------LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNL 114
Query: 366 EVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSG 425
L + NN ++ + D + + L +L N S + L G+ L+ +S G +
Sbjct: 115 TGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTD 169
Query: 426 LIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGL 485
L PL NL+ LE L++S N + + +L+NL +L + N+
Sbjct: 170 LKPL--ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI-------------- 211
Query: 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
S + +G L L L L+ L L L +L + L N +S
Sbjct: 212 -------SDITP-----LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605
S L L L L N + +I L +L L L+ NQ+ + P + L
Sbjct: 258 --LAPLSGLTKLTELKLGANQIS-NISPL-AGLTALTNLELNENQLEDISP--ISNLKNL 311
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
L L N+ + P +S L+++++L NK+S ++ +++ L+ N +S
Sbjct: 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD 367
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716
P + L+ +T L L+ + A A +S N +N I
Sbjct: 368 LTP--LANLTRITQLGLNDQAWTNAPVNYKANVS---IPNTVKNVTGALIA 413
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-55
Identities = 86/396 (21%), Positives = 152/396 (38%), Gaps = 51/396 (12%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
L I +FP ++ L + L+ + L VA ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
+ I + L+ +L GN+ + P L + L + +G N + + NL+
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTN 111
Query: 437 LETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496
L L L+E++I + L+ + +LNL N
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL------------------------ 145
Query: 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG 556
+ ++ L L ++ + PI L L +SL N + +SL
Sbjct: 146 -SDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLNYNQIED--ISPLASLTS 200
Query: 557 LQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
L Y N T P + L L + +N+I+ + P L S L LE+ +N +
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256
Query: 617 GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
+I + L+++K L++G N++S ++ S L SL L+ N L E L+N
Sbjct: 257 -DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312
Query: 677 LTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
LTTL LS N ++ P LA +S + + + ++
Sbjct: 313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-48
Identities = 72/315 (22%), Positives = 135/315 (42%), Gaps = 23/315 (7%)
Query: 407 LGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNL 466
+ L + + ++ L + L ++ + + I L+NL LNL
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS--IQGIEYLTNLEYLNL 73
Query: 467 SYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIE 526
+ N+ P + NL L L + + + ++ +L L L L+ N+S
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISP 127
Query: 527 LFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSL 586
L L + ++L N+ D S++ GL YL ++++ D+ L L LSL
Sbjct: 128 LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVK-DVTP-IANLTDLYSLSL 184
Query: 587 SHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKE 646
++NQI + P L + ++L N T P +++++R+ L +G NK++ P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 647 ISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNL 706
++ S L L + N +S + L+ L LN+ +N++S L +S L L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFL 294
Query: 707 SRNNLEGEIPKMLSS 721
+ N L E +++
Sbjct: 295 NNNQLGNEDMEVIGG 309
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-48
Identities = 74/352 (21%), Positives = 144/352 (40%), Gaps = 25/352 (7%)
Query: 365 LEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424
L ++ + PD + L+ + V + + + + +
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 425 GLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKG 484
+ + L+ LE LNL+ N I ++ L LT L + NK + NL
Sbjct: 58 SIQGI--EYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS 544
L L L+ S P + +L ++ +L+L N + L + L +++ E+ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGA-NHNLSDLSPLSNMTGLNYLTVTESKVK 168
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA 604
++L L L+L+ N P L SL + + NQI+ + P + +
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 605 LEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664
L L++ +N T P +++LS++ L++G N++S + + L L + N +S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716
+ LS L +L L+ N+L + +++L L LS+N++ P
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-46
Identities = 80/371 (21%), Positives = 155/371 (41%), Gaps = 31/371 (8%)
Query: 121 LRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGE 180
+ + P + +L + + ++ ++ + S+ L ++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-S 58
Query: 181 IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
I G + L+ +NL+ N + P + L +L L++ +N + T SA+ N ++L
Sbjct: 59 IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLR 113
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
L ++ + + P + ++ + L+L N + S L N+ + L + + +
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL--SPLSNM----TGLNYLTVTES 165
Query: 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360
V P L L L N+I + P L ++TSL N + P V
Sbjct: 166 KVKDV--TPIANLTD-LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VA 218
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420
++ +L L++ NN ++ L +A S L ++ N+ S + + LK++++G
Sbjct: 219 NMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGS 274
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG 480
N S + NLSQL +L L+ N + E I L+NLTTL LS N P +
Sbjct: 275 NQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330
Query: 481 NLKGLLVLNLS 491
+L + + +
Sbjct: 331 SLSKMDSADFA 341
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 78/358 (21%), Positives = 155/358 (43%), Gaps = 29/358 (8%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
ADL E + L + + + + + + + + I LTNL LN+
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 151 AHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVG 210
N ++ L L + +N T + + L+ + L+ ++ S + +
Sbjct: 74 NGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLA 129
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L ++ L L +NH + S +SN + L +L+ ++ +K + P I ++ L LSL+
Sbjct: 130 NLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
N++ + P+ +++SL N T + P L L + NN+I +
Sbjct: 187 NQIEDISPL-------ASLTSLHYFTAYVNQITDI--TPVANMTR-LNSLKIGNNKITDL 236
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
P L N++ L +++ N S AV L KL++L V +N +S + + S L
Sbjct: 237 SP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLN 290
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR 448
L N+ + +GG+ L + L +N + + PL+ +LS++++ + + I+
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-53
Identities = 105/501 (20%), Positives = 171/501 (34%), Gaps = 81/501 (16%)
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L+ S++L +P N S + + P G + V L
Sbjct: 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
+ + +SSL P LE L N + +
Sbjct: 68 CLDRQAHELELNNL---GLSSL---------------PEL---PPHLESLVASCNSLTEL 106
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
P ++ SL V + + S P LE L V+NN L L E+ S L+
Sbjct: 107 -PELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLK 156
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
+ D++ N ++P L+ ++ G N L NL L + N ++
Sbjct: 157 IIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEELPE--LQNLPFLTAIYADNNSLK-K 209
Query: 451 IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
+P+ +L ++ N + ++ NL L + + +P S L
Sbjct: 210 LPDL---PLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LE 260
Query: 511 TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGD 570
L++ + L+ +LP L L V + LS L YLN S N
Sbjct: 261 ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR-S 311
Query: 571 IPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIK 630
+ SL L++S+N++ +PA LE L NH +P +L K
Sbjct: 312 LC---DLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNL---K 360
Query: 631 KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGA 690
+L + N L E P L MNS +PE NL L++ TN L
Sbjct: 361 QLHVEYNPLR-EFPDIPESVED-----LRMNSHLAEVPEL---PQNLKQLHVETNPLR-E 410
Query: 691 IPADLALISSLRYLNLSRNNL 711
P + S+ L ++ +
Sbjct: 411 FP---DIPESVEDLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-51
Identities = 98/595 (16%), Positives = 175/595 (29%), Gaps = 151/595 (25%)
Query: 94 LHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHN 153
L++ HS++L +P Y ++ + + P + V +
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 154 LLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQ 213
L L+L++ + +P L+
Sbjct: 69 LD---------RQAHELELNNLGLS-------------------------SLPELPPHLE 94
Query: 214 ELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273
L N L LP + SL+ + L L P L+ L +S N+L
Sbjct: 95 SL---VASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQL 143
Query: 274 TGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS 333
L P L+++D+ NN ++ + P
Sbjct: 144 EKL-------------------------------PELQNSSF-LKIIDVDNNSLKKL-PD 170
Query: 334 WLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFD 393
+ L + N LP + +L L + NNSL L PD L+
Sbjct: 171 LPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKL-PDLPLS---LESIV 221
Query: 394 LEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPE 453
N NL L T+ N ++ +P+
Sbjct: 222 AGNNILE--------------------------ELPELQNLPFLTTIYADNNLLK-TLPD 254
Query: 454 EITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLD 513
+L LN+ N +P +L L V S + +L L+
Sbjct: 255 LP---PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFS----GLSELPPNL---YYLN 303
Query: 514 LSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPA 573
S+ + L PSL+ +++ N L ++P + L+ L S N ++P
Sbjct: 304 ASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPE 354
Query: 574 TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633
++L L + +N + P + +LR N +P +L K+L
Sbjct: 355 L---PQNLKQLHVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNL---KQLH 402
Query: 634 LGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS 688
+ N L E P S+ L ++ + + L +
Sbjct: 403 VETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-42
Identities = 79/419 (18%), Positives = 153/419 (36%), Gaps = 63/419 (15%)
Query: 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS 374
+ L+ ++ + + P NV S + + + N P G ++ V R+ +
Sbjct: 11 TFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 375 LSGL------------VPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNM 422
+P+ L+ N + ++P ++ L + +
Sbjct: 70 DRQAHELELNNLGLSSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 125
Query: 423 FSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482
S L P LE L +S N + +PE + S L +++ N K+P +L
Sbjct: 126 LSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSL 175
Query: 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENN 542
+ + + ++P + +L LT + N +L +LP SL+ + N
Sbjct: 176 E---FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNI 226
Query: 543 LSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGAC 602
L ++PE +L L + +N +P SL L++ N ++ +P +
Sbjct: 227 LE-ELPE-LQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTD-LPELPQSL 279
Query: 603 SALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNS 662
+ L+V E + + + L+ N++ + SL L + N
Sbjct: 280 TFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR-SLCDLPP---SLEELNVSNNK 328
Query: 663 LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
L +P L L S N L+ +P L +L+ L++ N L E P + S
Sbjct: 329 LI-ELPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPES 378
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-40
Identities = 76/370 (20%), Positives = 134/370 (36%), Gaps = 49/370 (13%)
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420
S L+ +++L+ + P E + + + P G R + + L
Sbjct: 9 SNTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 421 NMFSGLIPLSFGN---------LSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKF 471
+ L N LE+L S N + +PE L +L N +
Sbjct: 68 CLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 472 GGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLP 531
L L +S + K+P + + L +D+ N +L +LP P
Sbjct: 127 SD-------LPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---P 173
Query: 532 SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQI 591
SL+ ++ N L ++PE +L L + +N+ +P SL + +N +
Sbjct: 174 SLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNIL 227
Query: 592 SGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCS 651
EL L + +N +P L + L++ N L+ ++P+ +
Sbjct: 228 E--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSL---EALNVRDNYLT-DLPELPQSLT 280
Query: 652 SLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
L + LS P NL LN S+N + ++ L SL LN+S N L
Sbjct: 281 FLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKL 329
Query: 712 EGEIPKMLSS 721
E+P +
Sbjct: 330 I-ELPALPPR 338
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-37
Identities = 93/549 (16%), Positives = 160/549 (29%), Gaps = 163/549 (29%)
Query: 68 CYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQ 127
C + + EL L L L + L L N L +P L
Sbjct: 68 CLDRQAHELELNNLGL----SSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 128 YNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSS 187
+ S D+ P L YL +S+N ++P +
Sbjct: 123 LKALS-----------------------------DLPPLLEYLGVSNNQLE-KLP-ELQN 151
Query: 188 KSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
S L++I++ NS ++P L+ + +N L + N L + A++N
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPSLEF---IAAGNNQL--EELPELQNLPFLTAIYADNN 205
Query: 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK 307
LK L +L+ + N L L + L
Sbjct: 206 SLKKLPDL----PLSLESIVAGNNILEELPELQNLPF----------------------- 238
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEV 367
L + NN ++ + P + L +++ N+ + +LP SL L+V
Sbjct: 239 ---------LTTIYADNNLLKTL-PDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDV 284
Query: 368 LRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
+ LS L P L ++ N L
Sbjct: 285 SENIFSGLSELPP-------------------------------NLYYLNASSNEIRSLC 313
Query: 428 PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLV 487
L LE LN+S N + +P L L S+N
Sbjct: 314 DL----PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL---------------- 349
Query: 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDV 547
++P + L L + L E P + L++ N+ +V
Sbjct: 350 ---------AEVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEV 391
Query: 548 PEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEV 607
PE + L+ L++ N + P S+ L ++ ++ LE
Sbjct: 392 PELPQN---LKQLHVETNPLR-EFPDI---PESVEDLRMNSERVVDPYEFAHETTDKLED 444
Query: 608 LELRSNHFT 616
+H
Sbjct: 445 DVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 22/115 (19%), Positives = 40/115 (34%), Gaps = 20/115 (17%)
Query: 620 PVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLS---- 675
P ++S + +++ + L+ E+P E S + P +
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 676 ---------NLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
L L+ LS ++P L L L S N+L E+P++ S
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQS 112
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-53
Identities = 60/309 (19%), Positives = 117/309 (37%), Gaps = 31/309 (10%)
Query: 827 ITYVETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEAL 886
+ + V +RGR+G ++KA + V +++ E +L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQNEYEVYSL 72
Query: 887 GKVKHRNLTVLRGYYAGPPDV---RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI 943
+KH N+ G V L+ + G+L+ L+ +V++W I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHI 126
Query: 944 SLGLARGLSFLHS----------LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993
+ +ARGL++LH + H DIK +NVL + A +++FGL A +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 994 EASSSTTPIGSLGYVSPEAASTG-----QPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048
+ +G+ Y++PE D+Y+ G+VL E+ + DE
Sbjct: 187 AGDT-HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 1049 IVKWVKKQLQRGQISELLEPGLLE-LDPE-SSEWEEFLLGVKVGLL---CTAPDPLDRPS 1103
++ + ++ Q + ++ E + + P W++ + C D R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 1104 MADIVFMLE 1112
+ +
Sbjct: 306 AGCVGERIT 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-49
Identities = 62/327 (18%), Positives = 112/327 (34%), Gaps = 29/327 (8%)
Query: 365 LEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424
E L ++ D +++ D + + +I +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIETRTGRALK 69
Query: 425 GLIPLSFGNLSQ--LETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482
+ +Q L L + P++ RLS+L + + ++P +
Sbjct: 70 AT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENN 542
GL L L+ + +P SI SL RL L + ELP L
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------------ 173
Query: 543 LSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGAC 602
D LV LQ L L +PA+ L++L L + ++ +S + +
Sbjct: 174 ---DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228
Query: 603 SALEVLELRSNHFTGNIPVDISHLSRIKKLDL-GQNKLSGEIPKEISKCSSLVSLTLDMN 661
LE L+LR N P + +K+L L + L +P +I + + L L L
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGC 287
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLS 688
R+P ++L + + + +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-46
Identities = 56/334 (16%), Positives = 118/334 (35%), Gaps = 30/334 (8%)
Query: 389 LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR 448
+ +G+ L + R N + + + ++
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRALK 69
Query: 449 GNIPEEITRLS--NLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSL 506
+ + + L L + P L L + + A+G ++P ++
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 507 MRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566
L TL L+ L LP + L L+ +S+ ++PE +S
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------------ 173
Query: 567 FTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHL 626
D + L +L L L I +PA + L+ L++R++ + + I HL
Sbjct: 174 ---DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228
Query: 627 SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTL-DMNSLSGRIPESFSKLSNLTTLNLSTN 685
++++LDL P + L L L D ++L +P +L+ L L+L
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGC 287
Query: 686 RLSGAIPADLALISSLRYLNLSRNNLEGEIPKML 719
+P+ +A + + + + +L+ ++ +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 54/304 (17%), Positives = 105/304 (34%), Gaps = 23/304 (7%)
Query: 430 SFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLN 489
+ S E L + + +++ + + + N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 490 LSASGFSGKIPGSIGSL--MRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDV 547
+ + L+L + L + P + F L LQ ++++ L ++
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 548 PEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA--- 604
P+ GL+ L L+ N +PA+ L L LS+ +P L + A
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 605 ------LEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTL 658
L+ L L ++P I++L +K L + + LS + I L L L
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236
Query: 659 DMNSLSGRIPESFSKLSNLTTLNLS-TNRLSGAIPADLALISSLRYLNLSRNNLEGEIPK 717
+ P F + L L L + L +P D+ ++ L L+L +P
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 718 MLSS 721
+++
Sbjct: 296 LIAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 60/375 (16%), Positives = 111/375 (29%), Gaps = 53/375 (14%)
Query: 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLW 286
G+ + S +L + + + + +R
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-------- 53
Query: 287 GNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDL 346
N ++ +I A L+L++ + FP ++ L+ M +
Sbjct: 54 -NSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTI 111
Query: 347 SGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAF 406
LP + LE L +A N L L P IA + L+ + ++P
Sbjct: 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEP 169
Query: 407 LGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNL 466
L L L++L L IR ++P I L NL +L +
Sbjct: 170 LASTD---------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 467 SYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIE 526
+ L L +I L +L LDL P
Sbjct: 214 RNSP-----------LSAL--------------GPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 527 LFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSL 586
G L+ + L++ + +P L L+ L+L +P+ L + + +
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 587 SHNQISGMIPAELGA 601
+ + + A
Sbjct: 309 PPHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 55/375 (14%), Positives = 104/375 (27%), Gaps = 77/375 (20%)
Query: 191 LQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLK 250
+ + ++ + Q Q + H
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS------------------------- 48
Query: 251 GLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPN 310
+ Q+ + + L + G
Sbjct: 49 ---AWRQANSNNPQIETRTGRALKATADLLEDATQPG----------------------- 82
Query: 311 GRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRV 370
L+L++ + FP ++ L+ M + LP + LE L +
Sbjct: 83 ------RVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTL 134
Query: 371 ANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS 430
A N L L P IA + L+ + ++P L
Sbjct: 135 ARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTD---------------ASGE 178
Query: 431 FGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNL 490
L L++L L IR ++P I L NL +L + + + + +L L L+L
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDL 236
Query: 491 SASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG 550
P G L L L + + LP+++ L L+ + L +P
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 551 FSSLVGLQYLNLSDN 565
+ L + + +
Sbjct: 297 IAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-38
Identities = 54/381 (14%), Positives = 99/381 (25%), Gaps = 77/381 (20%)
Query: 164 SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223
S L + S + + + + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66
Query: 224 HLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLC 283
L + + + L L L P
Sbjct: 67 ALK-ATADLLEDATQP----------------------GRVALELRSVPLPQF-PDQA-- 100
Query: 284 NLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRV 343
+S L+ + + + + P + L
Sbjct: 101 ---FRLSH-------------------------LQHMTIDAAGLMEL-PDTMQQFAGLET 131
Query: 344 MDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQV 403
+ L+ N LPA++ SL++L L + +P+ +A
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA--------------- 175
Query: 404 PAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTT 463
G+ L+ + L L P S NL L++L + + + + I L L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233
Query: 464 LNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGEL 523
L+L P G L L L +P I L +L LDL L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 524 PIELFGLPSLQVVSLEENNLS 544
P + LP+ ++ + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-32
Identities = 52/320 (16%), Positives = 109/320 (34%), Gaps = 54/320 (16%)
Query: 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSL--LRAVYLQYNSF 131
+ + A+ + + + L + L + A+ L+
Sbjct: 36 QRHYNADRNRWHSAW-RQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL 93
Query: 132 SGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKS 189
P F L++L + + L ++ + L L L+ N +P + +S +
Sbjct: 94 P-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN 150
Query: 190 QLQLINLSYNSFSGEVPASVGQ---------LQELEYLWLDSNHLYGTLPSAISNCSSLV 240
+L+ +++ E+P + L L+ L L+ + +LP++I+N +L
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSR-NELTGLVPVSVLCNLWGNISSLRIVQLGF 299
L ++ L L I + L+ L L L P G + L+
Sbjct: 210 SLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNY-PPIF-----GGRAPLK------ 256
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQN-NRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAA 358
L L++ + + + P + +T L +DL G LP+
Sbjct: 257 -------------------RLILKDCSNLLTL-PLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 359 VGSLDKLEVLRVANNSLSGL 378
+ L ++ V + + L
Sbjct: 297 IAQLPANCIILVPPHLQAQL 316
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 13/179 (7%)
Query: 87 LTDQLADLHELRKLSLHSNHLNGSIPASLHQCSL---------LRAVYLQYNSFSGHLPL 137
L +A L+ LR+LS+ + +P L L+++ L++ LP
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 138 SIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQLQLIN 195
SI NL NL L + ++ LS + I P L LDL P F ++ L+ +
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259
Query: 196 LSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIP 254
L S +P + +L +LE L L LPS I+ + + ++ L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 29/178 (16%), Positives = 61/178 (34%), Gaps = 10/178 (5%)
Query: 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
G + L + + + + ++
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRAL 68
Query: 616 TGNIPVDISHLSRIK--KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSK 673
+ ++ L+L L + P + + S L +T+D L +P++ +
Sbjct: 69 K-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125
Query: 674 LSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAM 731
+ L TL L+ N L A+PA +A ++ LR L++ E+P+ L+S +
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-47
Identities = 53/390 (13%), Positives = 120/390 (30%), Gaps = 20/390 (5%)
Query: 337 NVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG 396
N ++ ++ + L + S ++ L ++ N LS + ++A + L++ +L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 397 NRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEIT 456
N + + L+ + L N +ETL+ + N+I +
Sbjct: 68 NVLY-ETLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR- 118
Query: 457 RLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG-KIPGSIGSLMRLTTLDLS 515
+ L+ NK D G + L+L + S L L+L
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 516 NQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATY 575
+ ++ ++ L+ + L N L+ + F S G+ +++L +N I
Sbjct: 178 YNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 576 GFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLG 635
F ++L L N + + V + + + G
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 636 QNKLSGEIPKEISKCSSLVSLTLDMNSLSG----RIPESFSKLSNLTTLNLSTNRLSGAI 691
+ +L + S G R+ + ++ + I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 692 PADLALISSLRYLNLSRNNLEGEIPKMLSS 721
+ L + L+ ++ +
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRA 382
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-45
Identities = 74/491 (15%), Positives = 167/491 (34%), Gaps = 30/491 (6%)
Query: 87 LTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLL 146
+ + + + + + + L ++ + ++ + L N S + T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 147 VLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
+LN++ N+L + + +LR LDL++N E+ ++ ++ + N+ S V
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVS 115
Query: 207 ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGL-IPGTIGRISTLQV 265
S Q + ++L +N + S + +L + N + + TL+
Sbjct: 116 CSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN 325
L+L N + + V + L+ + L N + P + + + + L+NN
Sbjct: 174 LNLQYNFIYDVKGQVVF-------AKLKTLDLSSNKLAFM--GPEFQSAAGVTWISLRNN 224
Query: 326 RIRAVFPSWLTNVTSLRVMDLSGNFFS-GNLPAAVGSLDKLEVLRVANNSLSGLVPDEIA 384
++ + L +L DL GN F G L +++ + A ++ L
Sbjct: 225 KLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEE 281
Query: 385 KCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSL----GRNMFSGLIPLSFGNLSQLETL 440
+C++ + F + LK G+ + + N ++ +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341
Query: 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIP 500
+ + R I + R TL +V L A G ++
Sbjct: 342 DALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQ 400
Query: 501 GSIGSLMRLTTLD-LSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGF--SSLVGL 557
+ L L + + + + +++ + ++ + E L G
Sbjct: 401 HATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGE 460
Query: 558 QYLNLSDNAFT 568
L L+ T
Sbjct: 461 ADLALASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 6e-45
Identities = 71/520 (13%), Positives = 154/520 (29%), Gaps = 52/520 (10%)
Query: 165 PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNH 224
+ ++ ++ + S ++ ++LS N S A + +LE L L SN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 225 LYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCN 284
L + + S+L L +N ++ L+ G +++ L + N ++
Sbjct: 70 L--YETLDLESLSTLRTLDLNNNYVQELLVGP-----SIETLHAANNNIS---------- 112
Query: 285 LWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVM 344
++ + G + + L NN+I + + ++ +
Sbjct: 113 -----------RVSCSRGQG------------KKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 345 DLSGNFFSG-NLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQV 403
DL N N S D LE L + N + + + L+ DL N+ + +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FM 206
Query: 404 PAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTT 463
G+ +SL N I + LE +L N + N
Sbjct: 207 GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRV 264
Query: 464 LNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSG-- 521
++ + + + A L+ L + + + G
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 522 --ELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLR 579
L E + + + + + L A +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 580 SLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKL 639
L + A + + + + + I+ D+ Q+K
Sbjct: 385 ELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
Query: 640 SGEIPKEISKCSSLV-SLTLDMNSLSGRIPESFSKLSNLT 678
+ ++ +E ++ L L + S + + E + NL
Sbjct: 445 T-QLAEENARLKKLNGEADLALASANATLQELVVREQNLA 483
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 1e-44
Identities = 62/287 (21%), Positives = 116/287 (40%), Gaps = 16/287 (5%)
Query: 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
I N ++ + ++++ ++ + N+ L+LS N D+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD 546
+LNLS++ + SL L TLDL+N + EL PS++ + NN+S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 547 VPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGM-IPAELGACSAL 605
V S G + + L++N T G + +L L N+I + + L
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
E L L+ N ++ + +++K LDL NKL+ + E + + ++L N L
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
I ++ NL +L N D + R +++ ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-44
Identities = 74/510 (14%), Positives = 158/510 (30%), Gaps = 38/510 (7%)
Query: 212 LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271
+ + + L L S + ++ L N L + + + L++L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 272 ELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVF 331
L + + ++S+LR + L N ++ P+ +E L NN I V
Sbjct: 69 VLYETLDL-------ESLSTLRTLDLNNNYVQELLVGPS------IETLHAANNNISRVS 115
Query: 332 PSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL-VPDEIAKCSLLQ 390
S ++ L+ N + G +++ L + N + + + A L+
Sbjct: 116 CSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
+L+ N V + LK + L N + + F + + + ++L N +
Sbjct: 173 HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-L 228
Query: 451 IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
I + + NL +L N F D K V ++ + T
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRD-FFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 511 TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD----VPEGFSSLVGLQYLNLSDNA 566
L +L+ + G + + + ++
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 567 FTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHL 626
+ I ++ + L + + A + L+ ++ +
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQ 406
Query: 627 SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686
S ++ L + V N+ K + L N +
Sbjct: 407 SPLQLLRAIVKRYE----------EMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKK 456
Query: 687 LSGAIPADLALI-SSLRYLNLSRNNLEGEI 715
L+G LA ++L+ L + NL ++
Sbjct: 457 LNGEADLALASANATLQELVVREQNLASQL 486
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-44
Identities = 80/551 (14%), Positives = 173/551 (31%), Gaps = 72/551 (13%)
Query: 110 SIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADIS--PS 166
+I + + + +S S+ + N+ L+++ N LS +AD++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 167 LRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLY 226
L L+LSSN E + S S L+ ++L+ N + +E L +N++
Sbjct: 60 LELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI- 111
Query: 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLW 286
+ S ++ +N + L G S +Q L L NE+ + + +
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS- 168
Query: 287 GNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDL 346
LE L+LQ N I V L+ +DL
Sbjct: 169 ----------------------------DTLEHLNLQYNFIYDVKGQ--VVFAKLKTLDL 198
Query: 347 SGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAF 406
S N + + S + + + NN L + + L+ FDL GN F
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 407 LGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNL 466
+ ++ ++ + L + + + RL L
Sbjct: 257 FFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEH 315
Query: 467 SYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIE 526
+ +L+ S ++ + R +D + + +
Sbjct: 316 A-------------------LLSGQGSETE-RLECERENQARQREIDALKEQYR-TVIDQ 354
Query: 527 LF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLS 585
+ + + ++ L V G + L AT + +
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRA 414
Query: 586 LSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIK-KLDLGQNKLSGEIP 644
+ + + +A+ ++ + T + + + L ++ + DL + +
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLNGEADLALASANATLQ 473
Query: 645 KEISKCSSLVS 655
+ + + +L S
Sbjct: 474 ELVVREQNLAS 484
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-47
Identities = 64/314 (20%), Positives = 122/314 (38%), Gaps = 17/314 (5%)
Query: 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
I N ++ + ++++ ++ + N+ L+LS N D+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD 546
+LNLS++ + SL L TLDL+N + EL PS++ + NN+S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 547 VPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGM-IPAELGACSAL 605
V S G + + L++N T G + +L L N+I + + L
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
E L L+ N ++ + +++K LDL NKL+ + E + + ++L N L
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFND 725
I ++ NL +L N D + R +++ ++ ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK-KLTGQNEEECTV 285
Query: 726 PSIFAMNRELCGKP 739
P++ C
Sbjct: 286 PTLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-45
Identities = 56/307 (18%), Positives = 110/307 (35%), Gaps = 19/307 (6%)
Query: 413 LKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFG 472
KI + + + + ++ L+LS N + ++ + L LNLS N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL- 70
Query: 473 GKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPS 532
D+ +L L L+L+ + + + TL +N N+S +
Sbjct: 71 -YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG--QG 121
Query: 533 LQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG-DIPATYGFLRSLVFLSLSHNQI 591
+ + L N ++ +QYL+L N + +L L+L +N I
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 592 SGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCS 651
+ ++ + L+ L+L SN + + + + + L NKL I K +
Sbjct: 182 Y-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 652 SLVSLTLDMNSLS-GRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNN 710
+L L N G + + FSK + T+ T + + ++ L
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGAY 294
Query: 711 LEGEIPK 717
++P
Sbjct: 295 CCEDLPA 301
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 56/357 (15%), Positives = 116/357 (32%), Gaps = 51/357 (14%)
Query: 212 LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271
+ + + L L S + ++ L N L + + + L++L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 272 ELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVF 331
L + + ++S+LR + L N ++ P+ +E L NN I V
Sbjct: 69 VLYETLDL-------ESLSTLRTLDLNNNYVQELLVGPS------IETLHAANNNISRVS 115
Query: 332 PSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL-VPDEIAKCSLLQ 390
S ++ L+ N + G +++ L + N + + + A L+
Sbjct: 116 CSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
+L+ N V + LK + L N + + F + + + ++L N +
Sbjct: 173 HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-L 228
Query: 451 IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
I + + NL +L N + G L+ N R+
Sbjct: 229 IEKALRFSQNLEHFDLRGN------GFHCGTLRDFFSKNQ-----------------RVQ 265
Query: 511 TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
T+ E +P+L + + + + L +
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTL----GHYGAYCCEDL---PAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 65/357 (18%), Positives = 122/357 (34%), Gaps = 49/357 (13%)
Query: 110 SIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADIS--PS 166
+I + + + +S S+ + N+ L+++ N LS +AD++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 167 LRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLY 226
L L+LSSN E + S S L+ ++L+ N + +E L +N++
Sbjct: 60 LELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI- 111
Query: 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLW 286
+ S ++ +N + L G S +Q L L NE+ + + +
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS- 168
Query: 287 GNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDL 346
LE L+LQ N I V L+ +DL
Sbjct: 169 ----------------------------DTLEHLNLQYNFIYDVKG--QVVFAKLKTLDL 198
Query: 347 SGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFS-GQVPA 405
S N + + S + + + NN L + + L+ FDL GN F G +
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 406 FLGGIRGLKIVSLGRNMF-SGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNL 461
F + ++ V+ +G + D+ + + L +
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHH 313
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 55/340 (16%), Positives = 127/340 (37%), Gaps = 27/340 (7%)
Query: 87 LTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLL 146
+ + + + + + + L ++ + ++ + L N S + T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 147 VLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
+LN++ N+L + + +LR LDL++N E+ ++ ++ + N+ S V
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVS 115
Query: 207 ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGL-IPGTIGRISTLQV 265
S Q + ++L +N + S + +L + N + + TL+
Sbjct: 116 CSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN 325
L+L N + + V + L+ + L N + P + + + + L+NN
Sbjct: 174 LNLQYNFIYDVKGQVVF-------AKLKTLDLSSNKLAFM--GPEFQSAAGVTWISLRNN 224
Query: 326 RIRAVFPSWLTNVTSLRVMDLSGNFFS-GNLPAAVGSLDKLEVLRVANNSLSGLVPDEIA 384
++ + L +L DL GN F G L +++ + A ++ L
Sbjct: 225 KLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEE 281
Query: 385 KCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424
+C++ + L ++++LG +
Sbjct: 282 ECTVPTLGHYGAYCCED-----LPAPFADRLIALGHHHHH 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-45
Identities = 67/354 (18%), Positives = 127/354 (35%), Gaps = 46/354 (12%)
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420
+L+ +++ N+++ L + +++ +L + ++ + +G
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDV 479
N L P F N+ L L L ND+ ++P I LTTL++S N
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE------- 154
Query: 480 GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
+ F L L LS+ L+ ++L +PSL ++
Sbjct: 155 ---------RIEDDTFQA--------TTSLQNLQLSSNRLTH---VDLSLIPSLFHANVS 194
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
N LS + + ++ L+ S N+ + L L L HN ++ L
Sbjct: 195 YNLLST-----LAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD-TAW-L 244
Query: 600 GACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTL 658
L ++L N I + R+++L + N+L + +L L L
Sbjct: 245 LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302
Query: 659 DMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
N L + + + L L L N + + +L+ L LS N+ +
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-42
Identities = 70/459 (15%), Positives = 143/459 (31%), Gaps = 102/459 (22%)
Query: 110 SIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI---SPS 166
I ++L + V++ + + L N ++ ++ + K+ A +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 167 LRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLY 226
+ L+L+ Q+ + +F+ ++ L++ N +
Sbjct: 71 VELLNLNDL----------------QIEEIDTYAFAY--------AHTIQKLYMGFNAIR 106
Query: 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLW 286
P N L L E N L L G L LS+S N
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN--------------- 151
Query: 287 GNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDL 346
+ ++ + F L+ L L +NR+ V S + ++ ++
Sbjct: 152 ------NLERIEDDTFQATTS---------LQNLQLSSNRLTHVDLSLIPSLFHA---NV 193
Query: 347 SGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAF 406
S N S + +E L ++NS++ + L + L+ N +
Sbjct: 194 SYNLLS-----TLAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLT-DTAWL 244
Query: 407 LGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNL 466
GL V L N ++ F + +LE L +S N + + + L L+L
Sbjct: 245 -LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302
Query: 467 SYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIE 526
S+N + + RL L L + ++ L +
Sbjct: 303 SHNHL-------------------------LHVERNQPQFDRLENLYLDHNSIV-TLKLS 336
Query: 527 LFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDN 565
+L+ ++L N+ + + + D
Sbjct: 337 TH--HTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-42
Identities = 69/423 (16%), Positives = 139/423 (32%), Gaps = 56/423 (13%)
Query: 181 IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
I N +++ + L + + ++ + + + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
L+ D ++ + T+Q L + N + L P V N+ L ++ L N
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL-PPHVFQNV----PLLTVLVLERN 127
Query: 301 AFTGVVKPPNG--RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAA 358
+ + P G L L + NN + + TSL+ + LS N + ++
Sbjct: 128 DLSSL---PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL- 182
Query: 359 VGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSL 418
+ L V+ N LS +A ++ D N + V L I+ L
Sbjct: 183 -SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKL 233
Query: 419 GRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPY 477
N + N L ++LS N++ I ++ L L +S N+
Sbjct: 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV----- 285
Query: 478 DVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVS 537
+ + L LDLS+ +L + L+ +
Sbjct: 286 --------------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324
Query: 538 LEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPA 597
L+ N++ + S+ L+ L LS N + + + R++ ++ I
Sbjct: 325 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDY 379
Query: 598 ELG 600
+L
Sbjct: 380 QLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-42
Identities = 77/369 (20%), Positives = 138/369 (37%), Gaps = 28/369 (7%)
Query: 226 YGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNL 285
Y + S + + + ++ ++++ + + L P ++L +
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL-PAALLDSF 68
Query: 286 WGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVM 344
+ ++ L + ++ L + N IR + P NV L V+
Sbjct: 69 ----RQVELLNLNDLQIEEI--DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 345 DLSGNFFSGNLPAAV-GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQV 403
L N S +LP + + KL L ++NN+L + D + LQ L NR + V
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV 180
Query: 404 PAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTT 463
L I L ++ N+ S + +E L+ S N I + + LT
Sbjct: 181 D--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTI 230
Query: 464 LNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGEL 523
L L +N + N GL+ ++LS + + + RL L +SN L L
Sbjct: 231 LKLQHNNL-TDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 524 PIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVF 583
+ +P+L+V+ L N+L V L+ L L N+ + +L
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKN 343
Query: 584 LSLSHNQIS 592
L+LSHN
Sbjct: 344 LTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-42
Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 22/314 (7%)
Query: 410 IRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSY 468
+ I ++++ G L+ + + + +R +P + + LNL+
Sbjct: 23 FYDVHIDMQTQDVYFGF---EDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 78
Query: 469 NKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF 528
+ Y + L + + P ++ LT L L +LS LP +F
Sbjct: 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 137
Query: 529 -GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLS 587
P L +S+ NNL + F + LQ L LS N T + + SL ++S
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVS 194
Query: 588 HNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI 647
+N +S L A+E L+ N + + + L L N L+ + +
Sbjct: 195 YNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WL 244
Query: 648 SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLS 707
LV + L N L + F K+ L L +S NRL A+ I +L+ L+LS
Sbjct: 245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303
Query: 708 RNNLEGEIPKMLSS 721
N+L + +
Sbjct: 304 HNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-37
Identities = 73/404 (18%), Positives = 133/404 (32%), Gaps = 72/404 (17%)
Query: 69 YNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQY 128
Y+ ++ + + L+ + ++ ++ + +PA+L
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL------------- 64
Query: 129 NSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSK 188
L + + L+L+ F+
Sbjct: 65 -------------LDSF-------------------RQVELLNLNDLQIEEIDTYAFAYA 92
Query: 189 SQLQLINLSYNSFSGEVPASVGQ-LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
+Q + + +N+ +P V Q + L L L+ N L N L LS +N
Sbjct: 93 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 151
Query: 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK 307
L+ + T ++LQ L LS N LT + I SL + +N + +
Sbjct: 152 NLERIEDDTFQATTSLQNLQLSSNRLTHVDL--------SLIPSLFHANVSYNLLSTLAI 203
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEV 367
P +E LD +N I V +T L L N + A + + L
Sbjct: 204 PIA------VEELDASHNSINVVRGPVNVELTIL---KLQHNNLTD--TAWLLNYPGLVE 252
Query: 368 LRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
+ ++ N L ++ K L+ + NR + + I LK++ L N +
Sbjct: 253 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-V 310
Query: 428 PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKF 471
+ +LE L L N I + L L LS+N +
Sbjct: 311 ERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-32
Identities = 72/416 (17%), Positives = 133/416 (31%), Gaps = 82/416 (19%)
Query: 71 NRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNS 130
N + + + L ++ L+L+ + + ++ +Y+ +N+
Sbjct: 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104
Query: 131 FSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGN-F 185
+LP +F N+ L VL + N LS + I +P L L +S+N I + F
Sbjct: 105 IR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 161
Query: 186 SSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAE 245
+ + LQ + LS N + V + L + + N L S ++ ++ L A
Sbjct: 162 QATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDAS 213
Query: 246 DNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGV 305
N + + L +L L N LT + L N
Sbjct: 214 HNSINVVRGPV---NVELTILKLQHNNLT---DTAWLLNY-------------------- 247
Query: 306 VKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKL 365
L +DL N + + + L + +S N L + L
Sbjct: 248 ---------PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 297
Query: 366 EVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSG 425
+VL +++N L + + L+ L+ N
Sbjct: 298 KVLDLSHNHLLHV-ERNQPQFDRLENLYLDHNSIV------------------------- 331
Query: 426 LIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGN 481
L L+ L LS ND N + N+ + K+ Y + +
Sbjct: 332 --TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 44/216 (20%), Positives = 86/216 (39%), Gaps = 14/216 (6%)
Query: 499 IPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQ 558
I ++ + + Q E L + ++V+ + + + S ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 559 YLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG 617
LNL+D +I + + ++ L + N I + P L VL L N +
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 618 NIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLS 675
++P I + ++ L + N L I + +SL +L L N L+ + S +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186
Query: 676 NLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
+L N+S N LS LA+ ++ L+ S N++
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-22
Identities = 40/192 (20%), Positives = 77/192 (40%), Gaps = 7/192 (3%)
Query: 523 LPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLV 582
+ L V ++ +L + + ++ A R +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 583 FLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSG 641
L+L+ QI + ++ L + N +P + ++ + L L +N LS
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 642 EIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISS 700
+P+ I L +L++ N+L ++F ++L L LS+NRL+ + L+LI S
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPS 187
Query: 701 LRYLNLSRNNLE 712
L + N+S N L
Sbjct: 188 LFHANVSYNLLS 199
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 9e-44
Identities = 89/574 (15%), Positives = 180/574 (31%), Gaps = 95/574 (16%)
Query: 126 LQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--------PSLRYLDLSSNAF 177
+YN +NL V +++ + D+ + + + ++
Sbjct: 5 QRYNVKPRQPEYK-CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 178 TGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNC 236
S Q++L+NL+ E+ ++ L++ N + P N
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 237 SSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQ 296
L L E N L L G L LS+S N L +
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED------------------ 164
Query: 297 LGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLP 356
+ F L+ L L +NR+ V S + ++ ++S N S
Sbjct: 165 ---DTFQATTS---------LQNLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLS---- 205
Query: 357 AAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416
+ +E L ++NS++ + L + L+ N + GL V
Sbjct: 206 -TLAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLT-DTAWL-LNYPGLVEV 259
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476
L N ++ F + +LE L +S N + + + L L+LS+N
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL----- 313
Query: 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVV 536
+ + RL L L + ++ L + +L+ +
Sbjct: 314 --------------------LHVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNL 350
Query: 537 SLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF--------LRSLVFLSLSH 588
+L N+ + V ++ +D D +G + ++
Sbjct: 351 TLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIAL 410
Query: 589 NQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEI----P 644
+ + G CSA + + + L ++L+ N+L E+
Sbjct: 411 TSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTN 470
Query: 645 KEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLT 678
++I + L L ++++ R L+ +
Sbjct: 471 EQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSS 504
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-43
Identities = 74/409 (18%), Positives = 141/409 (34%), Gaps = 46/409 (11%)
Query: 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSL 375
V + + F + + +++ + A + S ++E+L + + +
Sbjct: 28 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
+ A +Q + N P + L ++ L RN S L F N
Sbjct: 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP 147
Query: 436 QLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
+L TL++S N++ I ++ ++L L LS N+
Sbjct: 148 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL----------------------- 183
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554
+ + + L ++S LS L +++ + N+++ V
Sbjct: 184 --THVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--N 231
Query: 555 VGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNH 614
V L L L N T D LV + LS+N++ ++ LE L + +N
Sbjct: 232 VELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289
Query: 615 FTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKL 674
+ + + +K LDL N L + + + L +L LD NS+ + S
Sbjct: 290 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTH 344
Query: 675 SNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRF 723
L L LS N + AL ++ + + +I L
Sbjct: 345 HTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGL 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-41
Identities = 78/539 (14%), Positives = 163/539 (30%), Gaps = 66/539 (12%)
Query: 163 ISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDS 222
+ RY I N +++ + L + + +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 223 NHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVL 282
+ + + + + + L+ D ++ + T+Q L + N + L P V
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL-PPHVF 119
Query: 283 CNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLR 342
N+ L ++ L N + + L L + NN + + TSL+
Sbjct: 120 QNV----PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 174
Query: 343 VMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQ 402
+ LS N + ++ + L V+ N LS +A ++ D N +
Sbjct: 175 NLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-V 225
Query: 403 VPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNL 461
V L I+ L N + N L ++LS N++ I ++ L
Sbjct: 226 VRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRL 280
Query: 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSG 521
L +S N+ + + L LDLS+ +L
Sbjct: 281 ERLYISNNRL-------------------------VALNLYGQPIPTLKVLDLSHNHLL- 314
Query: 522 ELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSL 581
+ L+ + L+ N++ + S+ L+ L LS N + + + R++
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNV 369
Query: 582 VFLSLSHNQISGMIPAELG---ACSALE-------VLELRSNHFTGNIPVDISHLSRIKK 631
++ I +L C + + + + S
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDT 429
Query: 632 LDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRI----PESFSKLSNLTTLNLSTNR 686
++ Q+ + L ++N L + E + L L+ +
Sbjct: 430 INSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 102/662 (15%), Positives = 199/662 (30%), Gaps = 134/662 (20%)
Query: 71 NRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYN 129
N + + + L ++ L+L+ + I + ++ +Y+ +N
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 109
Query: 130 SFSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGN- 184
+ +LP +F N+ L VL + N LS + I +P L L +S+N I +
Sbjct: 110 AIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 185 FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSA 244
F + + LQ + LS N + V + L + + N L S ++ ++ L A
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDA 218
Query: 245 EDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTG 304
N + + L +L L N LT + L N
Sbjct: 219 SHNSINVVRGPV---NVELTILKLQHNNLT---DTAWLLNY------------------- 253
Query: 305 VVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDK 364
L +DL N + + + L + +S N L +
Sbjct: 254 ----------PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
Query: 365 LEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424
L+VL +++N L + + L+ L+ N
Sbjct: 303 LKVLDLSHNHLLHV-ERNQPQFDRLENLYLDHNSIV------------------------ 337
Query: 425 GLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKG 484
L L+ L LS ND N + N+ + K+ Y L+
Sbjct: 338 ---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDY---QLEH 389
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS 544
L S + ++ ++ ++ ++ + ++ ++
Sbjct: 390 GLCCKESDKPYLDRLL-----------QYIALTSVVEKVQRAQGRCSATDTINSVQSLSH 438
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA 604
+G L G + L N ++ L++ QI
Sbjct: 439 YITQQGGVPLQGNEQLEAEVNELRAEVQ------------QLTNEQIQQE--------QL 478
Query: 605 LEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664
L+ L + ++L R + G + S + K + + L
Sbjct: 479 LQGLHAEID----------TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQA- 527
Query: 665 GRIPESFSKLSNLTTLNLSTNRLSGAI-PADLALISSLRYLNLSRN---NLEGEIPKMLS 720
R E+ +K L L + + +L R LE + +
Sbjct: 528 -RRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPD 586
Query: 721 SR 722
+R
Sbjct: 587 TR 588
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 10/95 (10%), Positives = 30/95 (31%), Gaps = 2/95 (2%)
Query: 619 IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLT 678
I ++ + + + E ++ +T +++ +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 679 TLNLSTNRLSGAIPAD-LALISSLRYLNLSRNNLE 712
LNL+ ++ I A +++ L + N +
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 11/71 (15%), Positives = 22/71 (30%)
Query: 642 EIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSL 701
I + + +DM + L+N + + + A L +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 702 RYLNLSRNNLE 712
LNL+ +E
Sbjct: 78 ELLNLNDLQIE 88
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRN 893
+Q + L+ G ++K +Q + ++ L+ F +E L H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
+ + G PP L+ +MP G+L +L E V++ +L +ARG++
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMA 125
Query: 953 FLHSLD--MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
FLH+L+ + + ++V+ D D A +S + S + + +V+P
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF--------QSPGRMYAPAWVAP 177
Query: 1011 EA---ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067
EA + AD++SF ++L E++T P + +I V + R I +
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
P + +L +K +C DP RP IV +LE
Sbjct: 238 PHVSKL-------------MK---ICMNEDPAKRPKFDMIVPILE 266
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-43
Identities = 108/553 (19%), Positives = 191/553 (34%), Gaps = 86/553 (15%)
Query: 144 NLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSG 203
+ +++ + N L + D+S L++S N + + S S+L+++ +S+N
Sbjct: 1 SEFLVDRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 204 EVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGL-IPGTIGRIS 261
+ SV QELEYL L N L + +L HL N L I G +S
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKL-VKISC--HPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 262 TLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLD 321
L+ L LS L I+ L I ++ + + +
Sbjct: 116 QLKFLGLSTTHLEKSSV--------LPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
Query: 322 LQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPD 381
L ++ +V+ V +L + L + + L+ L +
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL--------EDNKCSYFLSILAKLQTN 219
Query: 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLN 441
L + N F L + + +
Sbjct: 220 PKLSNLTLNNIETTWNSFIR--------------------------ILQLVWHTTVWYFS 253
Query: 442 LSENDIRGNIPEEI-----TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496
+S ++G + T L L+ + + FG Y + + N + SG
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS--GDVPEGFSSL 554
+ LD SN L+ + L L+ + L+ N L + E + +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 555 VGLQYLNLSDNAFTGDIPATY-GFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSN 613
LQ L++S N+ + D + +SL+ L++S N ++ I L
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-------------- 419
Query: 614 HFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPE-SFS 672
RIK LDL NK+ IPK++ K +L L + N L +P+ F
Sbjct: 420 ------------PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFD 465
Query: 673 KLSNLTTLNLSTN 685
+L++L + L TN
Sbjct: 466 RLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-42
Identities = 88/489 (17%), Positives = 185/489 (37%), Gaps = 47/489 (9%)
Query: 96 ELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNL 154
+ L++ N+++ + + S LR + + +N +L +S+F L L+++HN
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNK 80
Query: 155 LSGKISADISPSLRYLDLSSNAFTG-EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQ 213
L KIS + +L++LDLS NAF I F + SQL+ + LS + L
Sbjct: 81 LV-KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 214 ELEYLW-LDSNHLYGTLPSAISNC--SSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
+ L L + P + + SL + + ++ ++ ++ L++ ++
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
Query: 271 NELTGL------VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEV--LDL 322
+ + N + +L ++ +N+F +++ V + + L
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259
Query: 323 QNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDE 382
Q F T++ +L + + + F + + + +
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 383 IAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS--FGNLSQLETL 440
+K S D N + V G + L+ + L N L ++ + L+ L
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQL 379
Query: 441 NLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKI 499
++S+N + + + + +L +LN+S N +
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL--------------------TDTIFRCL 419
Query: 500 PGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLVGLQ 558
P + LDL + + +P ++ L +LQ +++ N L VP+G F L LQ
Sbjct: 420 PPR------IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471
Query: 559 YLNLSDNAF 567
+ L N +
Sbjct: 472 KIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-32
Identities = 82/407 (20%), Positives = 149/407 (36%), Gaps = 26/407 (6%)
Query: 319 VLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL 378
++D N + V T L ++S N+ S + + SL KL +L +++N + L
Sbjct: 4 LVDRSKNGLIHVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 379 VPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS-FGNLSQL 437
L+ DL N+ + LK + L N F L FGN+SQL
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497
+ L LS + + I L+ L + + D L+ +L +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTN 175
Query: 498 KIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGL 557
K I + T +L N+ L + L+ N S + L
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP--------KLSNLTL 227
Query: 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS-----ALEVLELRS 612
+ + N+F + + ++ + S+S+ ++ G + S AL + ++ S
Sbjct: 228 NNIETTWNSFIRILQLVW--HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 613 NHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFS 672
+ F S + + + SK S + L N L+ + E+
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 673 KLSNLTTLNLSTNRLS--GAIPADLALISSLRYLNLSRNNLEGEIPK 717
L+ L TL L N+L I + SL+ L++S+N++ + K
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 53/331 (16%), Positives = 109/331 (32%), Gaps = 27/331 (8%)
Query: 90 QLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSG-----------HLPLS 138
L + SLH + S+ L+ ++ +
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
Query: 139 IFNLTNLLVLNVAHNLLSGKISADI-----SPSLRYLDLSSNAFTGEIPGNFSSKS---- 189
+ L L + + + I ++ Y +S+ G++ S
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275
Query: 190 -QLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
L + + + F + + S S +HL +N+
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP 308
L + G ++ L+ L L N+L L ++ + + SL+ + + N+ + K
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIA---EMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 309 PNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVL 368
+ L L++ +N + L ++V+DL N ++P V L+ L+ L
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 369 RVANNSLSGLVPDEIAKCSLLQMFDLEGNRF 399
VA+N L + + + LQ L N +
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 49/246 (19%), Positives = 91/246 (36%), Gaps = 22/246 (8%)
Query: 69 YNNRVRELRLPRLQLAGRLTDQLAD-----LHELRKLSLHSNHLNGSIPASLHQCSLLRA 123
++ V + ++L G+L + D L L + S+ S +
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 124 VYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFT--G 179
+ L ++ L L+ ++NLL+ + + L L L N
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 180 EIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNC-- 236
+I + LQ +++S NS S + + L L + SN L I C
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI----LTDTIFRCLP 420
Query: 237 SSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQ 296
+ L N +K + P + ++ LQ L+++ N+L VP + L +SL+ +
Sbjct: 421 PRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQLKS-VPDGIFDRL----TSLQKIW 474
Query: 297 LGFNAF 302
L N +
Sbjct: 475 LHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 33/164 (20%), Positives = 61/164 (37%), Gaps = 33/164 (20%)
Query: 560 LNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNI 619
++ S N +P + L++S N IS + +++ + S L +L + N +
Sbjct: 5 VDRSKNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YL 60
Query: 620 PVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLT 678
+ + ++ LDL NKL +S NL
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV---------------------KIS------CHPTVNLK 93
Query: 679 TLNLSTNRL-SGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
L+LS N + I + +S L++L LS +LE ++
Sbjct: 94 HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-43
Identities = 77/307 (25%), Positives = 127/307 (41%), Gaps = 12/307 (3%)
Query: 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
+++ LG+N L F + LE L L+EN + + L NL TL L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 470 KFGGKVPYDV-GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF 528
+ +P V L L L++S + + L L +L++ + +L + F
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 529 -GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLS 587
GL SL+ ++LE+ NL+ E S L GL L L ++ L L L +S
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 588 HNQISGMIPAELGACSALEVLELRSNHFTGNIPVD-ISHLSRIKKLDLGQNKLSGEIPKE 646
H + L L + + T +P + HL ++ L+L N +S I
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266
Query: 647 I-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADL-ALISSLRYL 704
+ + L + L L+ P +F L+ L LN+S N+L+ + + + +L L
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETL 325
Query: 705 NLSRNNL 711
L N L
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-42
Identities = 84/385 (21%), Positives = 136/385 (35%), Gaps = 59/385 (15%)
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEV 367
PP C + + R AV P + T R++DL N S LE
Sbjct: 4 PPRCECSAQDRAVLCHRKRFVAV-PEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEE 60
Query: 368 LRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
L + N +S +E F+ L+ + L N +
Sbjct: 61 LELNENIVS----------------AVEPGAFNNL--------FNLRTLGLRSNRLKLIP 96
Query: 428 PLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
F LS L L++SEN I + + + L NL +L + N
Sbjct: 97 LGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-------------- 141
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSG 545
+S FSG L L L L NL+ +P E L L V+ L N++
Sbjct: 142 --YISHRAFSG--------LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA 190
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605
F L L+ L +S + + + +L LS++H ++ + + L
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250
Query: 606 EVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSL 663
L L N + I + L R++++ L +L+ + + L L + N L
Sbjct: 251 RFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308
Query: 664 SGRIPESFSKLSNLTTLNLSTNRLS 688
+ F + NL TL L +N L+
Sbjct: 309 TTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-38
Identities = 69/315 (21%), Positives = 120/315 (38%), Gaps = 10/315 (3%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYL 218
+ I R LDL N F+S L+ + L+ N S P + L L L
Sbjct: 26 VPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTL 85
Query: 219 WLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVP 278
L SN L + S+L L +N + L+ + L+ L + N+L +
Sbjct: 86 GLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI-S 144
Query: 279 VSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNRIRAVFPSWLTN 337
L +SL + L T + P + L VL L++ I A+
Sbjct: 145 HRAFSGL----NSLEQLTLEKCNLTSI--PTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
+ L+V+++S + + L L + + +L+ + + L+ +L N
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN 258
Query: 398 RFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-T 456
S + L + L+ + L + + P +F L+ L LN+S N + + E +
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFH 317
Query: 457 RLSNLTTLNLSYNKF 471
+ NL TL L N
Sbjct: 318 SVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-38
Identities = 75/382 (19%), Positives = 136/382 (35%), Gaps = 63/382 (16%)
Query: 189 SQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
+Q + + F VP + E L L N + ++ L L +N+
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP 308
+ + PG + L+ L L N R+ + FTG+
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSN---------------------RLKLIPLGVFTGLSN- 105
Query: 309 PNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVL 368
L LD+ N+I + ++ +L+ +++ N A L+ LE L
Sbjct: 106 --------LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQL 157
Query: 369 RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
+ +L+ + + ++ L + L I ++ F
Sbjct: 158 TLEKCNLTSIPTEALSHLHGLIVLRLRHLN----------------INAIRDYSFKR--- 198
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLV 487
L +L+ L +S + NLT+L++++ VPY +L L
Sbjct: 199 -----LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRF 252
Query: 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGD 546
LNLS + S + L+RL + L L+ + F GL L+V+++ N L+
Sbjct: 253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-T 310
Query: 547 VPEG-FSSLVGLQYLNLSDNAF 567
+ E F S+ L+ L L N
Sbjct: 311 LEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 11/222 (4%)
Query: 499 IPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLVGL 557
+P I LDL + E P L+ + L EN +S V G F++L L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82
Query: 558 QYLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
+ L L N IP + L +L L +S N+I ++ L+ LE+ N
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 617 GNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKL 674
I S L+ +++L L + L+ IP E S L+ L L +++ SF +L
Sbjct: 142 -YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 675 SNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716
L L +S + + +L L+++ NL +P
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP 240
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 62/291 (21%), Positives = 103/291 (35%), Gaps = 38/291 (13%)
Query: 91 LADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVL 148
+L LR L L SN L IP S L + + N L +F +L NL L
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSL 133
Query: 149 NVAHNLLSGKISADIS---PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV 205
V N L IS SL L L T S L ++ L + + +
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR 192
Query: 206 PASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQV 265
S +L L+ L + T+ +L LS L + + + L+
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRF 252
Query: 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN 325
L+LS N ++ + + +++ L+ + L
Sbjct: 253 LNLSYNPISTIEG---------------------SMLHELLR---------LQEIQLVGG 282
Query: 326 RIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
++ V P + LRV+++SGN + + S+ LE L + +N L+
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-17
Identities = 42/222 (18%), Positives = 73/222 (32%), Gaps = 42/222 (18%)
Query: 69 YNNRVREL---------RLPRLQLAG-RLT----DQLADLHELRKLSLHSNHLNGSIPAS 114
+N + + L +L L LT + L+ LH L L L ++N S
Sbjct: 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 115 LHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLD 171
+ L+ + + + + + + NL L++ H L+ + LR+L+
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254
Query: 172 LSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPS 231
LS N + + + L L+ + L L P
Sbjct: 255 LSYN----------------PISTIEGSMLHE--------LLRLQEIQLVGGQLAVVEPY 290
Query: 232 AISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273
A + L L+ N L L + L+ L L N L
Sbjct: 291 AFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 69/302 (22%), Positives = 135/302 (44%), Gaps = 34/302 (11%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRN 893
+ + + G +G + +A + V +++ L + F +E + +++H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ + G PP++ +V +Y+ G+L LL L+ R ++ +A+G+++
Sbjct: 96 IVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 954 LHSLD--MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
LH+ + +VH ++K N+L D + + +FGL RL +T SS + G+ +++PE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF---LSSKSAAGTPEWMAPE 209
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+++DVYSFG++L E+ T ++P +V V + +R +I L P +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPS 1131
+ C +P RPS A I+ +L + SA P S
Sbjct: 270 AIIEG----------------CWTNEPWKRPSFATIMDLLR------PLIKSAVPPPNRS 307
Query: 1132 PM 1133
+
Sbjct: 308 DL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 38/300 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
+ + E V+ RG +G++ KA ++ V +I+++ + + F E L +V H N+ L
Sbjct: 9 EIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIESESERKA-FIVELRQLSRVNHPNIVKL 66
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
G P LV +Y G+L +L + L ++G+++LHS+
Sbjct: 67 YGACLNPV---CLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 958 D---MVHGDIKPQNVLFDADFE-AHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
++H D+KP N+L A + +FG + T GS +++PE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------IQTHMTNNKGSAAWMAPEVF 175
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+++ DV+S+GI+L E++T RKP + I+ V R + + L +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLIKNLPKPIE 234
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPS 1131
L + C + DP RPSM +IV ++ P + +P P
Sbjct: 235 SL-------------MT---RCWSKDPSQRPSMEEIVKIMTHLMR--YFPGADEPLQYPC 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 68/295 (23%), Positives = 126/295 (42%), Gaps = 49/295 (16%)
Query: 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENT--------FRKEAEALGK 888
+ + E + +G +GL+ K D V++I+ L G + T F++E +
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 889 VKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
+ H N+ L G PP +V +++P G+L L H + W ++ + L +A
Sbjct: 80 LNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRL----LDKAHPIKWSVKLRLMLDIA 132
Query: 949 RGLSFLHSLD--MVHGDIKPQNVLFD-----ADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
G+ ++ + + +VH D++ N+ A A +++FGL + S +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------SVHSVSGL 186
Query: 1002 IGSLGYVSPEA-ASTGQP-TKEADVYSFGIVLLEILTGRKPV--MFTQDEDIVKWVKKQL 1057
+G+ +++PE + + T++AD YSF ++L ILTG P + ++++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
R I E P L + LC + DP RP + IV L
Sbjct: 247 LRPTIPEDCPPRLRNV----------------IELCWSGDPKKRPHFSYIVKELS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 61/311 (19%), Positives = 124/311 (39%), Gaps = 50/311 (16%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRNL 894
Q + ++ +GR+G ++ + G V +IR + +E+ F++E A + +H N+
Sbjct: 34 QLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
+ G PP + ++ L +++ VL+ I+ + +G+ +L
Sbjct: 92 VLFMGACMSPPHL-AIITSLCKGRTLYSVV----RDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS--TTPIGSLGYVSPE- 1011
H+ ++H D+K +NV +D + + +++FGL ++ A G L +++PE
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 1012 -------AASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063
P +K +DV++ G + E+ P + K I
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-----------F--KTQPAEAII 252
Query: 1064 ELLEPGLLELDPESS---EWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120
+ G+ + E + L L C A + +RP+ ++ MLE +
Sbjct: 253 WQMGTGMKPNLSQIGMGKEISDIL------LFCWAFEQEERPTFTKLMDMLE------KL 300
Query: 1121 PSSADPTSLPS 1131
P S P
Sbjct: 301 PKRNRRLSHPG 311
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 33/284 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRNL 894
Q + G +G ++K + G V +++ L F+ E L K +H N+
Sbjct: 25 QITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
+ GY P +V + +L L H I+ ARG+ +L
Sbjct: 83 LLFMGYSTAPQ--LAIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYL 136
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
H+ ++H D+K N+ D + +FGL + + + GS+ +++PE
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 1015 TGQP---TKEADVYSFGIVLLEILTGRKP-VMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
+ ++DVY+FGIVL E++TG+ P + I++ V + +S++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV----- 250
Query: 1071 LELDPES--SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + + C +RPS I+ +E
Sbjct: 251 ----RSNCPKRMKRLM------AECLKKKRDERPSFPRILAEIE 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 61/341 (17%), Positives = 116/341 (34%), Gaps = 68/341 (19%)
Query: 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAE--ALGKVKHR 892
++ RGRYG ++K S + V +++ + F E + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFA--NRQNFINEKNIYRVPLMEHD 67
Query: 893 NLTVLRGYYAGPPDV----RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
N+ LLV +Y PNG+L L H +W ++ +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVT 121
Query: 949 RGLSFLHS---------LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS--- 996
RGL++LH+ + H D+ +NVL D +S+FGL
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 997 --SSTTPIGSLGYVSPE-------AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD- 1046
++ + +G++ Y++PE K+ D+Y+ G++ EI + +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 1047 -----------------EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKV 1089
ED+ V ++ QR + PE+ + +
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF------------PEAWKENSLAVRSLK 289
Query: 1090 GLL--CTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTS 1128
+ C D R + + + + S PT+
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-40
Identities = 86/418 (20%), Positives = 155/418 (37%), Gaps = 49/418 (11%)
Query: 162 DISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWL 220
++ + Y+DLS N+ +FS LQ + + + + + L L L L
Sbjct: 27 ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLI--PGTIGRISTLQVLSLSRNELTGLVP 278
D N A + ++L L+ L G + +++L++L L N + + P
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 279 VSVLCNLWGNISSLRIVQLGFNAFTGVVKPPN---GRCVSVLEVLDLQNNRIRAVFPSWL 335
S N+ ++ L FN + +L L + ++ + WL
Sbjct: 147 ASFFLNM----RRFHVLDLTFNKVKSI--CEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 336 TNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395
GN F + L ++ N + + ++
Sbjct: 201 GWEK-------CGNPF---------KNTSITTLDLSGNGFKESMAK--RFFDAIAGTKIQ 242
Query: 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNL--SQLETLNLSENDIRGNIPE 453
S S G F +F L S ++T +LS++ I + +
Sbjct: 243 SLILS---------NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLK 292
Query: 454 EI-TRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTT 511
+ + ++L L L+ N+ K+ + L LL LNLS + +L +L
Sbjct: 293 SVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351
Query: 512 LDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAF 567
LDLS ++ L + F GLP+L+ ++L+ N L VP+G F L LQ + L N +
Sbjct: 352 LDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 76/404 (18%), Positives = 138/404 (34%), Gaps = 59/404 (14%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSL 375
+ +DL N I + + + + L+ + + + L L +L++ N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
L + L++ L L L N F L+
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCN--------------LDGAVLSGNFFK--------PLT 129
Query: 436 QLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
LE L L +N+I+ P + L+L++NK D+ N +G L
Sbjct: 130 SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR--- 186
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554
L +T D++ L E F S+ + L N + + F
Sbjct: 187 -----------LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235
Query: 555 VG---LQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELR 611
+ +Q L LS++ G F + G+ S ++ +L
Sbjct: 236 IAGTKIQSLILSNSYNMGS------SFGHTNFKDPDNFTFKGL------EASGVKTCDLS 283
Query: 612 SNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPE 669
+ + + SH + +++L L QN+++ +I + L+ L L N L
Sbjct: 284 KSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSR 341
Query: 670 SFSKLSNLTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNLE 712
F L L L+LS N + A+ + +L+ L L N L+
Sbjct: 342 MFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 81/404 (20%), Positives = 136/404 (33%), Gaps = 69/404 (17%)
Query: 91 LADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVL 148
+ L +L+ L + I + S L + L YN F L F L NL VL
Sbjct: 50 FSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVL 108
Query: 149 NVAHNLL-SGKISADI---SPSLRYLDLSSNAFTGEIPGN-FSSKSQLQLINLSYNSFSG 203
+ L +S + SL L L N P + F + + +++L++N
Sbjct: 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168
Query: 204 EVPASVGQLQ--ELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRIS 261
+ Q L L S L + L G + +
Sbjct: 169 ICEEDLLNFQGKHFTLLRLSSITL----------------QDMNEYWLGWEKCGNPFKNT 212
Query: 262 TLQVLSLSRNELT--------GLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRC 313
++ L LS N + + + +L + S G F P N
Sbjct: 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK---DPDNFTF 269
Query: 314 V----SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVL 368
S ++ DL ++I A+ S ++ T L + L+ N + + L L L
Sbjct: 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 369 RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
++ N L + L++ DL N I +LG F G
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYN----------------HIRALGDQSFLG--- 369
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKF 471
L L+ L L N ++ ++P+ I RL++L + L N +
Sbjct: 370 -----LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 54/296 (18%), Positives = 91/296 (30%), Gaps = 68/296 (22%)
Query: 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQN 518
+++ ++LS N L+ + FS L L L + Q
Sbjct: 30 AHVNYVDLSLNSIA----------------ELNETSFSR--------LQDLQFLKVEQQT 65
Query: 519 LSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFTG-DIPATY 575
+ F GL SL ++ L+ N + G F+ L L+ L L+ G + +
Sbjct: 66 PGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 576 GF--LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633
F L SL L L N I + PA F + R LD
Sbjct: 125 -FKPLTSLEMLVLRDNNIKKIQPASF---------------FLN--------MRRFHVLD 160
Query: 634 LGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPA 693
L NK+ +++ L LS++T +++ L
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFTLLR--------------LSSITLQDMNEYWLGWEKCG 206
Query: 694 DLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPLDRECANVRK 749
+ +S+ L+LS N + + K I ++ K
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 41/229 (17%), Positives = 80/229 (34%), Gaps = 16/229 (6%)
Query: 76 LRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHL 135
+ L + L L N S+ + +Q S
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF--FDAIAGTKIQSLILS--- 247
Query: 136 PLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLIN 195
+ +N+ + + + + ++ DLS + + FS + L+ +
Sbjct: 248 --NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305
Query: 196 LSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLI 253
L+ N + ++ + L L L L N L G++ S + N L L N ++ L
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALG 363
Query: 254 PGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAF 302
+ + L+ L+L N+L VP + L +SL+ + L N +
Sbjct: 364 DQSFLGLPNLKELALDTNQLKS-VPDGIFDRL----TSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-08
Identities = 31/137 (22%), Positives = 57/137 (41%), Gaps = 8/137 (5%)
Query: 70 NNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQY 128
+ V+ L + ++ L + +L +L+L N +N I + + L + L
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332
Query: 129 NSFSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADIS---PSLRYLDLSSNAFTGEIPGN 184
N + +F NL L VL++++N + + P+L+ L L +N G
Sbjct: 333 NFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGI 390
Query: 185 FSSKSQLQLINLSYNSF 201
F + LQ I L N +
Sbjct: 391 FDRLTSLQKIWLHTNPW 407
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-40
Identities = 67/432 (15%), Positives = 155/432 (35%), Gaps = 41/432 (9%)
Query: 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS 374
++A + +L +D + + ++ + L L L +N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 375 LSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNL 434
++ L ++++ + L + N+ + + + + L ++ N L L
Sbjct: 76 ITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNK---LTKLDVSQN 126
Query: 435 SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
L LN + N + I ++ + LT L+ NK DV L L+ S +
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNK 181
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554
+ ++ + L L+ N++ ++L L + N L+ ++ + L
Sbjct: 182 IT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 555 VGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNH 614
L Y + S N T ++ L L L + + +L + L +
Sbjct: 233 TQLTYFDCSVNPLT-ELDV--STLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQA--EG 284
Query: 615 FTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKL 674
+D++H +++ LD ++ E+ +S+ LV L L+ L+ + S
Sbjct: 285 CRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHN 338
Query: 675 SNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRE 734
+ L +L+ + + + I +L + + L++ ++ +
Sbjct: 339 TKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLD 396
Query: 735 LCGKPLDRECAN 746
G P++ E +
Sbjct: 397 QFGNPMNIEPGD 408
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-37
Identities = 75/455 (16%), Positives = 164/455 (36%), Gaps = 52/455 (11%)
Query: 234 SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLR 293
N +S V + E + + +++TL L + +T + + ++ L
Sbjct: 18 DNFASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSITDMTGIE-------KLTGLT 67
Query: 294 IVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSG 353
+ N T + + + L L +N++ + +T +T L ++ N +
Sbjct: 68 KLICTSNNITTL---DLSQNTN-LTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLT- 119
Query: 354 NLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGL 413
L V L L A N+L+ + +++ + L D N+ ++ + L
Sbjct: 120 KLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQL 172
Query: 414 KIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGG 473
+ N + L L LN N+I + + + LT L+ S NK
Sbjct: 173 TTLDCSFN---KITELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE 226
Query: 474 KVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSL 533
DV L L + S + + ++ + +L +LTTL +L I+L L
Sbjct: 227 ---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQL 277
Query: 534 QVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISG 593
E ++ + L L+ T ++ LV+L L++ +++
Sbjct: 278 IYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDL--SQNPKLVYLYLNNTELT- 331
Query: 594 MIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSL 653
+ + + L+ L + H + + + + + + +PKE +SL
Sbjct: 332 ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSL 386
Query: 654 VSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS 688
++ + + L + + + +TN ++
Sbjct: 387 -TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 77/479 (16%), Positives = 140/479 (29%), Gaps = 117/479 (24%)
Query: 121 LRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGE 180
+ +S L L L+ ++ ++ + L L +SN T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-T 78
Query: 181 IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
+ S + L + N + V L +L YL D+N L L +S L
Sbjct: 79 LD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL-TKLD--VSQNPLLT 130
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
+L+ N L + + + L L N+ + V+
Sbjct: 131 YLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDVTPQTQ---------------- 171
Query: 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360
L LD N+I + S + L + N + L +
Sbjct: 172 ----------------LTTLDCSFNKITELDVSQNKLLNRL---NCDTNNIT-KLD--LN 209
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420
+L L ++N L+ + ++ + L FD N
Sbjct: 210 QNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNP---------------------- 244
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG 480
L L LS+L TL+ + +L ++L++N
Sbjct: 245 -----LTELDVSTLSKLTTLHCIQT--------------DLLEIDLTHNT---------- 275
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
L A G + +L LD ++ ++L P L + L
Sbjct: 276 QLI-----YFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNN 327
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599
L+ ++ S L+ L+ + D + G + +L + Q M L
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSV-GKIPALNNNFEAEGQTITMPKETL 381
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 76/439 (17%), Positives = 144/439 (32%), Gaps = 70/439 (15%)
Query: 89 DQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVL 148
+ L L KL SN++ ++ L Q + L + N + L + LT L L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYL 111
Query: 149 NVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPAS 208
N N L+ K+ +P L YL+ + N T EI S +QL ++ N ++
Sbjct: 112 NCDTNKLT-KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD-- 165
Query: 209 VGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSL 268
V +L L N + L +S L L+ + N + L + + L L
Sbjct: 166 VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC 219
Query: 269 SRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIR 328
S N+LT + V+ ++ L N T + L L +
Sbjct: 220 SSNKLTEI-DVT-------PLTQLTYFDCSVNPLTEL---DVSTLSK-LTTLHCIQTDLL 267
Query: 329 AVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSL 388
+ + T + G L V +L +L ++ L ++++
Sbjct: 268 EIDLTHNTQLIYF---QAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPK 319
Query: 389 LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR 448
L L + L + ++L++L+ I+
Sbjct: 320 LVYLYLNNTELTE---------------------------LDVSHNTKLKSLSCVNAHIQ 352
Query: 449 GNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG---KIPGSIGS 505
+ + ++ L + + + N + ++ G I G
Sbjct: 353 -DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGG 410
Query: 506 LMRLTTLDLSNQNLSGELP 524
+ T ++ +NLS + P
Sbjct: 411 VYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 66/341 (19%), Positives = 113/341 (33%), Gaps = 45/341 (13%)
Query: 68 CYNNRVREL------RLPRLQLAG-RLTD-QLADLHELRKLSLHSNHLNGSIPASLHQCS 119
C +N + L L L +LT+ + L +L L+ +N L + S Q
Sbjct: 71 CTSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLDVS--QNP 127
Query: 120 LLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTG 179
LL + N+ + + + + T L L+ N K+ L LD S N T
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT- 183
Query: 180 EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSL 239
E+ S L +N N+ + ++ + Q +L +L SN L + ++ + L
Sbjct: 184 ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQL 235
Query: 240 VHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGF 299
+ N L L T +S L L + +L + ++ L +
Sbjct: 236 TYFDCSVNPLTELDVST---LSKLTTLHCIQTDLLEI-DLTHNTQL----IYFQAEGCRK 287
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV 359
V L +LD Q I + S + L L+ + L V
Sbjct: 288 IKELDVTHNTQ------LYLLDCQAAGITELDLSQNPKLVYL---YLNNTELT-ELD--V 335
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFS 400
KL+ L N + + K L +
Sbjct: 336 SHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-18
Identities = 39/188 (20%), Positives = 74/188 (39%), Gaps = 16/188 (8%)
Query: 525 IELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFL 584
+ F + + L L L+ +++ T D+ L L L
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKL 69
Query: 585 SLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIP 644
+ N I+ + +L + L L SN T +D++ L+++ L+ NKL+ ++
Sbjct: 70 ICTSNNITTL---DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD 122
Query: 645 KEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYL 704
+S+ L L N+L+ I S + LT L+ N+ + D+ + L L
Sbjct: 123 --VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL 175
Query: 705 NLSRNNLE 712
+ S N +
Sbjct: 176 DCSFNKIT 183
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 4e-39
Identities = 98/532 (18%), Positives = 173/532 (32%), Gaps = 79/532 (14%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLW 219
D+ P + L LS N+ + + S S+L+++ LS+N + V Q+LEYL
Sbjct: 48 KDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLD 106
Query: 220 LDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGL-IPGTIGRISTLQVLSLSRNELTGLVP 278
+ N L + +SL HL N L + G ++ L L LS + L
Sbjct: 107 VSHNRL-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-D 162
Query: 279 VSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV 338
+ + +L L + L ++ + VL L + +V
Sbjct: 163 LLPVAHLH-----LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNR 398
+L + LS + L +L +
Sbjct: 218 NALGHLQLSNIKLNDE---NCQRLMTFLSELTRGPTLLNVT------------------- 255
Query: 399 FSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRL 458
L+ + L F +E LN+ I I E
Sbjct: 256 --------------LQHIETTWKCSVKL--FQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQN 518
S LK L++ ++ F + LS +
Sbjct: 300 SETA-------------------LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 519 LSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFL 578
+ S ++ +N + V +G S+L LQ L L N +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399
Query: 579 RSLVFLSLSHNQI----SGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDL 634
+++ L + S ++ VL L SN TG++ + ++K LDL
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDL 457
Query: 635 GQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTN 685
N++ IPK+++ +L L + N L +P+ F +L++L + L N
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 103/490 (21%), Positives = 180/490 (36%), Gaps = 53/490 (10%)
Query: 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLL 155
+ LSL N ++ + S LR + L +N L +F +L L+V+HN L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 156 SGKISADISPSLRYLDLSSNAFTGEIP--GNFSSKSQLQLINLSYNSFSGEVPASVGQLQ 213
IS SLR+LDLS N F +P F + ++L + LS F ++
Sbjct: 113 Q-NISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHL 169
Query: 214 ELEYLWLDSNHLY---GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L + LD + G S ++++HL N L + ++ L L LS
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS--VNALGHLQLSN 227
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGF-------NAFTGVVKPPNGRCVSVLEVLDLQ 323
+L ++ L ++ + + + R V L + +L
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287
Query: 324 NNRI--RAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPD 381
R F T + SL + + F + A ++ + ++ + +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347
Query: 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF--GNLSQLET 439
S + N F+ V ++ L+ + L RN ++ N+S LET
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407
Query: 440 LNLSENDIRGNIPEEITRL-SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGK 498
L++S N + + + ++ LNLS N
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNML--------------------TGSVFRC 447
Query: 499 IPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLVGL 557
+P + LDL N + +P ++ L +LQ +++ N L VP+G F L L
Sbjct: 448 LPPK------VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSL 499
Query: 558 QYLNLSDNAF 567
QY+ L DN +
Sbjct: 500 QYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 89/537 (16%), Positives = 165/537 (30%), Gaps = 90/537 (16%)
Query: 186 SSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAE 245
S +++ S + + VP + L L N + IS S L L
Sbjct: 28 FSNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLS 84
Query: 246 DNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGV 305
N ++ L L+ L +S N L + ++SLR + L FN F +
Sbjct: 85 HNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI--------SCCPMASLRHLDLSFNDFDVL 136
Query: 306 VKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVM-DLSGNFFSGNLPAAVGSL-- 362
++ L L L + R + + ++ ++ DL G ++
Sbjct: 137 PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196
Query: 363 DKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVP--AFLGGIRGLKIVSLGR 420
L ++ N+ S V + LQ+ +++ N + Q RG ++++
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256
Query: 421 NMFSGLIP-----LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV 475
F +E LN+ I I E S
Sbjct: 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETA------------- 303
Query: 476 PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQV 535
LK L++ ++ F + LS + + S
Sbjct: 304 ------LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTF 357
Query: 536 VSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMI 595
++ +N + V +G S+L LQ L L N + +++ L ++ +
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLN 416
Query: 596 PAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS 655
+ I L+L N L+G +
Sbjct: 417 S--------------------HAYDRTCAWAESILVLNLSSNMLTGSV------------ 444
Query: 656 LTLDMNSLSGRIPESFSKL-SNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
F L + L+L NR+ +IP D+ + +L+ LN++ N L
Sbjct: 445 ---------------FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 91/423 (21%), Positives = 159/423 (37%), Gaps = 31/423 (7%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSL 375
+ L L N I + ++ ++ LRV+ LS N +L V LE L V++N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRF-SGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNL 434
+ +A L+ DL N F V G + L + L F L L +L
Sbjct: 113 QNISCCPMAS---LRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 435 S-QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNK---FGGKVPYDVGNLKGL----L 486
L+L I+G E + N T L+L ++ F +V V L L +
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGL---PSLQVVSLEENNL 543
LN + L + L + + + ++LF ++ +++ +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 544 SGDVPEGF-----SSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAE 598
+ + ++L L ++ + F A Y + LS + +
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 599 LGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTL 658
+ S+ L N FT ++ S L R++ L L +N L K ++ SL
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLET 407
Query: 659 DMNSL----SGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGE 714
SL S + + ++ LNLS+N L+G++ L ++ L+L N +
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-S 464
Query: 715 IPK 717
IPK
Sbjct: 465 IPK 467
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-28
Identities = 90/431 (20%), Positives = 144/431 (33%), Gaps = 28/431 (6%)
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVA 371
V D N + V P L + + LS N S + L +L VLR++
Sbjct: 29 SNELESMV-DYSNRNLTHV-PKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLS 84
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGL-IPLS 430
+N + L L+ D+ NR + + L+ + L N F L +
Sbjct: 85 HNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKE 141
Query: 431 FGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNL 490
FGNL++L L LS R + L L + + + VL+L
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 491 SASGFSGKIPGSIGSLMRLTTLDLSNQNLSG-------ELPIELFGLPSLQVVSLEENNL 543
S S+ L L LSN L+ EL P+L V+L+
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 544 SGDVPEGFSSLV---GLQYLNLSDNAFTGDIPATYG-----FLRSLVFLSLSHNQISGMI 595
+ ++YLN+ + T I L+SL+ + +
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321
Query: 596 PAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS 655
A + + + L + V S L+ QN + + + S L +
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT 381
Query: 656 LTLDMNSLSGRIPESFSKLSNLTTLNLSTNRL----SGAIPADLALISSLRYLNLSRNNL 711
L L N L + N+++L L S A A S+ LNLS N L
Sbjct: 382 LILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
Query: 712 EGEIPKMLSSR 722
G + + L +
Sbjct: 441 TGSVFRCLPPK 451
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 65/385 (16%), Positives = 125/385 (32%), Gaps = 27/385 (7%)
Query: 94 LHELRKLSLHSNHLNGSIPASLHQCSL-LRAVYLQYNSFSGHLPLSIFNL-TNLLVLNVA 151
L +L L L + + L + L G S+ T +L L
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 152 HNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQ 211
N L +L +L LS+ E + + + +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT--------- 255
Query: 212 LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271
LQ +E W S L+ + +L+ + + I S + SL
Sbjct: 256 LQHIETTWKCSVKLFQFF-----WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310
Query: 272 ELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVF 331
+ V + L+ + + I L + + S L+ N
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS-FTFLNFTQNVFTDSV 369
Query: 332 PSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAK-CSL-- 388
+ + L+ + L N N + L + SL+ L + C+
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 389 -LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI 447
+ + +L N +G V F +K++ L N + P +L L+ LN++ N +
Sbjct: 429 SILVLNLSSNMLTGSV--FRCLPPKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQL 485
Query: 448 RGNIPEEI-TRLSNLTTLNLSYNKF 471
+ ++P+ + RL++L + L N +
Sbjct: 486 K-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 63/342 (18%), Positives = 113/342 (33%), Gaps = 24/342 (7%)
Query: 75 ELRLPRLQLAGRLTDQLADL-HELRKLSLHSNHLNGSI-PASLHQCSLLRAVYLQYNSFS 132
L L + G T+ L + L H N L S++ L+ ++ N +
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234
Query: 133 GHLPLSIFNLTNLLVLNVAHNLLSGKISADI---------SPSLRYLDLSSNAFTGEIPG 183
++ + + L + + + YL++ + T I
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294
Query: 184 NFSSKS-----QLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSS 238
+ S L + ++ F A E+ L + + SS
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354
Query: 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVS-VLCNLWGNISSLRIVQL 297
L+ NV + + LQ L L RN L V+ + N+ SSL + +
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM----SSLETLDV 410
Query: 298 GFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPA 357
N+ + VL+L +N + L ++V+DL N ++P
Sbjct: 411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPK 467
Query: 358 AVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRF 399
V L L+ L VA+N L + + + LQ L N +
Sbjct: 468 DVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 49/256 (19%), Positives = 91/256 (35%), Gaps = 14/256 (5%)
Query: 52 WDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSI 111
W S W V Y N + L + T L L + + S
Sbjct: 263 WKCSVKLFQFFWPRPVEYLN-IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321
Query: 112 PASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRY 169
A + + L + + + ++ LN N+ + + S L+
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT 381
Query: 170 LDLSSNAFT--GEIPGNFSSKSQLQLINLSYNSF-SGEVPASVGQLQELEYLWLDSNHLY 226
L L N ++ + S L+ +++S NS S + + + L L SN L
Sbjct: 382 LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
Query: 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLW 286
G++ + + L +N + + P + + LQ L+++ N+L VP V L
Sbjct: 442 GSVFRCLP--PKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLKS-VPDGVFDRL- 496
Query: 287 GNISSLRIVQLGFNAF 302
+SL+ + L N +
Sbjct: 497 ---TSLQYIWLHDNPW 509
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 63/292 (21%), Positives = 118/292 (40%), Gaps = 45/292 (15%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT-----FRKEAEALGKVKH 891
+ E ++ G +G +++A + V +++ R ++ + R+EA+ +KH
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 892 RNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
N+ LRG P++ LV ++ G L +L G + + ++ +ARG+
Sbjct: 66 PNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGM 118
Query: 952 SFLHS---LDMVHGDIKPQNVLFDADFEAHLSE--------FGLDRLAIATPAEASSSTT 1000
++LH + ++H D+K N+L E FGL R ++ +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMS 173
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
G+ +++PE +K +DV+S+G++L E+LTG P + V
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
I +L + C PDP RPS +I+ L
Sbjct: 234 PIPSTCPEPFAKLMED----------------CWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-38
Identities = 60/288 (20%), Positives = 111/288 (38%), Gaps = 41/288 (14%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVLSIRRL-RDGTIDENTFRKEAEALGKVKHRNLTVLRG 899
VL +G +G K ++ + G V+ ++ L R + TF KE + + ++H N+ G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDM 959
+ + +Y+ G L ++ W R + +A G+++LHS+++
Sbjct: 75 VLYKDKRL-NFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS-----------SSTTPIGSLGYV 1008
+H D+ N L + +++FGL RL + + T +G+ ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKP----VMFTQDEDIVKWVKKQLQRGQISE 1064
+PE + ++ DV+SFGIVL EI+ + T D +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---FGLNVRGFLDRYCPP 246
Query: 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
P + + C DP RPS + LE
Sbjct: 247 NCPPSFFPI----------------TVRCCDLDPEKRPSFVKLEHWLE 278
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 22/287 (7%)
Query: 436 QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGF 495
L + S+ + +P+++ + L+L NK D NLK L L L +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 496 SGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSL 554
S PG+ L++L L LS L ELP ++ +LQ + + EN ++ V + F+ L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGL 144
Query: 555 VGLQYLNLSDNAFTGDI--PATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRS 612
+ + L N + ++ L ++ ++ I+ IP G +L L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 201
Query: 613 NHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESF 671
N T + L+ + KL L N +S ++ L L L+ N L ++P
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 672 SKLSNLTTLNLSTNRLSG------AIPADLALISSLRYLNLSRNNLE 712
+ + + L N +S P +S ++L N ++
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 69/314 (21%), Positives = 116/314 (36%), Gaps = 27/314 (8%)
Query: 386 CSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEN 445
C L ++ +VP L ++ L N + + F NL L TL L N
Sbjct: 31 CHL-RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86
Query: 446 DIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGS 505
I P L L L LS N+ ++P + K L L + + +
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNG 143
Query: 506 LMRLTTLDLS-NQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLS 563
L ++ ++L N S + F G+ L + + + N++ +P+G L L+L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLD 200
Query: 564 DNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPV 621
N T + A L +L L LS N IS + L L L L +N +P
Sbjct: 201 GNKIT-KVDAAS-LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257
Query: 622 DISHLSRIKKLDLGQNKLSGEIPKE-------ISKCSSLVSLTLDMNSLSGRI--PESFS 672
++ I+ + L N +S I +K +S ++L N + P +F
Sbjct: 258 GLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 673 KLSNLTTLNLSTNR 686
+ + L +
Sbjct: 317 CVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-33
Identities = 66/315 (20%), Positives = 111/315 (35%), Gaps = 33/315 (10%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYL 218
+ D+ P LDL +N T G+F + L + L N S P + L +LE L
Sbjct: 46 VPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 105
Query: 219 WLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT-GLV 277
+L N L LP + +L L +N + + ++ + V+ L N L +
Sbjct: 106 YLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 278 PVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTN 337
+ L +++ T + P L L L N+I V + L
Sbjct: 163 ENGAFQGM----KKLSYIRIADTNITTI--PQG--LPPSLTELHLDGNKITKVDAASLKG 214
Query: 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
+ +L + LS N S ++ + L L + NN L VP +A +Q+ L N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 398 RFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR-GNIPEEI- 455
I ++G N F P + ++L N ++ I
Sbjct: 274 ----------------NISAIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTF 315
Query: 456 TRLSNLTTLNLSYNK 470
+ + L K
Sbjct: 316 RCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 55/289 (19%), Positives = 105/289 (36%), Gaps = 23/289 (7%)
Query: 96 ELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNL 154
+ L L +N + L + L N S + F L L L ++ N
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111
Query: 155 LSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSF-SGEVPASV-GQL 212
L ++ + +L+ L + N T F+ +Q+ ++ L N S + +
Sbjct: 112 LK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 213 QELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNE 272
++L Y+ + ++ T+P + SL L + N + + ++ ++ L L LS N
Sbjct: 171 KKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 227
Query: 273 LTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV-- 330
++ + N LR + L N V P ++V+ L NN I A+
Sbjct: 228 ISAVDN-----GSLANTPHLRELHLNNNKLVKV--PGGLADHKYIQVVYLHNNNISAIGS 280
Query: 331 ----FPSWLTNVTSLRVMDLSGNFFSGNL--PAAVGSLDKLEVLRVANN 373
P + T S + L N P+ + +++ N
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 48/236 (20%), Positives = 83/236 (35%), Gaps = 34/236 (14%)
Query: 97 LRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSF-SGHLPLSIF-NLTNLLVLNVAHN 153
L++L +H N + + + + + V L N S + F + L + +A
Sbjct: 123 LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 154 LLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQ 213
++ I + PSL L L N ++ + S G L
Sbjct: 182 NIT-TIPQGLPPSLTELHLDGN----------------KITKVDAASLKG--------LN 216
Query: 214 ELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273
L L L N + +++N L L +N L +PG + +QV+ L N +
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 274 TGLVPVSVLC--NLWGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNR 326
+ + + C +S V L N P+ RCV V + L N +
Sbjct: 276 SA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 29/136 (21%), Positives = 46/136 (33%), Gaps = 11/136 (8%)
Query: 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSG 133
EL L ++ L L+ L KL L N ++ SL LR ++L N
Sbjct: 195 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253
Query: 134 HLPLSIFNLTNLLVLNVAHNLLS--------GKISADISPSLRYLDLSSNAFT-GEI-PG 183
+P + + + V+ + +N +S S + L SN EI P
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 184 NFSSKSQLQLINLSYN 199
F + L
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 632 LDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAI 691
+ L ++PK++ L L N ++ F L NL TL L N++S
Sbjct: 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 692 PADLALISSLRYLNLSRNNLEGEIPKML 719
P A + L L LS+N L+ E+P+ +
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELPEKM 119
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 57/313 (18%), Positives = 109/313 (34%), Gaps = 59/313 (18%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAE--ALGKVKHRNL 894
+Q + +GRYG ++ ++ V +++ +E ++ +E E ++H N+
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRGEKV-AVKVFFTT--EEASWFRETEIYQTVLMRHENI 93
Query: 895 TVLRGYYAGPPDVR---LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
L+ DY NG+L L+ L+ ++ GL
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGL 147
Query: 952 SFLHSLD--------MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP-I 1002
LH+ + H D+K +N+L + +++ GL I+ E +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 1003 GSLGYVSPE------AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD---------- 1046
G+ Y+ PE + Q AD+YSFG++L E+ ++
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 1047 -----EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLL--CTAPDPL 1099
ED+ + V + R P D + + L+ C A +P
Sbjct: 268 SDPSYEDMREIVCIKKLRPSF-----PNRWSSDECLRQMGK--------LMTECWAHNPA 314
Query: 1100 DRPSMADIVFMLE 1112
R + + L
Sbjct: 315 SRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 63/314 (20%), Positives = 112/314 (35%), Gaps = 59/314 (18%)
Query: 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAE--ALGKVKHRN 893
R + +GRYG +++ S+Q V +++ DE ++ +E E ++H N
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGENV-AVKIFSSR--DEKSWFRETELYNTVMLRHEN 63
Query: 894 LTVLRGY---YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
+ L+ Y G+L LQ L+ I L +A G
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASG 117
Query: 951 LSFLHSLD--------MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS-SSTTP 1001
L+ LH + H D+K +N+L + + +++ GL + + + +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 1002 IGSLGYVSPE------AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD--------- 1046
+G+ Y++PE K D+++FG+VL E+ +D
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 1047 ------EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLL--CTAPDP 1098
ED+ K V QR I P DP + + L+ C +P
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNI-----PNRWFSDPTLTSLAK--------LMKECWYQNP 284
Query: 1099 LDRPSMADIVFMLE 1112
R + I L
Sbjct: 285 SARLTALRIKKTLT 298
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-35
Identities = 75/343 (21%), Positives = 129/343 (37%), Gaps = 44/343 (12%)
Query: 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLN 441
+ + ++ + + +P L + + + N + L +L TL
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLE 87
Query: 442 LSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPG 501
+S N + ++P L L+ + GL L + + + +P
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHL-------PALPSGLCKLWIFGNQLT-SLPV 138
Query: 502 SIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLN 561
L L +S+ L+ LP L L N L+ +P S L Q L+
Sbjct: 139 LPPGL---QELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGL---QELS 187
Query: 562 LSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPV 621
+SDN +P L L +N+++ +PA L+ L + N T ++PV
Sbjct: 188 VSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPV 238
Query: 622 DISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLN 681
S L K+L + N+L+ +P S L+SL++ N L+ R+PES LS+ TT+N
Sbjct: 239 LPSEL---KELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 682 LSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFN 724
L N LS L I+S + +
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-33
Identities = 71/345 (20%), Positives = 135/345 (39%), Gaps = 44/345 (12%)
Query: 362 LDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRN 421
+ VL V + L+ L PD + + + N + +PA +R L + N
Sbjct: 39 NNGNAVLNVGESGLTTL-PDCLPAH--ITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 422 MFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGN 481
+ L P+ L +L + ++P + L L + N+ +P
Sbjct: 92 QLTSL-PVLPPGLLELSIFSNPLT----HLPALPS---GLCKLWIFGNQLT-SLPVLPPG 142
Query: 482 LKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEEN 541
L+ L++S + + +P L L N L+ LP+ LQ +S+ +N
Sbjct: 143 LQ---ELSVSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPMLP---SGLQELSVSDN 191
Query: 542 NLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGA 601
L+ +P S L L +N T +PA L L +S N+++ +P
Sbjct: 192 QLA-SLPTLPSEL---YKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLTS-LPVLPSE 242
Query: 602 CSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661
L+ L + N T ++P+ S L L + +N+L+ +P+ + SS ++ L+ N
Sbjct: 243 ---LKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNL 706
LS R ++ ++++ + R A + +L
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-32
Identities = 83/379 (21%), Positives = 136/379 (35%), Gaps = 53/379 (13%)
Query: 68 CYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQ 127
C NN L + L L D L + L + N+L S+PA + LR + +
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTLEVS 89
Query: 128 YNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSS 187
N + LP+ L L + + L S L L + N T +P
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-----GLCKLWIFGNQLT-SLPVLPPG 142
Query: 188 KSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
LQ +++S N + +PA +L +L W +N L +LP S L LS DN
Sbjct: 143 ---LQELSVSDNQLA-SLPALPSELCKL---WAYNNQL-TSLPMLPSG---LQELSVSDN 191
Query: 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK 307
L L P L L N LT L P S L+ + + N T +
Sbjct: 192 QLASL-PTLPSE---LYKLWAYNNRLTSL-PAL--------PSGLKELIVSGNRLTSL-- 236
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEV 367
P S L+ L + NR+ ++ P + L + + N + LP ++ L
Sbjct: 237 PVL---PSELKELMVSGNRLTSL-PMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETT 288
Query: 368 LRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
+ + N LS + + + + RF + R L + + L+
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW-----LV 343
Query: 428 PLSFGNLSQLETLNLSEND 446
P G + + ++ +
Sbjct: 344 PAREGEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 35/177 (19%), Positives = 64/177 (36%), Gaps = 13/177 (7%)
Query: 54 SSTPSAPCDWRGIVCYNNRVREL-----RLPRLQLAG-RLTDQLADLHELRKLSLHSNHL 107
+S P+ P + + YNNR+ L L L ++G RLT EL++L + N L
Sbjct: 194 ASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRL 253
Query: 108 NGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSL 167
S+P L + N + LP S+ +L++ +N+ N LS + + +
Sbjct: 254 T-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREI 307
Query: 168 RYLDLSSNAFT-GEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223
S ++ G + + L + + + N
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDN 364
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 25/288 (8%)
Query: 436 QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGF 495
L + S+ ++ +P+EI+ + T L+L N D L+ L L L +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 496 SGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSL 554
S + L +L L +S +L E+P L SL + + +N + VP+G FS L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 555 VGLQYLNLSDNAFTGDIPATYGFLR-SLVFLSLSHNQISGMIPAELGACSALEVLELRSN 613
+ + + N F L +L +S +++ IP L L L N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHN 203
Query: 614 HFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESF 671
I ++ S++ +L LG N++ I S +L L LD N LS R+P
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 672 SKLSNLTTLNLSTNRLSGAIPAD-------LALISSLRYLNLSRNNLE 712
L L + L TN ++ + + + ++L N +
Sbjct: 261 PDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 59/314 (18%), Positives = 107/314 (34%), Gaps = 28/314 (8%)
Query: 386 CSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEN 445
C L ++ VP + ++ L N S L F L L L L N
Sbjct: 33 CHL-RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88
Query: 446 DIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIG 504
I I E+ + L L L +S N ++P ++ L+ L + + G
Sbjct: 89 KIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFS 144
Query: 505 SLMRLTTLDLSNQNL-SGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLS 563
L + +++ L + F L + + E L+G + +L L+L
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL---NELHLD 201
Query: 564 DNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPV 621
N I L L L HNQI + L L L L +N + +P
Sbjct: 202 HNKIQ-AIELED-LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258
Query: 622 DISHLSRIKKLDLGQNKLSGEIPKEI-------SKCSSLVSLTLDMNSLSGRI--PESFS 672
+ L ++ + L N ++ ++ K + ++L N + P +F
Sbjct: 259 GLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
Query: 673 KLSNLTTLNLSTNR 686
+++ + +
Sbjct: 318 CVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-31
Identities = 65/313 (20%), Positives = 112/313 (35%), Gaps = 34/313 (10%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220
+ISP LDL +N + +F L + L N S + L++L+ L++
Sbjct: 50 KEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109
Query: 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL-VPV 279
NHL +P + SSLV L DN ++ + G + + + + N L
Sbjct: 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 280 SVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVT 339
L L +++ TG+ P + L L L +N+I+A+ L +
Sbjct: 167 GAFDGL-----KLNYLRISEAKLTGI--PKD--LPETLNELHLDHNKIQAIELEDLLRYS 217
Query: 340 SLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRF 399
L + L N ++ L L L + NN LS VP + LLQ+ L N
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN-- 274
Query: 400 SGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR-GNIPEEI-TR 457
I +G N F + + ++L N + +
Sbjct: 275 --------------NITKVGVNDFCPVGF--GVKRAYYNGISLFNNPVPYWEVQPATFRC 318
Query: 458 LSNLTTLNLSYNK 470
+++ + K
Sbjct: 319 VTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 69/284 (24%), Positives = 107/284 (37%), Gaps = 18/284 (6%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
+LDLQNN I + + L + L N S A L KL+ L ++ N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRN--MFSGLIPLSFGNL 434
+ P+ + L + NR G+R + + +G N SG P +F L
Sbjct: 116 EIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 435 SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
L L +SE + IP+++ L L+L +NK D+ L L L +
Sbjct: 173 K-LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554
GS+ L L L L N LS +P L L LQVV L NN++ F +
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 555 VG------LQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQ 590
++L +N F + + + + +
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 55/287 (19%), Positives = 96/287 (33%), Gaps = 22/287 (7%)
Query: 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLL 155
L L +N ++ L A+ L N S + F L L L ++ N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 156 SGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSF-SGEVPASVGQLQE 214
+I ++ SL L + N G FS + I + N + +
Sbjct: 115 V-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK 173
Query: 215 LEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT 274
L YL + L +P + +L L + N ++ + + R S L L L N++
Sbjct: 174 LNYLRISEAKL-TGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230
Query: 275 GLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS- 333
+ + +LR + L N + V P + +L+V+ L N I V +
Sbjct: 231 MIEN-----GSLSFLPTLRELHLDNNKLSRV--PAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 334 -----WLTNVTSLRVMDLSGNFFSGNL--PAAVGSLDKLEVLRVANN 373
+ + L N PA + ++ N
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 42/235 (17%), Positives = 78/235 (33%), Gaps = 33/235 (14%)
Query: 97 LRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSF-SGHLPLSIFNLTNLLVLNVAHNL 154
L +L +H N + +P + + + N + F+ L L ++
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 155 LSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQE 214
L+ I D+ +L L L N ++ + +
Sbjct: 184 LT-GIPKDLPETLNELHLDHN----------------KIQAIELEDLLR--------YSK 218
Query: 215 LEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT 274
L L L N + ++S +L L ++N L +P + + LQV+ L N +T
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
Query: 275 GLVPVSVLCNL--WGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNR 326
V V+ C + + + L N P RCV+ + N +
Sbjct: 278 K-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 56/313 (17%), Positives = 110/313 (35%), Gaps = 59/313 (18%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAE--ALGKVKHRNL 894
R + + +GR+G +++ ++ V +++ +E ++ +EAE ++H N+
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKWRGEEV-AVKIFSSR--EERSWFREAEIYQTVMLRHENI 98
Query: 895 TVLRGY---YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
G LV DY +G+L L + + ++L A GL
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGL 152
Query: 952 SFLHS--------LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS-SSTTPI 1002
+ LH + H D+K +N+L + +++ GL + + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 1003 GSLGYVSPE------AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD---------- 1046
G+ Y++PE + K AD+Y+ G+V EI +D
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 1047 -----EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLL--CTAPDPL 1099
E++ K V +Q R I P + + ++ C +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNI-----PNRWQSCEALRVMAK--------IMRECWYANGA 319
Query: 1100 DRPSMADIVFMLE 1112
R + I L
Sbjct: 320 ARLTALRIKKTLS 332
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 67/282 (23%), Positives = 109/282 (38%), Gaps = 39/282 (13%)
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497
+ + + ++P I S+ T L L NK +L F
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKL----------------QSLPHGVFDK 50
Query: 498 KIPGSIGSLMRLTTLDLSNQNLS-GELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLV 555
L +LT L LS+ LS + G SL+ + L N + + F L
Sbjct: 51 --------LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 101
Query: 556 GLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSN 613
L++L+ + + F LR+L++L +SH S+LEVL++ N
Sbjct: 102 QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 614 HFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKC-SSLVSLTLDMNSLSGRIPESF 671
F N DI + L + LDL Q +L ++ SSL L + N+ +
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 672 SKLSNLTTLNLSTNRLSGAIPADL--ALISSLRYLNLSRNNL 711
L++L L+ S N + SSL +LNL++N+
Sbjct: 220 KCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 63/303 (20%), Positives = 105/303 (34%), Gaps = 61/303 (20%)
Query: 393 DLEGNRFSGQVPAFLGGI-RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI--RG 449
+ VP GI + L N L F L+QL L+LS N + +G
Sbjct: 13 RCNSKGLT-SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 450 NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRL 509
+ ++L L+LS+N + +S F G L +L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNG-----------------VITMSSNFLG--------LEQL 103
Query: 510 TTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
LD + NL +F L +L + + + F+ L L+ L ++ N+F
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 569 GDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLS 627
+ + LR+L FL LS Q+ +L F LS
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLE----------------QLSPTAFNS--------LS 199
Query: 628 RIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKL-SNLTTLNLSTN 685
++ L++ N + +SL L +N + + S+L LNL+ N
Sbjct: 200 SLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
Query: 686 RLS 688
+
Sbjct: 259 DFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 56/234 (23%), Positives = 88/234 (37%), Gaps = 10/234 (4%)
Query: 389 LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNM--FSGLIPLSFGNLSQLETLNLSEND 446
+LE N+ + L +SL N F G S + L+ L+LS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 447 IRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSGKIPGSIGS 505
+ + L L L+ ++ + V +L+ L+ L++S + G
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 506 LMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLS 563
L L L ++ + ++F L +L + L + L + F+SL LQ LN+S
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207
Query: 564 DNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL--GACSALEVLELRSNHF 615
N F Y L SL L S N I + S+L L L N F
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 10/246 (4%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYN--SFSGEVPASVGQLQELE 216
+ I S L+L SN G F +QL ++LS N SF G S L+
Sbjct: 22 VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK 81
Query: 217 YLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIP-GTIGRISTLQVLSLSRNELTG 275
YL L N + T+ S L HL + + LK + + L L +S
Sbjct: 82 YLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 140
Query: 276 LVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWL 335
+ L SSL ++++ N+F P + L LDL ++ + P+
Sbjct: 141 A-FNGIFNGL----SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195
Query: 336 TNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAK-CSLLQMFDL 394
+++SL+V+++S N F L+ L+VL + N + E+ S L +L
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
Query: 395 EGNRFS 400
N F+
Sbjct: 256 TQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 62/281 (22%), Positives = 97/281 (34%), Gaps = 54/281 (19%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
L+L++N+++++ +T L + LS N L + S
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN--------------GLSFKGCCSQSDF 75
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS-FGNLS 435
G + L+ DL N + + G+ L+ + + + S F +L
Sbjct: 76 GT--------TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 436 QLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
L L++S R I LS+L L ++ N F
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL------------------ 167
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSS 553
P L LT LDLS L +L F L SLQV+++ NN +
Sbjct: 168 -----PDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221
Query: 554 LVGLQYLNLSDNAFTGDIPAT--YGFLRSLVFLSLSHNQIS 592
L LQ L+ S N F SL FL+L+ N +
Sbjct: 222 LNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 40/190 (21%), Positives = 70/190 (36%), Gaps = 11/190 (5%)
Query: 532 SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQI 591
S + L+ VP G S L L N + L L LSLS N +
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 592 SGMIPAELGA---CSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI- 647
S + ++L+ L+L N + + L +++ LD + L +
Sbjct: 65 S-FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 648 SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNL 706
+L+ L + F+ LS+L L ++ N D + +L +L+L
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 707 SRNNLEGEIP 716
S+ LE ++
Sbjct: 183 SQCQLE-QLS 191
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 58/258 (22%), Positives = 95/258 (36%), Gaps = 32/258 (12%)
Query: 96 ELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLL 155
+L L SN L + + L + L N S +
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGT---------- 77
Query: 156 SGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQE 214
SL+YLDLS N + NF QL+ ++ +++ SV L+
Sbjct: 78 ---------TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 215 LEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN-VLKGLIPGTIGRISTLQVLSLSRNEL 273
L YL + H + SSL L N + +P + L L LS+ +L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 274 TGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNRIRAVFP 332
L + +L SSL+++ + N F + +C++ L+VLD N I
Sbjct: 188 EQL-SPTAFNSL----SSLQVLNMSHNNFFSL--DTFPYKCLNSLQVLDYSLNHIMTSKK 240
Query: 333 SWLTNV-TSLRVMDLSGN 349
L + +SL ++L+ N
Sbjct: 241 QELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 56/255 (21%), Positives = 91/255 (35%), Gaps = 34/255 (13%)
Query: 218 LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLV 277
+ +S L ++P+ I SS L E N L+ L G +++ L LSLS N L+
Sbjct: 12 IRCNSKGL-TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS--- 65
Query: 278 PVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTN 337
+ G L+ LDL N + + S
Sbjct: 66 ----------------FKGCCSQSDFGTTS---------LKYLDLSFNGVITM-SSNFLG 99
Query: 338 VTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG 396
+ L +D + +V SL L L +++ S L++ + G
Sbjct: 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159
Query: 397 NRFSGQVPA-FLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI 455
N F +R L + L + L P +F +LS L+ LN+S N+
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 456 TRLSNLTTLNLSYNK 470
L++L L+ S N
Sbjct: 220 KCLNSLQVLDYSLNH 234
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 38/210 (18%), Positives = 76/210 (36%), Gaps = 18/210 (8%)
Query: 69 YNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQY 128
+N + G L+ L L N + ++ ++ L + Q+
Sbjct: 60 SSNGLSFKGCCSQSDFG--------TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 110
Query: 129 NSFSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEI-PG 183
++ S+F +L NL+ L+++H I SL L ++ N+F P
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
Query: 184 NFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHL 242
F+ L ++LS ++ + L L+ L + N+ + +SL L
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 243 SAEDNVLKGLIPGTIGRIST-LQVLSLSRN 271
N + + + L L+L++N
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 78/298 (26%), Positives = 110/298 (36%), Gaps = 62/298 (20%)
Query: 393 DLEGNRFSGQVPAFLGGI-RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNI 451
S +VP GI + ++L N + +F +L LE L L N IR I
Sbjct: 60 VCTRRGLS-EVPQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QI 114
Query: 452 PEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
L++L TL L N L + + F L +L
Sbjct: 115 EVGAFNGLASLNTLELFDN-----------WLT-----VIPSGAFEY--------LSKLR 150
Query: 511 TLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFT 568
L L N + +P F +PSL + L E + EG F L L+YLNL
Sbjct: 151 ELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSR 628
D+P L L L +S N E+R F G LS
Sbjct: 210 -DMP-NLTPLVGLEELEMSGNHFP----------------EIRPGSFHG--------LSS 243
Query: 629 IKKLDLGQNKLSGEIPKE-ISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685
+KKL + +++S I + +SLV L L N+LS + F+ L L L+L N
Sbjct: 244 LKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 64/263 (24%), Positives = 101/263 (38%), Gaps = 10/263 (3%)
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEV 367
P C + + + V P + ++ R ++L N L LEV
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLSEV-PQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEV 103
Query: 368 LRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
L++ NS+ + + L +L N + + L+ + L N +
Sbjct: 104 LQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIP 163
Query: 428 PLSFGNLSQLETLNLSE-NDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGL 485
+F + L L+L E + I E L NL LNL +P ++ L GL
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGL 220
Query: 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLS 544
L +S + F PGS L L L + N +S + F GL SL ++L NNLS
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
Query: 545 GDVPEGFSSLVGLQYLNLSDNAF 567
+ F+ L L L+L N +
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 12/232 (5%)
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNL 543
+ + G S ++P I S L+L N+ + + F L L+V+ L N++
Sbjct: 56 FSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI 111
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGAC 602
F+ L L L L DN T IP+ + +L L L L +N I +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 603 SALEVLEL-RSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
+L L+L I L +K L+LG + ++P ++ L L +
Sbjct: 171 PSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
N P SF LS+L L + +++S ++SL LNL+ NNL
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 56/288 (19%), Positives = 106/288 (36%), Gaps = 46/288 (15%)
Query: 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHN 153
++ K+ L+ +P + S R + L N+ + F +L +L VL + N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 154 LLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVG 210
+ +I SL L+L N L + +F
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDN----------------WLTVIPSGAFEY------- 145
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLS-AEDNVLKGLIPGTIGRISTLQVLSLS 269
L +L LWL +N + A + SL+ L E L+ + G + L+ L+L
Sbjct: 146 -LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 270 RNELTGLVPVSVLCNLWG-NISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIR 328
+ + ++ L L +S ++ +F G+ L+ L + N+++
Sbjct: 205 MCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSS---------LKKLWVMNSQVS 255
Query: 329 AVFPSWLTNVTSLRVMDLSGNFFSGNLPA-AVGSLDKLEVLRVANNSL 375
+ + + SL ++L+ N S +LP L L L + +N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 40/281 (14%)
Query: 214 ELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273
+ + L +P I S+ +L+ +N ++ + T + L+VL L RN +
Sbjct: 55 QFSKVVCTRRGL-SEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 274 TGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS 333
+ AF G+ L L+L +N + +
Sbjct: 112 RQIEV---------------------GAFNGLAS---------LNTLELFDNWLTVIPSG 141
Query: 334 WLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVAN-NSLSGLVPDEIAKCSLLQMF 392
++ LR + L N A + L L + L + L+
Sbjct: 142 AFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201
Query: 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIP 452
+L +P + GL+ + + N F + P SF LS L+ L + + + I
Sbjct: 202 NLGMCNIK-DMPNLTP-LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE 258
Query: 453 EE-ITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLS 491
L++L LNL++N +P+D+ L+ L+ L+L
Sbjct: 259 RNAFDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLH 298
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 57/266 (21%), Positives = 99/266 (37%), Gaps = 22/266 (8%)
Query: 164 SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223
S + + + E+P S + +NL N+ + L LE L L N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 224 HLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLC 283
+ A + +SL L DN L + G +S L+ L L N + + P
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESI-PSYAFN 168
Query: 284 NLWGNISSL------RIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTN 337
+ ++ L ++ + AF G+ L+ L+L I+ + LT
Sbjct: 169 RV-PSLMRLDLGELKKLEYISEGAFEGLFN---------LKYLNLGMCNIKDM--PNLTP 216
Query: 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
+ L +++SGN F P + L L+ L V N+ +S + + + L +L N
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276
Query: 398 RFSGQVPAFLGGIRGLKIVSLGRNMF 423
S +R L + L N +
Sbjct: 277 NLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 51/282 (18%), Positives = 90/282 (31%), Gaps = 61/282 (21%)
Query: 72 RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSF 131
R L L + D LH L L L N + ++ +F
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR----------------QIEVGAF 119
Query: 132 SGHLPLSIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSK 188
+G L +L L + N L+ I + LR L L +N F+
Sbjct: 120 NG--------LASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 189 SQLQLINLS-YNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
L ++L + L L+YL L ++ ++ L L N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGN 228
Query: 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK 307
+ PG+ +S+L+ L + ++++ + NAF G+
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVSLIER---------------------NAFDGLAS 267
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGN 349
L L+L +N + ++ T + L + L N
Sbjct: 268 ---------LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 43/220 (19%)
Query: 69 YNNRVREL---------RLPRLQLAG-RLT----DQLADLHELRKLSLHSNHLNGSIPA- 113
N +R++ L L+L LT L +LR+L L +N + SIP+
Sbjct: 107 GRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 114 SLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADIS-PSLRYLD 171
+ ++ L + L ++ F L NL LN+ + + L L+
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELE 224
Query: 172 LSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPS 231
+S N + SF G L L+ LW+ ++ + +
Sbjct: 225 MSGN----------------HFPEIRPGSFHG--------LSSLKKLWVMNSQVSLIERN 260
Query: 232 AISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271
A +SLV L+ N L L + L L L N
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 42/187 (22%), Positives = 59/187 (31%), Gaps = 53/187 (28%)
Query: 531 PSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQ 590
V LS +VP+G S +YLNL +N T+ L L L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 591 ISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKC 650
I ++ F G L+ + L+L N L+ IP
Sbjct: 111 IR----------------QIEVGAFNG--------LASLNTLELFDNWLT-VIP------ 139
Query: 651 SSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNLSRN 709
+F LS L L L N + +IP+ + SL L+L
Sbjct: 140 -----------------SGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL 181
Query: 710 NLEGEIP 716
I
Sbjct: 182 KKLEYIS 188
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 509 LTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
+ L +S +P F +L ++ L N L+ F+ L L+ L+LSDNA
Sbjct: 34 SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 568 TGDIPA-TYGFLRSLVFLSLSHNQISGMIPAE-LGACSALEVLELRSNHFTGNIPVDI-S 624
+ T+ L L L L + + +AL+ L L+ N +P D
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 625 HLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLS 683
L + L L N++S +P+ SL L L N ++ P +F L L TL L
Sbjct: 151 DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 684 TNRLSGAIPAD-LALISSLRYLNLSRNNL 711
N LS A+P + LA + +L+YL L+ N
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 47/207 (22%), Positives = 71/207 (34%), Gaps = 10/207 (4%)
Query: 510 TTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569
T Q L +P+ + + Q + L N +S F + L L L N
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 570 DIPATYGFLRSLVFLSLSHNQISGMIPAE-LGACSALEVLELRSNHFTGNIPVDI-SHLS 627
A + L L L LS N + L L L + + L+
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA 129
Query: 628 RIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686
++ L L N L +P + +L L L N +S +F L +L L L NR
Sbjct: 130 ALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 687 LSGAIPAD-LALISSLRYLNLSRNNLE 712
++ + + L L L NNL
Sbjct: 189 VA-HVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/254 (21%), Positives = 83/254 (32%), Gaps = 53/254 (20%)
Query: 435 SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
+ + + L N I NLT L L N + A+
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA----------------RIDAAA 75
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSS 553
F+G L L LDLS+ + F GL L + L+ L
Sbjct: 76 FTG--------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ--------- 118
Query: 554 LVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSN 613
L F G L +L +L L N + + L L L N
Sbjct: 119 -------ELGPGLFRG--------LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 614 HFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESF 671
+ ++P L + +L L QN+++ + L++L L N+LS E+
Sbjct: 164 RIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 672 SKLSNLTTLNLSTN 685
+ L L L L+ N
Sbjct: 222 APLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 56/245 (22%), Positives = 90/245 (36%), Gaps = 37/245 (15%)
Query: 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWG 287
+P I ++ + N + + + L +L L N L +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA--------- 73
Query: 288 NISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN-RIRAVFPSWLTNVTSLRVMDL 346
AFTG+ LE LDL +N ++R+V P+ + L + L
Sbjct: 74 ------------AAFTGLAL---------LEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112
Query: 347 SGNFFSGNLPAAV-GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPA 405
L + L L+ L + +N+L L D L L GNR S
Sbjct: 113 DRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 406 FLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTL 464
G+ L + L +N + + P +F +L +L TL L N++ +P E L L L
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYL 230
Query: 465 NLSYN 469
L+ N
Sbjct: 231 RLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 54/228 (23%), Positives = 85/228 (37%), Gaps = 27/228 (11%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEY 217
+ I + + + L N + +F + L ++ L N + + A+ L LE
Sbjct: 26 VPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQ 84
Query: 218 LWLDSNHLYGTLPS-AISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276
L L N ++ L L + L+ L PG ++ LQ L L N L L
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL 144
Query: 277 VPVSVLCNLWGNISSLRIVQLGFN--------AFTGVVKPPNGRCVSVLEVLDLQNNRIR 328
P +L +L + L N AF G+ L+ L L NR+
Sbjct: 145 -PDDTFRDL----GNLTHLFLHGNRISSVPERAFRGLHS---------LDRLLLHQNRVA 190
Query: 329 AVFPSWLTNVTSLRVMDLSGNFFSGNLPA-AVGSLDKLEVLRVANNSL 375
V P ++ L + L N S LP A+ L L+ LR+ +N
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 50/259 (19%), Positives = 85/259 (32%), Gaps = 61/259 (23%)
Query: 96 ELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNL 154
+++ LH N ++ AS C L ++L N + + + F L L L+++ N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNA 91
Query: 155 LSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQ 211
+ L L L L L F G
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRC----------------GLQELGPGLFRG-------- 127
Query: 212 LQELEYLWLDSNHLYGTLPS-AISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L L+YL+L N L LP + +L HL N + + + +L L L +
Sbjct: 128 LAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
N + + P +AF + + L L L N + A+
Sbjct: 187 NRVAHVHP---------------------HAFRDLGR---------LMTLYLFANNLSAL 216
Query: 331 FPSWLTNVTSLRVMDLSGN 349
L + +L+ + L+ N
Sbjct: 217 PTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 40/186 (21%), Positives = 62/186 (33%), Gaps = 31/186 (16%)
Query: 91 LADLHELRKLSLHSNHLNGSIPAS-LHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVL 148
L L +L L N S+ + H L ++L L +F L L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 149 NVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV 205
+ N L + D +L +L L N ++ ++ +F G
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGN----------------RISSVPERAFRG-- 175
Query: 206 PASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQV 265
L L+ L L N + P A + L+ L N L L + + LQ
Sbjct: 176 ------LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229
Query: 266 LSLSRN 271
L L+ N
Sbjct: 230 LRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 30/135 (22%), Positives = 48/135 (35%), Gaps = 13/135 (9%)
Query: 77 RLPRLQLAG-RLT----DQLADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNS 130
RL L L L L L+ L L N L ++P + L ++L N
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164
Query: 131 FSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFS 186
S +P F L +L L + N ++ + L L L +N + +
Sbjct: 165 IS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 187 SKSQLQLINLSYNSF 201
LQ + L+ N +
Sbjct: 223 PLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 22/85 (25%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 632 LDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAI 691
Q L +P I ++ + L N +S SF NLT L L +N L+
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 692 PADLALISSLRYLNLSRNNLEGEIP 716
A ++ L L+LS N +
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVD 97
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 73/305 (23%), Positives = 108/305 (35%), Gaps = 81/305 (26%)
Query: 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
++++L N + SF +L LE L LS N IR I L+NL TL L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122
Query: 470 KFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF- 528
L + F L +L L L N + +P F
Sbjct: 123 -----------RLT-----TIPNGAFVY--------LSKLKELWLRNNPIE-SIPSYAFN 157
Query: 529 GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLS 587
+PSL+ + L E + EG F L L+YLNL+ +IP L L L LS
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215
Query: 588 HNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI 647
N +S +R F G L ++KL + Q+++ I
Sbjct: 216 GNHLS----------------AIRPGSFQG--------LMHLQKLWMIQSQIQ-VIE--- 247
Query: 648 SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNL 706
+F L +L +NL+ N L+ +P D + L ++L
Sbjct: 248 --------------------RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL 286
Query: 707 SRNNL 711
N
Sbjct: 287 HHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 63/266 (23%), Positives = 109/266 (40%), Gaps = 10/266 (3%)
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEV 367
P C + + +R V P ++ T+ R+++L N + L LE+
Sbjct: 36 PSVCSCSNQFSKVICVRKNLREV-PDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 368 LRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
L+++ N + + + L +L NR + + LK + L N +
Sbjct: 93 LQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIP 152
Query: 428 PLSFGNLSQLETLNLSE-NDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGL 485
+F + L L+L E + I E LSNL LNL+ ++P ++ L L
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNL-REIP-NLTPLIKL 209
Query: 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLS 544
L+LS + S PGS LM L L + + + F L SL ++L NNL+
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGD 570
+ F+ L L+ ++L N + +
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 9/209 (4%)
Query: 508 RLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566
L+L + + + F L L+++ L N++ F+ L L L L DN
Sbjct: 65 NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 567 FTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLEL-RSNHFTGNIPVDI- 623
T IP + +L L L L +N I + +L L+L + I
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAF 181
Query: 624 SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLS 683
LS ++ L+L L EIP ++ L L L N LS P SF L +L L +
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239
Query: 684 TNRLSGAIPADLALISSLRYLNLSRNNLE 712
+++ + SL +NL+ NNL
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 9/238 (3%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220
IS + R L+L N +F L+++ LS N + L L L L
Sbjct: 60 DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119
Query: 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR-NELTGLVPV 279
N L A S L L +N ++ + RI +L+ L L L+ +
Sbjct: 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYI-SE 178
Query: 280 SVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVT 339
L S+LR + L + PN + L+ LDL N + A+ P +
Sbjct: 179 GAFEGL----SNLRYLNLAMCNLREI---PNLTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 340 SLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
L+ + + + A +L L + +A+N+L+ L D L+ L N
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 8/230 (3%)
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS 544
LL+ ++ +G + P + + + +NL E+P + + ++++L EN +
Sbjct: 21 LLMGCVAETGSAQTCPSVCSCSNQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ 77
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSA 604
F L L+ L LS N + L +L L L N+++ + S
Sbjct: 78 IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSK 137
Query: 605 LEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNS 662
L+ L LR+N +IP + + +++LDLG+ K I + S+L L L M +
Sbjct: 138 LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN 196
Query: 663 LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
L IP + + L L L+LS N LS P + L+ L + ++ ++
Sbjct: 197 LR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 64/308 (20%), Positives = 109/308 (35%), Gaps = 62/308 (20%)
Query: 164 SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223
S + E+P S+ +L+NL N S L+ LE L L N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 224 HLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLC 283
H+ A + ++L L DN L + G +S L+ L L N + +
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPS----- 153
Query: 284 NLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQ-NNRIRAVFPSWLTNVTSLR 342
AF + L LDL R+ + +++LR
Sbjct: 154 ----------------YAFNRIPS---------LRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 343 VMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQ 402
++L+ +P + L KL+ L ++ N LS + P LQ + ++
Sbjct: 189 YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ---- 242
Query: 403 VPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNL 461
I + RN F L L +NL+ N++ +P ++ T L +L
Sbjct: 243 ------------IQVIERNAFDN--------LQSLVEINLAHNNLT-LLPHDLFTPLHHL 281
Query: 462 TTLNLSYN 469
++L +N
Sbjct: 282 ERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 56/282 (19%), Positives = 93/282 (32%), Gaps = 61/282 (21%)
Query: 72 RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSF 131
R L L Q+ + L L L L NH+ + + + L + L N
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 132 SGHLPLSIF-NLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSS 187
+ +P F L+ L L + +N + I + PSLR LDL
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL--------K--- 171
Query: 188 KSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
+L +S +F G L L YL L +L ++ L L N
Sbjct: 172 ----RLSYISEGAFEG--------LSNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGN 217
Query: 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK 307
L + PG+ + LQ L + ++++ + NAF +
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIER---------------------NAFDNLQS 256
Query: 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGN 349
L ++L +N + + T + L + L N
Sbjct: 257 ---------LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 28/115 (24%), Positives = 45/115 (39%), Gaps = 8/115 (6%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLN 149
L LR L+L +L IP L L + L N S + F L +L L
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 150 VAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSF 201
+ + + I + SL ++L+ N T F+ L+ I+L +N +
Sbjct: 238 MIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 68/331 (20%), Positives = 121/331 (36%), Gaps = 52/331 (15%)
Query: 386 CSLLQMFDLEGNRFSGQVPAFLGGI-RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSE 444
C + + +P+ G+ +K + L N + + L+ L L+
Sbjct: 30 CDRNGICKGSSGSLN-SIPS---GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 445 NDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSI 503
N I I E+ + L +L L+LSYN L NLS+S F
Sbjct: 86 NGIN-TIEEDSFSSLGSLEHLDLSYNY-----------LS-----NLSSSWFKP------ 122
Query: 504 GSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLN 561
L LT L+L LF L LQ++ + + + F+ L L+ L
Sbjct: 123 --LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 562 LSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPV 621
+ + P + ++++ L L Q ++ + S++E LELR
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF--- 237
Query: 622 DISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLN 681
S LS + L K + ++ + SL ++ + +++S L L
Sbjct: 238 HFSELSTGETNSL-------------IKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 682 LSTNRLSGAIPAD-LALISSLRYLNLSRNNL 711
S N+L +P ++SL+ + L N
Sbjct: 284 FSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 64/338 (18%), Positives = 125/338 (36%), Gaps = 48/338 (14%)
Query: 351 FSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGI 410
+ A S D+ + + ++ SL+ +P + ++ DL NR + + L
Sbjct: 19 KEESSNQASLSCDRNGICKGSSGSLNS-IPSGL--TEAVKSLDLSNNRITYISNSDLQRC 75
Query: 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
L+ + L N + + SF +L LE L+LS N + N+ LS+LT LNL N
Sbjct: 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGN 134
Query: 470 KFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF- 528
+ L + + +L L + N + ++ + F
Sbjct: 135 PY----------------KTLGETSLFSHLT-------KLQILRVGNMDTFTKIQRKDFA 171
Query: 529 GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSH 588
GL L+ + ++ ++L P+ S+ + +L L + S+ L L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 589 NQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEIS 648
+ EL + + + + + L ++ K ++
Sbjct: 232 TDLDT-----------FHFSELSTGETNS-----LIKKFTFRNVKITDESLF-QVMKLLN 274
Query: 649 KCSSLVSLTLDMNSLSGRIPES-FSKLSNLTTLNLSTN 685
+ S L+ L N L +P+ F +L++L + L TN
Sbjct: 275 QISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 58/314 (18%), Positives = 110/314 (35%), Gaps = 38/314 (12%)
Query: 165 PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSN 223
SS + IP + ++ ++LS N + + S + L+ L L SN
Sbjct: 31 DRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN 86
Query: 224 HLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLC 283
+ + S+ SL HL N L L +S+L L+L N L S+
Sbjct: 87 GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS 146
Query: 284 NL-----WGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV 338
+L + ++ F G+ LE L++ + +++ P L ++
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTF---------LEELEIDASDLQSYEPKSLKSI 197
Query: 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNR 398
++ + L L V +E L + + L +L
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT-----------FHFSELSTGE 246
Query: 399 FSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TR 457
+ L + V + ++ L +S L L S N ++ ++P+ I R
Sbjct: 247 TNS-----LIKKFTFRNVKITDESLFQVMKL-LNQISGLLELEFSRNQLK-SVPDGIFDR 299
Query: 458 LSNLTTLNLSYNKF 471
L++L + L N +
Sbjct: 300 LTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 68/299 (22%), Positives = 101/299 (33%), Gaps = 32/299 (10%)
Query: 426 LIPLSFGNLSQLETLNLSEN---DIRGN----IPEEITRLSNLTTLNLSYNKFGGKVPYD 478
+I LS S +L+ N IP +T + +L+LS N+ D
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSD 71
Query: 479 VGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVS 537
+ L L L+++G + S SL L LDLS LS L F L SL ++
Sbjct: 72 LQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLN 130
Query: 538 LEENNLSGDVPEG-FSSLVGLQYLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMI 595
L N FS L LQ L + + I + L L L + + +
Sbjct: 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190
Query: 596 PAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLV 654
P L + + L L + S ++ L+L L
Sbjct: 191 PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD-------------- 235
Query: 655 SLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEG 713
T + LS S K + ++ L + L IS L L SRN L+
Sbjct: 236 --TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 54/265 (20%), Positives = 112/265 (42%), Gaps = 17/265 (6%)
Query: 96 ELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNL 154
++ L L +N + + L +C L+A+ L N + + F +L +L L++++N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 155 LSGKISADI---SPSLRYLDLSSNAFTGEIP--GNFSSKSQLQLINLSYNSFSGEVPASV 209
LS +S+ SL +L+L N + + FS ++LQ++ + ++
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 210 -GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSL 268
L LE L +D++ L P ++ + ++ HL L+ + S+++ L L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 269 SRNELTGL----VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQN 324
+L + +L + R V++ + V +S L L+
Sbjct: 230 RDTDLDTFHFSELSTGETNSLI-KKFTFRNVKITDESLFQV--MKLLNQISGLLELEFSR 286
Query: 325 NRIRAVFPSWLTNVTSLRVMDLSGN 349
N++++V +TSL+ + L N
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 50/241 (20%), Positives = 98/241 (40%), Gaps = 9/241 (3%)
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS 544
++ + + + S R S+ +L+ +P L +++ + L N ++
Sbjct: 9 WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRIT 65
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACS 603
V LQ L L+ N I ++ L SL L LS+N +S + + S
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLS 124
Query: 604 ALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMN 661
+L L L N + + SHL++++ L +G +I ++ + + L L +D +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNLEGEIPKMLS 720
L P+S + N++ L L + + + SS+ L L +L+ LS
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 721 S 721
+
Sbjct: 244 T 244
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 8e-17
Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 20/223 (8%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASL-HQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVL 148
+ L L L L N+L ++ +S S L + L N + S+F +LT L +L
Sbjct: 96 FSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154
Query: 149 NVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV 205
V + KI L L++ ++ P + S + + L +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL 214
Query: 206 PASVGQLQELEYLWLDSNHLYGTLPSAIS--------NCSSLVHLSAEDNVLKGLIPGTI 257
V +E L L L S +S + ++ D L + +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLL 273
Query: 258 GRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
+IS L L SRN+L + P + L +SL+ + L N
Sbjct: 274 NQISGLLELEFSRNQLKSV-PDGIFDRL----TSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 25/148 (16%), Positives = 52/148 (35%), Gaps = 15/148 (10%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLN 149
A L L +L + ++ L P SL + + L L +++ L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 150 VAHNLLSGKISADIS----------PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYN 199
+ L +++S + R + ++ + ++ + S L + S N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287
Query: 200 SFSGEVPASV-GQLQELEYLWLDSNHLY 226
VP + +L L+ +WL +N
Sbjct: 288 QLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 64/297 (21%), Positives = 111/297 (37%), Gaps = 31/297 (10%)
Query: 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPY-DVGNLKGL 485
I L N L + N N I G + + L V +
Sbjct: 3 IMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61
Query: 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
L L+ S +P ++ ++T L+++ L LP L L +N LS
Sbjct: 62 SELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDNRLS- 113
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605
+PE +SL ++L++ +N T +P L +++ +NQ++ M+P + L
Sbjct: 114 TLPELPASL---KHLDVDNNQLT-MLPEL---PALLEYINADNNQLT-MLPELPTS---L 162
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSL----VSLTLDMN 661
EVL +R+N T +P L + LD+ N L +P + + N
Sbjct: 163 EVLSVRNNQLTF-LPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKM 718
++ IPE+ L T+ L N LS I L+ ++ + R +
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 68/397 (17%), Positives = 129/397 (32%), Gaps = 40/397 (10%)
Query: 317 LEVLDLQNNRIRAVFP-SWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSL 375
+ N ++ + + L L+ S +LP + ++ VL + N+L
Sbjct: 39 QALPGENRNEAVSLLKECLINQFSEL---QLNRLNLS-SLPDNLPP--QITVLEITQNAL 92
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
L P+ A L+ D NR S +P ++ L + N + L L +
Sbjct: 93 ISL-PELPAS---LEYLDACDNRLS-TLPELPASLKHLD---VDNNQLTMLPEL----PA 140
Query: 436 QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGF 495
LE +N N + +PE T +L L++ N+ +P +L+ L++S +
Sbjct: 141 LLEYINADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLPELPESLE---ALDVSTNLL 192
Query: 496 SGKIPGSIGSLMRLTT----LDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGF 551
+P ++ +P + L + LE+N LS + E
Sbjct: 193 ES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 552 SSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELR 611
S + F+ R L +++ E
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA--DAVTAWFPENKQSDVSQIWHAFEHEEH 308
Query: 612 SNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESF 671
+N F+ +S + + +++ + K S+ L +++ ES
Sbjct: 309 ANTFS-AFLDRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATESC 363
Query: 672 SKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSR 708
LT NL L L + L+L R
Sbjct: 364 EDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGR 400
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 59/313 (18%), Positives = 99/313 (31%), Gaps = 62/313 (19%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
+ N + + L L+ + +P N Q+ ++ ++ N+
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNA 91
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
+P L+ L+ N L TLP ++ L HL ++N L L P
Sbjct: 92 LI-SLPELPASLEYLD---ACDNRL-STLPELPAS---LKHLDVDNNQLTML-PELPA-- 140
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
L+ ++ N+LT L P + LEVL
Sbjct: 141 -LLEYINADNNQLTML-PEL-PTS--------------------------------LEVL 165
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLE----VLRVANNSLS 376
++NN++ + P + L +D+S N +LPA E R N ++
Sbjct: 166 SVRNNQLTFL-PELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI---PLSFGN 433
+ P+ I LE N S ++ L R FS
Sbjct: 221 HI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279
Query: 434 LSQLETLNLSEND 446
L+ T EN
Sbjct: 280 LADAVTAWFPENK 292
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-19
Identities = 65/385 (16%), Positives = 128/385 (33%), Gaps = 52/385 (13%)
Query: 72 RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSF 131
+ R + L + L +++ +L L+ +L+ S+P +L + + + N+
Sbjct: 38 KQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNAL 92
Query: 132 SGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQL 191
LP +L L+ N LS + SL++LD+ +N T +P + L
Sbjct: 93 I-SLPELPASLEY---LDACDNRLS-TLPELP-ASLKHLDVDNNQLT-MLP---ELPALL 142
Query: 192 QLINLSYNSFSGEVPASVGQLQEL-----------------EYLWLDSNHLYGTLPSAIS 234
+ IN N + +P L+ L E L + +N L +LP+
Sbjct: 143 EYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLL-ESLPAVPV 200
Query: 235 NCSSL----VHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSV-----LCNL 285
+ +N + + P I + + L N L+ + S+ +
Sbjct: 201 RNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259
Query: 286 WGNISSLRIVQLGFNAFTGVVK-------PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV 338
G + N + P N + ++ F ++L +
Sbjct: 260 HGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRL 319
Query: 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNR 398
+ + F + A + L LR + +++ + L +L
Sbjct: 320 SDTVSARNTSG-FREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTL 378
Query: 399 FSGQVPAFLGGIRGLKIVSLGRNMF 423
Q L ++SLGR MF
Sbjct: 379 LVHQASEGLFDNDTGALLSLGREMF 403
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 34/186 (18%), Positives = 58/186 (31%), Gaps = 12/186 (6%)
Query: 54 SSTPSAPCDWRGIVCYNNRVREL-----RLPRLQLAG-RLTDQLADLHELRKLSLHSNHL 107
+ P P I NN++ L L L + +LT L L + +N L
Sbjct: 133 TMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLL 192
Query: 108 NGSIPASLHQCSLLRAV----YLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI 163
S+PA + + N + H+P +I +L + + N LS +I +
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 164 SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223
S D + + L + F + V Q+ +N
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHAN 310
Query: 224 HLYGTL 229
L
Sbjct: 311 TFSAFL 316
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 51/285 (17%), Positives = 109/285 (38%), Gaps = 47/285 (16%)
Query: 426 LIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGL 485
+ P L+ + ++++ L +TTL+ V ++G+
Sbjct: 12 IFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTG--------VTTIEGV 59
Query: 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
L L L+L + ++ P++ L + + L N L
Sbjct: 60 ------------------QYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPLK- 98
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605
+ L ++ L+L+ T D+ G L +L L L NQI+ + P L + L
Sbjct: 99 -NVSAIAGLQSIKTLDLTSTQIT-DVTPLAG-LSNLQVLYLDLNQITNISP--LAGLTNL 153
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
+ L + + + ++ +++LS++ L NK+S +I ++ +L+ + L N +S
Sbjct: 154 QYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISD 209
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNN 710
+ SNL + L+ ++ ++L N+ +
Sbjct: 210 --VSPLANTSNLFIVTLTNQTITNQPVFYN---NNLVVPNVVKGP 249
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
L + + S + + L +TTL ++ ++ L +L + L++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKD 72
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600
N ++ D+ +L + L LS N ++ A G L+S+ L L+ QI+ + P L
Sbjct: 73 NQIT-DL-APLKNLTKITELELSGNPLK-NVSAIAG-LQSIKTLDLTSTQITDVTP--LA 126
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
S L+VL L N T NI ++ L+ ++ L +G ++S P ++ S L +L D
Sbjct: 127 GLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
N +S + L NL ++L N++S P LA S+L + L+ +
Sbjct: 183 NKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 505 SLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSD 564
+L + N++ + L + +S ++ + EG L L L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 565 NAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDIS 624
N T D+ L + L LS N + + + +++ L+L S T P ++
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 625 HLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLST 684
LS ++ L L N+++ I ++ ++L L++ +S + LS LTTL
Sbjct: 127 GLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADD 182
Query: 685 NRLSGAIPADLALISSLRYLNLSRNNLE 712
N++S P LA + +L ++L N +
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 71/315 (22%), Positives = 127/315 (40%), Gaps = 50/315 (15%)
Query: 263 LQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDL 322
++ ++ +T V + L + +L G GV N L L+L
Sbjct: 21 AIKIAAGKSNVTDTVTQADLDGIT----TLSAFGTGVTTIEGVQYLNN------LIGLEL 70
Query: 323 QNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDE 382
++N+I + P L N+T + ++LSGN N+ A + L ++ L + + ++ + P
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP-- 124
Query: 383 IAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNL 442
+A S LQ+ L+ N+ + P L G+ L+ +S+G S L PL+ NLS+L TL
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKA 180
Query: 443 SENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGS 502
+N I +I + L NL ++L N+ + ++S
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNNQ----------------ISDVSP---------- 212
Query: 503 IGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562
+ + L + L+NQ ++ + L VV P S NL
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNL 270
Query: 563 SDNAFTGDIPATYGF 577
+ N + +Y F
Sbjct: 271 TWNLTSFINNVSYTF 285
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 61/339 (17%), Positives = 118/339 (34%), Gaps = 57/339 (16%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
L N + + + ++ ++ + L T I G + L + L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
+ P + L ++ L L N L SAI+ S+ L + + P + +
Sbjct: 75 ITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
S LQVL L N++T + P++ L N L+ L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTN--------------------------------LQYL 156
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP 380
+ N ++ + P L N++ L + N S ++ + SL L + + NN +S +
Sbjct: 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV-- 210
Query: 381 DEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440
+A S L + L + Q + L + ++ + I + + +
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFYNN---NLVVPNVVKGPSGAPIAPA----TISDNG 263
Query: 441 NLSENDIRGNIPEEITRLS----NLTTLNLSYNKFGGKV 475
+ ++ N+ I +S T + F G V
Sbjct: 264 TYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 34/164 (20%), Positives = 69/164 (42%), Gaps = 12/164 (7%)
Query: 549 EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVL 608
+L + + T + L + LS ++ + + + L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGL 68
Query: 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIP 668
EL+ N T ++ + +L++I +L+L N L I+ S+ +L L ++
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD--V 122
Query: 669 ESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
+ LSNL L L N+++ P LA +++L+YL++ +
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 52/248 (20%), Positives = 101/248 (40%), Gaps = 46/248 (18%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
+ L+ L L L N + + PL NLT + L +
Sbjct: 59 VQYLNNLIGLELKDNQIT-DLA-----------------------PLK--NLTKITELEL 92
Query: 151 AHNLLSGKISADIS-PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV 209
+ N L +SA S++ LDL+S T ++ + S LQ++ L N + P +
Sbjct: 93 SGNPLK-NVSAIAGLQSIKTLDLTSTQIT-DVT-PLAGLSNLQVLYLDLNQITNISP--L 147
Query: 210 GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLS 269
L L+YL + + + + + ++N S L L A+DN + + P + + L + L
Sbjct: 148 AGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLK 203
Query: 270 RNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRA 329
N+++ + P++ N S+L IV L T P +++ ++
Sbjct: 204 NNQISDVSPLA-------NTSNLFIVTLTNQTIT---NQPVFYNNNLVVPNVVKGPSGAP 253
Query: 330 VFPSWLTN 337
+ P+ +++
Sbjct: 254 IAPATISD 261
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 50/224 (22%), Positives = 84/224 (37%), Gaps = 26/224 (11%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
+A L ++ L L S + P L S L+ +YL N + PL+ LTNL L++
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSI 158
Query: 151 AHNLLSGKISADISP-----SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV 205
+ +S D++P L L N + +I +S L ++L N S
Sbjct: 159 GNAQVS-----DLTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVS 211
Query: 206 PASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQV 265
P + L + L + + T N + +V + + P TI T
Sbjct: 212 P--LANTSNLFIVTLTNQTI--TNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYAS 267
Query: 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPP 309
+L+ N + + VS N + + F+G V P
Sbjct: 268 PNLTWNLTSFINNVSYTFNQSVTFKNTTVP------FSGTVTQP 305
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 40/310 (12%), Positives = 76/310 (24%), Gaps = 52/310 (16%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASYQD-GM-----VLSIRRLRDGTIDENTFRKEAEALG 887
+ R+ L G ++F + V ++ + + + A
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS-ELERLHEATFAAA 117
Query: 888 KVKHRNLTVLRGYY--AGPPDV-----------------------RLLVYDYMPNGNLAT 922
++ + R P D LL+ + +L
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLEL 176
Query: 923 LLQEASH--QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLS 980
L H+++ L R + L S +VHG P N+ D L
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLG 236
Query: 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPE--AASTGQPTKEADVYSFGIVLLEILTGR 1038
+ + + Y E AST T + + G+ + +
Sbjct: 237 DVSALW------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
Query: 1039 KPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDP 1098
P F +K K+ P + + L D
Sbjct: 291 LP--FGLVTPGIKGSWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIG----RFLN--FDR 341
Query: 1099 LDRPSMADIV 1108
R + +
Sbjct: 342 RRRLLPLEAM 351
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 62/264 (23%), Positives = 105/264 (39%), Gaps = 30/264 (11%)
Query: 879 FRKEAEALGKVKHRNL-TVL-RGYYAGPP-DVRLLVYDYMPNGNLATLLQEASHQDGHVL 935
FR+EA+ + H + V G P + +V +Y+ L ++ +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPM 113
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
+ + L+F H ++H D+KP N++ A + +FG+ R +
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
+ + IG+ Y+SPE A +DVYS G VL E+LTG P FT D + +
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQ- 230
Query: 1056 QLQRGQISELLEPGLLELDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVF 1109
+ E P S++ + +L A +P +R AD+V
Sbjct: 231 -----HVREDPIP-PSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMRADLVR 278
Query: 1110 MLEGCRVG-PDMPSSADPTSLPSP 1132
+ G P + + A+ TSL S
Sbjct: 279 VHNGEPPEAPKVLTDAERTSLLSS 302
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 60/299 (20%), Positives = 96/299 (32%), Gaps = 40/299 (13%)
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVL 488
L G S L + + +I + +L L + + ++ + L VL
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA-----LRVL 92
Query: 489 NLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVP 548
+S L L L N ++G P L + L N+S
Sbjct: 93 GIS----------------GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136
Query: 549 EGFSSLV------GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGAC 602
+ + + + GL+ L+++ +L L LS N G C
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196
Query: 603 ----SALEVLELRSNHFT---GNIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLV 654
L+VL LR+ G + +++ LDL N L S L
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 655 SLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEG 713
SL L L + L+ L+LS NRL P+ L + L+L N
Sbjct: 257 SLNLSFTGLKQVPKGLPA---KLSVLDLSYNRLDR-NPSPDEL-PQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 4e-22
Identities = 54/237 (22%), Positives = 83/237 (35%), Gaps = 19/237 (8%)
Query: 504 GSLMRLTTLDLSNQNLSGELPI-ELFGLPSLQVVSLEENNLSGDVPEGFSSLVG---LQY 559
G L L + ++ SL+ +++ + + G ++G LQ
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99
Query: 560 LNLSDNAFTGDIPATYGFL--RSLVFLSLSHNQISGM--IPAELGACS--ALEVLELRSN 613
L L + TG P L L+L + + AEL L+VL +
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 614 HFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKC----SSLVSLTLDMN---SLSGR 666
H + + LDL N GE + C +L L L + SG
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 667 IPESFSKLSNLTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNLEGEIPKMLSSR 722
+ L L+LS N L A A S L LNLS L+ ++PK L ++
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 55/279 (19%), Positives = 86/279 (30%), Gaps = 25/279 (8%)
Query: 406 FLGGIRGLKIVSLGRNMFSGLIP-LSFGNLSQLETLNLSENDIRGNIPEEITRL---SNL 461
GG R L+ + + + L L+ L + I I R+ S L
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97
Query: 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSI------GSLMRLTTLDLS 515
L L + G P + G + L+ S + L L ++
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 516 NQNLSGELPIELFG-LPSLQVVSLEENNLSGDVPEGFS----SLVGLQYLNLSDNAFT-- 568
S E P+L + L +N G+ + LQ L L +
Sbjct: 158 Q-AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 569 -GDIPATYGFLRSLVFLSLSHNQISGMIPAELGA-CSALEVLELRSNHFTGNIPVDISHL 626
G A L L LSHN + A S L L L +P +
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP-- 273
Query: 627 SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
+++ LDL N+L P + + +L+L N
Sbjct: 274 AKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 51/300 (17%), Positives = 82/300 (27%), Gaps = 41/300 (13%)
Query: 182 PGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVH 241
G S + L+ ++ + L+ L + S L
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99
Query: 242 LSAEDNVLKGLIPGTIGRI--STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGF 299
L+ E+ + G P + L +L+L W
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG--------- 150
Query: 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLP--- 356
L+VL + + +L +DLS N G
Sbjct: 151 -----------------LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 357 -AAVGSLDKLEVLRVANN---SLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPA-FLGGIR 411
L+VL + N + SG+ A LQ DL N A
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 412 GLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKF 471
L ++L + G ++L L+LS N + P L + L+L N F
Sbjct: 254 QLNSLNLSFTGLKQVPK---GLPAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 5e-20
Identities = 50/274 (18%), Positives = 85/274 (31%), Gaps = 50/274 (18%)
Query: 97 LRKLSLHSNHLNGSIPASLHQ---CSLLRAVYLQYNSFSGHLPLSIFNLT--NLLVLNVA 151
L++L++ + + I + S L+ + L+ +G P + T +L +LN+
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 152 HNLLSG------KISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV 205
+ + ++ + P L+ L ++ L ++LS N GE
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 206 P----ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRIS 261
+ L+ L L + + G+
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAARV 228
Query: 262 TLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK--PPNGRCVSVLEV 319
LQ L LS N L S L + L F V K P L V
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWP----SQLNSLNLSFTGLKQVPKGLPAK------LSV 278
Query: 320 LDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSG 353
LDL NR+ + + + L GN F
Sbjct: 279 LDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 6e-20
Identities = 50/283 (17%), Positives = 90/283 (31%), Gaps = 22/283 (7%)
Query: 280 SVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSW---LT 336
+ L+G SL + + + + + L+ L ++ RI + +
Sbjct: 33 AADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVL 92
Query: 337 NVTSLRVMDLSGNFFSGNLPAAVGSLD--KLEVLRVANNSLSGLVPDEIAKCSL----LQ 390
++ L+ + L +G P + L +L + N S + L+
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS----FGNLSQLETLNLSEND 446
+ + + L + L N G L L+ L L
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 447 IR---GNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSGKIPGS 502
+ G L L+LS+N L LNLS +G ++P
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
Query: 503 IGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
+ + +L+ LDLS L P LP + +SL+ N
Sbjct: 272 LPA--KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 53/285 (18%), Positives = 89/285 (31%), Gaps = 18/285 (6%)
Query: 129 NSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFS-- 186
+ L +L LL L S SL+ L + + I
Sbjct: 32 GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRV 91
Query: 187 -SKSQLQLINLSYNSFSGEVPASVGQLQ--ELEYLWLDSNHLYG--TLPSAISNCS--SL 239
S LQ + L +G P + + +L L L + + + L
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
Query: 240 VHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPV--SVLCNLWGNISSLRIVQL 297
LS + L L LS N G + ++ + + L +
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
Query: 298 GFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWL-TNVTSLRVMDLSGNFFSGNLP 356
G +GV V L+ LDL +N +R + + L ++LS +P
Sbjct: 212 GMETPSGVCSALAAARVQ-LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VP 269
Query: 357 AAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG 401
+ + KL VL ++ N L + + L+GN F
Sbjct: 270 KGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 35/168 (20%), Positives = 58/168 (34%), Gaps = 15/168 (8%)
Query: 68 CYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQC----SLLRA 123
++ L + + +Q+ L L L N G C L+
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205
Query: 124 VYLQYN---SFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAF 177
+ L+ + SG L L+++HN L A L L+LS
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
Query: 178 TGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHL 225
++P +K L +++LSYN P S +L ++ L L N
Sbjct: 266 K-QVPKGLPAK--LSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 24/99 (24%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 82 QLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQ-CSLLRAVYLQYNSFSGHLPLSIF 140
+G + A +L+ L L N L + A S L ++ L + +P +
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTG 179
L VL++++N L S D P + L L N F
Sbjct: 274 --AKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 27/273 (9%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
E L +G +G ++ ++ ++I+ L+ GT+ F +EA+ + K++H L L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
+ P +V +YM G+L L+ + G L P ++ +A G++++ ++ VH
Sbjct: 249 SEEP--IYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPTK 1020
D++ N+L + +++FGL RL A PI + +PEAA G+ T
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 360
Query: 1021 EADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079
++DV+SFGI+L E+ T GR P + + V Q++RG + P PES
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYR--MPCP---PECPESL- 410
Query: 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ C +P +RP+ + LE
Sbjct: 411 -------HDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 49/299 (16%)
Query: 836 TRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL 894
F+E VL +G +G + KA + D +I+++R +T E L + H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 895 TVLRGYYAGPPDVRL------------LVYDYMPNGNLATLLQEASHQD--GHVLNWPMR 940
+ + + +Y NG L L+ + R
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-FR 123
Query: 941 HLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS-- 998
++ LS++HS ++H D+KP N+ D + +FGL + +
Sbjct: 124 QILE-----ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 999 ---------TTPIGSLGYVSPE-AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048
T+ IG+ YV+ E TG ++ D+YS GI+ E++ T E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----FSTGMER 234
Query: 1049 IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ + K+L+ I P + D + ++ + L+ DP RP +
Sbjct: 235 VN--ILKKLRSVSIE---FPPDFD-DNKMKVEKKIIR----LLID--HDPNKRPGARTL 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-25
Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 27/273 (9%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
E L +G +G ++ ++ ++I+ L+ GT+ F +EA+ + K++H L L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
+ P +V +YM G+L L+ + G L P ++ +A G++++ ++ VH
Sbjct: 332 SEEP--IYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPTK 1020
D++ N+L + +++FGL RL A PI + +PEAA G+ T
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 443
Query: 1021 EADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSE 1079
++DV+SFGI+L E+ T GR P + + V Q++RG + P
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG---YRMPC------PPECP 490
Query: 1080 WEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ C +P +RP+ + LE
Sbjct: 491 ESLH----DLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 56/261 (21%), Positives = 100/261 (38%), Gaps = 37/261 (14%)
Query: 879 FRKEAEALGKVKHRNL-TVLRGYYAGP-PDVRLLVYDYMPNGNLATLLQEASHQDGHVLN 936
F +E ++ H+N+ ++ D LV +Y+ L+ ++ L+
Sbjct: 58 FEREVHNSSQLSHQNIVSM---IDVDEEDDCYYLVMEYIEGPTLSEYIES-----HGPLS 109
Query: 937 WPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
+ + G+ H + +VH DIKPQN+L D++ + +FG IA +
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFG-----IAKALSET 164
Query: 997 SSTTP---IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053
S T +G++ Y SPE A + D+YS GIVL E+L G P F + + +
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP--FNGETAVSIAI 222
Query: 1054 KKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIV 1108
K I + + ++ + + ++ L T D +R D+
Sbjct: 223 K------HIQDSVPNVTTDVRKDIPQSLSNVI-----LRATEKDKANRYKTIQEMKDDLS 271
Query: 1109 FMLEGCRVG-PDMPSSADPTS 1128
+L R T
Sbjct: 272 SVLHENRANEDVYELDKMKTI 292
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (272), Expect = 1e-24
Identities = 54/300 (18%), Positives = 100/300 (33%), Gaps = 42/300 (14%)
Query: 437 LETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496
+ I+ I + NL V L + + + S
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG 556
+ G I L +T L L+ L+ P+ L +L + L+EN + D+ L
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 557 LQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
L+ L+L N + DI L L L L +N+I+ +
Sbjct: 111 LKSLSLEHNGIS-DINGL-VHLPQLESLYLGNNKITDITV-------------------- 148
Query: 617 GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
+S L+++ L L N++S +I ++ + L +L L N +S + + L N
Sbjct: 149 ------LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKN 198
Query: 677 LTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELC 736
L L L + + + + + +L + P++ E
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 258
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 4e-21
Identities = 52/252 (20%), Positives = 98/252 (38%), Gaps = 24/252 (9%)
Query: 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLG 298
+ +K + P + +L + +T V + L ++ +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQNELNSI----DQIIANNSD 54
Query: 299 FNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAA 358
+ G+ PN + L L N++ + P LTN+ +L + L N +L +
Sbjct: 55 IKSVQGIQYLPN------VTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSS- 104
Query: 359 VGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSL 418
+ L KL+ L + +N +S + + L+ L N+ + L + L +SL
Sbjct: 105 LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSL 160
Query: 419 GRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYD 478
N S ++PL+ L++L+ L LS+N I ++ + L NL L L + K
Sbjct: 161 EDNQISDIVPLA--GLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINH 216
Query: 479 VGNLKGLLVLNL 490
NL +
Sbjct: 217 QSNLVVPNTVKN 228
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 4e-19
Identities = 52/261 (19%), Positives = 98/261 (37%), Gaps = 46/261 (17%)
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
E L + T + +S+ + A ++ +K + I + + L L+
Sbjct: 19 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 74
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
N+LT + P++ L NL L L N+I+ +
Sbjct: 75 NKLTDIKPLTNLKNL--------------------------------GWLFLDENKIKDL 102
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
L ++ L+ + L N S ++ + L +LE L + NN ++ + +++ + L
Sbjct: 103 SS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLD 156
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
LE N+ S VP L G+ L+ + L +N S L L+ L L+ L L +
Sbjct: 157 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNK 212
Query: 451 IPEEITRLSNLTTLNLSYNKF 471
+ L T+ +
Sbjct: 213 PINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 44/277 (15%), Positives = 102/277 (36%), Gaps = 24/277 (8%)
Query: 121 LRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGE 180
+ P + N+ ++ ++ + S+ + +++
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-S 57
Query: 181 IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240
+ G + + L+ N + P + L+ L +L+LD N + S++ + L
Sbjct: 58 VQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI--KDLSSLKDLKKLK 112
Query: 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
LS E N + + + + L+ L L N++T + +VL L + L + L N
Sbjct: 113 SLSLEHNGISDING--LVHLPQLESLYLGNNKITDI---TVLSRL----TKLDTLSLEDN 163
Query: 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360
+ + ++ L+ L L N I + L + +L V++L
Sbjct: 164 QISDI---VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQS 218
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
+L ++ + SL P+ I+ + +++ +
Sbjct: 219 NLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 6e-12
Identities = 44/196 (22%), Positives = 74/196 (37%), Gaps = 12/196 (6%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
+ L + KL L+ N L I L L ++L N L +L L L++
Sbjct: 61 IQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSL 116
Query: 151 AHNLLSGKISA-DISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV 209
HN +S I+ P L L L +N T +I S ++L ++L N S VP +
Sbjct: 117 EHNGIS-DINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIVP--L 171
Query: 210 GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLS 269
L +L+ L+L NH+ + A++ +L L + + +
Sbjct: 172 AGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 229
Query: 270 RNELTGLVPVSVLCNL 285
L +S +
Sbjct: 230 DGSLVTPEIISDDGDY 245
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 4e-10
Identities = 42/198 (21%), Positives = 74/198 (37%), Gaps = 28/198 (14%)
Query: 68 CYNNRVRELR-------LPRLQLAG-RLTD--QLADLHELRKLSLHSNHLNGSIPASLHQ 117
N++ +++ L L L ++ D L DL +L+ LSL N ++ I L
Sbjct: 72 LNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGIS-DING-LVH 129
Query: 118 CSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISP-----SLRYLDL 172
L ++YL N + LS LT L L++ N +S DI P L+ L L
Sbjct: 130 LPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYL 182
Query: 173 SSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSA 232
S N + ++ + L ++ L + L + L P
Sbjct: 183 SKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEI 238
Query: 233 ISNCSSLVHLSAEDNVLK 250
IS+ + + ++ +
Sbjct: 239 ISDDGDYEKPNVKWHLPE 256
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/259 (23%), Positives = 104/259 (40%), Gaps = 40/259 (15%)
Query: 879 FRKEAEALGKVKHRNL-TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLN 936
++EA G+++ ++ + + G D +L + + +LA +L+
Sbjct: 81 MQREARTAGRLQEPHVVPI---HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLA----- 132
Query: 937 WPMRHL-ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
P R + I + L H+ H D+KP+N+L AD A+L +FG IA+
Sbjct: 133 -PPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG-----IASATTD 186
Query: 996 SSSTTP---IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKW 1052
T +G+L Y++PE S T AD+Y+ VL E LTG P + D+ V
Sbjct: 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP--YQGDQLSV-- 242
Query: 1053 VKKQLQRG--QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDR-PSMADIVF 1109
+ + + + S + PG+ P + + V A +P DR + D+
Sbjct: 243 MGAHINQAIPRPST-VRPGI----PVAFD--------AVIARGMAKNPEDRYVTCGDLSA 289
Query: 1110 MLEGCRVGPDMPSSADPTS 1128
D + D
Sbjct: 290 AAHAALATADQDRATDILR 308
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 31/275 (11%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
E L G++G ++ A+Y ++++ ++ G++ F EA + ++H L L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
P ++ ++M G+L L+ +G P S +A G++F+ + +H
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPTK 1020
D++ N+L A +++FGL R+ A PI + +PEA + G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSFTI 364
Query: 1021 EADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077
++DV+SFGI+L+EI+T GR P M + V + L+RG + PE+
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERG---YRMPR------PEN 409
Query: 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
E + + + C P +RP+ I +L+
Sbjct: 410 CPEELY----NIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
L G++G ++ Y ++++ L+ G++ + F EA + +++H+ L L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
P ++ +YM NG+L L+ G L ++ +A G++F+ + +H
Sbjct: 78 TQEP--IYIITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPTK 1020
D++ N+L +++FGL RL A PI + +PEA + G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAINYGTFTI 189
Query: 1021 EADVYSFGIVLLEILT-GRKP 1040
++DV+SFGI+L EI+T GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 63/277 (22%), Positives = 101/277 (36%), Gaps = 39/277 (14%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR---DGTIDENTFRKEAEALGKV-KHR 892
F + L G YG +FK S +DG + +++R G D E + KV +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH--QDGHVLNWPMRHLISLGLARG 950
L + + L + +L + + V + +R +
Sbjct: 118 CCVRLEQAWEEGGIL-YLQTELC-GPSLQQHCEAWGASLPEAQVWGY-LRDTLL-----A 169
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
L+ LHS +VH D+KP N+ L +FGL + T G Y++P
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGE---VQEGDPRYMAP 225
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
E G ADV+S G+ +LE+ + E +QL++G + GL
Sbjct: 226 ELLQ-GSYGTAADVFSLGLTILEVACNMEL--PHGGEGW-----QQLRQGYLPPEFTAGL 277
Query: 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
SSE L+ PDP R + +
Sbjct: 278 ------SSELRSVLVM------MLEPDPKLRATAEAL 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 62/291 (21%), Positives = 109/291 (37%), Gaps = 56/291 (19%)
Query: 837 RQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT 895
F E ++ G +G +FKA DG I+R++ + +E +AL K+ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKALAKLDHVNIV 67
Query: 896 VLRGYYAGPPDVRL---------------LVYDYMPNGNLATLLQEASHQ---DGHVLNW 937
G + G + ++ G L +++ + L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997
+ G+ ++HS +++ D+KP N+ + + +FGL
Sbjct: 128 -FEQITK-----GVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND----GK 177
Query: 998 STTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056
T G+L Y+SPE S Q KE D+Y+ G++L E+L T
Sbjct: 178 RTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFETSK------FFTD 230
Query: 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
L+ G IS++ + + L LL P DRP+ ++I
Sbjct: 231 LRDGIISDIF----------DKKEKTLLQ----KLLS--KKPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 59/298 (19%), Positives = 106/298 (35%), Gaps = 54/298 (18%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGM--VLSIRRLRDGTIDENTFRKEAEALGKVKHRN- 893
F+ L RG +G++F+A + D + RL + + +E +AL K++H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 894 -------LTVLRGYYAGPPDVRLLVY---DYMPNGNLATLLQEASHQ----DGHVLNWPM 939
L P ++ +Y NL + L+
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI-F 124
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA---- 995
+ + FLHS ++H D+KP N+ F D + +FGL E
Sbjct: 125 LQIAE-----AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 996 -----SSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049
+ T +G+ Y+SPE G + + D++S G++L E+L P TQ E +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---P-FSTQMERV 234
Query: 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
++ + L + + +P P++RP +I
Sbjct: 235 RTL--TDVRNLKFPPL-------FTQKYPCEYVMV------QDMLSPSPMERPEAINI 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/276 (20%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY- 900
L G++G++ ++ ++++ +++G++ E+ F +EA+ + K+ H L G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 901 YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
P +V +Y+ NG L L+ G L + + G++FL S +
Sbjct: 73 SKEYP--IYIVTEYISNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPT 1019
H D+ +N L D D +S+FG+ R + +S T P+ + +PE + +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFHYFKYS 183
Query: 1020 KEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
++DV++FGI++ E+ + G+ P + + V ++ +G L P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQG---HRLYR------PH 228
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + ++ C P RP+ ++ +E
Sbjct: 229 LASDTIY----QIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 62/276 (22%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVL-SIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG- 899
++ L G+YG +++ ++ + +++ L++ T++ F KEA + ++KH NL L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 900 -YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
P ++ ++M GNL L+E + ++ + ++ ++ + +L +
Sbjct: 285 CTREPPF---YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQ 1017
+H ++ +N L + +++FGL RL A + PI + +PE+ + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNK 395
Query: 1018 PTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
+ ++DV++FG++L EI T G P V + L++ + P E PE
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDYR--MERP---EGCPE 446
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
++ C +P DRPS A+I E
Sbjct: 447 KV--------YELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 30/190 (15%), Positives = 66/190 (34%), Gaps = 7/190 (3%)
Query: 525 IELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFL 584
+ + S + + L Y+ L++ T D+ + ++ L
Sbjct: 14 NVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTGI-EYAHNIKDL 71
Query: 585 SLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIP 644
++++ + P + S LE L + T + ++S L+ + LD+ + I
Sbjct: 72 TINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 645 KEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYL 704
+I+ + S+ L N I L L +LN+ + + + L L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186
Query: 705 NLSRNNLEGE 714
+ G+
Sbjct: 187 YAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-22
Identities = 27/190 (14%), Positives = 62/190 (32%), Gaps = 31/190 (16%)
Query: 428 PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLV 487
++ ++ L + L+ ++ ++ I N+ L ++ N +
Sbjct: 37 NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH--------ATNYNPI-- 84
Query: 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDV 547
L L L + ++++ + L GL SL ++ + + +
Sbjct: 85 ----------------SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 548 PEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEV 607
++L + ++LS N DI L L L++ + + + L
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDIMPLKT-LPELKSLNIQFDGVHDYRG--IEDFPKLNQ 185
Query: 608 LELRSNHFTG 617
L S G
Sbjct: 186 LYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 34/209 (16%), Positives = 67/209 (32%), Gaps = 34/209 (16%)
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
K L L S + + + LT + L+N N++ IE +++ +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINN 75
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600
+ + S L L+ L + T D L SL L +SH+ I ++
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
+ ++L N +I + L +K L++ + +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH-------------------- 172
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSG 689
G L L + + G
Sbjct: 173 -DYRG-----IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 30/185 (16%), Positives = 70/185 (37%), Gaps = 10/185 (5%)
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420
+ + +S + + ++ L L + + +K +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG 480
+ P+S LS LE L + D+ + ++ L++LT L++S++ + +
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
L + ++LS +G I + +L L +L++ + IE P L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFS 190
Query: 541 NNLSG 545
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 30/161 (18%), Positives = 65/161 (40%), Gaps = 7/161 (4%)
Query: 362 LDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRN 421
++ L + +AN +++ L I ++ + + P + G+ L+ + +
Sbjct: 43 MNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 422 MFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGN 481
+ + L+ L L++S + +I +I L + +++LSYN + +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKT 157
Query: 482 LKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGE 522
L L LN+ G G I +L L +Q + G+
Sbjct: 158 LPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 24/190 (12%), Positives = 60/190 (31%), Gaps = 18/190 (9%)
Query: 92 ADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVA 151
+ L + A ++ + + + +G I N+ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTIN 74
Query: 152 HNLLSGKISADISP-----SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
+ + + +P +L L + T + N S + L L+++S+++ +
Sbjct: 75 NIHAT-----NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 207 ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVL 266
+ L ++ + L N + + L L+ + + + I L L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186
Query: 267 SLSRNELTGL 276
+ G
Sbjct: 187 YAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 17/119 (14%), Positives = 48/119 (40%), Gaps = 4/119 (3%)
Query: 603 SALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNS 662
S + + + + ++ + + L ++ ++ I ++ LT++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77
Query: 663 LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
+ S LSNL L + ++ +L+ ++SL L++S + + I +++
Sbjct: 78 ATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 35/263 (13%), Positives = 77/263 (29%), Gaps = 88/263 (33%)
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
+ L + T + +SL +++ + + L I ++ L+++
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
T P+S L NL E L + + +
Sbjct: 76 IHATNYNPISGLSNL--------------------------------ERLRIMGKDVTSD 103
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
L+ +TSL ++D+S + ++ + +L K+ + ++ N
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN----------------- 146
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
+ ++PL L +L++LN+ + + +
Sbjct: 147 ------------------------------GAITDIMPLK--TLPELKSLNIQFDGVH-D 173
Query: 451 IPEEITRLSNLTTLNLSYNKFGG 473
I L L GG
Sbjct: 174 Y-RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 14/116 (12%), Positives = 42/116 (36%), Gaps = 5/116 (4%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
++ L L +L + + +L + L + + +++ + I L + +++
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 151 AHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGE 204
++N I + P L+ L++ + +L + + G+
Sbjct: 144 SYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 59/276 (21%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY- 900
+ G++GL+ + + ++I+ +R+G + E F +EAE + K+ H L L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 901 YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
P LV ++M +G L+ L+ + + L + G+++L ++
Sbjct: 73 LEQAP--ICLVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPT 1019
H D+ +N L + +S+FG+ R + +S+ T P+ + SPE S + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSFSRYS 183
Query: 1020 KEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
++DV+SFG+++ E+ + G+ P + V + + G L P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTG---FRLYK------PR 228
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + ++ C P DRP+ + ++ L
Sbjct: 229 LASTHVY----QIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-23
Identities = 64/280 (22%), Positives = 112/280 (40%), Gaps = 37/280 (13%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVL-SIRRLRDGTIDE--NTFRKEAEALGKVKHRNLTVLR 898
+ RG +G +F + L +++ R+ + F +EA L + H N+ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 899 GY-YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
G P +V + + G+ T L+ +G L + A G+ +L S
Sbjct: 179 GVCTQKQP--IYIVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT--PIGSLGYVSPEAAST 1015
+H D+ +N L +S+FG+ R AS P+ + +PEA +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV---KWTAPEALNY 289
Query: 1016 GQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
G+ + E+DV+SFGI+L E + G P + Q ++ +++G G L
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKG--------GRLP 335
Query: 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ L+ C A +P RPS + I L+
Sbjct: 336 CPELCPDAVFRLM-----EQCWAYEPGQRPSFSTIYQELQ 370
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 38/271 (14%)
Query: 844 VLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRG 899
+ RG + ++K + + ++ L+D + + F++EAE L ++H N+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 900 YYAGPPDVRLLVY---DYMPNGNLATLLQEASH-QDGHVLNWPMRHLISLGLARGLSFLH 955
+ + + + M +G L T L+ + + +W R ++ GL FLH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW-CRQILK-----GLQFLH 146
Query: 956 SLDM--VHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+ +H D+K N+ + + GL AT AS + IG+ +++PE
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL-----ATLKRASFAKAVIGTPEFMAPEM 201
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
DVY+FG+ +LE+ T P + + +++ G +
Sbjct: 202 YEEKYDES-VDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFD----- 252
Query: 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
E +E + C + +R S
Sbjct: 253 -KVAIPEVKEII------EGCIRQNKDERYS 276
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 58/296 (19%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 836 TRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR---DGTIDENTFRKEAEALGKV-K 890
T +F E + G +G +FK DG + +I+R + G++DE +E A + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 891 HRNLTVLRGYYAGPPDVRLLVY-DYMPNGNLATLLQEASHQDGH-----VLNWPMRHLIS 944
H ++ +A D +L+ +Y G+LA + E + + + + +
Sbjct: 70 HSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL-LLQV-- 124
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP------------ 992
RGL ++HS+ +VH DIKP N+ + + D A+
Sbjct: 125 ---GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 993 AEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK 1051
SS G +++ E +AD+++ + ++ +
Sbjct: 182 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--PRNGDQW-- 237
Query: 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
++++G++ + P +L S E+ E L + PDP RPS +
Sbjct: 238 ---HEIRQGRLPRI--PQVL-----SQEFTELL------KVMIHPDPERRPSAMAL 277
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 41/281 (14%), Positives = 75/281 (26%), Gaps = 44/281 (15%)
Query: 836 TRQFDEENVLSRGRYGLIFKA---------------SYQDGMVLSIRRLRDGTIDENTFR 880
R VL + +A + +I+++++ + R
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 881 KEAEALGKVKHRNL-------------TVLRGYYAGPPDVRLLVYDYMP--NGNLATLLQ 925
H ++R L + P NL T +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 926 EASH--QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG 983
L R ++L + R L+ LH +VH ++P +++ D L+ F
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-----TKEADVYSFGIVLLEILTGR 1038
A+ S + GQ T D ++ G+ + I
Sbjct: 257 HLVRDGASA--VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 1039 KPVMFTQDEDIVKWVKKQLQRGQISELLEP---GLLELDPE 1076
P T D + I + + G L E
Sbjct: 315 LP--NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 47/289 (16%)
Query: 837 RQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHR 892
++ + G YG K DG +L + L G++ E E L ++KH
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 893 NLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGH-----VLNWPMRHLISLG 946
N+ + L +V +Y G+LA+++ + + + + VL M L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTL-- 122
Query: 947 LARGLSFLHSL-----DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
L H ++H D+KP NV D L +FGL R+ + A T
Sbjct: 123 ---ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KTF 176
Query: 1002 IGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
+G+ Y+SPE + +++D++S G +L E+ P F + K ++ G
Sbjct: 177 VGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPP--F-TAFSQKELAGK-IREG 231
Query: 1061 QISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ + P S E E + RPS+ +I
Sbjct: 232 KFRRI---------PYRYSDELNEIITR------MLNLKDYHRPSVEEI 265
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 2e-22
Identities = 35/216 (16%), Positives = 67/216 (31%), Gaps = 29/216 (13%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH--QDGHVLN 936
F + + + + + +R + NL T + L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 937 WPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
R ++L + R L+ LH +VH ++P +++ D L+ F
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------RDG 257
Query: 997 SSTTPIGSLGYVSPE-----------AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045
+ S G+ PE T D ++ G+V+ I P T+
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--ITK 315
Query: 1046 D--EDIVKWVKKQLQRGQISELLEP---GLLELDPE 1076
D +W+ + + I + + G L E
Sbjct: 316 DAALGGSEWIFRSCKN--IPQPVRALLEGFLRYPKE 349
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 50/276 (18%), Positives = 114/276 (41%), Gaps = 33/276 (11%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY- 900
L G++G++ ++ ++I+ +++G++ E+ F +EA+ + + H L L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 901 YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
P ++ +YM NG L L+E H+ + + + +L S +
Sbjct: 89 TKQRP--IFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPT 1019
H D+ +N L + +S+FGL R + +S + P+ + PE + +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLMYSKFS 199
Query: 1020 KEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
++D+++FG+++ EI + G+ P + + + +G L P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQG---LRLYR------PH 244
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + + + C +RP+ ++ +
Sbjct: 245 LASEKVY----TIMYSCWHEKADERPTFKILLSNIL 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-22
Identities = 44/262 (16%), Positives = 86/262 (32%), Gaps = 49/262 (18%)
Query: 879 FRKEAEALGKVKHRNLTVLR--GYYAGPPDVRL--LVYDYMPNGNLATLLQEASHQDGHV 934
E + L +V H ++ + + + +V +Y+ +L +
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------- 178
Query: 935 LNWPMRHLISLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
P+ I+ L LS+LHS+ +V+ D+KP+N++ + + L + G +
Sbjct: 179 --LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG-----AVSR 230
Query: 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKW 1052
+ G+ G+ +PE PT D+Y+ G L +
Sbjct: 231 INSFGYL--YGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPT--RNGR------ 279
Query: 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-SMADIVFML 1111
+ L E + +S + L PDP R + ++ L
Sbjct: 280 --------YVDGLPEDDPVLKTYDS--YGRLLRR------AIDPDPRQRFTTAEEMSAQL 323
Query: 1112 EGCRVGPDMPSSADPTSLPSPM 1133
G + P S +
Sbjct: 324 TGVLREVVAQDTGVPRPGLSTI 345
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 50/212 (23%), Positives = 80/212 (37%), Gaps = 17/212 (8%)
Query: 510 TTLDLSNQNLSGELPIELFGLP-SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
T N ++P LP S + + L N L F S LQ L+LS
Sbjct: 10 ITYQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 569 GDIPA-TYGFLRSLVFLSLSHNQISGMIPAEL-GACSALEVLELRSNHFTGNIPVDI-SH 625
I Y L L L L+ N I + S+L+ L + ++ H
Sbjct: 66 -TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
Query: 626 LSRIKKLDLGQNKL-SGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLT----TL 680
L +K+L++ N + S ++P+ S ++L L L N + L + +L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 681 NLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
+LS N ++ I L+ L L N L+
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 58/246 (23%), Positives = 88/246 (35%), Gaps = 44/246 (17%)
Query: 451 IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
IP+ + + L+LS+N +L + F L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLR----------------HLGSYSFFS--------FPELQ 55
Query: 511 TLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFT 568
LDLS + + + L L + L N + + G FS L LQ L +
Sbjct: 56 VLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
Query: 569 GDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACS---ALEVLELRSNHFTGNIPVDI- 623
+ G L++L L+++HN I S LE L+L SN +I
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQSFKLP--EYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169
Query: 624 SHLSRIK----KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTT 679
L ++ LDL N ++ I K L L LD N L F +L++L
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQK 228
Query: 680 LNLSTN 685
+ L TN
Sbjct: 229 IWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 53/243 (21%), Positives = 92/243 (37%), Gaps = 38/243 (15%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLW 219
++ S + LDLS N +F S +LQ+++LS + L L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 220 LDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVP 278
L N + +L S SSL L A + L L IG + TL+ L+++ N +
Sbjct: 83 LTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 279 VSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV 338
F+ + LE LDL +N+I++++ + L +
Sbjct: 142 P--------------------EYFSNLTN---------LEHLDLSSNKIQSIYCTDLRVL 172
Query: 339 TSLRVM----DLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394
+ ++ DLS N + + +L+ L + N L + + + LQ L
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231
Query: 395 EGN 397
N
Sbjct: 232 HTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 16/211 (7%)
Query: 509 LTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNA 566
LDLS L L F P LQV+ L + + +G + SL L L L+ N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 567 FTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVD--IS 624
+ L SL L ++ + +G L+ L + N + + S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 625 HLSRIKKLDLGQNKLSGEIPKEI-SKCSSL----VSLTLDMNSLSGRIPESFSKLSNLTT 679
+L+ ++ LDL NK+ I + +SL L +N ++ P +F ++ L
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKE 204
Query: 680 LNLSTNRLSGAIPAD-LALISSLRYLNLSRN 709
L L TN+L ++P ++SL+ + L N
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 59/254 (23%), Positives = 90/254 (35%), Gaps = 54/254 (21%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSL 375
+ LDL N +R + + L+V+DLS + SL L L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
L + S LQ + SL G+L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVET----------------NLASLE--------NFPIGHLK 124
Query: 436 QLETLNLSENDIRGNIPEEIT--RLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSA 492
L+ LN++ N I+ + L+NL L+LS NK + L + +LNLS
Sbjct: 125 TLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS- 181
Query: 493 SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-F 551
LDLS ++ + F L+ ++L+ N L VP+G F
Sbjct: 182 -------------------LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIF 220
Query: 552 SSLVGLQYLNLSDN 565
L LQ + L N
Sbjct: 221 DRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 12/187 (6%)
Query: 94 LHELRKLSLHSNHLNGSIPASL-HQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVA 151
EL+ L L + +I S L + L N L L F L++L L
Sbjct: 51 FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108
Query: 152 HNLLSG--KISADISPSLRYLDLSSNAFTG-EIPGNFSSKSQLQLINLSYN---SFSGEV 205
L+ +L+ L+++ N ++P FS+ + L+ ++LS N S
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 206 PASVGQLQELEY-LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQ 264
+ Q+ L L L N + + L L+ + N LK + G R+++LQ
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQ 227
Query: 265 VLSLSRN 271
+ L N
Sbjct: 228 KIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 40/164 (24%), Positives = 61/164 (37%), Gaps = 12/164 (7%)
Query: 93 DLHELRKLSLHSNHLNGSIPASL-HQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNV 150
L L L L N + S+ S L+ + + + L +L L LNV
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNV 131
Query: 151 AHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLIN----LSYNSFSG 203
AHNL+ + +L +LDLSSN + Q+ L+N LS N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 204 EVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
+ + L+ L LD+N L +SL + N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 18/120 (15%)
Query: 92 ADLHELRKLSLHSNHLNGSIP-----ASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNL 145
L L++L++ N + S ++L L + L N + + L +
Sbjct: 121 GHLKTLKELNVAHNLIQ-SFKLPEYFSNLTN---LEHLDLSSNKIQ-SIYCTDLRVLHQM 175
Query: 146 LVLNVAHNLLSGKISADISP------SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYN 199
+LN++ +L ++ I P L+ L L +N G F + LQ I L N
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 16/224 (7%)
Query: 505 SLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSD 564
+ +L ++++ + L S+ + +++ V +G L + L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 565 NAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDIS 624
N T DI L++L +L L N++ + L L+ L L N + +I +
Sbjct: 78 NKLT-DIKPLAN-LKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLV 131
Query: 625 HLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLST 684
HL +++ L LG NK++ +S+ + L +L+L+ N +S I + L+ L L LS
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSK 187
Query: 685 NRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSI 728
N +S LA + +L L L + S+ ++
Sbjct: 188 NHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 53/231 (22%), Positives = 98/231 (42%), Gaps = 16/231 (6%)
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
+ NL + + L + + +N ++ I+ LP++ + L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600
N L+ D+ + ++L L +L L +N D+ + L+ L LSL HN IS + L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSSLKD-LKKLKSLSLEHNGISDING--LV 131
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
LE L L +N T +I V +S L+++ L L N++S +I ++ + L +L L
Sbjct: 132 HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 187
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
N +S + + L NL L L + + + + + +L
Sbjct: 188 NHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 60/301 (19%), Positives = 108/301 (35%), Gaps = 29/301 (9%)
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF 431
+ + D+ + +L+ + V + + + + + +
Sbjct: 11 PTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ- 65
Query: 432 GNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLS 491
L + L L+ N + +I + + L NL L L NK K + +LK L L+L
Sbjct: 66 -YLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLE 120
Query: 492 ASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGF 551
+G S I G + L +L +L L N ++ + L L +SLE+N +S D+
Sbjct: 121 HNGIS-DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DI-VPL 174
Query: 552 SSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELR 611
+ L LQ L LS N + D+ A G L++L L L + ++
Sbjct: 175 AGLTKLQNLYLSKNHIS-DLRALAG-LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232
Query: 612 SNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESF 671
P IS +K ++ + ++ VS G+ F
Sbjct: 233 DGSLVT--PEIISDDGDYEKPNVKWHLPEF---------TNEVSFIFYQPVTIGKAKARF 281
Query: 672 S 672
Sbjct: 282 H 282
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 33/164 (20%), Positives = 66/164 (40%), Gaps = 12/164 (7%)
Query: 549 EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVL 608
+ NL + T + L S+ + +++ I + + + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIP 668
L N T +I +++L + L L +NK+ ++ + L SL+L+ N +S I
Sbjct: 74 FLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DI- 127
Query: 669 ESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
L L +L L N+++ L+ ++ L L+L N +
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 51/261 (19%), Positives = 98/261 (37%), Gaps = 46/261 (17%)
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
E L + T + +S+ + A ++ +K + I + + L L+
Sbjct: 22 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 271 NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV 330
N+LT + P++ L NL L L N+++ +
Sbjct: 78 NKLTDIKPLANLKNL--------------------------------GWLFLDENKVKDL 105
Query: 331 FPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQ 390
L ++ L+ + L N S ++ + L +LE L + NN ++ + +++ + L
Sbjct: 106 SS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLD 159
Query: 391 MFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450
LE N+ S VP L G+ L+ + L +N S L L+ L L+ L L +
Sbjct: 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNK 215
Query: 451 IPEEITRLSNLTTLNLSYNKF 471
+ L T+ +
Sbjct: 216 PINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 54/335 (16%), Positives = 108/335 (32%), Gaps = 71/335 (21%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
+ N+ ++ ++ + S+ + +++ + G + + L+ N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNK 79
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
+ P + L+ L +L+LD N + + SSL L
Sbjct: 80 LTDIKP--LANLKNLGWLFLDENK--------VKDLSSLKDLKK---------------- 113
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
L+ LSL N ++ + + L LE L
Sbjct: 114 --LKSLSLEHNGISDINGLVHLPQ--------------------------------LESL 139
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP 380
L NN+I + + L+ +T L + L N S ++ + L KL+ L ++ N +S L
Sbjct: 140 YLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL-- 193
Query: 381 DEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440
+A L + +L + + V +S + E
Sbjct: 194 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKP 251
Query: 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV 475
N+ + E T+ + +F G+V
Sbjct: 252 NVKWHLPEFT-NEVSFIFYQPVTIGKAKARFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 48/226 (21%), Positives = 96/226 (42%), Gaps = 23/226 (10%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
E K +L + ++ ++ + + + + + L N+ L +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFL 75
Query: 151 AHNLLSGKISADISP-----SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV 205
N L+ DI P +L +L L N ++ +L+ ++L +N S ++
Sbjct: 76 NGNKLT-----DIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI 127
Query: 206 PASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQV 265
+ L +LE L+L +N + T + +S + L LS EDN + ++P + ++ LQ
Sbjct: 128 NG-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182
Query: 266 LSLSRNELTGLVPVSVLCNLWG-NISSLRIVQLGFNAFTGVVKPPN 310
L LS+N ++ L ++ L NL + S + N + +V P
Sbjct: 183 LYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 37/150 (24%), Positives = 57/150 (38%), Gaps = 18/150 (12%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
L DL +L+ LSL N ++ I L L ++YL N + LS LT L L++
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSL 163
Query: 151 AHNLLSGKISADISP-----SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV 205
N +S DI P L+ L LS N + ++ + L ++ L +
Sbjct: 164 EDNQIS-----DIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKP 216
Query: 206 PASVGQLQELEYLWLDSNHLYGTLPSAISN 235
L + L P IS+
Sbjct: 217 INHQSNLVVPNTVKNTDGSL--VTPEIISD 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 5e-22
Identities = 34/265 (12%), Positives = 83/265 (31%), Gaps = 27/265 (10%)
Query: 836 TRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTIDE-NTFRKEAEALGK 888
++ ++L G + +++A+ D ++ + E + E L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 889 VKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
+ + +LV + G L + + V+ + ++ +
Sbjct: 124 SMQHMFMKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAH-----------LSEFGLDRLAIATPAEASS 997
+ +H +++HGDIKP N + F L + G P + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP-KGTI 241
Query: 998 STTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056
T + G+ E + +P + D + + +L G ++E +
Sbjct: 242 FTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCMLFGTYM--KVKNEGGECKPEGL 298
Query: 1057 LQRGQISELLEP---GLLELDPESS 1078
+R ++ +L +
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHH 323
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-22
Identities = 49/312 (15%), Positives = 97/312 (31%), Gaps = 62/312 (19%)
Query: 380 PDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLET 439
I CS ++F + ++ + ++P+ L R + + +F LE
Sbjct: 3 HHRICHCSN-RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 440 LNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKI 499
+ +S+ND+ I
Sbjct: 59 IEISQNDVLEVIE----------------------------------------------- 71
Query: 500 PGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQ 558
+L +L + + N + E F LP+LQ + + + +
Sbjct: 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131
Query: 559 YLNLSDNAFTGDIPAT--YGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616
L++ DN I G V L L+ N I + + E+ +N+
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191
Query: 617 GNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLT-LDMNSLSGRIPESFSKL 674
+P D+ S LD+ + ++ +P +L L +L ++P + KL
Sbjct: 192 -ELPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLK-KLP-TLEKL 245
Query: 675 SNLTTLNLSTNR 686
L +L+
Sbjct: 246 VALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-18
Identities = 52/293 (17%), Positives = 99/293 (33%), Gaps = 19/293 (6%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEY 217
I +D+ + L G FS L+ I +S N + A V L +L
Sbjct: 24 IPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE 83
Query: 218 LWL-DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276
+ + +N+L P A N +L +L + +K L +L + N
Sbjct: 84 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 277 VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG--RCVSVLEVLDLQNNRIRAVFPSW 334
+ + L I+ L N + N + E+ NN + +
Sbjct: 144 IERNSFVGLSFE---SVILWLNKNGIQEI---HNSAFNGTQLDELNLSDNNNLEELPNDV 197
Query: 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRV-ANNSLSGLVPDEIAKCSLLQMFD 393
+ ++D+S +LP+ L+ L+ LR + +L L + K L
Sbjct: 198 FHGASGPVILDISRTRIH-SLPS--YGLENLKKLRARSTYNLKKLPT--LEKLVALMEAS 252
Query: 394 LEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
L AF R + + N + + ++ + +L+E++
Sbjct: 253 LTYPS---HCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDN 302
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 47/264 (17%), Positives = 86/264 (32%), Gaps = 22/264 (8%)
Query: 96 ELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAH- 152
+L L I + L + + N + +F NL L + +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 153 NLLSGKISADIS---PSLRYLDLSSNAFTGEIP-GNFSSKSQLQLINLSYNSFSGEVPAS 208
N L I+ + P+L+YL +S+ +P + Q L+++ N + +
Sbjct: 90 NNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
Query: 209 V--GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVL 266
G E LWL+ N + SA + +++N L+ L S +L
Sbjct: 148 SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207
Query: 267 SLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR 326
+SR + L N+ LR + P + V+ L L
Sbjct: 208 DISRTRIHSLPS-----YGLENLKKLRA--RSTYNLKKL--PTLEKLVA-LMEASLTYPS 257
Query: 327 IRAVFPSWLTNVTSLRVMDLSGNF 350
F +W ++ L +
Sbjct: 258 HCCAFANWRRQISELHPICNKSIL 281
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 16/82 (19%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 630 KKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSG 689
+ ++K++ EIP ++ + + L + L +FS +L + +S N +
Sbjct: 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 690 AIPAD-LALISSLRYLNLSRNN 710
I AD + + L + + + N
Sbjct: 69 VIEADVFSNLPKLHEIRIEKAN 90
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 43/294 (14%)
Query: 824 NNKITYVETLEATRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE---NTF 879
+ Y +++E ++ + G +G S +DG I+ + +
Sbjct: 14 GTENLYFQSME---KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES 70
Query: 880 RKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQ---DGHVLN 936
R+E L +KH N+ R + + +V DY G+L + + +L+
Sbjct: 71 RREVAVLANMKHPNIVQYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 937 WPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
W + L +H ++H DIK QN+ D L +FG+ R+ +T A
Sbjct: 130 W-FVQICL-----ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA- 182
Query: 997 SSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
IG+ Y+SPE +P ++D+++ G VL E+ T + F + + V K
Sbjct: 183 --RACIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVLK 236
Query: 1056 QLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ G + S + + +P DRPS+ I
Sbjct: 237 -IISGSFPPV---------SLHYSYDLRSLVSQ------LFKRNPRDRPSVNSI 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 58/281 (20%), Positives = 116/281 (41%), Gaps = 36/281 (12%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHR 892
F E + RG++ +++A DG+ +++++++ + KE + L ++ H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGH-----VLNWPMRHLISLGL 947
N+ + ++ +V + G+L+ +++ Q V + L S
Sbjct: 93 NVIKYYASFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY-FVQLCS--- 147
Query: 948 ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
L +HS ++H DIKP NV A L + GL R + A + +G+ Y
Sbjct: 148 --ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYY 202
Query: 1008 VSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
+SPE ++D++S G +L E+ + P F D+ + + K++++ L
Sbjct: 203 MSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPLP 259
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S E + + +C PDP RP + +
Sbjct: 260 SDHY------SEELRQLV------NMCINPDPEKRPDVTYV 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 40/207 (19%), Positives = 75/207 (36%), Gaps = 38/207 (18%)
Query: 914 YMPNGNLATLLQEASHQD----GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
NL + + G L+ + + FLHS ++H D+KP N+
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHI-FIQIAE-----AVEFLHSKGLMHRDLKPSNI 195
Query: 970 LFDADFEAHLSEFGL---------DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTK 1020
F D + +FGL ++ + ++ T +G+ Y+SPE +
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 1021 EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEW 1080
+ D++S G++L E+L TQ E + ++ + L + +
Sbjct: 256 KVDIFSLGLILFELLYS----FSTQMERVRII--TDVRNLKFPLL-------FTQKYPQE 302
Query: 1081 EEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ +P P +RP DI
Sbjct: 303 HMMV------QDMLSPSPTERPEATDI 323
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 62/278 (22%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVL-SIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG- 899
++ L G+YG +++ ++ + +++ L++ T++ F KEA + ++KH NL L G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 900 -YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD 958
P ++ ++M GNL L+E + ++ + ++ ++ + +L +
Sbjct: 78 CTREPPF---YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQ 1017
+H D+ +N L + +++FGL RL A + PI + +PE+ + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---WTAPESLAYNK 188
Query: 1018 PTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074
+ ++DV++FG++L EI T G P + V + L++ +E
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYR---MER------ 233
Query: 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
PE + + ++ C +P DRPS A+I E
Sbjct: 234 PEGCPEKVY----ELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 38/237 (16%), Positives = 79/237 (33%), Gaps = 17/237 (7%)
Query: 386 CSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEN 445
C + F + ++P+ + L L + +F NL + + +S +
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 446 DIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSGKIPG-- 501
+ LS +T + + + + D L L L + +G P
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124
Query: 502 SIGSLMRLTTLDLSNQNLSGELPIELF-GLPS-LQVVSLEENNLSGDVPEGFSSLVGLQY 559
+ S L++++ +P+ F GL + + L N + V + L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 560 LNLSDNAFTGDIPAT--YGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNH 614
+ L+ N + I G L +S ++ +P+ L+ L R+
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS--KGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 42/256 (16%), Positives = 80/256 (31%), Gaps = 38/256 (14%)
Query: 435 SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
Q E ++ DI+ IP + + TL L + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHL----------------RTIPSHA 50
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FS 552
FS L ++ + +S +L F L + + + +
Sbjct: 51 FSN--------LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALK 102
Query: 553 SLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAEL--GACSALEVL 608
L L++L + + P L ++ N IP G C+ L
Sbjct: 103 ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161
Query: 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI--SKCSSLVSLTLDMNSLSGR 666
+L +N FT ++ + +++ + L +NK I K+ S L + S++
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220
Query: 667 IPESFSKLSNLTTLNL 682
+ L L N
Sbjct: 221 PSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 37/219 (16%), Positives = 81/219 (36%), Gaps = 21/219 (9%)
Query: 509 LTTLDLSNQNLSGELPIELFGLP-SLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNA 566
++ +++ +P LP S Q + L E +L +P FS+L + + +S +
Sbjct: 13 EEDFRVTCKDIQ-RIP----SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV 66
Query: 567 FTGDIPATYGF--LRSLVFLSLSHNQISGMIPAE-LGACSALEVLELRSNHFTGNIPVD- 622
+ + F L + + + + + I + L L+ L + + P
Sbjct: 67 TLQQLESHS-FYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124
Query: 623 -ISHLSRIKKLDLGQNKLSGEIPKEI--SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTT 679
+ L++ N IP C+ ++L L N + + + L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 680 LNLSTNRLSGAIPADL--ALISSLRYLNLSRNNLEGEIP 716
+ L+ N+ I D + S L++S+ ++ +P
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 40/229 (17%), Positives = 83/229 (36%), Gaps = 32/229 (13%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANN-S 374
+ L L +R + +N+ ++ + +S + L + +L K+ + + N +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 375 LSGLVPDEIAKCSLLQMFDLEGNRFSGQVPA--FLGGIRGLKIVSLGRNMFSGLIPL-SF 431
L+ + PD + + LL+ + P + I+ + N + IP+ +F
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 432 GNL-SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNL 490
L ++ TL L N ++ + L + L+ NK L +
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK----------YLT-----VI 195
Query: 491 SASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSL 538
F G G + LD+S +++ LP + L L +
Sbjct: 196 DKDAFGGVYSG-------PSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 40/256 (15%), Positives = 81/256 (31%), Gaps = 64/256 (25%)
Query: 96 ELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHN 153
+ L L HL +IP+ + + +Y+ + L F NL+ + + + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 154 LLSGKISADI---SPSLRYLDLSSNAFTGEIPGN--FSSKSQLQLINLSYNSFSGEVPAS 208
I D P L++L + + P S ++ ++ N + +P +
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 209 V--GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVL 266
G E L L +N +S+ + G L +
Sbjct: 150 AFQGLCNETLTLKLYNNGF-----------TSV-----QGYAFNGT---------KLDAV 184
Query: 267 SLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR 326
L++N+ + + +AF GV S +LD+
Sbjct: 185 YLNKNK--------------------YLTVIDKDAFGGVY--------SGPSLLDVSQTS 216
Query: 327 IRAVFPSWLTNVTSLR 342
+ A+ L ++ L
Sbjct: 217 VTALPSKGLEHLKELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 19/164 (11%), Positives = 43/164 (26%), Gaps = 31/164 (18%)
Query: 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
+ ++ IP S L L + + + + + +
Sbjct: 12 QEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 616 TGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKL 674
+ +LS++ +++ + I P++ +L
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYID-----------------------PDALKEL 104
Query: 675 SNLTTLNLSTNRLSGAIPADLALIS--SLRYLNLSRNNLEGEIP 716
L L + L P + S L ++ N IP
Sbjct: 105 PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-21
Identities = 82/450 (18%), Positives = 152/450 (33%), Gaps = 70/450 (15%)
Query: 339 TSLRVMDLSGNFFSGN-LPAAVGSLDKLEVLRVANNSLSGLVPDEIA----KCSLLQMFD 393
++ +D+ S + L + +V+R+ + L+ +I+ L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 394 LEGNRFSGQ-VPAFLGGIR----GLKIVSLGRNMFS----GLIPLSFGNLSQLETLNLSE 444
L N V L G++ ++ +SL + G++ + L L+ L+LS+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 445 NDIRGNIPEEITRL-----SNLTTLNLSYNKFGGKVPYDVG----NLKGLLVLNLSASGF 495
N + + + L L L Y + L +S +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 496 SGK-----IPGSIGSLMRLTTLDLSNQNLSGE----LPIELFGLPSLQVVSLEENNLSGD 546
+ G S +L L L + ++ + L + SL+ ++L N L GD
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL-GD 241
Query: 547 VPEGFSSLV--------GLQYLNLSDNAFTGD----IPATYGFLRSLVFLSLSHNQI--S 592
G + L L+ L + + T + SL LSL+ N++
Sbjct: 242 --VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 593 GMI---PAELGACSALEVLELRSNHFTGNIPVDIS----HLSRIKKLDLGQNKLSGEIPK 645
G L LE L ++S FT S + +L + N+L +
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359
Query: 646 EISK-----CSSLVSLTLDMNSLS----GRIPESFSKLSNLTTLNLSTNRL--SGAIPAD 694
E+ + S L L L +S + + +L L+LS N L +G +
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 419
Query: 695 LAL---ISSLRYLNLSRNNLEGEIPKMLSS 721
++ L L L E+ L +
Sbjct: 420 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 449
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-17
Identities = 98/497 (19%), Positives = 161/497 (32%), Gaps = 94/497 (18%)
Query: 96 ELRKLSLHSNHLN-GSIPASLHQCSLLRAVYLQYNSFS----GHLPLSIFNLTNLLVLNV 150
+++ L + L+ L + V L + + ++ L LN+
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 151 AHNLLSGKISADISP-------SLRYLDLSSNAFTGE----IPGNFSSKSQLQLINLSYN 199
N L + ++ L L + TG + + LQ ++LS N
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 200 SFSGEVPASVGQLQE-----LEYLWLDSNHLYGT----LPSAISNCSSLVHLSAEDNVL- 249
+ + LE L L+ L L S + L+ +N +
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
Query: 250 ----KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFT-- 303
+ L G L+ L L +T LC + + +SLR + LG N
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTS-DNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 304 GVVKPPNG--RCVSVLEVLDLQNNRIRAVFPSWLTNV----TSLRVMDLSGNFFSG---- 353
G+ + G S L L + I A L V SL+ + L+GN
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 354 NLPAAVGSLD-KLEVLRVANNSLSGLVPDEIA----KCSLLQMFDLEGNRFSGQVPAFLG 408
L + +LE L V + S + + + L + NR
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL--------- 353
Query: 409 GIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR----GNIPEEITRLSNLTTL 464
G++ + G L S L L L++ D+ ++ + +L L
Sbjct: 354 EDAGVRELCQG---------LGQPG-SVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 465 NLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELP 524
+LS N G D G +L L S + PG L L L + S E+
Sbjct: 404 DLSNNCLG-----DAG------ILQLVE---SVRQPGC-----LLEQLVLYDIYWSEEME 444
Query: 525 IELFGL----PSLQVVS 537
L L PSL+V+S
Sbjct: 445 DRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-17
Identities = 88/487 (18%), Positives = 161/487 (33%), Gaps = 94/487 (19%)
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG--------R 312
+Q L + EL + L L + ++V+L T R
Sbjct: 3 LDIQSLDIQCEEL-SDARWAELLPL---LQQCQVVRLDDCGLT-----EARCKDISSALR 53
Query: 313 CVSVLEVLDLQNNRI-----RAVFPSWLTNVTSLRVMDLSGNFFS----GNLPAAVGSLD 363
L L+L++N + V T ++ + L + G L + + +L
Sbjct: 54 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLP 113
Query: 364 KLEVLRVANNSLSGLVPDEIAK-----CSLLQMFDLEGNRFSGQVPAFLG----GIRGLK 414
L+ L +++N L + + L+ LE S L K
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 415 IVSLGRNMFS--GLIPLSFG---NLSQLETLNLSENDIR----GNIPEEITRLSNLTTLN 465
+++ N + G+ L G + QLE L L + ++ + ++L L
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 466 LSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGE--- 522
L NK G DVG + L G + RL TL + ++ +
Sbjct: 234 LGSNKLG-----DVG------MAELCP--------GLLHPSSRLRTLWIWECGITAKGCG 274
Query: 523 -LPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG-----LQYLNLSDNAFTGD----IP 572
L L SL+ +SL N L + + L+ L + +FT
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 573 ATYGFLRSLVFLSLSHNQI--SGMIP---AELGACSALEVLELRSNHFTGNIPVDIS--- 624
+ R L+ L +S+N++ +G+ S L VL L + + ++
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 394
Query: 625 -HLSRIKKLDLGQNKLSGEIPKEISK-----CSSLVSLTLDMNSLSGRIPESFSKL---- 674
+++LDL N L ++ + L L L S + + L
Sbjct: 395 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 454
Query: 675 SNLTTLN 681
+L ++
Sbjct: 455 PSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-16
Identities = 87/511 (17%), Positives = 155/511 (30%), Gaps = 128/511 (25%)
Query: 163 ISPSLRYLDLSSNAFTGE-IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLD 221
+S ++ LD+ + Q Q++ L + +
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS----------- 49
Query: 222 SNHLYGTLPSAISNCSSLVHLSAEDNVL-----KGLIPGTIGRISTLQVLSLSRNELTGL 276
SA+ +L L+ N L ++ G +Q LSL LTG
Sbjct: 50 ---------SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG- 99
Query: 277 VPVSVLCNLWGNISSLRIVQLGFN--------AFTGVVKPPNGRCVSVLEVLDLQNNRIR 328
VL + + +L+ + L N + P LE L L+ +
Sbjct: 100 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ----CRLEKLQLEYCSLS 155
Query: 329 AV----FPSWLTNVTSLRVMDLSGNFFSGN-----LPAAVGSLDKLEVLRVANNSLSGLV 379
A S L + + +S N + S +LE L++ + ++
Sbjct: 156 AASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215
Query: 380 PDEIA----KCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
++ + L+ L N+ G+ L L + S
Sbjct: 216 CRDLCGIVASKASLRELALGSNKLGDV------GMAELCPGLLHPS-------------S 256
Query: 436 QLETLNLSENDIR----GNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG----------N 481
+L TL + E I G++ + +L L+L+ N+ G D G
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG-----DEGARLLCETLLEP 311
Query: 482 LKGLLVLNLSASGFSGKIPGSIGSLMR----LTTLDLSNQNLSGELPIELFGLPSLQVVS 537
L L + + F+ S++ L L +SN L G+ L
Sbjct: 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA------GVREL-CQG 364
Query: 538 LEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFL-------RSLVFLSLSHNQ 590
L + L+ L L+D + ++ L SL L LS+N
Sbjct: 365 LGQPGSV------------LRVLWLADCDVS---DSSCSSLAATLLANHSLRELDLSNNC 409
Query: 591 ISGMIPAELGA-----CSALEVLELRSNHFT 616
+ +L LE L L +++
Sbjct: 410 LGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-15
Identities = 56/329 (17%), Positives = 109/329 (33%), Gaps = 55/329 (16%)
Query: 435 SQLETLNLSENDIRGN-IPEEITRLSNLTTLNLSYNKFGGKVPYDVG----NLKGLLVLN 489
+++L++ ++ E + L + L D+ L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 490 LSASGFSGKIPGSIGSLMR-----LTTLDLSNQNLSGE----LPIELFGLPSLQVVSLEE 540
L ++ + ++ + L L N L+G L L LP+LQ + L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 541 NNLSGDVPEGFSSLV-----GLQYLNLSDNAFT----GDIPATYGFLRSLVFLSLSHNQI 591
N L + + L+ L L + + + + L++S+N I
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 592 SGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGE----IPKEI 647
+ E G + L+ +++ L L ++ + + +
Sbjct: 183 N-----EAGVRVLCQGLK--------------DSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 648 SKCSSLVSLTLDMNSLSGRIPESFSK-----LSNLTTLNLSTNRLS----GAIPADLALI 698
+ +SL L L N L S L TL + ++ G + L
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 699 SSLRYLNLSRNNLEGEIPKMLSSRFNDPS 727
SL+ L+L+ N L E ++L +P
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPG 312
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 66/370 (17%), Positives = 111/370 (30%), Gaps = 95/370 (25%)
Query: 70 NNRVRELRLPRLQL----AGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVY 125
R+ +L+L L L L + ++L++ +N +N + L C L+
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVL--CQGLK--- 195
Query: 126 LQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS------PSLRYLDLSSNAFTG 179
+ L L + ++ D+ SLR L L SN
Sbjct: 196 --------------DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241
Query: 180 E-----IPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAIS 234
PG S+L+ + + + + + +
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC--------------------RVLR 281
Query: 235 NCSSLVHLSAEDNVL-----KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNI 289
SL LS N L + L + L+ L + T S ++
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA-ACCSHFSSVLAQN 340
Query: 290 SSLRIVQLGFNAFT--GVV------KPPNGRCVSVLEVLDLQNNRIR----AVFPSWLTN 337
L +Q+ N GV P SVL VL L + + + + L
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPG----SVLRVLWLADCDVSDSSCSSLAATLLA 396
Query: 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
SLR +DLS N A + L +E +R LL+ L
Sbjct: 397 NHSLRELDLSNNCLG---DAGILQL--VESVRQPG--------------CLLEQLVLYDI 437
Query: 398 RFSGQVPAFL 407
+S ++ L
Sbjct: 438 YWSEEMEDRL 447
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 51/206 (24%), Positives = 79/206 (38%), Gaps = 34/206 (16%)
Query: 509 LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
++ +NL+ LP +L ++ L EN L L LNL T
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLS 627
+ G L L L LSHNQ+ +P AL VL++ N T ++P+ L
Sbjct: 69 -KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 628 RIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRL 687
+++L L N+L +P P + L L+L+ N L
Sbjct: 125 ELQELYLKGNELK-TLP-----------------------PGLLTPTPKLEKLSLANNNL 160
Query: 688 SGAIPADL-ALISSLRYLNLSRNNLE 712
+ +PA L + +L L L N+L
Sbjct: 161 T-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 8/179 (4%)
Query: 509 LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
T L LS L L L ++L+ L+ + +L L L+LS N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ 90
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLS 627
+P L +L L +S N+++ + L L+ L L+ N +P + +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 628 RIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685
+++KL L N L+ E+P + + +L +L L NSL IP+ F L L N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 57/256 (22%), Positives = 86/256 (33%), Gaps = 59/256 (23%)
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVA 371
V+ ++ + A+ P + T L LS N A + +L L +
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF 431
L+ L G + L + L N L PL
Sbjct: 64 RAELTKL-------------------------QVD-GTLPVLGTLDLSHNQLQSL-PLLG 96
Query: 432 GNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNL 490
L L L++S N + ++P L L L L N+ LK L
Sbjct: 97 QTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNE-----------LK-----TL 139
Query: 491 SASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPE 549
+ +L L L+N NL+ ELP L GL +L + L+EN+L +P+
Sbjct: 140 PPGLLTP--------TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPK 189
Query: 550 GFSSLVGLQYLNLSDN 565
GF L + L N
Sbjct: 190 GFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 52/211 (24%), Positives = 75/211 (35%), Gaps = 15/211 (7%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
+ + L +N L+ + D+ L LS N ++L +NL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
+ ++ G L L L L N L +LP +L L N L L G + +
Sbjct: 67 LT-KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG--RCVSVLE 318
LQ L L NEL L P +L L + L N T + P G + L+
Sbjct: 124 GELQELYLKGNELKTL-PPGLLTPT----PKLEKLSLANNNLTEL---PAGLLNGLENLD 175
Query: 319 VLDLQNNRIRAVFPSWLTNVTSLRVMDLSGN 349
L LQ N + + P L L GN
Sbjct: 176 TLLLQENSLYTI-PKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 16/207 (7%)
Query: 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLL 155
+++ +L ++P L ++L N L+ T L LN+ L
Sbjct: 12 HLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL 67
Query: 156 SGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQE 214
+ P L LDLS N +P + L ++++S+N + +P L E
Sbjct: 68 TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGE 125
Query: 215 LEYLWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273
L+ L+L N L TLP + + L LS +N L L G + + L L L N L
Sbjct: 126 LQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 274 TGLVPVSVLCNLWGNISSLRIVQLGFN 300
++ +G+ L L N
Sbjct: 185 Y-----TIPKGFFGS-HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 44/178 (24%), Positives = 67/178 (37%), Gaps = 10/178 (5%)
Query: 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSG 133
L L L L L +L+L L + L + L +N
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPV-LGTLDLSHNQLQ- 90
Query: 134 HLPLSIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQ 190
LPL L L VL+V+ N L+ + L+ L L N PG + +
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 191 LQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
L+ ++L+ N+ + E+PA + L+ L+ L L N LY T+P L N
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 4e-21
Identities = 77/388 (19%), Positives = 135/388 (34%), Gaps = 54/388 (13%)
Query: 756 IILICVSAAGACLLALCCCGY-------IYSLLRWRQTLRAWATGEKKPSPSRGSSGAER 808
+ + S A +A GY S + Q A + G
Sbjct: 297 LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRS 356
Query: 809 GRGSGENGGPKLVMFNNKITYVETLEATRQFDEENV-----LSRGRYGLIFKASYQDGMV 863
S + + + TY + E + + G++G + + Y
Sbjct: 357 HTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN 416
Query: 864 LS----IRRLRDGTIDENT--FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917
+ I+ ++ T D F +EA + + H ++ L G P ++ +
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTL 474
Query: 918 GNLATLLQEASHQDGHVLNWPMRHLI--SLGLARGLSFLHSLDMVHGDIKPQNVLFDADF 975
G L + LQ + LI + L+ L++L S VH DI +NVL ++
Sbjct: 475 GELRSFLQVRKFS------LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 528
Query: 976 EAHLSEFGLDRLAIATPAEASSST-TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEI 1034
L +FGL R + +S PI +++PE+ + + T +DV+ FG+ + EI
Sbjct: 529 CVKLGDFGLSRYMEDSTYYKASKGKLPIK---WMAPESINFRRFTSASDVWMFGVCMWEI 585
Query: 1035 LT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGL 1091
L G KP + D V +++ G E L P + + +
Sbjct: 586 LMHGVKPFQGVKNND------VIGRIENG---ERLPM------PPNCPPTLY----SLMT 626
Query: 1092 LCTAPDPLDRPSMADIVFMLEGCRVGPD 1119
C A DP RP ++ L
Sbjct: 627 KCWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 55/295 (18%), Positives = 102/295 (34%), Gaps = 40/295 (13%)
Query: 837 RQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRNL 894
+ + L G + + DG +++R+ D ++EA+ H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 895 TVLRGYYAGPPDVR---LLVYDYMPNGNLATLLQEASHQDGH-----VLNWPMRHLISLG 946
L Y + L+ + G L ++ + +L + G
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL-LL-----G 142
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST------T 1000
+ RGL +H+ H D+KP N+L + + L + G A + +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 1001 PIGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
++ Y +PE S + DV+S G VL ++ G P + D+V +
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--Y----DMVFQKGDSV 256
Query: 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
++L P + SS + L DP RP + ++ LE
Sbjct: 257 ALAVQNQLSIP---QSPRHSSALWQLLNS------MMTVDPHQRPHIPLLLSQLE 302
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 31/279 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTV 896
F ++VL G G I D ++++R+ + +E + L + +H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL--PECFSFADREVQLLRESDEHPNVIR 82
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
+ + L +++ +D L L+ GL+ LHS
Sbjct: 83 YFCTEKDRQFQ-YIAIELCA-ATLQEYVEQ---KDFAHLGLEPITLL-QQTTSGLAHLHS 136
Query: 957 LDMVHGDIKPQNVLF-----DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
L++VH D+KP N+L +A +S+FGL + S + G+ G+++PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 1012 ---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068
PT D++S G V +++ + + + L P
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS----LDCLHP 252
Query: 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
E E + A DP RPS +
Sbjct: 253 ----EKHEDVIARELIEK------MIAMDPQKRPSAKHV 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 33/256 (12%)
Query: 863 VLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLAT 922
VL +L ++ R E E ++H N+ L GY+ V L+ +Y P G +
Sbjct: 41 VLFKAQLEKAGVEHQLRR-EVEIQSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYR 98
Query: 923 LLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982
LQ+ I+ LA LS+ HS ++H DIKP+N+L + E +++F
Sbjct: 99 ELQKL----SKFDEQRTATYITE-LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
G + A +S T G+L Y+ PE ++ D++S G++ E L G+ P
Sbjct: 154 GW-----SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-- 206
Query: 1043 FTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP 1102
F + + K+ + R + + P + + + + LL +P RP
Sbjct: 207 F-EANTYQETYKR-ISRVEFT---FPDFV-----TEGARDLI----SRLLK--HNPSQRP 250
Query: 1103 SMADIV---FMLEGCR 1115
+ +++ ++
Sbjct: 251 MLREVLEHPWITANSS 266
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 64/275 (23%), Positives = 118/275 (42%), Gaps = 35/275 (12%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
+ +G +G + Y+ V +++ +++ + F EA + +++H NL L G
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVI 83
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
+V +YM G+L L+ + VL SL + + +L + VH
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 962 GDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTGQPTK 1020
D+ +NVL D A +S+FGL + A + + P+ + +PEA + +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVK---WTAPEALREKKFST 193
Query: 1021 EADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077
++DV+SFGI+L EI + GR P + +D V ++++G ++ P+
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYK---MDA------PDG 238
Query: 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ +V C D RPS + LE
Sbjct: 239 CPPAVY----EVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 64/281 (22%), Positives = 113/281 (40%), Gaps = 38/281 (13%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS----IRRLRDGTIDENT--FRKEAEALGKVKHRNLT 895
+ G++G + + Y + I+ ++ T D F +EA + + H ++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L G P ++ + G L + LQ + L+ L + L+ L++L
Sbjct: 80 KLIGVITENP--VWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLE 133
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAAS 1014
S VH DI +NVL ++ L +FGL R + +S PI +++PE+ +
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---WMAPESIN 190
Query: 1015 TGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ T +DV+ FG+ + EIL G KP + D V +++ G E L
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENG---ERLPM--- 238
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
P + + + C A DP RP ++ L
Sbjct: 239 ---PPNCPPTLY----SLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 82/335 (24%), Positives = 134/335 (40%), Gaps = 54/335 (16%)
Query: 818 PKLVMFNNKITYVETLEATRQFDEE---------NVLSRGRYGLIFKASYQDGMVLS--- 865
P+ + TY E A R F E ++ G G + +
Sbjct: 21 PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 866 -IRRLRDGTIDEN--TFRKEAEALGKVKHRNLTVLRGY-YAGPPDVRLLVYDYMPNGNLA 921
I+ L+ G + F EA +G+ H N+ L G G ++V +YM NG+L
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL--AMIVTEYMENGSLD 138
Query: 922 TLLQEASHQDGHVLNWPMRHLI--SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL 979
T L+ Q + + L+ G+ G+ +L L VH D+ +NVL D++ +
Sbjct: 139 TFLRTHDGQ------FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192
Query: 980 SEFGLDRLAIATPAEASSSTT---PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
S+FGL R+ P A ++T PI + +PEA + + +DV+SFG+V+ E+L
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIR---WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 1037 -GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLC 1093
G +P M +D V ++ G L P ++ L C
Sbjct: 250 YGERPYWNMTNRD------VISSVEEG---YRLPA------PMGCPHALH----QLMLDC 290
Query: 1094 TAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTS 1128
D RP + IV +L+ P+ + S
Sbjct: 291 WHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 64/281 (22%), Positives = 115/281 (40%), Gaps = 38/281 (13%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIR----RLRDGTIDENT--FRKEAEALGKVKHRNLT 895
+L G +G +++ Y + I + +N F EA + + H ++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L G P ++ + P G L L+ + L L SL + + +++L
Sbjct: 77 KLIGIIEEEP--TWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLE 130
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAAS 1014
S++ VH DI +N+L + L +FGL R +S T PI ++SPE+ +
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK---WMSPESIN 187
Query: 1015 TGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ T +DV+ F + + EIL+ G++P + +D V L++G + L
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKG---DRLPK--- 235
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
P+ + + C DP DRP ++V L
Sbjct: 236 ---PDLCPPVLY----TLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 75/311 (24%), Positives = 132/311 (42%), Gaps = 48/311 (15%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS-----IRRLRDGTIDEN--TFRKEAEALGKVKHRNL 894
+ V+ G +G ++K + I+ L+ G ++ F EA +G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 895 TVLRGY-YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
L G P +++ +YM NG L L+E + + + G+A G+ +
Sbjct: 109 IRLEGVISKYKP--MMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKY 162
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST---TPIGSLGYVSP 1010
L +++ VH D+ +N+L +++ +S+FGL R+ P +++ PI + +P
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR---WTAP 219
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLE 1067
EA S + T +DV+SFGIV+ E++T G +P + + V K + G L
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDG---FRLP 270
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM------P 1121
P + L ++ C + RP ADIV +L+ PD
Sbjct: 271 T------PMDCPSAIYQLMMQ----CWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
Query: 1122 SSADPTSLPSP 1132
LPS
Sbjct: 321 DPRVSIRLPST 331
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 88/357 (24%), Positives = 152/357 (42%), Gaps = 55/357 (15%)
Query: 802 GSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEE---------NVLSRGRYGL 852
GS G+G P L F + T+ + + +F +E V+ G +G
Sbjct: 1 GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGE 60
Query: 853 IFKASYQ----DGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLTVLRGY-YAGPP 905
+ + + ++I+ L+ G ++ F EA +G+ H N+ L G P
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI--SLGLARGLSFLHSLDMVHGD 963
++V +YM NG+L + L++ Q + + L+ G+A G+ +L + VH D
Sbjct: 121 --VMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 964 IKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT---PIGSLGYVSPEAASTGQPTK 1020
+ +N+L +++ +S+FGL R+ P A ++ PI + SPEA + + T
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR---WTSPEAIAYRKFTS 229
Query: 1021 EADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077
+DV+S+GIVL E+++ G +P M QD V K + G L P P
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEG---YRLPP------PMD 274
Query: 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD-MPSSADPTSLPSPM 1133
+ L L C D +RP IV +L+ P + + PS +
Sbjct: 275 CPAALYQL----MLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 65/314 (20%), Positives = 117/314 (37%), Gaps = 51/314 (16%)
Query: 842 ENVLSRGRYGLIFKASYQDG------MVLSIRRLRDGTI--DENTFRKEAEALGKVKHRN 893
L G +G +++ + ++++ L + DE F EA + K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 894 LTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL--AR 949
+ G + P ++ + M G+L + L+E + + M L+ + A
Sbjct: 95 IVRCIGVSLQSLPR---FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHL---SEFGLDRLAIATPAEASSSTTPIGSLG 1006
G +L +H DI +N L + +FG+ R +S G
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RASYYRKGGCA 205
Query: 1007 YV-----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060
+ PEA G T + D +SFG++L EI + G P +++ V + + G
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSG 261
Query: 1061 QISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118
++P P+ + C P DRP+ A I+ +E C P
Sbjct: 262 G---RMDP------PKNCPGPVYRIM------TQCWQHQPEDRPNFAIILERIEYCTQDP 306
Query: 1119 DMPSSADPTSLPSP 1132
D+ ++A P
Sbjct: 307 DVINTALPIEYGPL 320
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 63/309 (20%), Positives = 126/309 (40%), Gaps = 48/309 (15%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS-----IRRLRDGTIDENT--FRKEAEALGKVKHRNL 894
VL G +G + K + I+ + D + ++ A+G + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI--SLGLARGLS 952
L G G LV Y+P G+L +++ G + + L+ + +A+G+
Sbjct: 78 VRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQ---HRGAL---GPQLLLNWGVQIAKGMY 129
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT--PIGSLGYVSP 1010
+L MVH ++ +NVL + + +++FG+ L + S PI +++
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---WMAL 186
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLE 1067
E+ G+ T ++DV+S+G+ + E++T G +P + + V L++G E L
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKG---ERLA 237
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP----DMPSS 1123
P+ + +++ VK C D RP+ ++ P +
Sbjct: 238 Q------PQICTIDVYMVMVK----CWMIDENIRPTFKELANEFTRMARDPPRYLVIKRE 287
Query: 1124 ADPTSLPSP 1132
+ P P P
Sbjct: 288 SGPGIAPGP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 842 ENVLSRGRYGLIFKASYQDG----MVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLT 895
V+ RG +G ++ + D + +++ L T + + F E + H N+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 896 VLRG---YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
L G G P L+V YM +G+L ++ +H L +A+G+
Sbjct: 90 SLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMK 142
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT----PIGSLGYV 1008
+L S VH D+ +N + D F +++FGL R + + T P+ ++
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK---WM 199
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067
+ E+ T + T ++DV+SFG++L E++T G P DI ++ + L
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------GRRLL 252
Query: 1068 PGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
PE E + L C P RPS +++V +
Sbjct: 253 Q------PEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRIS 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-20
Identities = 61/281 (21%), Positives = 117/281 (41%), Gaps = 47/281 (16%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
+ +G +G + Y+ V +++ +++ + F EA + +++H NL L
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-AFLAEASVMTQLRHSNLVQL---L 252
Query: 902 A----GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
+ +V +YM G+L L+ + VL SL + + +L
Sbjct: 253 GVIVEEKGGL-YIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT-PIGSLGYVSPEAASTG 1016
+ VH D+ +NVL D A +S+FGL + A + + P+ + +PEA
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVK---WTAPEALREK 361
Query: 1017 QPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
+ + ++DV+SFGI+L EI + GR P + +D V ++++G ++
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGY---KMDA----- 407
Query: 1074 DPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
P+ + + C D RP+ + LE
Sbjct: 408 -PDGCPPAVYDVM------KNCWHLDAATRPTFLQLREQLE 441
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 60/273 (21%), Positives = 102/273 (37%), Gaps = 43/273 (15%)
Query: 875 DENTFRKEAEALGKVKHRNLTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG 932
DE F EA + K H+N+ G + P ++ + M G+L + L+E +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPR---FILLELMAGGDLKSFLRETRPRPS 173
Query: 933 HVLNWPMRHLISLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL---SEFGLDRL 987
+ M L+ + A G +L +H DI +N L + +FG+ R
Sbjct: 174 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233
Query: 988 AIATPAEASSSTTPIGSLGYV-----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPV 1041
+ G + PEA G T + D +SFG++L EI + G P
Sbjct: 234 ------IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 1042 MFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPL 1099
+++ V + + G ++P P+ + C P
Sbjct: 288 PSKSNQE----VLEFVTSGG---RMDP------PKNCPGPVYRIM------TQCWQHQPE 328
Query: 1100 DRPSMADIVFMLEGCRVGPDMPSSADPTSLPSP 1132
DRP+ A I+ +E C PD+ ++A P
Sbjct: 329 DRPNFAIILERIEYCTQDPDVINTALPIEYGPL 361
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 27/224 (12%)
Query: 863 VLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLAT 922
VL +L ++ R E E ++H N+ + Y+ + L+ ++ P G L
Sbjct: 46 VLFKSQLEKEGVEHQLRR-EIEIQSHLRHPNILRMYNYFHDRKRI-YLMLEFAPRGELYK 103
Query: 923 LLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982
LQ + G + LA L + H ++H DIKP+N+L E +++F
Sbjct: 104 ELQ----KHGRFDEQRSATFMEE-LADALHYCHERKVIHRDIKPENLLMGYKGELKIADF 158
Query: 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
G + A + T G+L Y+ PE ++ D++ G++ E L G P
Sbjct: 159 GW-----SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP-- 211
Query: 1043 FTQDEDIVKWVKKQLQRGQIS----------ELLEPGLLELDPE 1076
F + ++ + + +L+ LL P
Sbjct: 212 F-DSPSHTETHRR-IVNVDLKFPPFLSDGSKDLIS-KLLRYHPP 252
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 59/285 (20%), Positives = 117/285 (41%), Gaps = 44/285 (15%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS-----IRRLRDGTIDENT--FRKEAEALGKVKHRNL 894
VL G +G ++K + I+ LR+ T + EA + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS--LGLARGLS 952
L G L+ MP G L ++E ++ ++L++ + +A+G++
Sbjct: 80 CRLLGICLTST--VQLITQLMPFGCLLDYVRE---HKDNI---GSQYLLNWCVQIAKGMN 131
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT--PIGSLGYVSP 1010
+L +VH D+ +NVL +++FGL +L A E + PI +++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK---WMAL 188
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLE 1067
E+ T ++DV+S+G+ + E++T G KP + + + L++G E L
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKG---ERLP 239
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
P + +++ K C D RP +++
Sbjct: 240 Q------PPICTIDVYMIMRK----CWMIDADSRPKFRELIIEFS 274
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 74/306 (24%), Positives = 136/306 (44%), Gaps = 27/306 (8%)
Query: 842 ENVLSRGRYGLIFKASY-----QDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRNLT 895
+ L +G +G + Y G ++++++L+ G + F++E + L + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 896 VLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
RG Y G +RL V +Y+P+G L LQ + L+ L S + +G+ +
Sbjct: 88 KYRGVSYGPGRQSLRL-VMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEY 142
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST---TPIGSLGYVSP 1010
L S VH D+ +N+L +++ +++FGL +L +PI + +P
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF---WYAP 199
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKP-VMFTQDEDIVKWVKKQLQRGQISELLEP 1068
E+ S ++++DV+SFG+VL E+ T K + ++ + ++ ELLE
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 1069 GL-LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPT 1127
G L P + E ++ LC AP P DRPS + + L+ G + T
Sbjct: 260 GQRLPA-PPACPAEVH----ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
Query: 1128 SLPSPM 1133
+ P
Sbjct: 315 AHPEGK 320
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 46/266 (17%), Positives = 84/266 (31%), Gaps = 24/266 (9%)
Query: 426 LIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGL 485
+ P L+ NL + + LS + N + + + L
Sbjct: 12 VFPDP--GLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNL 65
Query: 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
L+LS + S + + L +L L ++ L + L + L+ N L
Sbjct: 66 KELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD 120
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605
+ L L+ L++ +N I GFL L L L N+I+ L +
Sbjct: 121 --TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKV 174
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEI--PKEISKCSSLVSLTLDMNSL 663
++L + + + + ++ G P IS S V + + L
Sbjct: 175 NWIDLTGQKCVNE---PVKYQPELYITNTVKD-PDGRWISPYYISNGGSYVDGCV-LWEL 229
Query: 664 SGRIPESFSKLSNLTTLNLSTNRLSG 689
E K S + + G
Sbjct: 230 PVYTDEVSYKFSEYINVGETEAIFDG 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 38/208 (18%), Positives = 78/208 (37%), Gaps = 18/208 (8%)
Query: 503 IGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562
L +L Q+++ + + L +Q + + +N+ G L+ L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70
Query: 563 SDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVD 622
S N + D+ L L LS++ N++ + + L L L +N +
Sbjct: 71 SHNQIS-DLSPLKD-LTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELR-DTD-S 123
Query: 623 ISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNL 682
+ HL ++ L + NKL I + S L L L N ++ ++L + ++L
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDL 179
Query: 683 STNRLSGAIPADLALISSLRYLNLSRNN 710
+ + + L N ++
Sbjct: 180 TGQKCV---NEPVKYQPELYITNTVKDP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 34/164 (20%), Positives = 67/164 (40%), Gaps = 13/164 (7%)
Query: 549 EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVL 608
L NL + T D+ + L + + ++ I + + + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68
Query: 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIP 668
L N + ++ + L+++++L + +N+L + + L L LD N L
Sbjct: 69 HLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD--T 121
Query: 669 ESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLE 712
+S L NL L++ N+L + L +S L L+L N +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 43/263 (16%), Positives = 82/263 (31%), Gaps = 45/263 (17%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLS 376
+L + + ++ ++ + + +L + L+ L +++N +S
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSL--GRNMFSGLIPLSFGNL 434
L P + + L+ + NR L GI + L N L +L
Sbjct: 77 DLSP--LKDLTKLEELSVNRNRLKN-----LNGIPSACLSRLFLDNNELRDTDSLI--HL 127
Query: 435 SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
LE L++ N ++ +I + LS L L+L N+ + N GL
Sbjct: 128 KNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNE--------ITNTGGL--------- 168
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554
L ++ +DL+ Q E L V + P S+
Sbjct: 169 ---------TRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI--SPYYISNG 217
Query: 555 VGLQYLNLSDNAFTGDIPATYGF 577
+ +Y F
Sbjct: 218 GSYVDGCVLWELPVYTDEVSYKF 240
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 40/238 (16%), Positives = 82/238 (34%), Gaps = 33/238 (13%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
+L ++ + ++++ S+ + + L+ ++L +N S PL +LT L L+V
Sbjct: 37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSV 92
Query: 151 AHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVG 210
N L ++ S L L L +N + + L+++++ N V +G
Sbjct: 93 NRNRLK-NLNGIPSACLSRLFLDNNELR-DTD-SLIHLKNLEILSIRNNKLKSIVM--LG 147
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L +LE L L N + T ++ + + + L + + +
Sbjct: 148 FLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNE---PVKYQPELYITNTVK 202
Query: 271 NELTGLVPVSVLCNL---------WGNISSLRIVQLGFN----------AFTGVVKPP 309
+ + + N W V F+ F G V P
Sbjct: 203 DPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDGTVTQP 260
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 40/209 (19%), Positives = 78/209 (37%), Gaps = 43/209 (20%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
L N + N+ ++ +S ++ + ++ + + L+ ++LS+N
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQ 74
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRI 260
S + + L +LE L ++ N L + I + L L ++N L+ + +
Sbjct: 75 IS--DLSPLKDLTKLEELSVNRNRL--KNLNGIPSAC-LSRLFLDNNELRDTDS--LIHL 127
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
L++LS+ N+L +V + L LEVL
Sbjct: 128 KNLEILSIRNNKLKSIVMLGFLSK--------------------------------LEVL 155
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGN 349
DL N I LT + + +DL+G
Sbjct: 156 DLHGNEITNTGG--LTRLKKVNWIDLTGQ 182
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 841 EENVLSRGRYGLIFKASYQDGMVLS---IRRLRDGTIDENT---FRKEAEALGKVKHRNL 894
E+ L G +G + K YQ V+ ++ L++ D EA + ++ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
+ G +LV + G L LQ+ H + + ++ G+ +L
Sbjct: 81 VRMIGICEAES--WMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYL 133
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT---PIGSLGYVSPE 1011
+ VH D+ +NVL A +S+FGL + A + T P+ + +PE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK---WYAPE 190
Query: 1012 AASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEP 1068
+ + + ++DV+SFG+++ E + G+KP M + V L++G E +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKG---ERMGC 241
Query: 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
P E + + LC D +RP A + L
Sbjct: 242 ------PAGCPREMY----DLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/290 (18%), Positives = 115/290 (39%), Gaps = 39/290 (13%)
Query: 841 EENVLSRGRYGLIFKASYQDG---MVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNLT 895
+ L G +G + + Y+ + ++I+ L+ GT +T +EA+ + ++ + +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L G +LV + G L L + + + ++ G+ +L
Sbjct: 74 RLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLE 127
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT---PIGSLGYVSPEA 1012
+ VH D+ +NVL A +S+FGL + A + ++ + P+ + +PE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK---WYAPEC 184
Query: 1013 ASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
+ + + +DV+S+G+ + E L+ G+KP M + V +++G + +E
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQG---KRMEC- 234
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119
P E + + C DRP + + C
Sbjct: 235 -----PPECPPELY----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 65/308 (21%), Positives = 128/308 (41%), Gaps = 47/308 (15%)
Query: 842 ENVLSRGRYGLIFKASYQDG-----MVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNL 894
VL G +G ++K + + ++I+ LR+ T + EA + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS--LGLARGLS 952
L G L+ MP G L ++E ++ ++L++ + +A+G++
Sbjct: 80 CRLLGICLTST--VQLITQLMPFGCLLDYVRE---HKDNI---GSQYLLNWCVQIAKGMN 131
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT--PIGSLGYVSP 1010
+L +VH D+ +NVL +++FGL +L A E + PI +++
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI---KWMAL 188
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLE 1067
E+ T ++DV+S+G+ + E++T G KP + + + L++G E L
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKG---ERLP 239
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD---MPSSA 1124
P + +++ VK C D RP +++ P +
Sbjct: 240 Q------PPICTIDVYMIMVK----CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 289
Query: 1125 DPTSLPSP 1132
+ LPSP
Sbjct: 290 ERMHLPSP 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 56/293 (19%), Positives = 109/293 (37%), Gaps = 56/293 (19%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS--------IRRLRDGTID-ENTFRKEAEALGKVKHR 892
L +G + IFK ++ ++ L + +F + A + K+ H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 893 NLTVLRGY-YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
+L + G G +LV +++ G+L T L++ + + +N + ++ LA +
Sbjct: 73 HLVLNYGVCVCGDE--NILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAM 126
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAH--------LSEFGLDRLAIATPAEASSSTTPIG 1003
FL ++HG++ +N+L + + LS+ G+ + I
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL----PKDILQERIP 182
Query: 1004 SLGYVSPEAASTGQP-TKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQR 1059
+V PE + D +SFG L EI + G KP + +Q + +
Sbjct: 183 ---WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFYED 233
Query: 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
L P+++E + C +P RPS I+ L
Sbjct: 234 R---HQLPA------PKAAELANLIN------NCMDYEPDHRPSFRAIIRDLN 271
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 49/289 (16%)
Query: 842 ENVLSRGRYGLIFKASYQDG----MVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLT 895
V+ RG +G ++ + D + +++ L T + + F E + H N+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 896 VLRG---YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS--LGLARG 950
L G G P L+V YM +G+L ++ +H ++ LI L +A+G
Sbjct: 154 SLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKG 204
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT----PIGSLG 1006
+ FL S VH D+ +N + D F +++FGL R ++ + T P+
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--- 261
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065
+++ E+ T + T ++DV+SFG++L E++T G P DI ++ +
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------GRR 314
Query: 1066 LEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
L PE E +L C P RPS +++V +
Sbjct: 315 LLQ------PEYCPDPLYEVMLK------CWHPKAEMRPSFSELVSRIS 351
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 52/287 (18%), Positives = 110/287 (38%), Gaps = 40/287 (13%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRN 893
R + + G +F+ + + +I+ + D T +R E L K++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 894 LTVLR--GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
++R Y + +V + N +L + L++ D ++++ +
Sbjct: 88 DKIIRLYDYEITDQYI-YMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLE-----AV 140
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
+H +VH D+KP N L D L +FG+ + + + +G++ Y+ PE
Sbjct: 141 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 1012 A-----------ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
A S + + ++DV+S G +L + G+ P F Q + + + +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPN 256
Query: 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
E P + + ++ L C DP R S+ ++
Sbjct: 257 HEIEF--PDIP-----EKDLQDVLKC------CLKRDPKQRISIPEL 290
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 6e-19
Identities = 56/298 (18%), Positives = 118/298 (39%), Gaps = 41/298 (13%)
Query: 842 ENVLSRGRYGLIFKASYQDG---MVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNLTV 896
+ L G +G + + Y+ + ++I+ L+ GT +T +EA+ + ++ + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L G +LV + G L L + + + ++ G+ +L
Sbjct: 401 LIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEE 454
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT---PIGSLGYVSPEAA 1013
+ VH ++ +NVL A +S+FGL + A + ++ + P+ + +PE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK---WYAPECI 511
Query: 1014 STGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
+ + + +DV+S+G+ + E L+ G+KP M + V +++G + +E
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQG---KRMEC-- 560
Query: 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTS 1128
P E + + C DRP + + C S + S
Sbjct: 561 ----PPECPPELY----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA--SKVEGGS 608
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 35/283 (12%)
Query: 841 EENVLSRGRYGLIFKASYQDG----MVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNL 894
+ V+ +G +G+++ Y D + +I+ L T + F +E + + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
L G P + ++ YM +G+L ++ L +ARG+ +L
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYL 140
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT----PIGSLGYVSP 1010
VH D+ +N + D F +++FGL R + + P+ + +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK---WTAL 197
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
E+ T + T ++DV+SFG++L E+LT G P D+ L +G+ L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT----HFLAQGRR---LPQ- 249
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
PE + +V C DP RP+ +V +E
Sbjct: 250 -----PEYCPDSLY----QVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 63/296 (21%), Positives = 130/296 (43%), Gaps = 33/296 (11%)
Query: 837 RQFDEENV-----LSRGRYGLIFKASY-----QDGMVLSIRRLRDGTIDENT-FRKEAEA 885
QF+E ++ L +G +G + Y G V+++++L+ T + F +E E
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 886 LGKVKHRNLTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI 943
L ++H N+ +G Y AG +++L + +Y+P G+L LQ + ++
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKL-IMEYLPYGSLRDYLQ----KHKERIDHIKLLQY 119
Query: 944 SLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT--- 1000
+ + +G+ +L + +H D+ +N+L + + + +FGL ++
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK---QL 1057
PI + +PE+ + + + +DV+SFG+VL E+ T + E + Q+
Sbjct: 180 PIF---WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 1058 QRGQISELLEPGL-LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ ELL+ L P+ E +++ C + RPS D+ ++
Sbjct: 237 IVFHLIELLKNNGRLPR-PDGCPDEIYMI----MTECWNNNVNQRPSFRDLALRVD 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 56/311 (18%), Positives = 120/311 (38%), Gaps = 45/311 (14%)
Query: 826 KITYVETLEATR-QFDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTIDENT- 878
T V+ + L G +G + Y G ++++ L+ + +
Sbjct: 9 PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 879 -FRKEAEALGKVKHRNLTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVL 935
+KE E L + H N+ +G G ++L + +++P+G+L L + ++ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL-IMEFLPSGSLKEYLPKNKNK----I 123
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
N + ++ + +G+ +L S VH D+ +NVL +++ + + +FGL +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 183
Query: 996 SSSTT---PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051
+ P+ + +PE + +DV+SFG+ L E+LT +
Sbjct: 184 TVKDDRDSPVF---WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
Query: 1052 W----------VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDR 1101
+ L+ G+ L P + E + ++ C P +R
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKR---LPC------PPNCPDEVY----QLMRKCWEFQPSNR 287
Query: 1102 PSMADIVFMLE 1112
S +++ E
Sbjct: 288 TSFQNLIEGFE 298
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 509 LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
++D S++ L+ +P + + + L+ N LS + F L L+ L L+DN
Sbjct: 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 569 GDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGAC-SALEVLELRSNHFTGNIPVDI-SH 625
+PA + L++L L ++ N++ +P + L L L N ++P +
Sbjct: 75 -TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDS 131
Query: 626 LSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLST 684
L+++ L LG N+L +PK + K +SL L L N L +F KL+ L TL L
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 685 NRLSGAIPADLALISSLRYLNLSRN 709
N+L + L+ L L N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 57/177 (32%), Positives = 78/177 (44%), Gaps = 10/177 (5%)
Query: 418 LGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVP 476
L N S L +F L++L L L++N ++ +P I L NL TL ++ NK +P
Sbjct: 44 LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALP 101
Query: 477 YDV-GNLKGLLVLNLSASGFSGKIPGSI-GSLMRLTTLDLSNQNLSGELPIELF-GLPSL 533
V L L L L + +P + SL +LT L L L LP +F L SL
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159
Query: 534 QVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHN 589
+ + L N L VPEG F L L+ L L +N + L L L L N
Sbjct: 160 KELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEY 217
I ++I + LDL SN + F ++L+L+ L+ N +PA + +L+ LE
Sbjct: 31 IPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLET 89
Query: 218 LWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276
LW+ N L LP + +L L + N LK L P ++ L LSL NEL L
Sbjct: 90 LWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL 148
Query: 277 VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG--RCVSVLEVLDLQNNRIRAVFPSW 334
P V L +SL+ ++L N V P G ++ L+ L L NN+++ V
Sbjct: 149 -PKGVFDKL----TSLKELRLYNNQLKRV---PEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 335 LTNVTSLRVMDLSGN 349
++ L+++ L N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 60/240 (25%), Positives = 89/240 (37%), Gaps = 62/240 (25%)
Query: 450 NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRL 509
NIP ++ L+L NK +L + F L +L
Sbjct: 34 NIP------ADTKKLDLQSNKLS----------------SLPSKAFHR--------LTKL 63
Query: 510 TTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAF 567
L L++ L LP +F L +L+ + + +N L +P G F LV L L L N
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHL 626
+P VF SL + L L L N ++P + L
Sbjct: 122 K-SLPPR-------VFDSL----------------TKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 627 SRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685
+ +K+L L N+L +P+ K + L +L LD N L +F L L L L N
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 53/180 (29%), Positives = 77/180 (42%), Gaps = 8/180 (4%)
Query: 97 LRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFN-LTNLLVLNVAHNLL 155
+KL L SN L+ + H+ + LR +YL N LP IF L NL L V N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 156 SGKISADIS---PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQ 211
+ + +L L L N P F S ++L ++L YN +P V +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 212 LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271
L L+ L L +N L A + L L ++N LK + G + L++L L N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 25/232 (10%)
Query: 174 SNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAI 233
+ A + G S + ++ S + +P+ + + L L SN L A
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAF 57
Query: 234 SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLR 293
+ L L DN L+ L G + L+ L ++ N+L L P+ V L +L
Sbjct: 58 HRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQAL-PIGVFDQL----VNLA 112
Query: 294 IVQLGFN--------AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMD 345
++L N F + K L L L N ++++ +TSL+ +
Sbjct: 113 ELRLDRNQLKSLPPRVFDSLTK---------LTYLSLGYNELQSLPKGVFDKLTSLKELR 163
Query: 346 LSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
L N A L +L+ L++ NN L + L+M L+ N
Sbjct: 164 LYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 94 LHELRKLSLHSNHLNGSIPASL-HQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVA 151
L +LR L L+ N L ++PA + + L +++ N LP+ +F L NL L +
Sbjct: 60 LTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLD 117
Query: 152 HNLLSGKISADI---SPSLRYLDLSSNAFTGEIP-GNFSSKSQLQLINLSYNSFSGEVPA 207
N L + + L YL L N +P G F + L+ + L N VP
Sbjct: 118 RNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPE 174
Query: 208 SV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
+L EL+ L LD+N L A + L L ++N
Sbjct: 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 48/213 (22%), Positives = 77/213 (36%), Gaps = 38/213 (17%)
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
+ + L L N+L+ L AF + K L +L
Sbjct: 37 ADTKKLDLQSNKLSSLPS---------------------KAFHRLTK---------LRLL 66
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSLSGLV 379
L +N+++ + + +L + ++ N LP V L L LR+ N L L
Sbjct: 67 YLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLP 125
Query: 380 PDEIAKCSLLQMFDLEGNRFSGQVP--AFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQL 437
P + L L N +P F + LK + L N + +F L++L
Sbjct: 126 PRVFDSLTKLTYLSLGYNELQ-SLPKGVF-DKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183
Query: 438 ETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
+TL L N ++ +PE L L L L N
Sbjct: 184 KTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 35/137 (25%), Positives = 57/137 (41%), Gaps = 8/137 (5%)
Query: 92 ADLHELRKLSLHSNHLNGSIPASL-HQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLN 149
+L L L + N L ++P + Q L + L N LP +F +LT L L+
Sbjct: 82 KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLS 139
Query: 150 VAHNLLSGKISA---DISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
+ +N L + D SL+ L L +N G F ++L+ + L N
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 207 ASVGQLQELEYLWLDSN 223
+ L++L+ L L N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 12/120 (10%)
Query: 595 IPAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEI-SKCSS 652
IPA+ + L+L+SN + ++P L++++ L L NKL +P I + +
Sbjct: 35 IPADT------KKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 653 LVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNL 711
L +L + N L F +L NL L L N+L ++P + ++ L YL+L N L
Sbjct: 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 618 NIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPES-FSKLSN 676
NIP D KKLDL NKLS K + + L L L+ N L +P F +L N
Sbjct: 34 NIPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86
Query: 677 LTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNLE 712
L TL ++ N+L A+P + + +L L L RN L+
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 60/286 (20%), Positives = 126/286 (44%), Gaps = 28/286 (9%)
Query: 842 ENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTIDE-NTFRKEAEALGKVKHRNLT 895
L +G +G + Y G V+++++L+ T + F +E E L ++H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 896 VLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+G Y AG +++L + +Y+P G+L LQ+ + ++ + + +G+ +
Sbjct: 106 KYKGVCYSAGRRNLKL-IMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEY 160
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT---PIGSLGYVSP 1010
L + +H D+ +N+L + + + +FGL ++ PI + +P
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF---WYAP 217
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK---QLQRGQISELLE 1067
E+ + + + +DV+SFG+VL E+ T + E + Q+ + ELL+
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 1068 PG-LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
L P+ E +++ + C + RPS D+ ++
Sbjct: 278 NNGRLPR-PDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 318
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 60/286 (20%), Positives = 118/286 (41%), Gaps = 30/286 (10%)
Query: 842 ENVLSRGRYGLIFKASYQD-----GMVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNL 894
L G +G + Y G +++++ L+ ++ +++E + L + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 895 TVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
+G AG + LV +Y+P G+L L H + L + + G++
Sbjct: 96 IKYKGCCEDAGAASL-QLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMA 148
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT---PIGSLGYVS 1009
+LH+ +H D+ +NVL D D + +FGL + P+ + +
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---WYA 205
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVK-KQLQRGQISELLE 1067
PE + +DV+SFG+ L E+LT + + Q+ +++ELLE
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 1068 PG-LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
G L P+ E + L C + RP+ +++ +L+
Sbjct: 266 RGERLPR-PDKCPAEVYHL----MKNCWETEASFRPTFENLIPILK 306
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 52/287 (18%), Positives = 110/287 (38%), Gaps = 40/287 (13%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRN 893
R + + G +F+ + + +I+ + D T +R E L K++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 894 LTVLR--GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
++R Y + +V + N +L + L++ D ++++ +
Sbjct: 69 DKIIRLYDYEITDQYI-YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-----AV 121
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
+H +VH D+KP N L D L +FG+ + + + +G++ Y+ PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 1012 A-----------ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
A S + + ++DV+S G +L + G+ P F Q + + + +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPN 237
Query: 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
E P + + ++ L C DP R S+ ++
Sbjct: 238 HEIEF--PDIP-----EKDLQDVLKC------CLKRDPKQRISIPEL 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 41/242 (16%), Positives = 84/242 (34%), Gaps = 26/242 (10%)
Query: 880 RKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQD----GHVL 935
+ E + + +K+ G +V ++Y+YM N ++ + D +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEV-YIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 936 NWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994
++ +I + S++H+ ++ H D+KP N+L D + LS+FG +
Sbjct: 150 IQVIKCIIK-SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE-----SEYMV 203
Query: 995 ASSSTTPIGSLGYVSPEAASTGQPT--KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKW 1052
G+ ++ PE S + D++S GI L + P F+ +V+
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKISLVEL 261
Query: 1053 VKKQLQRGQIS----ELLEPGLLELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMA 1105
++ I L + L +P +R +
Sbjct: 262 FNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR--KNPAERITSE 318
Query: 1106 DI 1107
D
Sbjct: 319 DA 320
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 41/285 (14%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIR----RLRDGTIDENT----FRKEAEALGKVKHRN 893
L G +G++ + + ++ L+ + + F +E A+ + HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLI--SLGLARGL 951
L L G PP +V + P G+L L++ GH + L ++ +A G+
Sbjct: 83 LIRLYGVVLTPP--MKMVTELAPLGSLLDRLRK---HQGHF---LLGTLSRYAVQVAEGM 134
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST---TPIGSLGYV 1008
+L S +H D+ +N+L + +FGL R P +
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA---WC 191
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067
+PE+ T + +D + FG+ L E+ T G++P + I+ + K+ +R L
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------LP 245
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
PE + + + V+ C A P DRP+ + L
Sbjct: 246 R------PEDCPQDIYNVMVQ----CWAHKPEDRPTFVALRDFLL 280
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 57/292 (19%), Positives = 112/292 (38%), Gaps = 46/292 (15%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIR----RLRDGTIDE---NTFRKEAEALGKVKHRNL 894
+L +G +G + +A + ++ L+ I F +EA + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 895 T-----VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH-QDGHVLNWPMRHLISLGLA 948
LR G + +++ +M +G+L L + ++ L + +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
G+ +L S + +H D+ +N + D +++FGL R S G +
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK------IYSGDYYRQGCASKL 201
Query: 1009 -----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQI 1062
+ E+ + T +DV++FG+ + EI+T G+ P ++ +I L G
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY----NYLIGGN- 256
Query: 1063 SELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
L+ P E + + C + DP RPS + LE
Sbjct: 257 --RLKQ------PPECMEEVYDLM------YQCWSADPKQRPSFTCLRMELE 294
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 69/302 (22%), Positives = 133/302 (44%), Gaps = 50/302 (16%)
Query: 842 ENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNL 894
+ L G +G +F A +D M+++++ L+D T+ F++EAE L ++H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 895 TVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP---------MRHLI 943
G P ++V++YM +G+L L+ +++ + ++
Sbjct: 80 VKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 944 SLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT- 1000
+ A G+ +L S VH D+ +N L A+ + +FG+ R +T T
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 1001 -PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQ 1058
PI ++ PE+ + T E+DV+SFG++L EI T G++P + + V + +
Sbjct: 197 LPIR---WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----VIECIT 249
Query: 1059 RGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116
+G++ LE P E + +LG C +P R ++ +I +L
Sbjct: 250 QGRV---LER------PRVCPKEVYDVMLG------CWQREPQQRLNIKEIYKILHALGK 294
Query: 1117 GP 1118
Sbjct: 295 AT 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 54/321 (16%), Positives = 107/321 (33%), Gaps = 48/321 (14%)
Query: 796 KPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFK 855
K S + G + +N G L + Y E E + + RG +G + +
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHR 76
Query: 856 ASYQD-GMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913
+ G ++++ + E +E A + + L G P V + +
Sbjct: 77 MKDKQTGFQCAVKK-----VRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNI-FME 130
Query: 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973
+ G+L L+++ + + + GL +LH+ ++HGD+K NVL +
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALE-----GLEYLHTRRILHGDVKADNVLLSS 185
Query: 974 D-FEAHLSEFGL-DRLA-IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIV 1030
D A L +FG L + G+ +++PE + D++S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 1031 LLEILTGRKP--------VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEE 1082
+L +L G P + I +I + +
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLK----IASEPPPIR---EIPPSC----------APLTAQ 288
Query: 1083 FLLGVKVGLLCTAPDPLDRPS 1103
+ +P+ R S
Sbjct: 289 AI------QEGLRKEPVHRAS 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 52/287 (18%), Positives = 110/287 (38%), Gaps = 40/287 (13%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRN 893
R + + G +F+ + + +I+ + D T +R E L K++ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 894 LTVLR--GYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
++R Y + +V + N +L + L++ D ++++ +
Sbjct: 116 DKIIRLYDYEITDQYI-YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-----AV 168
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
+H +VH D+KP N L D L +FG+ + + + +G++ Y+ PE
Sbjct: 169 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 1012 A-----------ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
A S + + ++DV+S G +L + G+ P F Q + + + +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPN 284
Query: 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
E P + + ++ L C DP R S+ ++
Sbjct: 285 HEIEF--PDIP-----EKDLQDVLKC------CLKRDPKQRISIPEL 318
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 55/305 (18%)
Query: 842 ENVLSRGRYGLIFKASYQDG------MVLSIRRLRDGTIDE-NTFRKEAEALGKVKHRNL 894
+ L G +G +F A + M+++++ L++ + F++EAE L ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 895 TVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL----- 947
G P L+V++YM +G+L L+ + LGL
Sbjct: 106 VRFFGVCTEGRPL---LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 948 -----ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
A G+ +L L VH D+ +N L + +FG+ R S+ +
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD------IYSTDYYRV 216
Query: 1003 GSLGYV-----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQ 1056
G + PE+ + T E+DV+SFG+VL EI T G++P + + + + +
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ- 275
Query: 1057 LQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
G+ LE P E + G C +P R S+ D+ L+
Sbjct: 276 ---GRE---LER------PRACPPEVYAIMRG------CWQREPQQRHSIKDVHARLQAL 317
Query: 1115 RVGPD 1119
P
Sbjct: 318 AQAPP 322
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-18
Identities = 58/279 (20%), Positives = 107/279 (38%), Gaps = 44/279 (15%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVL---SIRRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
L G YG + + IR+ T + +E L + H N+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFL 954
++ + L V + G L + D V+ ++ ++S G+++L
Sbjct: 102 YDFFEDKRNYYL-VMECYKGGELFDEIIHRMKFNEVDAAVI---IKQVLS-----GVTYL 152
Query: 955 HSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
H ++VH D+KP+N+L + D + +FGL + +G+ Y++PE
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF----ENQKKMKERLGTAYYIAPE 208
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ ++ DV+S G++L +L G P D++I++ V+K
Sbjct: 209 VLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG--------------- 252
Query: 1072 ELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ +S EW+ G K +L D R S
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQ--FDSQRRISAQQA 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 59/294 (20%), Positives = 116/294 (39%), Gaps = 47/294 (15%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLSIR----RLRDGTIDENT---FRKEAEALGKVKHRNL 894
+L G +G + + + + S++ ++ + F EA + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 895 TVLRG--YYAGPPDVR--LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL--A 948
L G + +++ +M G+L T L + + G + P++ L+ + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP-KHIPLQTLLKFMVDIA 157
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
G+ +L + + +H D+ +N + D +++FGL + S G + +
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK------IYSGDYYRQGRIAKM 211
Query: 1009 -----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQI 1062
+ E+ + T ++DV++FG+ + EI T G P Q+ ++ L G
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY----DYLLHGH- 266
Query: 1063 SELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
L+ PE E E + C DPLDRP+ + + LE
Sbjct: 267 --RLKQ------PEDCLDELYEIM------YSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 45/264 (17%), Positives = 93/264 (35%), Gaps = 44/264 (16%)
Query: 875 DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGH 933
+ +E E L K+ H+N+ L L+ ++ P G+L T+L+E + +
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAY 107
Query: 934 VLNWP-----MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH----LSEFGL 984
L +R ++ G++ L +VH +IKP N++ + L++FG
Sbjct: 108 GLPESEFLIVLRDVVG-----GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
Query: 985 DRLAIATPAEASSSTTPIGSLGYVSPE-------AASTGQP-TKEADVYSFGIVLLEILT 1036
R + + G+ Y+ P+ + D++S G+ T
Sbjct: 163 AR----ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 1037 GRKP----VMFTQDEDIVKWVKKQLQRGQIS--ELLEPGLLELDPESSEWEEFLLGVK-- 1088
G P ++++++ + G IS + E G ++ + G++
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278
Query: 1089 -----VGLLCTAPDPLDRPSMADI 1107
+L D
Sbjct: 279 LTPVLANILEA--DQEKCWGFDQF 300
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 50/259 (19%), Positives = 97/259 (37%), Gaps = 39/259 (15%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP 938
E + H+++ G++ V +V + +L L + +
Sbjct: 62 MSMEISIHRSLAHQHVVGFHGFFEDNDFV-FVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
+R ++ G +LH ++H D+K N+ + D E + +FGL AT E
Sbjct: 121 LRQIVL-----GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL-----ATKVEYDGE 170
Query: 999 --TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056
G+ Y++PE S + E DV+S G ++ +L G+ P F + + + +
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F-ETSCLKETYLR- 226
Query: 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV---FMLEG 1113
I + + + L+ +L DP RP++ +++ F G
Sbjct: 227 -----IKK----NEYSIPKHINPVAASLIQ---KML--QTDPTARPTINELLNDEFFTSG 272
Query: 1114 CRVGPDMPSSADPTSLPSP 1132
+P+ T L P
Sbjct: 273 Y-----IPARLPITCLTIP 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 58/295 (19%), Positives = 115/295 (38%), Gaps = 51/295 (17%)
Query: 843 NVLSRGRYGLIFKASYQDGMVLS------IRRLRDGTIDE--NTFRKEAEALGKVKHRNL 894
L +G +G++++ + + I+ + + F EA + + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 895 TVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP---MRHLISLGL-- 947
L G P L++ + M G+L + L+ + + +I +
Sbjct: 91 VRLLGVVSQGQPT---LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 948 ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
A G+++L++ VH D+ +N + DF + +FG+ R + G G
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGL 201
Query: 1008 V-----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061
+ SPE+ G T +DV+SFG+VL EI T +P +E ++++V +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG----- 256
Query: 1062 ISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
LL+ P+ E + C +P RPS +I+ ++
Sbjct: 257 --GLLDK------PDNCPDMLFELMRM------CWQYNPKMRPSFLEIISSIKEE 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 57/359 (15%), Positives = 121/359 (33%), Gaps = 65/359 (18%)
Query: 802 GSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKA-SYQD 860
GS G GR + G + + ++ VL+ G + +++A
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLR------------VRRVLAEGGFAFVYEAQDVGS 52
Query: 861 GMVLSIRR-LRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVR------LLVY 912
G +++R L + +E + K+ H N+ + + L+
Sbjct: 53 GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 913 DYMPNGNLATLLQEASHQD----GHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKP 966
+ G L L++ + VL + +H ++H D+K
Sbjct: 113 TELCKGQLVEFLKKMESRGPLSCDTVLKI-FYQTCR-----AVQHMHRQKPPIIHRDLKV 166
Query: 967 QNVLFDADFEAHLSEFGLDRLAIATPAEASSST---------TPIGSLGYVSPE--AAST 1015
+N+L L +FG P + S+ T + Y +PE +
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 1016 GQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074
P ++ D+++ G +L + + P F +D K ++ G+ S + D
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQHP--F-EDG-----AKLRIVNGKYS------IPPHD 272
Query: 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPSPM 1133
+ + + + +P +R S+A++V L+ ++ + T L
Sbjct: 273 TQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQN 325
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 51/265 (19%), Positives = 113/265 (42%), Gaps = 17/265 (6%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFR---KEAEALGKVKHRN 893
F++ + L G G++FK S+ G+V++ + + I +E + L +
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPY 92
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ G + ++ + ++M G+L +L++A +L +S+ + +GL++
Sbjct: 93 IVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 146
Query: 954 LHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
L ++H D+KP N+L ++ E L +FG ++ S + + +G+ Y+SPE
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFG-----VSGQLIDSMANSFVGTRSYMSPER 201
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
+ ++D++S G+ L+E+ GR P+ +++ Q++ P
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 1073 LDPESSEWEEFLLGVKVGLLCTAPD 1097
+ LL +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVN 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 4e-17
Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 32/185 (17%)
Query: 875 DENTFRKEAEALGKVKHRNLTVLRGY-------YAGPPDVRLLVYDYMPNGNLATLLQEA 927
+ + E + + K+ H N V+ P D+ LL +Y G+L L +
Sbjct: 55 NRERWCLEIQIMKKLNHPN--VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF 112
Query: 928 SHQDG-------HVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH-- 978
+ G + + + S L +LH ++H D+KP+N++ +
Sbjct: 113 ENCCGLKEGPIRTL----LSDISS-----ALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163
Query: 979 -LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTG 1037
+ + G + + T +G+L Y++PE + T D +SFG + E +TG
Sbjct: 164 KIIDLGYAK----ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219
Query: 1038 RKPVM 1042
+P +
Sbjct: 220 FRPFL 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 50/261 (19%), Positives = 100/261 (38%), Gaps = 43/261 (16%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP 938
E + H+++ G++ V +V + +L L + +
Sbjct: 88 MSMEISIHRSLAHQHVVGFHGFFEDNDFV-FVVLELCRRRSLLELHKRRKALTEPEARYY 146
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
+R ++ G +LH ++H D+K N+ + D E + +FGL AT E
Sbjct: 147 LRQIVL-----GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL-----ATKVEYDGE 196
Query: 999 --TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056
G+ Y++PE S + E DV+S G ++ +L G+ P F + + + +
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F-ETSCLKETYLR- 252
Query: 1057 LQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV---FML 1111
+++ + S P+ + + +L DP RP++ +++ F
Sbjct: 253 IKKNEYSI----------PKHINPVAASLI----QKML--QTDPTARPTINELLNDEFFT 296
Query: 1112 EGCRVGPDMPSSADPTSLPSP 1132
G +P+ T L P
Sbjct: 297 SGY-----IPARLPITCLTIP 312
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 55/322 (17%), Positives = 101/322 (31%), Gaps = 68/322 (21%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGM-----VLSIRRLRDGT-IDENTFRKEAEALGK 888
+++ + + +G YG++ A Q +++ ++R D + E + K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 889 VKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
+ H N+ L Y + LV + G+L L +
Sbjct: 85 LHHPNIARLYEVYEDEQYI-CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 949 R-----------------------------------GLSFLHSLDMVHGDIKPQNVLFDA 973
L +LH+ + H DIKP+N LF
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 974 DFEAHL--SEFGLDR-LAIATPAEASSSTTPIGSLGYVSPEAASTGQP--TKEADVYSFG 1028
+ + +FGL + E TT G+ +V+PE +T + D +S G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 1029 IVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVK 1088
++L +L G P D D + V + +L E+ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNK---------------KLCFENPNYNVLSPLAR 308
Query: 1089 ---VGLLCTAPDPLDRPSMADI 1107
LL + +R
Sbjct: 309 DLLSNLLN--RNVDERFDAMRA 328
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 5e-17
Identities = 46/273 (16%), Positives = 86/273 (31%), Gaps = 21/273 (7%)
Query: 435 SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494
L +L++ + T + L ++ D + L LS
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVE- 359
Query: 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554
S + + S L L+ N+ L + + +L + E+ L + FS+L
Sbjct: 360 KSTVLQSELESCKELQELEPENKW---CLLTIILLMRALDPLLYEKETL-----QYFSTL 411
Query: 555 VGLQYLNLSD-----NAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLE 609
+ + + + F + + L L+H ++ + L + L+
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLD 469
Query: 610 LRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG-RIP 668
L N +P ++ L ++ L N L + ++ L L L N L
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526
Query: 669 ESFSKLSNLTTLNLSTNRLSGAIPADLALISSL 701
+ L LNL N L L L
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 53/339 (15%), Positives = 103/339 (30%), Gaps = 40/339 (11%)
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLI----PGTIGRISTLQVL 266
+ ++ + L ++ S + L + + P R S + +
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 267 SLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR 326
L L +P +W S + + + L +L +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQK--ECVLLKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 327 IRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKC 386
S L + L+ ++ + + + +LD L + S L +
Sbjct: 361 STV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL---KAVDP 416
Query: 387 SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
D ++F + ++++ L + L L L + L+LS N
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHL--EQLLLVTHLDLSHNR 474
Query: 447 IRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSL 506
+R +P + L L L S N L+ + G + +L
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNA-----------LE--------------NVDG-VANL 507
Query: 507 MRLTTLDLSNQNLSG-ELPIELFGLPSLQVVSLEENNLS 544
RL L L N L L P L +++L+ N+L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 50/316 (15%), Positives = 89/316 (28%), Gaps = 68/316 (21%)
Query: 163 ISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDS 222
P+ D I S+ + L+ + ++L L
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW----CRDSATDEQLFRCELSV 358
Query: 223 NHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVL 282
L S + +C L L E+ I + + L + + L
Sbjct: 359 EKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL------ 411
Query: 283 CNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSV-LEVLDLQNNRIRAVFPSWLTNVTSL 341
+ +R L +++ + + VL L + + + L + +
Sbjct: 412 ----KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLV 465
Query: 342 RVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG 401
+DLS N LP A+ +L LEVL+ ++N+L + D +A LQ L NR
Sbjct: 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNR--- 519
Query: 402 QVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNL 461
L Q + + + L
Sbjct: 520 --------------------------------LQQSAAI------------QPLVSCPRL 535
Query: 462 TTLNLSYNKFGGKVPY 477
LNL N +
Sbjct: 536 VLLNLQGNSLCQEEGI 551
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 31/133 (23%), Positives = 51/133 (38%), Gaps = 8/133 (6%)
Query: 70 NNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYN 129
R L R + + + ++R L L L ++ L Q L+ + L +N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHN 473
Query: 130 SFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFTG-EIPGNFS 186
LP ++ L L VL + N L + ++ P L+ L L +N
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 187 SKSQLQLINLSYN 199
S +L L+NL N
Sbjct: 531 SCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 25/108 (23%), Positives = 41/108 (37%), Gaps = 13/108 (12%)
Query: 72 RVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYN-- 129
V L L +L L LA L L L N L ++ + L+ + L N
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520
Query: 130 -SFSGHLPLSIFNLTNLLVLNVAHNLLSGKIS-----ADISPSLRYLD 171
+ PL + L++LN+ N L + A++ PS+ +
Sbjct: 521 QQSAAIQPLV--SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 59/300 (19%), Positives = 112/300 (37%), Gaps = 50/300 (16%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLT 895
E +L G G + G ++++R+ + E + L + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI 72
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL--GLARGLSF 953
+ + + N NL L++ + D ++ + ISL +A G++
Sbjct: 73 RYYCSETTDRFL-YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 954 LHSLDMVHGDIKPQNVLFD-------------ADFEAHLSEFGL-DRLAIATPAEASSST 999
LHSL ++H D+KPQN+L + +S+FGL +L + ++
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 1000 TPIGSLGYVSPE-------AASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051
P G+ G+ +PE + + T+ D++S G V IL+ G+ P F
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP--FGDKYSRES 248
Query: 1052 WVKKQLQRGQISELLEPGLLELDP-ESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ + G+ LD + + ++ DPL RP+ +
Sbjct: 249 NIIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMID--HDPLKRPTAMKV 293
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 21/190 (11%)
Query: 532 SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHN 589
+ ++S + L +VP+ S L+LS N + + A + L +L L LSHN
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN 74
Query: 590 QISGMIPAELGA---CSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPK 645
++ I + A L L+L SNH + + S L ++ L L N + + +
Sbjct: 75 HLN-FISS--EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDR 129
Query: 646 EI-SKCSSLVSLTLDMNSLSGRIPE----SFSKLSNLTTLNLSTNRLSGAIPADLALISS 700
+ L L L N +S R P +KL L L+LS+N+L DL + +
Sbjct: 130 NAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188
Query: 701 LRYLNLSRNN 710
L +N
Sbjct: 189 WVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 51/192 (26%), Positives = 76/192 (39%), Gaps = 38/192 (19%)
Query: 435 SQLETLNLSENDIRGNIPEEIT--RLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA 492
S L+LS N++ + E T RL+NL +L LS+N +S+
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN----------------FISS 81
Query: 493 SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG- 550
F + L LDLS+ +L L LF L +L+V+ L N++ V
Sbjct: 82 EAFVP--------VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNA 131
Query: 551 FSSLVGLQYLNLSDNAFTGDIPA----TYGFLRSLVFLSLSHNQISGMIPAELGACSAL- 605
F + LQ L LS N + P L L+ L LS N++ + +L A
Sbjct: 132 FEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190
Query: 606 -EVLELRSNHFT 616
L L +N
Sbjct: 191 KNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 38/193 (19%), Positives = 71/193 (36%), Gaps = 34/193 (17%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGN--FSSKSQLQLINLSYNSFSGEVPASV-GQLQEL 215
+ + LDLS N + + + + L + LS+N + + + + L
Sbjct: 33 VPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNL 90
Query: 216 EYLWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT 274
YL L SNHL TL + S+ +L L +N + + ++ LQ L LS+N+++
Sbjct: 91 RYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 275 GLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSW 334
K P L +LDL +N+++ + +
Sbjct: 150 RFPV---------------------ELIKDGNKLPK------LMLLDLSSNKLKKLPLTD 182
Query: 335 LTNVTSLRVMDLS 347
L + + L
Sbjct: 183 LQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 43/181 (23%), Positives = 70/181 (38%), Gaps = 32/181 (17%)
Query: 317 LEVLDLQNNRIRAVFPSW-LTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNS 374
+LDL +N + + W T +T+L + LS N + + + + L L +++N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99
Query: 375 LSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNL 434
L L + L++ L N IV + RN F +
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNN----------------HIVVVDRNAFEDM-------- 135
Query: 435 SQLETLNLSENDIRGNIPEEI----TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNL 490
+QL+ L LS+N I P E+ +L L L+LS NK D+ L + L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 491 S 491
Sbjct: 195 Y 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 38/215 (17%), Positives = 65/215 (30%), Gaps = 66/215 (30%)
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN--------AFTGVVKPPNGR 312
S +L LS N L+ L L ++L + L N AF V
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRL----TNLHSLLLSHNHLNFISSEAFVPVPN----- 89
Query: 313 CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVAN 372
L LDL +N + + +++ +L V+ L N + V+
Sbjct: 90 ----LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN--------------HIVVVD--R 129
Query: 373 NSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFG 432
N+ + + LQ L N+ I +
Sbjct: 130 NAFEDM--------AQLQKLYLSQNQ----------------ISRFPVELIKDG-----N 160
Query: 433 NLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLS 467
L +L L+LS N ++ ++ +L L
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 35/145 (24%), Positives = 55/145 (37%), Gaps = 13/145 (8%)
Query: 91 LADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVL 148
L L L L NHLN I + + LR + L N L +F +L L VL
Sbjct: 60 PTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVL 117
Query: 149 NVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKS---QLQLINLSYNSFS 202
+ +N + + + L+ L LS N + + +L L++LS N
Sbjct: 118 LLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 203 GEVPASVGQLQEL--EYLWLDSNHL 225
+ +L L+L +N L
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 632 LDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTNRLSGA 690
L + +L +P+ + S L L N+LS E + ++L+NL +L LS N L+
Sbjct: 23 LSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-F 78
Query: 691 IPAD-LALISSLRYLNLSRNNLE 712
I ++ + +LRYL+LS N+L
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLH 101
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 46/264 (17%), Positives = 90/264 (34%), Gaps = 44/264 (16%)
Query: 875 DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGH 933
+ +E E L K+ H+N+ L L+ ++ P G+L T+L+E + +
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAY 107
Query: 934 VLNWP-----MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH----LSEFGL 984
L +R ++ G++ L +VH +IKP N++ + L++FG
Sbjct: 108 GLPESEFLIVLRDVVG-----GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
Query: 985 DRLAIATPAEASSSTTPIGSLGYVSPE-------AASTGQP-TKEADVYSFGIVLLEILT 1036
R + + G+ Y+ P+ + D++S G+ T
Sbjct: 163 AR----ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 1037 GRKPVMFTQDEDIVKWVKKQLQRGQISEL------LEPGLLELDPESSEWEEFLLGVK-- 1088
G P + K V ++ G+ S E G ++ + G++
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278
Query: 1089 -----VGLLCTAPDPLDRPSMADI 1107
+L D
Sbjct: 279 LTPVLANILEA--DQEKCWGFDQF 300
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 53/233 (22%), Positives = 95/233 (40%), Gaps = 34/233 (14%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP 938
+ E + ++KH ++ L Y+ V LV + NG + L+ +
Sbjct: 58 VQNEVKIHCQLKHPSILELYNYFEDSNYV-YLVLEMCHNGEMNRYLKN---RVKPFSENE 113
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
RH + + G+ +LHS ++H D+ N+L + +++FGL AT +
Sbjct: 114 ARHFMH-QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGL-----ATQLKMPHE 167
Query: 999 --TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056
T G+ Y+SPE A+ E+DV+S G + +L GR P F + + + K
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP--F-DTDTVKNTLNK- 223
Query: 1057 LQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ P S E ++ + LL +P DR S++ +
Sbjct: 224 VVLADYEM----------PSFLSIEAKDLI----HQLL--RRNPADRLSLSSV 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 59/280 (21%), Positives = 109/280 (38%), Gaps = 45/280 (16%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVL---SIRRLR-DGTIDENTFRKEAEALGKVKHRNLTV 896
+ VL +G +G + G I + + D+ + +E + L ++ H N+
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSF 953
L ++ L V + G L + D + +R ++S G+++
Sbjct: 91 LYEFFEDKGYFYL-VGEVYTGGELFDEIISRKRFSEVDAARI---IRQVLS-----GITY 141
Query: 954 LHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
+H +VH D+KP+N+L D + +FGL + IG+ Y++P
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----EASKKMKDKIGTAYYIAP 197
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
E G ++ DV+S G++L +L+G P + DI+K V+K
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-------------- 242
Query: 1071 LELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ E +W++ K +L P R S D
Sbjct: 243 -KYTFELPQWKKVSESAKDLIRKMLT--YVPSMRISARDA 279
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 59/348 (16%), Positives = 117/348 (33%), Gaps = 72/348 (20%)
Query: 432 GNLSQLETLNLSENDIRG----NIPEEITRLSNLTTLNLSYNKFGGKVPYDVG------- 480
S +E +L + I ++ + ++ + LS N G
Sbjct: 2 ARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-----TEAARWLSEN 55
Query: 481 -----NLKGLLVLNLSASGFSGKIPGSIGSLMR-------LTTLDLSNQNLS--GELPIE 526
+L+ ++ +IP ++ L++ L T+ LS+ + P+
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 527 --LFGLPSLQVVSLEENNLSGDVPEGFSSLV-GLQYLNLSDNAFTGDIPATYGFLRSLVF 583
L L+ + L N L P+ + + LQ L ++ A L
Sbjct: 116 DFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNA---------PPLRS 163
Query: 584 LSLSHNQIS--GM--IPAELGACSALEVLELRSNHFT-----GNIPVDISHLSRIKKLDL 634
+ N++ M + L +++ N + +++ +K LDL
Sbjct: 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 223
Query: 635 GQNKLSGE----IPKEISKCSSLVSLTLDMNSLSGR----IPESFSKLSN--LTTLNLST 684
N + + + +L L L+ LS R + ++FSKL N L TL L
Sbjct: 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283
Query: 685 NRLS--GAIPADLAL---ISSLRYLNLSRNNL--EGEIPKMLSSRFND 725
N + + + L +L L+ N E ++ + F+
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 331
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 52/349 (14%), Positives = 94/349 (26%), Gaps = 79/349 (22%)
Query: 166 SLRYLDLSSNAFTGE----IPGNFSSKSQLQLINLSYNSFSGEVPASVGQL----QELEY 217
S+ L +A T E + ++ I LS N+ E + + ++LE
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 218 LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLV 277
L L+ L+ L + LS N G
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLL---------LQALLKCP-----KLHTVRLSDNAF-GPT 109
Query: 278 PVSVLCNLWGNISSLRIVQLGFN------------AFTGVVKPPNGRCVSVLEVLDLQNN 325
L + + L + L N A + + L + N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169
Query: 326 RIRAV----FPSWLTNVTSLRVMDLSGNFF-----SGNLPAAVGSLDKLEVLRVANNSLS 376
R+ + + L + + N L + +L+VL + +N+ +
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
Query: 377 GLVPDE--------IAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
+ L+ L RG V
Sbjct: 230 ----HLGSSALAIALKSWPNLRELGLNDCLL---------SARGAAAVVDA--------- 267
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEI-----TRLSNLTTLNLSYNKFG 472
S L+TL L N+I + + ++ +L L L+ N+F
Sbjct: 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 60/300 (20%), Positives = 110/300 (36%), Gaps = 57/300 (19%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS------IRRLRDGTIDE--NTFRKEAEALGKVKHRN 893
L R+G ++K I+ L+D FR EA +++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 894 LTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL--------- 942
+ L G P +++ Y +G+L L S R +
Sbjct: 74 VVCLLGVVTKDQPL---SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 943 --ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000
+ +A G+ +L S +VH D+ +NVL +S+ GL R ++
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY------AADYY 184
Query: 1001 PIGSLGYV-----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVK 1054
+ + +PEA G+ + ++D++S+G+VL E+ + G +P ++D V
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VV 240
Query: 1055 KQLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ ++ Q+ L P+ + ++ C P RP DI L
Sbjct: 241 EMIRNRQV---LPC------PDDCPAWVYALMIE------CWNEFPSRRPRFKDIHSRLR 285
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 28/257 (10%), Positives = 62/257 (24%), Gaps = 56/257 (21%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNW 937
L ++ V R +V +++ G+L + +
Sbjct: 78 TLSRTLRLSRIDKPG--VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS-------- 127
Query: 938 PMRHL-ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996
P+ + LA H + P V D + +A P
Sbjct: 128 PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID----------GDVVLAYP---- 173
Query: 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056
+ + D+ G L +L R P+ + ++
Sbjct: 174 ---------ATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217
Query: 1057 LQRGQISELLEPGLLELDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
+ +EP ++D + + D R + ++ +++
Sbjct: 218 TA----GQPIEPA--DIDRDIPFQISAVAAR------SVQGDGGIRSAST-LLNLMQQAT 264
Query: 1116 VGPDMPSSADPTSLPSP 1132
D P
Sbjct: 265 AVADRTEVLGPIDEAPV 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-16
Identities = 59/269 (21%), Positives = 101/269 (37%), Gaps = 51/269 (18%)
Query: 869 LRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGY--YAGPPDVRLLVYDYMPNGNLATL 923
L+ + E + L + H N+ L G GP L++ +Y G+L
Sbjct: 61 LKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT---LVITEYCCYGDLLNF 117
Query: 924 LQEASHQDGHVLNWP-----------MRHLISLGL--ARGLSFLHSLDMVHGDIKPQNVL 970
L+ P + L+S A+G++FL S + +H D+ +N+L
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177
Query: 971 FDADFEAHLSEFGLDRLAIATPAEASSSTT--PIGSLGYVSPEAASTGQPTKEADVYSFG 1028
+ +FGL R P+ +++PE+ T E+DV+S+G
Sbjct: 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYG 234
Query: 1029 IVLLEILT-GRKP--VMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE--SSEWEEF 1083
I L E+ + G P M + K ++ G + PE +E +
Sbjct: 235 IFLWELFSLGSSPYPGMPVDSK-----FYKMIKEGFR---MLS------PEHAPAEMYDI 280
Query: 1084 LLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ C DPL RP+ IV ++E
Sbjct: 281 M------KTCWDADPLKRPTFKQIVQLIE 303
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 37/223 (16%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENT----FRKEAEALGKVKHRN 893
F+ V+ RG + + + G V +++ + + + FR+E + L R
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR--- 949
+T L ++A + L LV +Y G+L TLL + + I +AR
Sbjct: 123 ITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGER------------IPAEMARFYL 168
Query: 950 -----GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
+ +H L VH DIKP N+L D L++FG A S +G+
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD--GTVRSLVAVGT 226
Query: 1005 LGYVSPE-------AASTGQPTKEADVYSFGIVLLEILTGRKP 1040
Y+SPE TG E D ++ G+ E+ G+ P
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 55/279 (19%), Positives = 105/279 (37%), Gaps = 44/279 (15%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVL---SIRRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
+L +G +G + K I + D +T +E E L K+ H N+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFL 954
+ V + G L + + D + ++ + S G++++
Sbjct: 87 FEILEDSSSFYI-VGELYTGGELFDEIIKRKRFSEHDAARI---IKQVFS-----GITYM 137
Query: 955 HSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
H ++VH D+KP+N+L + D + + +FGL + + IG+ Y++PE
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF----QQNTKMKDRIGTAYYIAPE 193
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
G ++ DV+S G++L +L+G P + DI+K V+
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--------------- 237
Query: 1072 ELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ + +W K +L P R +
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLT--FHPSLRITATQC 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 38/232 (16%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRN 893
F+ V+ RG +G + ++ V +++ L + + FR+E + L +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR--- 949
+T L +YA D L LV DY G+L TLL + + + +AR
Sbjct: 136 ITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR------------LPEEMARFYL 181
Query: 950 -----GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
+ +H L VH DIKP N+L D + L++FG + S+ +G+
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGT 239
Query: 1005 LGYVSPE-----AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK 1051
Y+SPE G+ E D +S G+ + E+L G P F E +V+
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FY-AESLVE 288
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 876 ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHV 934
N F+ E + + ++H L L Y+ + + +V D + G+L LQ Q+ H
Sbjct: 60 RNVFK-ELQIMQGLEHPFLVNLW--YSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHF 112
Query: 935 LNWPMRHLIS-LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993
++ I L +A L +L + ++H D+KP N+L D H+++F + +
Sbjct: 113 KEETVKLFICELVMA--LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---- 166
Query: 994 EASSSTTPIGSLGYVSPEAASTGQP---TKEADVYSFGIVLLEILTGRKPVMFTQDEDIV 1050
+ TT G+ Y++PE S+ + + D +S G+ E+L GR+P
Sbjct: 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226
Query: 1051 KWVKKQLQR-----GQISE----LLEPGLLELDPE 1076
+ V S+ LL+ LLE +P+
Sbjct: 227 EIVHTFETTVVTYPSAWSQEMVSLLK-KLLEPNPD 260
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 59/278 (21%), Positives = 118/278 (42%), Gaps = 37/278 (13%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFR---KEAEALGK-VKHR 892
+ L RG YG++ K + G +++++R+R T++ + + + + V
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL--ISLGLARG 950
G DV + + M + +L ++ + + P L I++ + +
Sbjct: 67 FTVTFYGALFREGDVWI-CMELM-DTSLDKFYKQVIDKGQTI---PEDILGKIAVSIVKA 121
Query: 951 LSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
L LHS L ++H D+KP NVL +A + + +FG+ + A+ G Y++
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMA 177
Query: 1010 PE----AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065
PE + + ++D++S GI ++E+ R P + +QL+ Q+ E
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPF----QQLK--QVVEE 229
Query: 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P L D S+E+ +F C + +RP+
Sbjct: 230 PSPQLPA-DKFSAEFVDFT------SQCLKKNSKERPT 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 35/279 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFR---KEAEALGK-VKHR 892
+ + RG YG + K + G +++++R+R T+DE + + + + +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
+ G D + + M + + + V+ + I+L + L+
Sbjct: 82 YIVQFYGALFREGDC-WICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 953 FLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS-TTPIGSLGYVSP 1010
L L ++H DIKP N+L D L +FG I+ S + T G Y++P
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFG-----ISGQLVDSIAKTRDAGCRPYMAP 194
Query: 1011 EAASTGQPTKE----ADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
E + +DV+S GI L E+ TGR P + + + QL Q+ +
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVF----DQLT--QVVKGD 246
Query: 1067 EPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P L + S + F V LC D RP
Sbjct: 247 PPQLSNSEEREFSPSFINF---VN---LCLTKDESKRPK 279
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 59/301 (19%), Positives = 114/301 (37%), Gaps = 55/301 (18%)
Query: 842 ENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGT--IDENTFRKEAEALGKV-KHR 892
L G +G + +A+ + ++++ L+ ++ E + + + +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 893 NLTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP-------MRHLI 943
N+ L G + GP L++ +Y G+L L+ S + R L+
Sbjct: 111 NIVNLLGACTHGGPV---LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 944 SLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT- 1000
A+G++FL S + +H D+ +NVL A + +FGL R +
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 1001 -PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP---VMFTQDEDIVKWVKK 1055
P+ +++PE+ T ++DV+S+GI+L EI + G P ++ K
Sbjct: 228 LPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYK 278
Query: 1056 QLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113
++ G + P + C A +P RP+ I L+
Sbjct: 279 LVKDGYQ---MAQ------PAFAPKNIYSIMQA------CWALEPTHRPTFQQICSFLQE 323
Query: 1114 C 1114
Sbjct: 324 Q 324
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-15
Identities = 53/290 (18%), Positives = 101/290 (34%), Gaps = 55/290 (18%)
Query: 842 ENVLSRGRYGLIFKAS---------------YQDGMVLSIRRLRDGTIDENTFRKEAEAL 886
L G YG + Q ++ E L
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 887 GKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLI 943
+ H N+ L + LV ++ G L + D + M+ ++
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYF-YLVTEFYEGGELFEQIINRHKFDECDAANI---MKQIL 156
Query: 944 SLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTT 1000
S G+ +LH ++VH DIKP+N+L ++ + +FGL ++
Sbjct: 157 S-----GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF----SKDYKLRD 207
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
+G+ Y++PE + ++ DV+S G+++ +L G P D+DI+K V+K
Sbjct: 208 RLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG---- 262
Query: 1061 QISELLEPGLLELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ + ++W+ K +L D R + +
Sbjct: 263 -----------KYYFDFNDWKNISDEAKELIKLMLT--YDYNKRCTAEEA 299
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-15
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 23/252 (9%)
Query: 798 SPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKAS 857
P + S + S + G K+ + + V+ G +G++++A
Sbjct: 15 KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74
Query: 858 YQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-----LV 911
D G +++I+++ +N +E + + K+ H N+ LR ++ + + LV
Sbjct: 75 LCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRH--LISLGLARGLSFLHSLDMVHGDIKPQNV 969
DY+P T+ + A H P+ + L L R L+++HS + H DIKPQN+
Sbjct: 132 LDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187
Query: 970 LFDAD-FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA--ASTGQPTKEADVYS 1026
L D D L +FG + + + + I S Y +PE +T T DV+S
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGAT-DYTSSIDVWS 242
Query: 1027 FGIVLLEILTGR 1038
G VL E+L G+
Sbjct: 243 AGCVLAELLLGQ 254
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 15/209 (7%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRR--LRDGTIDENTFRKEAEALGKVKHR 892
F + + +G +G +FK + V++I+ L + + ++E L +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 893 NLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
+T G Y D +L ++ +Y+ G+ LL+ + + I + +GL
Sbjct: 81 YVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEPGPLDETQI------ATILREILKGL 132
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
+LHS +H DIK NVL E L++FG+ T T +G+ +++PE
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPE 189
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+AD++S GI +E+ G P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 62/283 (21%), Positives = 117/283 (41%), Gaps = 62/283 (21%)
Query: 844 VLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE-NTFRKEAEALGKVKHRNLTVLRGYY 901
VL +G YG+++ + + ++I+ + + +E +KH+N+ G +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 902 AGPPDVRLLVY-DYMPNGNLATLLQEA----SHQDGHVLNWPMRHLISLGLARGLSFLHS 956
+ + + ++ + +P G+L+ LL+ + + + + ++ GL +LH
Sbjct: 89 SE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY-TKQILE-----GLKYLHD 140
Query: 957 LDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE---A 1012
+VH DIK NVL + +S+FG + + T G+L Y++PE
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFG---TSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP---- 1068
G AD++S G ++E+ TG+ P + EL EP
Sbjct: 198 GPRGYGKA-ADIWSLGCTIIEMATGKPP-----------F----------YELGEPQAAM 235
Query: 1069 ---GLLELDPE-----SSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
G+ ++ PE S+E + F+ L C PDP R
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFI------LKCFEPDPDKRAC 272
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 9e-15
Identities = 41/218 (18%), Positives = 77/218 (35%), Gaps = 18/218 (8%)
Query: 836 TRQFDEENVLSRGR--YGLIFKASY-QDGMVLSIRRL---RDGTIDENTFRKEAEALGKV 889
++ V+ +G + A Y G +++RR+ + E
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 890 KHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
H N+ R + D L +V +M G+ L+ +N I G+
Sbjct: 84 NHPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVL 138
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG----LDRLAIATPAEASSSTTPIGS 1004
+ L ++H + VH +K ++L D + +LS + +
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 1005 LGYVSPE--AASTGQPTKEADVYSFGIVLLEILTGRKP 1040
L ++SPE + ++D+YS GI E+ G P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 58/298 (19%)
Query: 842 ENVLSRGRYGLIFKASYQDG---MVLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLT 895
++V+ G +G + KA + M +I+R+++ D F E E L K+ H N+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 896 VLRGY--YAGPPDVRLLVYDYMPNGNLATLLQE-----------ASHQDGHVLNWPMRHL 942
L G + G L +Y P+GNL L++ ++ L+
Sbjct: 90 NLLGACEHRGYL---YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
+ +ARG+ +L +H D+ +N+L ++ A +++FGL R
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVK 197
Query: 1003 GSLGYV-----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVK 1054
++G + + E+ + T +DV+S+G++L EI++ G P M + +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY 251
Query: 1055 KQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
++L +G LE P + + E + L C P +RPS A I+ L
Sbjct: 252 EKLPQGY---RLEK------PLNCDDEVYDL----MRQCWREKPYERPSFAQILVSLN 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 47/272 (17%), Positives = 99/272 (36%), Gaps = 25/272 (9%)
Query: 794 EKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLI 853
+ + + ++ +D L G +G++
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 854 F----KASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909
+A+ + + + + RKE + + ++H L L + ++ +
Sbjct: 174 HRVTERATGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRHPTLVNLHDAFEDDNEM-V 230
Query: 910 LVYDYMPNGNL-ATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIK 965
++Y++M G L + E + + MR + GL +H + VH D+K
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEY---MRQVCK-----GLCHMHENNYVHLDLK 282
Query: 966 PQNVLFDADFEAHL--SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEAD 1023
P+N++F L +FGL P + S G+ + +PE A D
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTA--HLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 1024 VYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
++S G++ +L+G P D++ ++ VK
Sbjct: 339 MWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 54/301 (17%)
Query: 843 NVLSRGRYGLIFKASYQDGMVLS------IRRLRDGT--IDENTFRKEAEALGKV-KHRN 893
L RG +G + +A + ++ L++G + E + L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 894 LTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASH---------QDGHVLNWPMRHL 942
+ L G G P +++ ++ GNL+T L+ + +D + + HL
Sbjct: 93 VVNLLGACTKPGGP--LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 943 ISLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000
I A+G+ FL S +H D+ +N+L + +FGL R P
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 1001 --PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDEDIVKWVKK 1055
P+ +++PE T ++DV+SFG++L EI + G P + +E +
Sbjct: 211 RLPL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCR 262
Query: 1056 QLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113
+L+ G + P+ + E + + L C +P RP+ +++V L
Sbjct: 263 RLKEGTR---MRA------PDYTTPEMYQTM------LDCWHGEPSQRPTFSELVEHLGN 307
Query: 1114 C 1114
Sbjct: 308 L 308
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 41/244 (16%)
Query: 879 FRKEAEALGKV-KHRNLTVLRGYY---AGPPDVRLLVYDYMPNGNLATLLQEASHQ---- 930
R+E + + ++ + Y L++ + M G L + +QE Q
Sbjct: 68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 931 -DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDR 986
+ + MR + + + FLHS ++ H D+KP+N+L+ + D L++FG
Sbjct: 128 REAAEI---MRDIGT-----AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF-- 177
Query: 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD 1046
A ++ TP + YV+PE + K D++S G+++ +L G P
Sbjct: 178 ---AKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234
Query: 1047 EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPS 1103
+ I +K++++ GQ + EW E K LL T DP +R +
Sbjct: 235 QAISPGMKRRIRLGQY-----------GFPNPEWSEVSEDAKQLIRLLLKT--DPTERLT 281
Query: 1104 MADI 1107
+
Sbjct: 282 ITQF 285
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 29/232 (12%)
Query: 880 RKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWP 938
+E L K+ H N+ L P + L +V++ + G + + + +
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY- 142
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
+ LI G+ +LH ++H DIKP N+L D +++FG+ ++A S
Sbjct: 143 FQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NEFKGSDALLS 195
Query: 999 TTPIGSLGYVSPEAASTGQPT---KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
T G+ +++PE+ S + K DV++ G+ L + G+ P F DE I+ K
Sbjct: 196 NTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--F-MDERIMCLHSK 251
Query: 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
++ L P ++ + + L+ +L +P R + +I
Sbjct: 252 -IKSQ---ALEFPDQPDIAEDL----KDLIT---RMLD--KNPESRIVVPEI 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 53/277 (19%), Positives = 109/277 (39%), Gaps = 36/277 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFR---KEAEALGK-VKHR 892
+ + G G ++K + + G V++++++R + ++ + + + + K
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCP 84
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
+ G + DV + + M + + + +++ + + L
Sbjct: 85 YIVQCFGTFITNTDVFI-AMELMGTCAEKLKKRM-----QGPIPERILGKMTVAIVKALY 138
Query: 953 FLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
+L ++H D+KP N+L D + L +FG+ + A+ G Y++PE
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMAPE 194
Query: 1012 AASTGQPTKE-----ADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
PTK ADV+S GI L+E+ TG+ P + + + L ++ +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDF----EVLT--KVLQEE 246
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P L S +++ F VK C D RP
Sbjct: 247 PPLLPGHMGFSGDFQSF---VK---DCLTKDHRKRPK 277
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 28/153 (18%)
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKV 475
L +N + P +F +L ++LS N I + + L +L +L L NK
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK----- 91
Query: 476 PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQ 534
+ L L L L L+ ++ L ++ F L +L
Sbjct: 92 ------ITELP-------------KSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131
Query: 535 VVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
++SL +N L FS L +Q ++L+ N F
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 35/144 (24%), Positives = 57/144 (39%), Gaps = 9/144 (6%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLW 219
++ ++ + L N PG FS +L+ I+LS N S E+ L+ L L
Sbjct: 28 TNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV 86
Query: 220 LDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVP 278
L N + LP ++ SL L N + L + L +LSL N+L +
Sbjct: 87 LYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT-IA 144
Query: 279 VSVLCNLWGNISSLRIVQLGFNAF 302
L +++ + L N F
Sbjct: 145 KGTFSPL----RAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 31/129 (24%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGE 642
+ L N I + P L ++L +N + + D L + L L NK++ E
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 643 IPKEI-SKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTNRLSGAIPADLALISS 700
+PK + SL L L+ N ++ + +F L NL L+L N+L + + +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 701 LRYLNLSRN 709
++ ++L++N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 29/160 (18%)
Query: 529 GLP-SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPA-TYGFLRSLVFLSL 586
LP ++ + LE+N + P FS L+ ++LS+N + ++ + LRSL L L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87
Query: 587 SHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKE 646
N+I+ EL + F G L ++ L L NK++ + +
Sbjct: 88 YGNKIT----------------ELPKSLFEG--------LFSLQLLLLNANKIN-CLRVD 122
Query: 647 I-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685
+L L+L N L +FS L + T++L+ N
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 40/168 (23%), Positives = 63/168 (37%), Gaps = 34/168 (20%)
Query: 450 NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRL 509
N+P +T + L N + FS +L
Sbjct: 29 NLP------ETITEIRLEQNTIK----------------VIPPGAFSP--------YKKL 58
Query: 510 TTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAF 567
+DLSN +S EL + F GL SL + L N ++ ++P+ F L LQ L L+ N
Sbjct: 59 RRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI 116
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
+ L +L LSL N++ + A++ + L N F
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 35/154 (22%), Positives = 57/154 (37%), Gaps = 28/154 (18%)
Query: 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSLS 376
+ L+ N I+ + P + LR +DLS N S L L L L + N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
L LQ+ L N KI L + F +L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNAN----------------KINCLRVDAFQ--------DLHN 129
Query: 437 LETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
L L+L +N ++ I + + L + T++L+ N
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 27/108 (25%), Positives = 48/108 (44%), Gaps = 4/108 (3%)
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLS 664
+ L N P S +++++DL N++S E+ + SL SL L N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNL 711
F L +L L L+ N+++ + D + +L L+L N L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 29/136 (21%), Positives = 58/136 (42%), Gaps = 10/136 (7%)
Query: 216 EYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG 275
+ L+ N + P A S L + +N + L P + +L L L N++T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 276 LVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG--RCVSVLEVLDLQNNRIRAVFPS 333
L P S+ L SL+++ L N + + + L +L L +N+++ +
Sbjct: 95 L-PKSLFEGL----FSLQLLLLNANKINCL---RVDAFQDLHNLNLLSLYDNKLQTIAKG 146
Query: 334 WLTNVTSLRVMDLSGN 349
+ + +++ M L+ N
Sbjct: 147 TFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 35/148 (23%), Positives = 58/148 (39%), Gaps = 24/148 (16%)
Query: 125 YLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGN 184
L+ N+ +P F LR +DLS+N + P
Sbjct: 38 RLEQNTIK-VIPPGAF-----------SPY----------KKLRRIDLSNNQISELAPDA 75
Query: 185 FSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLS 243
F L + L N + E+P S+ L L+ L L++N + A + +L LS
Sbjct: 76 FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134
Query: 244 AEDNVLKGLIPGTIGRISTLQVLSLSRN 271
DN L+ + GT + +Q + L++N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 27/130 (20%), Positives = 49/130 (37%), Gaps = 6/130 (4%)
Query: 98 RKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFN-LTNLLVLNVAHNLLS 156
++ L N + P + LR + L N S L F L +L L + N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 157 GKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQ 213
++ + SL+ L L++N F L L++L N + L+
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 214 ELEYLWLDSN 223
++ + L N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 10/97 (10%)
Query: 618 NIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPE-SFSKLSN 676
N+P I ++ L QN + P S L + L N +S + +F L +
Sbjct: 29 NLPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 677 LTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNLE 712
L +L L N+++ +P L + SL+ L L+ N +
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 30/134 (22%), Positives = 58/134 (43%), Gaps = 8/134 (5%)
Query: 73 VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNSF 131
+ E+RL + + + +LR++ L +N ++ + + L ++ L N
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 132 SGHLPLSIF-NLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSS 187
+ LP S+F L +L +L + N ++ + D +L L L N G FS
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 188 KSQLQLINLSYNSF 201
+Q ++L+ N F
Sbjct: 151 LRAIQTMHLAQNPF 164
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 62/298 (20%), Positives = 112/298 (37%), Gaps = 68/298 (22%)
Query: 847 RGRYGLIFKASYQDGMVLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRG--YY 901
I K ++ + ++++ L+D D + E E + + KH+N+ L G
Sbjct: 99 MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEAS-----------HQDGHVLNWPMRHLISLGLARG 950
GP ++ +Y GNL L+ + + + LARG
Sbjct: 159 DGPL---YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY--- 1007
+ +L S +H D+ +NVL + +++FGL R I ++ Y
Sbjct: 216 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--------------INNIDYYKK 261
Query: 1008 ----------VSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQ 1056
++PEA T ++DV+SFG+++ EI T G P E+ + K
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKL 317
Query: 1057 LQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
L+ G ++ P ++E + C P RP+ +V L+
Sbjct: 318 LKEGH---RMDK------PANCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLD 360
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS------IRRLRDGT--IDENTFRKEAEALGKVKHRN 893
L G +G + KA+ + ++ L++ + E L +V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 894 LTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNW-------------- 937
+ L G GP LL+ +Y G+L L+E+ L
Sbjct: 88 VIKLYGACSQDGPL---LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 938 ---PMRHLISLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
M LIS ++G+ +L + +VH D+ +N+L + +S+FGL R
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 993 AEASSSTT--PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDI 1049
+ S P+ +++ E+ T ++DV+SFG++L EI+T G P E +
Sbjct: 205 SYVKRSQGRIPV---KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 1050 VKWVKKQLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
L+ G +E P+ S E + L C +P RP ADI
Sbjct: 262 F----NLLKTGHR---MER------PDNCSEEMYRLM------LQCWKQEPDKRPVFADI 302
Query: 1108 VFMLE 1112
LE
Sbjct: 303 SKDLE 307
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 31/155 (20%)
Query: 417 SLGRNMFSGLIPL-SFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGK 474
L N F+ L F L QL +N S N I +I E S + + L+ N+
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNR---- 92
Query: 475 VPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSL 533
L+ N+ F G L L TL L + ++ + + F GL S+
Sbjct: 93 -------LE-----NVQHKMFKG--------LESLKTLMLRSNRIT-CVGNDSFIGLSSV 131
Query: 534 QVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAF 567
+++SL +N ++ V G F +L L LNL N F
Sbjct: 132 RLLSLYDNQITT-VAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 35/168 (20%)
Query: 547 VPEGFSSLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGACSA 604
+PE L L++N FT + AT F L L ++ S+N+I+
Sbjct: 26 IPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT------------ 70
Query: 605 LEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSL 663
++ F G S + ++ L N+L + ++ SL +L L N +
Sbjct: 71 ----DIEEGAFEG--------ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI 117
Query: 664 SGRIPE-SFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNLSRN 709
+ + SF LS++ L+L N+++ + + SL LNL N
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 37/142 (26%), Positives = 60/142 (42%), Gaps = 7/142 (4%)
Query: 451 IPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSGKIPGSIGSLMRL 509
IPE I L L+ N+F + L L +N S + + G+ +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 510 TTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAF 567
+ L++ L + ++F GL SL+ + L N ++ V F L ++ L+L DN
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 568 TGDIPATYGFLRSLVFLSLSHN 589
T P + L SL L+L N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 32/155 (20%), Positives = 55/155 (35%), Gaps = 29/155 (18%)
Query: 318 EVLDLQNNRIRAVFPS-WLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSL 375
L L NN + + + LR ++ S N + ++ + + + +N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
+ MF G+ LK + L N + + SF LS
Sbjct: 94 ENVQHK---------MFK---------------GLESLKTLMLRSNRITCVGNDSFIGLS 129
Query: 436 QLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
+ L+L +N I + L +L+TLNL N
Sbjct: 130 SVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 606 EVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664
L L +N FT I L +++K++ NK++ S + + L N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADL--ALISSLRYLNLSRNNL 711
+ F L +L TL L +NR++ + D L SS+R L+L N +
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL-SSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 37/148 (25%), Positives = 54/148 (36%), Gaps = 23/148 (15%)
Query: 125 YLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGN 184
L N F+ IF L P LR ++ S+N T G
Sbjct: 38 RLNNNEFTVLEATGIF-----------KKL----------PQLRKINFSNNKITDIEEGA 76
Query: 185 FSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLS 243
F S + I L+ N V + L+ L+ L L SN + + SS+ LS
Sbjct: 77 FEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135
Query: 244 AEDNVLKGLIPGTIGRISTLQVLSLSRN 271
DN + + PG + +L L+L N
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 30/159 (18%), Positives = 55/159 (34%), Gaps = 31/159 (19%)
Query: 216 EYLWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT 274
L L++N + I L ++ +N + + G S + + L+ N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 275 GLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSW 334
+ + F G+ L+ L L++NRI V
Sbjct: 95 NV-QHKM--------------------FKGLES---------LKTLMLRSNRITCVGNDS 124
Query: 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANN 373
++S+R++ L N + P A +L L L + N
Sbjct: 125 FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 9/97 (9%)
Query: 618 NIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
+IP +L L N+ + I K L + N ++ +F S
Sbjct: 29 HIPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 677 LTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNLE 712
+ + L++NRL + + + SL+ L L N +
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT 118
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 34/135 (25%), Positives = 53/135 (39%), Gaps = 9/135 (6%)
Query: 73 VRELRLPRLQLAG-RLTDQLADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRAVYLQYNS 130
ELRL + T L +LRK++ +N + I + S + + L N
Sbjct: 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNR 92
Query: 131 FSGHLPLSIF-NLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFS 186
+ +F L +L L + N ++ + D S+R L L N T PG F
Sbjct: 93 LEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150
Query: 187 SKSQLQLINLSYNSF 201
+ L +NL N F
Sbjct: 151 TLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 33/186 (17%), Positives = 60/186 (32%), Gaps = 55/186 (29%)
Query: 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVL 320
L L+ NE T L + L L +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKL-----------------------------PQLRKI 62
Query: 321 DLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSLSGLV 379
+ NN+I + + + + L+ N N+ + L+ L+ L + +N ++ +
Sbjct: 63 NFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVG 121
Query: 380 PDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLET 439
D F G+ ++++SL N + + P +F L L T
Sbjct: 122 ND---------SFI---------------GLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157
Query: 440 LNLSEN 445
LNL N
Sbjct: 158 LNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 19/73 (26%), Positives = 30/73 (41%), Gaps = 5/73 (6%)
Query: 642 EIPKEISKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTNRLSGAIPAD-LALIS 699
+IP+ I L L+ N + F KL L +N S N+++ I S
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 700 SLRYLNLSRNNLE 712
+ + L+ N LE
Sbjct: 82 GVNEILLTSNRLE 94
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 63/298 (21%), Positives = 112/298 (37%), Gaps = 68/298 (22%)
Query: 847 RGRYGLIFKASYQDGMVLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGY--Y 901
I K ++ + ++++ L+D D + E E + + KH+N+ L G
Sbjct: 53 MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112
Query: 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP---------MRHLISLGL--ARG 950
GP ++ +Y GNL L+ + L+S ARG
Sbjct: 113 DGPL---YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY--- 1007
+ +L S +H D+ +NVL + +++FGL R I ++ Y
Sbjct: 170 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--------------INNIDYYKK 215
Query: 1008 ----------VSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQ 1056
++PEA T ++DV+SFG+++ EI T G P E+ + K
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKL 271
Query: 1057 LQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
L+ G ++ P ++E + C P RP+ +V L+
Sbjct: 272 LKEGH---RMDK------PANCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLD 314
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 36/187 (19%)
Query: 879 FRKEAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNW 937
F +E + + + L +YA D L +V +YMP G+L L+
Sbjct: 116 FWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMS------------ 161
Query: 938 PMRHLISLGLAR--------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989
+ + AR L +HS+ +H D+KP N+L D L++FG +
Sbjct: 162 --NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCM 216
Query: 990 ATPAEASSST-TPIGSLGYVSPE----AASTGQPTKEADVYSFGIVLLEILTGRKPVMFT 1044
E T +G+ Y+SPE G +E D +S G+ L E+L G P F
Sbjct: 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FY 274
Query: 1045 QDEDIVK 1051
+ +V
Sbjct: 275 -ADSLVG 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-14
Identities = 48/224 (21%), Positives = 89/224 (39%), Gaps = 39/224 (17%)
Query: 875 DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QD 931
E E L K+ H + ++ ++ D +V + M G L +
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDY-YIVLELMEGGELFDKVVGNKRLKEAT 240
Query: 932 GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLA 988
+ ++ + +LH ++H D+KP+NVL + D +++FG ++
Sbjct: 241 CKLY---FYQMLL-----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 989 IATPAEASSSTTPIGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045
E S T G+ Y++PE + T + D +S G++L L+G P F+
Sbjct: 293 ----GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FS- 345
Query: 1046 DEDIVKWVKKQLQRGQ----------ISEL---LEPGLLELDPE 1076
+ +K Q+ G+ +SE L LL +DP+
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 7e-14
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRN 893
F + VL RG +G +F + G + + ++L + E + L KV R
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR--- 949
+ L YA L LV M G++ + + A
Sbjct: 247 IVSL--AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP---------GFQEPRAIFYT 295
Query: 950 -----GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
GL LH ++++ D+KP+NVL D D +S+ G LA+ A + + G+
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG---LAVELKAGQTKTKGYAGT 352
Query: 1005 LGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK 1051
G+++PE G+ D ++ G+ L E++ R P F + V+
Sbjct: 353 PGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAARGP--FRARGEKVE 397
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDEN-TFRKEAEALGKVKH 891
+ +F E + +G +G + + GM ++I+++ N + + L + H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78
Query: 892 RNLTVLRGYY-----AGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRH--LI 943
N+ L+ Y+ D+ L +V +Y+P TL + + + P +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 944 SLGLARGLSFLH--SLDMVHGDIKPQNVLFD-ADFEAHLSEFGLDRLAIATPAEASSSTT 1000
L R + LH S+++ H DIKP NVL + AD L +FG + +P+E + +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAY- 191
Query: 1001 PIGSLGYVSPEA--ASTGQPTKEADVYSFGIVLLEILTGR 1038
I S Y +PE + T D++S G + E++ G
Sbjct: 192 -ICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 50/292 (17%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRN 893
F+ ++ G YG ++K + + G + +I+ + +E ++E L K HRN
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 894 LTVLRGYY----AGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
+ G + D +L LV ++ G++ L++ G+ L I +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN---TKGNTLKEEWIAYICREIL 139
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
RGLS LH ++H DIK QNVL + E L +FG+ T T IG+ ++
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT---VGRRNTFIGTPYWM 196
Query: 1009 SPEAASTGQPTKE-----ADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKK 1055
+PE + + +D++S GI +E+ G P +F I +
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRN--- 249
Query: 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
L+ S +++ F+ C + RP+ +
Sbjct: 250 -----------PAPRLKSKKWSKKFQSFI------ESCLVKNHSQRPATEQL 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 43/214 (20%), Positives = 86/214 (40%), Gaps = 14/214 (6%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRR--LRDGTIDENTFRKEAEALGKVKHRNL 894
++ + V+ G ++ A ++I+R L + KE +A+ + H N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 895 TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL----ISLGLAR 949
+ L LV + G++ +++ G + + I +
Sbjct: 76 VSYYTSFVV--KDELWLVMKLLSGGSVLDIIKHI-VAKGEHKSGVLDESTIATILREVLE 132
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR--LAIATPAEASSSTTPIGSLGY 1007
GL +LH +H D+K N+L D +++FG+ T +G+ +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 1008 VSPEAASTGQP-TKEADVYSFGIVLLEILTGRKP 1040
++PE + +AD++SFGI +E+ TG P
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 60/309 (19%), Positives = 108/309 (34%), Gaps = 62/309 (20%)
Query: 842 ENVLSRGRYGLIFKASYQDGMVLS------IRRLRDGT--IDENTFRKEAEALGKV-KHR 892
VL G +G + A+ ++ L++ + E + + ++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 893 NLTVLRGY--YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP------------ 938
N+ L G +GP L+++Y G+L L+ +
Sbjct: 110 NIVNLLGACTLSGPI---YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 939 ----MRHLISLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
L+ A+G+ FL VH D+ +NVL + +FGL R ++
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 993 AEASSSTT--PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKP--VMFTQDE 1047
P+ +++PE+ G T ++DV+S+GI+L EI + G P +
Sbjct: 227 NYVVRGNARLPV---KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283
Query: 1048 DIVKWVKKQLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105
K +Q G ++ P + E + C A D RPS
Sbjct: 284 -----FYKLIQNGFK---MDQ------PFYATEEIYIIM------QSCWAFDSRKRPSFP 323
Query: 1106 DIVFMLEGC 1114
++ L
Sbjct: 324 NLTSFLGCQ 332
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 58/279 (20%), Positives = 110/279 (39%), Gaps = 45/279 (16%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRN 893
+++ + +G G ++ A G ++IR++ + E + + K+ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
+ Y L +V +Y+ G+L ++ E +G + + + L
Sbjct: 79 IVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQI------AAVCRECLQALE 130
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
FLHS ++H DIK N+L D L++FG A TP E S +T +G+ +++PE
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITP-EQSKRSTMVGTPYWMAPEV 187
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKKQLQRGQISE 1064
+ + D++S GI+ +E++ G P ++ I+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----------------LIAT 230
Query: 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P L + S+ + +FL C D R S
Sbjct: 231 NGTPELQNPEKLSAIFRDFL------NRCLEMDVEKRGS 263
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/282 (20%), Positives = 107/282 (37%), Gaps = 52/282 (18%)
Query: 844 VLSRGRYGLIF----KASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG 899
L G +G + ++S + ++ +I + + E E L + H N+ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINK-DRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGH-------VLNWPMRHLISLGLARGLS 952
+ ++ + V + G L + A + L M+ +++ L+
Sbjct: 88 VFEDYHNMYI-VMETCEGGELLERIVSAQARGKALSEGYVAEL---MKQMMN-----ALA 138
Query: 953 FLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
+ HS +VH D+KP+N+LF + +FGL L ST G+ Y++
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF----KSDEHSTNAAGTALYMA 194
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
PE T + D++S G+V+ +LTG P T E++ +
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-------------K 240
Query: 1070 LLELDPE----SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
E + + + +K +L DP RPS A +
Sbjct: 241 EPNYAVECRPLTPQAVDL---LK-QMLT--KDPERRPSAAQV 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 53/274 (19%), Positives = 111/274 (40%), Gaps = 26/274 (9%)
Query: 792 TGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYG 851
+ + + G ++ + I + F+ E+ L RG
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 852 LIFKAS-YQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910
++++ +++ L T+D+ R E L ++ H N+ L+ + P ++ L
Sbjct: 68 IVYRCKQKGTQKPYALKVL-KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI-SL 125
Query: 911 VYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQ 967
V + + G L + E + +D ++ ++ +++LH +VH D+KP+
Sbjct: 126 VLELVTGGELFDRIVEKGYYSERDAADA---VKQILE-----AVAYLHENGIVHRDLKPE 177
Query: 968 NVLF-DADFEAHL--SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADV 1024
N+L+ +A L ++FGL ++ T G+ GY +PE E D+
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIV----EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233
Query: 1025 YSFGIVLLEILTGRKPVMF---TQDEDIVKWVKK 1055
+S GI+ +L G +P F D+ + + +
Sbjct: 234 WSVGIITYILLCGFEP--FYDERGDQFMFRRILN 265
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 65/295 (22%), Positives = 112/295 (37%), Gaps = 48/295 (16%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVL---SIRRLRDGTIDENTFRKEAEALGKVK-HRNLTV 896
E+VL G + + I + + G I FR E E L + + HRN+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFR-EVEMLYQCQGHRNVLE 75
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSF 953
L ++ LV++ M G++ + + + H + V+ ++ + S L F
Sbjct: 76 LIEFFEEEDRF-YLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVAS-----ALDF 126
Query: 954 LHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRL----AIATPAEASSSTTPIGSLG 1006
LH+ + H D+KP+N+L + + +F L +P TP GS
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 1007 YVSPE--AASTGQPT---KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ 1061
Y++PE A + + + K D++S G++L +L+G P F RG+
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP--FVGRCG----SDCGWDRGE 240
Query: 1062 ISELLEPGLLE------LDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ L E + +W K LL D R S A +
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLV--RDAKQRLSAAQV 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 39/215 (18%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 844 VLSRGRYGLIFKASY-QDGM-----VLSIRRLR-DGTIDENTFRKEAEALGKVKHRNLTV 896
V+ +G + ++ + + G ++ + + + ++EA +KH ++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG--------HVLNWPMRHLISLGLA 948
L Y+ + +V+++M +L + + + H MR ++
Sbjct: 91 LLETYSSDGML-YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY----MRQILE---- 141
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAH---LSEFGLDRLAIATPAEASSSTTPIGSL 1005
L + H +++H D+KP VL + + L FG +AI + +G+
Sbjct: 142 -ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG---VAIQLGESGLVAGGRVGTP 197
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+++PE K DV+ G++L +L+G P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-13
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 24/220 (10%)
Query: 838 QFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTI----DENTFRKEAEALGKVK-- 890
F ++ RG +G ++ D G + +++ L I E E L V
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 891 -HRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
+ + YA +L + D M G+L L Q G MR + +
Sbjct: 250 DCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAA-EII 302
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
GL +H+ +V+ D+KP N+L D +S+ GL A +G+ GY+
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-----ACDFSKKKPHASVGTHGYM 357
Query: 1009 SPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDE 1047
+PE G AD +S G +L ++L G P F Q +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHK 395
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 23/210 (10%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVL---SIRRLRDGTIDENTFRKEAEALGKVKH 891
T ++ L +G + ++ + G I + D +EA +KH
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 892 RNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLA 948
N+ L + L ++D + G L + + D ++ ++
Sbjct: 70 PNIVRLHDSISEEGHHYL-IFDLVTGGELFEDIVAREYYSEADASHC---IQQILE---- 121
Query: 949 RGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
+ H + +VH ++KP+N+L L++FG LAI E + G+
Sbjct: 122 -AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG---LAIEVEGEQQAWFGFAGTP 177
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEIL 1035
GY+SPE K D+++ G V+L IL
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACG-VILYIL 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 63/265 (23%), Positives = 104/265 (39%), Gaps = 46/265 (17%)
Query: 869 LRDGT--IDENTFRKEAEALGKV-KHRNLTVLRG--YYAGPPDVRLLVYDYMPNGNLATL 923
L+ D + E E + + KH+N+ L G GP ++ +Y GNL
Sbjct: 109 LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL---YVIVEYASKGNLREY 165
Query: 924 LQEASHQDGHVLNWP---------MRHLISLGL--ARGLSFLHSLDMVHGDIKPQNVLFD 972
LQ P + L+S ARG+ +L S +H D+ +NVL
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225
Query: 973 ADFEAHLSEFGLDRLAIATPAEASSSTT--PIGSLGYVSPEAASTGQPTKEADVYSFGIV 1030
D +++FGL R ++ P+ +++PEA T ++DV+SFG++
Sbjct: 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVL 282
Query: 1031 LLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE--SSEWEEFLLGV 1087
L EI T G P E+ + K L+ G ++ P ++E +
Sbjct: 283 LWEIFTLGGSPYPGVPVEE----LFKLLKEGH---RMDK------PSNCTNELYMMM--- 326
Query: 1088 KVGLLCTAPDPLDRPSMADIVFMLE 1112
C P RP+ +V L+
Sbjct: 327 ---RDCWHAVPSQRPTFKQLVEDLD 348
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 43/215 (20%), Positives = 89/215 (41%), Gaps = 23/215 (10%)
Query: 836 TRQFDEENVLSRGRYGLIFKASYQD-GMVL---SIRRLRDGTIDENTFRKEAEALGKVKH 891
+ +D + L +G + ++ + ++ G+ I + D +EA K++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 892 RNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLA 948
N+ L L V+D + G L + D ++ ++
Sbjct: 65 PNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHC---IQQILE---- 116
Query: 949 RGLSFLHSLDMVHGDIKPQNVLF-DADFEAHL--SEFGLDRLAIATPAEASSSTTPIGSL 1005
+++ HS +VH ++KP+N+L A + ++FGL ++ + G+
Sbjct: 117 -SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV----NDSEAWHGFAGTP 171
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
GY+SPE +K D+++ G++L +L G P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 48/220 (21%), Positives = 89/220 (40%), Gaps = 38/220 (17%)
Query: 880 RKEAEALGK-VKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVL 935
+E E L + +H N+ L+ Y V +V + M G L + ++ +
Sbjct: 63 TEEIEILLRYGQHPNIITLKDVYDDGKYV-YVVTELMKGGELLDKILRQKFFSEREASAV 121
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH----LSEFGLDRLAIAT 991
+ + + +LH+ +VH D+KP N+L+ + + +FG A
Sbjct: 122 ---LFTITK-----TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQL 170
Query: 992 PAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMF-TQDEDI 1049
AE TP + +V+PE Q D++S G++L +LTG P F +D
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTP--FANGPDDT 227
Query: 1050 VKWVKKQLQRGQ----------ISEL---LEPGLLELDPE 1076
+ + ++ G+ +S+ L +L +DP
Sbjct: 228 PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 46/279 (16%), Positives = 99/279 (35%), Gaps = 45/279 (16%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRN 893
D + G G++ A G ++++ + E + +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
+ + Y L ++ +++ G L ++ + + + + + + L+
Sbjct: 104 VVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQVRLNEEQI------ATVCEAVLQALA 155
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+LH+ ++H DIK ++L D LS+FG + + +G+ +++PE
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEV 212
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKKQLQRGQISE 1064
S E D++S GI+++E++ G P M ++ +
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-----------------RLRD 255
Query: 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P L S +FL DP +R +
Sbjct: 256 SPPPKLKNSHKVSPVLRDFL------ERMLVRDPQERAT 288
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 51/260 (19%), Positives = 94/260 (36%), Gaps = 37/260 (14%)
Query: 880 RKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPM 939
+E + + H N+ L + L+ +Y G + L
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTL-YLIMEYASGGEVFDYLVAHGRMKEKEARSKF 120
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
R ++S + + H +VH D+K +N+L DAD +++FG
Sbjct: 121 RQIVS-----AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF----SNEFTVGGKLD 171
Query: 1000 TPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
G+ Y +PE G+ E DV+S G++L +++G P F D +K +++++
Sbjct: 172 AFCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLP--F--DGQNLKELRERV 226
Query: 1058 QRGQ------ISELLE---PGLLELDPE---------SSEWEEFLLGVKVGLLCTAPDPL 1099
RG+ +S E L L+P W G + L +P
Sbjct: 227 LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW--INAGHEEDELKPFVEPE 284
Query: 1100 DRPSMADIVFMLEGCRVGPD 1119
S + ++ G +
Sbjct: 285 LDISDQKRIDIMVGMGYSQE 304
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 4e-13
Identities = 78/484 (16%), Positives = 156/484 (32%), Gaps = 52/484 (10%)
Query: 233 ISNCSSLVHLSAEDNVLKGLIPGTIGRIST----LQVLSLSRNELT--GLVPVSVLCNLW 286
+ + + G + I +S+ L+ + L R +T L ++
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSF--- 129
Query: 287 GNISSLRIVQL-GFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWL-------TNV 338
+ +++ L F+ L+ LDL+ + + V WL T++
Sbjct: 130 ---KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186
Query: 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG-- 396
SL + L+ L V L+ L++ + + + L+ G
Sbjct: 187 VSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYT 246
Query: 397 ----NRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN-I 451
+ L G + L+ +S + +P + S+L TLNLS ++ +
Sbjct: 247 AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDL 306
Query: 452 PEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGS--------- 502
+ + + L L + + K L L + S P
Sbjct: 307 VKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366
Query: 503 -IGSLMRLTTLDLSNQNLSGELPIEL-FGLPSLQVVSLEENNLSGDVP-------EGFSS 553
+L ++ + ++ I + P++ L GF +
Sbjct: 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGA 426
Query: 554 LV----GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGM-IPAELGACSALEVL 608
+V L+ L+LS + + + LS++ S + + L C +L L
Sbjct: 427 IVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486
Query: 609 ELRSNHFTGN-IPVDISHLSRIKKLDLGQNKLSGEIPKEIS-KCSSLVSLTLDMNSLSGR 666
E+R F + + S L ++ L + +S K + K L +D
Sbjct: 487 EIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDS 546
Query: 667 IPES 670
PES
Sbjct: 547 RPES 550
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 67/449 (14%), Positives = 134/449 (29%), Gaps = 53/449 (11%)
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTS----LRVMDLSGNFFS----GNLPAAVGSLD 363
+ +L + W+ ++S L + L + + + +
Sbjct: 74 KGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK 133
Query: 364 KLEVLRVANNSLSGLVPDEIAK-CSLLQMFDLEGNRFSGQVPAFLGGI-------RGLKI 415
L + S GL IA C L+ DL + +L L I
Sbjct: 134 VLVLSSCEGFSTDGLA--AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI 191
Query: 416 VSLGRNM-FSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSY------ 468
L + FS L L L++L L+ + + R L L
Sbjct: 192 SCLASEVSFSALERLV-TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVR 250
Query: 469 NKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF 528
+ + K L L+ +P RLTTL+LS + ++L
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLL 310
Query: 529 -GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATY----------GF 577
P LQ + + + + S+ L+ L + + P
Sbjct: 311 CQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG 370
Query: 578 LRSLVFLSLSHNQISGMIPAELGA-CSALEVLELR------SNHFTGNIPVD-----ISH 625
L + Q++ + + L ++ T + H
Sbjct: 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH 430
Query: 626 LSRIKKLDLGQNKLSGEIPKEISK-CSSLVSLTLDMNSLSGR-IPESFSKLSNLTTLNLS 683
+++L L L+ ++ + I + L++ S + S +L L +
Sbjct: 431 CKDLRRLSL-SGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR 489
Query: 684 TNRLSG-AIPADLALISSLRYLNLSRNNL 711
A+ A+ + + ++R L +S ++
Sbjct: 490 DCPFGDKALLANASKLETMRSLWMSSCSV 518
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 43/312 (13%), Positives = 88/312 (28%), Gaps = 33/312 (10%)
Query: 430 SFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSY---------------NKFGG 473
S+ + + + + P + R + ++ L
Sbjct: 36 SWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYP 95
Query: 474 KVPYDVGNLKGLLVLNLSASGFSGKIPGSIG-SLMRLTTLDLSN-QNLSGELPIELF-GL 530
+ + L + L + I S L LS+ + S + +
Sbjct: 96 WIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATC 155
Query: 531 PSLQVVSLEENNLSGDVPEGFSSLV----GLQYLNLSDNAFT---GDIPATYGFLRSLVF 583
+L+ + L E+++ S L LN+S A + +L
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS 215
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRS------NHFTGNIPVDISHLSRIKKLDLGQN 637
L L+ + L LE L + V +S ++ L +
Sbjct: 216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275
Query: 638 KLSGEIPKEISKCSSLVSLTLDMNSLSGR-IPESFSKLSNLTTLNLSTNRLSGAIPADLA 696
+ +P S CS L +L L ++ + + + L L + + +
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAS 335
Query: 697 LISSLRYLNLSR 708
LR L +
Sbjct: 336 TCKDLRELRVFP 347
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 89/598 (14%), Positives = 177/598 (29%), Gaps = 87/598 (14%)
Query: 21 YGEQNAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDW-RGIVCYNNRVRELRLP 79
Y A V+ + S +L K + W + + E+RL
Sbjct: 54 YAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLK 113
Query: 80 RLQLAGRLTDQLAD-LHELRKLSLHSNHL--NGSIPASLHQCSLLRAVYLQYNSFSGHLP 136
R+ + + +A + L L S + A C L+ + L+ +
Sbjct: 114 RMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSG 173
Query: 137 LSIF----NLTNLLVLNVAHNLLSGKISADI-------SPSLRYLDLSSNAFTGEIPGNF 185
+ T+L+ LN+ + L+ ++S P+L+ L L+ ++
Sbjct: 174 HWLSHFPDTYTSLVSLNI--SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLL 231
Query: 186 SSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAE 245
QL+ + Y +Y L A+S C L LS
Sbjct: 232 QRAPQLEELGTGG------------------YTAEVRPDVYSGLSVALSGCKELRCLSGF 273
Query: 246 DNVLKGLIPGTIGRISTLQVLSLSRNELT--GLVPVSVLCNLWGNISSLRIV-QLGFNAF 302
+ + +P S L L+LS + LV + C + L ++ +
Sbjct: 274 WDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC---PKLQRLWVLDYIEDAGL 330
Query: 303 TGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSL 362
+ C L L + +T ++ +S
Sbjct: 331 EVLAS----TCKD-LRELRV--FPSEPFVMEPNVALTEQGLVSVSMG------------C 371
Query: 363 DKLEVL-----RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVS 417
KLE + ++ N +L + + F L + +
Sbjct: 372 PKLESVLYFCRQMTNAALITIA----RNRPNMTRFRLCIIEPKAPDY-LTLEPLDIGFGA 426
Query: 418 LGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGK-VP 476
+ + L L+LS T + L++++ +
Sbjct: 427 IVE------------HCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474
Query: 477 YDVGNLKGLLVLNLSASGFSGK-IPGSIGSLMRLTTLDLSNQNLSGELPIEL-FGLPSLQ 534
+ + L L + F K + + L + +L +S+ ++S L +P L
Sbjct: 475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLN 534
Query: 535 VVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS 592
V ++E PE S V ++ + D+P + + S I+
Sbjct: 535 VEVIDERGAPDSRPE--SCPVERVFIYRTVAGPRFDMPGFVWNMDQDSTMRFSRQIIT 590
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN 893
+ + V+ G +G++F+A + ++I+++ +N +E + + VKH N
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN---RELQIMRIVKHPN 93
Query: 894 LTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQDGHVLNWPMRH--LISLG 946
+ L+ ++ D + LV +Y+P T+ + + H PM L
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
L R L+++HS+ + H DIKPQN+L D L +FG ++ IA + + I S
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP----NVSYICSR 205
Query: 1006 GYVSPEA--ASTGQPTKEADVYSFGIVLLEILTGR 1038
Y +PE +T T D++S G V+ E++ G+
Sbjct: 206 YYRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 54/277 (19%), Positives = 106/277 (38%), Gaps = 44/277 (15%)
Query: 844 VLSRGRYGLIFKASY-QDGMVL---SIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRG 899
+L +G +G + K I + D +T +E E L K+ H N+ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHS 956
+ V + G L + + D + ++ + S G++++H
Sbjct: 89 ILEDSSSFYI-VGELYTGGELFDEIIKRKRFSEHDAARI---IKQVFS-----GITYMHK 139
Query: 957 LDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
++VH D+KP+N+L + D + + +FGL + + IG+ Y++PE
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF----QQNTKMKDRIGTAYYIAPEVL 195
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
G ++ DV+S G++L +L+G P F + + K+++ G +
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPP--FYGKNE--YDILKRVETG-----------KY 239
Query: 1074 DPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ +W K +L P R +
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLT--FHPSLRITATQC 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 35/171 (20%), Positives = 70/171 (40%), Gaps = 31/171 (18%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMR 940
E + + ++ H L Y+ D +L Y NG L +++
Sbjct: 80 ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI------------- 124
Query: 941 HLISLGLAR--------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
R L +LH ++H D+KP+N+L + D +++FG ++
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 993 AEASSST---TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+A +++ T YVSPE + K +D+++ G ++ +++ G P
Sbjct: 185 KQARANSFVGTA----QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 57/278 (20%), Positives = 107/278 (38%), Gaps = 43/278 (15%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL 894
FD L G YG ++KA + + G +++I+++ D KE + + ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHV 86
Query: 895 TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
G Y + L +V +Y G+++ +++ L I +GL +
Sbjct: 87 VKYYGSYFK--NTDLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEY 140
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
LH + +H DIK N+L + + A L++FG +A + T IG+ +++PE
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHAKLADFG---VAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKKQLQRGQISEL 1065
AD++S GI +E+ G+ P +F I
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-----------------MIPTN 240
Query: 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
P + + S + +F+ C P R +
Sbjct: 241 PPPTFRKPELWSDNFTDFV------KQCLVKSPEQRAT 272
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 51/201 (25%), Positives = 78/201 (38%), Gaps = 41/201 (20%)
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLAIATPAEASS 997
+++ + HS +VH DIK +N+L D A L +FG L P
Sbjct: 145 FGQVVA-----AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---- 195
Query: 998 STTPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
T G+ Y PE S A V+S GI+L +++ G P F +D++I++
Sbjct: 196 -TDFDGTRVYSPPEWIS-RHQYHALPATVWSLGILLYDMVCGDIP--FERDQEILEA--- 248
Query: 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV---FMLE 1112
EL P + S + + C AP P RPS+ +I+ +M
Sbjct: 249 --------ELHFPAHV-----SPDCCALIRR------CLAPKPSSRPSLEEILLDPWMQT 289
Query: 1113 GCRVGPDMPSSADPTSLPSPM 1133
P PS P L +
Sbjct: 290 PAEDVPLNPSKGGPAPLAWSL 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 45/227 (19%)
Query: 875 DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNL------ATLLQEAS 928
E E L K+ H + ++ ++ D +V + M G L L+EA
Sbjct: 58 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDY-YIVLELMEGGELFDKVVGNKRLKEA- 114
Query: 929 HQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH---LSEFGLD 985
+ ++ + +LH ++H D+KP+NVL + E +++FG
Sbjct: 115 --TCKLY---FYQMLL-----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 986 RLAIATPAEASSSTTPIGSLGYVSPE---AASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
++ E S T G+ Y++PE + T + D +S G++L L+G P
Sbjct: 165 KIL----GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-- 218
Query: 1043 FTQDEDIVKWVKKQLQRGQ----------ISEL---LEPGLLELDPE 1076
F+ + +K Q+ G+ +SE L LL +DP+
Sbjct: 219 FS-EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 8e-13
Identities = 102/616 (16%), Positives = 178/616 (28%), Gaps = 168/616 (27%)
Query: 162 DISPSLRYLDLSSNAFTGEIPGNFSSKSQL-QLINLSYNSFSGEVPASVGQLQELEYLWL 220
D+ + + LS I + + S +L + V V ++ + Y +L
Sbjct: 37 DVQDMPKSI-LSKEEID-HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 221 -DSNHLYGTLPSAISNCSSLVHLSAED---NVLKGLIPGTIGRISTLQVLSLSRNELTGL 276
PS ++ +++ D N + + R+ L R L L
Sbjct: 95 MSPIKTEQRQPSMMTR----MYIEQRDRLYNDNQVFAKYNVSRLQPYLKL---RQALLEL 147
Query: 277 VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS--- 333
P + + G LG G+ L+V + +++
Sbjct: 148 RPAKNVL-IDG--------VLGS-----------GKTWVALDVC--LSYKVQCKMDFKIF 185
Query: 334 WLT--NVTS--------------LRVMDLSGNFFSGNLPAAVGSL-DKLEVL---RVANN 373
WL N S + S + S N+ + S+ +L L + N
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 374 SLSGLVPDEIAKCSLLQMFDLE-----GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
L LV + F+L RF QV FL I L
Sbjct: 246 CL--LVLLNVQNAKAWNAFNLSCKILLTTRFK-QVTDFLSAATTTHIS---------LDH 293
Query: 429 LSFGNLSQLETLNLSEN--DIR-GNIPEEITRLSNL------------------------ 461
S L+ E +L D R ++P E+ +
Sbjct: 294 HSMT-LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 462 ----TTLNLSYNKFGGKVPYDVGNL-KGLLVLNLSASGFSGKIP---------GSIGSLM 507
T + S N P + + L V SA IP I S +
Sbjct: 353 DKLTTIIESSLNVLE---PAEYRKMFDRLSVFPPSA-----HIPTILLSLIWFDVIKSDV 404
Query: 508 RLTTLDLSNQNLSGELPIE-LFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566
+ L +L + P E +PS+ + + + S+V Y N+
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE---NEYALHRSIVD-HY-NIPKTF 459
Query: 567 FTGDIPAT----YGF-----------------LRSLVFLSLS--HNQISGMIPAELGACS 603
+ D+ Y + L +VFL +I A + S
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 604 ALEVL-ELR--SNHFTGNIPVDISHLSRIKK--LDLGQNKLSGEIPKEISKCSSLVSLTL 658
L L +L+ + N P ++ I + +N + SK + L+ + L
Sbjct: 520 ILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI-------CSKYTDLLRIAL 572
Query: 659 DMNSLSGRIPESFSKL 674
M E+ ++
Sbjct: 573 -MAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-11
Identities = 79/580 (13%), Positives = 167/580 (28%), Gaps = 149/580 (25%)
Query: 566 AFTGDIPAT-YGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDIS 624
F ++ Y FL S + Q S M +E R + N
Sbjct: 81 KFVEEVLRINYKFLMSP--IKTEQRQPSMM---------TRMYIEQRDRLYNDNQVFAKY 129
Query: 625 HLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLD-MNSLSGRIPESFSKLSNLTTLNLS 683
++SR++ + L P + + +D + G K + +
Sbjct: 130 NVSRLQPYLKLRQALLELRPAKN--------VLIDGV---LG-----SGK-TWVALDVCL 172
Query: 684 TNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFN--DPSIFAMNRELCGKPLD 741
+ ++ + + +LNL N + +ML DP+ + + L
Sbjct: 173 SYKVQCKMDFKIF------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 742 RECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLR--W-RQTLRAWATGEKKPS 798
R+ L+ CLL +L + A+ K
Sbjct: 227 IHSIQAELRR------LLKSKPYENCLL----------VLLNVQNAKAWNAFNLSCKILL 270
Query: 799 PSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENV--LSRGRYGLIFKA 856
+R + + L + +T E ++ + L R +
Sbjct: 271 TTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR-------EV 322
Query: 857 SYQDGMVLSI--RRLRDGTIDENTFRK-EAEALGKVKHRNLTVL-----RGYYAG----P 904
+ LSI +RDG + ++ + L + +L VL R + P
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA-----RGLSFLHSLDM 959
P + P L+ + + D V+ + L L + S+ +
Sbjct: 383 PSAHI------PTILLSLIWFDVIKSDVMVV---VNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPT 1019
++K + + ++ H R + Y P+ +
Sbjct: 434 ---ELKVKL---ENEYALH-------RSIVDH---------------YNIPKTFDSDDLI 465
Query: 1020 KE-ADVYSFGIV---LLEILTGRKPVMFTQ---DEDIVKWVKKQLQRGQISELLEPGLLE 1072
D Y + + L I + +F D ++++++++ + +L
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD---FRFLEQKIRHDSTAWNASGSILN 522
Query: 1073 L--------------DPESSEW----EEFLLGVKVGLLCT 1094
DP+ +FL ++ L+C+
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS 562
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.0 bits (160), Expect = 6e-11
Identities = 122/768 (15%), Positives = 219/768 (28%), Gaps = 234/768 (30%)
Query: 339 TSLRVMDLS-GNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCS-----LLQMF 392
+ S A V + D +V + + LS D I L++F
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIP 452
++ V F+ + L N + L +S ++T + +
Sbjct: 69 WTLLSKQEEMVQKFVEEV-------LRIN-YKFL-------MSPIKTEQRQPSMMTRMYI 113
Query: 453 EEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTL 512
E+ RL N F Y+V L+ L L +L+ L
Sbjct: 114 EQRDRLYN------DNQVF---AKYNVSRLQPYLKLRQ--------------ALLELR-- 148
Query: 513 DLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGF--SSLVGLQYLNLSDNAFTGD 570
+N+ + G+ G + +
Sbjct: 149 --PAKNVL------IDGVL------------------GSGKTWVALDV---CLSYKVQCK 179
Query: 571 IPATYGFLRSLVF-LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRI 629
+ + +F L+L + + LE+L+ N H S I
Sbjct: 180 MD--FK-----IFWLNLKNCNSPETV---------LEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 630 K-KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESF---SK-LSNLTTLNLS- 683
K ++ Q +L + K + L L L N + + +F K L LTT
Sbjct: 224 KLRIHSIQAELR-RLLKSKPYENCL--LVLL-NVQNAKAWNAFNLSCKIL--LTTRFKQV 277
Query: 684 TNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFND-PSIFAMNRELC-GKPLD 741
T+ LS A ++L L+ + ++ + K L R D P RE+ P
Sbjct: 278 TDFLSAATTTHISLDHHSM--TLTPDEVKSLLLKYLDCRPQDLP------REVLTTNPR- 328
Query: 742 RECANVRKRKRKRLIILICVSAAGACLLALCCCGYIYSLLRWRQTLRAWATGEKKPSPSR 801
+ +I + L W W K + +
Sbjct: 329 -------------RLSII-----AESI--------RDGLATWDN----W----KHVNCDK 354
Query: 802 GSSGAERGRGSGENGGP--------KLVMF--NNKITYVETLE----ATRQFDEENVLSR 847
++ E S P +L +F + I L + D V+++
Sbjct: 355 LTTIIES---SLNVLEPAEYRKMFDRLSVFPPSAHIPT-ILLSLIWFDVIKSDVMVVVNK 410
Query: 848 -GRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906
+Y L+ K + S + ++ + AL HR+ + +Y P
Sbjct: 411 LHKYSLVEKQPKE-----STISIPSIYLELKVKLENEYAL----HRS---IVDHYNIP-- 456
Query: 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKP 966
+D + +L + D + + HL ++ ++
Sbjct: 457 ---KTFD---SDDLIPP-----YLDQYFYSHIGHHLKNIEHPERMTLF------------ 493
Query: 967 QNVLFDADF-EAHLSEFGLDRLAIATPAEASSSTTP-IGSL----GYVSPEAASTGQPTK 1020
+ V D F E + T AS S + L Y+ P
Sbjct: 494 RMVFLDFRFLEQKIRHDS-------TAWNASGSILNTLQQLKFYKPYICDN-----DPKY 541
Query: 1021 EADVYSFGIVLLEILTG--RKP-------VMFTQDEDIVKWVKKQLQR 1059
E V + L +I + +DE I + KQ+QR
Sbjct: 542 ERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 7e-05
Identities = 52/415 (12%), Positives = 112/415 (26%), Gaps = 131/415 (31%)
Query: 741 DRECANV-----RKRKRKRLIILICVSAAGACLLALCCCGYIYSLLR----WRQTLRAWA 791
E ++ RL + ++ +LR + +
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK------FVEEVLRINYKF--LMSPIK 99
Query: 792 TGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYG 851
T +++PS +R R N +N ++ ++ RQ E L +
Sbjct: 100 TEQRQPSMMTRMYIEQRDRL--YNDNQVFAKYN--VSRLQPYLKLRQALLE--LRPAKNV 153
Query: 852 LIFKASYQDGM------VLSIRRLRDGTIDEN--------TFRK--EAEALGKVKHRNLT 895
LI G+ +++ + + E + ++ + L
Sbjct: 154 LID------GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 896 VLRGYYAGPPD----VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
+ + D ++L ++ L LL+ ++ + L L+
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSI--QAELRRLLKSKPYE--NCL------LV-------- 249
Query: 952 SFLHSLDMVHGDIKPQNVL--FD--------------ADF--EAHLSEFGLDRLAIA-TP 992
L +++ F+ DF A + LD ++ TP
Sbjct: 250 -----LL----NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 993 AE-----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE 1047
E L P T P + ++ +
Sbjct: 301 DEVKSLLLKYLDCRPQDL----PREVLTTNP--------RRLSIIAESIRDGLATWDN-- 346
Query: 1048 DIVKWVKKQLQRGQISELLEPGLLELDPESSEWEE-------FLLGVKV--GLLC 1093
W K + +++ ++E L L+P E+ + F + LL
Sbjct: 347 ----W--KHVNCDKLTTIIESSLNVLEPA--EYRKMFDRLSVFPPSAHIPTILLS 393
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRN 893
F + VL +G +G + + G + + ++L I E E + L KV R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR--- 949
+ L YA L LV M G+L + + A
Sbjct: 246 VVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMG-----------QAGFPEARAVFYA 292
Query: 950 -----GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
GL LH +V+ D+KP+N+L D +S+ G LA+ P E + +G+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG---LAVHVP-EGQTIKGRVGT 348
Query: 1005 LGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK 1051
+GY++PE + T D ++ G +L E++ G+ P F Q + +K
Sbjct: 349 VGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSP--FQQRKKKIK 393
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 34/239 (14%)
Query: 880 RKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVL 935
+KE AL + H N+ L + LV + + G L +++ H + +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEVFHDQLHT-FLVMELLNGGELFERIKKKKHFSETEASYI 111
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATP 992
MR L+S +S +H + +VH D+KP+N+LF + + E + +FG A P
Sbjct: 112 ---MRKLVS-----AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG---FARLKP 160
Query: 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF-TQDEDIVK 1051
+ TP +L Y +PE + + D++S G++L +L+G+ P F + D +
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP--FQSHDRSLTC 218
Query: 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
++ + +I + G + W+ K GLL DP R M+ +
Sbjct: 219 TSAVEIMK-KIKK----GDFSFE--GEAWKNVSQEAKDLIQGLLT--VDPNKRLKMSGL 268
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 60/284 (21%), Positives = 112/284 (39%), Gaps = 48/284 (16%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRN 893
++ L G +G ++KA + G + + + + + + E E L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 894 LTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
+ L G Y D +L ++ ++ P G + ++ E L P ++ + L+
Sbjct: 78 IVKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALN 131
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
FLHS ++H D+K NVL + + L++FG+ + T + + IG+ +++PE
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR---DSFIGTPYWMAPEV 188
Query: 1013 ASTGQPTKE-----ADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKKQLQR 1059
AD++S GI L+E+ P V+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL---------------- 232
Query: 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
+I++ P LL S E+ +FL + +P RPS
Sbjct: 233 -KIAKSDPPTLLTPSKWSVEFRDFL------KIALDKNPETRPS 269
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 40/236 (16%)
Query: 864 LSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLAT 922
+ KE + L KV H N+ L+ Y LV+D M G L
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF-FLVFDLMKKGELFD 113
Query: 923 LLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL 979
L E ++ + MR L+ + LH L++VH D+KP+N+L D D L
Sbjct: 114 YLTEKVTLSEKETRKI---MRALLE-----VICALHKLNIVHRDLKPENILLDDDMNIKL 165
Query: 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPE-----AASTGQP-TKEADVYSFGIVLLE 1033
++FG G+ Y++PE KE D++S G+++
Sbjct: 166 TDFGFSCQL----DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 1034 ILTGRKPVMFTQDEDIVKWVKKQLQRGQ----------ISEL---LEPGLLELDPE 1076
+L G P F + ++ + + + G S+ L L + P+
Sbjct: 222 LLAGSPP--FWHRKQML--MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ 273
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 62/315 (19%), Positives = 118/315 (37%), Gaps = 65/315 (20%)
Query: 842 ENVLSRGRYGLIFKASYQDG------MVLSIRRLRDGT--IDENTFRKEAEALGKVKHRN 893
+ G +G +F+A +++++ L++ + F++EA + + + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 894 LTVLRG--YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWP------------- 938
+ L G P L+++YM G+L L+ S L+
Sbjct: 112 IVKLLGVCAVGKPM---CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 939 ----MRHLISLGL--ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
+ + A G+++L VH D+ +N L + +++FGL R
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN----- 223
Query: 993 AEASSSTTPIGSLGYV-----SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQD 1046
S+ + PE+ + T E+DV+++G+VL EI + G +P
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 1047 EDIVKWVKKQLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSM 1104
E+++ +V+ G I L PE E + C + P DRPS
Sbjct: 283 EEVIYYVRD----GNI---LAC------PENCPLELYNLMRL------CWSKLPADRPSF 323
Query: 1105 ADIVFMLEGCRVGPD 1119
I +L+ +
Sbjct: 324 CSIHRILQRMCERAE 338
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 52/303 (17%), Positives = 100/303 (33%), Gaps = 60/303 (19%)
Query: 459 SNLTTLNLSYNKFGGKVPYDVG-----NLKGLLVLNLSASGFSGKIPGSIGSLMR----- 508
+T+L+LS N ++ + LNLS + K + ++
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 509 LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
+T+L+LS LS + L V +L + + L+L N F+
Sbjct: 82 VTSLNLSGNFLSYK------SSDEL-VKTLAAIPFT------------ITVLDLGWNDFS 122
Query: 569 GD-----IPATYGFLRSLVFLSLSHNQISGMIPAELGAC-----SALEVLELRSNHFTGN 618
A S+ L+L N + EL + + L LR N+
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182
Query: 619 IPVDISHL-----SRIKKLDLGQNKLSGEIPKEISKC-----SSLVSLTLDMNSLSG--- 665
+++ + + LDL N L + E++ + +VSL L +N L G
Sbjct: 183 NCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242
Query: 666 -RIPESFSKLSNLTTLNLSTNRLSGAIPADLALI-------SSLRYLNLSRNNLEGEIPK 717
+ L +L T+ L + + + + ++ + +
Sbjct: 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302
Query: 718 MLS 720
+S
Sbjct: 303 PIS 305
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 61/426 (14%), Positives = 121/426 (28%), Gaps = 124/426 (29%)
Query: 317 LEVLDLQNNRI-----RAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVA 371
+ LDL N + + ++ S+ ++LSGN L +++L
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG---FKNSDEL--VQILAAI 78
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF 431
+++ L +L GN + + L+
Sbjct: 79 PANVTSL--------------NLSGNFL---------SYKSSDELVKT---------LAA 106
Query: 432 GNLSQLETLNLSENDIRGNIPEEITRL-----SNLTTLNLSYNKFGGKVPYDVGNL---K 483
+ L+L ND E + +++T+LNL N G + +
Sbjct: 107 IP-FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG-----IKSSDELIQ 160
Query: 484 GLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
L + + + +L+L NL+ + L L
Sbjct: 161 ILAAIPAN-----------------VNSLNLRGNNLASK------NCAEL-AKFLASIPA 196
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGD-----IPATYGFLRSLVFLSLSHNQISG----M 594
S + L+LS N +V L+L N + G
Sbjct: 197 S------------VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLEN 244
Query: 595 IPAELGACSALEVLELRSNHFTGNIPVD--------ISHLSRIKKLDLGQNKLSGEIPKE 646
+ + L+ + L + N+ + ++ +I +D ++
Sbjct: 245 LKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303
Query: 647 ISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNL 706
IS +S D+ S L N + ++ + DL + LR
Sbjct: 304 ISNLIRELSGKADVPS-----------LLNQCLIFAQKHQTN---IEDLNIPDELRESIQ 349
Query: 707 SRNNLE 712
+ L
Sbjct: 350 TCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 55/355 (15%), Positives = 105/355 (29%), Gaps = 64/355 (18%)
Query: 163 ISPSLRYLDLSSNAFTGE-----IPGNFSSKSQLQLINLSYNSFSGEVPASVGQL----- 212
I + LDLS N I ++ + + +NLS NS + + Q+
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 213 QELEYLWLDSNHLYGT----LPSAISNC-SSLVHLSAEDNVL-----KGLIPGTIGRIST 262
+ L L N L L ++ ++ L N ++
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 263 LQVLSLSRNELTGLVPVSVLCN-LWGNISSLRIVQLGFNAFT--------GVVKPPNGRC 313
+ L+L N+L G+ L L +++ + L N +
Sbjct: 140 ITSLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP--- 195
Query: 314 VSVLEVLDLQNNRIRAVFPSWL-----TNVTSLRVMDLSGNFFSG----NLPAAVGSLDK 364
+ + LDL N + + L + + ++L N G NL SL
Sbjct: 196 -ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254
Query: 365 LEVLRVANNSLSGLVPDE-------IAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVS 417
L+ + + + + + ++ + + D G + + I +
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE--------IHPSHSIPISN 306
Query: 418 LGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFG 472
L R + S N + N NIP+E L +
Sbjct: 307 LIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDE------LRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 27/104 (25%), Positives = 44/104 (42%), Gaps = 15/104 (14%)
Query: 623 ISHLSRIKKLDLGQNKLSGEIPKEISKC-----SSLVSLTLDMNSLSGRIPESFSKL--- 674
S + LDL N L E+ + +S+ SL L NSL + + ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 675 --SNLTTLNLSTNRLSGAIPADLALI-----SSLRYLNLSRNNL 711
+N+T+LNLS N LS +L ++ L+L N+
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 24/170 (14%)
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
L++ G+ +LH + + H DIKP+N+L D +S+FGL + E +
Sbjct: 112 HQLMA-----GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 1000 TPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
G+L YV+PE + + DV+S GIVL +L G P + Q D +
Sbjct: 167 M-CGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWK 222
Query: 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
++ ++D LL +L +P R ++ DI
Sbjct: 223 EKKTY----LNPWKKIDSAP----LALLH---KILV--ENPSARITIPDI 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 47/277 (16%), Positives = 100/277 (36%), Gaps = 29/277 (10%)
Query: 793 GEKKPS----PSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRG 848
G RG + + + + V+ +D L G
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62
Query: 849 RYGLIF----KASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP 904
+G++ KA+ + + I +D+ T + E + ++ H L L +
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 905 PDVRLLVYDYMPNGNLATLLQEASHQ----DGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
++ +L+ +++ G L + ++ + MR GL +H +V
Sbjct: 121 YEM-VLILEFLSGGELFDRIAAEDYKMSEAEVINY---MRQACE-----GLKHMHEHSIV 171
Query: 961 HGDIKPQNVLFDADFEAHL--SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
H DIKP+N++ + + + +FGL P E + + +PE
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDE--IVKVTTATAEFAAPEIVDREPV 227
Query: 1019 TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
D+++ G++ +L+G P D + ++ VK+
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 28/242 (11%)
Query: 870 RDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH 929
R IDEN R E ++H N+ + P + ++ +Y G L + A
Sbjct: 55 RGAAIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHL-AIIMEYASGGELYERICNAGR 112
Query: 930 QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL--SEFGLDRL 987
+ + L+S G+S+ HS+ + H D+K +N L D L +FG
Sbjct: 113 FSEDEARFFFQQLLS-----GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-- 165
Query: 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQ 1045
+ S + +G+ Y++PE Q K ADV+S G+ L +L G P F +
Sbjct: 166 --KSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGAYP--F-E 219
Query: 1046 DEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105
D + + +K +QR + P + + PE L+ + DP R S+
Sbjct: 220 DPEEPRDYRKTIQRILSVKYSIPDDIRISPEC----CHLIS---RIFV--ADPATRISIP 270
Query: 1106 DI 1107
+I
Sbjct: 271 EI 272
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 50/254 (19%), Positives = 102/254 (40%), Gaps = 36/254 (14%)
Query: 797 PSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKA 856
P + + G + GRGS ++ + K + +D + L +G + ++ +
Sbjct: 2 PHMASMTGGQQMGRGS-----EFMMNASTKFS--------DNYDVKEELGKGAFSVVRRC 48
Query: 857 SY-QDGMVL---SIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912
+ G+ I + D +EA K++H N+ L L V+
Sbjct: 49 VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL-VF 107
Query: 913 DYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
D + G L + D ++ ++ +++ HS +VH ++KP+N+
Sbjct: 108 DLVTGGELFEDIVAREFYSEADASHC---IQQILE-----SIAYCHSNGIVHRNLKPENL 159
Query: 970 LFDADFEAH---LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYS 1026
L + + L++FGL ++ + G+ GY+SPE +K D+++
Sbjct: 160 LLASKAKGAAVKLADFGLAIEV----NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 1027 FGIVLLEILTGRKP 1040
G++L +L G P
Sbjct: 216 CGVILYILLVGYPP 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 41/148 (27%), Positives = 62/148 (41%), Gaps = 21/148 (14%)
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
LI GL +LHS +VH DIKP N+L +S G+ + A +
Sbjct: 116 CQLID-----GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA-LHPFAADDTCR 169
Query: 1000 TPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
T GS + PE A+ + D++S G+ L I TG P F + ++I K + +
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP--F-EGDNIYKLFEN-I 225
Query: 1058 QRGQ------ISELLE---PGLLELDPE 1076
+G L G+LE +P
Sbjct: 226 GKGSYAIPGDCGPPLSDLLKGMLEYEPA 253
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 47/193 (24%), Positives = 73/193 (37%), Gaps = 34/193 (17%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEY 217
+ + I LDL S F ++L +NL YN + A V L EL
Sbjct: 29 VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGT 87
Query: 218 LWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276
L L +N L +LP + + + L L N LK L G R++ L+ L L+ N+L +
Sbjct: 88 LGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146
Query: 277 VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLT 336
P F+ T L+ L L N++++V
Sbjct: 147 -PAGA-----------------FDKLTN------------LQTLSLSTNQLQSVPHGAFD 176
Query: 337 NVTSLRVMDLSGN 349
+ L+ + L GN
Sbjct: 177 RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 28/178 (15%)
Query: 510 TTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFT 568
LDL + L+ GL L ++L+ N L + G F L L L L++N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSR 628
+ L L L L NQ+ +P+ G F L++
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPS--GV-------------FDR--------LTK 132
Query: 629 IKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685
+K+L L N+L IP K ++L +L+L N L +F +L L T+ L N
Sbjct: 133 LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 39/155 (25%), Positives = 60/155 (38%), Gaps = 8/155 (5%)
Query: 98 RKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFN-LTNLLVLNVAHNLLS 156
KL L S L A+ + L + L YN L +F+ LT L L +A+N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 157 GKISADISPS---LRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQL 212
+ + L L L N G F ++L+ + L+ N +PA +L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 213 QELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
L+ L L +N L A L ++ N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 45/156 (28%), Positives = 63/156 (40%), Gaps = 6/156 (3%)
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFS 496
E L+L + L+ LT LNL YN+ + V +L L L L+ + +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSL 554
G L +L L L L LP +F L L+ + L N L +P G F L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 555 VGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQ 590
LQ L+LS N + L L ++L NQ
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 10/157 (6%)
Query: 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLDKLEVLRVANNSLS 376
E LDLQ+ + + + +T L ++L N L A V L +L L +ANN L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 377 GL---VPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGN 433
L V D + + L L GN+ + LK + L N + +F
Sbjct: 97 SLPLGVFDHLTQ---LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK 153
Query: 434 LSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
L+ L+TL+LS N ++ ++P RL L T+ L N
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 37/133 (27%), Positives = 60/133 (45%), Gaps = 10/133 (7%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGE 642
L L ++ + A + L L L N + + L+ + L L N+L+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 643 IPKEI-SKCSSLVSLTLDMNSLSGRIPES-FSKLSNLTTLNLSTNRLSGAIPADL--ALI 698
+P + + L L L N L +P F +L+ L L L+TN+L +IPA L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL- 154
Query: 699 SSLRYLNLSRNNL 711
++L+ L+LS N L
Sbjct: 155 TNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 10/160 (6%)
Query: 216 EYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG 275
E L L S L + + L L+ + N L+ L G ++ L L L+ N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 276 LVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG--RCVSVLEVLDLQNNRIRAVFPS 333
L P+ V +L + L + LG N + P+G ++ L+ L L N+++++
Sbjct: 98 L-PLGVFDHL----TQLDKLYLGGNQLKSL---PSGVFDRLTKLKELRLNTNQLQSIPAG 149
Query: 334 WLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANN 373
+T+L+ + LS N A L KL+ + + N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 20/70 (28%), Positives = 31/70 (44%), Gaps = 4/70 (5%)
Query: 643 IPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADL-ALISSL 701
+P I + L L L+ +F L+ LT LNL N+L + A + ++ L
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 702 RYLNLSRNNL 711
L L+ N L
Sbjct: 86 GTLGLANNQL 95
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 54/271 (19%), Positives = 99/271 (36%), Gaps = 37/271 (13%)
Query: 791 ATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRY 850
+ + + +G + + + + RG
Sbjct: 50 QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV--IGRGVS 107
Query: 851 GLIFKASY-QDGM-----VLSIRRLR----DGTIDENTFRKEAEALGKVK-HRNLTVLRG 899
++ + + G ++ + R R+E L +V H ++ L
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHS 956
Y + LV+D M G L L E ++ + MR L+ +SFLH+
Sbjct: 168 SYESSSFM-FLVFDLMRKGELFDYLTEKVALSEKETRSI---MRSLLE-----AVSFLHA 218
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS-TTPIGSLGYVSPE---- 1011
++VH D+KP+N+L D + + LS+FG + E G+ GY++PE
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGF-----SCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 1012 -AASTGQP-TKEADVYSFGIVLLEILTGRKP 1040
T KE D+++ G++L +L G P
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 50/245 (20%), Positives = 106/245 (43%), Gaps = 35/245 (14%)
Query: 845 LSRGRYGLIFKA---SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYY 901
+ RG YG ++KA +D +++++ I + R E L ++KH N+ L+ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 87
Query: 902 AGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWP---------MRHLISLGLARGL 951
D ++ L++DY + +L +++ + + ++ G+
Sbjct: 88 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-----DGI 141
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAH----LSEFGLDRLAIATPAEASSSTTP-IGSLG 1006
+LH+ ++H D+KP N+L + +++ G R +P + + P + +
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFW 200
Query: 1007 YVSPE----AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL-QRGQ 1061
Y +PE A TK D+++ G + E+LT +P+ + EDI Q +
Sbjct: 201 YRAPELLLGAR---HYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 1062 ISELL 1066
I ++
Sbjct: 257 IFNVM 261
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 65/332 (19%), Positives = 126/332 (37%), Gaps = 50/332 (15%)
Query: 796 KPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDE----ENVLSRGRYG 851
P P + P+ + ++ D+ VL G G
Sbjct: 18 APPPQPPTPALPHPPAQPPPPPPQ-QFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGING 76
Query: 852 LIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYY---AGPPD 906
+ + + +++ L+D R+E E + + ++ + Y
Sbjct: 77 KVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132
Query: 907 VRLLVYDYMPNGNLATLLQEASHQ-----DGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
L+V + + G L + +Q+ Q + + M+ + + +LHS+++ H
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEI---MKSIGE-----AIQYLHSINIAH 184
Query: 962 GDIKPQNVLF-DADFEAHL--SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
D+KP+N+L+ A L ++FG A T + +S TTP + YV+PE +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFG---FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKY 240
Query: 1019 TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESS 1078
K D++S G+++ +L G P I +K +++ GQ + +
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-----------EFPNP 289
Query: 1079 EWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
EW E VK LL T +P R ++ +
Sbjct: 290 EWSEVSEEVKMLIRNLLKT--EPTQRMTITEF 319
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 24/170 (14%)
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
L++ G+ +LH + + H DIKP+N+L D +S+FGL + E +
Sbjct: 112 HQLMA-----GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 1000 TPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
G+L YV+PE + + DV+S GIVL +L G P + Q D +
Sbjct: 167 M-CGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWK 222
Query: 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
++ ++D LL +L +P R ++ DI
Sbjct: 223 EKKTY----LNPWKKIDSAP----LALLH---KILV--ENPSARITIPDI 259
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 38/139 (27%), Positives = 60/139 (43%), Gaps = 22/139 (15%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L + +L D++H DIK +N++ DF L +FG A T G++
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA----AYLERGKLFYTFCGTIE 194
Query: 1007 YVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK-------WVKKQL 1057
Y +PE G P E +++S G+ L ++ P F + E+ V+ V K+L
Sbjct: 195 YCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP--FCELEETVEAAIHPPYLVSKEL 251
Query: 1058 QRGQISELLEPGLLELDPE 1076
L GLL+ PE
Sbjct: 252 MS------LVSGLLQPVPE 264
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 37/212 (17%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL 894
++ L RG +G++ + + ++ D+ +KE L +HRN+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNL-ATLLQEASH---QDGHVLNWPMRHLISLGLARG 950
L + ++ +++++++ ++ + A ++ + +
Sbjct: 64 LHLHESFESMEEL-VMIFEFISGLDIFERINTSAFELNEREIVSY---VHQVCE-----A 114
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHL--SEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
L FLHS ++ H DI+P+N+++ + + EFG R P + + + Y
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGD--NFRLLFTAPEYY 170
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+PE + D++S G ++ +L+G P
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 53/279 (18%), Positives = 98/279 (35%), Gaps = 50/279 (17%)
Query: 844 VLSRGRYGLIFKASY-QDGMVLSI-----RRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
+ RG +G + A + + + D + F++E E + + H N+ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIRL 71
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFL 954
+ D+ L V + G L + D + M+ ++S +++
Sbjct: 72 YETFEDNTDIYL-VMELCTGGELFERVVHKRVFRESDAARI---MKDVLS-----AVAYC 122
Query: 955 HSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
H L++ H D+KP+N LF D L +FGL T +G+ YVSP+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF----KPGKMMRTKVGTPYYVSPQ 178
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
G E D +S G+++ +L G P D +++ +++
Sbjct: 179 VLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--------------- 222
Query: 1072 ELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+W + LL P R +
Sbjct: 223 TFTFPEKDWLNVSPQAESLIRRLLT--KSPKQRITSLQA 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 43/231 (18%), Positives = 82/231 (35%), Gaps = 51/231 (22%)
Query: 832 TLEATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEA----- 885
T +++ + G G++ A ++I++L F+ + A
Sbjct: 57 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYR 110
Query: 886 ----LGKVKHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQ---DGH 933
+ V H+N+ L + + LV + M L +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQMELDHER 165
Query: 934 VLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993
+ +L+ L G+ LHS ++H D+KP N++ +D + +FGL R A
Sbjct: 166 M-----SYLLYQML-CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TA 214
Query: 994 EASSSTTPIGSLGYVS------PEAASTGQPTKEADVYSFGIVLLEILTGR 1038
S T YV PE + D++S G ++ E++ +
Sbjct: 215 GTSFMMT-----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 49/221 (22%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 830 VETLEATRQFDEENVLSRGRYGLIFKASYQD-GMVL---SIRRLRDGTIDENTFRKEAEA 885
++T + F VL G + +F + G + I++ +++ E
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAV 59
Query: 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHL 942
L K+KH N+ L Y LV + G L + E +D ++ ++ +
Sbjct: 60 LKKIKHENIVTLEDIYESTTHY-YLVMQLVSGGELFDRILERGVYTEKDASLV---IQQV 115
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSST 999
+S + +LH +VH D+KP+N+L+ + + + +++FGL + + +
Sbjct: 116 LS-----AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL-----SKMEQNGIMS 165
Query: 1000 TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
T G+ GYV+PE + +K D +S G++ +L G P
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 44/210 (20%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 844 VLSRGRYGLIFKASY-QDGMVL---SIRRLRDGTIDENTFRKEAEALGKVKHR-NLTVLR 898
L RG++ ++ + G +++ R G E L K + L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 899 GYYAGPPDVRLLVYDYMPNGNL-----ATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
Y ++ +L+ +Y G + L + S D L ++ ++ G+ +
Sbjct: 96 EVYENTSEI-ILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQILE-----GVYY 146
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAH---LSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
LH ++VH D+KPQN+L + + + +FG+ R A +G+ Y++P
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----GHACELREIMGTPEYLAP 202
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
E + T D+++ GI+ +LT P
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 59/285 (20%), Positives = 107/285 (37%), Gaps = 55/285 (19%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIR----RLRDGTIDENTFRKEAEALGKVK 890
+ F + + G +G ++ A ++ V++I+ + KE L K++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 891 HRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
H N RG Y + LV +Y G+ + LL+ L ++ G +
Sbjct: 113 HPNTIQYRGCYLR--EHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQ 165
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL++LHS +M+H D+K N+L L +FG + + + + +G+ +++
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS-------ASIMAPANSFVGTPYWMA 218
Query: 1010 PEAASTGQPT---KEADVYSFGIVLLEILTGRKP--------VMFTQDEDIVKWVKKQLQ 1058
PE + DV+S GI +E+ + P ++ I + LQ
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQ 274
Query: 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS 1103
G SE F+ C P DRP+
Sbjct: 275 SGHWSEYF--------------RNFV------DSCLQKIPQDRPT 299
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 49/280 (17%), Positives = 107/280 (38%), Gaps = 33/280 (11%)
Query: 791 ATGEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYV--ETLEATRQFDEENVLSRG 848
R ++R + F+++I + + + +L G
Sbjct: 41 EVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGG 100
Query: 849 RYGLIFKASYQD-GM-----VLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYA 902
R+G + K G+ ++ R ++D + + E + ++ H NL L +
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKTRGMKD----KEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLN-----WPMRHLISLGLARGLSFLHSL 957
D+ +LV +Y+ G L + + + L M+ + G+ +H +
Sbjct: 157 SKNDI-VLVMEYVDGGELF----DRIIDESYNLTELDTILFMKQICE-----GIRHMHQM 206
Query: 958 DMVHGDIKPQNVLFDADFEAHL--SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
++H D+KP+N+L + +FGL R P E G+ +++PE +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLAR--RYKPRE--KLKVNFGTPEFLAPEVVNY 262
Query: 1016 GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
+ D++S G++ +L+G P + D + + +
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 44/207 (21%), Positives = 84/207 (40%), Gaps = 29/207 (14%)
Query: 844 VLSRGRYGLIFKASYQD-GM-----VLSIRRL--RDGTIDENTFRKEAEALGKVKHRNLT 895
L G++ ++ K + G + RRL + +E L +++H N+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLS 952
L + DV +L+ + + G L L E + ++ ++ G+
Sbjct: 72 TLHDIFENKTDV-VLILELVSGGELFDFLAEKESLTEDEATQF---LKQILD-----GVH 122
Query: 953 FLHSLDMVHGDIKPQNVLF-DADFEAH---LSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
+LHS + H D+KP+N++ D + L +FG+ + G+ +V
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI----EAGNEFKNIFGTPEFV 178
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEIL 1035
+PE + EAD++S G V+ IL
Sbjct: 179 APEIVNYEPLGLEADMWSIG-VITYIL 204
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 510 TTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569
+L ++++ + L S+ + +++ +G L ++YL L N
Sbjct: 22 IKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH- 76
Query: 570 DIPATYGF--LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHL 626
DI A L +L +L L+ NQ+ + + L+ L L N ++P + L
Sbjct: 77 DISA---LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132
Query: 627 SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPES-FSKLSNLTTLNLSTN 685
+ + L+L N+L K ++L L L N L +PE F KL+ L L L N
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
Query: 686 RL 687
+L
Sbjct: 192 QL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 42/182 (23%), Positives = 66/182 (36%), Gaps = 24/182 (13%)
Query: 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIP 452
+L+ + + + + + + L + L L N
Sbjct: 25 NLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGN------- 73
Query: 453 EEIT------RLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSGKIPGSIGS 505
++ L+NLT L L+ N+ +P V L L L L + G
Sbjct: 74 -KLHDISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDK 131
Query: 506 LMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLS 563
L LT L+L++ L LP +F L +L + L N L +PEG F L L+ L L
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLY 189
Query: 564 DN 565
N
Sbjct: 190 QN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 49/248 (19%), Positives = 86/248 (34%), Gaps = 52/248 (20%)
Query: 110 SIPASLHQCSL-LRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLR 168
P L+ S + + L ++ + ++ + P++R
Sbjct: 12 IFPD---DAFAETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQYLPNVR 66
Query: 169 YLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSNHLYG 227
YL L N + L + L+ N +P V +L L+ L L N L
Sbjct: 67 YLALGGNKLHD--ISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-Q 122
Query: 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWG 287
+LP G +++ L L+L+ N+L L P V L
Sbjct: 123 SLP-----------------------DGVFDKLTNLTYLNLAHNQLQSL-PKGVFDKL-- 156
Query: 288 NISSLRIVQLGFNAFTGVVKPPNGRCVSV------LEVLDLQNNRIRAVFPSWLTNVTSL 341
++L + L +N + P G V L+ L L N++++V +TSL
Sbjct: 157 --TNLTELDLSYNQLQSL---PEG----VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 207
Query: 342 RVMDLSGN 349
+ + L N
Sbjct: 208 QYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 42/194 (21%), Positives = 73/194 (37%), Gaps = 28/194 (14%)
Query: 288 NIS-SLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV--FPSWLTNVTSLRVM 344
+ L + T ++ ++ + N+ I++V L NV L
Sbjct: 16 DAFAETIKANLKKKSVTDA---VTQNELNSIDQIIANNSDIKSVQGIQY-LPNVRYL--- 68
Query: 345 DLSGNFFSGNLPAAVGSLDKL---EVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG 401
L GN + +L +L L + N L L K + L+ L N+
Sbjct: 69 ALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 402 QVPAFLGGI----RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-T 456
+P G+ L ++L N L F L+ L L+LS N ++ ++PE +
Sbjct: 123 SLPD---GVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178
Query: 457 RLSNLTTLNLSYNK 470
+L+ L L L N+
Sbjct: 179 KLTQLKDLRLYQNQ 192
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 33/132 (25%), Positives = 59/132 (44%), Gaps = 14/132 (10%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEI 643
+L ++ + ++++ + ++ + +L ++ L LG NKL
Sbjct: 24 ANLKKKSVTD-AVTQNEL-NSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKL---- 75
Query: 644 PKEISKCSSLVSLT---LDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADL-ALIS 699
+IS L +LT L N L F KL+NL L L N+L ++P + ++
Sbjct: 76 -HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT 133
Query: 700 SLRYLNLSRNNL 711
+L YLNL+ N L
Sbjct: 134 NLTYLNLAHNQL 145
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 44/226 (19%), Positives = 85/226 (37%), Gaps = 41/226 (18%)
Query: 832 TLEATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEA----- 885
T +++ + G G++ A ++I++L F+ + A
Sbjct: 20 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKRAYR 73
Query: 886 ----LGKVKHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQ---DGH 933
+ V H+N+ L + + +V + M L +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQMELDHER 128
Query: 934 VLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993
M +L+ L G+ LHS ++H D+KP N++ +D + +FGL R A
Sbjct: 129 -----MSYLLYQML-CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TA 177
Query: 994 EASSSTTP-IGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGR 1038
S TP + + Y +PE + D++S G ++ E++ G
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 44/212 (20%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 844 VLSRGRYGLIFKASYQD-GM-----VLSIRRLR--DGTIDENTFRKEAEALGKVKHRNLT 895
L G++ ++ K + G+ + R+ R + +E L +V H N+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLS 952
L Y DV +L+ + + G L L + ++ ++ ++ G++
Sbjct: 79 TLHDVYENRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF---IKQILD-----GVN 129
Query: 953 FLHSLDMVHGDIKPQNVLF-DADFEAH---LSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
+LH+ + H D+KP+N++ D + L +FGL + G+ +V
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI----EDGVEFKNIFGTPEFV 185
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+PE + EAD++S G++ +L+G P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 38/172 (22%)
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLAIATPAEASS 997
++ + H+ ++H DIK +N+L D + E L +FG + +
Sbjct: 155 FWQVLE-----AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS-----GALLKDTV 204
Query: 998 STTPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
T G+ Y PE + A V+S GI+L +++ G P F DE+I++
Sbjct: 205 YTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRG--- 258
Query: 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
++ + SSE + + C A P DRP+ +I
Sbjct: 259 --------QVFFRQRV-----SSECQHLIRW------CLALRPSDRPTFEEI 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 47/232 (20%), Positives = 96/232 (41%), Gaps = 28/232 (12%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GM-----VLSIRRL--RDGTIDENTFRKEAEALGKVK 890
+D L G++ ++ K + G+ + RR + +E L +++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 891 HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGL 947
H N+ L Y DV +L+ + + G L L E ++ ++ +++
Sbjct: 73 HPNVITLHEVYENKTDV-ILILELVAGGELFDFLAEKESLTEEEATEF---LKQILN--- 125
Query: 948 ARGLSFLHSLDMVHGDIKPQNVLF-DADFEAH---LSEFGLDRLAIATPAEASSSTTPIG 1003
G+ +LHSL + H D+KP+N++ D + + +FGL G
Sbjct: 126 --GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGN--EFKNIFG 179
Query: 1004 SLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
+ +V+PE + EAD++S G++ +L+G P + ++ + V
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 839 FDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEA-------LGKVK 890
FD +L +G +G + + G +++ LR I + E L +
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTR 63
Query: 891 HRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
H LT L YA RL V +Y G L L V +
Sbjct: 64 HPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVS 116
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
L +LHS D+V+ DIK +N++ D D +++FGL + I ++ ++ T G+ Y++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI---SDGATMKTFCGTPEYLA 173
Query: 1010 PEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
PE + D + G+V+ E++ GR P F QD +
Sbjct: 174 PEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 49/233 (21%), Positives = 85/233 (36%), Gaps = 42/233 (18%)
Query: 831 ETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE---NTFRKEAEA-- 885
E + + +S G YG + +G+ ++I+R+ + D N
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 886 -------LGKVKHRNLTVLRGYYAGPPDVRL----LVYDYMPNGNLATLL--QEASHQDG 932
L H N+ LR + + + LV + M +LA ++ Q
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQ 134
Query: 933 HVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
H+ ++ + L GL LH +VH D+ P N+L + + + +F L R A
Sbjct: 135 HI-----QYFMYHIL-LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 993 AEASSSTTPIGSLGYV------SPEA-ASTGQPTKEADVYSFGIVLLEILTGR 1038
T YV +PE TK D++S G V+ E+ +
Sbjct: 189 N----KT------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 28/223 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAE-------ALGKV 889
+F+ +L +G +G + + G +++ L+ I + E L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNS 205
Query: 890 KHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
+H LT L Y+ RL V +Y G L L V + +
Sbjct: 206 RHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIV 258
Query: 949 RGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
L +LHS ++V+ D+K +N++ D D +++FGL + I + ++ T G+ Y
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI---KDGATMKTFCGTPEY 315
Query: 1008 VSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
++PE + D + G+V+ E++ GR P F QD +
Sbjct: 316 LAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 355
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 13/176 (7%)
Query: 581 LVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLS 640
V L I + A L A + L L +N+ I +S + ++ L LG+N +
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83
Query: 641 GEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALIS 699
+I + +L L + N ++ + KL NL L +S N+++ D LA +
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 700 SLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELC---GKPL---DRECANVRK 749
L L L+ N L + + ++ + L G P+ +RE ANV +
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGMPVDVDEREQANVAR 196
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 32/155 (20%), Positives = 62/155 (40%), Gaps = 16/155 (10%)
Query: 423 FSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482
F + ++E L+ I + ++ L L LS N K+ + +
Sbjct: 14 FEERKSVVATEAEKVE-LHGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKIS-SLSGM 69
Query: 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSN---QNLSGELPIELFGLPSLQVVSLE 539
+ L +L+L + KI L L +S +LSG + L +L+V+ +
Sbjct: 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMS 123
Query: 540 ENNLS--GDVPEGFSSLVGLQYLNLSDNAFTGDIP 572
N ++ G++ + ++L L+ L L+ N D
Sbjct: 124 NNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 31/161 (19%), Positives = 61/161 (37%), Gaps = 25/161 (15%)
Query: 560 LNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNI 619
L+ + AT L++ L+LS N I + + L L +L L N
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK--- 83
Query: 620 PVDISHLS----RIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG-RIPESFSKL 674
I +L +++L + N+++ + I K +L L + N ++ + + L
Sbjct: 84 --KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 675 SNLTTLNLSTNRLSGAIPAD----------LALISSLRYLN 705
L L L+ N L + + + +L+ L+
Sbjct: 140 DKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 33/172 (19%), Positives = 62/172 (36%), Gaps = 45/172 (26%)
Query: 184 NFSSKSQLQLINLSYNSFSG--EVPASVGQLQELEYLWLDSNHLYGTLPSAISN---CSS 238
++ + + L + ++ A++ L+ ++L L +N++ IS+ +
Sbjct: 18 KSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNI-----EKISSLSGMEN 71
Query: 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLG 298
L LS N++K I TL+ L +S N++ L + L N
Sbjct: 72 LRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLSGIEKLVN-------------- 116
Query: 299 FNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFP-SWLTNVTSLRVMDLSGN 349
L VL + NN+I L + L + L+GN
Sbjct: 117 ------------------LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/117 (24%), Positives = 55/117 (47%), Gaps = 8/117 (6%)
Query: 86 RLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNL 145
++ L+ L + L+L +N++ I +SL LR + L N L L
Sbjct: 39 KMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIKKIENLD-AVADTL 95
Query: 146 LVLNVAHNLLSGKISA-DISPSLRYLDLSSNAFT--GEIPGNFSSKSQLQLINLSYN 199
L +++N ++ +S + +LR L +S+N T GEI ++ +L+ + L+ N
Sbjct: 96 EELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 14/123 (11%)
Query: 253 IPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGR 312
+ T+ + + L+LS N + + +S + N LRI+ LG N +
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLSGMEN-------LRILSLGRNLIKKI--ENLDA 90
Query: 313 CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLP--AAVGSLDKLEVLRV 370
LE L + N+I ++ + + +LRV+ +S N + N + +LDKLE L +
Sbjct: 91 VADTLEELWISYNQIASLSG--IEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLL 147
Query: 371 ANN 373
A N
Sbjct: 148 AGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 18/84 (21%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 631 KLDLGQNKLSGEIPKEISKCSSL--VSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS 688
K ++ + ++ + V L + + ++ + S L L LSTN +
Sbjct: 3 KATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE 61
Query: 689 GAIPADLALISSLRYLNLSRNNLE 712
I + L+ + +LR L+L RN ++
Sbjct: 62 -KI-SSLSGMENLRILSLGRNLIK 83
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 50/221 (22%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR--DGTID-ENTFRKEAEALGKV 889
+ ++ + + G YG++ A + + ++I+++ + + T R E + L +
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRF 82
Query: 890 KHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS 944
+H N+ + P + +V D M +L LL+ + H+ + +
Sbjct: 83 RHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHI-----CYFLY 135
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
L RGL ++HS +++H D+KP N+L + + + +FGL R+A T
Sbjct: 136 QIL-RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT----- 189
Query: 1005 LGYVS------PEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
YV+ PE ++ TK D++S G +L E+L+ R
Sbjct: 190 -EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 9e-11
Identities = 61/347 (17%), Positives = 124/347 (35%), Gaps = 38/347 (10%)
Query: 386 CSLLQMFDLEGNRFSGQVPAFL----GGIRGLKIVSLGRNMFS--GLIPLSFGNLSQLET 439
MF+L + G V ++ +R LK V R + S L L+ LET
Sbjct: 83 KPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLET 142
Query: 440 LNLSE-NDIRGNIPEEITR-LSNLTTLNLSYNKFGGKVPYDVG----NLKGLLVLNLSAS 493
L L + + + I + TL + + F K + + L VLN +
Sbjct: 143 LKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT 202
Query: 494 GFSGKIPGSIGSLMR----LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPE 549
F+ P + ++ R L ++ + + + + +L+ N +PE
Sbjct: 203 EFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF-FKAAANLEEFCGGSLNEDIGMPE 261
Query: 550 GFSSLVGLQYLNLSDNAFTGD--IPATYGFLRSLVFLSLSH-NQISGMIPAELGACSALE 606
+ +LV + L ++ G +P + F + L L + + + C LE
Sbjct: 262 KYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLE 321
Query: 607 VLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR 666
VLE R+ + V + ++K+L + + + + + +S R
Sbjct: 322 VLETRNVIGDRGLEVLAQYCKQLKRLRI-------------ERGADEQGMEDEEGLVSQR 368
Query: 667 IPESFSK-LSNLTTLNLSTNRLS----GAIPADLALISSLRYLNLSR 708
+ ++ L + + + ++ +I L + R + L R
Sbjct: 369 GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDR 415
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 78/552 (14%), Positives = 159/552 (28%), Gaps = 82/552 (14%)
Query: 92 ADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVA 151
D +++ + + + LR++ L G ++FNL
Sbjct: 47 IDSETREHVTM-ALCYTATPDRLSRRFPNLRSLKL-----KGKPRAAMFNLIPENWGGYV 100
Query: 152 HNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSK--SQLQLINLSY-NSFSGEVPAS 208
++ + L+ + + + L+ + L + F+ + S
Sbjct: 101 TPWVTEISNN--LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLS 158
Query: 209 VGQ-LQELEYLWLDSNHLYGTLPSAIS----NCSSLVHLSAEDNVLKGLIPGTIGRIST- 262
+ ++++ L ++ + + + +SL L+ + P + I+
Sbjct: 159 IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218
Query: 263 ---LQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEV 319
L + + E+ LV + + + R + L +
Sbjct: 219 CRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNE-DIGMPEKYMNLVFPRKLCRLGL 277
Query: 320 LDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGN-LPAAVGSLDKLEVLRVANN-SLSG 377
+ N + +FP +R +DL + LEVL N G
Sbjct: 278 SYMGPNEMPILFP----FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRG 333
Query: 378 LVPDEIAK-CSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
L +A+ C L+ +E + G + +++L + +
Sbjct: 334 LE--VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG------------CQE 379
Query: 437 LETLNLSENDIRGNIPEEITR----LSNLTTLNLSYNKFGGKVPYDVG------NLKGLL 486
LE + + +DI E I L + + L + +P D G K L
Sbjct: 380 LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLR 439
Query: 487 VLNLSA--SGFSGKIPGSIGSLM-RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
G + IG + + L S E GL
Sbjct: 440 RFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE------GLMEF---------- 483
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGD-IPATYGFLRSLVFLSLSHNQISGMIPAELGA- 601
LQ L + F+ I A L SL +L + + S +
Sbjct: 484 -------SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMA 536
Query: 602 --CSALEVLELR 611
+E++ R
Sbjct: 537 RPYWNIELIPSR 548
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 16/135 (11%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRH--LISLGLARGLSFLHSLDMVHGDIKPQ 967
++ +Y+P TL + + PM + L R + F+HSL + H DIKPQ
Sbjct: 115 VIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 968 NVLFDA-DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE---AASTGQPTKEAD 1023
N+L ++ D L +FG + P+E S + I S Y +PE A+ + T D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAK--KLIPSEPSVAY--ICSRFYRAPELMLGAT--EYTPSID 224
Query: 1024 VYSFGIVLLEILTGR 1038
++S G V E++ G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL--ARGLSFLHSLDMVHGDIKPQNV 969
++ +L+ + +E + +D + + HLI A+G+ FL S +H D+ +N+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSSTT--PIGSLGYVSPEAASTGQPTKEADVYSF 1027
L + +FGL R P P+ +++PE T ++DV+SF
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL---KWMAPETIFDRVYTIQSDVWSF 281
Query: 1028 GIVLLEILT-GRKP-VMFTQDEDIVKWVKK--QLQRGQISELLEPGLLELDPESSEWEEF 1083
G++L EI + G P DE+ + +K+ +++ P+ + E +
Sbjct: 282 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---------------PDYTTPEMY 326
Query: 1084 LLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
+ L C +P RP+ +++V L
Sbjct: 327 ----QTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 44/220 (20%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 836 TRQFDEENVLSRGRYGLIFKASYQD-GM-----VLSIRRL--RDGTIDENTFRKEAEALG 887
+D L G++ ++ K + G+ + R+ + +E L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 888 KVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASH---QDGHVLNWPMRHLIS 944
+V H N+ L Y DV +L+ + + G L L + ++ ++ ++
Sbjct: 71 QVLHPNIITLHDVYENRTDV-VLILELVSGGELFDFLAQKESLSEEEATSF---IKQILD 126
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLF-DADFEAH---LSEFGLDRLAIATPAEASSSTT 1000
G+++LH+ + H D+KP+N++ D + L +FGL +
Sbjct: 127 -----GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI----EDGVEFKN 177
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
G+ +V+PE + EAD++S G++ +L+G P
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 25/148 (16%)
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
+ ++S + + H +VH D+KP+NVL DA A +++FGL ++
Sbjct: 118 QQILS-----AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLR 168
Query: 1000 TPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
T GS Y +PE S G+ E D++S G++L +L G P F DE + KK +
Sbjct: 169 TSCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLP--F-DDEHVPTLFKK-I 223
Query: 1058 QRGQ------IS---ELLEPGLLELDPE 1076
+ G ++ L +L++DP
Sbjct: 224 RGGVFYIPEYLNRSVATLLMHMLQVDPL 251
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEAL--------GK 888
F+ VL +G +G + + + + +++ L+ + + + E
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALP 398
Query: 889 VKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL 947
K LT L + RL V +Y+ G+L +Q+ P + +
Sbjct: 399 GKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEI 451
Query: 948 ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
A GL FL S +++ D+K NV+ D++ +++FG+ + I + ++ T G+ Y
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI---WDGVTTKTFCGTPDY 508
Query: 1008 VSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
++PE QP K D ++FG++L E+L G+ P F +DED
Sbjct: 509 IAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDED 548
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 49/222 (22%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR--DGTID-ENTFRKEAEALGKV 889
+ F +++L G YG++ A++ G +++I+++ D + T R E + L
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHF 66
Query: 890 KHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS 944
KH N+ + P ++ + M +L ++ D H+ ++ I
Sbjct: 67 KHENIITIFNIQR-PDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHI-----QYFIY 119
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
L R + LH +++H D+KP N+L +++ + + +FGL R+ + A+ S T
Sbjct: 120 QTL-RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 1005 L-GYVS------PEA-ASTGQPTKEADVYSFGIVLLEILTGR 1038
+ +V+ PE ++ + ++ DV+S G +L E+ R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 25/148 (16%)
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
+ +I + + H +VH D+KP+N+L D + +++FGL + +
Sbjct: 115 QQIIC-----AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS----NIMTDGNFLK 165
Query: 1000 TPIGSLGYVSPEAASTGQPTK--EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
T GS Y +PE + G+ E DV+S GIVL +L GR P F DE I KK +
Sbjct: 166 TSCGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP--F-DDEFIPNLFKK-V 220
Query: 1058 QRGQ------IS---ELLEPGLLELDPE 1076
+S + L ++ DP
Sbjct: 221 NSCVYVMPDFLSPGAQSLIRRMIVADPM 248
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 22/113 (19%), Positives = 40/113 (35%), Gaps = 5/113 (4%)
Query: 601 ACSAL-EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKE-ISKCSSLVSLTL 658
+ R + + + +L + + + + L +LT+
Sbjct: 6 CPHGSSGLRCTRDGAL--DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 659 DMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
+ L P++F L+ LNLS N L ++ SL+ L LS N L
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 27/92 (29%), Positives = 37/92 (40%), Gaps = 2/92 (2%)
Query: 499 IPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGL 557
+ LT L + NQ L + GL L+ +++ ++ L P+ F L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHN 589
LNLS NA T L SL L LS N
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 450 NIPEEITRLSNLTTLNLSYNKFGGKVP-YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMR 508
+ + NLT L + + + D+ L L L + SG P + R
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 509 LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
L+ L+LS L L + SLQ + L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 15/100 (15%), Positives = 30/100 (30%), Gaps = 2/100 (2%)
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAEL 599
+ + D L L + + + L L L++ + + + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKL 639
L L L N ++ +++L L N L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 180 EIPGNFSSKSQLQLINLSYNSFSGEVPA-SVGQLQELEYLWLDSNHLYGTLPSAISNCSS 238
+ + L + + + + L EL L + + L P A
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT 274
L L+ N L+ L T+ +S LQ L LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 2/94 (2%)
Query: 379 VPDEIAKCSLLQMFDLEGNRFSGQVPAF-LGGIRGLKIVSLGRNMFSGLIPLSFGNLSQL 437
+ L +E + + L G+ L+ +++ ++ + P +F +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKF 471
LNLS N + ++ + + +L L LS N
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 14/76 (18%), Positives = 28/76 (36%), Gaps = 1/76 (1%)
Query: 204 EVPASVGQLQELEYLWLDSNHLYGTLPS-AISNCSSLVHLSAEDNVLKGLIPGTIGRIST 262
+ + + L L++++ L + L +L+ + L+ + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 263 LQVLSLSRNELTGLVP 278
L L+LS N L L
Sbjct: 82 LSRLNLSFNALESLSW 97
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 13/67 (19%), Positives = 21/67 (31%), Gaps = 2/67 (2%)
Query: 648 SKCSSLVSLTLD-MNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPA-DLALISSLRYLN 705
C S L + NLT L + + + DL + LR L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 706 LSRNNLE 712
+ ++ L
Sbjct: 63 IVKSGLR 69
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 19/93 (20%), Positives = 31/93 (33%), Gaps = 4/93 (4%)
Query: 136 PLSIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQ 192
+ NL L + + + LR L + + P F +L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 193 LINLSYNSFSGEVPASVGQLQELEYLWLDSNHL 225
+NLS+N+ + Q L+ L L N L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 54/230 (23%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEA------- 885
E + + + G YG + A + G ++I++L F+ E A
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL------SRPFQSEIFAKRAYREL 74
Query: 886 --LGKVKHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQ---DGHVL 935
L ++H N+ L + +R LV +M T LQ+ + +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEKI- 128
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
++L+ L +GL ++HS +VH D+KP N+ + D E + +FGL R A
Sbjct: 129 ----QYLVYQML-KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HA 176
Query: 996 SSSTTPIGSLGYVS------PEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
+ T GYV PE S + D++S G ++ E+LTG+
Sbjct: 177 DAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 39/229 (17%)
Query: 838 QFDEENVLSRGRYG---LIFKASYQD-GMVLSIRRLRDGTI---DENTFRKEAEALGKVK 890
QF+ VL +G +G L+ K S D + +++ L+ T+ D + E + L +V
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 891 HRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
H + L +YA + +L L+ D++ G+L T L + + + +
Sbjct: 85 HPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSK-------------EVMFTEEDVK 129
Query: 950 --------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTP 1001
L LHSL +++ D+KP+N+L D + L++FGL + +I + +
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---DHEKKAYSF 186
Query: 1002 IGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
G++ Y++PE + T+ AD +SFG+++ E+LTG P F +D
Sbjct: 187 CGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP--FQGKDRK 232
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 47/227 (20%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEA------- 885
E ++ + + G YG + A + G+ +++++L F+ A
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYREL 79
Query: 886 --LGKVKHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQDGHVLNWP 938
L +KH N+ L + + LV M +L +++ D HV
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHV---- 134
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
+ LI L RGL ++HS D++H D+KP N+ + D E + +FGL R +
Sbjct: 135 -QFLIYQIL-RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADE 185
Query: 999 TTPIGSLGYVS------PEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
T GYV+ PE + + D++S G ++ E+LTGR
Sbjct: 186 MT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 42/129 (32%), Positives = 63/129 (48%), Gaps = 3/129 (2%)
Query: 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTG 617
Q L L DN T P + L +L L L NQ+ + + + L VL+L +N T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 618 NIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
+P + L +K+L + NKL+ E+P+ I + + L L LD N L +F +LS+
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 677 LTTLNLSTN 685
LT L N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 44/144 (30%), Positives = 60/144 (41%), Gaps = 10/144 (6%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEY 217
+ A I + + L L N T PG F S L+ + L N +P V L +L
Sbjct: 34 VPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTV 92
Query: 218 LWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276
L L +N L LPSA+ L L N L +P I R++ L L+L +N+L
Sbjct: 93 LDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS- 149
Query: 277 VPVSVLCNLWGNISSLRIVQLGFN 300
+P L SSL L N
Sbjct: 150 IPHGAFDRL----SSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 35/126 (27%), Positives = 48/126 (38%), Gaps = 5/126 (3%)
Query: 125 YLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISA---DISPSLRYLDLSSNAFTGEI 181
YL N + P +L NL L + N L + D L LDL +N T
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLP 104
Query: 182 PGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVH 241
F L+ + + N + E+P + +L L +L LD N L A SSL H
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163
Query: 242 LSAEDN 247
N
Sbjct: 164 AYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 3/127 (2%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGE 642
L L NQI+ + P + L+ L L SN +PV + L+++ LDLG N+L+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 643 IPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLR 702
+ L L + N L+ +P +L++LT L L N+L +SSL
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 703 YLNLSRN 709
+ L N
Sbjct: 163 HAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 38/130 (29%), Positives = 56/130 (43%), Gaps = 5/130 (3%)
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFS 496
+ L L +N I P L NL L L N+ G +P V +L L VL+L + +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLV 555
L+ L L + L+ ELP + L L ++L++N L +P G F L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLS 159
Query: 556 GLQYLNLSDN 565
L + L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 39/142 (27%), Positives = 54/142 (38%), Gaps = 9/142 (6%)
Query: 450 NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRL 509
IP +N L L N+ P +L L L L ++ G SL +L
Sbjct: 37 GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 510 TTLDLSNQNLSGELPIELFG-LPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
T LDL L+ LP +F L L+ + + N L+ +P G L L +L L N
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148
Query: 569 GDIPATYGFLRSLVFLSLSHNQ 590
+ L SL L N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 216 EYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG 275
+ L+L N + P + +L L N L L G ++ L VL L N+LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 276 LVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG-RCVSVLEVLDLQNNRIRAVFPSW 334
L P +V L L+ + + N T + P G ++ L L L N+++++
Sbjct: 103 L-PSAVFDRL----VHLKELFMCCNKLTEL---PRGIERLTHLTHLALDQNQLKSIPHGA 154
Query: 335 LTNVTSLRVMDLSGN 349
++SL L GN
Sbjct: 155 FDRLSSLTHAYLFGN 169
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEA------- 885
E + + + G YG + A + G ++I++L F+ E A
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------RPFQSELFAKRAYREL 75
Query: 886 --LGKVKHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQDGHVLNWP 938
L ++H N+ L + + LV +M +L L++ + +
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRI---- 130
Query: 939 MRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998
+ L+ L +GL ++H+ ++H D+KP N+ + D E + +FGL R +A S
Sbjct: 131 -QFLVYQML-KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSE 181
Query: 999 TTPIGSLGYVS------PEAA-STGQPTKEADVYSFGIVLLEILTGR 1038
T GYV PE + + T+ D++S G ++ E++TG+
Sbjct: 182 MT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 1e-09
Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 838 QFDEENVLSRGRYG---LIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAE-------AL 886
F+ VL +G YG + K + + G + +++ L+ I N K+ L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNIL 75
Query: 887 GKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL 945
+VKH + L YA +L L+ +Y+ G L L+ +
Sbjct: 76 EEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLER-------------EGIFME 120
Query: 946 GLAR--------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997
A L LH +++ D+KP+N++ + L++FGL + +I + +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI---HDGTV 177
Query: 998 STTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
+ T G++ Y++PE + D +S G ++ ++LTG P FT ++
Sbjct: 178 THTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRK 227
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 618 NIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNL 677
IP D+ +L L N+ + +PKE+S L + L N +S +SFS ++ L
Sbjct: 28 GIPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 678 TTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNL 711
TL LS NRL IP + SLR L+L N++
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 9/108 (8%)
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
L L N FT +P ++S+ + +DL N++S + S + L++L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 666 RIPESFSKLSNLTTLNLSTNRLSGAIP----ADLALISSLRYLNLSRN 709
P +F L +L L+L N +S +P DL S+L +L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL---SALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 5/113 (4%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLW 219
I + L L N FT +P S+ L LI+LS N S + + +L L
Sbjct: 27 KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLI 84
Query: 220 LDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271
L N L +P SL LS N + + G +S L L++ N
Sbjct: 85 LSYNRL-RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 30/82 (36%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 390 QMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG 449
L+GN+F+ VP L + L ++ L N S L SF N++QL TL LS N +R
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 450 NIPEEIT-RLSNLTTLNLSYNK 470
IP L +L L+L N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGND 113
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 9/108 (8%)
Query: 510 TTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAFT 568
T L L + N +P EL L ++ L N +S + FS++ L L LS N
Sbjct: 34 TELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGA---CSALEVLELRSN 613
P T+ L+SL LSL N IS ++P GA SAL L + +N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPE--GAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 58/179 (32%)
Query: 510 TTLDLSNQNLSGELPIELFGLP-SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
T + SN+ L LP G+P + + L+ N + VP+ S+ L ++LS+N +
Sbjct: 13 TVVRCSNKGLK-VLPK---GIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS 67
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSR 628
L + F S++++
Sbjct: 68 --------TLSNQSF----------------------------------------SNMTQ 79
Query: 629 IKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTN 685
+ L L N+L IP SL L+L N +S +PE +F+ LS L+ L + N
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 21/69 (30%), Positives = 32/69 (46%), Gaps = 4/69 (5%)
Query: 499 IPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVG 556
+P + + LT +DLSN +S L + F + L + L N L +P F L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS 103
Query: 557 LQYLNLSDN 565
L+ L+L N
Sbjct: 104 LRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 6/85 (7%)
Query: 216 EYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG 275
L+LD N +P +SN L + +N + L + ++ L L LS N L
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 276 LVPVSVLCNLWGNISSLRIVQLGFN 300
+ P L SLR++ L N
Sbjct: 93 I-PPRTFDGL----KSLRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 33/135 (24%), Positives = 51/135 (37%), Gaps = 30/135 (22%)
Query: 336 TNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395
+VT L L GN F+ +P + + L ++ ++NN +S L F
Sbjct: 31 RDVTEL---YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQ---------SFS-- 75
Query: 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI 455
+ L + L N + P +F L L L+L NDI +PE
Sbjct: 76 -------------NMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGA 121
Query: 456 -TRLSNLTTLNLSYN 469
LS L+ L + N
Sbjct: 122 FNDLSALSHLAIGAN 136
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 25/148 (16%)
Query: 940 RHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSST 999
+ ++S G+ + H +VH D+KP+NVL DA A +++FGL ++
Sbjct: 123 QQILS-----GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLR 173
Query: 1000 TPIGSLGYVSPEAASTGQPTK--EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
T GS Y +PE S G+ E D++S G++L +L G P F D+ + KK +
Sbjct: 174 TSCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLP--F-DDDHVPTLFKK-I 228
Query: 1058 QRGQ------IS---ELLEPGLLELDPE 1076
G ++ L +L++DP
Sbjct: 229 CDGIFYTPQYLNPSVISLLKHMLQVDPM 256
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 49/278 (17%)
Query: 793 GEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYG- 851
G S G G + E L K+ F+ VL G YG
Sbjct: 17 GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVG-------IENFELLKVLGTGAYGK 69
Query: 852 --LIFKASYQD-GMVLSIRRLRDGTI---DENTFRKEAE--ALGKVKHRN-LTVLRGYYA 902
L+ K S D G + +++ L+ TI + T E L ++ L L +YA
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL--HYA 127
Query: 903 GPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR--------GLSF 953
+ +L L+ DY+ G L T L + R + + L
Sbjct: 128 FQTETKLHLILDYINGGELFTHLSQ-------------RERFTEHEVQIYVGEIVLALEH 174
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE-- 1011
LH L +++ DIK +N+L D++ L++FGL + + E + G++ Y++P+
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV--ADETERAYDFCGTIEYMAPDIV 232
Query: 1012 -AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048
+G K D +S G+++ E+LTG P FT D +
Sbjct: 233 RGGDSGH-DKAVDWWSLGVLMYELLTGASP--FTVDGE 267
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-09
Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 8/101 (7%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL FL S +++ D+K NV+ D++ +++FG+ + I + ++ T G+ Y++
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI---WDGVTTKTFCGTPDYIA 189
Query: 1010 PEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
PE QP K D ++FG++L E+L G+ P F +DED
Sbjct: 190 PEII-AYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGEDED 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-09
Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNV 969
V +Y+ G+L +Q H + + + GL FLHS +V+ D+K N+
Sbjct: 95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149
Query: 970 LFDADFEAHLSEFGLDRLAIATPAEASSST---TPIGSLGYVSPEAASTGQPTKEADVYS 1026
L D D +++FG+ + + +A ++T TP Y++PE + D +S
Sbjct: 150 LLDKDGHIKIADFGMCKENML--GDAKTNTFCGTP----DYIAPEILLGQKYNHSVDWWS 203
Query: 1027 FGIVLLEILTGRKPVMFT-QDED 1048
FG++L E+L G+ P F QDE+
Sbjct: 204 FGVLLYEMLIGQSP--FHGQDEE 224
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 9/144 (6%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEY 217
+ I YLDL +N+ G F + L + L N +P V +L L Y
Sbjct: 22 VPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTY 80
Query: 218 LWLDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276
L L +N L +LP+ + + L L+ N L+ L G +++ L+ L L +N+L
Sbjct: 81 LNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS- 138
Query: 277 VPVSVLCNLWGNISSLRIVQLGFN 300
VP V L +SL+ + L N
Sbjct: 139 VPDGVFDRL----TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 39/154 (25%), Positives = 60/154 (38%), Gaps = 28/154 (18%)
Query: 534 QVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISG 593
+ LE N+L F L L L L N + L SL +L+LS NQ+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 594 MIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSS 652
L + F L+++K+L L N+L +P + K +
Sbjct: 90 ---------------SLPNGVF--------DKLTQLKELALNTNQLQ-SLPDGVFDKLTQ 125
Query: 653 LVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTN 685
L L L N L +P+ F +L++L + L N
Sbjct: 126 LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 44/131 (33%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 438 ETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGN-LKGLLVLNLSASGFS 496
L+L N ++ L++LT L L NK +P V N L L LNLS +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELFG-LPSLQVVSLEENNLSGDVPEG-FSSL 554
G L +L L L+ L LP +F L L+ + L +N L VP+G F L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL 147
Query: 555 VGLQYLNLSDN 565
LQY+ L DN
Sbjct: 148 TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGE 642
L L N + + ++L L L N ++P + + L+ + L+L N+L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 643 IPKEI-SKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTNRL 687
+P + K + L L L+ N L +P+ F KL+ L L L N+L
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 12/137 (8%)
Query: 216 EYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG 275
YL L++N L +SL L N L+ L G ++++L L+LS N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 276 LVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG---RCVSVLEVLDLQNNRIRAVFP 332
L P V L + L+ + L N + P+G + L+ L L N++++V
Sbjct: 91 L-PNGVFDKL----TQLKELALNTNQLQSL---PDGVFDKLTQ-LKDLRLYQNQLKSVPD 141
Query: 333 SWLTNVTSLRVMDLSGN 349
+TSL+ + L N
Sbjct: 142 GVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 31/135 (22%), Positives = 53/135 (39%), Gaps = 8/135 (5%)
Query: 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL---VPDEIAKCSLLQMFDLE 395
+DL N L L L + N L L V +++ L +L
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS---LTYLNLS 84
Query: 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI 455
N+ + LK ++L N L F L+QL+ L L +N ++ ++P+ +
Sbjct: 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGV 143
Query: 456 -TRLSNLTTLNLSYN 469
RL++L + L N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-09
Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 16/139 (11%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
+A L +LHSL++V+ D+KP+N+L D+ L++FGL + I S+++T G+
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---EHNSTTSTFCGTPE 204
Query: 1007 YVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDEDIV--KWVKKQLQ-RGQ 1061
Y++PE QP + D + G VL E+L G P F ++ + + K LQ +
Sbjct: 205 YLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPN 261
Query: 1062 ISE----LLEPGLLELDPE 1076
I+ LLE GLL+ D
Sbjct: 262 ITNSARHLLE-GLLQKDRT 279
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 8e-09
Identities = 31/173 (17%), Positives = 59/173 (34%), Gaps = 21/173 (12%)
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI--SHL 626
D+ + L L + + L+ LE+ S ++ DI S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPR---PNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 627 SRIKKLDL---GQNKLSGEIPKEIS------KCSSLVSLTLDMNSLSGRIPESFSK---L 674
++KL L ++ + +L L + + E F + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 675 SNLTTLNLSTNRLSG----AIPADLALISSLRYLNLSRNNLEGEIPKMLSSRF 723
L T+++S L+ + + I L+++N+ N L E+ K L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 57.7 bits (138), Expect = 1e-08
Identities = 21/170 (12%), Positives = 54/170 (31%), Gaps = 21/170 (12%)
Query: 545 GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGA--C 602
D+ ++ L L + L+SL + + + ++
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE---IISGGLPDSVVEDILGSDL 218
Query: 603 SALEVLEL--RSNHFTGNIPVDI-------SHLSRIKKLDLGQNKLSGEIPKEISKC--- 650
LE L L + + +++ +K L + + + + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 651 SSLVSLTLDMNSLSGR----IPESFSKLSNLTTLNLSTNRLSGAIPADLA 696
L ++ + L+ + + K+ +L +N+ N LS + +L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 3e-06
Identities = 25/158 (15%), Positives = 53/158 (33%), Gaps = 21/158 (13%)
Query: 431 FGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG-----NLKGL 485
+ L L + + N+ NL +L + V D+ NL+ L
Sbjct: 168 LDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224
Query: 486 -LVLNLSASGFSGKIPG-----SIGSLMRLTTLDLSNQNLSGELPIELFG---LPSLQVV 536
L + + GF G + S L L + + + LP L+ +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 537 SLEENNLSGD----VPEGFSSLVGLQYLNLSDNAFTGD 570
+ L+ + + + + L+++N+ N + +
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 29/158 (18%), Positives = 56/158 (35%), Gaps = 20/158 (12%)
Query: 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSL--LRA--VYLQYN 129
L +++ L+ L+ L + S L S+ + L L +Y+
Sbjct: 172 PLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVE 231
Query: 130 SFSGHLPLSIF-------NLTNLLVLNVAHNLLSGKI-----SADISPSLRYLDLSSNAF 177
+ +++F NL L + + +DI P L +D+S+
Sbjct: 232 DYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291
Query: 178 TGE----IPGNFSSKSQLQLINLSYNSFSGEVPASVGQ 211
T E + + L+ IN+ YN S E+ + +
Sbjct: 292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 7e-06
Identities = 26/156 (16%), Positives = 52/156 (33%), Gaps = 21/156 (13%)
Query: 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394
L + L + + G NL L+ L + + L V ++I L + L
Sbjct: 168 LDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224
Query: 395 E---------GNRFSGQVPAFLGGIR--GLKIVSLGRNMFSGLIPLSFGN---LSQLETL 440
+ R LK + + ++ F L QLET+
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 441 NLSENDIRGN----IPEEITRLSNLTTLNLSYNKFG 472
++S + + + + ++ +L +N+ YN
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 7e-05
Identities = 21/129 (16%), Positives = 40/129 (31%), Gaps = 18/129 (13%)
Query: 412 GLKIVSLGRNMFS--GLIPLSFGNLSQLETLNL---SENDIRGNIPEEI------TRLSN 460
LK + + + + +L LE L L E+ R N
Sbjct: 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN 253
Query: 461 LTTLNLSYNKFGGKVPYDVGN---LKGLLVLNLSASGFSGK----IPGSIGSLMRLTTLD 513
L L + + V L L +++SA + + + + + L ++
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313
Query: 514 LSNQNLSGE 522
+ LS E
Sbjct: 314 MKYNYLSDE 322
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 29/141 (20%), Positives = 51/141 (36%), Gaps = 23/141 (16%)
Query: 505 SLMRLTTLDLSNQNLSGELPIELFG--LPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562
+ +R LDL + IE G L + +N + +GF L L+ L +
Sbjct: 17 NAVRDRELDLRGYKIP---VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLV 71
Query: 563 SDNAFTGDIPATYGFLRSLVFLSLSHNQISGM-IPAELGACSALEVLELRSNHFTGNIPV 621
++N L L L L++N + + L + +L L + N PV
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN------PV 125
Query: 622 D---------ISHLSRIKKLD 633
I + +++ LD
Sbjct: 126 TNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 624 SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLS 683
++ R ++LDL K+ I + ++ N + ++ + F L L TL ++
Sbjct: 16 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVN 72
Query: 684 TNRLSGAIPADLALISSLRYLNLSRNNLE 712
NR+ + L L L+ N+L
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 10/109 (9%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFS--GNLPAAVGSLDKLEVLRVANNS 374
LDL+ +I + + + +D S N P L +L+ L V NN
Sbjct: 21 DRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNR 75
Query: 375 LSGLVPDEIAKCSLLQMFDLEGNRFS--GQVPAFLGGIRGLKIVSLGRN 421
+ + L L N G + L ++ L + + RN
Sbjct: 76 ICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 10/129 (7%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEI 643
+ L+ I A+ L+LR I + L + +D N++ ++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 644 PKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD---LALISS 700
L +L ++ N + L +LT L L+ N L D LA + S
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKS 114
Query: 701 LRYLNLSRN 709
L YL + RN
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 30/154 (19%), Positives = 51/154 (33%), Gaps = 34/154 (22%)
Query: 319 VLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFS--GNLPAAVGSLDKLEVLRVANNSLS 376
++ L I + TN R +DL G NL A LD+ + + ++N +
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGAT---LDQFDAIDFSDNEIR 55
Query: 377 GLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
L+G +R LK + + N + L
Sbjct: 56 ----------------KLDG----------FPLLRRLKTLLVNNNRICRIGEGLDQALPD 89
Query: 437 LETLNLSENDIRG-NIPEEITRLSNLTTLNLSYN 469
L L L+ N + + + L +LT L + N
Sbjct: 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 27/152 (17%), Positives = 45/152 (29%), Gaps = 30/152 (19%)
Query: 535 VVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGM 594
+V L + +++ V + L+L I L + S N+I
Sbjct: 1 MVKLTAELIE--QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55
Query: 595 IPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLV 654
L+ L R+K L + N++ L
Sbjct: 56 ------------KLD------------GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91
Query: 655 SLTLDMNSLSG-RIPESFSKLSNLTTLNLSTN 685
L L NSL + + L +LT L + N
Sbjct: 92 ELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 18/90 (20%), Positives = 28/90 (31%), Gaps = 7/90 (7%)
Query: 89 DQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVL 148
Q + R+L L + I A+ N L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 69
Query: 149 NVAHNLLSGKISADIS---PSLRYLDLSSN 175
V +N + +I + P L L L++N
Sbjct: 70 LVNNNRIC-RIGEGLDQALPDLTELILTNN 98
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 21/114 (18%), Positives = 35/114 (30%), Gaps = 8/114 (7%)
Query: 381 DEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440
+ + DL G + + + + N L L +L+TL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 69
Query: 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKG---LLVLNLS 491
++ N I L +LT L L+ N D+ L L L +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCIL 121
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 11/132 (8%)
Query: 509 LTTLDLSN-QNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
+ L L N ++ G+L L+ +S L+ + L L+ L LSDN
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRV 76
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGM-IPAELGACSALEVLELRSNHFTGNIP-----V 621
+G + +L L+LS N+I + L L+ L+L + T N+ V
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENV 135
Query: 622 DISHLSRIKKLD 633
L ++ LD
Sbjct: 136 -FKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 26/111 (23%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 457 RLSNLTTLNLSYNKFG-GKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLS 515
S++ L L ++ GK+ + L L+ G + I + L +L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 516 NQNLSGELPIELFGLPSLQVVSLEENNLSG-DVPEGFSSLVGLQYLNLSDN 565
+ +SG L + P+L ++L N + E L L+ L+L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 25/89 (28%), Positives = 43/89 (48%), Gaps = 3/89 (3%)
Query: 625 HLSRIKKLDLGQNKLS-GEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLS 683
S +K+L L ++ + G++ + L L+ L+ I + KL+ L L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 684 TNRLSGAIPADLALISSLRYLNLSRNNLE 712
NR+SG + +L +LNLS N ++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 30/119 (25%), Positives = 49/119 (41%), Gaps = 6/119 (5%)
Query: 595 IPAELG--ACSALEVLELRSNHFT-GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCS 651
I EL S ++ L L ++ G + ++ L L+ I + K +
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 652 SLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSG-AIPADLALISSLRYLNLSRN 709
L L L N +SG + K NLT LNLS N++ + L + +L+ L+L
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 578 LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQN 637
L FLS + ++ + A L + L+ LEL N +G + V + L+L N
Sbjct: 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 638 KLSG-EIPKEISKCSSLVSLTLDMN 661
K+ + + K +L SL L
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 578 LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQN 637
++ LV + N+ + LE L + T +I ++ L+++KKL+L N
Sbjct: 19 VKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDN 74
Query: 638 KLSGEIPKEISKCSSLVSLTLDMNSLSG-RIPESFSKLSNLTTLNLSTN 685
++SG + KC +L L L N + E KL NL +L+L
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 22/111 (19%), Positives = 40/111 (36%), Gaps = 3/111 (2%)
Query: 288 NISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLS 347
S ++ + L + LE L N + ++ + L + L+ ++LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 348 GNFFSGNLPAAVGSLDKLEVLRVANNSLSGL-VPDEIAKCSLLQMFDLEGN 397
N SG L L L ++ N + L + + K L+ DL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 27/116 (23%), Positives = 43/116 (37%), Gaps = 8/116 (6%)
Query: 310 NGRCVSVLEVLDLQNNRIRAV-FPSWLTNVTSLRVMDLSGNFFS--GNLPAAVGSLDKLE 366
R S ++ L L N+R L + + NLP L+KL+
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLK 67
Query: 367 VLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG-QVPAFLGGIRGLKIVSLGRN 421
L +++N +SG + KC L +L GN+ L + LK + L
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 27/142 (19%), Positives = 49/142 (34%), Gaps = 28/142 (19%)
Query: 86 RLTDQL--ADLHELRKLSLHSNHLN-GSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNL 142
R+ +L ++++L L ++ N G + + L + + SI NL
Sbjct: 6 RIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANL 60
Query: 143 TNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFS 202
L L+ L+LS N +G + L +NLS N
Sbjct: 61 PKL-------------------NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
Query: 203 G-EVPASVGQLQELEYLWLDSN 223
+ +L+ L+ L L +
Sbjct: 102 DLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 71 NRVRELRLPRLQL-AGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYN 129
+ V+EL L + G+L + EL LS + L SI A+L + + L+ + L N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDN 74
Query: 130 SFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSN 175
SG L + NL LN++ N + + + +L+ LDL +
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 7/82 (8%)
Query: 413 LKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFG 472
L+ +S + + L L++L+ L LS+N + G + + NLT LNLS NK
Sbjct: 44 LEFLSTINVGLTSIANLP--KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI- 100
Query: 473 GKVPYDVGNLKG---LLVLNLS 491
K + LK L L+L
Sbjct: 101 -KDLSTIEPLKKLENLKSLDLF 121
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
L FLH +++ D+K NVL D + L++FG+ + I ++ T G+ Y++
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI---CNGVTTATFCGTPDYIA 192
Query: 1010 PEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFT-QDED 1048
PE D ++ G++L E+L G P F ++ED
Sbjct: 193 PEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAP--FEAENED 230
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 30/130 (23%), Positives = 49/130 (37%), Gaps = 7/130 (5%)
Query: 509 LTTLDLSNQNLSGELPIELFG-LPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
+ L L N + L +L+ +SL L V L L+ L LS+N
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRI 83
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAE-LGACSALEVLELRSN---HFTGNIPVDI 623
G + L +L L+LS N++ + E L L+ L+L + +
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVF 143
Query: 624 SHLSRIKKLD 633
L ++ LD
Sbjct: 144 KLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 3/88 (3%)
Query: 626 LSRIKKLDLGQNKLS-GEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLST 684
+ +++L L K + G+I ++ +L L+L L + + KL L L LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 685 NRLSGAIPADLALISSLRYLNLSRNNLE 712
NR+ G + + +L +LNLS N L+
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 30/140 (21%), Positives = 44/140 (31%), Gaps = 30/140 (21%)
Query: 429 LSFGNLSQLETLNLSENDIR-GNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLV 487
L + + L L G I NL L+L V NL
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLP---- 68
Query: 488 LNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS--G 545
L +L L+LS + G L + LP+L ++L N L
Sbjct: 69 -----------------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIS 111
Query: 546 DVPEGFSSLVGLQYLNLSDN 565
+ E L L+ L+L +
Sbjct: 112 TL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 34/139 (24%), Positives = 56/139 (40%), Gaps = 8/139 (5%)
Query: 578 LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQN 637
+R LV L + G I LE L L + ++ ++ L ++KKL+L +N
Sbjct: 26 VRELV-LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSEN 81
Query: 638 KLSGEIPKEISKCSSLVSLTLDMNSLSG-RIPESFSKLSNLTTLNLSTN---RLSGAIPA 693
++ G + K +L L L N L E KL L +L+L L+ +
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRES 141
Query: 694 DLALISSLRYLNLSRNNLE 712
L+ L YL+ +
Sbjct: 142 VFKLLPQLTYLDGYDREDQ 160
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 3/113 (2%)
Query: 286 WGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMD 345
+++R + L LE L L N + +V S L + L+ ++
Sbjct: 20 NRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLE 77
Query: 346 LSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP-DEIAKCSLLQMFDLEGN 397
LS N G L L L L ++ N L + + + K L+ DL
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 30/149 (20%), Positives = 50/149 (33%), Gaps = 30/149 (20%)
Query: 80 RLQLAGRLTDQLA--DLHELRKLSLHSNHLN-GSIPASLHQCSLLRAVYLQYNSFSGHLP 136
+ + R+ +L +R+L L + N G I + L + L
Sbjct: 7 GMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI---- 62
Query: 137 LSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINL 196
S+ NL L P L+ L+LS N G + L +NL
Sbjct: 63 -SVSNLPKL-------------------PKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 197 SYNSFS--GEVPASVGQLQELEYLWLDSN 223
S N + + +L+ L+ L L +
Sbjct: 103 SGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 33/128 (25%), Positives = 50/128 (39%), Gaps = 9/128 (7%)
Query: 358 AVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVS 417
+++ R + L P + + L D + G++ L+ +S
Sbjct: 1 GSSGSSGMDMKRRIHLELRNRTPAAVRELVL----DNCKSN-DGKIEGLTAEFVNLEFLS 55
Query: 418 LGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPY 477
L + L L +L+ L LSEN I G + +L NLT LNLS NK K
Sbjct: 56 LINVGLISVSNLP--KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL--KDIS 111
Query: 478 DVGNLKGL 485
+ LK L
Sbjct: 112 TLEPLKKL 119
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 23/92 (25%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
L++LH +++ D+K NVL D++ L+++G+ + + +++T G+ Y++
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIA 178
Query: 1010 PEAASTGQP-TKEADVYSFGIVLLEILTGRKP 1040
PE G+ D ++ G+++ E++ GR P
Sbjct: 179 PEIL-RGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 48/263 (18%), Positives = 103/263 (39%), Gaps = 44/263 (16%)
Query: 797 PSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGLIFKA 856
P+ G G E + K + L+ FD V+ RG Y +
Sbjct: 15 PTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ---DFDLLRVIGRGSYAKVLLV 71
Query: 857 SYQD-GMVLSIRRLRDGTIDENTFRKEAEA-------LGKV-KHRNLTVLRGYYAGPPDV 907
+ + ++R ++ +++ ++ + + H L L + +
Sbjct: 72 RLKKTDRIYAMRVVKKELVND---DEDIDWVQTEKHVFEQASNHPFLVGL--HSCFQTES 126
Query: 908 RL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR--------GLSFLHSLD 958
RL V +Y+ G+L +Q + + AR L++LH
Sbjct: 127 RLFFVIEYVNGGDLMFHMQR-------------QRKLPEEHARFYSAEISLALNYLHERG 173
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP 1018
+++ D+K NVL D++ L+++G+ + + +++T G+ Y++PE G+
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIAPEIL-RGED 229
Query: 1019 -TKEADVYSFGIVLLEILTGRKP 1040
D ++ G+++ E++ GR P
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 48/229 (20%), Positives = 94/229 (41%), Gaps = 38/229 (16%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRL--RDGTIDENTFRKEAEALGKVK 890
+ ++ + L G GL+F A D ++I+++ D ++ R E + + ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLD 66
Query: 891 HRNLTVLRGYYAGPPDVRL-------------LVYDYMPNGNLATLLQEASHQDGHVLNW 937
H N+ + +V +YM +LA +L++ + H
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHA--- 122
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAEAS 996
R + L RGL ++HS +++H D+KP N+ + D + +FGL R+ +
Sbjct: 123 --RLFMYQLL-RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 997 SSTTPIGSLGYV------SPEA-ASTGQPTKEADVYSFGIVLLEILTGR 1038
+ + SP S TK D+++ G + E+LTG+
Sbjct: 180 HLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 31/132 (23%)
Query: 558 QYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
L L+DN I + F L LV L L NQ++ + N F
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT----------------GIEPNAF 74
Query: 616 TGNIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPE-SFSK 673
S I++L LG+NK+ EI ++ L +L L N +S + SF
Sbjct: 75 --------EGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEH 124
Query: 674 LSNLTTLNLSTN 685
L++LT+LNL++N
Sbjct: 125 LNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 32/106 (30%), Positives = 46/106 (43%), Gaps = 3/106 (2%)
Query: 606 EVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664
L L N + L + KL+L +N+L+G P S + L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 665 GRIPE-SFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRN 709
I F L L TLNL N++S +P ++SL LNL+ N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 9/96 (9%)
Query: 618 NIPVDISHLSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPESFSKLSN 676
+IP+ +L L N+L + + LV L L N L+G P +F S+
Sbjct: 26 DIPLHT------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 677 LTTLNLSTNRLSGAIPADL-ALISSLRYLNLSRNNL 711
+ L L N++ I + + L+ LNL N +
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 32/154 (20%), Positives = 46/154 (29%), Gaps = 55/154 (35%)
Query: 418 LGRNMFSGLIPL-SFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKV 475
L N + FG L L L L N + I S++ L L NK
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK----- 89
Query: 476 PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQ 534
+ + ++F GL L+
Sbjct: 90 --------------IKE------------------------------ISNKMFLGLHQLK 105
Query: 535 VVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAF 567
++L +N +S V G F L L LNL+ N F
Sbjct: 106 TLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 5/86 (5%)
Query: 510 TTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEG-FSSLVGLQYLNLSDNAF 567
T L L++ L LF LP L + L+ N L+ + F +Q L L +N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 568 TGDIPA-TYGFLRSLVFLSLSHNQIS 592
+I + L L L+L NQIS
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 3/106 (2%)
Query: 366 EVLRVANNSLSGLVPDEI-AKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424
L + +N L + D + + L +L+ N+ +G P G ++ + LG N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 425 GLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYN 469
+ F L QL+TLNL +N I + L++LT+LNL+ N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/84 (28%), Positives = 37/84 (44%), Gaps = 2/84 (2%)
Query: 165 PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLWLDSN 223
P L L+L N TG P F S +Q + L N E+ + L +L+ L L N
Sbjct: 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDN 112
Query: 224 HLYGTLPSAISNCSSLVHLSAEDN 247
+ +P + + +SL L+ N
Sbjct: 113 QISCVMPGSFEHLNSLTSLNLASN 136
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 43/240 (17%), Positives = 79/240 (32%), Gaps = 15/240 (6%)
Query: 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS-GELPIELFGLPSLQVVSLEEN 541
+G++ S + R+ +DLSN + L L LQ +SLE
Sbjct: 70 QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 128
Query: 542 NLSGDVPEGFSSLVGLQYLNLSDNAFTGD--IPATYGFLRSLVFLSLSH-NQIS--GMIP 596
LS + + L LNLS + + + L L+LS + +
Sbjct: 129 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188
Query: 597 AELGACSALEVLELRS-NHFTGNIPVD--ISHLSRIKKLDLGQ-NKLSGEIPKEISKCSS 652
A + L L + + + LDL L + +E + +
Sbjct: 189 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 248
Query: 653 LVSLTLDM-NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
L L+L + ++ L TL + G + L +L +L ++ ++
Sbjct: 249 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL---QLLKEALPHLQINCSHF 305
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 56/255 (21%), Positives = 96/255 (37%), Gaps = 13/255 (5%)
Query: 387 SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
SL Q DL G V L +G+ R+ + F +++ ++LS +
Sbjct: 47 SLWQTLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSV 104
Query: 447 I-RGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA-SGFSGKIPGSIG 504
I + +++ S L L+L + + + L+ LNLS SGFS ++
Sbjct: 105 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 164
Query: 505 S-LMRLTTLDLSN-QNLS--GELPIELFGLPSLQVVSLEE--NNLSGD-VPEGFSSLVGL 557
S RL L+LS + + ++ ++L NL + L
Sbjct: 165 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 224
Query: 558 QYLNLSDNAF-TGDIPATYGFLRSLVFLSLSH-NQISGMIPAELGACSALEVLELRSNHF 615
+L+LSD+ D + L L LSLS I ELG L+ L++
Sbjct: 225 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 284
Query: 616 TGNIPVDISHLSRIK 630
G + + L ++
Sbjct: 285 DGTLQLLKEALPHLQ 299
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 41/201 (20%), Positives = 86/201 (42%), Gaps = 19/201 (9%)
Query: 845 LSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYA 902
L RG+Y +F+A + + ++ L+ + + ++E + L ++ N+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVK 101
Query: 903 GPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVH 961
P LV++++ N + L Q + D + R + + + L + HS+ ++H
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTLT--DYDI-----RFYM-YEILKALDYCHSMGIMH 153
Query: 962 GDIKPQNVLFDADF-EAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-T 1019
D+KP NV+ D + + L ++GL + S + PE Q
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELLVDYQMYD 209
Query: 1020 KEADVYSFGIVLLEILTGRKP 1040
D++S G +L ++ ++P
Sbjct: 210 YSLDMWSLGCMLASMIFRKEP 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.8 bits (133), Expect = 5e-08
Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 24/235 (10%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRN 893
++++ + G YG +FKA + + +++++R+R DE ++ +E L ++KH+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ L + LV+++ +L L+ + L +GL F
Sbjct: 63 IVRLHDVLHSDKKL-TLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA- 1012
HS +++H D+KPQN+L + + E L+ FGL R A P + + +L Y P+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVR--CYSAEVVTLWYRPPDVL 173
Query: 1013 -ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
+ T D++S G + E+ +P +F ++ QL+R I LL
Sbjct: 174 FGAKLYST-SIDMWSAGCIFAELANAGRP-LFPGNDVD-----DQLKR--IFRLL 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 30/168 (17%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRH 941
E L V L L + ++ +V +Y+ G + + L+
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNL-YMVMEYVAGGEMFSHLRRIGRFSEPH------- 142
Query: 942 LISLGLAR--------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993
AR +LHSLD+++ D+KP+N+L D +++FG +
Sbjct: 143 ------ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189
Query: 994 EASSST-TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
T T G+ ++PE + K D ++ G+++ E+ G P
Sbjct: 190 RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 28/236 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNL 894
++ + + G YG+++KA G +++++R+R DE +T +E L ++ H N+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLG--LARGLS 952
L + LV+++M +L +L D + + L RG++
Sbjct: 82 VSLIDVIHSERCL-TLVFEFMEK-DLKKVL------DENKTGLQDSQIKIYLYQLLRGVA 133
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
H ++H D+KPQN+L ++D L++FGL R A P S T + +L Y +P+
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVR--SYTHEVVTLWYRAPDV 190
Query: 1013 --ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
S T D++S G + E++T KP +F D QL + I +L
Sbjct: 191 LMGSKKYST-SVDIWSIGCIFAEMIT-GKP-LFPGVTDD-----DQLPK--IFSIL 236
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 4/113 (3%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLW 219
I S L+L SN G F +QL ++LS N +P V +L +L L+
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILY 82
Query: 220 LDSNHLYGTLPSAI-SNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271
L N L +LP+ + + L L+ + N LK + G R+++LQ + L N
Sbjct: 83 LHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDI-SHLSRIKKLDLGQNKLSGE 642
L L N++ + + L L L N ++P + L+++ L L +NKL
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 643 IPKEI-SKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTN 685
+P + K + L L LD N L +P+ F +L++L + L TN
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 33/116 (28%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 595 IPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLV 654
IP+ LEL SN L+++ KL L QN++ K + L
Sbjct: 26 IPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 655 SLTLDMNSLSGRIPES-FSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRN 709
L L N L +P F KL+ L L L TN+L ++SL+ + L N
Sbjct: 80 ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 41/245 (16%), Positives = 88/245 (35%), Gaps = 54/245 (22%)
Query: 834 EATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEA------- 885
+ ++++ RG YG ++ A ++ ++I+++ F +
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV------NRMFEDLIDCKRILREI 76
Query: 886 --LGKVKHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQ---DGHVL 935
L ++K + L P D+ +V + + +L L + + + H+
Sbjct: 77 TILNRLKSDYIIRLYDLII-PDDLLKFDELYIVLEIADS-DLKKLFK--TPIFLTEEHI- 131
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
+ ++ L G +F+H ++H D+KP N L + D + +FGL R +
Sbjct: 132 ----KTILYNLL-LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 996 SSSTTPIGSL-------------GYVS------PEAASTGQP-TKEADVYSFGIVLLEIL 1035
+ +V PE + TK D++S G + E+L
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 1036 TGRKP 1040
+
Sbjct: 247 NMLQS 251
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 5e-07
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 36/171 (21%)
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMR 940
E L V H + + + ++ ++ DY+ G L +LL+++ V
Sbjct: 56 ERLMLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV------ 107
Query: 941 HLISLGLAR--------GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
A+ L +LHS D+++ D+KP+N+L D + +++FG A
Sbjct: 108 -------AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AKY 155
Query: 993 AEASSST---TPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040
+ T TP Y++PE ST K D +SFGI++ E+L G P
Sbjct: 156 VPDVTYTLCGTP----DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 6e-07
Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 47/260 (18%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE----NTFRKEAEALGKVKHR 892
+++ ++ G YG++ K + G +++I++ + D+ R E + L +++H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHE 84
Query: 893 NLTVLRGYYAGPPDV-----RL-LVYDYMPNGNLATLLQEASH--QDGHVLNWPMRHLIS 944
NL L +V R LV++++ + + L+ + V + + +I
Sbjct: 85 NLVNLL-------EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKY-LFQII- 134
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
G+ F HS +++H DIKP+N+L L +FG R +A P E + +
Sbjct: 135 ----NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGE--VYDDEVAT 187
Query: 1005 LGYVSPEA-ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063
Y +PE + K DV++ G ++ E+ G P +F D DI QL I
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-P-LFPGDSDI-----DQLYH--IM 238
Query: 1064 ELLEPGLLELDPESSEWEEF 1083
L G + E F
Sbjct: 239 MCL--G----NLIPRHQELF 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 47/298 (15%), Positives = 91/298 (30%), Gaps = 63/298 (21%)
Query: 458 LSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQ 517
LS+L LNL+ + P + +L L ++L++
Sbjct: 71 LSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRH----------------ALDEVNLASC 111
Query: 518 NLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSL-----VGLQYLNLSDNAFTGD- 570
L L + + L+ N+L + + L + L LS+N T
Sbjct: 112 QLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAG 171
Query: 571 ---IPATYGFLRSLVFLSLSHNQIS--GMIP-AE-LGACSALEVLELRSNHFTGNIPVDI 623
+ S+ LSL H + G+ A L L+ L + N + +
Sbjct: 172 VAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231
Query: 624 SHL----SRIKKLDLGQNKLS-------GEIPKEISKCSSLVSLTLDMNSLSGRIPESFS 672
+ ++ L L N+LS ++ + +V + ++S S
Sbjct: 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILS 291
Query: 673 KL---------------SNLTTLNLSTNRLSGAIPADLALI----SSLRYLNLSRNNL 711
++ L +L +R + P A + +R L +
Sbjct: 292 EVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 35/252 (13%), Positives = 67/252 (26%), Gaps = 57/252 (22%)
Query: 513 DLSNQNLSGELPIELF--------------GLPSLQVVSLEENNLSGDVPEGFSSLV--- 555
L Q L ++ L SL+ ++L ++ P + +
Sbjct: 40 KLGRQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMT---PVKCTVVAAVL 96
Query: 556 -----GLQYLNLSDNAFTGD-----IPATYGFLRSLVFLSLSHNQIS--GMIP-AEL--G 600
L +NL+ +P L L N + +L
Sbjct: 97 GSGRHALDEVNLASCQLDPAGLRTLLPV----FLRARKLGLQLNSLGPEACKDLRDLLLH 152
Query: 601 ACSALEVLELRSNHFTGNIPVDISHL----SRIKKLDLGQNKLSGE----IPKEISKCSS 652
+ L L +N T + + + L L L E + ++ +
Sbjct: 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQ 212
Query: 653 LVSLTLDMNSLSGR----IPESFSKLSNLTTLNLSTNRLS----GAIPADLALISSLRYL 704
L L + N + + + +L L+L N LS + +
Sbjct: 213 LQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARV 272
Query: 705 NLS--RNNLEGE 714
+S E
Sbjct: 273 VVSLTEGTAVSE 284
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 56/360 (15%), Positives = 98/360 (27%), Gaps = 82/360 (22%)
Query: 141 NLTNLLVLNVAHNLL---SGKISADISPSLRYLDLSSNAFT-------GEIPGNFSSKSQ 190
L +L+ + + SA++ SLR L+L+ T + G S +
Sbjct: 45 VLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLG--SGRHA 102
Query: 191 LQLINLSYNSFSGEVPASVGQ-LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVL 249
L +NL+ ++ L L N L + L+H
Sbjct: 103 LDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSL--GPEACKDLRDLLLHDQ------ 154
Query: 250 KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCN-LWGNISSLRIVQLGFNAFT--GV- 305
+ L LS N LT V+VL L GN +S+ + L G+
Sbjct: 155 -----------CQITTLRLSNNPLTA-AGVAVLMEGLAGN-TSVTHLSLLHTGLGDEGLE 201
Query: 306 -----VKPPNGRCVSVLEVLDLQNNRIRAV----FPSWLTNVTSLRVMDLSGNFFSGNLP 356
+ L+ L++ N SL ++ L N S
Sbjct: 202 LLAAQLDRN-----RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS---S 253
Query: 357 AAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416
L ++ A + + + EG I+
Sbjct: 254 EGRQVL--RDLGGAAEG------------GARVVVSLTEGTAV---------SEYWSVIL 290
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRL----SNLTTLNLSYNKFG 472
S + + +L +L ++ P +L + L G
Sbjct: 291 SEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 51/312 (16%), Positives = 92/312 (29%), Gaps = 67/312 (21%)
Query: 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNR 398
+SLR ++L+G + P + VL ++L +L +
Sbjct: 72 SSLRQLNLAGVRMT---PVKCTVV--AAVLGSGRHAL--------------DEVNLASCQ 112
Query: 399 FSGQ-VPAFLGGIRGLKIVSLGRNMFS--GLIPLSFG---NLSQLETLNLSENDIRGN-- 450
+ L + + L N L + Q+ TL LS N +
Sbjct: 113 LDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGV 172
Query: 451 --IPEEITRLSNLTTLNLSYNKFGGKVPYDVG---------NLKGLLVLNLSASGFSGKI 499
+ E + +++T L+L + G D G + L LN++ +G
Sbjct: 173 AVLMEGLAGNTSVTHLSLLHTGLG-----DEGLELLAAQLDRNRQLQELNVAYNGAGDTA 227
Query: 500 PGSIGSLMR----LTTLDLSNQNLS-------GELPIELFGLPSLQVVSLEENNLSGDVP 548
++ R L L L LS +L G + V E +S
Sbjct: 228 ALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWS 287
Query: 549 EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGAC----SA 604
S + + LN D A L+ L ++ + + P
Sbjct: 288 VILSEV--QRNLNSWDRARVQRHL-------ELLLRDLEDSRGATLNPWRKAQLLRVEGE 338
Query: 605 LEVLELRSNHFT 616
+ L +
Sbjct: 339 VRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 68/390 (17%), Positives = 120/390 (30%), Gaps = 77/390 (19%)
Query: 355 LPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMF----DLEGNRFSGQVPAFLGGI 410
L + +LD LE + L L + LL + + RFS +V +
Sbjct: 18 LGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV------L 71
Query: 411 RGLKIVSLGRNMFS--GLIPLSFG---NLSQLETLNLSENDIRGNIPEEITRLS----NL 461
L+ ++L + ++ L+ +NL+ + P + L
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD---PAGLRTLLPVFLRA 128
Query: 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSG 521
L L N G + +L+ LL+ + ++TTL LSN L+
Sbjct: 129 RKLGLQLNSLGPE---ACKDLRDLLLHDQC----------------QITTLRLSNNPLTA 169
Query: 522 E----LPIELFGLPSLQVVSLEENNLSGDVPEGFSSL-------VGLQYLNLSDNAFTGD 570
L L G S+ +SL L EG L LQ LN++ N
Sbjct: 170 AGVAVLMEGLAGNTSVTHLSLLHTGLG---DEGLELLAAQLDRNRQLQELNVAYNGAGDT 226
Query: 571 -IPATYGFLR---SLVFLSLSHNQIS----GMIPAELGACSALEVLELRSNHFTGNIPVD 622
A R SL L L N++S ++ GA + + T
Sbjct: 227 AALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYW 286
Query: 623 ISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKL----SNLT 678
LS +++ L+ + + L+ L+ + + P ++L +
Sbjct: 287 SVILSEVQR------NLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVR 340
Query: 679 TLNLSTNRLSG----AIPADLALISSLRYL 704
L + +
Sbjct: 341 ALLEQLGSSGSPSGSWSHPQFEKGAGHHHH 370
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 8e-07
Identities = 37/168 (22%), Positives = 71/168 (42%), Gaps = 29/168 (17%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE----NTFRKEAEALGKVKHR 892
++++ + G YG++FK + G +++I++ + D R E L ++KH
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHP 62
Query: 893 NLTVLRGYYAGPPDV-----RL-LVYDYMPNGNLATLLQEASHQ--DGHVLNWPMRHLIS 944
NL L +V RL LV++Y + + L + V + +
Sbjct: 63 NLVNLL-------EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI-TWQTL- 112
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992
+ ++F H + +H D+KP+N+L L +FG R + P
Sbjct: 113 ----QAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTGP 155
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 50/274 (18%), Positives = 85/274 (31%), Gaps = 80/274 (29%)
Query: 910 LVYDYMPNG-NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQ 967
+V++ + G +L + + L P I + +GL +LH+ ++H DIKP+
Sbjct: 122 MVFEVL--GHHLLKWII---KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176
Query: 968 NVLFDAD---------------------------------------FEAHLSEFGLDRLA 988
N+L + ++
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 989 IATPAEASSS----TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGR------ 1038
IA A T I + Y S E AD++S + E+ TG
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 1039 KPVMFTQDEDIV----------------------KWVKKQLQRGQISELLEPGLLELDPE 1076
+T+DED + ++ K+ I++L GL E+ E
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 1077 SSEW--EEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
EW EE L P R + A+ +
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 48/286 (16%), Positives = 94/286 (32%), Gaps = 53/286 (18%)
Query: 793 GEKKPSPSRGSSGAERGRGSGENGGPKLVMFNNKITYVETLEATRQFDEENVLSRGRYGL 852
GS + R + P M + + +++ +++ G YG
Sbjct: 13 NSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDW----QIPDRYEIRHLIGTGSYGH 68
Query: 853 IFKASY-QDGMVLSIRRLRDGTIDEN----TFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907
+ +A + V++I+++ D R E L ++ H ++ + P DV
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVI-PKDV 126
Query: 908 RL-----LVYDYMPNGNLATLLQEASHQ---DGHVLNWPMRHLISLGLARGLSFLHSLDM 959
+V + + + L + + + H+ + L+ L G+ ++HS +
Sbjct: 127 EKFDELYVVLEIADS-DFKKLFR--TPVYLTELHI-----KTLL-YNLLVGVKYVHSAGI 177
Query: 960 VHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP- 1018
+H D+KP N L + D + +FGL R S T
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 1019 ------------------------TKEADVYSFGIVLLEILTGRKP 1040
T+ DV+S G + E+L K
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 28/236 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNL 894
++ + G YG+++KA G +++++R DE +T +E L ++KH N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLG--LARGLS 952
L + +LV++++ +L LL D S L G++
Sbjct: 63 VKLYDVIHTKKRL-VLVFEHLDQ-DLKKLL------DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+ H ++H D+KPQN+L + + E +++FGL R A P T I +L Y +P+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVR--KYTHEIVTLWYRAPDV 171
Query: 1013 --ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
S T D++S G + E++ P +F + QL R I +L
Sbjct: 172 LMGSKKYST-TIDIWSVGCIFAEMVN-GTP-LFPGVSEA-----DQLMR--IFRIL 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 19/109 (17%)
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL--- 1005
+ + +LHS ++H D+KP N+L +A+ +++FGL R + ++ I
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 1006 ---------GYVS------PEAASTGQP-TKEADVYSFGIVLLEILTGR 1038
YV+ PE TK D++S G +L EIL G+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 28/236 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLR----DGTIDENTFRKEAEALGKVKHR 892
+ + + L G Y ++K + +++++ +R +G R E L +KH
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIR-EVSLLKDLKHA 60
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
N+ L + LV++Y+ +L L G+++N L L RGL+
Sbjct: 61 NIVTLHDIIHTEKSL-TLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLRGLA 114
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+ H ++H D+KPQN+L + E L++FGL R A + P + + + +L Y P+
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTK--TYDNEVVTLWYRPPDI 171
Query: 1013 --ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
ST T + D++ G + E+ T +P +F +QL I +L
Sbjct: 172 LLGSTDYST-QIDMWGVGCIFYEMAT-GRP-LFPGSTVE-----EQLHF--IFRIL 217
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRN 893
++++ + +G +G +FKA + G ++++++ E T +E + L +KH N
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 894 LTVLRGYYAGPPDVRL-------LVYDYMPNGNLATLLQEASHQ--DGHVLNWPMRHLIS 944
+ L LV+D+ + +LA LL + + M+ L+
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV-MQMLL- 134
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL-AIATPAEASSSTTPIG 1003
GL ++H ++H D+K NVL D L++FGL R ++A ++ + T +
Sbjct: 135 ----NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 1004 SLGYVSPE----AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059
+L Y PE G P D++ G ++ E+ T R P+M E QL
Sbjct: 191 TLWYRPPELLLGERDYGPPI---DLWGAGCIMAEMWT-RSPIMQGNTEQ------HQLAL 240
Query: 1060 GQISELL 1066
IS+L
Sbjct: 241 --ISQLC 245
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 919 NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFD-ADFE 976
NL L+++ + + IS L GL ++H ++H DIKP+NVL + D
Sbjct: 115 NLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171
Query: 977 AHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA---ASTGQPTKEADVYSFGIVLLE 1033
+L + + L A + T I + Y SPE A G AD++S ++ E
Sbjct: 172 ENLIQIKIADLGNACWYD-EHYTNSIQTREYRSPEVLLGAPWGCG---ADIWSTACLIFE 227
Query: 1034 ILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068
++TG +F + ++ + K QI ELL
Sbjct: 228 LITGD--FLF-EPDEGHSYTKDDDHIAQIIELLGE 259
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 57/242 (23%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 833 LEATRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR----DGTIDENTFRKEAEALG 887
+ ++ QF + L G Y ++K + G+ ++++ ++ +G R E +
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-TPSTAIR-EISLMK 58
Query: 888 KVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLL-QEASHQDGHVLNWPMRHLISLG 946
++KH N+ L + LV+++M N +L + L +
Sbjct: 59 ELKHENIVRLYDVIHTENKL-TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
L +GL+F H ++H D+KPQN+L + + L +FGL R A P + ++ + +L
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVN--TFSSEVVTLW 173
Query: 1007 YVSPEA--ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064
Y +P+ S T D++S G +L E++T KP +F D +QL+ I +
Sbjct: 174 YRAPDVLMGSRTYST-SIDIWSCGCILAEMIT-GKP-LFPGTNDE-----EQLKL--IFD 223
Query: 1065 LL 1066
++
Sbjct: 224 IM 225
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 31/240 (12%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRN 893
++ L G YG ++KA ++I+R+R +E T +E L +++HRN
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ L+ + L+++Y N +L + + V+ + LI G++F
Sbjct: 95 IIELKSVIHHNHRL-HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI-----NGVNF 147
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAH-----LSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
HS +H D+KPQN+L + + +FGL R A T I +L Y
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR---AFGIPIRQFTHEIITLWYR 204
Query: 1009 SPEA--ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
PE S T D++S + E+L + P +F D +I QL + I E+L
Sbjct: 205 PPEILLGSRHYST-SVDIWSIACIWAEMLM-KTP-LFPGDSEI-----DQLFK--IFEVL 254
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 53/281 (18%), Positives = 107/281 (38%), Gaps = 68/281 (24%)
Query: 844 VLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYY 901
VL G G + + + +++ L+D R+E E + + ++ + Y
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVY 80
Query: 902 ---AGPPDVRLLVYDYMPNGNLATLLQEASHQ-----DGHVLNWPMRHLISLGLARGLSF 953
L+V + + G L + +Q+ Q + + M+ + + +
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI---MKSIGE-----AIQY 132
Query: 954 LHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
LHS+++ H D+KP+N+L+ + L++FG +
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------------AK 168
Query: 1011 EAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
E +TG+ K D++S G+++ +L G P I +K +++ GQ
Sbjct: 169 E--TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------- 219
Query: 1070 LLELDPESSEWEEFLLGVK---VGLLCTAPDPLDRPSMADI 1107
+ + EW E VK LL T +P R ++ +
Sbjct: 220 ----EFPNPEWSEVSEEVKMLIRNLLKT--EPTQRMTITEF 254
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 23/110 (20%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLF--DADFEAHLSEFGLDRLAIATPAEASSS------ 998
+ + L LH ++H D+KP+N+L + +FG SS
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG------------SSCYEHQRV 256
Query: 999 TTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDE 1047
T I S Y +PE G D++S G +L E+LTG P++ +DE
Sbjct: 257 YTYIQSRFYRAPEVI-LGARYGMPIDMWSLGCILAELLTG-YPLLPGEDE 304
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 6e-05
Identities = 35/148 (23%), Positives = 74/148 (50%), Gaps = 17/148 (11%)
Query: 848 GRYGLIFKA-SYQDGMVLSIRRLRDGTIDEN------TFRKEAEALGKVKHRNLTVLRGY 900
G++ ++KA +++I++++ G E T +E + L ++ H N+ L
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80
Query: 901 YAGPPDVRLLVYDYMPNGNLATLLQEASHQ--DGHVLNWPMRHLISLGLARGLSFLHSLD 958
+ ++ LV+D+M +L ++++ S H+ + M + +GL +LH
Sbjct: 81 FGHKSNI-SLVFDFMET-DLEVIIKDNSLVLTPSHIKAY-MLMTL-----QGLEYLHQHW 132
Query: 959 MVHGDIKPQNVLFDADFEAHLSEFGLDR 986
++H D+KP N+L D + L++FGL +
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 24/166 (14%)
Query: 838 QFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR-----DG-------TIDENTFRKEAE 884
+++ + G YG ++KA G ++++ +R G T+ E +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR-- 67
Query: 885 ALGKVKHRN----LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMR 940
L +H N + V LV++++ +L T L L
Sbjct: 68 -LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAETI 122
Query: 941 HLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986
+ RGL FLH+ +VH D+KP+N+L + L++FGL R
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 8e-05
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 35/244 (14%)
Query: 838 QFDEENVLSRGRYGLIFKA--SYQDGMVLSIRRLR-----DG----TIDENTFRKEAEAL 886
Q++ + G YG +FKA G ++++R+R +G TI E + L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---L 68
Query: 887 GKVKHRN----LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL 942
+H N V LV++++ +L T L +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKD 124
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
+ L RGL FLHS +VH D+KPQN+L + + L++FGL R + + T+ +
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQM---ALTSVV 180
Query: 1003 GSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062
+L Y +PE D++S G + E+ RKP +F D+ QL + I
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP-LFRGSSDV-----DQLGK--I 231
Query: 1063 SELL 1066
+++
Sbjct: 232 LDVI 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 22/111 (19%), Positives = 41/111 (36%), Gaps = 21/111 (18%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI---- 1002
+ + L++L + + H D+KP+N+L D + + +T I
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 1003 -GSLGYVSPEAAST--------------GQP-TKEADVYSFGIVLLEILTG 1037
G + S + + +D++SFG VL E+ TG
Sbjct: 206 FGCATFKS-DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 161 ADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASV-GQLQELEYLW 219
I + + L L N T PG F +QL ++L N + +PA V +L +L L
Sbjct: 26 TGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLS 84
Query: 220 LDSNHLYGTLPSAISNCSSLVHLSAEDN 247
L+ N L A N SL H+ +N
Sbjct: 85 LNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-04
Identities = 28/105 (26%), Positives = 43/105 (40%), Gaps = 15/105 (14%)
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLF-DADFEAHLSEFGLDRLAIATPAE------ASSS- 998
L L FLH + H D+KP+N+LF +++FE +E S++
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 999 -----TTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTG 1037
TT + + Y PE + DV+S G +L E G
Sbjct: 192 DHEHHTTIVATRHYRPPEVI-LELGWAQPCDVWSIGCILFEYYRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1133 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.38 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.35 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.28 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.16 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.13 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.04 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.03 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.92 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.87 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.79 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.28 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.12 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.93 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.76 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.76 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.61 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.14 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.49 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.05 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.85 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.52 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.66 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.45 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-94 Score=910.87 Aligned_cols=708 Identities=31% Similarity=0.469 Sum_probs=652.9
Q ss_pred ccCchhHHHHHHHHHHhCCCCCCCccCCCCCCCCCCCccceeeeCCCceEEEeeCCcccCcc---cchhhcccccCcEEE
Q 001171 25 NAVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGR---LTDQLADLHELRKLS 101 (1133)
Q Consensus 25 ~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c~w~gv~c~~~~v~~l~l~~~~l~g~---~~~~l~~l~~L~~L~ 101 (1133)
.++.++|++||++||+++.||. ++++|+.+ .+||.|.||+|+.++|++|+|.+.++.|. +++++.+|++|+.++
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~~--~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~ 83 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWSSN--KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT--SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCCCC--CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccC
Confidence 3446789999999999999998 89999744 47999999999989999999999999999 999999999999999
Q ss_pred cccCcccCCCCccccCCCCcceEeccCCcccCcCCC--ccccccchhhhhhcccccCCCccCcc---CCcceEEEccCCc
Q 001171 102 LHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPL--SIFNLTNLLVLNVAHNLLSGKISADI---SPSLRYLDLSSNA 176 (1133)
Q Consensus 102 l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~--~l~~l~~L~~L~l~~N~l~~~~~~~~---~~~l~~L~Ls~N~ 176 (1133)
++.|.+. .+|..++.+++|++|+|++|.++|.+|. .++++++|++|++++|.+++.+|..+ .++|++|||++|+
T Consensus 84 ~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 84 LSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp CTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 9999876 4678999999999999999999999999 99999999999999999998888765 4799999999999
Q ss_pred CCCCCCCC---CCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCC
Q 001171 177 FTGEIPGN---FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLI 253 (1133)
Q Consensus 177 ~~~~~p~~---~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 253 (1133)
+++..|.. +.++++|++|++++|++++.+|. +.+++|++|+|++|++++.+|. ++++++|++|++++|++++.+
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~ 239 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcc
Confidence 99988877 88999999999999999987774 8899999999999999988887 999999999999999999999
Q ss_pred CCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCc
Q 001171 254 PGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS 333 (1133)
Q Consensus 254 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 333 (1133)
|..|..+++|++|+|++|++++.+|. .++++|++|++++|.+++.+....+..+.+|++|+|++|++++..|.
T Consensus 240 ~~~l~~l~~L~~L~Ls~n~l~~~~~~-------~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~ 312 (768)
T 3rgz_A 240 SRAISTCTELKLLNISSNQFVGPIPP-------LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312 (768)
T ss_dssp HHHTTTCSSCCEEECCSSCCEESCCC-------CCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCG
T ss_pred cHHHhcCCCCCEEECCCCcccCccCc-------cccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccch
Confidence 99999999999999999999988775 26899999999999999877544445568999999999999999999
Q ss_pred hhhcccccceeeccCceeecccCcc-cCCCCCCcEEEccCCcccccCchhhccCC-CccEEEccCCcccccCCCccCC--
Q 001171 334 WLTNVTSLRVMDLSGNFFSGNLPAA-VGSLDKLEVLRVANNSLSGLVPDEIAKCS-LLQMFDLEGNRFSGQVPAFLGG-- 409 (1133)
Q Consensus 334 ~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~-- 409 (1133)
.|.++++|++|+|++|.+.+.+|.. ++.+++|++|++++|++++.+|..+.+++ +|++|+|++|++++.+|..+..
T Consensus 313 ~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~ 392 (768)
T 3rgz_A 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392 (768)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCST
T ss_pred HHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcc
Confidence 9999999999999999999888876 99999999999999999999999999998 9999999999999999998877
Q ss_pred CCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEE
Q 001171 410 IRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLN 489 (1133)
Q Consensus 410 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 489 (1133)
+++|+.|++++|.+++.+|..|.++++|++|++++|++++.+|..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 393 ~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 472 (768)
T 3rgz_A 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472 (768)
T ss_dssp TCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred cCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEE
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccC
Q 001171 490 LSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569 (1133)
Q Consensus 490 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 569 (1133)
+++|++++.+|..+.++++|++|++++|++++.+|.++..+++|++|+|++|++++.+|..+.++++|++|++++|.+++
T Consensus 473 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 552 (768)
T 3rgz_A 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEES
T ss_pred ecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccceeecccC----------------------ccCCCCCccccCCCCccEEEecCCcccCCCcccccccc
Q 001171 570 DIPATYGFLRSLVFLSLSHN----------------------QISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLS 627 (1133)
Q Consensus 570 ~~~~~~~~l~~L~~L~Ls~N----------------------~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 627 (1133)
.+|..+.....+..+++..+ .+.+..+..+..++.+..++++.|.++|.+|..++.++
T Consensus 553 ~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~ 632 (768)
T 3rgz_A 553 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632 (768)
T ss_dssp BCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSB
T ss_pred cCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccc
Confidence 99999888776666555442 23455666677778888889999999999999999999
Q ss_pred ccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccc
Q 001171 628 RIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLS 707 (1133)
Q Consensus 628 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls 707 (1133)
+|+.|||++|+++|.+|.+++.+++|+.|+|++|+++|.+|..|+++++|+.||||+|+++|.+|..+..+++|++||||
T Consensus 633 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp CCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred cccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccC-CCCCCcccCcCccccCCCCCCCCcchh
Q 001171 708 RNNLEGEIPKMLSS-RFNDPSIFAMNRELCGKPLDRECANVR 748 (1133)
Q Consensus 708 ~N~l~~~~p~~~~~-~~~~~~~~~~n~~lcg~~~~~~c~~~~ 748 (1133)
+|+++|+||..... .|... .|.||+++||.|+. .|....
T Consensus 713 ~N~l~g~iP~~~~~~~~~~~-~~~gN~~Lcg~~l~-~C~~~~ 752 (768)
T 3rgz_A 713 NNNLSGPIPEMGQFETFPPA-KFLNNPGLCGYPLP-RCDPSN 752 (768)
T ss_dssp SSEEEEECCSSSSGGGSCGG-GGCSCTEEESTTSC-CCCSCC
T ss_pred CCcccccCCCchhhccCCHH-HhcCCchhcCCCCc-CCCCCc
Confidence 99999999985332 24433 49999999999987 786543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-75 Score=740.11 Aligned_cols=627 Identities=32% Similarity=0.456 Sum_probs=573.9
Q ss_pred EeeCCcccCcccc--hhhcccccCcEEEcccCcccCCCCc--cccCCCCcceEeccCCcccCcCCCcc-ccccchhhhhh
Q 001171 76 LRLPRLQLAGRLT--DQLADLHELRKLSLHSNHLNGSIPA--SLHQCSLLRAVYLQYNSFSGHLPLSI-FNLTNLLVLNV 150 (1133)
Q Consensus 76 l~l~~~~l~g~~~--~~l~~l~~L~~L~l~~n~l~~~~p~--~~~~l~~L~~L~L~~n~~~g~~p~~l-~~l~~L~~L~l 150 (1133)
|++.+++..|.++ +.++.+++|++|||++|+++|.+|. .++++++|++|+|++|++++.+|..+ .++++|++|++
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 4444556666654 7899999999999999999999998 99999999999999999999999886 89999999999
Q ss_pred cccccCCCccCc---c--CCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccc
Q 001171 151 AHNLLSGKISAD---I--SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHL 225 (1133)
Q Consensus 151 ~~N~l~~~~~~~---~--~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 225 (1133)
++|.+++.++.. + .++|++|+|++|.+++.+|. ..+++|++|+|++|++++.+|. ++.+++|++|++++|++
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l 235 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCC
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcC
Confidence 999999877654 2 47999999999999988765 7899999999999999998888 99999999999999999
Q ss_pred cCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCccccc
Q 001171 226 YGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGV 305 (1133)
Q Consensus 226 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~ 305 (1133)
++.+|..+.++++|++|++++|++++.+|.. .+++|++|+|++|++++.+|..+ +..+++|+.|++++|.+++.
T Consensus 236 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~----~~~~~~L~~L~Ls~n~l~~~ 309 (768)
T 3rgz_A 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFL----SGACDTLTGLDLSGNHFYGA 309 (768)
T ss_dssp CSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCS----CTTCTTCSEEECCSSEEEEC
T ss_pred CCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHH----HhhcCcCCEEECcCCcCCCc
Confidence 9999999999999999999999999888765 89999999999999999888766 23359999999999999986
Q ss_pred ccCCCCCccccccEEeccCCcccccCCc-hhhcccccceeeccCceeecccCcccCCCC-CCcEEEccCCcccccCchhh
Q 001171 306 VKPPNGRCVSVLEVLDLQNNRIRAVFPS-WLTNVTSLRVMDLSGNFFSGNLPAAVGSLD-KLEVLRVANNSLSGLVPDEI 383 (1133)
Q Consensus 306 ~~~~~~~~~~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~ 383 (1133)
+ +..+..+++|++|+|++|++++..|. .|.++++|++|+|++|.+.+.+|..+..++ +|++|++++|++++.+|..+
T Consensus 310 ~-p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~ 388 (768)
T 3rgz_A 310 V-PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388 (768)
T ss_dssp C-CGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTT
T ss_pred c-chHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhh
Confidence 5 45567788999999999999944454 599999999999999999999999999998 99999999999999888888
Q ss_pred cc--CCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCC
Q 001171 384 AK--CSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNL 461 (1133)
Q Consensus 384 ~~--l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L 461 (1133)
.. +++|++|+|++|++++.+|..++++++|+.|+|++|.+++.+|..|.++++|++|++++|++++.+|..+..+++|
T Consensus 389 ~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 468 (768)
T 3rgz_A 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468 (768)
T ss_dssp TCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred hhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCc
Confidence 77 8899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCC
Q 001171 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEEN 541 (1133)
Q Consensus 462 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 541 (1133)
++|+|++|++++.+|..++.+++|++|++++|++++.+|.+++.+++|++|++++|++++.+|..+..+++|++|++++|
T Consensus 469 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 548 (768)
T 3rgz_A 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548 (768)
T ss_dssp CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSS
T ss_pred eEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCccCcEEEcccc----------------------cccCCCCcccccccccceeecccCccCCCCCccc
Q 001171 542 NLSGDVPEGFSSLVGLQYLNLSDN----------------------AFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599 (1133)
Q Consensus 542 ~l~~~~~~~~~~l~~L~~L~Ls~N----------------------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 599 (1133)
++++.+|..+.....+..+++..+ .+.+..+..+..++.+..++++.|.++|.+|..+
T Consensus 549 ~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~ 628 (768)
T 3rgz_A 549 LFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628 (768)
T ss_dssp EEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSC
T ss_pred ccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhh
Confidence 999999998877766655544431 2445667777788889999999999999999999
Q ss_pred cCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccc
Q 001171 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTT 679 (1133)
Q Consensus 600 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 679 (1133)
+.+++|++|||++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..|+++++|++
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 708 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCccccccccCccccccccc-ccc
Q 001171 680 LNLSTNRLSGAIPADLALISSLRYLNLSRNN-LEG 713 (1133)
Q Consensus 680 L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~-l~~ 713 (1133)
|||++|+++|.+|.. ..+..+....+.+|+ +.|
T Consensus 709 L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 709 IDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp EECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred EECcCCcccccCCCc-hhhccCCHHHhcCCchhcC
Confidence 999999999999975 566777888888997 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=625.90 Aligned_cols=602 Identities=23% Similarity=0.228 Sum_probs=414.5
Q ss_pred CccceeeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccc
Q 001171 61 CDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIF 140 (1133)
Q Consensus 61 c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~ 140 (1133)
|.++.|.|++.+. + .+|+.+. +++++|+|++|++++..|..|+++++|+.|+|++|++++..|..++
T Consensus 4 ~~~~~~~cs~~~L----------~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 70 (680)
T 1ziw_A 4 VSHEVADCSHLKL----------T-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70 (680)
T ss_dssp CBSSEEECCSSCC----------S-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHH
T ss_pred eECCeeECCCCCc----------c-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHh
Confidence 5666677775432 1 2444343 6888999999999877777788999999999999999887788888
Q ss_pred cccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEec
Q 001171 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220 (1133)
Q Consensus 141 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 220 (1133)
++++|++|++++|.+++ ..+..|+++++|++|+|++|++++..|..|+.+++|++|++
T Consensus 71 ~l~~L~~L~L~~n~l~~----------------------l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 71 KLPMLKVLNLQHNELSQ----------------------LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp HCTTCCEEECCSSCCCC----------------------CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred cccCcCEEECCCCccCc----------------------cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 88777666666555553 33334444444445555444444433344444444555555
Q ss_pred ccccccCCCCccccCccccceeeccccccCCCCCCccc--CcCcccEEEcccCCccCCcccccccCcccccccccEEecc
Q 001171 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIG--RISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLG 298 (1133)
Q Consensus 221 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~ 298 (1133)
++|++++..|..+.++++|++|++++|++++..+..+. .+++|++|++++|++++..|..+ ..+.+|+.++++
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~l~ 203 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF-----HAIGRLFGLFLN 203 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGG-----GGSSEECEEECT
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhh-----hhhhhhhhhhcc
Confidence 54444444444444444555555555544444433322 23445555555555544433322 444444444444
Q ss_pred CCcccccccCC--CCCccccccEEeccCCcccccCCchhhcccc--cceeeccCceeecccCcccCCCCCCcEEEccCCc
Q 001171 299 FNAFTGVVKPP--NGRCVSVLEVLDLQNNRIRAVFPSWLTNVTS--LRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS 374 (1133)
Q Consensus 299 ~n~l~~~~~~~--~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~ 374 (1133)
++.+.+..... .......|++|++++|+++++.|.+|.+++. |++|+|++|++++..|..|+.+++|++|++++|+
T Consensus 204 ~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (680)
T 1ziw_A 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283 (680)
T ss_dssp TCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCC
T ss_pred ccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCc
Confidence 44443211000 0001245777777777777777888877765 8888888888887777778888888888888888
Q ss_pred ccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChh
Q 001171 375 LSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEE 454 (1133)
Q Consensus 375 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~ 454 (1133)
+++..|..|..+++|++|++++|...+.++. +.+.......|..+++|++|++++|++++..+..
T Consensus 284 l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~---------------~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 348 (680)
T 1ziw_A 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISL---------------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348 (680)
T ss_dssp BSEECTTTTTTCTTCCEEECTTCBCCC---------------------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTT
T ss_pred cCccChhhhcCCCCccEEeccchhhhccccc---------------ccccccChhhcccCCCCCEEECCCCccCCCChhH
Confidence 8877777788888888888877655432210 0111112235566666666666666666666666
Q ss_pred hcCCCCCcEEecccCcCCCC--CCCCCCCC--CCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCC-hhccC
Q 001171 455 ITRLSNLTTLNLSYNKFGGK--VPYDVGNL--KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELP-IELFG 529 (1133)
Q Consensus 455 l~~l~~L~~L~Ls~N~l~~~--~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~ 529 (1133)
|.++++|++|++++|.+... ....+..+ ++|+.|++++|++++..|..|..+++|+.|++++|.+++.+| ..+.+
T Consensus 349 ~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 428 (680)
T 1ziw_A 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428 (680)
T ss_dssp TTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTT
T ss_pred hccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccC
Confidence 66666777777766654321 12223322 477888888888887777788888888888888888876555 67778
Q ss_pred CCCCcEeeccCCcccccCCCCCCCCccCcEEEccccccc--CCCCcccccccccceeecccCccCCCCCccccCCCCccE
Q 001171 530 LPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT--GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEV 607 (1133)
Q Consensus 530 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 607 (1133)
+++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..+..+++|++|+|++|++++..+..+..+++|++
T Consensus 429 l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~ 508 (680)
T 1ziw_A 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508 (680)
T ss_dssp CTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCE
Confidence 888888888888888788888888888888888888876 567788888888888888888888777777888888889
Q ss_pred EEecCCcccCC--------CccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccc
Q 001171 608 LELRSNHFTGN--------IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTT 679 (1133)
Q Consensus 608 L~L~~N~l~~~--------~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 679 (1133)
|+|++|++++. .+..+..+++|+.|+|++|+++...+..|.++++|+.|+|++|++++..+..|..+++|+.
T Consensus 509 L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 588 (680)
T 1ziw_A 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588 (680)
T ss_dssp EECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCE
Confidence 99988888753 1123788999999999999999544456899999999999999999877778899999999
Q ss_pred cccccccccccCCcccc-ccccCcccccccccccccCCc
Q 001171 680 LNLSTNRLSGAIPADLA-LISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 680 L~Ls~N~l~~~~p~~l~-~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
|+|++|++++..|..+. .+++|+.|++++|++.|.++.
T Consensus 589 L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp EECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred EECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99999999988777777 789999999999999999884
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-62 Score=611.12 Aligned_cols=566 Identities=22% Similarity=0.234 Sum_probs=492.5
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccC
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1133)
+++++++++ .+|..+|+++++|+|++|.+++..+..|.++++|++|+|++|++++..|..++++++|++|+|++|++++
T Consensus 9 ~~cs~~~L~-~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 87 (680)
T 1ziw_A 9 ADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ 87 (680)
T ss_dssp EECCSSCCS-SCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCC
T ss_pred eECCCCCcc-ccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCc
Confidence 444555554 4667777889999999999998888889999999999999999999889999999999999999999985
Q ss_pred CCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCccccccc
Q 001171 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK 307 (1133)
Q Consensus 228 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 307 (1133)
..+..|+++++|++|++++|+++++.|..|+++++|++|+|++|++++..|..+ +++++|+.|++++|.+++...
T Consensus 88 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ-----VQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSS-----SCCTTCCEEECCSSCCCCBCH
T ss_pred cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhh-----cccccCCEEEccCCcccccCH
Confidence 555579999999999999999998888899999999999999999988766554 789999999999999987542
Q ss_pred CCC-CCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccC---CCCCCcEEEccCCcccccCchhh
Q 001171 308 PPN-GRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG---SLDKLEVLRVANNSLSGLVPDEI 383 (1133)
Q Consensus 308 ~~~-~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~n~l~~~~~~~~ 383 (1133)
... ......|++|++++|+++++.|..|..+++|+.|++++|.+.+.....+. ..++|+.|++++|.+++..|..+
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 111 12347899999999999999999999999999999999998743322221 35899999999999999999999
Q ss_pred ccCCC--ccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccc-----cCC----
Q 001171 384 AKCSL--LQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG-----NIP---- 452 (1133)
Q Consensus 384 ~~l~~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~-----~~~---- 452 (1133)
..++. |++|+|++|++++..|..|+.+++|++|++++|.+++..|..|.++++|++|++++|...+ .+|
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 88865 9999999999999999999999999999999999999999999999999999999886553 223
Q ss_pred hhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccc--cCCCcCCc--ccccEEeccccCCCCCCChhcc
Q 001171 453 EEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGK--IPGSIGSL--MRLTTLDLSNQNLSGELPIELF 528 (1133)
Q Consensus 453 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~ 528 (1133)
..|..+++|++|++++|.+++..+..|..+++|++|++++|.++.. ....|..+ ++|+.|++++|++++..|..+.
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~ 402 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence 3788999999999999999999999999999999999999986432 23344443 5899999999999999999999
Q ss_pred CCCCCcEeeccCCcccccCC-CCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccC--CCCCccccCCCCc
Q 001171 529 GLPSLQVVSLEENNLSGDVP-EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS--GMIPAELGACSAL 605 (1133)
Q Consensus 529 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L 605 (1133)
.+++|++|++++|.+++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..+..+++|
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence 99999999999999987665 68999999999999999999999999999999999999999987 5788999999999
Q ss_pred cEEEecCCcccCCCccccccccccCeeecCCCcccCcCc--------hhhhccCCCcEEEeecCCCCccCCccccCcccc
Q 001171 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIP--------KEISKCSSLVSLTLDMNSLSGRIPESFSKLSNL 677 (1133)
Q Consensus 606 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p--------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 677 (1133)
++|++++|++++..+..+..+++|++|+|++|++++..+ ..+..+++|+.|+|++|+++...+..|.++++|
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 999999999998777779999999999999999986422 247899999999999999996555679999999
Q ss_pred cccccccccccccCCccccccccCcccccccccccccCCccc
Q 001171 678 TTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKML 719 (1133)
Q Consensus 678 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~ 719 (1133)
+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 604 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHH
T ss_pred ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHh
Confidence 999999999997666678899999999999999998776543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-59 Score=576.43 Aligned_cols=534 Identities=23% Similarity=0.263 Sum_probs=444.3
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccC
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1133)
+++++..++ .+|..+|+++++|||++|.+++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|++++
T Consensus 17 ~~c~~~~l~-~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~ 95 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF 95 (606)
T ss_dssp EECTTSCCS-SCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSE
T ss_pred EECCCCCcc-cCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccc
Confidence 334444444 5677788889999999999998889999999999999999999998888889999999999999999988
Q ss_pred CCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCccccccc
Q 001171 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK 307 (1133)
Q Consensus 228 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 307 (1133)
..|..++++++|++|++++|+++++.+..|.++++|++|+|++|++++..+..+
T Consensus 96 ~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------------- 149 (606)
T 3t6q_A 96 MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG-------------------------- 149 (606)
T ss_dssp ECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTT--------------------------
T ss_pred cChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccc--------------------------
Confidence 888889999999999999999988777788888888888888888875322111
Q ss_pred CCCCCccccccEEeccCCcccccCCchhhcccccc--eeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhcc
Q 001171 308 PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLR--VMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAK 385 (1133)
Q Consensus 308 ~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~--~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 385 (1133)
..+.+|++|++++|+|+++.|..|..+++|+ .|++++|.+.+..|..|.. .+|++|++++|. ..+..+..
T Consensus 150 ----~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~ 221 (606)
T 3t6q_A 150 ----FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKG 221 (606)
T ss_dssp ----CCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHH
T ss_pred ----cCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhh
Confidence 1244566666666666666677888888888 7888888888777666654 578888888886 23455556
Q ss_pred CCCccEEEccCCccc-----ccCCCccCCCC--CCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCC
Q 001171 386 CSLLQMFDLEGNRFS-----GQVPAFLGGIR--GLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRL 458 (1133)
Q Consensus 386 l~~L~~L~Ls~N~l~-----~~~p~~l~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l 458 (1133)
+.++....+..+.+. ...+..+.++. +|+.|++++|.+++..+..|.++++|++|++++|+++ .+|..+..+
T Consensus 222 l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l 300 (606)
T 3t6q_A 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300 (606)
T ss_dssp TTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSC
T ss_pred ccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhccc
Confidence 655555544433332 12233344433 7888999999998888888899999999999999988 677888889
Q ss_pred CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCC-CcCCcccccEEeccccCCCCCC--ChhccCCCCCcE
Q 001171 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPG-SIGSLMRLTTLDLSNQNLSGEL--PIELFGLPSLQV 535 (1133)
Q Consensus 459 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~ 535 (1133)
++|++|++++|++++..|..+..+++|++|++++|.+.+.+|. .+..+++|++|++++|.+++.. +..+.++++|++
T Consensus 301 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~ 380 (606)
T 3t6q_A 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380 (606)
T ss_dssp TTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCE
T ss_pred ccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCE
Confidence 9999999999999887788888999999999999988866654 4888999999999999998665 778889999999
Q ss_pred eeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcc-cccccccceeecccCccCCCCCccccCCCCccEEEecCCc
Q 001171 536 VSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPAT-YGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNH 614 (1133)
Q Consensus 536 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 614 (1133)
|++++|++.+..|..|..+++|++|++++|++++..+.. +..+++|++|++++|.+++..|..++.+++|++|++++|+
T Consensus 381 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 460 (606)
T 3t6q_A 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460 (606)
T ss_dssp EECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCB
T ss_pred EECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCC
Confidence 999999999888999999999999999999998776644 8899999999999999998889999999999999999999
Q ss_pred ccCC---CccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccC
Q 001171 615 FTGN---IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAI 691 (1133)
Q Consensus 615 l~~~---~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 691 (1133)
+++. .+..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|..|.++++| .|+|++|++++..
T Consensus 461 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~ 539 (606)
T 3t6q_A 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539 (606)
T ss_dssp CGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCC
T ss_pred CCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccC
Confidence 9862 33568899999999999999998889999999999999999999999999999999999 9999999999988
Q ss_pred CccccccccCcccccccccccccCCcc
Q 001171 692 PADLALISSLRYLNLSRNNLEGEIPKM 718 (1133)
Q Consensus 692 p~~l~~l~~L~~L~ls~N~l~~~~p~~ 718 (1133)
|..+..+++|+.|++++|++.|.++..
T Consensus 540 ~~~~~~l~~L~~L~l~~N~~~c~c~~~ 566 (606)
T 3t6q_A 540 PSLLPILSQQRTINLRQNPLDCTCSNI 566 (606)
T ss_dssp GGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred HhhcccCCCCCEEeCCCCCccccCCcH
Confidence 888999999999999999999988743
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=580.51 Aligned_cols=526 Identities=23% Similarity=0.235 Sum_probs=422.8
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCC-cccccCccccceEeccccccc
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEV-PASVGQLQELEYLWLDSNHLY 226 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 226 (1133)
.+++++.++ .+|. +|+++++|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|+++
T Consensus 9 ~dcs~~~L~-~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~ 86 (844)
T 3j0a_A 9 AFYRFCNLT-QVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY 86 (844)
T ss_dssp EEESCCCSS-CCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCC
T ss_pred EEccCCCCC-CCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCc
Confidence 344555555 3555 7889999999999999888999999999999999999777776 678999999999999999999
Q ss_pred CCCCccccCccccceeeccccccCCCCCCc--ccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccc
Q 001171 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGT--IGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTG 304 (1133)
Q Consensus 227 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~ 304 (1133)
+..|..|.++++|++|+|++|.+++.+|.. |..+++|++|+|++|++++..+... |+++++|+.|++++|.+++
T Consensus 87 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~----~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 87 FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS----FGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp EECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGG----GGTCSSCCEEEEESSCCCC
T ss_pred ccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchh----HhhCCCCCEEECCCCcCCe
Confidence 888999999999999999999998866554 8899999999999999987654322 3666666666666666554
Q ss_pred cccCCCCCccccccEEeccCCcccccCCchhhcc--cccceeeccCceeecccCcccCCCCC------CcEEEccCCccc
Q 001171 305 VVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV--TSLRVMDLSGNFFSGNLPAAVGSLDK------LEVLRVANNSLS 376 (1133)
Q Consensus 305 ~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~L~~n~l~ 376 (1133)
+.++.|..+ ++|+.|+|++|.+.+..|..++.+++ |++|++++|.++
T Consensus 163 -------------------------~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 217 (844)
T 3j0a_A 163 -------------------------VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217 (844)
T ss_dssp -------------------------CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSS
T ss_pred -------------------------eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCc
Confidence 335555555 66666666666666666655555544 677777777666
Q ss_pred ccCchhhccC---CCccEEEcc---------CCcccccCCCccCCC--CCCcEEEccCCcCccccCccccCccccceeec
Q 001171 377 GLVPDEIAKC---SLLQMFDLE---------GNRFSGQVPAFLGGI--RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNL 442 (1133)
Q Consensus 377 ~~~~~~~~~l---~~L~~L~Ls---------~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 442 (1133)
+..+..+... .+++.|+++ .|.+.+..+..|.++ ++|+.|+|++|.+.+..+..|..+++|+.|+|
T Consensus 218 ~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 297 (844)
T 3j0a_A 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNL 297 (844)
T ss_dssp TTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEE
T ss_pred hhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEEC
Confidence 6555554432 456666655 334444445555554 68999999999999888888999999999999
Q ss_pred ccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCC
Q 001171 443 SENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGE 522 (1133)
Q Consensus 443 ~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 522 (1133)
++|+|++..+..|..+++|++|+|++|.+++..+..+..+++|+.|++++|.+++..+..|..+++|++|++++|.+++
T Consensus 298 ~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~- 376 (844)
T 3j0a_A 298 AYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT- 376 (844)
T ss_dssp ESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-
T ss_pred CCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-
Confidence 9999998888889999999999999999988888899999999999999999988888889999999999999999884
Q ss_pred CChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCC-cccccccccceeecccCccCCCCCc-ccc
Q 001171 523 LPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP-ATYGFLRSLVFLSLSHNQISGMIPA-ELG 600 (1133)
Q Consensus 523 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~ 600 (1133)
++ .+++|+.|++++|+++ .+|.. ..+++.|++++|++++... ..+..+++|++|+|++|++++..+. .+.
T Consensus 377 i~----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 448 (844)
T 3j0a_A 377 IH----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448 (844)
T ss_dssp CS----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSC
T ss_pred cc----CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccc
Confidence 22 3788999999999998 44443 4678999999999986433 3456889999999999999865443 356
Q ss_pred CCCCccEEEecCCccc-----CCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcc
Q 001171 601 ACSALEVLELRSNHFT-----GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLS 675 (1133)
Q Consensus 601 ~l~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 675 (1133)
.+++|++|+|++|.++ +..+..+..+++|+.|+|++|.|++..|..+..+++|+.|+|++|++++..+..+. +
T Consensus 449 ~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~ 526 (844)
T 3j0a_A 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--A 526 (844)
T ss_dssp SCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--S
T ss_pred cCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--c
Confidence 6899999999999997 34456688999999999999999998888999999999999999999987777766 8
Q ss_pred cccccccccccccccCCccccccccCcccccccccccccCCcc
Q 001171 676 NLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKM 718 (1133)
Q Consensus 676 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~ 718 (1133)
+|+.|||++|++++.+|..+ .+|+.|++++|++.|.++..
T Consensus 527 ~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 527 NLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELS 566 (844)
T ss_dssp CCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCC
T ss_pred cccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccH
Confidence 99999999999999988775 47899999999999988753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=561.72 Aligned_cols=535 Identities=23% Similarity=0.255 Sum_probs=425.8
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccC
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1133)
++++++.++ .+|..+++++++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++
T Consensus 16 ~~c~~~~l~-~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~ 94 (606)
T 3vq2_A 16 YQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94 (606)
T ss_dssp EECTTSCCS-SCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred eEccCCCcc-cCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence 444455544 5667778899999999999999888899999999999999999998888899999999999999999998
Q ss_pred CCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccC-CcccccccCcccccccccEEeccCCcccccc
Q 001171 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG-LVPVSVLCNLWGNISSLRIVQLGFNAFTGVV 306 (1133)
Q Consensus 228 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 306 (1133)
..|..|+++++|++|++++|++++..+..|+++++|++|+|++|++++ .+|..+ +++++|++|++++|.+++..
T Consensus 95 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~-----~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF-----SNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGG-----GTCTTCCEEECCSSCCCEEC
T ss_pred cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhH-----hhcCCCCEEEccCCcceecC
Confidence 889999999999999999999998888889999999999999999986 456554 77777777777777776643
Q ss_pred cCCCCCcccccc----EEeccCCcccccCCchhhcccccceeeccCceee-cccCcccCCCCCCcEEEccCCcccccCch
Q 001171 307 KPPNGRCVSVLE----VLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFS-GNLPAAVGSLDKLEVLRVANNSLSGLVPD 381 (1133)
Q Consensus 307 ~~~~~~~~~~L~----~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 381 (1133)
+..+..+..|+ +|++++|.++.+.+..+... +|++|++++|.+. +..|..+++++.|+.+++..+.+.+.
T Consensus 170 -~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~--- 244 (606)
T 3vq2_A 170 -VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE--- 244 (606)
T ss_dssp -TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTS---
T ss_pred -hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccC---
Confidence 12222222222 45555555555444444333 4555555555443 23344444444444444443332211
Q ss_pred hhccCCCccEEEccCCcccccCCCccCCCC--CCcEEEc-cCCcCccccCccccCccccceeecccccccccCChhhcCC
Q 001171 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIR--GLKIVSL-GRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRL 458 (1133)
Q Consensus 382 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l 458 (1133)
+.+....+..+.++. .++.+++ ..|.+++.+|. +..+++|+.|++++|.+.. +| .+..+
T Consensus 245 ---------------~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~ 306 (606)
T 3vq2_A 245 ---------------RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKH 306 (606)
T ss_dssp ---------------CCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTT
T ss_pred ---------------CcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hcccc
Confidence 001111112222222 4556666 67778877776 8888899999999988874 45 78888
Q ss_pred CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCC--CChhccCCCCCcEe
Q 001171 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGE--LPIELFGLPSLQVV 536 (1133)
Q Consensus 459 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L 536 (1133)
++|++|++++|.+ +.+| .+ .+++|++|++++|...+.. .+..+++|++|++++|++++. .|..+..+++|++|
T Consensus 307 ~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L 381 (606)
T 3vq2_A 307 FKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381 (606)
T ss_dssp CCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEE
T ss_pred ccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEe
Confidence 8999999999998 4677 45 8899999999999655443 677899999999999999865 48889999999999
Q ss_pred eccCCcccccCCCCCCCCccCcEEEcccccccCCCC-cccccccccceeecccCccCCCCCccccCCCCccEEEecCCcc
Q 001171 537 SLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP-ATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615 (1133)
Q Consensus 537 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 615 (1133)
++++|.+++ +|..|..+++|++|++++|++++..+ ..+..+++|++|++++|++++..|..++.+++|++|++++|++
T Consensus 382 ~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 460 (606)
T 3vq2_A 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460 (606)
T ss_dssp ECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred ECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcC
Confidence 999999985 56889999999999999999998877 6889999999999999999999999999999999999999999
Q ss_pred cCC-CccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcc
Q 001171 616 TGN-IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD 694 (1133)
Q Consensus 616 ~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 694 (1133)
++. +|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|..|.++++|+.|||++|+++ .+|..
T Consensus 461 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~ 539 (606)
T 3vq2_A 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGI 539 (606)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESC
T ss_pred CCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHh
Confidence 974 7888999999999999999999988999999999999999999999999999999999999999999998 68888
Q ss_pred ccccc-cCcccccccccccccCCcc
Q 001171 695 LALIS-SLRYLNLSRNNLEGEIPKM 718 (1133)
Q Consensus 695 l~~l~-~L~~L~ls~N~l~~~~p~~ 718 (1133)
+..++ +|++|++++|++.|.++..
T Consensus 540 ~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 540 LQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp GGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred HhhhcccCcEEEccCCCcccCCccH
Confidence 98987 5999999999999988864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=555.96 Aligned_cols=520 Identities=19% Similarity=0.181 Sum_probs=367.3
Q ss_pred cCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCC
Q 001171 96 ELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSN 175 (1133)
Q Consensus 96 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N 175 (1133)
.+++|||++|++++..|..|+++++|+.|+|++|++++..|..|.++++| ++|+|++|
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L----------------------~~L~Ls~n 91 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL----------------------DTLVLTAN 91 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTC----------------------CEEECTTC
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcccc----------------------CeeeCCCC
Confidence 57788888888877667777788888888888877776666666666544 55666666
Q ss_pred cCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCC
Q 001171 176 AFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPG 255 (1133)
Q Consensus 176 ~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 255 (1133)
++++..|..|+.+++|++|++++|++++..|..++.+++|++|++++|++++..+..+.++++|++|++++|++++..|.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred cccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 66667777788888888888888888866566777788888888888877753333344477777777777777776666
Q ss_pred cccCcCccc--EEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCc
Q 001171 256 TIGRISTLQ--VLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS 333 (1133)
Q Consensus 256 ~~~~l~~L~--~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 333 (1133)
.|+.+++|+ .|++++|++++..|..+ ...+|+ +|++++|.. .+.
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~------~~~~L~-------------------------~L~l~~~~~---~~~ 217 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAF------DSAVFQ-------------------------SLNFGGTQN---LLV 217 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTT------TTCEEE-------------------------EEECTTCSC---HHH
T ss_pred hhhhhcccceeEEecCCCccCccChhHh------hhcccc-------------------------ccccCCchh---HHH
Confidence 777777777 77777777765544322 113344 444444431 134
Q ss_pred hhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCC--CccEEEccCCcccccCCCccCCCC
Q 001171 334 WLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCS--LLQMFDLEGNRFSGQVPAFLGGIR 411 (1133)
Q Consensus 334 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~ 411 (1133)
.+..+.++....+.-+.+. .+....+.. ..+..+. +|+.|++++|.+++..+..|++++
T Consensus 218 ~~~~l~~~~l~~l~~~~~~-----------~~~~~~i~~--------~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~ 278 (606)
T 3t6q_A 218 IFKGLKNSTIQSLWLGTFE-----------DMDDEDISP--------AVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278 (606)
T ss_dssp HHHHTTTCEEEEEECCCCT-----------TSCCCCCCG--------GGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCT
T ss_pred Hhhhccccchhheechhhc-----------cccccccCh--------hHhchhhcCceeEEEeecCccCccCHHHhcccc
Confidence 4555554444333322221 111111111 1222221 566666666666666666666666
Q ss_pred CCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCC-CCCCCCCCcEEEc
Q 001171 412 GLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPY-DVGNLKGLLVLNL 490 (1133)
Q Consensus 412 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L 490 (1133)
+|++|++++|.++ .+|..+.++++|++|++++|++++..|..+..+++|++|++++|.+.+.++. .+..+++|++|++
T Consensus 279 ~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l 357 (606)
T 3t6q_A 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357 (606)
T ss_dssp TCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEEC
T ss_pred CCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEEC
Confidence 6666666666666 4566666777777777777777766666677777777777777776655544 3677777777777
Q ss_pred ccCCCcccc--CCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCC-CCCCCccCcEEEcccccc
Q 001171 491 SASGFSGKI--PGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPE-GFSSLVGLQYLNLSDNAF 567 (1133)
Q Consensus 491 ~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l 567 (1133)
++|.+++.. +..+..+++|++|++++|++++..|..+..+++|++|++++|++.+..+. .|..+++|++|++++|.+
T Consensus 358 ~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l 437 (606)
T 3t6q_A 358 SHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437 (606)
T ss_dssp CSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCC
T ss_pred CCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCcc
Confidence 777777655 66777777888888888877777777777788888888888888766544 477888888888888888
Q ss_pred cCCCCcccccccccceeecccCccCCC---CCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCc
Q 001171 568 TGDIPATYGFLRSLVFLSLSHNQISGM---IPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIP 644 (1133)
Q Consensus 568 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 644 (1133)
++..|..++.+++|++|++++|++++. .+..+..+++|++|++++|++++..|..+..+++|+.|+|++|++++..|
T Consensus 438 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 517 (606)
T 3t6q_A 438 DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517 (606)
T ss_dssp BTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGG
T ss_pred CCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCCh
Confidence 877788888888888888888888752 33567888889999999998888778888888999999999999988888
Q ss_pred hhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCC
Q 001171 645 KEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIP 692 (1133)
Q Consensus 645 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 692 (1133)
..+..++.| .|++++|++++.+|..|..+++|+.|++++|+++...+
T Consensus 518 ~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 518 EALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp GGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred hHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 889999999 99999999998888888889999999999999886544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=570.34 Aligned_cols=494 Identities=19% Similarity=0.247 Sum_probs=309.6
Q ss_pred cCchhHHHHHHHHHHhCCCCCCC--------ccCCCCCCCCCCCcc---ceeeeCC-CceEEEeeCCcccCcccchhhcc
Q 001171 26 AVVLSEIQALTSFKLHLKDPLGA--------LDGWDSSTPSAPCDW---RGIVCYN-NRVRELRLPRLQLAGRLTDQLAD 93 (1133)
Q Consensus 26 ~~~~~~~~~l~~~k~~~~~~~~~--------l~~w~~~~~~~~c~w---~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~ 93 (1133)
+...+|++||.+||.++.+|.+. ..+|+.+ .+||.| .||+|+. ++|++|+|.+++++|.+|+++++
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhc
Confidence 33457999999999999766543 2479754 479999 9999975 69999999999999999999999
Q ss_pred cccCcEEEcccCcc------cC------CCCccccCCCCcceEeccCCcccCcCCCccc-cccchhhhhhcccccCCCcc
Q 001171 94 LHELRKLSLHSNHL------NG------SIPASLHQCSLLRAVYLQYNSFSGHLPLSIF-NLTNLLVLNVAHNLLSGKIS 160 (1133)
Q Consensus 94 l~~L~~L~l~~n~l------~~------~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~-~l~~L~~L~l~~N~l~~~~~ 160 (1133)
|++|++|+|++|++ .| .+|... +..|+ +++++|.+.+.+|..+. .+.++..+++....+..
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~--- 177 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK--- 177 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC---
T ss_pred CccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc---
Confidence 99999999999987 33 445444 56677 88888888888887765 34455555555443321
Q ss_pred CccCCcceEEEc--cCCcCCCCCCCCCCCCCcCcEEeccCCcCCCC-----------------Cccccc--CccccceEe
Q 001171 161 ADISPSLRYLDL--SSNAFTGEIPGNFSSKSQLQLINLSYNSFSGE-----------------VPASVG--QLQELEYLW 219 (1133)
Q Consensus 161 ~~~~~~l~~L~L--s~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~-----------------~p~~~~--~l~~L~~L~ 219 (1133)
.....++.+++ .+|+++| +|..|+++++|++|+|++|+++|. +|..++ ++++|++|+
T Consensus 178 -~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~ 255 (636)
T 4eco_A 178 -SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255 (636)
T ss_dssp -CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred -ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence 11122333333 3577777 777788888888888888888875 777777 777788888
Q ss_pred cccccccCCCCccccCccccceeeccccc-cCC-CCCCcccCc------CcccEEEcccCCccCCccc--ccccCccccc
Q 001171 220 LDSNHLYGTLPSAISNCSSLVHLSAEDNV-LKG-LIPGTIGRI------STLQVLSLSRNELTGLVPV--SVLCNLWGNI 289 (1133)
Q Consensus 220 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~~~~~~l 289 (1133)
|++|++.+.+|..+.++++|++|++++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .+ +++
T Consensus 256 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l-----~~l 329 (636)
T 4eco_A 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL-----QKM 329 (636)
T ss_dssp EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH-----TTC
T ss_pred ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh-----ccC
Confidence 87777777777777777777777777777 776 666666665 77777777777777 5554 44 666
Q ss_pred ccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCC-CcEE
Q 001171 290 SSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDK-LEVL 368 (1133)
Q Consensus 290 ~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L 368 (1133)
++|+.|++++|.++|.+ | .|.++++|++|+|++|+++ .+|..++.+++ |++|
T Consensus 330 ~~L~~L~L~~N~l~g~i-------------------------p-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L 382 (636)
T 4eco_A 330 KKLGMLECLYNQLEGKL-------------------------P-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENL 382 (636)
T ss_dssp TTCCEEECCSCCCEEEC-------------------------C-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEE
T ss_pred CCCCEEeCcCCcCccch-------------------------h-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEE
Confidence 66666666666666544 3 4444455555555555554 44444555544 5555
Q ss_pred EccCCcccccCchhhccCC--CccEEEccCCcccccCCCccC-------CCCCCcEEEccCCcCccccCccccCccccce
Q 001171 369 RVANNSLSGLVPDEIAKCS--LLQMFDLEGNRFSGQVPAFLG-------GIRGLKIVSLGRNMFSGLIPLSFGNLSQLET 439 (1133)
Q Consensus 369 ~L~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 439 (1133)
++++|+++ .+|..+..++ +|++|+|++|++++.+|..+. .+++|+.|+|++|.++...+..+..+++|++
T Consensus 383 ~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~ 461 (636)
T 4eco_A 383 SFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461 (636)
T ss_dssp ECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSE
T ss_pred EccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCE
Confidence 55555554 3344443332 455555555555555555444 4445555555555555333333444555555
Q ss_pred eecccccccccCChhhcCC-------CCCcEEecccCcCCCCCCCCCC--CCCCCcEEEcccCCCccccCCCcCCccccc
Q 001171 440 LNLSENDIRGNIPEEITRL-------SNLTTLNLSYNKFGGKVPYDVG--NLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510 (1133)
Q Consensus 440 L~L~~N~i~~~~~~~l~~l-------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 510 (1133)
|+|++|+++...+..+... ++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+
T Consensus 462 L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~ 539 (636)
T 4eco_A 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK 539 (636)
T ss_dssp EECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCC
T ss_pred EECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCC
Confidence 5555555552222222222 25666666666666 4555554 56666666666666665 566666666666
Q ss_pred EEecc------ccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEccccccc
Q 001171 511 TLDLS------NQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568 (1133)
Q Consensus 511 ~L~Ls------~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 568 (1133)
+|+++ +|++.+.+|..+..+++|++|+|++|++ +.+|..+. ++|+.|+|++|++.
T Consensus 540 ~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp EEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred EEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 66664 4444555555555555555555555555 23343333 44555555555444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=569.15 Aligned_cols=498 Identities=18% Similarity=0.223 Sum_probs=318.2
Q ss_pred ccCchhHHHHHHHHHHhCCCCCCCccCCCCCC---CCCC--Ccc------------ceeeeCC-CceEEEeeCCcccCcc
Q 001171 25 NAVVLSEIQALTSFKLHLKDPLGALDGWDSST---PSAP--CDW------------RGIVCYN-NRVRELRLPRLQLAGR 86 (1133)
Q Consensus 25 ~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~---~~~~--c~w------------~gv~c~~-~~v~~l~l~~~~l~g~ 86 (1133)
.++..+|++||++||+++.|| +|+.++ ..+| |.| .||+|+. ++|++|+|.+++|+|.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 345568999999999999887 786554 2345 999 9999984 8999999999999999
Q ss_pred cchhhcccccCcEEEc-ccCcccCCCCcccc-------------------------------------------------
Q 001171 87 LTDQLADLHELRKLSL-HSNHLNGSIPASLH------------------------------------------------- 116 (1133)
Q Consensus 87 ~~~~l~~l~~L~~L~l-~~n~l~~~~p~~~~------------------------------------------------- 116 (1133)
+|+++++|++|+.||| ++|.++|..|....
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 89999887553311
Q ss_pred --CCCCcceEeccC--CcccCcCCCccccccchhhhhhcccccCC-CccCccCCcceEEEccCCcCCCCCCCCCC--CCC
Q 001171 117 --QCSLLRAVYLQY--NSFSGHLPLSIFNLTNLLVLNVAHNLLSG-KISADISPSLRYLDLSSNAFTGEIPGNFS--SKS 189 (1133)
Q Consensus 117 --~l~~L~~L~L~~--n~~~g~~p~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~--~l~ 189 (1133)
....++.+.++. |+++| +|.+++++++|++|+|++|.|++ .++..+.+ ++.|.++|.+|..++ +++
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~------~s~n~~~g~iP~~l~f~~L~ 491 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED------ANSDYAKQYENEELSWSNLK 491 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC------TTSHHHHHHTTSCCCGGGCT
T ss_pred cccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccc------cccccccccCChhhhhccCC
Confidence 112233334433 67776 77777777777777777777765 33333221 233555567898887 999
Q ss_pred cCcEEeccCCcCCCCCcccccCccccceEeccccc-ccC-CCCccccCcc-------ccceeeccccccCCCCCC--ccc
Q 001171 190 QLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNH-LYG-TLPSAISNCS-------SLVHLSAEDNVLKGLIPG--TIG 258 (1133)
Q Consensus 190 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~l~~N~l~~~~~~--~~~ 258 (1133)
+|++|+|++|++.+.+|..++++++|++|+|++|+ ++| .+|..+.+++ +|++|++++|+++ .+|. .|+
T Consensus 492 ~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~ 570 (876)
T 4ecn_A 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQ 570 (876)
T ss_dssp TCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHT
T ss_pred CCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhh
Confidence 99999999999999999999999999999999998 887 7887776665 8888888888888 5666 788
Q ss_pred CcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcc
Q 001171 259 RISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV 338 (1133)
Q Consensus 259 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l 338 (1133)
++++|+.|+|++|+++ .+| .+ +++++|+.|++++|.++. + |..+.++
T Consensus 571 ~L~~L~~L~Ls~N~l~-~lp-~~-----~~L~~L~~L~Ls~N~l~~-l-------------------------p~~l~~l 617 (876)
T 4ecn_A 571 KMVKLGLLDCVHNKVR-HLE-AF-----GTNVKLTDLKLDYNQIEE-I-------------------------PEDFCAF 617 (876)
T ss_dssp TCTTCCEEECTTSCCC-BCC-CC-----CTTSEESEEECCSSCCSC-C-------------------------CTTSCEE
T ss_pred cCCCCCEEECCCCCcc-cch-hh-----cCCCcceEEECcCCcccc-c-------------------------hHHHhhc
Confidence 8888888888888887 555 22 566666666666666552 1 3444555
Q ss_pred cc-cceeeccCceeecccCcccCCCCC--CcEEEccCCcccccCchhh---c--cCCCccEEEccCCcccccCCCccCCC
Q 001171 339 TS-LRVMDLSGNFFSGNLPAAVGSLDK--LEVLRVANNSLSGLVPDEI---A--KCSLLQMFDLEGNRFSGQVPAFLGGI 410 (1133)
Q Consensus 339 ~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~p~~l~~l 410 (1133)
++ |++|+|++|.|+ .+|..+..++. |+.|+|++|++++.+|... . .+++|+.|+|++|+++...+..+..+
T Consensus 618 ~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l 696 (876)
T 4ecn_A 618 TDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATG 696 (876)
T ss_dssp CTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTT
T ss_pred cccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccC
Confidence 55 555555555555 44444444432 5555555555544333211 1 22244555555555542222222344
Q ss_pred CCCcEEEccCCcCccccCccc-------cCccccceeecccccccccCChhhc--CCCCCcEEecccCcCCCCCCCCCCC
Q 001171 411 RGLKIVSLGRNMFSGLIPLSF-------GNLSQLETLNLSENDIRGNIPEEIT--RLSNLTTLNLSYNKFGGKVPYDVGN 481 (1133)
Q Consensus 411 ~~L~~L~L~~N~l~~~~p~~~-------~~l~~L~~L~L~~N~i~~~~~~~l~--~l~~L~~L~Ls~N~l~~~~~~~~~~ 481 (1133)
++|+.|+|++|.++...+..+ .++++|++|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..
T Consensus 697 ~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~ 774 (876)
T 4ecn_A 697 SPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774 (876)
T ss_dssp CCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGG
T ss_pred CCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhc
Confidence 444444444444442211111 22336666666666666 4555554 56666666666666664 4555555
Q ss_pred CCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEE
Q 001171 482 LKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLN 561 (1133)
Q Consensus 482 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 561 (1133)
+++|+.|+|++|+ ++++|++.+.+|..+.++++|+.|+|++|++ +.+|..+. ++|+.|+
T Consensus 775 L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~Ld 833 (876)
T 4ecn_A 775 SSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILD 833 (876)
T ss_dssp CTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEE
T ss_pred CCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEE
Confidence 5666666655543 3445666666666666666666666666666 34555443 4666666
Q ss_pred cccccccCCCCcccccccccceeecccCccC
Q 001171 562 LSDNAFTGDIPATYGFLRSLVFLSLSHNQIS 592 (1133)
Q Consensus 562 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1133)
|++|++....+..+.....+..+.|.+|++.
T Consensus 834 Ls~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp CCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred CCCCCCCccChHHccccccchheeecCCCcc
Confidence 6666665544444444444555555555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=544.57 Aligned_cols=512 Identities=20% Similarity=0.179 Sum_probs=336.3
Q ss_pred ccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccC--CcceEEEc
Q 001171 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDL 172 (1133)
Q Consensus 95 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~--~~l~~L~L 172 (1133)
++|++|+|++|++++..|..|.++++|+.|+|++|++++..|.+|.++++|++|++++|.+++..|..+. ++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 7899999999999988888899999999999999999987788899999998888888888877676663 77888888
Q ss_pred cCCcCCCCCCCCCCCCCcCcEEeccCCcCCC-CCcccccCccccceEecccccccCCCCccccCccccc----eeecccc
Q 001171 173 SSNAFTGEIPGNFSSKSQLQLINLSYNSFSG-EVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV----HLSAEDN 247 (1133)
Q Consensus 173 s~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~l~~N 247 (1133)
++|.+++..|..|+++++|++|++++|++++ .+|..++++++|++|++++|++++..|..+.++++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 8888887777778888888888888888875 5688888888888888888888877777777777665 6888888
Q ss_pred ccCCCCCCcccCcCcccEEEcccCCccC-CcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCc
Q 001171 248 VLKGLIPGTIGRISTLQVLSLSRNELTG-LVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR 326 (1133)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~ 326 (1133)
.++++.+..+... +|+.|++++|.+++ .+|..+ .++++|+.+++..+.+.+.. .
T Consensus 192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~-----~~l~~L~~l~l~~~~~~~~~-------------------~ 246 (606)
T 3vq2_A 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCL-----QNLAGLHVHRLILGEFKDER-------------------N 246 (606)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHH-----HTTTTCEEEEEEEECCTTSC-------------------C
T ss_pred CcceeCcccccCc-eeeeeeccCCccchhHHHHHh-----ccccccccccccccccccCC-------------------c
Confidence 8887766666555 78888888887763 233333 67777777777665554321 1
Q ss_pred ccccCCchhhccc--ccceeec-cCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccC
Q 001171 327 IRAVFPSWLTNVT--SLRVMDL-SGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQV 403 (1133)
Q Consensus 327 i~~~~~~~~~~l~--~L~~L~L-s~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 403 (1133)
+..+.+..+..+. +++.+++ ..|.+.+.+|. +..+++|+.|++++|.+... | .+..+++|++|++++|.+ +.+
T Consensus 247 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l-~~l 322 (606)
T 3vq2_A 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQL-KQF 322 (606)
T ss_dssp CSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCC-SSC
T ss_pred ccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccC-ccc
Confidence 1112222233222 3445555 56666666665 66677777777777777543 3 566667777777777777 455
Q ss_pred CCccCCCCCCcEEEccCCcCccccCccccCccccceeeccccccccc--CChhhcCCCCCcEEecccCcCCCCCCCCCCC
Q 001171 404 PAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN--IPEEITRLSNLTTLNLSYNKFGGKVPYDVGN 481 (1133)
Q Consensus 404 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 481 (1133)
|. + .+++|+.|++++|...+.. .+..+++|++|++++|++++. .+..+..+++|++|++++|.+++ +|..+..
T Consensus 323 p~-~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~ 397 (606)
T 3vq2_A 323 PT-L-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG 397 (606)
T ss_dssp CC-C-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTT
T ss_pred cc-C-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccC
Confidence 53 3 6677777777777544332 555677777777777777654 26666667777777777766653 3355555
Q ss_pred CCCCcEEEcccCCCccccC-CCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEE
Q 001171 482 LKGLLVLNLSASGFSGKIP-GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYL 560 (1133)
Q Consensus 482 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 560 (1133)
+++|++|++++|.+.+..| ..+..+++|++|++++|.+++..| ..|.++++|++|
T Consensus 398 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~------------------------~~~~~l~~L~~L 453 (606)
T 3vq2_A 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD------------------------GIFLGLTSLNTL 453 (606)
T ss_dssp CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCT------------------------TTTTTCTTCCEE
T ss_pred CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccch------------------------hhhcCCCCCCEE
Confidence 5555555555555554444 344455555555555555544444 444444444445
Q ss_pred EcccccccC-CCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcc
Q 001171 561 NLSDNAFTG-DIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKL 639 (1133)
Q Consensus 561 ~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 639 (1133)
++++|++++ .+|..++.+++|++|+|++|++++..|..++.+++|++|+|++|++++..|..+..+++|+.|+|++|++
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 533 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCC
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcC
Confidence 554554444 2344455555555555555555555555555555555555555555554555555555666666666666
Q ss_pred cCcCchhhhccC-CCcEEEeecCCCCc
Q 001171 640 SGEIPKEISKCS-SLVSLTLDMNSLSG 665 (1133)
Q Consensus 640 ~~~~p~~l~~l~-~L~~L~Ls~N~l~~ 665 (1133)
+ .+|..+..++ +|+.|++++|.+..
T Consensus 534 ~-~~p~~~~~l~~~L~~l~l~~N~~~c 559 (606)
T 3vq2_A 534 E-TSKGILQHFPKSLAFFNLTNNSVAC 559 (606)
T ss_dssp C-CEESCGGGSCTTCCEEECCSCCCCC
T ss_pred c-ccCHhHhhhcccCcEEEccCCCccc
Confidence 5 4555555554 36666666666654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=555.86 Aligned_cols=510 Identities=24% Similarity=0.247 Sum_probs=436.1
Q ss_pred eEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCC-CccccCccccceeeccc
Q 001171 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTL-PSAISNCSSLVHLSAED 246 (1133)
Q Consensus 168 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~l~~ 246 (1133)
+..|.++++++. +|. -.++|++|||++|++++..|..|+.+++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 7 ~~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 567889999985 455 4578999999999999888999999999999999999776666 77899999999999999
Q ss_pred cccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCc
Q 001171 247 NVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR 326 (1133)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~ 326 (1133)
|++++..|..|.++++|++|+|++|.+++.+|... .++++++|+.|++++|.++
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~---~~~~L~~L~~L~Ls~N~l~----------------------- 136 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDG---YFRNLKALTRLDLSKNQIR----------------------- 136 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTC---CCSSCSSCCEEEEESCCCC-----------------------
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCc---cccccCCCCEEECCCCccc-----------------------
Confidence 99999989999999999999999999987655431 1255555555555555554
Q ss_pred ccccC-CchhhcccccceeeccCceeecccCcccCCC--CCCcEEEccCCcccccCchhhccCCC------ccEEEccCC
Q 001171 327 IRAVF-PSWLTNVTSLRVMDLSGNFFSGNLPAAVGSL--DKLEVLRVANNSLSGLVPDEIAKCSL------LQMFDLEGN 397 (1133)
Q Consensus 327 i~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~Ls~N 397 (1133)
++. +..|.++++|++|+|++|.+++..+..+..+ ++|+.|++++|.+.+..|..+..+++ |++|+|++|
T Consensus 137 --~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 214 (844)
T 3j0a_A 137 --SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214 (844)
T ss_dssp --CCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSC
T ss_pred --ccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCC
Confidence 433 3679999999999999999999999999888 89999999999999988887777766 999999999
Q ss_pred cccccCCCccCCC---CCCcEEEccC---------CcCccccCccccCc--cccceeecccccccccCChhhcCCCCCcE
Q 001171 398 RFSGQVPAFLGGI---RGLKIVSLGR---------NMFSGLIPLSFGNL--SQLETLNLSENDIRGNIPEEITRLSNLTT 463 (1133)
Q Consensus 398 ~l~~~~p~~l~~l---~~L~~L~L~~---------N~l~~~~p~~~~~l--~~L~~L~L~~N~i~~~~~~~l~~l~~L~~ 463 (1133)
.+++..+..+... ..++.+.++. +.+.+..+..|..+ ++|+.|++++|.+.+..+..|..+++|+.
T Consensus 215 ~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 294 (844)
T 3j0a_A 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294 (844)
T ss_dssp CSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCE
T ss_pred cCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCE
Confidence 9998888877643 5788888873 34444455566665 78999999999999999999999999999
Q ss_pred EecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcc
Q 001171 464 LNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543 (1133)
Q Consensus 464 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 543 (1133)
|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|+.|++++|++++..+..|.++++|++|+|++|.+
T Consensus 295 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 374 (844)
T 3j0a_A 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374 (844)
T ss_dssp EEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCS
T ss_pred EECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCC
Confidence 99999999999999999999999999999999998899999999999999999999988888899999999999999999
Q ss_pred cccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCC-ccccCCCCccEEEecCCcccCCCcc-
Q 001171 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIP-AELGACSALEVLELRSNHFTGNIPV- 621 (1133)
Q Consensus 544 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~- 621 (1133)
++. ..+++|+.|++++|+++ .+|.. ..+++.|++++|++++... ..+..+++|++|+|++|++++..+.
T Consensus 375 ~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 445 (844)
T 3j0a_A 375 TTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445 (844)
T ss_dssp CCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSS
T ss_pred Ccc-----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccc
Confidence 843 33889999999999998 45543 5679999999999996432 3456899999999999999965433
Q ss_pred ccccccccCeeecCCCccc-----CcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcccc
Q 001171 622 DISHLSRIKKLDLGQNKLS-----GEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLA 696 (1133)
Q Consensus 622 ~l~~l~~L~~L~Ls~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 696 (1133)
.+..+++|+.|+|++|.++ +..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|..+.
T Consensus 446 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~ 525 (844)
T 3j0a_A 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525 (844)
T ss_dssp SSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC
T ss_pred ccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh
Confidence 3566899999999999997 44556788999999999999999999999999999999999999999987666665
Q ss_pred ccccCcccccccccccccCCcccc
Q 001171 697 LISSLRYLNLSRNNLEGEIPKMLS 720 (1133)
Q Consensus 697 ~l~~L~~L~ls~N~l~~~~p~~~~ 720 (1133)
++|+.|||++|++++.+|..+.
T Consensus 526 --~~L~~L~Ls~N~l~~~~~~~~~ 547 (844)
T 3j0a_A 526 --ANLEILDISRNQLLAPNPDVFV 547 (844)
T ss_dssp --SCCCEEEEEEECCCCCCSCCCS
T ss_pred --ccccEEECCCCcCCCCChhHhC
Confidence 8999999999999999997653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=506.76 Aligned_cols=513 Identities=23% Similarity=0.254 Sum_probs=364.1
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccC
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1133)
+++++..++ .+|..+|+++++|||++|++++..+..|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++
T Consensus 12 ~~c~~~~l~-~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~ 90 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (570)
T ss_dssp EECCSSCCS-SCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEeCCCCcc-ccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc
Confidence 334444443 5677788889999999999998888899999999999999999998777889999999999999999987
Q ss_pred CCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCC-cccccccCcccccccccEEeccCCcccccc
Q 001171 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL-VPVSVLCNLWGNISSLRIVQLGFNAFTGVV 306 (1133)
Q Consensus 228 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 306 (1133)
..|..|.++++|++|++++|+++++.+..|+++++|++|+|++|++++. +|..+ +++++|+.|++++|.+
T Consensus 91 ~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~-----~~l~~L~~L~l~~n~l---- 161 (570)
T 2z63_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-----SNLTNLEHLDLSSNKI---- 161 (570)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGG-----GGCTTCCEEECTTSCC----
T ss_pred cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhh-----cccCCCCEEeCcCCcc----
Confidence 7778899999999999999999988777789999999999999988762 45444 5555555555555444
Q ss_pred cCCCCCccccccEEeccCCcccccCCchhhccccc----ceeeccCceeecccCcccCCCCCCcEEEccCCcccc-cCch
Q 001171 307 KPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSL----RVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSG-LVPD 381 (1133)
Q Consensus 307 ~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~ 381 (1133)
+++.+..|..+++| +.|++++|.+.+..|..|..+ +|++|++++|.... ..+.
T Consensus 162 ---------------------~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~ 219 (570)
T 2z63_A 162 ---------------------QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219 (570)
T ss_dssp ---------------------CEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHH
T ss_pred ---------------------ceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhh
Confidence 44446667777777 677777777777666666655 67777777774432 2355
Q ss_pred hhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCcc--ccceeecccc-cccccCChhhcCC
Q 001171 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS--QLETLNLSEN-DIRGNIPEEITRL 458 (1133)
Q Consensus 382 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N-~i~~~~~~~l~~l 458 (1133)
.+..++.++.+++..+.+... ..++ ......+..+. .++.+++++| .+.+..+..+..+
T Consensus 220 ~~~~l~~l~~~~l~~~~~~~~--------~~l~----------~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l 281 (570)
T 2z63_A 220 CIQGLAGLEVHRLVLGEFRNE--------GNLE----------KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281 (570)
T ss_dssp HHHTTTTCEEEEEEEEECCCC--------SSCE----------ECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGG
T ss_pred hhcCccccceeeeccccccCc--------hhhh----------hcchhhhccccccchhhhhhhcchhhhhhchhhhcCc
Confidence 566667776666554333210 1111 01111122221 2445555555 4555555566666
Q ss_pred CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeec
Q 001171 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSL 538 (1133)
Q Consensus 459 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 538 (1133)
++|++|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++
T Consensus 282 ~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l 354 (570)
T 2z63_A 282 TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDL 354 (570)
T ss_dssp TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEEC
T ss_pred CcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeC
Confidence 66666666666665 355555555 6666666666665 3332 3456666666666666654443 55666777777
Q ss_pred cCCcccccC--CCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCC-ccccCCCCccEEEecCCcc
Q 001171 539 EENNLSGDV--PEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIP-AELGACSALEVLELRSNHF 615 (1133)
Q Consensus 539 ~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l 615 (1133)
++|++++.. +..+.++++|++|++++|.+++..+. +..+++|++|++++|++++..| ..+..+++|++|++++|++
T Consensus 355 ~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l 433 (570)
T 2z63_A 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433 (570)
T ss_dssp CSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCC
T ss_pred cCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcc
Confidence 777666443 45566677777777777777654433 7777777777777777776555 4567778888888888888
Q ss_pred cCCCccccccccccCeeecCCCccc-CcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcc
Q 001171 616 TGNIPVDISHLSRIKKLDLGQNKLS-GEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD 694 (1133)
Q Consensus 616 ~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 694 (1133)
++..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..
T Consensus 434 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 513 (570)
T 2z63_A 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513 (570)
T ss_dssp EECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHH
Confidence 7777777788888888888888887 467888888888888888888888877888888888888888888888877777
Q ss_pred ccccccCcccccccccccccCCcc
Q 001171 695 LALISSLRYLNLSRNNLEGEIPKM 718 (1133)
Q Consensus 695 l~~l~~L~~L~ls~N~l~~~~p~~ 718 (1133)
+..+++|+.|++++|+++|.+|..
T Consensus 514 ~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 514 FDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hhcccCCcEEEecCCcccCCCcch
Confidence 888888888899999888888853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=491.71 Aligned_cols=494 Identities=20% Similarity=0.211 Sum_probs=306.7
Q ss_pred ccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCcc--CCcceEEEc
Q 001171 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI--SPSLRYLDL 172 (1133)
Q Consensus 95 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~--~~~l~~L~L 172 (1133)
++++.|||++|++++..+..|.++++|+.|+|++|++++..|..+.++++|++|++++|.+++..+..+ .++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 578999999999998778889999999999999999997777789999999888888888876555544 367888888
Q ss_pred cCCcCCCCCCCCCCCCCcCcEEeccCCcCCC-CCcccccCccccceEecccccccCCCCccccCcccc----ceeecccc
Q 001171 173 SSNAFTGEIPGNFSSKSQLQLINLSYNSFSG-EVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSL----VHLSAEDN 247 (1133)
Q Consensus 173 s~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L----~~L~l~~N 247 (1133)
++|++++..+..|+++++|++|++++|++++ .+|..++++++|++|++++|++++..|..+..+++| ++|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 8888887666668888888888888888876 468888888888888888888877667777777777 78888888
Q ss_pred ccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcc
Q 001171 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRI 327 (1133)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i 327 (1133)
.++++.|..|..+ +|+.|++++|...... +...+.++++++.+.+..+.+... +.+
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~----~~~~~~~l~~l~~~~l~~~~~~~~-------------------~~l 243 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNV----MKTCIQGLAGLEVHRLVLGEFRNE-------------------GNL 243 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTH----HHHHHHTTTTCEEEEEEEEECCCC-------------------SSC
T ss_pred CceecCHHHhccC-cceeEecccccccccc----hhhhhcCccccceeeeccccccCc-------------------hhh
Confidence 8887777777665 7888888887543211 111224556666555543332211 111
Q ss_pred cccCCchhhcccc--cceeeccCc-eeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCC
Q 001171 328 RAVFPSWLTNVTS--LRVMDLSGN-FFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVP 404 (1133)
Q Consensus 328 ~~~~~~~~~~l~~--L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 404 (1133)
..+....|..+.+ ++.+++++| .+.+..|..+..+++|++|++++|.++. +|+.+..+ +|++|++++|.+. .+|
T Consensus 244 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~-~l~ 320 (570)
T 2z63_A 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFG-QFP 320 (570)
T ss_dssp EECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCS-SCC
T ss_pred hhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccc-ccC
Confidence 2222233333322 334455554 4455555555555555555555555552 34444444 5555555555555 233
Q ss_pred CccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccC--ChhhcCCCCCcEEecccCcCCCCCCCCCCCC
Q 001171 405 AFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNI--PEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482 (1133)
Q Consensus 405 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 482 (1133)
. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. +..+..+++|++|++++|.+++..+. +..+
T Consensus 321 ~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l 395 (570)
T 2z63_A 321 T--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGL 395 (570)
T ss_dssp B--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETC
T ss_pred c--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-cccc
Confidence 2 2445555555555555544333 45556666666666655433 45555566666666666655533222 5555
Q ss_pred CCCcEEEcccCCCccccC-CCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCccc-ccCCCCCCCCccCcEE
Q 001171 483 KGLLVLNLSASGFSGKIP-GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS-GDVPEGFSSLVGLQYL 560 (1133)
Q Consensus 483 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L 560 (1133)
++|++|++++|.+.+..+ ..+..+++|++|++++|.+++..|..+.++++|++|++++|.++ +.+|..|..+++|++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 555555555555554433 34555555555555555555555555555555555555555554 3455555555566666
Q ss_pred EcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCc
Q 001171 561 NLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIP 620 (1133)
Q Consensus 561 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 620 (1133)
+|++|++++..|..+..+++|++|+|++|++++..|..+..+++|++|++++|++++..|
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 666665555555555555555555555555555555555555555555555555554433
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=502.38 Aligned_cols=460 Identities=18% Similarity=0.251 Sum_probs=328.0
Q ss_pred ccCcEEEcccCcccCCCCccccCCCCcceEeccCCcc------cC------cCCCccccccchhhhhhcccccCCCccCc
Q 001171 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSF------SG------HLPLSIFNLTNLLVLNVAHNLLSGKISAD 162 (1133)
Q Consensus 95 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~------~g------~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 162 (1133)
.+++.|+|++|++.|.+|.++++|++|+.|+|++|.+ .| .+|... +.+|+ +++++|.+.+.++..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4678999999999999999999999999999999987 34 455544 67788 999999999888877
Q ss_pred cC---CcceEEEccCCcCCCCCCCCCCCCCcCcEEec--cCCcCCCCCcccccCccccceEecccccccCC---------
Q 001171 163 IS---PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINL--SYNSFSGEVPASVGQLQELEYLWLDSNHLYGT--------- 228 (1133)
Q Consensus 163 ~~---~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~l--s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------- 228 (1133)
+. ..+..+++....+.. .....++.+.+ ..|+++| ||..++++++|++|+|++|+++|.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 75 344555555444431 12223333333 3689998 999999999999999999999985
Q ss_pred --------CCcccc--CccccceeeccccccCCCCCCcccCcCcccEEEcccCC-ccC-CcccccccCcccccccccEEe
Q 001171 229 --------LPSAIS--NCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNE-LTG-LVPVSVLCNLWGNISSLRIVQ 296 (1133)
Q Consensus 229 --------~p~~l~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~~~~~~l~~L~~l~ 296 (1133)
+|..++ ++++|++|++++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+ +++.
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~-----~~L~------ 299 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW-----QALA------ 299 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHH-----HHHH------
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHH-----Hhhh------
Confidence 899888 99999999999999999999999999999999999998 887 677655 3221
Q ss_pred ccCCcccccccCCCCCccccccEEeccCCcccccCCc--hhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCc
Q 001171 297 LGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS--WLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS 374 (1133)
Q Consensus 297 l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~ 374 (1133)
....+++|++|++++|+++.+ |. .|.++++|++|+|++|+++|.+| .|+.+++|++|+|++|+
T Consensus 300 -------------~~~~l~~L~~L~L~~n~l~~i-p~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~ 364 (636)
T 4eco_A 300 -------------DAPVGEKIQIIYIGYNNLKTF-PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQ 364 (636)
T ss_dssp -------------HSGGGGTCCEEECCSSCCSSC-CCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSE
T ss_pred -------------ccccCCCCCEEECCCCcCCcc-CchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCc
Confidence 011224456666666666644 55 78888999999999999988888 88888889999999998
Q ss_pred ccccCchhhccCCC-ccEEEccCCcccccCCCccCCCC--CCcEEEccCCcCccccCcccc-------Cccccceeeccc
Q 001171 375 LSGLVPDEIAKCSL-LQMFDLEGNRFSGQVPAFLGGIR--GLKIVSLGRNMFSGLIPLSFG-------NLSQLETLNLSE 444 (1133)
Q Consensus 375 l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~ 444 (1133)
++ .+|..+..+++ |++|+|++|+++ .+|..+..++ +|+.|++++|.+++.+|..|. .+++|++|++++
T Consensus 365 l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~ 442 (636)
T 4eco_A 365 IT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442 (636)
T ss_dssp EE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCS
T ss_pred cc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcC
Confidence 88 66777888888 899999988888 6777777654 788888888888888888777 677888888888
Q ss_pred ccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCC-CCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCC
Q 001171 445 NDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGN-LKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGEL 523 (1133)
Q Consensus 445 N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 523 (1133)
|+++...+..+..+++|++|+|++|+++ .+|..+.. .. ..+.++++|++|++++|+++ .+
T Consensus 443 N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~-----------------~~~~~l~~L~~L~Ls~N~l~-~l 503 (636)
T 4eco_A 443 NQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDEN-----------------ENFKNTYLLTSIDLRFNKLT-KL 503 (636)
T ss_dssp SCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETT-----------------EECTTGGGCCEEECCSSCCC-BC
T ss_pred CccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhcccc-----------------ccccccCCccEEECcCCcCC-cc
Confidence 8888544445556788888888888777 44433221 11 01223446666666666666 56
Q ss_pred Chhcc--CCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccc------cccCCCCcccccccccceeecccCccCCCC
Q 001171 524 PIELF--GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDN------AFTGDIPATYGFLRSLVFLSLSHNQISGMI 595 (1133)
Q Consensus 524 p~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 595 (1133)
|..+. .+++|++|+|++|++++ +|..+.++++|++|+|++| ++.+.+|..++.+++|++|+|++|++ +.+
T Consensus 504 p~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~i 581 (636)
T 4eco_A 504 SDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKV 581 (636)
T ss_dssp CGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBC
T ss_pred ChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-Ccc
Confidence 66665 66666666666666665 5666666666666666544 44444444444444444444444444 233
Q ss_pred CccccCCCCccEEEecCCcc
Q 001171 596 PAELGACSALEVLELRSNHF 615 (1133)
Q Consensus 596 p~~l~~l~~L~~L~L~~N~l 615 (1133)
|..+. ++|++|+|++|++
T Consensus 582 p~~~~--~~L~~L~Ls~N~l 599 (636)
T 4eco_A 582 NEKIT--PNISVLDIKDNPN 599 (636)
T ss_dssp CSCCC--TTCCEEECCSCTT
T ss_pred CHhHh--CcCCEEECcCCCC
Confidence 43332 3444444444443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=485.67 Aligned_cols=491 Identities=18% Similarity=0.248 Sum_probs=274.2
Q ss_pred CCccceeeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCcc
Q 001171 60 PCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSI 139 (1133)
Q Consensus 60 ~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l 139 (1133)
.|.|.|| |+.. +.+++ .+|+.+. ++|++|+|++|++++..|..++++++|+.|+|++|++++..|..+
T Consensus 3 ~C~~~~~-c~~~--------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 70 (549)
T 2z81_A 3 SCDASGV-CDGR--------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70 (549)
T ss_dssp EECTTSE-EECT--------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT
T ss_pred cCCCCce-EECC--------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc
Confidence 5999999 8631 11221 2333332 456666666666665555556666666666666665554444444
Q ss_pred ccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCC-CCcccccCccccceE
Q 001171 140 FNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSG-EVPASVGQLQELEYL 218 (1133)
Q Consensus 140 ~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L 218 (1133)
.++++| ++|+|++|++++..|..|+.+++|++|+|++|++++ .+|..++.+++|++|
T Consensus 71 ~~l~~L----------------------~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 71 YSLGSL----------------------EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp TTCTTC----------------------CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred cccccC----------------------CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 444333 444444555554444455555666666666665554 244455555555555
Q ss_pred ecccccccCCCC-ccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEec
Q 001171 219 WLDSNHLYGTLP-SAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQL 297 (1133)
Q Consensus 219 ~L~~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l 297 (1133)
++++|++.+.+| ..+.++++|++|++++|++++..|..+..+++|++|++++|.+.. +|.
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~------------------ 189 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLE------------------ 189 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHH------------------
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccc-cch------------------
Confidence 555555333333 345555555555555555555555555555555555555555431 121
Q ss_pred cCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeeccc--C-cccCCCCCCcEEEccCCc
Q 001171 298 GFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNL--P-AAVGSLDKLEVLRVANNS 374 (1133)
Q Consensus 298 ~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~L~L~~n~ 374 (1133)
..+..+++|++|++++|++++.. | .....+++|+.|++++|.
T Consensus 190 -----------------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 234 (549)
T 2z81_A 190 -----------------------------------IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234 (549)
T ss_dssp -----------------------------------HHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred -----------------------------------hhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence 11233444444444444444321 1 112234445555555554
Q ss_pred ccccCch----hhccCCCccEEEccCCcccccC------CCccCCCCCCcEEEccCCcCccccCccccCccccceeeccc
Q 001171 375 LSGLVPD----EIAKCSLLQMFDLEGNRFSGQV------PAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSE 444 (1133)
Q Consensus 375 l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~------p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 444 (1133)
+++..+. .+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+.... .+.+
T Consensus 235 l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~--~~~~----------- 301 (549)
T 2z81_A 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY--LFYD----------- 301 (549)
T ss_dssp EEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGG--GSCC-----------
T ss_pred cchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhh--hccc-----------
Confidence 4433222 2234455566666665554321 112233444555555554443210 0000
Q ss_pred ccccccCChhhcCCCCCcEEecccCcCCCCCCCCC-CCCCCCcEEEcccCCCcccc---CCCcCCcccccEEeccccCCC
Q 001171 445 NDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV-GNLKGLLVLNLSASGFSGKI---PGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 445 N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
.+..+....+|+.|++++|.++ .+|..+ ..+++|++|++++|++++.+ +..++.+++|++|++++|+++
T Consensus 302 ------l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 374 (549)
T 2z81_A 302 ------LSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374 (549)
T ss_dssp ------CCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCC
T ss_pred ------chhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccc
Confidence 1111222344555555555554 333333 34555555555555555443 233556666666666666666
Q ss_pred CCCC--hhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCcc
Q 001171 521 GELP--IELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAE 598 (1133)
Q Consensus 521 ~~~p--~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 598 (1133)
+..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++ +|..+ .++|++|+|++|+|++.+
T Consensus 375 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~--- 447 (549)
T 2z81_A 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS--- 447 (549)
T ss_dssp CHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC---
T ss_pred ccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc---
Confidence 4322 34666777777777777776 456667777777777777777763 33332 257888888888887542
Q ss_pred ccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCC
Q 001171 599 LGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIP 668 (1133)
Q Consensus 599 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 668 (1133)
..+++|++|+|++|+++ .+|. ...+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+..|
T Consensus 448 -~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 448 -LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp -CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred -ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 46788999999999888 5775 4678899999999999998888888999999999999999887654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=483.75 Aligned_cols=489 Identities=19% Similarity=0.205 Sum_probs=353.0
Q ss_pred eEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeecccc
Q 001171 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247 (1133)
Q Consensus 168 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 247 (1133)
...|+++|.++ .+|..+. ++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..+.++++|++|++++|
T Consensus 8 ~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 8 GVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp SEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred ceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 34677888887 4555543 67888888888888777777888888888888888887777777888888888888888
Q ss_pred ccCCCCCCcccCcCcccEEEcccCCccCC-cccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCc
Q 001171 248 VLKGLIPGTIGRISTLQVLSLSRNELTGL-VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNR 326 (1133)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~ 326 (1133)
++++.+|..|+++++|++|+|++|++++. +|.. ++++++|+.|++++|.+
T Consensus 85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-----~~~l~~L~~L~L~~n~~------------------------ 135 (549)
T 2z81_A 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL-----FPNLTNLQTLRIGNVET------------------------ 135 (549)
T ss_dssp CCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCS-----CTTCTTCCEEEEEESSS------------------------
T ss_pred ccCccCHHHhccCCCCcEEECCCCcccccchhhh-----hhccCCccEEECCCCcc------------------------
Confidence 88877776777888888888888877642 2222 24455555554444442
Q ss_pred ccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccC--C
Q 001171 327 IRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQV--P 404 (1133)
Q Consensus 327 i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p 404 (1133)
+..+.+..|.++++|++|++++|.+++..|..++.+++|++|++++|.+....+..+..+++|++|++++|++++.. |
T Consensus 136 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 215 (549)
T 2z81_A 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP 215 (549)
T ss_dssp CCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCC
T ss_pred ccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccc
Confidence 33444566777777777777777777777777777777777777777766443333455777777777777776532 1
Q ss_pred -CccCCCCCCcEEEccCCcCccccCc----cccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCC
Q 001171 405 -AFLGGIRGLKIVSLGRNMFSGLIPL----SFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV 479 (1133)
Q Consensus 405 -~~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 479 (1133)
.....+++|+.|++++|.+++..+. .+..+++|+.|++++|.+.+...- .......+
T Consensus 216 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~------------------~~~~~~~~ 277 (549)
T 2z81_A 216 LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF------------------NPSESDVV 277 (549)
T ss_dssp CSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCC------------------CCCTTTCC
T ss_pred cchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccc------------------cccchhhh
Confidence 1223455666666666666543322 233445555555555555432100 00011223
Q ss_pred CCCCCCcEEEcccCCCccc-----cCCCcCCcccccEEeccccCCCCCCChhc-cCCCCCcEeeccCCcccccC---CCC
Q 001171 480 GNLKGLLVLNLSASGFSGK-----IPGSIGSLMRLTTLDLSNQNLSGELPIEL-FGLPSLQVVSLEENNLSGDV---PEG 550 (1133)
Q Consensus 480 ~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~---~~~ 550 (1133)
..+.+|+.|++.++.+... ++..+....+|+.|++++|+++ .+|..+ ..+++|++|++++|++++.. +..
T Consensus 278 ~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 356 (549)
T 2z81_A 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356 (549)
T ss_dssp CCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTC
T ss_pred hhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhh
Confidence 4455566666666554321 1111233568999999999987 677766 47999999999999998765 345
Q ss_pred CCCCccCcEEEcccccccCCCC--cccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccc
Q 001171 551 FSSLVGLQYLNLSDNAFTGDIP--ATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSR 628 (1133)
Q Consensus 551 ~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 628 (1133)
++.+++|++|+|++|++++..+ ..+..+++|++|++++|+++ .+|..++.+++|++|++++|++++ +|..+ .++
T Consensus 357 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~ 432 (549)
T 2z81_A 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQT 432 (549)
T ss_dssp TTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTT
T ss_pred hhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCC
Confidence 7889999999999999986543 56889999999999999999 688889999999999999999984 55444 268
Q ss_pred cCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCccccccc
Q 001171 629 IKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSR 708 (1133)
Q Consensus 629 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~ 708 (1133)
|+.|+|++|++++.+ ..+++|+.|+|++|+++ .+|. ...+++|+.|||++|++++.+|..+..+++|+.|++++
T Consensus 433 L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 506 (549)
T 2z81_A 433 LEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506 (549)
T ss_dssp CSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCS
T ss_pred ceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecC
Confidence 999999999999643 57899999999999999 6776 56899999999999999998888899999999999999
Q ss_pred ccccccCCc
Q 001171 709 NNLEGEIPK 717 (1133)
Q Consensus 709 N~l~~~~p~ 717 (1133)
|++.|.+|.
T Consensus 507 N~~~~~~~~ 515 (549)
T 2z81_A 507 NPWDCSCPR 515 (549)
T ss_dssp SCBCCCHHH
T ss_pred CCccCCCcc
Confidence 999999883
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=482.08 Aligned_cols=521 Identities=25% Similarity=0.261 Sum_probs=358.9
Q ss_pred ccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccc
Q 001171 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSS 238 (1133)
Q Consensus 159 ~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 238 (1133)
||.++|+++++|||++|+|++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|++++..+..|.++++
T Consensus 46 vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~ 125 (635)
T 4g8a_A 46 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 125 (635)
T ss_dssp CCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTT
T ss_pred cCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCC
Confidence 34445555666666666666555566666666666666666666555555666666666666666666444455666666
Q ss_pred cceeeccccccCCCCCCcccCcCcccEEEcccCCccCC-cccccccCcccccccccEEeccCCcccccccCCCCCccccc
Q 001171 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL-VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317 (1133)
Q Consensus 239 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L 317 (1133)
|++|++++|+++++.+..|+++++|++|+|++|++++. +|..+ +++++|+.|++++|.+++
T Consensus 126 L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~-----~~l~~L~~L~L~~N~l~~------------- 187 (635)
T 4g8a_A 126 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-----SNLTNLEHLDLSSNKIQS------------- 187 (635)
T ss_dssp CCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG-----GGCTTCCEEECCSSCCCE-------------
T ss_pred CCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhh-----ccchhhhhhcccCccccc-------------
Confidence 66666666666666555666666666666666666542 22222 334444444444444333
Q ss_pred cEEeccCCcccccCCchhhcccccc----eeeccCceeecccCcccCCCCCCcEEEccCCcccc-cCchhhccCCCccEE
Q 001171 318 EVLDLQNNRIRAVFPSWLTNVTSLR----VMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSG-LVPDEIAKCSLLQMF 392 (1133)
Q Consensus 318 ~~L~L~~n~i~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 392 (1133)
+.+..|..+.+++ .++++.|.+....+..+ ....++.|++.+|.... ..+..+..+..++..
T Consensus 188 ------------~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~ 254 (635)
T 4g8a_A 188 ------------IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 254 (635)
T ss_dssp ------------ECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEE
T ss_pred ------------cccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccc
Confidence 2233333333222 34444444443322222 22234444444443331 112334444444444
Q ss_pred EccCCc------ccccCCCccCCCCCCcEEEccCCcCc---cccCccccCccccceeecccccccccCChhhcCCCCCcE
Q 001171 393 DLEGNR------FSGQVPAFLGGIRGLKIVSLGRNMFS---GLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTT 463 (1133)
Q Consensus 393 ~Ls~N~------l~~~~p~~l~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~ 463 (1133)
.+..+. +.......+..+..+....+..+... ...+..+..+.+++.+++.+|.+... ..+....+|+.
T Consensus 255 ~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~ 332 (635)
T 4g8a_A 255 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQH 332 (635)
T ss_dssp EEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSE
T ss_pred cccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhh
Confidence 443222 22223334444555555555544332 22344566677888888888877643 34566778888
Q ss_pred EecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCC--CCCChhccCCCCCcEeeccCC
Q 001171 464 LNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS--GELPIELFGLPSLQVVSLEEN 541 (1133)
Q Consensus 464 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~L~~N 541 (1133)
|++++|.+.+..+ ..+..|+.+++..|.+... .....+++|+.|++++|.+. +..+..+..+.+|+.+++..|
T Consensus 333 L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~ 407 (635)
T 4g8a_A 333 LELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFN 407 (635)
T ss_dssp EEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSC
T ss_pred hhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccc
Confidence 9998888875443 3456788888888887643 34557889999999999886 345677788899999999999
Q ss_pred cccccCCCCCCCCccCcEEEcccccccCCCC-cccccccccceeecccCccCCCCCccccCCCCccEEEecCCccc-CCC
Q 001171 542 NLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP-ATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT-GNI 619 (1133)
Q Consensus 542 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~ 619 (1133)
.+.. .+..+..+++|+.++++.|......+ ..+..+++++.++++.|++.+..+..+..+++|++|+|++|++. +..
T Consensus 408 ~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~ 486 (635)
T 4g8a_A 408 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 486 (635)
T ss_dssp SEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEE
T ss_pred cccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccC
Confidence 9874 55678889999999999988776554 56788999999999999999988999999999999999999854 456
Q ss_pred ccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcccccc-
Q 001171 620 PVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALI- 698 (1133)
Q Consensus 620 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l- 698 (1133)
|..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|||++|+|++..|..+..+
T Consensus 487 ~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 566 (635)
T 4g8a_A 487 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 566 (635)
T ss_dssp CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCC
T ss_pred chhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhh
Confidence 7889999999999999999999889999999999999999999999889999999999999999999999999999988
Q ss_pred ccCcccccccccccccCCcc
Q 001171 699 SSLRYLNLSRNNLEGEIPKM 718 (1133)
Q Consensus 699 ~~L~~L~ls~N~l~~~~p~~ 718 (1133)
++|++|+|++|+|.|.+...
T Consensus 567 ~~L~~L~L~~Np~~C~C~~~ 586 (635)
T 4g8a_A 567 SSLAFLNLTQNDFACTCEHQ 586 (635)
T ss_dssp TTCCEEECTTCCBCCSGGGH
T ss_pred CcCCEEEeeCCCCcccCCcH
Confidence 68999999999999988743
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=448.39 Aligned_cols=264 Identities=23% Similarity=0.385 Sum_probs=208.2
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|.+.++||+|+||+||+|+++ +++.||||++..... ..++|.+|+++|++++|||||+++|+|.+.+ ..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-PL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EE
Confidence 356788899999999999999875 478999999975433 2467999999999999999999999998764 45
Q ss_pred EEEEeccCCCCHHHHHHhhccC----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 909 LLVYDYMPNGNLATLLQEASHQ----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
++|||||++|+|.++++..... ....++|.++..|+.|||+||+|||+++|+||||||+|||+++++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 9999999999999999875421 124589999999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
|+|||+|+...... .........||+.|||||++.+..|+.++|||||||++|||+| |+.||......+....+.+..
T Consensus 199 i~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 199 IGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp ECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EcccccceeccCCC-cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998653322 1222344679999999999999999999999999999999999 999998877776666554431
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
+ ...+..+ .. ...+++.+||+.||++|||++||+++|+.+...|
T Consensus 278 ~-~~~p~~~----------~~------~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 278 E-LERPRAC----------PP------EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp C-CCCCTTC----------CH------HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred C-CCCcccc----------cH------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1 1111100 01 1237899999999999999999999999876643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=442.41 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=210.7
Q ss_pred cCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++++.+.||+|+||+||+|.+. +++.||||++..... ..++|.+|++++++++|||||+++|+|.+.+. .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~-~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP-L 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-C
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE-E
Confidence 35677899999999999999863 468999999975432 35789999999999999999999999987654 4
Q ss_pred EEEEeccCCCCHHHHHHhhccCC-----------CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCce
Q 001171 909 LLVYDYMPNGNLATLLQEASHQD-----------GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEA 977 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 977 (1133)
++|||||++|+|.+++....... ...++|..+..++.|||+||+|||+++||||||||+|||+++++.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 99999999999999997643211 2358999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHH
Q 001171 978 HLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 978 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
||+|||+|+...... .........||+.|||||++.++.|+.++|||||||++|||+| |+.||......++...+...
T Consensus 185 Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 185 KISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp EECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred EECCcccceeccCCC-ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998653322 1223345679999999999999999999999999999999999 89999887777666555432
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
...... ... .. ...+++.+||+.||++||+|+||+++|+..
T Consensus 264 ----~~~~~p--------~~~---~~--~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 264 ----QVLPCP--------DDC---PA--WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----CCCCCC--------TTC---CH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----CCCCCc--------ccc---hH--HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111110 010 01 123789999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=443.22 Aligned_cols=262 Identities=22% Similarity=0.381 Sum_probs=211.6
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|.+.+.||+|+||+||+|++. +++.||||++..... ..++|.+|++++++++|||||+++|+|.+.+ ..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-PL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EE
Confidence 357889999999999999999874 478999999975433 2467999999999999999999999998764 45
Q ss_pred EEEEeccCCCCHHHHHHhhcc--------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEe
Q 001171 909 LLVYDYMPNGNLATLLQEASH--------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLS 980 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 980 (1133)
++|||||++|+|.++++..+. .....++|..+..++.|||+||+|||+++|+||||||+|||+++++.+||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 999999999999999987531 223469999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhh
Q 001171 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQR 1059 (1133)
Q Consensus 981 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~ 1059 (1133)
|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||...+..++...+.+...
T Consensus 171 DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~- 248 (299)
T 4asz_A 171 DFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV- 248 (299)
T ss_dssp CCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-
T ss_pred CcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 9999986533221 112234568999999999999999999999999999999999 9999988777766665544211
Q ss_pred ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
... +... .. ...+++.+||+.||++|||++||++.|+.+..
T Consensus 249 ---~~~--------p~~~---~~--~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 249 ---LQR--------PRTC---PQ--EVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ---CCC--------CTTC---CH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCC--------Cccc---hH--HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 110 0000 01 12378999999999999999999999988654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=490.83 Aligned_cols=496 Identities=17% Similarity=0.207 Sum_probs=320.2
Q ss_pred ccCcEEEcccCcccCCCCccccCCCCcceEec-cCCcccCcCCCcccc----cc-----chhhhhhcccccCCCccCccC
Q 001171 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYL-QYNSFSGHLPLSIFN----LT-----NLLVLNVAHNLLSGKISADIS 164 (1133)
Q Consensus 95 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L-~~n~~~g~~p~~l~~----l~-----~L~~L~l~~N~l~~~~~~~~~ 164 (1133)
.+++.|+|++|++.|.+|..|++|++|+.|+| ++|.++|..|..... ++ .++..+.. ..+....+..+.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~-~~l~~~~~~~~s 401 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK-MFLDYDQRLNLS 401 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHH-HHTCCCGGGGSC
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhh-hhhccCcchhhh
Confidence 57889999999999999999999999999999 999999885543211 11 11111111 000000000000
Q ss_pred CcceEEEccCCcCCCCCCCCCCCCCcCcEEeccC--CcCCCCCcccccCccccceEecccccccC---------------
Q 001171 165 PSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSY--NSFSGEVPASVGQLQELEYLWLDSNHLYG--------------- 227 (1133)
Q Consensus 165 ~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--------------- 227 (1133)
.+....+..+. ...+........++.+.++. |+++| ||..++++++|++|+|++|+++|
T Consensus 402 -~l~~~~l~~~~--~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~ 477 (876)
T 4ecn_A 402 -DLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYA 477 (876)
T ss_dssp -HHHHHHHHTCT--TSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred -HHHHHHhhhCc--cccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccc
Confidence 00000000000 00111111222233333332 56665 56666666666666666666655
Q ss_pred --CCCcccc--CccccceeeccccccCCCCCCcccCcCcccEEEcccCC-ccC-CcccccccCcccccccccEEeccCCc
Q 001171 228 --TLPSAIS--NCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNE-LTG-LVPVSVLCNLWGNISSLRIVQLGFNA 301 (1133)
Q Consensus 228 --~~p~~l~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~~~~~~l~~L~~l~l~~n~ 301 (1133)
.+|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+ ++++
T Consensus 478 ~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i-----~~L~----------- 541 (876)
T 4ecn_A 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW-----TRLA----------- 541 (876)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHH-----HHHH-----------
T ss_pred cccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHH-----Hhhh-----------
Confidence 5777776 88888888888888887888888888888888888887 776 666544 2221
Q ss_pred ccccccCCCCCccccccEEeccCCcccccCCc--hhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccC
Q 001171 302 FTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPS--WLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLV 379 (1133)
Q Consensus 302 l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 379 (1133)
..+..+++|++|+|++|+++.+ |. .|.++++|++|+|++|+|+ .+| .|+.+++|++|+|++|+++ .+
T Consensus 542 -------~~~~~l~~L~~L~Ls~N~L~~i-p~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~l 610 (876)
T 4ecn_A 542 -------DDEDTGPKIQIFYMGYNNLEEF-PASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EI 610 (876)
T ss_dssp -------HCTTTTTTCCEEECCSSCCCBC-CCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CC
T ss_pred -------hcccccCCccEEEeeCCcCCcc-CChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cc
Confidence 0122334566777777777755 55 7888888888888888888 777 8888888888888888888 67
Q ss_pred chhhccCCC-ccEEEccCCcccccCCCccCCCCC--CcEEEccCCcCccccCccc---c--CccccceeecccccccccC
Q 001171 380 PDEIAKCSL-LQMFDLEGNRFSGQVPAFLGGIRG--LKIVSLGRNMFSGLIPLSF---G--NLSQLETLNLSENDIRGNI 451 (1133)
Q Consensus 380 ~~~~~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~i~~~~ 451 (1133)
|..+.++++ |++|+|++|+++ .+|..+..++. |+.|+|++|.+++.+|... . .+++|+.|+|++|+++. +
T Consensus 611 p~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-l 688 (876)
T 4ecn_A 611 PEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-F 688 (876)
T ss_dssp CTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-C
T ss_pred hHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-c
Confidence 777888888 888888888888 67777776654 8888888888887655322 2 33478888888888884 4
Q ss_pred Chh-hcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhcc--
Q 001171 452 PEE-ITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-- 528 (1133)
Q Consensus 452 ~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-- 528 (1133)
|.. +..+++|+.|+|++|+++ .+|..+.... +..+.++++|+.|+|++|+++ .+|..+.
T Consensus 689 p~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~----------------~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~ 750 (876)
T 4ecn_A 689 PTELFATGSPISTIILSNNLMT-SIPENSLKPK----------------DGNYKNTYLLTTIDLRFNKLT-SLSDDFRAT 750 (876)
T ss_dssp CHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT----------------TSCCTTGGGCCEEECCSSCCC-CCCGGGSTT
T ss_pred CHHHHccCCCCCEEECCCCcCC-ccChHHhccc----------------cccccccCCccEEECCCCCCc-cchHHhhhc
Confidence 444 447788888888888777 4443322110 011234557777777777777 5666666
Q ss_pred CCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEE
Q 001171 529 GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVL 608 (1133)
Q Consensus 529 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 608 (1133)
.+++|+.|+|++|++++ +|..+.++++|+.|+|++|+ ++++|++.+.+|..++.+++|+.|
T Consensus 751 ~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L 811 (876)
T 4ecn_A 751 TLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQL 811 (876)
T ss_dssp TCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEE
T ss_pred cCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEE
Confidence 77777777777777775 56677777777777777765 455566666666666666666666
Q ss_pred EecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCC
Q 001171 609 ELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664 (1133)
Q Consensus 609 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 664 (1133)
+|++|++ +.+|..+. ++|+.|+|++|++....+..++....+..+.|.+|++.
T Consensus 812 ~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 812 QIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp ECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred ECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 6666666 45665544 46666666666666555555555555666666666655
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=433.56 Aligned_cols=260 Identities=22% Similarity=0.380 Sum_probs=200.8
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.++||+|+||+||+|++++ .||||+++....+ .+.|.+|++++++++|||||+++|++.++ . .++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~-~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-N-LAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S-CEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-e-EEEEE
Confidence 4578899999999999999998764 4899998644333 36789999999999999999999998653 3 58999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|||++|+|.++++... ..++|..+..|+.|||+||+|||+++||||||||+|||+++++.+||+|||+|+......
T Consensus 111 Ey~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp ECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999997643 348999999999999999999999999999999999999999999999999997643222
Q ss_pred CCCCCCCCCCCCCCccCccccCC---CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST---GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
........+||+.|||||++.+ +.|+.++|||||||++|||+||+.||...+.......... .+. ..+.
T Consensus 187 -~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~---~~~----~~p~ 258 (307)
T 3omv_A 187 -GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG---RGY----ASPD 258 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---TTC----CCCC
T ss_pred -cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh---cCC----CCCC
Confidence 1223345689999999999853 4589999999999999999999999976554433332222 111 1111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
........ .. ...+++.+||+.||++|||+.||+++||.++.
T Consensus 259 ~~~~~~~~---~~--~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 LSKLYKNC---PK--AMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp STTSCTTS---CH--HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cccccccc---hH--HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111111 11 12378899999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=436.38 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=206.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+.|++.+.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+.+ ..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEEeC
Confidence 56999999999999999999875 69999999996432 33567899999999999999999999998764 55999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
|++|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 153 ~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 223 (346)
T 4fih_A 153 LEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 223 (346)
T ss_dssp CTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred CCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence 9999999999752 3899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+....+..... +......
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~~~~~~~ 294 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------PRLKNLH 294 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---------CCCSCGG
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------CCCCccc
Confidence 2234567899999999999999999999999999999999999999987766665554433210 0010000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.-.. ...+++.+||+.||++|||++|++++
T Consensus 295 ~~s~------~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 295 KVSP------SLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GSCH------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCH------HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011 12378999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=437.77 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=200.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.+.||+|+||+||+|+++ +|+.||||++...... .+.+.+|++++++++|||||++++++.+. +..|+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEE
Confidence 368999999999999999999875 6999999999755433 45788999999999999999999999876 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||||+||+|.+++...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999986432 34788899999999999999999999999999999999999999999999999754221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..++...+... .++.. .
T Consensus 179 ---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----~~~~~-~---- 246 (350)
T 4b9d_A 179 ---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPPV-S---- 246 (350)
T ss_dssp ---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CCCCC-C----
T ss_pred ---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----CCCCC-C----
Confidence 11223457999999999999999999999999999999999999999877766655554432 11111 0
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. +.. ...+++.+||+.||++|||++|++++
T Consensus 247 ---~~---~s~--~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 ---LH---YSY--DLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ---TT---SCH--HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---cc---CCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 001 12378999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=434.68 Aligned_cols=255 Identities=18% Similarity=0.230 Sum_probs=204.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.+.|++.++||+|+||+||+|+++ +|+.||||++..... ..+|++++++++|||||++++++.+. +..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREG-PWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEec
Confidence 346888899999999999999875 689999999975432 34799999999999999999999876 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCcccccccCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+||+|.+++++.+ .+++..+..++.||+.||+|||+++|+||||||+|||++.++ ++||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999998754 389999999999999999999999999999999999999988 699999999986543322
Q ss_pred CC--CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 994 EA--SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 994 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.. ......+||+.|||||++.+..|+.++||||+||++|||++|++||......++...+.... ..+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~~-------- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PPIR-------- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CGGG--------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CCch--------
Confidence 11 12234579999999999999999999999999999999999999998766655555444321 0001
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
+.++... ....+++.+||+.||++|||+.|++++|+...
T Consensus 277 ~~~~~~s-----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 277 EIPPSCA-----PLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GSCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCccCC-----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1111110 11237889999999999999999999886543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=429.35 Aligned_cols=247 Identities=17% Similarity=0.312 Sum_probs=206.5
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||+||+|+++ +|+.||||++.+. ....+.+.+|++++++++|||||++++++.+. +..|+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence 47999999999999999999875 6899999999642 23356789999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||++||+|.+++++.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999998754 3889999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. ........+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..++...+.+. ...+++ .+
T Consensus 186 ~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~p~----~~- 257 (311)
T 4aw0_A 186 S-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--EYDFPE----KF- 257 (311)
T ss_dssp T-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCT----TC-
T ss_pred C-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCc----cc-
Confidence 1 223345678999999999999999999999999999999999999999877766666555432 111111 00
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1108 (1133)
.. .+.+++.+|++.||++|||++|++
T Consensus 258 -----s~------~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 -----FP------KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CH------HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CH------HHHHHHHHHccCCHhHCcChHHHc
Confidence 01 123789999999999999999864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=468.91 Aligned_cols=459 Identities=19% Similarity=0.231 Sum_probs=297.0
Q ss_pred cEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccC
Q 001171 192 QLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRN 271 (1133)
Q Consensus 192 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 271 (1133)
++||+++|+++ .+|..+. ++|++|+|++|++++..|..+.++++|++|++++|+++++.|..|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46888888888 5776665 78888888888887666677777888888888888887777777777777777777777
Q ss_pred CccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCccccc-CCchhhcccccceeeccCce
Q 001171 272 ELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV-FPSWLTNVTSLRVMDLSGNF 350 (1133)
Q Consensus 272 ~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~Ls~N~ 350 (1133)
++++ +|.. .+.+|++|+|++|+|+++ .|..|.++++|++|+|++|.
T Consensus 80 ~l~~-lp~~--------------------------------~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~ 126 (520)
T 2z7x_B 80 KLVK-ISCH--------------------------------PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126 (520)
T ss_dssp CCCE-EECC--------------------------------CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESS
T ss_pred ceee-cCcc--------------------------------ccCCccEEeccCCccccccchhhhccCCcceEEEecCcc
Confidence 7763 2221 233445555555555543 36777777888888888877
Q ss_pred eecccCcccCCCCCC--cEEEccCCcc--cccCchhhccCC-CccEEEccCCcccccCCC-ccCCCCCCcEEEccCCc--
Q 001171 351 FSGNLPAAVGSLDKL--EVLRVANNSL--SGLVPDEIAKCS-LLQMFDLEGNRFSGQVPA-FLGGIRGLKIVSLGRNM-- 422 (1133)
Q Consensus 351 l~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~-- 422 (1133)
|.+ ..+..+++| ++|++++|.+ .+..|..+..+. +...+++++|.+.+.++. .+.++++|+.|++++|.
T Consensus 127 l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 203 (520)
T 2z7x_B 127 LEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203 (520)
T ss_dssp CCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCST
T ss_pred cch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccc
Confidence 765 345556666 7777777777 566666665554 334556666666554433 44556666666666665
Q ss_pred -----CccccCccccCccccceeecccccccccCChhhc---CCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCC
Q 001171 423 -----FSGLIPLSFGNLSQLETLNLSENDIRGNIPEEIT---RLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494 (1133)
Q Consensus 423 -----l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 494 (1133)
+.+.+| .+..+++|+.|++++|.+++..+..+. ..++|++|++++|++++.+|..+...
T Consensus 204 ~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~------------ 270 (520)
T 2z7x_B 204 NKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY------------ 270 (520)
T ss_dssp TTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC------------
T ss_pred cccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc------------
Confidence 444444 555566666666666555543222111 12345555555555554444444000
Q ss_pred CccccCCCcCCcccccEEeccccCCCCCCC-hhccCC---CCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCC
Q 001171 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELP-IELFGL---PSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGD 570 (1133)
Q Consensus 495 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 570 (1133)
...++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++.
T Consensus 271 -------~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~ 339 (520)
T 2z7x_B 271 -------SGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDT 339 (520)
T ss_dssp -------CSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTT
T ss_pred -------ccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChh
Confidence 005555566666666655 233 333333 45666666666654321 124566677777777777766
Q ss_pred CCcccccccccceeecccCccCC--CCCccccCCCCccEEEecCCcccCCCccc-cccccccCeeecCCCcccCcCchhh
Q 001171 571 IPATYGFLRSLVFLSLSHNQISG--MIPAELGACSALEVLELRSNHFTGNIPVD-ISHLSRIKKLDLGQNKLSGEIPKEI 647 (1133)
Q Consensus 571 ~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~l 647 (1133)
+|..++.+++|++|++++|++++ .+|..++.+++|++|++++|++++.+|.. +..+++|+.|+|++|++++.+|..+
T Consensus 340 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp TTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred hhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhh
Confidence 66677777777777777777765 44556777777777777777777655554 6667778888888888776666655
Q ss_pred hccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcc-ccccccCcccccccccccccCCc
Q 001171 648 SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 648 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
. ++|+.|++++|+++ .+|..+..+++|+.|+|++|+++ .+|.. +..+++|++|++++|+++|.++.
T Consensus 420 ~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 420 P--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp C--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred c--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 4 67888888888888 67777778888888888888887 45554 77888888888888888887764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=422.02 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=194.8
Q ss_pred CcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeC---CCCcEEEEE
Q 001171 840 DEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAG---PPDVRLLVY 912 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~lV~ 912 (1133)
.+.++||+|+||+||+|.++ +++.||+|++...... .+.|.+|++++++++|||||++++++.. .+...|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999875 5899999999654333 4578999999999999999999999864 234568999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCC-CCceEEeccCcccccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 989 (1133)
|||++|+|.+++++.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998753 3889999999999999999999998 999999999999984 7999999999997532
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCCh-hhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD-EDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ..+...+ ..+..+..++.
T Consensus 184 ~-----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i----~~~~~~~~~~~ 253 (290)
T 3fpq_A 184 A-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----TSGVKPASFDK 253 (290)
T ss_dssp T-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH----TTTCCCGGGGG
T ss_pred C-----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH----HcCCCCCCCCc
Confidence 1 22345689999999999865 699999999999999999999999965433 2222222 22211111111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .. ...+++.+||+.||++|||++|++++
T Consensus 254 ~~------~~------~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 254 VA------IP------EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CC------CH------HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cC------CH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 01 12378999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=439.26 Aligned_cols=268 Identities=22% Similarity=0.336 Sum_probs=213.2
Q ss_pred HHHHHhcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCcC--HHHHHHHHHHHhhccC-CCeeeEEEEE
Q 001171 831 ETLEATRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTID--ENTFRKEAEALGKVKH-RNLTVLRGYY 901 (1133)
Q Consensus 831 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h-pniv~l~~~~ 901 (1133)
+++...++|++.+.||+|+||+||+|.+.. ++.||||++...... .+.|.+|++++++++| ||||+++|+|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 344456789999999999999999997642 478999999764432 4578999999999965 8999999999
Q ss_pred eCCCCcEEEEEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcccee
Q 001171 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVL 970 (1133)
Q Consensus 902 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIl 970 (1133)
.......++|||||++|+|.++++..... ....+++..+..++.|||+||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 77656669999999999999999875321 1245899999999999999999999999999999999999
Q ss_pred eCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCCh-hh
Q 001171 971 FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQD-ED 1048 (1133)
Q Consensus 971 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~-~~ 1048 (1133)
+++++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||..... +.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986533221 222345678999999999999999999999999999999998 9999976553 33
Q ss_pred HHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1049 IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
+...+.+.. +...++.+ .. ...+++.+||+.||++|||+.||+++|+.+..
T Consensus 297 ~~~~i~~g~-~~~~p~~~----------~~------~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 FCRRLKEGT-RMRAPDYT----------TP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHTC-CCCCCTTC----------CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCC-CCCCCccC----------CH------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 333333321 11111111 11 12378889999999999999999999987643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=460.69 Aligned_cols=454 Identities=21% Similarity=0.235 Sum_probs=274.3
Q ss_pred hhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccc
Q 001171 146 LVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHL 225 (1133)
Q Consensus 146 ~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 225 (1133)
++|++++|.++ .+|..+++++++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 81 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81 (520)
T ss_dssp CEEECTTSCCS-SCCCSCCTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCC
T ss_pred ceEecCCCCcc-cccccccccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCce
Confidence 35788888888 57787888888888888888888778888888888888888888887788888888888888888888
Q ss_pred cCCCCccccCccccceeeccccccCCC-CCCcccCcCcccEEEcccCCccCCcccccccCcccccccc--cEEeccCCcc
Q 001171 226 YGTLPSAISNCSSLVHLSAEDNVLKGL-IPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSL--RIVQLGFNAF 302 (1133)
Q Consensus 226 ~~~~p~~l~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L--~~l~l~~n~l 302 (1133)
+ .+|.. .+++|++|++++|+++++ +|..|+++++|++|+|++|++++. . +..+++| +.|++++|.+
T Consensus 82 ~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~-----~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 82 V-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS---S-----VLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp C-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG---G-----GGGGTTSCEEEEEEEECTT
T ss_pred e-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh---h-----ccccccceeeEEEeecccc
Confidence 7 56665 788888888888888874 577888888888888888888651 1 2445555 6666666665
Q ss_pred cccccCCCCCccccccEEeccCCcccccCCchhhccc-ccceeeccCceeecccCc-ccCCCCCCcEEEccCCc------
Q 001171 303 TGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVT-SLRVMDLSGNFFSGNLPA-AVGSLDKLEVLRVANNS------ 374 (1133)
Q Consensus 303 ~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~n~------ 374 (1133)
.+ .+..|..+..+. ....+++++|.+.+.++. .+.++++|+.|++++|.
T Consensus 151 ~~-----------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 207 (520)
T 2z7x_B 151 YG-----------------------EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207 (520)
T ss_dssp TT-----------------------SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTH
T ss_pred cc-----------------------cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccc
Confidence 11 222333343333 222344444544433332 34445555555555554
Q ss_pred -ccccCchhhccCCCccEEEccCCcccccCCCccC---CCCCCcEEEccCCcCccccCccc-----cCccccceeecccc
Q 001171 375 -LSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLG---GIRGLKIVSLGRNMFSGLIPLSF-----GNLSQLETLNLSEN 445 (1133)
Q Consensus 375 -l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N 445 (1133)
+.+.+| .+..+++|+.|++++|.+++..+..+. ..++|+.|++++|.+++.+|..+ ..+++|+.+++++|
T Consensus 208 ~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n 286 (520)
T 2z7x_B 208 YFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286 (520)
T ss_dssp HHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEEC
T ss_pred eeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEecccccc
Confidence 333333 444555555555555554432211110 12355555555555555555555 66666666676666
Q ss_pred cccccCC-hhhcCC---CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCC
Q 001171 446 DIRGNIP-EEITRL---SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSG 521 (1133)
Q Consensus 446 ~i~~~~~-~~l~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 521 (1133)
.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++..|..++.+++|++|++++|++++
T Consensus 287 ~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 362 (520)
T 2z7x_B 287 VF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362 (520)
T ss_dssp CC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCB
T ss_pred ce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCc
Confidence 66 233 344433 55777777777665321 11455556666666666655555555556666666666665553
Q ss_pred --CCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccc
Q 001171 522 --ELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599 (1133)
Q Consensus 522 --~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 599 (1133)
.+|..+..+++|++|++++|++++.+|. ..+..+++|++|++++|++++..|..+
T Consensus 363 l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~-----------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKK-----------------------GDCSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp HHHHHHHHTTCTTCCEEECCSSCCBCCGGG-----------------------CSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred cccchHHHhhCCCCCEEECCCCcCCccccc-----------------------chhccCccCCEEECcCCCCCcchhhhh
Confidence 2334455555555555555555442221 123444455555555555544444443
Q ss_pred cCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchh-hhccCCCcEEEeecCCCCcc
Q 001171 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKE-ISKCSSLVSLTLDMNSLSGR 666 (1133)
Q Consensus 600 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~ 666 (1133)
. ++|++|++++|+++ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|+.|++++|++++.
T Consensus 420 ~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 420 P--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp C--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred c--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence 2 45666666666666 45655556666666666666666 34443 66667777777777776654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=416.16 Aligned_cols=245 Identities=20% Similarity=0.313 Sum_probs=190.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||+||+|+++ +|+.||||++.+... ..+.+.+|++++++++|||||++++++.+. +..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-DEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEE
Confidence 58999999999999999999875 699999999965332 246789999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+ +|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EeCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 9999 789999998643 389999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+...+.+.+.... ..++..+
T Consensus 165 ---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~---- 235 (275)
T 3hyh_A 165 ---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFL---- 235 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTS----
T ss_pred ---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCC----
Confidence 122345689999999999988876 579999999999999999999998776665555443321 1111100
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ...+++.+|++.||++|||++|++++
T Consensus 236 ------s~------~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 236 ------SP------GAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------CH------HHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------CH------HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01 12378999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=437.77 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=207.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.+.|++.++||+|+||.||+|+++ +|+.||||++.... ...+.+.+|+++|++++|||||+++++|.+.+ ..|+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-EEEEEEe
Confidence 357999999999999999999875 69999999996433 33567899999999999999999999998764 5599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
||+||+|.++++.. .+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 229 y~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 229 FLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp CCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 99999999999752 3889999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+....+..... +.....
T Consensus 301 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~~~~~~ 370 (423)
T 4fie_A 301 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------PRLKNL 370 (423)
T ss_dssp -CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------CCCSCT
T ss_pred -CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------CCCccc
Confidence 2234567899999999999999999999999999999999999999987766665555433210 111100
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..... ...+++.+||+.||++|||+.|++++
T Consensus 371 ~~~s~------~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 371 HKVSP------SLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TSSCH------HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCH------HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111 12378899999999999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=460.01 Aligned_cols=514 Identities=20% Similarity=0.211 Sum_probs=327.9
Q ss_pred ccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCcc--CCcceEEEc
Q 001171 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI--SPSLRYLDL 172 (1133)
Q Consensus 95 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~--~~~l~~L~L 172 (1133)
+.+++|||++|+|++..|..|.++++|+.|+|++|+|++..|.+|.+|++|++|+|++|+|++..+..+ .++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 478999999999997777789999999999999999997666779999999888888888875444433 367888888
Q ss_pred cCCcCCCCCCCCCCCCCcCcEEeccCCcCCC-CCcccccCccccceEecccccccCCCCccccCccccc----eeecccc
Q 001171 173 SSNAFTGEIPGNFSSKSQLQLINLSYNSFSG-EVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV----HLSAEDN 247 (1133)
Q Consensus 173 s~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~l~~N 247 (1133)
++|++++..+..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|++++..|..+..+.+++ .++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 8888887777778888888888888888865 3677778888888888888888777777776665543 5677778
Q ss_pred ccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcc
Q 001171 248 VLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRI 327 (1133)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i 327 (1133)
.++.+.+..+.. ..++.|++++|.....++.. .+..+..++...+..+..... ..+
T Consensus 212 ~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~----~~~~l~~l~~~~l~~~~~~~~-------------------~~l 267 (635)
T 4g8a_A 212 PMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKT----CIQGLAGLEVHRLVLGEFRNE-------------------GNL 267 (635)
T ss_dssp CCCEECTTTTTT-CEEEEEEEESCCSSHHHHHH----HHHTTTTCEEEEEEEECCTTS-------------------CCC
T ss_pred cccccCcccccc-hhhhhhhhhcccccccccch----hhcCCcccccccccccccccc-------------------ccc
Confidence 877665555443 45677777777654322221 124455555555543332221 122
Q ss_pred cccCCchhhcccccceeeccCceee---cccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCC
Q 001171 328 RAVFPSWLTNVTSLRVMDLSGNFFS---GNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVP 404 (1133)
Q Consensus 328 ~~~~~~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 404 (1133)
.......+..+..+..+++..+... ...+..+..+.+++.+++.+|.+... ..+.....|+.|++++|.+....+
T Consensus 268 ~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~ 345 (635)
T 4g8a_A 268 EKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPT 345 (635)
T ss_dssp SCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCC
T ss_pred ccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCc
Confidence 2333444555555555555544332 12233455566677777777766543 234555667777777777764433
Q ss_pred CccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccc--cCChhhcCCCCCcEEecccCcCCCCCCCCCCCC
Q 001171 405 AFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG--NIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL 482 (1133)
Q Consensus 405 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~--~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 482 (1133)
. .+..|+.+++..|.+... ..+.++++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+.. .+..+..+
T Consensus 346 ~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l 419 (635)
T 4g8a_A 346 L---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGL 419 (635)
T ss_dssp C---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTC
T ss_pred c---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccccccc
Confidence 3 345666777777766543 334467777777777777643 345556666777777777776652 34455666
Q ss_pred CCCcEEEcccCCCccccC-CCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcc-cccCCCCCCCCccCcEE
Q 001171 483 KGLLVLNLSASGFSGKIP-GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL-SGDVPEGFSSLVGLQYL 560 (1133)
Q Consensus 483 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L 560 (1133)
++|+.++++.|+.....+ ..+..+.+++.++++.|.+.+..+..+..+++|+.|++++|.+ .+..|..|..+++|++|
T Consensus 420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L 499 (635)
T 4g8a_A 420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 499 (635)
T ss_dssp TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence 666666666665544332 3455666666666666666655555566666666666666653 23455556666666666
Q ss_pred EcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccc-cccCeeecCCCcc
Q 001171 561 NLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHL-SRIKKLDLGQNKL 639 (1133)
Q Consensus 561 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l 639 (1133)
+|++|++++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..+ ++|+.|+|++|.+
T Consensus 500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 666666665555556666666666666666655555555555566666666666655555555554 3555555555555
Q ss_pred c
Q 001171 640 S 640 (1133)
Q Consensus 640 ~ 640 (1133)
.
T Consensus 580 ~ 580 (635)
T 4g8a_A 580 A 580 (635)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=424.74 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=198.1
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC---cEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD---VRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~lV~e 913 (1133)
++|.+.++||+|+||+||+|+++ |+.||||++.........+++|+..+.+++|||||++++++.+... ..++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 46888999999999999999885 8999999997543323334456666778899999999999975432 4589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC--------CceecccCccceeeCCCCceEEeccCcc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL--------DMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
||++|+|.++++.. .++|..+.+++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 82 y~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999863 388999999999999999999987 8999999999999999999999999999
Q ss_pred cccccCCCC-CCCCCCCCCCCCccCccccCCC------CCCCCCchhHHHHHHHHHHhCCCCCccCChh-----------
Q 001171 986 RLAIATPAE-ASSSTTPIGSLGYVSPEAASTG------QPTKEADVYSFGIVLLEILTGRKPVMFTQDE----------- 1047 (1133)
Q Consensus 986 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~----------- 1047 (1133)
+........ .......+||+.|||||++.+. .++.++|||||||++|||+||+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 865443322 1223346799999999998654 3577999999999999999998776432111
Q ss_pred hHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1048 DIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
.....+.+...... .++... ......+......+++.+||+.||++||||.||++.|+++....
T Consensus 236 ~~~~~~~~~~~~~~----~rp~~p---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 236 PSVEEMRKVVCEQK----LRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSC----CCCCCC---GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chHHHHHHHHhccc----CCCCCC---ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 01122222221111 111111 11111122223348999999999999999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=422.48 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=196.6
Q ss_pred cCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
++|++.+.||+|+||+||+|+.. .++.||||++.+... +...+.+|++++++++|||||++++++.+. +..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEE
Confidence 47999999999999999999763 478999999965322 234688999999999999999999999876 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 103 ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999998754 38999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..++...+.+. ...+++.+
T Consensus 178 ~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~--- 249 (304)
T 3ubd_A 178 DH---EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFL--- 249 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTS---
T ss_pred CC---CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcC---
Confidence 22 22334578999999999999999999999999999999999999999877776665555432 11111110
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH-----HHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM-----ADIVF 1109 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1109 (1133)
.. ...+++.+||+.||++|||+ +|+++
T Consensus 250 -------s~------~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 250 -------SP------EAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -------CH------HHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -------CH------HHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 01 12378999999999999984 67765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=409.53 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=187.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC-------
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPD------- 906 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------- 906 (1133)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ..+.+.+|++++++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999875 689999999965432 24578899999999999999999999864322
Q ss_pred ----cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 907 ----VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 907 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
..|+|||||++|+|.++++..... ...++..++.++.||++||+|||++||+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 358999999999999999864432 22456678889999999999999999999999999999999999999999
Q ss_pred CcccccccCCCC---------CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHH
Q 001171 983 GLDRLAIATPAE---------ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053 (1133)
Q Consensus 983 g~a~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 1053 (1133)
|+|+........ .......+||+.|||||++.+..|+.++||||+||++|||++ ||... .+....+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 999865432211 112234579999999999999999999999999999999996 77432 2222222
Q ss_pred HHHhhhccccccccCCcCCCCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1054 KKQLQRGQISELLEPGLLELDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .....++. .+... ....+++.+||+.||++|||+.|++++
T Consensus 238 ~~-~~~~~~p~--------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TD-VRNLKFPP--------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH-HHTTCCCH--------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH-HhcCCCCC--------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 21 12221111 11111 122378999999999999999999974
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=440.70 Aligned_cols=461 Identities=21% Similarity=0.254 Sum_probs=316.7
Q ss_pred EEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhccc
Q 001171 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHN 153 (1133)
Q Consensus 74 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N 153 (1133)
+.+++.++++++ +|..+. ++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..+.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 567777777775 666554 78889999999988777778888999999999999988777888888888888887777
Q ss_pred ccCCCccCccCCcceEEEccCCcCCC-CCCCCCCCCCcCcEEeccCCcCCCCCcccccCcccc--ceEecccccc--cCC
Q 001171 154 LLSGKISADISPSLRYLDLSSNAFTG-EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQEL--EYLWLDSNHL--YGT 228 (1133)
Q Consensus 154 ~l~~~~~~~~~~~l~~L~Ls~N~~~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~ 228 (1133)
+++ .+|..-.++|++|+|++|++++ .+|..|+++++|++|++++|++++. .++.+++| ++|++++|++ ++.
T Consensus 111 ~l~-~lp~~~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~ 186 (562)
T 3a79_B 111 RLQ-NISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGG 186 (562)
T ss_dssp CCC-EECSCCCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSS
T ss_pred cCC-ccCccccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccccc
Confidence 776 3444444667777777777765 3456666667777777777766642 23334444 6666666666 666
Q ss_pred CCccccCcc-ccceeeccccccCCCCCC-cccCcCcccEEEcccCCccC-CcccccccCcccccccccEEeccCCccccc
Q 001171 229 LPSAISNCS-SLVHLSAEDNVLKGLIPG-TIGRISTLQVLSLSRNELTG-LVPVSVLCNLWGNISSLRIVQLGFNAFTGV 305 (1133)
Q Consensus 229 ~p~~l~~l~-~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~ 305 (1133)
.|..+.++. ....+++++|.+.+.++. .+..+++|+.|++++|+..- .++..+ ..+..+++|+.+++.++.
T Consensus 187 ~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~--~~l~~l~~L~~L~L~~~~---- 260 (562)
T 3a79_B 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL--SELTRGPTLLNVTLQHIE---- 260 (562)
T ss_dssp SCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH--HHHHSCSSCEEEEEEEEE----
T ss_pred CcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH--HHHhccCcceEEEecCCc----
Confidence 666655543 122445566665554433 34556666666666654110 000000 001233344444333222
Q ss_pred ccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCccc-----CCCCCCcEEEccCCcccccCc
Q 001171 306 VKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAV-----GSLDKLEVLRVANNSLSGLVP 380 (1133)
Q Consensus 306 ~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~n~l~~~~~ 380 (1133)
+++|.+.++. ..+ ..++|++|++++|.++|.+|..+ .+++.|+.++++.|.+ .+|
T Consensus 261 ----------------l~~~~~~~~~-~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p 320 (562)
T 3a79_B 261 ----------------TTWKCSVKLF-QFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFS 320 (562)
T ss_dssp ----------------ECHHHHHHHH-HHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSC
T ss_pred ----------------CcHHHHHHHH-Hhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecC
Confidence 2223333332 222 23589999999999998888877 7777788888888877 234
Q ss_pred -hhhcc---CCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccccccccc--CChh
Q 001171 381 -DEIAK---CSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN--IPEE 454 (1133)
Q Consensus 381 -~~~~~---l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~--~~~~ 454 (1133)
..+.. ..+|++|++++|.+.... ....+++|++|++++|.+++.+|..|.++++|++|++++|++++. .|..
T Consensus 321 ~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 398 (562)
T 3a79_B 321 KEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398 (562)
T ss_dssp HHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHT
T ss_pred hhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhh
Confidence 33332 267999999999886322 226788899999999999988888899999999999999998863 3456
Q ss_pred hcCCCCCcEEecccCcCCCCCCC-CCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCC
Q 001171 455 ITRLSNLTTLNLSYNKFGGKVPY-DVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSL 533 (1133)
Q Consensus 455 l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 533 (1133)
+.++++|++|+|++|++++.+|. .+..+++|++|++++|++++..|..+. ++|++|++++|+++ .+|..++++++|
T Consensus 399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L 475 (562)
T 3a79_B 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL 475 (562)
T ss_dssp TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC
T ss_pred hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC
Confidence 88889999999999998874444 577888888888888888877776654 67888888888887 677777788888
Q ss_pred cEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCC
Q 001171 534 QVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP 572 (1133)
Q Consensus 534 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 572 (1133)
++|+|++|++++..+..|..+++|++|++++|.+.+..+
T Consensus 476 ~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 476 QELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp SEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 888888888885444447778888888888888776543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=434.61 Aligned_cols=457 Identities=21% Similarity=0.228 Sum_probs=266.8
Q ss_pred chhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccc
Q 001171 144 NLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223 (1133)
Q Consensus 144 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 223 (1133)
..+++++++|.++. +|..+++++++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 32 ~~~~l~ls~~~L~~-ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 32 LESMVDYSNRNLTH-VPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp -CCEEECTTSCCCS-CCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCcEEEcCCCCCcc-CCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 34677888888874 77777788888888888888777777888888888888888888777777888888888888888
Q ss_pred cccCCCCccccCccccceeeccccccCCCC-CCcccCcCcccEEEcccCCccCCcccccccCcccccccc--cEEeccCC
Q 001171 224 HLYGTLPSAISNCSSLVHLSAEDNVLKGLI-PGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSL--RIVQLGFN 300 (1133)
Q Consensus 224 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L--~~l~l~~n 300 (1133)
+++ .+|.. .+++|++|++++|+++++. |..|+++++|++|+|++|++++.. +..+++| +.|++++|
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~--------~~~l~~L~L~~L~L~~n 179 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD--------LLPVAHLHLSCILLDLV 179 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT--------TGGGTTSCEEEEEEEES
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc--------hhhhhhceeeEEEeecc
Confidence 877 56655 6778888888888877643 567777788888888877776421 1233333 55555554
Q ss_pred cccccccCCCCCccccccEEeccCCcccccCCchhhccc-ccceeeccCceeecccCc-ccCCCCCCcEEEccCCc----
Q 001171 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVT-SLRVMDLSGNFFSGNLPA-AVGSLDKLEVLRVANNS---- 374 (1133)
Q Consensus 301 ~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~n~---- 374 (1133)
.+.. ++..|..|..+. ..-.+++++|.+.+.++. .+..+++|+.|++++|+
T Consensus 180 ~l~~-----------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 236 (562)
T 3a79_B 180 SYHI-----------------------KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236 (562)
T ss_dssp SCCC-----------------------CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH
T ss_pred cccc-----------------------cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc
Confidence 4400 444455554433 111345566665554443 34556666666666663
Q ss_pred -ccccCchhhccCCCccEEEccCCcccccC----CCccCCCCCCcEEEccCCcCccccCccc-----cCccccceeeccc
Q 001171 375 -LSGLVPDEIAKCSLLQMFDLEGNRFSGQV----PAFLGGIRGLKIVSLGRNMFSGLIPLSF-----GNLSQLETLNLSE 444 (1133)
Q Consensus 375 -l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~ 444 (1133)
+.+. ...+..+++|+.|+|+++.+++.. +..+ ..++|++|++++|.+++.+|..+ .+++.|+.++++.
T Consensus 237 ~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~ 314 (562)
T 3a79_B 237 RLMTF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314 (562)
T ss_dssp HHHHH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEE
T ss_pred hHHHH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccc
Confidence 1111 234555666666666655554211 1111 12356666666666666566555 5566666666666
Q ss_pred ccccccCC-hhhcC---CCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCC
Q 001171 445 NDIRGNIP-EEITR---LSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 445 N~i~~~~~-~~l~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
|.+ .+| ..+.. ..+|++|++++|.+.... ..+.+++|++|++++|++++..|..+..+++|++|++++|+++
T Consensus 315 ~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 390 (562)
T 3a79_B 315 QVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390 (562)
T ss_dssp CCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCC
T ss_pred cee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcC
Confidence 665 233 22222 245777777777664221 1144555555555555555555555555555555555555555
Q ss_pred CCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCC-cccccccccceeecccCccCCCCCccc
Q 001171 521 GELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP-ATYGFLRSLVFLSLSHNQISGMIPAEL 599 (1133)
Q Consensus 521 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l 599 (1133)
+.. ..|..|.++++|++|++++|++++.+| ..+..+++|++|++++|++++..|..+
T Consensus 391 ~~~----------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 448 (562)
T 3a79_B 391 NFF----------------------KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448 (562)
T ss_dssp BTT----------------------HHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSC
T ss_pred Ccc----------------------cchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhh
Confidence 311 112334444444444444444444222 234445555555555555554444433
Q ss_pred cCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchh-hhccCCCcEEEeecCCCCccC
Q 001171 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKE-ISKCSSLVSLTLDMNSLSGRI 667 (1133)
Q Consensus 600 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~ 667 (1133)
. ++|++|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|+.|++++|.+.+..
T Consensus 449 ~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp C--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred c--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 2 45666666666666 45555556666666666666666 34444 666677777777777766543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=408.85 Aligned_cols=268 Identities=20% Similarity=0.304 Sum_probs=206.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC-----CCc
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP-----PDV 907 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 907 (1133)
++|++.++||+|+||+||+|+++ +|+.||||++...... .+.+.+|+++|++++|||||++++++... ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999875 6999999999754433 35678899999999999999999987642 245
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 699999995 7899999753 3489999999999999999999999999999999999999999999999999986
Q ss_pred cccCCC-CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 988 AIATPA-EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 988 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
...... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..+....+.+..........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 543222 22334567899999999998775 4689999999999999999999999888777776666654432211100
Q ss_pred ccCC-------cCCCC-CCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPG-------LLELD-PESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~-------~~~~~-~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ...++ .....+... ..+.+++.+||..||++|||++|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 001111111 123489999999999999999999975
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=409.98 Aligned_cols=428 Identities=24% Similarity=0.302 Sum_probs=219.7
Q ss_pred hhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceE
Q 001171 90 QLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRY 169 (1133)
Q Consensus 90 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 169 (1133)
.--+.++|+.|++++|++ |.+|.+++++++|+.|++++|+++|.+|.+++++++|+++++.++.. .++++
T Consensus 6 ~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~---------~~l~~ 75 (454)
T 1jl5_A 6 RNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD---------RQAHE 75 (454)
T ss_dssp -----------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH---------HTCSE
T ss_pred cccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc---------cCCCE
Confidence 333568999999999999 89999999999999999999999999999999999999999887653 46889
Q ss_pred EEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeecccccc
Q 001171 170 LDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVL 249 (1133)
Q Consensus 170 L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l 249 (1133)
|++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|... ++|++|++++|++
T Consensus 76 L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~~---~~L~~L~L~~n~l 143 (454)
T 1jl5_A 76 LELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDLP---PLLEYLGVSNNQL 143 (454)
T ss_dssp EECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSCC---TTCCEEECCSSCC
T ss_pred EEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCCC---CCCCEEECcCCCC
Confidence 9999999986 3442 3689999999999997 7754 3789999999998874 34321 5788888888888
Q ss_pred CCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccc
Q 001171 250 KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRA 329 (1133)
Q Consensus 250 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~ 329 (1133)
++ +| .|+++++|++|++++|++++ +|... .+|+.|++++|.+++
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~--------~~L~~L~L~~n~l~~------------------------- 187 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP--------PSLEFIAAGNNQLEE------------------------- 187 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC--------TTCCEEECCSSCCSS-------------------------
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc--------ccccEEECcCCcCCc-------------------------
Confidence 87 45 58888888888888888875 34221 355555555555554
Q ss_pred cCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCC
Q 001171 330 VFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGG 409 (1133)
Q Consensus 330 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 409 (1133)
+ | .|.++++|++|++++|++++ +|... ++|++|++++|+++ .+| .+..+++|++|++++|++++ +|..
T Consensus 188 l-~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~--- 255 (454)
T 1jl5_A 188 L-P-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL--- 255 (454)
T ss_dssp C-C-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---
T ss_pred C-c-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---
Confidence 3 2 24445555555555555543 22211 34555555555554 223 24455555555555555543 2221
Q ss_pred CCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCC-CCCcEE
Q 001171 410 IRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNL-KGLLVL 488 (1133)
Q Consensus 410 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L 488 (1133)
+++|+.|++++|.+++ +|.. .++|++|++++|++++. +. -.++|++|++++|++++. + .+ ++|++|
T Consensus 256 ~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~---~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L 322 (454)
T 1jl5_A 256 PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRSL-C----DLPPSLEEL 322 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSEE-C----CCCTTCCEE
T ss_pred ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cC---cCCcCCEEECcCCcCCcc-c----CCcCcCCEE
Confidence 2455555555555554 2322 24555566666655542 11 014566666666666531 1 22 356666
Q ss_pred EcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccc--cCCCCCCCCccCcEEEccccc
Q 001171 489 NLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG--DVPEGFSSLVGLQYLNLSDNA 566 (1133)
Q Consensus 489 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~ 566 (1133)
++++|++++ +|.. +++|++|++++|+++ .+|. .+++|++|++++|++++ .+|..+.. |+.|.
T Consensus 323 ~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~ 386 (454)
T 1jl5_A 323 NVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNS 386 (454)
T ss_dssp ECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC
T ss_pred ECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcc
Confidence 666666664 3433 356777777777776 3454 35677777777777776 45554432 23455
Q ss_pred ccCCCCcccccccccceeecccCccCC--CCCccccCCCCccEEEecCCcccCCCcccccc
Q 001171 567 FTGDIPATYGFLRSLVFLSLSHNQISG--MIPAELGACSALEVLELRSNHFTGNIPVDISH 625 (1133)
Q Consensus 567 l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 625 (1133)
+.+.+|.. +++|++|++++|++++ .+|. +|+.|.+.+|.+.+.++.+...
T Consensus 387 ~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~~~~~ 438 (454)
T 1jl5_A 387 HLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEFAHET 438 (454)
T ss_dssp -------------------------------------------------------------
T ss_pred cccccccc---cCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCccccCHHH
Confidence 55555543 4678888888888876 4443 3566677788777666555443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=401.99 Aligned_cols=201 Identities=21% Similarity=0.383 Sum_probs=169.6
Q ss_pred HhcCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++.++||+|+||+||+|+++ .++.||+|++.... ....+.+|+++++++ +|||||++++++.+. +..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-DHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-TEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-CEEE
Confidence 4578999999999999999999763 47899999986543 456788999999998 699999999999876 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLA 988 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~ 988 (1133)
+||||+++|+|.++++. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~~--------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS--------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHTT--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHcC--------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999853 7899999999999999999999999999999999999877 79999999999754
Q ss_pred ccCCCC-------------------------CCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCc
Q 001171 989 IATPAE-------------------------ASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVM 1042 (1133)
Q Consensus 989 ~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~ 1042 (1133)
...... .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 332110 0112345799999999999775 58999999999999999999999996
Q ss_pred cCC
Q 001171 1043 FTQ 1045 (1133)
Q Consensus 1043 ~~~ 1045 (1133)
...
T Consensus 249 ~~~ 251 (361)
T 4f9c_A 249 KAS 251 (361)
T ss_dssp CCS
T ss_pred CCC
Confidence 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=406.99 Aligned_cols=420 Identities=25% Similarity=0.326 Sum_probs=254.4
Q ss_pred CCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEE
Q 001171 188 KSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLS 267 (1133)
Q Consensus 188 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 267 (1133)
.+.|++|++++|++ |.+|.+++++++|++|++++|+++|.+|..++++++|+.+++..+.. .+|++|+
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 46788888888888 68888888888888888888888888888888888887777776643 4677788
Q ss_pred cccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeecc
Q 001171 268 LSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLS 347 (1133)
Q Consensus 268 Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls 347 (1133)
+++|.+++. |. + .+ .|++|++++|+++++ |+. +++|++|+++
T Consensus 78 l~~~~l~~l-p~-~-------~~-------------------------~L~~L~l~~n~l~~l-p~~---~~~L~~L~l~ 119 (454)
T 1jl5_A 78 LNNLGLSSL-PE-L-------PP-------------------------HLESLVASCNSLTEL-PEL---PQSLKSLLVD 119 (454)
T ss_dssp CTTSCCSCC-CS-C-------CT-------------------------TCSEEECCSSCCSSC-CCC---CTTCCEEECC
T ss_pred ecCCccccC-CC-C-------cC-------------------------CCCEEEccCCcCCcc-ccc---cCCCcEEECC
Confidence 888877652 21 0 12 345555555555554 332 3678888888
Q ss_pred CceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCcccc
Q 001171 348 GNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427 (1133)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 427 (1133)
+|++++ +|.. .++|++|++++|++++ +| .+.++++|++|++++|++++ +|..+ .+|++|++++|.+++ +
T Consensus 120 ~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l 188 (454)
T 1jl5_A 120 NNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-L 188 (454)
T ss_dssp SSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-C
T ss_pred CCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-C
Confidence 888874 3322 2689999999999987 56 58999999999999999986 55543 589999999999987 4
Q ss_pred CccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcc
Q 001171 428 PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLM 507 (1133)
Q Consensus 428 p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 507 (1133)
| .|+++++|++|++++|++++ +|.. .++|++|++++|.++ .+| .++.+++|++|++++|++++ +|.. ++
T Consensus 189 ~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~ 257 (454)
T 1jl5_A 189 P-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PP 257 (454)
T ss_dssp C-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CT
T ss_pred c-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---cc
Confidence 5 68899999999999999885 4432 258889999999888 566 48888889999999988885 4432 36
Q ss_pred cccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccc-cccceeec
Q 001171 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFL-RSLVFLSL 586 (1133)
Q Consensus 508 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L 586 (1133)
+|++|++++|++++ +|.. .++|++|++++|++++. |.. .++|++|++++|++++. + .+ ++|++|++
T Consensus 258 ~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~L 324 (454)
T 1jl5_A 258 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNV 324 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEEC
T ss_pred ccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEEC
Confidence 78888888888885 4543 37788888888888762 211 15788888888888752 2 22 47888888
Q ss_pred ccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccC--cCchhhhccCCCcEEEeecCCCC
Q 001171 587 SHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSG--EIPKEISKCSSLVSLTLDMNSLS 664 (1133)
Q Consensus 587 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~ 664 (1133)
++|++++ +|.. +++|++|++++|++++ +|. .+++|++|+|++|++++ .+|.++.. ++.|.+.
T Consensus 325 s~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~ 388 (454)
T 1jl5_A 325 SNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHL 388 (454)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--
T ss_pred CCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccc
Confidence 8888875 5543 4778888888888874 665 36778888888888876 56665543 3456666
Q ss_pred ccCCccccCcccccccccccccccc--cCCccccccccCcccccccccccccCCc
Q 001171 665 GRIPESFSKLSNLTTLNLSTNRLSG--AIPADLALISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 665 ~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
+.+|.. +++|+.||+++|++++ .+|.+ ++.|.+++|.+.+.+|.
T Consensus 389 ~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 389 AEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp -------------------------------------------------------
T ss_pred cccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence 666653 4678888888888876 55543 45566777777776664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=408.32 Aligned_cols=384 Identities=22% Similarity=0.248 Sum_probs=298.3
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccC-chhhccCCCccEEEc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLV-PDEIAKCSLLQMFDL 394 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L 394 (1133)
.-+.++.++++++.++ . + .++|++|||++|.|++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|
T Consensus 11 ~~~~~~c~~~~l~~lp-~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 11 IGYNAICINRGLHQVP-E-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp ETTEEECCSSCCSSCC-C-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred EccccCcCCCCcccCC-C-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence 3455677777777763 3 2 267778888888887777777788888888888888776433 566777888888888
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCccccCcc--ccCccccceeecccccccccCChh-hcCCCCCcEEecccCcC
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLS--FGNLSQLETLNLSENDIRGNIPEE-ITRLSNLTTLNLSYNKF 471 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~i~~~~~~~-l~~l~~L~~L~Ls~N~l 471 (1133)
++|++++..|..|+++++|++|+|++|.+++..+.. |.++++|++|++++|++++..|.. +.++++|++|++++|++
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 166 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence 888887777777888888888888888887644443 777888888888888888776665 67788888888888888
Q ss_pred CCCCCCCCCCC--CCCcEEEcccCCCccccCCC--------cCCcccccEEeccccCCCCCCChhccCC---CCCcEeec
Q 001171 472 GGKVPYDVGNL--KGLLVLNLSASGFSGKIPGS--------IGSLMRLTTLDLSNQNLSGELPIELFGL---PSLQVVSL 538 (1133)
Q Consensus 472 ~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~L 538 (1133)
++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|++|++++|++++..|..+... ++|+.|++
T Consensus 167 ~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l 246 (455)
T 3v47_A 167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246 (455)
T ss_dssp SCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEEC
T ss_pred cccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEee
Confidence 87777777766 67778888888777654443 3356788888888888887777766543 77888888
Q ss_pred cCCcccccCCCCCCCCccCcEEEcccccccCCCCccccc--ccccceeecccCccCCCCCccccCCCCccEEEecCCccc
Q 001171 539 EENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF--LRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616 (1133)
Q Consensus 539 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 616 (1133)
++|.+.+... ..+.+.+..+..+.. .++|++|++++|++++..|..++.+++|++|+|++|+++
T Consensus 247 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 312 (455)
T 3v47_A 247 SNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN 312 (455)
T ss_dssp TTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred cccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccc
Confidence 8887654311 122333333333333 367899999999999888888999999999999999999
Q ss_pred CCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcccc
Q 001171 617 GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLA 696 (1133)
Q Consensus 617 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 696 (1133)
+..|..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+.
T Consensus 313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 392 (455)
T 3v47_A 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392 (455)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhc
Confidence 87788888999999999999999888888899999999999999999988899999999999999999999976666778
Q ss_pred ccccCcccccccccccccCCc
Q 001171 697 LISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 697 ~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
.+++|++|++++|+++|.+|.
T Consensus 393 ~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 393 RLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp TCTTCCEEECCSSCBCCCTTT
T ss_pred cCCcccEEEccCCCcccCCCc
Confidence 999999999999999999984
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=406.91 Aligned_cols=388 Identities=17% Similarity=0.197 Sum_probs=217.2
Q ss_pred CCccce--eeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCC-
Q 001171 60 PCDWRG--IVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLP- 136 (1133)
Q Consensus 60 ~c~w~g--v~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p- 136 (1133)
.|.|.+ |.|++..++ .+|. + .++|++|||++|++++..|..++++++|+.|+|++|.+.+.+|
T Consensus 7 ~c~~~~~~~~c~~~~l~-----------~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~ 72 (455)
T 3v47_A 7 ECSVIGYNAICINRGLH-----------QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72 (455)
T ss_dssp CCEEETTEEECCSSCCS-----------SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECT
T ss_pred eeEEEccccCcCCCCcc-----------cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECc
Confidence 466666 888865432 2232 1 1689999999999998888899999999999999999987775
Q ss_pred CccccccchhhhhhcccccCCCccCccC--CcceEEEccCCcCCCCCCCC--CCCCCcCcEEeccCCcCCCCCccc-ccC
Q 001171 137 LSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAFTGEIPGN--FSSKSQLQLINLSYNSFSGEVPAS-VGQ 211 (1133)
Q Consensus 137 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~--~~l~~L~Ls~N~~~~~~p~~--~~~l~~L~~L~ls~N~l~~~~p~~-~~~ 211 (1133)
..+.++++|++|+|++|++++..|..+. ++|++|+|++|++++.+|.. |..+++|++|+|++|++++..|.. ++.
T Consensus 73 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 152 (455)
T 3v47_A 73 NTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152 (455)
T ss_dssp TTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGG
T ss_pred ccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCC
Confidence 4588888877777777666655454443 56666666666666543333 666666666666666666555554 566
Q ss_pred ccccceEecccccccCCCCccccCc--cccceeeccccccCCCCCCcc--------cCcCcccEEEcccCCccCCccccc
Q 001171 212 LQELEYLWLDSNHLYGTLPSAISNC--SSLVHLSAEDNVLKGLIPGTI--------GRISTLQVLSLSRNELTGLVPVSV 281 (1133)
Q Consensus 212 l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~l~~N~l~~~~~~~~--------~~l~~L~~L~Ls~N~l~~~~p~~~ 281 (1133)
+++|++|++++|++++..|..+.++ .+|+.|++++|.+.+..+..+ ..+++|++|+|++|++++..|..+
T Consensus 153 l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 232 (455)
T 3v47_A 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232 (455)
T ss_dssp CTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred CCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhh
Confidence 6666666666666666556555554 456666666666665444332 244566666666666655544433
Q ss_pred ccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCC
Q 001171 282 LCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGS 361 (1133)
Q Consensus 282 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 361 (1133)
... ...++|+.|++++|.+.+.. +..+.+....+..+..+ .
T Consensus 233 ~~~--~~~~~L~~L~l~~~~~~~~~---------------~~~~~~~~~~~~~~~~~----------------------~ 273 (455)
T 3v47_A 233 FDA--IAGTKIQSLILSNSYNMGSS---------------FGHTNFKDPDNFTFKGL----------------------E 273 (455)
T ss_dssp HHH--TTTCCEEEEECTTCTTTSCC---------------TTCCSSCCCCTTTTGGG----------------------T
T ss_pred hcc--ccccceeeEeeccccccccc---------------cchhhhccCcccccccc----------------------c
Confidence 110 11245555555555443321 11112222222222222 1
Q ss_pred CCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceee
Q 001171 362 LDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLN 441 (1133)
Q Consensus 362 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 441 (1133)
.++|++|++++|++++..|..+..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 274 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp TSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred ccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 13444444444444444444444444444444444444444444444444455555555555444444555555555555
Q ss_pred cccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccC
Q 001171 442 LSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIP 500 (1133)
Q Consensus 442 L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 500 (1133)
|++|++++..|..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..|
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 55555555445555555555555555555554444445555555555555555554443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=388.82 Aligned_cols=291 Identities=31% Similarity=0.473 Sum_probs=219.5
Q ss_pred cCchhHHHHHHHHHHhCCCCCCCccCCCCCCCCCCCc--cceeeeCC----CceEEEeeCCcccCc--ccchhhcccccC
Q 001171 26 AVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPCD--WRGIVCYN----NRVRELRLPRLQLAG--RLTDQLADLHEL 97 (1133)
Q Consensus 26 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c~--w~gv~c~~----~~v~~l~l~~~~l~g--~~~~~l~~l~~L 97 (1133)
.|.++|++||++||+++.||. .+++|+.+ .+||. |.||+|+. ++|+.|+|.+++++| .+|+.++++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~--~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC--CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 588999999999999999886 78999754 37898 99999985 689999999999999 888899999999
Q ss_pred cEEEccc-CcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCc
Q 001171 98 RKLSLHS-NHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNA 176 (1133)
Q Consensus 98 ~~L~l~~-n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~ 176 (1133)
++|+|++ |++.+.+|..++++++|+.|+|++|+++|.+|..+.++++| ++|+|++|.
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L----------------------~~L~Ls~N~ 136 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL----------------------VTLDFSYNA 136 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC----------------------CEEECCSSE
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCC----------------------CEEeCCCCc
Confidence 9999995 88998899889999999999999999988888877776655 566667777
Q ss_pred CCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCcc-ccceEecccccccCCCCccccCccccceeeccccccCCCCCC
Q 001171 177 FTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQ-ELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPG 255 (1133)
Q Consensus 177 ~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 255 (1133)
+++.+|..|..+++|++|++++|+++|.+|..++.+. +|++|++++|++++.+|..+..++ |++|++++|++++.+|.
T Consensus 137 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~ 215 (313)
T 1ogq_A 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGG
T ss_pred cCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCH
Confidence 7777788888888888888888888888888888887 888888888888888888887776 88888888888877777
Q ss_pred cccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchh
Q 001171 256 TIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWL 335 (1133)
Q Consensus 256 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~ 335 (1133)
.|..+++|++|+|++|++++.+|. + ..++ +|++|+|++|+|++..|.+|
T Consensus 216 ~~~~l~~L~~L~L~~N~l~~~~~~-~-----~~l~-------------------------~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 216 LFGSDKNTQKIHLAKNSLAFDLGK-V-----GLSK-------------------------NLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp GCCTTSCCSEEECCSSEECCBGGG-C-----CCCT-------------------------TCCEEECCSSCCEECCCGGG
T ss_pred HHhcCCCCCEEECCCCceeeecCc-c-----cccC-------------------------CCCEEECcCCcccCcCChHH
Confidence 778888888888888877654432 1 1222 23333333333333335555
Q ss_pred hcccccceeeccCceeecccCcccCCCCCCcEEEccCCc
Q 001171 336 TNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS 374 (1133)
Q Consensus 336 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~ 374 (1133)
..+++|++|+|++|++++.+|.. +.+++|+.|++++|.
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 55555555555555555555543 444455555555444
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=410.76 Aligned_cols=247 Identities=19% Similarity=0.270 Sum_probs=195.4
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHH---HHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRK---EAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
++|++.++||+|+||+||+|+++ +|+.||||++.+.. .....+.+ ++++++.++|||||+++++|.+. +..
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-CEE
Confidence 57999999999999999999875 69999999996432 12233333 46677788999999999999876 455
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999998754 3899999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.. ......+||+.|||||++.+ ..|+.++|+||+||++|||++|++||......+......... ...+ . +.
T Consensus 343 ~~-----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~-~~~~-~-~p 414 (689)
T 3v5w_A 343 SK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAV-E-LP 414 (689)
T ss_dssp SS-----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH-HCCC-C-CC
T ss_pred CC-----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-CCCC-C-CC
Confidence 32 22345689999999999964 579999999999999999999999997654433332222221 1111 0 00
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVF 1109 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~ 1109 (1133)
..+ . ..+.+++.+|++.||.+|++ ++||++
T Consensus 415 ~~~------S------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DSF------S------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTS------C------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ccC------C------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 000 0 11237899999999999998 688875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=413.12 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=206.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||+||+|.++ +|+.||+|++..... +.+.+.+|+++|++++|||||++++++.+. ...|+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEe
Confidence 368999999999999999999875 699999999965433 356788999999999999999999999876 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC--CceEEeccCcccccccC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD--FEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~ 991 (1133)
||+||+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 235 ~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 235 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred ecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999996432 348899999999999999999999999999999999999854 89999999999865322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+....+.... ..+.....+.+
T Consensus 311 ----~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~- 383 (573)
T 3uto_A 311 ----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--WNMDDSAFSGI- 383 (573)
T ss_dssp ----SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCSGGGTTS-
T ss_pred ----CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC--CCCCcccccCC-
Confidence 22334579999999999999999999999999999999999999998777766655544321 11111110100
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ..+.+++.+||+.||++||++.|++++
T Consensus 384 -----s------~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 384 -----S------EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -----C------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----C------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 112378999999999999999999885
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=373.93 Aligned_cols=263 Identities=25% Similarity=0.437 Sum_probs=203.6
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..++|++.+.||+|+||+||+|++ .|+.||||++...... .+.+.+|++++++++||||+++++++..... .++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN-LSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC-CEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc-eEEE
Confidence 456899999999999999999987 4889999999765433 3468899999999999999999999987655 4999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCCCCceEEeccCcccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
|||+++|+|.+++..... ...+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999986332 123889999999999999999999999 9999999999999999999999999986432
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+........++..++
T Consensus 191 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 265 (309)
T 3p86_A 191 ST---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN-- 265 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC--
T ss_pred cc---ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC--
Confidence 21 1223445799999999999999999999999999999999999999987766655544433222111111111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
. ...+++.+||+.||++||+++|+++.|+.+......
T Consensus 266 --------~------~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 266 --------P------QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp --------H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred --------H------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 1 123788999999999999999999999998775443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=376.18 Aligned_cols=268 Identities=25% Similarity=0.415 Sum_probs=210.4
Q ss_pred hcCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.++||+|+||.||+|.+. .+..||||++..... ..+.+.+|++++++++||||+++++++.... ..+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-LAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-CCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-ccE
Confidence 457999999999999999999874 456799999975432 2457899999999999999999999997764 459
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.++++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 127 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999997532 348999999999999999999999999999999999999999999999999997654
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.............+|+.|+|||++.+..++.++||||+||++|||++ |+.||......+....+....... ...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~ 277 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-----APM 277 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-----CCT
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-----CCC
Confidence 43332223334457788999999988889999999999999999999 999998777666555543321110 000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCCC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSAD 1125 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~ 1125 (1133)
. .. . ...+++.+||+.||++||++.||++.|+.+...+...+...
T Consensus 278 ~------~~----~--~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~~ 322 (325)
T 3kul_A 278 G------CP----H--ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322 (325)
T ss_dssp T------CC----H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC------
T ss_pred C------cC----H--HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccccC
Confidence 0 00 1 12378899999999999999999999999887766654443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=371.33 Aligned_cols=285 Identities=35% Similarity=0.672 Sum_probs=227.0
Q ss_pred cccHHHHHHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeC
Q 001171 826 KITYVETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAG 903 (1133)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 903 (1133)
.+++.+.....++|++.++||+|+||.||+|++++|+.||||++..... ....+.+|++++++++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 4667788889999999999999999999999988899999999975432 23478999999999999999999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC---CceecccCccceeeCCCCceEEe
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL---DMVHGDIKPQNVLFDADFEAHLS 980 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 980 (1133)
.... ++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 99 ~~~~-~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 99 PTER-LLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp SSCC-EEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred CCce-EEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 6544 899999999999999986443 234589999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCcc-----CChhhHHHHHHH
Q 001171 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF-----TQDEDIVKWVKK 1055 (1133)
Q Consensus 981 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~-----~~~~~~~~~~~~ 1055 (1133)
|||+++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.. ........++..
T Consensus 177 Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 177 DFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCSSCEECCSSS--SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred cCccccccCccc--ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999997553221 2223345699999999999888899999999999999999999999952 223334555544
Q ss_pred HhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
...........+...... ..........+++.+||+.||.+|||+.||+++|++.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGN----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTSSCCSTTSSCTTCTTS----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HhhchhhhhhcChhhccc----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 444444444444433211 11222333448999999999999999999999999754443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=361.55 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=213.1
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|.+.+++.||+|++.......+.+.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ceEEEEEeC
Confidence 3578999999999999999999988999999999887777889999999999999999999999998764 459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... ..+++..+..++.|+++|++|||+.||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QY 161 (269)
T ss_dssp TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH--HH
T ss_pred CCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc--cc
Confidence 9999999997533 34889999999999999999999999999999999999999999999999998754321 11
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+...... ..+..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~---- 231 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------YKPRL---- 231 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------CCCTT----
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC------CCCCc----
Confidence 22334557788999999988889999999999999999999 99999877666555544332110 00000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
... ...+++.+||+.||++||++.|++++|+++..
T Consensus 232 -~~~------~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 232 -AST------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -SCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCH------HHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 011 12378889999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=365.81 Aligned_cols=247 Identities=17% Similarity=0.260 Sum_probs=204.2
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.+.||+|+||.||+|.+ .+|+.||||++...... .+.+.+|++++++++||||+++++++... ...++|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEE
Confidence 45799999999999999999987 57999999999654333 35678999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999998753 3889999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCC-CCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPT-KEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
......+||+.|+|||++.+..++ .++||||+||++|||++|+.||...+..+....+..... .++..
T Consensus 168 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~----- 236 (328)
T 3fe3_A 168 ----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFY----- 236 (328)
T ss_dssp ----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTT-----
T ss_pred ----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCC-----
Confidence 233456799999999999887764 789999999999999999999987776665554443210 11100
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ...+++.+|++.||.+|||++|++++
T Consensus 237 -----~s~------~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 -----MST------DCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----SCH------HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCH------HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011 12378899999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.85 Aligned_cols=258 Identities=22% Similarity=0.393 Sum_probs=213.4
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|+++++..||+|++.......+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-YPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CceEEEEEcc
Confidence 467999999999999999999999899999999988777788899999999999999999999999776 4459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++..... .+++..++.++.|++.|++|||+.||+||||||+||+++.++.++|+|||+++.......
T Consensus 86 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-- 159 (268)
T ss_dssp TTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE--
T ss_pred CCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh--
Confidence 99999999987532 388999999999999999999999999999999999999999999999999975433221
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+..... ...+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~---- 229 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------LYRPHL---- 229 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------CCCCTT----
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC------CCCCCc----
Confidence 22234456778999999988889999999999999999999 9999987666554444322110 000100
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
... ...+++.+||+.||++||++.|++++|+.+...
T Consensus 230 -~~~------~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 -ASD------TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -SCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -ChH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011 123788999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=374.00 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=209.8
Q ss_pred hcCCCcccccccccceeEEEEEE--------CCceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY--------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
.++|++.+.||+|+||.||+|++ .++..||||++..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46899999999999999999976 2467899999975432 235788999999999 899999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
.. .++||||+++|+|.+++...+. .....+++..+..++.||++||+|||++||+||||||+||+++.
T Consensus 160 ~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 160 GP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CC-EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 44 5999999999999999987542 12345889999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TCCEEECCCSSCEETTCCCT-TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCEEEccccCCcccCcccc-eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999975433221 122334567889999999998899999999999999999999 9999987776665554
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
+..... ... +.... . ...+++.+||+.||++||++.|+++.|+.+.
T Consensus 318 ~~~~~~----~~~--------~~~~~---~--~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 318 LKEGHR----MDK--------PANCT---N--ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHTTCC----CCC--------CTTSC---H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCC----CCC--------CCCCC---H--HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 433211 000 00000 0 1237888999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=365.86 Aligned_cols=277 Identities=30% Similarity=0.561 Sum_probs=221.1
Q ss_pred HHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
...+++|++.+.||+|+||.||+|.+++|+.||||++..... ..+.+.+|++++++++||||+++++++..... .++|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-MILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC-CEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe-EEEE
Confidence 346779999999999999999999988899999999875433 35678999999999999999999999987644 4999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++..... ....+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 114 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998865432 2235899999999999999999999999999999999999999999999999998754222
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh---hHHHHHHHHhhhccccccccC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE---DIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
. .........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....+.........+...+++
T Consensus 193 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 D-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp S-CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred c-ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 1 112233456899999999998888999999999999999999999999654332 334444444445555555555
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
...... .........+++.+||+.||++||++.|++++|+....
T Consensus 272 ~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 272 NLADKI----RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SCTTCS----CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccc----CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 443211 11222233489999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=360.38 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=203.2
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccC-CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDG-TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||+||+|.+ .+|+.||||++... ....+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEEEEEE
Confidence 45899999999999999999986 46899999998643 334577899999999999999999999998764 4599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp CCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 99999999999763 3789999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...........+..... .....+.
T Consensus 170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~---- 240 (297)
T 3fxz_A 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNPE---- 240 (297)
T ss_dssp -TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS----CCCSCGG----
T ss_pred -ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----CCCCCcc----
Confidence 1233456799999999999999999999999999999999999999976655444333322211 0100000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ...+++.+||+.||++||++.|++++
T Consensus 241 -----~~~~--~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 -----KLSA--IFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -----GSCH--HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----ccCH--HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0001 12278899999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=378.01 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=198.6
Q ss_pred hcCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..+|++.++||+|+||.||+|+++ ++..||||++..... ..+.+.+|++++++++||||+++++++..... .+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP-VM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-CE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc-eE
Confidence 357999999999999999999775 578899999975432 24578999999999999999999999987644 49
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.++++... ..+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 123 lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999997643 348999999999999999999999999999999999999999999999999997654
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.............+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+........ ..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~-----~~ 273 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-----PM 273 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC-----CT
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----Cc
Confidence 33222222233346778999999998899999999999999999998 9999987766655544433211100 00
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
... ....+++.+||+.||++||++.||++.|+.+...+.
T Consensus 274 ------~~~------~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 274 ------DCP------AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp ------TCB------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred ------ccc------HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 000 112378899999999999999999999998765543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=384.28 Aligned_cols=262 Identities=22% Similarity=0.414 Sum_probs=215.6
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..++|++.+.||+|+||.||+|.++++..||||++.......+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeC--CccEEEEee
Confidence 356789999999999999999999889999999998777778899999999999999999999999874 345899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.++++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 264 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~--~ 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--E 338 (454)
T ss_dssp CTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH--H
T ss_pred cCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC--c
Confidence 999999999985432 23788899999999999999999999999999999999999999999999999764321 1
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........+++.|+|||++....++.++|||||||++|||++ |+.||......+....+....+... ...
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-----~~~---- 409 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-----PEN---- 409 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-----CTT----
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----CCC----
Confidence 112233456789999999988889999999999999999999 9999987776666555544321100 000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
.. . ...+++.+||+.||++||++.+|++.|+.+......
T Consensus 410 --~~----~--~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 410 --CP----E--ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp --SC----H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred --CC----H--HHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 00 1 123788999999999999999999999998765443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=372.50 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=204.9
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC---cEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD---VRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~lV~ 912 (1133)
.++|++.++||+|+||.||+|++. ++.||||++.........+.+|+.++++++||||+++++++..... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 468999999999999999999886 8999999997655555667789999999999999999999976432 358999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC----------CceecccCccceeeCCCCceEEecc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL----------DMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
||+++|+|.++++.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999763 388999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCC-----CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHH-------
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG-----QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV------- 1050 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~------- 1050 (1133)
|+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 176 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 176 GLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 99976543222 2223446799999999999763 4566889999999999999999999653322111
Q ss_pred -----HHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1051 -----KWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1051 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
..+......... .+..... ...........+++.+||+.||++|||+.|+++.|++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKK----RPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCC----CCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccC----CCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111111111 1111100 0111112223489999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=367.73 Aligned_cols=250 Identities=18% Similarity=0.286 Sum_probs=204.2
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||+|++..... ..+.+.+|++++++++||||+++++++... ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-TD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-CE
Confidence 467999999999999999999876 589999999965432 246799999999999999999999999876 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC----ceEEeccC
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF----EAHLSEFG 983 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 983 (1133)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 59999999999999999753 3489999999999999999999999999999999999998876 79999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||......+....+.... ..+.
T Consensus 165 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~ 238 (361)
T 2yab_A 165 LAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS--YDFD 238 (361)
T ss_dssp SCEECCTT----CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--CCCC
T ss_pred CceEcCCC----CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCC
Confidence 99754321 22345679999999999998899999999999999999999999998776665554443211 0000
Q ss_pred ccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ..+.... ...+++.+|+..||++||++.|++++
T Consensus 239 ~-------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 E-------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp H-------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c-------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0011111 12378999999999999999999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=362.84 Aligned_cols=247 Identities=21% Similarity=0.327 Sum_probs=203.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||.||+|+.+ +|+.||+|++.+. ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-EEEEE
Confidence 57999999999999999999875 6899999999643 234567889999999999999999999998764 55999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++++||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999998643 3889999999999999999999999999999999999999999999999998743221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...++.
T Consensus 159 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~------- 226 (337)
T 1o6l_A 159 ---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPR------- 226 (337)
T ss_dssp ---TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT-------
T ss_pred ---CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCC-------
Confidence 12334567999999999999999999999999999999999999999876665555444331 111111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
... ....+++.+||+.||++|| +++|++++
T Consensus 227 ----~~s-----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 227 ----TLS-----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----TSC-----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCC-----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 100 1123788999999999999 89999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=366.01 Aligned_cols=252 Identities=16% Similarity=0.271 Sum_probs=206.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.++|++.+.||+|+||.||+|.+. +++.||+|.+.........+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-ELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-EEEEEEEe
Confidence 468999999999999999999875 5899999999766555677899999999999999999999998764 55999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC--CCceEEeccCcccccccCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA--DFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~ 992 (1133)
+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999999997532 34889999999999999999999999999999999999987 789999999999765321
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+...... +.
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~--------- 223 (321)
T 1tki_A 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FD--------- 223 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CC---------
T ss_pred ---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC--CC---------
Confidence 1223456899999999998888899999999999999999999999877666655544432110 00
Q ss_pred CCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1073 LDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1073 ~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
...+..+. ...+++.+|+..||++|||+.|++++=
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ----hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 00111111 123789999999999999999999753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=373.38 Aligned_cols=131 Identities=17% Similarity=0.178 Sum_probs=86.3
Q ss_pred cEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCC
Q 001171 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQN 637 (1133)
Q Consensus 558 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 637 (1133)
+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. ..++|+.|++++| ++|++|+|++|
T Consensus 267 ~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N 328 (457)
T 3bz5_A 267 LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNT 328 (457)
T ss_dssp SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTC
T ss_pred CEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCC
Confidence 344455555444443 34556666666666665555553 2344555544444 56777778888
Q ss_pred cccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccccCCc
Q 001171 638 KLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 638 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
++++. + ++.+++|+.|++++|++++ ++.|..|++++|+++|. ..+..|+.+++++|+++|.+|.
T Consensus 329 ~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 329 ELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp CCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred ccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 77763 3 7778888888888888875 25677788888888875 3566788888999999998887
Q ss_pred cccCC
Q 001171 718 MLSSR 722 (1133)
Q Consensus 718 ~~~~~ 722 (1133)
.+...
T Consensus 393 ~~~~~ 397 (457)
T 3bz5_A 393 DLLDQ 397 (457)
T ss_dssp TCBCT
T ss_pred hHhcc
Confidence 65443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=357.44 Aligned_cols=257 Identities=20% Similarity=0.365 Sum_probs=209.8
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|+++++..||+|++.......+.+.+|++++++++||||+++++++.... ..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-CeEEEEecc
Confidence 4579999999999999999999998999999999887777889999999999999999999999998764 459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 102 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EY 175 (283)
T ss_dssp TTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH--HH
T ss_pred CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc--cc
Confidence 9999999997643 23899999999999999999999999999999999999999999999999998754321 11
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+.+.... ..+..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~---- 245 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------YRPHL---- 245 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------CCCTT----
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC------CCCCc----
Confidence 22334457788999999988889999999999999999998 99999876666555444332110 00000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
... ...+++.+||+.||++||++.|++++|+++..
T Consensus 246 -~~~------~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 246 -ASE------KVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCH------HHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 011 12378899999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=375.34 Aligned_cols=273 Identities=22% Similarity=0.341 Sum_probs=216.5
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.++||+|+||.||+|.+. +++.||||++..... ....+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999853 467899999965322 245688999999999999999999999876444
Q ss_pred EEEEEeccCCCCHHHHHHhhccC--CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC---ceEEecc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQ--DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF---EAHLSEF 982 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Df 982 (1133)
++||||+++|+|.+++...+.. ....+++..++.++.||++||+|||++||+||||||+|||++.++ .+||+||
T Consensus 150 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 150 -FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp -EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred -EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 9999999999999999876532 223588999999999999999999999999999999999999655 4999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+......
T Consensus 229 G~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~-- 305 (367)
T 3l9p_A 229 GMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-- 305 (367)
T ss_dssp HHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--
T ss_pred ccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 99975432211 122334568899999999988899999999999999999998 99999877766655544332110
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCCCCC
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPT 1127 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~~~ 1127 (1133)
.. .. .... ...+++.+||+.||++||++.||+++|+.+...++......|.
T Consensus 306 --~~-~~------~~~~------~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~~~p~ 356 (367)
T 3l9p_A 306 --DP-PK------NCPG------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 356 (367)
T ss_dssp --CC-CT------TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCC
T ss_pred --CC-Cc------cCCH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccCCCcc
Confidence 00 00 0011 1237889999999999999999999999998877665554444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=369.63 Aligned_cols=350 Identities=21% Similarity=0.197 Sum_probs=253.6
Q ss_pred cccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCc
Q 001171 287 GNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLE 366 (1133)
Q Consensus 287 ~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 366 (1133)
+++++|+.|++++|.+++. +.+..+..|++|+|++|+|+++ | +..+++|++|+|++|+|++. + ++++++|+
T Consensus 39 ~~l~~L~~L~Ls~n~l~~~---~~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~ 109 (457)
T 3bz5_A 39 EQLATLTSLDCHNSSITDM---TGIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLT 109 (457)
T ss_dssp HHHTTCCEEECCSSCCCCC---TTGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCC
T ss_pred hHcCCCCEEEccCCCcccC---hhhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCC
Confidence 6788888888888888874 2456677888888888888886 3 77788888888888888764 3 77888888
Q ss_pred EEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccccc
Q 001171 367 VLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446 (1133)
Q Consensus 367 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 446 (1133)
+|++++|++++. | +..+++|++|++++|++++. + ++.+++|++|++++|...+.+ .+..+++|++|++++|+
T Consensus 110 ~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~ 181 (457)
T 3bz5_A 110 YLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK 181 (457)
T ss_dssp EEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence 888888888764 3 77788888888888888764 2 677888888888888554444 46777888888888888
Q ss_pred ccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChh
Q 001171 447 IRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIE 526 (1133)
Q Consensus 447 i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 526 (1133)
+++. | +..+++|+.|++++|++++. .++.+++|++|++++|++++ +| +..+++|+.|++++|++++..+..
T Consensus 182 l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~ 252 (457)
T 3bz5_A 182 ITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVST 252 (457)
T ss_dssp CCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTT
T ss_pred ccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHH
Confidence 8763 3 67778888888888888764 37777888888888888876 44 777788888888888887655444
Q ss_pred ccCCC-------CCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccc
Q 001171 527 LFGLP-------SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAEL 599 (1133)
Q Consensus 527 l~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 599 (1133)
+.+++ +|+.|++++|.+.+.+| ++.+++|+.|++++|.+.+.+|. ..++|+.|++++|
T Consensus 253 l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~---------- 317 (457)
T 3bz5_A 253 LSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN---------- 317 (457)
T ss_dssp CTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC----------
T ss_pred CCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc----------
Confidence 44443 44555566665555544 45677888888888877666553 3345555555444
Q ss_pred cCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccc
Q 001171 600 GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTT 679 (1133)
Q Consensus 600 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 679 (1133)
++|++|++++|++++ ++ ++.+++|+.|++++|+|++ ++.|..|++++|.+.|. .++..|+.
T Consensus 318 ---~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~ 378 (457)
T 3bz5_A 318 ---PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPK 378 (457)
T ss_dssp ---TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCC
T ss_pred ---ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCc
Confidence 567788888888876 33 7777888888888888774 24566667777877765 35567777
Q ss_pred cccccccccccCCcccc
Q 001171 680 LNLSTNRLSGAIPADLA 696 (1133)
Q Consensus 680 L~Ls~N~l~~~~p~~l~ 696 (1133)
+++++|+++|.+|..+.
T Consensus 379 l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 379 ETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp BCCBTTBEEEECCTTCB
T ss_pred cccccCcEEEEcChhHh
Confidence 88888888888877643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=362.04 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=203.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|.+.++||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEE
Confidence 457899999999999999999875 58999999885432 2356789999999999999999999999876 44589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.++++... ..+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999998743 3489999999999999999999999999999999999999999999999999976533221
Q ss_pred CC-----------CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhH--HHHHHHHhhhc
Q 001171 994 EA-----------SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI--VKWVKKQLQRG 1060 (1133)
Q Consensus 994 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~ 1060 (1133)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||........ ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 11 111245799999999999999999999999999999999999999864322110 0000111000
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
..+..+.+ ...+++.+||+.||++||++.|+++.|+.+...
T Consensus 243 ~~~~~~~~----------------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 YCPPNCPP----------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TCCTTCCT----------------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCH----------------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00111111 122688899999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=373.48 Aligned_cols=270 Identities=21% Similarity=0.315 Sum_probs=211.3
Q ss_pred HHHHHHHhcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEE
Q 001171 829 YVETLEATRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRG 899 (1133)
Q Consensus 829 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~ 899 (1133)
...+....++|++.+.||+|+||.||+|++ .+++.||||++...... .+.+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 334445678999999999999999999974 24689999999754332 35689999999999 7999999999
Q ss_pred EEeCCCCcEEEEEeccCCCCHHHHHHhhccCC------------------------------------------------
Q 001171 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQD------------------------------------------------ 931 (1133)
Q Consensus 900 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~------------------------------------------------ 931 (1133)
++.......++||||+++|+|.++++......
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 99887666699999999999999998753210
Q ss_pred -------------CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCC
Q 001171 932 -------------GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSS 998 (1133)
Q Consensus 932 -------------~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 998 (1133)
...+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 252 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRK 252 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhc
Confidence 12288899999999999999999999999999999999999999999999999975432221 2233
Q ss_pred CCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCC
Q 001171 999 TTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077 (1133)
Q Consensus 999 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1133)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+..............+.. ..
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 322 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY----------TT 322 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT----------CC
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCC----------CC
Confidence 44568899999999988899999999999999999998 99999765544333222222111111110 01
Q ss_pred hhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1078 ~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
. ...+++.+||+.||++||++.|++++|+.+.
T Consensus 323 ~------~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 P------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H------HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 1237888999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=352.64 Aligned_cols=268 Identities=20% Similarity=0.307 Sum_probs=206.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|++++++++||||+++++++... +..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-DCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-SEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-CeEEE
Confidence 357999999999999999999875 6899999998543322 35788999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 89 v~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999998753 388999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||........... .... ........ .
T Consensus 164 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~---~~~~-~~~~~~~~-~ 236 (294)
T 4eqm_A 164 TS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK---HIQD-SVPNVTTD-V 236 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH---HHSS-CCCCHHHH-S
T ss_pred cc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---Hhhc-cCCCcchh-c
Confidence 21 1223345799999999999998999999999999999999999999976554433222 1111 11111000 0
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-CHHHHHHHHhcCcCCCCCCCCC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-SMADIVFMLEGCRVGPDMPSSA 1124 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-s~~evl~~Le~~~~~~~~~~~~ 1124 (1133)
. ... .. ...+++.+|++.||++|| +++++.+.|+.+..........
T Consensus 237 ~---~~~---~~--~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~ 283 (294)
T 4eqm_A 237 R---KDI---PQ--SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDV 283 (294)
T ss_dssp C---TTS---CH--HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCC
T ss_pred c---cCC---CH--HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcch
Confidence 0 000 01 122788999999999998 9999999999988766555443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=378.50 Aligned_cols=263 Identities=24% Similarity=0.421 Sum_probs=210.9
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..++|++.+.||+|+||.||+|.++.+..||||++.......+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehh
Confidence 346789999999999999999999888889999998776677889999999999999999999999876 345899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 334 (452)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc--
Confidence 999999999976432 238899999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+..+.. ..
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-----~~------ 403 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----CP------ 403 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----CC------
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----CC------
Confidence 112233457789999999988899999999999999999999 999998776666555443321100 00
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
.. ..+ ...+++.+||+.||++||+++++++.|+.+......+
T Consensus 404 -~~---~~~--~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 404 -PE---CPE--SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp -TT---SCH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred -CC---CCH--HHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 00 001 1227889999999999999999999999987765544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=357.05 Aligned_cols=261 Identities=18% Similarity=0.277 Sum_probs=208.3
Q ss_pred CcccHHHHHHHhcC----------CCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCC
Q 001171 825 NKITYVETLEATRQ----------FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHR 892 (1133)
Q Consensus 825 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp 892 (1133)
..+++.+...+++. |+..+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34566666666553 777889999999999999886 699999999865433 356789999999999999
Q ss_pred CeeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC
Q 001171 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 893 niv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~ 972 (1133)
||+++++++.... ..++||||+++|+|.+++.. ..+++..+..++.||++||+|||+.||+||||||+||+++
T Consensus 103 niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGE-ELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETT-EEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECC-EEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 9999999998764 45999999999999999864 2389999999999999999999999999999999999999
Q ss_pred CCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHH
Q 001171 973 ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~ 1052 (1133)
.++.+||+|||+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp TTCCEEECCCTTCEECCSS---SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCcEEEeeeeeeeecccC---ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999998754322 1223456799999999999998999999999999999999999999976665544443
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+... ........ ..... ...+++.+||+.||++||++.|++++
T Consensus 253 ~~~~----~~~~~~~~---------~~~~~--~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 LRDS----PPPKLKNS---------HKVSP--VLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHS----SCCCCTTG---------GGSCH--HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcC----CCCCcCcc---------ccCCH--HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3221 11110000 00001 12378889999999999999999975
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=369.30 Aligned_cols=344 Identities=26% Similarity=0.367 Sum_probs=175.4
Q ss_pred ccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEc
Q 001171 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 315 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 394 (1133)
..++.|++++|.++.+ | .+..+++|++|||++|.+.+..+ +.++++|++|++++|.+++..+ +.++++|++|+|
T Consensus 46 ~~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCccC-c-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 3455555555555554 2 25666666666666666664433 6666666666666666665433 666666666666
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCC
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGK 474 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 474 (1133)
++|.+++..+ +..+++|++|++++|.+++. + .+..+++|++|+++ |.+.+. ..+.++++|++|++++|.+++.
T Consensus 120 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 120 FNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCcCCCC
Confidence 6666654332 55666666666666665542 2 35556666666664 333322 1255555666666666655532
Q ss_pred CCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCC
Q 001171 475 VPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554 (1133)
Q Consensus 475 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 554 (1133)
..+..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..+..+++|++|++++|.+++..+
T Consensus 193 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~------ 260 (466)
T 1o6v_A 193 --SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP------ 260 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG------
T ss_pred --hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh------
Confidence 124445555555555555544333 44445555555555555421 234444444444444444443322
Q ss_pred ccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeec
Q 001171 555 VGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDL 634 (1133)
Q Consensus 555 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 634 (1133)
+..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|+|
T Consensus 261 --------------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 261 --------------------LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp --------------------GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred --------------------hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 3444444444444444443222 4444444445554444443222 444445555555
Q ss_pred CCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccc
Q 001171 635 GQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEG 713 (1133)
Q Consensus 635 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 713 (1133)
++|++++..| +..+++|+.|++++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 5555543333 44455555555555555432 234455555555555555554443 4455555555555555554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=358.17 Aligned_cols=250 Identities=19% Similarity=0.314 Sum_probs=203.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||+|++..... ..+.+.+|++++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TD 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CE
Confidence 457999999999999999999875 589999999864322 357899999999999999999999999876 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC----ceEEeccC
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF----EAHLSEFG 983 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 983 (1133)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 59999999999999999753 3488999999999999999999999999999999999998887 79999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+....+.... ..+.
T Consensus 164 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~ 237 (326)
T 2y0a_A 164 LAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN--YEFE 237 (326)
T ss_dssp TCEECCTT----SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC--CCCC
T ss_pred CCeECCCC----CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC--CCcC
Confidence 99754321 22334579999999999998899999999999999999999999998766655544443321 0000
Q ss_pred ccccCCcCCCCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .+... ....+++.+||+.||++|||+.|++++
T Consensus 238 ~~-------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DE-------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HH-------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc-------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00001 112378999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=353.01 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=203.9
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.++||+|+||+||+|++.+|+.||+|++...... .+.+.+|++++++++||||+++++++... ...++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEEE
Confidence 4689999999999999999999988999999999654332 35788999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||++ |+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 172 (311)
T 3niz_A 99 EFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP- 172 (311)
T ss_dssp ECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred cCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence 9997 58888887533 34889999999999999999999999999999999999999999999999999754221
Q ss_pred CCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc----
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE---- 1067 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---- 1067 (1133)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+..............
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 122344578999999999876 5689999999999999999999999987777766666655443322111100
Q ss_pred -----CCcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 -----PGLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 -----~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..... .....+... ....+++.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQV--FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCC--CCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhccccc--ccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 001111111 122379999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=381.20 Aligned_cols=259 Identities=21% Similarity=0.394 Sum_probs=213.5
Q ss_pred hcCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..+|++.++||+|+||.||+|.++. +..||||++.......+.|.+|++++++++||||+++++++..... .++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-FYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc-EEEEEEc
Confidence 4578999999999999999998875 8999999998777678899999999999999999999999987644 4999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.++++.... ..+++..+..++.||++||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-- 372 (495)
T ss_dssp CTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC--
T ss_pred cCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc--
Confidence 999999999986432 348899999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.+..+. . ....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~----~~~~---- 443 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-E----RPEG---- 443 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-C----CCTT----
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C----CCCC----
Confidence 122233456789999999988889999999999999999999 99999877666655544332110 0 0000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
.. ....+++.+||+.||++||++.||++.|+.+...
T Consensus 444 --~~------~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 444 --CP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp --CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred --CC------HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 00 1123788999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=365.69 Aligned_cols=248 Identities=20% Similarity=0.313 Sum_probs=199.1
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
..++|++.++||+|+||.||+|+++ +|+.||||++.+. ....+.+.+|.++++.+ +||||+++++++.... ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-RL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC-EE
Confidence 4568999999999999999999875 5899999998643 22346678899999998 7999999999998764 55
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999998753 3889999999999999999999999999999999999999999999999998743
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..++...+... ...++..
T Consensus 175 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~--- 246 (353)
T 3txo_A 175 IC---NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTW--- 246 (353)
T ss_dssp CC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTT---
T ss_pred cc---CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCC---
Confidence 21 122334567999999999998888999999999999999999999999877776665555432 1111100
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH------HHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM------ADIVF 1109 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~------~evl~ 1109 (1133)
.. ....+++.+|++.||++||++ .|+++
T Consensus 247 -------~~------~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 -------LH------EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------SC------HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CC------HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 00 112378999999999999998 77774
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=363.80 Aligned_cols=252 Identities=17% Similarity=0.287 Sum_probs=203.8
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
..++|++.+.||+|+||.||+|.++ +|+.||+|++...... .+.+.+|++++++++||||+++++++.+. ...++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEE
Confidence 4568999999999999999999875 5899999999754433 35688999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC---ceEEeccCcccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF---EAHLSEFGLDRL 987 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~ 987 (1133)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999998753 3488999999999999999999999999999999999998654 599999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.......+...... ...
T Consensus 181 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~ 251 (362)
T 2bdw_A 181 VNDS----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----YPS 251 (362)
T ss_dssp CTTC----CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----CCT
T ss_pred ecCC----cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----CCc
Confidence 4321 2233467999999999999989999999999999999999999999877666555554432110 001
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.+... . ....+++.+||+.||++||++.|++++
T Consensus 252 ~~~~~~-------~--~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 PEWDTV-------T--PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TGGGGS-------C--HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccCC-------C--HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111000 0 112378999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=372.97 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=206.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|.++ +++.||||++...... .+.+.+|++++++++||||+++++++..... .++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-IYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS-CEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC-cEEEE
Confidence 457899999999999999999886 6899999998754321 3467899999999999999999999987644 49999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|+|.++++..+. .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp ECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999986542 38899999999999999999999999999999999999999999999999987532211
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.........+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+..+ ...+
T Consensus 268 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~-------- 337 (377)
T 3cbl_A 268 -YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LPCP-------- 337 (377)
T ss_dssp -EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CCCC--------
T ss_pred -eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC--------
Confidence 1111122345678999999988889999999999999999998 9999987766655444432211 0000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
... .. ...+++.+||+.||++||++.|+++.|+.+.
T Consensus 338 ---~~~---~~--~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 338 ---ELC---PD--AVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---TTC---CH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCC---CH--HHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 000 01 1237889999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=371.97 Aligned_cols=253 Identities=17% Similarity=0.250 Sum_probs=204.2
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
..++|++.+.||+|+||+||+|.+. +|+.||+|++...... .+.+.+|++++++++||||+++++++.+. ...++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-GHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-SEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-CEEEE
Confidence 4568999999999999999999774 6899999998754432 45688999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC---CCCceEEeccCcccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD---ADFEAHLSEFGLDRL 987 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~ 987 (1133)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999998643 388999999999999999999999999999999999998 467899999999965
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+....+...... ...
T Consensus 163 ~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~ 234 (444)
T 3soa_A 163 VEGE---QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-----FPS 234 (444)
T ss_dssp CCTT---CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----CCT
T ss_pred ecCC---CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----CCc
Confidence 4321 12234567999999999999889999999999999999999999999877766666555442111 111
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.+... .. ...+++.+|++.||++||++.|++++
T Consensus 235 ~~~~~~---s~------~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 PEWDTV---TP------EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTTS---CH------HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccC---CH------HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111111 11 12378999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.03 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=212.0
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|.+.++..||+|++.......+.+.+|++++++++||||+++++++..... .++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-ICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-CEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC-eEEEEeCC
Confidence 35789999999999999999999889999999998777777889999999999999999999999987644 59999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++.... ..+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 86 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QY 159 (267)
T ss_dssp TTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH--HH
T ss_pred CCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc--cc
Confidence 9999999998643 34789999999999999999999999999999999999999999999999998754221 11
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+..... ......
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-----~~~~~~----- 229 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----LYKPRL----- 229 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----CCCCTT-----
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----CCCCcc-----
Confidence 22234467789999999988889999999999999999999 8999987666555444333211 000000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
... ...+++.+||+.||++||++.|++++|+++..
T Consensus 230 -~~~------~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 230 -AST------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -SCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011 12378899999999999999999999988654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=367.89 Aligned_cols=323 Identities=28% Similarity=0.455 Sum_probs=241.2
Q ss_pred cccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEE
Q 001171 314 VSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFD 393 (1133)
Q Consensus 314 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 393 (1133)
+.+|++|+|++|+++++.+ +.++++|++|++++|.+.+..+ ++++++|++|++++|.+++..+ +.++++|++|+
T Consensus 67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 140 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEE
Confidence 3445555555555555533 7777778888888887775544 7777888888888887776533 77778888888
Q ss_pred ccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCC
Q 001171 394 LEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGG 473 (1133)
Q Consensus 394 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~ 473 (1133)
+++|.+++. + .++.+++|+.|+++ |.+.+.. .+.++++|++|++++|.+++. ..+..+++|++|++++|.+++
T Consensus 141 l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 213 (466)
T 1o6v_A 141 LSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD 213 (466)
T ss_dssp EEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccc
Confidence 888887753 3 47778888888886 4555433 377888888888888888753 347788888888888888876
Q ss_pred CCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCC
Q 001171 474 KVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSS 553 (1133)
Q Consensus 474 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 553 (1133)
..+ ++.+++|++|++++|++++. ..+..+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +..
T Consensus 214 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~ 285 (466)
T 1o6v_A 214 ITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 285 (466)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTT
T ss_pred ccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccC
Confidence 655 67788888888888888753 357788889999999998886544 7888889999999998886544 778
Q ss_pred CccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeee
Q 001171 554 LVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633 (1133)
Q Consensus 554 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 633 (1133)
+++|+.|++++|++++..+ +..+++|++|++++|++++..| ++.+++|++|++++|++++. ..+..+++|+.|+
T Consensus 286 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 359 (466)
T 1o6v_A 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS 359 (466)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred CCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEe
Confidence 8888888888888876443 6778888888888888886655 66778888888888888753 3577777888888
Q ss_pred cCCCcccCcCchhhhccCCCcEEEeecCCCCc
Q 001171 634 LGQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665 (1133)
Q Consensus 634 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 665 (1133)
+++|++++..| +..+++|+.|++++|++++
T Consensus 360 l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 88888876655 7777788888888887775
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=355.23 Aligned_cols=276 Identities=18% Similarity=0.229 Sum_probs=206.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-CcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~~lV 911 (1133)
.++|++.++||+|+||.||+|.+. +|+.||||++.... ...+.+.+|++++++++||||+++++++.... ...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357999999999999999999876 48999999986433 23567889999999999999999999987653 356899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee----CCCCceEEeccCcccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF----DADFEAHLSEFGLDRL 987 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~ 987 (1133)
|||+++|+|.+++...... ..+++..+..++.||+.||+|||+.||+||||||+||++ +.++.+||+|||+++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999999875432 338999999999999999999999999999999999999 8888899999999975
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccC--------CCCCCCCCchhHHHHHHHHHHhCCCCCccCChh----hHHHHHHH
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAAS--------TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE----DIVKWVKK 1055 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~----~~~~~~~~ 1055 (1133)
.... .......||+.|+|||++. +..++.++||||+||++|||++|+.||...... +....+..
T Consensus 166 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CCTT----CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred cCCC----CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 4322 2223457999999999985 567899999999999999999999999643322 22222222
Q ss_pred HhhhccccccccC---Cc---CCCCCCChhHHHHHHh-HhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1056 QLQRGQISELLEP---GL---LELDPESSEWEEFLLG-VKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1056 ~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~-~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
......+...... .+ ...+....-....... .+++.+||+.||++||+++|++++..+-...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 1111111100000 00 0001111111222222 3899999999999999999999998764443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=367.50 Aligned_cols=268 Identities=22% Similarity=0.279 Sum_probs=213.5
Q ss_pred HhcCCCcccccccccceeEEEEEEC--------CceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAG 903 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 903 (1133)
..++|.+.++||+|+||.||+|++. .+..||||++...... .+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468999999999999999999762 3478999999754332 35788999999999 99999999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~ 972 (1133)
... .++||||+++|+|.+++...... ....+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 147 ~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 147 DGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCc-eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 644 49999999999999999875421 124589999999999999999999999999999999999999
Q ss_pred CCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHH
Q 001171 973 ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~ 1051 (1133)
.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999975432211 122334567889999999999999999999999999999999 999998776665554
Q ss_pred HHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
.+...... .. .. .... ...+++.+||+.||++||++.||+++|+.+.......
T Consensus 305 ~~~~~~~~----~~-~~------~~~~------~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 305 LLKEGHRM----DK-PS------NCTN------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHTTCCC----CC-CS------SCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHcCCCC----CC-Cc------cCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 44332111 00 00 0111 1237888999999999999999999999876544433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=375.83 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=208.4
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|.++ |+.||||+++... ..+.+.+|++++++++||||+++++++.......++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 467899999999999999999886 7899999997654 46789999999999999999999999877665679999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++|+|.++++..+. ..+++..+..++.||++||+|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus 270 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 341 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 341 (450)
T ss_dssp TTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-----
Confidence 99999999987542 3378899999999999999999999999999999999999999999999999874321
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+..+. .. ...
T Consensus 342 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~~----p~~----- 410 (450)
T 1k9a_A 342 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DA----PDG----- 410 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-CC----CTT-----
T ss_pred -cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC----CCc-----
Confidence 1122357889999999999999999999999999999998 99999877666655554332110 00 000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
... ...+++.+||+.||++||++.|+++.|+.+..
T Consensus 411 -~~~------~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 411 -CPP------AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 001 12278899999999999999999999988654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=361.79 Aligned_cols=247 Identities=22% Similarity=0.360 Sum_probs=202.9
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
..++|++.++||+|+||.||+|+++ +|+.||+|++.+. ....+.+.+|.++++.+ +||||+++++++.... ..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-~~ 93 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NL 93 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-EE
Confidence 4578999999999999999999885 5899999999653 22356788899999987 9999999999998764 55
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++++||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999998743 3889999999999999999999999999999999999999999999999998743
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..++...+... ...++..+
T Consensus 169 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~-- 241 (345)
T 1xjd_A 169 MLG---DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWL-- 241 (345)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTS--
T ss_pred ccC---CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCccc--
Confidence 221 12334568999999999999999999999999999999999999999877766655554331 11111000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHH-HHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMA-DIV 1108 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl 1108 (1133)
. ....+++.+|++.||++||++. |++
T Consensus 242 --------s------~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 242 --------E------KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------C------HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------C------HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 1123789999999999999997 665
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=354.45 Aligned_cols=263 Identities=22% Similarity=0.381 Sum_probs=212.2
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|.++++..||+|++.......+.+.+|++++++++||||+++++++... ..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE--PIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC--CcEEEEecC
Confidence 467999999999999999999998888999999987766778999999999999999999999998753 358999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++..... ..+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 90 ~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--Y 164 (279)
T ss_dssp TTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--E
T ss_pred CCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc--c
Confidence 99999999975431 238899999999999999999999999999999999999999999999999997553221 1
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......++..|+|||++.+..++.++||||+||++|||++ |+.||......+....+.+... ......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~----- 234 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-----MVRPDN----- 234 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----CCCCTT-----
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-----CCCccc-----
Confidence 22234457789999999988888999999999999999999 9999987666555444332211 000000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPS 1122 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~ 1122 (1133)
.. ....+++.+|++.||++||++.++++.|+.+......+.
T Consensus 235 -~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 235 -CP------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp -CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred -cc------HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 00 112378899999999999999999999998876555443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=360.52 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=202.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|++.++||+|+||.||+|++. +++ .||+|.+.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--e
Confidence 457999999999999999999864 343 46888875432 33578999999999999999999999998753 5
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 89999999999999998743 34899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+....... . .
T Consensus 168 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~----~ 241 (327)
T 3poz_A 168 GAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-Q----P 241 (327)
T ss_dssp TTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-C----C
T ss_pred cCCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-C----C
Confidence 33222 222334457889999999999999999999999999999999 999998776666555443321110 0 0
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
+ ... ....+++.+||+.||++||++.|++++|+.+...
T Consensus 242 ~------~~~------~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 242 P------ICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp T------TBC------HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred c------cCC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0 000 1123788999999999999999999999887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=362.12 Aligned_cols=253 Identities=18% Similarity=0.297 Sum_probs=192.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.++|++.+.||+|+||+||+|+.+ +++.||||++.......+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-EEEEEEEe
Confidence 457999999999999999999886 6899999999876666678999999999999999999999998764 45999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc--eEEeccCcccccccCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE--AHLSEFGLDRLAIATP 992 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~ 992 (1133)
+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999997643 3889999999999999999999999999999999999987765 99999999864321
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCC-CchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKE-ADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
........||+.|+|||++.+..++.+ +||||+||++|||++|+.||.............+........ ... ..
T Consensus 171 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~-~~ 245 (361)
T 3uc3_A 171 --HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS--IPD-DI 245 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC--CCT-TS
T ss_pred --cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC--CCC-cC
Confidence 122334579999999999987777655 899999999999999999997654432222222222211110 000 00
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ....+++.+||+.||++|||+.|++++
T Consensus 246 ---~~s------~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 246 ---RIS------PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCC------HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCC------HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001 112378999999999999999999976
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=361.26 Aligned_cols=254 Identities=17% Similarity=0.334 Sum_probs=200.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC------CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG------TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||||++... ....+.+.+|++++++++||||+++++++... ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEE
Confidence 457999999999999999999875 6899999998532 22467899999999999999999999999876 455
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc---eEEeccCcc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE---AHLSEFGLD 985 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a 985 (1133)
++||||+++|+|.+++...... ...+++..+..++.||++||+|||++||+||||||+||+++.++. +||+|||++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999999888764322 234889999999999999999999999999999999999987655 999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ......+.+ .....
T Consensus 181 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~----~~~~~- 251 (351)
T 3c0i_A 181 IQLGES---GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIK----GKYKM- 251 (351)
T ss_dssp EECCTT---SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHH----TCCCC-
T ss_pred eEecCC---CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHc----CCCCC-
Confidence 754322 122345679999999999999899999999999999999999999997543 222222222 11100
Q ss_pred ccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....+..+. ...+++.+||+.||++||++.|++++
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 252 ----------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000111111 12378999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=350.75 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=200.5
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.+.||+|+||.||+|+..+|+.||+|++.....+ .+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-eEEEEEE
Confidence 579999999999999999999888999999998654322 367889999999999999999999998764 5599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ ++|.+++.... ..+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-- 153 (288)
T ss_dssp CCS-EEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ecC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence 996 49999887532 34889999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc-------
Q 001171 994 EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL------- 1065 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------- 1065 (1133)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+.+..........
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 1122345789999999998764 5899999999999999999999999877666655555443322111100
Q ss_pred -ccCCcCCCCCC-----ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 -LEPGLLELDPE-----SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 -~~~~~~~~~~~-----~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.++......+. ..... ....+++.+|++.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLD--ESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCC--HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcC--HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01111000000 00000 112378999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=354.25 Aligned_cols=245 Identities=21% Similarity=0.339 Sum_probs=202.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||.||+|+.+ +|+.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEE
Confidence 357999999999999999999875 68999999986432 2356788999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999998643 388999999999999999999999999999999999999999999999999975421
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...++
T Consensus 159 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p------- 223 (318)
T 1fot_A 159 ------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFP------- 223 (318)
T ss_dssp ------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCC-------
T ss_pred ------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCC-------
Confidence 223467999999999999999999999999999999999999999876655554444331 11111
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.... ....+++.+|+..||++|| +++|++++
T Consensus 224 ----~~~~-----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 224 ----PFFN-----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----TTSC-----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCC-----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1100 1123788999999999999 89999853
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=361.80 Aligned_cols=273 Identities=23% Similarity=0.363 Sum_probs=206.1
Q ss_pred hcCCCcccccccccceeEEEEEE-----CCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeC-CCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAG-PPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~ 908 (1133)
.++|++.+.||+|+||.||+|++ .+++.||||++..... ..+.+.+|++++++++||||+++++++.. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 45899999999999999999984 3689999999975432 24568999999999999999999998864 34556
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 899999999999999987532 3899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhH-----------HHHHHHHh
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI-----------VKWVKKQL 1057 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~-----------~~~~~~~~ 1057 (1133)
..............||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ...+.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 4333322334455688899999999888889999999999999999999999864332211 11111111
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCCC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSAD 1125 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~ 1125 (1133)
....... .... ... ...+++.+||+.||++||++.|++++|+.+...........
T Consensus 258 ~~~~~~~--------~~~~---~~~--~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 312 (327)
T 3lxl_A 258 EEGQRLP--------APPA---CPA--EVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312 (327)
T ss_dssp HTTCCCC--------CCTT---CCH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----------
T ss_pred hcccCCC--------CCCc---ccH--HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccc
Confidence 1111000 0000 001 12378899999999999999999999999877665554433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=373.21 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=206.6
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
...++|++.++||+|+||+||+|+++ +++.||+|++.+.. ...+.+.+|.+++..++||||+++++++.+. ...
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-NNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-SEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CEE
Confidence 34679999999999999999999886 48999999986421 1234588999999999999999999999876 455
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 99999999999999998632 34899999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
.... .......+||+.|+|||++. ...++.++||||+||++|||++|+.||...+..+....+........++
T Consensus 226 ~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 226 MEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp CTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred ccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 3221 12234468999999999986 5568999999999999999999999998777766666654432222222
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCC--CCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD--RPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1110 (1133)
.... . ... ...+++.+|+..+|++ ||+++|++++
T Consensus 304 ~~~~----~---~s~------~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 TQVT----D---VSE------NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SSCC----C---SCH------HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc----c---CCH------HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2110 0 011 1237888999888888 9999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=360.45 Aligned_cols=258 Identities=20% Similarity=0.329 Sum_probs=203.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|++.++||+|+||.||+|.+. +++ .||+|.+.... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Ccc
Confidence 357899999999999999999874 344 47888875432 223567889999999999999999999864 345
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 89999999999999997642 24888999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..... ........|+..|+|||++.+..++.++||||+||++|||++ |+.||......+....+.... ....+..+.
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (325)
T 3kex_A 166 PPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQPQICT 243 (325)
T ss_dssp CCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-BCCCCTTBC
T ss_pred Ccccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CCCCCCcCc
Confidence 33222 222344568889999999988899999999999999999999 999998766666555443321 111111111
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
+. ..+++.+||+.||++||++.|++++|+.+...
T Consensus 244 ~~----------------~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 244 ID----------------VYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TT----------------TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HH----------------HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 12788999999999999999999999887654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=361.64 Aligned_cols=266 Identities=22% Similarity=0.372 Sum_probs=210.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
..++|++.+.||+|+||.||+|++. +++.||||++...... .+.+.+|++++++++||||+++++++.....
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999874 3589999999754322 4578999999999999999999999987644
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCC-------------------CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQD-------------------GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQ 967 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~ 967 (1133)
.++||||+++|+|.+++....... ...+++..++.++.||++||+|||++||+||||||+
T Consensus 125 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 125 -MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp -CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 599999999999999998743211 145899999999999999999999999999999999
Q ss_pred ceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCCh
Q 001171 968 NVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQD 1046 (1133)
Q Consensus 968 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~ 1046 (1133)
||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 99999999999999999975532211 122334568889999999988889999999999999999999 9999987666
Q ss_pred hhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1047 EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
.+....+... ..... +... .. ...+++.+||+.||++||++.|++++|+++.....
T Consensus 283 ~~~~~~~~~~----~~~~~--------~~~~---~~--~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 283 EEVIYYVRDG----NILAC--------PENC---PL--ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHHHHHHTT----CCCCC--------CTTC---CH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHHHHHHhCC----CcCCC--------CCCC---CH--HHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 5554443321 11111 0000 01 12378899999999999999999999999876544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.14 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=193.1
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc-----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI-----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||.||+|.+. |+.||||++..... ..+.+.+|++++++++||||+++++++..... .++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN-LCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc-eEE
Confidence 357899999999999999999876 88999999864322 24678999999999999999999999987644 499
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC---ceecccCccceeeCC--------CCceEE
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD---MVHGDIKPQNVLFDA--------DFEAHL 979 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---ivH~Dlkp~NIll~~--------~~~~kl 979 (1133)
||||+++++|.+++.. ..+++..+..++.|+++|++|||++| |+||||||+||+++. ++.+|+
T Consensus 84 v~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999863 34889999999999999999999999 899999999999986 678999
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 1059 (1133)
+|||+++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...........+...
T Consensus 158 ~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--- 229 (271)
T 3dtc_A 158 TDFGLAREWHRT-----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN--- 229 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS---
T ss_pred ccCCcccccccc-----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC---
Confidence 999998654221 122456899999999998888999999999999999999999999766554433332221
Q ss_pred ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
......... ... ...+++.+||+.||++||++.|++++|+++
T Consensus 230 -~~~~~~~~~------~~~------~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -KLALPIPST------CPE------PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCCCCCCTT------CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCCCCCCcc------cCH------HHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111101100 011 123788999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=349.55 Aligned_cols=281 Identities=29% Similarity=0.502 Sum_probs=218.5
Q ss_pred CcccHHHHHHHhcCCCcc------cccccccceeEEEEEECCceEEEEEEcccCC-----cCHHHHHHHHHHHhhccCCC
Q 001171 825 NKITYVETLEATRQFDEE------NVLSRGRYGLIFKASYQDGMVLSIRRLRDGT-----IDENTFRKEAEALGKVKHRN 893 (1133)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpn 893 (1133)
..+++.+...++..|... +.||+|+||.||+|.+ +++.||||++.... ...+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 356788888888888877 8999999999999987 58899999986432 12467899999999999999
Q ss_pred eeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 894 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
|+++++++..... .++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+.||+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDD-LCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSS-CEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCc-eEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC
Confidence 9999999987644 4999999999999999976432 245899999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV 1053 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 1053 (1133)
++.+||+|||+++....... ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||...........+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 99999999999875432211 112334579999999999865 5789999999999999999999999765443333333
Q ss_pred HHHhhh--ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1054 KKQLQR--GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1054 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.+.... ..+.+.+++.... ..... .....+++.+||+.||.+||++.|++++|+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMND---ADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSC---CCHHH--HHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccccc---cchHH--HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 332221 1223333333321 11111 2223379999999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=347.49 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=203.7
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~lV 911 (1133)
.++|++.+.||+|+||.||+|+++ ++.||||++...... .+.+.+|++++++++||||+++++++... ....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357999999999999999999986 889999999754433 35788999999999999999999999765 2455899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCCCCceEEeccCcccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++++|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~- 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF- 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-
T ss_pred ecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee-
Confidence 999999999999986432 34899999999999999999999999 999999999999999999999999876431
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCC---CCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTK---EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
......||+.|+|||++.+..++. ++||||+||++|||++|+.||......+....+........ .
T Consensus 164 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~ 232 (271)
T 3kmu_A 164 -------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT----I 232 (271)
T ss_dssp -------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC----C
T ss_pred -------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC----C
Confidence 223356899999999997765544 79999999999999999999987665554443332211111 1
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.... .. ...+++.+||+.||++||++.|+++.|+.+..
T Consensus 233 ~~~~------~~------~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 PPGI------SP------HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CTTC------CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCC------CH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1110 11 12378889999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=369.64 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=204.9
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++.++||+|+||.||+|+++ +++.||+|++.+. ....+.+.+|+++++.++|||||++++++.+. ...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-SEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEE
Confidence 4568999999999999999999886 5899999998642 12235688999999999999999999999876 4569
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.++++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++...
T Consensus 146 lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 999999999999999753 27899999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCC----CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQ----PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
... .......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||...+..+....+........++..
T Consensus 220 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 220 KEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp TTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred cCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 221 12234568999999999997654 789999999999999999999999877776666655443222111110
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCC--CCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLD--RPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~--RPs~~evl~~ 1110 (1133)
..+ . ....+++.+|+..+|.+ ||+++||+++
T Consensus 298 --~~~------s------~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 --NDI------S------KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --CCC------C------HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --ccc------c------HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 0 11237889999999988 9999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.04 Aligned_cols=264 Identities=20% Similarity=0.328 Sum_probs=200.0
Q ss_pred hcCCCcccccccccceeEEEEEE-----CCceEEEEEEcccCCcC-HHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTID-ENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~ 908 (1133)
.++|++.+.||+|+||.||+|++ .+++.||||++...... .+.+.+|++++++++||||+++++++... ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 35899999999754322 36788999999999999999999998542 2345
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 899999999999999987532 3889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh------------hHHHHHHHH
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE------------DIVKWVKKQ 1056 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~------------~~~~~~~~~ 1056 (1133)
..............++..|+|||++.+..++.++||||+||++|||++|..||...... .....+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 43332222333455778899999999889999999999999999999999998532211 011111111
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
........ .+.. ... ...+++.+||+.||++||++.|+++.|+.+..
T Consensus 245 ~~~~~~~~--------~~~~---~~~--~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 245 LKNNGRLP--------RPDG---CPD--EIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHTTCCCC--------CCTT---CCH--HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCcCC--------CCcC---cCH--HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11111000 0000 001 12378899999999999999999999988754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=359.00 Aligned_cols=244 Identities=20% Similarity=0.277 Sum_probs=202.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|+++ +|+.||+|++.+.. ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEE
Confidence 57999999999999999999875 68999999986432 2356788999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 99999999999998753 388999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... ...++. .+
T Consensus 194 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~- 261 (350)
T 1rdq_E 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPS----HF- 261 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT----TC-
T ss_pred -----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCC----CC-
Confidence 223467999999999999999999999999999999999999999877666555544432 111110 00
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
.. ...+++.+||+.||++||+ ++|++++
T Consensus 262 -----~~------~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 262 -----SS------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CH------HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CH------HHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 01 1237899999999999998 8888854
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=371.79 Aligned_cols=320 Identities=24% Similarity=0.249 Sum_probs=211.8
Q ss_pred cEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccc
Q 001171 366 EVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEN 445 (1133)
Q Consensus 366 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 445 (1133)
+.++.+++.++. +|..+. ++++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 467777777764 344432 46788888888887777777778888888888888887777777777888888888888
Q ss_pred cccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCCh
Q 001171 446 DIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPI 525 (1133)
Q Consensus 446 ~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 525 (1133)
+++...+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77766666677777777788777777777777777777777777777777777777777777777777777777765556
Q ss_pred hccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCc
Q 001171 526 ELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605 (1133)
Q Consensus 526 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 605 (1133)
.+.++++|+.|++++|.+.+..+..|..+++|++|++++|.+.+.++.......+|++|+|++|++++..+..+..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 67777777777777777776666666667777777777666655555544444456666666666554333445555555
Q ss_pred cEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccc
Q 001171 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685 (1133)
Q Consensus 606 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 685 (1133)
+.|+|++|++++..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 55555555555444444555555555555555555555555555555555555555555444444555555555555555
Q ss_pred ccc
Q 001171 686 RLS 688 (1133)
Q Consensus 686 ~l~ 688 (1133)
+++
T Consensus 331 ~l~ 333 (477)
T 2id5_A 331 PLA 333 (477)
T ss_dssp CEE
T ss_pred Ccc
Confidence 554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.41 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=198.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
.++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|++++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 457999999999999999999874 6899999998643322 167899999999999999999999986643
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCCCCc-----eEE
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDADFE-----AHL 979 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-----~kl 979 (1133)
++||||+++|+|.+++.... ..+++..+..++.|++.|++|||++| |+||||||+||+++.++. +||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred --eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999887533 34899999999999999999999999 999999999999988776 999
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccC--CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS--TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
+|||+++... .......||+.|+|||++. ...++.++||||+||++|||++|+.||........... ...
T Consensus 171 ~Dfg~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~- 242 (287)
T 4f0f_A 171 ADFGLSQQSV------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-NMI- 242 (287)
T ss_dssp CCCTTCBCCS------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-HHH-
T ss_pred CCCCcccccc------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-HHH-
Confidence 9999986332 1233457899999999983 44578899999999999999999999976554432211 111
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
............. . ....+++.+||+.||++||++.|+++.|+++
T Consensus 243 ~~~~~~~~~~~~~------~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGLRPTIPEDC------P------PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCCCCCCCTTS------C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCCCCCCCccc------C------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111111110 0 1123788999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=360.76 Aligned_cols=251 Identities=21% Similarity=0.354 Sum_probs=197.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.++||+|+||.||+|+++ +++.||+|++.+... ..+.+.+|..+++++ +||||+++++++... ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-CEEE
Confidence 457999999999999999999876 589999999975432 234678899999887 899999999999876 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++...
T Consensus 130 lV~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999998753 38999999999999999999999999999999999999999999999999997432
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh-----HHHHHHHHhhhccccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED-----IVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~ 1064 (1133)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+.+......+
T Consensus 205 ~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 205 RP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CT---TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cC---CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 21 223445689999999999999999999999999999999999999996432111 11112222211111
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH------HHHHH
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM------ADIVF 1109 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~------~evl~ 1109 (1133)
.++.... ....+++.+||+.||++||++ +|+++
T Consensus 280 -------~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 -------RIPRSLS-----VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -------CCCTTSC-----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -------CCCCcCC-----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 0111100 112378999999999999985 67764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=356.93 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=203.2
Q ss_pred HhcCCCcccccccccceeEEEEEECC-ceEEEEEEcccC----CcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDG----TIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
..++|++.++||+|+||.||+|+++. |+.||||++.+. ....+.+.+|.+++..+ +||+|+++++++... +..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-SEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-CEE
Confidence 45689999999999999999998864 889999998643 22356788999999988 899999999999876 456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||+++..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999998753 3889999999999999999999999999999999999999999999999998743
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..++...+... ...++
T Consensus 172 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p----- 241 (353)
T 2i0e_A 172 IWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYP----- 241 (353)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCC-----
T ss_pred ccC---CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCC-----
Confidence 211 22334568999999999999999999999999999999999999999877766655554431 11111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
.... ....+++.+|++.||.+||+ +.|++++
T Consensus 242 ------~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 ------KSMS-----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------TTSC-----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCC-----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0000 11237899999999999995 5777754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=353.60 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=194.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---------------------------CHHHHHHHHHHHh
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---------------------------DENTFRKEAEALG 887 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~ 887 (1133)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999875 689999999864321 1246889999999
Q ss_pred hccCCCeeeEEEEEeCC-CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCc
Q 001171 888 KVKHRNLTVLRGYYAGP-PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKP 966 (1133)
Q Consensus 888 ~l~hpniv~l~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp 966 (1133)
+++||||+++++++... ....++||||+++++|.+++.. ..+++..+..++.||++||+|||++||+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 99999999999999763 4566899999999998775432 3489999999999999999999999999999999
Q ss_pred cceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCC---CCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 967 QNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ---PTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 967 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||..
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999987543221 1223457999999999997655 37789999999999999999999976
Q ss_pred CChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1044 TQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.........+... ... ... . ..... ...+++.+||+.||++||++.|++++
T Consensus 243 ~~~~~~~~~~~~~----~~~-~~~--~---~~~~~------~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERIMCLHSKIKSQ----ALE-FPD--Q---PDIAE------DLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSHHHHHHHHHHC----CCC-CCS--S---SCCCH------HHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccHHHHHHHHhcc----cCC-CCC--c---cccCH------HHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 6554443333221 110 000 0 00111 12378899999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.97 Aligned_cols=268 Identities=19% Similarity=0.296 Sum_probs=214.3
Q ss_pred cCCCccc-ccccccceeEEEEEEC---CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEEN-VLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|.+.+ .||+|+||.||+|.++ ++..||+|++..... ..+.+.+|++++++++||||+++++++.. +..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CCcEE
Confidence 4566666 8999999999999764 578899999976432 34678899999999999999999999954 34699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... ..+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999997432 3489999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
............+|+.|+|||++.+..++.++||||+||++|||++ |+.||......+....+.... ... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~----~~~-~~~~ 237 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----RME-CPPE 237 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----CCC-CCTT
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC----cCC-CCCC
Confidence 3322223344567889999999988889999999999999999998 999998766655554443321 111 0110
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCCCCC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPT 1127 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~~~ 1127 (1133)
... ...+++.+||+.||++||++.|++++|+.+......+.++.+.
T Consensus 238 ------~~~------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 283 (287)
T 1u59_A 238 ------CPP------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283 (287)
T ss_dssp ------CCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred ------cCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence 011 1227889999999999999999999999988877777666544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=357.12 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=194.9
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC---c
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD---V 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~ 907 (1133)
.++|++.+.||+|+||.||+|++ .+++.||||++...... ...+.+|++++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45799999999999999999987 56899999999754322 2468899999999999999999999865322 2
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++++|.++++..+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 489999999999999998643 388999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc-cc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE-LL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 1066 (1133)
...............||+.|+|||++.+..++.++||||+||++|||++|+.||......+....... ...... ..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~ 242 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR---EDPIPPSAR 242 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---CCCCCHHHH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---CCCCCcccc
Confidence 54333322333456799999999999988999999999999999999999999976665443332222 111100 00
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHH-HHHhcCc
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV-FMLEGCR 1115 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl-~~Le~~~ 1115 (1133)
...+ .. ...+++.+||+.||++||++.+++ +.+....
T Consensus 243 ~~~~------~~------~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 243 HEGL------SA------DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp STTC------CH------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCC------CH------HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000 00 122788999999999999766655 4555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=354.59 Aligned_cols=248 Identities=19% Similarity=0.321 Sum_probs=194.4
Q ss_pred hcCCCcccccccccceeEEEEEE----CCceEEEEEEcccCC-----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY----QDGMVLSIRRLRDGT-----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
.++|++.++||+|+||.||+|+. .+|+.||+|++.+.. .....+.+|++++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG- 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence 45799999999999999999987 468999999997542 22356788999999999999999999998764
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 4599999999999999998643 37889999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.+.. ..++
T Consensus 170 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p--- 241 (327)
T 3a62_A 170 ESIHD---GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLP--- 241 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCC---
T ss_pred ccccC---CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCC---
Confidence 43221 122344579999999999999899999999999999999999999998766655554443321 1111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.... ....+++.+||+.||++|| ++.|++++
T Consensus 242 --------~~~~-----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 242 --------PYLT-----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------TTSC-----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------CCCC-----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1100 1123788999999999999 78888764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=357.20 Aligned_cols=261 Identities=13% Similarity=0.178 Sum_probs=206.9
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +||||+++++++... ...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-KYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-TEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecC-CccEEEEE
Confidence 35799999999999999999986 568999999987543 245688999999999 999999999999875 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc-----eEEeccCccccc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE-----AHLSEFGLDRLA 988 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~ 988 (1133)
|+ +++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 999999998642 34899999999999999999999999999999999999999887 999999999765
Q ss_pred ccCCCCC----CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc--cc
Q 001171 989 IATPAEA----SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG--QI 1062 (1133)
Q Consensus 989 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~ 1062 (1133)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 4332211 12345679999999999999999999999999999999999999998655444333333221110 00
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.+.... . +. ...+++.+||+.||.+||++.+|++.|+.+..
T Consensus 241 ~~~~~~-------~---~p---~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 241 IEVLCE-------N---FP---EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHTT-------T---CH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhc-------c---Ch---HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 000000 0 11 22378889999999999999999999976543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=367.64 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=204.2
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
...++|++.++||+|+||.||+|+++ +|+.||||++.+.. ...+.+.+|.+++.+++||||+++++++.+. +..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-NYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-SEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEE
Confidence 34678999999999999999999885 68999999986422 1234578999999999999999999999876 456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence 99999999999999998753 24889999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccC-------CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAAS-------TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
.... .......+||+.|+|||++. +..++.++||||+||++|||++|+.||...+..+....+........
T Consensus 213 ~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 213 RADG--TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp CTTS--CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred cCCC--ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 3221 11233468999999999986 35689999999999999999999999987776666555543322211
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCC---CCHHHHHHH
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDR---PSMADIVFM 1110 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R---Ps~~evl~~ 1110 (1133)
++.. +..+ . ....+++.+|+. +|++| |+++|++++
T Consensus 291 ~p~~-~~~~------s------~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 LPLV-DEGV------P------EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC-----CC------C------HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCcc-ccCC------C------HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1110 0000 0 112378999999 99998 699999865
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=362.65 Aligned_cols=280 Identities=20% Similarity=0.313 Sum_probs=200.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCC-CcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVK-HRNLTVLRGYYAGPP-DVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~~ 908 (1133)
..++|++.+.||+|+||.||+|.++ +|+.||||++..... ..+.+.+|+.+++++. ||||+++++++...+ ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4678999999999999999999775 689999999865332 2456778999999997 999999999997543 356
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+||||++ |+|.+++... .+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6899998762 3888999999999999999999999999999999999999999999999999754
Q ss_pred ccCCC------------------CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhH
Q 001171 989 IATPA------------------EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049 (1133)
Q Consensus 989 ~~~~~------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~ 1049 (1133)
..... ........+||+.|+|||++.+ ..++.++||||+||++|||++|++||...+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 32110 1112344689999999999976 6789999999999999999999999987776665
Q ss_pred HHHHHHHhhhccccccc--cCC----------------cCCCCCCChhHHHH-----------HHhHhhhhccCCCCCCC
Q 001171 1050 VKWVKKQLQRGQISELL--EPG----------------LLELDPESSEWEEF-----------LLGVKVGLLCTAPDPLD 1100 (1133)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~--~~~----------------~~~~~~~~~~~~~~-----------~~~~~li~~Cl~~dP~~ 1100 (1133)
...+............. ... ..........+... ....+++.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 55554433221110000 000 00000000111110 12348999999999999
Q ss_pred CCCHHHHHHH--HhcCcCCCCCC
Q 001171 1101 RPSMADIVFM--LEGCRVGPDMP 1121 (1133)
Q Consensus 1101 RPs~~evl~~--Le~~~~~~~~~ 1121 (1133)
|||++|++++ +..+....+.|
T Consensus 320 R~t~~e~l~Hp~~~~~~~~~~~~ 342 (388)
T 3oz6_A 320 RISANDALKHPFVSIFHNPNEEP 342 (388)
T ss_dssp SCCHHHHTTSTTTTTTCCGGGCC
T ss_pred CCCHHHHhCCHHHHHhcCCccCC
Confidence 9999999987 55544443333
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=380.36 Aligned_cols=263 Identities=24% Similarity=0.421 Sum_probs=215.1
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
..++|++.++||+|+||.||+|.++.+..||||++.......+.|.+|++++++++||||+++++++.. +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeeh
Confidence 345789999999999999999999888899999998776677889999999999999999999999876 345899999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.++++.... ..+++..+..++.||++||+|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 343 ~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--E 417 (535)
T ss_dssp CTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH--H
T ss_pred hcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC--c
Confidence 999999999976432 23889999999999999999999999999999999999999999999999999754221 1
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+..+. . ....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----~-~~~~---- 488 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----P-CPPE---- 488 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC----C-CCTT----
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----C-CCCC----
Confidence 112233457789999999988899999999999999999999 99999877666655544332110 0 0000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
.. + ...+++.+||+.||++||++.+|++.|+.+....+..
T Consensus 489 --~~----~--~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 489 --CP----E--SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp --CC----H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred --CC----H--HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 00 1 1237889999999999999999999999987665544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=358.91 Aligned_cols=249 Identities=20% Similarity=0.287 Sum_probs=198.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||.||+|+++ +++.||+|++... ....+.+.+|++++++++|||||++++++.... ..++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEEE
Confidence 357999999999999999999875 5899999998642 223567889999999999999999999998764 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999863 2388999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCC---CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAST---GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+.... ....
T Consensus 168 ----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~----- 237 (384)
T 4fr4_A 168 ----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVV----- 237 (384)
T ss_dssp ----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCC-----
T ss_pred ----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hccc-----
Confidence 223345679999999999864 458999999999999999999999997544433332222211 1110
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-HHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-MADIVF 1109 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~ 1109 (1133)
.++... . ....+++.+||+.||.+||+ ++++.+
T Consensus 238 ----~~p~~~---s--~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ----TYPSAW---S--QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCTTS---C--HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----CCCCcC---C--HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000010 0 11237899999999999998 677664
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.49 Aligned_cols=270 Identities=20% Similarity=0.306 Sum_probs=193.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||+|++..... ..+.+.+|++++++++||||+++++++... +..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE-NKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-TEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-CeEEEEE
Confidence 457999999999999999999775 589999999864332 346788999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccC-CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQ-DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||++ |+|.+++...... ....+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9997 6999999765422 2234889999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc---cc--
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS---EL-- 1065 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~-- 1065 (1133)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+.+........ ..
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 162 ---VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp ---CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred ---cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 1223345789999999999764 58999999999999999999999998877766666655543221100 00
Q ss_pred ---ccCCcCCCCCC-ChhHH------HH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 ---LEPGLLELDPE-SSEWE------EF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ---~~~~~~~~~~~-~~~~~------~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+........ ..... .+ ....+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000000 00000 00 123388999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=357.60 Aligned_cols=254 Identities=22% Similarity=0.274 Sum_probs=198.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|.++ +++.||||++..... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEE
Confidence 468999999999999999999876 689999999864332 235688999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999988653 348999999999999999999999999999999999999999999999999997543222
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............... ... ... ...
T Consensus 160 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~~~---~~~-~~~ 232 (323)
T 3tki_A 160 R-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKT---YLN-PWK 232 (323)
T ss_dssp E-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT--TCT---TST-TGG
T ss_pred c-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--ccc---cCC-ccc
Confidence 1 222345679999999999977665 77899999999999999999999765443221111111 100 000 000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
. .. ....+++.+||+.||++||++.|++++-
T Consensus 233 ~-------~~--~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 233 K-------ID--SAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp G-------SC--HHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred c-------CC--HHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0 00 1123789999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=357.60 Aligned_cols=263 Identities=25% Similarity=0.444 Sum_probs=201.8
Q ss_pred hcCCCcccccccccceeEEEEEECC-----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
..+|++.++||+|+||.||+|.++. +..||||++..... ....+.+|++++++++||||+++++++... ...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-CCc
Confidence 3578888999999999999997642 35699999975432 235688999999999999999999999875 455
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999997642 34889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..............+++.|+|||++.+..++.++||||+||++|||++ |+.||......+....+..... .. ..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---~~--~~ 272 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LP--TP 272 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CC--CC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---CC--Cc
Confidence 433222222233456789999999988899999999999999999999 9999977666555444332211 00 00
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
. .... ...+++.+||+.||++||++.|++++|+.+...++.
T Consensus 273 ~------~~~~------~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 273 M------DCPS------AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp T------TCBH------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred c------cCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 0 0011 123788999999999999999999999887655443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=361.81 Aligned_cols=269 Identities=17% Similarity=0.208 Sum_probs=202.1
Q ss_pred HhcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCcC------------HHHHHHHHHHHhhccCCCeee
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTID------------ENTFRKEAEALGKVKHRNLTV 896 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~hpniv~ 896 (1133)
..++|++.+.||+|+||.||+|.++. ++.||||++...... ...+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999998864 478999998654311 122334555667778999999
Q ss_pred EEEEEeCC---CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC-
Q 001171 897 LRGYYAGP---PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD- 972 (1133)
Q Consensus 897 l~~~~~~~---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~- 972 (1133)
+++++... ....++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 99998653 23468999999 999999998642 3489999999999999999999999999999999999999
Q ss_pred -CCCceEEeccCcccccccCCCC----CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC-h
Q 001171 973 -ADFEAHLSEFGLDRLAIATPAE----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ-D 1046 (1133)
Q Consensus 973 -~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-~ 1046 (1133)
.++.+||+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999765432211 112234569999999999999999999999999999999999999997533 3
Q ss_pred hhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1047 EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
........... ...+.+.+++.+... .... ...+++.+||+.||++||++.+|++.|+.+..
T Consensus 268 ~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~------~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 268 PKYVRDSKIRY-RENIASLMDKCFPAA-NAPG------EIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHHHHHHHHHH-HHCHHHHHHHHSCTT-CCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHh-hhhHHHHHHHhcccc-cCHH------HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 33333222222 222333333322110 0111 12268889999999999999999999877654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=360.36 Aligned_cols=245 Identities=20% Similarity=0.287 Sum_probs=196.9
Q ss_pred cCCCcccccccccceeEEEEEE-CCceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|.+.+.||+|+||.||+|.+ .+|+.||+|++... ......+.+|+++++.++||||+++++++.... ..++|
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv 87 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-DIVMV 87 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEEE
Confidence 5799999999999999999987 46899999998542 122457899999999999999999999998764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+ +|+|.+++...+ .+++..+..++.||+.|++|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred EECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 9999 789999987643 388999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||......... ..+....
T Consensus 161 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------~~i~~~~ 224 (336)
T 3h4j_B 161 ---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------KKVNSCV 224 (336)
T ss_dssp ---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------CCCCSSC
T ss_pred ---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHHcCC
Confidence 122345679999999999988776 78999999999999999999999754332211 1111111
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+.... ....+++.+|++.||.+|||++|++++
T Consensus 225 ~~~p~~~s-----~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLS-----PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSC-----HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCC-----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11111111 112378999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=353.21 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=207.4
Q ss_pred HhcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ..+.+.+|+++++++ +||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999975 3478999999975432 246788999999999 9999999999998765
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ-------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~ 972 (1133)
. .++||||+++|+|.+++...... ....+++..++.++.||++||+|||++||+||||||+||+++
T Consensus 101 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 101 P-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp S-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred C-cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 4 49999999999999999875421 123489999999999999999999999999999999999999
Q ss_pred CCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHH
Q 001171 973 ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVK 1051 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~ 1051 (1133)
.++.+||+|||+++....... ........|++.|+|||++.+..++.++||||+||++|||++ |+.||..........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 999999999999875533221 112234457889999999988889999999999999999999 999997655443332
Q ss_pred HHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
........ ...... .. ....+++.+||+.||.+||++.|++++|++...
T Consensus 259 ~~~~~~~~----~~~~~~------~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 KMIKEGFR----MLSPEH------AP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHTCC----CCCCTT------SC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCCC----CCCccc------CC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 22221111 000000 00 112378899999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=349.36 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=198.2
Q ss_pred hcCCCcccccccccceeEEEEEECC-c-------eEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD-G-------MVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
.++|.+.+.||+|+||.||+|.++. + ..||+|++.... ...+.+.+|++++++++||||+++++++.....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4579999999999999999997653 2 579999986433 335778999999999999999999999987654
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc--------eE
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE--------AH 978 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~--------~k 978 (1133)
. ++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +|
T Consensus 87 ~-~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 N-ILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp C-EEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred C-EEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 4 89999999999999998743 23889999999999999999999999999999999999998887 99
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCC-CCccCChhhHHHHHHHH
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRK-PVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~-Pf~~~~~~~~~~~~~~~ 1056 (1133)
++|||+++.... .....|++.|+|||++.+ ..++.++||||+||++|||++|.. ||.............
T Consensus 162 l~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-- 232 (289)
T 4fvq_A 162 LSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-- 232 (289)
T ss_dssp ECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--
T ss_pred eccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--
Confidence 999999854311 122357889999999977 678999999999999999999554 444433332222211
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCC
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSA 1124 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~ 1124 (1133)
.....+....+. ..+++.+||+.||++||++.|++++|+.+..+...++.+
T Consensus 233 -~~~~~~~~~~~~----------------l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 233 -DRHQLPAPKAAE----------------LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp -TTCCCCCCSSCT----------------THHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred -ccCCCCCCCCHH----------------HHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence 111111111111 237888999999999999999999999998866666443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=357.31 Aligned_cols=270 Identities=20% Similarity=0.328 Sum_probs=197.8
Q ss_pred HhcCCCcccccccccceeEEEEEECCc----eEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDG----MVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
..++|++.+.||+|+||.||+|.+... ..||||++.... ...+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 345899999999999999999977542 379999997532 2346789999999999999999999998765322
Q ss_pred -----EEEEEeccCCCCHHHHHHhhccCC-CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 908 -----RLLVYDYMPNGNLATLLQEASHQD-GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 908 -----~~lV~e~~~~gsL~~~l~~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
.++||||+++|+|.+++....... ...+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 389999999999999997654321 22589999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhc
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
||+++....... ........+++.|+|||++.+..++.++||||+||++|||++ |+.||......+....+.......
T Consensus 181 fg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 181 FGLSRKIYSGDY-YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred cccccccccccc-ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 999975432221 122233457789999999988889999999999999999999 999998777666555443321110
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPS 1122 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~ 1122 (1133)
..+. .. ....+++.+||+.||++||++.|+++.|+++...+....
T Consensus 260 -----~~~~------~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 260 -----QPPE------CM------EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp -----CCTT------CC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred -----CCCc------cC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 0000 01 112378999999999999999999999998877665543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=353.81 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=209.6
Q ss_pred HhcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
..++|.+.+.||+|+||.||+|.+ .+++.||||++..... ..+.+.+|++++++++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356899999999999999999976 2458999999975432 23678899999999999999999999987644
Q ss_pred cEEEEEeccCCCCHHHHHHhhccC-------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQ-------------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQ 967 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~ 967 (1133)
.++||||+++|+|.+++...... ....+++..++.++.||++||+|||++||+||||||+
T Consensus 101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 101 -LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp -CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 59999999999999999875431 1234788999999999999999999999999999999
Q ss_pred ceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCCh
Q 001171 968 NVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQD 1046 (1133)
Q Consensus 968 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~ 1046 (1133)
||+++.++.+||+|||+++....... ........+++.|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999875533221 122334567889999999988889999999999999999999 9999987776
Q ss_pred hhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1047 EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
......+..... ... ... ... ...+++.+||+.||++||++.|++++|+++..
T Consensus 259 ~~~~~~~~~~~~----~~~-~~~------~~~------~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ERLFNLLKTGHR----MER-PDN------CSE------EMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGHHHHHHTTCC----CCC-CTT------CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCc----CCC-Ccc------CCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 665544433211 000 000 011 12378899999999999999999999987644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.42 Aligned_cols=268 Identities=21% Similarity=0.257 Sum_probs=203.8
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCC------cCHHHHHHHHHHHhhcc---CCCeeeEEEEEeCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT------IDENTFRKEAEALGKVK---HRNLTVLRGYYAGP 904 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 904 (1133)
..++|++.++||+|+||+||+|++ .+|+.||+|++.... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999987 468999999986322 12356788998888875 99999999998764
Q ss_pred CC----cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEe
Q 001171 905 PD----VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLS 980 (1133)
Q Consensus 905 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 980 (1133)
.. ..++||||++ |+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 32 3589999996 699999986432 338999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 981 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
|||+++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.+.....
T Consensus 163 Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999875422 122344578999999999999999999999999999999999999998877776666665543322
Q ss_pred cccccccCC---cCCCCC-CChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEPG---LLELDP-ESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~~---~~~~~~-~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
......... ...+.. ....... + ....+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111110000 000000 0000000 0 122378999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=351.63 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=198.5
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhh--ccCCCeeeEEEEEeCC---CCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGK--VKHRNLTVLRGYYAGP---PDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~---~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|++ +|+.||||++... ..+.+.+|.+++.. ++||||+++++++... ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46899999999999999999988 5899999998653 34566677777766 7999999999986432 344689
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHh--------cCCceecccCccceeeCCCCceEEecc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH--------SLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
||||+++|+|.++++. ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 84 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999964 24889999999999999999999 999999999999999999999999999
Q ss_pred CcccccccCCCCC-CCCCCCCCCCCccCccccCCC------CCCCCCchhHHHHHHHHHHhC----------CCCCccCC
Q 001171 983 GLDRLAIATPAEA-SSSTTPIGSLGYVSPEAASTG------QPTKEADVYSFGIVLLEILTG----------RKPVMFTQ 1045 (1133)
Q Consensus 983 g~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~el~tg----------~~Pf~~~~ 1045 (1133)
|+++......... .......||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654332221 123345799999999999776 345689999999999999999 88885432
Q ss_pred h-hhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1046 D-EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1046 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
. ......+.+..........+.. ............+++.+||+.||++|||+.||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPN-------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCG-------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCCh-------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 1112222222211111111110 000111112233899999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=350.14 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=196.7
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|+++ ++.||+|++... ...+.+.+|++++++++||||+++++++.+. .++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLNP---VCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT---TEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---cEEEEEcC
Confidence 357899999999999999999886 788999998643 2457789999999999999999999987642 48999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc---CCceecccCccceeeCCCCc-eEEeccCcccccccC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS---LDMVHGDIKPQNVLFDADFE-AHLSEFGLDRLAIAT 991 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~ 991 (1133)
++|+|.+++..... ...+++..+..++.||++||+|||+ +||+||||||+||+++.++. +||+|||+++....
T Consensus 82 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~- 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT- 158 (307)
T ss_dssp TTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-
Confidence 99999999986432 1247788899999999999999999 89999999999999998886 79999999864321
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ........... .
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~-~-- 228 (307)
T 2eva_A 159 -----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWA-VHNGTRPPLIK-N-- 228 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHH-HHTTCCCCCBT-T--
T ss_pred -----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHH-HhcCCCCCccc-c--
Confidence 122346899999999999989999999999999999999999999754332211 1111 11111111110 0
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
... ...+++.+||+.||++||++.|++++|+.+.....
T Consensus 229 ----~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 229 ----LPK------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ----CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ----cCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 011 12378899999999999999999999988765443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=353.56 Aligned_cols=252 Identities=19% Similarity=0.341 Sum_probs=197.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.++||+|+||.||+|+++ +++.||+|++.+.... .+.+.+|.++++++ +||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-CEEE
Confidence 357999999999999999999876 5899999999754322 34578899999988 899999999999876 4569
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||+++...
T Consensus 87 lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999998653 38899999999999999999999999999999999999999999999999987432
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh-----hHHHHHHHHhhhccccc
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE-----DIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~ 1064 (1133)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.+.......
T Consensus 162 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 162 RP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred CC---CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 21 12334568999999999999999999999999999999999999999642111 111112222211111
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH------HHHHHH
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM------ADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~------~evl~~ 1110 (1133)
.++.... ....+++.+||+.||++||++ .|++++
T Consensus 237 -------~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 -------RIPRSLS-----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -------CCCTTSC-----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -------CCCCCCC-----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0111100 112378899999999999995 677643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=359.18 Aligned_cols=267 Identities=20% Similarity=0.292 Sum_probs=205.4
Q ss_pred HhcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCC--cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.+.||+|+||.||+|.+ ..+..||+|++.... ...+.+.+|+++++++ +||||+++++++....
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999986 246789999997432 2346789999999999 8999999999998764
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ------------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQ 967 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~ 967 (1133)
. .++||||+++|+|.+++...... ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 123 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 123 P-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp S-CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred c-cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 4 59999999999999999864321 0123789999999999999999999999999999999
Q ss_pred ceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCCh
Q 001171 968 NVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQD 1046 (1133)
Q Consensus 968 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~ 1046 (1133)
||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999975533221 112234457889999999988889999999999999999998 9999976554
Q ss_pred hhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1047 EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
............... ... .... ...+++.+||+.||.+||++.|++++|+.+.....
T Consensus 281 ~~~~~~~~~~~~~~~----~~~------~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 DANFYKLIQNGFKMD----QPF------YATE------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SHHHHHHHHTTCCCC----CCT------TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHHHHhcCCCCC----CCC------CCCH------HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 433322222110100 000 0011 12368899999999999999999999998766543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=348.07 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=195.4
Q ss_pred hcCCCcccccccccceeEEEEEECC----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|++++++++||||+++++++.+ +..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--CccE
Confidence 4589999999999999999997743 56799999865332 24578899999999999999999999854 3458
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999998643 248899999999999999999999999999999999999999999999999997553
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... ........+++.|+|||++.+..++.++||||+||++|||++ |..||......+....+..... .. ..+
T Consensus 168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----~~-~~~ 240 (281)
T 1mp8_A 168 DST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----LP-MPP 240 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----CC-CCT
T ss_pred ccc--ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----CC-CCC
Confidence 221 112233457789999999988889999999999999999997 9999987766665554433210 00 000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
. ... ...+++.+||+.||++||++.|++++|+.+.
T Consensus 241 ~------~~~------~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 241 N------CPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp T------CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C------CCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 011 1227889999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=349.29 Aligned_cols=259 Identities=22% Similarity=0.393 Sum_probs=212.3
Q ss_pred HhcCCCcccccccccceeEEEEEECC-ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..++|++.+.||+|+||.||+|.++. +..||+|++.......+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CEEEEEE
Confidence 45689999999999999999998864 889999999876666788999999999999999999999998764 4599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 90 ~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred cCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence 9999999999986432 348999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
........+++.|+|||++.+..++.++||||+|+++|+|++ |..||...+.......+....... ....
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~--- 236 (288)
T 3kfa_A 166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-----RPEG--- 236 (288)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-----CCTT---
T ss_pred -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC-----CCCC---
Confidence 122233457788999999988889999999999999999999 999998776666555443321110 0000
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.. ....+++.+|++.||++||++.|+++.|+.+..
T Consensus 237 ---~~------~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 237 ---CP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ---CC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CC------HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 01 112378889999999999999999999987543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.81 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=192.8
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.++||+|+||.||+|+++. .||+|++...... .+.+.+|++++++++||||+++++++... ..++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP--QLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC--ccEEEE
Confidence 4689999999999999999998753 4899998654433 35788999999999999999999976543 358999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999996532 348999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
. ........||+.|+|||++. +..++.++||||+||++|||++|+.||......+....... .........
T Consensus 175 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~-- 248 (289)
T 3og7_A 175 G-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG---RGSLSPDLS-- 248 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH---HTSCCCCTT--
T ss_pred c-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc---ccccCcchh--
Confidence 1 22233457999999999986 56678899999999999999999999976544332222222 111111111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
...... . ....+++.+||+.||++||++.|+++.|+++..
T Consensus 249 --~~~~~~---~--~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 --KVRSNC---P--KRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --SSCTTS---C--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --hccccC---C--HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 110010 0 112378889999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=358.09 Aligned_cols=247 Identities=19% Similarity=0.307 Sum_probs=194.0
Q ss_pred CcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccCC
Q 001171 840 DEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~~ 917 (1133)
...++||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++... ...++||||+++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~ 170 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVDG 170 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCC
Confidence 33678999999999999875 68999999997543 2356789999999999999999999999876 455999999999
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee--CCCCceEEeccCcccccccCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF--DADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
|+|.+++.... ..+++..+..++.||++||+|||+.||+||||||+||++ +.++.+||+|||+++.....
T Consensus 171 ~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---- 242 (373)
T 2x4f_A 171 GELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---- 242 (373)
T ss_dssp CEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT----
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc----
Confidence 99999987643 238899999999999999999999999999999999999 66789999999999765322
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..... .+ ....+...
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~~---~~~~~~~~-- 315 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW--DL---EDEEFQDI-- 315 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CS---CSGGGTTS--
T ss_pred cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CC---ChhhhccC--
Confidence 223345799999999999888899999999999999999999999987766655544433211 00 00001000
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
. ....+++.+|++.||++||++.|+++
T Consensus 316 -~------~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 -S------EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -C------HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -C------HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 11237899999999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=343.93 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=198.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.+.||+|+||+||+|.++ +|+.||+|++...... .+.+.+|++++++++||||+++++++... ...++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEE
Confidence 57999999999999999999875 5899999999754332 36788999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++ ++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp ECCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred ecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 99965 6666665432 34899999999999999999999999999999999999999999999999999754221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCC-ccCChhhHHHHHHHHhhhcccccccc---
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPV-MFTQDEDIVKWVKKQLQRGQISELLE--- 1067 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1067 (1133)
........||+.|+|||++.+.. ++.++||||+||++|||++|+.|| ...+..+....+.+............
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22334457899999999997765 799999999999999999988885 44444444444444332211110000
Q ss_pred -CCcCCC---------CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 -PGLLEL---------DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 -~~~~~~---------~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+..... ........ ....+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLN--ATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCC--HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccC--hHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 00000001 112378999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=360.24 Aligned_cols=252 Identities=17% Similarity=0.249 Sum_probs=202.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||.||+|..+ +|+.||+|++..... +...+.+|++++++++||||+++++++... ...++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-CEEEEEEE
Confidence 457999999999999999999875 689999999865432 345788999999999999999999999876 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC--CCceEEeccCcccccccC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA--DFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~ 991 (1133)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 129 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999987532 34889999999999999999999999999999999999974 577999999999754321
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+..... .+. .....
T Consensus 205 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~---~~~~~ 275 (387)
T 1kob_A 205 ----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFD---EDAFS 275 (387)
T ss_dssp ----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCC---SSTTT
T ss_pred ----cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCC---ccccc
Confidence 122334699999999999998899999999999999999999999987666555544433210 000 00000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .. ....+++.+||+.||++||++.|++++
T Consensus 276 ~---~s------~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 S---VS------PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp T---SC------HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c---CC------HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00 112378999999999999999999975
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=366.56 Aligned_cols=296 Identities=23% Similarity=0.247 Sum_probs=142.0
Q ss_pred cEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccC
Q 001171 293 RIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVAN 372 (1133)
Q Consensus 293 ~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 372 (1133)
+.++++++.++.+.. .....+++|+|++|+|+++.+..|.++++|++|+|++|.|++..|..|+++++|++|+|++
T Consensus 14 ~~v~c~~~~l~~ip~----~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFVAVPE----GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCSSCCS----CCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCcCCC----CCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 345555555544321 1123455555555555555555555555555555555555555555555555555555555
Q ss_pred CcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCC
Q 001171 373 NSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIP 452 (1133)
Q Consensus 373 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~ 452 (1133)
|+++...+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|.+++..+..|.++++|++|++++|++++..+
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 55554444445555555555555555555555555555555555555555555555555555555555555555554444
Q ss_pred hhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCC
Q 001171 453 EEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPS 532 (1133)
Q Consensus 453 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 532 (1133)
..|.++++|+.|+|++|.+.+..+..+..+++|+.|++++|.+.+.+|..+....+|++|++++|+++...+..+..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 44555555555555555555444444444444555554444444444433333334444444444444322233444444
Q ss_pred CcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccC
Q 001171 533 LQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS 592 (1133)
Q Consensus 533 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1133)
|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|+
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 309 (477)
T 2id5_A 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309 (477)
T ss_dssp CCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCS
T ss_pred cCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCc
Confidence 444444444444333333444444444444444443333333333333333333333333
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=357.60 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=191.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHH-HhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEA-LGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.++||+|+||.||+|+++ +++.||||++.+... ....+.+|..+ ++.++||||+++++++... +..|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEE
Confidence 457999999999999999999886 588999999965432 23456667776 5778999999999999876 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+||+++.++++||+|||+++...
T Consensus 116 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999998753 37888999999999999999999999999999999999999999999999997532
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+... ...+ .+.
T Consensus 191 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~----~~~ 261 (373)
T 2r5t_A 191 EH---NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQL----KPN 261 (373)
T ss_dssp CC---CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCC----CSS
T ss_pred cC---CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCC----CCC
Confidence 22 22344568999999999999999999999999999999999999999877666655554432 1011 111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1106 (1133)
+ .. ...+++.+|++.||.+||++.+
T Consensus 262 ~------~~------~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 262 I------TN------SARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp S------CH------HHHHHHHHHTCSSGGGSTTTTT
T ss_pred C------CH------HHHHHHHHHcccCHHhCCCCCC
Confidence 1 01 1237889999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=354.57 Aligned_cols=268 Identities=22% Similarity=0.341 Sum_probs=209.5
Q ss_pred HHHHHhcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEE
Q 001171 831 ETLEATRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYY 901 (1133)
Q Consensus 831 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~ 901 (1133)
......++|++.+.||+|+||.||+|++ .+++.||||++...... .+.+.+|+++++++ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3344567899999999999999999974 34789999999754332 35788999999999 799999999999
Q ss_pred eCCCCcEEEEEeccCCCCHHHHHHhhccCC-----------CCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcccee
Q 001171 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQD-----------GHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVL 970 (1133)
Q Consensus 902 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIl 970 (1133)
.......++||||+++|+|.+++....... ...+++..+..++.||++||+|||+.||+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 876666699999999999999998643210 123788999999999999999999999999999999999
Q ss_pred eCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhh-
Q 001171 971 FDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDED- 1048 (1133)
Q Consensus 971 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~- 1048 (1133)
++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||+||++|||++ |+.||.......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 99999999999999975432211 122234567889999999988889999999999999999998 999997654333
Q ss_pred HHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1049 IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
....+... .....+.. ... ...+++.+||+.||.+||++.|++++|+.+..
T Consensus 260 ~~~~~~~~-~~~~~~~~----------~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 260 FCRRLKEG-TRMRAPDY----------TTP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHHHHT-CCCCCCTT----------CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhccC-ccCCCCCC----------CCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22222221 11100000 011 12378889999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=347.51 Aligned_cols=267 Identities=20% Similarity=0.279 Sum_probs=197.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|++++++++||||+++++++... ...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEE
Confidence 3568999999999999999999875 6899999998654322 36788999999999999999999999875 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999998753 38899999999999999999999999999999999999999999999999986543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
... ........|++.|+|||++.+..++.++||||+|+++|||++|+.||...........+.. .........+.
T Consensus 186 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~ 260 (309)
T 2h34_A 186 DEK--LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ---AIPRPSTVRPG 260 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS---CCCCGGGTSTT
T ss_pred ccc--cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc---CCCCccccCCC
Confidence 221 1223345689999999999998999999999999999999999999976544322222211 11001111111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-CHHHHHHHHhcCcCCCCCCCCC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-SMADIVFMLEGCRVGPDMPSSA 1124 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-s~~evl~~Le~~~~~~~~~~~~ 1124 (1133)
+ .. ...+++.+||+.||++|| +++++++.|+......+.....
T Consensus 261 ~------~~------~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~ 304 (309)
T 2h34_A 261 I------PV------AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT 304 (309)
T ss_dssp C------CT------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--------
T ss_pred C------CH------HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchh
Confidence 1 01 122688899999999999 9999999999987777655443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.77 Aligned_cols=251 Identities=21% Similarity=0.333 Sum_probs=186.5
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..++|++.+.||+|+||.||+|+++ +++.||||++.... ..+.+.+|++++++++||||+++++++... ...++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECS-SEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEEE
Confidence 3567999999999999999999886 57899999997543 456788999999999999999999999876 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCccccccc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 990 (1133)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999753 33889999999999999999999999999999999999975 88999999999875422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh-HHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED-IVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. .... ....+.
T Consensus 204 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~----~~~~-~~~~~~ 274 (349)
T 2w4o_A 204 Q----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----NCEY-YFISPW 274 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH----TTCC-CCCTTT
T ss_pred c----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH----hCCC-ccCCch
Confidence 1 12234579999999999999899999999999999999999999997554433 222221 1111 011111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... . ....+++.+|++.||++||++.|++++
T Consensus 275 ~~~~---~------~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 WDEV---S------LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTS---C------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhC---C------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 0 112378999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=361.31 Aligned_cols=209 Identities=19% Similarity=0.268 Sum_probs=177.1
Q ss_pred hcCCCcccccccc--cceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRG--RYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.++||+| +||.||+|+++ +|+.||||++...... .+.+.+|++++++++|||||++++++.... ..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC-EEE
Confidence 4579999999999 99999999886 6999999999754433 356788999999999999999999998764 459
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999987432 338999999999999999999999999999999999999999999999999886443
Q ss_pred cCCC----CCCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCCccCChhh
Q 001171 990 ATPA----EASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048 (1133)
Q Consensus 990 ~~~~----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~ 1048 (1133)
.... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 2211 1112234578999999999987 578999999999999999999999997655443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.54 Aligned_cols=263 Identities=15% Similarity=0.174 Sum_probs=207.9
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.... ..+.+.+|+++++++ +|+|++++++++... ...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-ceeEEEEE
Confidence 45799999999999999999986 569999999986533 345688999999999 799999999998765 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc-----eEEeccCccccc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE-----AHLSEFGLDRLA 988 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~ 988 (1133)
|+ +++|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999998643 34899999999999999999999999999999999999988776 999999999765
Q ss_pred ccCCCCC----CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh---hHHHHHHHHhhhcc
Q 001171 989 IATPAEA----SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE---DIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 989 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~ 1061 (1133)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4332211 1234567999999999999999999999999999999999999999764332 22233322222211
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
..+.. +.+ . ....+++.+||+.||++||++++|++.|+++....
T Consensus 242 ~~~~~-~~~------~------~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 242 LRELC-AGF------P------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHT-TTS------C------HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHH-hhC------c------HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 11111 111 0 01227889999999999999999999998876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=365.81 Aligned_cols=263 Identities=19% Similarity=0.215 Sum_probs=198.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----C
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----D 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 906 (1133)
.++|++.++||+|+||+||+|.+. +|+.||||++..... ..+.+.+|++++++++||||+++++++.... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999775 689999999975322 2457889999999999999999999996543 3
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||+++ ++.+.+.. .+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 45899999965 56666642 27899999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc---
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS--- 1063 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 1063 (1133)
.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.+........
T Consensus 213 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ecCC----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 5422 122345689999999999999999999999999999999999999998777666555554433221000
Q ss_pred -------ccccCC--cCC-----------CCCCChhHHH-HHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 -------ELLEPG--LLE-----------LDPESSEWEE-FLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 -------~~~~~~--~~~-----------~~~~~~~~~~-~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+... ... +......... -....+++.+|++.||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000 0001111111 1223489999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=348.26 Aligned_cols=251 Identities=18% Similarity=0.287 Sum_probs=203.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|++++++++||||+++++++... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-TD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CE
Confidence 457999999999999999999876 589999999864332 356799999999999999999999999876 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC----ceEEeccC
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF----EAHLSEFG 983 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 983 (1133)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 59999999999999999753 3478999999999999999999999999999999999999887 79999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+....+..... ...
T Consensus 165 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~ 238 (321)
T 2a2a_A 165 LAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY--DFD 238 (321)
T ss_dssp TCEECCTT----CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--CCC
T ss_pred cceecCcc----ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--ccC
Confidence 98754321 223345799999999999988999999999999999999999999977665554444332110 000
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....... . ....+++.+|++.||++||++.|++++
T Consensus 239 ~~~~~~~------~------~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFFSHT------S------ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHTTC------C------HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhhccc------C------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 112378999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=340.02 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=201.9
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC-CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG-TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
..++|++.+.||+|+||.||+|.++ ++..||+|++... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-TDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeEEEEE
Confidence 3457999999999999999999876 4788999998653 33467899999999999999999999999876 4459999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee---CCCCceEEeccCcccccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 989 (1133)
||+++++|.+++.... .+++..+..++.|++.|++|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 86 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999998643 38899999999999999999999999999999999999 788999999999986543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. .......||+.|+|||++.+ .++.++||||+|+++|||++|+.||......+....+.+... ..+. ..
T Consensus 161 ~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~---~~ 230 (277)
T 3f3z_A 161 PG----KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF--TFPE---KD 230 (277)
T ss_dssp TT----SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCH---HH
T ss_pred Cc----cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--CCCc---hh
Confidence 22 22334579999999999865 489999999999999999999999987666655544433211 0000 00
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... . ....+++.+|++.||++||++.|++++
T Consensus 231 ~~~~---~------~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 231 WLNV---S------PQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HTTS---C------HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhcC---C------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 112378899999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=342.75 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=199.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEE
Confidence 468999999999999999999775 57899999985422 2246788999999999999999999999876 44599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++.... .+++..+..++.||+.|++|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999998753 388999999999999999999999999999999999999999999999998854321
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+....+... ...++..
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~----- 229 (279)
T 3fdn_A 162 -----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF----- 229 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTT-----
T ss_pred -----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCc-----
Confidence 2223457899999999999989999999999999999999999999876655554444331 1111110
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
... ...+++.+||+.||++||++.|++++-
T Consensus 230 -----~~~------~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 230 -----VTE------GARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp -----SCH------HHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred -----CCH------HHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 001 122788999999999999999999763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=353.03 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=208.7
Q ss_pred hcCCCcccccccccceeEEEEEEC--------CceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
.++|++.+.||+|+||.||+|++. ++..||||++..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999863 467899999975432 235788999999999 899999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
. ..++||||+++|+|.+++...... ....+++..++.++.||++||+|||+.||+||||||+||+++.
T Consensus 114 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 G-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp S-CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred C-ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 4 459999999999999999875421 1234889999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.+||+|||+++....... ........+++.|+|||++.+..++.++||||+||++|||++ |+.||......+....
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 99999999999975432211 122334467889999999988889999999999999999999 9999987766665554
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
+...... .. .. .... ...+++.+||+.||.+||++.|++++|+++...
T Consensus 272 ~~~~~~~----~~-~~------~~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 272 LKEGHRM----DK-PA------NCTN------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHTCCC----CC-CT------TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCC----CC-Cc------cCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4332110 00 00 0011 123788899999999999999999999987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=361.43 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=196.6
Q ss_pred CCCcccccccccceeEEEEEEC--C--ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ--D--GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~--~--g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.|++.++||+|+||.||+|.+. + +..||||.+..... ..+.+.+|++++++++||||+++++++...+...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5777899999999999999763 2 35689999864332 2467899999999999999999999987655566999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.++++... ..+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997533 34788999999999999999999999999999999999999999999999999755332
Q ss_pred CCC-CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 992 PAE-ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 992 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
... ........+++.|+|||++.+..++.++|||||||++|||++ |.+||......+....+...... ..+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------~~p~ 319 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------LQPE 319 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC------CCCT
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC------CCCC
Confidence 211 112234467889999999998899999999999999999999 77888766555554443322100 0000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
.... ...+++.+||+.||++||++.|+++.|+.+.....
T Consensus 320 -----~~~~------~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 320 -----YCPD------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -----TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -----CCCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0011 12378889999999999999999999998765444
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=367.11 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=201.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|.+.+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|+++++.++||||+++++++.... ..++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-DIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEE
Confidence 57999999999999999999876 69999999986432 23467899999999999999999999998764 55999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999753 34899999999999999999999999999999999999999999999999999754321
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...........+... ..
T Consensus 170 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----~~-------- 233 (476)
T 2y94_A 170 ----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG----IF-------- 233 (476)
T ss_dssp ----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT----CC--------
T ss_pred ----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC----Cc--------
Confidence 22345679999999999988765 68999999999999999999999876655554443321 10
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+.... ....+++.+||+.||++||++.|++++
T Consensus 234 -~~p~~~s-----~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 -YTPQYLN-----PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -CCCTTCC-----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCCccCC-----HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0000000 112378999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=353.58 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=197.3
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.+.|+..+.||+|+||.||+|+. .+|+.||||++...... .+.+.+|++++++++||||+++++++... ...++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEE
Confidence 45689999999999999999986 57999999999654322 24688999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||++ |++.+++.... ..+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 132 v~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~- 205 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA- 205 (348)
T ss_dssp EEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-
T ss_pred EEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-
Confidence 999996 68888886543 348999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
......||+.|+|||++. +..++.++|||||||++|||++|+.||...........+... .......
T Consensus 206 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~----~~~~~~~ 275 (348)
T 1u5q_A 206 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQS 275 (348)
T ss_dssp ------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCCC
T ss_pred ------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCC
Confidence 123457999999999984 567899999999999999999999999765544433332221 1111111
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.. +.+. ..+++.+||+.||++||+++|++++-
T Consensus 276 ~~----------~~~~--l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 276 GH----------WSEY--FRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp TT----------SCHH--HHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CC----------CCHH--HHHHHHHHcccChhhCcCHHHHhhCh
Confidence 10 1111 22788899999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=346.18 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=199.9
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||.||+|+++ |+.||||++.... ..+.+.+|++++++++||||+++++++.......++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468999999999999999999876 8899999997543 45789999999999999999999999876655669999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++++|.+++..... ..+++..+..++.|+++|++|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 99999999986532 23788899999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+.+... .. ....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~----~~-~~~~----- 238 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MD-APDG----- 238 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC----CC-CCTT-----
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----CC-Cccc-----
Confidence 123357889999999988889999999999999999998 9999987666555444322110 00 0000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
... ...+++.+||+.||++||++.|+++.|+.++.
T Consensus 239 -~~~------~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 239 -CPP------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCH------HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 011 12378889999999999999999999988653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.04 Aligned_cols=257 Identities=21% Similarity=0.313 Sum_probs=202.4
Q ss_pred hcCCCccc-ccccccceeEEEEEEC---CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEEN-VLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|++.+ .||+|+||.||+|.+. .++.||||++.....+ .+.+.+|++++++++||||+++++++.. +..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--CCc
Confidence 45788888 9999999999999552 4789999999754322 4678999999999999999999999954 445
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 89999999999999998642 3889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..............+++.|+|||++.+..++.++||||+|+++|||++ |+.||......+....+... ..... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~-~ 242 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG----ERMGC-P 242 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----CCCCC-C
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----CCCCC-C
Confidence 433322222333457789999999988888999999999999999999 99999876665554443322 11110 0
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.. ... ...+++.+||+.||++||++.|+++.|+.+..
T Consensus 243 ~~------~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 243 AG------CPR------EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp TT------CCH------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC------CCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 011 12378899999999999999999999987543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=343.23 Aligned_cols=256 Identities=23% Similarity=0.427 Sum_probs=203.2
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeC----------
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAG---------- 903 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---------- 903 (1133)
...+|++.+.||+|+||.||+|.+. +|+.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 4457999999999999999999886 78999999997543 467899999999999999999998753
Q ss_pred -----CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 904 -----PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 904 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
.....++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 12345899999999999999986432 3488999999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
|+|||+++..... .......|++.|+|||++.+..++.++||||+||++|||++|..|+... ... .....
T Consensus 163 l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~----~~~~~ 232 (284)
T 2a19_B 163 IGDFGLVTSLKND----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKF----FTDLR 232 (284)
T ss_dssp ECCCTTCEESSCC----SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHH----HHHHH
T ss_pred ECcchhheecccc----ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHH----HHHhh
Confidence 9999998754322 1233456899999999999888999999999999999999999987421 111 11122
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPS 1122 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~ 1122 (1133)
...+...++ . ...+++.+||+.||++||++.|++++|+.++..+....
T Consensus 233 ~~~~~~~~~----------~------~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 233 DGIISDIFD----------K------KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp TTCCCTTSC----------H------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred cccccccCC----------H------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 221111111 1 12278889999999999999999999999887766543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.84 Aligned_cols=267 Identities=15% Similarity=0.178 Sum_probs=198.1
Q ss_pred hcCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCc------------CHHHHHHHHHHHhhccCCCeeeEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTI------------DENTFRKEAEALGKVKHRNLTVLRG 899 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~hpniv~l~~ 899 (1133)
.++|++.+.||+|+||.||+|.+. .+..||+|++..... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999875 578899999875432 1234667888899999999999999
Q ss_pred EEeCC---CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-
Q 001171 900 YYAGP---PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF- 975 (1133)
Q Consensus 900 ~~~~~---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~- 975 (1133)
++... ....++||||+ +++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 98752 45669999999 999999997644 489999999999999999999999999999999999998887
Q ss_pred -ceEEeccCcccccccCCCC----CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC-hhhH
Q 001171 976 -EAHLSEFGLDRLAIATPAE----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ-DEDI 1049 (1133)
Q Consensus 976 -~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-~~~~ 1049 (1133)
.+||+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999765332211 111245579999999999998889999999999999999999999995422 2222
Q ss_pred HHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.......... .++......... ..... ...+++.+||+.||++||++.||++.|+....
T Consensus 270 ~~~~~~~~~~-~~~~~~~~~~~~-~~~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLLD-ELPQSVLKWAPS-GSSCC------EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHH-TTTHHHHHHSCT-TSCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhcc-cccHHHHhhccc-cccHH------HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 2222222211 111111110000 00000 12378889999999999999999999998765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=379.15 Aligned_cols=256 Identities=19% Similarity=0.314 Sum_probs=200.6
Q ss_pred CCCccc-ccccccceeEEEEEEC---CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEEN-VLSRGRYGLIFKASYQ---DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++.+.+ .||+|+||.||+|.++ ++..||||+++... ...+.+.+|++++++++|||||++++++... ..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS--SEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC--CeEEE
Confidence 344444 7999999999999764 56789999997543 2457899999999999999999999999763 46999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999997532 34899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
...........+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+..+ ...+ +.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p----~~- 563 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECP----PE- 563 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-CCCC----TT-
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCCC----Cc-
Confidence 222222233456789999999988899999999999999999998 9999987776665555443211 0000 00
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
... ...+++.+||+.||++||++.+|++.|+.+..
T Consensus 564 -----~~~------~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 564 -----CPP------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp -----CCH------HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 001 12278899999999999999999999987543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=340.69 Aligned_cols=251 Identities=18% Similarity=0.294 Sum_probs=203.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||+|++...... .+.+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-CEEEEE
Confidence 468999999999999999999875 5899999998654433 35678999999999999999999999876 445999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc---eEEeccCccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE---AHLSEFGLDRLA 988 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~ 988 (1133)
|||+++++|.+++.... .+++..+..++.|++.|++|||+.||+||||||+||+++.++. +||+|||++...
T Consensus 84 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999999987643 3889999999999999999999999999999999999987665 999999998654
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...........+...... ...+
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~ 229 (284)
T 3kk8_A 159 NDS----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-----YPSP 229 (284)
T ss_dssp CSS----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----CCTT
T ss_pred ccC----ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc-----CCch
Confidence 321 2223457999999999999999999999999999999999999999877666555554432111 1111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ... ...+++.+|++.||++||++.|++++
T Consensus 230 ~~~~---~~~------~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 EWDT---VTP------EAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTT---SCH------HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhcc---cCH------HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1110 011 12378899999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=353.03 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=195.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPD------ 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 906 (1133)
.++|++.+.||+|+||.||+|+++ +|+.||||++..... ..+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999886 799999999974332 35678999999999999999999998854322
Q ss_pred --------------------------------------------------cEEEEEeccCCCCHHHHHHhhccCCCCCCC
Q 001171 907 --------------------------------------------------VRLLVYDYMPNGNLATLLQEASHQDGHVLN 936 (1133)
Q Consensus 907 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~ 936 (1133)
..++||||+++|+|.+++...... ...+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--EDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cchh
Confidence 268999999999999999875432 3356
Q ss_pred hHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC---------CCCCCCCCCCCCc
Q 001171 937 WPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE---------ASSSTTPIGSLGY 1007 (1133)
Q Consensus 937 ~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~~gt~~y 1007 (1133)
+..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........ ........||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 6778899999999999999999999999999999999999999999999765433211 1123445799999
Q ss_pred cCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHH-HHh
Q 001171 1008 VSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEF-LLG 1086 (1133)
Q Consensus 1008 ~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1086 (1133)
+|||++.+..++.++||||+||++|||++|..|+.. .... .........+. ..... ...
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~-~~~~~~~~~~~--------------~~~~~~~~~ 302 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRI-ITDVRNLKFPL--------------LFTQKYPQE 302 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHH-HHHHHTTCCCH--------------HHHHHCHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHH-HHHhhccCCCc--------------ccccCChhH
Confidence 999999998999999999999999999998877521 1111 11111111111 11111 122
Q ss_pred HhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1087 VKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1087 ~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+++.+||+.||++||++.|++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 378999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.95 Aligned_cols=255 Identities=21% Similarity=0.389 Sum_probs=203.1
Q ss_pred hcCCCcccccccccceeEEEEEECC----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|++++++++||||+++++++... . .+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~-~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P-TW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S-CE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C-CE
Confidence 4679999999999999999997642 45799999875432 346788999999999999999999998754 3 48
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++++|.+++.... ..+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999998643 338899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... ........+++.|+|||++.+..++.++||||+||++|||++ |+.||......+....+...... ..+.
T Consensus 165 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-~~~~---- 237 (281)
T 3cc6_A 165 DED--YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-PKPD---- 237 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-CCCT----
T ss_pred ccc--ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-CCCC----
Confidence 221 112234457889999999988889999999999999999998 99999876666655544332110 0000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.... ...+++.+||+.||++||++.|++++|+.+.
T Consensus 238 ------~~~~------~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 238 ------LCPP------VLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCH------HHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0001 1237889999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=352.14 Aligned_cols=265 Identities=18% Similarity=0.248 Sum_probs=206.2
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc-----CCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK-----HRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~~~~ 908 (1133)
..++|++.++||+|+||.||+|++. +++.||||++.......+.+..|++++++++ ||||+++++++... ...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-~~~ 111 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-DHM 111 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-TEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-Cee
Confidence 4578999999999999999999874 6899999999765545567888999999996 99999999999876 445
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---------------
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA--------------- 973 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~--------------- 973 (1133)
++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 9999999987543 23889999999999999999999999999999999999975
Q ss_pred ----------CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCcc
Q 001171 974 ----------DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMF 1043 (1133)
Q Consensus 974 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~ 1043 (1133)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 78899999999975321 22345789999999999999999999999999999999999999987
Q ss_pred CChhhHHHHHHHHhhhcc-----------ccccccCC-----cCCCCCCChhHHHH------------HHhHhhhhccCC
Q 001171 1044 TQDEDIVKWVKKQLQRGQ-----------ISELLEPG-----LLELDPESSEWEEF------------LLGVKVGLLCTA 1095 (1133)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-----~~~~~~~~~~~~~~------------~~~~~li~~Cl~ 1095 (1133)
....+....+........ .....+.. +............. ....+++.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 776665555544322110 00000000 00000000000000 122389999999
Q ss_pred CCCCCCCCHHHHHHH
Q 001171 1096 PDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1096 ~dP~~RPs~~evl~~ 1110 (1133)
.||++|||++|++++
T Consensus 342 ~dP~~Rpta~elL~h 356 (360)
T 3llt_A 342 IDPTLRPSPAELLKH 356 (360)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999853
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=347.94 Aligned_cols=262 Identities=20% Similarity=0.321 Sum_probs=202.4
Q ss_pred hcCCCcccccccccceeEEEEEE-----CCceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-Cc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~ 907 (1133)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34689999999999999999984 368999999986433 23478899999999999999999999987642 44
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 589999999999999997643 2389999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC-----------hhhHHHHHHHH
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ-----------DEDIVKWVKKQ 1056 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-----------~~~~~~~~~~~ 1056 (1133)
...............||..|+|||++.+..++.++||||+||++|||++|+.|+.... .......+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 5443322233445678889999999988888999999999999999999999864211 11111111221
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
........ .+.. .. ....+++.+||+.||.+||++.|+++.|+.+
T Consensus 256 ~~~~~~~~--------~~~~---~~--~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRLP--------CPPN---CP--DEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCCC--------CCTT---CC--HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCC--------CCCC---CC--HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111000 0000 00 1123789999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=347.54 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=198.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.+.||+|+||.||+|.+. +|+.||+|++...... .+.+.+|++++++++||||+++++++... ...++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEEE
Confidence 57999999999999999999886 5899999998654433 35678899999999999999999999876 4458999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP- 155 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-
Confidence 999999999887753 23889999999999999999999999999999999999999999999999999754321
Q ss_pred CCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc--------c
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI--------S 1063 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--------~ 1063 (1133)
........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+....+.+....... .
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 --SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred --ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 112234578999999999865 56799999999999999999999999877766655555443221100 0
Q ss_pred ccccCCcCCCCCCChhHH----HHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWE----EFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~----~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.................. ... ...+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000000 001 12378999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.45 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=201.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccC--CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDG--TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
.++|++.++||+|+||.||+|.+. +++ .||+|.+... ....+.+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--c
Confidence 457999999999999999999864 343 4677877543 234678999999999999999999999998753 5
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred eEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 89999999999999998743 34889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..... ........+|+.|+|||++.+..++.++||||+||++|||++ |+.||......+....+....... . .
T Consensus 168 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-~----~ 241 (327)
T 3lzb_A 168 GAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-Q----P 241 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-C----C
T ss_pred cCccc-cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-C----C
Confidence 33221 122234457889999999999999999999999999999999 999998777666555443321110 0 0
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
+. ... ...+++.+||+.||.+||++.|+++.|+.+...+
T Consensus 242 ~~------~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 242 PI------CTI------DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp TT------BCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred cc------CCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 00 001 1237889999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=349.69 Aligned_cols=271 Identities=21% Similarity=0.295 Sum_probs=201.7
Q ss_pred HHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhc--cCCCeeeEEEEEeCCC---Cc
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV--KHRNLTVLRGYYAGPP---DV 907 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~---~~ 907 (1133)
....++|++.+.||+|+||.||+|+++ |+.||||++.... ...+.+|.+++... +||||+++++++.... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 345678999999999999999999886 8999999986433 34556666666655 8999999999987652 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC--------CceecccCccceeeCCCCceEE
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL--------DMVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl 979 (1133)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 68999999999999999753 388999999999999999999998 9999999999999999999999
Q ss_pred eccCcccccccCCCC-CCCCCCCCCCCCccCccccCCCCCCCC------CchhHHHHHHHHHHhC----------CCCCc
Q 001171 980 SEFGLDRLAIATPAE-ASSSTTPIGSLGYVSPEAASTGQPTKE------ADVYSFGIVLLEILTG----------RKPVM 1042 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlG~il~el~tg----------~~Pf~ 1042 (1133)
+|||+++........ ........||+.|+|||++.+..++.+ +|||||||++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999654332221 112235579999999999987777665 9999999999999999 66764
Q ss_pred cCCh-hhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1043 FTQD-EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1043 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
.... .......................+ ..........+++.+||+.||++||++.|++++|+.+....+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRW-------SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGG-------GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccc-------hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 3221 111222222222111111111100 000111223389999999999999999999999999877554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=346.93 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=203.4
Q ss_pred hcCCCcccccccccceeEEEEEECC----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..+|++.++||+|+||.||+|.+.+ +..||+|.+..... ..+.+.+|++++++++||||+++++++...+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468889999999999999997642 34689999865332 24678899999999999999999999766666679
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999997532 347899999999999999999999999999999999999999999999999997543
Q ss_pred cCCCC-CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 990 ATPAE-ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 990 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..... ........+|+.|+|||.+.+..++.++||||+||++|||++ |.+||......+....+...... ..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 253 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------LQ 253 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC------CC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC------CC
Confidence 22211 122334567889999999988899999999999999999999 66677655555544443332110 00
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
+.. ... ...+++.+||+.||++||++.|+++.|+++...
T Consensus 254 ~~~-----~~~------~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 254 PEY-----CPD------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CTT-----CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred Ccc-----CCH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 000 011 123788999999999999999999999987553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=366.38 Aligned_cols=247 Identities=20% Similarity=0.315 Sum_probs=194.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||.||+|... +|+.||||++... ......+.+|++++++++||||+++++++...+ ..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-EEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-EEEE
Confidence 467999999999999999999875 6899999998642 223356788999999999999999999998764 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 226 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999998743 38899999999999999999998 999999999999999999999999999987432
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+... ...++.
T Consensus 301 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~----- 370 (446)
T 4ejn_A 301 KD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPR----- 370 (446)
T ss_dssp C--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT-----
T ss_pred CC---CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CCCCCc-----
Confidence 21 22334568999999999999999999999999999999999999999877666555544331 111111
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVF 1109 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1109 (1133)
... ....+++.+||+.||.+|| +++|+++
T Consensus 371 ------~~~-----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 371 ------TLG-----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------TSC-----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------cCC-----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 100 1123789999999999999 9999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=353.31 Aligned_cols=274 Identities=22% Similarity=0.347 Sum_probs=211.0
Q ss_pred hcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999974 247789999996432 2345788999999999999999999999876544
Q ss_pred EEEEEeccCCCCHHHHHHhhccC--CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEecc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQ--DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEF 982 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Df 982 (1133)
++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.||+||||||+||+++. +..+||+||
T Consensus 109 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 109 -FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp -EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred -EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 9999999999999999875432 1234889999999999999999999999999999999999984 446999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++....... ........|++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.....
T Consensus 188 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--- 263 (327)
T 2yfx_A 188 GMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--- 263 (327)
T ss_dssp HHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---
T ss_pred ccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC---
Confidence 99875432221 122334567889999999988889999999999999999998 9999977666555444332211
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCCCCCCCCC
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTS 1128 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~~~~ 1128 (1133)
.. .... ... ...+++.+||+.||.+||++.|++++|+.+...++......+..
T Consensus 264 -~~-~~~~------~~~------~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~ 316 (327)
T 2yfx_A 264 -MD-PPKN------CPG------PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 316 (327)
T ss_dssp -CC-CCTT------CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCCC
T ss_pred -CC-CCCC------CCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhccccccc
Confidence 00 0000 001 12378899999999999999999999999887776655555443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.61 Aligned_cols=260 Identities=19% Similarity=0.313 Sum_probs=201.8
Q ss_pred CCcccccccccceeEEEEEEC-----CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEE
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-----DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLL 910 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~l 910 (1133)
|++.+.||+|+||.||++.++ +++.||||++..... ..+.+.+|++++++++||||+++++++... ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999998653 589999999975432 245789999999999999999999999764 355689
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999753 288999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh-----------HHHHHHHHhhh
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED-----------IVKWVKKQLQR 1059 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~-----------~~~~~~~~~~~ 1059 (1133)
............++..|+|||++.+..++.++||||+||++|||++|+.||....... ....+.+....
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 3222223344568889999999988888999999999999999999999986432110 11111111111
Q ss_pred ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
...... ... .. ....+++.+||+.||++||++.|+++.|+.+...
T Consensus 267 ~~~~~~--------~~~---~~--~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 267 GERLPR--------PDK---CP--AEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp TCCCCC--------CTT---CC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCC--------Ccc---cc--HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 110000 000 00 1123788999999999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=348.12 Aligned_cols=263 Identities=20% Similarity=0.349 Sum_probs=208.6
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
..++|++.+.||+|+||.||+|.++ .++.||+|++..... ....+.+|++++++++||||+++++++.....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4568999999999999999999764 378899999975432 23468899999999999999999999987644
Q ss_pred cEEEEEeccCCCCHHHHHHhhcc-----CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 907 VRLLVYDYMPNGNLATLLQEASH-----QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
.++||||+++|+|.+++...+. .....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|
T Consensus 103 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 103 -TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp -CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred -cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence 4999999999999999986431 1113468899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhc
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
||+++....... ........+|+.|+|||++.+..++.++||||+||++|||++ |+.||......+....+...
T Consensus 182 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---- 256 (322)
T 1p4o_A 182 FGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG---- 256 (322)
T ss_dssp TTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT----
T ss_pred Cccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC----
Confidence 999875432211 112234467889999999988889999999999999999999 89999776655544443321
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
..... .... .. ...+++.+||+.||++||++.|++++|++...
T Consensus 257 ~~~~~--------~~~~---~~--~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 257 GLLDK--------PDNC---PD--MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCC--------CTTC---CH--HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CcCCC--------CCCC---CH--HHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11110 0000 01 12378899999999999999999999998655
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=342.09 Aligned_cols=266 Identities=15% Similarity=0.187 Sum_probs=208.4
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.++|++.+.||+|+||.||+|++ .+|+.||||++.... ..+.+.+|++++++++|++++..+.++.......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 46899999999999999999987 579999999986543 3457899999999999998887777776555677999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee---CCCCceEEeccCcccccccC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9 999999997533 348999999999999999999999999999999999999 48899999999999765433
Q ss_pred CCCC----CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCCh---hhHHHHHHHHhhhccccc
Q 001171 992 PAEA----SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD---EDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 992 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~ 1064 (1133)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 2211 123456799999999999999999999999999999999999999975332 223333332211111110
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
....+. ....+++.+||+.||++||++.|+++.|+.+......
T Consensus 242 -~~~~~~------------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 242 -LCKGYP------------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -HTTTSC------------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -HHhhCC------------HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 111110 1123788999999999999999999999987665444
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=346.38 Aligned_cols=245 Identities=22% Similarity=0.254 Sum_probs=188.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||+||+|++. +|+.||||++...... ...+.+|+..+.++ +||||+++++++.+. ...++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEE
Confidence 357999999999999999999886 6999999998654333 23445566666555 899999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+ +++|.+++...+ ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 135 v~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 779999988753 3489999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .... ..............
T Consensus 210 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~----~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 210 A----GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQ----LRQGYLPPEFTAGL 277 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHH----HTTTCCCHHHHTTS
T ss_pred C----CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHH----HhccCCCcccccCC
Confidence 1 22334569999999999875 78999999999999999999977664321 1111 11111111111110
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ....+++.+|++.||++||+++|++++
T Consensus 278 ------~------~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 278 ------S------SELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ------C------HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------C------HHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0 112378999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=338.84 Aligned_cols=250 Identities=19% Similarity=0.310 Sum_probs=199.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
++|++.+.||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|++++++++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-CeE
Confidence 57999999999999999999886 689999999864322 357899999999999999999999999876 445
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC----ceEEeccCc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF----EAHLSEFGL 984 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~ 984 (1133)
++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999997643 388999999999999999999999999999999999998877 799999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
++..... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+....+.... .....
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 232 (283)
T 3bhy_A 159 AHKIEAG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN--YDFDE 232 (283)
T ss_dssp CEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCH
T ss_pred ceeccCC----CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc--cCCcc
Confidence 8754221 12234568999999999998899999999999999999999999998766554443332210 00000
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+. .. ....+++.+|++.||++||++.|++++
T Consensus 233 ~~~~~------~~------~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 233 EYFSN------TS------ELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHTT------CC------HHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred hhccc------CC------HHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00000 00 112378999999999999999999973
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.83 Aligned_cols=260 Identities=21% Similarity=0.338 Sum_probs=196.6
Q ss_pred hcCCCcccccccccceeEEEEEEC--Cc--eEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--DG--MVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|++. ++ ..||+|++.... ...+.+.+|++++++++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 457999999999999999999763 23 468999986532 22467889999999999999999999998653
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++++|.+++.... ..+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 589999999999999998753 2388999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
...............++..|+|||++.+..++.++||||+|+++|||++ |+.||......+....+....... . .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~-~ 246 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---P-R 246 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---C-C
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC---C-C
Confidence 5433222223334567889999999988888999999999999999999 999998766655444432211000 0 0
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
.. ... ....+++.+||+.||++||++.|+++.|++....
T Consensus 247 ~~------~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 247 PE------DCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CT------TCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred Cc------CcC------HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00 001 1123788899999999999999999999986543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=349.53 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=202.6
Q ss_pred HHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---------HHHHHHHHHHHhhc-cCCCeeeEEEEE
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---------ENTFRKEAEALGKV-KHRNLTVLRGYY 901 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~hpniv~l~~~~ 901 (1133)
....++|++.++||+|+||.||+|.++ +|+.||||++...... .+.+.+|+++++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445678999999999999999999885 6999999998654321 34678899999999 799999999999
Q ss_pred eCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEec
Q 001171 902 AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSE 981 (1133)
Q Consensus 902 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 981 (1133)
... ...++||||+++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+|++|
T Consensus 170 ~~~-~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESS-SFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBS-SEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeC-CEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEe
Confidence 875 45699999999999999998643 388999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccCC------CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHH
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST------GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 1055 (1133)
||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 244 fG~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~ 319 (365)
T 2y7j_A 244 FGFSCHLEPG----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319 (365)
T ss_dssp CTTCEECCTT----CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCcccccCCC----cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 9998754321 22344679999999999853 3578999999999999999999999977665554444333
Q ss_pred HhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ...+.+.. .. ....+++.+|++.||++||++.|++++
T Consensus 320 ~~~~-----~~~~~~~~---~~------~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 320 GQYQ-----FSSPEWDD---RS------STVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp TCCC-----CCHHHHSS---SC------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCC-----CCCccccc---CC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2110 00000000 00 112378999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=378.84 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=197.1
Q ss_pred cccccccceeEEEEEEC---CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
+.||+|+||.||+|.++ .++.||||+++....+ .+.+.+|++++++++|||||++++++... ..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEEEEccC
Confidence 47999999999999653 4689999999754332 47899999999999999999999999753 3589999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 453 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999999763 2388999999999999999999999999999999999999999999999999986543332222
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.+.... ..+. .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-~~p~----~------ 596 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCPA----G------ 596 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CCCT----T------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCCC----C------
Confidence 3344557889999999998899999999999999999998 99999877766655554432111 0000 0
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.. ....+++.+||+.||++||++++|++.|+.+
T Consensus 597 ~~------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 597 CP------REMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00 1123788999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=352.86 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=191.2
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhccC--CCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVKH--RNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|..++++.||||++...... .+.+.+|++++++++| |||+++++++... ...++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-CEEEE
Confidence 3579999999999999999999888999999998754433 3578899999999986 9999999999876 45699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|||+ .+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++....
T Consensus 87 v~e~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EECC-CSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEeC-CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9995 5889999998743 388999999999999999999999999999999999997 67899999999975432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCC-----------CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhh
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAST-----------GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 1059 (1133)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ...+......
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~ 236 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDP 236 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHCT
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHhcC
Confidence 211 112335579999999999854 66889999999999999999999999643322 1111121111
Q ss_pred ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.. .. ..+.... ....+++.+||+.||.+||++.|++++-
T Consensus 237 ~~-~~-------~~~~~~~-----~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 237 NH-EI-------EFPDIPE-----KDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp TS-CC-------CCCCCSC-----HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Cc-cc-------CCcccCC-----HHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 10 00 0011100 1123788899999999999999999763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=369.11 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=201.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||.||+|+++ +|+.||+|++.+. ......+.+|++++++++|||||++++++... ...++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEEE
Confidence 357899999999999999999875 6999999998543 22356788999999999999999999999876 45699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++...+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++++||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999976432 3489999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.+...... ..+...+
T Consensus 339 ~----~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--~~~p~~~ 412 (576)
T 2acx_A 339 G----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYSERF 412 (576)
T ss_dssp T----CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--CCCCTTS
T ss_pred C----ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--ccCCccC
Confidence 1 122345899999999999988899999999999999999999999976543222222222222111 0011100
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
. ....+++.+|++.||++|| +++||+++
T Consensus 413 ------s------~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 413 ------S------PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------C------HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------C------HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 1123789999999999999 78999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=359.46 Aligned_cols=254 Identities=21% Similarity=0.338 Sum_probs=189.3
Q ss_pred hcCCCcc-cccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeC---CCCcEE
Q 001171 836 TRQFDEE-NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAG---PPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~~~~~~ 909 (1133)
.++|.+. ++||+|+||+||+|.++ +|+.||||++.. ...+.+|++++.++ +||||+++++++.. .....+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3467666 78999999999999875 689999999863 35678899987554 89999999998864 234568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLDR 986 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~ 986 (1133)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+||+++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999986432 34899999999999999999999999999999999999987 7889999999997
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..................+.+. ..
T Consensus 213 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-~~ 287 (400)
T 1nxk_A 213 ETTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-FP 287 (400)
T ss_dssp ECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-CC
T ss_pred ccCC----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-CC
Confidence 5422 122345678999999999999999999999999999999999999997544322111111111111110 11
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.+.. .. . ...+++.+||+.||++||++.|++++
T Consensus 288 ~~~~~~---~s----~--~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 NPEWSE---VS----E--EVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTT---SC----H--HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cccccc---CC----H--HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111110 00 1 12378999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=343.82 Aligned_cols=260 Identities=21% Similarity=0.336 Sum_probs=204.2
Q ss_pred CCCcccccccccceeEEEEEEC----CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.|...++||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++++++||||+++++++...+...++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5667799999999999999753 234799999875332 2367889999999999999999999998766666899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997632 34789999999999999999999999999999999999999999999999999754322
Q ss_pred CC-CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCC-CCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 992 PA-EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK-PVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 992 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. .........+++.|+|||.+.+..++.++||||+||++|||++|.. ||...+..+....+...... .. ..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~----~~- 251 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQ----PE- 251 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CC----CT-
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CC----Cc-
Confidence 21 1223344568889999999999999999999999999999999554 45555555544443332110 00 00
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
.... ...+++.+||+.||.+||++.|+++.|+++...-
T Consensus 252 -----~~~~------~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 252 -----YCPD------SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -----TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----cchH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 0011 1237889999999999999999999999876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=359.58 Aligned_cols=275 Identities=18% Similarity=0.225 Sum_probs=206.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-CcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~~lV 911 (1133)
.++|.+.++||+|+||.||+|+++ +|+.||||++.... ...+.+.+|++++++++||||+++++++.... ...++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357999999999999999999886 48999999986433 23567889999999999999999999987653 356899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee----CCCCceEEeccCcccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF----DADFEAHLSEFGLDRL 987 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~ 987 (1133)
|||+++|+|.+++...... ..+++..++.++.||+.||+|||+.||+||||||+||++ +.++.+||+|||+++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999999864432 238999999999999999999999999999999999999 7888899999999975
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCC--------CCCCCCCchhHHHHHHHHHHhCCCCCccCChh-hHHHHHHHHhh
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAAST--------GQPTKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQLQ 1058 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~~~ 1058 (1133)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+.+.+..
T Consensus 166 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~- 240 (396)
T 4eut_A 166 LEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII- 240 (396)
T ss_dssp CCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH-
T ss_pred ccCC----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh-
Confidence 4321 22334579999999999864 45678999999999999999999999643321 1112222221
Q ss_pred hccccccc----cCC-----cC-CCCCCChhHHHHHHhH-hhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1059 RGQISELL----EPG-----LL-ELDPESSEWEEFLLGV-KVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1059 ~~~~~~~~----~~~-----~~-~~~~~~~~~~~~~~~~-~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
.+.....+ ... +. ..+....-.......+ +++.+||+.||++||++.|+++.++.+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111100 000 00 0011111112222222 899999999999999999999999876553
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=342.87 Aligned_cols=266 Identities=15% Similarity=0.189 Sum_probs=204.3
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ..+.+.+|++++++++|++++..++++.......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999987 568999999875433 234688999999999999888887777655667799999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee---CCCCceEEeccCccccccc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred cc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99 999999998543 238999999999999999999999999999999999999 7889999999999976543
Q ss_pred CCCCC----CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh---hHHHHHHHHhhhcccc
Q 001171 991 TPAEA----SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE---DIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 991 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~~~~ 1063 (1133)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 32211 2234567999999999999999999999999999999999999999754332 2222222221111100
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
.....+. ....+++.+||+.||++||++.|+++.|+.+.....
T Consensus 241 -~~~~~~~------------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 -VLCKGYP------------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -HHTTTSC------------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -hhhccCC------------HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0001110 112378899999999999999999999988765443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=353.27 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=200.0
Q ss_pred HHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC------CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG------TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 905 (1133)
....++|++.+.||+|+||.||+|.++ +++.||+|++... ....+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 100 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE- 100 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-
Confidence 346678999999999999999999774 6889999998542 22346789999999999999999999999876
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCC-----------------------------------CCCCChHHHHHHHHHHHHH
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQD-----------------------------------GHVLNWPMRHLISLGLARG 950 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~-----------------------------------~~~l~~~~~~~i~~~ia~~ 950 (1133)
...++||||+++|+|.+++....... ...+++..++.++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 45699999999999999986321110 1123566778899999999
Q ss_pred HHHHhcCCceecccCccceeeCCCC--ceEEeccCcccccccCCCC-CCCCCCCCCCCCccCccccCC--CCCCCCCchh
Q 001171 951 LSFLHSLDMVHGDIKPQNVLFDADF--EAHLSEFGLDRLAIATPAE-ASSSTTPIGSLGYVSPEAAST--GQPTKEADVY 1025 (1133)
Q Consensus 951 L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvw 1025 (1133)
|+|||+.+|+||||||+||+++.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 8999999999765432221 122345679999999999865 6789999999
Q ss_pred HHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHH
Q 001171 1026 SFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105 (1133)
Q Consensus 1026 SlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~ 1105 (1133)
|+||++|||++|+.||......+....+...... ...+.... .. ....+++.+||+.||.+||++.
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~-------~~--~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-----FENPNYNV-------LS--PLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----TTSGGGGG-------SC--HHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-----cCCccccc-------CC--HHHHHHHHHHcCCChhHCCCHH
Confidence 9999999999999999876665554444332110 00000000 00 1123789999999999999999
Q ss_pred HHHHH
Q 001171 1106 DIVFM 1110 (1133)
Q Consensus 1106 evl~~ 1110 (1133)
|++++
T Consensus 327 ~~l~h 331 (345)
T 3hko_A 327 RALQH 331 (345)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=352.23 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=196.3
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
..++|++.+.||+|+||.||+|.++ +|+.||+|++..... ...+|++++.++ +||||+++++++.+. ...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDG-KYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcC-CEEEEEE
Confidence 4567999999999999999999875 689999999976443 346789999888 799999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC----CceEEeccCccccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD----FEAHLSEFGLDRLA 988 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~ 988 (1133)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||++..+ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999997642 38899999999999999999999999999999999998443 35999999999754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||........... ......+.+.. ...
T Consensus 171 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-~~~i~~~~~~~-~~~ 245 (342)
T 2qr7_A 171 RAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI-LARIGSGKFSL-SGG 245 (342)
T ss_dssp BCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH-HHHHHHCCCCC-CST
T ss_pred cCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH-HHHHccCCccc-Ccc
Confidence 3221 223456789999999999887789999999999999999999999975332222222 22222222110 000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.. .. . ...+++.+|+..||++||++.|++++
T Consensus 246 ~~~~---~s----~--~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 246 YWNS---VS----D--TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTTT---SC----H--HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccc---CC----H--HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 00 1 12378999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=364.80 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=201.9
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC---CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG---TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
..++|++.++||+|+||+||+|.++ +++.||||++... ......+.+|++++++++||||+++++++... ...++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-CEEEE
Confidence 3467999999999999999999875 6899999998532 33467889999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC---CCCceEEeccCcccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD---ADFEAHLSEFGLDRL 987 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~ 987 (1133)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999999987653 388999999999999999999999999999999999995 456799999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+....+........ .
T Consensus 174 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----~ 243 (486)
T 3mwu_A 174 FQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-----L 243 (486)
T ss_dssp BCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-----S
T ss_pred CCCC----CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----C
Confidence 4321 22344579999999999865 589999999999999999999999987776666555443211100 0
Q ss_pred CCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+ .+..+. ...+++.+||+.||++|||+.|++++
T Consensus 244 ~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 P----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp G----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred c----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 111111 12378999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=352.58 Aligned_cols=269 Identities=18% Similarity=0.214 Sum_probs=206.0
Q ss_pred hcCCCcccccccccceeEEEEEECC---------ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeee----------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD---------GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTV---------- 896 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------- 896 (1133)
.++|++.+.||+|+||.||+|++.. ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3579999999999999999998764 789999998753 46889999999999999987
Q ss_pred -----EEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee
Q 001171 897 -----LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF 971 (1133)
Q Consensus 897 -----l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll 971 (1133)
+++++.......++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6677766556779999999 9999999987521 348999999999999999999999999999999999999
Q ss_pred CCCC--ceEEeccCcccccccCCCC----CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC
Q 001171 972 DADF--EAHLSEFGLDRLAIATPAE----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045 (1133)
Q Consensus 972 ~~~~--~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~ 1045 (1133)
+.++ .+||+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999765432211 112234579999999999999899999999999999999999999997643
Q ss_pred -hhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1046 -DEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1046 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
.............. ......+..... .... ....+++.+||+.||++||++.|+++.|+++......
T Consensus 273 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 273 PNTEDIMKQKQKFVD-KPGPFVGPCGHW-IRPS------ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TCHHHHHHHHHHHHH-SCCCEECTTSCE-ECCC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHhccC-Chhhhhhhcccc-CCCc------HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 22222222222111 111221111000 0001 1123788899999999999999999999987765543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=349.67 Aligned_cols=247 Identities=21% Similarity=0.363 Sum_probs=175.9
Q ss_pred ccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 842 ENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
.++||+|+||.||+|.++ +|+.||||++... ....+.+|+++++++. ||||+++++++.+. ...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-LHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-CEEEEEEEccCCCc
Confidence 378999999999999875 5899999999643 3567889999999997 99999999999876 44599999999999
Q ss_pred HHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC---ceEEeccCcccccccCCCCCC
Q 001171 920 LATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF---EAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 920 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~ 164 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD---NQ 164 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC---CC
Confidence 99999874 3489999999999999999999999999999999999997765 7999999999754322 12
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh---HHHHHHHHhhhccccccccCCcCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED---IVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.+....+.+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~----------- 233 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF----------- 233 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-----------
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-----------
Confidence 2344578999999999999999999999999999999999999997543211 11112222222111
Q ss_pred CCCChhHHHHHH-hHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLL-GVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~-~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
......+..+.. ..+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 011112222222 2378999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=344.61 Aligned_cols=264 Identities=17% Similarity=0.304 Sum_probs=200.2
Q ss_pred HhcCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC-
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD- 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 906 (1133)
..++|.+.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|++++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4568999999999999999999664 3568999999754333 3568899999999999999999999876432
Q ss_pred ---cEEEEEeccCCCCHHHHHHhhcc-CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 907 ---VRLLVYDYMPNGNLATLLQEASH-QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 907 ---~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
..++||||+++|+|.+++..... .....+++..++.++.||++||+|||++||+||||||+||+++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 34899999999999999965432 22345899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||...........+......
T Consensus 192 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-- 268 (313)
T 3brb_A 192 GLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-- 268 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--
T ss_pred Ccceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC--
Confidence 99875432211 122234457889999999998899999999999999999999 89999877666655544332111
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.. ... ... ...+++.+||+.||++||++.|++++|+.+..
T Consensus 269 --~~-~~~------~~~------~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 269 --KQ-PED------CLD------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp --CC-BTT------CCH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CC-Ccc------ccH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 000 001 12378899999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=340.52 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=197.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|.+.+.||+|+||.||+|..+ ++..||+|++.... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-HNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-CeEEEEE
Confidence 457999999999999999999875 58999999986543 3457899999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee---CCCCceEEeccCcccccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 989 (1133)
||+++|+|.+++...... ...+++..+..++.||++||+|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 100 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999998764321 2448999999999999999999999999999999999999 456789999999986543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. .......||+.|+|||++. +.++.++||||+||++|||++|+.||......+......... ..... .
T Consensus 179 ~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~--~-- 247 (285)
T 3is5_A 179 SD----EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--PNYAV--E-- 247 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCC-----
T ss_pred Cc----ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--ccccc--c--
Confidence 21 2233457899999999985 568899999999999999999999998766555444332211 10000 0
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ..... ...+++.+|++.||++||++.|++++
T Consensus 248 ~---~~~~~------~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 C---RPLTP------QAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----CCCCH------HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred c---CcCCH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00111 12378899999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=351.61 Aligned_cols=263 Identities=20% Similarity=0.280 Sum_probs=205.6
Q ss_pred HhcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+++++++ +||||+++++++....
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35689999999999999999998742 24799999975432 246788999999999 8999999999998765
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC---------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ---------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE 976 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 976 (1133)
. .++||||+++|+|.+++...... ....+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 124 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 124 P-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp S-CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred c-eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 4 49999999999999999865321 1234789999999999999999999999999999999999999999
Q ss_pred eEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHH
Q 001171 977 AHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKK 1055 (1133)
Q Consensus 977 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~ 1055 (1133)
+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..
T Consensus 203 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred EEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 99999999975533221 112234557889999999988889999999999999999998 9999976554433322222
Q ss_pred HhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
...... ... .... ...+++.+||+.||.+||++.|+++.|+...
T Consensus 282 ~~~~~~----~~~------~~~~------~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 282 DGYQMA----QPA------FAPK------NIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HTCCCC----CCT------TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCC----CCC------CCCH------HHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111100 000 0011 1237888999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=349.38 Aligned_cols=265 Identities=21% Similarity=0.321 Sum_probs=198.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+|++++++++||||+++++++.... ..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-SLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-CEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-EEEEEec
Confidence 57999999999999999999876 6899999998643322 124567999999999999999999998764 4599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++ |+|.+++...+ ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 153 (324)
T ss_dssp CCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence 996 69999988643 34889999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc---cccC-
Q 001171 994 EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE---LLEP- 1068 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 1068 (1133)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.+......... ....
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 122334578999999999876 5689999999999999999999999988877777766666543221110 0000
Q ss_pred -----CcCCCCCCC--hhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 -----GLLELDPES--SEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 -----~~~~~~~~~--~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
......... .....+ ....+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 000000 122378999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=364.88 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=201.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--------------cCHHHHHHHHHHHhhccCCCeeeEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--------------IDENTFRKEAEALGKVKHRNLTVLRG 899 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~l~~ 899 (1133)
..++|.+.++||+|+||+||+|.++ +++.||+|++.... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999875 57899999986533 22467889999999999999999999
Q ss_pred EEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC---c
Q 001171 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF---E 976 (1133)
Q Consensus 900 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~---~ 976 (1133)
++... ...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++ .
T Consensus 114 ~~~~~-~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDK-KYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECS-SEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcC-CEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99876 45599999999999999997643 389999999999999999999999999999999999998776 6
Q ss_pred eEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHH
Q 001171 977 AHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 977 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
+||+|||+++..... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||......+....+.+.
T Consensus 188 ~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp EEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred EEEEECCCCEEcCCC----CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 999999999754321 2234567999999999986 46899999999999999999999999877776666555442
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .....+..+. ...+++.+|++.||.+|||+.|++++
T Consensus 263 ~~~---------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYY---------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCC---------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC---------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 110 0001111111 12378999999999999999999865
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=364.81 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=198.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.++||+|+||+||+|+++ ++..||+|++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-RNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence 457999999999999999999876 68999999986532 2356789999999999999999999999876 445999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC---CceEEeccCccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD---FEAHLSEFGLDRLA 988 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~ 988 (1133)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.. +.+||+|||+++..
T Consensus 115 ~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999999987643 38899999999999999999999999999999999999764 45999999998754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||......+....+...... ...+
T Consensus 190 ~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~ 259 (494)
T 3lij_A 190 ENQ----KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT-----FDSP 259 (494)
T ss_dssp BTT----BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----CCSG
T ss_pred CCC----ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCch
Confidence 322 2234467999999999986 56899999999999999999999999877776666555442111 0111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+... . ....+++.+||+.||.+|||+.|++++
T Consensus 260 ~~~~~---s------~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 260 EWKNV---S------EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GGTTS---C------HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hcccC---C------HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11110 0 112378999999999999999999854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=362.33 Aligned_cols=195 Identities=21% Similarity=0.333 Sum_probs=153.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC----CCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP----PDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~ 907 (1133)
.++|++.++||+|+||+||+|.++ +|+.||||++.....+ .+.+.+|++++++++|||||++++++... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999775 6899999998654332 46788999999999999999999998533 245
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+||||+ +|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 69999998 57999998753 3489999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCC------------------------CCCCCCCCCCCccCcccc-CCCCCCCCCchhHHHHHHHHHHh
Q 001171 988 AIATPAEA------------------------SSSTTPIGSLGYVSPEAA-STGQPTKEADVYSFGIVLLEILT 1036 (1133)
Q Consensus 988 ~~~~~~~~------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~t 1036 (1133)
........ ......+||+.|+|||++ .+..++.++||||+||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 53221110 123445789999999986 56679999999999999999999
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=355.58 Aligned_cols=250 Identities=19% Similarity=0.286 Sum_probs=191.4
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhcc--CCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVK--HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|...+++.||||++.....+ .+.+.+|++++++++ ||||+++++++.... ..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-EEEEE
Confidence 469999999999999999999888999999999654433 367889999999996 599999999998764 46999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|| +.+++|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 135 ~E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 56889999998643 378889999999999999999999999999999999995 589999999999754322
Q ss_pred CCCCCCCCCCCCCCCccCccccCC-----------CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAST-----------GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+.......
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~~~~~~ 284 (390)
T 2zmd_A 208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPN 284 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHCTT
T ss_pred Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHHHhCcc
Confidence 11 112345679999999999864 36888999999999999999999999654322 11122211111
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ..+.... ....+++.+||+.||++||++.|++++
T Consensus 285 -~~~-------~~~~~~~-----~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 -HEI-------EFPDIPE-----KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -SCC-------CCCCCSC-----HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -ccC-------CCCccch-----HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 000 0001100 112378899999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=346.44 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=198.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----C
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----D 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 906 (1133)
.++|++.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|++++++++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 6899999999654332 356789999999999999999999997542 2
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||+ +++|.++++.. .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 348999999 88999999762 37899999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---- 1061 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 1061 (1133)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+.+......
T Consensus 177 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 5421 2344578999999999876 6789999999999999999999999987766555554444322110
Q ss_pred --------------ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcC
Q 001171 1062 --------------ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRV 1116 (1133)
Q Consensus 1062 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~ 1116 (1133)
++......+........ ....+++.+|++.||++|||++|++++ ++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNAS-----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC-----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCC-----HHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 00000011111111100 123378999999999999999999985 455443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.44 Aligned_cols=246 Identities=21% Similarity=0.343 Sum_probs=201.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-KRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-CEEEE
Confidence 357999999999999999999875 5889999998542 22346789999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++...+ .+++..+..++.||++|++|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999998753 388999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.......|++.|+|||++.+..++.++||||+|+++|||++|+.||......+....+.. ...
T Consensus 167 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~-------- 229 (284)
T 2vgo_A 167 -----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN----VDL-------- 229 (284)
T ss_dssp -----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCC--------
T ss_pred -----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc----ccc--------
Confidence 122345789999999999998899999999999999999999999976665544333222 110
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.++.... . ...+++.+|++.||.+||++.|++++
T Consensus 230 -~~~~~~~---~--~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 -KFPPFLS---D--GSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -CCCTTSC---H--HHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -CCCCcCC---H--HHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0011100 0 12378899999999999999999963
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.17 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=194.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeC---CCCcEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAG---PPDVRLL 910 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~l 910 (1133)
.|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|++++++++||||+++++++.. .....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 5788899999999999999775 5889999998654332 4568899999999999999999998864 2345689
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeC-CCCceEEeccCcccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFD-ADFEAHLSEFGLDRL 987 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~ 987 (1133)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999998743 3789999999999999999999999 99999999999997 789999999999864
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh-hHHHHHHHHhhhccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 1066 (1133)
... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||...... .....+ .........
T Consensus 182 ~~~-----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRA-----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----TSGVKPASF 251 (290)
T ss_dssp CCT-----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH----TTTCCCGGG
T ss_pred ccc-----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH----hccCCcccc
Confidence 322 1223456899999999886 45899999999999999999999999754332 222221 111111111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+... . ....+++.+||+.||++||++.|++++
T Consensus 252 ~~~~------~------~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 DKVA------I------PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGCC------C------HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCC------C------HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 0 112378999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=352.59 Aligned_cols=271 Identities=20% Similarity=0.294 Sum_probs=194.9
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHH--HhhccCCCeeeEEEEEe----CCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEA--LGKVKHRNLTVLRGYYA----GPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~----~~~~~~~ 909 (1133)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.++ +..++||||+++++++. ......+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46899999999999999999977 58999999997543 3444445554 55589999999997653 2233458
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC---------CceecccCccceeeCCCCceEEe
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL---------DMVHGDIKPQNVLFDADFEAHLS 980 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~ivH~Dlkp~NIll~~~~~~kl~ 980 (1133)
+||||+++|+|.+++.... .++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 9999999999999997632 57889999999999999999999 99999999999999999999999
Q ss_pred ccCcccccccCCC-----CCCCCCCCCCCCCccCccccCC-------CCCCCCCchhHHHHHHHHHHhCCCCCccCCh-h
Q 001171 981 EFGLDRLAIATPA-----EASSSTTPIGSLGYVSPEAAST-------GQPTKEADVYSFGIVLLEILTGRKPVMFTQD-E 1047 (1133)
Q Consensus 981 Dfg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~-~ 1047 (1133)
|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999976533211 1122334579999999999976 3456789999999999999999877643211 1
Q ss_pred h-------------HHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1048 D-------------IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1048 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
. ....+............+...+ ....... ....+++.+||+.||++|||+.|+++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW----KENSLAV--RSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC----CCCSHHH--HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc----ccccchH--HHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 0 0011111111111111111111 1111111 1233899999999999999999999999887
Q ss_pred cCCCCCC
Q 001171 1115 RVGPDMP 1121 (1133)
Q Consensus 1115 ~~~~~~~ 1121 (1133)
...-..-
T Consensus 317 l~~~~~~ 323 (336)
T 3g2f_A 317 MMIWERN 323 (336)
T ss_dssp HHCCCC-
T ss_pred HHHHHhc
Confidence 6544433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=343.34 Aligned_cols=270 Identities=19% Similarity=0.218 Sum_probs=205.7
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGP------- 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 904 (1133)
.++|++.++||+|+||.||+|++ .+|+.||+|++..... ....+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35899999999999999999988 4689999999864332 245788999999999999999999998753
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
....++||||++ |++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 234689999996 57877776532 3389999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 985 DRLAIATPA-EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 985 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
++....... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+.+.......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 976543222 2223345678999999999876 45799999999999999999999999887777666666554332211
Q ss_pred cc---cccC----CcCCCCCCChhH-HHH------HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 SE---LLEP----GLLELDPESSEW-EEF------LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 ~~---~~~~----~~~~~~~~~~~~-~~~------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. .... ............ ... ....+++.+|++.||++||+++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 0000 000000000111 111 123489999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=350.12 Aligned_cols=268 Identities=21% Similarity=0.304 Sum_probs=205.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCC----CcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 908 (1133)
.++|++.++||+|+||.||+|.+. +++.||||++...... .+.+.+|++++++++||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999775 6899999999743322 367889999999999999999999986542 356
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||++ |+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 89999996 6999998752 3889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc-
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL- 1066 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~- 1066 (1133)
..............||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.............
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 433322223345689999999998654 458999999999999999999999998777766666655433221110000
Q ss_pred --cC---C-cCCC-CCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 --EP---G-LLEL-DPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 --~~---~-~~~~-~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+. . .... ......+... ....+++.+|++.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 0000 0000001111 122389999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=347.77 Aligned_cols=267 Identities=20% Similarity=0.245 Sum_probs=195.4
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
...++|++.++||+|+||+||+|.+. +++.||||++...... .+.+.+|++++++++||||+++++++... ...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEE
Confidence 35678999999999999999999765 6899999999654332 34677899999999999999999999876 4459
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee-----CCCCceEEeccCc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF-----DADFEAHLSEFGL 984 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll-----~~~~~~kl~Dfg~ 984 (1133)
+||||++ |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+
T Consensus 110 lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999997 59999998643 38899999999999999999999999999999999999 4555699999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
++..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+..........
T Consensus 184 a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIP---IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccCCc---ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9755321 1223345689999999999774 48999999999999999999999998776666555554433221110
Q ss_pred ccc----cCCcCCCC--CCChhHHHH------HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELL----EPGLLELD--PESSEWEEF------LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~----~~~~~~~~--~~~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .+.+.... ......... ....+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 00000000 000111111 122389999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=347.99 Aligned_cols=266 Identities=21% Similarity=0.358 Sum_probs=198.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.++||+|+||.||+|++. +|+.||+|++...... .+.+.+|++++++++||||+++++++... ...++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEE
Confidence 458999999999999999999876 4899999998654433 34578899999999999999999999876 445999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999888876543 23889999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc----------
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG---------- 1060 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---------- 1060 (1133)
. .......|++.|+|||++.+. .++.++||||+||++|||++|+.||......+....+.......
T Consensus 178 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 G---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 1 223345789999999999765 68999999999999999999999998776655444443321110
Q ss_pred --cccccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 --QISELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 --~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.......+...........+..+. ...+++.+||+.||++||+++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001111111111000000000111 12378999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=354.69 Aligned_cols=264 Identities=19% Similarity=0.262 Sum_probs=206.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc------cCCCeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV------KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~~~ 908 (1133)
..+|++.++||+|+||.||+|.+. +++.||||++.......+.+.+|+++++.+ .|+||+++++++... ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-CeE
Confidence 457999999999999999999775 589999999976554456788899999888 467999999999876 445
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc--eEEeccCccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE--AHLSEFGLDR 986 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 986 (1133)
++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 799999987543 23899999999999999999999999999999999999999887 9999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc----
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI---- 1062 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---- 1062 (1133)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.+.......
T Consensus 251 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 251 YEH------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp ETT------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ecC------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 432 1233457899999999999999999999999999999999999999887776665555543221110
Q ss_pred -----cccccCC--------------------------cCCCCCCChhHHHH------HHhHhhhhccCCCCCCCCCCHH
Q 001171 1063 -----SELLEPG--------------------------LLELDPESSEWEEF------LLGVKVGLLCTAPDPLDRPSMA 1105 (1133)
Q Consensus 1063 -----~~~~~~~--------------------------~~~~~~~~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~ 1105 (1133)
...++.. .....+....+... ....+++.+||+.||++|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0000000 00001112222222 1234899999999999999999
Q ss_pred HHHHH
Q 001171 1106 DIVFM 1110 (1133)
Q Consensus 1106 evl~~ 1110 (1133)
|++++
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=348.70 Aligned_cols=255 Identities=14% Similarity=0.173 Sum_probs=203.1
Q ss_pred hcCCCcccccccccceeEEEEE------ECCceEEEEEEcccCCcCHHHHHHHHHHHhhcc---CCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKAS------YQDGMVLSIRRLRDGTIDENTFRKEAEALGKVK---HRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~ 906 (1133)
.++|.+.++||+|+||+||+|. ...++.||||++... ....+.+|++++++++ |+||+.+++++...+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 4679999999999999999994 346889999999754 4567888999988886 9999999999987644
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-----------CC
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-----------DF 975 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-----------~~ 975 (1133)
.++||||+++|+|.+++...+......+++..+..++.||++||+|||++||+||||||+|||++. ++
T Consensus 142 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 142 -SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp -EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred -cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 499999999999999998766555567999999999999999999999999999999999999998 89
Q ss_pred ceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHH
Q 001171 976 EAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055 (1133)
Q Consensus 976 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 1055 (1133)
.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 221 ~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp TEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred CEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 99999999997543221 1223345679999999999999999999999999999999999999995432211
Q ss_pred HhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCC-CCHHHHHHHHhcCcC
Q 001171 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDR-PSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~R-Ps~~evl~~Le~~~~ 1116 (1133)
.......... .....+. +++.+|++.+|.+| |+++++.+.|+.+..
T Consensus 293 --------~~~~~~~~~~-~~~~~~~------~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 --------CKPEGLFRRL-PHLDMWN------EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp --------EEECSCCTTC-SSHHHHH------HHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------eeechhcccc-CcHHHHH------HHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0011111111 1112222 56778999999998 678888888877544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=367.55 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=203.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.++||+|+||.||+|.++ +|+.||||++... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-GYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEE
Confidence 457999999999999999999876 6899999998543 23467899999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee---CCCCceEEeccCcccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRL 987 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 987 (1133)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999763 238899999999999999999999999999999999999 5678999999999975
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+....+.+...... .
T Consensus 179 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----~ 248 (484)
T 3nyv_A 179 FEAS----KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-----L 248 (484)
T ss_dssp BCCC----CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----S
T ss_pred cccc----cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----C
Confidence 4322 12233569999999999865 689999999999999999999999987776666555544211100 0
Q ss_pred CCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+ .+..+. ...+++.+||+.||++|||+.|++++
T Consensus 249 ~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 P----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp G----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 111111 12378999999999999999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.82 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=197.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCC-----CCc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGP-----PDV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-----~~~ 907 (1133)
..++|++.+.||+|+||.||+|++. +|+.||+|++.......+.+.+|+++++++ +||||+++++++... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 4668999999999999999999874 689999999976666678899999999999 899999999998753 355
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 6899999999999999987432 3488999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
.... ........|++.|+|||++. +..++.++||||+||++|+|++|+.||...........+.. ...
T Consensus 179 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~ 251 (326)
T 2x7f_A 179 LDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPA 251 (326)
T ss_dssp ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCC
T ss_pred cCcC---ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----Ccc
Confidence 4221 11223457899999999986 56689999999999999999999999976554443332222 111
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.......+ .. ...+++.+||..||++||++.|++++
T Consensus 252 ~~~~~~~~------~~------~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 252 PRLKSKKW------SK------KFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCSCSCS------CH------HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCcccc------CH------HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111111 11 12378889999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=342.39 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=192.5
Q ss_pred hcCCCcc-cccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEE-NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++. ++||+|+||.||+|.+. +++.||||++.... ...+.+.+|++++.++ +||||+++++++... +..++|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEE
Confidence 3468874 78999999999999764 68999999996543 3357889999999995 799999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc---eEEeccCccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE---AHLSEFGLDRLA 988 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~ 988 (1133)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++..
T Consensus 90 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999998753 3889999999999999999999999999999999999988776 999999998654
Q ss_pred ccCCCC----CCCCCCCCCCCCccCccccCC-----CCCCCCCchhHHHHHHHHHHhCCCCCccCChhh-----------
Q 001171 989 IATPAE----ASSSTTPIGSLGYVSPEAAST-----GQPTKEADVYSFGIVLLEILTGRKPVMFTQDED----------- 1048 (1133)
Q Consensus 989 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~----------- 1048 (1133)
...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 322111 112234569999999999864 457899999999999999999999996543211
Q ss_pred HHHHHHHHhhhccccccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1049 IVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....+.+....... .... ..+..+. ...+++.+|++.||++||+++|++++
T Consensus 245 ~~~~~~~~i~~~~~-~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPD----------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCH----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc-ccCc----------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111122222111 0000 0000111 12378999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=343.62 Aligned_cols=268 Identities=19% Similarity=0.261 Sum_probs=199.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
..++|++.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|++++++++||||+++++++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN- 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc-
Confidence 4568999999999999999999875 5899999999643221 2467899999999999999999999987644
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 4999999975 8888887532 3488899999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.... ........||+.|+|||++.+. .++.++||||+||++|||++|.+||......+....+.+...........
T Consensus 162 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 162 FGSP---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTSC---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ccCC---cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 4322 1223456789999999998654 47899999999999999999999998777666655555443222111110
Q ss_pred cC----CcCCCCC-CChhHHH----H-HHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1067 EP----GLLELDP-ESSEWEE----F-LLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1067 ~~----~~~~~~~-~~~~~~~----~-~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
+. ....... ....... . ....+++.+|++.||++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00 0000000 0000000 0 1223789999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=363.06 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=199.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|.+.++||+|+||.||+|+++ +|+.||+|++.+.. ...+.+.+|++++++++||||+++++++... ...|+|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEEE
Confidence 57889999999999999999885 69999999996432 2346788999999999999999999999876 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...... ...+++..+..++.||+.||+|||++||+||||||+||+++.++++||+|||+++.....
T Consensus 264 mE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 9999999999999764321 235899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.+.......
T Consensus 343 ~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--------- 410 (543)
T 3c4z_A 343 Q---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--------- 410 (543)
T ss_dssp C---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC---------
T ss_pred C---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc---------
Confidence 1 1233458999999999999999999999999999999999999999764322111222222211111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH-----HHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM-----ADIVF 1109 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1109 (1133)
.++.... ....+++.+||+.||++||++ +|+++
T Consensus 411 ~~p~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 TYPDKFS-----PASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCTTSC-----HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCcccC-----HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0010100 112278899999999999965 67764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=350.60 Aligned_cols=266 Identities=20% Similarity=0.342 Sum_probs=199.7
Q ss_pred HhcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCC---------
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP--------- 904 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------- 904 (1133)
..++|++.++||+|+||+||+|.+ .+|+.||||++.... ....+|++++++++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 567899999999999999999977 468999999986543 2345799999999999999999988432
Q ss_pred ----------------------------CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 001171 905 ----------------------------PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956 (1133)
Q Consensus 905 ----------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 956 (1133)
....++||||++ |+|.+.+...... ...+++..+..++.||++||+|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 223679999997 6888888754322 3458999999999999999999999
Q ss_pred CCceecccCccceeeC-CCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHH
Q 001171 957 LDMVHGDIKPQNVLFD-ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEI 1034 (1133)
Q Consensus 957 ~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el 1034 (1133)
.||+||||||+||+++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|||
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 9999999999999998 6889999999999754322 223445789999999998765 489999999999999999
Q ss_pred HhCCCCCccCChhhHHHHHHHHhhhcccccc--ccCCcCCC---CCCChhHHHH------HHhHhhhhccCCCCCCCCCC
Q 001171 1035 LTGRKPVMFTQDEDIVKWVKKQLQRGQISEL--LEPGLLEL---DPESSEWEEF------LLGVKVGLLCTAPDPLDRPS 1103 (1133)
Q Consensus 1035 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~------~~~~~li~~Cl~~dP~~RPs 1103 (1133)
++|+.||......+....+.+.......... ..+..... ......+... ....+++.+||+.||++|||
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999877766655555543322211100 00000000 0001111111 11348999999999999999
Q ss_pred HHHHHH
Q 001171 1104 MADIVF 1109 (1133)
Q Consensus 1104 ~~evl~ 1109 (1133)
+.|+++
T Consensus 316 ~~e~l~ 321 (383)
T 3eb0_A 316 PYEAMA 321 (383)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=339.96 Aligned_cols=249 Identities=20% Similarity=0.342 Sum_probs=178.3
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-NYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-SEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-CeEEE
Confidence 45799999999999999999987 468999999986432 1246789999999999999999999999876 45699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... ..+++..++.++.|+++|++|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999997532 3489999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+ .. .. .
T Consensus 165 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~---~~-----~ 229 (278)
T 3cok_A 165 PH---EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----VL---AD-----Y 229 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----CS---SC-----C
T ss_pred CC---CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----hh---cc-----c
Confidence 11 1223456899999999999888999999999999999999999999755433322111 00 00 0
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+... . ....+++.+||+.||++||+++|++++
T Consensus 230 -~~~~~~---~--~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 -EMPSFL---S--IEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCTTS---C--HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCcccc---C--HHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000100 0 112378999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=342.59 Aligned_cols=260 Identities=17% Similarity=0.273 Sum_probs=197.8
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCC-CCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGP-PDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~-~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|.+ .+++.||||++... ..+.+.+|++++++++ ||||+++++++... ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46799999999999999999976 46899999998743 4578999999999997 99999999999863 34568999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 991 (1133)
||+++++|.++++. +++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998854 78889999999999999999999999999999999999777 8999999999754322
Q ss_pred CCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCC-hhhHHHHHHHHhhhccccccccCC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQ-DEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.......|+..|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+....+.+........+.++..
T Consensus 185 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 ----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp ----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ----CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 22344578999999999877 668999999999999999999999995332 222222222222111111111100
Q ss_pred cCC-------------------CCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLE-------------------LDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~-------------------~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ...... ...+ ....+++.+|++.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSEN-QHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTT-GGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccc-cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000000 0001 122378999999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=344.08 Aligned_cols=267 Identities=20% Similarity=0.321 Sum_probs=196.6
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ..+.+.+|++++++++||||+++++++.... ..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-cEEE
Confidence 45799999999999999999987 4689999999874321 2456889999999999999999999998764 5599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++...... ...+++..++.++.||++||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999764322 24588999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .... .+...............
T Consensus 189 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 189 KT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL-CKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHH-HHHHHTTCSCCCCTTTS
T ss_pred CC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHH-HHHhhcccCCCCccccc
Confidence 21 1223456899999999999889999999999999999999999999643322 1111 12222222111111100
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
. . ...+++.+||+.||++||++.|+++.|+++......|
T Consensus 264 ------~----~--~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 264 ------S----E--ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp ------C----H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ------C----H--HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 0 1 1227888999999999999999999999987655544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=338.25 Aligned_cols=248 Identities=19% Similarity=0.339 Sum_probs=201.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++... +..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-CEEEE
Confidence 468999999999999999999876 588999999865322 245788999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... .+++..+..++.|+++|++|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999999987643 388999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. ........|++.|+|||++.+..++.++||||+|+++|||++|+.||......+....+.. ...
T Consensus 168 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~-------- 232 (294)
T 2rku_A 168 D---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----NEY-------- 232 (294)
T ss_dssp T---TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCC--------
T ss_pred C---ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----ccC--------
Confidence 1 1223345789999999999988899999999999999999999999976655444333221 110
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+.... . ...+++.+||+.||++||++.|++++
T Consensus 233 -~~~~~~~---~--~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -SIPKHIN---P--VAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCTTSC---H--HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCccccC---H--HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 1 12378899999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.17 Aligned_cols=249 Identities=19% Similarity=0.332 Sum_probs=203.1
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+. +..+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEE
Confidence 3568999999999999999999876 57899999986432 1246788999999999999999999999876 4569
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++++|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 118 lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999999987643 38899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ........|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+... ...++.
T Consensus 193 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~----- 262 (335)
T 2owb_A 193 YD---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPK----- 262 (335)
T ss_dssp ST---TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCT-----
T ss_pred cC---cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCc-----
Confidence 22 12234457999999999998888999999999999999999999999766655444333221 111110
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... . ...+++.+||+.||++||++.|++++
T Consensus 263 ------~~~---~--~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 263 ------HIN---P--VAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ------TSC---H--HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ------cCC---H--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 12378899999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=339.56 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=204.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeC-CCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAG-PPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|... +|+.||+|++...... .+.+.+|++++++++||||+++++++.. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457999999999999999999875 6899999999754432 4568899999999999999999998753 3456689
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC-----ceecccCccceeeCCCCceEEeccCcc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD-----MVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
||||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999999999999875432 244899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
+...... .......|++.|+|||++.+..++.++||||+|+++|||++|+.||......+....+... .....
T Consensus 164 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----~~~~~ 236 (279)
T 2w5a_A 164 RILNHDT---SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KFRRI 236 (279)
T ss_dssp HHC---C---HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CCCCC
T ss_pred eeecccc---ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc----ccccC
Confidence 7542211 1112346889999999998888999999999999999999999999876665554444332 11111
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.. .. .. ...+++.+||+.||++||++.|+++++..-.
T Consensus 237 -~~-------~~---~~--~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 237 -PY-------RY---SD--ELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -CT-------TS---CH--HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -Cc-------cc---CH--HHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 00 00 01 1237889999999999999999998776543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=334.27 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=193.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|.+.+.||+|+||.||+|.++ +|+.||+|++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEE
Confidence 357999999999999999999886 68999999985422 2346789999999999999999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999998653 378999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
. .......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...........+.... ... .
T Consensus 164 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~----~-- 231 (276)
T 2h6d_A 164 G----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYI----P-- 231 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCC----C--
T ss_pred C----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--ccC----c--
Confidence 1 12234568999999999987765 689999999999999999999997766555444433211 000 0
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ....+++.+|++.||++||++.|++++
T Consensus 232 -----~~~~-----~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 -----EYLN-----RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----TTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----hhcC-----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 112378899999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.36 Aligned_cols=251 Identities=21% Similarity=0.364 Sum_probs=200.5
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
..++|.+.+.||+|+||.||+|+.. +|+.||+|++..... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-THYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-CEEEEEE
Confidence 3467999999999999999999875 689999999975432 345788999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee---CCCCceEEeccCcccccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 989 (1133)
||+++++|.+++...+ .+++..+..++.|++.||+|||+.||+||||||+||++ +.++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999997643 37899999999999999999999999999999999999 788999999999986431
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
. .......|++.|+|||++.+..++.++||||+||++|||++|+.||...........+.+.... ...+.
T Consensus 161 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~ 230 (304)
T 2jam_A 161 N-----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-----FESPF 230 (304)
T ss_dssp C-----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-----CCTTT
T ss_pred C-----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----CCccc
Confidence 1 1122346899999999999989999999999999999999999999876665555444332110 00000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .. ....+++.+|++.||++||++.|++++
T Consensus 231 ~~~---~~------~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 231 WDD---IS------ESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTT---SC------HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccc---CC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 00 112378999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=350.99 Aligned_cols=270 Identities=21% Similarity=0.310 Sum_probs=200.0
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----CcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----DVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~~l 910 (1133)
..+|++.++||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++.... ...++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 347999999999999999999997777799999865432 2347999999999999999999985432 23579
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC-CCCceEEeccCcccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD-ADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 989 (1133)
||||++++ +.+.+...... ...+++..+..++.||++||+|||++||+||||||+||+++ .++.+||+|||+++...
T Consensus 116 v~e~~~~~-l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKL-KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCcc-HHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99999764 44444332211 24589999999999999999999999999999999999999 79999999999997653
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc-----
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS----- 1063 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~----- 1063 (1133)
.. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+....+.+........
T Consensus 194 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 194 AG----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TT----CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CC----CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 223345789999999998664 58999999999999999999999998777666555554432221110
Q ss_pred --ccccCCcCCCCCCChhHHHH------HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcC
Q 001171 1064 --ELLEPGLLELDPESSEWEEF------LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRV 1116 (1133)
Q Consensus 1064 --~~~~~~~~~~~~~~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~ 1116 (1133)
............ ..+... ....+++.+||+.||++||++.|++++ ++++..
T Consensus 270 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 270 NPNYMEHKFPQIRP--HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CGGGSSSCCCCCCC--CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred ChhhhhhccccccC--CcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011111111000 011110 123489999999999999999999986 555444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=346.24 Aligned_cols=268 Identities=20% Similarity=0.276 Sum_probs=201.9
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeC---CCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAG---PPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|++++++++||||+++++++.. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45899999999999999999987 568999999986432 235678899999999999999999999862 2345689
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++...... ...+++..++.++.||++||+|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999999875332 34589999999999999999999999999999999999999999999999998864321
Q ss_pred CCCCC------CCCCCCCCCCCccCccccCCCC---CCCCCchhHHHHHHHHHHhCCCCCccCC--hhhHHHHHHHHhhh
Q 001171 991 TPAEA------SSSTTPIGSLGYVSPEAASTGQ---PTKEADVYSFGIVLLEILTGRKPVMFTQ--DEDIVKWVKKQLQR 1059 (1133)
Q Consensus 991 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~Pf~~~~--~~~~~~~~~~~~~~ 1059 (1133)
..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+.. .
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~ 263 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---Q 263 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---c
Confidence 11100 0012235789999999987554 6899999999999999999999995311 1111111111 0
Q ss_pred ccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
... +... ... . ...+++.+||+.||.+||++.|++++|+.+......+
T Consensus 264 ~~~-----~~~~---~~~----~--~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 264 LSI-----PQSP---RHS----S--ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp --C-----CCCT---TSC----H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred CCC-----Cccc---cCC----H--HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 000 0000 001 1 1237889999999999999999999999987644443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=343.37 Aligned_cols=243 Identities=19% Similarity=0.306 Sum_probs=196.4
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---------CHHHHHHHHHHHhhccCCCeeeEEEEEeC
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---------DENTFRKEAEALGKVKHRNLTVLRGYYAG 903 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 903 (1133)
...++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 35678999999999999999999764 689999999975432 23457789999999999999999999987
Q ss_pred CCCcEEEEEeccCCC-CHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 904 PPDVRLLVYDYMPNG-NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
. ...++||||+.+| +|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus 101 ~-~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 Q-GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp S-SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred C-CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeec
Confidence 6 4558999999777 9999998643 3899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++..... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 175 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------- 236 (335)
T 3dls_A 175 GSAAYLERG----KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------- 236 (335)
T ss_dssp TTCEECCTT----CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------
T ss_pred ccceECCCC----CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------
Confidence 999754322 12234569999999999988776 78899999999999999999999642110
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
............. ...+++.+||+.||++||++.|++++
T Consensus 237 ----~~~~~~~~~~~~~------~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----VEAAIHPPYLVSK------ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTTCCCCSSCCCH------HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HhhccCCCcccCH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000111 12378889999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=335.81 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=197.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-----cCHHHHHHHHHHHhhccCCCeeeEEEEEeC-CCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-----IDENTFRKEAEALGKVKHRNLTVLRGYYAG-PPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~ 908 (1133)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999875 68999999986432 234678999999999999999999999853 33456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||++++ +.+++.... ...+++..+..++.||++||+|||++||+||||||+||+++.++.+|++|||.++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 777777543 245899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCC--CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQP--TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..... ........|++.|+|||++.+... +.++||||+||++|||++|+.||...........+.+. ... +
T Consensus 160 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----~~~--~ 232 (305)
T 2wtk_C 160 HPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----SYA--I 232 (305)
T ss_dssp CTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC----CCC--C
T ss_pred Ccccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC----CCC--C
Confidence 32211 122334568999999999876443 77999999999999999999999876655544443321 110 0
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ... ...+++.+||+.||++||++.|++++
T Consensus 233 ~~~------~~~------~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 PGD------CGP------PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CSS------SCH------HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCc------cCH------HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 011 12278889999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=352.22 Aligned_cols=200 Identities=22% Similarity=0.324 Sum_probs=164.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC----Cc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP----DV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 907 (1133)
.++|++.++||+|+||.||+|.++ +|+.||||++...... .+.+.+|++++++++||||+++++++.... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999875 5899999999754332 467889999999999999999999987543 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+||||++ |+|.+++... ..+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 699999995 6999999753 3489999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCC-------------------CCCCCCCCCCCCccCcccc-CCCCCCCCCchhHHHHHHHHHHhCCCCC
Q 001171 988 AIATPAE-------------------ASSSTTPIGSLGYVSPEAA-STGQPTKEADVYSFGIVLLEILTGRKPV 1041 (1133)
Q Consensus 988 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~tg~~Pf 1041 (1133)
....... .......+||+.|+|||++ .+..++.++||||+||++|||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 5432211 0123566899999999986 5667999999999999999999854444
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=349.10 Aligned_cols=271 Identities=20% Similarity=0.277 Sum_probs=203.0
Q ss_pred HHHHHHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC------------HHHHHHHHHHHhhccCCCeee
Q 001171 829 YVETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID------------ENTFRKEAEALGKVKHRNLTV 896 (1133)
Q Consensus 829 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~hpniv~ 896 (1133)
..+.....++|++.+.||+|+||.||+|...+|+.||||++...... .+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 44566778999999999999999999999888999999998543221 267899999999999999999
Q ss_pred EEEEEeCC----CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC
Q 001171 897 LRGYYAGP----PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD 972 (1133)
Q Consensus 897 l~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~ 972 (1133)
+++++... ....++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc
Confidence 99998532 235689999997 68888887532 3489999999999999999999999999999999999999
Q ss_pred CCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHH
Q 001171 973 ADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK 1051 (1133)
Q Consensus 973 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~ 1051 (1133)
.++.+||+|||+++.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTA----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp TTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCCEEEEecCccccccc----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999864322 122334578999999999876 678999999999999999999999998777666665
Q ss_pred HHHHHhhhccccc-----------cccCCcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1052 WVKKQLQRGQISE-----------LLEPGLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.+......... ............ .+... ....+++.+|++.||++|||+.|++++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR--AWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC--CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh--hHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 5554433222111 111111111100 01111 112378999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.38 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=202.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceE--EEEEEcccCC--cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMV--LSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.+.||+|+||.||+|+++ +|.. ||+|++.... ...+.+.+|+++++++ +||||+++++++... ...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceE
Confidence 367999999999999999999764 4654 4999886432 2346789999999999 899999999999876 4559
Q ss_pred EEEeccCCCCHHHHHHhhcc-----------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceE
Q 001171 910 LVYDYMPNGNLATLLQEASH-----------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
+||||+++|+|.+++...+. .....+++..++.++.||++||+|||++||+||||||+||+++.++.+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 99999999999999986531 1224589999999999999999999999999999999999999999999
Q ss_pred EeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHh
Q 001171 979 LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
|+|||+++.... ........+++.|+|||++.+..++.++||||+||++|||++ |+.||......+....+...
T Consensus 183 L~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~- 257 (327)
T 1fvr_A 183 IADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 257 (327)
T ss_dssp ECCTTCEESSCE----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred EcccCcCccccc----cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-
Confidence 999999863211 122233457889999999988888999999999999999998 99999776655444332221
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
.... .+.... ....+++.+||+.||++||++.|++++|+.+....
T Consensus 258 ---~~~~--------~~~~~~-----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 258 ---YRLE--------KPLNCD-----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ---CCCC--------CCTTBC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---CCCC--------CCCCCC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 000000 11237889999999999999999999998766544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=373.02 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=203.4
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 908 (1133)
..++|++.++||+|+||.||+|+++ +++.||||++.+. ....+.+..|.+++..+ +||+|+.+++++.+. +..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-SEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-CEE
Confidence 4568999999999999999999875 5889999998642 22346778899999988 799999999998875 455
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+||||+++|+|.++++..+ .+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999998754 3889999999999999999999999999999999999999999999999999753
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+... ...++
T Consensus 493 ~~~---~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p----- 562 (674)
T 3pfq_A 493 IWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYP----- 562 (674)
T ss_dssp CCT---TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--CCCCC-----
T ss_pred ccC---CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCC-----
Confidence 222 22344568999999999999999999999999999999999999999877766655554331 11111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCH-----HHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSM-----ADIVF 1109 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~-----~evl~ 1109 (1133)
.... ....+++.+||+.||++||++ +||++
T Consensus 563 ------~~~s-----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 ------KSMS-----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------TTSC-----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------ccCC-----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1100 112378999999999999997 77774
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=345.89 Aligned_cols=263 Identities=21% Similarity=0.351 Sum_probs=198.4
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..++|++.+.||+|+||.||+|.++. .||+|++..... ..+.+.+|++++++++||||+++++++.... ..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-HLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-CEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-ceEEE
Confidence 35689999999999999999998864 489998864322 2356788999999999999999999998764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999997532 3488999999999999999999999999999999999998 689999999998654321
Q ss_pred CC--CCCCCCCCCCCCCccCccccCC---------CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 992 PA--EASSSTTPIGSLGYVSPEAAST---------GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 992 ~~--~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
.. .........|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+...
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---- 258 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG---- 258 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT----
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC----
Confidence 11 1222334568999999999864 34788999999999999999999999876665544433222
Q ss_pred cccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 001171 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMP 1121 (1133)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 1121 (1133)
.......... . . ...+++.+||+.||++||++.|+++.|+.+.......
T Consensus 259 ~~~~~~~~~~---~---~------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 259 MKPNLSQIGM---G---K------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp CCCCCCCSSC---C---T------THHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred CCCCCCcCCC---C---H------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 1111111111 0 1 1227888999999999999999999999988765443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=351.21 Aligned_cols=271 Identities=18% Similarity=0.258 Sum_probs=185.2
Q ss_pred cCCCc-ccccccccceeEEEEEEC---CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeC-CCCcEEEE
Q 001171 837 RQFDE-ENVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAG-PPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~~lV 911 (1133)
+.|++ +++||+|+||.||+|+++ +++.||||++..... ...+.+|++++++++||||+++++++.. .....++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 34665 568999999999999875 578999999975443 4578899999999999999999999853 34566899
Q ss_pred EeccCCCCHHHHHHhhccC----CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee----CCCCceEEeccC
Q 001171 912 YDYMPNGNLATLLQEASHQ----DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF----DADFEAHLSEFG 983 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg 983 (1133)
|||++ |+|.+++...... ....+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 99995 6888888654321 11248899999999999999999999999999999999999 678899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChh---------hHHHHH
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDE---------DIVKWV 1053 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~---------~~~~~~ 1053 (1133)
+++................||+.|+|||++.+. .++.++||||+||++|||++|+.||...... +....+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 997654332222334456799999999999774 5899999999999999999999999654331 223333
Q ss_pred HHHhhhccccccccCCcCCCCC-------------CChhHHH---------HHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1054 KKQLQRGQISELLEPGLLELDP-------------ESSEWEE---------FLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~---------~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
............ +....... ....... -....+++.+||+.||++|||++|++++=
T Consensus 258 ~~~~g~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 258 FNVMGFPADKDW--EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHCCCCTTTC--GGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhhCCCChhhc--chhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 322221110000 00000000 0000000 01223789999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=356.38 Aligned_cols=251 Identities=19% Similarity=0.300 Sum_probs=189.1
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---------CHHHHHHHHHHHhhccCCCeeeEEEEEeC
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---------DENTFRKEAEALGKVKHRNLTVLRGYYAG 903 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 903 (1133)
...++|.+.+.||+|+||.||+|.++ +++.||||++..... ....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35678999999999999999999775 589999999864321 12357899999999999999999999865
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC---ceEEe
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF---EAHLS 980 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~ 980 (1133)
. ..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+
T Consensus 212 ~--~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 E--DYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp S--EEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred C--ceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence 4 358999999999998887643 3489999999999999999999999999999999999997544 59999
Q ss_pred ccCcccccccCCCCCCCCCCCCCCCCccCccccCC---CCCCCCCchhHHHHHHHHHHhCCCCCccCChh-hHHHHHHHH
Q 001171 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST---GQPTKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQ 1056 (1133)
Q Consensus 981 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~ 1056 (1133)
|||+++.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 285 DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~- 359 (419)
T 3i6u_A 285 DFGHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 359 (419)
T ss_dssp CSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-
T ss_pred ecccceecCC----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-
Confidence 9999975422 122344679999999999853 56788999999999999999999999754332 22222221
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..... .. ..+..+. ...+++.+||+.||++||+++|++++
T Consensus 360 ---~~~~~-~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 ---GKYNF-IP----------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---TCCCC-CH----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCCC-Cc----------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11100 00 0001111 12378999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.46 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=198.2
Q ss_pred hcCCCcccccccccceeEEEEEE----CCceEEEEEEcccCC-----cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY----QDGMVLSIRRLRDGT-----IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
.++|++.++||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 36899999999999999999987 368999999986432 2345678899999999 699999999998775
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcc
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
...++||||+++|+|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 44589999999999999998643 3889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCccCccccCCC--CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 986 RLAIATPAEASSSTTPIGSLGYVSPEAASTG--QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 986 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+.......
T Consensus 207 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~- 283 (355)
T 1vzo_A 207 KEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP- 283 (355)
T ss_dssp EECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-
T ss_pred eecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC-
Confidence 7543221 1223345799999999999753 4789999999999999999999999754332222222222211110
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFML 1111 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~L 1111 (1133)
. .+... .. ...+++.+||+.||++|| ++.|++++.
T Consensus 284 -----~---~~~~~---~~--~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -----P---YPQEM---SA--LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----C---CCTTS---CH--HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----C---CCccc---CH--HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 00110 01 123789999999999999 999999765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=344.32 Aligned_cols=262 Identities=19% Similarity=0.231 Sum_probs=193.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----C
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----D 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 906 (1133)
.++|++.+.||+|+||.||+|... +++.||||++...... .+.+.+|++++++++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 458999999999999999999775 6899999999754332 356789999999999999999999997643 2
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||++ |+|.+++.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 5689999996 578888752 27889999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.+..... .++..
T Consensus 176 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~ 250 (371)
T 2xrw_A 176 TAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-CPEFM 250 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC-CHHHH
T ss_pred ccccc----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-CHHHH
Confidence 54221 12334578999999999999899999999999999999999999998766655444433221110 00000
Q ss_pred -------------cCCcC-----------CCCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 -------------EPGLL-----------ELDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 -------------~~~~~-----------~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+... ..+......... ....+++.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000 000111111111 223489999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=351.16 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=197.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCC-----CCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP-----PDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~~ 909 (1133)
..+|++.++||+|+||.||+|++. +|+.||||++.... ....+|++++++++|||||++++++... ....+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 346899999999999999999885 58999999986543 2345799999999999999999988431 12346
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLA 988 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~ 988 (1133)
+||||+++ ++.+.+...... ...+++..+..++.||++||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eehhcccc-cHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 89999964 677766543221 2458999999999999999999999999999999999999965 56899999999754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc--
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL-- 1065 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 1065 (1133)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+....+.+.........+
T Consensus 208 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTT----CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ccC----CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 322 223345789999999998764 6899999999999999999999999877665544444443221110000
Q ss_pred ccCCcCCCC---CCChhHHHH------HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELD---PESSEWEEF------LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~---~~~~~~~~~------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+...++. .....|... ....+++.+||+.||++||++.|++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 011111100 001112111 123489999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=338.92 Aligned_cols=269 Identities=23% Similarity=0.313 Sum_probs=205.8
Q ss_pred HhcCCCcccccccccceeEEEEEE--CCceEEEEEEcccCCc---CHHHHHHHHHHHhhc---cCCCeeeEEEEEe----
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASY--QDGMVLSIRRLRDGTI---DENTFRKEAEALGKV---KHRNLTVLRGYYA---- 902 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~hpniv~l~~~~~---- 902 (1133)
..++|++.+.||+|+||.||+|.+ .+|+.||+|++..... ....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999987 3689999999864322 234677888888777 8999999999986
Q ss_pred CCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 903 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
......++||||++ |+|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 23345689999997 699999987432 33889999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
|+++.... ........|++.|+|||++.+..++.++||||+||++|||++|+.||......+....+.+.......
T Consensus 165 g~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCG----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cccccccC----CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99865422 12234457899999999999989999999999999999999999999877766666555544322111
Q ss_pred ccccc--------------CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcC
Q 001171 1063 SELLE--------------PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRV 1116 (1133)
Q Consensus 1063 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~ 1116 (1133)
..... ......... ... ...+++.+||+.||++||++.|++++ +..+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTD---IDE--LGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCS---CCH--HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccCccccccchhhhcccCcchhhhcccc---CCH--HHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 11000 000000000 011 12378999999999999999999964 444443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=346.72 Aligned_cols=203 Identities=23% Similarity=0.426 Sum_probs=174.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEE
Confidence 357999999999999999999876 689999999875432 246788999999999999999999999876 4459999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||+++++|.+++...+ .+++..+..++.+++.|++|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 111 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999998753 388999999999999999999996 9999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhH
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~ 1049 (1133)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 186 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp -----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred -----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 22345789999999999999999999999999999999999999976655443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=344.71 Aligned_cols=263 Identities=20% Similarity=0.322 Sum_probs=202.2
Q ss_pred hcCCCcccccccccceeEEEEEE-----CCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC-CcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-----QDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPP-DVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~ 908 (1133)
.++|++.+.||+|+||.||+|++ .+|+.||||++..... ..+.+.+|++++++++||||+++++++.... ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45789999999999999999984 3689999999975432 2467899999999999999999999986543 345
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++++|.+++.... ..+++..++.++.||++||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999998743 34889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh------------hHHHHHHHH
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE------------DIVKWVKKQ 1056 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~------------~~~~~~~~~ 1056 (1133)
..............++..|+|||++.+..++.++||||+||++|||++|..||...... .....+.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 43322112233456778899999998888899999999999999999999998532110 111111111
Q ss_pred hhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1057 LQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
....... ..+.. .. ....+++.+||+.||++||++.|+++.|+.+.
T Consensus 276 ~~~~~~~--------~~~~~---~~--~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNGRL--------PRPDG---CP--DEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTCCC--------CCCTT---CC--HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCC--------CCCCc---cc--HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111100 00000 00 11237889999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=341.88 Aligned_cols=270 Identities=19% Similarity=0.284 Sum_probs=206.0
Q ss_pred HHHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhh--ccCCCeeeEEEEEeCCC---C
Q 001171 832 TLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGK--VKHRNLTVLRGYYAGPP---D 906 (1133)
Q Consensus 832 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~---~ 906 (1133)
.....++|++.+.||+|+||.||+|+++ |+.||||++... ..+.+.+|+++++. ++||||+++++++.... .
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3445678999999999999999999885 899999998643 35678889999888 78999999999998764 2
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHh--------cCCceecccCccceeeCCCCceE
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH--------SLDMVHGDIKPQNVLFDADFEAH 978 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~ivH~Dlkp~NIll~~~~~~k 978 (1133)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 568999999999999999763 3789999999999999999999 89999999999999999999999
Q ss_pred EeccCcccccccCCCCC-CCCCCCCCCCCccCccccCCCC------CCCCCchhHHHHHHHHHHhC----------CCCC
Q 001171 979 LSEFGLDRLAIATPAEA-SSSTTPIGSLGYVSPEAASTGQ------PTKEADVYSFGIVLLEILTG----------RKPV 1041 (1133)
Q Consensus 979 l~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~el~tg----------~~Pf 1041 (1133)
|+|||+++......... .......||+.|+|||++.+.. ++.++|||||||++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997654332211 1234557999999999997653 23689999999999999999 7788
Q ss_pred ccCChh-hHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1042 MFTQDE-DIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1042 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
...... .....+.+..........+...+ ..........+++.+||+.||++||++.||+++|+.+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-------QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccc-------cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 643221 11122222222111111111111 0111122233899999999999999999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=336.35 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=203.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.+.|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence 457999999999999999999764 68999999986443 2357899999999999999999999999875 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999999864 248899999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+.+. .... +....
T Consensus 174 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~-~~~~~-- 243 (303)
T 3a7i_A 174 ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN----NPPT-LEGNY-- 243 (303)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCC-CCSSC--
T ss_pred ---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC----CCCC-Ccccc--
Confidence 2234457899999999999989999999999999999999999999766555444333221 1111 11110
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
.. ...+++.+||+.||++||++.|++++.
T Consensus 244 ----~~------~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 244 ----SK------PLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ----CH------HHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ----CH------HHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 11 123788899999999999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=344.31 Aligned_cols=261 Identities=18% Similarity=0.231 Sum_probs=185.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhcc-CCCeeeEEEEEe-------CCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVK-HRNLTVLRGYYA-------GPP 905 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~-------~~~ 905 (1133)
..+|++.++||+|+||.||+|++. +|+.||||++..... ..+.+.+|+++++++. ||||+++++++. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999875 689999999854432 3467889999999996 999999999984 233
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeCCCCceEEeccC
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
...++||||+. |+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 44689999995 799999876432 234899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCC---------CCCCCCCCCCCccCcccc---CCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHH
Q 001171 984 LDRLAIATPAEA---------SSSTTPIGSLGYVSPEAA---STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK 1051 (1133)
Q Consensus 984 ~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~ 1051 (1133)
+++......... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~- 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV- 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-
Confidence 997653322111 111245689999999998 5667889999999999999999999999643322211
Q ss_pred HHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
... ....... .... ...+++.+||+.||++||++.|++++|+.+.....
T Consensus 263 --~~~-----~~~~~~~------~~~~------~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 263 --NGK-----YSIPPHD------TQYT------VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----------CCCCTTC------CSSG------GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --cCc-----ccCCccc------ccch------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 110 0000000 0001 12378889999999999999999999998776443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.03 Aligned_cols=267 Identities=19% Similarity=0.300 Sum_probs=185.2
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-CEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEEE
Confidence 4568999999999999999999764 68999999986432 23467889999999999999999999998765 45999
Q ss_pred EeccCCCCHHHHHHhhcc---CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 912 YDYMPNGNLATLLQEASH---QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|||+++++|.+++..... .....+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999999975321 12345899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC--CCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 989 IATPA--EASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 989 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
..... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........................
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 33211 1112234579999999999865 56899999999999999999999999766555433322211100000000
Q ss_pred ccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.++.... .... ...+++.+||+.||.+||++.|++++
T Consensus 252 ~~~~~~~--~~~~------~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 252 QDKEMLK--KYGK------SFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ---CCCC--CCCH------HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccchhhh--hhhH------HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111100 0111 12378889999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.68 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=198.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
..++|++.+.||+|+||.||+|.++ +++.||+|++.... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEE
Confidence 3467999999999999999999876 68999999986432 2246789999999999999999999999875 455899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++++|.+++... ..+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999888642 34889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
.. ........|++.|+|||++.+..+ +.++||||+||++|||++|+.||.............. .... ... ..
T Consensus 159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---~~~-~~ 231 (276)
T 2yex_A 159 NR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKKT---YLN-PW 231 (276)
T ss_dssp TE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH--TTCT---TST-TG
T ss_pred cc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh--hccc---ccC-ch
Confidence 21 122344578999999999987665 7789999999999999999999976544321111111 1100 000 00
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .... ...+++.+|++.||++||++.|++++
T Consensus 232 ~-------~~~~--~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 232 K-------KIDS--APLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp G-------GSCH--HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred h-------hcCH--HHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 0001 12378999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=354.05 Aligned_cols=261 Identities=18% Similarity=0.214 Sum_probs=201.5
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.++|++.++||+|+||.||+|.+ .+++.||||++..... ...+.+|+++++.++|++.+..+.++.......++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 35899999999999999999987 4689999998765432 346889999999998755554444444444666999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee---CCCCceEEeccCcccccccC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 85 ~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp C-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred C-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9 999999998643 348999999999999999999999999999999999999 68899999999999765433
Q ss_pred CCCC----CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh---hccccc
Q 001171 992 PAEA----SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ---RGQISE 1064 (1133)
Q Consensus 992 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~---~~~~~~ 1064 (1133)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 2211 122356799999999999999999999999999999999999999976544332222222111 111111
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.. ..+ . ....+++.+||+.||++||++.+|++.|+.+.
T Consensus 240 l~-~~~------p------~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 240 LC-RGY------P------TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HH-TTS------C------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred Hh-cCC------c------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11 111 0 11237888999999999999999999998763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=335.31 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=197.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ..+.+.+|++++++++||||+++++++... ...++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEee
Confidence 4568999999999999999999876 58999999997543 456789999999999999999999999875 44599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 105 YCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp CCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 999999999997432 34899999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 994 EASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........|++.|+|||++.+..++.++||||+||++|+|++|+.||...........+... .......+
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~----- 248 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN----PPPTFRKP----- 248 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSSG-----
T ss_pred -ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC----CCcccCCc-----
Confidence 12233457899999999999889999999999999999999999999765544333222111 10000000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+.. ...+++.+||+.||.+||++.|++++
T Consensus 249 ----~~~~~--~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 249 ----ELWSD--NFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----GGSCH--HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----ccCCH--HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00011 12378899999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=333.56 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=200.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----------CHHHHHHHHHHHhhcc-CCCeeeEEEEEeC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----------DENTFRKEAEALGKVK-HRNLTVLRGYYAG 903 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 903 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||||++..... ..+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999875 689999999864321 1356788999999995 9999999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccC
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
. ...++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 96 ~-~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 N-TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp S-SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred C-CeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 5 45699999999999999998643 38899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccC------CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHh
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAAS------TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 1057 (1133)
+++..... .......|++.|+|||++. ...++.++||||+|+++|||++|+.||...........+....
T Consensus 170 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 170 FSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp TCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred chhhcCCC----cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 98754321 2233457899999999984 4567899999999999999999999997766555444433321
Q ss_pred hhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.. ...+.. ..... ...+++.+||+.||++||++.|+++
T Consensus 246 ~~-----~~~~~~-------~~~~~--~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 YQ-----FGSPEW-------DDYSD--TVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC-----CCTTTG-------GGSCH--HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cc-----cCcccc-------cccCH--HHHHHHHHHccCCcccCCCHHHHHh
Confidence 10 000100 00111 1237899999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=362.31 Aligned_cols=244 Identities=16% Similarity=0.140 Sum_probs=186.3
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccC----CcCHHHHHHHHH---HHhhccCCCeeeEE-------EE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDG----TIDENTFRKEAE---ALGKVKHRNLTVLR-------GY 900 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~---~l~~l~hpniv~l~-------~~ 900 (1133)
.++|++.+.||+|+||.||+|.+ .+|+.||||++... ....+.+.+|++ ++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45789999999999999999986 46999999998632 223467889994 55556899999988 66
Q ss_pred EeCCCC----------------cEEEEEeccCCCCHHHHHHhhccCCC--CCCChHHHHHHHHHHHHHHHHHhcCCceec
Q 001171 901 YAGPPD----------------VRLLVYDYMPNGNLATLLQEASHQDG--HVLNWPMRHLISLGLARGLSFLHSLDMVHG 962 (1133)
Q Consensus 901 ~~~~~~----------------~~~lV~e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~ 962 (1133)
+..... ..++||||+ +|+|.+++...+.... ..+++..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 654422 258999999 6899999987543221 224457888899999999999999999999
Q ss_pred ccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCC-----------CCCCCCchhHHHHHH
Q 001171 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG-----------QPTKEADVYSFGIVL 1031 (1133)
Q Consensus 963 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlG~il 1031 (1133)
||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999987421 12234567 999999999877 799999999999999
Q ss_pred HHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1032 LEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1032 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
|||++|+.||.......... .+...... ... ...+++.+||+.||++||++.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~-------------~~~~~~~~---~~~------~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSE-------------WIFRSCKN---IPQ------PVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CCSG-------------GGGSSCCC---CCH------HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccchh-------------hhhhhccC---CCH------HHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999996433221110 01111111 111 1237889999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=342.61 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=186.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC-----CC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP-----PD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 906 (1133)
.++|++.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|++++++++||||+++++++... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999764 6899999999654322 45778999999999999999999998653 13
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 358999999 7899888864 238899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+.+....... +.
T Consensus 181 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~-~~ 253 (367)
T 2fst_X 181 HTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA-EL 253 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH-HH
T ss_pred cccc------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH-HH
Confidence 5421 2334578999999999876 67899999999999999999999999877766665555544322110 00
Q ss_pred ccC-----------CcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEP-----------GLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~-----------~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .+..... ..+... ....+++.+|++.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPK--MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCC--CCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCC--CCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000000 011111 123489999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=341.76 Aligned_cols=256 Identities=18% Similarity=0.254 Sum_probs=200.4
Q ss_pred HHHhcCCCcc-cccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCC
Q 001171 833 LEATRQFDEE-NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 833 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 906 (1133)
....++|.+. +.||+|+||.||+|... +|+.||+|++.... .....+.+|++++++++ ||||+++++++... .
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-~ 102 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-S 102 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-S
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-C
Confidence 3445577777 89999999999999876 58999999986432 23578899999999994 69999999999876 4
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccC
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFG 983 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg 983 (1133)
..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 4599999999999998885432 245899999999999999999999999999999999999988 7899999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+..... ...
T Consensus 180 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~ 253 (327)
T 3lm5_A 180 MSRKIGHA----CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV--DYS 253 (327)
T ss_dssp GCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCC
T ss_pred cccccCCc----cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc--ccC
Confidence 99754321 122345799999999999999999999999999999999999999987666555444433211 110
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..... ... . ...+++.+||+.||++||+++|++++
T Consensus 254 ---~~~~~---~~~----~--~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 ---EETFS---SVS----Q--LATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---TTTTT---TSC----H--HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---chhhc---ccC----H--HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00000 001 1 12378899999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=333.99 Aligned_cols=252 Identities=19% Similarity=0.310 Sum_probs=182.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.+.||+|+||.||+|++. +|+.||+|++...... .+.+.+|...++.++||||+++++++.... ..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-SEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-CEEEE
Confidence 468999999999999999999874 6899999999754322 223445555688889999999999998764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCccccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|||++ |+|.+++...... ...+++..+..++.|++.|++|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred Eehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99996 5888888654322 24589999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCCCCCccCcccc----CCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAA----STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
. .......||+.|+|||++ .+..++.++||||+||++|||++|+.||....... ..+........ ....
T Consensus 163 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~-~~~~ 235 (290)
T 3fme_A 163 D----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPS-PQLP 235 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHHSCC-CCCC
T ss_pred c----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhccCC-CCcc
Confidence 2 122334689999999996 55678899999999999999999999997533221 11122211111 1111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.... .. ...+++.+|++.||++||++.|+++
T Consensus 236 ~~~~------~~------~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 ADKF------SA------EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTTS------CH------HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccC------CH------HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1000 11 1237889999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=338.50 Aligned_cols=264 Identities=16% Similarity=0.246 Sum_probs=203.3
Q ss_pred hcCCCcccccccccceeEEEEEE-C-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCC------eeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-Q-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN------LTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|.+ + +++.||||++.......+.+.+|+++++.++|++ ++++++++.... .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~-~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG-H 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-E
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-c
Confidence 35899999999999999999976 3 6899999999765545577899999999997664 999999998764 5
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC--------------
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-------------- 973 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-------------- 973 (1133)
.++||||+ +++|.+++...+. ..+++..+..++.||++||+|||++||+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 59999999 8999999987542 34789999999999999999999999999999999999987
Q ss_pred -----CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh
Q 001171 974 -----DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048 (1133)
Q Consensus 974 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~ 1048 (1133)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccCCCceEeeCcccccCcc------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999865321 2234578999999999999999999999999999999999999998776666
Q ss_pred HHHHHHHHhhhccc--------cccccCCcCCCCCCC------------------hhHHHHHHhHhhhhccCCCCCCCCC
Q 001171 1049 IVKWVKKQLQRGQI--------SELLEPGLLELDPES------------------SEWEEFLLGVKVGLLCTAPDPLDRP 1102 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~------------------~~~~~~~~~~~li~~Cl~~dP~~RP 1102 (1133)
....+.+....... ............... ..........+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 55554443221100 000000000000000 0001112234899999999999999
Q ss_pred CHHHHHHH
Q 001171 1103 SMADIVFM 1110 (1133)
Q Consensus 1103 s~~evl~~ 1110 (1133)
++.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999865
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=343.19 Aligned_cols=336 Identities=19% Similarity=0.205 Sum_probs=212.4
Q ss_pred CCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCcccccee
Q 001171 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440 (1133)
Q Consensus 361 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 440 (1133)
.++++++|++++|.++...+..+..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 36788999999999887777778888999999999999887777788888888888888888888777778888888888
Q ss_pred ecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCC
Q 001171 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 441 ~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
++++|+++...+..|.++++|++|++++|.+++..+..++.+++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 8888888855555567788888888888888776677777777777777777777653 2455666777777777665
Q ss_pred CCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCcccc
Q 001171 521 GELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600 (1133)
Q Consensus 521 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 600 (1133)
+ +...++|++|++++|.+....... .++|+.|++++|++++. .. +.
T Consensus 200 ~-----~~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~n~l~~~--~~------------------------l~ 245 (390)
T 3o6n_A 200 T-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT--AW------------------------LL 245 (390)
T ss_dssp E-----EECCSSCSEEECCSSCCCEEECCC---CSSCCEEECCSSCCCCC--GG------------------------GG
T ss_pred c-----cCCCCcceEEECCCCeeeeccccc---cccccEEECCCCCCccc--HH------------------------Hc
Confidence 2 223345566666666555332211 23455555555555432 23 44
Q ss_pred CCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccccc
Q 001171 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTL 680 (1133)
Q Consensus 601 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 680 (1133)
.+++|++|++++|.+++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 4444555555555544444444444555555555555554 23444444555555555555555 344445555555555
Q ss_pred ccccccccccCCccccccccCcccccccccccccCCccccCCCCCCcccCcCccccCCC
Q 001171 681 NLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKP 739 (1133)
Q Consensus 681 ~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 739 (1133)
+|++|++++. | +..+++|+.|++++|++++.....+...+.... +.+++..|..+
T Consensus 324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~-~~~~~~~c~~~ 378 (390)
T 3o6n_A 324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPA-VDDADQHCKID 378 (390)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTT-BCCCCSCCCTT
T ss_pred ECCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHHHHHhhc-ccccCceeccc
Confidence 5555555532 2 445566666666666666654444333333333 45556666644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=334.82 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=197.4
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-eEEEEE
Confidence 4568999999999999999999886 58999999986433 34578899999999999999999999998764 559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp ECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999987643 23899999999999999999999999999999999999999999999999987532211
Q ss_pred CCCCCCCCCCCCCCccCcccc-----CCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 993 AEASSSTTPIGSLGYVSPEAA-----STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
........|++.|+|||++ .+..++.++||||+||++|||++|+.||...+.......+.+. .......
T Consensus 171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~ 244 (302)
T 2j7t_A 171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----DPPTLLT 244 (302)
T ss_dssp --HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSS
T ss_pred --ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc----CCcccCC
Confidence 1112345689999999998 4667899999999999999999999999766654443332221 1111111
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+ ..+.. ...+++.+||+.||++||++.|++++
T Consensus 245 ~---------~~~~~--~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 P---------SKWSV--EFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp G---------GGSCH--HHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred c---------cccCH--HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00011 12378899999999999999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=357.89 Aligned_cols=349 Identities=17% Similarity=0.143 Sum_probs=194.1
Q ss_pred CCccCCCCCCCCCCCc----cceeeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcc
Q 001171 47 GALDGWDSSTPSAPCD----WRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLR 122 (1133)
Q Consensus 47 ~~l~~w~~~~~~~~c~----w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 122 (1133)
..+++|..+. +||. |.+|.|+. + ++....+... ...-..+.+++.|++++|.+.+..+..++.+++|+
T Consensus 7 ~~l~~~~~~~--~C~~~~~~~~c~~~~~-~---i~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~ 78 (597)
T 3oja_B 7 YNVKPRQPEY--KCIDSNLQYDCVFYDV-H---IDMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78 (597)
T ss_dssp ----CCCSEE--CCCCC--CCSEEECSC-E---ECSSCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCS
T ss_pred ccccCCCCCC--cCcccCcCceeEecCc-e---eccccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHccCCCCc
Confidence 3468896543 4553 77776652 1 1111111111 11122356777777777777644444466777777
Q ss_pred eEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCC
Q 001171 123 AVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFS 202 (1133)
Q Consensus 123 ~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~ 202 (1133)
.|+|++|.+++..|..++++++| ++|+|++|.+++..|..|+++++|++|+|++|+++
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~~L----------------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 136 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAHTI----------------------QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCTTC----------------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EEECCCCCCCCCChHHhcCCCCC----------------------CEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC
Confidence 77777777776555556655544 44455555555555555666666666666666666
Q ss_pred CCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccc
Q 001171 203 GEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVL 282 (1133)
Q Consensus 203 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 282 (1133)
+..+..|+.+++|++|+|++|.+++..|..+.++++|++|++++|.+++.. ++.+++|+.|++++|.+++.
T Consensus 137 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l------ 207 (597)
T 3oja_B 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL------ 207 (597)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE------
T ss_pred CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc------
Confidence 433334456666666666666665555555556666666666666555432 34455555666666655432
Q ss_pred cCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCC
Q 001171 283 CNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSL 362 (1133)
Q Consensus 283 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 362 (1133)
....+|+.|++++| .++.+.+.. .++|++|+|++|.+++ +..++.+
T Consensus 208 ----~~~~~L~~L~ls~n-------------------------~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l 253 (597)
T 3oja_B 208 ----AIPIAVEELDASHN-------------------------SINVVRGPV---NVELTILKLQHNNLTD--TAWLLNY 253 (597)
T ss_dssp ----ECCTTCSEEECCSS-------------------------CCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGC
T ss_pred ----cCCchhheeeccCC-------------------------ccccccccc---CCCCCEEECCCCCCCC--ChhhccC
Confidence 11233444444444 444432222 1345555555555553 2445555
Q ss_pred CCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeec
Q 001171 363 DKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNL 442 (1133)
Q Consensus 363 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 442 (1133)
++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|+|
T Consensus 254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L 331 (597)
T 3oja_B 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 331 (597)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEEC
Confidence 556666666666555555556666666666666666654 3444555666666666666666 34555666677777777
Q ss_pred ccccccccCChhhcCCCCCcEEecccCcCCC
Q 001171 443 SENDIRGNIPEEITRLSNLTTLNLSYNKFGG 473 (1133)
Q Consensus 443 ~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~ 473 (1133)
++|.|++.. +..+++|+.|+|++|.+.+
T Consensus 332 ~~N~l~~~~---~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 332 DHNSIVTLK---LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CSSCCCCCC---CCTTCCCSEEECCSSCEEH
T ss_pred CCCCCCCcC---hhhcCCCCEEEeeCCCCCC
Confidence 777776432 5556677777777777654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=346.23 Aligned_cols=265 Identities=18% Similarity=0.209 Sum_probs=198.2
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc--------CCCeeeEEEEEeC---
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK--------HRNLTVLRGYYAG--- 903 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~~--- 903 (1133)
.++|++.++||+|+||+||+|++. +++.||||++.......+.+.+|++++++++ ||||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 368999999999999999999764 6899999999765545678889999999996 7889999998862
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCC-------
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADF------- 975 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~------- 975 (1133)
.....++||||+ ++++.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 234568999999 6677777765432 3489999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------ceEEeccCcccccccCCCCCCCCCCCCCCCCccCcccc
Q 001171 976 ------------------------------------------EAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013 (1133)
Q Consensus 976 ------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 1013 (1133)
.+||+|||.++.... ......||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCccCCCCCcccCChhh
Confidence 799999999975422 23345789999999999
Q ss_pred CCCCCCCCCchhHHHHHHHHHHhCCCCCccCCh------hhHHHHHHHHhhhc--------ccc-ccccC--Cc---CCC
Q 001171 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQD------EDIVKWVKKQLQRG--------QIS-ELLEP--GL---LEL 1073 (1133)
Q Consensus 1014 ~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~------~~~~~~~~~~~~~~--------~~~-~~~~~--~~---~~~ 1073 (1133)
.+..++.++|||||||++|||++|+.||..... .+....+.+..... ... +.+.. .. ...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 998999999999999999999999999975442 22222222221110 000 00000 00 000
Q ss_pred CCCC----------hhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1074 DPES----------SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1074 ~~~~----------~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.. ..........+++.+||+.||++|||++|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 001111223489999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=341.34 Aligned_cols=210 Identities=20% Similarity=0.288 Sum_probs=176.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CC-----CeeeEEEEEeCCCCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HR-----NLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~~~~~ 908 (1133)
.++|++.++||+|+||+||+|.+. +++.||||++.........+.+|+++++.++ |+ +++++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-NHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-TEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-Cce
Confidence 568999999999999999999875 6899999999765444567788999999885 55 499999998876 455
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHh--cCCceecccCccceeeC--CCCceEEeccCc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH--SLDMVHGDIKPQNVLFD--ADFEAHLSEFGL 984 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~ 984 (1133)
++||||++ |+|.+++..... ..+++..+..++.||+.||+||| +.||+||||||+||+++ .++.+||+|||+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999995 699999987532 33889999999999999999999 47899999999999994 478899999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHH
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 1056 (1133)
++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.+.
T Consensus 208 a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 208 SCQLGQ------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp CEETTC------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ceeccc------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 975421 223467899999999999999999999999999999999999999877776666655553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=353.38 Aligned_cols=253 Identities=13% Similarity=0.084 Sum_probs=176.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc----CHHHHHHHHHHHhhc--cCCCeeeEE-------EEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI----DENTFRKEAEALGKV--KHRNLTVLR-------GYYA 902 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l--~hpniv~l~-------~~~~ 902 (1133)
.+|++.+.||+|+||.||+|.+. +|+.||||++..... ..+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999875 789999999986443 245677886655555 599988755 3433
Q ss_pred CCC----------------CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHH------HHHHHHHHHHHHHHhcCCce
Q 001171 903 GPP----------------DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMR------HLISLGLARGLSFLHSLDMV 960 (1133)
Q Consensus 903 ~~~----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~iv 960 (1133)
... ...++||||++ |+|.+++...... +++..+ ..++.||++||+|||++||+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV----YVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc----cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 221 22589999998 8999999875432 455556 77889999999999999999
Q ss_pred ecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCC
Q 001171 961 HGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGR 1038 (1133)
Q Consensus 961 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~ 1038 (1133)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999975421 1113456799999999987 67899999999999999999999
Q ss_pred CCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1039 KPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1039 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.||.......... ............... +. ....... ...+++.+||+.||++||++.|+++
T Consensus 291 ~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~-~~~~~~~--~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS-----WKRPSLRVPGTDSLA-FG-SCTPLPD--FVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC-----CCBCCTTSCCCCSCC-CT-TSSCCCH--HHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc-----hhhhhhhhccccccc-hh-hccCCCH--HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997553321100 000000000000000 00 0000011 1237889999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=333.12 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=193.0
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+..+.++ +||||+++++++... +..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEE
Confidence 3467999999999999999999886 689999999875322 346788899999999 999999999999876 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC---------------
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD--------------- 974 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~--------------- 974 (1133)
+||||+++++|.+++...... ...+++..+..++.||++||+|||++||+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999999875431 1348999999999999999999999999999999999999844
Q ss_pred ----CceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhH
Q 001171 975 ----FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI 1049 (1133)
Q Consensus 975 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~ 1049 (1133)
..+|++|||.++.... .....||+.|+|||++.+. .++.++||||+||++|||++|.+|+.... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS-------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTC-------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred cCCceEEEEcccccccccCC-------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence 4789999999865422 1234589999999999765 55689999999999999999988764321 1
Q ss_pred HHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+ ......... .. ... ...+++.+||+.||++||++.|++++
T Consensus 237 ~~~~----~~~~~~~~~-~~------~~~------~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHEI----RQGRLPRIP-QV------LSQ------EFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHH----HTTCCCCCS-SC------CCH------HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHH----HcCCCCCCC-cc------cCH------HHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111 111111110 00 011 12378889999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=338.77 Aligned_cols=279 Identities=19% Similarity=0.259 Sum_probs=197.3
Q ss_pred HHHHHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCC---
Q 001171 831 ETLEATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPD--- 906 (1133)
Q Consensus 831 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 906 (1133)
......++|++.++||+|+||.||+|+++ +|+.||||++...........+|++.++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 34567789999999999999999999885 68999999997665555677889999999999999999999854222
Q ss_pred ---cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHh--cCCceecccCccceeeCC-CCceEEe
Q 001171 907 ---VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH--SLDMVHGDIKPQNVLFDA-DFEAHLS 980 (1133)
Q Consensus 907 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~ivH~Dlkp~NIll~~-~~~~kl~ 980 (1133)
..++||||+++ ++.+.+..... ....+++..+..++.|++.|++||| +.||+||||||+||+++. ++.+||+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 25799999975 56555543221 2345888999999999999999999 999999999999999997 8999999
Q ss_pred ccCcccccccCCCCCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhh
Q 001171 981 EFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059 (1133)
Q Consensus 981 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 1059 (1133)
|||+++..... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...........+.+....
T Consensus 175 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 175 DFGSAKKLSPS----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCTTCBCCCTT----SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eCCCceecCCC----CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999754322 2233457899999999986554 899999999999999999999999877766666555543322
Q ss_pred cccc--ccccCCcCC---CCCCChhHHH---------HHHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCc
Q 001171 1060 GQIS--ELLEPGLLE---LDPESSEWEE---------FLLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCR 1115 (1133)
Q Consensus 1060 ~~~~--~~~~~~~~~---~~~~~~~~~~---------~~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~ 1115 (1133)
.... ...++.... .......+.. -....+++.+||+.||.+||++.|++++ +++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 1100 000000000 0000011111 1123389999999999999999999976 44443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=366.60 Aligned_cols=256 Identities=22% Similarity=0.366 Sum_probs=202.9
Q ss_pred HhcCCCcccccccccceeEEEEEEC----CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
..++|++.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+.++++++||||+++++++.+ +..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cce
Confidence 3467899999999999999999874 2578999998653322 3678899999999999999999999854 335
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|+|.++++..+ ..+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 89999999999999998643 24889999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+...... . ..
T Consensus 542 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----~-~~ 614 (656)
T 2j0j_A 542 EDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----P-MP 614 (656)
T ss_dssp CC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----C-CC
T ss_pred CCCc--ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----C-CC
Confidence 3221 122233457789999999988889999999999999999997 99999877666655554432110 0 00
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
+.. . ....+++.+||+.||++||++.|+++.|+.+.
T Consensus 615 ~~~------~------~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 615 PNC------P------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TTC------C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccc------c------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 000 0 11237889999999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.76 Aligned_cols=268 Identities=19% Similarity=0.284 Sum_probs=192.2
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCC---------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGP--------- 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------- 904 (1133)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... ..+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 458999999999999999999886 489999999865432 246788999999999999999999988432
Q ss_pred ----CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC-CCCceEE
Q 001171 905 ----PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD-ADFEAHL 979 (1133)
Q Consensus 905 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl 979 (1133)
....++||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 245689999997 699999864 2378999999999999999999999999999999999997 5679999
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
+|||+++................++..|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999765332222223344567899999998755 6789999999999999999999999987666554444433211
Q ss_pred hcc----------ccccccCCcCCCCCCChhH-HHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1059 RGQ----------ISELLEPGLLELDPESSEW-EEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1059 ~~~----------~~~~~~~~~~~~~~~~~~~-~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... +.................. ..+ ....+++.+|++.||++||+++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000 0000000000000000000 000 112378999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=329.15 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=200.6
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC---cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT---IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
...++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-CeEE
Confidence 45678999999999999999999876 68999999986432 3457889999999999999999999999876 4559
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC---CceEEeccCccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD---FEAHLSEFGLDR 986 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~ 986 (1133)
+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999987643 38899999999999999999999999999999999999764 469999999987
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..... .......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||......+....+... ......
T Consensus 173 ~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~ 243 (287)
T 2wei_A 173 CFQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG----KYAFDL 243 (287)
T ss_dssp TBCCC----SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCS
T ss_pred eecCC----CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCCCCc
Confidence 54221 12233458889999999865 4899999999999999999999999876665554443332 111000
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+.... ... ...+++.+|++.||++||++.|++++
T Consensus 244 -~~~~~---~~~------~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 244 -PQWRT---ISD------DAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -GGGTT---SCH------HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhhhh---cCH------HHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00000 001 12378999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=337.35 Aligned_cols=249 Identities=19% Similarity=0.305 Sum_probs=192.1
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---------CHHHHHHHHHHHhhccCCCeeeEEEEEeCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---------DENTFRKEAEALGKVKHRNLTVLRGYYAGP 904 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 904 (1133)
..++|.+.+.||+|+||.||+|.+. +++.||||++..... ....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999875 589999999864321 123578999999999999999999999765
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc---eEEec
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE---AHLSE 981 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~D 981 (1133)
. .++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|
T Consensus 88 ~--~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D--YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S--EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c--eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 3 59999999999999998753 34889999999999999999999999999999999999987665 99999
Q ss_pred cCcccccccCCCCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHhCCCCCccCChh-hHHHHHHHHh
Q 001171 982 FGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQL 1057 (1133)
Q Consensus 982 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~~ 1057 (1133)
||+++..... .......||+.|+|||++. ...++.++||||+||++|||++|+.||...... .....+...
T Consensus 161 fg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 235 (322)
T 2ycf_A 161 FGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG- 235 (322)
T ss_dssp CTTCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT-
T ss_pred Cccceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC-
Confidence 9998754221 1112346899999999973 567899999999999999999999999754432 232222221
Q ss_pred hhccccccccCCcCCCCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1058 QRGQISELLEPGLLELDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.... .. ..+... ....+++.+||+.||++||++.|+++
T Consensus 236 ---~~~~-~~----------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 ---KYNF-IP----------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---CCCC-CH----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cccc-Cc----------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 00 000001 11237899999999999999999984
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=360.69 Aligned_cols=337 Identities=19% Similarity=0.207 Sum_probs=223.6
Q ss_pred CCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCcccccee
Q 001171 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETL 440 (1133)
Q Consensus 361 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 440 (1133)
.+++++.|++++|.+..+.+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 35678888888888888777778888888888888888887777788888888888888888888777777888888888
Q ss_pred ecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCC
Q 001171 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 441 ~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
+|++|.|++..+..|.++++|++|+|++|.+++..|..|+.+++|++|++++|.+++. .+..+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccc
Confidence 8888888765555667777777777777777777777777777777777777777653 2444566666666666655
Q ss_pred CCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCcccc
Q 001171 521 GELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600 (1133)
Q Consensus 521 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 600 (1133)
+ +...++|+.|++++|.+....+.. .++|+.|+|++|.+++ +..++
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l~~~~~~~---------------------------~~~L~~L~L~~n~l~~--~~~l~ 251 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSINVVRGPV---------------------------NVELTILKLQHNNLTD--TAWLL 251 (597)
T ss_dssp E-----EECCTTCSEEECCSSCCCEEECSC---------------------------CSCCCEEECCSSCCCC--CGGGG
T ss_pred c-----ccCCchhheeeccCCccccccccc---------------------------CCCCCEEECCCCCCCC--Chhhc
Confidence 2 223344555555555554322211 1345555555555543 24455
Q ss_pred CCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccccc
Q 001171 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTL 680 (1133)
Q Consensus 601 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 680 (1133)
.+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L 329 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence 55555555555555555555555555666666666666653 4555555666666666666666 455556666666666
Q ss_pred ccccccccccCCccccccccCcccccccccccccCCccccCCCCCCcccCcCccccCCCC
Q 001171 681 NLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPL 740 (1133)
Q Consensus 681 ~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~ 740 (1133)
+|++|++++. | +..+++|+.|++++|+++|..+..+...+.... +.++...|+.+.
T Consensus 330 ~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~-~~~~~~~C~~~~ 385 (597)
T 3oja_B 330 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPA-VDDADQHCKIDY 385 (597)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTT-BCCCCCCCCTTC
T ss_pred ECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhc-cccccccCCcch
Confidence 6666666643 2 456677788888888887776555444444444 667778888653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=339.35 Aligned_cols=258 Identities=20% Similarity=0.281 Sum_probs=197.6
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc----
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV---- 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---- 907 (1133)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|++++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 458999999999999999999775 6899999999754333 35788999999999999999999999765432
Q ss_pred -EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 908 -RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 908 -~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
.++||||++ ++|.+++.. .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 389999996 688877642 38899999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1133)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+.+...... .+.
T Consensus 193 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~ 265 (371)
T 4exu_A 193 HADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-TEF 265 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-HHH
T ss_pred cccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-HHH
Confidence 4321 2234578999999999877 6789999999999999999999999987766665555544322110 000
Q ss_pred ccC-----------CcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1066 LEP-----------GLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1066 ~~~-----------~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... ..... ....+... ....+++.+|++.||++||+++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQT--PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCC--CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCC--cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 00000 00001110 122378999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.51 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=192.3
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
+|....+||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEeC
Confidence 4555668999999999999874 688999999875432 356789999999999999999999999875 4558999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-CCceEEeccCcccccccCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
++++|.+++..... ....++..+..++.||+.||+|||+.||+||||||+||+++. ++.+||+|||+++.....
T Consensus 102 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--- 176 (295)
T 2clq_A 102 PGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--- 176 (295)
T ss_dssp SEEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC---
Confidence 99999999986432 234678888899999999999999999999999999999987 899999999998754321
Q ss_pred CCCCCCCCCCCCccCccccCCCC--CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQ--PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
........|++.|+|||++.+.. ++.++||||||+++|||++|+.||............... ...... +....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~-~~~~~-- 251 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKVHPE-IPESM-- 251 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCCCCC-CCTTS--
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--cccccc-ccccC--
Confidence 11233457899999999986543 789999999999999999999999654332221111111 110000 11000
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ...+++.+||+.||++||++.|++++
T Consensus 252 ----~~------~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 252 ----SA------EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----CH------HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----CH------HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 12278899999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=337.04 Aligned_cols=266 Identities=18% Similarity=0.267 Sum_probs=199.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCC----CCcE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGP----PDVR 908 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 908 (1133)
.++|++.+.||+|+||.||+|.+. +|+.||||++..... ....+.+|++++++++||||+++++++... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999875 689999999964332 235678999999999999999999988653 2456
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||++ |+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999998762 3889999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCC-------CCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc
Q 001171 989 IATPAEA-------SSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060 (1133)
Q Consensus 989 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 1060 (1133)
....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 4322111 11234578999999998754 678999999999999999999999998776655554444432221
Q ss_pred cccccccC-----------CcCCCCCCChhHH----HH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1061 QISELLEP-----------GLLELDPESSEWE----EF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1061 ~~~~~~~~-----------~~~~~~~~~~~~~----~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
........ ....... .... .+ ....+++.+||+.||++||+++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPA--APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCC--CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCC--cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11000000 0000000 0000 00 112378999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=334.03 Aligned_cols=289 Identities=20% Similarity=0.244 Sum_probs=239.8
Q ss_pred cccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEE
Q 001171 337 NVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416 (1133)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 416 (1133)
.++++++|++++|.+....+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|+++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46899999999999996666678999999999999999999888899999999999999999999999999999999999
Q ss_pred EccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCc
Q 001171 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496 (1133)
Q Consensus 417 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 496 (1133)
+|++|.++...+..|.++++|++|++++|++++..+..|..+++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999977667789999999999999999988888999999999999999999864 4677899999999999987
Q ss_pred cccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccc
Q 001171 497 GKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYG 576 (1133)
Q Consensus 497 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 576 (1133)
+. ...++|+.|++++|.++.. |.. ..++|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..+.
T Consensus 200 ~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 200 TL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp EE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred cc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 53 3346899999999999843 432 357999999999999864 5788899999999999999887777888
Q ss_pred cccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCccc
Q 001171 577 FLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLS 640 (1133)
Q Consensus 577 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 640 (1133)
.+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|.++
T Consensus 270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~ 331 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331 (390)
T ss_dssp TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC
T ss_pred ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc
Confidence 88888888888887773 4545555666666666666655 24444555555555555555554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=330.78 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=189.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCC----------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP---------- 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---------- 904 (1133)
.++|++.+.||+|+||.||+|+.. +|+.||||++.......+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 467999999999999999999875 689999999976544457789999999999999999999987542
Q ss_pred --CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 905 --PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 905 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
....++||||+++|+|.+++.... ..+++..++.++.||++||+|||++||+||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 245589999999999999998643 23678889999999999999999999999999999999999999999999
Q ss_pred CcccccccCCC-----------CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHH
Q 001171 983 GLDRLAIATPA-----------EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIV 1050 (1133)
Q Consensus 983 g~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~ 1050 (1133)
|+++....... .........|++.|+|||++.+. .++.++||||+||++|||++ ||.... +..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~~ 235 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ERV 235 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hHH
Confidence 99875432110 01122345789999999999764 68999999999999999998 553211 111
Q ss_pred HHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1051 KWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... +...... ....+... .. .. ....+++.+||+.||.+||++.|++++
T Consensus 236 ~~~-~~~~~~~--~~~~~~~~---~~---~~--~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NIL-KKLRSVS--IEFPPDFD---DN---KM--KVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHH-HHHHSTT--CCCCTTCC---TT---TS--HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHH-Hhccccc--cccCcccc---cc---ch--HHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111 1111111 00111110 00 00 112378999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=344.34 Aligned_cols=266 Identities=16% Similarity=0.277 Sum_probs=199.7
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC------------------HHHHHHHHHHHhhccCCCeeeE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID------------------ENTFRKEAEALGKVKHRNLTVL 897 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~hpniv~l 897 (1133)
.++|++.+.||+|+||.||+|.+ +|+.||+|++...... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45899999999999999999988 8999999998643221 1789999999999999999999
Q ss_pred EEEEeCCCCcEEEEEeccCCCCHHHHHHhhc---cCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCC
Q 001171 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEAS---HQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 898 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~ 973 (1133)
++++... +..++||||+++|+|.+++.... ......+++..+..++.||+.||+|||+ .||+||||||+||+++.
T Consensus 109 ~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 9999876 45599999999999998832211 1113458999999999999999999999 99999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCC-CCCC-CCchhHHHHHHHHHHhCCCCCccCCh-hhHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTK-EADVYSFGIVLLEILTGRKPVMFTQD-EDIV 1050 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlG~il~el~tg~~Pf~~~~~-~~~~ 1050 (1133)
++.+||+|||.++..... ......|++.|+|||++.+. .++. ++||||+||++|||++|+.||..... .+..
T Consensus 188 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred CCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999998754322 23445789999999999877 5555 99999999999999999999976554 4433
Q ss_pred HHHHHHhhhccccccccCCcCCCCCCC--hhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1051 KWVKKQLQRGQISELLEPGLLELDPES--SEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+... ...++.............. ...... ....+++.+||+.||.+||++.|++++
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 333221 0111100000000000000 000001 112378999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=333.09 Aligned_cols=264 Identities=19% Similarity=0.296 Sum_probs=201.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-Cc-eEEEEEEcccCCcCHHHHHHHHHHHhhccCCC------eeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DG-MVLSIRRLRDGTIDENTFRKEAEALGKVKHRN------LTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||.||+|... ++ +.||+|++.......+.+.+|++++++++|++ ++.+.+++.... .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG-H 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT-E
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC-e
Confidence 458999999999999999999874 34 79999999765555677889999999998766 889999887654 5
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceee----------------
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLF---------------- 971 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll---------------- 971 (1133)
.++||||+ ++++.+++..... ..+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 59999999 6778887776432 348999999999999999999999999999999999999
Q ss_pred ---CCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhh
Q 001171 972 ---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDED 1048 (1133)
Q Consensus 972 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~ 1048 (1133)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999875321 2234579999999999999999999999999999999999999998776666
Q ss_pred HHHHHHHHhhhccc--------cccccCCcCCCCCCC------------------hhHHHHHHhHhhhhccCCCCCCCCC
Q 001171 1049 IVKWVKKQLQRGQI--------SELLEPGLLELDPES------------------SEWEEFLLGVKVGLLCTAPDPLDRP 1102 (1133)
Q Consensus 1049 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~------------------~~~~~~~~~~~li~~Cl~~dP~~RP 1102 (1133)
....+.+....... ............... .....-....+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 55555443221100 000000000000000 0001112234899999999999999
Q ss_pred CHHHHHHH
Q 001171 1103 SMADIVFM 1110 (1133)
Q Consensus 1103 s~~evl~~ 1110 (1133)
|+.|++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=331.20 Aligned_cols=256 Identities=20% Similarity=0.264 Sum_probs=195.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC-----
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD----- 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 906 (1133)
.++|.+.+.||+|+||.||+|.++ +|+.||||++...... .+.+.+|++++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357999999999999999999875 6999999999754333 3567899999999999999999999976533
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 2489999996 677766532 38899999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---- 1061 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 1061 (1133)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+....+.+......
T Consensus 175 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred CCCC------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5321 1234578999999999876 6789999999999999999999999987766555544443221110
Q ss_pred --------------ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 --------------ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
++......+....... . ....+++.+|++.||++||+++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRA---S--PQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTS---C--HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCc---C--HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000111110110 0 122378999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=330.53 Aligned_cols=253 Identities=19% Similarity=0.272 Sum_probs=190.6
Q ss_pred HhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcC---HHHHHHHHHHHhhcc--CCCeeeEEEEEeCCCCcEE
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---ENTFRKEAEALGKVK--HRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~ 909 (1133)
..++|++.+.||+|+||.||+|.+++++.||||++...... .+.+.+|++++++++ ||||+++++++... ...+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-SEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-CEEE
Confidence 35679999999999999999999888999999999654333 367889999999997 59999999999876 4568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||| +.+++|.+++.... .+++..+..++.||++||+|||+.||+||||||+||+++ ++.+||+|||+++...
T Consensus 105 lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred EEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 9999 55889999998643 478999999999999999999999999999999999996 4899999999987543
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCC-----------CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAAST-----------GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
.... ........|++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ..+.....
T Consensus 178 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 254 (313)
T 3cek_A 178 PDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID 254 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHC
T ss_pred Cccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHHHHh
Confidence 2211 112234568999999999865 467889999999999999999999996543221 11112111
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHH
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~L 1111 (1133)
..... .++.... ....+++.+||+.||++||++.|++++-
T Consensus 255 ~~~~~--------~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 255 PNHEI--------EFPDIPE-----KDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp TTSCC--------CCCCCSC-----HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccccc--------CCcccch-----HHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11000 0001100 1123788899999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=339.22 Aligned_cols=200 Identities=20% Similarity=0.294 Sum_probs=169.2
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-----------CCCeeeEEEEEeC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-----------HRNLTVLRGYYAG 903 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~~ 903 (1133)
.++|++.+.||+|+||.||+|.+ .+++.||||++.......+.+.+|++++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 45799999999999999999987 46899999999865555678899999999986 8999999999875
Q ss_pred CC---CcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeC------C
Q 001171 904 PP---DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFD------A 973 (1133)
Q Consensus 904 ~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~------~ 973 (1133)
.. ...++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 32 2568999999 8999999987432 3388999999999999999999998 999999999999994 4
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCC
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQ 1045 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~ 1045 (1133)
.+.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 174 ~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cceEEEcccccccccCC------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 45799999999875422 2234578999999999999899999999999999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=335.68 Aligned_cols=255 Identities=21% Similarity=0.345 Sum_probs=169.6
Q ss_pred HhcCCCcc-cccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeC---CCCcEE
Q 001171 835 ATRQFDEE-NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAG---PPDVRL 909 (1133)
Q Consensus 835 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~ 909 (1133)
..++|.+. ++||+|+||.||+|.++ +|+.||||++.... ....+....++.+.||||+++++++.. .....+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 35678885 46999999999999886 68999999986532 222333334666799999999999864 234468
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLDR 986 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~ 986 (1133)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999986432 35899999999999999999999999999999999999976 4559999999986
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..................... ...
T Consensus 180 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 253 (336)
T 3fhr_A 180 ETTQ-----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-GFP 253 (336)
T ss_dssp EC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCC
T ss_pred eccc-----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc-ccC
Confidence 5421 1223457899999999998888899999999999999999999999755544332222222211111 001
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.... ... ...+++.+|++.||++||++.|++++
T Consensus 254 ~~~~~~---~~~------~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 254 NPEWSE---VSE------DAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TTTSTT---CCH------HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred chhhcc---CCH------HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111100 111 12378899999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=343.08 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=182.5
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.+|.+.++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+. ...++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDR-QFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEET-TEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecC-CEEEEEEECC
Confidence 46889999999999997766666799999999965432 3467899999999 799999999998865 4559999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-----CCceEEeccCccccccc
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-----DFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~ 990 (1133)
+ |+|.+++..... ...+..+..++.||++||+|||++||+||||||+||+++. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 5 699999986432 2445566789999999999999999999999999999953 23578999999976543
Q ss_pred CCCCCCCCCCCCCCCCccCccccC---CCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAS---TGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
............||+.|+|||++. ...++.++||||+||++|||++ |..||......... ........ ..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----~~~~~~~~-~~- 249 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----ILLGACSL-DC- 249 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----HHTTCCCC-TT-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----HHhccCCc-cc-
Confidence 322223344567999999999997 4567889999999999999999 89998644332211 11111100 00
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
..+. ... -....+++.+||+.||++||++.|+++
T Consensus 250 ------~~~~-~~~--~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ------LHPE-KHE--DVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------SCTT-CHH--HHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCcc-ccc--cHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0011 111 112237999999999999999999994
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=330.87 Aligned_cols=244 Identities=25% Similarity=0.318 Sum_probs=187.5
Q ss_pred HHhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-------CHHHHHHHHHHHhhc----cCCCeeeEEEEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-------DENTFRKEAEALGKV----KHRNLTVLRGYY 901 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~hpniv~l~~~~ 901 (1133)
...++|++.+.||+|+||.||+|++. +++.||||++..... ....+.+|+++++++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34668999999999999999999774 689999999965432 223456799999999 899999999999
Q ss_pred eCCCCcEEEEEec-cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC-CCCceEE
Q 001171 902 AGPPDVRLLVYDY-MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD-ADFEAHL 979 (1133)
Q Consensus 902 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl 979 (1133)
...+. .++|||| +.+++|.+++.... .+++..+..++.||++||+|||+.||+||||||+||+++ .++.+||
T Consensus 108 ~~~~~-~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEG-FMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCe-EEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence 77644 4899999 78999999998743 388999999999999999999999999999999999999 8899999
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
+|||+++.... .......|+..|+|||++.+..+ +.++||||+||++|||++|+.||.... . +.. .
T Consensus 182 ~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~--~ 248 (312)
T 2iwi_A 182 IDFGSGALLHD-----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILE--A 248 (312)
T ss_dssp CCCSSCEECCS-----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH--T
T ss_pred EEcchhhhccc-----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhh--h
Confidence 99999875432 12234568999999999876665 458999999999999999999995321 1 111 0
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHh
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le 1112 (1133)
...+ ... ... ...+++.+||+.||++||++.|++++--
T Consensus 249 ~~~~----~~~------~~~------~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 249 ELHF----PAH------VSP------DCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp CCCC----CTT------SCH------HHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred ccCC----ccc------CCH------HHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 1000 000 011 1237889999999999999999998643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=330.78 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=173.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHH-HHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAE-ALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||||++...... ...+.+|+. +++.++||||+++++++... +..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEE
Confidence 367899999999999999999885 6899999999754322 334555665 67778999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCccccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|||++ |+|.+++..........+++..+..++.|++.|++|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 99997 5888888754333345689999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCCCCCCCCCccCcccc----CCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAA----STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
. .......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ...+... .........
T Consensus 179 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~-~~~~~~~~~ 251 (327)
T 3aln_A 179 S----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQV-VKGDPPQLS 251 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC-CCSCCCCCC
T ss_pred c----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHH-hcCCCCCCC
Confidence 1 122334689999999998 4566899999999999999999999999643221 1111110 001000110
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
..... .... ...+++.+||+.||++||++.|+++
T Consensus 252 ~~~~~---~~~~------~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSEER---EFSP------SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSSC---CCCH------HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccccc---cCCH------HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000 0111 1237889999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=331.91 Aligned_cols=241 Identities=22% Similarity=0.353 Sum_probs=192.7
Q ss_pred HhcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-------CHHHHHHHHHHHhhcc--CCCeeeEEEEEeCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-------DENTFRKEAEALGKVK--HRNLTVLRGYYAGP 904 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~ 904 (1133)
..++|++.++||+|+||.||+|.+. +++.||||++..... ..+.+.+|++++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4568999999999999999999764 689999999865432 2245778999999996 59999999999876
Q ss_pred CCcEEEEEeccCC-CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC-CCCceEEecc
Q 001171 905 PDVRLLVYDYMPN-GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD-ADFEAHLSEF 982 (1133)
Q Consensus 905 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Df 982 (1133)
. ..++||||+.+ ++|.+++...+ .+++..+..++.||++||+|||+.||+||||||+||+++ .++.+||+||
T Consensus 121 ~-~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 D-SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp S-EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred C-cEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 4 45899999976 89999998743 388999999999999999999999999999999999999 7899999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+++.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . +.. ..
T Consensus 195 g~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~----~~ 259 (320)
T 3a99_A 195 GSGALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIR----GQ 259 (320)
T ss_dssp TTCEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH----CC
T ss_pred cccccccc-----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhc----cc
Confidence 99875432 12234568999999999876665 688999999999999999999995321 1 111 10
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ...... .. ...+++.+||+.||++||+++|++++
T Consensus 260 ~--~~~~~~------~~------~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 V--FFRQRV------SS------ECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C--CCSSCC------CH------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--cccccC------CH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011110 11 12378899999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=342.84 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=181.8
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
.|...++||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++... ...++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTD-RFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecC-CeEEEEEecCC
Confidence 455678899999999988777789999999986532 45678999999987 899999999998775 45699999995
Q ss_pred CCCHHHHHHhhccCCCC--CCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-------------CceEEec
Q 001171 917 NGNLATLLQEASHQDGH--VLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-------------FEAHLSE 981 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-------------~~~kl~D 981 (1133)
|+|.+++......... ..++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 6999999875432111 12344567899999999999999999999999999999754 4899999
Q ss_pred cCcccccccCCCCC-CCCCCCCCCCCccCccccCC-------CCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 982 FGLDRLAIATPAEA-SSSTTPIGSLGYVSPEAAST-------GQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 982 fg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
||+++......... .......||+.|+|||++.+ ..++.++||||+||++|||++ |+.||....... ..
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~ 249 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SN 249 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HH
Confidence 99997654322111 12234579999999999965 568999999999999999999 999996543322 11
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
+.+.. ..... ... ...... .....+++.+||+.||.+||++.|+++
T Consensus 250 i~~~~--~~~~~-----~~~--~~~~~~--~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 IIRGI--FSLDE-----MKC--LHDRSL--IAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTC--CCCCC-----CTT--CCCHHH--HHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCC--CCccc-----ccc--cccccc--hHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11110 00000 000 011111 122338999999999999999999986
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=319.33 Aligned_cols=307 Identities=22% Similarity=0.368 Sum_probs=181.0
Q ss_pred hhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCc
Q 001171 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLK 414 (1133)
Q Consensus 335 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 414 (1133)
+..+++|++|++++|.+.. ++ .+..+++|++|++++|++++..+ +..+++|++|+|++|.++.. ..+.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 4455566666666666552 22 25555555555555555554322 55555555555555555431 1344444444
Q ss_pred EEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCC
Q 001171 415 IVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494 (1133)
Q Consensus 415 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 494 (1133)
+|++++|.+++..+ +..+++|++|++++|...... ..+..+++|++|++++|.+.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~---------------------- 168 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVK---------------------- 168 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCC----------------------
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcC----------------------
Confidence 44444444443222 444444444444444332221 22444444444444444443
Q ss_pred CccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcc
Q 001171 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPAT 574 (1133)
Q Consensus 495 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 574 (1133)
+..+ +..+++|++|++++|.+++. +. +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+
T Consensus 169 --~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 169 --DVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp --CCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred --Cchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence 2222 44455555555555555432 21 5555556666666665554333 5566666666666666664333
Q ss_pred cccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCc
Q 001171 575 YGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLV 654 (1133)
Q Consensus 575 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 654 (1133)
+..+++|++|++++|++++. ..+..+++|++|++++|++++ + ..+..+++|+.|+|++|.+++..|..++.+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 66677777777777777643 356777888888888888875 3 3477788888888888888877788888888888
Q ss_pred EEEeecCCCCccCCccccCccccccccccccccc
Q 001171 655 SLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS 688 (1133)
Q Consensus 655 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 688 (1133)
.|++++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 88888888887655 778888888888888875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=325.88 Aligned_cols=270 Identities=18% Similarity=0.225 Sum_probs=242.4
Q ss_pred ccCchhHHHHHHHHHHhC-CCCCCCccCCC--CCCCCCCCccceeeeCC----------CceEEEeeCCcccCcccchhh
Q 001171 25 NAVVLSEIQALTSFKLHL-KDPLGALDGWD--SSTPSAPCDWRGIVCYN----------NRVRELRLPRLQLAGRLTDQL 91 (1133)
Q Consensus 25 ~~~~~~~~~~l~~~k~~~-~~~~~~l~~w~--~~~~~~~c~w~gv~c~~----------~~v~~l~l~~~~l~g~~~~~l 91 (1133)
.++..+|++||++||+++ .||.+.+.+|. .....++|.|.||+|+. .+|+.|+|.++++. .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 456778999999999999 68878889993 11234789999999952 68999999999998 889999
Q ss_pred cccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCcc--------
Q 001171 92 ADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADI-------- 163 (1133)
Q Consensus 92 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~-------- 163 (1133)
+++++|++|+|++|+++ .+|..++.+++|+.|+|++|+++ .+|..++++++|++|++++|.+.+.+|..+
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 89999999999999999999999 899999999999999999999999898876
Q ss_pred ---CCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccc
Q 001171 164 ---SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLV 240 (1133)
Q Consensus 164 ---~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 240 (1133)
.++|++|+|++|.++ .+|..|+.+++|++|+|++|++++ +|..++.+++|++|+|++|++.+.+|..+.++++|+
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 689999999999998 788889999999999999999995 677799999999999999999999999999999999
Q ss_pred eeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccc
Q 001171 241 HLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTG 304 (1133)
Q Consensus 241 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~ 304 (1133)
+|++++|++.+.+|..+..+++|++|+|++|++.+.+|..+ +++++|+.+++..+.+..
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l-----~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI-----AQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG-----GGSCTTCEEECCGGGSCC
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH-----hhccCceEEeCCHHHHHH
Confidence 99999999999999999999999999999999999999877 888999998888776654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=317.91 Aligned_cols=304 Identities=22% Similarity=0.375 Sum_probs=194.1
Q ss_pred ccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEE
Q 001171 313 CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMF 392 (1133)
Q Consensus 313 ~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 392 (1133)
.+.+|++|++++|.+..+ + .+..+++|++|++++|++++..+ +..+++|++|++++|.++.. +.+.++++|++|
T Consensus 42 ~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L 115 (347)
T 4fmz_A 42 ELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLREL 115 (347)
T ss_dssp HHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEE
T ss_pred hcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEE
Confidence 345567777777777766 2 37778888888888888875433 78888888888888888764 357888888888
Q ss_pred EccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCC
Q 001171 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFG 472 (1133)
Q Consensus 393 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 472 (1133)
++++|++++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|.++
T Consensus 116 ~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (347)
T 4fmz_A 116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE 190 (347)
T ss_dssp ECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred ECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence 888888875443 7788888888888886554433 47888889999999988875433 778888888888888887
Q ss_pred CCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCC
Q 001171 473 GKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFS 552 (1133)
Q Consensus 473 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 552 (1133)
+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|++|++++|.+++. ..+.
T Consensus 191 ~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~ 262 (347)
T 4fmz_A 191 DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVK 262 (347)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGT
T ss_pred cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHh
Confidence 5433 6667777777777777665443 5666667777777776664322 55566666666666655532 2344
Q ss_pred CCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCee
Q 001171 553 SLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKL 632 (1133)
Q Consensus 553 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 632 (1133)
.+++|++|++++|++++. ..+..+++|++|++++|++++..|..++.+++|++|++++|++++..| +..+++|++|
T Consensus 263 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 338 (347)
T 4fmz_A 263 DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA 338 (347)
T ss_dssp TCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEE
T ss_pred cCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhcccee
Confidence 555555555555555432 234444444444554444444444444444444444444444443222 4444444444
Q ss_pred ecCCCcc
Q 001171 633 DLGQNKL 639 (1133)
Q Consensus 633 ~Ls~N~l 639 (1133)
++++|.|
T Consensus 339 ~l~~N~i 345 (347)
T 4fmz_A 339 DFANQVI 345 (347)
T ss_dssp SSSCC--
T ss_pred ehhhhcc
Confidence 4444444
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=321.97 Aligned_cols=249 Identities=18% Similarity=0.289 Sum_probs=175.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCH---HHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDE---NTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
.++|++.+.||+|+||.||+|.++ +|+.||||++....... +.+.++..+++.++||||+++++++... ...++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEE
Confidence 457999999999999999999885 68999999997543322 2344455678888999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcC-CceecccCccceeeCCCCceEEeccCccccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL-DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
|||+ ++.+..+..... ..+++..+..++.||++||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp ECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred Eecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9999 566666655432 3488999999999999999999995 999999999999999999999999999865432
Q ss_pred CCCCCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCC-hhhHHHHHHHHhhhccccc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQ-DEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~ 1064 (1133)
. .......|++.|+|||++. +..++.++||||+||++|||++|+.||.... ..+....+.. . ....
T Consensus 178 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~-~~~~ 249 (318)
T 2dyl_A 178 D----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---E-EPPL 249 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---S-CCCC
T ss_pred C----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---c-CCCC
Confidence 1 1223456899999999984 4568899999999999999999999997532 2222222222 1 1111
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
... . ..... ...+++.+||+.||.+||++.|+++
T Consensus 250 ~~~--~---~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPG--H---MGFSG------DFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCS--S---SCCCH------HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCc--c---CCCCH------HHHHHHHHHccCChhHCcCHHHHhh
Confidence 100 0 00111 1226888999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=319.62 Aligned_cols=235 Identities=11% Similarity=0.014 Sum_probs=177.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
.++|++.+.||+|+||.||+|.+. +|+.||||++...... .+.+.+|++++++++||||+++++++... +..|+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEE
Confidence 357999999999999999999886 4899999999765433 26789999999999999999999999876 45699
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.++++.. .....+..++.||+.||+|||++||+||||||+||+++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999998531 3445678899999999999999999999999999999999999997543
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
|++| ++.++|||||||++|||++|+.||......+......+. ......+ .
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~-~ 225 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-----TAGQPIE-P 225 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-----TTSCBCC-H
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-----hccCCCC-h
Confidence 3332 578999999999999999999999754432100000000 0000000 0
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
....... .. ...+++.+||+.||++| |+.|+++.|+.+......
T Consensus 226 ~~~~~~~---~~--~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~ 269 (286)
T 3uqc_A 226 ADIDRDI---PF--QISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR 269 (286)
T ss_dssp HHHCTTS---CH--HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred hhcccCC---CH--HHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence 0000000 00 12378999999999999 999999999997766553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=342.96 Aligned_cols=261 Identities=20% Similarity=0.292 Sum_probs=190.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeC-----CCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAG-----PPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~ 907 (1133)
.++|++.++||+|+||.||+|.+. +|+.||||++..... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999774 689999999865422 24578899999999999999999998754 2345
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCc---eEEeccCc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE---AHLSEFGL 984 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~ 984 (1133)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 5899999999999999986432 234888999999999999999999999999999999999997765 89999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc----
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG---- 1060 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---- 1060 (1133)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .|........
T Consensus 171 a~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~--~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 171 AKELDQG----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV--QWHGKVREKSNEHI 244 (676)
T ss_dssp CCBTTSC----CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH--HSSTTCC------C
T ss_pred ccccccc----cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh--hhhhhhhcccchhh
Confidence 9754322 22344679999999999999999999999999999999999999996533221 1111000000
Q ss_pred cccccccC------CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHH
Q 001171 1061 QISELLEP------GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1061 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~e 1106 (1133)
...+.... .............. ...+++.+|+..||++||++.|
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~--~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHH--HHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhccccccccccCCchhhchhhhH--HHHHHHHHHccCCHhhCcCHHH
Confidence 00000000 00000001111111 1237999999999999999977
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-32 Score=307.25 Aligned_cols=295 Identities=22% Similarity=0.272 Sum_probs=193.1
Q ss_pred chhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccc
Q 001171 144 NLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSN 223 (1133)
Q Consensus 144 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 223 (1133)
+|++++++++.++ .+|..+++++++|+|++|.+++..+..|.++++|++|+|++|++++..|..++.+++|++|++++|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCeEEEecCCCcc-ccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 3444445554444 456667788999999999999888888999999999999999999888999999999999999999
Q ss_pred cccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccC--CcccccccCcccccccccEEeccCCc
Q 001171 224 HLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG--LVPVSVLCNLWGNISSLRIVQLGFNA 301 (1133)
Q Consensus 224 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~~~l~~L~~l~l~~n~ 301 (1133)
+++ .+|..+. ++|++|++++|+++++.+..|.++++|++|++++|+++. ..+.. +.++++|+.|++++|.
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA-----FQGMKKLSYIRIADTN 182 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTG-----GGGCTTCCEEECCSSC
T ss_pred cCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhh-----ccCCCCcCEEECCCCc
Confidence 997 6776654 789999999999998888888999999999999999863 33332 3667777777777777
Q ss_pred ccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCch
Q 001171 302 FTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPD 381 (1133)
Q Consensus 302 l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 381 (1133)
++.... . ....|++|++++|+|+++.|..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+++ .+|.
T Consensus 183 l~~l~~--~--~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 257 (330)
T 1xku_A 183 ITTIPQ--G--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257 (330)
T ss_dssp CCSCCS--S--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred cccCCc--c--ccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCCh
Confidence 765321 1 1144555555555555555555555555555555555555444444555555555555555554 2344
Q ss_pred hhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccc--cCChhhcCCC
Q 001171 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG--NIPEEITRLS 459 (1133)
Q Consensus 382 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~--~~~~~l~~l~ 459 (1133)
.+..+++|++|+|++|+|++..+..|.... .......|+.|++++|.+.. ..|..|..+.
T Consensus 258 ~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~ 319 (330)
T 1xku_A 258 GLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319 (330)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred hhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccceEeecCcccccccCcccccccc
Confidence 444455555555555555444333332210 00112556666777776643 4455666677
Q ss_pred CCcEEecccCc
Q 001171 460 NLTTLNLSYNK 470 (1133)
Q Consensus 460 ~L~~L~Ls~N~ 470 (1133)
+++.++|++|+
T Consensus 320 ~l~~l~L~~N~ 330 (330)
T 1xku_A 320 VRAAVQLGNYK 330 (330)
T ss_dssp CGGGEEC----
T ss_pred ceeEEEecccC
Confidence 77777777664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-32 Score=306.17 Aligned_cols=128 Identities=19% Similarity=0.229 Sum_probs=63.2
Q ss_pred cccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEE
Q 001171 314 VSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFD 393 (1133)
Q Consensus 314 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 393 (1133)
...++.++++++.++.++.. + .++|++|+|++|.|.+..|..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~-~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKE-I--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EEETTEEECCSSCCSSCCSC-C--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred cccCCEEECCCCCccccCCC-C--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 34566666666666655322 2 24555566666655555455555555555555555555555555555555555555
Q ss_pred ccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccc
Q 001171 394 LEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI 447 (1133)
Q Consensus 394 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i 447 (1133)
|++|+++. +|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+
T Consensus 109 L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 109 ISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp CCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCC
T ss_pred CCCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcc
Confidence 55555542 222221 3444444444444433333344444444444444433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=313.98 Aligned_cols=248 Identities=27% Similarity=0.459 Sum_probs=144.7
Q ss_pred ccceeecccccccc--cCChhhcCCCCCcEEeccc-CcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEE
Q 001171 436 QLETLNLSENDIRG--NIPEEITRLSNLTTLNLSY-NKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTL 512 (1133)
Q Consensus 436 ~L~~L~L~~N~i~~--~~~~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 512 (1133)
+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|.. |+++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~------------------------l~~l~~L~~L 106 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA------------------------IAKLTQLHYL 106 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGG------------------------GGGCTTCSEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChh------------------------HhcCCCCCEE
Confidence 45555555555554 4455555555555555552 4444444444 4444444444
Q ss_pred eccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCccccccc-ccceeecccCcc
Q 001171 513 DLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLR-SLVFLSLSHNQI 591 (1133)
Q Consensus 513 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l 591 (1133)
++++|++++.+|..+.++++|++|++++|.+++.+|..|..+++|++|+|++|++++.+|..++.++ +|++|++++|++
T Consensus 107 ~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp EEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred ECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence 4444444444444444444455555555555444455555555555555555555555555555554 555555555555
Q ss_pred CCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccc
Q 001171 592 SGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESF 671 (1133)
Q Consensus 592 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 671 (1133)
++.+|..++.++ |++|++++|++++..|..+..+++|+.|+|++|.+++.+|. +..+++|++|+|++|++++.+|..|
T Consensus 187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 555555555554 66666666666665666666666666666666666644443 5666777777777777776777777
Q ss_pred cCcccccccccccccccccCCccccccccCccccccccc
Q 001171 672 SKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNN 710 (1133)
Q Consensus 672 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~ 710 (1133)
..+++|+.|+|++|+++|.+|.. ..+++|+.|++++|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 77777777777777777777665 667777777766665
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-31 Score=304.81 Aligned_cols=250 Identities=29% Similarity=0.364 Sum_probs=157.0
Q ss_pred ccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEE
Q 001171 290 SSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLR 369 (1133)
Q Consensus 290 ~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 369 (1133)
.+++.++++++.++.... . ..+.+++|++++|+|+++.|..|.++++|++|+|++|+|++..|..|+++++|++|+
T Consensus 33 c~l~~l~~~~~~l~~ip~--~--~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPK--E--ISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EETTEEECCSSCCSSCCS--C--CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred ccCCEEECCCCCccccCC--C--CCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 467777777777765321 1 135677777777777777777777777777777777777777677777777777777
Q ss_pred ccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCcc--ccCccccCccccceeecccccc
Q 001171 370 VANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSG--LIPLSFGNLSQLETLNLSENDI 447 (1133)
Q Consensus 370 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~i 447 (1133)
|++|+++.. |..+. ++|++|++++|++++..+..|.++++|+.|++++|.++. ..+..|..+ +|++|++++|++
T Consensus 109 L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 777777743 33333 677777777777776666667777777777777777753 556666666 677777777776
Q ss_pred cccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhc
Q 001171 448 RGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIEL 527 (1133)
Q Consensus 448 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 527 (1133)
++ +|..+. ++|++|++++|.+++..+..+..+++|++|++++|++++..+..+..+++|++|++++|+++ .+|..+
T Consensus 185 ~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 260 (332)
T 2ft3_A 185 TG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260 (332)
T ss_dssp SS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred Cc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence 64 333332 45666666666665555555555555555555555555544444555555555555555554 444444
Q ss_pred cCCCCCcEeeccCCcccccCCCCC
Q 001171 528 FGLPSLQVVSLEENNLSGDVPEGF 551 (1133)
Q Consensus 528 ~~l~~L~~L~L~~N~l~~~~~~~~ 551 (1133)
..+++|++|++++|++++..+..|
T Consensus 261 ~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 261 PDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp GGCTTCCEEECCSSCCCBCCTTSS
T ss_pred hcCccCCEEECCCCCCCccChhHc
Confidence 444444444444444444333333
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-36 Score=356.49 Aligned_cols=356 Identities=19% Similarity=0.176 Sum_probs=221.4
Q ss_pred ccccEEeccCCcccccCCch-hhcccccceeeccCceeec----ccCcccCCCCCCcEEEccCCcccccCchhhc-cCC-
Q 001171 315 SVLEVLDLQNNRIRAVFPSW-LTNVTSLRVMDLSGNFFSG----NLPAAVGSLDKLEVLRVANNSLSGLVPDEIA-KCS- 387 (1133)
Q Consensus 315 ~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~- 387 (1133)
..|++|+|++|+++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.++...+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46888999999887654333 7788889999999998874 3466777788888888888888765444333 344
Q ss_pred ---CccEEEccCCcccc----cCCCccCCCCCCcEEEccCCcCccccCcccc-----CccccceeecccccccccC----
Q 001171 388 ---LLQMFDLEGNRFSG----QVPAFLGGIRGLKIVSLGRNMFSGLIPLSFG-----NLSQLETLNLSENDIRGNI---- 451 (1133)
Q Consensus 388 ---~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~i~~~~---- 451 (1133)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 58888888888763 4466677777777777777777654333222 2345666666666666532
Q ss_pred ChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCc-CCcccccEEeccccCCCCC----CChh
Q 001171 452 PEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSI-GSLMRLTTLDLSNQNLSGE----LPIE 526 (1133)
Q Consensus 452 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~----~p~~ 526 (1133)
+..+..+++|++|++++|.+++..+..+.. .+ ...++|++|++++|.+++. ++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~--------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQ--------------------GLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHH--------------------HHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHH--------------------HHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 334444556666666665554322211111 00 0133556666666655542 3445
Q ss_pred ccCCCCCcEeeccCCcccccC-----CCCCCCCccCcEEEcccccccCC----CCcccccccccceeecccCccCCCCCc
Q 001171 527 LFGLPSLQVVSLEENNLSGDV-----PEGFSSLVGLQYLNLSDNAFTGD----IPATYGFLRSLVFLSLSHNQISGMIPA 597 (1133)
Q Consensus 527 l~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 597 (1133)
+..+++|++|++++|++++.. +..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 555666666666666655422 22233456677777777766643 455555667777777777776644433
Q ss_pred cccC-----CCCccEEEecCCcccCC----CccccccccccCeeecCCCcccCcCchhhhc-----cCCCcEEEeecCCC
Q 001171 598 ELGA-----CSALEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKLSGEIPKEISK-----CSSLVSLTLDMNSL 663 (1133)
Q Consensus 598 ~l~~-----l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~Ls~N~l 663 (1133)
.+.. .++|++|++++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|+.|++++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 3322 25777777777777654 3445556677777777777777655555543 56777777777777
Q ss_pred Cc----cCCccccCccccccccccccccccc
Q 001171 664 SG----RIPESFSKLSNLTTLNLSTNRLSGA 690 (1133)
Q Consensus 664 ~~----~~~~~~~~l~~L~~L~Ls~N~l~~~ 690 (1133)
++ .+|..+..+++|++|+|++|++++.
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 75 5666667777777777777777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-31 Score=303.25 Aligned_cols=292 Identities=19% Similarity=0.240 Sum_probs=155.5
Q ss_pred ccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEE
Q 001171 313 CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMF 392 (1133)
Q Consensus 313 ~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 392 (1133)
|...++.++++++.++.++ ..+ .++|++|+|++|+|++..+..|+++++|++|+|++|++++..|..|.++++|++|
T Consensus 29 c~c~l~~l~~~~~~l~~lp-~~~--~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVP-KDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 105 (330)
T ss_dssp CEEETTEEECTTSCCCSCC-CSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CcCCCeEEEecCCCccccC-ccC--CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence 4445666666666666653 222 2466667777777766555566666777777777776666666666666666777
Q ss_pred EccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccc--cCChhhcCCCCCcEEecccCc
Q 001171 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG--NIPEEITRLSNLTTLNLSYNK 470 (1133)
Q Consensus 393 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~--~~~~~l~~l~~L~~L~Ls~N~ 470 (1133)
+|++|+++. +|..+. ++|+.|++++|.+++..+..|.++++|++|++++|.++. ..+..+..+++|++|++++|.
T Consensus 106 ~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 106 YLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp ECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred ECCCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence 766666663 333322 456666666666665555555666666666666666542 444555555666666666655
Q ss_pred CCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCC
Q 001171 471 FGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEG 550 (1133)
Q Consensus 471 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 550 (1133)
++. +|..+. ++|++|++++|.+++..|..|..+++|++|++++|.++ +..+..
T Consensus 183 l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~------------------------~~~~~~ 235 (330)
T 1xku_A 183 ITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS------------------------AVDNGS 235 (330)
T ss_dssp CCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC------------------------EECTTT
T ss_pred ccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc------------------------eeChhh
Confidence 552 232221 34444444444444444444444444444444444444 433344
Q ss_pred CCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccC------CCCccEEEecCCcccC--CCccc
Q 001171 551 FSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGA------CSALEVLELRSNHFTG--NIPVD 622 (1133)
Q Consensus 551 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~------l~~L~~L~L~~N~l~~--~~p~~ 622 (1133)
|..+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..|.. ...|+.|++++|.+.. ..|..
T Consensus 236 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~ 314 (330)
T 1xku_A 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314 (330)
T ss_dssp GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGG
T ss_pred ccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccc
Confidence 444444444444444444 33444444444444444444444333333321 2456666666666642 34455
Q ss_pred cccccccCeeecCCCc
Q 001171 623 ISHLSRIKKLDLGQNK 638 (1133)
Q Consensus 623 l~~l~~L~~L~Ls~N~ 638 (1133)
+..+.+++.++|++|+
T Consensus 315 f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 315 FRCVYVRAAVQLGNYK 330 (330)
T ss_dssp GTTCCCGGGEEC----
T ss_pred cccccceeEEEecccC
Confidence 6666666666666664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-35 Score=353.05 Aligned_cols=359 Identities=18% Similarity=0.141 Sum_probs=245.1
Q ss_pred cccccEEeccCCcccccccCCCCCccccccEEeccCCccccc----CCchhhcccccceeeccCceeecccCccc-CCCC
Q 001171 289 ISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV----FPSWLTNVTSLRVMDLSGNFFSGNLPAAV-GSLD 363 (1133)
Q Consensus 289 l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~ 363 (1133)
+++|+.|++++|.++.......+..+++|++|+|++|+++.. .+..+..+++|++|||++|.+.+..+..+ ..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 367899999999998654222245677899999999999853 25678888999999999999986544433 3455
Q ss_pred ----CCcEEEccCCcccc----cCchhhccCCCccEEEccCCcccccCCCccC-----CCCCCcEEEccCCcCcccc---
Q 001171 364 ----KLEVLRVANNSLSG----LVPDEIAKCSLLQMFDLEGNRFSGQVPAFLG-----GIRGLKIVSLGRNMFSGLI--- 427 (1133)
Q Consensus 364 ----~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~--- 427 (1133)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|.+++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 79999999999984 4588899999999999999999765444332 3568999999999999743
Q ss_pred -CccccCccccceeecccccccccCChhhc-----CCCCCcEEecccCcCCCC----CCCCCCCCCCCcEEEcccCCCcc
Q 001171 428 -PLSFGNLSQLETLNLSENDIRGNIPEEIT-----RLSNLTTLNLSYNKFGGK----VPYDVGNLKGLLVLNLSASGFSG 497 (1133)
Q Consensus 428 -p~~~~~l~~L~~L~L~~N~i~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~ 497 (1133)
+..+..+++|++|++++|.++...+..+. ..++|++|+|++|.+++. ++..+..+++|++|++++|.+++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 56677789999999999999876555554 366899999999988753 34455566777777777777654
Q ss_pred cc-----CCCcCCcccccEEeccccCCCCC----CChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEccccccc
Q 001171 498 KI-----PGSIGSLMRLTTLDLSNQNLSGE----LPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568 (1133)
Q Consensus 498 ~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 568 (1133)
.. +..+..+++|++|++++|+++.. ++..+..+++|++|++++|.+++..+..+...
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-------------- 307 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET-------------- 307 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH--------------
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH--------------
Confidence 32 12222455666666666665532 34444445555555555555443222111110
Q ss_pred CCCCcccccccccceeecccCccCCC----CCccccCCCCccEEEecCCcccCCCcccccc-----ccccCeeecCCCcc
Q 001171 569 GDIPATYGFLRSLVFLSLSHNQISGM----IPAELGACSALEVLELRSNHFTGNIPVDISH-----LSRIKKLDLGQNKL 639 (1133)
Q Consensus 569 ~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~Ls~N~l 639 (1133)
.....++|++|+|++|.+++. ++..+..+++|++|++++|++++..+..+.. .++|++|+|++|.+
T Consensus 308 -----l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 308 -----LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp -----HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred -----hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 000114566666666665543 3444555667777777777766544443332 45777777777777
Q ss_pred cC----cCchhhhccCCCcEEEeecCCCCcc
Q 001171 640 SG----EIPKEISKCSSLVSLTLDMNSLSGR 666 (1133)
Q Consensus 640 ~~----~~p~~l~~l~~L~~L~Ls~N~l~~~ 666 (1133)
++ .+|..+..+++|++|++++|++++.
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 75 5677777778888888888877754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=343.80 Aligned_cols=239 Identities=20% Similarity=0.288 Sum_probs=186.5
Q ss_pred hcCCCcccccccccceeEEEEEEC--CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc----
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV---- 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---- 907 (1133)
.++|++.++||+|+||.||+|.+. +|+.||||++..... ....+.+|++++++++||||+++++++......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 589999999865332 235688999999999999999999999764331
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+||||+++++|.+++.. .+++..+..++.||++||+|||++||+||||||+||+++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 5899999999999887653 38999999999999999999999999999999999999885 899999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
... .....||+.|+|||++.+. ++.++|||||||++|||++|..||.......
T Consensus 231 ~~~-------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 231 INS-------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp TTC-------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred ccc-------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 422 1345799999999998654 4889999999999999999998875311100
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-HHHHHHHHhcC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-MADIVFMLEGC 1114 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-~~evl~~Le~~ 1114 (1133)
. ..............+++.+||+.||++||+ ++++.+.|.++
T Consensus 284 --~---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 --L---PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --C---CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --c---cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 001111111112237899999999999995 55566655543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.9e-33 Score=309.20 Aligned_cols=232 Identities=19% Similarity=0.330 Sum_probs=174.6
Q ss_pred hcCCCcc-cccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHH-hhccCCCeeeEEEEEeC---CCCcEE
Q 001171 836 TRQFDEE-NVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEAL-GKVKHRNLTVLRGYYAG---PPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~---~~~~~~ 909 (1133)
.++|.+. ++||+|+||.||+|.+. +++.||+|++.. ...+.+|++++ +..+||||+++++++.. .....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3467776 78999999999999874 689999999864 35678899998 55599999999998864 234568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLDR 986 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~ 986 (1133)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 99999999999999987432 34899999999999999999999999999999999999998 7889999999875
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
... +..++.++||||+||++|||++|+.||............ ...+
T Consensus 169 ~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---------~~~~ 214 (299)
T 3m2w_A 169 ETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------KTRI 214 (299)
T ss_dssp ECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---------CCSS
T ss_pred ccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---------HHHH
Confidence 321 234577899999999999999999999654332211100 0000
Q ss_pred cCCcCCCCCCChhHHHHH-HhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFL-LGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~-~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....... ....+..+. ...+++.+||+.||++||++.|++++
T Consensus 215 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 RMGQYEF--PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CTTCCSS--CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccC--CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 000001111 12378999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=321.85 Aligned_cols=243 Identities=18% Similarity=0.140 Sum_probs=175.9
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHHHHHHHhhccC-CCe---------e-----
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRKEAEALGKVKH-RNL---------T----- 895 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h-pni---------v----- 895 (1133)
..+|...++||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778899999999999999864 69999999987322 224679999999999987 221 1
Q ss_pred -e------EEEEEeCC----CCcEEEEEeccCCCCHHHHHHhhc--cCCCCCCChHHHHHHHHHHHHHHHHHhcCCceec
Q 001171 896 -V------LRGYYAGP----PDVRLLVYDYMPNGNLATLLQEAS--HQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962 (1133)
Q Consensus 896 -~------l~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~ 962 (1133)
. +..++... ....+++|+++ +++|.++++... ......+++..+..++.||++||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1 11111111 12236677765 789999986432 1122347788999999999999999999999999
Q ss_pred ccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCcccc----------CCCCCCCCCchhHHHHHHH
Q 001171 963 DIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA----------STGQPTKEADVYSFGIVLL 1032 (1133)
Q Consensus 963 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlG~il~ 1032 (1133)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||||||++|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999865322 1334567 999999999 5556888999999999999
Q ss_pred HHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHH
Q 001171 1033 EILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1033 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl 1108 (1133)
||++|+.||.......... ..+. ..... . ....+++.+||+.||++||++.|++
T Consensus 309 elltg~~Pf~~~~~~~~~~------------~~~~-~~~~~---~------~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE------------WIFR-SCKNI---P------QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG------------GGGS-SCCCC---C------HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhhHH------------HHHh-hcccC---C------HHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999996544322111 1111 11111 1 1123788999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=308.05 Aligned_cols=240 Identities=12% Similarity=0.112 Sum_probs=180.5
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc---------CHHHHHHHHHHHhhcc---------CCCeeeE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI---------DENTFRKEAEALGKVK---------HRNLTVL 897 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------hpniv~l 897 (1133)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ..+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45789999999999999999988 689999999975432 2377899999999986 8888888
Q ss_pred EEEEe-----------------C------------CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHH
Q 001171 898 RGYYA-----------------G------------PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948 (1133)
Q Consensus 898 ~~~~~-----------------~------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 948 (1133)
.+.+. . .....++||||+++|++.+.+.+ ..+++..+..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 77642 1 14566999999999976666543 2378999999999999
Q ss_pred HHHHHHh-cCCceecccCccceeeCCCC--------------------ceEEeccCcccccccCCCCCCCCCCCCCCCCc
Q 001171 949 RGLSFLH-SLDMVHGDIKPQNVLFDADF--------------------EAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007 (1133)
Q Consensus 949 ~~L~~LH-~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 1007 (1133)
.||+||| ++||+||||||+|||++.++ .+||+|||+|+.... ....||+.|
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCT
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecc
Confidence 9999999 99999999999999999887 899999999976532 134799999
Q ss_pred cCccccCCCCCCCCCchhHHHHH-HHHHHhCCCCCccCChhhHHHHHHHHhh-hccccccccCCcCCCCCCChhHHHHHH
Q 001171 1008 VSPEAASTGQPTKEADVYSFGIV-LLEILTGRKPVMFTQDEDIVKWVKKQLQ-RGQISELLEPGLLELDPESSEWEEFLL 1085 (1133)
Q Consensus 1008 ~aPE~~~~~~~~~~~DvwSlG~i-l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1085 (1133)
+|||++.+.. +.++||||++++ .+++++|..||.... .......... ..... .......+..+..
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~---------~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFK---------TKCNTPAMKQIKR 310 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCS---------SCCCSHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccC---------cccchhhhhhcCH
Confidence 9999998666 889999998777 788888999984211 0011111111 11100 0111122333333
Q ss_pred hH-hhhhccCCCCCCCCCCHHHHH
Q 001171 1086 GV-KVGLLCTAPDPLDRPSMADIV 1108 (1133)
Q Consensus 1086 ~~-~li~~Cl~~dP~~RPs~~evl 1108 (1133)
.+ +++.+|++.| |++|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 33 8999999976 999988
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-32 Score=334.46 Aligned_cols=65 Identities=23% Similarity=0.207 Sum_probs=28.8
Q ss_pred ccccCeeecCCCcccCc-CchhhhccCCCcEEEeecCCCCccCC-ccccCccccccccccccccccc
Q 001171 626 LSRIKKLDLGQNKLSGE-IPKEISKCSSLVSLTLDMNSLSGRIP-ESFSKLSNLTTLNLSTNRLSGA 690 (1133)
Q Consensus 626 l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~ 690 (1133)
+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++... ..+..+++|+.|+|++|++++.
T Consensus 462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 44455555555544432 22333444555555555555443322 2223344555555555554443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=289.41 Aligned_cols=276 Identities=23% Similarity=0.235 Sum_probs=172.1
Q ss_pred ccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEecc
Q 001171 436 QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLS 515 (1133)
Q Consensus 436 ~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 515 (1133)
.....++++|.++ .+|..+. ++|++|++++|.+++..+..+..+++|++|++++|++++..+..|.++++|++|+++
T Consensus 32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 3334455555555 2333332 255555555555554444455556666666666666665555566666666666666
Q ss_pred ccCCCCCCChhccCCCCCcEeeccCCcccccCC-CCCCCCccCcEEEcccc-cccCCCCcccccccccceeecccCccCC
Q 001171 516 NQNLSGELPIELFGLPSLQVVSLEENNLSGDVP-EGFSSLVGLQYLNLSDN-AFTGDIPATYGFLRSLVFLSLSHNQISG 593 (1133)
Q Consensus 516 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 593 (1133)
+|++++..+..+.++++|++|++++|++++..+ ..|.++++|++|++++| .+++..+..+..+++|++|++++|++++
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc
Confidence 666664444446666666666666666664333 35666667777777666 3555555666666777777777777766
Q ss_pred CCCccccCCCCccEEEecCCcccCCCccc-cccccccCeeecCCCcccCcCchhhh---ccCCCcEEEeecCCCCc----
Q 001171 594 MIPAELGACSALEVLELRSNHFTGNIPVD-ISHLSRIKKLDLGQNKLSGEIPKEIS---KCSSLVSLTLDMNSLSG---- 665 (1133)
Q Consensus 594 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~---- 665 (1133)
..|..++.+++|++|++++|+++. +|.. +..+++|+.|+|++|.+++..+..+. ....++.+++++|.+++
T Consensus 189 ~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~ 267 (353)
T 2z80_A 189 YEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267 (353)
T ss_dssp ECTTTTTTCSEEEEEEEECSCSTT-HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHH
T ss_pred cCHHHHhccccCCeecCCCCcccc-chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchh
Confidence 666666667777777777777653 3332 34466777777777777654444332 35567777777777765
Q ss_pred cCCccccCcccccccccccccccccCCcc-ccccccCcccccccccccccCC
Q 001171 666 RIPESFSKLSNLTTLNLSTNRLSGAIPAD-LALISSLRYLNLSRNNLEGEIP 716 (1133)
Q Consensus 666 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~ls~N~l~~~~p 716 (1133)
.+|..+..+++|+.|+|++|+++ .+|.. +..+++|++|++++|++.|.+|
T Consensus 268 ~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 35666777788888888888887 45555 4777888888888888887776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-31 Score=326.49 Aligned_cols=384 Identities=15% Similarity=0.119 Sum_probs=286.5
Q ss_pred hcccccceeeccCceeecccCcccCCC--CCCcEEEccCCc-ccc-cCchhhccCCCccEEEccCCccccc----CCCcc
Q 001171 336 TNVTSLRVMDLSGNFFSGNLPAAVGSL--DKLEVLRVANNS-LSG-LVPDEIAKCSLLQMFDLEGNRFSGQ----VPAFL 407 (1133)
Q Consensus 336 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l 407 (1133)
.++++|++|+|++|.+++..+..+... .+|++|+|++|. ++. .++.....+++|++|+|++|.+++. ++..+
T Consensus 109 ~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188 (592)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred hhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHH
Confidence 367778888888887776655656553 348888888776 221 1123334778888888888887655 33345
Q ss_pred CCCCCCcEEEccCCcCc----cccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCC---CCCCCCCC
Q 001171 408 GGIRGLKIVSLGRNMFS----GLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFG---GKVPYDVG 480 (1133)
Q Consensus 408 ~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~---~~~~~~~~ 480 (1133)
.++++|+.|++++|.++ +.++..+.++++|++|++++|.+.+ ++..+..+++|++|+++.+... +..+..+.
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~ 267 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV 267 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhh
Confidence 66788888888888886 3344556678899999999998885 6678888999999999864332 33455678
Q ss_pred CCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCC-hhccCCCCCcEeeccCCcccc-cCCCCCCCCccCc
Q 001171 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELP-IELFGLPSLQVVSLEENNLSG-DVPEGFSSLVGLQ 558 (1133)
Q Consensus 481 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~ 558 (1133)
.+++|+.|+++++.. +.+|..+..+++|++|++++|.+++... ..+..+++|++|+++ +.+.+ .++..+..+++|+
T Consensus 268 ~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~ 345 (592)
T 3ogk_B 268 FPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLK 345 (592)
T ss_dssp CCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCC
T ss_pred ccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCC
Confidence 889999999988643 3577788889999999999999764433 346789999999999 44443 3344446688999
Q ss_pred EEEccc-----------ccccCCCC-cccccccccceeecccCccCCCCCccccC-CCCccEEEec----CCcccCC---
Q 001171 559 YLNLSD-----------NAFTGDIP-ATYGFLRSLVFLSLSHNQISGMIPAELGA-CSALEVLELR----SNHFTGN--- 618 (1133)
Q Consensus 559 ~L~Ls~-----------N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~L~----~N~l~~~--- 618 (1133)
+|++++ |.+++... .....+++|++|+++.|++++..+..++. +++|+.|+++ .|++++.
T Consensus 346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~ 425 (592)
T 3ogk_B 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD 425 (592)
T ss_dssp EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH
T ss_pred EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH
Confidence 999993 66664322 33456899999999999999877777776 8999999996 7788863
Q ss_pred --CccccccccccCeeecCCC--cccCcCchhhhc-cCCCcEEEeecCCCCcc-CCccccCcccccccccccccccccC-
Q 001171 619 --IPVDISHLSRIKKLDLGQN--KLSGEIPKEISK-CSSLVSLTLDMNSLSGR-IPESFSKLSNLTTLNLSTNRLSGAI- 691 (1133)
Q Consensus 619 --~p~~l~~l~~L~~L~Ls~N--~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~- 691 (1133)
++..+..+++|+.|+|++| .+++..+..+.. +++|+.|+|++|++++. ++..+..+++|+.|+|++|++++..
T Consensus 426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 505 (592)
T 3ogk_B 426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI 505 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence 3344677999999999854 477776666665 89999999999999874 4455678999999999999998654
Q ss_pred CccccccccCcccccccccccccCCccccCC
Q 001171 692 PADLALISSLRYLNLSRNNLEGEIPKMLSSR 722 (1133)
Q Consensus 692 p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~ 722 (1133)
+.....+++|++|++++|++++.....+...
T Consensus 506 ~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~ 536 (592)
T 3ogk_B 506 AAAVTKLPSLRYLWVQGYRASMTGQDLMQMA 536 (592)
T ss_dssp HHHHHHCSSCCEEEEESCBCCTTCTTGGGGC
T ss_pred HHHHHhcCccCeeECcCCcCCHHHHHHHHHh
Confidence 4445678999999999999987755544433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=276.90 Aligned_cols=281 Identities=20% Similarity=0.229 Sum_probs=188.5
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCccccc--CchhhccCCCccEEEc
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL--VPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L 394 (1133)
.+.+++++++++.++.. + .++|++|+|++|+++...+..|.++++|++|+|++|+++.. .+..+..+++|++|+|
T Consensus 9 ~~~l~c~~~~l~~ip~~-~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 9 GTEIRCNSKGLTSVPTG-I--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TTEEECCSSCCSSCCSC-C--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CCEEEcCCCCcccCCCC-C--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 34566666666666332 2 24677777777777744444567777777777777777633 2556666777777777
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCccccC-ccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCC
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP-LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGG 473 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~ 473 (1133)
++|.++. +|..+.++++|++|++++|.+++..+ ..+..+++|++|++++|.+++..+..+..+++|++|++++|.+++
T Consensus 86 s~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 7777763 45556677777777777777766544 467777777777777777777667777777777777777777765
Q ss_pred -CCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCC
Q 001171 474 -KVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFS 552 (1133)
Q Consensus 474 -~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 552 (1133)
..|..+..+++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 4566777777777777777777776677777777777788877777766666677777777777777777777777777
Q ss_pred CCc-cCcEEEcccccccCCCC--cccccccccceeecccCccCCCCCccccC
Q 001171 553 SLV-GLQYLNLSDNAFTGDIP--ATYGFLRSLVFLSLSHNQISGMIPAELGA 601 (1133)
Q Consensus 553 ~l~-~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 601 (1133)
.++ +|++|+|++|.+++..+ .....+...+.+....+.+....|..+.+
T Consensus 245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 773 77777777777765432 11223344444555555555555554443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=278.57 Aligned_cols=260 Identities=23% Similarity=0.256 Sum_probs=163.0
Q ss_pred CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccc--cCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEe
Q 001171 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGK--IPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVV 536 (1133)
Q Consensus 459 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 536 (1133)
++|++|+|++|.++...+..|+.+++|++|++++|.++.. .+..+..+++|++|++++|.++ .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 3455555555555533333445555555555555555422 2344445666666666666666 455556666777777
Q ss_pred eccCCcccccCC-CCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCC-CCCccccCCCCccEEEecCCc
Q 001171 537 SLEENNLSGDVP-EGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISG-MIPAELGACSALEVLELRSNH 614 (1133)
Q Consensus 537 ~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~ 614 (1133)
++++|++++..+ ..|..+++|++|++++|.+++..+..+..+++|++|++++|.+++ ..|..+..+++|++|++++|+
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 777777665444 456667777777777777766666666667777777777777665 456666677777777777777
Q ss_pred ccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcc-cccccccccccccccCCc
Q 001171 615 FTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLS-NLTTLNLSTNRLSGAIPA 693 (1133)
Q Consensus 615 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~ 693 (1133)
+++..|..+..+++|+.|+|++|.+++..+..+..+++|+.|++++|++++..|..+..++ +|+.|+|++|++++..+.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 7665566666677777777777777665555666777777777777777776676676663 677777777777653221
Q ss_pred --cccccccCcccccccccccccCCccc
Q 001171 694 --DLALISSLRYLNLSRNNLEGEIPKML 719 (1133)
Q Consensus 694 --~l~~l~~L~~L~ls~N~l~~~~p~~~ 719 (1133)
...-+...+.+.+..+.+.+..|..+
T Consensus 267 ~~~~~~l~~~~~~~~~~~~~~C~~p~~~ 294 (306)
T 2z66_A 267 QSFLQWIKDQRQLLVEVERMECATPSDK 294 (306)
T ss_dssp HHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred HHHHHHHHhhhhhhccccccccCCchhh
Confidence 12223445555666666666666543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=284.47 Aligned_cols=274 Identities=19% Similarity=0.213 Sum_probs=143.9
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
.....++++|+++.++.+ +. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 32 ~~~~c~~~~~~l~~iP~~-~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 32 RNGICKGSSGSLNSIPSG-LT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TTSEEECCSTTCSSCCTT-CC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCeEeeCCCCCccccccc-cc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 344567777777776332 22 366777777777765555566666666666666666666656666666666666666
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccC-ccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCC
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP-LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGK 474 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 474 (1133)
+|++++..+..|+++++|++|++++|.+++..+ ..|.++++|++|++++|+ .+++.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~-----------------------~~~~~ 165 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD-----------------------TFTKI 165 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS-----------------------SCCEE
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc-----------------------ccccc
Confidence 666664444445555555555555555553322 244444455555544442 23333
Q ss_pred CCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChh-ccCCCCCcEeeccCCcccccCCCCCC-
Q 001171 475 VPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIE-LFGLPSLQVVSLEENNLSGDVPEGFS- 552 (1133)
Q Consensus 475 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~- 552 (1133)
.+..++.+++|++|++++|++++..|..+..+++|++|++++|+++. +|.. +..+++|++|++++|++++..+..+.
T Consensus 166 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 244 (353)
T 2z80_A 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELST 244 (353)
T ss_dssp CTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT-HHHHHHHHTTTEEEEEEESCBCTTCCCC----
T ss_pred CHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc-chhhhhhhcccccEEECCCCcccccccccccc
Confidence 33444444455555555555554455555555556666666665542 2322 23355566666666655544333222
Q ss_pred --CCccCcEEEcccccccC----CCCcccccccccceeecccCccCCCCCcc-ccCCCCccEEEecCCcccC
Q 001171 553 --SLVGLQYLNLSDNAFTG----DIPATYGFLRSLVFLSLSHNQISGMIPAE-LGACSALEVLELRSNHFTG 617 (1133)
Q Consensus 553 --~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~ 617 (1133)
....++.++|+++.+++ .+|..+..+++|++|+|++|+++ .+|.. ++.+++|++|+|++|++++
T Consensus 245 ~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp --CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccC
Confidence 23445555555555543 23444445555555555555555 23322 3445555555555555443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=298.81 Aligned_cols=301 Identities=26% Similarity=0.283 Sum_probs=201.5
Q ss_pred CCCCccCCCCCCCCCCCccceeeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceE
Q 001171 45 PLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAV 124 (1133)
Q Consensus 45 ~~~~l~~w~~~~~~~~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 124 (1133)
.....++|...+ +||.|+|..|.-.. ..-+....++.|++++|+++ .+|..+. ++|+.|
T Consensus 8 ~~~~w~~W~~~~--~~~~~~~r~~~~~~----------------~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L 66 (622)
T 3g06_A 8 YDAVWSAWRRAA--PAEESRGRAAVVQK----------------MRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTL 66 (622)
T ss_dssp --CHHHHHHHTC--CGGGHHHHHHHHHH----------------HHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEE
T ss_pred HHHHHHHHHhcC--CcchhccccccCcc----------------cccccCCCCcEEEecCCCcC-ccChhhC--CCCcEE
Confidence 344567886543 68999875442100 00111123556666666666 5555554 566666
Q ss_pred eccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCC
Q 001171 125 YLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGE 204 (1133)
Q Consensus 125 ~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~ 204 (1133)
+|++|+++ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|++|.+++. |. .+++|++|++++|++++
T Consensus 67 ~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~- 135 (622)
T 3g06_A 67 VIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV-LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS- 135 (622)
T ss_dssp EECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC-CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-
T ss_pred EecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC-CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-
Confidence 66666666 4554 45666666666666653 343 446677777777777653 33 45677777777777774
Q ss_pred CcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccC
Q 001171 205 VPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCN 284 (1133)
Q Consensus 205 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 284 (1133)
+|.. +++|++|+|++|++++ +|.. +++|+.|++++|+++++ | ..+++|+.|+|++|+|++ +|.
T Consensus 136 lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~-l~~----- 198 (622)
T 3g06_A 136 LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSL-P---MLPSGLQELSVSDNQLAS-LPT----- 198 (622)
T ss_dssp CCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCC-----
T ss_pred CCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCCCCC-c---ccCCCCcEEECCCCCCCC-CCC-----
Confidence 5543 3677777777777763 4432 35677777777777764 3 345777778888887775 332
Q ss_pred cccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCC
Q 001171 285 LWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDK 364 (1133)
Q Consensus 285 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 364 (1133)
.+++|+.|++++|.++... ..+++|++|+|++|+|++++ ..+++|++|+|++|+|+ .+|. .+++
T Consensus 199 ---~~~~L~~L~L~~N~l~~l~-----~~~~~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~ 262 (622)
T 3g06_A 199 ---LPSELYKLWAYNNRLTSLP-----ALPSGLKELIVSGNRLTSLP----VLPSELKELMVSGNRLT-SLPM---LPSG 262 (622)
T ss_dssp ---CCTTCCEEECCSSCCSSCC-----CCCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-CCCC---CCTT
T ss_pred ---ccchhhEEECcCCcccccC-----CCCCCCCEEEccCCccCcCC----CCCCcCcEEECCCCCCC-cCCc---cccc
Confidence 2367777788888777543 12467888888888888874 45688999999999998 4555 6788
Q ss_pred CcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCC
Q 001171 365 LEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIR 411 (1133)
Q Consensus 365 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 411 (1133)
|++|+|++|+|+ .+|..+.++++|+.|+|++|.+++.+|..+..++
T Consensus 263 L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 263 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 999999999998 5578899999999999999999988888776554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=286.67 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=172.3
Q ss_pred CccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCcc
Q 001171 158 KISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCS 237 (1133)
Q Consensus 158 ~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 237 (1133)
.+|..+++++++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+.+++
T Consensus 68 ~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 147 (452)
T 3zyi_A 68 EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLS 147 (452)
T ss_dssp SCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCT
T ss_pred ccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccC
Confidence 46667778899999999999999999999999999999999999988888999999999999999999977777799999
Q ss_pred ccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccc
Q 001171 238 SLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317 (1133)
Q Consensus 238 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L 317 (1133)
+|++|++++|+++.+.+..|.++++|+.|+|++|+..+.+|.. .|.++++|+.|++++|.+++. +.
T Consensus 148 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~----~~~~l~~L~~L~L~~n~l~~~---~~------- 213 (452)
T 3zyi_A 148 KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG----AFEGLFNLKYLNLGMCNIKDM---PN------- 213 (452)
T ss_dssp TCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT----TTTTCTTCCEEECTTSCCSSC---CC-------
T ss_pred CCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh----hccCCCCCCEEECCCCccccc---cc-------
Confidence 9999999999999888888999999999999985444444432 235666666666666666543 22
Q ss_pred cEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCC
Q 001171 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397 (1133)
Q Consensus 318 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 397 (1133)
+..+++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 214 -----------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 276 (452)
T 3zyi_A 214 -----------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276 (452)
T ss_dssp -----------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred -----------------ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCC
Confidence 444555555555555555555555555555555555555555555555555555555555555
Q ss_pred cccccCCCccCCCCCCcEEEccCCcCc
Q 001171 398 RFSGQVPAFLGGIRGLKIVSLGRNMFS 424 (1133)
Q Consensus 398 ~l~~~~p~~l~~l~~L~~L~L~~N~l~ 424 (1133)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 277 ~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 277 NLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred cCCccChHHhccccCCCEEEccCCCcC
Confidence 555555555555566666666666554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-29 Score=284.33 Aligned_cols=135 Identities=18% Similarity=0.116 Sum_probs=105.6
Q ss_pred cccccchhhhhhcccccCCCccCccCCcceEEEccCCcCC-CCCCCCCC-------CCCcCcEEeccCCcCCCCCcccc-
Q 001171 139 IFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFT-GEIPGNFS-------SKSQLQLINLSYNSFSGEVPASV- 209 (1133)
Q Consensus 139 l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~-~~~p~~~~-------~l~~L~~L~ls~N~l~~~~p~~~- 209 (1133)
+++.++|+.|++++|.+ .+|..++..+++|+|++|+++ +.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHHHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred EccCCCceeEeeccccc--ccHHHHHHHHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 56778889999999998 677777777888888888884 55666554 67888888888888888888765
Q ss_pred -cCccccceEecccccccCCCCccccCc-----cccceeeccccccCCCCCCcccCcCcccEEEcccCCccCC
Q 001171 210 -GQLQELEYLWLDSNHLYGTLPSAISNC-----SSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276 (1133)
Q Consensus 210 -~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 276 (1133)
+.+++|++|+|++|++++. |..+.++ ++|++|++++|++++..|..|+.+++|++|+|++|++.+.
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHH
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcc
Confidence 7888888888888888766 7777666 7778888888887777777777777777777777776543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=283.74 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=172.1
Q ss_pred CccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCcc
Q 001171 158 KISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCS 237 (1133)
Q Consensus 158 ~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 237 (1133)
.+|..+++++++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+.+++
T Consensus 57 ~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 136 (440)
T 3zyj_A 57 EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLS 136 (440)
T ss_dssp SCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCS
T ss_pred cCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccc
Confidence 45667778899999999999998889999999999999999999988888899999999999999999866667899999
Q ss_pred ccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccc
Q 001171 238 SLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317 (1133)
Q Consensus 238 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L 317 (1133)
+|++|++++|+++.+.+..|.++++|++|+|++|+..+.++.. .|.++++|+.|++++|.++.. +.
T Consensus 137 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~----~~~~l~~L~~L~L~~n~l~~~---~~------- 202 (440)
T 3zyj_A 137 KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG----AFEGLSNLRYLNLAMCNLREI---PN------- 202 (440)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT----TTTTCSSCCEEECTTSCCSSC---CC-------
T ss_pred cCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcc----hhhcccccCeecCCCCcCccc---cc-------
Confidence 9999999999999888889999999999999986544444432 235666666666666666543 12
Q ss_pred cEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCC
Q 001171 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397 (1133)
Q Consensus 318 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 397 (1133)
+..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 203 -----------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 265 (440)
T 3zyj_A 203 -----------------LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265 (440)
T ss_dssp -----------------CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTS
T ss_pred -----------------cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCC
Confidence 445555555555555555555555555555555555555555555555555555666666666
Q ss_pred cccccCCCccCCCCCCcEEEccCCcCc
Q 001171 398 RFSGQVPAFLGGIRGLKIVSLGRNMFS 424 (1133)
Q Consensus 398 ~l~~~~p~~l~~l~~L~~L~L~~N~l~ 424 (1133)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 266 ~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 266 NLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCccChhHhccccCCCEEEcCCCCcc
Confidence 665555555555666666666666554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=281.03 Aligned_cols=249 Identities=22% Similarity=0.246 Sum_probs=161.9
Q ss_pred ccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEc
Q 001171 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 315 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 394 (1133)
.....++.++++++.++. .+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 54 ~~~~~v~c~~~~l~~iP~-~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 54 NQFSKVVCTRRGLSEVPQ-GIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSSCEEECCSSCCSSCCS-CCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCcEEEECCCCcCccCC-CCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 345667777777777633 332 57778888888887777777777888888888888777777777777777777777
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccc-ccccccCChhhcCCCCCcEEecccCcCCC
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSE-NDIRGNIPEEITRLSNLTTLNLSYNKFGG 473 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~ 473 (1133)
++|++++..+..|.++++|++|+|++|.++...+..|.++++|++|++++ |.+....+..|..+++|++|+|++|.+++
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 77777766666677777777777777777766666677777777777776 44444444456666666666666666653
Q ss_pred CCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCC
Q 001171 474 KVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSS 553 (1133)
Q Consensus 474 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 553 (1133)
. | . +..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|.+
T Consensus 211 ~-~-~------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 264 (452)
T 3zyi_A 211 M-P-N------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264 (452)
T ss_dssp C-C-C------------------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred c-c-c------------------------ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcC
Confidence 2 2 2 344455555555555555555555555555555555555555555555666
Q ss_pred CccCcEEEcccccccCCCCcccccccccceeecccCccC
Q 001171 554 LVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS 592 (1133)
Q Consensus 554 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1133)
+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus 265 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 666666666666666555555666666666666666554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=264.84 Aligned_cols=236 Identities=25% Similarity=0.256 Sum_probs=122.9
Q ss_pred CCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccC-CCCCCChhccCCCCCcEeec
Q 001171 460 NLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQN-LSGELPIELFGLPSLQVVSL 538 (1133)
Q Consensus 460 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L 538 (1133)
+|++|++++|.+++..+..|..+++|++|++++|.+++..|..|..+++|++|++++|. ++...|..+..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 44444444444443333444444444444444444444444445555555555555554 44333444555555555555
Q ss_pred cCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCC
Q 001171 539 EENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGN 618 (1133)
Q Consensus 539 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 618 (1133)
++|++++..+..|.++++|++|++++|++++..+..++.+++|++|+|++|++++..+..+..+++|++|++++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 55555544455555555555555555555544444455555555555555555544444455555666666666666555
Q ss_pred CccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcccc
Q 001171 619 IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLA 696 (1133)
Q Consensus 619 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 696 (1133)
.|..+..+++|+.|+|++|.+++..+..+..+++|+.|++++|++....+.. .-...++.+..+.|.+....|..+.
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence 5555555566666666666666544445566666666666666665432211 1123344555555666555555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-27 Score=278.79 Aligned_cols=251 Identities=23% Similarity=0.270 Sum_probs=167.5
Q ss_pred ccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEE
Q 001171 313 CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMF 392 (1133)
Q Consensus 313 ~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 392 (1133)
|......++.++++++.++.. +. +++++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|
T Consensus 41 C~~~~~~v~c~~~~l~~iP~~-~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L 117 (440)
T 3zyj_A 41 CSNQFSKVICVRKNLREVPDG-IS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL 117 (440)
T ss_dssp ECTTSCEEECCSCCCSSCCSC-CC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEE
T ss_pred eCCCCCEEEeCCCCcCcCCCC-CC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEE
Confidence 333456778888888887443 32 578888888888887777888888888888888888888777888888888888
Q ss_pred EccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccc-ccccccCChhhcCCCCCcEEecccCcC
Q 001171 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSE-NDIRGNIPEEITRLSNLTTLNLSYNKF 471 (1133)
Q Consensus 393 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~l~~l~~L~~L~Ls~N~l 471 (1133)
+|++|+|+...+..|.++++|++|+|++|.++...+..|.++++|++|++++ |.+....+..|.++++|++|+|++|.+
T Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 197 (440)
T 3zyj_A 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197 (440)
T ss_dssp ECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred ECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence 8888888877677788888888888888888877777777888888888877 445544445667777777777777776
Q ss_pred CCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCC
Q 001171 472 GGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGF 551 (1133)
Q Consensus 472 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 551 (1133)
+. +| .+..+++|++|+|++|++++..|..|..+++|+.|++++|+++ +..+..|
T Consensus 198 ~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~------------------------~~~~~~~ 251 (440)
T 3zyj_A 198 RE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ------------------------VIERNAF 251 (440)
T ss_dssp SS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC------------------------EECTTSS
T ss_pred cc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCcee------------------------EEChhhh
Confidence 62 23 2445555555555555555444445555555555555554444 4444455
Q ss_pred CCCccCcEEEcccccccCCCCcccccccccceeecccCccC
Q 001171 552 SSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQIS 592 (1133)
Q Consensus 552 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1133)
.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 252 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 55555555555555555444444555555555555555543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=266.57 Aligned_cols=225 Identities=25% Similarity=0.245 Sum_probs=159.0
Q ss_pred cEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCC
Q 001171 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397 (1133)
Q Consensus 318 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 397 (1133)
.+++++++.++.++. .+ .++|++|+|++|.|++..+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~ip~-~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPV-GI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSCCT-TC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccCCc-CC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 456666666666632 22 356777777777777666666777777777777777777666777777777777777777
Q ss_pred c-ccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCC
Q 001171 398 R-FSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476 (1133)
Q Consensus 398 ~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 476 (1133)
+ ++...|..|..+++|++|++++|.+++..|..|.++++|++|++++|++++..+..|..+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 6 665556677777777777777777776666777777777777777777776666667777777777777777776555
Q ss_pred CCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccc
Q 001171 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545 (1133)
Q Consensus 477 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 545 (1133)
..+..+++|++|++++|.+++..|..|..+++|+.|++++|++++..+..+..+++|++|++++|.+..
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 567777777777777777777777777777777777777777776555667777777777777777654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=268.09 Aligned_cols=234 Identities=21% Similarity=0.282 Sum_probs=123.2
Q ss_pred CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeec
Q 001171 459 SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSL 538 (1133)
Q Consensus 459 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 538 (1133)
.+++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..++.+++|++|++++|+++ .+|..+.++++|++|++
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 34444444444444 33444444444444444444444 44444555555555555555555 44555555555555555
Q ss_pred cCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCC
Q 001171 539 EENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGN 618 (1133)
Q Consensus 539 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 618 (1133)
++|++.+.+|..+... ..+..+..+++|++|+|++|+++ .+|..++.+++|++|+|++|++++
T Consensus 158 ~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~- 220 (328)
T 4fcg_A 158 RACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA- 220 (328)
T ss_dssp EEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-
T ss_pred CCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-
Confidence 5554444444433220 01122334555555555555555 445555555555555555555553
Q ss_pred CccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcccccc
Q 001171 619 IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALI 698 (1133)
Q Consensus 619 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 698 (1133)
+|..+..+++|++|+|++|.+.+.+|..++.+++|+.|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..+.++
T Consensus 221 l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L 300 (328)
T 4fcg_A 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300 (328)
T ss_dssp CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGS
T ss_pred CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhc
Confidence 44445555555555555555555555555666666666666666555666556666666666666666666666666666
Q ss_pred ccCccccccccccc
Q 001171 699 SSLRYLNLSRNNLE 712 (1133)
Q Consensus 699 ~~L~~L~ls~N~l~ 712 (1133)
++|+.+++..|.+.
T Consensus 301 ~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 301 PANCIILVPPHLQA 314 (328)
T ss_dssp CTTCEEECCGGGSC
T ss_pred cCceEEeCCHHHHH
Confidence 66666666555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-28 Score=278.08 Aligned_cols=262 Identities=21% Similarity=0.224 Sum_probs=149.5
Q ss_pred ccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCcc
Q 001171 418 LGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497 (1133)
Q Consensus 418 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 497 (1133)
++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|++++|++++
T Consensus 17 ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~ 94 (317)
T 3o53_A 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE 94 (317)
T ss_dssp CCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE
T ss_pred ccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc
Confidence 33333333333333344445555555555554444444555555555555554443222 4444444444444444432
Q ss_pred ccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCccccc
Q 001171 498 KIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGF 577 (1133)
Q Consensus 498 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 577 (1133)
.. ..++|++|+++ +|++++..+.. +++|++|++++|++++..+..++.
T Consensus 95 l~-----~~~~L~~L~l~------------------------~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~ 142 (317)
T 3o53_A 95 LL-----VGPSIETLHAA------------------------NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGC 142 (317)
T ss_dssp EE-----ECTTCCEEECC------------------------SSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGG
T ss_pred cc-----CCCCcCEEECC------------------------CCccCCcCccc---cCCCCEEECCCCCCCCccchhhhc
Confidence 11 11344444444 44444333222 344555666666665555555556
Q ss_pred ccccceeecccCccCCCCCccc-cCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEE
Q 001171 578 LRSLVFLSLSHNQISGMIPAEL-GACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSL 656 (1133)
Q Consensus 578 l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 656 (1133)
+++|++|+|++|++++..+..+ ..+++|++|+|++|++++. +. ...+++|++|+|++|++++ +|..+..+++|+.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L 219 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEE
Confidence 6666666666666665555544 2566667777777766642 22 2346777777777777773 44557777788888
Q ss_pred EeecCCCCccCCccccCccccccccccccccc-ccCCccccccccCccccccc-ccccccCCc
Q 001171 657 TLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS-GAIPADLALISSLRYLNLSR-NNLEGEIPK 717 (1133)
Q Consensus 657 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~ls~-N~l~~~~p~ 717 (1133)
+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++ +.++|..|.
T Consensus 220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 88888777 46777777888888888888887 66777777888888888884 456666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-28 Score=275.65 Aligned_cols=266 Identities=19% Similarity=0.197 Sum_probs=160.2
Q ss_pred cEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCC
Q 001171 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397 (1133)
Q Consensus 318 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 397 (1133)
+.++++.+.+.......+..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..+ +..+++|++|+|++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 344555555554444455555566666666666665555566666666666666666655433 556666666666666
Q ss_pred cccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCC
Q 001171 398 RFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPY 477 (1133)
Q Consensus 398 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 477 (1133)
++++.. ..++|+.|++++|.+++..+.. +++|++|++++|++++..+..+..+++|++|+|++|.+++..+.
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 665322 2255666666666666544333 34566666666666655555566666666666666666655444
Q ss_pred CC-CCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCcc
Q 001171 478 DV-GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG 556 (1133)
Q Consensus 478 ~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 556 (1133)
.+ ..+++|++|++++|.+++..+ ...+++|++|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCC
Confidence 44 245666666666666654421 2236677777777777763 3444667777777777777776 35566777777
Q ss_pred CcEEEccccccc-CCCCcccccccccceeeccc-CccCCCCCc
Q 001171 557 LQYLNLSDNAFT-GDIPATYGFLRSLVFLSLSH-NQISGMIPA 597 (1133)
Q Consensus 557 L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~ 597 (1133)
|+.|++++|.++ +.++..+..+++|+.|++++ +.+++..|.
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 777777777776 55666677777777777773 345544443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-26 Score=276.09 Aligned_cols=268 Identities=29% Similarity=0.372 Sum_probs=142.1
Q ss_pred CCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecc
Q 001171 364 KLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLS 443 (1133)
Q Consensus 364 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 443 (1133)
+++.|++++|.++ .+|..+. ++|++|+|++|.|+. +|. .+++|++|+|++|.+++ +|. .+++|++|+++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 4566666666665 3343333 456666666666552 333 34455555555555543 222 33445555555
Q ss_pred cccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCC
Q 001171 444 ENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGEL 523 (1133)
Q Consensus 444 ~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 523 (1133)
+|+|++. |. .+++|+.|++++|+++ + +|.. +++|++|++++|++++ +
T Consensus 110 ~N~l~~l-~~---~l~~L~~L~L~~N~l~------------------------~-lp~~---l~~L~~L~Ls~N~l~~-l 156 (622)
T 3g06_A 110 SNPLTHL-PA---LPSGLCKLWIFGNQLT------------------------S-LPVL---PPGLQELSVSDNQLAS-L 156 (622)
T ss_dssp SCCCCCC-CC---CCTTCCEEECCSSCCS------------------------C-CCCC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCCC-CC---CCCCcCEEECCCCCCC------------------------c-CCCC---CCCCCEEECcCCcCCC-c
Confidence 5554432 22 2344444444444444 2 2222 2445555555555542 2
Q ss_pred ChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCC
Q 001171 524 PIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603 (1133)
Q Consensus 524 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 603 (1133)
|. .+++|+.|++++|.+++ +| ..+++|+.|++++|++++ +|. .+++|+.|++++|.++ .+|.. ++
T Consensus 157 ~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-~l~~~---~~ 221 (622)
T 3g06_A 157 PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLT-SLPAL---PS 221 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-SCCCC---CT
T ss_pred CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCccc-ccCCC---CC
Confidence 22 23445555555555553 22 234556666666666653 222 1355666666666666 33332 35
Q ss_pred CccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccc
Q 001171 604 ALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLS 683 (1133)
Q Consensus 604 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 683 (1133)
+|++|+|++|+|++ +| ..+++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|+
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 66666666666664 44 33456666666666666 3444 4566667777777766 556666667777777777
Q ss_pred cccccccCCccccccc
Q 001171 684 TNRLSGAIPADLALIS 699 (1133)
Q Consensus 684 ~N~l~~~~p~~l~~l~ 699 (1133)
+|++++.+|..+..++
T Consensus 293 ~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 293 GNPLSERTLQALREIT 308 (622)
T ss_dssp SCCCCHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHhcc
Confidence 7777666666555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-28 Score=272.65 Aligned_cols=202 Identities=22% Similarity=0.223 Sum_probs=109.9
Q ss_pred CCCCCcEEEccCCcCccccCccc--cCccccceeecccccccccCChhhcCC-----CCCcEEecccCcCCCCCCCCCCC
Q 001171 409 GIRGLKIVSLGRNMFSGLIPLSF--GNLSQLETLNLSENDIRGNIPEEITRL-----SNLTTLNLSYNKFGGKVPYDVGN 481 (1133)
Q Consensus 409 ~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~i~~~~~~~l~~l-----~~L~~L~Ls~N~l~~~~~~~~~~ 481 (1133)
++++|++|+|++|.+++.+|..+ ..+++|++|++++|++++. |..+..+ ++|++|+|++|++++..+..++.
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 34445555555555554444443 5555666666666666554 5555544 66666666666666666666666
Q ss_pred CCCCcEEEcccCCCccc--cCCC--cCCcccccEEeccccCCCCC--CC-hhccCCCCCcEeeccCCcccccCC-CCCCC
Q 001171 482 LKGLLVLNLSASGFSGK--IPGS--IGSLMRLTTLDLSNQNLSGE--LP-IELFGLPSLQVVSLEENNLSGDVP-EGFSS 553 (1133)
Q Consensus 482 l~~L~~L~L~~N~l~~~--~~~~--~~~l~~L~~L~Ls~N~l~~~--~p-~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~ 553 (1133)
+++|++|++++|++.+. .+.. +..+++|++|++++|++++. ++ ..+.++++|++|++++|++++..| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 66666666666665543 1222 25667777777777776621 11 222355666666666666665443 33444
Q ss_pred CccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCccc
Q 001171 554 LVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT 616 (1133)
Q Consensus 554 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 616 (1133)
+++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|+++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 555555555555555 3444333 4455555555555433 33 444455555555555444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-27 Score=280.65 Aligned_cols=234 Identities=25% Similarity=0.273 Sum_probs=163.6
Q ss_pred CCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeecc
Q 001171 460 NLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539 (1133)
Q Consensus 460 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 539 (1133)
+|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.+++.. ..++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence 45555555555554444455555555555555555554443 555556666666666555321 22566666666
Q ss_pred CCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCcccc-CCCCccEEEecCCcccCC
Q 001171 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG-ACSALEVLELRSNHFTGN 618 (1133)
Q Consensus 540 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~ 618 (1133)
+|.+++..+.. +++|+.|+|++|.+++..|..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|.+++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 66666554443 45677778888887777777777788888888888888877777765 678888888888888753
Q ss_pred CccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccccccccccccc-ccCCccccc
Q 001171 619 IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLS-GAIPADLAL 697 (1133)
Q Consensus 619 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~ 697 (1133)
|. +..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+|..+..
T Consensus 185 -~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 -KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp -EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred -cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 32 3457888888888888885 44558888888999999888885 6777888889999999999887 677778888
Q ss_pred cccCcccccc
Q 001171 698 ISSLRYLNLS 707 (1133)
Q Consensus 698 l~~L~~L~ls 707 (1133)
++.|+.++++
T Consensus 261 l~~L~~l~~~ 270 (487)
T 3oja_A 261 NQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHH
T ss_pred CCCCcEEecc
Confidence 8888888887
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-28 Score=304.20 Aligned_cols=374 Identities=16% Similarity=0.141 Sum_probs=233.0
Q ss_pred hhcccccceeeccCceeecccCcccC-CCCCCcEEEccCC-ccccc-CchhhccCCCccEEEccCCcccccCCCccC---
Q 001171 335 LTNVTSLRVMDLSGNFFSGNLPAAVG-SLDKLEVLRVANN-SLSGL-VPDEIAKCSLLQMFDLEGNRFSGQVPAFLG--- 408 (1133)
Q Consensus 335 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~--- 408 (1133)
+..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.++.
T Consensus 101 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 180 (594)
T 2p1m_B 101 SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP 180 (594)
T ss_dssp HHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred HHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence 34566777777777776655555554 5667777777776 44332 233444677777777777776654443332
Q ss_pred -CCCCCcEEEccCCc--Cccc-cCccccCccccceeecccc-cccccCChhhcCCCCCcEEecccCc-------CCCCCC
Q 001171 409 -GIRGLKIVSLGRNM--FSGL-IPLSFGNLSQLETLNLSEN-DIRGNIPEEITRLSNLTTLNLSYNK-------FGGKVP 476 (1133)
Q Consensus 409 -~l~~L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~i~~~~~~~l~~l~~L~~L~Ls~N~-------l~~~~~ 476 (1133)
.+++|+.|++++|. ++.. ++..+.++++|++|++++| .+.+ ++..+..+++|++|+++.+. +.+ ++
T Consensus 181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~ 258 (594)
T 2p1m_B 181 DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LS 258 (594)
T ss_dssp TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HH
T ss_pred hcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HH
Confidence 45577777777765 2211 1112234577777777776 3443 56666677777777754432 222 22
Q ss_pred CCCCCCCCCcEE-EcccCCCccccCCCcCCcccccEEeccccCCCCCCCh-hccCCCCCcEeeccCCccccc-CCCCCCC
Q 001171 477 YDVGNLKGLLVL-NLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPI-ELFGLPSLQVVSLEENNLSGD-VPEGFSS 553 (1133)
Q Consensus 477 ~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~-~~~~~~~ 553 (1133)
..+.++++|+.| .+.+... +.++..+..+++|++|++++|.+++.... .+..+++|++|++++| +.+. ++.....
T Consensus 259 ~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~ 336 (594)
T 2p1m_B 259 VALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAST 336 (594)
T ss_dssp HHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred HHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence 245667777777 3333222 23444445677888888888876533222 2456788888888877 4322 2222234
Q ss_pred CccCcEEEccc---------ccccCCCCcccc-cccccceeecccCccCCCCCcccc-CCCCccEEEec--C----Cccc
Q 001171 554 LVGLQYLNLSD---------NAFTGDIPATYG-FLRSLVFLSLSHNQISGMIPAELG-ACSALEVLELR--S----NHFT 616 (1133)
Q Consensus 554 l~~L~~L~Ls~---------N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~--~----N~l~ 616 (1133)
+++|++|++++ +.+++.....+. .+++|++|.++.|.+++..+..+. .+++|+.|+++ + |.++
T Consensus 337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~ 416 (594)
T 2p1m_B 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT 416 (594)
T ss_dssp CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence 67788888733 445433333333 477888888888888766555554 47888888888 3 5555
Q ss_pred CC-----CccccccccccCeeecCCCcccCcCchhhhc-cCCCcEEEeecCCCCccCCccc-cCcccccccccccccccc
Q 001171 617 GN-----IPVDISHLSRIKKLDLGQNKLSGEIPKEISK-CSSLVSLTLDMNSLSGRIPESF-SKLSNLTTLNLSTNRLSG 689 (1133)
Q Consensus 617 ~~-----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~ 689 (1133)
+. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++
T Consensus 417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 21 112256678888888877 677666666665 8888888888888877666555 567888888888888865
Q ss_pred cCCcc-ccccccCcccccccccccc
Q 001171 690 AIPAD-LALISSLRYLNLSRNNLEG 713 (1133)
Q Consensus 690 ~~p~~-l~~l~~L~~L~ls~N~l~~ 713 (1133)
..+.. ...+++|+.|++++|+++.
T Consensus 496 ~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 496 KALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp HHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred HHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 55443 3457888888888888754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=272.70 Aligned_cols=234 Identities=22% Similarity=0.229 Sum_probs=149.0
Q ss_pred CccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecc
Q 001171 388 LLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLS 467 (1133)
Q Consensus 388 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls 467 (1133)
+|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| |..+++|++|+|++|.|++.. ..++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence 56666666666655555556666666666666666655444 666666677777776666432 22667777777
Q ss_pred cCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhcc-CCCCCcEeeccCCccccc
Q 001171 468 YNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGD 546 (1133)
Q Consensus 468 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~ 546 (1133)
+|.+++..+. .+++|+.|++++|.+++..|..++.+++|+.|+|++|.+++..|..+. .+++|++|+|++|.+++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 7777655443 245677777777777777677777777777777777777766666665 577777777777777655
Q ss_pred CCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCccc-CCCcccccc
Q 001171 547 VPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT-GNIPVDISH 625 (1133)
Q Consensus 547 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~l~~ 625 (1133)
.+ +..+++|++|+|++|.+++..| .+..+++|+.|+|++|.|++ +|..++.+++|+.|++++|.+. +.+|..+..
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 32 2246677777777777765333 36666666677776666663 5555666666666666666665 444555555
Q ss_pred ccccCeeecC
Q 001171 626 LSRIKKLDLG 635 (1133)
Q Consensus 626 l~~L~~L~Ls 635 (1133)
++.|+.|+++
T Consensus 261 l~~L~~l~~~ 270 (487)
T 3oja_A 261 NQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHH
T ss_pred CCCCcEEecc
Confidence 5555555554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-27 Score=286.77 Aligned_cols=184 Identities=17% Similarity=0.098 Sum_probs=126.7
Q ss_pred ccccccceeEEEEE-ECCceEEEEEEcccCCc-----------CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEE
Q 001171 844 VLSRGRYGLIFKAS-YQDGMVLSIRRLRDGTI-----------DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 844 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~l 910 (1133)
..+.|++|.++.++ .-.|+.||+|++.+... ..++|.+|+++|+++ .|+||+++++++++.. ..||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~-~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ-SGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-EEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-EEEE
Confidence 35677777776663 33588999999965421 135689999999999 7999999999998864 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||++|++|.+++.+.+. ++. ..|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~~~-----l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEE-----IDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEECCCSEEHHHHHHTTCC-----CCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEecCCCCcHHHHHHhCCC-----CCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999986432 443 35889999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCC
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP 1040 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~P 1040 (1133)
. .......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 392 ~---~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 D---CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C---CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 223345679999999999965 567889999999998877665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=242.17 Aligned_cols=216 Identities=25% Similarity=0.337 Sum_probs=129.2
Q ss_pred CCCccceeeeCC-CceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCC
Q 001171 59 APCDWRGIVCYN-NRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPL 137 (1133)
Q Consensus 59 ~~c~w~gv~c~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~ 137 (1133)
++|.|.|+.|+- ..++.+++.+.+++. +|..+. +.|++|+|++|++++..+..|+++++|+.|+|++|++++..+.
T Consensus 3 ~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~ 79 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG 79 (270)
T ss_dssp CCBGGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT
T ss_pred ccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh
Confidence 689999999963 334556666666553 443332 4566666666666654444566666666666666666632222
Q ss_pred ccccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccce
Q 001171 138 SIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEY 217 (1133)
Q Consensus 138 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 217 (1133)
.+.++++| ++|+|++|.+++..+..|..+++|++|++++|++++..|..++.+++|++
T Consensus 80 ~~~~l~~L----------------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 137 (270)
T 2o6q_A 80 IFKELKNL----------------------ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137 (270)
T ss_dssp TTSSCTTC----------------------CEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred hhcCCCCC----------------------CEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE
Confidence 34455544 55555555555555555666666666666666666555555666666666
Q ss_pred EecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEec
Q 001171 218 LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQL 297 (1133)
Q Consensus 218 L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l 297 (1133)
|+|++|++++..+..+.++++|++|++++|+++++.+..|..+++|++|+|++|++++..+.. |..+++|+.|++
T Consensus 138 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~~l~~L~~L~l 212 (270)
T 2o6q_A 138 LSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA-----FDSLEKLKMLQL 212 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTT-----TTTCTTCCEEEC
T ss_pred EECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHH-----hccccCCCEEEe
Confidence 666666666444444566666666666666666655556666666666666666666433322 255666666666
Q ss_pred cCCcccc
Q 001171 298 GFNAFTG 304 (1133)
Q Consensus 298 ~~n~l~~ 304 (1133)
++|.+..
T Consensus 213 ~~N~~~c 219 (270)
T 2o6q_A 213 QENPWDC 219 (270)
T ss_dssp CSSCBCC
T ss_pred cCCCeeC
Confidence 6666543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-28 Score=299.61 Aligned_cols=433 Identities=15% Similarity=0.094 Sum_probs=228.6
Q ss_pred cccCcCcccEEEcccCCccC---Cccccc-------ccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCC
Q 001171 256 TIGRISTLQVLSLSRNELTG---LVPVSV-------LCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN 325 (1133)
Q Consensus 256 ~~~~l~~L~~L~Ls~N~l~~---~~p~~~-------~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n 325 (1133)
.+.++++|+.|+|++|.... ..|... +...+..+++|+.|++++|.+++.........+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 45677889999999886321 111110 01112344556666666555544221000112334555555544
Q ss_pred -ccccc-CCchhhcccccceeeccCceeecccCccc----CCCCCCcEEEccCCc--cccc-CchhhccCCCccEEEccC
Q 001171 326 -RIRAV-FPSWLTNVTSLRVMDLSGNFFSGNLPAAV----GSLDKLEVLRVANNS--LSGL-VPDEIAKCSLLQMFDLEG 396 (1133)
Q Consensus 326 -~i~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~n~--l~~~-~~~~~~~l~~L~~L~Ls~ 396 (1133)
.++.. .+..+.++++|++|+|++|.+++..+.++ ..+++|++|++++|. ++.. ++..+..+++|++|+|++
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~ 220 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR 220 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCC
Confidence 33321 12223344555555555555443322222 233445555555443 1100 011122334444444444
Q ss_pred C-cccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEE-ecccCcCCCC
Q 001171 397 N-RFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTL-NLSYNKFGGK 474 (1133)
Q Consensus 397 N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L-~Ls~N~l~~~ 474 (1133)
| .+.+ +|..+..+++|+.|+++.+.. +++.|.+.+ ++..+.++++|+.| .+.+... +.
T Consensus 221 ~~~~~~-l~~~~~~~~~L~~L~l~~~~~-----------------~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~ 280 (594)
T 2p1m_B 221 AVPLEK-LATLLQRAPQLEELGTGGYTA-----------------EVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AY 280 (594)
T ss_dssp TSCHHH-HHHHHHHCTTCSEEECSBCCC-----------------CCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GG
T ss_pred CCcHHH-HHHHHhcCCcceEcccccccC-----------------ccchhhHHH-HHHHHhcCCCcccccCCcccch-hh
Confidence 4 2222 333444444444444322210 022223332 22345555556555 2222211 12
Q ss_pred CCCCCCCCCCCcEEEcccCCCccccC-CCcCCcccccEEeccccCCCCCCChhc-cCCCCCcEeecc---------CCcc
Q 001171 475 VPYDVGNLKGLLVLNLSASGFSGKIP-GSIGSLMRLTTLDLSNQNLSGELPIEL-FGLPSLQVVSLE---------ENNL 543 (1133)
Q Consensus 475 ~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~---------~N~l 543 (1133)
++..+..+++|++|++++|.+++... ..+..+++|++|++++| ++......+ ..+++|++|++. .+.+
T Consensus 281 l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l 359 (594)
T 2p1m_B 281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL 359 (594)
T ss_dssp GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCC
T ss_pred HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCC
Confidence 22223345566666666666543322 12345666777777666 332111122 246667777663 3344
Q ss_pred cccCCCCC-CCCccCcEEEcccccccCCCCcccc-cccccceeecc--c----CccCCCC-----CccccCCCCccEEEe
Q 001171 544 SGDVPEGF-SSLVGLQYLNLSDNAFTGDIPATYG-FLRSLVFLSLS--H----NQISGMI-----PAELGACSALEVLEL 610 (1133)
Q Consensus 544 ~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~~-----p~~l~~l~~L~~L~L 610 (1133)
++.....+ .++++|++|+++.|.+++.....+. .+++|++|+++ + |.+++.. +..+..+++|+.|+|
T Consensus 360 ~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L 439 (594)
T 2p1m_B 360 TEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL 439 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEEC
T ss_pred CHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEee
Confidence 43222222 2367888888888888765555554 57888888888 4 5665321 122567889999999
Q ss_pred cCCcccCCCcccccc-ccccCeeecCCCcccCcCchhh-hccCCCcEEEeecCCCCccCCc-cccCcccccccccccccc
Q 001171 611 RSNHFTGNIPVDISH-LSRIKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGRIPE-SFSKLSNLTTLNLSTNRL 687 (1133)
Q Consensus 611 ~~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l 687 (1133)
++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|++
T Consensus 440 ~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 440 SG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp CS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred cC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 77 666555555554 7889999999999987666666 6789999999999999765554 345589999999999998
Q ss_pred cccCCccc-cccccCccccccccc
Q 001171 688 SGAIPADL-ALISSLRYLNLSRNN 710 (1133)
Q Consensus 688 ~~~~p~~l-~~l~~L~~L~ls~N~ 710 (1133)
+......+ ..++.|+...+..+.
T Consensus 519 ~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 519 SFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp BHHHHHHHHHHCTTEEEEEECSSS
T ss_pred CHHHHHHHHHhCCCCEEEEecCCC
Confidence 65544444 345666655555443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=241.60 Aligned_cols=209 Identities=24% Similarity=0.304 Sum_probs=135.8
Q ss_pred cccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecc
Q 001171 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLS 587 (1133)
Q Consensus 508 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 587 (1133)
+|++|++++|++++..+..+.++++|++|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555554444455555555555555555555555555566666666666666665555556666666666666
Q ss_pred cCccCCCCCccccCCCCccEEEecCCcccCC-CccccccccccCeeecCCCcccCcCchhhhccCCCc----EEEeecCC
Q 001171 588 HNQISGMIPAELGACSALEVLELRSNHFTGN-IPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLV----SLTLDMNS 662 (1133)
Q Consensus 588 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~Ls~N~ 662 (1133)
+|++++..+..++.+++|++|++++|++++. +|..+..+++|+.|+|++|++++..+..+..+.+|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 6666655555566666666777776666642 466677777777777777777765566666666666 77888888
Q ss_pred CCccCCccccCcccccccccccccccccCCccccccccCcccccccccccccCCc
Q 001171 663 LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 663 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
+++..+..+.. .+|+.|+|++|++++..+..+..+++|+.|++++|+++|.+|.
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 87655554443 4788888888888866555667888888888888888887763
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=236.60 Aligned_cols=180 Identities=26% Similarity=0.305 Sum_probs=94.0
Q ss_pred ccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEcc
Q 001171 340 SLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419 (1133)
Q Consensus 340 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 419 (1133)
+|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45566666666655544455556666666666666555555555555566666666665555555555555555555555
Q ss_pred CCcCccccCccccCccccceeeccccccccc-CChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCc----EEEcccCC
Q 001171 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGN-IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL----VLNLSASG 494 (1133)
Q Consensus 420 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N~ 494 (1133)
+|.+++..+..+.++++|++|++++|++++. +|..+..+++|++|+|++|++++..+..+..+++|+ .|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 5555555444555555556666555555542 355555555555555555555544444443333333 34444444
Q ss_pred CccccCCCcCCcccccEEeccccCCC
Q 001171 495 FSGKIPGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 495 l~~~~~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
+++..+..+.. .+|+.|++++|+++
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~ 213 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLK 213 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCS
T ss_pred ccccCccccCC-CcccEEECCCCcee
Confidence 44332222222 23444444444444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=235.83 Aligned_cols=229 Identities=18% Similarity=0.276 Sum_probs=148.9
Q ss_pred cccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEec
Q 001171 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220 (1133)
Q Consensus 141 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 220 (1133)
.+.++..+++..+.+...+...-.++|+.|++++|.++.. ..+..+++|++|++++|++++ + ..++.+++|++|++
T Consensus 17 ~~~~l~~l~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred hHHHHHHHHhcCcccccccccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 4556777777777776555444457788888888888743 357778888888888888876 3 36778888888888
Q ss_pred ccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCC
Q 001171 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300 (1133)
Q Consensus 221 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n 300 (1133)
++|++++..+..+.++++|++|++++|++++..+..|..+++|++|+|++|++++..+..+ +++++
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~--------- 158 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF-----DKLTN--------- 158 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-----TTCTT---------
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHh-----ccCcc---------
Confidence 8888876666667778888888888888877777777777777777777777764433211 23333
Q ss_pred cccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCc
Q 001171 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP 380 (1133)
Q Consensus 301 ~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~ 380 (1133)
|++|++++|+|+++.+..|..+++|++|+|++|++++..+..|+.+++|++|++++|.+.+.
T Consensus 159 ----------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-- 220 (272)
T 3rfs_A 159 ----------------LTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-- 220 (272)
T ss_dssp ----------------CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC--
T ss_pred ----------------CCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc--
Confidence 33344444444444455556666666666666666655555556666666666666655432
Q ss_pred hhhccCCCccEEEccCCcccccCCCccCCC
Q 001171 381 DEIAKCSLLQMFDLEGNRFSGQVPAFLGGI 410 (1133)
Q Consensus 381 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 410 (1133)
+++|++|+++.|.++|.+|.+++.+
T Consensus 221 -----~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 221 -----CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp -----TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred -----CcHHHHHHHHHHhCCCcccCccccc
Confidence 3345555566666655555555443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-23 Score=229.51 Aligned_cols=205 Identities=24% Similarity=0.314 Sum_probs=140.7
Q ss_pred ccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeeccc
Q 001171 509 LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSH 588 (1133)
Q Consensus 509 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 588 (1133)
.+.+++++++++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 455666666655 3444332 4566666666666655555666666666666666666655555556667777777777
Q ss_pred CccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCC
Q 001171 589 NQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIP 668 (1133)
Q Consensus 589 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 668 (1133)
|++++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|.+++..+..+..+++|+.|+|++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 77765555566667777777777777776555566777777777777777775555557777788888888888776666
Q ss_pred ccccCcccccccccccccccccCCccccccccCcccccccccccccCC
Q 001171 669 ESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716 (1133)
Q Consensus 669 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 716 (1133)
..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+.++
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 667778888888888888876555567778888888888888876554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=231.95 Aligned_cols=211 Identities=23% Similarity=0.293 Sum_probs=103.6
Q ss_pred hhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCc
Q 001171 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLK 414 (1133)
Q Consensus 335 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 414 (1133)
+..+++|+.|++++|.+.. + ..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++..+..|.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 4455555555555555542 1 2344555555555555555442 2444555555555555555544444444444555
Q ss_pred EEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCC
Q 001171 415 IVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494 (1133)
Q Consensus 415 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 494 (1133)
+|+|++|.+++..+..|..+++|++|++++|++++..+..+..+++|++|++++|+++
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---------------------- 170 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ---------------------- 170 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC----------------------
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC----------------------
Confidence 5555554444444444444444444444444444433333444444444444444444
Q ss_pred CccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcc
Q 001171 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPAT 574 (1133)
Q Consensus 495 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 574 (1133)
+..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+.+. +++|++|+++.|.++|.+|..
T Consensus 171 --~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 171 --SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp --CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred --ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 33333444444444555555554444444444555555555555544432 234555566666666666655
Q ss_pred cccccc
Q 001171 575 YGFLRS 580 (1133)
Q Consensus 575 ~~~l~~ 580 (1133)
++.++.
T Consensus 242 ~~~~~~ 247 (272)
T 3rfs_A 242 AGSVAP 247 (272)
T ss_dssp TSCBCG
T ss_pred ccccCC
Confidence 554443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-23 Score=230.82 Aligned_cols=204 Identities=26% Similarity=0.248 Sum_probs=131.2
Q ss_pred CcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCccccccccccee
Q 001171 505 SLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFL 584 (1133)
Q Consensus 505 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 584 (1133)
++++++++++++|.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+. +.+++|++|
T Consensus 8 ~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L 82 (290)
T 1p9a_G 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTL 82 (290)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEE
T ss_pred ccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEE
Confidence 3444455555555554 3333332 3455555555555555555555555555555555555533221 456666666
Q ss_pred ecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCC
Q 001171 585 SLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLS 664 (1133)
Q Consensus 585 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 664 (1133)
+|++|+|+ .+|..+..+++|++|+|++|++++..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+++
T Consensus 83 ~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 66666666 45666666777777777777777655566777777777777777777655566677777777777777777
Q ss_pred ccCCccccCcccccccccccccccccCCccccccccCcccccccccccccC
Q 001171 665 GRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEI 715 (1133)
Q Consensus 665 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 715 (1133)
...+..|..+++|+.|+|++|+++ .+|..+....+|+.|+|++|++.+.+
T Consensus 162 ~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 655556677788888888888887 67777777778888888888876544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-23 Score=223.45 Aligned_cols=189 Identities=22% Similarity=0.272 Sum_probs=107.3
Q ss_pred CCCccceeeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCc
Q 001171 59 APCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLS 138 (1133)
Q Consensus 59 ~~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~ 138 (1133)
.||.|.|++|..+ .+.+++++++++ .+|..+. ++|+.|+|++|++++..|..
T Consensus 3 ~Cp~~~gC~C~~~-------------------------~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~ 54 (251)
T 3m19_A 3 TCETVTGCTCNEG-------------------------KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDAT 54 (251)
T ss_dssp -CHHHHSSEEEGG-------------------------GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTT
T ss_pred cCCCCCceEcCCC-------------------------CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhH
Confidence 4889999999632 224444444444 3443333 34555555555555444444
Q ss_pred cccccchhhhhhcccccCCCccCcc--CCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccc
Q 001171 139 IFNLTNLLVLNVAHNLLSGKISADI--SPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELE 216 (1133)
Q Consensus 139 l~~l~~L~~L~l~~N~l~~~~~~~~--~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 216 (1133)
+.++++|++|+|++|.+++..+..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..++.+++|+
T Consensus 55 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 134 (251)
T 3m19_A 55 FRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLK 134 (251)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCccc
Confidence 4444444333333333332222111 13445556666666655556666666677777777766655555556666666
Q ss_pred eEecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccC
Q 001171 217 YLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG 275 (1133)
Q Consensus 217 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 275 (1133)
+|+|++|++++..+..+.++++|++|++++|+++++.+..|..+++|++|+|++|.+++
T Consensus 135 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 135 ELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred EEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 66666666665555556666666666666666666666666666666666666666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-25 Score=251.79 Aligned_cols=256 Identities=17% Similarity=0.194 Sum_probs=127.7
Q ss_pred EEEccCCcccccCchhhccCCCccEEEccCCcccccCC----CccCCCC-CCcEEEccCCcCccccCccccCc-----cc
Q 001171 367 VLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVP----AFLGGIR-GLKIVSLGRNMFSGLIPLSFGNL-----SQ 436 (1133)
Q Consensus 367 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 436 (1133)
.+++++|.+++.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|.+++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35677777777766666666667777777777765555 4555555 66666666666665555555443 55
Q ss_pred cceeecccccccccCChhhcC----C-CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCC-ccccc
Q 001171 437 LETLNLSENDIRGNIPEEITR----L-SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGS-LMRLT 510 (1133)
Q Consensus 437 L~~L~L~~N~i~~~~~~~l~~----l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~ 510 (1133)
|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+.. .+.. .++|+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~--------------------~l~~~~~~L~ 141 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ--------------------AFSNLPASIT 141 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH--------------------HHTTSCTTCC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH--------------------HHHhCCCcee
Confidence 666666666665544443322 2 45555555555554333222111 1111 13455
Q ss_pred EEeccccCCCCCCCh----hccCCC-CCcEeeccCCcccccCCCCC----CCC-ccCcEEEcccccccCC----CCcccc
Q 001171 511 TLDLSNQNLSGELPI----ELFGLP-SLQVVSLEENNLSGDVPEGF----SSL-VGLQYLNLSDNAFTGD----IPATYG 576 (1133)
Q Consensus 511 ~L~Ls~N~l~~~~p~----~l~~l~-~L~~L~L~~N~l~~~~~~~~----~~l-~~L~~L~Ls~N~l~~~----~~~~~~ 576 (1133)
+|++++|.+++..+. .+..++ +|++|+|++|++++..+..+ ..+ ++|++|+|++|.+++. ++..+.
T Consensus 142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 555555554432222 222333 45555555555544333222 222 3555555555555532 222333
Q ss_pred c-ccccceeecccCccCCCCC----ccccCCCCccEEEecCCcccCCCc-------cccccccccCeeecCCCcccCc
Q 001171 577 F-LRSLVFLSLSHNQISGMIP----AELGACSALEVLELRSNHFTGNIP-------VDISHLSRIKKLDLGQNKLSGE 642 (1133)
Q Consensus 577 ~-l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~p-------~~l~~l~~L~~L~Ls~N~l~~~ 642 (1133)
. .++|++|+|++|++++..+ ..+..+++|++|+|++|.+.+..+ ..+..+++|+.|||++|++.+.
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 3 2356666666666654333 223445556666666665443222 1233344444444444444433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-24 Score=250.81 Aligned_cols=258 Identities=22% Similarity=0.238 Sum_probs=133.8
Q ss_pred eeecccccccccCChhhcCCCCCcEEecccCcCCCCCC----CCCCCCC-CCcEEEcccCCCccccCCCcCCc-----cc
Q 001171 439 TLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP----YDVGNLK-GLLVLNLSASGFSGKIPGSIGSL-----MR 508 (1133)
Q Consensus 439 ~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~ 508 (1133)
++++++|.+++.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 45777888887777777666778888888888776555 4555565 66777777776666555555443 66
Q ss_pred ccEEeccccCCCCCCChhccC----C-CCCcEeeccCCcccccCCCCC----CC-CccCcEEEcccccccCCCCcccccc
Q 001171 509 LTTLDLSNQNLSGELPIELFG----L-PSLQVVSLEENNLSGDVPEGF----SS-LVGLQYLNLSDNAFTGDIPATYGFL 578 (1133)
Q Consensus 509 L~~L~Ls~N~l~~~~p~~l~~----l-~~L~~L~L~~N~l~~~~~~~~----~~-l~~L~~L~Ls~N~l~~~~~~~~~~l 578 (1133)
|++|++++|.+++..+..+.. + ++|++|+|++|++++..+..+ .. .++|++|+|++|++++.....+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--- 158 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL--- 158 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH---
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH---
Confidence 666666666666544443332 2 555555555555554433222 12 1345555555555543222221
Q ss_pred cccceeecccCccCCCCCccccCCC-CccEEEecCCcccCCCccccccc-----cccCeeecCCCcccCc----Cchhhh
Q 001171 579 RSLVFLSLSHNQISGMIPAELGACS-ALEVLELRSNHFTGNIPVDISHL-----SRIKKLDLGQNKLSGE----IPKEIS 648 (1133)
Q Consensus 579 ~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~Ls~N~l~~~----~p~~l~ 648 (1133)
+..+..++ +|++|+|++|++++..+..+... ++|+.|+|++|.|++. ++..+.
T Consensus 159 -----------------~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 159 -----------------IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp -----------------HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred -----------------HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 11122222 45555555555544333332222 3555555555555432 223333
Q ss_pred c-cCCCcEEEeecCCCCccCC----ccccCccccccccccccccccc-------CCccccccccCcccccccccccccCC
Q 001171 649 K-CSSLVSLTLDMNSLSGRIP----ESFSKLSNLTTLNLSTNRLSGA-------IPADLALISSLRYLNLSRNNLEGEIP 716 (1133)
Q Consensus 649 ~-l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~l~~l~~L~~L~ls~N~l~~~~p 716 (1133)
. .++|+.|+|++|++++..+ ..+..+++|+.|+|++|.+.+. ++..+..+++|+.||+++|++.+..|
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3 2355555555555554333 2234445555555555553321 22234455566666666666654433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-22 Score=221.96 Aligned_cols=175 Identities=22% Similarity=0.246 Sum_probs=68.7
Q ss_pred CCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecc
Q 001171 364 KLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLS 443 (1133)
Q Consensus 364 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 443 (1133)
++++|+|++|++++..+..|..+++|++|+|++|.|++..+. +.+++|+.|+|++|.++ .+|..+..+++|++|+++
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 344444444444433333444444444444444444322111 23333333333333333 223333344444444444
Q ss_pred cccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCC
Q 001171 444 ENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGEL 523 (1133)
Q Consensus 444 ~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 523 (1133)
+|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+++...+..|..+++|+.|++++|+++ .+
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~i 187 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-cc
Confidence 44444333333444444444444444444333333333444444444444443333333334444444444444443 33
Q ss_pred ChhccCCCCCcEeeccCCc
Q 001171 524 PIELFGLPSLQVVSLEENN 542 (1133)
Q Consensus 524 p~~l~~l~~L~~L~L~~N~ 542 (1133)
|..++.+++|+.|+|++|.
T Consensus 188 p~~~~~~~~L~~l~L~~Np 206 (290)
T 1p9a_G 188 PKGFFGSHLLPFAFLHGNP 206 (290)
T ss_dssp CTTTTTTCCCSEEECCSCC
T ss_pred ChhhcccccCCeEEeCCCC
Confidence 3333333333333333333
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=260.29 Aligned_cols=185 Identities=16% Similarity=0.184 Sum_probs=139.6
Q ss_pred CcccccccccceeEEEEEECCceEEEEEEcccCCcC---------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 840 DEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID---------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 840 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
...++||+|+||.||+|.. .+..+++|+....... .+.+.+|++++++++||||+++..++...... ++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~-~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK-RI 416 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT-EE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc-EE
Confidence 4467899999999999954 4778888886432211 24578999999999999999555444444344 99
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++++|.+++.. +..++.|+++||+|||+++|+||||||+|||++. .+||+|||+++....
T Consensus 417 VmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999999874 3468999999999999999999999999999998 999999999976532
Q ss_pred CCCCCC----CCCCCCCCCCccCccccCC--CCCCCCCchhHHHHHHHHHHhCCCCC
Q 001171 991 TPAEAS----SSTTPIGSLGYVSPEAAST--GQPTKEADVYSFGIVLLEILTGRKPV 1041 (1133)
Q Consensus 991 ~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~Pf 1041 (1133)
...... ......||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 111000 1134579999999999976 55788889999999888888877776
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-22 Score=216.40 Aligned_cols=203 Identities=19% Similarity=0.207 Sum_probs=141.1
Q ss_pred CccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCc-CCCCCcccccCccccceEeccc-ccccCCCCccccC
Q 001171 158 KISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS-FSGEVPASVGQLQELEYLWLDS-NHLYGTLPSAISN 235 (1133)
Q Consensus 158 ~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~ 235 (1133)
.+|. +++++++|+|++|++++..+..|..+++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..+.+
T Consensus 25 ~ip~-~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~ 103 (239)
T 2xwt_C 25 RIPS-LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103 (239)
T ss_dssp SCCC-CCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEEC
T ss_pred ccCC-CCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCC
Confidence 4566 77789999999999998888889999999999999997 8766666788999999999998 8998666678888
Q ss_pred ccccceeeccccccCCCCCCcccCcCccc---EEEcccC-CccCCcccccccCccccccccc-EEeccCCcccccccCCC
Q 001171 236 CSSLVHLSAEDNVLKGLIPGTIGRISTLQ---VLSLSRN-ELTGLVPVSVLCNLWGNISSLR-IVQLGFNAFTGVVKPPN 310 (1133)
Q Consensus 236 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~~~~~~l~~L~-~l~l~~n~l~~~~~~~~ 310 (1133)
+++|++|++++|++++ +|. |..+++|+ +|++++| ++++..+.. |.++++|+ .|++++|.++
T Consensus 104 l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~-----~~~l~~L~~~L~l~~n~l~------- 169 (239)
T 2xwt_C 104 LPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNA-----FQGLCNETLTLKLYNNGFT------- 169 (239)
T ss_dssp CTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTT-----TTTTBSSEEEEECCSCCCC-------
T ss_pred CCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCccc-----ccchhcceeEEEcCCCCCc-------
Confidence 9999999999999887 444 77788887 8888888 887543322 25566666 6666655555
Q ss_pred CCccccccEEeccCCcccccCCchhhcccccceeeccCce-eecccCcccCCC-CCCcEEEccCCcccccCchhhccCCC
Q 001171 311 GRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNF-FSGNLPAAVGSL-DKLEVLRVANNSLSGLVPDEIAKCSL 388 (1133)
Q Consensus 311 ~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~ 388 (1133)
.+++..|.. ++|++|+|++|+ +++..+..|..+ ++|++|++++|++++..+. .+++
T Consensus 170 ------------------~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~ 227 (239)
T 2xwt_C 170 ------------------SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEH 227 (239)
T ss_dssp ------------------EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTT
T ss_pred ------------------ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---Hhcc
Confidence 333333433 455555555553 554444455555 5555555555555543222 3445
Q ss_pred ccEEEccCC
Q 001171 389 LQMFDLEGN 397 (1133)
Q Consensus 389 L~~L~Ls~N 397 (1133)
|+.|+++++
T Consensus 228 L~~L~l~~~ 236 (239)
T 2xwt_C 228 LKELIARNT 236 (239)
T ss_dssp CSEEECTTC
T ss_pred CceeeccCc
Confidence 555555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-24 Score=251.16 Aligned_cols=197 Identities=20% Similarity=0.265 Sum_probs=128.5
Q ss_pred cCCcccccCCchhhcccccceeeccCceeecccC----cccCCCCCCcEEEccCC---cccccCchhh-------ccCCC
Q 001171 323 QNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLP----AAVGSLDKLEVLRVANN---SLSGLVPDEI-------AKCSL 388 (1133)
Q Consensus 323 ~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~n---~l~~~~~~~~-------~~l~~ 388 (1133)
....+..+ +..+..+++|++|+|++|.|.+..+ ..+..+++|++|+|++| ++++.+|..+ ..+++
T Consensus 17 ~~~~~~~l-~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~ 95 (386)
T 2ca6_A 17 TTEDEKSV-FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPK 95 (386)
T ss_dssp CSHHHHTT-SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTT
T ss_pred CHHHHHHH-HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCc
Confidence 33344444 6778889999999999999986633 44778999999999986 4555556555 67888
Q ss_pred ccEEEccCCcccc----cCCCccCCCCCCcEEEccCCcCccccCccccC----c---------cccceeeccccccc-cc
Q 001171 389 LQMFDLEGNRFSG----QVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGN----L---------SQLETLNLSENDIR-GN 450 (1133)
Q Consensus 389 L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~i~-~~ 450 (1133)
|++|+|++|.+++ .+|..+..+++|+.|+|++|.+++..+..+.. + ++|++|++++|+++ ..
T Consensus 96 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~ 175 (386)
T 2ca6_A 96 LHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175 (386)
T ss_dssp CCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGG
T ss_pred ccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHH
Confidence 8888888888876 46667777888888888888886544443333 2 67777777777775 22
Q ss_pred CC---hhhcCCCCCcEEecccCcCCC-----CCCCCCCCCCCCcEEEcccCCCc----cccCCCcCCcccccEEeccccC
Q 001171 451 IP---EEITRLSNLTTLNLSYNKFGG-----KVPYDVGNLKGLLVLNLSASGFS----GKIPGSIGSLMRLTTLDLSNQN 518 (1133)
Q Consensus 451 ~~---~~l~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~ 518 (1133)
++ ..+..+++|++|+|++|.++. ..+..+..+++|++|+|++|.++ ..+|..+..+++|++|+|++|.
T Consensus 176 ~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~ 255 (386)
T 2ca6_A 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred HHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCC
Confidence 33 345566667777777766651 22334555555555555555553 3344444555555555555555
Q ss_pred CC
Q 001171 519 LS 520 (1133)
Q Consensus 519 l~ 520 (1133)
++
T Consensus 256 i~ 257 (386)
T 2ca6_A 256 LS 257 (386)
T ss_dssp CC
T ss_pred Cc
Confidence 54
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-23 Score=251.11 Aligned_cols=206 Identities=26% Similarity=0.394 Sum_probs=148.4
Q ss_pred CccCCCCCCCCCCC-----cccee-eeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCc
Q 001171 48 ALDGWDSSTPSAPC-----DWRGI-VCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLL 121 (1133)
Q Consensus 48 ~l~~w~~~~~~~~c-----~w~gv-~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 121 (1133)
.+.+|..+ .++| .|.|+ .|..++++.|+|.++++++ +|+.+. ++|++|+|++|+|+ .+| ..+++|
T Consensus 32 ~l~~W~~~--~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEKQ--ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHTT--CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhcc--CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 45678543 3578 79999 7987788888888888887 776653 77888888888888 677 457888
Q ss_pred ceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcC
Q 001171 122 RAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSF 201 (1133)
Q Consensus 122 ~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l 201 (1133)
+.|+|++|+|++ +|. +.+ +|++|+|++|.|++ +|. ..++|++|+|++|.|++ +|. .+++|++|+|++|+|
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCC
Confidence 888888888886 777 655 77778888888776 555 56777788888877776 554 456777777777777
Q ss_pred CCCCcccccCccccceEecccccccCCCCccccCcccc-------ceeeccccccCCCCCCcccCcCcccEEEcccCCcc
Q 001171 202 SGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSL-------VHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT 274 (1133)
Q Consensus 202 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 274 (1133)
++ +|. +. ++|++|+|++|+|+ .+|. +.. +| ++|+|++|+|+. +|..+..+++|+.|+|++|+++
T Consensus 173 ~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~ 243 (571)
T 3cvr_A 173 TF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS 243 (571)
T ss_dssp SC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCC
T ss_pred CC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCC
Confidence 76 666 55 77777777777776 5666 543 56 777777777774 4555666777777777777777
Q ss_pred CCccccc
Q 001171 275 GLVPVSV 281 (1133)
Q Consensus 275 ~~~p~~~ 281 (1133)
+.+|..+
T Consensus 244 ~~~p~~l 250 (571)
T 3cvr_A 244 SRIRESL 250 (571)
T ss_dssp HHHHHHH
T ss_pred CcCHHHH
Confidence 6665544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.3e-25 Score=253.81 Aligned_cols=240 Identities=23% Similarity=0.299 Sum_probs=116.6
Q ss_pred ChhhcCCCCCcEEecccCcCCCCCC----CCCCCCCCCcEEEcccC---CCccccCCCc-------CCcccccEEecccc
Q 001171 452 PEEITRLSNLTTLNLSYNKFGGKVP----YDVGNLKGLLVLNLSAS---GFSGKIPGSI-------GSLMRLTTLDLSNQ 517 (1133)
Q Consensus 452 ~~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N---~l~~~~~~~~-------~~l~~L~~L~Ls~N 517 (1133)
+..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|
T Consensus 25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n 104 (386)
T 2ca6_A 25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 104 (386)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCC
Confidence 3444444445555555554443211 22334444555555443 2233333332 45566666666666
Q ss_pred CCCC----CCChhccCCCCCcEeeccCCcccccCCCCCC----CC---------ccCcEEEccccccc-CCCC---cccc
Q 001171 518 NLSG----ELPIELFGLPSLQVVSLEENNLSGDVPEGFS----SL---------VGLQYLNLSDNAFT-GDIP---ATYG 576 (1133)
Q Consensus 518 ~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~l---------~~L~~L~Ls~N~l~-~~~~---~~~~ 576 (1133)
.+++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ +.++ ..+.
T Consensus 105 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~ 184 (386)
T 2ca6_A 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184 (386)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH
Confidence 6664 2445555666666666666666533222222 22 55666666666554 2222 2344
Q ss_pred cccccceeecccCccCC-----CCCccccCCCCccEEEecCCccc----CCCccccccccccCeeecCCCcccCc----C
Q 001171 577 FLRSLVFLSLSHNQISG-----MIPAELGACSALEVLELRSNHFT----GNIPVDISHLSRIKKLDLGQNKLSGE----I 643 (1133)
Q Consensus 577 ~l~~L~~L~Ls~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~----~ 643 (1133)
.+++|++|+|++|+|+. ..|..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|.+++. +
T Consensus 185 ~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l 264 (386)
T 2ca6_A 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264 (386)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred hCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHH
Confidence 45555555555555542 12224455555555555555553 33444455555555555555555543 2
Q ss_pred chhhhc--cCCCcEEEeecCCCCc----cCCccc-cCcccccccccccccccccC
Q 001171 644 PKEISK--CSSLVSLTLDMNSLSG----RIPESF-SKLSNLTTLNLSTNRLSGAI 691 (1133)
Q Consensus 644 p~~l~~--l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~~ 691 (1133)
|..+.. +++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..
T Consensus 265 ~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 333322 4555555555555554 244443 33455555555555554433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-22 Score=212.26 Aligned_cols=131 Identities=18% Similarity=0.186 Sum_probs=55.3
Q ss_pred ccceeeccCceeecccCcccCCCCCCcEEEccCCc-ccccCchhhccCCCccEEEccC-CcccccCCCccCCCCCCcEEE
Q 001171 340 SLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNS-LSGLVPDEIAKCSLLQMFDLEG-NRFSGQVPAFLGGIRGLKIVS 417 (1133)
Q Consensus 340 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~ 417 (1133)
+|++|+|++|+|++..+..|.++++|++|++++|+ ++.+.+..|.++++|++|+|++ |++++..+..|.++++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 44444444444443333344444444444444443 4433333444444444444444 444433333444444444444
Q ss_pred ccCCcCccccCccccCccccc---eeecccc-cccccCChhhcCCCCCc-EEecccCcCC
Q 001171 418 LGRNMFSGLIPLSFGNLSQLE---TLNLSEN-DIRGNIPEEITRLSNLT-TLNLSYNKFG 472 (1133)
Q Consensus 418 L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~i~~~~~~~l~~l~~L~-~L~Ls~N~l~ 472 (1133)
+++|.+++ +|. |..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 44444443 222 33333333 4444444 44433333344444444 4444444443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=238.10 Aligned_cols=255 Identities=21% Similarity=0.255 Sum_probs=161.7
Q ss_pred cccEEeccCCcccccCCchhhcc--cccceeeccCceeecccCcccCCCCCCcEEEccCCccccc-CchhhccCCCccEE
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNV--TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGL-VPDEIAKCSLLQMF 392 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L 392 (1133)
.++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3667777777766 4667777 8888888888888866555 55688888888888888765 67778888888888
Q ss_pred EccCCcccccCCCccCCCCCCcEEEccCC-cCccc-cCccccCccccceeecccc-ccccc-CChhhcCCC-CCcEEecc
Q 001171 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRN-MFSGL-IPLSFGNLSQLETLNLSEN-DIRGN-IPEEITRLS-NLTTLNLS 467 (1133)
Q Consensus 393 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~i~~~-~~~~l~~l~-~L~~L~Ls 467 (1133)
+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 88888887777777777888888888888 56652 4555677777888888877 77654 455566777 77777777
Q ss_pred cC--cCC-CCCCCCCCCCCCCcEEEcccCC-CccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcc
Q 001171 468 YN--KFG-GKVPYDVGNLKGLLVLNLSASG-FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543 (1133)
Q Consensus 468 ~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 543 (1133)
+| .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++|. .+
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~-----------------------~~ 260 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY-----------------------DI 260 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT-----------------------TC
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC-----------------------CC
Confidence 77 333 2233333444555555555554 343344444444444444444442 12
Q ss_pred cccCCCCCCCCccCcEEEcccccccCCCCcccccc-cccceeecccCccCCCCCccccC
Q 001171 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFL-RSLVFLSLSHNQISGMIPAELGA 601 (1133)
Q Consensus 544 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~ 601 (1133)
.......+.++++|++|++++| ++. ..+..+ .+|..|++++|++++..|..++.
T Consensus 261 ~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 261 IPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 1111123445556666666655 221 123333 23566666777777666665543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=224.75 Aligned_cols=202 Identities=20% Similarity=0.205 Sum_probs=146.7
Q ss_pred cccccceeeccCceeecccCccc--CCCCCCcEEEccCCcccccCc----hhhccCCCccEEEccCCcccccCCCccCCC
Q 001171 337 NVTSLRVMDLSGNFFSGNLPAAV--GSLDKLEVLRVANNSLSGLVP----DEIAKCSLLQMFDLEGNRFSGQVPAFLGGI 410 (1133)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 410 (1133)
.+++|++|+|++|.+.+..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..|+++
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 45678889999998888888877 888899999999998887544 344578899999999999988888888899
Q ss_pred CCCcEEEccCCcCccc---c-CccccCccccceeecccccccccCCh----hhcCCCCCcEEecccCcCCCCCCCCCCCC
Q 001171 411 RGLKIVSLGRNMFSGL---I-PLSFGNLSQLETLNLSENDIRGNIPE----EITRLSNLTTLNLSYNKFGGKVPYDVGNL 482 (1133)
Q Consensus 411 ~~L~~L~L~~N~l~~~---~-p~~~~~l~~L~~L~L~~N~i~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 482 (1133)
++|++|+|++|++.+. . +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 9999999999987652 2 2334678899999999998873 232 24677888889988888887777766665
Q ss_pred ---CCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCccc
Q 001171 483 ---KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS 544 (1133)
Q Consensus 483 ---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 544 (1133)
++|++|++++|+++ .+|..+. ++|++|++++|++++. |. +..+++|+.|+|++|+++
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 47777777777776 4455443 5666666666666532 22 344455555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=226.10 Aligned_cols=203 Identities=21% Similarity=0.213 Sum_probs=95.9
Q ss_pred CCCcEEecccCcCCCCCCCCC--CCCCCCcEEEcccCCCccccC----CCcCCcccccEEeccccCCCCCCChhccCCCC
Q 001171 459 SNLTTLNLSYNKFGGKVPYDV--GNLKGLLVLNLSASGFSGKIP----GSIGSLMRLTTLDLSNQNLSGELPIELFGLPS 532 (1133)
Q Consensus 459 ~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 532 (1133)
++|++|++++|.+++..|..+ ..+++|++|++++|.+++..+ ..+..+++|++|++++|++++..+..+.++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 445566666665555555554 555555555555555544322 12234455555555555555444444555555
Q ss_pred CcEeeccCCccccc----CCCCCCCCccCcEEEcccccccCCCCc----ccccccccceeecccCccCCCCCccccCCCC
Q 001171 533 LQVVSLEENNLSGD----VPEGFSSLVGLQYLNLSDNAFTGDIPA----TYGFLRSLVFLSLSHNQISGMIPAELGACSA 604 (1133)
Q Consensus 533 L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 604 (1133)
|++|+|++|++.+. .+..+..+++|++|+|++|+++. ++. .++.+++|++|+|++|++++..|..+..+.
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~- 248 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM- 248 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC-
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc-
Confidence 55555555544321 11222344445555555554431 111 123344444444444444444343333331
Q ss_pred ccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccccccccc
Q 001171 605 LEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLST 684 (1133)
Q Consensus 605 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 684 (1133)
.+++|++|+|++|+|+ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|+|++
T Consensus 249 --------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 249 --------------------WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDG 303 (310)
T ss_dssp --------------------CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSS
T ss_pred --------------------CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcC
Confidence 0135555555555555 3444442 4555555555555532 22 44555666666666
Q ss_pred cccc
Q 001171 685 NRLS 688 (1133)
Q Consensus 685 N~l~ 688 (1133)
|+++
T Consensus 304 N~l~ 307 (310)
T 4glp_A 304 NPFL 307 (310)
T ss_dssp TTTS
T ss_pred CCCC
Confidence 6654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-23 Score=238.87 Aligned_cols=252 Identities=17% Similarity=0.204 Sum_probs=142.5
Q ss_pred cceeecccccccccCChhhcCC--CCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccc-cCCCcCCcccccEEe
Q 001171 437 LETLNLSENDIRGNIPEEITRL--SNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGK-IPGSIGSLMRLTTLD 513 (1133)
Q Consensus 437 L~~L~L~~N~i~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ 513 (1133)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 444555555443 2334444 5555666666655543332 33344455555554444433 333444444455555
Q ss_pred ccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccc-cccCC-CCcccccccccceeecccC-c
Q 001171 514 LSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDN-AFTGD-IPATYGFLRSLVFLSLSHN-Q 590 (1133)
Q Consensus 514 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~ 590 (1133)
+++|.+++..+..+.. +++|++|+|++| .+++. ++..+..+++|++|++++| .
T Consensus 125 L~~~~l~~~~~~~l~~------------------------~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~ 180 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAK------------------------NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180 (336)
T ss_dssp CTTCBCCHHHHHHHTT------------------------CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred CcCcccCHHHHHHHhc------------------------CCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCC
Confidence 5544444334444444 444444444444 34331 3444555566666666666 6
Q ss_pred cCCC-CCccccCCC-CccEEEecCC--ccc-CCCccccccccccCeeecCCCc-ccCcCchhhhccCCCcEEEeecCC-C
Q 001171 591 ISGM-IPAELGACS-ALEVLELRSN--HFT-GNIPVDISHLSRIKKLDLGQNK-LSGEIPKEISKCSSLVSLTLDMNS-L 663 (1133)
Q Consensus 591 l~~~-~p~~l~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~Ls~N~-l 663 (1133)
+++. ++..+..++ +|++|++++| .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|+.|++++|. +
T Consensus 181 l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~ 260 (336)
T 2ast_B 181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI 260 (336)
T ss_dssp CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTC
T ss_pred cChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCC
Confidence 5543 345556666 7777777776 343 3355556667777777777777 666667777777778888887774 3
Q ss_pred CccCCccccCcccccccccccccccccCCcccccc-ccCcccccccccccccCCcccc
Q 001171 664 SGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALI-SSLRYLNLSRNNLEGEIPKMLS 720 (1133)
Q Consensus 664 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~ls~N~l~~~~p~~~~ 720 (1133)
+......++++++|+.|++++| ++. ..+..+ ..++.|++++|++++..|...+
T Consensus 261 ~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 261 IPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence 3333335677788888888877 332 233444 3477778888888888876544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-21 Score=209.30 Aligned_cols=178 Identities=22% Similarity=0.260 Sum_probs=101.8
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
..++++++++.++.+++. +. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~-~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSG-IP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCSSCCSC-CC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCccccCCC-CC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 455666666666665332 22 456666666666666555566666666666666666666555556666666666666
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCC
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV 475 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 475 (1133)
+|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66666555555555555555555555555554445555555555555555555444445555555555555555555444
Q ss_pred CCCCCCCCCCcEEEcccCCCc
Q 001171 476 PYDVGNLKGLLVLNLSASGFS 496 (1133)
Q Consensus 476 ~~~~~~l~~L~~L~L~~N~l~ 496 (1133)
+..+..+++|+.|++++|.++
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBC
T ss_pred HHHHhCCCCCCEEEeeCCcee
Confidence 444444555555555555444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=223.43 Aligned_cols=240 Identities=18% Similarity=0.133 Sum_probs=148.8
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcc-cccCccccce-Eecccccc
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPA-SVGQLQELEY-LWLDSNHL 225 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~-L~L~~N~l 225 (1133)
+++++|+++ .+|.++|+++++|+|++|+|+...++.|.++++|++|+|++|++.+.+|. .|.++++|++ +.+++|++
T Consensus 14 v~C~~~~Lt-~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l 92 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92 (350)
T ss_dssp EEEESTTCC-SCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred EEecCCCCC-ccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence 344444444 56677788899999999999976667899999999999999999877764 5778888765 56677888
Q ss_pred cCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEccc-CCccCCcccccccCcccccccccEEeccCCcccc
Q 001171 226 YGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR-NELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTG 304 (1133)
Q Consensus 226 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~ 304 (1133)
++..|..|.++++|++|++++|+++...+..+....++..|++++ |+++...+..+ ..+.
T Consensus 93 ~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f-----~~~~-------------- 153 (350)
T 4ay9_X 93 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF-----VGLS-------------- 153 (350)
T ss_dssp CEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSS-----TTSB--------------
T ss_pred cccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccch-----hhcc--------------
Confidence 877778888889999999999998887777777777888888865 45553222111 2221
Q ss_pred cccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccC-ceeecccCcccCCCCCCcEEEccCCcccccCchhh
Q 001171 305 VVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSG-NFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEI 383 (1133)
Q Consensus 305 ~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~ 383 (1133)
..+++|+|++|+|+.+.+..|. ..+|++|++++ |.++.+.++.|..+++|++|+|++|+|+.+.+..+
T Consensus 154 ----------~~l~~L~L~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~ 222 (350)
T 4ay9_X 154 ----------FESVILWLNKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 222 (350)
T ss_dssp ----------SSCEEEECCSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC
T ss_pred ----------hhhhhhccccccccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh
Confidence 2244455555555555444332 33455555543 44443333345555555555555555554433333
Q ss_pred ccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCc
Q 001171 384 AKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNM 422 (1133)
Q Consensus 384 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 422 (1133)
.++++|+.+++ +.++ .+| .+.++++|+.+++.++.
T Consensus 223 ~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 223 ENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred ccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence 33333222222 1222 334 25556666666665443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=217.62 Aligned_cols=193 Identities=27% Similarity=0.419 Sum_probs=100.9
Q ss_pred CCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEE
Q 001171 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYL 560 (1133)
Q Consensus 481 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 560 (1133)
++++|++|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|++|++++|++
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l----------------- 97 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL----------------- 97 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC-----------------
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcC-----------------
Confidence 44555555555555543 22 34555555555555555543222 44455555555555544
Q ss_pred EcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCccc
Q 001171 561 NLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLS 640 (1133)
Q Consensus 561 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 640 (1133)
++. ..+..+++|++|++++|++++. +. +..+++|++|++++|++++ ++. +..+++|+.|+|++|.++
T Consensus 98 -------~~~--~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 98 -------KNV--SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp -------SCC--GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCC
T ss_pred -------CCc--hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCC
Confidence 431 1344455555555555555532 21 4555555555555555553 222 555555666666666555
Q ss_pred CcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccc
Q 001171 641 GEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEG 713 (1133)
Q Consensus 641 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~ 713 (1133)
+ ++. +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|++++|++++
T Consensus 165 ~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 165 D-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp C-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred C-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 3 222 5556666666666666654322 5556666666666666654332 5566666666666666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=216.78 Aligned_cols=194 Identities=24% Similarity=0.415 Sum_probs=97.7
Q ss_pred hhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCc
Q 001171 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLK 414 (1133)
Q Consensus 335 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 414 (1133)
+..+++|++|++++|.+.. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 4455566666666666653 23 35555666666666666554433 55555566666666555532 1344455555
Q ss_pred EEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCC
Q 001171 415 IVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASG 494 (1133)
Q Consensus 415 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 494 (1133)
.|++++|.+++.. .+..+++|++|++++|++++..+ +..+++|++|+|++|++++.
T Consensus 111 ~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-------------------- 166 (308)
T 1h6u_A 111 TLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-------------------- 166 (308)
T ss_dssp EEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--------------------
T ss_pred EEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC--------------------
Confidence 5555555554421 14445555555555555543222 44444455555544444432
Q ss_pred CccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEccccccc
Q 001171 495 FSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568 (1133)
Q Consensus 495 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 568 (1133)
.+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|+|++|.++
T Consensus 167 ----~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 167 ----TP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp ----GG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred ----hh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 22 3444444444444444443221 4455555555555555554332 555566666666666665
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=215.44 Aligned_cols=152 Identities=15% Similarity=0.112 Sum_probs=66.2
Q ss_pred cEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccC-chhhccCCCccE-EEcc
Q 001171 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLV-PDEIAKCSLLQM-FDLE 395 (1133)
Q Consensus 318 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~-L~Ls 395 (1133)
++++.++++++.| |..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+ +..|.+++++.+ ++++
T Consensus 12 ~~v~C~~~~Lt~i-P~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVTEI-PSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCCSC-CTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCCcc-CcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 3445555555554 2222 234555555555555333344555555555555555543322 233444444332 3333
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccc-ccccccCChhhcCCC-CCcEEecccCcCC
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSE-NDIRGNIPEEITRLS-NLTTLNLSYNKFG 472 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~l~~l~-~L~~L~Ls~N~l~ 472 (1133)
+|+++...|..|.++++|++|++++|.++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 4444444444444444444444444444444333344444444444432 333333333333322 2444444444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.4e-22 Score=216.55 Aligned_cols=148 Identities=14% Similarity=0.099 Sum_probs=118.2
Q ss_pred HHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc-------------------CHHHHHHHHHHHhhccCCC
Q 001171 833 LEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI-------------------DENTFRKEAEALGKVKHRN 893 (1133)
Q Consensus 833 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~hpn 893 (1133)
......|.+.+.||+|+||.||+|.+.+|+.||+|.++.+.. ....+.+|++++++++|
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-- 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-- 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--
Confidence 344556778899999999999999887799999999964321 23468899999999994
Q ss_pred eeeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 894 iv~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
+++.+++.. +..++||||+++|+|.+ +. ......++.||++|++|||+.||+||||||+||+++
T Consensus 164 -~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~-----------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 -LAVPKVYAW--EGNAVLMELIDAKELYR-VR-----------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp -SSSCCEEEE--ETTEEEEECCCCEEGGG-CC-----------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred -CCcCeEEec--cceEEEEEecCCCcHHH-cc-----------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-
Confidence 555555543 23489999999999987 32 123446999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccC
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 1014 (1133)
++.+||+|||+|+. +..|+|||++.
T Consensus 228 ~~~vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99999999999852 23578899874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-20 Score=193.90 Aligned_cols=180 Identities=21% Similarity=0.235 Sum_probs=106.1
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccC
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG 396 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 396 (1133)
-+.++++++.++.++... .++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++
T Consensus 9 ~~~v~c~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 9 GTTVECYSQGRTSVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TTEEECCSSCCSSCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCccCCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 345666666666653322 34666677777776655555566666666666666666655555566666666666666
Q ss_pred CcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCC
Q 001171 397 NRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476 (1133)
Q Consensus 397 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 476 (1133)
|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|++++|++++..+..+..+++|++|++++|.+.+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--- 162 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--- 162 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec---
Confidence 66665555555666666666666666665555555666666666666666665444445556666666666665442
Q ss_pred CCCCCCCCCcEEEcccCCCccccCCCcCCc
Q 001171 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSL 506 (1133)
Q Consensus 477 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 506 (1133)
.+++|+.|+++.|+++|.+|..++.+
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccc
Confidence 23345555555555555555554444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.5e-20 Score=192.47 Aligned_cols=176 Identities=23% Similarity=0.256 Sum_probs=80.6
Q ss_pred EEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCc
Q 001171 511 TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQ 590 (1133)
Q Consensus 511 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 590 (1133)
.++.+++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+
T Consensus 11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 4445555444 233222 2345555555555554444444555555555555555554433444445555555555555
Q ss_pred cCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCcc
Q 001171 591 ISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPES 670 (1133)
Q Consensus 591 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 670 (1133)
+++..+..+..+++|++|++++|++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.+
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----- 162 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----- 162 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-----
Confidence 544333334445555555555555543333334444444444444444443333334444444444444444332
Q ss_pred ccCcccccccccccccccccCCcccc
Q 001171 671 FSKLSNLTTLNLSTNRLSGAIPADLA 696 (1133)
Q Consensus 671 ~~~l~~L~~L~Ls~N~l~~~~p~~l~ 696 (1133)
.+++|++|+++.|+++|.+|..++
T Consensus 163 --~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 163 --TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp --CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred --CCCCHHHHHHHHHhCCceeeccCc
Confidence 123344444444444444444433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.3e-20 Score=221.70 Aligned_cols=194 Identities=27% Similarity=0.405 Sum_probs=98.4
Q ss_pred CCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeecc
Q 001171 460 NLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539 (1133)
Q Consensus 460 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 539 (1133)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|++++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 77888888888775 554442 56777777777666 344 335566666666666664 444 333 55555555
Q ss_pred CCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCC
Q 001171 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNI 619 (1133)
Q Consensus 540 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 619 (1133)
+|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 555554 332 34455555555555543 332 33445555555555443 333 32 44444444444444 23
Q ss_pred ccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcccccc
Q 001171 620 PVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALI 698 (1133)
Q Consensus 620 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 698 (1133)
|. +.. +| ......|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 196 p~-~~~--~L-----------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 196 PA-VPV--RN-----------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CC-CC---------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred hh-HHH--hh-----------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 33 221 23 000011155555555555 345545555555555555555555555555444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.2e-21 Score=233.02 Aligned_cols=198 Identities=17% Similarity=0.151 Sum_probs=150.1
Q ss_pred hcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCc-------------ccCcCCCccccccchhhhh-hcccccC
Q 001171 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNS-------------FSGHLPLSIFNLTNLLVLN-VAHNLLS 156 (1133)
Q Consensus 91 l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~-------------~~g~~p~~l~~l~~L~~L~-l~~N~l~ 156 (1133)
++..++|+.|+|++|+|. .+|..+++|++|+.|++++|. +.|.+|..++++++|+.|+ ++.|.+.
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence 467899999999999997 899999999999999998886 6778888999999999998 6666543
Q ss_pred CC---------ccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccC
Q 001171 157 GK---------ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227 (1133)
Q Consensus 157 ~~---------~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1133)
.. +..-.+..|++|+|++|.|++ +|. |+.+++|++|+|++|+|+ .+|..++.+++|++|+|++|++++
T Consensus 424 ~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp HHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred hhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC
Confidence 10 101112357788888888876 565 788888888888888888 678788888888888888888875
Q ss_pred CCCccccCccccceeeccccccCCCC-CCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEe
Q 001171 228 TLPSAISNCSSLVHLSAEDNVLKGLI-PGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQ 296 (1133)
Q Consensus 228 ~~p~~l~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~ 296 (1133)
+| .++++++|++|+|++|+|++.+ |..|+.+++|+.|+|++|++++.+|... ..+..+++|+.|+
T Consensus 501 -lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~--~l~~~lp~L~~L~ 566 (567)
T 1dce_A 501 -VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE--RLAEMLPSVSSIL 566 (567)
T ss_dssp -CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT--HHHHHCTTCSEEE
T ss_pred -Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH--HHHHHCcccCccC
Confidence 66 7788888888888888888776 7788888888888888888876655321 1123355555554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-20 Score=235.80 Aligned_cols=233 Identities=20% Similarity=0.189 Sum_probs=129.7
Q ss_pred cCchhHHHHHHHHHHhCCCC-CCCccCCCCCCCCCCCccceeeeCCCceEEEeeCCcccCcccchhhcccccCc-----E
Q 001171 26 AVVLSEIQALTSFKLHLKDP-LGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELR-----K 99 (1133)
Q Consensus 26 ~~~~~~~~~l~~~k~~~~~~-~~~l~~w~~~~~~~~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~-----~ 99 (1133)
.....++++|+++..+...+ ...-.+|... +..++.|.+++++..+|+.++|..+++.+. +..+.....|. .
T Consensus 128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~ 205 (727)
T 4b8c_D 128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGD-STPSGTATNSAVSTPLTPKIELFANGKDEA-NQALLQHKKLSQYSIDE 205 (727)
T ss_dssp ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred hccccchhhhhhhhhhcccccCcccCCCcCC-CCccccCCCceecCCccceEEeeCCCCCcc-hhhHhhcCccCcccccC
Confidence 34567899999999887322 2233567433 335679999999999999999988877763 33332222222 2
Q ss_pred EEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccC--CcceEEEccCCcC
Q 001171 100 LSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADIS--PSLRYLDLSSNAF 177 (1133)
Q Consensus 100 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~--~~l~~L~Ls~N~~ 177 (1133)
++++.|++. ..|..+..++.|+.|+|++|.++ .+|..++++++|++|+|++|.|+ .+|..+. ++|++|+|++|.|
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 333334444 44777899999999999999998 89999999999999999999998 6776664 7899999999999
Q ss_pred CCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCcc-ccceeeccccccCCCCCCc
Q 001171 178 TGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCS-SLVHLSAEDNVLKGLIPGT 256 (1133)
Q Consensus 178 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~~~~ 256 (1133)
+ .+|..|+.+++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+. .+..|+|++|.+++.+|.
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~- 359 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH- 359 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc-
Confidence 8 77888999999999999999887 6788899999999999999999888888776553 334578889998887775
Q ss_pred ccCcCcccEEEcccC
Q 001171 257 IGRISTLQVLSLSRN 271 (1133)
Q Consensus 257 ~~~l~~L~~L~Ls~N 271 (1133)
.|+.|+++.|
T Consensus 360 -----~l~~l~l~~n 369 (727)
T 4b8c_D 360 -----ERRFIEINTD 369 (727)
T ss_dssp -----C---------
T ss_pred -----ccceeEeecc
Confidence 4556667766
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.2e-19 Score=187.22 Aligned_cols=158 Identities=25% Similarity=0.362 Sum_probs=95.3
Q ss_pred CCCccceeeeCCCceEEEeeCCcccCcccchhhcccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCc
Q 001171 59 APCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLS 138 (1133)
Q Consensus 59 ~~c~w~gv~c~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~ 138 (1133)
+.|.|.+|.|++.++ +.+|..+. ++|++|+|++|++++..|..+..+++|+.|+|++|+++
T Consensus 17 ~~Cs~~~v~c~~~~l-----------~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~------ 77 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRH-----------ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG------ 77 (229)
T ss_dssp CEEETTEEECTTSCC-----------SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC------
T ss_pred CEEeCCEeEccCCCc-----------CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC------
Confidence 679999999986442 12222221 45555555555555544545555555555555555443
Q ss_pred cccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceE
Q 001171 139 IFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYL 218 (1133)
Q Consensus 139 l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 218 (1133)
+..+..|..+++|++|+|++|+|++..+..+..+++|++|
T Consensus 78 ----------------------------------------~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 117 (229)
T 3e6j_A 78 ----------------------------------------ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKEL 117 (229)
T ss_dssp ----------------------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ----------------------------------------CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeE
Confidence 2333444555556666666666665444445566666666
Q ss_pred ecccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCC
Q 001171 219 WLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276 (1133)
Q Consensus 219 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 276 (1133)
+|++|+++ .+|..+.++++|++|++++|+|+++.+..|..+++|+.|+|++|.+...
T Consensus 118 ~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 118 FMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp ECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred eccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 66666665 5566666666667777777777666666677777777778877777643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=192.11 Aligned_cols=158 Identities=21% Similarity=0.223 Sum_probs=112.5
Q ss_pred cEEEcccccccCCCCcccccccccceeecccCccCCCCC-ccccCCCCccEEEecCCcccCCCccccccccccCeeecCC
Q 001171 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIP-AELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQ 636 (1133)
Q Consensus 558 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 636 (1133)
+.+++++|.++. +|..+ .+.+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..+..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 356666666653 44433 2345667777777665533 3466677777777777777765555677777777777777
Q ss_pred CcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccccCC
Q 001171 637 NKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716 (1133)
Q Consensus 637 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 716 (1133)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+|.++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 77776666667777888888888888887777778888888888888888887777778888888888888888887776
Q ss_pred cc
Q 001171 717 KM 718 (1133)
Q Consensus 717 ~~ 718 (1133)
..
T Consensus 171 l~ 172 (220)
T 2v70_A 171 LA 172 (220)
T ss_dssp GH
T ss_pred hH
Confidence 43
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-19 Score=197.23 Aligned_cols=192 Identities=20% Similarity=0.320 Sum_probs=99.5
Q ss_pred cccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEec
Q 001171 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220 (1133)
Q Consensus 141 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 220 (1133)
++.++..+++..+.+++.++..-.++|++|++++|.++.. | .+..+++|++|++++|++++..| +..+++|++|++
T Consensus 22 ~l~~~~~~~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l 97 (291)
T 1h6t_A 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97 (291)
T ss_dssp HHHHHHHHHTTCSCTTSEECHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHHHhcCCCcccccchhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence 3455556666666665443333345566666666666543 2 35566666666666666664333 556666666666
Q ss_pred ccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCC
Q 001171 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300 (1133)
Q Consensus 221 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n 300 (1133)
++|++++ +| .+.++++|++|++++|+++++ ..+..+++|++|+|++|+++
T Consensus 98 ~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~-------------------------- 147 (291)
T 1h6t_A 98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-------------------------- 147 (291)
T ss_dssp CSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC--------------------------
T ss_pred CCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCC--------------------------
Confidence 6665543 22 244444444444444444432 22333333333333333333
Q ss_pred cccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCc
Q 001171 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP 380 (1133)
Q Consensus 301 ~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~ 380 (1133)
++ ..+..+++|++|+|++|+|++..| +..+++|++|+|++|++++. +
T Consensus 148 ----------------------------~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~ 194 (291)
T 1h6t_A 148 ----------------------------DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R 194 (291)
T ss_dssp ----------------------------CC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G
T ss_pred ----------------------------cc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h
Confidence 22 234555555666666665554333 55556666666666665543 2
Q ss_pred hhhccCCCccEEEccCCccc
Q 001171 381 DEIAKCSLLQMFDLEGNRFS 400 (1133)
Q Consensus 381 ~~~~~l~~L~~L~Ls~N~l~ 400 (1133)
.+..+++|+.|++++|+++
T Consensus 195 -~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 195 -ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp -GGTTCTTCSEEEEEEEEEE
T ss_pred -hhccCCCCCEEECcCCccc
Confidence 2555566666666666555
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=203.07 Aligned_cols=177 Identities=23% Similarity=0.252 Sum_probs=132.2
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCC-CCCcCcEEeccCCcCCCCCcccccCccccceEeccccccc
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFS-SKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLY 226 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 226 (1133)
+++++|.|+ .+|..+++.+++|+|++|+|++..+..|. .+++|++|+|++|+|++..|..|..+++|++|+|++|+++
T Consensus 23 l~c~~~~l~-~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~ 101 (361)
T 2xot_A 23 LSCSKQQLP-NVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH 101 (361)
T ss_dssp EECCSSCCS-SCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred EEeCCCCcC-ccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCC
Confidence 444444444 35666777889999999999988888887 8999999999999999877778999999999999999998
Q ss_pred CCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccc
Q 001171 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVV 306 (1133)
Q Consensus 227 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 306 (1133)
+..+..|.++++|++|+|++|+|+++.|..|..+++|+.|+|++|+|++. |...+ ..
T Consensus 102 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l-~~~~~----~~------------------ 158 (361)
T 2xot_A 102 TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRF-PVELI----KD------------------ 158 (361)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSC-CGGGT----C-------------------
T ss_pred cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCee-CHHHh----cC------------------
Confidence 77777788899999999999999988888898999999999999988753 33221 00
Q ss_pred cCCCCCccccccEEeccCCcccccCCchhhccccc--ceeeccCceee
Q 001171 307 KPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSL--RVMDLSGNFFS 352 (1133)
Q Consensus 307 ~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L--~~L~Ls~N~l~ 352 (1133)
...+.+|++|+|++|+|+.+++..|..++.+ +.|+|++|.+.
T Consensus 159 ----~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 159 ----GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp -------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ----cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 0123345555566666666655666666653 66666666665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8e-19 Score=213.22 Aligned_cols=188 Identities=24% Similarity=0.310 Sum_probs=107.2
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccC
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG 396 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 396 (1133)
+..+.+..+.+..+.+ +..+++|+.|++++|.|.. ++ .+..+++|+.|+|++|++++..| +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 4444555555555433 5667777777777777763 23 46677777777777777776544 66777777777777
Q ss_pred CcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCC
Q 001171 397 NRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476 (1133)
Q Consensus 397 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 476 (1133)
|+|++ +| .+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+++..|
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 77764 22 455666666666666666542 2355556666666666666543 445555555555555555554433
Q ss_pred CCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCC
Q 001171 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 477 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+.
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 44444455555544444432 12444444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4e-19 Score=188.29 Aligned_cols=155 Identities=20% Similarity=0.291 Sum_probs=84.5
Q ss_pred EEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCc
Q 001171 559 YLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNK 638 (1133)
Q Consensus 559 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 638 (1133)
.+++++|.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|.
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 2333221 345555555555554444455555555555555555554445555555555555555555
Q ss_pred ccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccccCC
Q 001171 639 LSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716 (1133)
Q Consensus 639 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p 716 (1133)
|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|.+.+.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 553333344556666666666666665555566666666666666666665555555666666666666666665544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.9e-19 Score=195.16 Aligned_cols=185 Identities=25% Similarity=0.305 Sum_probs=93.9
Q ss_pred EeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcc
Q 001171 320 LDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRF 399 (1133)
Q Consensus 320 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 399 (1133)
+.+..+.++.+ ..+..+++|++|++++|.+... + .+..+++|++|+|++|++++..+ +.++++|++|+|++|++
T Consensus 29 ~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l 102 (291)
T 1h6t_A 29 DNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV 102 (291)
T ss_dssp HHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhcCCCcccc--cchhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcC
Confidence 33444444433 2234556666666666666532 2 35556666666666666655433 55566666666666665
Q ss_pred cccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCC
Q 001171 400 SGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV 479 (1133)
Q Consensus 400 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 479 (1133)
++. | .+..+++|+.|++++|.+++. ..+..+++|++|++++|++++. ..+..+++|++|+|++|++++..+ +
T Consensus 103 ~~~-~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l 174 (291)
T 1h6t_A 103 KDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L 174 (291)
T ss_dssp CCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred CCC-h-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--h
Confidence 531 2 255555555555555555542 2345555555555555555533 345555555555555555554332 4
Q ss_pred CCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCC
Q 001171 480 GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLS 520 (1133)
Q Consensus 480 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 520 (1133)
..+++|+.|++++|.+++. + .+..+++|+.|++++|.++
T Consensus 175 ~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 175 AGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp TTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred cCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence 4444444444444444432 1 2444444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=210.99 Aligned_cols=193 Identities=20% Similarity=0.311 Sum_probs=129.2
Q ss_pred cccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEec
Q 001171 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220 (1133)
Q Consensus 141 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 220 (1133)
++.++..++++.+.++..++..-.++|++|+|++|.++.. | .|..+++|+.|+|++|++++..| +..+++|++|+|
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEECHHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHHHhccCCCcccccchhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 4556666777777766555544456778888888888753 3 57788888888888888886544 788888888888
Q ss_pred ccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCC
Q 001171 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300 (1133)
Q Consensus 221 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n 300 (1133)
++|++++ +| .+.++++|++|+|++|+++++ ..+..+++|+.|+|++|+|++. + . +..+++|+.|+|++|
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~-~-----l~~l~~L~~L~Ls~N 163 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-T-V-----LSRLTKLDTLSLEDN 163 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-G-----GGSCTTCSEEECCSS
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc-h-h-----hcccCCCCEEECcCC
Confidence 8888874 33 677788888888888888764 3577788888888888887754 1 1 245555555555555
Q ss_pred cccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccc
Q 001171 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSG 377 (1133)
Q Consensus 301 ~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 377 (1133)
.+++. .| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+.+
T Consensus 164 ~l~~~-------------------------~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 164 QISDI-------------------------VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCCCC-------------------------GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred cCCCc-------------------------hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 55543 23 55555555566665555542 245555666666666665554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=181.75 Aligned_cols=153 Identities=23% Similarity=0.272 Sum_probs=78.8
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccC-cccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLP-AAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
-+++++++|.++.++ ..+ ...+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 13 ~~~l~~s~n~l~~iP-~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLNKIP-EHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCSSCC-SCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCcccCc-cCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 345666666666553 222 1234566666666654433 335555555555555555555555555555555555555
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCC
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFG 472 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 472 (1133)
+|+|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 55555544444555555555555555555444444545555555555555554444444444444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.7e-18 Score=180.87 Aligned_cols=152 Identities=22% Similarity=0.335 Sum_probs=90.8
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccC
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG 396 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 396 (1133)
-+.+++++++++.++. .+. ++|++|+|++|+|++..+..|..+++|++|+|++|++++..|+.|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~~iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 13 NNIVDCRGKGLTEIPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TTEEECTTSCCSSCCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CCEEEcCCCCcCcCCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 3566677777766633 222 5667777777777765556666677777777777776666666666666666666666
Q ss_pred CcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcC
Q 001171 397 NRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKF 471 (1133)
Q Consensus 397 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l 471 (1133)
|+|+...+..|.++++|+.|+|++|.+++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 666655445555555555555555555555555555555555555555555544444444455555555555544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-20 Score=227.69 Aligned_cols=121 Identities=18% Similarity=0.187 Sum_probs=63.2
Q ss_pred cceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccC
Q 001171 341 LRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGR 420 (1133)
Q Consensus 341 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 420 (1133)
|++|+|++|.|++ +|. |+.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +| .++++++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 4445555555543 333 455555555555555554 334455555555555555555554 33 455555555555555
Q ss_pred CcCcccc-CccccCccccceeecccccccccCCh---hhcCCCCCcEEec
Q 001171 421 NMFSGLI-PLSFGNLSQLETLNLSENDIRGNIPE---EITRLSNLTTLNL 466 (1133)
Q Consensus 421 N~l~~~~-p~~~~~l~~L~~L~L~~N~i~~~~~~---~l~~l~~L~~L~L 466 (1133)
|.|++.. |..|+.+++|+.|+|++|++++..+. .+..+++|+.|++
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 5555554 55555666666666666666544332 1233566666653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=199.01 Aligned_cols=176 Identities=23% Similarity=0.242 Sum_probs=107.3
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccC-CCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG-SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
-+.+++++++++.++. .+. ..+++|+|++|+|++..+..|. .+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus 20 ~~~l~c~~~~l~~iP~-~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 20 SNILSCSKQQLPNVPQ-SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TTEEECCSSCCSSCCS-SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcCccCc-cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 4566777777776633 222 3466777777777766666666 67777777777777776666667777777777777
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhh---cCCCCCcEEecccCcCC
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI---TRLSNLTTLNLSYNKFG 472 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l---~~l~~L~~L~Ls~N~l~ 472 (1133)
+|+|++..+..|.++++|+.|+|++|.|++..|..|..+++|++|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 777766666666666666666666666666666666666666666666666664433333 34556666666666655
Q ss_pred CCCCCCCCCCCC--CcEEEcccCCC
Q 001171 473 GKVPYDVGNLKG--LLVLNLSASGF 495 (1133)
Q Consensus 473 ~~~~~~~~~l~~--L~~L~L~~N~l 495 (1133)
+..+..+..++. ++.|+|++|.+
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred ccCHHHhhhccHhhcceEEecCCCc
Confidence 433333333333 13344444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-17 Score=176.81 Aligned_cols=156 Identities=23% Similarity=0.280 Sum_probs=92.5
Q ss_pred ccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEE
Q 001171 313 CVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMF 392 (1133)
Q Consensus 313 ~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 392 (1133)
+....+.+++++++++.++.. + .++|++|+|++|.|++..|..|..+++|++|+|++|+|+...+..|..+++|++|
T Consensus 17 ~~Cs~~~v~c~~~~l~~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRHASVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL 93 (229)
T ss_dssp CEEETTEEECTTSCCSSCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CEEeCCEeEccCCCcCccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence 334466777777777776432 2 2667777777777776666667777777777777777765555556666666666
Q ss_pred EccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCC
Q 001171 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFG 472 (1133)
Q Consensus 393 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 472 (1133)
+|++|+|++..+..|..+++|+.|+|++|.++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 66666666555555555555555555555555 33444455555555555555555444444444444555555444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.9e-18 Score=185.95 Aligned_cols=150 Identities=21% Similarity=0.282 Sum_probs=77.8
Q ss_pred CCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccce
Q 001171 504 GSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVF 583 (1133)
Q Consensus 504 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 583 (1133)
..+++|++|++++|.++ .++ .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. |.. .. ++|++
T Consensus 38 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l-~~~-~~-~~L~~ 110 (263)
T 1xeu_A 38 KELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL-NGI-PS-ACLSR 110 (263)
T ss_dssp HHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCC-TTC-CC-SSCCE
T ss_pred hhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCc-Ccc-cc-CcccE
Confidence 33344444444444443 222 33444444444444444443322 44444555555555555432 211 11 55666
Q ss_pred eecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCC
Q 001171 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSL 663 (1133)
Q Consensus 584 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 663 (1133)
|+|++|++++. + .++.+++|++|++++|++++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|++
T Consensus 111 L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 111 LFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp EECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEE
T ss_pred EEccCCccCCC-h-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcc
Confidence 66666666532 2 35566666666666666664 33 456666666666666666644 4566666677777777766
Q ss_pred Ccc
Q 001171 664 SGR 666 (1133)
Q Consensus 664 ~~~ 666 (1133)
++.
T Consensus 185 ~~~ 187 (263)
T 1xeu_A 185 VNE 187 (263)
T ss_dssp ECC
T ss_pred cCC
Confidence 654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.7e-18 Score=183.57 Aligned_cols=135 Identities=19% Similarity=0.202 Sum_probs=105.3
Q ss_pred CCCcccccccccceeEEEEEE-CCceE--EEEEEcccCCcC-------------------------HHHHHHHHHHHhhc
Q 001171 838 QFDEENVLSRGRYGLIFKASY-QDGMV--LSIRRLRDGTID-------------------------ENTFRKEAEALGKV 889 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l 889 (1133)
-|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ...+.+|+++++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999988 67888 999987543211 13678999999999
Q ss_pred cCCCe--eeEEEEEeCCCCcEEEEEeccCC-C----CHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHh-cCCcee
Q 001171 890 KHRNL--TVLRGYYAGPPDVRLLVYDYMPN-G----NLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH-SLDMVH 961 (1133)
Q Consensus 890 ~hpni--v~l~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~ivH 961 (1133)
.|+++ ...+++ ...++||||+.+ | +|.++... .++..+..++.|++.|++||| +.||+|
T Consensus 128 ~~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HhCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 88764 333332 123899999942 4 67766432 234566789999999999999 999999
Q ss_pred cccCccceeeCCCCceEEeccCcccc
Q 001171 962 GDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 962 ~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
|||||+|||++. .++|+|||+|..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999998 999999999854
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.5e-18 Score=185.49 Aligned_cols=169 Identities=17% Similarity=0.227 Sum_probs=102.4
Q ss_pred cccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEE
Q 001171 314 VSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFD 393 (1133)
Q Consensus 314 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 393 (1133)
+..+..+++++|.++++. .+..+++|++|++++|.|+. ++ .+..+++|++|+|++|++++..+ +..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 334555566666666553 46667777777777777763 33 56667777777777777765544 66677777777
Q ss_pred ccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCC
Q 001171 394 LEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGG 473 (1133)
Q Consensus 394 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~ 473 (1133)
|++|++++. |.... ++|+.|+|++|.+++. ..+..+++|++|++++|+|++. ..+..+++|++|+|++|++++
T Consensus 92 L~~N~l~~l-~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNL-NGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCC-TTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCc-Ccccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcc
Confidence 777777642 22222 6666666666666653 2466666666666666666643 245566666666666666654
Q ss_pred CCCCCCCCCCCCcEEEcccCCCcc
Q 001171 474 KVPYDVGNLKGLLVLNLSASGFSG 497 (1133)
Q Consensus 474 ~~~~~~~~l~~L~~L~L~~N~l~~ 497 (1133)
. ..+..+++|+.|++++|.+++
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEEC
T ss_pred h--HHhccCCCCCEEeCCCCcccC
Confidence 3 445555555555555555543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.8e-18 Score=175.66 Aligned_cols=154 Identities=14% Similarity=0.174 Sum_probs=101.5
Q ss_pred cccccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEE
Q 001171 92 ADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLD 171 (1133)
Q Consensus 92 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 171 (1133)
+++++|+.|++++|+++ .+| .+..+++|+.|++++|.++ .+..+.++ ++|++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l----------------------~~L~~L~ 94 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGL----------------------SNLERLR 94 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTC----------------------TTCCEEE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcC----------------------CCCCEEE
Confidence 34455555555555555 344 3555555555555555433 11122222 4567777
Q ss_pred ccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCC
Q 001171 172 LSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKG 251 (1133)
Q Consensus 172 Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 251 (1133)
|++|.+++..|..|+.+++|++|++++|++++..|..++.+++|++|++++|++.+.+| .+.++++|++|++++|++++
T Consensus 95 l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp EECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred eECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence 77777777677778888888888888888887777788888888888888887333555 57777888888888888876
Q ss_pred CCCCcccCcCcccEEEcccCCcc
Q 001171 252 LIPGTIGRISTLQVLSLSRNELT 274 (1133)
Q Consensus 252 ~~~~~~~~l~~L~~L~Ls~N~l~ 274 (1133)
+. .+..+++|++|++++|++.
T Consensus 174 ~~--~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 174 YR--GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CT--TGGGCSSCCEEEECBC---
T ss_pred hH--HhccCCCCCEEEeeCcccC
Confidence 43 6777778888888888765
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-18 Score=213.78 Aligned_cols=198 Identities=20% Similarity=0.240 Sum_probs=94.1
Q ss_pred cccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccC
Q 001171 490 LSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569 (1133)
Q Consensus 490 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 569 (1133)
++.|.+. ..+..+..+++|+.|+|++|.+. .+|..++++++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 45566667777777777777776 56666667777777777777776 56666666777777777777776
Q ss_pred CCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccc-cCeeecCCCcccCcCchhhh
Q 001171 570 DIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSR-IKKLDLGQNKLSGEIPKEIS 648 (1133)
Q Consensus 570 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~l~ 648 (1133)
.+|..|+.+++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-- 360 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-- 360 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc--
Confidence 55666666777777777777666 55666666777777777777776666655544322 233566666666655543
Q ss_pred ccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCccccccccccccc
Q 001171 649 KCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGE 714 (1133)
Q Consensus 649 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 714 (1133)
|..|++++|... ...+ +.|.+..+..+..+..+....+++|-+.+.
T Consensus 361 ----l~~l~l~~n~~~---~~~~-------------~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~ 406 (727)
T 4b8c_D 361 ----RRFIEINTDGEP---QREY-------------DSLQQSTEHLATDLAKRTFTVLSYNTLCQH 406 (727)
T ss_dssp -------------------------------------------------------------CCCGG
T ss_pred ----cceeEeeccccc---cccc-------------CCccccccchhhcccccceeeeeccccccc
Confidence 334444444100 0111 133344444455666667777788877643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.5e-18 Score=191.82 Aligned_cols=221 Identities=16% Similarity=0.097 Sum_probs=122.4
Q ss_pred ccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcc----cccCCCccCCCCCC
Q 001171 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRF----SGQVPAFLGGIRGL 413 (1133)
Q Consensus 338 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l----~~~~p~~l~~l~~L 413 (1133)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+..+.+.+|..+.++..+.+..+.. .......|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 44444444444 34333333444444444444444444444444444444444444333211 11222334344444
Q ss_pred c-EEEccCCc-CccccCccccCccccceeecccccccccCChhh-cCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEc
Q 001171 414 K-IVSLGRNM-FSGLIPLSFGNLSQLETLNLSENDIRGNIPEEI-TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNL 490 (1133)
Q Consensus 414 ~-~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 490 (1133)
+ .+.+.... +.......-....+++.+.+.++-.. .....+ ..+++|+.|+|++|.++.+....|.++.+|+.|++
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 4 33332211 11001111112445555555544211 111112 23677777777777777666677777777888877
Q ss_pred ccCCCccccCCCcCCccccc-EEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEc
Q 001171 491 SASGFSGKIPGSIGSLMRLT-TLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNL 562 (1133)
Q Consensus 491 ~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 562 (1133)
.+| +....+..|.++.+|+ .+++.+ +++.+.+.+|.++++|+.|++++|.++...+.+|.++++|+.++.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 776 6666677788888887 888877 666666778888888888888888888777778888888888763
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=172.42 Aligned_cols=154 Identities=18% Similarity=0.299 Sum_probs=98.5
Q ss_pred CCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCe
Q 001171 552 SSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKK 631 (1133)
Q Consensus 552 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 631 (1133)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..++.+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34455666666666665 333 45566666666666665542 235666677777777777776655666667777777
Q ss_pred eecCCCcccCcCchhhhccCCCcEEEeecCC-CCccCCccccCcccccccccccccccccCCccccccccCccccccccc
Q 001171 632 LDLGQNKLSGEIPKEISKCSSLVSLTLDMNS-LSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNN 710 (1133)
Q Consensus 632 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~ 710 (1133)
|+|++|++++..|..++.+++|+.|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 7777777776666777777777777777776 44 444 56777777777777777764 33 56777777777777777
Q ss_pred ccc
Q 001171 711 LEG 713 (1133)
Q Consensus 711 l~~ 713 (1133)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-17 Score=188.16 Aligned_cols=263 Identities=14% Similarity=0.069 Sum_probs=121.3
Q ss_pred ccccceeeccCceee--cccCcccCCCCCCcEEEccCCcccccCchhhcc--------CCCccEEEccCCcccccCCCcc
Q 001171 338 VTSLRVMDLSGNFFS--GNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAK--------CSLLQMFDLEGNRFSGQVPAFL 407 (1133)
Q Consensus 338 l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~p~~l 407 (1133)
+++|++|||++|+|. ...+. .++.+..+.+..|.+ .+..|.+ |++|+.|+|.+ .++.+.+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 566777777777766 22221 222244455555533 2344555 66666666666 6665555666
Q ss_pred CCCCCCcEEEccCCcCccccCccccCccccceeecccccc----cccCChhhcCCCCCc-EEecccCcCCCCCCCCCCCC
Q 001171 408 GGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDI----RGNIPEEITRLSNLT-TLNLSYNKFGGKVPYDVGNL 482 (1133)
Q Consensus 408 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i----~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~~l 482 (1133)
.++++|+.+++++|.+..+.+.+|.++.++..+.+..+.. .......|.++.+|+ .+.+.... .++.
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~----- 192 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLED----- 192 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHH-----
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHH-----
Confidence 6666666666666666656666666666565555544221 111222333344443 22222110 0000
Q ss_pred CCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhcc-CCCCCcEeeccCCcccccCCCCCCCCccCcEEE
Q 001171 483 KGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLN 561 (1133)
Q Consensus 483 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 561 (1133)
.....-....+++.+.+.++-.. .....+. .+++|+.|+|++|+++...+.+|.++.+|+.|+
T Consensus 193 ---------------~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~ 256 (329)
T 3sb4_A 193 ---------------EIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIK 256 (329)
T ss_dssp ---------------HHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEE
T ss_pred ---------------HHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEE
Confidence 00000011233333433332111 1111111 144455555555555444444455555555555
Q ss_pred cccccccCCCCcccccccccc-eeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeee
Q 001171 562 LSDNAFTGDIPATYGFLRSLV-FLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633 (1133)
Q Consensus 562 Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 633 (1133)
|.+| ++.+.+.+|.++++|+ .+++.+ .++...+..|..+++|+.|++++|+++...+..|.++++|+.++
T Consensus 257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 5544 4444444455555555 555544 44434444555555555555555555543334455555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=2.3e-17 Score=170.73 Aligned_cols=130 Identities=28% Similarity=0.378 Sum_probs=71.7
Q ss_pred cEEEcccccccCCCCcccccccccceeecccCccCCCCCc-cccCCCCccEEEecCCcccCCCccccccccccCeeecCC
Q 001171 558 QYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPA-ELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQ 636 (1133)
Q Consensus 558 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 636 (1133)
+.+++++|+++ .+|..+. .+|++|++++|+|++..+. .++.+++|++|+|++|+|++..|..+..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 55666666664 3444332 2556666666666544432 255555566666665555555555555555555555555
Q ss_pred CcccCcCchhhhccCCCcEEEeecCCCCccCCccccCccccccccccccccccc
Q 001171 637 NKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGA 690 (1133)
Q Consensus 637 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 690 (1133)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 555555455555555555555555555555555555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=165.15 Aligned_cols=130 Identities=26% Similarity=0.344 Sum_probs=69.9
Q ss_pred cEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCc-ccccccccceeecccCccCCCCCccccCCCCccEEEecC
Q 001171 534 QVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPA-TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRS 612 (1133)
Q Consensus 534 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 612 (1133)
+.+++++|+++ .+|..+.. +|++|++++|++++..+. .|+.+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45555555554 33333322 555555555555544432 255555555555555555555555555555555555555
Q ss_pred CcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCcc
Q 001171 613 NHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR 666 (1133)
Q Consensus 613 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 666 (1133)
|+|++..+..+..+++|++|+|++|+|++..|..+..+++|+.|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 555554444455555555555555555555555555555555555555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.6e-15 Score=172.16 Aligned_cols=268 Identities=15% Similarity=0.113 Sum_probs=149.6
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccC
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEG 396 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 396 (1133)
++.+.+. |.++.|...+|.++ +|+.++|.+| +..+-..+|.++ +|+.+.+.+ .++.+.+.+|.+|++|+.++|++
T Consensus 115 l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEEC-CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 3444443 34666666777765 5777777666 554555566664 577777765 55555566677777777777777
Q ss_pred CcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCC
Q 001171 397 NRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476 (1133)
Q Consensus 397 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 476 (1133)
|+++......|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+....|.+ .+|+.+.+. +.++.+..
T Consensus 190 n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~ 264 (401)
T 4fdw_A 190 TKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIAS 264 (401)
T ss_dssp SCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECT
T ss_pred CcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEECh
Confidence 776655555555 366666666633 55555666666666666666654 44444445544 456666552 33443444
Q ss_pred CCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCcc
Q 001171 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVG 556 (1133)
Q Consensus 477 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 556 (1133)
..|.++++|+.+++.+|.+.. +.+....+.+|.++++|+.+.|. +.++.....+|.++.+
T Consensus 265 ~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~ 324 (401)
T 4fdw_A 265 RAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRK 324 (401)
T ss_dssp TTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCS
T ss_pred hHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCC
Confidence 455555555555555444330 00002333445555555555555 2344444555555666
Q ss_pred CcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCC-CccEEEecCCccc
Q 001171 557 LQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS-ALEVLELRSNHFT 616 (1133)
Q Consensus 557 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~ 616 (1133)
|+.++|..| ++.....+|.++ +|+.+++++|.+....+..|..++ +++.|++..+.+.
T Consensus 325 L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 325 VTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred ccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 666666433 444445555555 666666666665544445555553 5666666665543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-14 Score=166.17 Aligned_cols=242 Identities=10% Similarity=0.048 Sum_probs=160.3
Q ss_pred CccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecc
Q 001171 388 LLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLS 467 (1133)
Q Consensus 388 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls 467 (1133)
+|+.++|..| ++.+...+|.+. +|+.+.+.. .++.+.+.+|.+|++|+.+++++|+++.+....|. ..+|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 3444444433 333333444442 355555543 34444445555555555555555555544444443 3556666665
Q ss_pred cCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCccc---
Q 001171 468 YNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS--- 544 (1133)
Q Consensus 468 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--- 544 (1133)
.+ ++.+....|.++++|+.+++..| ++......|.+ ++|+.+++. +.++.....+|.++++|+.+.+.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~ 287 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDP 287 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence 33 44455555666666666666553 44445556666 677777773 4455556677777778888887777664
Q ss_pred --ccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccc
Q 001171 545 --GDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVD 622 (1133)
Q Consensus 545 --~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 622 (1133)
...+.+|.++++|+.++|. +.++.....+|.++.+|+.+.|..| ++......|..+ +|+.+++++|.+....+..
T Consensus 288 ~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~ 364 (401)
T 4fdw_A 288 EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKV 364 (401)
T ss_dssp TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSS
T ss_pred ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccccc
Confidence 4677899999999999999 5588777889999999999999665 776677889999 9999999999988655566
Q ss_pred ccccc-ccCeeecCCCccc
Q 001171 623 ISHLS-RIKKLDLGQNKLS 640 (1133)
Q Consensus 623 l~~l~-~L~~L~Ls~N~l~ 640 (1133)
+..++ +++.|++..+.+.
T Consensus 365 F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 365 WYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCCSCTTCCEEEECGGGHH
T ss_pred ccCCCCCccEEEeCHHHHH
Confidence 77774 7889999888765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.8e-16 Score=160.73 Aligned_cols=132 Identities=24% Similarity=0.351 Sum_probs=93.0
Q ss_pred ceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecC
Q 001171 582 VFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661 (1133)
Q Consensus 582 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 661 (1133)
+.+++++|.++ .+|..+ .++|++|+|++|+|+ .+|..+..+++|+.|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 35566666665 444443 246777777777776 46666777777777777777777666667777777777777777
Q ss_pred CCCccCCccccCcccccccccccccccccCCccccccccCcccccccccccccCCc
Q 001171 662 SLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 662 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|++++|+|.+.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 77776667777777788888888887755555677778888888888888776653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=158.05 Aligned_cols=126 Identities=27% Similarity=0.309 Sum_probs=97.4
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccC
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1133)
+++++|.++ .+|..+++++++|+|++|+|+ .+|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++
T Consensus 15 l~~~~~~l~-~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~ 92 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92 (193)
T ss_dssp EECTTSCCS-SCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred EEcCCCCCC-cCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCE
Confidence 344444443 355556677888888888887 567788888888888888888887777778888888888888888887
Q ss_pred CCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccC
Q 001171 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTG 275 (1133)
Q Consensus 228 ~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 275 (1133)
..|..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+..
T Consensus 93 i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 777778888888888888888887777778888888888888887763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=153.27 Aligned_cols=132 Identities=24% Similarity=0.247 Sum_probs=66.1
Q ss_pred ccCcEEEccccccc-CCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeee
Q 001171 555 VGLQYLNLSDNAFT-GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633 (1133)
Q Consensus 555 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 633 (1133)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34555555555554 34444455555555555555555533 4445555555555555555544444444455555555
Q ss_pred cCCCcccCcC-chhhhccCCCcEEEeecCCCCccCC---ccccCccccccccccccccc
Q 001171 634 LGQNKLSGEI-PKEISKCSSLVSLTLDMNSLSGRIP---ESFSKLSNLTTLNLSTNRLS 688 (1133)
Q Consensus 634 Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~ 688 (1133)
|++|.+++.. +..+..+++|+.|++++|++++..+ ..|..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555555321 1444555555555555555553332 24445555555555555544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-15 Score=153.17 Aligned_cols=120 Identities=26% Similarity=0.341 Sum_probs=103.6
Q ss_pred ccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccc
Q 001171 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSS 238 (1133)
Q Consensus 159 ~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 238 (1133)
+|..++++|++|+|++|++++..+..|..+++|++|++++|++++..+..++.+++|++|+|++|++++..+..+.++++
T Consensus 22 ~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 101 (177)
T 2o6r_A 22 VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQ 101 (177)
T ss_dssp CCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred CCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcc
Confidence 44556678899999999999877788899999999999999999776677889999999999999999777777889999
Q ss_pred cceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcc
Q 001171 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVP 278 (1133)
Q Consensus 239 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 278 (1133)
|++|++++|+++++.+..+..+++|++|+|++|.+.+..|
T Consensus 102 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 102 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999999999998877778889999999999999886544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=153.56 Aligned_cols=108 Identities=19% Similarity=0.182 Sum_probs=59.4
Q ss_pred ccccEEeccCCccc-ccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEE
Q 001171 315 SVLEVLDLQNNRIR-AVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFD 393 (1133)
Q Consensus 315 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 393 (1133)
..|++|++++|+|+ +..|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45666666666666 22255566666666666666666643 5556666666666666666655555555566666666
Q ss_pred ccCCcccccCC-CccCCCCCCcEEEccCCcCc
Q 001171 394 LEGNRFSGQVP-AFLGGIRGLKIVSLGRNMFS 424 (1133)
Q Consensus 394 Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 424 (1133)
|++|++++..+ ..+..+++|+.|++++|.++
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence 66665553211 33344444444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-14 Score=166.07 Aligned_cols=316 Identities=12% Similarity=0.090 Sum_probs=150.4
Q ss_pred ccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCc
Q 001171 327 IRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAF 406 (1133)
Q Consensus 327 i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 406 (1133)
++.|...+|.++++|+.+.|..+ ++.+-..+|.++++|+.+++.++ ++.+....|.++.+|+.+.+..+ +......+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 45555566666666666666543 44344455666666666666543 44444555666666666555433 33333444
Q ss_pred cCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCc
Q 001171 407 LGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486 (1133)
Q Consensus 407 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 486 (1133)
|.++..++...... +......+|.++++|+.+.+.++- ..+....|.++.+|+.+++..| ++.+....|.++..|+
T Consensus 136 F~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 136 FKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLE 211 (394)
T ss_dssp TTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCC
T ss_pred eecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccc
Confidence 54444333222222 122234556666666666665442 2244455666666666666554 3334445555555665
Q ss_pred EEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEccccc
Q 001171 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566 (1133)
Q Consensus 487 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 566 (1133)
.+.+..+... +...+....+|+.+.+..+ ++......+.++..|+.+.+..+... .....|..+..++.+....+.
T Consensus 212 ~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~ 287 (394)
T 4fs7_A 212 NMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI 287 (394)
T ss_dssp BCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE
T ss_pred eeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee
Confidence 5555444322 1222233345555555432 22233344555555555555544332 344455555555555554433
Q ss_pred ccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchh
Q 001171 567 FTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKE 646 (1133)
Q Consensus 567 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 646 (1133)
+. ...|..+.+|+.+.+..+ ++......|..+.+|+.++|.++ ++......|.++.+|+.+++..| ++.....+
T Consensus 288 i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a 361 (394)
T 4fs7_A 288 VP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANA 361 (394)
T ss_dssp EC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred ec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHH
Confidence 22 233444455555555433 33233334444555555554322 33222233444444444444443 33233344
Q ss_pred hhccCCCcEEEee
Q 001171 647 ISKCSSLVSLTLD 659 (1133)
Q Consensus 647 l~~l~~L~~L~Ls 659 (1133)
|.+|.+|+.+++.
T Consensus 362 F~~C~~L~~i~lp 374 (394)
T 4fs7_A 362 FQGCINLKKVELP 374 (394)
T ss_dssp BTTCTTCCEEEEE
T ss_pred hhCCCCCCEEEEC
Confidence 4444444444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-15 Score=149.75 Aligned_cols=127 Identities=25% Similarity=0.365 Sum_probs=69.2
Q ss_pred cccceeecccCccC-CCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEE
Q 001171 579 RSLVFLSLSHNQIS-GMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLT 657 (1133)
Q Consensus 579 ~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 657 (1133)
++|++|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|+.|+|++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34455555555554 34444445555555555555555532 3455555555555555555544555555556666666
Q ss_pred eecCCCCcc-CCccccCcccccccccccccccccCC---ccccccccCcccccc
Q 001171 658 LDMNSLSGR-IPESFSKLSNLTTLNLSTNRLSGAIP---ADLALISSLRYLNLS 707 (1133)
Q Consensus 658 Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~ls 707 (1133)
+++|++++. .+..++.+++|+.|++++|++++..+ ..+..+++|++||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666665542 23555666666666666666654433 345566666666654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-15 Score=170.89 Aligned_cols=136 Identities=14% Similarity=0.124 Sum_probs=100.5
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCc---------------CHH--------HHHHHHHHHhhccCCCe
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI---------------DEN--------TFRKEAEALGKVKHRNL 894 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------------~~~--------~~~~E~~~l~~l~hpni 894 (1133)
-|++.+.||+|+||.||+|...+|+.||||+++.... ... ...+|...+.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3899999999999999999998999999998753211 011 12457777888765554
Q ss_pred eeEEEEEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC
Q 001171 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD 974 (1133)
Q Consensus 895 v~l~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~ 974 (1133)
....-+... . .++||||++|++|.++. .......++.||+.++.|||+.|||||||||.|||++++
T Consensus 176 ~vp~p~~~~--~-~~LVME~i~G~~L~~l~-----------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQS--R-HTIVMSLVDALPMRQVS-----------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEEE--T-TEEEEECCSCEEGGGCC-----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCeeeecc--C-ceEEEEecCCccHhhhc-----------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 322222111 1 27999999988764332 122345688999999999999999999999999999877
Q ss_pred C----------ceEEeccCcccc
Q 001171 975 F----------EAHLSEFGLDRL 987 (1133)
Q Consensus 975 ~----------~~kl~Dfg~a~~ 987 (1133)
+ .+.|+||+-+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 6 388999997753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.7e-15 Score=148.29 Aligned_cols=128 Identities=23% Similarity=0.270 Sum_probs=86.8
Q ss_pred ccCcEEEccccccc-CCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeee
Q 001171 555 VGLQYLNLSDNAFT-GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633 (1133)
Q Consensus 555 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 633 (1133)
++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..++.+++|++|++++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 45566666666666666666666644 5566677777777777777765666666677777777
Q ss_pred cCCCcccCc-CchhhhccCCCcEEEeecCCCCccCC---ccccCccccccccccc
Q 001171 634 LGQNKLSGE-IPKEISKCSSLVSLTLDMNSLSGRIP---ESFSKLSNLTTLNLST 684 (1133)
Q Consensus 634 Ls~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~ 684 (1133)
|++|.+++. .+..++.+++|+.|++++|++++..+ ..++.+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777752 34667777777777777777776554 4677777777777763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-14 Score=147.88 Aligned_cols=132 Identities=17% Similarity=0.192 Sum_probs=77.7
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
..+.+++++|+++.++... .++|++|++++|++++..+..|+.+++|++|++++|++++..+..+..+++|++|+|+
T Consensus 8 ~~~~l~~~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCSSCCTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCccCCCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 3455666666666653222 2466666666666665555556666666666666666665555555666666666666
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccccccccc
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN 450 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~ 450 (1133)
+|+|++..+..+..+++|++|++++|.+++..+..|..+++|++|++++|.+.+.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 6666655555555556666666666666554444455555566666665555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.7e-13 Score=158.88 Aligned_cols=322 Identities=13% Similarity=0.114 Sum_probs=168.6
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
+|+.+.|.+ .++.|...+|.+|++|+.++|.++ ++.+-..+|.++++|+.+.+..+ +......+|..+..+......
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~ 148 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPE 148 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCc
Confidence 344444432 244555555555555555555543 33233345555555555544433 333334444444433332222
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCC
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV 475 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 475 (1133)
.. ......+|.++++|+.+.+..+. ..+....|.++.+|+.+.+..| ++.+....|.++..|+.+.+..+... +
T Consensus 149 ~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i 222 (394)
T 4fs7_A 149 GV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--L 222 (394)
T ss_dssp TC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--E
T ss_pred cc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--e
Confidence 22 11233455556666666665432 2244455666666666666554 44344455566666666655544322 1
Q ss_pred CCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCc
Q 001171 476 PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLV 555 (1133)
Q Consensus 476 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 555 (1133)
.........|+.+.+..+ ++......|..+.+|+.+.+..+... .....|..+..++.+....+.+ ....|..+.
T Consensus 223 ~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~ 297 (394)
T 4fs7_A 223 GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCS 297 (394)
T ss_dssp CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCT
T ss_pred ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccc
Confidence 222223345566655432 23234445566666666666655433 4455566666666666655432 234566666
Q ss_pred cCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecC
Q 001171 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLG 635 (1133)
Q Consensus 556 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 635 (1133)
+|+.+.+.++ ++.....+|.++.+|+.++|..+ ++......|.++.+|+.+++..| ++......|.++++|+.+++.
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 6776666544 44444556666677777776543 55444556666777777777655 543334556667777777776
Q ss_pred CCcccCcCchhhhccCCCcEE
Q 001171 636 QNKLSGEIPKEISKCSSLVSL 656 (1133)
Q Consensus 636 ~N~l~~~~p~~l~~l~~L~~L 656 (1133)
.+ ++ .+..+|.++++|+.+
T Consensus 375 ~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 375 KR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp GG-GG-GGGGGBCTTCEEEEE
T ss_pred CC-CE-EhhheecCCCCCcEE
Confidence 54 22 234456666666553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-16 Score=164.45 Aligned_cols=133 Identities=22% Similarity=0.274 Sum_probs=92.3
Q ss_pred ccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCC
Q 001171 574 TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSL 653 (1133)
Q Consensus 574 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 653 (1133)
.+..+++|++|+|++|++++ +| .+..+++|++|++++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 66666777777777777764 45 6666777777777777776 466666666777777777777774 44 57777777
Q ss_pred cEEEeecCCCCccCC-ccccCcccccccccccccccccCCcc----------ccccccCcccccccccccc
Q 001171 654 VSLTLDMNSLSGRIP-ESFSKLSNLTTLNLSTNRLSGAIPAD----------LALISSLRYLNLSRNNLEG 713 (1133)
Q Consensus 654 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~l~~L~~L~ls~N~l~~ 713 (1133)
+.|++++|++++..+ ..+..+++|+.|++++|++++.+|.. +..+++|+.|| +|+++.
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 777777777774322 45677777888888888777665543 67778888776 666653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.49 E-value=4.9e-16 Score=161.74 Aligned_cols=152 Identities=25% Similarity=0.300 Sum_probs=98.5
Q ss_pred CCCCcEeeccCCcccccCCC------CCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCC
Q 001171 530 LPSLQVVSLEENNLSGDVPE------GFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603 (1133)
Q Consensus 530 l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 603 (1133)
.+.++.++++.+.+++..|. .|..+++|++|+|++|++++ +| .+..+++|++|++++|+++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34444444444444444443 55566666666666666664 44 6666667777777777766 4565566666
Q ss_pred CccEEEecCCcccCCCccccccccccCeeecCCCcccCcCc-hhhhccCCCcEEEeecCCCCccCCcc----------cc
Q 001171 604 ALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIP-KEISKCSSLVSLTLDMNSLSGRIPES----------FS 672 (1133)
Q Consensus 604 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~----------~~ 672 (1133)
+|++|++++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|++++.+|.. +.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 77777777777764 44 56677777777777777774322 46777778888888888777665542 67
Q ss_pred Cccccccccccccccc
Q 001171 673 KLSNLTTLNLSTNRLS 688 (1133)
Q Consensus 673 ~l~~L~~L~Ls~N~l~ 688 (1133)
.+++|+.|| +|.++
T Consensus 172 ~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVD 185 (198)
T ss_dssp HCSSCSEEC--CGGGT
T ss_pred hCCCcEEEC--CcccC
Confidence 778888776 66665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=3.6e-14 Score=144.41 Aligned_cols=130 Identities=17% Similarity=0.184 Sum_probs=79.1
Q ss_pred cccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEE
Q 001171 314 VSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFD 393 (1133)
Q Consensus 314 ~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 393 (1133)
+.+|++|++++|+|+.+ |......++|++|+|++|.|++. ..|+.+++|++|+|++|++++..+..+..+++|++|+
T Consensus 18 ~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 44566666666666655 33333333777777777777754 5667777777777777777765555556777777777
Q ss_pred ccCCcccccCCC--ccCCCCCCcEEEccCCcCccccCc----cccCccccceeeccccccc
Q 001171 394 LEGNRFSGQVPA--FLGGIRGLKIVSLGRNMFSGLIPL----SFGNLSQLETLNLSENDIR 448 (1133)
Q Consensus 394 Ls~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~i~ 448 (1133)
|++|+|+. +|. .+..+++|+.|++++|.++.. |. .+..+++|++|++++|.+.
T Consensus 95 L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777753 333 555566666666666666532 33 2555555555555555543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=4.2e-14 Score=143.97 Aligned_cols=130 Identities=21% Similarity=0.228 Sum_probs=65.1
Q ss_pred cccccceeecccCccCCCCCccccCC-CCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcE
Q 001171 577 FLRSLVFLSLSHNQISGMIPAELGAC-SALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVS 655 (1133)
Q Consensus 577 ~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 655 (1133)
.+.+|++|++++|+++. +|. +..+ ++|++|++++|++++. ..+..+++|+.|+|++|.|++..+..+..+++|+.
T Consensus 17 ~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp CTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 33444444444444442 222 2222 2455555555555432 34445555555555555555333333355555555
Q ss_pred EEeecCCCCccCCc--cccCcccccccccccccccccCCcc----ccccccCccccccccccc
Q 001171 656 LTLDMNSLSGRIPE--SFSKLSNLTTLNLSTNRLSGAIPAD----LALISSLRYLNLSRNNLE 712 (1133)
Q Consensus 656 L~Ls~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~ls~N~l~ 712 (1133)
|++++|+++ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|++||+++|.+.
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 555555554 2333 4555666666666666665 34443 556666666666666554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=7.4e-13 Score=133.64 Aligned_cols=107 Identities=23% Similarity=0.292 Sum_probs=76.1
Q ss_pred ceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccc
Q 001171 167 LRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAED 246 (1133)
Q Consensus 167 l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 246 (1133)
.+.+++++|.++. +|..+. ++|++|+|++|+|++..|..|+.+++|++|+|++|++++..+..+.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 3566677777664 454442 6677777777777766666777777777777777777755555667777777777777
Q ss_pred cccCCCCCCcccCcCcccEEEcccCCccCC
Q 001171 247 NVLKGLIPGTIGRISTLQVLSLSRNELTGL 276 (1133)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 276 (1133)
|+|+++.+..|..+++|++|+|++|.++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 777777777788888888888888887644
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=131.82 Aligned_cols=105 Identities=20% Similarity=0.317 Sum_probs=69.6
Q ss_pred eEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeecccc
Q 001171 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247 (1133)
Q Consensus 168 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 247 (1133)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..+.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666664 4454443 56666666666666666666666667777777777766544445566777777777777
Q ss_pred ccCCCCCCcccCcCcccEEEcccCCccC
Q 001171 248 VLKGLIPGTIGRISTLQVLSLSRNELTG 275 (1133)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 275 (1133)
+|+++.+..|..+++|++|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 7776666667777777788888777763
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=132.02 Aligned_cols=108 Identities=19% Similarity=0.207 Sum_probs=71.5
Q ss_pred ccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEc
Q 001171 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 315 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 394 (1133)
...+++++++|+++.++. .+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|
T Consensus 9 C~~~~l~~s~n~l~~ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 85 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSL 85 (170)
T ss_dssp EETTEEECTTSCCSSCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEEeCCCCcCccCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEEC
Confidence 345667777777777633 22 266777777777777666667777777777777777777666666666777777777
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCcc
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSG 425 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 425 (1133)
++|+|++..+..|..+++|+.|+|++|.++.
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 7777766555556666666666666666653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=8.9e-13 Score=133.49 Aligned_cols=104 Identities=26% Similarity=0.279 Sum_probs=86.8
Q ss_pred hhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccC
Q 001171 148 LNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227 (1133)
Q Consensus 148 L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 227 (1133)
+++++|+++ .+|..++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|+.+++|++|+|++|+|++
T Consensus 17 l~~~~n~l~-~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~ 95 (174)
T 2r9u_A 17 VNCQNIRLA-SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS 95 (174)
T ss_dssp EECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred EEeCCCCCC-ccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce
Confidence 344444442 4556667788999999999999999999999999999999999997666667899999999999999996
Q ss_pred CCCccccCccccceeeccccccCCC
Q 001171 228 TLPSAISNCSSLVHLSAEDNVLKGL 252 (1133)
Q Consensus 228 ~~p~~l~~l~~L~~L~l~~N~l~~~ 252 (1133)
..+..+.++++|++|++++|.+...
T Consensus 96 l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 96 IPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred eCHHHhccccCCCEEEeCCCCcccc
Confidence 6666699999999999999999854
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.5e-11 Score=139.46 Aligned_cols=133 Identities=13% Similarity=0.222 Sum_probs=59.1
Q ss_pred CCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCcccccccc
Q 001171 548 PEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLS 627 (1133)
Q Consensus 548 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 627 (1133)
..+|.++..|+.+.+.++..+ .....|.++++|+.+.+. +.++......|..+.+|+.++|..+ ++......|.++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 344444455555554433221 333444445555555553 2333233344555555555555433 3322233455555
Q ss_pred ccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccc
Q 001171 628 RIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRL 687 (1133)
Q Consensus 628 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 687 (1133)
+|+.+.|..+ ++.....+|.+|++|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 5666666443 443444556666666666666654331 3445555666666655543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.6e-11 Score=138.41 Aligned_cols=322 Identities=13% Similarity=0.133 Sum_probs=140.8
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCce---eecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEE
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNF---FSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFD 393 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 393 (1133)
|+.+.+-+ .++.|...+|.+|++|+.+.+++|. ++.+-..+|..+.+|+.+.+..+ ++.+....|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 44444433 2555556666666666666666553 33333445666666666555443 3334445556666666666
Q ss_pred ccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCC
Q 001171 394 LEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGG 473 (1133)
Q Consensus 394 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~ 473 (1133)
+..+ +.......|.++..|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-. ......|..+.+++......+....
T Consensus 144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~ 219 (394)
T 4gt6_A 144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPA 219 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCB
T ss_pred ccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc-ccccchhhhccccceeccccccccc
Confidence 6533 23244445556666666666543 33344444443 4466665544322 2344455555555555554443321
Q ss_pred CCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCC
Q 001171 474 KVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSS 553 (1133)
Q Consensus 474 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 553 (1133)
..-..+........... .+.....+..+.+.+ .++.....+|.++..|+.+.+..+..+ ....+|.+
T Consensus 220 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~ 286 (394)
T 4gt6_A 220 IDNVLYEKSANGDYALI-----------RYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMN 286 (394)
T ss_dssp SSSCEEEECTTSCEEEE-----------ECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTT
T ss_pred ccceeeccccccccccc-----------ccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCccccc
Confidence 11000000000000000 000111122222211 122222334444445555544433222 33444555
Q ss_pred CccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeee
Q 001171 554 LVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633 (1133)
Q Consensus 554 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 633 (1133)
+.+|+.+.+. +.++......|.++.+|+.+.|..+ ++......|..+.+|+.+.+..+ ++......|.++++|+.++
T Consensus 287 c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 287 CPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIE 363 (394)
T ss_dssp CTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEE
T ss_pred ccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEE
Confidence 5555555553 2333333444555555555555433 33333444555555666555433 4433334455556666666
Q ss_pred cCCCcccCcCchhhhccCCCcEEEeecCCC
Q 001171 634 LGQNKLSGEIPKEISKCSSLVSLTLDMNSL 663 (1133)
Q Consensus 634 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 663 (1133)
+.+|.... ..+..+.+|+.+.+..|.+
T Consensus 364 ~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 364 YSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp ESSCHHHH---HTCBCCCCC----------
T ss_pred ECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 65554331 3445556666666655543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=4.1e-14 Score=161.73 Aligned_cols=141 Identities=18% Similarity=0.159 Sum_probs=71.8
Q ss_pred ccCcEEEcccccccCCCCccc-ccccccceeecccCccCCCCCccc-----cCCCCccEEEecCCcccCC----Cccccc
Q 001171 555 VGLQYLNLSDNAFTGDIPATY-GFLRSLVFLSLSHNQISGMIPAEL-----GACSALEVLELRSNHFTGN----IPVDIS 624 (1133)
Q Consensus 555 ~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~----~p~~l~ 624 (1133)
++|++|+|++|.+++.....+ ..+++|++|+|++|.|++.....+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555555443222222 233455666666665554333332 2345566666666666531 223334
Q ss_pred cccccCeeecCCCcccCcC----chhhhccCCCcEEEeecCCCCccCC----ccccCcccccccccccccccccCCccc
Q 001171 625 HLSRIKKLDLGQNKLSGEI----PKEISKCSSLVSLTLDMNSLSGRIP----ESFSKLSNLTTLNLSTNRLSGAIPADL 695 (1133)
Q Consensus 625 ~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~p~~l 695 (1133)
.+++|++|+|++|.|++.. +..+..+++|+.|+|++|.|++... ..+...++|++|||++|.|++.....+
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 5566666666666665432 3444555666666666666654322 223344566666666666654444333
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=8.4e-14 Score=159.15 Aligned_cols=143 Identities=16% Similarity=0.191 Sum_probs=91.0
Q ss_pred CCCcEeeccCCcccccCCCCC-CCCccCcEEEcccccccCCCCccc-----ccccccceeecccCccCCC----CCcccc
Q 001171 531 PSLQVVSLEENNLSGDVPEGF-SSLVGLQYLNLSDNAFTGDIPATY-----GFLRSLVFLSLSHNQISGM----IPAELG 600 (1133)
Q Consensus 531 ~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~l~ 600 (1133)
++|++|+|++|.++......+ ..+.+|+.|+|++|.+++.....+ ...++|++|+|++|.|++. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 355555555555543222222 234556677777776664433333 2346677788888877642 333345
Q ss_pred CCCCccEEEecCCcccCC----CccccccccccCeeecCCCcccCc----CchhhhccCCCcEEEeecCCCCccCCcccc
Q 001171 601 ACSALEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKLSGE----IPKEISKCSSLVSLTLDMNSLSGRIPESFS 672 (1133)
Q Consensus 601 ~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 672 (1133)
.+++|++|+|++|.|++. ++..+...++|+.|+|++|.|++. ++..+..+++|+.|+|++|.|++.....+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 677888888888888742 244566677889999999988754 334455678899999999999876555554
Q ss_pred C
Q 001171 673 K 673 (1133)
Q Consensus 673 ~ 673 (1133)
.
T Consensus 261 ~ 261 (372)
T 3un9_A 261 D 261 (372)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=5.3e-11 Score=135.45 Aligned_cols=103 Identities=23% Similarity=0.192 Sum_probs=80.1
Q ss_pred EEEccCC-cCCCCCCCCCCCCCcCcEEeccC-CcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccc
Q 001171 169 YLDLSSN-AFTGEIPGNFSSKSQLQLINLSY-NSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAED 246 (1133)
Q Consensus 169 ~L~Ls~N-~~~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 246 (1133)
.++++++ ++++ +|. |..+++|++|+|++ |+|++..|..|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577776 7774 666 88888888888885 888877777788888888888888888877777788888888888888
Q ss_pred cccCCCCCCcccCcCcccEEEcccCCcc
Q 001171 247 NVLKGLIPGTIGRISTLQVLSLSRNELT 274 (1133)
Q Consensus 247 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 274 (1133)
|+|+++++..|..++ |+.|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 888877666666665 888888888776
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.13 E-value=5.8e-11 Score=135.15 Aligned_cols=89 Identities=25% Similarity=0.266 Sum_probs=40.6
Q ss_pred ccCCCCccEEEecC-CcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccc
Q 001171 599 LGACSALEVLELRS-NHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNL 677 (1133)
Q Consensus 599 l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 677 (1133)
+..+++|++|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..++ |
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L 105 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L 105 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence 44444444444443 444443334444444444444444444444444444444444444444444433333333333 4
Q ss_pred ccccccccccc
Q 001171 678 TTLNLSTNRLS 688 (1133)
Q Consensus 678 ~~L~Ls~N~l~ 688 (1133)
+.|+|++|++.
T Consensus 106 ~~l~l~~N~~~ 116 (347)
T 2ifg_A 106 QELVLSGNPLH 116 (347)
T ss_dssp CEEECCSSCCC
T ss_pred eEEEeeCCCcc
Confidence 55555555444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.9e-10 Score=123.68 Aligned_cols=141 Identities=10% Similarity=0.039 Sum_probs=109.5
Q ss_pred HHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCC-cCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEE
Q 001171 834 EATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGT-IDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 834 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV 911 (1133)
.....|++...++.|+++.||++... +..+++|+..... .....+.+|+++++.+. +..+.++++++... ...|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-CceEEE
Confidence 34567988899999999999999755 6789999986421 23456899999999984 56677888887654 456999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS----------------------------------- 956 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~----------------------------------- 956 (1133)
|||++|.++.+... +......++.+++++++.||+
T Consensus 89 ~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999876521 122334678899999999998
Q ss_pred ------------------------CCceecccCccceeeCCCCceEEeccCccc
Q 001171 957 ------------------------LDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 957 ------------------------~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
.+++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.9e-08 Score=115.81 Aligned_cols=81 Identities=9% Similarity=0.084 Sum_probs=43.3
Q ss_pred CccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccE
Q 001171 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQM 391 (1133)
Q Consensus 312 ~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 391 (1133)
...++|+.+.+. ..++.|...+|.+|.+|+.++|..+ ++.+-..+|.++ +|+.+.+..+ ++.+...+|..+ +|+.
T Consensus 43 ~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~ 117 (379)
T 4h09_A 43 KDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDD 117 (379)
T ss_dssp GGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSE
T ss_pred ccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cccc
Confidence 344556666664 3466666666666666666666544 443444556555 4555555433 333333444433 5666
Q ss_pred EEccCC
Q 001171 392 FDLEGN 397 (1133)
Q Consensus 392 L~Ls~N 397 (1133)
+++..+
T Consensus 118 i~lp~~ 123 (379)
T 4h09_A 118 FEFPGA 123 (379)
T ss_dssp EECCTT
T ss_pred ccCCCc
Confidence 655543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.3e-08 Score=117.10 Aligned_cols=147 Identities=10% Similarity=0.086 Sum_probs=77.0
Q ss_pred CCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCccccccc
Q 001171 500 PGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLR 579 (1133)
Q Consensus 500 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 579 (1133)
...+....+|+.+.+..+ +.......+.++..|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++......|..+.
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 334444555555555433 22234445555555665555443 44344455556666666665433 3334444555666
Q ss_pred ccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccC
Q 001171 580 SLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCS 651 (1133)
Q Consensus 580 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 651 (1133)
+|+.+.+.++.++......|..+.+|+.++|..+ ++......|.++++|+.+.+..+ ++.....+|.+++
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 6666666666555444555666666666666543 43223344566666666666544 4433345555543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=1.6e-09 Score=117.61 Aligned_cols=133 Identities=19% Similarity=0.187 Sum_probs=95.8
Q ss_pred CCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCe--eeEEEEEeCCCCcEEEEEecc
Q 001171 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL--TVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.|.+..+.+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+..+ .+++++.... +..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEEEec
Confidence 44444444566679999998777888999997653 23568899999999965554 4577777654 4459999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD------------------------------------- 958 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 958 (1133)
+|.++. ... . ....++.++++.++.||+..
T Consensus 98 ~G~~l~--~~~--------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 98 PGQDLL--SSH--------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SSEETT--TSC--------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCcccC--cCc--------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 987763 110 1 12245666777777777543
Q ss_pred ---------------------ceecccCccceeeCCCCceEEeccCccc
Q 001171 959 ---------------------MVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 959 ---------------------ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
++|+|++|.||+++++..+.++||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.92 E-value=4.9e-10 Score=126.68 Aligned_cols=62 Identities=18% Similarity=0.136 Sum_probs=33.5
Q ss_pred CChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccc--cccccceeecc
Q 001171 523 LPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYG--FLRSLVFLSLS 587 (1133)
Q Consensus 523 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls 587 (1133)
+...+..+|+|+.|+|++|.-. .++. +. +++|+.|+|..|.++......+. .+++|++|+|+
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 3344556677777777766211 1222 22 56677777766666533333332 45666666664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.5e-11 Score=129.90 Aligned_cols=149 Identities=22% Similarity=0.275 Sum_probs=78.6
Q ss_pred CCCccceeeeCCC--ceEEEeeCC---cccCcccch-hhcccccCcEEEcccCcccCCCCc-cccCCCCcce--EeccCC
Q 001171 59 APCDWRGIVCYNN--RVRELRLPR---LQLAGRLTD-QLADLHELRKLSLHSNHLNGSIPA-SLHQCSLLRA--VYLQYN 129 (1133)
Q Consensus 59 ~~c~w~gv~c~~~--~v~~l~l~~---~~l~g~~~~-~l~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~--L~L~~n 129 (1133)
..|.|.|+.|+.+ +|+.+..++ .++.|.+.+ .+..++. .|....|.-++.++- .+...+.|+. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 3589999999853 776666655 455666643 3333333 222222222221111 1333333333 344444
Q ss_pred cccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCC--CCCCCCCCCCcCcEEeccCCcCCCCCcc
Q 001171 130 SFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTG--EIPGNFSSKSQLQLINLSYNSFSGEVPA 207 (1133)
Q Consensus 130 ~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 207 (1133)
+.. .++..+ .+...-.++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. .
T Consensus 154 ~~~-~~~~~l------------------~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~ 212 (267)
T 3rw6_A 154 RRS-CMAATL------------------RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--R 212 (267)
T ss_dssp SHH-HHHHHH------------------HHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--G
T ss_pred HHH-HHHHHH------------------HHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--h
Confidence 221 011000 0000112467777777777776 4456666777788888888877754 2
Q ss_pred cccCcc--ccceEecccccccCCCC
Q 001171 208 SVGQLQ--ELEYLWLDSNHLYGTLP 230 (1133)
Q Consensus 208 ~~~~l~--~L~~L~L~~N~l~~~~p 230 (1133)
.+..+. +|++|+|++|.+.+.+|
T Consensus 213 ~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 213 ELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp GGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhhhcccCCcceEEccCCcCccccC
Confidence 344444 77777777777766555
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.87 E-value=3.9e-10 Score=127.51 Aligned_cols=156 Identities=13% Similarity=0.139 Sum_probs=85.0
Q ss_pred CCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCcccc--CCCCccEEEecC--CcccCC-----Cc
Q 001171 550 GFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG--ACSALEVLELRS--NHFTGN-----IP 620 (1133)
Q Consensus 550 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~--~l~~L~~L~L~~--N~l~~~-----~p 620 (1133)
.+..+++|+.|+|++|.-. .++. + .+++|++|+|..|.++......+. .+++|+.|+|+. |...+. +.
T Consensus 167 ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~ 243 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred HHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence 3455677888888776311 1222 3 267788888877776644333343 577788877753 221111 11
Q ss_pred ccc--ccccccCeeecCCCcccCcCchhhh---ccCCCcEEEeecCCCCccC----CccccCcccccccccccccccccC
Q 001171 621 VDI--SHLSRIKKLDLGQNKLSGEIPKEIS---KCSSLVSLTLDMNSLSGRI----PESFSKLSNLTTLNLSTNRLSGAI 691 (1133)
Q Consensus 621 ~~l--~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~ 691 (1133)
..+ ..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.+++.. +..+..+++|+.|+|++|.++...
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 112 2356677777777766654444443 3566777777776666532 223344566666667666665443
Q ss_pred Cccccc-cccCccccccccc
Q 001171 692 PADLAL-ISSLRYLNLSRNN 710 (1133)
Q Consensus 692 p~~l~~-l~~L~~L~ls~N~ 710 (1133)
-..+.. + ...++++.|+
T Consensus 324 ~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 324 KKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHHc--CCEEEecCCc
Confidence 333332 1 2345666555
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.79 E-value=9.8e-09 Score=117.14 Aligned_cols=139 Identities=13% Similarity=0.182 Sum_probs=101.9
Q ss_pred cccccccccceeEEEEEECCceEEEEEEcc--cCC--cCHHHHHHHHHHHhhccC--CCeeeEEEEEeCCC--CcEEEEE
Q 001171 841 EENVLSRGRYGLIFKASYQDGMVLSIRRLR--DGT--IDENTFRKEAEALGKVKH--RNLTVLRGYYAGPP--DVRLLVY 912 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~--~~~~lV~ 912 (1133)
..+.++.|.++.||+....+ ..+++|+.. .+. .....+.+|+++++.+.+ ..+.+++.++.+.. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45679999999999998764 577888876 332 124578899999999974 45677888776542 2358999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc------------------------------------
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS------------------------------------ 956 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~------------------------------------ 956 (1133)
||++|..+.+.. ...++...+..++.++++.|+.||+
T Consensus 121 e~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 121 EFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp ECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999987653210 1225677788889999999999996
Q ss_pred ----------------------CCceecccCccceeeCCCCc--eEEeccCcccc
Q 001171 957 ----------------------LDMVHGDIKPQNVLFDADFE--AHLSEFGLDRL 987 (1133)
Q Consensus 957 ----------------------~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 987 (1133)
.+++|||+++.||+++.++. +.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=6.8e-09 Score=115.42 Aligned_cols=186 Identities=16% Similarity=0.147 Sum_probs=112.9
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CCCe--eeEEEEEeCCC--CcEEEEEeccC
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNL--TVLRGYYAGPP--DVRLLVYDYMP 916 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~~--~~~~lV~e~~~ 916 (1133)
.+.++.|.+..||++. ..+++|+.... .....+.+|+++++.+. +..+ .+.+.+..... ...|+|||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568899999999873 45778875432 23467899999999883 3332 23434332222 13378999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS---------------------------------------- 956 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------------------- 956 (1133)
|.++.+.... .++..++..++.++++.++.||+
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9777543221 14455556666666666666664
Q ss_pred ------------------CCceecccCccceeeCC--CCceEEeccCcccccccCCCCCCCCCCC--CCC---------C
Q 001171 957 ------------------LDMVHGDIKPQNVLFDA--DFEAHLSEFGLDRLAIATPAEASSSTTP--IGS---------L 1005 (1133)
Q Consensus 957 ------------------~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--~gt---------~ 1005 (1133)
..++|+|++|.||++++ ...+.++||+.+....+..+-....... .+. .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 23799999999999988 4567899999886432211000000000 000 0
Q ss_pred CccC-ccccCCCCCCCCCchhHHHHHHHHHHhCCCCC
Q 001171 1006 GYVS-PEAASTGQPTKEADVYSFGIVLLEILTGRKPV 1041 (1133)
Q Consensus 1006 ~y~a-PE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf 1041 (1133)
++.. |+.... .....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0111 221110 012258999999999999998876
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=3.4e-08 Score=100.67 Aligned_cols=63 Identities=19% Similarity=0.259 Sum_probs=31.4
Q ss_pred cCCCcEEEeecCCCCcc----CCccccCccccccccc--ccccccccC----CccccccccCccccccccccc
Q 001171 650 CSSLVSLTLDMNSLSGR----IPESFSKLSNLTTLNL--STNRLSGAI----PADLALISSLRYLNLSRNNLE 712 (1133)
Q Consensus 650 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~~~----p~~l~~l~~L~~L~ls~N~l~ 712 (1133)
.+.|++|+|++|.|+.. +...+...++|++|+| ++|.++... ...+...++|++|+|++|.+.
T Consensus 92 n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 92 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 34455555555555432 2233444455566666 555555432 222333456666666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=4.5e-08 Score=99.77 Aligned_cols=89 Identities=12% Similarity=0.224 Sum_probs=48.2
Q ss_pred cCCCCccEEEecCCcccCC----CccccccccccCeeecCCCcccCc----CchhhhccCCCcEEEe--ecCCCCccCC-
Q 001171 600 GACSALEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKLSGE----IPKEISKCSSLVSLTL--DMNSLSGRIP- 668 (1133)
Q Consensus 600 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L--s~N~l~~~~~- 668 (1133)
...++|++|+|++|+|... +...+...+.|++|+|++|.|++. +...+...+.|++|+| ++|.|+....
T Consensus 62 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~ 141 (185)
T 1io0_A 62 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 141 (185)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH
Confidence 3345555555555555421 222233445566666666666543 2344455566666666 6666665432
Q ss_pred ---ccccCccccccccccccccc
Q 001171 669 ---ESFSKLSNLTTLNLSTNRLS 688 (1133)
Q Consensus 669 ---~~~~~l~~L~~L~Ls~N~l~ 688 (1133)
+.+...++|++|+|++|.+.
T Consensus 142 ~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 142 EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCcCEEeccCCCCC
Confidence 23334466777777777664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.28 E-value=8.7e-08 Score=102.45 Aligned_cols=41 Identities=24% Similarity=0.414 Sum_probs=18.6
Q ss_pred cccccceeeccCceeec--ccCcccCCCCCCcEEEccCCcccc
Q 001171 337 NVTSLRVMDLSGNFFSG--NLPAAVGSLDKLEVLRVANNSLSG 377 (1133)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~n~l~~ 377 (1133)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~ 210 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 210 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC
Confidence 34455555555555543 223333444444444444444443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=5.7e-06 Score=91.59 Aligned_cols=76 Identities=12% Similarity=0.014 Sum_probs=53.8
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCC---CeeeEEEEEeCCCCcEEEEEeccCCC
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHR---NLTVLRGYYAGPPDVRLLVYDYMPNG 918 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~lV~e~~~~g 918 (1133)
.+.++.|....||+. |..+++|+-.. ......+.+|+++++.+.+. .+.+.+.+.....+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788888899998 56677787432 22346789999999999652 24455566544445568999999987
Q ss_pred CHHH
Q 001171 919 NLAT 922 (1133)
Q Consensus 919 sL~~ 922 (1133)
++.+
T Consensus 99 ~l~~ 102 (306)
T 3tdw_A 99 ILGE 102 (306)
T ss_dssp ECHH
T ss_pred ECch
Confidence 7765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=2.7e-05 Score=84.56 Aligned_cols=131 Identities=21% Similarity=0.203 Sum_probs=87.7
Q ss_pred ccccccce-eEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcEEEEEeccCCCCH
Q 001171 844 VLSRGRYG-LIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVRLLVYDYMPNGNL 920 (1133)
Q Consensus 844 ~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~lV~e~~~~gsL 920 (1133)
.+..|..| .||+...+ ++..+++|+-+.+ ....+.+|+++++.+. +--+-++++++... +..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCccc
Confidence 34556555 68998765 4567888886543 2457889999998884 22244566776655 455999999999887
Q ss_pred HHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 001171 921 ATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-------------------------------------------- 956 (1133)
Q Consensus 921 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-------------------------------------------- 956 (1133)
.+..... ......++.++++.++.||+
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 7654321 11222344444444444442
Q ss_pred --------------CCceecccCccceeeCCCCceEEeccCccc
Q 001171 957 --------------LDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 957 --------------~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127899999999999987777799999763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.76 E-value=7e-06 Score=81.17 Aligned_cols=34 Identities=9% Similarity=0.050 Sum_probs=17.0
Q ss_pred ccceeecccCccCCCCCccccCCCCccEEEecCC
Q 001171 580 SLVFLSLSHNQISGMIPAELGACSALEVLELRSN 613 (1133)
Q Consensus 580 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 613 (1133)
+|++||++++.|++..-..+..+++|+.|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555555444444444555555555554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=2.9e-05 Score=88.06 Aligned_cols=79 Identities=13% Similarity=0.042 Sum_probs=54.4
Q ss_pred cccc-ccccceeEEEEEEC-------CceEEEEEEcccCC---c-CHHHHHHHHHHHhhcc-C--CCeeeEEEEEeCCC-
Q 001171 842 ENVL-SRGRYGLIFKASYQ-------DGMVLSIRRLRDGT---I-DENTFRKEAEALGKVK-H--RNLTVLRGYYAGPP- 905 (1133)
Q Consensus 842 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~- 905 (1133)
.+.| +.|....+|+.... ++..+++|...... . ....+.+|+++++.+. + -.+.+++.++.+..
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998664 26778888865432 1 2356788999999884 3 24556777765432
Q ss_pred -CcEEEEEeccCCCCH
Q 001171 906 -DVRLLVYDYMPNGNL 920 (1133)
Q Consensus 906 -~~~~lV~e~~~~gsL 920 (1133)
...++||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 234899999987553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.76 E-value=1.1e-05 Score=79.81 Aligned_cols=84 Identities=12% Similarity=0.129 Sum_probs=50.7
Q ss_pred CCccEEEecCCcccCCCccccccccccCeeecCCCc-ccCcCchhhhcc----CCCcEEEeecCC-CCccCCccccCccc
Q 001171 603 SALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNK-LSGEIPKEISKC----SSLVSLTLDMNS-LSGRIPESFSKLSN 676 (1133)
Q Consensus 603 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~ 676 (1133)
-.|+.||++++.++...-..+..+++|+.|+|++|. |++..-..+..+ ++|++|+|++|. ++...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666665444455666666666666663 555444455543 356666666653 66555555666666
Q ss_pred cccccccccc
Q 001171 677 LTTLNLSTNR 686 (1133)
Q Consensus 677 L~~L~Ls~N~ 686 (1133)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00019 Score=82.63 Aligned_cols=74 Identities=15% Similarity=0.086 Sum_probs=48.7
Q ss_pred ccccccccceeEEEEEEC-CceEEEEEEcccCC--------cCHHHHHHHHHHHhhccC--CCee-eEEEEEeCCCCcEE
Q 001171 842 ENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT--------IDENTFRKEAEALGKVKH--RNLT-VLRGYYAGPPDVRL 909 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--pniv-~l~~~~~~~~~~~~ 909 (1133)
.+.+|.|.++.||++... +++.+++|...... ...+.+..|+++++.+.. |..+ +++.+ .. +. .+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~-~~-~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT-EM-AV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET-TT-TE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cC-Cc-cE
Confidence 467999999999999754 46789999764321 123567889999988843 3333 44443 32 23 38
Q ss_pred EEEeccCCC
Q 001171 910 LVYDYMPNG 918 (1133)
Q Consensus 910 lV~e~~~~g 918 (1133)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00021 Score=80.39 Aligned_cols=140 Identities=17% Similarity=0.233 Sum_probs=79.0
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhcc-----CCCeeeEE-E-EEeCCCCcEEEEEecc
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-----HRNLTVLR-G-YYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~-~-~~~~~~~~~~lV~e~~ 915 (1133)
+.|+.|..+.||+....+|. +++|+... +...+..|+++++.+. .|.++... | ++....+..++||||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 45666788999999877654 88898865 2345566777776663 24444310 0 0111123458999999
Q ss_pred CCCCHH--------------HHHHhhccC---C-C-----CCCChHHHH-------------------------------
Q 001171 916 PNGNLA--------------TLLQEASHQ---D-G-----HVLNWPMRH------------------------------- 941 (1133)
Q Consensus 916 ~~gsL~--------------~~l~~~~~~---~-~-----~~l~~~~~~------------------------------- 941 (1133)
+|..+. ..++..... . . ....|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 885431 122222110 0 0 011232110
Q ss_pred HHHHHHHHHHHHHh-------------cCCceecccCccceeeCCCCceEEeccCccc
Q 001171 942 LISLGLARGLSFLH-------------SLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 942 ~i~~~ia~~L~~LH-------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
.+...+..++++|+ ..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 01112334566665 3579999999999999888899999999763
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.23 E-value=6.1e-05 Score=75.94 Aligned_cols=17 Identities=18% Similarity=0.139 Sum_probs=9.2
Q ss_pred ccccccCcccccccccc
Q 001171 695 LALISSLRYLNLSRNNL 711 (1133)
Q Consensus 695 l~~l~~L~~L~ls~N~l 711 (1133)
+..-+.|+.|+++.|.+
T Consensus 153 L~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 153 IEENESLLRVGISFASM 169 (197)
T ss_dssp HHHCSSCCEEECCCCCH
T ss_pred HHhCCCcCeEeccCCCc
Confidence 34445666666665543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.19 E-value=5.9e-05 Score=76.05 Aligned_cols=64 Identities=13% Similarity=0.139 Sum_probs=28.9
Q ss_pred ccccceeecccC-ccCCC----CCccccCCCCccEEEecCCcccCC----CccccccccccCeeecCCCcccC
Q 001171 578 LRSLVFLSLSHN-QISGM----IPAELGACSALEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKLSG 641 (1133)
Q Consensus 578 l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 641 (1133)
-+.|++|+|++| +|.+. +...+..-+.|+.|+|++|+|... +...+...+.|+.|+|++|.|++
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 345555555553 54432 122233344555555555555421 22223334445555555555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00032 Score=66.12 Aligned_cols=56 Identities=18% Similarity=0.274 Sum_probs=43.0
Q ss_pred hhhhcccccC-CCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCC
Q 001171 147 VLNVAHNLLS-GKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFS 202 (1133)
Q Consensus 147 ~L~l~~N~l~-~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~ 202 (1133)
+++.+++.|+ ..+|..+|++|++|+|++|+|+...++.|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566666665 4677788888888888888888776777788888888888888665
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0034 Score=68.45 Aligned_cols=78 Identities=19% Similarity=0.292 Sum_probs=56.3
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCc-CHHHHHHHHHHHhhccCC---CeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHR---NLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~lV~ 912 (1133)
.+..-.+.+|.|..+.||+.+..+|+.|++|+-..... ....|.+|++.|+.+... -+.+.+++. . .++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~-~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D-RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T-TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C-ceEEE
Confidence 34555678999999999999999999999998764332 245789999999988422 233344432 1 27999
Q ss_pred eccCCCC
Q 001171 913 DYMPNGN 919 (1133)
Q Consensus 913 e~~~~gs 919 (1133)
||++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.003 Score=73.09 Aligned_cols=81 Identities=10% Similarity=0.100 Sum_probs=47.8
Q ss_pred hcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCC---CCCCCchhHHHHHH
Q 001171 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ---PTKEADVYSFGIVL 1031 (1133)
Q Consensus 955 H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il 1031 (1133)
+...++|+|++|.||+++.++ ++++||+.+....+.-+-...... -...|.+|+...... .....++......+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 566799999999999998876 999999987543211110000000 012456666553111 11223455777788
Q ss_pred HHHHhCC
Q 001171 1032 LEILTGR 1038 (1133)
Q Consensus 1032 ~el~tg~ 1038 (1133)
|+.+.+.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8777653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.002 Score=70.86 Aligned_cols=70 Identities=19% Similarity=0.132 Sum_probs=42.9
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCee-eEEEEEeCCCCcEEEEEecc-CCCC
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT-VLRGYYAGPPDVRLLVYDYM-PNGN 919 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~lV~e~~-~~gs 919 (1133)
.+.|+.|....+|+. ..+++|+...+........+|+++++.+....+. +++++..+ . .++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~-~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--T-GVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--T-CCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--C-CEEEEeecCCCcc
Confidence 577889999999999 4577777654322222346788888887533333 44443322 2 26899999 5533
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0041 Score=68.96 Aligned_cols=158 Identities=15% Similarity=0.149 Sum_probs=84.9
Q ss_pred ccHHHHHHHhcCCCc-----ccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCe--eeEEE
Q 001171 827 ITYVETLEATRQFDE-----ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL--TVLRG 899 (1133)
Q Consensus 827 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~ 899 (1133)
++..+......+|.+ .+.|+.|....+|+....+| .+++|..... ...+.+..|+++++.+....+ .+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344445555555655 24567788899999987666 5778887642 233567788888888742222 22221
Q ss_pred EEe-----CCCCcEEEEEeccCCCCHH--------------HHHHhhccC-CCC---CC---ChHHHHH-----------
Q 001171 900 YYA-----GPPDVRLLVYDYMPNGNLA--------------TLLQEASHQ-DGH---VL---NWPMRHL----------- 942 (1133)
Q Consensus 900 ~~~-----~~~~~~~lV~e~~~~gsL~--------------~~l~~~~~~-~~~---~l---~~~~~~~----------- 942 (1133)
... ...+..+++|+|++|..+. ..++..... ... .. .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 100 0113348999999875421 112221110 000 00 1211000
Q ss_pred -HHHHHHHHHHHHh-------cCCceecccCccceeeCCCCceEEeccCccc
Q 001171 943 -ISLGLARGLSFLH-------SLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 943 -i~~~ia~~L~~LH-------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
+...+.+.+++++ ..+++|+|+.+.||+++++..+.++||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0111334455554 2369999999999999887666899998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0043 Score=68.99 Aligned_cols=140 Identities=10% Similarity=0.145 Sum_probs=81.1
Q ss_pred cccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCC--eeeEEEEEeC-----CCCcEEEEEecc
Q 001171 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN--LTVLRGYYAG-----PPDVRLLVYDYM 915 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~-----~~~~~~lV~e~~ 915 (1133)
..++ |....||+....+|+.+++|...........+..|.++++.+.... +.+++.. .. ..+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEec
Confidence 3466 7888999987777878999998754445677888999988884222 3333332 11 123447899999
Q ss_pred CCCCH-----HH------H---HHhhccC-C---CCCCChHHH----------------------HHHHHHHHHHHHHH-
Q 001171 916 PNGNL-----AT------L---LQEASHQ-D---GHVLNWPMR----------------------HLISLGLARGLSFL- 954 (1133)
Q Consensus 916 ~~gsL-----~~------~---l~~~~~~-~---~~~l~~~~~----------------------~~i~~~ia~~L~~L- 954 (1133)
+|..+ .. . ++..... . ....++... ...+..++..++..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 87432 11 1 2221110 0 011121110 01111122222222
Q ss_pred ---hcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 955 ---HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 955 ---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
+...++|+|+++.||+++ + .+.++||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234589999999999999 4 88999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0064 Score=66.71 Aligned_cols=75 Identities=15% Similarity=0.189 Sum_probs=56.7
Q ss_pred ccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhcc---CCCeeeEEEEEeCCCCcEEEEEeccCCC
Q 001171 842 ENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVK---HRNLTVLRGYYAGPPDVRLLVYDYMPNG 918 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~lV~e~~~~g 918 (1133)
.+.|+.|....+|+.... +..+++|+.... ....+.+|++.|+.+. ...+.+++++.... +..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEeccCC
Confidence 466899999999999764 667888887543 3567899999999884 24566777776654 4569999999987
Q ss_pred CH
Q 001171 919 NL 920 (1133)
Q Consensus 919 sL 920 (1133)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0047 Score=68.87 Aligned_cols=140 Identities=9% Similarity=0.078 Sum_probs=72.0
Q ss_pred ccccccccee-EEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCC--eeeEEEEEeCCCCcEEEEEeccCCCC
Q 001171 843 NVLSRGRYGL-IFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN--LTVLRGYYAGPPDVRLLVYDYMPNGN 919 (1133)
Q Consensus 843 ~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~lV~e~~~~gs 919 (1133)
+.|+.|.... +|+....+|..+++|...... ...+..|+++++.+.... +.+++.+... .. ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g-~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RG-LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TT-EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCC--CC-EEEEeeCCCcc
Confidence 3455554444 667765446667777654322 134566788877774222 3345554322 22 78999997767
Q ss_pred HHHHHHhhc------------------cCC-C--CCCChHHHH---------H-----------HHHHHHHHHHHH----
Q 001171 920 LATLLQEAS------------------HQD-G--HVLNWPMRH---------L-----------ISLGLARGLSFL---- 954 (1133)
Q Consensus 920 L~~~l~~~~------------------~~~-~--~~l~~~~~~---------~-----------i~~~ia~~L~~L---- 954 (1133)
+.+++.... ... . ..++..... . ....+...++.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 665443211 000 0 011111000 0 001111222333
Q ss_pred --hcCCceecccCccceeeCCC----CceEEeccCcccc
Q 001171 955 --HSLDMVHGDIKPQNVLFDAD----FEAHLSEFGLDRL 987 (1133)
Q Consensus 955 --H~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~ 987 (1133)
+...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23469999999999999875 6789999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0076 Score=68.01 Aligned_cols=139 Identities=17% Similarity=0.197 Sum_probs=78.8
Q ss_pred cccccccceeEEEEEEC--------CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCe-eeEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL-TVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~lV~e 913 (1133)
+.+..|-...+|+.... ++..+++|+..........+.+|.++++.+....+ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE-----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----ccEEE
Confidence 45767888899999764 24678888864333345667799999988853233 355555532 38999
Q ss_pred ccCCCCHH--------------HHH---HhhccCCCCCCC--hHHHHHHHHHHH-------------------HHHHHHh
Q 001171 914 YMPNGNLA--------------TLL---QEASHQDGHVLN--WPMRHLISLGLA-------------------RGLSFLH 955 (1133)
Q Consensus 914 ~~~~gsL~--------------~~l---~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~L~~LH 955 (1133)
|++|.++. +.+ +.....-..... |.+..++..++. ..++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99874432 111 111111111122 233333333321 1223332
Q ss_pred ----c----CCceecccCccceeeCCC----CceEEeccCccc
Q 001171 956 ----S----LDMVHGDIKPQNVLFDAD----FEAHLSEFGLDR 986 (1133)
Q Consensus 956 ----~----~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~ 986 (1133)
. ..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 248999999999999876 689999999874
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0042 Score=58.41 Aligned_cols=56 Identities=23% Similarity=0.312 Sum_probs=38.2
Q ss_pred eEeccccccc-CCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCcc
Q 001171 217 YLWLDSNHLY-GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELT 274 (1133)
Q Consensus 217 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 274 (1133)
.++.+++.++ ..+|..+. ++|++|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5556666654 24554433 35777777777777777777788888888888888764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.25 E-value=0.011 Score=68.11 Aligned_cols=70 Identities=17% Similarity=0.286 Sum_probs=47.9
Q ss_pred ccccccccceeEEEEEECC--------ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCe-eeEEEEEeCCCCcEEEEE
Q 001171 842 ENVLSRGRYGLIFKASYQD--------GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL-TVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~lV~ 912 (1133)
.+.|+.|-...||++...+ +..+++|+.... ...+.+.+|+.+++.+...++ .++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~-----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG-----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----CEEE
Confidence 3567888889999998753 467888887432 122556689999998853333 455665432 4899
Q ss_pred eccCC
Q 001171 913 DYMPN 917 (1133)
Q Consensus 913 e~~~~ 917 (1133)
||++|
T Consensus 152 e~l~G 156 (429)
T 1nw1_A 152 EYIPS 156 (429)
T ss_dssp CCCCE
T ss_pred EEeCC
Confidence 99976
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0064 Score=68.89 Aligned_cols=72 Identities=8% Similarity=0.069 Sum_probs=43.4
Q ss_pred cccccccceeEEEEEECCc---------eEEEEEEcccCCcCHHHHHHHHHHHhhccCCCe-eeEEEEEeCCCCcEEEEE
Q 001171 843 NVLSRGRYGLIFKASYQDG---------MVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL-TVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g---------~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~lV~ 912 (1133)
+.++.|....+|+....++ ..+++|+.............|.++++.+....+ .++++.. . . ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-~---~-~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-N---G-GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-T---T-EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-C---C-cEEE
Confidence 4577888889999977542 678888765432211234678888888853333 3555443 1 1 6899
Q ss_pred eccCCCC
Q 001171 913 DYMPNGN 919 (1133)
Q Consensus 913 e~~~~gs 919 (1133)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.77 E-value=0.045 Score=63.40 Aligned_cols=71 Identities=11% Similarity=0.139 Sum_probs=46.2
Q ss_pred cccccccceeEEEEEECC-ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCee-eEEEEEeCCCCcEEEEEeccCCC
Q 001171 843 NVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT-VLRGYYAGPPDVRLLVYDYMPNG 918 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~lV~e~~~~g 918 (1133)
+.|+.|-...+|++...+ +..+++|+........-...+|..+++.+...+++ ++++++. + ..||||++|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~---~--G~v~e~I~G~ 186 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT---N--GRIEEFMDGY 186 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET---T--EEEEECCCSE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC---C--eEEEEeeCCc
Confidence 568888889999998865 57788887643321111226899999999655553 5666552 2 3599999873
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.038 Score=63.15 Aligned_cols=72 Identities=8% Similarity=0.055 Sum_probs=46.8
Q ss_pred cccccccceeEEEEEECC--------ceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCe-eeEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASYQD--------GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL-TVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~lV~e 913 (1133)
+.+..|-...+|+....+ +..+++++........-...+|.++++.+....+ .++++.+. -+.|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~-----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP-----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET-----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC-----CCEEEE
Confidence 457778888999998763 5778888865433222234679999988853233 34444332 178999
Q ss_pred ccCCCC
Q 001171 914 YMPNGN 919 (1133)
Q Consensus 914 ~~~~gs 919 (1133)
|++|..
T Consensus 151 fI~G~~ 156 (424)
T 3mes_A 151 FIDGEP 156 (424)
T ss_dssp CCCSEE
T ss_pred EeCCcc
Confidence 998854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.69 E-value=0.093 Score=58.35 Aligned_cols=31 Identities=23% Similarity=0.305 Sum_probs=27.3
Q ss_pred CCceecccCccceeeCCCCceEEeccCcccc
Q 001171 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 957 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.+++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.66 E-value=1 Score=45.42 Aligned_cols=98 Identities=15% Similarity=0.087 Sum_probs=64.7
Q ss_pred CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHH-hcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 918 GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL-HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 918 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
-+|.++|+..+ ..++++++|.++.|.+.+|.-. +++.-..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 47999998764 4599999999999999998776 211112333457899999999888764 1110
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t 1036 (1133)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0112466888763 344677889999999999886
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.45 E-value=1.2 Score=50.63 Aligned_cols=29 Identities=21% Similarity=0.381 Sum_probs=24.6
Q ss_pred ceecccCccceee------CCCCceEEeccCcccc
Q 001171 959 MVHGDIKPQNVLF------DADFEAHLSEFGLDRL 987 (1133)
Q Consensus 959 ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~~ 987 (1133)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4566789999998753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1133 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-29 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-29 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-28 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-27 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-19 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-14 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-09 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-52
Identities = 58/279 (20%), Positives = 113/279 (40%), Gaps = 23/279 (8%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDE-NTFRKEAEALGKVKHRNLTV 896
Q + G +G ++K + + + + + T + F+ E L K +H N+ +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
GY P +V + +L L H I+ A+G+ +LH+
Sbjct: 69 FMGYSTAPQ--LAIVTQWCEGSSLYHHL----HIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
++H D+K N+ D + +FGL + + + + GS+ +++PE
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 1017 QP---TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
+ ++DVY+FGIVL E++TG+ P + + + + RG L P L ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY---SNINNRDQIIFMVGRG----YLSPDLSKV 234
Query: 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + L+ C +RP I+ +E
Sbjct: 235 RSNCPKAMKRLM-----AECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-52
Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 23/275 (8%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
L G++G ++ Y ++++ L+ G++ + F EA + +++H+ L L
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
P ++ +YM NG+L L+ G L ++ +A G++F+
Sbjct: 74 YAVVTQEP--IYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
+ +H D++ N+L +++FGL RL E ++ + + +PEA + G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 1018 PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077
T ++DV+SFGI+L EI+T + V ++ R + L +L
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL---- 242
Query: 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
LC P DRP+ + +LE
Sbjct: 243 ------------MRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-50
Identities = 70/295 (23%), Positives = 133/295 (45%), Gaps = 31/295 (10%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
E L +G +G ++ ++ ++I+ L+ GT+ F +EA+ + K++H L L
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
+ P +V +YM G+L L + G L P ++ +A G++++ +
Sbjct: 78 YAVVSEEP--IYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
+ VH D++ N+L + +++FGL RL E ++ + + +PEAA G+
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 1018 PTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
T ++DV+SFGI+L E+ T GR P + +++ V++ + + PE
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------MPCPPE 238
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDMPSSADPTSLPS 1131
E + C +P +RP+ + LE D +S +P P
Sbjct: 239 CPES-----LHDLMCQCWRKEPEERPTFEYLQAFLE------DYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 55/275 (20%), Positives = 113/275 (41%), Gaps = 23/275 (8%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
+ + G++GL+ + + ++I+ +R+G + E F +EAE + K+ H L L
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 898 RGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSL 957
G + LV+++M +G L+ + + L + G+++L
Sbjct: 66 YGVCLEQAPI-CLVFEFMEHGCLSDY----LRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 958 DMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQ 1017
++H D+ +N L + +S+FG+ R + +SST + + SPE S +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 1018 PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPES 1077
+ ++DV+SFG+++ E+ + K + V R L + ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI---- 234
Query: 1078 SEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
C P DRP+ + ++ L
Sbjct: 235 ------------MNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 49/277 (17%), Positives = 111/277 (40%), Gaps = 25/277 (9%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTV 896
+ L G++G++ ++ ++I+ +++G++ E+ F +EA+ + + H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L G + ++ +YM NG L L + H + + + +L S
Sbjct: 64 LYGVCTKQRPI-FIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+H D+ +N L + +S+FGL R E +SS + + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 1017 QPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
+ + ++D+++FG+++ EI + G+ P + + + + + L R L + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTI-- 233
Query: 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
C +RP+ ++ +
Sbjct: 234 --------------MYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 29/280 (10%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTV 896
++ + +G +G + Y G ++++ +++ + F EA + +++H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQ 64
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L G +V +YM G+L L+ + VL SL + + +L
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+ VH D+ +NVL D A +S+FGL + A +S+ T + + +PEA
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREK 175
Query: 1017 QPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075
+ + ++DV+SFGI+L EI + GR P +D+V V+K + + P + E+
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYEV-- 232
Query: 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
C D RPS + LE +
Sbjct: 233 --------------MKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-47
Identities = 55/279 (19%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 841 EENVLSRGRYGLIFKASYQD---GMVLSIRRLRDGTIDENT---FRKEAEALGKVKHRNL 894
E+ L G +G + K YQ ++++ L++ D EA + ++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY- 69
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
++R + +LV + G L LQ+ H + + ++ G+ +L
Sbjct: 70 -IVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYL 123
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
+ VH D+ +NVL A +S+FGL + A + T + + +PE +
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 1015 TGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
+ + ++DV+SFG+++ E + G+KP + ++ ++K + G +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-------- 235
Query: 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
E + + LC D +RP A + L
Sbjct: 236 ---PREMYDLM------NLCWTYDVENRPGFAAVELRLR 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 5e-47
Identities = 65/314 (20%), Positives = 133/314 (42%), Gaps = 40/314 (12%)
Query: 828 TYVETLEATRQFDEE---------NVLSRGRYGLIFKASY----QDGMVLSIRRLRDGTI 874
T+ + EA R+F +E V+ G +G + + + ++I+ L+ G
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 875 DENT--FRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDG 932
++ F EA +G+ H N+ L G +++ ++M NG+L + Q+
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSF----LRQND 122
Query: 933 HVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI--A 990
+ G+A G+ +L ++ VH D+ +N+L +++ +S+FGL R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDI 1049
+ +S+ + + +PEA + T +DV+S+GIV+ E+++ G +P ++D+
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 1050 VKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109
+ +++ + L P ++ L C D RP IV
Sbjct: 243 INAIEQDYR--------------LPPPMDCPSAL---HQLMLDCWQKDRNHRPKFGQIVN 285
Query: 1110 MLEGCRVGPDMPSS 1123
L+ P+ +
Sbjct: 286 TLDKMIRNPNSLKA 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-47
Identities = 63/297 (21%), Positives = 133/297 (44%), Gaps = 31/297 (10%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDG-----MVLSIRRLRDGTIDEN--TFRKEAEALGKVK 890
+ V+ G +G ++K + + ++I+ L+ G ++ F EA +G+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 891 HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
H N+ L G + + +++ +YM NG L + + + + G+A G
Sbjct: 68 HHNIIRLEGVISKYKPM-MIITEYMENG----ALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
+ +L +++ VH D+ +N+L +++ +S+FGL R+ P +++ + + +P
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMF-TQDEDIVKWVKKQLQRGQISELLEPG 1069
EA S + T +DV+SFGIV+ E++T + + + +++K + +
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----------- 231
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD-MPSSAD 1125
L + ++ + C + RP ADIV +L+ PD + + AD
Sbjct: 232 -LPTPMDCPSA-----IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-46
Identities = 53/280 (18%), Positives = 113/280 (40%), Gaps = 29/280 (10%)
Query: 841 EENVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTIDENT--FRKEAEALGKVKHRNLT 895
+ L G +G + + Y+ + ++I+ L+ GT +T +EA+ + ++ + +
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L G +LV + G L L + + ++ G+ +L
Sbjct: 73 RLIGVCQAEA--LMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
+ VH D+ +NVL A +S+FGL + A + ++ + L + +PE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 1016 GQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074
+ + +DV+S+G+ + E L+ G+KP + +++ ++++ +R + P L L
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYAL- 244
Query: 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
C DRP + + C
Sbjct: 245 ---------------MSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 1e-45
Identities = 60/276 (21%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 838 QFDEENVLSRGRYGLIFKASYQD-GMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTV 896
++ L G+YG +++ ++ + ++++ L++ T++ F KEA + ++KH NL
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L G P + + ++M GNL L+E + Q+ ++ + ++ ++ + +L
Sbjct: 78 LLGVCTREPPFYI-ITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK 133
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+ +H D+ +N L + +++FGL RL T ++ + + +PE+ +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
+ + ++DV++FG++L EI T D V + ++ R + E + EL
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL--- 248
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
C +P DRPS A+I E
Sbjct: 249 -------------MRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 4e-45
Identities = 51/304 (16%), Positives = 102/304 (33%), Gaps = 35/304 (11%)
Query: 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTV 896
R + + +GR+G +++ + G ++++ E ++H N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 897 LRGYY---AGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
G LV DY +G+L L + + ++L A GL+
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAH 115
Query: 954 LHS--------LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI-ATPAEASSSTTPIGS 1004
LH + H D+K +N+L + +++ GL AT + +G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 1005 LGYVSPEAAST------GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDI-------VK 1051
Y++PE + K AD+Y+ G+V EI +D +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 1052 WVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFML 1111
+++++ + L P + K+ C + R + I L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM---AKIMRECWYANGAARLTALRIKKTL 292
Query: 1112 EGCR 1115
Sbjct: 293 SQLS 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-45
Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 27/281 (9%)
Query: 842 ENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLT 895
V+ RG +G ++ + D + +++ L T + + F E + H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L G L+V YM +G+L + H L +A+G+ FL
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA-SSSTTPIGSLGYVSPEAAS 1014
S VH D+ +N + D F +++FGL R ++ + T + +++ E+
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074
T + T ++DV+SFG++L E++T P D + LQ G L
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ----------GRRLLQ 255
Query: 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
PE +V L C P RPS +++V +
Sbjct: 256 PEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 5e-45
Identities = 65/310 (20%), Positives = 125/310 (40%), Gaps = 46/310 (14%)
Query: 831 ETLEATR-QFDEENVLSRGRYGLIFKA------SYQDGMVLSIRRLRDGTID--ENTFRK 881
+LE R + + G +G +F+A Y+ +++++ L++ + F++
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 882 EAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQ----------- 930
EA + + + N+ L G A L+++YM G+L L+ S
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 931 --------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982
L+ + I+ +A G+++L VH D+ +N L + +++F
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM 1042
GL R I + + + ++ PE+ + T E+DV+++G+VL EI +
Sbjct: 185 GLSRN-IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 1043 FTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP 1102
+ + V ++ G I E LEL + LC + P DRP
Sbjct: 244 YGMAHE---EVIYYVRDGNILACPENCPLEL-------------YNLMRLCWSKLPADRP 287
Query: 1103 SMADIVFMLE 1112
S I +L+
Sbjct: 288 SFCSIHRILQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-43
Identities = 56/300 (18%), Positives = 123/300 (41%), Gaps = 43/300 (14%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR--DGTIDENTFRKEAEALGKVKHRNLT 895
F++ + L G G++FK S+ G+V++ + + N +E + L + +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G + ++ + ++M G+L +L++A + + +S+ + +GL++L
Sbjct: 68 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLR 121
Query: 956 S-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
++H D+KP N+L ++ E L +FG+ + S + + +G+ Y+SPE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074
+ ++D++S G+ L+E+ GR P+ D ++ + G +E
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI-PPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 1075 PESSEWEEFLLGVKVGLL---------------------------CTAPDPLDRPSMADI 1107
P SS + + + L C +P +R + +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-43
Identities = 60/301 (19%), Positives = 113/301 (37%), Gaps = 43/301 (14%)
Query: 838 QFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKV 889
+ L G +G + +A+ M ++++ L+ + E + L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 890 K-HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQE-------------ASHQDGHVL 935
H N+ L G L++ +Y G+L L+ D L
Sbjct: 84 GNHMNIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
+ S +A+G++FL S + +H D+ +N+L + +FGL R I +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD-IKNDSNY 201
Query: 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
+ +++PE+ T E+DV+S+GI L E+ + D
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------- 254
Query: 1056 QLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113
+ ++++ G L PE +E + + C DPL RP+ IV ++E
Sbjct: 255 ----SKFYKMIKEGFRMLSPEHAPAEMYDIM------KTCWDADPLKRPTFKQIVQLIEK 304
Query: 1114 C 1114
Sbjct: 305 Q 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-43
Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 31/280 (11%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRNL 894
++ + G YG K DG +L + L G++ E E L ++KH N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 895 TVLRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ L +V +Y G+LA+++ + + + + L+ + L L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKE 124
Query: 954 LHSLD-----MVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
H ++H D+KP NV D L +FGL A + S + +G+ Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL---ARILNHDTSFAKAFVGTPYYM 181
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068
SPE + +++D++S G +L E+ P +++ +++ + +I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRY-- 238
Query: 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
S E E + RPS+ +I+
Sbjct: 239 --------SDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 56/291 (19%), Positives = 123/291 (42%), Gaps = 33/291 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKV 889
+ L +G +G++++ + ++I+ + + + F EA + +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 890 KHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQ-----EASHQDGHVLNWPMRHLIS 944
++ L G + L++ + M G+L + L+ A++ + ++
Sbjct: 81 NCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
+A G+++L++ VH D+ +N + DF + +FG+ R I +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLP 198
Query: 1005 LGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK-PVMFTQDEDIVKWVKKQLQRGQIS 1063
+ ++SPE+ G T +DV+SFG+VL EI T + P +E ++++V
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---------- 248
Query: 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
+E GLL+ + ++ +C +P RPS +I+ ++
Sbjct: 249 --MEGGLLDKPDNCPDM-----LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-42
Identities = 59/295 (20%), Positives = 114/295 (38%), Gaps = 38/295 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDG---MVLSIRRLRDGTIDENT--FRKEAEALGKV-KH 891
++V+ G +G + KA + M +I+R+++ ++ F E E L K+ H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 892 RNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQE-----------ASHQDGHVLNWPMR 940
N+ L G L +Y P+GNL L++ ++ L+
Sbjct: 71 PNIINLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 941 HLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTT 1000
+ +ARG+ +L +H D+ +N+L ++ A +++FGL R T
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTM 185
Query: 1001 PIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG 1060
+ +++ E+ + T +DV+S+G++L EI++ + Q R
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 1061 QISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115
+ + + +L C P +RPS A I+ L
Sbjct: 246 EKPLNCDDEVYDL----------------MRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 57/282 (20%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHR 892
R + + RG + ++K + + ++ L+D + ++ F++EAE L ++H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 893 NLTVLRGYYAGPPDVR---LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
N+ + + +LV + M +G L T L+ V+ + + +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILK 123
Query: 950 GLSFLHSLD--MVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLG 1006
GL FLH+ ++H D+K N+ + + GL AT AS + IG+
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL-----ATLKRASFAKAVIGTPE 178
Query: 1007 YVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
+++PE + + DVY+FG+ +LE+ T P +++ ++ + ++ ++ +
Sbjct: 179 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRR------VTSGV 229
Query: 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
+P + E +E + G C + +R S+ D++
Sbjct: 230 KPASFD-KVAIPEVKEIIEG------CIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 5e-42
Identities = 61/275 (22%), Positives = 118/275 (42%), Gaps = 34/275 (12%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRN 893
F+ L +G++G ++ A Q +L+++ L ++ E+ R+E E ++H N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ L GY+ V L+ +Y P G + LQ+ S + LA LS+
Sbjct: 68 ILRLYGYFHDATRV-YLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSY 121
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
HS ++H DIKP+N+L + E +++FG + A +S TT G+L Y+ PE
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTTLCGTLDYLPPEMI 176
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
++ D++S G++ E L G+ P ++ K + + + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFV------- 227
Query: 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
+ + + +P RP + +++
Sbjct: 228 ---TEGARDLISR------LLKHNPSQRPMLREVL 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 9e-42
Identities = 64/318 (20%), Positives = 119/318 (37%), Gaps = 46/318 (14%)
Query: 825 NKITYVETLEATR-QFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGTI--D 875
+ Y E R + VL G +G + A+ + ++++ L++ +
Sbjct: 24 REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83
Query: 876 ENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQE-------- 926
E + + ++ H N+ L G + L+++Y G+L L+
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSED 142
Query: 927 ----------ASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFE 976
+D +VL + + +A+G+ FL VH D+ +NVL
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 202
Query: 977 AHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT 1036
+ +FGL R I + + + +++PE+ G T ++DV+S+GI+L EI +
Sbjct: 203 VKICDFGLARD-IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 1037 GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAP 1096
+ K +Q G ++D EE + C A
Sbjct: 262 LGVNPY--PGIPVDANFYKLIQNG----------FKMDQPFYATEEI---YIIMQSCWAF 306
Query: 1097 DPLDRPSMADIVFMLEGC 1114
D RPS ++ L GC
Sbjct: 307 DSRKRPSFPNLTSFL-GC 323
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 53/285 (18%), Positives = 107/285 (37%), Gaps = 31/285 (10%)
Query: 837 RQFDEENVLSRGRYGLIFKASY----QDGMVLSIRRLRDGTIDE----NTFRKEAEALGK 888
+ L G +G++ + + + ++++ L+ + + + F +E A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 889 VKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
+ HRNL L G PP +V + P G+L + + ++ +A
Sbjct: 68 LDHRNLIRLYGVVLTPP--MKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
G+ +L S +H D+ +N+L + +FGL R +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 1009 SPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067
+PE+ T + +D + FG+ L E+ T G++P + I+ + K+ +R E
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ + + C A P DRP+ + L
Sbjct: 242 QDIYNV----------------MVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 55/285 (19%), Positives = 113/285 (39%), Gaps = 34/285 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASY----QDGMVLSIRRLRDGTIDE--NTFRKEAEALGKVKH 891
+ + + G++G + + Y + ++I+ ++ T D F +EA + + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 892 RNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGL 951
++ L G + ++ + G L + + L+ L + L+ L
Sbjct: 68 PHIVKLIGVI--TENPVWIIMELCTLGELRSF----LQVRKYSLDLASLILYAYQLSTAL 121
Query: 952 SFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE 1011
++L S VH DI +NVL ++ L +FGL R + ++ + +++PE
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPE 179
Query: 1012 AASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
+ + + T +DV+ FG+ + EIL G KP ++ D++ ++ +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------ 227
Query: 1071 LELDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
L + P + C A DP RP ++ L
Sbjct: 228 LPMPPNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 5e-41
Identities = 47/276 (17%), Positives = 110/276 (39%), Gaps = 30/276 (10%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDE-NTFRKEAEALGKVKHRNLTV 896
++ L G +G ++KA + ++ + + + + +E + E + L H N+
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L + ++ ++ ++ G + ++ + L ++ L++LH
Sbjct: 74 LLDAFYYENNL-WILIEFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
++H D+K N+LF D + L++FG ++ + IG+ +++PE
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 1017 QP-----TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ADV+S GI L+E+ P ++ ++ + + L +P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL----LKIAKSEPPTLAQP--- 238
Query: 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
SS +++FL C + R + + +
Sbjct: 239 --SRWSSNFKDFLKK------CLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-41
Identities = 55/273 (20%), Positives = 96/273 (35%), Gaps = 26/273 (9%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN--TFRKEAEALGKVKHRNLT 895
+D L G YG + A ++++ + + +KE + H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
G+ +++ L +Y G L ++ + P L G+ +LH
Sbjct: 67 KFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 120
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
+ + H DIKP+N+L D +S+FGL + G+L YV+PE
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 1016 GQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074
+ + DV+S GIVL +L G + Q D + ++
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSDWKEKKTYLN-------PWK 230
Query: 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S L +P R ++ DI
Sbjct: 231 KIDSAPLALLHK------ILVENPSARITIPDI 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 7e-41
Identities = 59/297 (19%), Positives = 111/297 (37%), Gaps = 36/297 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTIDEN--TFRKEAEALGKV 889
+ L RG +G + +A ++++ L++G E + L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 890 KHRNLTV-LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQD-----------GHVLNW 937
H V L G P +++ ++ GNL+T L+ ++ L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 938 PMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASS 997
S +A+G+ FL S +H D+ +N+L + +FGL R P +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVR 192
Query: 998 STTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL 1057
L +++PE T ++DV+SFG++L EI + I + ++L
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRRL 250
Query: 1058 QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
+ G D + E + + L C +P RP+ +++V L
Sbjct: 251 KEGTRMRA-------PDYTTPEMYQTM------LDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 8e-41
Identities = 58/281 (20%), Positives = 108/281 (38%), Gaps = 37/281 (13%)
Query: 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN----TFRKEAEALGKVK 890
+ F + + G +G ++ A ++ V++I+++ N KE L K++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 891 HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
H N RG Y LV +Y L L ++ G +G
Sbjct: 74 HPNTIQYRGCYLREHTA-WLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQG 127
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
L++LHS +M+H D+K N+L L +FG + + + + +G+ +++P
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWMAP 180
Query: 1011 E---AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067
E A GQ + DV+S GI +E+ + P+ + + + E
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----------E 230
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
L+ S + F+ C P DRP+ ++
Sbjct: 231 SPALQSGHWSEYFRNFVDS------CLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-40
Identities = 56/307 (18%), Positives = 117/307 (38%), Gaps = 35/307 (11%)
Query: 838 QFDEENVLSRGRYGLIFKASYQD-----GMVLSIRRLRDGTIDENT--FRKEAEALGKVK 890
+F + VL G +G ++K + + ++I+ LR+ T + EA + V
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 891 HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
+ + V R L+ MP G L + + + + +A+G
Sbjct: 70 NPH--VCRLLGICLTSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
+++L +VH D+ +NVL +++FGL +L + + + + +++
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMAL 182
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
E+ T ++DV+S+G+ + E++T G KP +I ++K +R +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTID 241
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD---MPSSADP 1126
+ + + C D RP +++ P + +
Sbjct: 242 VYMI----------------MVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
Query: 1127 TSLPSPM 1133
LPSP
Sbjct: 286 MHLPSPT 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-39
Identities = 54/282 (19%), Positives = 112/282 (39%), Gaps = 27/282 (9%)
Query: 828 TYVETLEATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR-DGTIDENTFRKEAEA 885
+ V + +++ + +G G ++ A G ++IR++ + E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 886 LGKVKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL 945
+ + K+ N+ Y ++ +V +Y+ G+L ++ E + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETCM------DEGQIAAVCR 123
Query: 946 GLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
+ L FLHS ++H DIK N+L D L++FG E S +T +G+
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTP 180
Query: 1006 GYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISEL 1065
+++PE + + D++S GI+ +E++ G P +E+ ++ + G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQ 237
Query: 1066 LEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
L S+ + +FL C D R S ++
Sbjct: 238 NPEKL------SAIFRDFLNR------CLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (365), Expect = 3e-38
Identities = 54/302 (17%), Positives = 118/302 (39%), Gaps = 37/302 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRNLT 895
+D L G +G++ + + G + + + D+ T RKE + + ++H L
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L + ++ +++Y++M G L + + + ++ + +GL +H
Sbjct: 87 NLHDAFEDDNEM-VMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 956 SLDMVHGDIKPQNVLFDADFEAH--LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
+ VH D+KP+N++F L +FGL S G+ + +PE A
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVA 197
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
D++S G++ +L+G P D++ ++ VK + + G+
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--CDWNMDDSAFSGI--- 252
Query: 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV---FMLEGCRVGPDMPSSADPTSLP 1130
S + ++F+ DP R ++ + ++ G + + +P
Sbjct: 253 ---SEDGKDFIRK------LLLADPNTRMTIHQALEHPWLTPG-------NAPGRDSQIP 296
Query: 1131 SP 1132
S
Sbjct: 297 SS 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 60/299 (20%), Positives = 108/299 (36%), Gaps = 40/299 (13%)
Query: 838 QFDEENVLSRGRYGLIFKASY--------QDGMVLSIRRLRDGTIDENT--FRKEAEALG 887
+ L G +G + A ++++ L+ +++ E E +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 888 KV-KHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQ-----------EASHQDGHVL 935
+ KH+N+ L G + ++ +Y GNL LQ SH L
Sbjct: 74 MIGKHKNIINLLGACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
+ + +ARG+ +L S +H D+ +NVL D +++FGL R I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-IHHIDYY 191
Query: 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKK 1055
+T + +++PEA T ++DV+SFG++L EI T + + + K
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 1056 QLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114
+ R L + C P RP+ +V L+
Sbjct: 252 EGHRMDKPSNCTNELYMM----------------MRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 43/267 (16%), Positives = 101/267 (37%), Gaps = 26/267 (9%)
Query: 844 VLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYA 902
L RG +G++ + + ++ D+ +KE L +HRN+ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 903 GPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHG 962
++ +++++++ ++ + + LN + L FLHS ++ H
Sbjct: 72 SMEEL-VMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 963 DIKPQNVLFDADFEAH--LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTK 1020
DI+P+N+++ + + EFG R + + Y +PE +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 1021 EADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPESSEW 1080
D++S G ++ +L+G P + ++ I++ + E + S E
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--AEYTFDEEAFKEI------SIEA 234
Query: 1081 EEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+F+ + R + ++
Sbjct: 235 MDFVDR------LLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (343), Expect = 4e-36
Identities = 55/279 (19%), Positives = 107/279 (38%), Gaps = 27/279 (9%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDE----NTFRKEAEALGKVKHR 892
+++ +L G + A + ++++ LR + FR+EA+ + H
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 893 NLTVLRGYYAGP---PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
+ + + +V +Y+ L ++ + + +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQ 122
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
L+F H ++H D+KP N++ A + +FG+ R + + + IG+ Y+S
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
PE A +DVYS G VL E+LTG P FT D + + + E P
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPV------SVAYQHVREDPIPP 234
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
+ S++ + +L A +P +R A +
Sbjct: 235 SARHEGLSADLDAVVLK------ALAKNPENRYQTAAEM 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (347), Expect = 7e-36
Identities = 45/273 (16%), Positives = 102/273 (37%), Gaps = 27/273 (9%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR-DGTIDENTFRKEAEALGKVKHRNLTV 896
+D L G +G++ + G V + + +D+ T + E + ++ H L
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
L + ++ +L+ +++ G L + + + ++ GL +H
Sbjct: 91 LHDAFEDKYEM-VLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 957 LDMVHGDIKPQNVLFDADFEAH--LSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
+VH DIKP+N++ + + + +FGL + + +PE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPEIVD 201
Query: 1015 TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074
D+++ G++ +L+G P D + ++ VK+ + E +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR--CDWEFDEDAFSSV---- 255
Query: 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S E ++F+ +P R ++ D
Sbjct: 256 --SPEAKDFIKN------LLQKEPRKRLTVHDA 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 41/275 (14%), Positives = 101/275 (36%), Gaps = 32/275 (11%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT----FRKEAEALGKVKHRN 893
F +L G + + A +I+ L I + +E + + ++ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
L + + Y NG L +++ + + + L +
Sbjct: 70 FVKLYFTFQDDEKL-YFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEY 123
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
LH ++H D+KP+N+L + D +++FG ++ ++ ++ + + + +G+ YVSPE
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV-LSPESKQARANSFVGTAQYVSPELL 182
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
+ K +D+++ G ++ +++ G P + I + + K +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------LEYDF 229
Query: 1074 DPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ + + + D R ++
Sbjct: 230 PEKFFPKARDLVEK------LLVLDATKRLGCEEM 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 5e-35
Identities = 39/283 (13%), Positives = 97/283 (34%), Gaps = 24/283 (8%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTV 896
++ + G +G I+ + G ++I+ T E++ ++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-LHIESKIYKMMQGGVGIP 66
Query: 897 LRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
+ D ++V + + L++ + + L++ + + ++HS
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 957 LDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLA----IATPAEASSSTTPIGSLGYVS 1009
+ +H D+KP N L ++ +FGL + + G+ Y S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
+ ++ D+ S G VL+ G P + + ++ ++ ++ P
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KMSTPI 237
Query: 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
+ SE+ +L C + D+P + + +
Sbjct: 238 EVLCKGYPSEFATYL------NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-34
Identities = 56/288 (19%), Positives = 114/288 (39%), Gaps = 27/288 (9%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRG 899
VL G G + + + +++ L+D R+E E + + ++ +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVD 72
Query: 900 YYAGPPDVR---LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS 956
Y R L+V + + G L + +Q+ Q I + + +LHS
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS 129
Query: 957 LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTG 1016
+++ H D+KP+N+L+ + + + D +S TTP + YV+PE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLT-DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 1017 QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDPE 1076
+ K D++S G+++ +L G P I +K +++ GQ E E
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY----EFPNPEWSEV 244
Query: 1077 SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV---FMLEGCRVGPDMP 1121
S E + + +P R ++ + + ++++ +V P P
Sbjct: 245 SEEVKMLIRN------LLKTEPTQRMTITEFMNHPWIMQSTKV-PQTP 285
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 131 bits (330), Expect = 2e-34
Identities = 56/288 (19%), Positives = 102/288 (35%), Gaps = 42/288 (14%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT----------FRKEAEAL 886
++ + +L RG ++ + + +++ + + KE + L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 887 GKVK-HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISL 945
KV H N+ L+ Y LV+D M G L L E L+ I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFF-FLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMR 117
Query: 946 GLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSL 1005
L + LH L++VH D+KP+N+L D D L++FG G+
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTP 173
Query: 1006 GYVSPEAASTGQP------TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR 1059
Y++PE KE D++S G+++ +L G P + +++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--- 230
Query: 1060 GQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ G E D S ++ + P R + +
Sbjct: 231 -----NYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 8e-34
Identities = 57/275 (20%), Positives = 108/275 (39%), Gaps = 30/275 (10%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLT 895
+D +VL G + + A + +++I+ + ++ E + E L K+KH N+
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L Y + L+ + G L + E + + + +LH
Sbjct: 71 ALDDIYESGGHL-YLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLH 124
Query: 956 SLDMVHGDIKPQNVLF---DADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
L +VH D+KP+N+L+ D D + +S+FGL ++ S +T G+ GYV+PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME----DPGSVLSTACGTPGYVAPEV 180
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
+ +K D +S G++ +L G P D + + + K + +
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDI-- 236
Query: 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S ++F+ DP R +
Sbjct: 237 ----SDSAKDFIRH------LMEKDPEKRFTCEQA 261
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-33
Identities = 51/297 (17%), Positives = 108/297 (36%), Gaps = 26/297 (8%)
Query: 831 ETLEATRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLR--DGTIDENTFRKEAEALG 887
+ + ++ + + G YG++ A + + ++I+++ + +E + L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 888 KVKHRNLTVLRGYYAGPP---DVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIS 944
+ +H N+ + P + + ++ +L LL+ L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT------QHLSNDHICYFL 115
Query: 945 LGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGS 1004
+ RGL ++HS +++H D+KP N+L + + + +FGL R+A T + +
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 1005 LGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063
Y +PE + TK D++S G +L E+L+ R D + + L
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 1064 ELLEPGLLEL--------DPESSEWEEFLLGVKVGLL-----CTAPDPLDRPSMADI 1107
+L L+ W L +P R +
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (312), Expect = 7e-32
Identities = 38/282 (13%), Positives = 86/282 (30%), Gaps = 28/282 (9%)
Query: 842 ENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGY 900
+ G +G+IF+ + + ++I+ + R E + Y
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-LRDEYRTYKLLAGCTGIPNVYY 68
Query: 901 YAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMV 960
+ +LV D + L G + + + + + +H +V
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 961 HGDIKPQNVLFDADFEAH-----LSEFGLDRLAIATPAEAS----SSTTPIGSLGYVSPE 1011
+ DIKP N L + + +FG+ + + G+ Y+S
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 1012 AASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071
+ ++ D+ + G V + L G P + + ++ ++ Q L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-----TPLR 238
Query: 1072 ELDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLE 1112
EL E+ +++ P + +
Sbjct: 239 ELCAGFPEEFYKYM------HYARNLAFDATPDYDYLQGLFS 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-31
Identities = 62/319 (19%), Positives = 116/319 (36%), Gaps = 43/319 (13%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVL 897
+ + V+ G +G++++A G +++I+++ D+ +E + + K+ H N+ L
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVRL 78
Query: 898 RGYYAGPPDVR-----LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
R ++ + + LV DY+P + L L L R L+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAH-LSEFGLDRLAIATPAEASSSTTPIGSLGYVSP- 1010
++HS + H DIKPQN+L D D L +FG + + + I S Y +P
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVSYICSRYYRAPE 192
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKP---------------VMFTQDEDIVKWVKK 1055
T DV+S G VL E+L G+ V+ T + ++ +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 1056 QLQRGQISELLEPGLLELDPE--SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV---FM 1110
+ ++ ++ E P R + + F
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR------LLEYTPTARLTPLEACAHSFF 306
Query: 1111 LEGCRVGPDMPSSADPTSL 1129
E +P+ D +L
Sbjct: 307 DELRDPNVKLPNGRDTPAL 325
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (306), Expect = 4e-31
Identities = 60/285 (21%), Positives = 114/285 (40%), Gaps = 24/285 (8%)
Query: 838 QFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRNL 894
++ + G YG+++KA G +++++R DE T +E L ++KH N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
L + +LV++++ L L L L G+++
Sbjct: 63 VKLYDVIHTKKRL-VLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYC 116
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE-AA 1013
H ++H D+KPQN+L + + E +++FG LA A T I +L Y +P+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFG---LARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG------QISELLE 1067
+ + + D++S G + E++ G + D + + + L ++EL +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 1068 PGLLELDPESSEWEEFLLGVKVGLL-----CTAPDPLDRPSMADI 1107
E WE FL G+ + DP R +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-31
Identities = 60/313 (19%), Positives = 115/313 (36%), Gaps = 41/313 (13%)
Query: 843 NVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN------TFRKEAEALGKVKHRNLT 895
+ L G++ ++KA +++I++++ G E T +E + L ++ H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 896 VLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L + G LV+D+M + + VL L +GL +LH
Sbjct: 64 GLLDAF-GHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 956 SLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAST 1015
++H D+KP N+L D + L++FGL + + + + T + + Y +PE
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 1016 GQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL- 1073
+ D+++ G +L E+L + D D + + + L G +E P + L
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL--GTPTEEQWPDMCSLP 232
Query: 1074 ------DPESSEWEEFLLGVKVGLL-----CTAPDPLDRPSMADIV---FMLEGCRVGPD 1119
LL +P R + + + +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS-------N 285
Query: 1120 MPSSADPTSLPSP 1132
P LP P
Sbjct: 286 RPGPTPGCQLPRP 298
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-31
Identities = 54/276 (19%), Positives = 106/276 (38%), Gaps = 33/276 (11%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT----FRKEAEALGKV-KHR 892
F +L +G +G +F A + + +I+ L+ + + E L +H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
LT + + + V +Y+ G+L +Q H + + + GL
Sbjct: 64 FLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQ 117
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
FLHS +V+ D+K N+L D D +++FG+ + + T G+ Y++PE
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
+ D +SFG++L E+L G+ P +E++ ++ L
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWL------ 226
Query: 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIV 1108
E ++ L+ +P R + +
Sbjct: 227 ----EKEAKDLLVK------LFVREPEKRLGVRGDI 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (308), Expect = 9e-31
Identities = 53/277 (19%), Positives = 93/277 (33%), Gaps = 37/277 (13%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN-------TFRKEAEALGKVK 890
F ++ RG +G ++ G + +++ L I R +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 891 HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
+ + + P D + D M G+L L + + + + G
Sbjct: 66 CPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILG 119
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
L +H+ +V+ D+KP N+L D +S+ GL A +G+ GY++P
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-----ACDFSKKKPHASVGTHGYMAP 174
Query: 1011 EAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069
E G AD +S G +L ++L G P + +D + + L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TM 224
Query: 1070 LLELDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105
+EL S E L G D R
Sbjct: 225 AVELPDSFSPELRSLLEG------LLQRDVNRRLGCL 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 47/277 (16%), Positives = 100/277 (36%), Gaps = 28/277 (10%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN-------TFRKEAEALGKVK 890
+D L G++ ++ K G+ + + ++ + +E L +++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 891 HRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARG 950
H N+ L Y DV +L+ + + G L + L + G
Sbjct: 72 HPNVITLHEVYENKTDV-ILILELVAGGELFD-----FLAEKESLTEEEATEFLKQILNG 125
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSP 1010
+ +LHSL + H D+KP+N++ +D + G+ +V+P
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 1011 EAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070
E + EAD++S G++ +L+G P + ++ + V + +
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--VNYEFEDEYFSNT 243
Query: 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
S+ ++F+ DP R ++ D
Sbjct: 244 ------SALAKDFIRR------LLVKDPKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-30
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 28/287 (9%)
Query: 839 FDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRNL 894
F + + G YG+++KA G V++++++R T E T +E L ++ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 895 TVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFL 954
L + LV++++ L + + P+ L +GL+F
Sbjct: 64 VKLLDVIHTENKL-YLVFEFLHQD----LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 955 HSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPE-AA 1013
HS ++H D+KPQN+L + + L++FGL R A + T + +L Y +PE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG---L 1070
+ D++S G + E++T R F D +I + + G E++ PG +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 1071 LELDPESSEWEEFLLGVKVGLL----------CTAPDPLDRPSMADI 1107
+ P +W V L DP R S
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 29/294 (9%)
Query: 835 ATRQFDEENVLSRGRYGLIFKASYQ--DGMVLSIRRLRDGTIDEN---TFRKEAE---AL 886
A +Q++ + G YG +FKA G ++++R+R T +E + +E L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 887 GKVKHRNLTVLRGYYAGPPDVR----LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL 942
+H N+ L R LV++++ L +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKD 120
Query: 943 ISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPI 1002
+ L RGL FLHS +VH D+KPQN+L + + L++FGL R+ + + T+ +
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVV 176
Query: 1003 GSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062
+L Y +PE D++S G + E+ + + D D + + +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 1063 SELLE----PGLLELDPESSEWEEFLLGVKVGLL-----CTAPDPLDRPSMADI 1107
+ P + E+F+ + C +P R S
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 119 bits (299), Expect = 2e-29
Identities = 82/387 (21%), Positives = 145/387 (37%), Gaps = 33/387 (8%)
Query: 189 SQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
++ L + + V + L ++ L D + + ++L ++ +N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQ 77
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKP 308
L + P + ++ L + ++ N++ + P++ L NL G +
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 309 PNGRCVSVLEVLDLQNNRIRAVFP---------SWLTNVTSLRVMDLSGNFFSGNLPAAV 359
+ + + + L N+T+L +D+S N S +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV--L 193
Query: 360 GSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419
L LE L NN +S + P I + L L GN+ L + L + L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV 479
N S L P L++L L L N I P + L+ LT L L+ N+ + +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL--EDISPI 303
Query: 480 GNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
NLK L L L + S P + SL +L L +N +S L L ++ +S
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 540 ENNLSGDVPEGFSSLVGLQYLNLSDNA 566
N +S P ++L + L L+D A
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 110 bits (276), Expect = 2e-26
Identities = 80/400 (20%), Positives = 143/400 (35%), Gaps = 37/400 (9%)
Query: 323 QNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDE 382
Q+ I +F T + L + + LD++ L+ + + D
Sbjct: 8 QDTPINQIFTD--TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DG 61
Query: 383 IAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNL 442
+ + L + N+ + P L + L + + N + + PL+ TL
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 443 SENDIRGNIPEEITR------LSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496
++ + + ++ ++ + + L L +
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 497 GKIPGSI-------GSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPE 549
I + L L +L +N +S P+ + +L +SL N L
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235
Query: 550 GFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLE 609
+SL L L+L++N + P L L L L NQIS + P L +AL LE
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 291
Query: 610 LRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPE 669
L N IS+L + L L N +S P +S + L L N +S
Sbjct: 292 LNENQL--EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VS 345
Query: 670 SFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRN 709
S + L+N+ L+ N++S P LA ++ + L L+
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 105 bits (262), Expect = 1e-24
Identities = 84/392 (21%), Positives = 148/392 (37%), Gaps = 55/392 (14%)
Query: 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN 325
L + +T V + L +++L+ +LG + GV N L ++ NN
Sbjct: 27 TVLGKTNVTDTVSQTDL----DQVTTLQADRLGIKSIDGVEYLNN------LTQINFSNN 76
Query: 326 RIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKL-------------------- 365
++ + P L N+T L + ++ N + P A +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 366 EVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSG 425
L +++N++S + F + L + L+ + + N S
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK-----PLANLTTLERLDISSNKVS- 188
Query: 426 LIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGL 485
L+ LE+L + N I P I +NL L+L+ N+ + +L L
Sbjct: 189 -DISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNL 243
Query: 486 LVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
L+L+ + S P + L +LT L L +S P L GL +L + L EN
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--L 297
Query: 546 DVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSAL 605
+ S+L L YL L N + P L L L ++N++S + L + +
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 606 EVLELRSNHFTGNIPVDISHLSRIKKLDLGQN 637
L N + P +++L+RI +L L
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 101 bits (251), Expect = 3e-23
Identities = 61/375 (16%), Positives = 143/375 (38%), Gaps = 29/375 (7%)
Query: 125 YLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGN 184
L + + + + +L + L + + +L ++ S+N T P
Sbjct: 28 VLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP-- 83
Query: 185 FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNC------SS 238
+ ++L I ++ N + P + L+ + L + + ++
Sbjct: 84 LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNT 143
Query: 239 LVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLG 298
+ +SA + +++ L+ L+ + + + ++ + L
Sbjct: 144 ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLI 203
Query: 299 F--NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLP 356
N + + ++ L+ L L N+++ L ++T+L +DL+ N S P
Sbjct: 204 ATNNQISDI---TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258
Query: 357 AAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416
+ L KL L++ N +S + P L + +LE N + + + ++ L +
Sbjct: 259 --LSGLTKLTELKLGANQISNISPL----AGLTALTNLELNENQLEDISPISNLKNLTYL 312
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476
+L N S + P +L++L+ L + N + + L+N+ L+ +N+ P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
Query: 477 YDVGNLKGLLVLNLS 491
+ NL + L L+
Sbjct: 369 --LANLTRITQLGLN 381
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.2 bits (238), Expect = 1e-21
Identities = 76/370 (20%), Positives = 143/370 (38%), Gaps = 41/370 (11%)
Query: 91 LADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
DL ++ L + SI + + L + N + PL NLT L+ + +
Sbjct: 40 QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILM 95
Query: 151 AHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQL------QLINLSYNSFSGE 204
+N ++ +L L L +N T P + + ++S S
Sbjct: 96 NNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTS 155
Query: 205 VPASVGQLQELEYLWLDS---------NHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPG 255
+ Q + L + + + S ++ ++L L A +N + + P
Sbjct: 156 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL 215
Query: 256 TIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVS 315
I ++ L LSL+ N+L + ++ L NL + L N + + P
Sbjct: 216 GI--LTNLDELSLNGNQLKDIGTLASLTNLT-------DLDLANNQISNL--APLSGLTK 264
Query: 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSL 375
L L L N+I + P +T+L ++L+ N P + +L L L + N++
Sbjct: 265 -LTELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI 319
Query: 376 SGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLS 435
S + P ++ + LQ N+ S + L + + +S G N S L PL NL+
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLT 373
Query: 436 QLETLNLSEN 445
++ L L++
Sbjct: 374 RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.1 bits (217), Expect = 6e-19
Identities = 68/329 (20%), Positives = 125/329 (37%), Gaps = 47/329 (14%)
Query: 418 LGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPY 477
LG+ + + + +L Q+ TL I+ +I + + L+NLT +N S N+ P
Sbjct: 29 LGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP- 83
Query: 478 DVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPI------------ 525
+ NL L+ + ++ + + P + + + TL + L
Sbjct: 84 -LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 142
Query: 526 ELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF-TGDIPATYGFLRSLVFL 584
+ + +L ++ + G+ L L L D + + L +L L
Sbjct: 143 TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESL 202
Query: 585 SLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIP 644
++NQIS + P + + L+ L L N ++ L+ + LDL N++S P
Sbjct: 203 IATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258
Query: 645 KEISKCSSLVSLTLDMNSLSGRIP--------------------ESFSKLSNLTTLNLST 684
+S + L L L N +S P S L NLT L L
Sbjct: 259 --LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316
Query: 685 NRLSGAIPADLALISSLRYLNLSRNNLEG 713
N +S P ++ ++ L+ L + N +
Sbjct: 317 NNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.0 bits (214), Expect = 1e-18
Identities = 41/208 (19%), Positives = 80/208 (38%), Gaps = 19/208 (9%)
Query: 94 LHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHN 153
L L L +N ++ P + L + L N ++ +LTNL L++A+N
Sbjct: 196 LTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 154 LLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQ 213
+S L L L +N + P + +N + + L+
Sbjct: 252 QISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS----NLK 307
Query: 214 ELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273
L YL L N++ P +S+ + L L +N + ++ ++ + LS N++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 274 TGLVPVSVLCNLWGNISSLRIVQLGFNA 301
+ L P+ N++ + + L A
Sbjct: 364 SDLTPL-------ANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.6 bits (161), Expect = 5e-12
Identities = 50/299 (16%), Positives = 105/299 (35%), Gaps = 49/299 (16%)
Query: 433 NLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA 492
L++ L + ++ + + L +TTL + ++ G
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG--------IKSIDG-------- 61
Query: 493 SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFS 552
+ L LT ++ SN L+ P++ L L + + N ++ P
Sbjct: 62 ----------VEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLANL 109
Query: 553 SLVGLQYLNLSDNAFTGDIPATYGFLR------SLVFLSLSHNQISGMIPAELGACSALE 606
+ + L + + R ++ +S S + + L+
Sbjct: 110 TNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK 169
Query: 607 VLELRSNHF-------TGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLD 659
L + + ++ L+ ++ L N++S P I ++L L+L+
Sbjct: 170 PLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLN 227
Query: 660 MNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKM 718
N L + + L+NLT L+L+ N++S P L+ ++ L L L N + P
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 282
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 3e-04
Identities = 20/106 (18%), Positives = 45/106 (42%), Gaps = 10/106 (9%)
Query: 514 LSNQNLSGELPI-ELFGLPSLQVV---SLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569
L + ++ + PI ++F +L L + N++ V + + L + L
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK- 57
Query: 570 DIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
I +L +L ++ S+NQ++ + P L + L + + +N
Sbjct: 58 SIDGV-EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (295), Expect = 2e-29
Identities = 53/273 (19%), Positives = 99/273 (36%), Gaps = 37/273 (13%)
Query: 839 FDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDE----NTFRKEAEALGKVKHRN 893
F L G +G + S +G +++ L+ + E L V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ + G + ++ DY+ G L +L + P+ + + L +
Sbjct: 66 IIRMWGTFQ-DAQQIFMIMDYIEGGELFSL-----LRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
LHS D+++ D+KP+N+L D + +++FG + + T G+ Y++PE
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEVV 173
Query: 1014 STGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073
ST K D +SFGI++ E+L G P + + + L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------------AELRF 220
Query: 1074 DPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105
P + + ++ L D R
Sbjct: 221 PPFFNEDVKDLLSR------LITRDLSQRLGNL 247
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 58/282 (20%), Positives = 102/282 (36%), Gaps = 46/282 (16%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT-------FRKEAEALGKV 889
Q+ +L G +G ++ D + ++I+ + I + E L KV
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 890 KHRNLTVLRGYYAGP-PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
V+R PD +L+ + + L + +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF----ITERGALQEELARSFFWQVL 120
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
+ H+ ++H DIK +N+L D + E L +FG L + + T G+ Y
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFDGTRVY 175
Query: 1008 VSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
PE + + A V+S GI+L +++ G P F DE+I++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIR--------------- 218
Query: 1067 EPGLLELDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
G + SSE + + C A P DRP+ +I
Sbjct: 219 --GQVFFRQRVSSECQHLIRW------CLALRPSDRPTFEEI 252
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (275), Expect = 6e-27
Identities = 64/289 (22%), Positives = 103/289 (35%), Gaps = 15/289 (5%)
Query: 402 QVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNL 461
+VP L ++ L N + + F NL L TL L N I P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSG 521
L LS N+ L+ L V + + + + M + L + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSG 140
Query: 522 ELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSL 581
G+ L + + + N++ S L L+L N T A+ L +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKITKVDAASLKGLNNL 197
Query: 582 VFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSG 641
L LS N IS + L L L L +N+ +P ++ I+ + L N +S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHL-NNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
Query: 642 ------EIPKEISKCSSLVSLTLDMNSLSGR--IPESFSKLSNLTTLNL 682
P +K +S ++L N + P +F + + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (263), Expect = 2e-25
Identities = 57/283 (20%), Positives = 105/283 (37%), Gaps = 14/283 (4%)
Query: 436 QLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGF 495
L + S+ + +P+++ + L+L NK D NLK L L L +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 496 SGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLV 555
S PG+ L++L L LS L ELP ++ V E + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
+ L + +G + ++ L ++ ++ I+ + G +L L L N
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKI 183
Query: 616 TGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLS 675
T + L+ + KL L N +S ++ L L L+ N L ++P +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242
Query: 676 NLTTLNLSTNRLSG------AIPADLALISSLRYLNLSRNNLE 712
+ + L N +S P +S ++L N ++
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (260), Expect = 5e-25
Identities = 68/311 (21%), Positives = 113/311 (36%), Gaps = 31/311 (9%)
Query: 158 KISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEY 217
K+ D+ P LDL +N T G+F + L + L N S P + L +LE
Sbjct: 24 KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 83
Query: 218 LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLV 277
L+L N L LP + L +N + + ++ + V+ L N L
Sbjct: 84 LYLSKNQL-KELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS- 139
Query: 278 PVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTN 337
+ + + L +++ T + P G S L L L N+I V + L
Sbjct: 140 --GIENGAFQGMKKLSYIRIADTNITTI---PQGLPPS-LTELHLDGNKITKVDAASLKG 193
Query: 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397
+ +L + LS N S ++ + L L + NN L VP +A +Q+ L N
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNN 252
Query: 398 RFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR-GNIPEEIT 456
S ++G N F P + ++L N ++ I
Sbjct: 253 NIS----------------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
Query: 457 R-LSNLTTLNL 466
R + + L
Sbjct: 295 RCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.9 bits (219), Expect = 1e-19
Identities = 55/299 (18%), Positives = 105/299 (35%), Gaps = 36/299 (12%)
Query: 61 CDWRGIVCYNNRVREL--RLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQC 118
C R + C + + ++ LP + L L +N +
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPP---------------DTALLDLQNNKITEIKDGDFKNL 54
Query: 119 SLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFT 178
L + L N S P + L L L ++ N L + + +L+ L + N T
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEIT 113
Query: 179 GEIPGNFSSKSQLQLINL--SYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNC 236
F+ +Q+ ++ L + SG + +++L Y+ + ++ T+P
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLP 170
Query: 237 SSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQ 296
SL L + N + + ++ ++ L L LS N ++ + S+ L +
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 297 LGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV------FPSWLTNVTSLRVMDLSGN 349
L P ++V+ L NN I A+ P + T S + L N
Sbjct: 231 LVKV-------PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 7e-19
Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 11/233 (4%)
Query: 509 LTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
L + S+ L ++P +L P ++ L+ N ++ F +L L L L +N +
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSR 628
P + L L L LS NQ+ + L+ L + N T + L++
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPE---KMPKTLQELRVHENEITKVRKSVFNGLNQ 125
Query: 629 IKKLDL--GQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNR 686
+ ++L K SG L + + +++ IP+ +LT L+L N+
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 182
Query: 687 LSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKP 739
++ A L +++L L LS N++ L++ + + N +L P
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 7e-19
Identities = 40/213 (18%), Positives = 73/213 (34%), Gaps = 7/213 (3%)
Query: 532 SLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQI 591
L+VV + L VP+ L+L +N T + L++L L L +N+I
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 592 SGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCS 651
S + P LE L L N L ++ + K+ + +++
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 652 SLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNL 711
+ L + SG +F + L+ + ++ ++ IP L SL L+L N +
Sbjct: 128 VV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183
Query: 712 EGEIPKMLSSRFNDPSIFAMNRELCGKPLDREC 744
L N + +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 216
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 32/133 (24%), Positives = 48/133 (36%), Gaps = 11/133 (8%)
Query: 74 RELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSG 133
EL L ++ L L+ L KL L N ++ SL LR ++L N
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
Query: 134 HLPLSIFNLTNLLVLNVAHNLLSGKISADISP--------SLRYLDLSSNAFT-GEI-PG 183
P + + + V+ + +N +S S D P S + L SN EI P
Sbjct: 234 V-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
Query: 184 NFSSKSQLQLINL 196
F + L
Sbjct: 293 TFRCVYVRAAVQL 305
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (275), Expect = 1e-26
Identities = 49/249 (19%), Positives = 97/249 (38%), Gaps = 22/249 (8%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN----TFRKEAEALGKVKHR 892
QFD L G +G + + + G +++ L + + E L V
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
L L + ++ + V +Y+ G + + L+ + P + +
Sbjct: 102 FLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFE 155
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+LHSLD+++ D+KP+N+L D +++FG + + T G+ ++PE
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWTLCGTPEALAPEI 209
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR--GQISELLEP-- 1068
+ K D ++ G+++ E+ G P Q I + + R S L+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 1069 -GLLELDPE 1076
LL++D
Sbjct: 270 RNLLQVDLT 278
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-26
Identities = 57/306 (18%), Positives = 107/306 (34%), Gaps = 40/306 (13%)
Query: 825 NKITYVETLEATRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDEN---TFR 880
K + E + + + G YG + A + G ++I++L E
Sbjct: 10 TKTAW----EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 881 KEAEALGKVKHRNLTVLRGYYAGPPDVRL-----LVYDYMPNGNLATLLQEASHQDGHVL 935
+E L ++H N+ L + + LV +M L
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG-------KLMKHEKL 118
Query: 936 NWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995
+ + +GL ++H+ ++H D+KP N+ + D E + +FGL R A
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA------D 172
Query: 996 SSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVK 1054
S T + + Y +PE T+ D++S G ++ E++TG+ + D +K +
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 1055 KQL--------QRGQISELLEPGLLELDPESSEWEEFLLGVKVGLL-----CTAPDPLDR 1101
K QR Q E + E ++ L + D R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292
Query: 1102 PSMADI 1107
+ +
Sbjct: 293 VTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 3e-26
Identities = 55/287 (19%), Positives = 115/287 (40%), Gaps = 26/287 (9%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRN 893
++++ + G YG +FKA + +++++R+R DE + +E L ++KH+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 894 LTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSF 953
+ L + L V+++ L+ + L +GL F
Sbjct: 63 IVRLHDVLHSDKKLTL-VFEFCDQDLKKY-----FDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 954 LHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAA 1013
HS +++H D+KPQN+L + + E L+ FGL R A + + +L Y P+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLAR---AFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 1014 STGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDED-------IVKWVKKQLQRGQISEL 1065
+ + D++S G + E+ +P+ D D + + Q +++L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 1066 LEPGLLELDPESSEWEEFLLGVKVGLL-----CTAPDPLDRPSMADI 1107
+ + P ++ + + +P+ R S +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 54/297 (18%), Positives = 107/297 (36%), Gaps = 32/297 (10%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHRN 893
++++ + +G +G +FKA + + G ++++++ E T +E + L +KH N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 894 LTVLRGYYAGPPDVRL-------LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLG 946
+ L LV+D+ + L +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQM 125
Query: 947 LARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR-LAIATPAEASSSTTPIGSL 1005
L GL ++H ++H D+K NVL D L++FGL R ++A ++ + T + +L
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 1006 GYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQR----- 1059
Y PE + D++ G ++ E+ T + ++ + + +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 1060 -GQISELLEPGLLELDPESSEWEEFLLGVKVG------LL--CTAPDPLDRPSMADI 1107
+ LEL + L V L+ DP R D
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-25
Identities = 57/274 (20%), Positives = 97/274 (35%), Gaps = 34/274 (12%)
Query: 838 QFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENT----FRKEAEALGKVKHR 892
FD +L +G +G + G +++ LR I E+ L +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 893 NLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLS 952
LT L+ + D V +Y G L L V + L
Sbjct: 66 FLTALKYAFQ-THDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALE 119
Query: 953 FLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEA 1012
+LHS D+V+ DIK +N++ D D +++FG L ++ ++ T G+ Y++PE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 1013 ASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072
+ D + G+V+ E++ GR P E + + + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------EEIR 223
Query: 1073 LDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105
S E + L G DP R
Sbjct: 224 FPRTLSPEAKSLLAG------LLKKDPKQRLGGG 251
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 6e-25
Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 34/280 (12%)
Query: 838 QFDEENVLSRGRYGLIFKA----SYQDGMVLSIRRLRDGTIDENT-----FRKEAEALGK 888
F+ VL G YG +F + G + +++ L+ TI + R E + L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 889 VKHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLA 948
++ V Y L+ DY+ G L T L + H + + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI-----V 139
Query: 949 RGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYV 1008
L LH L +++ DIK +N+L D++ L++FGL + E + G++ Y+
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYM 197
Query: 1009 SPEAASTGQ--PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066
+P+ G K D +S G+++ E+LTG P +++ + +++ + +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP---- 253
Query: 1067 EPGLLELDPE-SSEWEEFLLGVKVGLLCTAPDPLDRPSMA 1105
E S+ ++ + DP R
Sbjct: 254 -----PYPQEMSALAKDLIQR------LLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 103 bits (257), Expect = 2e-24
Identities = 54/294 (18%), Positives = 111/294 (37%), Gaps = 39/294 (13%)
Query: 839 FDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTV 896
+ L RG+Y +F+A + + + ++ L+ + + ++E + L ++ N+
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIIT 94
Query: 897 LRGYYAGPPDVRL-LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLH 955
L P LV++++ N + L Q L + + L + H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCH 146
Query: 956 SLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAAS 1014
S+ ++H D+KP NV+ D + + L ++GL + S + PE
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY----HPGQEYNVRVASRYFKGPELLV 202
Query: 1015 TGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQLQRGQISELLEPGLLE 1072
Q D++S G +L ++ ++P D D + + K L + + ++ +E
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 1073 LDPESSE---------WEEFLLGVKVGLL----------CTAPDPLDRPSMADI 1107
LDP ++ WE F+ L+ D R + +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 3e-23
Identities = 51/293 (17%), Positives = 103/293 (35%), Gaps = 28/293 (9%)
Query: 834 EATRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLR---DGTIDENTFRKEAEALGKV 889
E ++ + + G YG + A + G+ +++++L I +E L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 890 KHRNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLAR 949
KH N+ L + + Y+ + L L + + R
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 950 GLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVS 1009
GL ++HS D++H D+KP N+ + D E + +FGL A + +
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTDDEMTGYVATRWYRAP 187
Query: 1010 PEAASTGQPTKEADVYSFGIVLLEILTGRKP---------------VMFTQDEDIVKWVK 1054
+ + D++S G ++ E+LTGR ++ T +++K +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 1055 KQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADI 1107
+ R I L + + + + +L D R + A
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV--LDSDKRITAAQA 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.4 bits (246), Expect = 3e-23
Identities = 80/362 (22%), Positives = 126/362 (34%), Gaps = 58/362 (16%)
Query: 30 SEIQALTSFKLHLKDPLGALDGWDSSTPSAPCDWRGIVCYNNRVRELRLPRLQLAGRLTD 89
+ QAL K L +P L W +T W G++C +
Sbjct: 6 QDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQ---------------- 48
Query: 90 QLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNL--LV 147
+ + L L +L P +P S+ NL L L
Sbjct: 49 ----TYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFLY 82
Query: 148 LNVAHNLLSGKISADISPS-LRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
+ +NL+ A + L YL ++ +G IP S L ++ SYN+ SG +P
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 207 ASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVH-LSAEDNVLKGLIPGTIGRISTLQV 265
S+ L L + D N + G +P + + S L ++ N L G IP T ++ V
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFV 202
Query: 266 LSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN 325
S ++ + L LDL+NN
Sbjct: 203 DLSRNMLEG--------DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 326 RIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAK 385
RI P LT + L +++S N G +P G+L + +V ANN P +
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPA 311
Query: 386 CS 387
C+
Sbjct: 312 CT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 95.6 bits (236), Expect = 6e-22
Identities = 72/265 (27%), Positives = 111/265 (41%), Gaps = 26/265 (9%)
Query: 502 SIGSLMRLTTLDLSNQNLSGELPI--ELFGLPSLQVVSLEEN-NLSGDVPEGFSSLVGLQ 558
+ R+ LDLS NL PI L LP L + + NL G +P + L L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 559 YLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGN 618
YL ++ +G IP +++LV L S+N +SG +P + + L + N +G
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 619 IPVDISHLSR-IKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM----------------- 660
IP S+ + + +N+L+G+IP + +
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 661 -----NSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEI 715
+ NL L+L NR+ G +P L + L LN+S NNL GEI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 716 PKMLSSRFNDPSIFAMNRELCGKPL 740
P+ + + D S +A N+ LCG PL
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 82.1 bits (201), Expect = 2e-17
Identities = 70/278 (25%), Positives = 113/278 (40%), Gaps = 9/278 (3%)
Query: 330 VFPSWLTNVTSLRVMDLSGNFFSGN--LPAAVGSLDKLEVLRVANN-SLSGLVPDEIAKC 386
V T + +DLSG +P+++ +L L L + +L G +P IAK
Sbjct: 41 VLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 387 SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSEND 446
+ L + SG +P FL I+ L + N SG +P S +L L + N
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 447 IRGNIPEEITRLSNLTT-LNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGS 505
I G IP+ S L T + +S N+ GK+P NL + +
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFG 218
Query: 506 LMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDN 565
+ T +N ++ +L + L N + G +P+G + L L LN+S N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 566 AFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603
G+IP G L+ + ++N+ P L AC+
Sbjct: 279 NLCGEIPQG-GNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.0 bits (180), Expect = 1e-14
Identities = 57/266 (21%), Positives = 98/266 (36%), Gaps = 8/266 (3%)
Query: 258 GRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317
+ + L LS L P + + N+ L + +G PP ++ L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYP---IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSG 377
L + + + P +L+ + +L +D S N SG LP ++ SL L + N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 378 LVPDEIAKC-SLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQ 436
+PD L + NR +G++P + +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDASVLFGSDK 221
Query: 437 LETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496
+ ++ NL L+L N+ G +P + LK L LN+S +
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 497 GKIPGSIGSLMRLTTLDLS-NQNLSG 521
G+IP G+L R + N+ L G
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCG 306
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (245), Expect = 1e-22
Identities = 56/304 (18%), Positives = 104/304 (34%), Gaps = 45/304 (14%)
Query: 837 RQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDEN---TFRKEAEALGKVKHR 892
+++ + G G++ A ++I++L ++ +E + V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 893 NLTVLRGYYAGPPDVR-----LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGL 947
N+ L + + LV + M + E + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQM 128
Query: 948 ARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGY 1007
G+ LHS ++H D+KP N++ +D + +FGL R T + T + + Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYY 184
Query: 1008 VSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQL---------- 1057
+PE + D++S G ++ E++ + D V +QL
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 1058 ----------QRGQISELLEPGLL--ELDPESSEWEEFLLGVKVGLL--CTAPDPLDRPS 1103
R + + L P L L P SE + LL DP R S
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 1104 MADI 1107
+ D
Sbjct: 305 VDDA 308
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (224), Expect = 1e-20
Identities = 58/254 (22%), Positives = 91/254 (35%), Gaps = 5/254 (1%)
Query: 437 LETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFS 496
+ + L N I NLT L L N L L L+LS +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 497 GKI-PGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLV 555
+ P + L RL TL L L P GL +LQ + L++N L + F L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHF 615
L +L L N + + L SL L L N+++ + P L L L +N+
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 616 TGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLS 675
+ ++ L ++ L L N + + L + + +P+ L+
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR---LA 269
Query: 676 NLTTLNLSTNRLSG 689
L+ N L G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (219), Expect = 7e-20
Identities = 59/254 (23%), Positives = 93/254 (36%), Gaps = 5/254 (1%)
Query: 365 LEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424
+ + + N +S + C L + L N + A G+ L+ + L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 425 GLI-PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLK 483
+ P +F L +L TL+L ++ P L+ L L L N +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 484 GLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543
L L L + S + L L L L ++ P L L + L NNL
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 544 SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACS 603
S E + L LQYL L+DN + D A L S +++ +P L +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLPQRL---A 269
Query: 604 ALEVLELRSNHFTG 617
++ L +N G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (215), Expect = 2e-19
Identities = 48/270 (17%), Positives = 87/270 (32%), Gaps = 11/270 (4%)
Query: 228 TLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWG 287
+P I ++ + N + + + L +L L N + +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-----LARIDAAAFT 77
Query: 288 NISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLS 347
++ L + L NA V P + L L L ++ + P + +L+ + L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 348 GNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFL 407
N L L L + N +S + L L NR + P
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 408 GGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLS 467
+ L + L N S L + L L+ L L++N + + L S
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGS 256
Query: 468 YNKFGGKVPYDVGNLKGLLVLNLSASGFSG 497
++ +P L G + L+A+ G
Sbjct: 257 SSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (206), Expect = 4e-18
Identities = 50/264 (18%), Positives = 84/264 (31%), Gaps = 29/264 (10%)
Query: 484 GLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENN- 542
+ + G +P I + + L +S +L ++ L N
Sbjct: 12 PKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 543 ------------------------LSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFL 578
L P F L L L+L P + L
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 579 RSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNK 638
+L +L L N + + L L L N + L + +L L QN+
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 639 LSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALI 698
++ P L++L L N+LS E+ + L L L L+ N A L
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLW 247
Query: 699 SSLRYLNLSRNNLEGEIPKMLSSR 722
+ L+ S + + +P+ L+ R
Sbjct: 248 AWLQKFRGSSSEVPCSLPQRLAGR 271
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (154), Expect = 2e-11
Identities = 54/322 (16%), Positives = 87/322 (27%), Gaps = 67/322 (20%)
Query: 60 PCDWRGIVCYNNRVRELRLPRLQLAGRLTDQLADL-HELRKLSLHSNHLNGSIPASLHQC 118
PC VCYN P+ L + +++ LH N ++ AS C
Sbjct: 1 PCP-GACVCYNEPKVTTSCPQQ----GLQAVPVGIPAASQRIFLHGNRISHVPAASFRAC 55
Query: 119 SLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISA---DISPSLRYLDLSSN 175
L ++L N + + L L L+++ N + L L L
Sbjct: 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 176 AFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISN 235
PG F + LQ + L N+ + L L +L+L N + A
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 236 CSSLVHLSAEDNVLKGLIPGTI------------------------GRISTLQVLSLSRN 271
SL L N + + P + LQ L L+ N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
Query: 272 ELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVF 331
C + L+ ++ +
Sbjct: 236 PWVC------DCRARPLWAWLQK-------------------------FRGSSSEVPCSL 264
Query: 332 PSWLTNVTSLRVMDLSGNFFSG 353
P L + L+ N G
Sbjct: 265 PQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 35/197 (17%), Positives = 58/197 (29%), Gaps = 4/197 (2%)
Query: 595 IPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLV 654
+P + +A + + L N + + L L N L+ + + L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 655 SLTLDMNSLSGRI-PESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEG 713
L L N+ + P +F L L TL+L L P +++L+YL L N L+
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 714 EIPKMLSSRFNDPSIFAMNRELCGKPLDRECANVRKRKRKRLIILICVSAAGACLLALCC 773
N +F + P + R L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPER-AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 774 CGYIYSLLRWRQTLRAW 790
+Y L
Sbjct: 203 LMTLYLFANNLSALPTE 219
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.9 bits (219), Expect = 2e-19
Identities = 56/267 (20%), Positives = 98/267 (36%), Gaps = 20/267 (7%)
Query: 831 ETLEATRQFDEENVLSRGRYGLIFKA-SYQDGMVLSIRRLRDGTIDENTFRKEAEALGKV 889
E + R + L G + ++ A + ++++ +R + E + L +V
Sbjct: 8 EPYKDAR-YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 890 KHRNLTVLRGYYAGPPDVRLLVY--DYMPNGNLATLLQEASHQDGHVL---------NWP 938
+ T A ++LL + PNG ++ E ++ L
Sbjct: 67 NDADNTKEDSMGA-NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 939 MRHLISLGLARGLSFLH-SLDMVHGDIKPQNVLFDA-DFEAHLSEFGLDRLAIATPAEAS 996
IS L GL ++H ++H DIKP+NVL + D +L + + L A
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDE 184
Query: 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQ 1056
T I + Y SPE AD++S ++ E++TG + ++ + K
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF---EPDEGHSYTKDD 241
Query: 1057 LQRGQISELLEPGLLELDPESSEWEEF 1083
QI ELL L F
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTF 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (178), Expect = 2e-14
Identities = 48/274 (17%), Positives = 92/274 (33%), Gaps = 16/274 (5%)
Query: 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSG 521
TL+L+ V + + G++ S + S R+ +DLSN +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 522 E-LPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSD--NAFTGDIPATYGFL 578
L L LQ +SLE LS + + L LNLS +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 579 RSLVFLSL------SHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKL 632
L L+L + + + + L + R N ++ + + L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 633 DLGQN-KLSGEIPKEISKCSSLVSLTL-DMNSLSGRIPESFSKLSNLTTLNLSTNRLSGA 690
DL + L + +E + + L L+L + ++ L TL + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 691 IPADLALISSLRYLNLSRNNLEGEIPKMLSSRFN 724
+ L +L +L ++ ++ + ++ N
Sbjct: 241 LQ---LLKEALPHLQINCSHFTTIARPTIGNKKN 271
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 2e-11
Identities = 45/280 (16%), Positives = 93/280 (33%), Gaps = 14/280 (5%)
Query: 170 LDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG-T 228
LDL+ ++ G S+ + + + + ++++ L ++ + T
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 229 LPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVS----VLCN 284
L +S CS L +LS E L I T+ + S L L+LS +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 285 LWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVM 344
L S + V L + N ++ + + +L +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNL--SGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 345 DLSGNF-FSGNLPAAVGSLDKLEVLRVAN-NSLSGLVPDEIAKCSLLQMFDLEGNRFSGQ 402
DLS + + L+ L+ L ++ + E+ + L+ + G G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 403 VPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNL 442
+ + L+I + F+ + + GN E +
Sbjct: 241 LQLLKEALPHLQINC---SHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 3e-11
Identities = 37/268 (13%), Positives = 88/268 (32%), Gaps = 9/268 (3%)
Query: 153 NLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGE-VPASVGQ 211
NL +S + + + +FS ++Q ++LS + + + Q
Sbjct: 11 NLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTLHGILSQ 69
Query: 212 LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVL---KGLIPGTIGRISTLQVLSL 268
+L+ L L+ L + + ++ S+LV L+ L ++
Sbjct: 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 129
Query: 269 SRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIR 328
+ T + ++ I+ L + N + RC +++ + + ++
Sbjct: 130 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 189
Query: 329 AVFPSWLTNVTSLRVMDLSG-NFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCS 387
+ L+ + LS +G + L+ L+V G +
Sbjct: 190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP 249
Query: 388 LLQMFDLEGNRFSGQVPAFLGGIRGLKI 415
LQ + + F+ +G + +I
Sbjct: 250 HLQ---INCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 1e-07
Identities = 40/230 (17%), Positives = 76/230 (33%), Gaps = 12/230 (5%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGN-LPAAVGSLDKLEVLRVANNSL 375
+ + + + ++ MDLS + + L + KL+ L + L
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 376 SGLVPDEIAKCSLLQMFDL--------EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLI 427
S + + +AK S L +L + + L + +
Sbjct: 84 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143
Query: 428 PLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYN-KFGGKVPYDVGNLKGLL 486
++QL +N + ++ + R NL L+LS + + L L
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 487 VLNLS-ASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQV 535
L+LS + +G + L TL + G L + LP LQ+
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 253
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 6e-05
Identities = 47/257 (18%), Positives = 92/257 (35%), Gaps = 22/257 (8%)
Query: 70 NNRVRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNG-SIPASLHQCSLLRAVYLQY 128
+ V R PR + L + + ++ + L ++ + ++ L QCS L+ + L+
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 129 NSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISA----------DISPSLRYLDLSSNAFT 178
S + ++ +NL+ LN++ + + D D +
Sbjct: 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140
Query: 179 GEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLY-GTLPSAISNCS 237
+ + +QL L N ++ V + L +L L + + +
Sbjct: 141 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200
Query: 238 SLVHLSAED-NVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQ 296
L HLS + +G I TL+ L + G+VP L L + L+I
Sbjct: 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF-----GIVPDGTLQLLKEALPHLQINC 255
Query: 297 LGFNAFTGVVKPPNGRC 313
+ FT + +P G
Sbjct: 256 ---SHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 3e-04
Identities = 45/271 (16%), Positives = 87/271 (32%), Gaps = 21/271 (7%)
Query: 252 LIPGTIGRI--STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPP 309
L P GR+ + R+ + + + ++ + L +
Sbjct: 12 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEH------FSPFRVQHMDLSNSVIEVSTLHG 65
Query: 310 NGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSG--NFFSGNLPAAVGSLDKLEV 367
S L+ L L+ R+ + L ++L ++LSG F L + S +L+
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125
Query: 368 LRVANNSLSG------LVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRN 421
L ++ V + L + N + + L + L +
Sbjct: 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 185
Query: 422 M-FSGLIPLSFGNLSQLETLNLSE-NDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDV 479
+ F L+ L+ L+LS DI E+ + L TL + G +
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK 245
Query: 480 GNLKGLLVLNLSASGFSGKIPGSIGSLMRLT 510
L L ++ S F+ +IG+
Sbjct: 246 EALPH---LQINCSHFTTIARPTIGNKKNQE 273
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 3e-12
Identities = 21/154 (13%), Positives = 44/154 (28%), Gaps = 23/154 (14%)
Query: 843 NVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENT-----------FRKEAEALGKVKH 891
++ G+ +F + ++ + G F A + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 892 RNLTVLRGYYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHL-ISLGLARG 950
R L L+G Y + N +L E + +
Sbjct: 66 RALQKLQGLAVPKV------YAWEGNA----VLMELIDAKELYRVRVENPDEVLDMILEE 115
Query: 951 LSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984
++ + +VHGD+ NVL + + +F
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 148
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 7e-12
Identities = 45/208 (21%), Positives = 67/208 (32%), Gaps = 30/208 (14%)
Query: 287 GNISSLRIVQLGFNAFTGVVK--PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVM 344
++S V T + P + +L L N + + L T L +
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPKD------TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 345 DLSGN---------------------FFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEI 383
+L +LP +L L VL V+ N L+ L +
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 384 AKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLS 443
LQ L+GN P L L+ +SL N + L L L+TL L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 444 ENDIRGNIPEEITRLSNLTTLNLSYNKF 471
EN + IP+ L L N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (155), Expect = 1e-11
Identities = 42/207 (20%), Positives = 71/207 (34%), Gaps = 25/207 (12%)
Query: 502 SIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLN 561
+ + ++ +NL+ LP +L ++ L EN L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 562 LSDN---------------------AFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600
L +P L +L L +S N+++ + L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
L+ L L+ N P ++ +++KL L N L+ ++ +L +L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 661 NSLSGRIPESFSKLSNLTTLNLSTNRL 687
NSL IP+ F L L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 47/214 (21%), Positives = 69/214 (32%), Gaps = 11/214 (5%)
Query: 138 SIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLS 197
+ + + L +N L+ + D+ L LS N ++L +NL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 198 YNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTI 257
+ G L L L L N L + + L N L L G +
Sbjct: 64 RAELTKLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGAL 120
Query: 258 GRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVL 317
+ LQ L L NEL L P L L + L N T + + L
Sbjct: 121 RGLGELQELYLKGNELKTLPP-----GLLTPTPKLEKLSLANNNLTELP-AGLLNGLENL 174
Query: 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFF 351
+ L LQ N + + P L L GN +
Sbjct: 175 DTLLLQENSLYTI-PKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 6e-10
Identities = 44/189 (23%), Positives = 66/189 (34%), Gaps = 6/189 (3%)
Query: 427 IPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
+P L+LSEN + + + LT LNL + +L
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---VL 79
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGD 546
+ +P +L LT LD+S L+ L GL LQ + L+ N L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 547 VPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALE 606
P + L+ L+L++N T L +L L L N + IP L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 607 VLELRSNHF 615
L N +
Sbjct: 199 FAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 41/208 (19%), Positives = 69/208 (33%), Gaps = 7/208 (3%)
Query: 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLN 441
E++K + + + + +P L + I+ L N+ + ++L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 442 LSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPG 501
L + L L TL+LS+N+ ++ S +
Sbjct: 62 LD--RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 502 SIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLN 561
G N+ P L P L+ +SL NNL+ + L L L
Sbjct: 120 LRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 562 LSDNAFTGDIPATYGFLRSLVFLSLSHN 589
L +N+ IP + L F L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 5e-08
Identities = 48/217 (22%), Positives = 74/217 (34%), Gaps = 16/217 (7%)
Query: 530 LPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHN 589
+ S V+ ++ NL+ +P L+LS+N AT L L+L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 590 QISGMIPAELGACSALEVLELRSNHFTGNIPVD--ISHLSRIKKLDLGQNKLSGEIPKEI 647
+++ + L VL + L + LD+ N+L+ +
Sbjct: 66 ELTKLQV-----DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 648 SKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLS 707
L L L N L P + L L+L+ N L+ L + +L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 708 RNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPLDREC 744
N+L IPK P F L G P C
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAF-----LHGNPWLCNC 211
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 42/210 (20%), Positives = 75/210 (35%), Gaps = 10/210 (4%)
Query: 93 DLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAH 152
+ +++ +L ++P L ++L N ++ T L LN+
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 153 NLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQL 212
L+ P L LDLS N + + ++++S+N + ++ L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGL 123
Query: 213 QELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNE 272
EL+ L+L N L P ++ L LS +N L L G + + L L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 273 LTGLVPVSVLCNLWGNISSLRIVQLGFNAF 302
L + + L L N +
Sbjct: 184 LYTIPK------GFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 8e-07
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 3/65 (4%)
Query: 646 EISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLN 705
E+SK +S + + D +L+ +P K + T L+LS N L A L + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 706 LSRNN 710
L R
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 31/175 (17%), Positives = 51/175 (29%), Gaps = 2/175 (1%)
Query: 73 VRELRLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFS 132
L L L L L +L+L + L S
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNL-DRAELTKLQVDGTLPVLGTLDLSHNQLQS 91
Query: 133 GHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQ 192
L +L ++ + L+ L L N PG + +L+
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151
Query: 193 LINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247
++L+ N+ + + L+ L+ L L N LY T+P L N
Sbjct: 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 14/52 (26%), Positives = 21/52 (40%), Gaps = 3/52 (5%)
Query: 670 SFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
SK+++ +N L+ A+P DL L+LS N L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMP 53
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 58.9 bits (141), Expect = 5e-10
Identities = 38/217 (17%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 505 SLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSD 564
+L + N++ + L + +S ++ EG L L L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 565 NAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDIS 624
N T P + + LS + + I + ++ ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 625 HLSRIKKLDLGQNKL--------------SGEIPKEISKCSSLVSLTLDMNSLSGRIPES 670
L + L ++ S L +L D N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 671 FSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLS 707
+ L NL ++L N++S P LA S+L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 40/211 (18%), Positives = 67/211 (31%), Gaps = 23/211 (10%)
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476
+ G++ + + + +L + TL+ + I E + L+NL L L N+ P
Sbjct: 25 AAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP 80
Query: 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVV 536
L L+ + I G T L L
Sbjct: 81 LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQ 140
Query: 537 SLEENNL--------------SGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLV 582
+ L ++L L L DN + P L +L+
Sbjct: 141 ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLI 198
Query: 583 FLSLSHNQISGMIPAELGACSALEVLELRSN 613
+ L +NQIS + P L S L ++ L +N
Sbjct: 199 EVHLKNNQISDVSP--LANTSNLFIVTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 4e-07
Identities = 32/251 (12%), Positives = 81/251 (32%), Gaps = 42/251 (16%)
Query: 433 NLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA 492
L+ + ++++ + + L +TTL+ V ++G
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTG--------VTTIEG-------- 58
Query: 493 SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFS 552
+ L L L+L + ++ P++ + +S + S
Sbjct: 59 ----------VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQS 108
Query: 553 SLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRS 612
+ + L + + + ++G+ + +
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSI---------- 158
Query: 613 NHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFS 672
+ + +++LS++ L NK+S P ++ +L+ + L N +S P +
Sbjct: 159 GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LA 214
Query: 673 KLSNLTTLNLS 683
SNL + L+
Sbjct: 215 NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 39/217 (17%), Positives = 71/217 (32%), Gaps = 24/217 (11%)
Query: 518 NLSGELPI-ELFGLPSLQVV---SLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPA 573
+++ I +F P+L + ++N++ V + + L G+ L+ T I
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEG 58
Query: 574 TYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633
+L +L+ L L NQI+ + P + L I S +
Sbjct: 59 -VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117
Query: 634 LGQ--------------NKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTT 679
+I L + + + LS LTT
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT 177
Query: 680 LNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716
L N++S P LA + +L ++L N + P
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 33/215 (15%), Positives = 66/215 (30%), Gaps = 16/215 (7%)
Query: 189 SQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
+ I ++ + V + L + L + T + ++L+ L +DN
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ 74
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVK- 307
+ L P T LS + + + S+ + +
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 308 -------PPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360
+ + L + + L N++ L + N S P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 361 SLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395
SL L + + NN +S + P +A S L + L
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 39/244 (15%), Positives = 75/244 (30%), Gaps = 30/244 (12%)
Query: 230 PSAIS------NCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLC 283
P+AI+ ++ + ++A + + + T + + LS +T + V L
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEGVQYLN 63
Query: 284 NLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRV 343
NL ++L N T + N ++ LE+ + A+ L
Sbjct: 64 NL-------IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTS 116
Query: 344 MDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQV 403
++ L L + + L + L
Sbjct: 117 TQITDVTPLAGLSNLQVLYLDLNQITNISPL-----------AGLTNLQYLSIGNAQVSD 165
Query: 404 PAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTT 463
L + L + N S + P +L L ++L N I P + SNL
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 464 LNLS 467
+ L+
Sbjct: 222 VTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 34/216 (15%), Positives = 69/216 (31%), Gaps = 16/216 (7%)
Query: 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNS 200
L N + + + ++ ++ + L T I G + L + L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 201 FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAIS--------NCSSLVHLSAEDNVLKGL 252
+ P L + + S + V A + L+ L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 253 IPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLW-GNISSLRIVQLGFNAFTGVVKPPNG 311
+ + L+ + + V N+S L ++ N + + P
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI--SPLA 192
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLS 347
+ L + L+NN+I V P L N ++L ++ L+
Sbjct: 193 SLPN-LIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 4e-05
Identities = 29/218 (13%), Positives = 63/218 (28%), Gaps = 23/218 (10%)
Query: 288 NISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLS 347
+++ + G + T V + + + L + + + + +L ++L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQAD---LDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 348 GNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFL 407
N + P + L + + +L + + L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 408 GGIRGLKIVSLGRNMF--------------SGLIPLSFGNLSQLETLNLSENDIRGNIPE 453
+ + NLS+L TL +N I P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 454 EITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLS 491
+ L NL ++L N+ P + N L ++ L+
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 29/208 (13%), Positives = 70/208 (33%), Gaps = 22/208 (10%)
Query: 94 LHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHN 153
L K++ +++ ++ + + + + + L NL+ L + N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDN 73
Query: 154 LL--SGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQ 211
+ + + L + I G S K+ + +++
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 212 LQELEYLWLDSNHLYG--------------TLPSAISNCSSLVHLSAEDNVLKGLIPGTI 257
L + + L G + + ++N S L L A+DN + + P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 258 GRISTLQVLSLSRNELTGLVPVSVLCNL 285
+ L + L N+++ + P++ NL
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLANTSNL 219
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 30/210 (14%), Positives = 60/210 (28%), Gaps = 22/210 (10%)
Query: 393 DLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIP 452
+ + V + G+ +S + + + L+ L L L +N I P
Sbjct: 25 AAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQITDLAP 80
Query: 453 EEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSL------ 506
+ L+ + K + L ++ L
Sbjct: 81 LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQ 140
Query: 507 --------MRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQ 558
LS N L L L + ++N +S +SL L
Sbjct: 141 ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLI 198
Query: 559 YLNLSDNAFTGDIPATYGFLRSLVFLSLSH 588
++L +N + P +L ++L++
Sbjct: 199 EVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 15/71 (21%), Positives = 29/71 (40%), Gaps = 2/71 (2%)
Query: 103 HSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISAD 162
+ S L S L + N S PL+ +L NL+ +++ +N +S
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSPLA 214
Query: 163 ISPSLRYLDLS 173
+ +L + L+
Sbjct: 215 NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 9e-04
Identities = 33/231 (14%), Positives = 66/231 (28%), Gaps = 24/231 (10%)
Query: 323 QNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDE 382
Q I +FP + + + + + + A LD + L ++ + +
Sbjct: 5 QPTAINVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EG 58
Query: 383 IAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNL 442
+ + L +L+ N+ + P +S I + T
Sbjct: 59 VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ 118
Query: 443 SENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPY--------------DVGNLKGLLVL 488
+ + L + + G + NL L L
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178
Query: 489 NLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLE 539
+ S P + SL L + L N +S P+ +L +V+L
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 14/59 (23%), Positives = 26/59 (44%), Gaps = 2/59 (3%)
Query: 139 IFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLS 197
+ NL+ L L N +S P+L + L +N + P ++ S L ++ L+
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.4 bits (134), Expect = 8e-09
Identities = 43/333 (12%), Positives = 95/333 (28%), Gaps = 34/333 (10%)
Query: 183 GNFSSKSQ-LQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHL----YGTLPSAISNCS 237
FS + + L+L ++ V A + + ++ + L N + L I++
Sbjct: 1 ARFSIEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 238 SLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQL 297
L D + L++L + + L V + N +G + ++
Sbjct: 60 DLEIAEFSDIFTGRVKDEIP---EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 116
Query: 298 GFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPA 357
+ + + N LR + N
Sbjct: 117 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 176
Query: 358 AVGS----LDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFS---------GQVP 404
L +++ N + + + L +L+ +
Sbjct: 177 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236
Query: 405 AFLGGIRGLKIVSLGRNMFSGLIP------LSFGNLSQLETLNLSENDIRGNIPEEI--- 455
L L+ + L + S S L+TL L N+I + +
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 456 --TRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
++ +L L L+ N+F + V ++ +
Sbjct: 297 IDEKMPDLLFLELNGNRFSEE-DDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.8 bits (122), Expect = 2e-07
Identities = 47/328 (14%), Positives = 87/328 (26%), Gaps = 34/328 (10%)
Query: 411 RGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGN----IPEEITRLSNLTTLNL 466
+ LK+ ++ + ++ + LS N I + E I +L
Sbjct: 8 KSLKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 467 SYN---KFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGEL 523
S + ++P + L L+ + LS L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 524 PIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDI----PATYGFLR 579
+ GL + V + + L+ + N T+ R
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 580 SLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIK--------- 630
L + + N I L EL+ N + +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 631 KLDLGQNKLSGEIPKEISKC------SSLVSLTLDMNSLSGRIPES-----FSKLSNLTT 679
+L L LS + L +L L N + + K+ +L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 680 LNLSTNRLS--GAIPADLALISSLRYLN 705
L L+ NR S + ++ + S R
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 13/69 (18%), Positives = 23/69 (33%), Gaps = 6/69 (8%)
Query: 152 HNLLSGKISADISPSLRYLDLSSNAFTGEIP-----GNFSSKSQLQLINLSYNSFSGEVP 206
+ S + L+ L L N + L + L+ N FS E
Sbjct: 260 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE-D 318
Query: 207 ASVGQLQEL 215
V +++E+
Sbjct: 319 DVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 44/345 (12%), Positives = 87/345 (25%), Gaps = 47/345 (13%)
Query: 137 LSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGE----IPGNFSSKSQLQ 192
L + +T +V LL S++ + LS N E + N +SK L+
Sbjct: 10 LKLDAITTEDEKSVFAVLLE-------DDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62
Query: 193 LINLSYNS----------FSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHL 242
+ S + ++ + +L + L N T + + S
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 243 SAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAF 302
+ + G + L+ N+ P N ++ F
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182
Query: 303 TGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSL 362
+ V + + + + + S L A+ S
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242
Query: 363 DKLEVLRVANNSLSGLVPDEIAKC------SLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416
L L + + LS + LQ L+ N
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV------------ 290
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNL 461
L + + L L L+ N + + + +
Sbjct: 291 -------RTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 7e-04
Identities = 9/93 (9%), Positives = 29/93 (31%), Gaps = 8/93 (8%)
Query: 652 SLVSLTLDMNSLSGR----IPESFSKLSNLTTLNLSTNRLSG----AIPADLALISSLRY 703
S+ +L +++++ + + ++ + LS N + + ++A L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 704 LNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELC 736
S ++ + +L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 9e-04
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 8/91 (8%)
Query: 605 LEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKLSGE----IPKEISKCSSLVSL 656
+E L+ + T + + +K++ L N + E + + I+ L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 657 TLDMNSLSGRIPESFSKLSNLTTLNLSTNRL 687
E L L L +L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 15/95 (15%), Positives = 32/95 (33%), Gaps = 6/95 (6%)
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGK----VPYDVGNLKG 484
S S L+ ++ D + ++ + ++ + LS N G + + ++ + K
Sbjct: 3 FSIEGKS-LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNL 519
L + S +L L L L
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 9e-09
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 629 IKKLDLGQNKLSGEIPKEI-SKCSSLVSLTLDMNSLSGR----IPESFSKLSNLTTLNLS 683
I+ LD+ +LS E+ + LD L+ I + L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 684 TNRLSGAIPADLA-----LISSLRYLNLSRNN 710
+N L + ++ L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 1e-08
Identities = 19/81 (23%), Positives = 27/81 (33%), Gaps = 5/81 (6%)
Query: 652 SLVSLTLDMNSLS-GRIPESFSKLSNLTTLNLSTNRLSG----AIPADLALISSLRYLNL 706
+ SL + LS R E L + L L+ I + L + +L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 707 SRNNLEGEIPKMLSSRFNDPS 727
N L + PS
Sbjct: 63 RSNELGDVGVHCVLQGLQTPS 83
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 2e-08
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 460 NLTTLNLSYNKFGGK-VPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMR----LTTLDL 514
++ +L++ + + L+ V+ L G + I S +R L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 515 SNQNLSGELPIELFGLPSLQVVSLEENNLSG 545
+ L + +++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 2e-08
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 10/89 (11%)
Query: 650 CSSLVSLTLDMNSLSGR----IPESFSKLSNLTTLNLSTNRLSGAIPADLA-----LISS 700
S L L L +S + + +L L+LS N L A L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 701 LRYLNLSRNNLEGEIPKMLSS-RFNDPSI 728
L L L E+ L + + PS+
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 2e-08
Identities = 24/115 (20%), Positives = 38/115 (33%), Gaps = 27/115 (23%)
Query: 431 FGNLSQLETLNLSENDIRGN----IPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLL 486
S L L L++ D+ + + + +L L+LS N G + L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA---GILQLVESV 421
Query: 487 VLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGL----PSLQVVS 537
L L L + S E+ L L PSL+V+S
Sbjct: 422 RQPGC----------------LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 18/91 (19%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 580 SLVFLSLSHNQISGMIPAEL-GACSALEVLELRSNHFTGNIPVDIS----HLSRIKKLDL 634
+ L + ++S AEL +V+ L T DIS + +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 635 GQNKLSGEIPKEISKCSSLVSLTLDMNSLSG 665
N+L + + S + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 16/95 (16%), Positives = 29/95 (30%), Gaps = 9/95 (9%)
Query: 564 DNAFTGDIPATYGFLRSLVFLSLSHNQISGM----IPAELGACSALEVLELRSNHFTGNI 619
D L L L+ +S + A L A +L L+L +N
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 620 PVDIS-----HLSRIKKLDLGQNKLSGEIPKEISK 649
+ + +++L L S E+ +
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 20/113 (17%), Positives = 39/113 (34%), Gaps = 26/113 (23%)
Query: 509 LTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAF 567
+ +LD+ + LS EL L QVV L++ L+ + SS +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALR----------- 52
Query: 568 TGDIPATYGFLRSLVFLSLSHNQISGMIPAELGA-----CSALEVLELRSNHF 615
+L L+L N++ + + ++ L L++
Sbjct: 53 ---------VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 5e-07
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 11/85 (12%)
Query: 141 NLTNLLVLNVAHNLLSGKISADIS------PSLRYLDLSSNAFTGEIPGNFSS-----KS 189
+ L VL +A +S + ++ SLR LDLS+N
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 190 QLQLINLSYNSFSGEVPASVGQLQE 214
L+ + L +S E+ + L++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 389 LQMFDLEGNRFS-GQVPAFLGGIRGLKIVSLGRNMFSG----LIPLSFGNLSQLETLNLS 443
+Q D++ S + L ++ ++V L + I + L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 444 ENDIRGNIPEEITRL-----SNLTTLNLSYNKF 471
N++ + + + L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 16/100 (16%), Positives = 31/100 (31%), Gaps = 13/100 (13%)
Query: 594 MIPAELGACSALEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKLSGEIPKEISK 649
+ S L VL L + + + + +++LDL N L ++ +
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 650 -----CSSLVSLTLDMNSLSGRIPESFSKLS----NLTTL 680
L L L S + + L +L +
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 9e-06
Identities = 19/83 (22%), Positives = 30/83 (36%), Gaps = 9/83 (10%)
Query: 312 RCVSVLEVLDLQNNRIR----AVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGS-----L 362
+ SVL VL L + + + + L SLR +DLS N +
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 363 DKLEVLRVANNSLSGLVPDEIAK 385
LE L + + S + D +
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 16/93 (17%), Positives = 29/93 (31%), Gaps = 12/93 (12%)
Query: 144 NLLVLNVAHNLLSGKISADISP---SLRYLDLSSNAFTGE----IPGNFSSKSQLQLINL 196
++ L++ LS A++ P + + L T I L +NL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 197 SYNSFSGEVPASVGQL-----QELEYLWLDSNH 224
N V Q +++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 16/75 (21%), Positives = 27/75 (36%), Gaps = 9/75 (12%)
Query: 507 MRLTTLDLSNQNLSGE----LPIELFGLPSLQVVSLEENNLSGDVPEGFSSLV-----GL 557
L L L++ ++S L L SL+ + L N L V L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 558 QYLNLSDNAFTGDIP 572
+ L L D ++ ++
Sbjct: 429 EQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 14/89 (15%), Positives = 28/89 (31%), Gaps = 10/89 (11%)
Query: 413 LKIVSLGRNMFSGL-IPLSFGNLSQLETLNLSENDIRG----NIPEEITRLSNLTTLNLS 467
++ + + S L Q + + L + + +I + L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 468 YNKFGGKVPYDVG-----NLKGLLVLNLS 491
N+ G + V + L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 13/92 (14%), Positives = 29/92 (31%), Gaps = 12/92 (13%)
Query: 96 ELRKLSLHSNHLNGS-IPASLHQCSLLRAVYLQYNSFSG----HLPLSIFNLTNLLVLNV 150
+++ L + L+ + L + V L + + ++ L LN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 151 AHNLLSGKISADI-------SPSLRYLDLSSN 175
N L + S ++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/90 (15%), Positives = 28/90 (31%), Gaps = 10/90 (11%)
Query: 164 SPSLRYLDLSSNAFTGE-IPGNFSSKSQLQLINLSYNSFSGE----VPASVGQLQELEYL 218
S ++ LD+ + Q Q++ L + + +++ L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 219 WLDSNHLYGTLPSAI-----SNCSSLVHLS 243
L SN L + + + LS
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 3e-05
Identities = 16/90 (17%), Positives = 28/90 (31%), Gaps = 7/90 (7%)
Query: 121 LRAVYLQYNSFS-GHLPLSIFNLTNLLVLNVAHNLLSGKISADIS------PSLRYLDLS 173
++++ +Q S + L V+ + L+ DIS P+L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 174 SNAFTGEIPGNFSSKSQLQLINLSYNSFSG 203
SN Q + S
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 12/89 (13%), Positives = 26/89 (29%), Gaps = 9/89 (10%)
Query: 404 PAFLGGIRGLKIVSLGRNMFSGL----IPLSFGNLSQLETLNLSENDIRGNIPEEITR-- 457
L+++ L S + + L L+LS N + ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 458 ---LSNLTTLNLSYNKFGGKVPYDVGNLK 483
L L L + ++ + L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 6e-05
Identities = 17/61 (27%), Positives = 22/61 (36%), Gaps = 4/61 (6%)
Query: 671 FSKLSNLTTLNLSTNRLSG----AIPADLALISSLRYLNLSRNNLEGEIPKMLSSRFNDP 726
S L L L+ +S ++ A L SLR L+LS N L L P
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 727 S 727
Sbjct: 425 G 425
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 15/80 (18%), Positives = 27/80 (33%), Gaps = 9/80 (11%)
Query: 531 PSLQVVSLEENNLSGD----VPEGFSSLVGLQYLNLSDNAFTGDIP-----ATYGFLRSL 581
L+V+ L + ++S + + L+ L+LS+N + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 582 VFLSLSHNQISGMIPAELGA 601
L L S + L A
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 10/74 (13%), Positives = 25/74 (33%), Gaps = 5/74 (6%)
Query: 340 SLRVMDLSGNFFSGN-LPAAVGSLDKLEVLRVANNSLSGLVPDEIAK----CSLLQMFDL 394
++ +D+ S + L + +V+R+ + L+ +I+ L +L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 395 EGNRFSGQVPAFLG 408
N +
Sbjct: 63 RSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 19/112 (16%), Positives = 35/112 (31%), Gaps = 29/112 (25%)
Query: 191 LQLINLSYNSFSGE-VPASVGQLQELEYLWLDSNHL----YGTLPSAISNCSSLVHLSAE 245
+Q +++ S + LQ+ + + LD L + SA+ +L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN-- 61
Query: 246 DNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQL 297
L NEL + VL L ++ + L
Sbjct: 62 ----------------------LRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 18/83 (21%), Positives = 31/83 (37%), Gaps = 9/83 (10%)
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMR----LTTLDLSNQNLSGELPIELFG-----LP 531
L VL L+ S S+ + + L LDLSN L ++L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 532 SLQVVSLEENNLSGDVPEGFSSL 554
L+ + L + S ++ + +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 21/119 (17%), Positives = 36/119 (30%), Gaps = 26/119 (21%)
Query: 182 PGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVH 241
G S L+++ L+ S +S L + + SL
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSS--------------------LAATLLANHSLRE 401
Query: 242 LSAEDNVL-----KGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIV 295
L +N L L+ L+ L L + + L L + SLR++
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME-DRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 10/91 (10%), Positives = 26/91 (28%), Gaps = 4/91 (4%)
Query: 291 SLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAV----FPSWLTNVTSLRVMDL 346
++ + + + + +V+ L + + S L +L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 347 SGNFFSGNLPAAVGSLDKLEVLRVANNSLSG 377
N V + ++ SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 31/119 (26%), Positives = 45/119 (37%), Gaps = 5/119 (4%)
Query: 98 RKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSG 157
R L L L ++ L Q L+ + L +N P ++ L L VL + N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 158 KISADISPSLRYLDLSSNAFTG-EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQEL 215
P L+ L L +N S +L L+NL NS E +L E+
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE-EGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 6/109 (5%)
Query: 439 TLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGK 498
L+L+ D+ + + +L +T L+LS+N+ P + L+ L VL AS + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALE 56
Query: 499 IPGSIGSLMRLTTLDLSNQNL-SGELPIELFGLPSLQVVSLEENNLSGD 546
+ +L RL L L N L L P L +++L+ N+L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 4e-08
Identities = 25/123 (20%), Positives = 40/123 (32%), Gaps = 6/123 (4%)
Query: 584 LSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEI 643
L L+H ++ + L + L+L N P ++ L ++ L N E
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57
Query: 644 PKEISKCSSLVSLTLDMNSL-SGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLR 702
++ L L L N L + L LNL N L L L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 703 YLN 705
++
Sbjct: 118 SVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 29/109 (26%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 607 VLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR 666
VL L T + + L + LDL N+L P ++ L L + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALE 56
Query: 667 IPESFSKLSNLTTLNLSTNRL-SGAIPADLALISSLRYLNLSRNNLEGE 714
+ + L L L L NRL A L L LNL N+L E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 4e-07
Identities = 22/110 (20%), Positives = 41/110 (37%), Gaps = 6/110 (5%)
Query: 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYG 227
R L L+ T + + + ++LS+N P ++ L+ LE L ++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNAL 55
Query: 228 TLPSAISNCSSLVHLSAEDNVLKGL-IPGTIGRISTLQVLSLSRNELTGL 276
++N L L +N L+ + L +L+L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 29/127 (22%), Positives = 49/127 (38%), Gaps = 9/127 (7%)
Query: 534 QVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISG 593
+V+ L +L+ V L+ + +L+LS N PA LR L L S N +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNAL-- 55
Query: 594 MIPAELGACSALEVLELRSNHFTGNIPVD-ISHLSRIKKLDLGQNKLSGE---IPKEISK 649
+ L+ L L +N + + + R+ L+L N L E +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 650 CSSLVSL 656
S+ S+
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 26/112 (23%), Positives = 44/112 (39%), Gaps = 6/112 (5%)
Query: 367 VLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGL 426
VL +A+ L+ L + + L+ DL NR PA +R L+++ N +
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALENV 58
Query: 427 IPLSFGNLSQLETLNLSENDIRG-NIPEEITRLSNLTTLNLSYNKFGGKVPY 477
NL +L+ L L N ++ + + L LNL N +
Sbjct: 59 DG--VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 22/127 (17%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 342 RVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG 401
RV+ L+ + + L + L +++N L L P A +L + L+ + +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNAL 55
Query: 402 QVPAFLGGIRGLKIVSLGRNMFSGLIPL-SFGNLSQLETLNLSEN---DIRGNIPEEITR 457
+ + + L+ + L N + + +L LNL N G
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 458 LSNLTTL 464
L +++++
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 29/118 (24%), Positives = 48/118 (40%), Gaps = 5/118 (4%)
Query: 147 VLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVP 206
VL++AH L+ + + +LDLS N P + + L L + + E
Sbjct: 2 VLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRC---LEVLQASDNALENV 58
Query: 207 ASVGQLQELEYLWLDSNHL-YGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTL 263
V L L+ L L +N L + +C LV L+ + N L G R++ +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 14/104 (13%)
Query: 264 QVLSLSRNELTGLVPVSVLCNL-------------WGNISSLRIVQLGFNAFTGVVKPPN 310
+VL L+ +LT L + L + +++LR +++ + +
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 311 GRCVSVLEVLDLQNNRIRAV-FPSWLTNVTSLRVMDLSGNFFSG 353
+ L+ L L NNR++ L + L +++L GN
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 29/156 (18%), Positives = 53/156 (33%), Gaps = 40/156 (25%)
Query: 192 QLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKG 251
++++L++ + V + QL + +L L N L P+ ++ L L A DN L+
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 252 LIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNG 311
+ Q L L N L + L +
Sbjct: 58 VDGVANLPRL--QELLLCNNRLQQSAAIQPLVSC-------------------------- 89
Query: 312 RCVSVLEVLDLQNNRI------RAVFPSWLTNVTSL 341
L +L+LQ N + + L +V+S+
Sbjct: 90 ---PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 4e-08
Identities = 24/86 (27%), Positives = 33/86 (38%), Gaps = 9/86 (10%)
Query: 636 QNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADL 695
N S EI SL L + N L +P L L S N L+ +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE-- 321
Query: 696 ALISSLRYLNLSRNNLEGEIPKMLSS 721
L +L+ L++ N L E P + S
Sbjct: 322 -LPQNLKQLHVEYNPLR-EFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 5e-08
Identities = 58/374 (15%), Positives = 108/374 (28%), Gaps = 37/374 (9%)
Query: 48 ALDGWDSSTPSAPCDWRGIV------CYNNRVRELRLPRLQLAGRLTDQLADLHELRKLS 101
A W+ + P + R + C + + EL L L L+ L + L L
Sbjct: 9 AWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLV 64
Query: 102 LHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISA 161
N L +P L+++ + N+ ++ +L LL N K+
Sbjct: 65 ASCNSLT-ELPELPQS---LKSLLVDNNNLK-----ALSDLPPLLEYLGVSNNQLEKLPE 115
Query: 162 DISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLD 221
+ S + N ++P S + N + L
Sbjct: 116 LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175
Query: 222 SNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSV 281
+I ++++ E L L + L +
Sbjct: 176 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE-------- 227
Query: 282 LCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSL 341
+ + +L + V +S L N S SL
Sbjct: 228 -ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 286
Query: 342 RVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSG 401
+++S N LPA +LE L + N L+ + P+ L+ +E N
Sbjct: 287 EELNVSNNKLI-ELPA---LPPRLERLIASFNHLAEV-PELPQN---LKQLHVEYNPLR- 337
Query: 402 QVPAFLGGIRGLKI 415
+ P + L++
Sbjct: 338 EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 561 NLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIP 620
NA + +I + SL L++S+N++ +PA LE L NH +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVP 320
Query: 621 VDISHLSRIKKLDLGQNKLSGEIPKEISKCSSL 653
+L K+L + N L E P L
Sbjct: 321 ELPQNL---KQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 1e-06
Identities = 18/94 (19%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 514 LSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPA 573
S E+ PSL+ +++ N L ++P L + L S N ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVP- 320
Query: 574 TYGFLRSLVFLSLSHNQISGMIPAELGACSALEV 607
++L L + +N + P + L +
Sbjct: 321 --ELPQNLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 1e-06
Identities = 21/115 (18%), Positives = 32/115 (27%), Gaps = 33/115 (28%)
Query: 421 NMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVG 480
N S I LE LN+S N + +P L L S+N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHL--------- 316
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQV 535
++P + L L + L E P + L++
Sbjct: 317 ----------------AEVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 1e-05
Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 7/94 (7%)
Query: 102 LHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISA 161
+ N + I + L + + N LP L L + N L+ ++
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE 321
Query: 162 DISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLIN 195
+L+ L + N E P S L++ +
Sbjct: 322 LP-QNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 19/64 (29%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 658 LDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPK 717
+N+ S I +L LN+S N+L +P AL L L S N+L E+P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPE 321
Query: 718 MLSS 721
+ +
Sbjct: 322 LPQN 325
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 4e-04
Identities = 14/47 (29%), Positives = 21/47 (44%), Gaps = 5/47 (10%)
Query: 675 SNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKMLSS 721
L L+ LS ++P L L L S N+L E+P++ S
Sbjct: 38 RQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQS 79
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.003
Identities = 16/57 (28%), Positives = 26/57 (45%), Gaps = 5/57 (8%)
Query: 435 SQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLS 491
Q L L+ + ++PE +L +L S N ++P +LK LLV N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNN 89
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.003
Identities = 20/91 (21%), Positives = 33/91 (36%), Gaps = 8/91 (8%)
Query: 650 CSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRN 709
L L+ LS +PE +L +L S N L+ +P L SL+ L + N
Sbjct: 37 DRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELP---ELPQSLKSLLVDNN 88
Query: 710 NLEGEIPKMLSSRFNDPSIFAMNRELCGKPL 740
NL+ + S + + +
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNS 119
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (123), Expect = 9e-08
Identities = 31/235 (13%), Positives = 64/235 (27%), Gaps = 34/235 (14%)
Query: 510 TTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTG 569
++ E+P +L + + L FS L+ + +S N
Sbjct: 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 570 DIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRI 629
I A + + + + + L ++ D+ + +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 630 KK----------------------------LDLGQNKLSGEIPKEISKCSSLVSLTLDMN 661
+K L L +N + + D N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 662 SLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIP 716
+L + F S L++S R+ L + LR + NL+ ++P
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 4e-05
Identities = 28/241 (11%), Positives = 60/241 (24%), Gaps = 6/241 (2%)
Query: 230 PSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNI 289
I +CS+ V +++ + IP + L +L + ++
Sbjct: 2 HHRICHCSNRV-FLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVI-QKGAFSGFG-DL 55
Query: 290 SSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGN 349
+ I Q N + + + N ++ +G
Sbjct: 56 EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 115
Query: 350 FFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGG 409
++ L ++ N + + + L N G
Sbjct: 116 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG 175
Query: 410 IRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYN 469
+ ++ N L F S L++S I + L L +
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
Query: 470 K 470
K
Sbjct: 236 K 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 27/222 (12%), Positives = 57/222 (25%), Gaps = 4/222 (1%)
Query: 159 ISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYL 218
I +D+ + L G FS L+ I +S N + A V L
Sbjct: 23 IPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL--PKL 80
Query: 219 WLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVP 278
L + + I + + + +
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 279 VSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNV 338
++ N + +S ++ + + E+ NN + +
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVP 380
+ ++D+S + +L KL +L L
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 20/233 (8%), Positives = 56/233 (24%), Gaps = 5/233 (2%)
Query: 166 SLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHL 225
S R + T EIP + + + +LE + + N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 226 YGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNL 285
+ + + + +H + L + + L + + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG--IKHLPDVHK 123
Query: 286 WGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMD 345
++ + + + + +L L N I+ + +
Sbjct: 124 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL 183
Query: 346 LSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNR 398
N +L ++ + L + L+ +
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 42/245 (17%), Positives = 69/245 (28%), Gaps = 28/245 (11%)
Query: 61 CDWRGIVCYNNRVREL--RLPRLQLAGRLTDQLADLHELRKLSLHSNHLNGSIPASLHQC 118
C R +C ++V E+ LPR +L L +
Sbjct: 8 CSNRVFLCQESKVTEIPSDLPR---------------NAIELRFVLTKLRVIQKGAFSGF 52
Query: 119 SLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFT 178
L + + N + +F+ L + +
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 179 GEIPGN------FSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSA 232
I S + L I + N + E + VG E LWL+ N + A
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 233 ISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSL 292
+ +++N L+ L S +L +SR + L P L NL L
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL-PSYGLENL----KKL 227
Query: 293 RIVQL 297
R
Sbjct: 228 RARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 32/234 (13%), Positives = 64/234 (27%), Gaps = 10/234 (4%)
Query: 439 TLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGK 498
E+ + IP ++ N L K L + +S +
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 499 IPGSIGSLMRLTTLDL----SNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554
I + S + +N + ++S DV + S
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 555 VGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNH 614
L + + N T + + G V L L+ N I + E+ +N+
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 615 FTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIP 668
S LD+ + ++ + L + +L ++P
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 28/241 (11%), Positives = 55/241 (22%), Gaps = 11/241 (4%)
Query: 309 PNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVL 368
+ C V Q +++ + N L A LE +
Sbjct: 2 HHRICHCSNRVFLCQESKVTEIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKI 58
Query: 369 RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIP 428
++ N + ++ ++ + + L +
Sbjct: 59 EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118
Query: 429 LSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTT----LNLSYNKFGGKVPYDVGNLKG 484
+ L+ + L D E L+ L L+ N +
Sbjct: 119 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQL 178
Query: 485 LLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELF-GLPSLQVVSLEENNL 543
+ + LD+S + LP L L+ S NL
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNL 235
Query: 544 S 544
Sbjct: 236 K 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 29/222 (13%), Positives = 58/222 (26%), Gaps = 14/222 (6%)
Query: 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRV----AN 372
L ++R + + L +++S N + A V S N
Sbjct: 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90
Query: 373 NSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFG 432
+ + G + V + L + N+ + G
Sbjct: 91 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 150
Query: 433 NLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA 492
+ L L++N I+ N G ++L++S
Sbjct: 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 210
Query: 493 SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQ 534
+ + +L +L N L LP+L+
Sbjct: 211 TRIHSLPSYGLENLKKLRARSTYN----------LKKLPTLE 242
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 42/203 (20%), Positives = 75/203 (36%), Gaps = 16/203 (7%)
Query: 481 NLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEE 540
+ NL + + + L + + +N ++ I+ LP++ + L
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 541 NNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELG 600
N L+ P ++L L +L L +N SLS L
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLK----KLKSLSLEHNGISDINGLV 131
Query: 601 ACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDM 660
LE L L +N T + L+++ L L N++S +P ++ + L +L L
Sbjct: 132 HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 661 NSLSGRIPESFSKLSNLTTLNLS 683
N +S + + L NL L L
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 32/214 (14%), Positives = 77/214 (35%), Gaps = 26/214 (12%)
Query: 513 DLSNQNLSGELPI-ELFGLPSLQVV---SLEENNLSGDVPEGFSSLVGLQYLNLSDNAFT 568
L ++ ++ PI ++F + +L++ +++ V + + L + + +++
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK 59
Query: 569 GDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFT------------ 616
+L ++ L L+ N+++ + P L+
Sbjct: 60 SVQGI--QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117
Query: 617 ---GNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSK 673
N DI+ L + +L+ + + + + ++ I +
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAG 176
Query: 674 LSNLTTLNLSTNRLSGAIPADLALISSLRYLNLS 707
L+ L L LS N +S + A LA + +L L L
Sbjct: 177 LTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 16/196 (8%)
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476
+L + + + + L+ ++ + + +DI+ I L N+T L L+ NK
Sbjct: 30 NLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD--I 83
Query: 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVV 536
+ NLK L L L + ++ LS ++ L LP L+ +
Sbjct: 84 KPLANLKNLGWLFLDENKVKDLSSLKDLKKLK----SLSLEHNGISDINGLVHLPQLESL 139
Query: 537 SLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIP 596
L N ++ L L L+L DN + +P L L L LS N IS +
Sbjct: 140 YLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-- 193
Query: 597 AELGACSALEVLELRS 612
L L+VLEL S
Sbjct: 194 RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 30/194 (15%), Positives = 58/194 (29%), Gaps = 21/194 (10%)
Query: 288 NISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLS 347
+ L + T V ++ ++ + N+ I++V + + ++ + L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNE---LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 348 GNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFL 407
GN + P A L + D SL + + L
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 408 GGIRGLKIVSLGRNMFSGLI--------------PLSFGNLSQLETLNLSENDIRGNIPE 453
+ + S L + L++L+ L LS+N I
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LR 194
Query: 454 EITRLSNLTTLNLS 467
+ L NL L L
Sbjct: 195 ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 28/192 (14%), Positives = 64/192 (33%), Gaps = 14/192 (7%)
Query: 189 SQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
++ NL S + V + +L ++ + +++ + I ++ L N
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNK 79
Query: 249 LKGLIPGTIGRISTLQVLSLSRNELTG--LVPVSVLCNLWGNISSLRIVQLGFNAFTGVV 306
L + P + L ++ + + + I L +
Sbjct: 80 LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 307 KPPNGRCVSVLEVLDLQNNRIRAVFPSW------LTNVTSLRVMDLSGNFFSGNLPAAVG 360
N + + + L ++ + L +T L+ + LS N S +L A+
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALA 197
Query: 361 SLDKLEVLRVAN 372
L L+VL + +
Sbjct: 198 GLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 30/204 (14%), Positives = 66/204 (32%), Gaps = 20/204 (9%)
Query: 205 VPASVGQ------LQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIG 258
VP + Q E L + + + +S+ + A ++ +K + I
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQ 65
Query: 259 RISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLE 318
+ + L L+ N+LT + P++ L NL V+ + + +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 319 VLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPA--------AVGSLDKLEVLRV 370
++ + + N + + + L KL+ L +
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185
Query: 371 ANNSLSGLVPDEIAKCSLLQMFDL 394
+ N +S L +A L + +L
Sbjct: 186 SKNHISDL--RALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 36/193 (18%), Positives = 69/193 (35%), Gaps = 12/193 (6%)
Query: 93 DLHELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAH 152
E K +L + ++ + + + + + + I L N+ L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 153 NLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQL 212
N L+ L L F E S + S + + G +
Sbjct: 78 NKLTDI------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 213 QELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNE 272
+ L + T + +S + L LS EDN + ++P + ++ LQ L LS+N
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189
Query: 273 LTGLVPVSVLCNL 285
++ L ++ L NL
Sbjct: 190 ISDLRALAGLKNL 202
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 2e-06
Identities = 25/156 (16%), Positives = 58/156 (37%), Gaps = 6/156 (3%)
Query: 513 DLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIP 572
+L + + +L + + +L+ L D + LN + +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSD--PDLVAQNIDVVLNRRSS-MAATLR 58
Query: 573 ATYGFLRSLVFLSLSHNQISGM--IPAELGACSALEVLELRSNHFTGNIPVDISHLSRIK 630
+ L+ L+LS+N++ + + + + L++L L N +D +++
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 631 KLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGR 666
+L L N LS + + S++ + L G
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 25/156 (16%), Positives = 45/156 (28%), Gaps = 26/156 (16%)
Query: 441 NLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIP 500
L + + +++ + + L + D+ +VLN S + +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 501 GSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYL 560
++ L +L+LSN L D+ L+ L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRL----------------------DDMSSIVQKAPNLKIL 96
Query: 561 NLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIP 596
NLS N + L L L N +S
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 1e-05
Identities = 30/157 (19%), Positives = 45/157 (28%), Gaps = 6/157 (3%)
Query: 586 LSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPK 645
L Q+ + + L D+ + L+ ++ ++ +
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNR-RSSMAATLRI 59
Query: 646 EISKCSSLVSLTLDMNSLSGR--IPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRY 703
L+SL L N L + K NL LNLS N L D L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 704 LNLSRNNLEGEIPKMLSSRFNDPSIFAMNRELCGKPL 740
L L N+L + F L G L
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHEL 156
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 5/136 (3%)
Query: 110 SIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSG-KISADISPSLR 168
+ + + L + +VLN ++ + +I + P L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 169 YLDLSSNAFTG--EIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLY 226
L+LS+N ++ L+++NLS N E + +LE LWLD N L
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 227 GTLPSAISNCSSLVHL 242
T + S++
Sbjct: 129 DTFRDQSTYISAIRER 144
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 5e-06
Identities = 29/177 (16%), Positives = 59/177 (33%), Gaps = 32/177 (18%)
Query: 439 TLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA------ 492
T++ + ++ IP +I + T L L+ N+ G + LV
Sbjct: 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 493 -------------------SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSL 533
+ L +L TL+L + +S +P L SL
Sbjct: 69 IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128
Query: 534 QVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQ 590
++L N + + + + + +L+ A P+ +R + L H++
Sbjct: 129 TSLNLASNPFNCNCHLAWFAEWLRK-KSLNGGAARCGAPSK---VRDVQIKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 32/171 (18%), Positives = 57/171 (33%), Gaps = 11/171 (6%)
Query: 159 ISADISPSLRYLDLSSNAFTGEI-PGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEY 217
I DI L L+ N G F L + L N +G P + ++
Sbjct: 23 IPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82
Query: 218 LWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLV 277
L L N + L L+ DN + ++PG+ +++L L+L+ N
Sbjct: 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142
Query: 278 PVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIR 328
++ S L A V +++ DL ++ +
Sbjct: 143 HLAWFAEWLRKKS------LNGGAARCGAPSK----VRDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 36/208 (17%), Positives = 65/208 (31%), Gaps = 30/208 (14%)
Query: 312 RCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVA 371
C +D ++ + + T L L+ N
Sbjct: 5 MCHCEGTTVDCTGRGLKEIPRDIPLHTTEL---LLNDNELGRISS--------------- 46
Query: 372 NNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF 431
+ L +L+ N+ +G P G ++ + LG N + F
Sbjct: 47 --------DGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMF 98
Query: 432 GNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLS 491
L QL+TLNL +N I +P L++LT+LN + + + L +L+
Sbjct: 99 LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLN 157
Query: 492 ASGFSGKIPGSIGSLMRLTTLDLSNQNL 519
P + + DL +
Sbjct: 158 GGAARCGAP---SKVRDVQIKDLPHSEF 182
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (105), Expect = 9e-06
Identities = 24/137 (17%), Positives = 45/137 (32%), Gaps = 7/137 (5%)
Query: 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394
TN R +DL G + +LD+ + + ++N + L D L+ +
Sbjct: 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLV 70
Query: 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSF-GNLSQLETLNLSE---NDIRGN 450
NR + L + L N L L +L L L + + +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 451 IPEEITRLSNLTTLNLS 467
I ++ + L+
Sbjct: 131 RLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 8e-04
Identities = 25/138 (18%), Positives = 47/138 (34%), Gaps = 8/138 (5%)
Query: 402 QVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNL 461
Q + +R + + L I L Q + ++ S+N+I + L L
Sbjct: 10 QAAQYTNAVR-DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRL 65
Query: 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSG-KIPGSIGSLMRLTTLDLSNQN-- 518
TL ++ N+ L L L L+ + + SL LT L +
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 519 -LSGELPIELFGLPSLQV 535
++ +P ++V
Sbjct: 126 NKKHYRLYVIYKVPQVRV 143
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.001
Identities = 24/177 (13%), Positives = 51/177 (28%), Gaps = 30/177 (16%)
Query: 507 MRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNA 566
++LT L + + + + L + + ++L ++ SDN
Sbjct: 1 VKLT------AELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE 52
Query: 567 FTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHL 626
+ LR L L +++N+I + A L L L +N ++ L
Sbjct: 53 I--RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDL 105
Query: 627 SRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLS 683
+ L P + + K+ + L+
Sbjct: 106 DPLASLKSLTYLCILRNP---------------VTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 34/199 (17%), Positives = 65/199 (32%), Gaps = 16/199 (8%)
Query: 506 LMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDN 565
L L N++ + L + + + + +G L L +N S+N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 566 AFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISH 625
T P L L+ + + A F I
Sbjct: 73 QLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 626 LSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTN 685
+ L + + +S +SL L N ++ P + L+ L L++S+N
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 686 RLSGAIPADLALISSLRYL 704
++S + LA +++L L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 31/193 (16%), Positives = 66/193 (34%), Gaps = 25/193 (12%)
Query: 288 NISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLS 347
++ LG T V + + + L I+++ + + +L ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTD---LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 70
Query: 348 GNFFSGNL----------------PAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQM 391
N + A + + + D +L +
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 392 FDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNI 451
LE + + + L G+ L+ ++ N + L P NL+ LE L++S N +
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD-- 186
Query: 452 PEEITRLSNLTTL 464
+ +L+NL +L
Sbjct: 187 ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 40/192 (20%), Positives = 69/192 (35%), Gaps = 16/192 (8%)
Query: 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVP 476
LG+ + + + +L Q+ TL I+ +I + + L+NLT +N S N+ P
Sbjct: 24 VLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP 79
Query: 477 YDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVV 536
+++N + + + + L
Sbjct: 80 LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN-------- 131
Query: 537 SLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIP 596
LE ++ + S L LQ LN S N T P L +L L +S N++S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--I 187
Query: 597 AELGACSALEVL 608
+ L + LE L
Sbjct: 188 SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 43/195 (22%), Positives = 79/195 (40%), Gaps = 14/195 (7%)
Query: 92 ADLHELRKLSLHSNHLNGSIP-ASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNV 150
L E K L ++ ++ L Q + L+A L S G + L NL +N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 69
Query: 151 AHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVG 210
++N L+ L + +++N P + + + + +
Sbjct: 70 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK---- 125
Query: 211 QLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSR 270
L L L L SN + SA+S +SL L+ N + L P + ++TL+ L +S
Sbjct: 126 NLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 271 NELTGLVPVSVLCNL 285
N+++ + ++ L NL
Sbjct: 182 NKVSDISVLAKLTNL 196
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 23/188 (12%), Positives = 56/188 (29%), Gaps = 14/188 (7%)
Query: 189 SQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNV 248
++ L + + V + L ++ L D + + ++L ++ +N
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQ 73
Query: 249 LKG--------LIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFN 300
L + + + + ++ N + + L
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133
Query: 301 AFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVG 360
+ + + L + + L N+T+L +D+S N S + +
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLA 191
Query: 361 SLDKLEVL 368
L LE L
Sbjct: 192 KLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 38/224 (16%), Positives = 77/224 (34%), Gaps = 40/224 (17%)
Query: 433 NLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSA 492
L++ L + ++ + + L +TTL + ++ G
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG--------IKSIDG-------- 57
Query: 493 SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFS 552
+ L LT ++ SN L+ P++ +++ + +
Sbjct: 58 ----------VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLT- 106
Query: 553 SLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRS 612
L+ L +L L LS N IS + + L S
Sbjct: 107 -----NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL--QQLNFSS 159
Query: 613 NHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSL 656
N T P +++L+ +++LD+ NK+S ++K ++L SL
Sbjct: 160 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1133 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.23 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.16 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.32 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.28 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.99 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.53 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.19 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.88 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.7 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.64 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=421.34 Aligned_cols=256 Identities=23% Similarity=0.406 Sum_probs=203.8
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++|++.+.||+|+||+||+|++++++.||||++.......++|.+|++++++++|||||+++|++...+. .++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-ICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCc-eEEEEEecC
Confidence 4688999999999999999999989999999998877778899999999999999999999999987655 499999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.+++.... ..+++..+..++.|||+||+|||+++|+||||||+||++++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--T 157 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc--e
Confidence 999999987643 3488999999999999999999999999999999999999999999999999976533221 2
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......||+.|+|||++.+..++.++|||||||++|||+| |++||......++...+....+. . .+..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~-----~p~~----- 226 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-Y-----KPRL----- 226 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-C-----CCTT-----
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-C-----Cccc-----
Confidence 2334578999999999999999999999999999999999 56666665665555554442111 0 1100
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.. ....+++.+||+.||++|||++||+++|+++..
T Consensus 227 ~~------~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 AS------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp SC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 00 112378999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=411.19 Aligned_cols=254 Identities=20% Similarity=0.375 Sum_probs=214.1
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++|++.++||+|+||+||+|++++++.||||+++.+....++|.+|++++++++|||||+++|++.++. ..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-SEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-ceEEEEEccC
Confidence 578999999999999999999998999999999887778889999999999999999999999998764 4599999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|++.+++..... .+++..+..++.|||+||+|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 83 ~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYT 156 (258)
T ss_dssp TEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS--SCC
T ss_pred CCcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC--Cce
Confidence 9999999876433 3889999999999999999999999999999999999999999999999999755332 222
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......++...+.+..+ .. .+..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~-----~p~~----- 225 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LY-----RPHL----- 225 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-CC-----CCTT-----
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC-CC-----Cccc-----
Confidence 3345679999999999999999999999999999999998 8999987777666655443211 01 1110
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.. + ...+++.+||+.||++|||++||+++|.++
T Consensus 226 ~~---~---~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 AS---E---KVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CC---H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cc---H---HHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 00 1 123789999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-48 Score=423.44 Aligned_cols=259 Identities=22% Similarity=0.386 Sum_probs=210.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.++|++.+.||+|+||+||+|.++ +|+.||||+++.+....++|.+|++++++++|||||++++++.+.+.. ++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-YIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC-EEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee-EEEeec
Confidence 457899999999999999999886 589999999987777788999999999999999999999999876544 999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.+++..... ..+++..+..++.|||+||+|||++||+||||||+|||+++++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-- 169 (287)
T d1opja_ 95 MTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-- 169 (287)
T ss_dssp CTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS--
T ss_pred ccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC--
Confidence 999999999976432 458999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCc-cCChhhHHHHHHHHhhhccccccccCCcCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVM-FTQDEDIVKWVKKQLQRGQISELLEPGLLEL 1073 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1133)
........|++.|+|||++.+..++.++|||||||++|||++|+.||. ..+...+.+.+..... .+. ...
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~----~~~-~~~---- 240 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----MER-PEG---- 240 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----CCC-CTT----
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC----CCC-Ccc----
Confidence 122334468899999999999999999999999999999999766654 4444444333322111 000 000
Q ss_pred CCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1074 DPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1074 ~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
.. + ...+++.+||+.||++|||++||++.|+.+...
T Consensus 241 --~~----~--~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 241 --CP----E--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --CC----H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --ch----H--HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 00 1 123789999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=414.67 Aligned_cols=259 Identities=21% Similarity=0.363 Sum_probs=200.2
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.++||+|+||+||+|+++. .||||++..... ..+.|.+|++++++++|||||++++++.++ ..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP--QLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc--EEEEEE
Confidence 4679999999999999999998753 499999864432 246788999999999999999999998653 358999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|+|.+++.... ..+++..+..++.|||+||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp ECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred ecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999997543 348999999999999999999999999999999999999999999999999997653222
Q ss_pred CCCCCCCCCCCCCCccCccccCC---CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHH-HHHHHhhhccccccccC
Q 001171 993 AEASSSTTPIGSLGYVSPEAAST---GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVK-WVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 1068 (1133)
.........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.......... .+.+........
T Consensus 159 -~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~----- 232 (276)
T d1uwha_ 159 -GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS----- 232 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG-----
T ss_pred -CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch-----
Confidence 1223345679999999999864 347889999999999999999999997655443332 222221111111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
....... + ...+++.+||+.||++|||++||+++|+.+..
T Consensus 233 ---~~~~~~~---~--~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 ---KVRSNCP---K--AMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ---GSCTTCC---H--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hccccch---H--HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111110 1 12278899999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=412.83 Aligned_cols=245 Identities=24% Similarity=0.408 Sum_probs=204.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||+||+|+++ +|+.||+|++.+. ....+.+.+|++++++++|||||++++++.+.. ..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-EEEEE
Confidence 57999999999999999999885 6899999998532 233567899999999999999999999998764 45999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred EeecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 99999999999998754 389999999999999999999999999999999999999999999999999965422
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.......||+.|||||++.+..++.++||||+||++|||++|+.||...+..+....+.+. ...+++.+
T Consensus 159 ----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~----- 227 (263)
T d2j4za1 159 ----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFV----- 227 (263)
T ss_dssp ----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTS-----
T ss_pred ----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccC-----
Confidence 2234467999999999999999999999999999999999999999877666655444321 11111100
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ...+++.+||+.||++|||++|++++
T Consensus 228 -----s~------~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 228 -----TE------GARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -----CH------HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----CH------HHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 01 12378999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=415.97 Aligned_cols=255 Identities=22% Similarity=0.389 Sum_probs=208.6
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.+.||+|+||+||+|.+++++.||||++.......+.|.+|++++++++|||||+++|++.+. . .++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~-~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P-IYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S-CEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-C-eEEEEEeC
Confidence 457899999999999999999999889999999988777788999999999999999999999988653 3 48999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++|+|.+++..... ..+++..+..++.|||+||+|||+++|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 90 ~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--Y 164 (272)
T ss_dssp TTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--E
T ss_pred CCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc--c
Confidence 99999998765432 238999999999999999999999999999999999999999999999999998653321 2
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCC-CCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRK-PVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......||+.|||||++.++.++.++|||||||++|||+||.. ||......+....+....+. . ....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~----~-~p~~----- 234 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM----V-RPDN----- 234 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----C-CCTT-----
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----C-Cccc-----
Confidence 23345678999999999988889999999999999999999655 55555555544444322110 0 0000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
... ...+++.+||+.||++|||++||++.|+.+
T Consensus 235 -~~~------~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 235 -CPE------ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ChH------HHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 001 123789999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-47 Score=421.87 Aligned_cols=260 Identities=22% Similarity=0.413 Sum_probs=199.0
Q ss_pred cCCCcccccccccceeEEEEEECC----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|++.++||+|+||+||+|+++. ...||||++..... ..+.|.+|++++++++|||||+++|++...+. .++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-VMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-CEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE-EEE
Confidence 457778999999999999998752 34689999865433 24578999999999999999999999987654 499
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.+++.... ..+++..+..++.|||+||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 v~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999887633 3489999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCC--CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 991 TPAEA--SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 991 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..... .......||+.|||||++.++.++.++|||||||++|||+| |+.||......++...+.+..+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------- 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------- 253 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 32211 12233468899999999999999999999999999999998 899998777766655554321110
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGP 1118 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~ 1118 (1133)
.+... .+ ...+++.+||+.||++|||+.||++.|+++...|
T Consensus 254 -----~~~~~---~~--~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 254 -----PPMDC---PS--ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp -----CCTTC---CH--HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----CCccc---hH--HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 00000 01 1237899999999999999999999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=411.70 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=203.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
++|++.+.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|++++++++|||||++++++.+.+ ..|+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEEEEe
Confidence 47999999999999999999874 69999999986433 34678999999999999999999999998764 45999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 99 ~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--- 169 (293)
T d1yhwa1 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (293)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred cCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc---
Confidence 9999999988752 3889999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 995 ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 995 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+... ... ....+.
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~-~~~~~~----- 240 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTP-ELQNPE----- 240 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSC-CCSSGG-----
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CCC-CCCCcc-----
Confidence 22334567999999999999999999999999999999999999999766655444333322 110 100000
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... ...+++.+||+.||++|||++|++++
T Consensus 241 ----~~s~--~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 241 ----KLSA--IFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ----GSCH--HHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ----cCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001 12378999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=412.22 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=207.8
Q ss_pred hcCCCcccc-cccccceeEEEEEEC---CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENV-LSRGRYGLIFKASYQ---DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|.+.++ ||+|+||+||+|.++ ++..||||++..... ..+.|.+|++++++++|||||+++|++..+ ..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--eEE
Confidence 346777775 999999999999764 356899999975432 246789999999999999999999999753 358
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|+|.+++...+ ..+++..+..++.|||+||+|||+++|+||||||+||+++.++.+||+|||+|+...
T Consensus 85 lvmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999986532 348999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.............||+.|+|||++.++.++.++|||||||++|||+| |+.||......++...+.+..+ .+. .+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----~~~-p~ 235 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----MEC-PP 235 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----CCC-CT
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCC-CC
Confidence 44333334445678999999999988899999999999999999998 9999987766665555433211 111 00
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.. .. ...+++.+||+.||++||++.+|++.|+.+
T Consensus 236 ~~------~~------~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 236 EC------PP------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TC------CH------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC------CH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00 01 123789999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=410.75 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=196.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC-CCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP-PDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~~lV 911 (1133)
++|++.+.||+|+||+||+|+++ +|+.||||++.....+ .+.+.+|++++++++|||||++++++.+. +...|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999875 6899999999765443 35688999999999999999999988653 3456899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC-----ceecccCccceeeCCCCceEEeccCccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD-----MVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
|||+++|+|.+++.+.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999764332 245899999999999999999999876 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..... ........||+.|||||++.+..++.++||||+||++|||++|+.||...+..++...+... .....
T Consensus 163 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~----~~~~~- 234 (269)
T d2java1 163 ILNHD---TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KFRRI- 234 (269)
T ss_dssp HC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CCCCC-
T ss_pred ecccC---CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC----CCCCC-
Confidence 65322 12234567999999999999999999999999999999999999999877766655544332 21111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+ .. ...+++.+||+.||++|||++|++++
T Consensus 235 ~~~~------s~------~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 PYRY------SD------ELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CTTS------CH------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cccc------CH------HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000 11 12378899999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=412.04 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=199.0
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ..+.+.+|++++++++|||||++++++.+. +..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEE
Confidence 357999999999999999999885 689999999865432 245689999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+++|+|.+++... ..+++..+..++.||++||+|||++||+||||||+|||+++++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999998653 348999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. .......+||+.|||||++.+..+ +.++||||+||++|||++|++||.............. ..... .+...
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~--~~~~~----~~~~~ 230 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKKTY----LNPWK 230 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--TTCTT----STTGG
T ss_pred c-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCC----CCccc
Confidence 2 223345689999999999987775 6789999999999999999999976544332221111 11100 00000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. . ....+++.+||+.||++|||++|++++
T Consensus 231 ~~---s------~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 231 KI---D------SAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GS---C------HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cC---C------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 0 112378999999999999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=407.82 Aligned_cols=260 Identities=23% Similarity=0.394 Sum_probs=208.0
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++|++.+.||+|+||+||+|++++++.||||++.......+.|.+|++++++++|||||++++++.+. + .++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~-~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-P-IYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S-CEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-C-eEEEEEecC
Confidence 57999999999999999999999888999999988777788999999999999999999999998653 3 489999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|..++..... ..++|..+..++.|||.||+|||+++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 95 ~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~--~~ 169 (285)
T d1fmka3 95 KGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YT 169 (285)
T ss_dssp TCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC--ce
Confidence 9999999876432 348999999999999999999999999999999999999999999999999997653222 22
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCC-ccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPV-MFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......||+.|+|||++.++.++.++|||||||++|||++|..|| ......+....+.+..+. + ..+..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~----~-~~~~~----- 239 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----P-CPPEC----- 239 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----C-CCTTS-----
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----C-CCccc-----
Confidence 334467899999999999999999999999999999999965555 444555555544332110 0 11111
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPDM 1120 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~~ 1120 (1133)
.+ ...+++.+||+.||++||++++|++.|+........
T Consensus 240 -----~~--~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 240 -----PE--SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp -----CH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -----CH--HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 11 123789999999999999999999999997765543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=410.87 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=199.5
Q ss_pred cCCCcccccccccceeEEEEEECCc-----eEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDG-----MVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
+.|++.++||+|+||+||+|.++.. ..||||++.....+ ...|.+|++++++++|||||+++|++.+.. ..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-PMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-ceE
Confidence 4688899999999999999987532 57999998654332 356889999999999999999999998764 458
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+.+|++.+++.... ..+++..+..++.|||.|++|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999887643 348999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCC-CccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKP-VMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.............||+.|||||++.++.++.++|||||||++|||++|..| +......++...+....+. .
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----~---- 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----P---- 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----C----
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC----C----
Confidence 433322333445689999999999999999999999999999999996555 4444454444443322111 0
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCCCC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVGPD 1119 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~~~ 1119 (1133)
.+... . ....+++.+||+.||++||++.||++.|+.+...|+
T Consensus 234 ----~~~~~---~--~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 234 ----TPMDC---P--SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp ----CCTTC---B--HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ----Cchhh---H--HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 00000 0 112378999999999999999999999998776544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=407.96 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=197.9
Q ss_pred cccccccceeEEEEEEC---CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEeccC
Q 001171 843 NVLSRGRYGLIFKASYQ---DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYMP 916 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~~ 916 (1133)
++||+|+||+||+|.++ .++.||||+++....+ .+.|.+|++++++++|||||++++++..+ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS--SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC--CEEEEEEcCC
Confidence 46999999999999764 3578999999654332 46789999999999999999999999753 3589999999
Q ss_pred CCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCCC
Q 001171 917 NGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEAS 996 (1133)
Q Consensus 917 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 996 (1133)
+|+|.++++... .+++..+..++.|||.||+|||+++|+||||||+||+++.++.+|++|||+|+..........
T Consensus 91 ~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp TEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999998643 389999999999999999999999999999999999999999999999999986544333333
Q ss_pred CCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCCC
Q 001171 997 SSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELDP 1075 (1133)
Q Consensus 997 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1133)
......||+.|||||++.+..++.++|||||||++|||++ |+.||......++...+.+. ..... +...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~----~~~~~-p~~~----- 235 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG----ERMGC-PAGC----- 235 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----CCCCC-CTTC-----
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC----CCCCC-Cccc-----
Confidence 3445679999999999998899999999999999999998 89999877666655544332 11111 0000
Q ss_pred CChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1076 ESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1076 ~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
. . ...+++.+||+.||++|||++||++.|+.
T Consensus 236 -~----~--~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 236 -P----R--EMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -C----H--HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -C----H--HHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 0 1 12378999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=401.78 Aligned_cols=245 Identities=22% Similarity=0.358 Sum_probs=194.0
Q ss_pred CCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeC---CCCcEEEE
Q 001171 839 FDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAG---PPDVRLLV 911 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~~lV 911 (1133)
|++.++||+|+||+||+|.++ +++.||+|++...... .+.+.+|++++++++|||||++++++.. .+...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356778999999999999875 5889999998654332 3578899999999999999999999864 23456899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCC--ceecccCccceeeC-CCCceEEeccCccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLD--MVHGDIKPQNVLFD-ADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~ 988 (1133)
|||+++|+|.+++.+.. .+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999998753 3889999999999999999999998 99999999999996 5789999999999753
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCCh-hhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQD-EDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.. ......+||+.|||||++.+ .++.++||||+||++|||++|+.||..... ..+...+. .+..+..++
T Consensus 166 ~~-----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~----~~~~~~~~~ 235 (270)
T d1t4ha_ 166 RA-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT----SGVKPASFD 235 (270)
T ss_dssp CT-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT----TTCCCGGGG
T ss_pred cC-----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH----cCCCCcccC
Confidence 21 22335679999999999865 599999999999999999999999965433 22322222 211111111
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
... .. ...+++.+||++||++|||++|++++
T Consensus 236 ~~~------~~------~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 KVA------IP------EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GCC------CH------HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccC------CH------HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111 01 12378999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=408.38 Aligned_cols=252 Identities=19% Similarity=0.296 Sum_probs=203.5
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.+.|++.+.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|++++++++|||||++++++.+.+ ..++|||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lvmE 89 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILIE 89 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-eEEEEEe
Confidence 356899999999999999999875 68999999996543 33467899999999999999999999998764 4599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+++|+|.+++.+.. ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 y~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-- 163 (288)
T d2jfla1 90 FCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 163 (288)
T ss_dssp CCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred cCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence 999999999987643 34899999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCCccCccccC-----CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 994 EASSSTTPIGSLGYVSPEAAS-----TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
........||+.|+|||++. +..|+.++||||+||++|||++|+.||......+....+.+. ..+....+
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----~~~~~~~~ 238 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----EPPTLAQP 238 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS----CCCCCSSG
T ss_pred -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----CCCCCCcc
Confidence 11233567999999999983 456789999999999999999999999877766655544432 11111000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..... ...+++.+||+.||++|||++|++++
T Consensus 239 ---------~~~s~--~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 239 ---------SRWSS--NFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---------GGSCH--HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---------ccCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001 12378999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=415.48 Aligned_cols=201 Identities=23% Similarity=0.424 Sum_probs=175.7
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.++|++.++||+|+||+||+|+++ +|+.||+|++...... .+.+.+|++++++++|||||+++++|.+.. ..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 468999999999999999999875 6899999999754322 467899999999999999999999998764 459999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999998754 38899999999999999999997 59999999999999999999999999999865321
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE 1047 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~ 1047 (1133)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..
T Consensus 159 -----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 159 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp -----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred -----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 234568999999999999999999999999999999999999999765443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=409.10 Aligned_cols=248 Identities=16% Similarity=0.299 Sum_probs=201.4
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. ....+.+.+|++++++++|||||++++++.+. +..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEE
Confidence 47999999999999999999875 6899999998632 22356789999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999988754 3899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
. ........+||+.|||||++.+..++.++||||+||++|||++|+.||...+..++...+.+. ...++ ..+
T Consensus 162 ~-~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p----~~~- 233 (288)
T d1uu3a_ 162 S-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFP----EKF- 233 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCC----TTC-
T ss_pred C-cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCC----ccC-
Confidence 2 122334567999999999999999999999999999999999999999877666655444321 11111 100
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVF 1109 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~ 1109 (1133)
.. ...+++.+||+.||++|||++|+++
T Consensus 234 -----s~------~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 -----FP------KARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CH------HHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CH------HHHHHHHHHccCCHhHCcCHHHHcC
Confidence 01 1237899999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=414.61 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=203.2
Q ss_pred hcCCCcccccccccceeEEEEEECC------ceEEEEEEcccCC--cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD------GMVLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 906 (1133)
.++|++.++||+|+||+||+|+++. ...||||++.... .....+.+|+++++++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4689999999999999999997642 2479999986432 2346789999999998 89999999999987755
Q ss_pred cEEEEEeccCCCCHHHHHHhhccC------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQ------------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQN 968 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~N 968 (1133)
.++||||+++|+|.++++..... ....+++..++.++.||++||+|||+++|+||||||+|
T Consensus 116 -~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 116 -IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp -CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred -EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 49999999999999999764321 12358999999999999999999999999999999999
Q ss_pred eeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChh
Q 001171 969 VLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDE 1047 (1133)
Q Consensus 969 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~ 1047 (1133)
|+++.++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||+| |+.||...+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999976543222 122234568999999999999999999999999999999998 89999765544
Q ss_pred hHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhc
Q 001171 1048 DIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEG 1113 (1133)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~ 1113 (1133)
.....+.+...+...+.. ... ...+++.+||+.||++|||++||+++|..
T Consensus 274 ~~~~~~~~~~~~~~~p~~----------~~~------~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFY----------ATE------EIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHTTCCCCCCTT----------CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCc----------CCH------HHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 433332221111111100 011 12378999999999999999999999963
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=408.67 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=190.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
.+.|++.++||+|+||+||+|+++ +|+.||||++..... ..+.+.+|++++++++|||||++++++.+. +..|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-GHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEE
Confidence 467999999999999999999875 689999999965432 245678999999999999999999999876 4559999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC---CCCceEEeccCcccccc
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD---ADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~ 989 (1133)
||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||++. +++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999763 3489999999999999999999999999999999999994 57899999999997542
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPG 1069 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1133)
.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+....+.+... .+. .+.
T Consensus 162 ~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~~---~~~ 232 (307)
T d1a06a_ 162 PG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--EFD---SPY 232 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC--CCC---TTT
T ss_pred CC----CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--CCC---Ccc
Confidence 21 223456799999999999999999999999999999999999999987766665554433211 000 000
Q ss_pred cCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1070 LLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1070 ~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... .. ...+++.+||+.||++|||++|++++
T Consensus 233 ~~~~---s~------~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 233 WDDI---SD------SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTS---CH------HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCC---CH------HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 01 12378999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=408.49 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=198.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
+.|+..+.||+|+||+||+|++. +|+.||||++...... .+.+.+|++++++++|||||++++++.+. +..++|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEE
Confidence 46999999999999999999875 6899999999754432 24688999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
||||++|++..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-- 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 166 (309)
T ss_dssp EECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred EEecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC--
Confidence 9999999987766543 348999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCCCCCCCCCCCccCccccCC---CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAAST---GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
......||+.|||||++.+ +.|+.++||||+||++|||++|+.||......+....+... ..+.....
T Consensus 167 -----~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~~ 237 (309)
T d1u5ra_ 167 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSG 237 (309)
T ss_dssp -----SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCSCT
T ss_pred -----CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----CCCCCCCC
Confidence 2234579999999999854 45899999999999999999999999766554443333221 11111111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+ .+ ...+++.+||+.||++|||++|++++
T Consensus 238 ~~----------s~--~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 238 HW----------SE--YFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TS----------CH--HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC----------CH--HHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11 11 12378999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=399.23 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=202.4
Q ss_pred hcCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
.++|++.++||+|+||.||+|+++ |+.||||+++.+. ..+.+.+|++++++++|||||+++|++.+..+..++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 357889999999999999999985 7889999997643 45789999999999999999999999866545559999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAEA 995 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 995 (1133)
++|+|.+++..... ..+++..++.++.|||.||+|||+.+|+||||||+||+++.++.+|++|||+++....
T Consensus 84 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-----
Confidence 99999999976442 2389999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccCCcCCCC
Q 001171 996 SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLELD 1074 (1133)
Q Consensus 996 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1133)
......++..|+|||++.++.++.++|||||||++|||+| |+.||......++...+....+ .+. .+..
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~----~~~-~~~~---- 225 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MDA-PDGC---- 225 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC----CCC-CTTC----
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCC-CccC----
Confidence 2233467889999999998999999999999999999998 7888887777776666543211 111 1100
Q ss_pred CCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1075 PESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1075 ~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
. . ...+++.+||+.||.+|||+.|++++|+.++.
T Consensus 226 --~---~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 226 --P---P---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --C---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C---H---HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 0 1 12378999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=399.83 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=204.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-------CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-------DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+... ..+.+.+|++++++++|||||++++++.+. ..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CE
Confidence 467999999999999999999875 689999999854321 256899999999999999999999999876 45
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC----ceEEeccC
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF----EAHLSEFG 983 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 983 (1133)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++|+||||||+||+++.++ .+|++|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence 599999999999999998753 389999999999999999999999999999999999998776 48999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.... ..+.
T Consensus 163 ~a~~~~~~----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~~ 236 (293)
T d1jksa_ 163 LAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN--YEFE 236 (293)
T ss_dssp TCEECTTS----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCC
T ss_pred hhhhcCCC----ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--CCCC
Confidence 99765322 23345679999999999999999999999999999999999999998776666554443321 0011
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....+.. . ....+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~------s------~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEYFSNT------S------ALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTS------C------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhcCCC------C------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1000000 0 112378999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-45 Score=409.53 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=205.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc-CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI-DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
.++|++.++||+|+||+||+|+++ +|+.||||++..... +.+.+.+|++++++++|||||++++++.+. +..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEE
Confidence 358999999999999999999875 699999999965432 346788999999999999999999999876 45599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC--CCceEEeccCcccccccC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA--DFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~ 991 (1133)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 104 ~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999996432 34899999999999999999999999999999999999954 678999999999765322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.......||+.|||||++.+..++.++||||+||++|||++|+.||...+..+....+..... .+.....+.+
T Consensus 180 ----~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~- 252 (350)
T d1koaa2 180 ----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW--NMDDSAFSGI- 252 (350)
T ss_dssp ----SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CSCCGGGGGC-
T ss_pred ----cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCC-
Confidence 223346799999999999999999999999999999999999999987776666655543211 1111000000
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ....+++.+||+.||++|||++|++++
T Consensus 253 -----s------~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 253 -----S------EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----C------HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----C------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 012378999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=398.77 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=197.9
Q ss_pred cCCCcccccccccceeEEEEEEC--C--ceEEEEEEcccCCc----CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ--D--GMVLSIRRLRDGTI----DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~--~--g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
++|++.+.||+|+||+||+|+++ + ...||||++..... ..+.|.+|++++++++|||||+++|++.++ . .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~-~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P-M 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S-C
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c-h
Confidence 57999999999999999999763 2 35799999864322 235789999999999999999999999763 3 4
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
++||||+++|++.+++..... .+++..+..++.|||+||+|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 899999999999998876542 3899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
..............|+..|+|||++.+..++.++|||||||++|||+| |+.||...+..+...++.+...+... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~ 237 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR----P 237 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC----C
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC----c
Confidence 444333334445568889999999999999999999999999999998 89999877777666554432111100 0
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
+. ... ...+++.+||+.||++|||+.||++.|++.
T Consensus 238 ~~------~~~------~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 ED------CPQ------DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TT------CCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc------ccH------HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00 001 123789999999999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=401.10 Aligned_cols=247 Identities=21% Similarity=0.327 Sum_probs=205.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.++||+|+||.||+|+.+ +|+.||||++.+. ....+.+.+|++++++++|||||++++++.+. +..|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-cccccc
Confidence 57999999999999999999874 6999999998642 22457788999999999999999999999886 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999987543 788899999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.......+||+.|+|||++.+..|+.++||||+||++|||++|++||...+..++...+... ...++.
T Consensus 159 ---~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~------- 226 (337)
T d1o6la_ 159 ---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPR------- 226 (337)
T ss_dssp ---TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT-------
T ss_pred ---CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCc-------
Confidence 22334568999999999999999999999999999999999999999887776655544332 111111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
... ..+.+++.+||+.||++||+ +.|++++
T Consensus 227 ----~~s-----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 227 ----TLS-----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----TSC-----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----cCC-----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 100 01237899999999999995 8888864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-44 Score=400.52 Aligned_cols=262 Identities=22% Similarity=0.365 Sum_probs=209.6
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 906 (1133)
..++|++.+.||+|+||+||+|+++ +++.||||++...... .++|.+|++++++++||||+++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4678999999999999999999864 3689999999754332 4678999999999999999999999987644
Q ss_pred cEEEEEeccCCCCHHHHHHhhcc-------------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCcc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASH-------------------QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQ 967 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~ 967 (1133)
.++||||+++|+|.+++..... .....+++..+..++.|||.||+|||+++|+||||||+
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 91 -MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp -CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 4999999999999999975321 11234889999999999999999999999999999999
Q ss_pred ceeeCCCCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCC-CCCccCCh
Q 001171 968 NVLFDADFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGR-KPVMFTQD 1046 (1133)
Q Consensus 968 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~-~Pf~~~~~ 1046 (1133)
|||+|.++.+||+|||+|+...... .........|++.|+|||.+.+..++.++|||||||++|||++|. +||.....
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999997553322 222334567889999999999999999999999999999999985 67877777
Q ss_pred hhHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1047 EDIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.+....+.+. ..... + .... . ...+++.+||+.||++||||.||+++|+++.
T Consensus 249 ~e~~~~v~~~----~~~~~-p-------~~~~--~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVIYYVRDG----NILAC-P-------ENCP--L---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHTT----CCCCC-C-------TTCC--H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHcC----CCCCC-C-------ccch--H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6666554432 11111 0 0000 0 1237899999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=401.94 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=198.5
Q ss_pred HhcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCC
Q 001171 835 ATRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPP 905 (1133)
Q Consensus 835 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 905 (1133)
..++|++.++||+|+||.||+|.+. +++.||||++..... ..+.+.+|.+++.++ +|+|||.+++++....
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3468999999999999999999763 357899999975432 245677888888887 6899999999988766
Q ss_pred CcEEEEEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC
Q 001171 906 DVRLLVYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD 974 (1133)
Q Consensus 906 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~ 974 (1133)
...++||||+++|+|.++++..+.. ....+++..+..++.|||+||+|||+++|+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 6679999999999999999865421 12348899999999999999999999999999999999999999
Q ss_pred CceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhC-CCCCccCChhh-HHHH
Q 001171 975 FEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTG-RKPVMFTQDED-IVKW 1052 (1133)
Q Consensus 975 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~Pf~~~~~~~-~~~~ 1052 (1133)
+.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++| .+||......+ +...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999976533222 2233456799999999999999999999999999999999996 56786554333 3333
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
+.+. .....++.+ .. ...+++.+||+.||++|||++||+++|+.+.
T Consensus 250 ~~~~-~~~~~~~~~----------~~------~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 250 LKEG-TRMRAPDYT----------TP------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHT-CCCCCCTTC----------CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcC-CCCCCCccC----------CH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2221 111111110 11 1237899999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-44 Score=395.67 Aligned_cols=261 Identities=21% Similarity=0.294 Sum_probs=201.3
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----HHHHHHHHHHHhhccCCCeeeEEEEEeCCC---Cc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----ENTFRKEAEALGKVKHRNLTVLRGYYAGPP---DV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~ 907 (1133)
.++|++.+.||+|+||+||+|++. +|+.||||++...... .+.+.+|++++++++|||||++++++.... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 357999999999999999999874 6999999999754332 346889999999999999999999986533 23
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++..+++|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 589999999999999987754 389999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc-ccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS-ELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 1066 (1133)
...............||+.|+|||++.+..++.++||||+||++|||+||++||...+..+......+ ..... ...
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~ 237 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR---EDPIPPSAR 237 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---CCCCCGGGT
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh---cCCCCCchh
Confidence 54433333445566899999999999999999999999999999999999999987665554333322 21111 111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCC-CHHHHHHHHhcCcC
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-SMADIVFMLEGCRV 1116 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-s~~evl~~Le~~~~ 1116 (1133)
.+.+ .. ...+++.+|++.||++|| +++|+++.|.++..
T Consensus 238 ~~~~------s~------~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 238 HEGL------SA------DLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp SSSC------CH------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ccCC------CH------HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1111 01 122788999999999999 89999999987643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-44 Score=407.10 Aligned_cols=251 Identities=17% Similarity=0.254 Sum_probs=204.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC-cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT-IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
++|++.++||+|+||+||+|+++ +|+.||||++.... .+.+.+.+|++++++++|||||++++++.+. ...|+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEc
Confidence 47999999999999999999875 69999999986543 2346788999999999999999999999876 455999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC--CCCceEEeccCcccccccCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD--ADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
+++|+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 108 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999998876532 3489999999999999999999999999999999999997 5789999999999765322
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.... ..++....+.+
T Consensus 183 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~-- 255 (352)
T d1koba_ 183 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--WEFDEDAFSSV-- 255 (352)
T ss_dssp ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--CCCCSSTTTTS--
T ss_pred ---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCcccccCC--
Confidence 22334579999999999999999999999999999999999999998777666555544321 11111110100
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.. ...+++.+||+.||.+|||++|++++
T Consensus 256 ----s~------~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 256 ----SP------EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ----CH------HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----CH------HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01 12378999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-44 Score=397.02 Aligned_cols=244 Identities=21% Similarity=0.349 Sum_probs=203.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. ....+.+.+|++++++++|||||++++++.+. +..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-CeeeeE
Confidence 57999999999999999999875 6999999998642 22356789999999999999999999999876 455999
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+++|++..++.... .+++..+..++.||+.|++|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eeecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 99999999999988744 378888889999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+....+... ...++..+
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~----- 224 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFF----- 224 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTS-----
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCC-----
Confidence 223468999999999999999999999999999999999999999877666655544332 11111111
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVFM 1110 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~~ 1110 (1133)
.. ...+++.+|+..||.+|+ +++|++++
T Consensus 225 -----s~------~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 -----NE------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -----CH------HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CH------HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 01 123788999999999996 89999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=392.58 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=197.9
Q ss_pred hcCCCcccccccccceeEEEEEECC----ceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.++|++.+.||+|+||+||+|.+.. +..||||++.....+ .+.+.+|++++++++|||||++++++.+ +..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence 4689999999999999999998743 467999998654332 4578999999999999999999999964 3458
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+||||+++|++.+++.... ..+++..+..++.||++||+|||+++|+||||||+||+++.++.+||+|||+|+...
T Consensus 84 iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999999887643 348999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||......++...+..... .. +++
T Consensus 160 ~~~--~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~----~~-~~~ 232 (273)
T d1mp8a_ 160 DST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----LP-MPP 232 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----CC-CCT
T ss_pred CCc--ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----CC-CCC
Confidence 221 223344568999999999999999999999999999999998 8999988777776665543211 11 111
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.. .. ...+++.+||+.||++|||+.||+++|+.+.
T Consensus 233 ~~------~~------~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 233 NC------PP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TC------CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC------CH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 01 1237899999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=398.80 Aligned_cols=252 Identities=16% Similarity=0.263 Sum_probs=206.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
.++|++.+.||+|+||+||+|.++ +|+.||||++.....+...+.+|++++++++|||||++++++.+.. ..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-ELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEEEec
Confidence 368999999999999999999875 6899999999876666677899999999999999999999998764 45999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC--CceEEeccCcccccccCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD--FEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~ 992 (1133)
|++|+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+|++|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 99999999997533 248999999999999999999999999999999999999854 57899999998754221
Q ss_pred CCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
.......||+.|+|||...+..++.++||||+||++|||++|+.||......+....+.+.. ..++....+.+
T Consensus 158 ---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~-- 230 (321)
T d1tkia_ 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE--YTFDEEAFKEI-- 230 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCHHHHTTS--
T ss_pred ---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCChhhccCC--
Confidence 22334578999999999999999999999999999999999999998777766655554321 11111111111
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. ..+.+++.+|+..||++|||++|++++
T Consensus 231 ----s------~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 231 ----S------IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----C------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----C------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 012378999999999999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=397.58 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=203.2
Q ss_pred cCCCcccccccccceeEEEEEEC-Cce----EEEEEEcccCC--cCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGM----VLSIRRLRDGT--IDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 909 (1133)
.+|++.++||+|+||+||+|.+. +|+ .||+|++.... ...+.|.+|++++++++|||||+++|++.+. ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cee
Confidence 46999999999999999999875 343 68999886432 3357899999999999999999999999864 347
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
+++||+.+|+|.+++.... ..+++..+..++.|||+||+|||+++|+||||||+||+++.++.+||+|||+|+...
T Consensus 87 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999999887643 348999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
.... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||......++...+.+..+. ..+..+
T Consensus 163 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~p~~~-- 238 (317)
T d1xkka_ 163 AEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPIC-- 238 (317)
T ss_dssp TTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-CCCTTB--
T ss_pred cccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCCccc--
Confidence 3222 222334568999999999999999999999999999999998 89999877777766655443211 111000
Q ss_pred CcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1069 GLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1069 ~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
. + ...+++.+||+.||++|||+.||+++|+.+..
T Consensus 239 --------~---~---~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 239 --------T---I---DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --------C---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------C---H---HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0 12378999999999999999999999887643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-43 Score=383.53 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=202.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC----------HHHHHHHHHHHhhcc-CCCeeeEEEEEeCC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID----------ENTFRKEAEALGKVK-HRNLTVLRGYYAGP 904 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 904 (1133)
++|++.+.||+|+||+||+|++. +|+.||||++...... .+.+.+|++++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 58999999999999999999874 6999999998654321 235788999999997 99999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
+..|+||||+++|+|.++++..+ .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 83 -~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 -TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -cceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 45599999999999999998654 389999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccC------CCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhh
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAAS------TGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
++..... .......||+.|+|||++. ...++.++||||+||++|||++|+.||......+....+.....
T Consensus 157 a~~~~~~----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeEccCC----CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 9765322 2334567999999999984 33468899999999999999999999987776665544443211
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+ ..+.... ..+ ...+++.+||++||++||+++|++++
T Consensus 233 --~~---~~~~~~~-------~s~--~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 --QF---GSPEWDD-------YSD--TVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --CC---CTTTGGG-------SCH--HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --CC---CCccccc-------CCH--HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 10 1111100 001 12378999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-43 Score=397.21 Aligned_cols=243 Identities=20% Similarity=0.266 Sum_probs=202.6
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLV 911 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV 911 (1133)
++|++.+.||+|+||.||+|+++ +|+.||||++.+. ....+.+.+|++++++++|||||++++++.... ..++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-ccccc
Confidence 57999999999999999999875 6999999998532 223467889999999999999999999998764 45899
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccC
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIAT 991 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 991 (1133)
|||+.+|+|.+++.+.+. +++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~~~-----l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cccccccchhhhHhhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 999999999999987543 88999999999999999999999999999999999999999999999999976522
Q ss_pred CCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 992 PAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 992 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
......||+.|||||++.+..++.++||||+||++|||++|+.||...+.......+.... ..++. .
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~----~-- 260 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPS----H-- 260 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCT----T--
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCc----c--
Confidence 2234679999999999999999999999999999999999999998766655555443321 11110 0
Q ss_pred CCCCCChhHHHHHHhHhhhhccCCCCCCCCC-----CHHHHHH
Q 001171 1072 ELDPESSEWEEFLLGVKVGLLCTAPDPLDRP-----SMADIVF 1109 (1133)
Q Consensus 1072 ~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RP-----s~~evl~ 1109 (1133)
... ...+++.+||+.||.+|+ +++|+++
T Consensus 261 ----~s~------~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 ----FSS------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCH------HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCH------HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011 123788999999999994 8999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=393.36 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=200.6
Q ss_pred cccccccccceeEEEEEECC----ceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEec
Q 001171 841 EENVLSRGRYGLIFKASYQD----GMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
+.++||+|+||+||+|.+.+ ...||||++..... ..++|.+|++++++++|||||+++|++...+...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 35789999999999998753 24699999864322 2467999999999999999999999987665667999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCCC
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPAE 994 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 994 (1133)
+++|+|.+++.... ...++..+..++.|+|+||.|+|+.+|+||||||+|||+++++.+||+|||+++........
T Consensus 111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred eecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999987543 33778889999999999999999999999999999999999999999999999865443322
Q ss_pred C-CCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccC-ChhhHHHHHHHHhhhccccccccCCcCC
Q 001171 995 A-SSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFT-QDEDIVKWVKKQLQRGQISELLEPGLLE 1072 (1133)
Q Consensus 995 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1133)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||... +..+....+... .... .+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g----~~~~--~p~--- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLL--QPE--- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT----CCCC--CCT---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----CCCC--Ccc---
Confidence 2 2233457899999999999999999999999999999999988877533 222333333221 1110 110
Q ss_pred CCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1073 LDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1073 ~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
.... ...+++.+||+.||++||++.||+++|+.+...
T Consensus 258 --~~~~------~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 258 --YCPD------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --TCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --cCcH------HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0001 123789999999999999999999999988754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=389.49 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=205.3
Q ss_pred hcCCCcccccccccceeEEEEEEC--------CceEEEEEEcccCCcC--HHHHHHHHHHHhhc-cCCCeeeEEEEEeCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ--------DGMVLSIRRLRDGTID--ENTFRKEAEALGKV-KHRNLTVLRGYYAGP 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 904 (1133)
.++|++.+.||+|+||.||+|+.. ++..||||++..+... ...+.+|+..+.++ +|||||++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468999999999999999999753 2468999999765432 36788899999998 899999999999876
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQ-----------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
.. .++||||+++|+|.+++...... ....+++..+..++.|||.||+|||+.+|+||||||+|||++.
T Consensus 92 ~~-~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 92 GP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SS-CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred Ce-EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 44 59999999999999999765421 2345899999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.+||+|||+++....... ........|++.|+|||.+.++.|+.++|||||||++|||++ |++||......++...
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 99999999999976544322 223445678999999999999999999999999999999998 7888877666655544
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
+....+ ... +... .. ...+++.+||+.||++|||+.||++.|+++.
T Consensus 250 i~~~~~----~~~-p~~~------~~------~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 250 LKEGHR----MDK-PSNC------TN------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHTTCC----CCC-CSSC------CH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCC----CCC-Cccc------hH------HHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 432211 111 1100 01 1237899999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=391.48 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=206.2
Q ss_pred hcCCCcccccccccceeEEEEEE------CCceEEEEEEcccCCc--CHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCC
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY------QDGMVLSIRRLRDGTI--DENTFRKEAEALGKV-KHRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 906 (1133)
.++|++.++||+|+||.||+|++ ..++.||||++..... ....+.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46899999999999999999976 2468999999975433 245688999999999 69999999999987755
Q ss_pred cEEEEEeccCCCCHHHHHHhhccC-------------CCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQ-------------DGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA 973 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~ 973 (1133)
.++||||+++|+|.++++..... ....+++..+..++.|||+|++|||+++|+||||||+||+++.
T Consensus 102 -~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 102 -TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp -CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred -EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 49999999999999999875421 2235889999999999999999999999999999999999999
Q ss_pred CCceEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHh-CCCCCccCChhhHHHH
Q 001171 974 DFEAHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILT-GRKPVMFTQDEDIVKW 1052 (1133)
Q Consensus 974 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~Pf~~~~~~~~~~~ 1052 (1133)
++.+|++|||.++....... ........||+.|+|||++.++.++.++|||||||++|||+| |.+||......+....
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred cCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999976543222 223345679999999999999999999999999999999999 5666655444333333
Q ss_pred HHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1053 VKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
+.+...+...+. . .. ....+++.+||+.||++|||++||+++|++.
T Consensus 260 ~i~~~~~~~~~~-----------~---~~--~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 260 MIKEGFRMLSPE-----------H---AP--AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHTCCCCCCT-----------T---SC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCcc-----------c---cc--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222211111000 0 00 1123789999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=388.46 Aligned_cols=259 Identities=19% Similarity=0.229 Sum_probs=197.2
Q ss_pred cccccccccceeEEEEEEC-CceEEEEEEcccCCcC------HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 841 EENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID------ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 841 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
..++||+|+||+||+|+++ +|+.||||++...... .+.+.+|++++++++|||||++++++..... .++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~-~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-ISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-CEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc-eeehhh
Confidence 3578999999999999875 5899999998644322 2468899999999999999999999988755 499999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|++++++..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 ~~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-- 153 (299)
T d1ua2a_ 81 FMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 153 (299)
T ss_dssp CCSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred hhcchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--
Confidence 9988776655443 234888999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC----
Q 001171 994 EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP---- 1068 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 1068 (1133)
.......+||+.|+|||++.+. .|+.++||||+||++|||++|++||....+.+....+.+...........+.
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 154 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2233446799999999998654 5799999999999999999999999887777766666554332211111000
Q ss_pred ---CcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1069 ---GLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1069 ---~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...... ....... ....+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 0011111 123478999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=389.83 Aligned_cols=266 Identities=19% Similarity=0.250 Sum_probs=197.4
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCC---CcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPP---DVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~lV~e 913 (1133)
++|.+.+.||+|+||+||+|+++ |+.||||++..........+.|+..+.+++|||||++++++.... ...++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 56888999999999999999874 889999999654332222344555566789999999999997543 24589999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc--------CCceecccCccceeeCCCCceEEeccCcc
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS--------LDMVHGDIKPQNVLFDADFEAHLSEFGLD 985 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 985 (1133)
|+++|+|.+++++. .++|..+..++.|+|.||+|+|+ +||+||||||+|||++.++.+||+|||++
T Consensus 82 y~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999863 38899999999999999999996 58999999999999999999999999999
Q ss_pred cccccCCCC-CCCCCCCCCCCCccCccccCCCC------CCCCCchhHHHHHHHHHHhCCCCCccCChh-----------
Q 001171 986 RLAIATPAE-ASSSTTPIGSLGYVSPEAASTGQ------PTKEADVYSFGIVLLEILTGRKPVMFTQDE----------- 1047 (1133)
Q Consensus 986 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~el~tg~~Pf~~~~~~----------- 1047 (1133)
+........ ........||+.|+|||++.+.. ++.++|||||||++|||+||..||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 866543322 22334568999999999986543 567899999999999999999887432211
Q ss_pred hHHHHHHHHhhhccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1048 DIVKWVKKQLQRGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
.....+.+....... .+... ......+......+++.+||+.||++|||+.||++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCC---GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCC---cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 112222222222111 11111 111111222233489999999999999999999999987653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=391.57 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=200.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccC----CcCHHHHHHHHHHHh-hccCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDG----TIDENTFRKEAEALG-KVKHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|++.++||+|+||+||+|+++ +|+.||||++.+. ....+.+.+|..++. .++|||||++++++.+++ ..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-ceeE
Confidence 57999999999999999999875 6999999999642 223456677777765 689999999999998874 4599
Q ss_pred EEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccccc
Q 001171 911 VYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIA 990 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 990 (1133)
||||+++|+|.++++.... +++..+..++.||+.||+|||+++|+||||||+|||+++++.+|++|||+++....
T Consensus 81 vmEy~~~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEECCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeecCCCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999987543 78899999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCc
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGL 1070 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1133)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..++...+... ...++..+
T Consensus 156 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~---- 226 (320)
T d1xjda_ 156 G---DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWL---- 226 (320)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTS----
T ss_pred c---cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccC----
Confidence 2 22334567999999999999999999999999999999999999999877766655554331 11111100
Q ss_pred CCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHH-HHHH
Q 001171 1071 LELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMA-DIVF 1109 (1133)
Q Consensus 1071 ~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~-evl~ 1109 (1133)
. ..+.+++.+||+.||++||++. |+++
T Consensus 227 ------s------~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 ------E------KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------C------HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------C------HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 1123789999999999999995 6753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=393.51 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=197.8
Q ss_pred hcCCCcc-cccccccceeEEEEEE-CCceEEEEEEcccCCcCHHHHHHHHHHHhhc-cCCCeeeEEEEEeC---CCCcEE
Q 001171 836 TRQFDEE-NVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTIDENTFRKEAEALGKV-KHRNLTVLRGYYAG---PPDVRL 909 (1133)
Q Consensus 836 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~~~~~~ 909 (1133)
.++|.+. ++||+|+||+||+|++ .+|+.||||++.+ ...+.+|++++.++ +|||||+++++|.+ .+...|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 3578876 4699999999999987 4689999999864 35688999997665 89999999999864 235568
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC---CCceEEeccCccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA---DFEAHLSEFGLDR 986 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~ 986 (1133)
+|||||+||+|.+++...+ ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+|++|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 9999999999999998533 235899999999999999999999999999999999999975 5679999999997
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
..... .......||+.|||||++.+..|+.++||||+||++|||++|+.||...........+.........
T Consensus 163 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~---- 234 (335)
T d2ozaa1 163 ETTSH----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY---- 234 (335)
T ss_dssp ECCCC----CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS----
T ss_pred eccCC----CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC----
Confidence 65332 2334567999999999999999999999999999999999999999766555444433332221110
Q ss_pred cCCcCCCCCCChhHHHHHH-hHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1067 EPGLLELDPESSEWEEFLL-GVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~-~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
. .....+..+.. ..+++.+|++.||++|||+.|++++
T Consensus 235 -----~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -----E--FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----S--CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----C--CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 11112222222 2389999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=392.38 Aligned_cols=258 Identities=23% Similarity=0.378 Sum_probs=202.4
Q ss_pred cCCCcccccccccceeEEEEEEC-Cce--EEEEEEcccCC--cCHHHHHHHHHHHhhc-cCCCeeeEEEEEeCCCCcEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGM--VLSIRRLRDGT--IDENTFRKEAEALGKV-KHRNLTVLRGYYAGPPDVRLL 910 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~l 910 (1133)
++|++.++||+|+||+||+|.++ +|. .||||++.... ...+.+.+|+++++++ +|||||++++++... +..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEE
Confidence 67899999999999999999875 343 57888875432 2345799999999999 799999999999876 45599
Q ss_pred EEeccCCCCHHHHHHhhc-----------cCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEE
Q 001171 911 VYDYMPNGNLATLLQEAS-----------HQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 911 V~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 979 (1133)
||||+++|+|.++++... ......+++..+..++.|||+|+.|+|+++|+||||||+|||++.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 999999999999997542 122356899999999999999999999999999999999999999999999
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCC-CCCccCChhhHHHHHHHHhh
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGR-KPVMFTQDEDIVKWVKKQLQ 1058 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~-~Pf~~~~~~~~~~~~~~~~~ 1058 (1133)
+|||+|+.... ........||..|+|||.+.++.++.++|||||||++|||++|. +||...+..++...+.+..
T Consensus 169 ~DfG~a~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~- 243 (309)
T d1fvra_ 169 ADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 243 (309)
T ss_dssp CCTTCEESSCE----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred ccccccccccc----cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Confidence 99999874322 12223456899999999999999999999999999999999965 5676666666554443211
Q ss_pred hccccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcC
Q 001171 1059 RGQISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRV 1116 (1133)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 1116 (1133)
..+. +... .+ ...+++.+||+.||++||||.||+++|+++..
T Consensus 244 ---~~~~--------~~~~---~~--~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 244 ---RLEK--------PLNC---DD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ---CCCC--------CTTB---CH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCC--------CccC---CH--HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1100 0000 01 12378999999999999999999999988654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-42 Score=394.84 Aligned_cols=248 Identities=19% Similarity=0.256 Sum_probs=195.1
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCC----cCHHHHHH---HHHHHhhccCCCeeeEEEEEeCCCCcE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGT----IDENTFRK---EAEALGKVKHRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~~ 908 (1133)
++|++.++||+|+||.||+|+++ +|+.||||++.+.. .....+.+ |+++++.++|||||++++++... +..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEE
Confidence 57999999999999999999875 69999999985322 12233444 46677778899999999999876 445
Q ss_pred EEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccccc
Q 001171 909 LLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLA 988 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 988 (1133)
|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999998754 3788999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc
Q 001171 989 IATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE 1067 (1133)
Q Consensus 989 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1133)
.. .......||+.|+|||++.+ ..|+.++||||+||++|||++|+.||......+......... ... ....
T Consensus 158 ~~-----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~--~~~~ 229 (364)
T d1omwa3 158 SK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMA--VELP 229 (364)
T ss_dssp SS-----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SCC--CCCC
T ss_pred CC-----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCC--CCCC
Confidence 32 22345679999999999965 568999999999999999999999997655444333222211 110 0001
Q ss_pred CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1068 PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1068 ~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
..+ .. ...+++.+||+.||++||+ ++|++++
T Consensus 230 ~~~------s~------~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 230 DSF------SP------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSS------CH------HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCC------CH------HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 100 01 1237899999999999999 6888753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-43 Score=387.24 Aligned_cols=263 Identities=19% Similarity=0.329 Sum_probs=210.3
Q ss_pred hcCCCcccccccccceeEEEEEEC------CceEEEEEEcccCCcC--HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ------DGMVLSIRRLRDGTID--ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 907 (1133)
.++|++.+.||+|+||+||+|.++ .++.||||++...... ...|.+|++++++++|||||++++++...+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~- 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP- 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc-
Confidence 468899999999999999999764 3678999999754332 3468899999999999999999999987654
Q ss_pred EEEEEeccCCCCHHHHHHhhcc-----CCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEecc
Q 001171 908 RLLVYDYMPNGNLATLLQEASH-----QDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEF 982 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 982 (1133)
.++||||+++|+|.+++...+. .....+++..+..++.|+|+||.|||+++|+||||||+|||+++++.+||+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence 4999999999999999876431 12234788999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhC-CCCCccCChhhHHHHHHHHhhhcc
Q 001171 983 GLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTG-RKPVMFTQDEDIVKWVKKQLQRGQ 1061 (1133)
Q Consensus 983 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~ 1061 (1133)
|+|+....... ........||+.|+|||.+.++.++.++|||||||++|||+|| ++||......+....+.+. .
T Consensus 178 Gla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~----~ 252 (308)
T d1p4oa_ 178 GMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG----G 252 (308)
T ss_dssp TCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT----C
T ss_pred ccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC----C
Confidence 99976533221 2233445789999999999999999999999999999999998 5778776666655554332 1
Q ss_pred ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCcCC
Q 001171 1062 ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCRVG 1117 (1133)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 1117 (1133)
..+.. .... . ...+++.+||+.||++|||+.||+++|++...+
T Consensus 253 ~~~~p--------~~~~---~--~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 253 LLDKP--------DNCP---D--MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp CCCCC--------TTCC---H--HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCCc--------ccch---H--HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11110 0100 1 123789999999999999999999999886543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=376.28 Aligned_cols=268 Identities=22% Similarity=0.339 Sum_probs=202.8
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.+.||+|+||+||+|.+. +|+.||||++..... ..+.+.+|++++++++|||||++++++.+.. ..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-KLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-ceeEEE
Confidence 58999999999999999999874 689999999964432 2467899999999999999999999998764 459999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
||+.+ ++.+++.... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+|++|||.|+.....
T Consensus 81 e~~~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~- 155 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155 (298)
T ss_dssp ECCSE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-
T ss_pred eecCC-chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-
Confidence 99965 5555554322 234899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccCCcC
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEPGLL 1071 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1133)
........||+.|+|||++.... ++.++||||+||++|+|++|+.||...+..+....+.+..... .+...+...
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~ 231 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP--DEVVWPGVT 231 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC--CTTTSTTGG
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC--chhhccccc
Confidence 22334567999999999976665 5789999999999999999999998776665554444432211 111111100
Q ss_pred -------CCC-CCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcC
Q 001171 1072 -------ELD-PESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGC 1114 (1133)
Q Consensus 1072 -------~~~-~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~ 1114 (1133)
... ......... ..+.+++.+|++.||++|||+.|++++ ++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 011111111 122378999999999999999999986 5543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.7e-41 Score=380.41 Aligned_cols=225 Identities=29% Similarity=0.456 Sum_probs=165.5
Q ss_pred cCchhHHHHHHHHHHhCCCCCCCccCCCCCCCCCCC--ccceeeeCC----CceEEEeeCCcccCc--ccchhhcccccC
Q 001171 26 AVVLSEIQALTSFKLHLKDPLGALDGWDSSTPSAPC--DWRGIVCYN----NRVRELRLPRLQLAG--RLTDQLADLHEL 97 (1133)
Q Consensus 26 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~~c--~w~gv~c~~----~~v~~l~l~~~~l~g--~~~~~l~~l~~L 97 (1133)
-|.++|++||++||+++.||. .+++|..++ ||| .|+||+|++ .||++|+|.+++++| .+|+++++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~--d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTT--DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTS--CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCC--CCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 489999999999999999885 689997554 789 599999985 278999998888888 467888888888
Q ss_pred cEEEccc-CcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccCCc
Q 001171 98 RKLSLHS-NHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNA 176 (1133)
Q Consensus 98 ~~L~l~~-n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~ 176 (1133)
++|+|++ |+++|.+|..|+++++|++|+|++|++++..|..+.++++| +++++++|.
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L----------------------~~l~l~~N~ 136 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL----------------------VTLDFSYNA 136 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC----------------------CEEECCSSE
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhh----------------------ccccccccc
Confidence 8888886 78888888888888888888888888877666555554433 555666666
Q ss_pred CCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCcccc-ceEecccccccCCCCccccCccccceeeccccccCCCCCC
Q 001171 177 FTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQEL-EYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPG 255 (1133)
Q Consensus 177 ~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 255 (1133)
+.+.+|..|.+++.|+++++++|.++|.+|..++.+.++ +.+++++|++++..|..+.++..+ .+++++|...+.+|.
T Consensus 137 ~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~ 215 (313)
T d1ogqa_ 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASV 215 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGG
T ss_pred ccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc
Confidence 666677777777777777777777777777777666665 667777777776666666555433 466666666666666
Q ss_pred cccCcCcccEEEcccCCccCC
Q 001171 256 TIGRISTLQVLSLSRNELTGL 276 (1133)
Q Consensus 256 ~~~~l~~L~~L~Ls~N~l~~~ 276 (1133)
.+..+++|+.|++++|.+.+.
T Consensus 216 ~~~~~~~l~~l~~~~~~l~~~ 236 (313)
T d1ogqa_ 216 LFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp GCCTTSCCSEEECCSSEECCB
T ss_pred ccccccccccccccccccccc
Confidence 666666666666666655543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-41 Score=375.58 Aligned_cols=265 Identities=20% Similarity=0.276 Sum_probs=199.6
Q ss_pred cCCCcccccccccceeEEEEEECCceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e 913 (1133)
++|++.++||+|+||+||+|++++|+.||||++..... ..+.+.+|+.++++++|||||++++++..... .++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-EEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-eeEEEE
Confidence 58999999999999999999999999999999965432 24689999999999999999999999987644 599999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATPA 993 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 993 (1133)
|+.++.+..+.+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|++|||.|......
T Consensus 81 ~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-- 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-- 153 (286)
T ss_dssp CCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--
Confidence 99877666665432 34899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccccccc-----
Q 001171 994 EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLE----- 1067 (1133)
Q Consensus 994 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1067 (1133)
........|++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..+....+.+...........+
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 1223445689999999998654 468999999999999999999999987766665555444322211110000
Q ss_pred ---CCcCCCCCC--ChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1068 ---PGLLELDPE--SSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1068 ---~~~~~~~~~--~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
......... ....... ....+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 0000000 122378999999999999999999854
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=377.75 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=200.1
Q ss_pred hcCCCcccccccccceeEEEEEEC-C-ceEEEEEEcccCCc---CHHHHHHHHHHHhhc---cCCCeeeEEEEEeC----
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-D-GMVLSIRRLRDGTI---DENTFRKEAEALGKV---KHRNLTVLRGYYAG---- 903 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---- 903 (1133)
.++|++.++||+|+||+||+|++. + ++.||||++..... ....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999874 3 67899999864322 234567888887776 79999999998852
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccC
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFG 983 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 983 (1133)
.....+++|||++++.+....... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+|++|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 234568999999887665444332 2348899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 984 LDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 984 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|++||...+..+....+.+........
T Consensus 162 ~~~~~~~----~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCG----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhcc----cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9864321 223455689999999999999999999999999999999999999998877766666655543221111
Q ss_pred cccc--------------CCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLE--------------PGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.... .....+.... . ....+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s--~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDI---D--ELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSC---C--HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccC---C--HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000000000 0 112378999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=376.96 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=191.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC-------HHHHHHHHHHHhhcc--CCCeeeEEEEEeCCCC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID-------ENTFRKEAEALGKVK--HRNLTVLRGYYAGPPD 906 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 906 (1133)
++|++.++||+|+||+||+|++. +|+.||||++...... ...+.+|++++++++ |||||++++++.+.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~- 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence 57999999999999999999875 6899999998643221 234678999999996 899999999998764
Q ss_pred cEEEEEeccCC-CCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCC-CceEEeccCc
Q 001171 907 VRLLVYDYMPN-GNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDAD-FEAHLSEFGL 984 (1133)
Q Consensus 907 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~ 984 (1133)
..++||||+.+ +++.+++.... .+++..++.++.||++||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 45999999976 68888887643 38899999999999999999999999999999999999854 7899999999
Q ss_pred ccccccCCCCCCCCCCCCCCCCccCccccCCCCC-CCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcccc
Q 001171 985 DRLAIATPAEASSSTTPIGSLGYVSPEAASTGQP-TKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQIS 1063 (1133)
Q Consensus 985 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 1063 (1133)
|+.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... .+ +.+ ...
T Consensus 158 a~~~~~-----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~----i~~----~~~- 221 (273)
T d1xwsa_ 158 GALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--EE----IIR----GQV- 221 (273)
T ss_dssp CEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--HH----HHH----CCC-
T ss_pred ceeccc-----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--hH----Hhh----ccc-
Confidence 975422 22345679999999999977665 67789999999999999999999642 11 111 110
Q ss_pred ccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1064 ELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
.+.+.+ .. ...+++.+||+.||++|||++|++++
T Consensus 222 -~~~~~~------s~------~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 -FFRQRV------SS------ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CCSSCC------CH------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCCC------CH------HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011111 11 12378999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=375.92 Aligned_cols=278 Identities=20% Similarity=0.267 Sum_probs=204.1
Q ss_pred hcCCCcccccccccceeEEEEEE-CCceEEEEEEcccCCc--CHHHHHHHHHHHhhccCCCeeeEEEEEeCCC---CcEE
Q 001171 836 TRQFDEENVLSRGRYGLIFKASY-QDGMVLSIRRLRDGTI--DENTFRKEAEALGKVKHRNLTVLRGYYAGPP---DVRL 909 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~ 909 (1133)
+.+|++.+.||+|+||+||+|.+ .+|+.||||++..... ..+.+.+|+++|++++||||+++++++.... ...+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999976 4799999999965432 2457889999999999999999999986532 1224
Q ss_pred EEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccc
Q 001171 910 LVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 910 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 989 (1133)
++++|+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 556667799999999752 38999999999999999999999999999999999999999999999999997655
Q ss_pred cCCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccccC
Q 001171 990 ATPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELLEP 1068 (1133)
Q Consensus 990 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1133)
............+||+.|+|||++.. ..++.++||||+||++|||++|+.||...+..+....................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 44333344456789999999999854 45789999999999999999999999876655544443332211110000000
Q ss_pred -------CcCCCC-CCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCC
Q 001171 1069 -------GLLELD-PESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPD 1119 (1133)
Q Consensus 1069 -------~~~~~~-~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~ 1119 (1133)
...... .....+... ..+.+++.+|++.||.+|||++|++++ ++......+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~ 306 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence 000000 000011111 123489999999999999999999986 655444333
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=368.49 Aligned_cols=268 Identities=22% Similarity=0.305 Sum_probs=197.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCC-----C
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPP-----D 906 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 906 (1133)
.++|++.++||+|+||+||+|.++ +|+.||||++...... .+.+.+|+++|++++|||||+++++|...+ .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999875 6999999999754433 356789999999999999999999997543 2
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||+ +++|..+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccccee
Confidence 348999999 6788887764 238999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc----
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ---- 1061 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---- 1061 (1133)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+.............
T Consensus 170 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QAD------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECC------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccC------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 542 223456799999999998664 568999999999999999999999987665554444333221110
Q ss_pred --------------ccccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 001171 1062 --------------ISELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCRVGPDMP 1121 (1133)
Q Consensus 1062 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~~~~~~ 1121 (1133)
..+.....+........ ....+++.+|+..||.+|||++|++++ ++++....+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNAS-----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC-----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCC-----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence 00000000100000100 112378999999999999999999987 77665544444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=367.00 Aligned_cols=268 Identities=18% Similarity=0.204 Sum_probs=199.8
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCc---CHHHHHHHHHHHhhccCCCeeeEEEEEeCC-------
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTI---DENTFRKEAEALGKVKHRNLTVLRGYYAGP------- 904 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 904 (1133)
.++|++.++||+|+||+||+|+++ +|+.||||++..... ..+++.+|++++++++|||++++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999874 799999999854322 346788999999999999999999988543
Q ss_pred CCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCc
Q 001171 905 PDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGL 984 (1133)
Q Consensus 905 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 984 (1133)
+...++||||++++.+...... ...++...+..++.||+.||+|||++||+||||||+|||++.++.+|++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 2345899999987765544332 23478889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc
Q 001171 985 DRLAIATPA-EASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI 1062 (1133)
Q Consensus 985 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 1062 (1133)
++....... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||....+......+.+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~- 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT- 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC-
Confidence 976543221 12233445799999999998755 689999999999999999999999987777666666555432211
Q ss_pred cccccCCc---------CCCCCCChhHH-HH------HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 SELLEPGL---------LELDPESSEWE-EF------LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 ~~~~~~~~---------~~~~~~~~~~~-~~------~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
....... ........... .+ ....+++.+|++.||++|||++|++++
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 -PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp -TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1000000 00000111111 11 122378999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-40 Score=371.22 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=196.0
Q ss_pred CCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCC-----CCcEEEE
Q 001171 838 QFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGP-----PDVRLLV 911 (1133)
Q Consensus 838 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~~lV 911 (1133)
+|+..++||+|+||+||+|++. +|+.||||++..+.. ...+|++++++++|||||++++++... ....++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 6888999999999999999885 699999999976442 345799999999999999999998532 2345799
Q ss_pred EeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCccccccc
Q 001171 912 YDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIA 990 (1133)
Q Consensus 912 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 990 (1133)
|||++++.+..+.+... ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 98 ~Ey~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EECCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EeccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99997654443333221 234589999999999999999999999999999999999999875 899999999976532
Q ss_pred CCCCCCCCCCCCCCCCccCccccCC-CCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhcc-------c
Q 001171 991 TPAEASSSTTPIGSLGYVSPEAAST-GQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQ-------I 1062 (1133)
Q Consensus 991 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-------~ 1062 (1133)
. .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.+...... .
T Consensus 176 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 176 G----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp T----SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred C----cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 2 22344679999999998765 5689999999999999999999999987766555444433221110 0
Q ss_pred cccccCCcCCCCCC------ChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHH--HhcCc
Q 001171 1063 SELLEPGLLELDPE------SSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFM--LEGCR 1115 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~~ 1115 (1133)
....+......... ..... ....+++.+|+..||++|||+.|++++ ++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTP--PEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSC--HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCC--HHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000000000000 00000 113378999999999999999999975 44443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-40 Score=364.06 Aligned_cols=260 Identities=16% Similarity=0.193 Sum_probs=195.9
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEEecc
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVYDYM 915 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~e~~ 915 (1133)
++|++.+.||+|+||+||+|++. +|+.||||++.... ..+.+.+|++++++++|++++..++.+.......++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 47999999999999999999874 68999999986543 33568899999999988877666665554456668999999
Q ss_pred CCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeC---CCCceEEeccCcccccccCC
Q 001171 916 PNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFD---ADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 916 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
++++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+||+++ .+..++++|||+|+......
T Consensus 86 -~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 -GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred -CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 667777665533 3489999999999999999999999999999999999975 35579999999998664332
Q ss_pred CC----CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhc--cccccc
Q 001171 993 AE----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRG--QISELL 1066 (1133)
Q Consensus 993 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 1066 (1133)
.. ........||+.|||||++.+..++.++|||||||++|||++|+.||......+....+.+..... ...+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 21 122345679999999999999999999999999999999999999997655444333332221110 000111
Q ss_pred cCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcC
Q 001171 1067 EPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGC 1114 (1133)
Q Consensus 1067 ~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~ 1114 (1133)
.+.+. . ...+++.+||+.||++||+++++.+.|+..
T Consensus 241 ~~~~p------~------~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 241 CKGYP------S------EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp TTTSC------H------HHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ccCCC------H------HHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11110 0 123788899999999999999998888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.6e-39 Score=362.24 Aligned_cols=259 Identities=18% Similarity=0.271 Sum_probs=194.2
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCC-CCcEEEEEe
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK-HRNLTVLRGYYAGP-PDVRLLVYD 913 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~-~~~~~lV~e 913 (1133)
++|++.++||+|+||+||+|++. +|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++... ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 57999999999999999999874 6999999998753 3578899999999995 99999999998753 345689999
Q ss_pred ccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCC-ceEEeccCcccccccCC
Q 001171 914 YMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADF-EAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 914 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 992 (1133)
|+++++|.++.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+|++|||+|+.....
T Consensus 113 ~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 113 HVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp CCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred ecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 999999866532 388999999999999999999999999999999999998765 5899999999765322
Q ss_pred CCCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCccCChh-hHHHHHHHHhhh---------cc
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMFTQDE-DIVKWVKKQLQR---------GQ 1061 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~~~~~-~~~~~~~~~~~~---------~~ 1061 (1133)
.......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||...... +....+.+.... ..
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2234567899999999987654 799999999999999999999999654432 222222111110 00
Q ss_pred ------ccccccCCc----CCCCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1062 ------ISELLEPGL----LELDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1062 ------~~~~~~~~~----~~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
+........ ...... .....+ ....+++.+|+..||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccc-cccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 000000 000111 123478999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.7e-39 Score=354.24 Aligned_cols=259 Identities=16% Similarity=0.183 Sum_probs=201.7
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhccC-CCeeeEEEEEeCCCCcEEEEEec
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVKH-RNLTVLRGYYAGPPDVRLLVYDY 914 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~lV~e~ 914 (1133)
++|++.++||+|+||+||+|++. +|+.||||++.... +...+.+|+++++.++| +|++.+++++... ...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecC-CccEEEEEe
Confidence 57999999999999999999875 68999999886533 34567889999999975 8999999988776 445999999
Q ss_pred cCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCC-----CCceEEeccCcccccc
Q 001171 915 MPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDA-----DFEAHLSEFGLDRLAI 989 (1133)
Q Consensus 915 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~~~ 989 (1133)
+ +++|.++++..+ ..+++..+..++.|++.||+|||++||+||||||+||+++. ++.+|++|||+|+...
T Consensus 83 ~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 789999987643 34889999999999999999999999999999999999974 5789999999998654
Q ss_pred cCCCC----CCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHH---HHHhhhccc
Q 001171 990 ATPAE----ASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWV---KKQLQRGQI 1062 (1133)
Q Consensus 990 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~~~ 1062 (1133)
..... ........||+.|||||++.+..++.++||||+||++|||++|+.||............ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 33221 12234567999999999999999999999999999999999999999755443322222 222111111
Q ss_pred cccccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCCHHHHHHHHhcCc
Q 001171 1063 SELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPSMADIVFMLEGCR 1115 (1133)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 1115 (1133)
.+.. +.+. ++ ..+++..|+..+|++||+++.+.+.|+++.
T Consensus 238 ~~l~-~~~p---------~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 238 RELC-AGFP---------EE---FYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHT-TTSC---------HH---HHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhc-CCCC---------HH---HHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111 1110 11 226778899999999999999988877653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=363.17 Aligned_cols=260 Identities=20% Similarity=0.221 Sum_probs=192.0
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC-----CCc
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP-----PDV 907 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 907 (1133)
++|++.++||+|+||+||+|++. +|+.||||++.....+ .+.+.+|++++++++|||||++++++... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999876 6999999999755433 34688999999999999999999998643 245
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 68999999655 444443 2378999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccc-----
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQI----- 1062 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----- 1062 (1133)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......+.........
T Consensus 169 ~~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccc----ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 422 22344567999999999999999999999999999999999999999876665555444332221100
Q ss_pred --------------------cccccCCcCCCCCCChhHHHHHHh-HhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1063 --------------------SELLEPGLLELDPESSEWEEFLLG-VKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1063 --------------------~~~~~~~~~~~~~~~~~~~~~~~~-~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
...+.... .............. .+++.+|+..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGG--SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCcccccccccccccccc--ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 01111222223333 389999999999999999999966
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-39 Score=355.06 Aligned_cols=265 Identities=20% Similarity=0.299 Sum_probs=199.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCCCCcEEEEE
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGPPDVRLLVY 912 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~lV~ 912 (1133)
++|++.++||+|+||+||+|++. +|+.||||+++..... ..++.+|++++++++||||+++++++..... .++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc-eeEEe
Confidence 58999999999999999999874 6899999998644322 4678999999999999999999999988654 48999
Q ss_pred eccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccccccCC
Q 001171 913 DYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRLAIATP 992 (1133)
Q Consensus 913 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 992 (1133)
|++.++++..+++..+ .+++..+..++.|+++||+|||++||+||||||+|||++.++.+|++|||.|+.....
T Consensus 81 ~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~- 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp ECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred eecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-
Confidence 9999998888876543 3788999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCCCCCCCCCCCccCccccCCCC-CCCCCchhHHHHHHHHHHhCCCCCcc-CChhhHHHHHHHHhhhccccc------
Q 001171 993 AEASSSTTPIGSLGYVSPEAASTGQ-PTKEADVYSFGIVLLEILTGRKPVMF-TQDEDIVKWVKKQLQRGQISE------ 1064 (1133)
Q Consensus 993 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~------ 1064 (1133)
........+++.|+|||++.+.. ++.++||||+||++|||++|+.||.. .+..+....+...........
T Consensus 155 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22233446788999999987655 68999999999999999999999743 333444444333322111000
Q ss_pred cccC---CcC-CCCCCChhHHHH-HHhHhhhhccCCCCCCCCCCHHHHHHH
Q 001171 1065 LLEP---GLL-ELDPESSEWEEF-LLGVKVGLLCTAPDPLDRPSMADIVFM 1110 (1133)
Q Consensus 1065 ~~~~---~~~-~~~~~~~~~~~~-~~~~~li~~Cl~~dP~~RPs~~evl~~ 1110 (1133)
..+. ... ............ ....+++.+|++.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000 000000000011 122378999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=362.86 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=199.4
Q ss_pred cCCCcccccccccceeEEEEEEC----CceEEEEEEcccCC-----cCHHHHHHHHHHHhhccC-CCeeeEEEEEeCCCC
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ----DGMVLSIRRLRDGT-----IDENTFRKEAEALGKVKH-RNLTVLRGYYAGPPD 906 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~ 906 (1133)
++|++.++||+|+||+||+|+.. +|+.||||++.+.. ...+.+.+|++++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 57999999999999999999762 48999999985432 234678899999999977 89999999998764
Q ss_pred cEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCccc
Q 001171 907 VRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 907 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
..++||||+.+|+|.+++...+. .+......++.||+.|++|+|+++|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceeeeeecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 45999999999999999987643 6778888999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCCCCCCccCccccCCC--CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccc
Q 001171 987 LAIATPAEASSSTTPIGSLGYVSPEAASTG--QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISE 1064 (1133)
Q Consensus 987 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1133)
...... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+....+.+........
T Consensus 178 ~~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~- 254 (322)
T d1vzoa_ 178 EFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP- 254 (322)
T ss_dssp ECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-
T ss_pred hhcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-
Confidence 553222 2223456799999999999754 46889999999999999999999997766555555554443322211
Q ss_pred cccCCcCCCCCCChhHHHHHHhHhhhhccCCCCCCCCCC-----HHHHHHH
Q 001171 1065 LLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPS-----MADIVFM 1110 (1133)
Q Consensus 1065 ~~~~~~~~~~~~~~~~~~~~~~~~li~~Cl~~dP~~RPs-----~~evl~~ 1110 (1133)
. +... . ....+++.+||++||++||+ ++|++++
T Consensus 255 -----~---~~~~---s--~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 255 -----Y---PQEM---S--ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----C---CTTS---C--HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----C---cccC---C--HHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 0000 0 11237888999999999994 7888863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=360.06 Aligned_cols=264 Identities=21% Similarity=0.307 Sum_probs=199.4
Q ss_pred hcCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcC---HHHHHHHHHHHhhccCCCeeeEEEEEeCC----CCc
Q 001171 836 TRQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTID---ENTFRKEAEALGKVKHRNLTVLRGYYAGP----PDV 907 (1133)
Q Consensus 836 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~ 907 (1133)
.++|++.++||+|+||+||+|++. +|+.||||++.....+ .+.+.+|++++++++|||+|++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999874 6999999999754433 35678999999999999999999998632 122
Q ss_pred EEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEEeccCcccc
Q 001171 908 RLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHLSEFGLDRL 987 (1133)
Q Consensus 908 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 987 (1133)
.+++|+|+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.+..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 3566778889999999864 2389999999999999999999999999999999999999999999999999864
Q ss_pred cccCCCCCCCCCCCCCCCCccCccccCCC-CCCCCCchhHHHHHHHHHHhCCCCCccCChhhHHHHHHHHhhhccccccc
Q 001171 988 AIATPAEASSSTTPIGSLGYVSPEAASTG-QPTKEADVYSFGIVLLEILTGRKPVMFTQDEDIVKWVKKQLQRGQISELL 1066 (1133)
Q Consensus 988 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1133)
.. .......|++.|+|||+..+. .++.++||||+||++|+|++|+.||...+.......+.+....... +..
T Consensus 171 ~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~-~~~ 243 (348)
T d2gfsa1 171 TD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA-ELL 243 (348)
T ss_dssp CT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH-HHH
T ss_pred cC------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh-HHh
Confidence 32 223456789999999987665 4689999999999999999999999877766666555544322110 000
Q ss_pred c-----------CCcCCCCCCChhHHHH-----HHhHhhhhccCCCCCCCCCCHHHHHHH--HhcC
Q 001171 1067 E-----------PGLLELDPESSEWEEF-----LLGVKVGLLCTAPDPLDRPSMADIVFM--LEGC 1114 (1133)
Q Consensus 1067 ~-----------~~~~~~~~~~~~~~~~-----~~~~~li~~Cl~~dP~~RPs~~evl~~--Le~~ 1114 (1133)
. ........ ..+... ..+.+++.+|++.||++|||++|++++ +.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPK--MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCC--CCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccchhhhhhhhhcccCCC--cchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 00000000 000000 123478999999999999999999984 4443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-34 Score=331.84 Aligned_cols=278 Identities=17% Similarity=0.181 Sum_probs=192.3
Q ss_pred cCCCcccccccccceeEEEEEEC-CceEEEEEEcccCCcCHHHHHHHHHHHhhcc-----------CCCeeeEEEEEeC-
Q 001171 837 RQFDEENVLSRGRYGLIFKASYQ-DGMVLSIRRLRDGTIDENTFRKEAEALGKVK-----------HRNLTVLRGYYAG- 903 (1133)
Q Consensus 837 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~~- 903 (1133)
++|++.++||+|+||+||+|+.. +|+.||||++.......+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 36999999999999999999874 6999999999866555577889999998885 5789999988754
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhc-CCceecccCccceeeCCCCc------
Q 001171 904 PPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHS-LDMVHGDIKPQNVLFDADFE------ 976 (1133)
Q Consensus 904 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~Dlkp~NIll~~~~~------ 976 (1133)
.....+++|+++..+.......... .....++..+..++.||+.|++|||+ .||+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 2344466777665554333322222 22457889999999999999999997 89999999999999987653
Q ss_pred eEEeccCcccccccCCCCCCCCCCCCCCCCccCccccCCCCCCCCCchhHHHHHHHHHHhCCCCCccCChh------hHH
Q 001171 977 AHLSEFGLDRLAIATPAEASSSTTPIGSLGYVSPEAASTGQPTKEADVYSFGIVLLEILTGRKPVMFTQDE------DIV 1050 (1133)
Q Consensus 977 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~Pf~~~~~~------~~~ 1050 (1133)
++++|||.++.... ......||+.|+|||++....++.++||||+||+++||++|+.||...+.. +..
T Consensus 171 ~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 171 IKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeEeeccccccccc------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 89999999864321 223467999999999999999999999999999999999999999643321 111
Q ss_pred HHHHHHhhh--------ccc-ccccc-----CCcCCCCCCC---------hhHHHH-HHhHhhhhccCCCCCCCCCCHHH
Q 001171 1051 KWVKKQLQR--------GQI-SELLE-----PGLLELDPES---------SEWEEF-LLGVKVGLLCTAPDPLDRPSMAD 1106 (1133)
Q Consensus 1051 ~~~~~~~~~--------~~~-~~~~~-----~~~~~~~~~~---------~~~~~~-~~~~~li~~Cl~~dP~~RPs~~e 1106 (1133)
......... ... ....+ .......... ...... ....+++.+|+..||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111111110 000 00000 0000000000 001112 22348999999999999999999
Q ss_pred HHHH--HhcCcCCCCCCC
Q 001171 1107 IVFM--LEGCRVGPDMPS 1122 (1133)
Q Consensus 1107 vl~~--Le~~~~~~~~~~ 1122 (1133)
++++ ++++....+...
T Consensus 325 ~L~Hp~f~~~~~~~~~~~ 342 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEEIRV 342 (362)
T ss_dssp HHTCGGGTTCTTCTTCCC
T ss_pred HhcCcccCCCCCcccCCC
Confidence 9986 665444444333
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2.4e-30 Score=289.04 Aligned_cols=232 Identities=28% Similarity=0.455 Sum_probs=131.4
Q ss_pred CCCCCCCCCCcEEEccc-CCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCC
Q 001171 476 PYDVGNLKGLLVLNLSA-SGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554 (1133)
Q Consensus 476 ~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 554 (1133)
|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..++.|+.+++++|.+.+.+|..|.++
T Consensus 69 p~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l 148 (313)
T d1ogqa_ 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred ChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccC
Confidence 33444444444444433 34444444444444444444444444444444444444555555555555544555555555
Q ss_pred ccCcEEEcccccccCCCCccccccccc-ceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeee
Q 001171 555 VGLQYLNLSDNAFTGDIPATYGFLRSL-VFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLD 633 (1133)
Q Consensus 555 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 633 (1133)
+.|+.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++|+.++
T Consensus 149 ~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred cccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence 555555555555555555555555443 555556666655555555554333 466666666666666666666666666
Q ss_pred cCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCccccccccc
Q 001171 634 LGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNN 710 (1133)
Q Consensus 634 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~ 710 (1133)
+++|.+++.+| .++.+++|+.|+|++|+++|.+|+.|+++++|++|||++|+|+|.+|. +.++++|+.+++++|+
T Consensus 228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 66666665433 466666667777777777666666677777777777777777766663 4566666666666665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=4.1e-28 Score=279.40 Aligned_cols=363 Identities=23% Similarity=0.312 Sum_probs=204.2
Q ss_pred ccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecc
Q 001171 142 LTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLD 221 (1133)
Q Consensus 142 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 221 (1133)
+......+++.+.+++.++..-..+|++|++++|.|+.. ++++.+++|++|+|++|+|++ +|. ++++++|++|+++
T Consensus 21 l~~~~~~~l~~~~~~~~~~~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~ 96 (384)
T d2omza2 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMN 96 (384)
T ss_dssp HHHHHHHHTTCSSTTSEECHHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECC
T ss_pred HHHHHHHHhCCCCCCCccCHHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Ccc-ccCCccccccccc
Confidence 333344566666666655544446788899998888754 467888899999999999885 443 8888899999999
Q ss_pred cccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCc
Q 001171 222 SNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNA 301 (1133)
Q Consensus 222 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~ 301 (1133)
+|++.+. + .++++++|+.|++++|.+++..+ ......+..+....|.+....+... ...............
T Consensus 97 ~n~i~~i-~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~ 167 (384)
T d2omza2 97 NNQIADI-T-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG-----LTSLQQLSFGNQVTD 167 (384)
T ss_dssp SSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTT-----CTTCSEEEEEESCCC
T ss_pred ccccccc-c-ccccccccccccccccccccccc--ccccccccccccccccccccccccc-----cccccccccccccch
Confidence 9988753 3 37788888888888888876533 3445677777777777764433211 111111111111111
Q ss_pred ccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCch
Q 001171 302 FTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPD 381 (1133)
Q Consensus 302 l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 381 (1133)
+.. .............+|.... ...+..+++++.+++++|.+++..| ++.+++|++|++++|+++.. .
T Consensus 168 ~~~------~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~ 235 (384)
T d2omza2 168 LKP------LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--G 235 (384)
T ss_dssp CGG------GTTCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred hhh------hcccccccccccccccccc--ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--c
Confidence 111 1111222223333333322 2334445555555555555543322 23344455555555544432 2
Q ss_pred hhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCC
Q 001171 382 EIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNL 461 (1133)
Q Consensus 382 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L 461 (1133)
.+..++ +|+.|++++|.+++..+ +..+++|++|++++|++++.. .+..+..+
T Consensus 236 ~l~~l~------------------------~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l 287 (384)
T d2omza2 236 TLASLT------------------------NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTAL 287 (384)
T ss_dssp GGGGCT------------------------TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTC
T ss_pred hhhccc------------------------ccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccc
Confidence 344444 44444444444443322 444555555555555554321 24455555
Q ss_pred cEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCC
Q 001171 462 TTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEEN 541 (1133)
Q Consensus 462 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 541 (1133)
+.++++.|.+++. ..+..+++++.|++++|++++.. .+..+++|++|++++|++++ ++ .+.++++|++|++++|
T Consensus 288 ~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 288 TNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHN 361 (384)
T ss_dssp SEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSS
T ss_pred ccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCC
Confidence 5555555555431 23455555666666666665432 25566667777777776663 33 4666777777777777
Q ss_pred cccccCCCCCCCCccCcEEEcccc
Q 001171 542 NLSGDVPEGFSSLVGLQYLNLSDN 565 (1133)
Q Consensus 542 ~l~~~~~~~~~~l~~L~~L~Ls~N 565 (1133)
++++..| +.++++|+.|+|++|
T Consensus 362 ~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 362 QISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCCBCGG--GTTCTTCSEEECCCE
T ss_pred cCCCChh--hccCCCCCEeeCCCC
Confidence 7765443 667777777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=8.9e-28 Score=276.56 Aligned_cols=340 Identities=25% Similarity=0.295 Sum_probs=179.7
Q ss_pred ccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEc
Q 001171 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 315 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 394 (1133)
.+|++|++++|+|+.+ +.+..+++|++|||++|+|++.. .++++++|++|++++|++.+.. .+.++++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccccc
Confidence 3455555555555554 23556666666666666666432 2566666666666666665432 2555566666666
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCC
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGK 474 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 474 (1133)
++|.+++..+ ......+..+....|.+....+................. ....+...
T Consensus 118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---------------- 174 (384)
T d2omza2 118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANL---------------- 174 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTC----------------
T ss_pred cccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhhhccc----------------
Confidence 6655553322 122334444444444443322221111111111111111 11122222
Q ss_pred CCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCC
Q 001171 475 VPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSL 554 (1133)
Q Consensus 475 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 554 (1133)
..........|... ....+..+++++.+++++|.+++..| +...++|++|++++|++++. ..+..+
T Consensus 175 --------~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l 240 (384)
T d2omza2 175 --------TTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASL 240 (384)
T ss_dssp --------TTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGC
T ss_pred --------cccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcc
Confidence 22333333333322 12233445555555555555554322 33445566666666655532 245556
Q ss_pred ccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeec
Q 001171 555 VGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDL 634 (1133)
Q Consensus 555 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 634 (1133)
++|+.|++++|++++.. .+..+++|++|++++|++++.. .+..++.++.++++.|++++ + ..+..+++++.|++
T Consensus 241 ~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~l 314 (384)
T d2omza2 241 TNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTL 314 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEEC
T ss_pred cccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEEC
Confidence 66666666666665433 2555666666666666666432 25556666777777776664 2 23566667777777
Q ss_pred CCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCcccccccc
Q 001171 635 GQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRN 709 (1133)
Q Consensus 635 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N 709 (1133)
++|++++. + .+..+++|+.|++++|++++ ++ .|+++++|++|+|++|++++..| +.++++|+.|+|++|
T Consensus 315 s~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 315 YFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 77777643 2 26667777777777777763 32 46677777777777777775443 667777777777776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=8.2e-26 Score=250.99 Aligned_cols=123 Identities=27% Similarity=0.410 Sum_probs=89.7
Q ss_pred hhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEeccccccc
Q 001171 147 VLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLY 226 (1133)
Q Consensus 147 ~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 226 (1133)
+++.+++.++ .+|..+|+++++|+|++|+|+...+..|.++++|++|++++|.+....|..|..+++|++|++++|+++
T Consensus 14 ~~~C~~~~L~-~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~ 92 (305)
T d1xkua_ 14 VVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92 (305)
T ss_dssp EEECTTSCCC-SCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred EEEecCCCCC-ccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC
Confidence 3444444444 456677788899999999998776778999999999999999999777888888899999999998887
Q ss_pred CCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCc
Q 001171 227 GTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273 (1133)
Q Consensus 227 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 273 (1133)
.+|..+. ..++.|++.+|.+.++.+..+.....+..++...|..
T Consensus 93 -~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 93 -ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 136 (305)
T ss_dssp -BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred -cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccc
Confidence 5555432 4667777777777666555555555666666655543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6.7e-25 Score=243.54 Aligned_cols=244 Identities=21% Similarity=0.270 Sum_probs=116.0
Q ss_pred ccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEc
Q 001171 315 SVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDL 394 (1133)
Q Consensus 315 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 394 (1133)
...+.+|.++++++.+++ .+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++
T Consensus 10 c~~~~~~C~~~~L~~lP~-~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPK-DLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp EETTEEECTTSCCCSCCC-SCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred ecCCEEEecCCCCCccCC-CCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 345555666666665532 332 45666666666666444445666666666666666666555555666666666666
Q ss_pred cCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeeccccccc--ccCChhhcCCCCCcEEecccCcCC
Q 001171 395 EGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIR--GNIPEEITRLSNLTTLNLSYNKFG 472 (1133)
Q Consensus 395 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~--~~~~~~l~~l~~L~~L~Ls~N~l~ 472 (1133)
++|+++. +|..+ ...++.|++..|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++
T Consensus 87 ~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 87 SKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp CSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 6666653 22221 234555555555555544444444555555555554322 122334444555555555555544
Q ss_pred CCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCC
Q 001171 473 GKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFS 552 (1133)
Q Consensus 473 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 552 (1133)
. +|.. ..++|+.|++++|.+.+..+..|..++.+++|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|.
T Consensus 164 ~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~ 239 (305)
T d1xkua_ 164 T-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239 (305)
T ss_dssp S-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred c-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccc
Confidence 2 2221 1234444444444444444444444444444444444444333333344444444444444443 2233344
Q ss_pred CCccCcEEEccccccc
Q 001171 553 SLVGLQYLNLSDNAFT 568 (1133)
Q Consensus 553 ~l~~L~~L~Ls~N~l~ 568 (1133)
++++|++|+|++|+|+
T Consensus 240 ~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 240 DHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TCSSCCEEECCSSCCC
T ss_pred cccCCCEEECCCCccC
Confidence 4444444444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-24 Score=236.97 Aligned_cols=249 Identities=25% Similarity=0.262 Sum_probs=142.6
Q ss_pred CcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEecc-ccCCCCCCChhccCCCCCcEeecc
Q 001171 461 LTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLS-NQNLSGELPIELFGLPSLQVVSLE 539 (1133)
Q Consensus 461 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~p~~l~~l~~L~~L~L~ 539 (1133)
+++|+|++|+|+...+..|.++++|++|++++|++....+..+..++.++.++.. .|.++...+..|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 3444444444443333344444444444444444444444444445555554443 334444445555555556666666
Q ss_pred CCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCC
Q 001171 540 ENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNI 619 (1133)
Q Consensus 540 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 619 (1133)
+|.+....+..+....+|+.+++++|++++..+..|..+++|++|++++|++++..+..|..+++|+++++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 55555555555555666666666666666555555666666666666666666555566666666666666666666655
Q ss_pred ccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccc
Q 001171 620 PVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALIS 699 (1133)
Q Consensus 620 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 699 (1133)
|..|..+++|++|++++|++.+..+..|+.+++|++|++++|.+...-+ .-+-...++.+....+++....|..+.+
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g-- 270 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG-- 270 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT--
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC--
Confidence 6666666666677777777766666666677777777777777664322 1111234556666666666666665543
Q ss_pred cCcccccccccccc
Q 001171 700 SLRYLNLSRNNLEG 713 (1133)
Q Consensus 700 ~L~~L~ls~N~l~~ 713 (1133)
+...+++.+.|+|
T Consensus 271 -~~l~~l~~~~l~g 283 (284)
T d1ozna_ 271 -RDLKRLAANDLQG 283 (284)
T ss_dssp -CBGGGSCGGGSCC
T ss_pred -CccccCCHHHCCC
Confidence 4555566666655
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.2e-24 Score=238.58 Aligned_cols=223 Identities=26% Similarity=0.269 Sum_probs=145.1
Q ss_pred EeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc-CCc
Q 001171 320 LDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE-GNR 398 (1133)
Q Consensus 320 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls-~N~ 398 (1133)
++.++++++.+ |..+. +++++|+|++|+|+...+.+|.++++|++|++++|++....+..+..+..++.++.. .|.
T Consensus 16 v~c~~~~L~~i-P~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQAV-PVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCSSC-CTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCCcc-CCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 44555555555 32222 345666666666665444556666666666666666666655666666666666543 445
Q ss_pred ccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCC
Q 001171 399 FSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYD 478 (1133)
Q Consensus 399 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~ 478 (1133)
++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+|+++.+..|..+++|++|++++|++++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 55555666666666666666666666555666666667777777777776655566666677777777777776666666
Q ss_pred CCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccc
Q 001171 479 VGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSG 545 (1133)
Q Consensus 479 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 545 (1133)
|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..+..|.++++|++|++++|.+..
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 7777777777777777776667777777777777777777776666667777777777777777664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.5e-22 Score=219.27 Aligned_cols=201 Identities=27% Similarity=0.263 Sum_probs=141.1
Q ss_pred cccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccccccCCCCcccccccccceeecc
Q 001171 508 RLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLS 587 (1133)
Q Consensus 508 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 587 (1133)
.+.+.+.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+. ++ .++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccc
Confidence 3344455555555 3444332 345666666666665555566666666666666666653 22 24566777777777
Q ss_pred cCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhccCCCcEEEeecCCCCccC
Q 001171 588 HNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRI 667 (1133)
Q Consensus 588 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 667 (1133)
+|+++ ..+..+..+++|++|++++|.+....+..+..+.+++.|++++|.++...+..+..++.|+.|++++|++++..
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 77776 34556677777777777777777656666777778888888888887666666777888888888888888777
Q ss_pred CccccCcccccccccccccccccCCccccccccCcccccccccccccC
Q 001171 668 PESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEI 715 (1133)
Q Consensus 668 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~ 715 (1133)
+..|..+++|++|||++|+|+ .+|+++..+++|+.|+|++|+|.+.+
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 777888888888888888887 78888888888888888888887644
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.8e-21 Score=210.59 Aligned_cols=176 Identities=22% Similarity=0.268 Sum_probs=74.8
Q ss_pred ccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEcc
Q 001171 340 SLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419 (1133)
Q Consensus 340 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 419 (1133)
+|++|||++|+|++..+..|.++++|++|+|++|+|+.+ | .+..+++|++|+|++|+++. .+..+.++++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccccccccc-ccccccccccccccccc
Confidence 445555555555544344455555555555555555432 1 12344444444444444442 23333333444444444
Q ss_pred CCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCcccc
Q 001171 420 RNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKI 499 (1133)
Q Consensus 420 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 499 (1133)
+|.+.+..+..+..+.++++|++++|.++... +..+..+++|+.|++++|++++..
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~------------------------~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLP------------------------PGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCC------------------------TTTTTTCTTCCEEECTTSCCSCCC
T ss_pred ccccceeeccccccccccccccccccccceec------------------------cccccccccchhcccccccccccC
Confidence 44433333333333333333333333333333 333333333333333333333333
Q ss_pred CCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcc
Q 001171 500 PGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNL 543 (1133)
Q Consensus 500 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 543 (1133)
+..|..+++|++|+|++|+|+ .+|..++.+++|+.|+|++|.+
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 333444444444444444444 3444444444444444444444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=2.7e-22 Score=205.24 Aligned_cols=162 Identities=12% Similarity=0.065 Sum_probs=119.2
Q ss_pred CCcccccccccceeEEEEEECCceEEEEEEcccCCcC-------------------HHHHHHHHHHHhhccCCCeeeEEE
Q 001171 839 FDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGTID-------------------ENTFRKEAEALGKVKHRNLTVLRG 899 (1133)
Q Consensus 839 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~hpniv~l~~ 899 (1133)
+.++++||+|+||+||+|...+|+.||||+++.+... .....+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3568899999999999999888999999987532110 123457889999999999998876
Q ss_pred EEeCCCCcEEEEEeccCCCCHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHHHHhcCCceecccCccceeeCCCCceEE
Q 001171 900 YYAGPPDVRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLISLGLARGLSFLHSLDMVHGDIKPQNVLFDADFEAHL 979 (1133)
Q Consensus 900 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 979 (1133)
+.. .++||||+++..+. .++......++.|+++|++|||++||+||||||+|||++++ .+++
T Consensus 82 ~~~-----~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG-----NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET-----TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEE
T ss_pred ecC-----CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEE
Confidence 532 27999999875431 14555667899999999999999999999999999999865 5899
Q ss_pred eccCcccccccCCCCCCCCCCCCCCCCccC------ccccCCCCCCCCCchhHHHHH
Q 001171 980 SEFGLDRLAIATPAEASSSTTPIGSLGYVS------PEAASTGQPTKEADVYSFGIV 1030 (1133)
Q Consensus 980 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlG~i 1030 (1133)
+|||.|+....... ..|.. .|.+ .+.|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~-----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGW-----------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTH-----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCc-----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99999864321111 01111 1111 3567889999996543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=7.2e-19 Score=198.50 Aligned_cols=314 Identities=25% Similarity=0.320 Sum_probs=176.3
Q ss_pred ccCcEEEcccCcccCCCCccccCCCCcceEeccCCcccCcCCCccccccchhhhhhcccccCCCccCccCCcceEEEccC
Q 001171 95 HELRKLSLHSNHLNGSIPASLHQCSLLRAVYLQYNSFSGHLPLSIFNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSS 174 (1133)
Q Consensus 95 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~~~g~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~ 174 (1133)
.++++|||++|+++ .+|.. +++|+.|+|++|+|+ .+|..++ +|+.|++++|+++. ++ .+|+.|++|+|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~---~L~~L~l~~n~l~~-l~-~lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLKA-LS-DLPPLLEYLGVSN 107 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCT---TCCEEECCSSCCSC-CC-SCCTTCCEEECCS
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchh---hhhhhhhhhcccch-hh-hhccccccccccc
Confidence 46789999999987 57753 467899999999998 7887654 56667788888763 32 4667788888888
Q ss_pred CcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeeccccccCCCCC
Q 001171 175 NAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIP 254 (1133)
Q Consensus 175 N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 254 (1133)
|.++. +|. ++.+++|++|++++|.++.. |.. ...+..+.+.++... .+..+..++.++.|++++|.+.....
T Consensus 108 n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~ 179 (353)
T d1jl5a_ 108 NQLEK-LPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD 179 (353)
T ss_dssp SCCSS-CCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCC
T ss_pred ccccc-ccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--ccccccccccceeccccccccccccc
Confidence 88874 453 56788888888888887743 322 345666666665543 23456667777777777777654321
Q ss_pred CcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCch
Q 001171 255 GTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSW 334 (1133)
Q Consensus 255 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~ 334 (1133)
.....+.+..+++.+.. +|. +..++.|+.+++++|...... .....+..+.+.++.+...
T Consensus 180 ----~~~~~~~l~~~~~~~~~-~~~------~~~l~~L~~l~l~~n~~~~~~-----~~~~~l~~~~~~~~~~~~~---- 239 (353)
T d1jl5a_ 180 ----LPLSLESIVAGNNILEE-LPE------LQNLPFLTTIYADNNLLKTLP-----DLPPSLEALNVRDNYLTDL---- 239 (353)
T ss_dssp ----CCTTCCEEECCSSCCSS-CCC------CTTCTTCCEEECCSSCCSSCC-----SCCTTCCEEECCSSCCSCC----
T ss_pred ----ccccccccccccccccc-ccc------ccccccccccccccccccccc-----ccccccccccccccccccc----
Confidence 12233455555555442 121 144555566666555544321 1222334444444444332
Q ss_pred hhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCc
Q 001171 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLK 414 (1133)
Q Consensus 335 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 414 (1133)
+ .....+...++..+.+.+... -.......++..|.+.+. ...+++|+
T Consensus 240 ---------------------~---~~~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~----~~~~~~L~ 287 (353)
T d1jl5a_ 240 ---------------------P---ELPQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL----CDLPPSLE 287 (353)
T ss_dssp ---------------------C---CCCTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE----CCCCTTCC
T ss_pred ---------------------c---ccccccccccccccccccccc----ccchhcccccccCccccc----cccCCCCC
Confidence 1 112334444444443332110 011233444444444321 12245566
Q ss_pred EEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEc
Q 001171 415 IVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNL 490 (1133)
Q Consensus 415 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 490 (1133)
+|+|++|+++. +|.. +++|+.|+|++|+|+ .+|+. +.+|++|+|++|+++ .+|... ..|+.|.+
T Consensus 288 ~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~ 351 (353)
T d1jl5a_ 288 ELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRM 351 (353)
T ss_dssp EEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEEC
T ss_pred EEECCCCccCc-cccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeEC
Confidence 66666666653 3332 356666677777666 34432 356777777777776 444432 24455544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=1.5e-18 Score=195.83 Aligned_cols=304 Identities=29% Similarity=0.372 Sum_probs=143.5
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
++++|||++|+++.+ |+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++.+ ++. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~l-p~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSSL-PEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSCC-CSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCCCC-CCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhh---cccccccccc
Confidence 456666666666665 332 356677777777776 455443 4566667777666532 211 1346666666
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCC
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKV 475 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 475 (1133)
+|.++. +|. ++.+++|+.|++++|.+... +.. ...+..+.+.++... ....+..++.++.|++++|.+...
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~- 177 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL- 177 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-
T ss_pred cccccc-ccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--ccccccccccceeccccccccccc-
Confidence 666653 332 34556666666666655532 111 234444444444332 223344455555555555554421
Q ss_pred CCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCcccccCCCCCCCCc
Q 001171 476 PYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLSGDVPEGFSSLV 555 (1133)
Q Consensus 476 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 555 (1133)
+.. ....+.+. .+++.+. .++ .+..++.|+.+++++|.... .+. ...
T Consensus 178 ~~~---~~~~~~l~------------------------~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~ 224 (353)
T d1jl5a_ 178 PDL---PLSLESIV------------------------AGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPP 224 (353)
T ss_dssp CCC---CTTCCEEE------------------------CCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCT
T ss_pred ccc---cccccccc------------------------ccccccc-ccc-cccccccccccccccccccc-ccc---ccc
Confidence 111 11122333 3333322 111 12334444444444444331 111 123
Q ss_pred cCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecC
Q 001171 556 GLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLG 635 (1133)
Q Consensus 556 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 635 (1133)
++..+.+.+|.+... +. ....+...++..|.+.+. +.. .......++..|.+.+ + ...+++|++|+|+
T Consensus 225 ~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l-~~l---~~~~~~~~~~~~~~~~-~---~~~~~~L~~L~Ls 292 (353)
T d1jl5a_ 225 SLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-L---CDLPPSLEELNVS 292 (353)
T ss_dssp TCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-E---CCCCTTCCEEECC
T ss_pred ccccccccccccccc-cc---cccccccccccccccccc-ccc---cchhcccccccCcccc-c---cccCCCCCEEECC
Confidence 344445555444321 11 123344444444443311 100 1223444555554442 1 1224556666666
Q ss_pred CCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcc
Q 001171 636 QNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD 694 (1133)
Q Consensus 636 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 694 (1133)
+|+|+ .+|.. +++|+.|+|++|+|+ .+|+. +++|+.|+|++|+|+ .+|..
T Consensus 293 ~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 293 NNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI 342 (353)
T ss_dssp SSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred CCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc
Confidence 66665 44532 456666666666666 44433 345667777777766 45543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.6e-21 Score=229.09 Aligned_cols=381 Identities=19% Similarity=0.159 Sum_probs=185.7
Q ss_pred ccEEeccCCcccccC-CchhhcccccceeeccCceeec----ccCcccCCCCCCcEEEccCCcccccCchhh----c-cC
Q 001171 317 LEVLDLQNNRIRAVF-PSWLTNVTSLRVMDLSGNFFSG----NLPAAVGSLDKLEVLRVANNSLSGLVPDEI----A-KC 386 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~----~-~l 386 (1133)
|+.||+++|+|+... .+.+..++++++|+|++|.|+. .+...+..+++|++|+|++|+|+......+ . ..
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~ 83 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 83 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCC
Confidence 455555555555421 2335556666667777776652 223445566666666666666642211111 1 12
Q ss_pred CCccEEEccCCccccc----CCCccCCCCCCcEEEccCCcCccccCcccc-----CccccceeecccccccccC----Ch
Q 001171 387 SLLQMFDLEGNRFSGQ----VPAFLGGIRGLKIVSLGRNMFSGLIPLSFG-----NLSQLETLNLSENDIRGNI----PE 453 (1133)
Q Consensus 387 ~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~i~~~~----~~ 453 (1133)
.+|++|+|++|++++. ++..+..+++|++|++++|.++......+. ..............+.... ..
T Consensus 84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (460)
T d1z7xw1 84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 163 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccc
Confidence 3566666666666532 233445555666666666655432111110 1111222222222221110 01
Q ss_pred hhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCc-CCcccccEEeccccCCCCCC----Chhcc
Q 001171 454 EITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSI-GSLMRLTTLDLSNQNLSGEL----PIELF 528 (1133)
Q Consensus 454 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~----p~~l~ 528 (1133)
.+.....++.++++++.........+ ...+ ........+++..+.+.... ...+.
T Consensus 164 ~l~~~~~~~~~~ls~~~~~~~~~~~~--------------------~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~ 223 (460)
T d1z7xw1 164 VLRAKPDFKELTVSNNDINEAGVRVL--------------------CQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 223 (460)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHH--------------------HHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccc--------------------ccccccccccccccccccccccchhhhccccccc
Confidence 12233444555554443321000000 0000 01122334444444433111 11223
Q ss_pred CCCCCcEeeccCCccccc-----CCCCCCCCccCcEEEcccccccCCC----CcccccccccceeecccCccCCCCCccc
Q 001171 529 GLPSLQVVSLEENNLSGD-----VPEGFSSLVGLQYLNLSDNAFTGDI----PATYGFLRSLVFLSLSHNQISGMIPAEL 599 (1133)
Q Consensus 529 ~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 599 (1133)
..+.++.+++.+|.+... ....+.....++.|++++|.+.... ...+...+.++.+++++|.+++.....+
T Consensus 224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l 303 (460)
T d1z7xw1 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 303 (460)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred ccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 345566666666654321 1222334456666677666665321 2233445667777777777653222221
Q ss_pred -----cCCCCccEEEecCCcccCCCcccc----ccccccCeeecCCCcccCcCchh----hh-ccCCCcEEEeecCCCCc
Q 001171 600 -----GACSALEVLELRSNHFTGNIPVDI----SHLSRIKKLDLGQNKLSGEIPKE----IS-KCSSLVSLTLDMNSLSG 665 (1133)
Q Consensus 600 -----~~l~~L~~L~L~~N~l~~~~p~~l----~~l~~L~~L~Ls~N~l~~~~p~~----l~-~l~~L~~L~Ls~N~l~~ 665 (1133)
.....|+.+++++|.++......+ ...++|++|+|++|++++..... +. ..+.|+.|+|++|+|+.
T Consensus 304 ~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 304 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred hccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 123567777777777764432222 33456777777777776533222 22 34567778888777765
Q ss_pred c----CCccccCcccccccccccccccccCCcccc-----ccccCcccccccccccccCCc
Q 001171 666 R----IPESFSKLSNLTTLNLSTNRLSGAIPADLA-----LISSLRYLNLSRNNLEGEIPK 717 (1133)
Q Consensus 666 ~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~ls~N~l~~~~p~ 717 (1133)
. +++.+..+++|++|||++|+++......+. +...|+.|++++|.+..+.+.
T Consensus 384 ~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~ 444 (460)
T d1z7xw1 384 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444 (460)
T ss_dssp HHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred HHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHH
Confidence 3 233455567788888888877654433332 234677888888777755443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.9e-21 Score=228.57 Aligned_cols=389 Identities=19% Similarity=0.152 Sum_probs=190.3
Q ss_pred CcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCCcccccCCchhhcccc
Q 001171 261 STLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTS 340 (1133)
Q Consensus 261 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~ 340 (1133)
.+|+.||+++|++++..=.. .+..+++++.|+|++|.++..- +.. ....+..+++
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~----l~~~l~~l~~L~L~~~~i~~~~--------------------~~~-l~~~L~~~~~ 56 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAE----LLPLLQQCQVVRLDDCGLTEAR--------------------CKD-ISSALRVNPA 56 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHH----HHHHHTTCSEEEEESSCCCHHH--------------------HHH-HHHHHHTCTT
T ss_pred CCCCEEEeeCCcCChHHHHH----HHHhCCCCCEEEeCCCCCCHHH--------------------HHH-HHHHHhcCCC
Confidence 36788888888886421111 1233455555555555443210 001 1345667778
Q ss_pred cceeeccCceeecc----cCcccC-CCCCCcEEEccCCccccc----CchhhccCCCccEEEccCCcccccCCCcc----
Q 001171 341 LRVMDLSGNFFSGN----LPAAVG-SLDKLEVLRVANNSLSGL----VPDEIAKCSLLQMFDLEGNRFSGQVPAFL---- 407 (1133)
Q Consensus 341 L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l---- 407 (1133)
|++|||++|.|+.. +...+. ...+|++|+|++|+++.. ++..+..+++|++|+|++|+++......+
T Consensus 57 L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l 136 (460)
T d1z7xw1 57 LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL 136 (460)
T ss_dssp CCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHH
T ss_pred CCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcc
Confidence 88888888877532 122222 234688888888887643 24556677888888888888764322211
Q ss_pred -CCCCCCcEEEccCCcCcccc----CccccCccccceeecccccccccCC----hhh-cCCCCCcEEecccCcCCCCCC-
Q 001171 408 -GGIRGLKIVSLGRNMFSGLI----PLSFGNLSQLETLNLSENDIRGNIP----EEI-TRLSNLTTLNLSYNKFGGKVP- 476 (1133)
Q Consensus 408 -~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~i~~~~~----~~l-~~l~~L~~L~Ls~N~l~~~~~- 476 (1133)
...............+.... ...+.....++.++++++.+..... ..+ ........+++..+.+.....
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~ 216 (460)
T d1z7xw1 137 LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 216 (460)
T ss_dssp TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH
T ss_pred cccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhh
Confidence 12223344444444333211 1123344677788887776542211 111 122345567776665542110
Q ss_pred ---CCCCCCCCCcEEEcccCCCccc-----cCCCcCCcccccEEeccccCCCCC----CChhccCCCCCcEeeccCCccc
Q 001171 477 ---YDVGNLKGLLVLNLSASGFSGK-----IPGSIGSLMRLTTLDLSNQNLSGE----LPIELFGLPSLQVVSLEENNLS 544 (1133)
Q Consensus 477 ---~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 544 (1133)
..+...+.++.+++++|.+... ..........++.|++++|.+... ....+...+.++.+++++|.++
T Consensus 217 ~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~ 296 (460)
T d1z7xw1 217 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 296 (460)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred cccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1123345666666666655321 122233345566666666655422 1122334455555566555554
Q ss_pred ccCCCCC-----CCCccCcEEEcccccccCCCCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCC-
Q 001171 545 GDVPEGF-----SSLVGLQYLNLSDNAFTGDIPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGN- 618 (1133)
Q Consensus 545 ~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~- 618 (1133)
+.....+ .....|+.+++++|.++......+. ..+...++|++|+|++|++++.
T Consensus 297 ~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~--------------------~~~~~~~~L~~L~Ls~N~i~~~g 356 (460)
T d1z7xw1 297 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS--------------------SVLAQNRFLLELQISNNRLEDAG 356 (460)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH--------------------HHHHHCSSCCEEECCSSBCHHHH
T ss_pred ccccchhhccccccccccccccccccchhhhhhhhcc--------------------cccccccchhhhheeeecccCcc
Confidence 2111110 1123344444444444322211111 1122334555666666555432
Q ss_pred ---Cccccc-cccccCeeecCCCcccCc----CchhhhccCCCcEEEeecCCCCccCCcccc-----Ccccccccccccc
Q 001171 619 ---IPVDIS-HLSRIKKLDLGQNKLSGE----IPKEISKCSSLVSLTLDMNSLSGRIPESFS-----KLSNLTTLNLSTN 685 (1133)
Q Consensus 619 ---~p~~l~-~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N 685 (1133)
++..+. ..+.|++|+|++|.|++. ++..+..+++|++|+|++|+|+......|. +...|+.|++++|
T Consensus 357 ~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~ 436 (460)
T d1z7xw1 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 436 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTC
T ss_pred cchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCC
Confidence 112221 234466666666666532 233344556666666666666643333321 2235777777777
Q ss_pred cccccCCcc
Q 001171 686 RLSGAIPAD 694 (1133)
Q Consensus 686 ~l~~~~p~~ 694 (1133)
.+.......
T Consensus 437 ~~~~~~~~~ 445 (460)
T d1z7xw1 437 YWSEEMEDR 445 (460)
T ss_dssp CCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 776544333
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.1e-18 Score=181.42 Aligned_cols=187 Identities=21% Similarity=0.339 Sum_probs=78.3
Q ss_pred ceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCC
Q 001171 342 RVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRN 421 (1133)
Q Consensus 342 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 421 (1133)
..++++.+++++.. .+..+.+|+.|++.+|.++.+ +.+.++++|++|++++|++++..| +..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 33444444444322 223344444555555444432 234445555555555555443222 344444444444444
Q ss_pred cCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCC
Q 001171 422 MFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPG 501 (1133)
Q Consensus 422 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 501 (1133)
.++.. ..+..+++|++++++++.+.+. ..+...+.++.+.++++.+.... .+..+++|+.|++++|.+.+..
T Consensus 96 ~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~-- 167 (227)
T d1h6ua2 96 PLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT-- 167 (227)
T ss_dssp CCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--
T ss_pred ccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--
Confidence 44421 1344445555555555544321 22334444455555444443211 1333344444444444433221
Q ss_pred CcCCcccccEEeccccCCCCCCChhccCCCCCcEeeccCCccc
Q 001171 502 SIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQVVSLEENNLS 544 (1133)
Q Consensus 502 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 544 (1133)
.++++++|++|++++|++++ ++ .+.++++|++|+|++|+++
T Consensus 168 ~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 168 PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCC
T ss_pred hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCC
Confidence 13444444444444444442 11 1334444444444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.3e-18 Score=181.07 Aligned_cols=104 Identities=21% Similarity=0.240 Sum_probs=61.6
Q ss_pred hhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcc-cccCccccceEeccc-c
Q 001171 146 LVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPA-SVGQLQELEYLWLDS-N 223 (1133)
Q Consensus 146 ~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~-N 223 (1133)
++++++++.++ .+|..+++++++|||++|+|+...+..|.++++|++|++++|.+...+|. .|..+++++++.+.. |
T Consensus 11 ~~i~c~~~~l~-~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp SEEEEESCSCS-SCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred CEEEEeCCCCC-CcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence 34556666665 56666777777777777777655555666777777777777766654432 455566666665543 4
Q ss_pred cccCCCCccccCccccceeeccccccC
Q 001171 224 HLYGTLPSAISNCSSLVHLSAEDNVLK 250 (1133)
Q Consensus 224 ~l~~~~p~~l~~l~~L~~L~l~~N~l~ 250 (1133)
++....+..+.++++|++|++++|++.
T Consensus 90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 90 NLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp TCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccchhhhc
Confidence 444444444555555555555555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=5.8e-18 Score=177.98 Aligned_cols=210 Identities=21% Similarity=0.322 Sum_probs=105.6
Q ss_pred ccccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEe
Q 001171 140 FNLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLW 219 (1133)
Q Consensus 140 ~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 219 (1133)
..++++..++++.+.+++.++..-..+|++|++++|.++.. +.++.+++|++|++++|++++..| +..+++|++++
T Consensus 16 ~~l~~~~~~~l~~~~~~d~~~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 16 PALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHHHTTCSSTTSEECHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHHHhCCCCcCCcCCHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 34555566667666666544322224566666666666532 235566666666666666654322 55555556665
Q ss_pred cccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccC
Q 001171 220 LDSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGF 299 (1133)
Q Consensus 220 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~ 299 (1133)
+++|.++ .++ .+..+++|+.+++++|+..+..+. ...+.++.+.++.
T Consensus 92 ~~~n~~~-~i~-------------------------~l~~l~~L~~l~l~~~~~~~~~~~-------~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 92 LSGNPLK-NVS-------------------------AIAGLQSIKTLDLTSTQITDVTPL-------AGLSNLQVLYLDL 138 (227)
T ss_dssp CCSCCCS-CCG-------------------------GGTTCTTCCEEECTTSCCCCCGGG-------TTCTTCCEEECCS
T ss_pred ccccccc-ccc-------------------------cccccccccccccccccccccchh-------ccccchhhhhchh
Confidence 5555554 222 234445555555555544432221 2223333333333
Q ss_pred CcccccccCCCCCccccccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccC
Q 001171 300 NAFTGVVKPPNGRCVSVLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLV 379 (1133)
Q Consensus 300 n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 379 (1133)
+.+... ..+.++++|++|++++|.+.+. ..++++++|++|+|++|++++.
T Consensus 139 ~~~~~~---------------------------~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l- 188 (227)
T d1h6ua2 139 NQITNI---------------------------SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI- 188 (227)
T ss_dssp SCCCCC---------------------------GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-
T ss_pred hhhchh---------------------------hhhccccccccccccccccccc--hhhcccccceecccCCCccCCC-
Confidence 333221 2234445555555555555422 2255555556666655555543
Q ss_pred chhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEcc
Q 001171 380 PDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLG 419 (1133)
Q Consensus 380 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 419 (1133)
+ .+.++++|++|+|++|++++..| ++++++|++|+++
T Consensus 189 ~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 189 S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 1 25555666666666666654322 5566666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=5.2e-18 Score=180.41 Aligned_cols=200 Identities=18% Similarity=0.177 Sum_probs=116.5
Q ss_pred eEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCC-ccccCccccceeecc-
Q 001171 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLP-SAISNCSSLVHLSAE- 245 (1133)
Q Consensus 168 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~- 245 (1133)
+.++.+++.++ .+|..+. +++++|++++|+|+...+..|.++++|++|++++|.+...+| ..+.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56778888887 5665543 467888888888875444567888888888888888765544 356777888887765
Q ss_pred ccccCCCCCCcccCcCcccEEEcccCCccCCcccccccCcccccccccEEeccCCcccccccCCCCCccccccEEeccCC
Q 001171 246 DNVLKGLIPGTIGRISTLQVLSLSRNELTGLVPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDLQNN 325 (1133)
Q Consensus 246 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L~~n 325 (1133)
.|++....+..|.++++|++|++++|+++...+... +..+. .+..+...++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~----~~~l~-------------------------~l~~~~~~n~ 138 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK----IHSLQ-------------------------KVLLDIQDNI 138 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTT----TCBSS-------------------------CEEEEEESCT
T ss_pred cccccccccccccccccccccccchhhhcccccccc----ccccc-------------------------cccccccccc
Confidence 467777777777888888888888887764322111 12222 2333444444
Q ss_pred cccccCCchhhccc-ccceeeccCceeecccCcccCCCCCCcEE-EccCCcccccCchhhccCCCccEEEccCCccc
Q 001171 326 RIRAVFPSWLTNVT-SLRVMDLSGNFFSGNLPAAVGSLDKLEVL-RVANNSLSGLVPDEIAKCSLLQMFDLEGNRFS 400 (1133)
Q Consensus 326 ~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 400 (1133)
++..+.+..|..++ .++.|++++|+++...+..+ ...+++++ ++++|+++.+.++.|.++++|++|+|++|+|+
T Consensus 139 ~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp TCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred ccccccccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence 55555455555443 45555665555553322222 22332222 34444444433334444444444444444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2e-18 Score=176.19 Aligned_cols=129 Identities=21% Similarity=0.267 Sum_probs=110.9
Q ss_pred hhhhcccccCCCccCccCCcceEEEccCCcCCCCC-CCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccc
Q 001171 147 VLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEI-PGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHL 225 (1133)
Q Consensus 147 ~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 225 (1133)
++++++|+|+ .+|.++|+++++|+|++|+|++.+ +..|..+++|++|+|++|++.+..+..+..+++|++|+|++|++
T Consensus 12 ~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l 90 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90 (192)
T ss_dssp EEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred EEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence 3445555555 567778889999999999998754 56788999999999999999988888999999999999999999
Q ss_pred cCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCccCC
Q 001171 226 YGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNELTGL 276 (1133)
Q Consensus 226 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 276 (1133)
++..|..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+...
T Consensus 91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 977778899999999999999999998889999999999999999988754
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2e-17 Score=171.21 Aligned_cols=125 Identities=16% Similarity=0.278 Sum_probs=67.6
Q ss_pred cccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEec
Q 001171 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220 (1133)
Q Consensus 141 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 220 (1133)
++.+....+++.+.+++.++..-..+|++|++++|.++... .+..+++|++|++++|+|++ ++ .++.+++|++|++
T Consensus 22 ~l~~~i~~~l~~~~~~~~~~~~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l 97 (210)
T d1h6ta2 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHHHHTTCSCTTSEECHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEEC
T ss_pred HHHHHHHHHhCcCccCCccCHHHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccc
Confidence 34455556677777665554433346677777777776432 35666667777777776664 23 2456666666666
Q ss_pred ccccccCCCCccccCccccceeeccccccCCCCCCcccCcCcccEEEcccCCc
Q 001171 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLKGLIPGTIGRISTLQVLSLSRNEL 273 (1133)
Q Consensus 221 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 273 (1133)
++|++++ +| .+.++++|+.|++++|.+... ..+..+++|+.+++++|.+
T Consensus 98 ~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l 146 (210)
T d1h6ta2 98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI 146 (210)
T ss_dssp CSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCC
T ss_pred ccccccc-cc-ccccccccccccccccccccc--ccccccccccccccccccc
Confidence 6666652 33 244455555555555544321 1233444444444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=5.2e-17 Score=166.53 Aligned_cols=104 Identities=15% Similarity=0.223 Sum_probs=55.4
Q ss_pred cccchhhhhhcccccCCCccCccCCcceEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEec
Q 001171 141 NLTNLLVLNVAHNLLSGKISADISPSLRYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWL 220 (1133)
Q Consensus 141 ~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 220 (1133)
++.+...+.++.+.+++.++..-.+++++|++++|.++.. +.++.+++|++|++++|++++..| ++.+++|++|++
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l 91 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHHHhCCCCCCCccCHHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence 4555566667776666544332235666666666666532 235556666666666666654322 555566666666
Q ss_pred ccccccCCCCccccCccccceeeccccccC
Q 001171 221 DSNHLYGTLPSAISNCSSLVHLSAEDNVLK 250 (1133)
Q Consensus 221 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 250 (1133)
++|.+. .++ .+.++++|++|++++|.+.
T Consensus 92 ~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~ 119 (199)
T d2omxa2 92 NNNQIA-DIT-PLANLTNLTGLTLFNNQIT 119 (199)
T ss_dssp CSSCCC-CCG-GGTTCTTCSEEECCSSCCC
T ss_pred cccccc-ccc-ccccccccccccccccccc
Confidence 655554 222 2444444444444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.2e-17 Score=168.20 Aligned_cols=181 Identities=22% Similarity=0.333 Sum_probs=91.0
Q ss_pred cccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEc
Q 001171 339 TSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSL 418 (1133)
Q Consensus 339 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 418 (1133)
.+...++++.+.+++.++ ...++++++|++++|.++.+ +.+..+++|++|+|++|++++..| ++++++|+.|++
T Consensus 18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l 91 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence 333444555555554322 22445566666666666543 235556666666666666654332 555555666666
Q ss_pred cCCcCccccCccccCccccceeecccccccccCChhhcCCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccc
Q 001171 419 GRNMFSGLIPLSFGNLSQLETLNLSENDIRGNIPEEITRLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGK 498 (1133)
Q Consensus 419 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 498 (1133)
++|.+.... .+.++++|++|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++.
T Consensus 92 ~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 92 NNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC
T ss_pred ccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC
Confidence 655555321 255556666666665555432 234555555555555555542 1 1344445555555555554432
Q ss_pred cCCCcCCcccccEEeccccCCCCCCChhccCCCCCcE
Q 001171 499 IPGSIGSLMRLTTLDLSNQNLSGELPIELFGLPSLQV 535 (1133)
Q Consensus 499 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 535 (1133)
. .++++++|++|++++|++++ ++ .+.++++|++
T Consensus 166 ~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 166 K--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp G--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred c--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 1 24445555555555555542 22 2444444443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=3.2e-17 Score=167.10 Aligned_cols=157 Identities=22% Similarity=0.256 Sum_probs=87.6
Q ss_pred cCcEEEcccccccCCC-CcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeec
Q 001171 556 GLQYLNLSDNAFTGDI-PATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDL 634 (1133)
Q Consensus 556 ~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 634 (1133)
++++|+|++|+|++.+ +..|..+++|++|+|++|++....+..+..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 3444444444444322 334445555555555555555555555555555555555555555444444555555666666
Q ss_pred CCCcccCcCchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCccccccccCccccccccccccc
Q 001171 635 GQNKLSGEIPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGE 714 (1133)
Q Consensus 635 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 714 (1133)
++|+|++..|..|..+++|++|+|++|.+..... ...-...++.+.+..|.++...|.. +..++.+||+.|.+.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCCC
T ss_pred CCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCcCC
Confidence 6666655555556666666666666666653322 1112234666677777777666654 34566788888888765
Q ss_pred CC
Q 001171 715 IP 716 (1133)
Q Consensus 715 ~p 716 (1133)
.+
T Consensus 186 ~~ 187 (192)
T d1w8aa_ 186 SE 187 (192)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=2.9e-17 Score=170.01 Aligned_cols=103 Identities=23% Similarity=0.356 Sum_probs=46.8
Q ss_pred CCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEEEccCCcCccccCccccCccccceee
Q 001171 362 LDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLN 441 (1133)
Q Consensus 362 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 441 (1133)
+.+|++|++++|.+++.. .+..+++|++|+|++|+|++.. .++.+++|+.|++++|++++. | .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc-c-cccccccccccc
Confidence 344455555555544321 2444555555555555554322 134444444444444444432 1 244455555555
Q ss_pred cccccccccCChhhcCCCCCcEEecccCcCC
Q 001171 442 LSENDIRGNIPEEITRLSNLTTLNLSYNKFG 472 (1133)
Q Consensus 442 L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 472 (1133)
+++|.+.. ...+..+++++.+++++|.++
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKIT 147 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCC
T ss_pred cccccccc--ccccccccccccccccccccc
Confidence 55554432 123444444555555544443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=2.4e-15 Score=163.08 Aligned_cols=202 Identities=16% Similarity=0.171 Sum_probs=105.6
Q ss_pred eEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCC-CcccccCccccceEecccccccCCCCccccCccccceeeccc
Q 001171 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGE-VPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAED 246 (1133)
Q Consensus 168 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 246 (1133)
..+.++...+...+.. .....+|++||+++|.++.. ++..+..+++|++|+|++|.+++..+..++.+++|++|++++
T Consensus 26 ~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 26 IAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp SEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 3445555444433222 22345677777777776643 334456677777777777777665566666667777777766
Q ss_pred c-ccCCC-CCCcccCcCcccEEEcccC-CccCC-cccccccCcccccccccEEeccCCcccccccCCCCCccccccEEec
Q 001171 247 N-VLKGL-IPGTIGRISTLQVLSLSRN-ELTGL-VPVSVLCNLWGNISSLRIVQLGFNAFTGVVKPPNGRCVSVLEVLDL 322 (1133)
Q Consensus 247 N-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~L~~L~L 322 (1133)
+ .++.. +...+..+++|++|+++++ .++.. +...+ ....++|+.|++++..
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~----~~~~~~L~~L~l~~~~--------------------- 159 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV----AHVSETITQLNLSGYR--------------------- 159 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH----HHSCTTCCEEECCSCG---------------------
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhh----cccccccchhhhcccc---------------------
Confidence 3 44321 1111245667777777764 23211 00000 0112333333333211
Q ss_pred cCCccccc-CCchhhcccccceeeccCc-eeecccCcccCCCCCCcEEEccCC-cccccCchhhccCCCccEEEccCC
Q 001171 323 QNNRIRAV-FPSWLTNVTSLRVMDLSGN-FFSGNLPAAVGSLDKLEVLRVANN-SLSGLVPDEIAKCSLLQMFDLEGN 397 (1133)
Q Consensus 323 ~~n~i~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N 397 (1133)
+.++.. ....+.++++|++|+|++| .+++.....+..+++|++|+|+++ .+++.....+.++++|++|+++++
T Consensus 160 --~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 160 --KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp --GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred --cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 112110 0223455667777777664 355555556666666777777663 455444445566666666666655
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.4e-15 Score=161.96 Aligned_cols=188 Identities=18% Similarity=0.176 Sum_probs=97.2
Q ss_pred CCCCCcEeeccCCcccccCCCCCCCCccCcEEEcccc-cccCCC-CcccccccccceeecccC-ccCCC-CCccccC-CC
Q 001171 529 GLPSLQVVSLEENNLSGDVPEGFSSLVGLQYLNLSDN-AFTGDI-PATYGFLRSLVFLSLSHN-QISGM-IPAELGA-CS 603 (1133)
Q Consensus 529 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~-~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~l~~-l~ 603 (1133)
.+++|++|+|++|.+++..+..++.+++|++|++++| .+++.. ......+++|++|+++++ .+++. +...+.. .+
T Consensus 69 ~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~ 148 (284)
T d2astb2 69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE 148 (284)
T ss_dssp TBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCT
T ss_pred hCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccc
Confidence 3344444444444443333333444444444444442 232111 111234455566666553 23321 1111222 35
Q ss_pred CccEEEecCCc--ccCC-CccccccccccCeeecCCC-cccCcCchhhhccCCCcEEEeec-CCCCccCCccccCccccc
Q 001171 604 ALEVLELRSNH--FTGN-IPVDISHLSRIKKLDLGQN-KLSGEIPKEISKCSSLVSLTLDM-NSLSGRIPESFSKLSNLT 678 (1133)
Q Consensus 604 ~L~~L~L~~N~--l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~ 678 (1133)
+|+.|+++++. ++.. +......+++|++|+|++| .+++..+..+.++++|++|+|++ +.+++.....++++++|+
T Consensus 149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~ 228 (284)
T d2astb2 149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228 (284)
T ss_dssp TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred ccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCC
Confidence 66777776542 3221 2222345677777777775 46666677777778888888877 467766666777778888
Q ss_pred ccccccccccccCCccccccccCcccccccccccccCCccc
Q 001171 679 TLNLSTNRLSGAIPADLALISSLRYLNLSRNNLEGEIPKML 719 (1133)
Q Consensus 679 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~ 719 (1133)
.|+++++ ++...-..+. ..+..|++..+++++..+..+
T Consensus 229 ~L~l~~~-~~d~~l~~l~--~~lp~L~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 229 TLQVFGI-VPDGTLQLLK--EALPHLQINCSHFTTIARPTI 266 (284)
T ss_dssp EEECTTS-SCTTCHHHHH--HHSTTSEESCCCSCCTTCSSC
T ss_pred EEeeeCC-CCHHHHHHHH--HhCccccccCccCCCCCCCcc
Confidence 8888776 3322111111 234455567777776555443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=2.6e-15 Score=168.36 Aligned_cols=243 Identities=22% Similarity=0.265 Sum_probs=131.9
Q ss_pred CchhhcccccceeeccCceeecc----cCcccCCCCCCcEEEccCCccccc---C-------chhhccCCCccEEEccCC
Q 001171 332 PSWLTNVTSLRVMDLSGNFFSGN----LPAAVGSLDKLEVLRVANNSLSGL---V-------PDEIAKCSLLQMFDLEGN 397 (1133)
Q Consensus 332 ~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~---~-------~~~~~~l~~L~~L~Ls~N 397 (1133)
...+.+...|++|+|++|.|... +...+...++|+.|+++++..... . ...+..+++|+.|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 45577788889999999988643 334566778899999987755322 1 223456778888888888
Q ss_pred ccccc----CCCccCCCCCCcEEEccCCcCccccCccc-------------cCccccceeecccccccccC----Chhhc
Q 001171 398 RFSGQ----VPAFLGGIRGLKIVSLGRNMFSGLIPLSF-------------GNLSQLETLNLSENDIRGNI----PEEIT 456 (1133)
Q Consensus 398 ~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-------------~~l~~L~~L~L~~N~i~~~~----~~~l~ 456 (1133)
.++.. +...+...++|+.|++++|.++......+ ...+.|+.|++++|+++... ...+.
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~ 183 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh
Confidence 87643 22334456777777777777653211111 12345555555555554221 12233
Q ss_pred CCCCCcEEecccCcCCCCCCCCCCCCCCCcEEEcccCCCccccCCCcCCcccccEEeccccCCCCC----CChhccCCCC
Q 001171 457 RLSNLTTLNLSYNKFGGKVPYDVGNLKGLLVLNLSASGFSGKIPGSIGSLMRLTTLDLSNQNLSGE----LPIELFGLPS 532 (1133)
Q Consensus 457 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~ 532 (1133)
..++|++|+|++|.++.... ...+...+..+++|+.|++++|.++.. +...+..+++
T Consensus 184 ~~~~L~~L~L~~n~i~~~g~-------------------~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~ 244 (344)
T d2ca6a1 184 SHRLLHTVKMVQNGIRPEGI-------------------EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244 (344)
T ss_dssp HCTTCCEEECCSSCCCHHHH-------------------HHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred hhhhhccccccccccccccc-------------------ccchhhhhcchhhhccccccccccccccccccccccccccc
Confidence 34555555555555442100 001223344445555555555554321 2233445555
Q ss_pred CcEeeccCCcccccCCCC----CC--CCccCcEEEcccccccCCC----Ccccc-cccccceeecccCccCC
Q 001171 533 LQVVSLEENNLSGDVPEG----FS--SLVGLQYLNLSDNAFTGDI----PATYG-FLRSLVFLSLSHNQISG 593 (1133)
Q Consensus 533 L~~L~L~~N~l~~~~~~~----~~--~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~ 593 (1133)
|++|+|++|.|++..... +. ....|++|++++|+|+... ...+. ..++|++|+|++|++..
T Consensus 245 L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred chhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 666666666554322111 11 2345777777777765322 22221 45667777777777763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=1.4e-15 Score=170.41 Aligned_cols=112 Identities=20% Similarity=0.233 Sum_probs=53.1
Q ss_pred CCCccEEEecCCcccCC-----CccccccccccCeeecCCCcccCc----CchhhhccCCCcEEEeecCCCCccCCcccc
Q 001171 602 CSALEVLELRSNHFTGN-----IPVDISHLSRIKKLDLGQNKLSGE----IPKEISKCSSLVSLTLDMNSLSGRIPESFS 672 (1133)
Q Consensus 602 l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 672 (1133)
++.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....++
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~ 264 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 264 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence 34455555555544321 112234445555555555555422 223344555555555555555543222221
Q ss_pred ------CcccccccccccccccccC----Ccccc-ccccCcccccccccccc
Q 001171 673 ------KLSNLTTLNLSTNRLSGAI----PADLA-LISSLRYLNLSRNNLEG 713 (1133)
Q Consensus 673 ------~l~~L~~L~Ls~N~l~~~~----p~~l~-~l~~L~~L~ls~N~l~~ 713 (1133)
..+.|++||+++|+++... ...+. +.++|+.|+|++|.+..
T Consensus 265 ~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 265 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 1244666666666665322 22222 34566666666666653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=8.9e-14 Score=129.41 Aligned_cols=103 Identities=23% Similarity=0.278 Sum_probs=86.1
Q ss_pred eEEEccCCcCCCCCCCCCCCCCcCcEEeccCCcCCCCCcccccCccccceEecccccccCCCCccccCccccceeecccc
Q 001171 168 RYLDLSSNAFTGEIPGNFSSKSQLQLINLSYNSFSGEVPASVGQLQELEYLWLDSNHLYGTLPSAISNCSSLVHLSAEDN 247 (1133)
Q Consensus 168 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 247 (1133)
|+|||++|+++. ++ .++.+++|++|++++|+|+ .+|..++.+++|+.|++++|++++ +| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 578999999984 34 4888999999999999998 578888999999999999999974 44 4888999999999999
Q ss_pred ccCCCCC-CcccCcCcccEEEcccCCccC
Q 001171 248 VLKGLIP-GTIGRISTLQVLSLSRNELTG 275 (1133)
Q Consensus 248 ~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~ 275 (1133)
+|+.... ..+..+++|++|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9987643 567888999999999998874
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=4.4e-14 Score=138.45 Aligned_cols=106 Identities=19% Similarity=0.169 Sum_probs=64.8
Q ss_pred cccEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 316 VLEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 316 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
.+++|+|++|+|+.+ +..+..+++|++|||++|+|+.. +.|..+++|++|++++|+++...+..+..+++|++|+++
T Consensus 19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 456666666666666 45556677777777777777633 246667777777777777766555555666777777777
Q ss_pred CCcccccCC-CccCCCCCCcEEEccCCcCc
Q 001171 396 GNRFSGQVP-AFLGGIRGLKIVSLGRNMFS 424 (1133)
Q Consensus 396 ~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 424 (1133)
+|+|+.... ..+..+++|++|++++|.++
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccccccccccccccccccchhhcCCCccc
Confidence 776653211 23444555555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=4.4e-14 Score=138.45 Aligned_cols=128 Identities=19% Similarity=0.222 Sum_probs=86.3
Q ss_pred hhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCc
Q 001171 335 LTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLK 414 (1133)
Q Consensus 335 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 414 (1133)
|.++.+|++|||++|+|+. ++..+..+++|++|+|++|+|+.+ +.+..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 5677778888888888874 466667778888888888887754 3467777777777777777765555566677777
Q ss_pred EEEccCCcCccccC-ccccCccccceeecccccccccCC---hhhcCCCCCcEEe
Q 001171 415 IVSLGRNMFSGLIP-LSFGNLSQLETLNLSENDIRGNIP---EEITRLSNLTTLN 465 (1133)
Q Consensus 415 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~---~~l~~l~~L~~L~ 465 (1133)
.|++++|+++.... ..+..+++|++|++++|.++.... ..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 77777777765322 345666677777777776653221 2355566666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.7e-13 Score=127.37 Aligned_cols=102 Identities=27% Similarity=0.353 Sum_probs=64.1
Q ss_pred cEEeccCCcccccCCchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCC
Q 001171 318 EVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGN 397 (1133)
Q Consensus 318 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 397 (1133)
++|+|++|+|+.+. .+.++++|++||+++|+|+ .+|..|+.+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCCc--ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 35667777776652 3677777777777777776 4566677777777777777777653 2 3666677777777777
Q ss_pred cccccCC-CccCCCCCCcEEEccCCcCc
Q 001171 398 RFSGQVP-AFLGGIRGLKIVSLGRNMFS 424 (1133)
Q Consensus 398 ~l~~~~p-~~l~~l~~L~~L~L~~N~l~ 424 (1133)
+|+.... ..+..+++|+.|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 6664321 33445555555555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=1.3e-13 Score=140.10 Aligned_cols=130 Identities=23% Similarity=0.298 Sum_probs=83.4
Q ss_pred CCcccccccccceeecccCccCCCCCccccCCCCccEEEecCCcccCCCccccccccccCeeecCCCcccCcCchhhhcc
Q 001171 571 IPATYGFLRSLVFLSLSHNQISGMIPAELGACSALEVLELRSNHFTGNIPVDISHLSRIKKLDLGQNKLSGEIPKEISKC 650 (1133)
Q Consensus 571 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 650 (1133)
++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|.....+++|+.|++++|+++. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 34556666677777777777763 33 3666677777777777776 355444555667777777777763 3 346667
Q ss_pred CCCcEEEeecCCCCccCC-ccccCcccccccccccccccccCCcc----------ccccccCcccc
Q 001171 651 SSLVSLTLDMNSLSGRIP-ESFSKLSNLTTLNLSTNRLSGAIPAD----------LALISSLRYLN 705 (1133)
Q Consensus 651 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~l~~L~~L~ 705 (1133)
++|+.|++++|+|+.... ..|..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 777777777777764221 35667777777777777776443332 45677888776
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=1.2e-11 Score=119.95 Aligned_cols=106 Identities=15% Similarity=0.132 Sum_probs=63.4
Q ss_pred ccEEeccCCcccccCCchhhcccccceeeccCc-eeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEcc
Q 001171 317 LEVLDLQNNRIRAVFPSWLTNVTSLRVMDLSGN-FFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLE 395 (1133)
Q Consensus 317 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 395 (1133)
.+.++++++++..+ |..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~~~-p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCCTT-TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCccC-cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 34455555555554 455666666666666544 3665555566666666666666666666666666666666666666
Q ss_pred CCcccccCCCccCCCCCCcEEEccCCcCc
Q 001171 396 GNRFSGQVPAFLGGIRGLKIVSLGRNMFS 424 (1133)
Q Consensus 396 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 424 (1133)
+|+|+...+..|..+ .|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCcccChhhhccc-cccccccCCCccc
Confidence 666664444444333 4566666666553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=1.7e-13 Score=139.17 Aligned_cols=112 Identities=16% Similarity=0.241 Sum_probs=57.4
Q ss_pred CchhhcccccceeeccCceeecccCcccCCCCCCcEEEccCCcccccCchhhccCCCccEEEccCCcccccCCCccCCCC
Q 001171 332 PSWLTNVTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANNSLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIR 411 (1133)
Q Consensus 332 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 411 (1133)
+..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+. +|..+..+++|++|++++|+++.. ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccc
Confidence 3456666666666666666653 22 35556666666666666553 233334444555666666655532 1234444
Q ss_pred CCcEEEccCCcCccccC-ccccCccccceeeccccccc
Q 001171 412 GLKIVSLGRNMFSGLIP-LSFGNLSQLETLNLSENDIR 448 (1133)
Q Consensus 412 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~ 448 (1133)
+|+.|++++|+++.... ..+..+++|++|++++|.+.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 55555555555543211 23445555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=4e-11 Score=116.10 Aligned_cols=109 Identities=16% Similarity=0.090 Sum_probs=78.4
Q ss_pred ccccceeeccCceeecccCcccCCCCCCcEEEccCC-cccccCchhhccCCCccEEEccCCcccccCCCccCCCCCCcEE
Q 001171 338 VTSLRVMDLSGNFFSGNLPAAVGSLDKLEVLRVANN-SLSGLVPDEIAKCSLLQMFDLEGNRFSGQVPAFLGGIRGLKIV 416 (1133)
Q Consensus 338 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 416 (1133)
+...+.++.+++.+. ..|..+..+++|++|++++| .|+.+.++.|.++++|+.|+|++|+|+.+.|..|.++++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344566788888777 45677777888888888655 4777767777788888888888888877777777777777777
Q ss_pred EccCCcCccccCccccCccccceeeccccccc
Q 001171 417 SLGRNMFSGLIPLSFGNLSQLETLNLSENDIR 448 (1133)
Q Consensus 417 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~ 448 (1133)
+|++|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhccc-cccccccCCCccc
Confidence 777777776555555444 5777777777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=3e-08 Score=96.18 Aligned_cols=83 Identities=23% Similarity=0.211 Sum_probs=50.5
Q ss_pred cccccccCeeecCCCcccCc--CchhhhccCCCcEEEeecCCCCccCCccccCcccccccccccccccccCCcc------
Q 001171 623 ISHLSRIKKLDLGQNKLSGE--IPKEISKCSSLVSLTLDMNSLSGRIPESFSKLSNLTTLNLSTNRLSGAIPAD------ 694 (1133)
Q Consensus 623 l~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~------ 694 (1133)
...+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|++++.....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 34566677777777777642 2344566777777777777776433223334456777777777776544322
Q ss_pred -ccccccCcccc
Q 001171 695 -LALISSLRYLN 705 (1133)
Q Consensus 695 -l~~l~~L~~L~ 705 (1133)
+..+++|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 44567777776
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=3.2e-08 Score=95.96 Aligned_cols=70 Identities=21% Similarity=0.135 Sum_probs=33.0
Q ss_pred chhhccCCCccEEEccCCcccccC--CCccCCCCCCcEEEccCCcCccccCccccCccccceeecccccccc
Q 001171 380 PDEIAKCSLLQMFDLEGNRFSGQV--PAFLGGIRGLKIVSLGRNMFSGLIPLSFGNLSQLETLNLSENDIRG 449 (1133)
Q Consensus 380 ~~~~~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 449 (1133)
+..+.++++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+....+|+.|++++|.+..
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 333445666666666666665321 2233344444444444444443322222233345555555555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.99 E-value=1.2e-05 Score=84.32 Aligned_cols=90 Identities=6% Similarity=-0.073 Sum_probs=58.3
Q ss_pred HHHHHhcCCCcccccccccceeEEEEEECCceEEEEEEcccCC-cCHHHHHHHHHHHhhcc-CCCeeeEEEEEeCCCCcE
Q 001171 831 ETLEATRQFDEENVLSRGRYGLIFKASYQDGMVLSIRRLRDGT-IDENTFRKEAEALGKVK-HRNLTVLRGYYAGPPDVR 908 (1133)
Q Consensus 831 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 908 (1133)
+.....+.|+..+..+.++.+.||+...+ +..+++|+..... .....+.+|+++++.+. +--+-+++.+.... +..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC-Cce
Confidence 33444567777776655556789998754 5556777775332 23446788999888774 22234555665544 455
Q ss_pred EEEEeccCCCCHHH
Q 001171 909 LLVYDYMPNGNLAT 922 (1133)
Q Consensus 909 ~lV~e~~~~gsL~~ 922 (1133)
++||++++|.++.+
T Consensus 86 ~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 86 NLLMSEADGVLCSE 99 (263)
T ss_dssp EEEEECCSSEEHHH
T ss_pred EEEEEecccccccc
Confidence 89999999877654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.53 E-value=1.1e-05 Score=77.85 Aligned_cols=14 Identities=21% Similarity=0.415 Sum_probs=6.3
Q ss_pred cccCeeecCCCccc
Q 001171 627 SRIKKLDLGQNKLS 640 (1133)
Q Consensus 627 ~~L~~L~Ls~N~l~ 640 (1133)
+.|++|+|++|.++
T Consensus 72 ~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 72 PSLRVLNVESNFLT 85 (167)
T ss_dssp SSCCEEECCSSBCC
T ss_pred ccccceeeehhhcc
Confidence 34444444444444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.49 E-value=1.7e-05 Score=76.50 Aligned_cols=87 Identities=18% Similarity=0.180 Sum_probs=44.7
Q ss_pred ccccccceeecccCccCCCCC----ccccCCCCccEEEecCCcccCC----CccccccccccCeeecCCCcccCc-----
Q 001171 576 GFLRSLVFLSLSHNQISGMIP----AELGACSALEVLELRSNHFTGN----IPVDISHLSRIKKLDLGQNKLSGE----- 642 (1133)
Q Consensus 576 ~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----- 642 (1133)
...++|++|+|++|.+++... ..+...+.|++|+|++|.++.. +-..+...+.|++|+|++|.+...
T Consensus 41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~ 120 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 120 (167)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence 334455555555555543222 2233456666777777766532 112244445666777766654421
Q ss_pred --CchhhhccCCCcEEEeecCC
Q 001171 643 --IPKEISKCSSLVSLTLDMNS 662 (1133)
Q Consensus 643 --~p~~l~~l~~L~~L~Ls~N~ 662 (1133)
+...+...++|+.|+++.+.
T Consensus 121 ~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 121 MDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHhCCCccEeeCcCCC
Confidence 23334445666666665544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.48 E-value=9.8e-05 Score=76.55 Aligned_cols=74 Identities=19% Similarity=0.204 Sum_probs=51.2
Q ss_pred ccccccc-eeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCC--eeeEEEEEeCCCCcEEEEEeccCCCCH
Q 001171 844 VLSRGRY-GLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRN--LTVLRGYYAGPPDVRLLVYDYMPNGNL 920 (1133)
Q Consensus 844 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~lV~e~~~~gsL 920 (1133)
.+..|.. +.||+...+++..+++|...... ...+.+|++.++.+.... +.+++++..+. +..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccc-cceEEEEEeeecccc
Confidence 3445553 68999988888888889875443 345788999988875333 34556665554 456899999987543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.19 E-value=0.0008 Score=74.18 Aligned_cols=75 Identities=16% Similarity=0.130 Sum_probs=46.9
Q ss_pred ccccccccceeEEEEEECC-ceEEEEEEccc-----C---CcCHHHHHHHHHHHhhcc-C-C-CeeeEEEEEeCCCCcEE
Q 001171 842 ENVLSRGRYGLIFKASYQD-GMVLSIRRLRD-----G---TIDENTFRKEAEALGKVK-H-R-NLTVLRGYYAGPPDVRL 909 (1133)
Q Consensus 842 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~-----~---~~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~~~~~~ 909 (1133)
.+.||.|....||++...+ ++.|+||.-.. + ..+..+...|++.++.+. + | .+.+++.+. .. . .+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~-~-~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TE-M-AV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TT-T-TE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CC-C-CE
Confidence 3568999999999997754 67788886421 1 123345677888888773 2 2 344454443 22 2 37
Q ss_pred EEEeccCCCC
Q 001171 910 LVYDYMPNGN 919 (1133)
Q Consensus 910 lV~e~~~~gs 919 (1133)
+|||++++..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.88 E-value=9.3e-05 Score=71.10 Aligned_cols=62 Identities=19% Similarity=0.202 Sum_probs=29.2
Q ss_pred ccCCCcEEEeecCCCCccCC----ccccCcccccc--cccccccccc----cCCccccccccCccccccccc
Q 001171 649 KCSSLVSLTLDMNSLSGRIP----ESFSKLSNLTT--LNLSTNRLSG----AIPADLALISSLRYLNLSRNN 710 (1133)
Q Consensus 649 ~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~--L~Ls~N~l~~----~~p~~l~~l~~L~~L~ls~N~ 710 (1133)
..++++.+++++|.++.... ..+...++|+. |++++|++.. .+...+...+.|+.|+++.|+
T Consensus 72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 34455555555555543221 23344455554 3344555543 223334445666666665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.80 E-value=0.00013 Score=70.16 Aligned_cols=15 Identities=27% Similarity=0.432 Sum_probs=7.5
Q ss_pred CCCccEEEecCCccc
Q 001171 602 CSALEVLELRSNHFT 616 (1133)
Q Consensus 602 l~~L~~L~L~~N~l~ 616 (1133)
.+.++.+++++|.++
T Consensus 73 ~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 73 NNTLKSLNVESNFIS 87 (166)
T ss_dssp CSSCCEEECCSSCCC
T ss_pred cccchhhhhcccccc
Confidence 344555555555443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.70 E-value=0.0021 Score=68.69 Aligned_cols=67 Identities=6% Similarity=0.096 Sum_probs=46.7
Q ss_pred eeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCe--eeEEEE----EeCCCCcEEEEEeccCC
Q 001171 851 GLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNL--TVLRGY----YAGPPDVRLLVYDYMPN 917 (1133)
Q Consensus 851 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~----~~~~~~~~~lV~e~~~~ 917 (1133)
-.||++...+|+.|++|+.+.+..+.+++..|.+.+..+....+ +..+.. ........+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47999999999999999988777678889999999988853222 111110 00112445789999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.94 E-value=0.0091 Score=63.26 Aligned_cols=157 Identities=13% Similarity=0.021 Sum_probs=81.4
Q ss_pred cHHHHHHHhcCCCccccc-----ccccceeEEEEEECCceEEEEEEcccCCcCHHHHHHHHHHHhhccCCCee--eEEEE
Q 001171 828 TYVETLEATRQFDEENVL-----SRGRYGLIFKASYQDGMVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT--VLRGY 900 (1133)
Q Consensus 828 ~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv--~l~~~ 900 (1133)
+..+......+|.++++. ..|---+.|+.+..+|+ +++|+.... .+.+.+..|++++..+....+. ..+..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhcccccccccee
Confidence 455666667788775443 35656778999887665 888887543 2445677788888887532221 11100
Q ss_pred E-----eCCCCcEEEEEeccCCCCHH--------------HHHHhhccCC--CC--C------------------CChHH
Q 001171 901 Y-----AGPPDVRLLVYDYMPNGNLA--------------TLLQEASHQD--GH--V------------------LNWPM 939 (1133)
Q Consensus 901 ~-----~~~~~~~~lV~e~~~~gsL~--------------~~l~~~~~~~--~~--~------------------l~~~~ 939 (1133)
. ..-......++.+..+.... ..++...... .. . .....
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0 00012235566666552211 1111110000 00 0 00011
Q ss_pred HHHHHHHHHHHHHHHh----cCCceecccCccceeeCCCCceEEeccCccc
Q 001171 940 RHLISLGLARGLSFLH----SLDMVHGDIKPQNVLFDADFEAHLSEFGLDR 986 (1133)
Q Consensus 940 ~~~i~~~ia~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 986 (1133)
....+..+...+...+ ..|+||+|+.+.||+++++...-|.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1112222223333333 2469999999999999988777899999763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.64 E-value=0.014 Score=63.82 Aligned_cols=70 Identities=17% Similarity=0.280 Sum_probs=47.6
Q ss_pred cccccccceeEEEEEECCc--------eEEEEEEcccCCcCHHHHHHHHHHHhhccCCCee-eEEEEEeCCCCcEEEEEe
Q 001171 843 NVLSRGRYGLIFKASYQDG--------MVLSIRRLRDGTIDENTFRKEAEALGKVKHRNLT-VLRGYYAGPPDVRLLVYD 913 (1133)
Q Consensus 843 ~~lg~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~lV~e 913 (1133)
+.|+.|-.=.+|++...++ +.|.+++.. +........+|.++++.+.-.+++ ++++++.+ ..|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG-----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----ceEEE
Confidence 5677888889999987543 455655554 333445667899999988533444 66666542 68999
Q ss_pred ccCCC
Q 001171 914 YMPNG 918 (1133)
Q Consensus 914 ~~~~g 918 (1133)
|++|.
T Consensus 122 fi~g~ 126 (395)
T d1nw1a_ 122 YIPSR 126 (395)
T ss_dssp CCCEE
T ss_pred Eeccc
Confidence 99874
|